HIV,NEOPLASMS,PCR
198,222,DIED,HEMOSTASIS,RESISTANT
AFTER,CHOL,D53A,DOTAP,PCNA,SPC,SVV,TUNEL,WESTERN
WHILE
001,114,2015,2283,243,BACKGROUND,BASED,COLORECTAL,CONCLUSION,COX,CXR,GOVERNMENT,HRS,INTERVIEW,LABEL,LDCT,LUNG,METHODS,NEXT,NHIS,OVARIAN,PLCO,PRESS,PUBLISHED,RESULTS,SCREENING,TRIAL,UNIVERSITY
HOWEVER,NON,NSCLC,TODAY
EVERY,STILL
177,BACKGROUND,EBUS,LABEL,MEDICAL,MEIR,METHODS,SIDE,SIXTEEN,THERE,THREE
2003,2013,CHEST,JOURNAL,LUNG,SCI
AFTER,CURRENTLY,DESPITE,FOUR,HCC,SEVEN,TACE,THREE
CASE,HOWEVER,PTX,STAGE
DESPITE,GEFITINIB,STAGE,THEREAFTER
160,DEBATES,HOWEVER,INITIALLY,OBESITY
99M,CORE,DUE,HYNIC,LATER,SPECT,TOC
DUE,HOWEVER,ZDA
1975,549,956,DYSIDEA,ESI,IC50,NMR,NONE,THEIR,VIETNAMESE
177,239,BACKGROUND,CRP,HOWEVER,LABEL,METHODS,PENTRAXIN,PTX3,RESULTS
AFTER,AWS,BENTALL,EXCHANGER,NEXT,SOFT,TUBE
009,106,201,AIM,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SUBCARINAL,THESE
2011,2014,AIM,BACKGROUND,BOTH,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVENTY,WHILE
AFTER,SPO2
ANOVA,BACKGROUND,CRP,DATA,ICU,LABEL,METHODS,POD,RESULTS,THERE,VATS,WBC
100,177,215,2MM,CONCLUSION,DISTANCES,DTA,ECLIPSE,FIVE,IMRT,LABEL,METHODS,NOVALISTX,PTW,RESULTS,SEVEN29,SSD,SSDS,SURFACE,TPS,TREATMENT
001,013,014,037,049,0682,125,177,187,219,221,2838,3994,6096,808,853,898,AUC,FINALLY,HOWEVER,LABEL,MAS,METHODS,MGRD,MRGD,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,ROC,TNM
946,CONCLUSION,CSCS,FACS,LABEL,LUNG,METHODS,OBJECTIVE,OCT,PCR,PURPOSE,RESULTS,THEN,WESTERN,WNT
ALSO,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PCNA,PURPOSE,RESULTS,TNM
007,008,018,024,030,136,177,596,BASED,CEA,COLORECTAL,CONCLUSION,CRC,CRCS,EMERGENCY,HOWEVER,LABEL,METHODS,MPV,NLR,OBJECTIVE,PURPOSE,RDW,RESULTS,THERE
003,2455,2731,276,284,469,704,853,898,BMI,CONCLUSION,DFS,LABEL,METHODS,OBESE,OBESITY,OBJECTIVE,PURPOSE,RESULTS,THERE
002,057,290,292,8805,AMONG,BACKGROUND,BRISTOL,CHECKMATE,IGG4,LABEL,METHODS,MYERS,NIVOLUMAB,NSCLC,OVERALL,RESULTS,TREATMENT
100,945,946,956,964,CANDIDA,CLEVENGER,DIOSPYROS,FID,MIC
177,BACKGROUND,CPEX,FIFTEEN,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VO2
014,036,946,HOXB7,MMP,MTT,SMAD3,TAKEN,TGF,TRANSWELL,VEGFA
113,146,354,AMONG,BASED,BESIDES,DFS,FIRST,HER2,III,NANTONG,NUCLEAR
18F,690,BECAUSE,D690,DISCOVERY,DSTEP,ELITE,FWHM,HOWEVER,NEMA,OSEM,PET,PSF,SUV,THEN,THUS,TOF
CSF,DIAGNOSES,DUE,HODGKIN,PNS
ACCORDING,KUDO,MOST,PROF
CD10,HOWEVER
137,2011,2013,366,413,8544,8545,8546,8547,965,JANUARY,JUNE,POST,THREE
100,956,BOTH,GST,HOWEVER,MNO,PCR,PEG,ROS
177,956,985,AES,H460,IC50,ICP,NCI,NMR,PAMAM,TEM,THEREFORE,VIS
BACKGROUND,CASE,CONCLUSION,EGD,LABEL,METHODS,MSCI,UNDERGOING,USING,VATS
2016,280,AGREEMENT,ALSO,BACKGROUND,END,LABEL,METHODS,PATHOLOGIC,RESULTS,TNM
ADHESIONS,BACKGROUND,CABG,EIGHT,LABEL,LAD,LIMA,MEAN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
PRESENTED
HIGH,MRI,SPIO,SPIOS
CMV,DOX,EXPRESSION,HELF,PCR,TAP73,TUNEL
CHEST,SCLC
100,956,AFFYMETRIX,AKT,BEAS,BMP,CANONICAL,DEGUSSA,IGF1,INGENUITY,IPA,KRAS,NRF2,PATHWAY,PI3K,RAS,TIO2
AFTER,CD56,ESOPHAGEAL,IVA,LNS,NEC,NSE,STAGE
093,2008,2010,318,411,527,726,811,BETWEEN,GROUP,JAPAN,JLCRG,LUNG,MARCH,UFT
2014,BETWEEN,CDTM,EGFR,GRADE,HOWEVER,MAY,NSCLC,OCTOBER,TKI,TKIS
169,2015,COPYRIGHT,DRUGS,INC,ONGOING,PROGRAMMED
001,003,006,009,022,169,2015,32X10,35X10,467,591,72X10,BACKGROUND,CH12Q24,GAME,GECCO,GWAS,INSTITUTE,LABEL,METHODS,NETWORK,PRESS,PUBLISHED,RESULTS,SH2B3,UNIVERSITY
140,169,2015,AUTHORS,BONE,EXPRESSION,FGF23,LIMITED,PRESS,THESE
INC,LUNG,PUBLISHED,SCREENING
ASSOCIATES,BAPTIST,FLORIDA,PART,RADIOLOGY,SOUTH
ASSESSMENT,BANQIAO,EPA,ICP,MODEL,RISK,XUANWEI
0003,0006,001,006,4949,8202,8805,EGFR,FURTHER,GRADE,III,NINE,NSCLC,SEVERAL
1997,2014,8202,FDG,HALF,HOWEVER,JANUARY,MEIER,MOST,PATIENT,PET,PPSS
947,AFTER,ENGLISH,HCC,HEHE,IMAGING
2012,2014,CARDIAC,CHINA,JANUARY,PULMONARY,PVS,THREE,UNIVERSITY,VEINS
002,178,2014,351,594,BMI,CHINESE,CONCLUSION,KNOWLEDGE,LABEL,META,METHODS,OBJECTIVE,RESULTS,SCHOLAR,SEPTEMBER,SEVEN,TIME,WANFANG
129,132,145,1999,2013,BIOMEDICAL,CBM,CHINA,CHINESE,CNKI,CONCLUSION,DATABASES,ETS,JANUARY,KNOWLEDGE,LABEL,LITERATURE,META,METHODS,OBJECTIVE,QUALIFIED,RESULTS,SCIENCE,STRATIFIED,VIP,WANFANG,WEB
C60,CYTOTOXIC,DOX,LEWIS
BASED,LUNG
1948,1958,239,LIFE,LOST,MAYAK,POTENTIAL,YEARS,YPLL
001,0069,0263,149,169,185,2015,378,399,807,8804,BACKGROUND,CD3,CONCLUSION,COX,EPIC,FOXP3,HEIDELBERG,HOWEVER,HRS,IMMUNOCRIT,LABEL,LABORATORY,METHODS,PRESS,PUBLISHED,REGARDING,RESULTS,UNIVERSITY
169,2015,2096,BACKGROUND,COMPARISON,CONCLUSION,CONTINUED,COX,DATA,EVALUATION,HOWEVER,LABEL,METHODS,METRICS,NSCLC,PRESS,PUBLISHED,RESULTS,SOLID,UNIVERSITY
001,007,012,013,020,036,161,CCRT,CONCLUSION,COX,DFS,FDG,III,IIIA,LABEL,MATERIALS,MEIER,METHODS,MTV,NSCLC,OBJECTIVE,OVERALL,PET,RESULTS
001,016,024,193,2010,2014,405,AFTER,CHRONIC,CONCLUSION,COPD,DISEASE,FEV1,FOUR,FVC,INITIATIVE,JANUARY,LABEL,LOWER,LUNG,MARCH,MATERIALS,METHODS,OBJECTIVE,RESULTS,THEREFORE
122,BACKGROUND,BRAF,CHESTER,ERDHEIM,GENENTECH,LABEL,LANGERHANS,METHODS,RESULTS,ROCHE,THERE,V600
001,003,027,041,123,197,2006,2011,415,437,514,781,8202,916,967,982,984,BANK,BIO,COX,DFS,DIFFERENCE,HOWEVER,III,JANUARY,NSCLC,OPIOIDS,PROVINCIAL,UNIVARIATE
PHYLLODES,RENAL,SURGERY,TREATMENT
001,097,153,773,8202,BIM,DATA,DCR,DCRS,EGFR,ELECTRONIC,HOWEVER,NSCLC,ORR,ORRS,PFS,TKI,TKIS
ELDERLY,HOWEVER
MALIGNANT,REGARDING,THERE,THUS
ALK,EGFR,FURTHER,HOWEVER,SEVERAL,TKI,TKIS
OPTIMIZED
AIM,ALPHA,AMACR,BACKGROUND,COA,CONCLUSION,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,OVERALL,RESULTS
001,169,2015,CHANGES,CONTOUR,COPYRIGHT,DICE,DIR,INC,LABEL,LUNG,MEASURING,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RIGID,THERE
139,154,169,2015,COPYRIGHT,CROWN,DISTANT,EASTERN,FDG,GROUP,IMAGING,INC,LABC,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PUBLISHED,PURPOSE,RESULTS
169,2015,8805,ADDITIONAL,AES,COPYRIGHT,EASTERN,FIFTY,GROUP,INC,LABEL,MATERIALS,METHODS,MTD,NSCLC,OBJECTIVE,PRECISION,PURPOSE,RESULTS,THERE,TREATMENT
011,028,032,033,102,108,109,118,138,169,170,172,2003,201,2010,2015,2345,260,303,8804,ACT,BETWEEN,CONTINUED,COPYRIGHT,CSI,DLCO,EBT,FEV1,FVC,INC,IQR,JUNE,LABEL,MARCH,METHODS,OBJECTIVE,PFT,PFTS,PULMONARY,PURPOSE,RESULTS,THERE,THESE,TLC
BACKGROUND,CURRENT,LABEL,METHODS,PULMONARY,RESULTS,SOCIETY,THERE
001,169,338,365,BCS,COPYRIGHT,GATA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ODDS,PATHOLOGY,PLCS,RESULTS,SOCIETY,TFF1,THEREFORE
100,115,117,169,183,2001,2012,2015,232,BACKGROUND,COPYRIGHT,EDUCATION,FUNDING,GERMANY,IIIA,INNOVATION,LABEL,LTD,METHODS,RESULTS,SERI,STATE,SWISS,THOSE,THREE
160,916,946,956,968,A549,BILIRUBIN,CONCLUSION,DAILY,LABEL,MAIN,METHODS,OBJECTIVE,PACO2,PAO2,RESULTS,SETTING,SHAM,SPRAGUE
19DEL,2011,ACCORDING,CONCLUSION,EGFR,L858R,LABEL,LUNG,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SOCIETY
216,270,282,284,350,566,604,ALK,AMONG,D5F3,EGFR,FIVE,IHC,III,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VENTANA
2008,2013,JANUARY,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,THERE,UNIVARIATE
177,2005,2013,2014,8805,ACADEMY,CHINESE,COLLEGE,CONCLUSION,DEC,FEDERATION,FIGO,GYNECOLOGY,IB1,IB2,IIA,IIA1,IIA2,JAN,JUL,LABEL,LVSI,MEDICAL,METHODS,NECUC,OBJECTIVE,OBSTETRICS,PATHOLOGIC,PFS,RECURRENT,RESULTS,TEN,UNION
2001,2010,236,911,BSS,CARE,EOL,INDIVIDUAL,INSURANCE,MEDICAL,MRI,PET,TAIWANESE,UNDERGOING
016,143,150,2005,2011,293,356,7TH,8202,ACCORDING,APM,COMMITTEE,DFS,EFFECTIVE,EVEN,GREATER,HOWEVER,JANUARY,JOINT,JUNE,LUNG,NSCLC
000,114,2015,398,456,580,649,8202,933,974,APRIL,CIS,COCHRAN,DATA,ECM,GALBR,HOWEVER,III,ORS,POTENTIAL,SIX,SMD,SMDS,STUDIES,THUS
001,2007,2013,259,343,399,412,473,8202,8805,949,JANUARY,JUNE,MEIER,NSCLC,PATIENT
160,169,2015,COPYRIGHT,INC,MTT,NSCLC,PCR,RIP,TDP
0019,036,1997,2015,BASED,COPYRIGHT,EMA,FGF,HOWEVER,III,LUME,LUNG,NINTEDANIB,PDGFR,PHASE,PROUS,SCIENCE,THERE,VEGF
169,2015,CSF1,FLT1,FMS,MAM,MAMS,QIAN,THUS,USING
AFTER,BILATERAL,LAPAROTOMY
PRIMARY,YST,YSTS
CSF,MRI,NEOPLASTIC,PET
00001,0001,0005,002,8202,9703,AAS,CIS,ELECTRONIC,HRS,III,NSCLC,OTHER,RCTS,TCC,TOXICITIES
GIVEN,PRIMARY,VATS
HER2,MUIR,SEBACEOUS,THREE,TORRE
2004,2011,542,BACKGROUND,FINNISH,LABEL,METHODS,RESULTS,THERE
MANAGEMENT,OPEN
IIIA,THESE,THUS


THUS
956,A549,ADDITIONAL,ASPC,FOUR,GI50,HEP3B,IC50,STAT3
2013,HISTOLOGIC,SURGERY,UNIT
0001,2011,266,2962,912,946,EGFR,EIGHT,III,IIIB,NSCLC,OPTIMAL,PFS,STUDIES,THESE,THUS,TKI
ALK,BRAF,EGFR,EML4,FLT,G469R,KIT,LUNG,NSCLC,PDGFR,RAF,RET,ROS1,SORAFENIB,VEGFR
00084,0029,013,169,2015,215,485,BACKGROUND,CCP,COPYRIGHT,COX,FIVE,LABEL,LTD,METHODS,MORTALITY,NOVEL,PCR,PRIMARY,RESULTS
169,2015,COPYRIGHT,HISTOLOGIC,INC,PUBLISHED,SOCIETY
160,169,2008,2015,AFTER,COPYRIGHT,INC,MALT,MOST,PRIMARY,PUBLISHED,PULMONARY,SOCIETY
956,BACKGROUND,CONTEXT,DATA,FIBER,LABEL,METHODS,OBJECTIVE,SIMILAR,SIMILARLY,SOURCES,THERE
BACKGROUND,CONTEXT,DATA,LABEL,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,SOURCES
THESE
109,120,169,197,2015,235,238,289,339,938,BASED,BRAF,COPYRIGHT,EGFR,ENTROPY,IDH1,INC,JAK2,KIT,KRAS,NGS,NRAS,PTEN,SEQUENCING,SHANNON,STTS,THERE
945,947,ACCORDING,AMONG,CD16,CD25,CD3,CD4,CTL,ELISA,FCM,IFN,INJECTION,LDH,MTT,PHA,TANREQING,TNF,TREG
945,946,947,CD68,CHINESE,CONCLUSION,DDP,EFFORTS,ELISA,FUZHENG,IFN,INTERVENED,LABEL,LEWIS,METHODS,OBJECTIVE,RESULTS,TAMS,TCM,TGF,TNF
945,946,AKT,CELASTROL,CHINESE,GSK,PCR,PDK1,RAF,THEREFORE,WESTERN
ASIAN,CAP,CD143,CIS,CNKI,FEM,ODDS,ORS,SCHOLAR,SNP,THERE
CONSORTIUM,IDRI,IMAGE,INITIATIVE,LIDC,LUNG,MCNN,MULTI,TOMOGRAPHY
GIVEN,HASHING,HOWEVER,THEREFORE
169,2015,COLD,GENOMIC,LABORATORY,LUNG,PRESS,PUBLISHED,SCLC
169,2015,33342,7901,AMONG,ANNEXIN,BACKGROUND,CDK4,CDK6,CELL,CONCLUSION,COPYRIGHT,FITC,GASTRIC,GMBH,HOECHST,LABEL,METHODS,MTT,OBJECTIVE,PARP,PHASE,PROTEIN,PURPOSE,RESULTS,ROSAMULTIC,SGC
277,CONCLUSION,FOCI,HOWEVER,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,RXWBS,SPECT,THESE,TNM,WBS
AKT,BMP,BMPR,EGFR,HOWEVER,NSCLC,PI3K,SMAD1,SQCC,SQCCS,TARGETING,TKI,TKIS
APT,FURTHER,NUCLEIC,SELEX,USING
169,2015,COPYRIGHT,ERP,INC,SURGERY
169,1995,2011,2015,231,233,CONCLUSION,COPYRIGHT,GRADE,HER2,LABEL,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SAS,SBR,SFAX,SFRO,SOCI
10YEARS,169,2015,231,233,COPYRIGHT,PROGNOSIS,PUBLISHED,RISK,SAS,SFRO,SOCI
AFTER,ANEURYSMAL,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS
122,125,250,CONCLUSION,LABEL,MEAN,METHODS,OBJECTIVE,ONCOLOGIC,PURPOSE,RAPID,RESULTS,SINCE,TRANSIENT,VEGF
00001,0009,009,1995,2014,889,CONTROLLED,FURTHER,HOWEVER,LABEL,LRF,LVI,METHODS,NSCLC,OBJECTIVE,PURPOSE,RCTS,RESULTS,THERE,THESE,VPI
100,CTCS,EGFR,EXPRESSION,LABEL,METHODS,MUC,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS
001,0023,0039,2005,2008,APRIL,DFS,GIVEN,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS
CURRENT,WHETHER
100,150,CESSATION,DLTS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,002,003,004,007,013,021,029,031,038,044,049,8805,AAD,HENCE,HIGH,KI67,LABEL,MEIER,METHODS,MPM,OBJECTIVE,OBJECTIVES,PCI,RESULTS,SPECIMENS,USING
100,1000,122,138,525,945,BEP,FOUR,GERM,HDCT,LABEL,LONGEST,METHODS,NONE,OBJECTIVE,OBJECTIVES,PACLITAXEL,RESULTS,TEN,THESE
122,169,178,194,2015,300,380,381,652,660,8201,ADC,AUC,CA125,CEA,COPYRIGHT,CYFRA21,IRELAND,LTD,NSCLC,SCC,THREE
169,2015,COPYRIGHT,CYP3A,EGFR,FURTHER,GEF,GEFITINIB,GSH,HOWEVER,INC,USING
12P,169,2015,55NM,8320,8322,8325,A549,BAD,BAX,BCL,CDC2,COPYRIGHT,FURTHER,INC,MMP,ROS,TAKEN
169,2015,COPYRIGHT,LTD,PCI,SMALL
2003,2011,215,645,BACKGROUND,BASE,COLLEGE,COMMISSION,DATA,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE
177,947,CALCULATED,CONCLUSION,CRT,DVH,IMRT,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,VMAT
100,133,2004,2014,AFTER,AIM,BETWEEN,JANUARY,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,SEMSS,THERE,ULTIMATELY
113,2005,2012,AIM,BONE,IASI,INSTITUTE,IRCI,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,ROMANIA
BOTH,CEA,CEAS,CONCLUSION,COST,LABEL,LUNG,NLST,OBJECTIVE,SCREENING,TRIAL
ANOMALOUS,COLORECTAL,CONCLUSION,LABEL,LUNG,NLST,OBJECTIVE,OVARIAN,SCREENING,TRIAL
167,AIM,AMONG,CONCLUSION,EASTERN,ECOG,GROUP,HOWEVER,HRV,KOREA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SDNN,SEVERAL,SOUTH
AIM,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVEN
101,177,1ST,2013,2014,EBUS,FEWER,FIFTY,HENCE,MOST,OCTOBER,REASONS,SEPTEMBER,TBNA,THESE
FDG,FINALLY,MRI,PPDLBCL,PRIMARY
18F,2011,2013,224,229,740,780,788,808,843,853,875,897,925,EGFR,JANUARY,SCN,SCNS,SUV,THERE
LUNG,MRI
AFTER,FOLLOWING,THUS
ASCO,CINV,GUIDELINES,HOWEVER,HT3,NK1,SOCIETY,THEREFORE,THESE
2009,2012,8805,CCR,GIFU,GRADE,MAY,NON,THERE,THEREFORE,THUS,UNIVERSITY
1ST,AFTER,CHEST,MHE,THREE

ACTH,CUSHING,PULMONARY

THERE
120,2ND,AFTER,DOSE,EGFR,LEUCOVORIN
CLINICIANS,EGFR,PCI,TKI
549,841,956,CCD,CON,IC50,MRC,UACC,WHILE
000,099,100,1261,181,193,1997,2002,2005,2012,236,449,453,464,507,AMONG,CALIFORNIA,COHORTS,CRUDE,EVER,EXPOSURES,HODGKIN,IMPORTANCE,JUNE,LABEL,MAIN,METHODS,OBJECTIVE,PERMANENTE,RELEVANCE,RESULTS,SETTING,STUDIES
160,169,18F,2015,COPYRIGHT,FIFTY,FLT,HOWEVER,INC,KNOWLEDGE,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,USING
100,160,169,2015,CONCLUSION,COPYRIGHT,GRADE,HDR,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,THERE
000,8764,CD161,CIBERSORT,FOXM1,HOWEVER,KLRB1,MOLECULAR
ACCESSORY,AFTER,BACKGROUND,CASE,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,METHODS,PRIMARY,THERE
224,945,DESPITE,ERK,HOWEVER,INCREASED,LOCAL,LUNG,NSCLC,SMAD4,TNF,TNFAIP1
160,169,2015,680,956,AIR,COPYRIGHT,FVB,HISTOLOGY,INC,KUPFFER,MBS,NIR,OCCASIONAL,PVA,VIVOTAG
CONCLUSION,DOPPLER,LABEL,PAS,PRIMARY,PTE,UNLABELLED
135,169,COPYRIGHT,LABEL,METHODS,NUCLEAR,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY
013,038,046,140,169,2009,2013,2015,AFFILIATED,BOTH,FIBULIN,HOWEVER,LABEL,METHODS,NANTONG,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY,WESTERN
111,177,8201,ACTUARIAL,CONCLUSION,DOSE,DSS,GRADE,KNOWLEDGE,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,SBRT,SECONDARY,TREATMENT
ADVANCE,CBCT,CONCLUSION,ITV,LABEL,METHODS,OBJECTIVE,RESULTS,STUDIES
15Q15,169,17Q24,2015,MGMT,OVERALL,SNP,UBR1
0001,00018,037,125,127,268,607,BACKGROUND,CEA,CYFRA,LABEL,LAMC2,METHODS,NON,NSCLC,PROGNOSTIC,RESULTS,SCC
003,004,005,120,169,2000,2012,2015,8201,8805,AMONG,BACKGROUND,CONCLUSION,COX,DFI,INC,LABEL,MEIER,METHODS,PULMONARY,RESULTS,WHILE,WILEY
169,2015,AUTHORS,BCL,BH3,COPYRIGHT,FOLLOWING,INC,MYC,PUBLISHED,TAXOL,THESE,USING
160,169,2015,COPYRIGHT,EPIGENETIC,GSK2879552,INC,LSD1,SCLC
160,169,2015,CELL,COPYRIGHT,INC,INHIBITION,LSD1,SCLC
150,169,2015,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,EVALUATION,FOUR,HOWEVER,LABEL,LOW,LTD,METHODS,NSCLC,RESULTS,SOLID,TREATMENT,TUMOURS
BACKGROUND,CASE,CONCLUSION,HIGH,LABEL,MALIGNANT,MEST,METASTATIC,METHODS
001,048,150,169,2015,360,CONCLUSION,EGFR,KRAS,LABEL,MET,METHODS,MOST,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY,SOCIETY,TIVANTINIB
0008,0080,0087,160,169,2015,AKT,ALK,CELL,COPYRIGHT,EML4,ERK,H3122,INC,KRCA,PARP,THROUGH
AGING,BACKGROUND,BASED,COPD,DISCUSSION,EXCEPTFOR,HOWEVER,LABEL,METHODS,OVERALL,RESULTS
169,2015,945,946,947,948,ANTICANCER,CD8,COPYRIGHT,HOWEVER,INSTITUTE,JOHN,TH1,THESE,TREGS
169,2015,8805,916,A549,AIM,ANTICANCER,BACKGROUND,CHOL,COPYRIGHT,DDS,DISCUSSION,DPPC,INSTITUTE,JOHN,LABEL,LPETG,LTBP,MATERIALS,METHODS,N59SRTA,OBJECTIVE,RESULTS,SEVERAL,SRTA,THESE
018,047,178,2011,2014,550,715,940,967,APRIL,BAL,GMG,HOWEVER,JANUARY,OTHER,PCP,PCR,WEGENER
231,361,753,LUNG,RADON,THUS
169,2015,BONE,COPYRIGHT,INC,JAK2,JUNB,MMP2,MMP9,NSCLC,PIM1,STAT3,THESE,TTP,XCL1,XCR1
134,169,2015,COPYRIGHT,ERK1,H69,INC,LACTATE,LDH,MICRORNAS,MIR,MTT,NSCLC,PCR,SCLC,THESE,WWOX
169,2015,COPYRIGHT,IRELAND,LTD,MSC,MSCS,POTENTIAL
AVASTIN,CETUXIMAB,EWING,PNET,PNETS,PRIMITIVE
BASED,BECAUSE,FIVE
1047,8202,DCR,EIGHT,META,NSCLC,ORR,TTP
106,109,164,169,177,2015,AAS,COPYRIGHT,EGFR,EPIDERMAL,HOWEVER,IGF,INC

5AS,ARRANGE,ASK,TOBACCO
169,2015,COPYRIGHT,COUNTRIES,IAEA,IRELAND,LTD,OPTIMAL,RTU
169,2015,COPYRIGHT,HOWEVER,IRELAND,KSN,LTD,MES,MICROARRAY,PRIMARY,TNNT1,UTERINE,ZIC1
801D,ADENOVIRUS
CEA,CURRENT,HOWEVER,TABLE
10878,10GY,169,16GY,1MONTHS,2015,39GY,8MONTHS,BACKGROUND,CHT,COPYRIGHT,COX,HIGH,IIIA,IIIB,IRELAND,KPS,LABEL,LTD,MATERIALS,METHODS,NSCLC,PRIMARY,RESULTS,THERE,THEREFORE,TREATMENT
169,2015,500,CHIP,COPYRIGHT,EMSA,EXPRESSION,HEAD,KNOCKDOWN,PRR11,RACE,REMARKABLY,SIRNA,SKA2,THUS
100,160,946,947,956,AP105,AP67,GYY4137,H2S,HOWEVER,NA2S,NASH
215,809,951,A2780,ATM,DOWNSTREAM,I257V,L517P,N447S,NADH,ND5,PF6,ROS,SUPEROXIDE,TIME,WHOLE
169,2015,AML,COPYRIGHT,HELA,INC,LPS,MSC,NKG2D,THESE,TLR4,TOLL
107,132,133,169,183,2012,2013,2014,2015,250,265,500,AFTER,ASIA,BACKGROUND,BETWEEN,COPYRIGHT,DEC,EGFR,EVALUATION,FUNDING,IIIB,IMPRESS,LABEL,LTD,MARCH,MAY,METHODS,NSCLC,OPTIMUM,PACIFIC,RESULTS,SOLID
137,160,2005,2006,2007,2011,AIMS,BACKGROUND,III,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STAGE,THEIR
0020,0077,0103,0427,0551,103,150,157,169,183,201,2015,224,227,392,395,397,398,795,ADVERSE,ASIAN,BACKGROUND,BOEHRINGER,CLINICIANS,COPYRIGHT,EGFR,ERBB,FUNDING,IIIB,INGELHEIM,IQR,LABEL,LTD,LUNG,LUX,METHODS,RESULTS,THERE
005,012,105,139,2011,2013,CONCLUSION,HT3,LABEL,METHODS,OBJECTIVE,PERHAPS,RESULTS,SOCIETY,TREATMENT
042,2005,2011,CONCLUSION,EPIDERMAL,LABEL,METHODS,OBJECTIVE,RESULTS
160,320,8201,954,CNR,CONCLUSION,EMPHYSEMA,FBP,GGO,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SIMULATED,THERE,THESE
169,2000,2010,2015,AMONG,BACKGROUND,CONCLUSION,INC,LABEL,LIMITED,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PDAC,RESULTS,WILEY
156,191,2003,2013,ALSO,APC,ASRS,BACKGROUND,ESTIMATED,INCIDENCE,JOINPOINT,LABEL,MALIGNANT,METHODS,PERCENT,PLEURAL,POPULATION,RATES,RESULTS,SIRS,UMBRIAN
DUE,THUS
PROVING
ABOUT,AKT,BIM,DESPITE,DUSP6,EGFR,ERK1,ETS,GTP,MAPK,MEK,NSCLC,RAF,RAS,REDUCTION,RTK,RTKS,SRC,THEREFORE,THESE,THUS,TKIS
143,169,2005,2011,2015,209,211,420,437,APRIL,CCRT,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PATIENT,PFS,PURPOSE,RESULTS,SEVENTEEN,SOCIETY
169,2015,ALK,ATLAS,COPYRIGHT,EGFR,LTD,SEQUENCING,THESE,TREATMENT
169,2015,AKT,COPYRIGHT,FEDERATION,ILT,ILT4,NSCLC,PI3K,PUBLISHED,SOCIETIES
169,2015,410,AKT,BRD7,COPYRIGHT,FEDERATION,HOWEVER,INHIBITION,MIR,NSCLC,PUBLISHED,SOCIETIES
054,2011,939,993,DATA,LDCT,LUNG,NSLT,ONSC,SCREENING,TRIAL,XRAY
001,049,2012,2014,6TH,APRIL,CONCLUSION,DOPPLER,HOWEVER,IVA,LABEL,LEFT,METHODS,NEITHER,OBJECTIVE,RESULTS,RIGHT,RVFAC,TAPSE,TDI
AMES,BOTH,COMPOUNDS,GYY4137,H2S,MCF7,MOST,PARP,POTENCY,THEIR,WI38
169,2015,ALK,COPYRIGHT,EML4,FINALLY,INC,ROS1,THESE
160,169,2015,ALSO,BACKGROUND,COPYRIGHT,H358,HOWEVER,INC,LABEL,METHODS,PC9,PUBLISHED,RESULTS,SOCIETY
126,156,190,2010,2014,ENB,JUNE,PRIMARY,THESE,UPPER
169,2015,COPYRIGHT,INC,PUBLISHED,SOCIETY,VARIOUS
169,2015,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2015,BRAF,CHK1,COPYRIGHT,DESPITE,INC,KRAS,MK2,THESE

169,2015,946,ACUTE,AKT,AUTHORS,CAS9N,CCP,CME,DYNAMIN,EGF,GSK3,H1299,RPE,THESE
169,193,2015,543,703,AMSTERDAM,BOTH,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RPA,SABR,UNIVARIATE,WORLD
001,110,160,169,193,2015,303,8804,945,946,BACKGROUND,BIOMARKER,BMP,COPYRIGHT,EGF,HGF,IGF,IGFBP,INC,LABEL,LOW,MANN,METHODS,NSCLC,PLGF,PUBLISHED,RESULTS,SDF,SOCIETY,THESE,TNF,VEGF,WHITNEY
ANTI,BACKGROUND,LABEL,METHODS,RESULTS,SCLC,SMALL,THEREFORE
945,BACKGROUND,CX43,FMS,LABEL,METHODS,RESULTS
BMJ,BRITISH,GROUP,LIMITED,PUBLISHED,PUBLISHING,SOCIETY
LUNG,PALLIATIVE
100NM,169,2015,24H,5GY,945,AIMS,AKT,CL1,COPYRIGHT,HIF,HLAC,INC,KEY,LABEL,MAIN,METHODS,MTT,OBJECTIVE,PI3K,PTX,RESULTS,TUNEL,WESTERN
169,2014,2015,209,APRIL,AUSTRALIA,CONCLUSION,DIAGNOSIS,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PULMONARY,RESULTS,SIXTY,SOCIETY,SPECT,THERE,THREE,UNLABELLED
177,215,6XFFF,8201,CONCLUSION,FFF,KNOWLEDGE,LABEL,METHODS,NTCP,OARS,OBJECTIVE,PLANS,RESULTS,SBRT,STAGE,TREATMENT
439,668,AID,ASXL1,BACKGROUND,BCOR,DARWINIAN,GRANT,HOWEVER,LABEL,METHODS,MUTATIONS,PIGA,RESULTS,SCIENTIFIC,SOMATIC
2015,ACADEMY,COPYRIGHT,CSD,ETHICAL,HOSPICE,JOURNAL,MEDICAL,PAIN,PALLIATIVE
102,160,215,224,300,354,GENOMIC,GIVEN,HOWEVER,MENDELIAN,SIMILAR,SINCE
1996,2011,4259,876,8805,AGE,BASED,COPD,CRC,INSURANCE,SIR,SIRS,SPM,SPMS
001,0339,1000,157,2007,2010,297,444,628,740,8202,8805,AFTER,CAP,IDS,INCIDENCE,INSURANCE,IRR,LESS,MEIER,NHIRD,POISSON,PYS
176,177,185,7429,FDG,IMAGE,PET,PHYSICIANS,ROBOT,SBRT,STATE
000,160,169,2015,945,BACKGROUND,COPYRIGHT,FIFTY,FOUR,INC,LABEL,METHODS,MOLECULAR,PUBLISHED,RESULTS,SURGERY
946,CD4,CD8,LUNG
ANAPLASTIC,BACKGROUND,CASE,CONCLUSION,IMAGING,LABEL,METHODS,VIDEO
ARRY,AZD6244,BACKGROUND,CONCLUSION,DIFFERENT,G12C,G12V,IIIB,KRAS,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS
0001,101,8201,AUC,BACKGROUND,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,THERE
215,246,454,529,AKT1,APPLIED,BACKGROUND,BRAF,CONTEXT,EGFR,ERBB2,HRAS,INDIANA,KRAS,LABEL,METHODS,NRAS,OBJECTIVE,PTEN,RESULTS,ROCHE,SCIENCE
150,169,2015,956,ATLAS,CONCLUSION,EGFR,LABEL,LUNG,METHODS,NOD,NSCLC,OBJECTIVE,PATIENT,PDX,PDXS,PURPOSE,RESULTS,SCID,SOCIETY,SURGICALLY,TKI,TKIS
0077,0084,169,2015,315,321,ADDITIONAL,AFTER,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
139,169,2011,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,RESULTS,SMALL,TNM
111,161,169,198,2015,AIM,ANTICANCER,COMPARING,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,SPECT,SRS,TOMOGRAPHY
169,2007,2013,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,CPB,ILD,INSTITUTE,JOHN,JULY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2001,2010,2015,569,AFRICAN,AGE,AMERICANS,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,INSTITUTE,INSURANCE,JOHN,LABEL,LUNG,MEIER,METHODS,RESULTS
169,2010,2014,2015,215,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,MEV,MPM,OBJECTIVE,RESULTS,THREE,UNTIL
000,001,169,2015,661,675,747,AIM,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,END,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS,SEER,SIR
001,169,177,2010,2015,AIM,ANTICANCER,BACKGROUND,BCE,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,JUNE,LABEL,MBDLC,METHODS,NTX,OBJECTIVE,RESULTS,THERE
169,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,EPIDERMAL,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MUTATIONS,NSCLC,RESULTS,SWEDISH,TKI,WESTERN
0017,0045,169,2015,358,716,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,IIFESTYLE,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TAIWANESE,XRCC3
025,169,2002,2012,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,EGFR,G719S,G719X,G874S,INSTITUTE,JOHN,JUNE,L858R,L861Q,LABEL,MARCH,METHODS,NON,NSCLC,OBJECTIVE,PFS,RESULTS,THREE,TKI,TKIS,TREATMENT
169,2015,963,ANTICANCER,BRCA1,COPYRIGHT,DAPI,H2A,H460,HISTONE,INSTITUTE,JOHN,MDC1,MGMT,NCI,S140,TAKEN,THUS
215,8901,SEVERAL,THEREBY,THESE
148A,8764,HOWEVER,MICRORNAS,MMP15,NSCLC,RHO,RNAS,ROCK1,THESE,TNF,TRAIL
169,2015,ALK,HOWEVER,NSCLC
950,ARG,BACKGROUND,CD11B,CD33,CFSE,CHRONIC,COPD,ELISA,HLA,LABEL,LIN,MDSCS,METHODS,MYELOID,RESULTS,TCR,THESE
033,036,054,382,III,THROUGH
001,CONCLUSION,COX,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM,USP9X
169,2015,231,233,COPYRIGHT,FRAN,PUBLI,PUBLISHED,SAS,SOCI,TOUS
169,2015,231,233,COPYRIGHT,FRAN,PUBLI,PUBLISHED,SAS,SOCI,TOUS
169,2015,231,233,ALK,CELL,COPYRIGHT,EFGR,EGFR,FRAN,FREE,HEAT,HOWEVER,HSP,IFCT,INHIBITORS,INTERGROUP,LUNG,NON,NSCLC,PFS,PROTEIN,PUBLI,PUBLISHED,ROS1,SAS,SHOCK,SMALL,SOCI,STRATEGIES,THESE,TKIS,TOUS
300,BACKGROUND,CASA,HOWEVER,IHC,LABEL,METHODS,MYC,NSCLC,PREDICTIVE,RESULTS,THEN,THESE,TMA,USING
124,196,3A9,BACKGROUND,CEA,CK18,CONTROL,CURRENTLY,III,LABEL,METHODS,NSCLC,POST,RESULTS,SERUM,UICC,UNION

174,BAYER,BOTH,LOW
129,160,169,2015,COPYRIGHT,HCC,INC,PAK5,TAKEN
169,2015,3DPET,4DCT,4DPET,665,716,733,750,CONCLUSION,COPYRIGHT,EVALUATION,FDG,INTER,IRELAND,ITV,ITVS,LABEL,LTD,METHODS,OBJECTIVE,PET,PTVS,PURPOSE,RESULTS,SBRT
AQ4N,B16,KHT,THESE
169,2015,946,954,BIOLOGY,DBEQ,FINALLY,FURTHER,INC,K11,K48,LPS,MOLECULAR,NFKB2,NPL4,PAGET,PARTIAL,SCF,SOCIETY,TRCP,UFD1
035,169,2015,312,353,355,ACCORDING,ALLELIC,AMONG,ASIAN,BPH,COPYRIGHT,DUE,GENOTYPING,HRM,INC,MINOR,PCA,PCR,PSA,RFLP,SAME,SERBIAN
2000,CD59,CONCLUSION,GLC,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PCR,RESULTS
169,2015,ACADEMY,CRMP5,EATON,GABAB,GAD65,HUD,LABEL,LAMBERT,LGI1,MA2,METHODS,NEUROLOGY,NMDA,OBJECTIVE,OTHER,PNDS,RESULTS,SCLC,SERUM,SOX2,VGCC,VGKC
169,2015,ABCC1,AUTHORS,EXPRESSION,H69,JOURNAL,LOW,MICRORNAS,MRP1,PATHOLOGY,RNAS,SCLC,THERE,UTR
2008,2012,BASED,CHINA,KOREA,OBC
001,022,036,169,2015,277,304,503,547,590,593,599,624,640,682,988,BACKGROUND,COPYRIGHT,COX,INC,LABEL,METHODS,NLR,NSCLC,PLR,RESULTS,SIX
100,169,2015,8805,CCRT,CEST,CONCLUSION,COPYRIGHT,GROUP,IMRT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,STRIKINGLY,THERAPY,V45,V55
131,138,156,169,2015,229,256,372,ACCORDING,AMONG,BACKGROUND,CONCLUSION,CONTEXT,DATA,DTC,FACTORS,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS,SOCIETY,WBS,YOUNGER
2013,EGFR,ERLOTINIB,MARCH,SMOKING,TKIS
169,2015,A549,ABL,COPYRIGHT,FAK,INC,INULA,NSCLC,SRC,TAKEN,VEGF,VEGFR
HOWEVER
001,005,106,1995,2013,2014,8201,947,EIGHT,FIFTEEN,GAD,GAD65,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,PNS,PREDICTORS,RELEVANCE,RESULTS,SETTING
19A,19B,945,A549,EMT,HOWEVER,PTEN,TAKEN,TNF
169,2015,6MM,7MM,BACKGROUND,CBCT,CBCTS,COPYRIGHT,FIVE,FORTY,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
125,169,183,2003,2012,2015,956,APRIL,BACKGROUND,COPYRIGHT,DEPARTMENT,DUE,FUNDING,FURTHER,INSTITUTE,LABEL,LTD,METHODS,RADIATION,RESULTS,SECONDARY,SIMON,THUS,UNIVERSITY,YORK
169,2015,474,4T1,AUTHORS,COPYRIGHT,IRELAND,LTD,PRLR,PRLRS,PUBLISHED,USING
001,004,005,006,016,019,040,046,160,169,2015,BACKGROUND,CD34,CHICAGO,COPYRIGHT,HSF1,IBM,INC,LABEL,METHODS,MVD,NSCLC,PUBLISHED,RESULTS,SOCIETY,SPSS,STATISTICS,THEIR,THESE
160,169,2015,ASP,BAX,BCL2,CADM1,COPYRIGHT,FOXA2,GLU,HDAC1,HDAC3,HOWEVER,HSP,INC,LUNG,NR0B2,THESE
CAD,CELL,CTR,EWING,MC3T3,THESE
169,2015,8594,BEAS,CCC,CCG,CGC,CHRONIC,COPYRIGHT,HOWEVER,III,INC,MECHANISMS,SELECTION,SER15,TCG,THESE
100,153,186,783,ATLAS,BSND,FINALLY,RCC,RCCS,TCGA,THESE
0001,4308,4599,ASIAN,AVAIL,COMBINING,DISEASE,ECOG,III,JO19907,NSCLC,RANDOMIZED,RESULTS,SAIL
1964,2000,2001,2009,2011,2012,INSTITUTE,JOINPOINT,OVERALL,PANAMANIAN,REGRESSION,STATISTICS
1996,1999,2005,2008,AMONG,EGFR,LUNG,OVERALL
021,HOWEVER,IIIA,NSCLC,PET,RFS,SIX
18F,FDG,NSCLC,PET,RFA
016,100,149,215,407,508,8201,8805,CONCLUSION,FIRSTLY,GGNS,IPA,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,THEN,USING
100,169,2015,99M,CONCLUSION,CURRENT,FREE,IMAGING,INC,KNOWLEDGE,LABEL,MAA,METHODS,MOLECULAR,NMI,NUCLEAR,RESULTS,SOCIETY,SPECT,THREE,UNLABELLED
001,0047,169,2015,239,BACKGROUND,CELL,DEPLETION,E2F,E2F1,E2F3,E2F4,E2F7,E2F8,HOWEVER,LABEL,MEIER,METHODS,MICROARRAY,PHD,PRESS,PUBLISHED,RESULTS,RING,STUDENT,THESE,UHRF1,UNIVERSITY
000,120,175,200,240,AIM,CONCLUSION,CTS,FATPH,LABEL,LIVPH,LUNPH,MATERIALS,METHODS,OBJECTIVE,RESULTS,SLOW,THREE,TVS
169,2015,764,AKT,APC,ATRX,BON,BON1,BRCA1,COPYRIGHT,DAXX,EP300,EXCAVATOR,FOUR,GATK,GNAS,H720,H727,H835,INC,KDR,MEN1,NCI,NET,PI3K,QGP1,RB1,STK11,THESE,TP53,TSC2,UMC11,VEGF,YY1
65310,945,AFTER,HOWEVER,PULMONARY
0001,001,DISCOVERY,EGFR,OBJECTIVE
HOWEVER,OTHER,PLANT,REDUCTIONS
160,169,2015,A549,COPYRIGHT,ERBB,ERBB1,ERBB2,FGF,FGFR1,GRG1,GROUCHO,HDAC,HOWEVER,INC,PREVIOUSLY,TSA,VEGF
169,2015,BIOLOGY,CDH1,DNMT1,FURTHER,INC,KIT,LUNG,MOLECULAR,SOCIETY,THESE
003,004,1986,2010,2015,731,909,ADIPOSITY,ALPHA,BETA,BLOOMBERG,COLORECTAL,GOVERNMENT,HOPKINS,INCIDENCE,JOHNS,LUNG,NUTRITION,OVARIAN,OVERALL,PRESS,PREVENTION,PUBLISHED,SCREENING,SEX,THERE,TOCOPHEROL,TRIAL,UNIVERSITY
ACCORDING,COX,FLAVONOIDS,THEIR
MAJOR,MRI,PET
2008,2010,BASED,BOTH,CHINA,DALY,DALYS,DISABILITY,DISEASE,GBD,THERE,YLD,YLDS
000,038,055,060,118,120,130,140,152,154,1990,2010,214,230,235,236,260,280,284,330,360,404,410,429,458,460,600,605,770,8805,926,970,CHINA,CONCLUSION,COPD,DALY,GBD,LABEL,LUNG,METHODS,OBJECTIVE,PAF,RESULTS
000,100,150,169,196,1990,2010,206,269,303,521,529,749,787,830,892,968,CHINA,CONCLUSION,DALY,DISEASE,GBD,LABEL,METHODS,OBJECTIVE,PREVENTION,RESULTS,THEIR,YLD,YLL
5000,946,A549,BACKGROUND,BAECKEA,CIOCALTEAU,CONCLUSION,DPPH,FOLIN,H1299,LABEL,METHODS,MTT,NCI,PENINSULAR,RESULTS
125I,177,197,2001,2010,332,592,997,BETWEEN,CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,OCTOBER,RESULTS,UNIVARIATE
169,2015,8201,BACKGROUND,BRAF,CONCLUSION,GRADE,INC,LABEL,MACCALLUM,METHODS,PATIENT,PETER,RESECTION,RESULTS,THERE,WILEY
7TM,CX3C,FTP,HCMV,US28
100,30C,954,FINALLY,HOWEVER,THUS,TNF,TRAIL
1986,2004,ALGORITHM,ASIAN,BACKGROUND,ENGLAND,GROUP,LABEL,METHODS,NAMES,RESULTS,SOUTH
169,2015,AUTHORS,BUTADIENE,CLARA,COPYRIGHT,INHALATION,IRELAND,LTD,METABOLIC,PBPK,PUBLISHED,PULMONARY,RESULTS,SINCE,TYPE,VOC,WHERE
169,1996,2010,2015,459,461,816,AFTER,AIDS,CONCLUSION,COX,DESPITE,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
AFTER,ATTENUATED,CASE,CHEST,CONCLUSION,DEPENDING,FLAIR,FLUID,INVERSION,LABEL,METHODS,MRI,OBJECTIVE,PATHOLOGY,PLE,PURPOSE,RECOVER,SIX
068,08092,102,169,2015,257,600,64YEARS,800MG,AES,BACKGROUND,CELL,COPYRIGHT,EORTC,GRADE,LABEL,LTD,LUNG,METHODS,NON,NSCLC,PAZOPANIB,PFS,RESULTS,SGPT,SMALL,TKI
160,169,189,2015,614,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PET,PUBLISHED,RESULTS,SIX,SOCIETY,THERE
BECAUSE
943,VARIOUS
CD56,CGA,LARGE,SYN,THESE
169,2015,COPYRIGHT,FRA,LPS,PCR,PREVIOUSLY,SOCIETY,TDTG,THUS,WESTERN
169,2015,BIG,OTHER,PRESS,PUBLISHED,RIGID,SUBXIPHOID,SURGERY,THROUGH,UNIVERSITY
169,2015,8201,COPYRIGHT,CSC,IRELAND,LTD,THUS
100,169,177,2015,400,AFTER,CONCLUSION,DRUG,HENCE,HIGH,IFP,IMAGING,INC,LABEL,METHODS,MOLECULAR,NINE,NUCLEAR,PET,PTF,RESULTS,SIX,SOCIETY,TBF,UNLABELLED,VOLUMES
0009,137,169,2015,557,791,8805,ASSESSMENT,CBCT,CBCTS,COPYRIGHT,COX,CRT,D43,HISTOLOGIC,INC,LABEL,MATERIALS,METHODS,NEITHER,NSCLC,OBJECTIVE,OVERALL,PERCENTAGE,PURPOSE,RESULTS
001,013,019,165,169,1999,2010,2015,COPYRIGHT,COX,DATA,FACTORS,GLASGOW,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,RPA,SBRT,SCORE,SEPTEMBER
169,2015,APT,AUNP,COPYRIGHT,DDR2,DISCOIDIN,INC,PEPTIDE,THUS
AFTER,CHEST,UNDER
AFTER,BECAUSE,CHEST,FORTY
169,2015,BRAF,COPYRIGHT,INC,MOFFITT,NSCLC,SEVERAL,V600E
169,2015,945,BOTH,COPYRIGHT,HTO,NSCLC,SOCIETY
947,ATLAS,IFN,THESE,TLR4,TOLL,TP53,WHEREAS
669,AKT,EGFR,ELISA,GFP,HEPATOCYTE,HGF,LABEL,MET,METHODS,MTT,NCTD,NSCLC,OBJECTIVE,PI3K,PI3KP85,PURPOSE,RESULTS,SCID,THESE,THR,TKI,TKIS,WESTERN,XENOGRAFT
177,CD4,CD8,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SIMILARLY,TILS,TIM
001,100,160,169,183,18G,664,COMPARING,COMPARISON,CONCLUSION,GEORG,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMOKERS,STUTTGART,THERE,USING,YORK
018,026,037,046,060,135,177,185,200,286,8202,8304,8313,8804,99M,AFTER,LUNG,MAA,PET,PFS,POST,SIRT,SPECT
8202,METASTASES,NSCLC,PANCREATIC,RCC
1049,8202,CENTRAL,CIS,IIIA,MEDLINE,NSCLC,OPTIMAL,ORS,PFS,SEVEN,THERE
084,160,169,177,2015,CONCLUSION,COPYRIGHT,DEPARTMENT,FIFTY,GERMANY,HALLE,INC,LABEL,METHODS,NK1,OBJECTIVE,PURPOSE,RADIATION,RANDOMIZED,RESULTS,SAALE,UNIVERSITY
001,006,122,169,2015,ACT,BACKGROUND,CONCLUSION,COPYRIGHT,DOCTORS,FACTORS,IQR,IQRS,LABEL,LTD,METHODS,MOST,NSCLC,RESULTS
169,2015,2965,ANALYZING,AUTHORS,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,FIRST,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SRT,TCP
005,2007,2011,CONCLUSION,DEPARTMENT,EXPLORE,HENCE,JANUARY,LABEL,METHODS,OBJECTIVE,RADIOLOGY,RESULTS,SIXTY,TNB
169,2015,AZD9291,COPYRIGHT,EGFR,INC,T790M
100,168,200,350,584,8805,ASSESSMENT,BACKGROUND,CD4,CHEST,CROSS,HIV,LABEL,LDCT,METHODS,PREVALENCE,RESULTS,SMOKING,THREE
BACKGROUND,BRCA1,FINALLY,FURTHER,LABEL,METHODS,RESULTS,THESE
001,400,AFFYMETRIX,ERMS,EXON,IGF2,INSULIN,PPB,RNAS,SAMPLES
TREATMENT
122,169,2015,224,8804,AMONG,LABEL,METHODS,OBJECTIVE,PRE,PRESS,PUBLISHED,RESULTS,T1BN0,UNIVERSITY
8764,HOWEVER,NPS,NSCLC,PEG,PHB1,RNAI,USING
001,0095,135,169,2015,312,AMONG,CANDIDATE,CONCLUSION,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,R331W,RESULTS,SOCIETY,THESE,VALIDATION,WHOLE,YAP1
000,100,161,169,2001,2010,2015,315,925,BIOMEDICAL,BOARD,CDC,CHINA,CONCLUSION,COPYRIGHT,EDITORIAL,GANSU,LABEL,LUNG,METHODS,MORTALITY,OBJECTIVE,PUBLISHED,RESULTS,TREND
0001,001,002,177,281,735,8201,BOTH,CONCLUSION,GTV,GTVS,KNOWLEDGE,LABEL,LNS,METHODS,NSCLC,OBJECTIVE,RESULTS,SCLC
169,2015,A549,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FINALLY,GMBH,KRG,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,RU486,SIRT1,TAKEN,THIRD,WESTERN
169,2015,A549,BPD,EGFR,H460,NCSLC,NSCLC,PDT,RESULTS,SIMILAR,THESE,THUS
100,169,183,2015,600,ASIAN,BACKGROUND,BOEHRINGER,COPYRIGHT,EGFR,FUNDING,GLY719XAA,HOWEVER,IIIB,INGELHEIM,LABEL,LEU858ARG,LEU861GLN,LTD,LUNG,LUX,METHODS,MOST,RESULTS,SER768ILE,THERE,THESE,THR790MET
169,2009,2011,ANN,ARTIFICIAL,BACKGROUND,CEA,CYFRA,FINALLY,HOWEVER,ITALY,KNN,LABEL,LLM,LOGIC,MACHINE,METHODS,MPM,MTX,NEAREST,NEIGHBOUR,NETWORK,RESULTS,SMRP,SWITCHING,TREE
160,293,757,CNS,COMPETING,CONCLUSION,COX,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,UNIVARIATE,WBRT
169,2015,BOTH,FGFR,FGFR2,FRS2,GOLGI
001,016,169,2004,2011,2015,254,BACKGROUND,COPYRIGHT,FIFTY,III,IIIA,INC,LABEL,METHODS,NSCLC,OPTIONS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY,THERE
169,2015,8804,946,956,A549,COPYRIGHT,IRELAND,LTD,MMP,PM10,THESE
033,BMJ,EGFR,GROUP,HOWEVER,LIMITED,MASI,NSCLC,PUBLISHED,PUBLISHING
001,239,947,ACTIVATED,CD25,CD4,FOXP3,FRII,III,IL10,IL17,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PERIPHERAL,REGULATORY,RESULTS,ROR,SAMPLES,TREG,TREGS,USA
169,2015,946,COPYRIGHT,EMT,IRELAND,LRRFIP1,LTD,SILENCING,WNT
169,2015,BARR,COPYRIGHT,EBV,EPSTEIN,FOUR,INC,PUBLISHED,SOCIETY
169,2015,CD3,CD4,CD8,COPYRIGHT,INC,PUBLISHED,SOCIETY,THUS
169,2015,COPYRIGHT,HOWEVER,INC,PUBLISHED,SOCIETY
169,2015,COPYRIGHT,ENGLISH,INC,PUBLISHED,PULMONARY,SOCIETY
ADC,ALDH1,CD133,CSC,CSCS,LOW,NSCLC,SCC,SCLC,THUS
1093,120,1250,169,183,184,2010,2012,2015,203,257,333,388,538,541,545,548,800,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,EASTERN,ECOG,EGFR,ELI,FEB,FUNDING,GROUP,INCLUDING,JAN,LABEL,LILLY,LTD,METHODS,NEITHER,OVERALL,RESULTS
000,065,100,160,188,1976,1980,1992,1993,2002,2008,514,530,845,AMONG,BACKGROUND,BARI,BMJ,BRONI,COR,DIAGNOSTIC,GROUP,ITALIAN,ITALY,LABEL,LIMITED,METHODS,MONFALCONE,MONFERRATO,NAZIONALE,OPERATING,PUBLISHED,PUBLISHING,RENAM,RESULTS,TRIESTE
100,ACCORDING,AFFYMETRIX,ANNOTATION,BACKGROUND,COL10A1,DAVID,DEGS,DISCOVERY,EXPRESSION,FINALLY,GENOMES,GEO,INITIALLY,KEGG,KYOTO,LABEL,METHODS,OMNIBUS,PPAR,RESULTS,TMEM100
BOTH,CAR,CARS,CD19,CRLF2,FINALLY,SHORT,TSLPR
HIGH,LUNG,MMTV,PYMT,TAKEN,UROKINASE
2011,ALK,CRIZOTINIB,DOCKING,EVIDENCES,FDA,HENCE,HOWEVER,NSCLC,THESE
000003177,001,044,150,155,305,310,8201,BACKGROUND,DIAGNOSTIC,EBUS,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,UMIN,UTB
6TH,AFTER,BARRE,BASED,BONE,SEVERAL,UNDER
AFTER,BECAUSE,LATER,PECOMAS,THEREFORE
2318,2338,4656,DFS,HOWEVER,IIIB,NSCLC,SIX,SIXTEEN
002,016,033,102,117,177,8202,ACEI,ACEIS,ARBS,HOWEVER,NSCLC,RASB,RASBS
3RD,BASED,HOWEVER,INTRONR,LEFT,SERUM,SINCE,THEN
169,2015,846,BACKGROUND,COPYRIGHT,DATA,INC,LABEL,MAYO,MEDICAL,METHODS,PUBLISHED,RESULTS,SOCIETY,UNION,UNIVARIATE,UNIVERSITY
158,169,2009,2014,2015,211,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,VATS
021,115,2007,2012,8805,BACKGROUND,BSA,CONCLUSION,EGFR,GEFITINIB,LABEL,METHODS,NSCLC,PFS,RESULTS
AKT,EPIDERMAL,FOXO1,HDAC,HOWEVER,NSCLC,PI3K,TKI,TKIS
126,169,2015,BACKGROUND,CASES,CHRONIC,CLINICIAN,CLINICIANS,COPD,COPYRIGHT,DISEASE,GOLD,INITIATIVE,IRELAND,LABEL,LIMITED,LTD,LUNG,METHODS,NSCLC,OBJECTIVE,PULMONARY,PURPOSE,RESPONSES,RESULTS,SABR,SURGERY,WORLD
2005,2010,2858,3244,AFTER,CARIBBEAN,CONCLUSION,DEEP,JUAN,LABEL,METHODS,REGARDING,RESULTS,SAN,SECONDARY,UNLABELLED,VTE
2012,2014,246,312,ACCORDING,BEAM,BETWEEN,CONE,NOVALIS,OCTOBER,OCTREOTID,PET,TOTAL
BASED,CTV,INSTITUTE,ITV,PTV,PTVS,USING
0001,001,177,185,18FDG,2006,2011,3DCRT,4N1,AFTER,CUP,DSS,GTV,GTVCT,ICT,IMRT,PET,PRIOR,VOLUMETRIC
10878,265,281,546,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,NAB,NSCLC,ORR,PFS,PHASE,QOL,RESULTS,TWIST,USING
000,2005,2007,2900,AOR,BACKGROUND,IMPLANTING,LABEL,METHODS,RESULTS,SEER,WHILE
116,945,946,947,956,BOTH,COMPOUNDS,GRAM,HCT,HRMS,IC50S,MALAYSIAN,MRC5,NMR,THEIR,VITEX,VITEXOLIDE
169,2015,BALB,COPYRIGHT,EXPEC,FOLLOWING,ORAL,SOCIETY,THERE
000,024,160,169,1700,200,2015,ASIA,AUTHORS,CONVERSELY,HOWEVER,JAPAN,LTD,PTY,PUBLISHING,SCIENCE,SUMMARY,THEREFORE,WILEY
163,169,200,2015,8201,8805,ADL,ADVERSE,AMONG,BACKGROUND,CTCAE,EASTERN,GROUP,INSTITUTE,LABEL,MAX2,METHODS,RESULTS,SIXTY,SOCIETY,WITHOUT
215,8201,ARIZONA
169,183,200,2015,956,CELLS,FEBS,MMP,MMPS,MRC,QDS,QUANTUM,SIO2
160,169,2015,COPYRIGHT,INC,NON
160,169,2015,COPYRIGHT,FAK,GEO,HKOS,HOS,INC,KHOS,KNOCKDOWN,KRIB,MEANWHILE,MMP9,SPON1,SPONDIN,SRC,TAKEN,THEN,TREATMENT,U2OS
169,2015,COLLEGE,EAST,FINALLY,PHYSICIANS,ROYAL,THERE,THEREFORE,VARIOUS
100,ACCORDING,GERTSEN,INSTITUTE,OVERALL,THERE
1501,169,177,2015,326,665,8201,956,AVERAGE,CLARK,INC,INTRA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROSWELL,SIZE,THERE,THREE,VATS,WILEY
946,BECAUSE,CERTAIN,CLR01,LYS,THEREFORE
AIMS,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN
017,111,143,151,169,183,2015,206,207,8805,ADT,AVENTIS,BACKGROUND,COPYRIGHT,DOCETAXEL,EARLY,FUNDING,GLEASON,IQR,LABEL,LIGUE,LOCAL,LTD,METHODS,NEITHER,RESULTS
001,008,017,272,AMONG,BACKGROUND,BRISTOL,CHECKMATE,IGG4,LABEL,METHODS,MYERS,NSCLC,RESULTS,TREATMENT
113,134,169,2015,753,AGE,CONCLUSION,COPYRIGHT,DFS,ENDPOINTS,FIVE,GTV,III,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RBE,RESULTS
100,3100,ABI,APPLIED,BIOSYSTEMS,BLAST,CONCLUSION,DAB,DAKO,DENMARK,FFPBS,FFPE,KIT,LABEL,METHODS,OBJECTIVE,PCR,POLYMERASE,PRISM,QIAMP,RESULTS,STATISTICA,USA
001,218,4B5,CEP1,CEPI,CONCLUSION,HER2,INTRATUMOR,LABEL,METHODS,OBJECTIVE,RESULTS,SISH,THERE,THUS,VENTANA
BASED,CONCLUSION,LABEL,METHODS,OBJECTIVE,PMMT,RESULTS
169,2015,954,COPYRIGHT,EGFR,ICP,IRELAND,L858R,LTD,MEIER,RECK,RFS,SPRY2
169,2015,ANTICANCER,COPYRIGHT,FIVE,HOWEVER,INSTITUTE,JOHN,THESE,VATS
169,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,CTA,CTAS,ESO,ESOPHAGEAL,INSTITUTE,JOHN,KITA,LABEL,MAGE,MATERIALS,METHODS,RESULTS,YORK
003,169,2015,8805,ANTICANCER,COPYRIGHT,CRC,GROUP,INSTITUTE,JOHN,LMS,OVERALL,SEVENTY,THERE,THUS
169,2015,AIM,ANTICANCER,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS,SURGERY,THERE
169,2015,ANTICANCER,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,LDLT,METHODS,RESULTS,THREE
169,2015,946,ANTICANCER,BACKGROUND,BASED,CATENIN,CONCLUSION,COPYRIGHT,EGFR,FISH,HMB,HMB45,INSTITUTE,JOHN,LABEL,LAM,LHS,MATERIALS,MCM3,METHODS,RESULTS,THERE
169,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EZR,INSTITUTE,JOHN,LABEL,LAM,LAM1,MATERIALS,METHODS,MYH10,MYLK,PCR,RAPAMYCIN,RESULTS,SVIL,TSC1,TSC2
169,2015,947,ADC,ADCS,CARLO,CONCLUSION,COPYRIGHT,D02,D50,D95,DOSE,INC,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TCP
0004,100,122,160,169,2003,2014,2015,8805,945,946,BED10,COLORECTAL,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SABR
CAUCASIAN,CD4,CD8,EPITOPE,THESE,XAGE
CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
169,2015,AKT,BIOLOGY,EGFR,ERK,FINALLY,GLUT1,HOWEVER,INC,LAD,MEK,MOLECULAR,ONCOGENIC,PI3K,PPP,RAS,RNAI,SOCIETY,TAKEN
169,2015,34A,A549,COPYRIGHT,DEEP,HEPG2,MSA,RNAS,SOCIETY,THESE
169,ACTA,BELGICA,CHIRURGICA,COPYRIGHT,EARLY,INITIAL,VATS,VIDEO
169,ACTA,BELGICA,CHIRURGICA,COPYRIGHT,DIAGNOSIS,GCCL,SBO,SMALL,THEREFORE
177,219,242,250,252,494,995,AIMS,BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS
BECAUSE,BLOOD,ESBL,THEREFORE
100,LUNG,YEARS
673,AMONG,ASIAN,LIBRARY,NSCLC,OVERALL,SCHOLAR,SCIENCE,THERE,WEB
185,8312,FDG,PATHOLOGIC,PET
2605,BLOOD,EGFR,LIBRARY,MEDLINE,NSCLC,PFS,RISK,SERUM,TKIS
2015,COPYRIGHT,III,PROUS,SCIENCE,VEGFR
169,177,2007,2010,2015,24HR,285,BACKGROUND,LABEL,METHODS,MVMM,MVMMS,NUTRITION,OBJECTIVE,PREVALENCE,RESULTS,SOCIETY
IMT,RENAL,WILMS
ALK,CONCLUSION,CRIZOTINIB,EML4,LABEL,METHODS,NSCLC,OBJEVTIVE,OOR,PFS,RESULTS,UNASSIGNED
169,2015,8764,ALCL,ALK,INSTEAD,NOTABLY,NPM,NSCLC
169,2015,BIOLOGY,CONSISTENT,FOS,FRA1,INC,INDUCIBLE,JUN,MOLECULAR,PREVIOUSLY,SOCIETY,TAP73,THESE

47Q,CELL,COUNTER
016,107,160,177,527,563,8201,AFTER,BOTH,DATA,TEST,THERE,WALK
2012,2013,2522,ABORIGINAL,ABOUT,AMONG,APRIL,CONCLUSION,FRAMING,KNOWLEDGE,LABEL,LACK,MAIN,METHODS,MOST,OBJECTIVE,OBJECTIVES,OCTOBER,OUTCOME,RESULTS,SETTING,SHS,SIMILARLY,TALKING
246,ANA,IGG,IGM,RAYNAUD,SECONDARY,UPON
2012,ROD,SINCE,THERE
110,2M0,2N0,513,DESPITE,TIS,V20
124,125,259,DISEASE,ECOG,IDENTIFIED,III,THERE
427,616,CRR,GENERAL,THEREFORE
EQD2,KARNOFSKY,SOD
207,FOLLOWING,PALLIATIVE,THERE
CONGO,INITIALLY,MALT,PATIENT,PULMONARY
055,138,1945,1970,1998,2012,2160,BACKGROUND,CENTRAL,LABEL,METHODS,PROGRAMME,RESULTS,TOTAL
001,0154,138,169,175,2015,276,8804,8805,CHINESE,CONCLUSION,EGFR,III,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SOCIETY
001,10877,10878,149,169,1YEAR,2004,2007,2015,3908,583,5DAYS,6646,732,CONCLUSION,COPYRIGHT,COX,DIAGNOSIS,FACTORS,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RECEIPT,RESULTS
200B,ACCORDING,EMT,EPITHELIAL,H1299,HES,HEY,HYPOXIA,JAGGED1,NOBILETIN,NOTCH,TREATMENT,ZEB1
ATF4,HO1,INCREASED,ISR,NRF2,THESE,UPON
2013,CRT,DMEAN,FFF,FLATTENING,IMRT,JULY,MUS,NSCLC,OCTOBER,THERE,VMAT
169,2015,AFTER,ASIA,AUTHORS,BAP1,BRCA1,FIRST,LTD,MALIGNANT,NEXT,PTY,PUBLISHING,SCIENCE,WILEY
001,003,011,014,021,029,126,147,164,166,197,200,2014,285,321,374,376,429,486,499,548,577,583,588,648,733,741,791,792,82G,831,874,924,931,934,965,AUG,CAUCASIANS,CHINA,CNKI,CONCLUSION,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PURPOSE,RAGE,RESULTS,THEREFORE
001,015,046,168,223,ABSENCE,CONCLUSION,COX,CRT,EASTERN,ECOG,GROUP,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RELATIVELY,RESULTS,T4N2,THERE
ETHIC,HOWEVER,MALIGNANT,MPM
163,173,178,289,660,8201,BACKGROUND,BCOC,CLEAR,ENGLAND,HOWEVER,ICERS,LABEL,METHODS,NSCLC,QALY,QALYS,RESULTS,SUBJECT
169,2005,2012,2015,529,8805,955,ACS,BACKGROUND,BMI,CONCLUSION,COPYRIGHT,DATA,III,INC,LABEL,METHODS,NSQIP,OBESE,OVERWEIGHT,PROPENSITY,RESULTS,RISK,WORLD,WORSE
169,2015,2276,BACKGROUND,COPYRIGHT,CRF,CRP,LABEL,LTD,METHODS,RESULTS
003,022,128,169,2015,387,473,512,823,951,BACKGROUND,COPYRIGHT,DFS,INC,LABEL,METHODS,MORBIDITY,OPERATIVE,PROPENSITY,PUBLISHED,QOL,RESULTS,SOCIETY,UNMATCHED,USING
0001,001,062,169,2000,2011,2015,284,370,BACKGROUND,CARDIAC,COPYRIGHT,COX,FIVE,INC,INDEX,LABEL,MEIER,METHODS,MORTALITY,PUBLISHED,RESULTS,REVISED,RISK,SOCIETY
169,2015,72H,AUTHORS,BACKGROUND,CELL,COPYRIGHT,GB3,GCS,GSLS,H1299,HOWEVER,INC,LABEL,MDR1,METHODS,MPM,MRP1,NSCLC,P31,PPMP,PUBLISHED,RESULTS,THERAPY
169,2015,COPYRIGHT,KINGDOM,PUBLISHED,SAS
169,2015,366,BCL2,BDA,BH4,COPYRIGHT,INC
150,160,2013,2014,BETWEEN,EGFR,ELDERLY,EPIDERMAL,ERLOTINIB,L858R,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SKIN
001,011,012,101,150,157,160,161,224,326,913,931,946,967,BRCA1,CHI,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIMILARLY
169,2015,3Q26,7Q11,7Q36,ACS,AMONG,CNA,CNAS,COPYRIGHT,HOWEVER,III,INC,NSCLC,SCC,SCCS,TP63
001,169,2015,887,888,BACKGROUND,COPYRIGHT,EBUS,FALSE,FNA,INC,LABEL,LUNG,MEAN,METHODS,PUBLISHED,RESULTS,SOCIETY,SPECIMENS,TCP,THERE,TIME
169,2015,408,COPYRIGHT,IRELAND,LTD,NTRK1,PCR,THESE,TPM3,TPR,TRKA,USING
169,2015,JNK,LARYNGEAL,LSCC,MAPK,RNAI,SOX2,SRY,THEREFORE,TU212
169,2013,2015,304,946,947,948,949,950,951,952,963,964,ABD,CELL,COPYRIGHT,H441,HOWEVER,INHIBITION,L722,L735,LUNG,MOL,NCI,PHYSIOL,SOCIETY,UTR
630,CONCLUSION,CTDI,LABEL,MATERIALS,METHODS,OBJECTIVE,PULMONARY,RESULTS,THESE
193,1998,2012,248,525,760,954,CONCLUSION,DELAY,IIP,JULY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OCTOBER,RESULTS,T1A,T1B
SCIENTIFIC,THESE
169,2015,A549,MOAP1,NSCLC,PRESS,PUBLISHED,UNIVERSITY
169,2015,BELGIUM,CONCLUSION,COPYRIGHT,DTT,IBRI,IRELAND,JAPAN,LABEL,LTD,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SEVERAL,THESE,UZB
001,200,215,2F8,511,956,ANTI,HOWEVER,MONOCLONAL,MOST,MUC1,NANOSTRING,SPLENOCYTE,THESE,TREATMENT
160,169,2015,954,COPYRIGHT,EGFR,HOWEVER,INC,NON,NSCLC,THESE,TKI,TKIS
AFTER,MCG,MCGS,MOST,MRI,MULTIFOCAL,PET,THROUGH
AMONG,HENCE,HOWEVER,P63,PCR,TFF3,TOTALLY
001,100,177,8201,CONCERNING,CONCLUSION,KNOWLEDGE,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PTV,RESULTS,SBRT,STAGE,THERE,THESE,TOKYO,UNIVERSITY
169,2015,916,ALTOGETHER,BIOLOGY,FINALLY,HIPPO,INC,MOLECULAR,NP63,PDZ,SOCIETY,TAZ,TEAD,TTF1
001,150,160,AUC0,BACKGROUND,CONCLUSION,GMR,HOWEVER,LABEL,METHODS,RESULTS
169,2014,2015,21153,21162,289,945,946,BARKANA,BECAUSE,BIOL,CARDIAC,CHEM,COPYRIGHT,H1299,HAVIV,KARLISH,KATZ,MARCOVICH,RABAH,SJD,SOCIETY,TAL,THESE,XENOPUS
HISTOLOGY,LIFE,MAJOR,NON,NSCLC,NSQ,OVERALL,PARAMOUNT,PEMETREXED,QOL,QUALITY
ALK,CRIZOTINIB,JOHNSON,NSCLC,SKIN,STEVENS
ACCORDING,CAD,THEN
169,2015,945,946,947,ATL,COPYRIGHT,INC,PREVIOUSLY,RETR,THESE
2010,2013,CONCLUSION,FRANKEL,JANUARY,JULY,KARNOFSKY,LABEL,LOG,MAIN,METHODS,RANK,RESULTS,SCORE,SIXTY,SPINE,UNLABELLED,VERTEBRAL
ANOTHER,COPD,LUNG,THROUGH,VARIOUS,WHILE
BESIDES,DESPITE,MORTALITY
169,2015,ADVANTAGES,ALK,COPYRIGHT,EGFR,LTD,NSCLC,TKI
ALK,EGFR,KRAS,LUNG,NEXT
0011,0188,2004,2013,8201,ACT,CONCLUSION,HEPATIC,HST,INSURANCE,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PTLD,RESULTS,SOT,THERE
107,CCL,CONCLUSION,ERCC1,HIGH,LABEL,LOW,METHODS,NPC,OBJECTIVE,RESULTS,THERE,TNM
169,2015,COPYRIGHT,INC,METASTASIS,ORAL,PUBLISHED,SOFT
001,104,153,169,189,2015,293,GRAY,HEMATOLOGY,LOG,OVERALL,SOCIETY,THERE
169,2015,COPYRIGHT,CPT,INC,NSCLC,REGARDLESS,TDP1,TOP1
130,157,169,177,2015,956,ATP,BAMB,BIP,COPYRIGHT,DOCKING,H1299,IC50,INC,INS,INSP3
160,215,8805,CKD,COCKCROFT,CRCL,EPI,EQUATIONS,FORTY,GAULT,LABEL,MDRD,METHODS,MSA,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCR,STUDIES
0001,169,177,1996,2012,2015,2N0M0,972,986,BACKGROUND,COPYRIGHT,COX,DLCO,FEV1,INC,LABEL,MEIER,METHODS,PUBLISHED,PULMONARY,RESULTS,SOCIETY
1995,2014,ACP,ASSESSMENT,CLINICIANS,EACH,EVALUATION,FIVE,GRADE,GRADING,IMPORTANCE,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,PSYCHINFO,RELEVANCE,RESULTS,SERIOUS,SEVENTEEN
2009,2014,443,938,956,AIMS,BACKGROUND,HOWEVER,IMT,IMTS,IPT,IPTS,LABEL,LABORATORY,LESIONS,METHODS,MORPHOLOGY,OBJECTIVE,REPORTS,RESULTS,THERE
053,100,177,2011,2014,324,877,945,AIMS,APRIL,BACKGROUND,COX,HIF,HYPOXIA,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,VEGF
001,003,037,1017,1227,169,2015,244,BACKGROUND,CGEMS,COLORECTAL,DRE,GERM,INC,LABEL,LUNG,MARKERS,METHODS,OVARIAN,PCA,PGS,PLCO,PSA,RESULTS,SCREENING,SNPS,TRIAL,WILEY
231,GPIIB,IIIA,MDA,THESE,UPON
169,2015,8201,AKT,BALB,BRIEFLY,COPYRIGHT,DSB,DSBS,ECS,FINALLY,H1975,IRELAND,LTD,NSCLC,PI3K,PKCS,USING,VEGR2
017,037,100,169,183,190,2015,ACCURAY,AWARD,BACKGROUND,BECAUSE,BOTH,COPYRIGHT,ESTIMATED,FUNDING,GRADE,INC,IQR,LABEL,LTD,METHODS,N0M0,NCI,NSCLC,RECURRENCE,RESULTS,ROSEL,SABR,SCIENCE,SIX,STARS,SUPPORT,THREE
DESPITE,FOLLOWING,GEM,HOWEVER,SMV,STAGE,THEREFORE,THREE
215,FOUR,ROUX
046,134,669,784,AMONG,BASED,COMMITTEE,THESE
2014,EGFR,GRADE,HANGE,HOWEVER,III,LUNG,LUX,MAY,PFS,SEVEN,TKI
100,2005,2014,2025,600,AICHI,ALDH2,JAPAN,JPHC,MEDICAL,MICC,MULTI
101,298,341,639,AEGIS,ALLEGRO,AUC,BACKGROUND,CURRENT,LABEL,METHODS,RESULTS
169,2015,945,ACCORDING,BNIP3,COPYRIGHT,DESPITE,EGFR,HIF,INC,KNOCK,NSCLC,TAKEN,TKIS,TREATMENT
15P,169,2015,5MM,95TH,ALSO,ANOVA,BASED,BEV,BOTH,CONCLUSION,COPYRIGHT,CYBERKNIFE,DUAL,FIFTEEN,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTTT,VERO
007,169,2015,3302,6153,8805,ASA,BACKGROUND,CARDIAC,CONCLUSION,COPYRIGHT,INCIDENCE,LABEL,LTD,METHODS,MORBIDITY,OVERALL,RCTS,RESULTS,THERE
170,177,213,7721,956,A549,BCL,IC50,MCF,PREVIOUSLY,SMMC,THESE
1993,1ST,2000,FOOT,HAND,HODGKIN,MOUTH,MRI,MYELOMA,NON,PET,RAY,SCAN,SINCE,SOFT,THERE,VISIBLE
169,2015,CAR,CASC,CASCS,CLINICALLY,FAP,FIBROBLAST,HOWEVER,MALIGNANT,PRIOR,THESE
000,100,169,2015,26TH,APRIL,BAP1,BRCA1,COPYRIGHT,ERC,ERCC1,FISH,HOWEVER,III,LACK,LITERATURE,LTD,MALIGNANT,MESOTHELIN,MPM,MUTATIONS,PLOS,TYMS
0001,002,150,169,2015,399,ADDITIONAL,AMONG,BACKGROUND,BRAF,BSC,CONCLUSION,COPYRIGHT,COX,EGFR,KRAS,LABEL,LTD,MCC,METHODS,NCIC,PFS,RESULTS,RIGHT
169,2015,945,AUTHORS,CELL,EZH2,LAT1,MET,METHIONINE,PRC2,RXR,SAM

169,2015,BIOLOGY,CONVERSELY,ERK1,EVANS,INC,MOLECULAR,NADPH,NCX,NCX1,PAR,PARS,REVERSE,RNAI,ROS,SEA0400,SOCIETY,TARGETING
169,2008,2011,2015,676,713,HOSPITALS,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
001,104,177,747,AUC,BACKGROUND,BPE,BPES,CEA,CONCLUSION,FIFTY,HOWEVER,LABEL,METHODS,MPE,MPES,PLEURAL,RESULTS,USING
CAD,EIGHT,HOWEVER,ROI,SMOTE,SVM
1706,1983,2010,3381,AFTER,BMJ,CIS,EMP,GROUP,LABEL,LIMITED,LUNG,METHODS,MINNESOTA,OBJECTIVE,ORS,PUBLISHED,PUBLISHING,RESULTS
169,2015,ERK,MAPK,MEK,MET,ONCOGENIC,RAS,REMARKABLY
169,2015,239,8201,945,AMONG,COPYRIGHT,DESS,DIGITAL,EVALUATION,HEALTHY,IRELAND,LABEL,LTD,METHODS,MIP,NSCLC,OBJECTIVE,RESULTS,SCORE
169,2015,945,ATP,BECAUSE,CONSISTENT,COPYRIGHT,H1299,HIF,HSP90,IGF2,L80,SOCIETY,THEREFORE,THESE,VEGF
160,2002,2013,DOCETAXEL,IIIB,JANUARY,LABEL,METHODS,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
004,017,1998,2013,278,329,65285,CONCLUSION,COX,LABEL,LOG,MARCH,METHODS,OBJECTIVE,RESULTS,THEIR
1974,2012,AGE,DISTANT,III,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
2004,2008,266,ADC,CD68,CSF1,EGFR,LABEL,METHODS,OBJECTIVE,RESULTS,TAMS,TNM,UNIVARIATE
001,004,007,010,035,160,165,169,2015,954,CHINESE,COPYRIGHT,HAN,INC,KARNOFSKY,MST,OVERALL,SNPS,STAT3
145,1522B,AG0,H460,IMRT,MCT,RIBES,SCT,THESE,UNDER
7402,7901,946,A549,AMONG,BEL,IC50S,PC3,SAR,SGC
CORE,HRQOL,JANEIRO,LABEL,LIFE,METHODS,MOST,NON,NSCLC,OBJECTIVE,QUALITY,RESULTS,RIO,TREATMENT
169,2015,945,AGS,ANTITUMOR,BATF3,CD103,CD8,COPYRIGHT,IFN,INC,SIMILARLY,THESE,XBP1
169,BAP1,BCC,BCCS,BRCA1,COPYRIGHT,EARLY,LABEL,LOSS,METHODS,OBJECTIVE,OBJECTIVES,OMIM,PATHOLOGY,RESULTS,SIX,SOCIETY,THESE
169,ALI,CONCLUSION,COPYRIGHT,DISEASE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SIZE,SOCIETY
BACKGROUND,ISOPURE,LABEL,REPLACING,RESULTS
EGF,EGFR,EPIDERMAL,L858R,PREVIOUSLY,T790M,THESE,TKI,TKIS,UPON,Y1068,Y1086,Y1173
005,1000,177,2000,AIM,DYSPNEA,LABEL,MATERIALS,METHODS,NEOPLASTIC,OBJECTIVE,PEARSON,RESULTS
EBUS,LUNG,NON,PROCEDURES,TBNA,THERE
8805,FOUR,MECA,PERINEURAL
001,110,1549,1995,2010,AIS,AISS,BETWEEN,EGFR,HOWEVER,KRAS,LUNG,TAKEN,TTF
169,2015,3141,CAM,CHROMATIN,GEO,LABEL,LUCIFERASE,METASTASIS,METHODS,MTA2,OBJECTIVE,PRESS,PUBLISHED,RESULTS,TRANSWELL,UNIVERSITY,WOUND
150,169,178,2015,610,AUC,COPYRIGHT,EGFR,FORTY,INC,LABEL,MATERIALS,METHODS,MONDAYS,OBJECTIVE,PURPOSE,RESULTS,TUESDAY
169,2015,954,A549,ALSO,COPYRIGHT,NAC,PM10,PUBLISHED,ROS,SINCE,SO2
169,2015,ALK,ANAPLASTIC,BACKGROUND,BASEL,CONCLUSION,FINE,FISH,FIVE,FNA,HOWEVER,ICC,LABEL,METHODS,RESULTS
068,157,1980,2013,281,519,805,868,954,ABSTRACTS,BMJ,GROUP,LABEL,LIMITED,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,REFERENCE,RESULTS,SURGERY,SYSTEMATIC
169,2015,DAMPS,FOUNDATION,IMMUNOLOGY,JOURNAL,THESE
1082,169,2014,2015,BRAF,COPYRIGHT,INC,KEY,MEK,OX40
169,2015,3475,COPYRIGHT,INC,NIVOLUMAB,PUBLISHED
169,2015,COPYRIGHT,CTLA,HOWEVER,INC,MONOCLONAL
169,2015,COPYRIGHT,CURRENT,INC,MALIGNANT
169,2015,COPYRIGHT,CTLA,DESPITE,INC,NSCLC
169,2007,2013,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,PLC,RESULTS,SBRT,THEREFORE
001,133,169,1973,2007,2010,2015,675,933,ANTICANCER,BACKGROUND,CHI,CONCLUSION,COPYRIGHT,COX,EXCEL,INSTITUTE,JOHN,LABEL,METHODS,MICROSOFT,PRIMARY,PRISM,RADIATION,RESULTS,SCCO,SCLC,SEER,STAT,USING
169,2015,ALK,ANTICANCER,ATM,COPYRIGHT,EGFR,INSTITUTE,JOHN,KIRSTEN,KRAS,NSCLC,Q22K,STK11,TESTING
169,176,2015,500,8805,956,AMONG,ANTICANCER,COPYRIGHT,FDG,FORTY,INSTITUTE,JOHN,PET,THESE
012,027,169,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SCLC
169,2015,AAA,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FORTY,GUIDELINES,INSTITUTE,JOHN,LABEL,METHODS,MOST,OBJECTIVE,PBC,RESULTS,THEIR,THESE
169,2015,AIM,AKT,ANOIKIS,ANTICANCER,BACKGROUND,BCL,CONCLUSION,COPYRIGHT,ERK,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS
169,2013,2015,AIM,ANTICANCER,BACKGROUND,BLOOD,CONCLUSION,COPYRIGHT,CTC,CTCS,INSTITUTE,JOHN,JUNE,LABEL,METHODS,NINE,OBJECTIVE,RESULTS,RFA,SCREENCELL
169,2015,AMONG,ANRIL,ANTICANCER,COPYRIGHT,H460,INK4,INSTITUTE,JOHN,PLD,RNAS
169,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FPR,FPRS,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,REAL,RESULTS
169,2015,963,ANTICANCER,BRCA1,CHINESE,COMET,COPYRIGHT,DAPI,DMC,H2A,H460,INSTITUTE,JOHN,MDC1,MGMT,NCI,TAKEN,WESTERN
0076,0337,169,177,2015,8804,956,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,ED50,FORTY,HDRA,HIGH,III,INSTITUTE,IR25,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,PTX,RESULTS,TUBB3
169,177,2015,916,AIM,ANTI,ANTICANCER,AUC,BACKGROUND,BL6,C57,CD31,CONCLUSION,COPYRIGHT,EGF,FINALLY,INSTITUTE,JOHN,LABEL,LEWIS,LLC,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIMAX,USING,VEGF
169,2015,AIM,ANTICANCER,BACKGROUND,CFP,CONCLUSION,COPYRIGHT,GFP,INSTITUTE,JOHN,LABEL,MATERIALS,METASTASES,METHODS,OBJECTIVE,OLYMPUS,PANCREATIC,RESULTS,RFP,THREE,XPA
169,2015,ANTICANCER,COPYRIGHT,EGFR,FIRST,HOWEVER,III,INSTITUTE,JOHN,NSCLC,PFS,SEVERAL,THEREFORE,TKI,TKIS,VEGF
169,2015,ANTICANCER,COPYRIGHT,INSTITUTE,JOHN,MALIGNANT,MPM
AFTER,CNS,CRANIOTOMY,III,NINE,RESTAGING
121,169,2015,BACKGROUND,EGFR,HOWEVER,KIT,LABEL,METHODS,MINI,MULTITECH,PNA,RESULTS,SOCIETY
ACH,ACTIVATION,AFTER,AKT,EGFR,HOWEVER,M3R,NSCLC,PI3K,TAKEN,THUS
177,BACKGROUND,CONCLUSION,FOUR,INC,LABEL,METHODS,NONE,NTG,PUBLISHED,RESULTS,SEM
001,008,169,2000,2011,2015,8201,HODGKIN,INC,NHL,SEER,USING,WILEY
CHEST,HOWEVER
2012,2013,6TH,AFTER,JUNE,MARCH,THESE
2ND,ECMO,ND2A,RIGHT
IRINOTECAN,LIVER,PCG,UPPER
100MG,AUC
B12,CONCLUSION,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,THEREFORE
ALK,EGFR,EML4,MOLECULAR,NSCLC,SCLC,T790M,TKI
169,2015,231,233,4TH,BONE,CELL,COPYRIGHT,FRAN,LEA,LEUC,PUBLISHED,SAS,SFGM,SOCI,SOCIETY,THERAPY,UNDER
ADVANTAGES,CORRECT,THERE
2012,PET,RUSSIAN,THERE,THUS
PCH,PULMONARY
31ST,32ND,CAESARIAN,FIBREOPTIC
ALCL,ALK,NSCLC
1672,2010,2012,2013,215,365,4509,6000,809,8201,ABCA1,ACOT4,AFRICAN,AMERICANS,BLOOD,DISCOVERY,ESP,EXOME,GWAS,HEART,IMPORTANCE,INSTITUTE,JANUARY,JULY,JUNE,LABEL,LUNG,MAIN,METHODS,NHLBI,OBJECTIVE,PDE4DIP,PROJECT,RELEVANCE,RESULTS,SEQUENCING,SETTING,THESE,ZFHX3
169,2015,COPYRIGHT,DATA,FGFR,FGFRS,FGFS,LTD,NSCLC
169,183,2015,BASED,BRITISH,CHINESE,DETECTION,IMMUNOLOGY,PCR,RIBOSOMAL,ROC,SOCIETY,THESE
169,2015,321,BIOLOGY,CTSL,INC,MDA,MOLECULAR,SOCIETY,UTR
169,2015,COPYRIGHT,MACROPHAGE,MIF,SOCIETY

HISTONE
ILD,RISK
ALK,ROS1
250,ACTIVATING,AFTER,ALK,CAUCASIAN,EGFR,GEFITINIB,HOWEVER,NSCLC,TKIS
169,177,2015,BECAUSE,BIAS,CONCLUSION,EVALUATION,HOUNSFIELD,IMAGING,INC,INTER,LABEL,LUNG,MEAN,METHODS,MOLECULAR,NUCLEAR,PEDIATRIC,PET,RESULTS,SDS,SEGBASE,SEGWBONEAD,SEGWBONEPE,SOCIETY,UNLABELLED,VOI,VOIS
BRAIN,EVEN,HOWEVER,THERAPIES
169,2015,COPYRIGHT,CURRENTLY,HOWEVER,INC,PUBLISHED,SOCIETY
169,2015,COPYRIGHT,GGO,GGOS,INC,PUBLISHED,ROLL,SOCIETY,THEREFORE
169,2015,ABDOMINAL,COPYRIGHT,INC,PUBLISHED,SOCIETY,STERNAL
169,1995,2008,2010,2012,2013,2015,COPYRIGHT,HEART,INC,PUBLISHED,SOCIETY,THUS
EGFR,ERLOTINIB,HOWEVER,NSCLC,PFS
160,169,2015,A549,APN,ASIA,AUTHORS,B16,CD13,GIVEN,H1299,LTD,MT95,NOD,PC14,PTY,PUBLISHING,SCID,SCIENCE,THESE,WILEY
001,10878,6965,AWARENESS,BACKGROUND,BELIEFS,HOWEVER,LABEL,METHODS,RESULTS,SMOKERS,SMOKING,THESE
CHEST,DPB,HOB
004,005,006,026,194,CONCLUSION,EBUS,LABEL,METHODS,NVBNA,OBJECTIVE,RCT,RESULTS,VBN,VBNA
177,215,ACUTE,AMONG,CONCLUSION,IPF,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,TTV
3436,3463,ATM,BCL,CDK1,CELL,CSC,FADD,JUN,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PRO,PROTEIN,PURPOSE,RAD3,RESULTS,RIP,SER,THR,TRADD
ANAMORELIN,AREAS,BACKGROUND,CACS,COVERED,LABEL,METHODS,NSCLC,OPINION,TARGETING
CAD,FCM,GGO
169,2015,ASCO,ASTRO,BECAUSE,COMMITTEE,CURRENT,GUIDELINE,III,IMPORTANT,LABEL,METHODS,NSCLC,OBJECTIVE,PANEL,PRACTICAL,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE
123,361,AMDIS,AUC,AUTOMATIC,FURTHER,NIST,SPME,SQL,VOCS
DOGS,GENERALLY,PARTICULAR
169,2015,CONSISTENT,DESPITE,FP3,RDB,TAKEN,UICC,VARIOUS,VEGF
169,2015,504,789,8734,AML,BENZENE,CHINA,CHINESE,HLD,HODGKIN,LUNG,POISSON,RRS,UICC
169,2015,COPYRIGHT,FINALLY,LTD,SILIBININ,SILYBUM,STAT3
169,2015,ARAB,BAHRAIN,COPYRIGHT,COUNCIL,DESPITE,GULF,HODGKIN,LTD,OMAN,QATAR,SAUDI
101,2009,2011,AFTER,APRIL,BACKGROUND,BETWEEN,CLINICIANS,CONCLUSION,FDG,HODGKIN,JUNE,LABEL,METHODS,NSCL,ONTARIO,PET,RESULTS,SOMETIMES
IAP,STEM
160,169,2015,218,945,ECTOPIC,FEBS,HOWEVER,RPTP,SLIT2,SRC,THESE,UTR
001,160,169,172,2015,412,535,ASIA,AUTHORS,CCL3,CURRENTLY,HOWEVER,LTD,MALIGNANT,PTY,PUBLISHING,SCIENCE,THREE,WELFARE,WILEY
100,160,169,2015,946,956,ACC,AMP,AMPK,ASPIRIN,AUTHORS,COA,LIMITED,MEFS,MRC,PNT1A,PRE,PRESS,SALICYLATE
100,956,A549,ABCG2,ALDH,ALDH1A3,ALDH1B1,ATP,CD105,CD44,CD73,CD90,CONCLUSION,CSCS,DDP,DEAB,EPCAM,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THERE,THEREFORE,WESTERN
8201,ASSOCIATED
BASED,EBUS,PET,SEVERAL,TBNA
101,169,2015,AMONG,BACKGROUND,BAL,CONCLUSION,HSCT,INC,LABEL,METHODS,PROCEDURE,RESULTS,THERE,WILEY
137,169,2015,PREDICTIVE,USING
104,1992,2001,2009,2015,208,8721,BDE,BDES,BLOOMBERG,CASES,COLORECTAL,GOVERNMENT,HOPKINS,INCREASING,JOHNS,LUNG,ODDS,OVARIAN,PBDE,PBDES,PRESS,PUBLISHED,SCREENING,TRIAL,UNIVERSITY
AZD9291,C797S,EGFR,PCR,T790M,TKI
178,568,BACKGROUND,BMI,CONCLUSION,COX,DATA,ENGLAND,FUNDING,HOWEVER,HULL,INSTITUTE,LABEL,LIMITATION,METHODS,OBJECTIVE,OVERWEIGHT,PRIMARY,RESULTS,SERVICE,SETTING,UNIVERSITY,WHETHER
001,006,1544C,169,2015,20Q11,215,348,410C,699,6P21,850G,915,998,BAT2,COPYRIGHT,FKBPL,HOWEVER,INC,PRO137LEU,PRO515LEU,PUBLISHED,SOCIETY,VAL284MET
169,2015,AKT,COPYRIGHT,ERK,HENCE,IRELAND,LTD,MEK,NSCLC,PI3K,RAS
169,175,2015,916,945,946,AFTER,BOTH,COPYRIGHT,EQD2,FACTORS,INC,INT,JAC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V20,VENT,VENTINT,VENTJAC
169,2015,ADC,AST,COPYRIGHT,FURTHER,G12D,INC,KRAS,LKB1,NSCLC,ROS,SCC,SIMILAR
048,1016,130,169,174,2015,548,AUTHORS,COPYRIGHT,COX,DATA,DSS,III,INC,LABEL,MATERIALS,METHODS,NOMOGRAMS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,TNM,VARIABLES,WORLD
100,169,177,2015,947,BASED,COPYRIGHT,CYBERKNIFE,FTTS,HOUNSFIELD,INC,KOREA,LABEL,LOKIT,LUNG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THOSE,THREE,XLTS
169,2015,COPYRIGHT,DUE,HOWEVER,LTD,MOST,NSCLC,THUS
0GY,169,2015,4GY,50TH,5GY,60GY,70TH,7GY,8GY,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,D95,FUNCTIONAL,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MLD,NSCLC,OBJECTIVE,PET,PLAN,PLANS,PTV,PURPOSE,RESULTS,SUV,THERE,V10,V20,V30,V40,V50,V60,VLUNG
1999,2014,AUSTRALIA,BETWEEN,FIVE,JULY,TRANSPLANT,ZEALAND
2015,COPYRIGHT,OCT,SLACK
001,019,1697,2006,2013,265,329,342,409,413,452,803,917,999,ANOVA,ASIA,BECAUSE,CHI,METHODS,MINI,MIS,RESULTS,THERE
112,160,166,169,2011,2013,2014,2015,250,374,946,99M,CONCLUSION,HOWEVER,IMAGING,INC,JANUARY,LABEL,MAA,MARCH,MBQ,METHODS,MOLECULAR,NUCLEAR,RESULTS,SOCIETY,SPECT,THESE,UNLABELLED,VOLUMES
169,2015,BACKGROUND,EACH,LABEL,MEDICAL,METHODS,MINNESOTA,NORTH,OSA,RESULTS,ROSE,SHORE,SOCIETY,THERE,THREE,UNIVERSITY,YORK

1047,169,2001,2011,2015,6112,BACKGROUND,END,ESOPHAGEAL,GIST,GISTS,HODGKIN,HOWEVER,LABEL,METHODS,MOST,OVARIAN,RESULTS,SIR,SIRS,SOCIETY,SPR,SPRS,THERE,THESE
EVALUATION,HOWEVER
0010,0020,0034,0037,0039,0054,0126,0145,0262,0301,0469,0858,2009,2014,3575,8202,DMAX,DOSIMETRIC,ECS,IMRT,JULY,JUNE,PTV,PTVS,THUS,V20,VERSION,VMAT
8202,CIS,FURTHER,INSURANCE,MDS,NHI,ORS,OVERALL,TAIWANESE
ADDITIONAL,BASED,CTS,DOSIMETRIC,DUAL,FDG,FLT,IMRT,MAXIMUM,METABOLIC,MVS,NSCLC,NTCP,ORS,OVERLAP,PET,PVS,SUVMEAN,TCP,TOTALLY
MBC,RECURRENCE
1000,AMERICA,AUSTRALIA,BACKGROUND,GROUP,IARC,LABEL,META,METHODS,MONOGRAPHS,NORTH,RESULTS,SMR,SMRS,SOURCES,WORKING
8201,ADJUSTING,BACKGROUND,BLACK,EXAMINE,HOWEVER,LABEL,LDCT,LUNG,MAIN,METHODS,NLST,OBJECTIVE,OBJECTIVES,OVERALL,RATIONALE,RESULTS,SCREENING,SMOKING,TRIAL
025,149,272,313,362,589,643,875A,878,946,BACKGROUND,C509T,CHINESE,G875A,GENOTYPING,HOWEVER,LABEL,METHODS,RESULTS,SNP,SNPS,TGF,TGFB1
1695,2008,403,414,420,436,442,461,510,744,8201,BACKGROUND,COX,GRAM,JANUARY,LABEL,METHODS,PROWESS,REGISTERED,RESULTS,SHOCK,SIMILARLY,SOFA,TRIAL
148B,A549,BACKGROUND,CELL,DDP,DNMT1,DNMTS,LABEL,METHODS,MICRORNAS,MTT,NSCLC,PCR,REAL,RESULTS,SPC,TIME,UTR,WHILE
169,2015,AMONG,BACKGROUND,BASEL,LABEL,METHODS,NSCLC,RESULTS
169,2015,947,BIOLOGY,CATENIN,EXPRESSION,HAI,HGF,HOWEVER,INC,MET,MOLECULAR,NSCLC,SOCIETY,SPINT,TAKEN,THEREFORE,TYPE
169,183,2011,2012,2015,375,8200,AFTER,BACKGROUND,BETWEEN,CD79B,CLL,COPYRIGHT,FUNDING,GENENTECH,GRADE,HODGKIN,LABEL,LTD,MARCH,METHODS,NHL,NOV,RESULTS,SERIOUS,SEVEN
WHETHER
160,2009,2013,239,500,8804,8805,APRIL,BETWEEN,CONCLUSION,EASTERN,ECOG,EGFR,FEBRILE,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,PEMETREXED,PFS,PURPOSE,RESULTS,SEPTEMBER,SIXTEEN,THERE
093,169,2015,496,638,735,CLPTM1L,DATA,GWAS,HOWEVER,ISRAELI,JEWS,LUNG,SMOKING,TERT,UICC
150,185,ADP,GPC,LY293,METHOXY,MITOTIC,NMR,PARP,POLYMERIC,TREATMENT,TUBULIN
BACKGROUND,BCA,CO2,CONCLUSION,FIG,HCA,HCG,HYDRATASE,I50,INHIBITION,LABEL,OBJECTIVE,PAP,REF,RESULTS,TAB
000,160,169,176,183,2002,2005,2008,2011,2020,513,BACKGROUND,BASED,BETWEEN,DUE,EUR,FEDERAL,GEORG,INSURANCE,LABEL,METHODS,NUMBERS,OUTPATIENT,PHYSICIANS,POPULATION,PREVALENT,REGISTRIES,RESULTS,STATISTICS,STATUTORY,STUTTGART,THESE,WINHO,YORK
160,169,183,FDG,GEORG,PET,STUTTGART,YORK
1000,130,150,1686,500,625,750,900,BACKGROUND,EGFR,HBR,KEY,LABEL,METHODS,NON,NSCLC,RESULTS,T790M,TREATMENT
127,222,240,253,AMONG,AZD9291,BACKGROUND,EGFR,LABEL,METHODS,RESULTS,T790M
1002,169,2015,BACKGROUND,CARE,COX,FINLAND,FINNISH,HEART,HISTORICAL,INC,LABEL,MEIER,METHODS,OBJECTIVE,POSTSTROKE,PURPOSE,RESULTS,STATISTICS,YOUNG
169,2015,231,233,CONCLUSION,COPYRIGHT,IMRT,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI,THERE
160,2007,2013,8805,AFTER,APRIL,BACKGROUND,BETWEEN,CNS,CONCLUSION,EGFR,HIGH,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SURVIVALS,TKIS
001,009,025,169,2000,2010,2015,492,8201,AKT,BACKGROUND,BOTH,EGFR,INC,LABEL,MALDI,MAPK,METHODS,MUTATIONS,NRAS,OBJECTIVE,OBJECTIVES,PI3K,PTEN,RAF,RAS,RESULTS,SOMATIC,TOF,WILEY
956,A549,DU145,IC50,NTUB1,SOLANUM
169,199,2015,229,BACKGROUND,CCAT2,ESCC,HIGH,INC,LABEL,LNM,METHODS,MYC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RNAS,TNM,WILEY
0008,177,1992,2006,231,FIVE,OVERALL
231,956,A549,CHCL3,EIGHT,HELA,IC50,KAEMPFERIA,MDA,MYANMAR,PANC,PSN,TIG
13C,COSY,ESI,HMBC,HSQC,MEL,NINE,NMR,NOESY,RHIZOPHORA
100,169,1992,2006,2015,AMONG,BAL,BALS,CMV,HCT,HEMATOLOGY,HHV,HRV,IPS,MORTALITY,NEWER,SOCIETY,THUS
169,2015,8805,AIM,ANY,BACKGROUND,BRITISH,CONCLUSION,CONTINUITY,ENGLAND,GENERAL,JOURNAL,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SECONDARY,SETTING,TIME,TRS
169,2015,227,AFRICAN,AMERICANS,CONCLUSION,COPY,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMARCA4,SOCIETY
169,2015,BCL,COPYRIGHT,FBXW7,GSK3,HENCE,MCL,SCF,SIN1,SOCIETY,THUS,TORKINIBS
169,2015,947,A549,ATM,ATR,BIOLOGY,CALU,CDK2,CHK1,CHK2,CIP1,ERK,H2AX,H460,H526,HOWEVER,INC,MOLECULAR,NCI,PNAS,SOCIETY,TAKEN,WAF1
169,2015,COPYRIGHT,INC,RCC,RENAL
058,079,101,169,2015,286,781,8805,ADJUSTING,COLORECTAL,CONCLUSION,COPYRIGHT,DATA,GLEASON,HOWEVER,INC,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PSA,RESULTS,RISKS,SCREENING,TRIAL
0010,0040,0050,036,169,2015,384,387,CHINESE,COPYRIGHT,NFKB1,THERE
169,2015,8201,BID,COPYRIGHT,DR5,FLLL,HOWEVER,IC50,IRELAND,LTD,PARP,PTPS,SRB,TAKEN
001,169,2007,2010,2015,688,794,AMONG,BACKGROUND,END,INSURANCE,LABEL,LUNG,METHODS,PATIENT,RATES,RESULTS,SEER,SOCIETY,VARIATION
549,956,ETOAC,IC50,THREE
003,160,169,2007,2013,2015,967,BACKGROUND,BECAUSE,BRIEFER,COPYRIGHT,DATA,INC,KRUSKAL,LABEL,LUNG,MEIER,METHODS,PUBLISHED,RESECTIONS,RESULTS,SOCIETY,STAGE,VATS
PROSPECTS,SPECIAL
197,300,956,ANPS,BECAUSE,CC50,GMP,MIC50,MTHGPRT,THESE
945,946,AMONG,ANXA2,MET5A,NEXT,TFRC,THEREAFTER,THESE,THUS
946,954,AB1,CCL2,EVALUATION,KIT,MAST,MCS,MPE,MPES,ONCE,TREATMENT
079,100,105,304,467,691,920,AMONG,BACKGROUND,COPD,COPENHAGEN,GENERAL,LABEL,MAIN,METHODS,NEVER,OBJECTIVE,OBJECTIVES,POPULATION,RATIONALE,RESULTS,THUS
169,2015,AIM,COPYRIGHT,LTD,RESULTS,SABR
001,160,169,1998,2010,2015,459,631,714,AMONG,BACKGROUND,CCI,COPYRIGHT,COX,CRS,DATA,FACTORS,IIIB,INC,INDEX,LABEL,METHODS,NCDB,NSCLC,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,T4N2,THERE
169,2015,AFTER,COPYRIGHT,INC,PUBLISHED,SOCIETY
004,160,169,2015,BACKGROUND,COPYRIGHT,INC,LABEL,LIPOB,MEAN,METHODS,PAIN,POSTERIOR,PUBLISHED,RESULTS,SOCIETY,TEA,THERE
169,2015,AMONG,CD82,COPYRIGHT,EGFR,EGFRS,EPIDERMAL,IMMUNOBLOT,NSCLC,PUBLISHED
AREAS,ASPECTS,BACKGROUND,BESIDES,COVERED,DRUG,HOWEVER,LABEL,METHODS,OPINION
2010,2012,AIMS,BACKGROUND,JANUARY,LABEL,LYMPH,METASTASIS,METHODS,OBJECTIVE,RESULTS
000,150,205,956,AGILENT,C18,CONCLUSION,DAD,ESI,FIVE,HPLC,LABEL,METHODS,OBJECTIVE,RESULTS,USING
169,2015,946,BECAUSE,C5A,COPYRIGHT,DEPLETION,INC,TGF,TH1,TH2,USING
169,177,398,5DN,945,946,BOTH,FASEB
045,440,8805,AGE,BACKGROUND,COMBINING,EVEN,LABEL,METHODS,OBJECTIVE,OLDER,PRESENTING,RESULTS,WEB
BONE,GASTRIC
2010,ACCORDING,MAMMARY,THREE
BACKGROUND,BDUMP,BMJ,CMEP,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,THESE,TREATMENT
008,0646,169,177,2015,6678,ACRIN,BLAND,CONCLUSION,FDG,III,IMAGING,INC,LABEL,MERCK,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RCS,RESULTS,SOCIETY,SOLID,SUV,SUVPEAK,TEST,UNLABELLED
116,2010,2013,500,ASIA,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,TES,THERE
001,019,105,140,669,8805,AIMS,BACKGROUND,LABEL,METHODS,OBJECTIVE,OVERALL,PAIN,RESULTS
2000,2013,AIMS,ASIAN,BACKGROUND,FIRST,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RESULTS,TTP
GTN,GTNS,PLACENTAL,PRIMARY,PSTT,PSTTS
EGFR,FIRST,HOWEVER,SCLC,TKI,TKIS
AVP,ECTOPIC,OTHER,SIADH
ALK,CRIZOTINIB,INCREASED,NON,ROS1
BACKGROUND,CASE,LABEL,METHODS,MRI,STAGING,ULTRASOUND
AFTER,BACKGROUND,BRONCHIAL,DOCETAXEL,FIBEROPTIC,LABEL,MATERIALS,METHODS,NSCLC,PULMONARY,RESULTS,SPIROMETRY
512,64257,AIMS,BACKGROUND,ESCC,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SPCS,SUBSEQUENT
BACKGROUND,BXPR,CUMULATIVE,FDG,LABEL,MEIER,METHODS,NSCLC,PET,RADDX,RECORDS,RESULTS,SBRT,SIXTY
BOOP
130,BACKGROUND,CIGARETTE,CONCLUSION,COPD,HNC,LABEL,METHODS,PRIMARY,RESULTS,SECONDARY,SIXTY
169,2015,APMIS,GIANT,JOHN,KI67,LTD,PUBLISHED,SONS,WILEY
ANOTHER,AREAS,ASIA,ASIAN,BACKGROUND,BASED,COVERED,DEL19,EGFR,L858R,LABEL,METHODS,NSCLC,OPINION,ROUTINE,TKIS
169,2015,954,E2F,FINALLY,MARK,MARK2,MARKS,MAX,MYC,UICC
1993,1997,1998,2005,2010,2011,283,656,8805,AHS,AMONG,BMJ,GROUP,IOWA,LABEL,LIMITED,METHODS,NEWLY,NORTH,OBJECTIVE,POISSON,PUBLISHED,PUBLISHING,RESULTS,RRS
CPFE,FOUR,PAH,PULMONARY,REDUCED,SHORTNESS,SMOKING
2004,2007,2013,394,438,439,7294,CONCLUSION,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPGGN
DCLDS,LANGERHANS
001,022,182,8201,954,BACKGROUND,CARD,CHROMATIN,LABEL,MAIN,MEIER,METHODS,NME2,OBJECTIVE,OBJECTIVES,PEARSON,RATIONALE,RESULTS
0001,113,144,181,2000,2011,286,312,BOSNIAK,CAPTURE,CONCLUSION,DATA,ELECTRONIC,IIF,III,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PATHOLOGIC,RESULTS,THERE,WEB
CENTERS,POPULATION,THESE
100,169,1993,2010,2015,295,3670,590,7149,8805,BACKGROUND,BETWEEN,CIS,COLORECTAL,CONCLUSION,DBP,FURTHER,LABEL,LUNG,METHODS,NUTRITION,OBJECTIVE,ORS,OVARIAN,RESULTS,SOCIETY,VITAMIN
169,2015,8201,ALSO,BRITAIN,COPYRIGHT,EMT,FINALLY,GREAT,IRELAND,JOHN,LTD,NSCLC,PUBLISHED,SOCIETY,SONS,WILEY
108,126,167,169,1985,2007,2008,2015,299,762,AMONG,EVER,HEAVY,HOWEVER,IRRS,POISSON,SPC,SPCS,UICC
004,160,2010,2013,250,CONCLUSION,DCR,EGFR,FORTY,GEFITINIB,HOWEVER,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,OCTOBER,OPTIMIZED,PCR,PFS,PNA,PURPOSE,REGARDING,RESULTS,SEVENTY,SKIN,SMALL,THUS,TKI
101,169,2003,2009,2015,8804,8805,CONCLUSION,ENROLLMENT,LABEL,METHODS,NOGUCHI,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
169,2015,A549,BASED,CL1,COPYRIGHT,FIRSTLY,HOWEVER,IRELAND,JNK,JUN,LTD,MAP,MAPK,MMP,PIPOXOLAN,PUBLISHED,THEREFORE,THESE
001,160,1996,1999,2008,2011,278,421,ALSO,CHI,CRC,ESPECIALLY,HOWEVER,MEIER,STAGE
AKT,BMI1,CTL,EMT,METASTATIC,NANOG,PREVIOUSLY,TCL1,TCL1A,THEREFORE,THESE,THUS
169,2015,233,BIRT,CLEVELAND,COPYRIGHT,DUB,HOGG,ONCE
001,002,ACCORDING,CHANGES,CONCLUSION,COX,EVALUATION,FDG,FIRST,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PERCENTAGE,PET,PURPOSE,RESULTS,SOLID
129,169,2015,AMONG,CONCLUSION,GRADE,LABEL,METHODS,NIVOLUMAB,NSCLC,OBJECTIVE,PROGRAMMED,PURPOSE,RANDOMIZED,RESULTS,SOCIETY,THREE
001,169,2015,649,CIS,CONCLUSION,EGFR,HRS,L858R,LABEL,METHODS,NEVER,OBJECTIVE,PFS,PURPOSE,RESULTS,SOCIETY,THESE,TKIS,WOMEN
169,182,1992,1993,2009,2015,538,772,CANCERS,CONCLUSION,LABEL,METHODS,NUTRITION,OBJECTIVE,PREVENTION,PURPOSE,QUIT,RESULTS,SOCIETY
169,2015,A549,AIM,ANNEXIN,COPYRIGHT,FURTHER,INC,JNK,KEY,LABEL,MAIN,MAPK,METHODS,MNQ,OBJECTIVE,OXIDATIVE,RESULTS,ROS,WESTERN
169,2015,945,947,BEAS,BOTH,COPYRIGHT,FURTHER,H446,IRELAND,LTD,NCI,RESULTS,THESE,TNF,U937
0MM,169,177,181,2015,945,954,CDKS,CHRONIC,COX,FURTHER,I3C,LPS,MICE,NNK,PRESS,PUBLISHED,SIL,THEREFORE,THESE,UNIVERSITY
160,INC,PUBLISHED,SDHX,TYPICAL
FURTHER,PRC2,RNAS,THESE
946,CAFS,FGF2,RIG,TGF
160,CISPLATIN,CONCLUSION,DDH1,H2O2,HOWEVER,JNK,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,ROS,SIMILAR,TREATMENT
2013,CLINICIANS,FORCE,LDCT,LUNG,NLST,PREVENTIVE,SCREENING,TASK,TRIAL
001,8805,BACKGROUND,BCS,COMPARISON,CONCLUSION,DIBH,LABEL,MATERIALS,METHODS,RESULTS,V10,V15,V20
001,136,1487,169,2015,2158,AIM,CONCLUSION,COPYRIGHT,CURRENT,ENF,ENFS,FORTY,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,REPORTS,RESULTS,SBRT,THERE,THESE
DOSE,MLC,VMAT
169,2015,ASIA,AUTHORS,FANCONI,ICL,LTD,PTY,PUBLISHING,SCIENCE,THESE,WILEY
169,2010,2012,2015,ACCORDING,BACKGROUND,BECAUSE,COPYRIGHT,EIGHT,INC,JANUARY,LABEL,LUNG,METHODS,RESULTS
169,2015,2297,3040,8201,946,ADDITIONAL,BACKGROUND,CARE,CONSORTIUM,CRC,HRQOL,LABEL,MCS,MEDICAL,METHODS,PCS,RESULTS,SOCIETY,TREATMENT
001,182,313,495,AMONG,BACKGROUND,KEYNOTE,LABEL,MERCK,METHODS,RESULTS
0001,0002,169,2005,2009,2015,8113,8201,BACKGROUND,HOWEVER,LABEL,METASTATIC,METHODS,MOST,NSCLC,OLDER,ONTARIO,PATIENT,RESULTS,SOCIETY,THOSE
000,0001,001,022,160,169,177,1998,2010,2015,658,995,BACKGROUND,BASE,COPYRIGHT,DATA,DELAY,DELAYED,HOWEVER,INC,LABEL,METHODS,NCDB,NSCLC,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,STRATEGIES,THOSE,TREATMENT
A549,AKT,APOPTOSIS,BACKGROUND,BAX,BID,CASPASE,DAPI,HOWEVER,LABEL,METHODS,MTT,NSCLC,PI3K,RESULTS,RYONG,SCRT,TANG,THESE,WESTERN
169,2015,956,A549,COPYRIGHT,INC,LUNG,PCR,RNAS
169,2015,956,CARROLL,COLIGAN,COMMITTEE,COPYRIGHT,ENSEMBL,FAIM3,FAS,FCMR,FCR,HOWEVER,IGM,INC,JOHN,MCANDREWS,MICHAEL,MOUSE,RUTH,SEAL,TOSO
BACKGROUND,BASED,DESPITE,HODGKIN,HOWEVER,LABEL,MBSR,METHODS,REDUCTION,RESULTS,STUDIES,WEAK
001,105,181,ARMS,BACKGROUND,CHINA,EGFR,HAN,L858R,LABEL,RESULTS,T790
160,169,1995,2012,2015,BACKGROUND,COPYRIGHT,DEFINITIVE,IIIA,IIIB,INC,LABEL,LOBECTOMY,METHODS,NONE,NSCLC,PUBLISHED,RESULTS,SALVAGE,SOCIETY,THERE
112,388,419,858,942,AMBER,AMONG,BACKGROUND,EGFR,EPIDERMAL,HOWEVER,L858R,LABEL,NSCLC,RESULTS,ROSETTA,STRUCTURAL,THESE
947,948
000,2011,213,249,375,415,501,541,672,833,BACKGROUND,CENTRAL,DESPITE,LABEL,LIFE,LOST,METHODS,REGARDING,RESULTS,SEYLL,YEARS
150,205,ALA205LEU,AMP,AMPS,CATHEPSINS,LEU205ALA,LUNG,MOLECULAR
AFTER,ASKIN,MOST
2013,3846,BACKGROUND,EGFR,ERK1,ERK2,HGF,LABEL,MET,RESULTS,SCC,SEVERAL,SSCS,THESE
DIETARY
185,554,604,677,681,710,715,739,744,748,760,766,781,784,837,839,897,923,AUC,CONCLUSION,FUDAN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2015,231,233,AFTER,COPYRIGHT,DOSE,FRAN,PEDIATRIC,PUBLISHED,SAS,SOCI
8202,EGFR,G719X,KEY,S768I,THEN,TKIS
100,8202,CECT,DIAGNOSTIC,FDG,HOUNSFIELD,NPV,PET,PPV,SPN,SUV
0001,169,2015,BACKGROUND,HISTORY,HNC,LABEL,METHODS,RESULTS,SPLC,SPLCS
0001,0005,0011,0125,016,0221,024,0311,0410,0424,0483,109,169,1A1,2015,3883,416,8314,ALDH1A1,BESIDES,BOTH,COPYRIGHT,FURTHER,HIGH,III,INC,LEUCINE,LGR5,NSCLC,PCR,TNM
CONCLUSION,DCR,FACTORS,III,LABEL,METHODS,NSCLC,OBJECTIVE,P4HB,RESULTS,TOTALLY,YCR,YIQI
223,A549,BACKGROUND,EPB41L3,INCUBATION,LABEL,MVS,NSCLC,RESULTS
120,160,BACKGROUND,CCL16,EMT,FEW,LABEL,RESULTS,SEVENTY
001,179,8201,8804,AFTER,FILIPINOS,HAWAIIANS,LABEL,MEAN,METHODS,NMR,OBJECTIVE,OBJECTIVES,RESULTS,WHITE
A2780,A549,BACKGROUND,BFU,FIRSTLY,HEPG2,LABEL,LEWIS,LLC,METHODS,MTT,MVD,NOTABLY,RESULTS,S180,TAFU,THEN,THESE
ABCC1,BACKGROUND,H446,H69,H69AR,HOWEVER,KCNJ2,KIR2,KIR21,KNOCKDOWN,LABEL,MAPK,MDR,MEK,METHODS,MRP1,PKC,RAS,RESULTS,SCLC
000,100,152,2007,2011,312,330,CDC,CENTRAL,CESSATION,LABEL,METHODS,POPULATION,RICAN,RICO,STATISTICS,UNLABELLED,USCS
ACCORDING,AIM,ASSESSMENT,BACKGROUND,BIA,BMI,CONCLUSION,FAT,FFMI,FMI,LABEL,METHODS,MINI,MNA,OBJECTIVE,OVERWEIGHT,RESULTS
169,183,197,2015,BIOLOGY,BPTI,INC,K13L,LYS,MOLECULAR,PPE,SHPI,SOCIETY,STRUCTURAL
0001,169,2015,452,ACADEMY,ASCT,CLASS,CONCLUSION,FATAL,IMPAIRMENT,LABEL,MAYO,METHODS,NEUROLOGY,NEUROPATHY,OBJECTIVE,POEMS,PREDICTED,RESULTS,ROCHESTER,SCALE,SCORE,SIX,SIXTY
169,2015,EPIDERMAL,EVALUATION,HOWEVER,L858R,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEVENTY,SOLID,THERE,UNIVERSITY
005,161,169,2015,926,BACKGROUND,COX,LABEL,LACK,MEIER,METHODS,RESULTS,SHS,SOCIETY,SPOUSAL,THERE
967
001,123,177,201,382,533,607,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THROMBOSIS
8805,AMONG,FURTHER,LABEL,METHODS,OBJECTIVE,POLYMERASE,RESULTS,TA5,TA7,UGT,UTG
180,212,AFB,CONCLUSION,DIAGNOSTIC,LABEL,METHODS,OBJECTIVE,RESULTS,WLB
160,169,2015,214,945,ABNORMALLY,AUTHORS,CHIP,DNM3,DRUG,EPO,FDA,FINALLY,FOOD,HIF,HRES,JOURNAL,PHT,PLACENTAL,PLGF,PPAR,SCD,SOCIETY,THESE,UTR
2003,2010,AE1,AE3,CAM5,CHINESE,CK5,CONCLUSION,HOWEVER,LABEL,METHODS,MOC31,OBJECTIVE,RESULTS,TEN,THERE,WILMS,WT1
001,100,176,2010,2011,738,967,ACADEMY,ARMS,BOTH,CHINESE,EGFR,EXTRACTED,FFPE,INSTITUTE,KAPPA,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SAMPLES,SCORPIONS
001,105,171,177,183,264,342,423,471,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,STRATIFIED,THERE
204,205,821,AFTER,CHINESE,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
CHEST,PTE
2015,ALECTINIB,ALK,COPYRIGHT,DUE,EML4,FDA,HOWEVER,III,JAPAN,NSCLC,PROUS,SCIENCE
001,003,169,2015,8201,AMONG,ANECDOTAL,BACKGROUND,EGFR,ERLOTINIB,EVALUATION,FACTORS,LABEL,METHODS,RESULTS,SOCIETY,SOLID,TTC
155,2000,2008,216,252,252A,307,341,460,471,946,956,994,ACADEMY,CHINESE,CONCLUSION,HAN,JANUARY,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,RFLP,SCIENCE,SMOKING,THERE,TNF,TOTAL
315,ACCORDING,AFTER,BALB,CONCLUSION,HIGH,LABEL,LINGTAI,METHODS,NTCU,OBJECTIVE,RESULTS,SPF,THERE
169,2015,BRITAIN,COPYRIGHT,GREAT,GREMLIN,IRELAND,JOHN,JOURNAL,LAVOZ,LTD,PATHOLOGY,PUBLISHED,SOCIETY,SONS,WILEY
15A,A549,CHICAGO,DUAL,GLO,MICRORNAS,NSCLC,PCR,SPSS,USA,UTR,WESTERN
0042,072,15Q25,169,2015,AMONG,BACKGROUND,COCHRAN,CONCLUSION,COX,GIVEN,LABEL,META,METHODS,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
169,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PULMONARY,RESULTS,SOCIETY,UNTIL,WHILE
169,COPYRIGHT,EWING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THREE
08113,22113,EORTC,HOWEVER,NSCLC,OUTLINE,SBRT,TREATMENT
0001,2001,2011,2015,2897,7593,8805,AMONG,BACKGROUND,BOTH,COMMITTEE,COX,DATA,GOVERNMENT,III,JOINT,LABEL,MEIER,METHODS,NSCLC,OLDER,PUBLISHED,RESULTS,USA
3466,8197,9122,BLLS,BMJ,BRITAIN,COX,CVD,FURTHER,GREAT,GROUP,IHD,LABEL,LIMITED,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR,SMRS
001,038,181,2002,2007,222,AFTER,COX,LABEL,LOBECTOMY,LUNG,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PROPENSITY,RESULTS,THESE,UNIVERSITY
18F,FDG,INSTEAD,LABEL,LINE,NSCLC,OBJECTIVE,PET,THESE,WHAT
001,006,018,025,041,049,2007,2011,441,ABSENCE,BACKGROUND,CONCLUSION,EASTERN,ECOG,EGFR,FIRST,FOLLOWING,GROUP,LABEL,METHODS,PEARSON,PFS,RESULTS,TKI,TKIS
1999,2009,449,480,8G7G3,CD56,CURRENTLY,HOWEVER,SPT24,TTF
BMJ,BRITISH,BTS,GROUP,GUIDELINE,HOME,LIMITED,PUBLISHED,PUBLISHING,SOCIETY
169,2015,ARRY,AZD6244,AZD9291,E63K,EARLY,EGFR,EGFRM,H1975,KRAS,MEK,NCI,NRAS,PC9,RESISTANCE,T790M
150,169,2015,CONCLUSION,EGFR,HSP,HSP90,LABEL,METHODS,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,SOCIETY,T790M
169,2015,AUTHORS,COPYRIGHT,CRP,FDG,IAEA,IRELAND,LTD,NSCLC,PET,PROJECT,PUBLISHED,RTP,THESE,TVD
001,007,130,169,2007,2012,2015,224,446,840,BACKGROUND,COLLEGE,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MST,OPERATIVE,PROPENSITY,PUBLISHED,RESULTS,SHORT,THERE,VATS,VIDEO
CHEST,THERE
2009,2010,206,DIAGNOSTIC,HISTOLOGIC,KARNOFSKY,LUNG,MONTENEGRO,SPECIAL,SURGERY,THERE
013,032,036,042,045,124,197,2100,AGILENT,BACKGROUND,LABEL,METHODS,MIR,NSCLC,RESULTS,TOTAL
AIM,BACKGROUND,CONCLUSION,IIB,IIIB,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PRIMARY,RESULTS,THEIR,WORLD
8212,946,FOXQ1,INCREASED,LAMA4,THESE,THROUGH
169,2015,4AI,593,ATP,COPYRIGHT,DENV,DENV1,DENV2,DENV3,INC,NS4A,PKR,RNAI
MALIGNANT
100,169,183,2015,315,AFTER,BACKGROUND,BESIDES,COMPLIANCE,COPYRIGHT,FTE,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SELECTION
160,AIM,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,RESULTS
946,CEA,PCR,PLC,TGF
LUNG,PTN,TNM
169,173,2015,8201,AUTHORS,CCL20,CLINICALLY,COPYRIGHT,IRELAND,LTD,NNK,PUBLISHED,THESE,TOBACCO
019,110,150,169,2009,2013,2015,967,AUTHORS,COPYRIGHT,FEW,GROUP,HODGKIN,IMRT,INC,LABEL,MATERIALS,METHODS,NHL,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,RADIATION,RESULTS,RISK,RTOG,SEVERAL,THERAPY,THESE,V10,V15,V20
0001,004,038,169,2015,AER,CARDIAC,COPYRIGHT,CRT,DISEASE,HODGKIN,INC,LABEL,LAR,LUNG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VMAT
169,2015,AUTHORS,COMMISSION,COPYRIGHT,ENL,ENLS,EXTRANODAL,GROUP,HODGKIN,ICRU,ILROG,INC,NHL,ORGAN,PUBLISHED,RADIATION,THUS,UNITS
169,2015,8805,ADDITIONAL,ANK2,ASPM,ASTN1,CSMD2,EXOME,EXPRESSION,FBN3,MUTATED,PRESS,PTEN,PUBLISHED,RB1,SCLC,SCLCS,SMALL,SPTA1,THEREFORE,TP53,UNIVERSITY
007,027,035,169,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HIGH,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SKAP2,SRC,THEREFORE
135,169,2003,2013,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EPIRUBICIN,INSTITUTE,JOHN,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,SCLC,SIXTY
169,2015,AIM,AKT1,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DUAL,INSTITUTE,JOHN,LA1,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PDCD4,PEI,RESULTS,SDA,THEREFORE
169,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,IC50,INSTITUTE,JOHN,L858R,LABEL,LUNG3,LUNG6,LUX,MATERIALS,METHODS,MTT,NSCLC,RESULTS,TKI,WESTERN
100,143,155,169,2015,210,372,AIM,ANTICANCER,BAL,CLUSTER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2015,CELLS,COPYRIGHT,FALLS,IGUASSU,OVERALL,PAN,SOCIETY,THESE,THUS
001,140,169,2004,2011,2015,8805,CONSORTIUM,GRADE,LABEL,MEDICAL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SAPPORO,THERE,UNIVERSITY
2006,2010,379,ADDITIONAL,CENTRAL,CONCLUSION,CSO,LABEL,METHODS,NUTS,OBJECTIVE,PETO,RESULTS,SAM,UNIVERSITY
169,1DAY,2004,2011,2015,2356,30DM,6334,915,972,APRIL,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FACTORS,IQR,IRELAND,JANUARY,LABEL,LTD,METHODS,NHS,OVERALL,PUBLISHED,RESULTS
1424,836,864,AMONG,ATLAS,AUC,BACKGROUND,CHIP,CPG,EPIGENETIC,HOWEVER,LABEL,METHODS,RELIEFF,RESULTS,SEQ,SEQUENTIAL,TCGA,TSS1500,VARIOUS
AMONG,ANGPTL5,ATLAS,C7ORF16,DAVID,DEGS,EDN3,FUNCTIONAL,GJB6,GPCR,III,IL1F5,LAC,LOC150622,PPI,USH1G,WNT
143,2008,2013,AIM,BACKGROUND,BEST,DISTANT,LABEL,METHODS,NODAL,OBJECTIVE,PET,RESULTS,SIXTY,SKIP,TOMOGRAPHY,VALUE
ATS,BASED,BOTH,DIAGNOSTIC,IDSA,LADY,MAC,NTM,PTNB,SPN,SPNS,WINDERMERE
163,BACKGROUND,DENDRIX,FURTHER,LABEL,LARGE,MAXIMUM,METHODS,MULTI,NBM,P53,PROBLEM,RAS,RESULTS,RME,RTK,SUB
169,2015,946,A549,APE1,BASED,COPYRIGHT,ECM,ENDOGENOUS,FN1,HELA,INC,LAMC1,TGF,TGFB1,THESE
169,2015,A549,AUTHORS,CAM,CAS9,CHOP,COPYRIGHT,EGFR,GADD153,GEF,GEFITINIB,GRP78,H226,INC,K562,KNOCKDOWN,MEF,NSCLC,PUBLISHED,THESE
169,2015,946,947,CD8,ELICITING,GENERATED,IFN,RADIATION,TGF,THUS
AIDS,AMERICANS,GREATER,HIV,INSTITUTES,NIH
169,2015,CONCLUSION,DIXON,FDG,FINALLY,FIVE,GMM,IMAGING,INC,LABEL,METHODS,MLAA,MOLECULAR,MRAC,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
116,148,169,2015,226,384,712,AMONG,BACKGROUND,BAL,CONCLUSION,COPYRIGHT,EBLB,ILDS,INDIA,LABEL,METHODS,PUBLISHED,RESULTS,TBLB,TBNA
COLORECTAL,ERSPC,FOUR,GROUP,LUNG,OVARIAN,PIVOT,PLCO,PSA,RANDOMIZED,SCREENING,SPCG,TRIAL
ANTI,DRUG,FOOD,HODGKIN,THERE
176,177,945,954,A549,BACKGROUND,BCL,CONCLUSION,H2O2,HIF,HMGB,IRI,LABEL,LEWIS,METHODS,PHOSPHO,RECIPIENTS,RESULTS,SOLTRAN,TLR,UPON,XENON
0001,0008,150,169,2015,254,519,595,746,8804,8805,CHINA,CHINESE,COX,EASTERN,GROUP,IIIB,LABEL,LUNG,METHODS,NON,OBJECTIVE,PHASE,PRESS,PUBLISHED,RESULTS,STAGE,TARCEVA,TREATMENT,TRUST,UNIVERSITY
0001,169,200,2015,230,ALK,EACH,LADC,LADCS,RET,ROS1,SNF,SWI,THESE,WHOLE
0310,0371,0430,0479,0590,108,169,2015,AKT,AKT1,AKT2,AKT3,ASIA,AUTHORS,BECAUSE,EXPRESSION,FISH,LTD,PTY,PUBLISHING,SCIENCE,WILEY
371,ACA,ANGIOGENIC,CAM,CD105,CD34,EXPRESSION,EXTENSIVE,LOW,MEL,MVD,NSCLC,SCC,VEGF
169,2015,ALSO,ANALOGOUS,ANGPTL7,ATLAS,CD11B,CONCLUSION,EXPRESSION,HEPATIC,LABEL,LEWIS,LIVER,MC38,MYELOID,UNLABELLED
231,954,H1339,HSF1,HSP90,INHIBITION,MDA,MICA,MICB,NKG2D,NVP,NZ28,SP1,T47D,THEREFORE,THESE
ACCORDING,AFTER,CONCLUSION,ERM,GV248,LABEL,LENTI,LENTIVIRAL,LENTIVIRUS,METHODS,MOI,OBJECTIVE,PCR,RAT,RESULTS,WESTERN
104,145,169,2015,279,COLD,DEPENDING,FOXM1,FUNCTIONAL,HOWEVER,LABORATORY,MITRA,PRESS,PUBLISHED,SOCIETY,USING

169,2015,COPYRIGHT,INC,KEAP1,MSH3,PMS1,TP53,WHOLE
A549,ANNEXIN,CCK,CELL,FITC,GINSENG,HCS,RADIX,REAL,RHIZOMA,SALVIAE
CLONTRACER,HOWEVER,RESISTANCE,THESE,THUS
DIFFUSE,MLNS,PULMONARY,THESE,VATS
NPM1,PARP1,RNAS,USING
REDUCED,S203,S211
169,2015,8804,AMONG,CHILDHOOD,CONCLUSION,DIFFUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SURVIVORS,THESE
DIAGNOSIS,EVEN
001,005,169,2007,2009,2015,367,711,8201,8805,ACUTE,BACKGROUND,END,HOWEVER,IRR,LABEL,MATCHED,METHODS,MORTALITY,NSCLC,OVERALL,POISSON,RESULTS,SBRT,SOCIETY
157,158,169,2015,245,248,249,273,AUTHORS,BAP,BPDE,COPYRIGHT,CPG,FOLLOWING,FURTHER,HIMA,HUF,HUFS,HUPKI,NER,NULL,PUBLISHED,SOMATIC,THEREFORE,TP53,WHILE,XPA
169,2015,ARG,BIOLOGY,EMT,HOWEVER,INC,MOLECULAR,PRMT1,PROTEIN,SOCIETY,TAKEN,THEREFORE
AIR,FEW,ILD,THERE
169,2015,COPYRIGHT,EGFR,LTD,LUNG,NSCLC,SCLC
ALTERED,FIBULIN,MICE,PVA
180,1998,2011,210,240,AIM,BACKGROUND,BLOOD,CERVICO,CONTROL,LABEL,METHODS,NEITHER,OBJECTIVE,RESULTS,SIX
140,FBP1,THERE
002,1999,2008,AIDS,ART,BACKGROUND,CONVERSELY,HIV,HODGKIN,IRR,JOINT,KAMPALA,LABEL,METHODS,NATIONS,POISSON,PROGRAM,RESULTS,SAHARAN,THESE
169,2015,COPYRIGHT,EMT,INC,NSCLC,TRIPARTITE
169,2015,30D,CCNE2,COPYRIGHT,IRELAND,LTD,MICRORNAS,NSCLC
160,169,2015,CONSISTENT,COPYRIGHT,EFFECTORS,INC,KRAS,NSCLC,PDAC,RAC,TRAIL
ADC,CPG,DMGS,DMLS,FUNCTIONAL,MOST,SCC,TCGA,THEN,USING
2006,2010,204,347,4118,856,LUNG,POPULATION,POTENTIAL,PYLL
DATA,NATURAL
169,2015,ALK,AMONG,BRAF,COPYRIGHT,DDR2,EGFR,FGFR1,HER2,KRAS,LTD,MET,NSCLC,RET,ROS1
160,169,2015,60GY,COPYRIGHT,HOWEVER,III,LOCALLY,METASTATIC,PUBLISHED,SAS
169,2015,AFTER,COPYRIGHT,INC,LOBECTOMY,PUBLISHED,SOCIETY
169,2015,AFTER,COPYRIGHT,GENERALLY,HOWEVER,INC,PUBLISHED,SOCIETY
169,2015,COPYRIGHT,INC,PRIMARY,PUBLISHED,SOCIETY
169,2015,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2015,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2015,COPYRIGHT,GIVEN,INC,LUNG,PUBLISHED,SOCIETY
001,021,100,1026,169,2015,268,826,COPYRIGHT,INC,LABEL,MALIGNANT,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SPN,SPNS,SURGERY
169,2003,2014,2015,ADVERSE,COPYRIGHT,DFS,DISTANT,DLCO,FEV1,INC,JULY,KARNOFSKY,LABEL,LRC,LUNG,MATERIALS,MEAN,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,THREE,TOXICITIES,TREATMENT
169,2015,COPYRIGHT,III,MEDLINE,PUBLISHED,SAS
107,169,2015,COPYRIGHT,INC,LABEL,LOW,METHODS,NUCLEAR,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY
169,2015,AKT,COPYRIGHT,ERK,HUVEC,INC,MAPK,NSCLC,PD0325901,PI3K,SINCE
500,8201,916,945,956,968,A549,BACKGROUND,BAX,BCL,CLEAVED,CONCLUSION,DEX,ERK1,H2O2,LABEL,METHODS,OXIDATIVE,RESULTS,ROS,THEIR
COLON,EXPERIMENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
026,169,2015,3X10,5942,8086,BRCA2,LATIN,PRESS,PUBLISHED,SNP,UADT,UNIVERSITY
2013,2014,FIVE,HOWEVER,JANUARY,OCTOBER
1030,125,169,2007,2015,228,283,327,373,624,658,677,725,729,799,874,COX,FURTHER,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
001,500,8804,8805,945,946,BACKGROUND,BED,DMAX,DMEAN,DOSE,HEART,LABEL,LADCA,METHODS,OARS,RESULTS,RTOG,V10,V100,V103,V105,V14,V90,V95
187,AIMS,BACKGROUND,CLINICIANS,DETECTION,ITALIAN,LABEL,LUNG,METHODS,MILD,OBJECTIVE,RESULTS,TRIAL
0001,026,100,116,1362,139,169,2015,374,704,ASSESSMENT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSI,RSIS,SBRT,SIXTY,THESE
0038,0089,1041,169,1998,2005,2015,230,233,584,COPYRIGHT,DOSE,IIIA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
001,004,064,108,130,2009,2014,238,569,8202,AFTER,CONVERSION,FEW,INTUBATED,OVERALL,SEPTEMBER,TEA
001,002,006,034,113,771,8202,954,IIP,NTM
109,129,361,554,745,AMONG,DESPITE,HCV,INCREASING,WHETHER
99M,CURRENT,FDG,FIVE,HOWEVER,MDP,NAF,PET,WBBS
000,071,099,100,102,112,124,130,152,168,169,174,1950,2005,2015,617,945,AFTER,BLOOMBERG,HOPKINS,HOWEVER,JOHNS,PLATEAU,PRESS,PUBLISHED,UNIVERSITY
169,2015,2AND,946,AUTOPHAGY,COPYRIGHT,FOXO1,GAL,GMBH,HDAC1,IMR,NRF,SIRT1,SIRT6,THEREFORE
1930S,1950S,PAP,SINCE
100,AMONG,BRAF,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,PNA,PTC,PURPOSE,RESULTS,SEVENTY,THESE,V600E
485,7TH,CONCLUSION,EIGHT,FIVE,GENERAL,LABEL,LUNG,METHODS,MRI,OBJECTIVE,OPERATIVE,RECORDS,RESULTS,RULES,THREE
BECAUSE,CASE,RCC,UNDER
101,1997,2014,934,BMS,DES,HOWEVER,INCREASING,MARCH
2007,ACCP,CHEST,COLLEGE,PHYSICIANS,SINCE
047,2005,2014,AMONG,APRIL,ASPIRIN,EIGHT,MARCH,THREE
005,1997,2014,ACCORDING,AMONG,BACKGROUND,IHD,JANUARY,JAPAN,JUNE,LABEL,LOBECTOMY,MATERIALS,MEN,METHODS,RESULTS,UNIVARIATE,UNIVERSITY,VIDEO
135,2005,2012,DRUGELUTED,IHD,ORAL,SHORT,THERE,THESE,VSA
FIFTEEN,HOWEVER,LUNG,THESE
2010,2013,458,BETWEEN,FORTY,SHORT,THERE
001,005,023,024,177,2010,2014,467,APRIL,CONCLUSION,DATA,FIFTY,LABEL,MARCH,RESULTS,THERE,UNLABELLED
2014,399,411,418,ASIAN,BIOLOGY,CHINESE,THEIR,WANG,XRCC1
169,2007,2012,2015,2184,442,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
0617,100,1274,169,196,2003,2007,2015,225,497,552,72GY,8804,8GY,BED,BIOLOGICAL,COPYRIGHT,COX,DOSE,EFFECTIVE,GROUP,III,INC,IQR,LABEL,MATCHED,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,THERAPY,THERE
169,1D11,2015,946,947,A549,ATM,CELLS,COPYRIGHT,H1299,H292,H2AX,INC,INHIBITION,LABEL,LEWIS,LLC,MATERIALS,METHODS,MICE,NCI,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,TGF,THESE,TRP53
231,946,956,HOWEVER,HSA,IC50,MANNICH,MAP,MDA,THREE
BAL,CHEST
FOLLOWING,MCNS,MINIMAL,THEREFORE,TKI
FNAB

ABDOMINAL,NOMI,PHYSICIANS,SEVEN,THEREFORE
137,160,169,2015,250,53BP1,8804,947,956,BRAGG,BRCA,CALU,COPYRIGHT,FANCONI,FIVE,GROWING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RAD51,RBE,RESULTS
000,160,169,1989,2005,2015,836,COPYRIGHT,EAR,INC,LABEL,LRRT,LRT,MATERIALS,METHODS,MVA,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SIR
HOWEVER,PCR,REAL,SGMS1,SMS1,TIME
104,172,177,181,198,204,226,300,393,74YEARS,ASA,EACH,ECG,ILL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,P4E,POAF,RESULTS,THESE,UNLABELLED
2008,2012,CONCLUSION,DEPARTMENT,HOWEVER,LABEL,METHODS,OBJECTIVE,PULMONARY,RESULTS,SEPTEMBER,SURGERY,THERE
489,CELL,EMT,HOWEVER,INHIBITION,LUNG,NON,NSCLC,RNAS,SMALL,SUZ12,WESTERN
125,169,2015,8804,ADC,AIM,ALK,ATS,BASEL,EGFR,ERS,FISH,IASLC,KRAS,L858R,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SOCIETY,THESE
GPCRS,ONCE,S1P,WHILE
124,2002,2010,317,513,CONGESTIVE,HOWEVER,INPATIENT,RISK,THERE
308,473,AKT,ALDH1,CD133,NSCLC,PTEN,SER,SGPP1,SNX1,TARGETING,THR
169,2015,629,ACIDS,META,NUCLEIC,PRESS,PUBLISHED,UNIVERSITY,USING
101,103,105,109,12H,158,8734,AUC,BACKGROUND,BOTH,COMPARISON,CONCLUSION,HPLC,LABEL,MATERIALS,METHODS,RESULTS
169,2015,2327,ALSO,BACKGROUND,DATA,FNA,LABEL,MEDICAL,METHODS,PANCREATIC,RESULTS,SOCIETY,THERE
169,2015,CD1A,CD207,DESPITE,HEMATOLOGY,LANGERHANS,LCH,REGARDLESS,SOCIETY
1975,DIAGNOSIS,DIAL,HOWEVER,PEH,PET,THERE
ABOUT,CHEST,COP,DESPITE,HOWEVER,NIP,VIDEO
143,169,2015,BACKGROUND,COPYRIGHT,CPG,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
0006,001,002,003,169,2015,AFTER,BACKGROUND,C30,COPYRIGHT,CORE,EPD,HRQOL,INC,LABEL,LIFE,MAXIMAL,METHODS,PUBLISHED,PULMONARY,QUALITY,RESULTS,SOCIETY,TREATMENT,WORLD
121,147,169,177,198,2011,2014,2015,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE,VATS
169,2015,BACKGROUND,COPYRIGHT,FEW,FIVE,INC,LABEL,LUNG,METHODS,PUBLISHED,RESULTS,SOCIETY
169,2015,BOTH,COPYRIGHT,DARWINIAN,OWING,PUBLISHED
169,2015,231,946,CDK5,COPYRIGHT,EMT,FAK,IRELAND,LTD,MDA,PACLITAXEL,STRIKINGLY,TAKEN,U87VIII
116,956,A549,ANOTHER,BOTH,EC50,H1299,HCT,MEL2,ROS,SAN4601,SAN5201,SAN7401
169,2015,CD94,COPYRIGHT,DNAM,DNAX,HLA,HOWEVER,INC,LFA,NKG2A,THUS,UPON
169,2015,COPYRIGHT,CURRENT,LTD,LUNG,RNAS
100,169,1993,2011,2015,291,ACCORDING,BACKGROUND,COPYRIGHT,GGO,HRCT,INC,LABEL,METHODS,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,TYPE
0001,0004,0005,0018,109,169,2005,2011,2015,BACKGROUND,COPYRIGHT,COX,DLX4,EVEN,INC,JUNE,LABEL,METHODS,METHYLATED,NSCLC,PUBLISHED,RESULTS,SOCIETY,SURGERY,THUS
169,177,2015,BACKGROUND,CONCLUSION,COPYRIGHT,DEFORMABLE,DICE,DIR,ELASTICITY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MPN,MPNS,OBJECTIVE,PURPOSE,RESULTS,VOLUMES
169,2012,2013,2014,2015,ACADEMY,ADDITIONAL,BACKGROUND,BASEL,CAPE,DATA,GROUP,IAC,IMIG,LABEL,METHODS,OBJECTIVE,PARIS,RATIONALE,REFERENCE,SOURCES,TOWN
169,2015,COPYRIGHT,INC,MALIGNANT,MPM,SEVERAL,THESE
169,2015,33324,8243,946,A549,ACGC,ANNEXIN,BAD,BAX,BCL,COPYRIGHT,FITC,H1299,HOECHST,IC50,IRELAND,LTD,MTT,NCI,WESTERN
1045,1046,1047,169,2015,A549,AMONG,COPYRIGHT,EGF,EGFR,IRELAND,LTD,RG3,THESE,THROUGH
169,2015,CELLULITIS,COLLEGE,PHYSICIANS,ROYAL
100,945,946,AMRUBICIN,FEBRILE,GRADE,NSCLC,ORR
001,100,120,169,2012,2013,2015,480,600,ADDITIONAL,ASPIRATES,BASEL,CHINA,EBUS,JAPAN,JUNE,LABEL,LBC,METHODS,OBJECTIVE,OL8,OLYMPUS,RESULTS,SEPTEMBER,TBNA,TOKYO,WEST
215,ABDOMINAL,CLOSE,FIFTEEN,MAIN,THERE,TREATMENT
ACCORDING,AIM,BAL,BASED,CONCLUSION,FOUR,LABEL,LATER,LUNG,METHODS,OBJECTIVE,RESULTS,THREE,TREATMENT,USG
1995,2009,ADULT,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SHAUKAT,SPSS
CHEST,FIBREOPTIC
100,178,8804,AMONG,BACKGROUND,EGFR,GEFITINIB,INDIA,KARNOFSKY,LABEL,LIMITED,METHODS,MOST,NORTH,NSCLC,OCCURRENCE,ORAL,RESULTS,TKI,TKIS
160,947,DOTA,DOTATOC,HOWEVER,PHE,TAKEN,THEIR,TYR
BACKGROUND,LABEL,METHODS,PCB,PCBS,RESULTS,THESE
954,EPIGENETIC,IRX1,MEDIP,THESE,USING
945,INHIBITION
169,2015,8201,8804,8805,987,COX,F2RL3,HARRELL,HRS,MASSARRAY,SMOKING,THESE,UICC
0001,169,2015,207,8201,ATP,COX,GLN,GPNA,NSCLC,TARGETING,THESE,UICC
A549,AFB1,AKT,ERK,ERK1,IGF,IRS,IRS1,IRS2,SPCA,SRC,TREATMENT,WESTERN
001,016,024,043,065,072,078,115,127,1600,177,2012,2013,453,547,813,814,816,8201,946,ELISA,FIRST,JULY,NSCLC,OCTOBER,PLT,TGF,THEREFORE,VEGF
103,946,CLAUDIN,DECREASED,SIMILARLY,SQCC,TNM,UNIVARIATE
008,033,034,038,041,115,8201,946,954,COX,DFS,EXPRESSION,IHC,NUCLEAR,THUS
169,16HBE,2015,BPDE,HOWEVER,INC,LOC728228,LUNG,PCR,RNAS,WILEY
169,2015,COPYRIGHT,INC,LESS,NSCLC
1007,1014,160,169,1ST,2015,231,233,ALK,AP26113,COPYRIGHT,EGFR,EML4,FRAN,HOWEVER,III,KRAS,NSCLC,PROFILE,PUBLISHED,SAS,SOCI
169,2015,490,A549,BCL,CCND1,CDK1,COPYRIGHT,DUAL,FEDERATION,FIGO,GYNECOLOGY,IRELAND,LTD,MIR,MMP2,OBSTETRICS,P53,SMARCD1,THESE
293,711,861,CONCLUSION,EGFR,FIFTY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
001,005,008,017,026,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PKM2,RESULTS,TNM,WESTERN
008,084,100,157,178,185,298,356,453,474,501,692,8312,8313,8805,927,967,CONCLUSION,EUR,FDG,LABEL,METHODS,MIBI,NPV,OBJECTIVE,PET,PPV,RESULTS,ROC,SNPS,SPECT,SPNS
177,CONCLUSION,LABEL,METHODS,MWA,OBJECTIVE,RESULTS,SEVEN,ULTRASOUND
BACKGROUND,INCREASING,LABEL,METHODS,NONCODING,NSCLC,RESULTS,RNAS,SNHG1
2000,2013,AFTER,BACKGROUND,COMPARING,GEFITINIB,LABEL,LIBRARY,MATERIALS,METHODS,NSCLC,ORR,PFS,RESULTS,THERE
300,500,CONCLUSION,DDP,ELISA,LABEL,METHODS,MPM,OBJECTIVE,ORR,PFS,RESULTS,THERE,TOXICITIES,VEGF
449A,FURTHER,L9981,LABEL,LUNG,MATERIALS,METHODS,MICRORNAS,NEAT1,OBJECTIVE,PCR,RESULTS,RNAS
BACKGROUND,CHINESE,CNKI,COLLEGE,CONCLUSION,ENGLISH,III,LABEL,LUNG,MATERIALS,METHODS,NSCLC,RESULTS,STATA,STATION
945,947,BARRETT,DUOX1,DUOX2,KNOWLEDGE,NADPH,NOX,NOX1,NOX4,NOX5,NOXS,ROS
169,176,2015,257,BACKGROUND,BOTH,CBCT,CBCTS,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MMFD,NCC,OBJECTIVE,PURPOSE,RESULTS,USING,VPE
169,2015,COPYRIGHT,COX,DESPITE,INC,NSCLC,SILENCING,USP22
169,2015,4DCT,4DCTS,8804,BECAUSE,COPYRIGHT,FEV1,FOUR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFT,PFTS,PULMONARY,PURPOSE,REGRESSION,RESULTS,V20,VALIDATION
12PG,131,162,169,2015,20NG,214,323,500PG,504,50NG,71PG,AIMS,COPYRIGHT,DIAGNOSTIC,DTC,INC,KEY,LABEL,MAIN,MEIER,METASTASIS,METHODS,MIDKINE,OBJECTIVE,PRE,PROGNOSTIC,RESULTS,ROC
100,2010,2014,375,CNB,CNBS,JANUARY,JUNE,MOLECULAR,ROUGHLY
1087,169,178,2015,AIM,BMI,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,RESULTS
169,2015,946,ABL,ABL1,ABL2,ARG,HEART,INC,THESE
169,2015,ALLOGENEIC,BOTH,CONSISTENT,DLI,GVHD,GVL,HEMATOLOGY,MEMBERS,SOCIETY,TREG,TREGS
019,169,2015,BRAF,CONCLUSION,DTC,DTCS,FDG,FORTY,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PDTC,PDTCS,PET,RESULTS,SOCIETY,THERE,THESE,THYROID,UNLABELLED,V600E
169,2015,COPYRIGHT,INC,STUDIES,THESE
100,169,200,2015,518A2,956,CEO2,CONP,COPYRIGHT,DATA,DECREASED,DLD1,FREE,FURTHER,H460,HACAT,HOWEVER,IC50,IRELAND,LTD,MRC,NCI,ROS,SELF,TEMPONE,TXR
100,169,2015,250,53BP1,8805,956,A549,CAPSAICIN,COPYRIGHT,DU145
169,2015,360,386,400,ALK,ALKEX20,AMONG,COPYRIGHT,DCTN1,DETECTION,EGFR,EML4EX6,FISH,IRELAND,LTD,NEXT,NSCLC,OVERALL,PCR,PUBLISHED,SYSTEMATIC
ALK,DETECTION,EGFR,III,KRAS,NSCLC,PPMA,PRIMARY,SEVENTY
001,005,169,2008,2010,2011,2015,353,BACKGROUND,COPYRIGHT,COST,EXCLUDING,HCUP,HEALTHCARE,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,PROJECT,QUALITY,RESULTS,USING,VATS
2012,2014,65291,AFTER,CD20,CHOP,HODGKIN,JULY,UNDER
100,2005,2010,945,AFTER,OVERALL,RCC
CBDCA,IIIA,PFS,PTX
DTX,PTX,THEREFORE
CK7,HOWEVER,SUBSEQUENT,THEREFORE
HER2,STAGE
HOWEVER,PACLITAXEL,PFS
CARVEDILOL,FURTHER,JOINT,NADPH,PHYCB
114,8201,945,950,CACO,CALU,HACAT,HDF,MANGOSTIN,MCF,MTT,NMR
DESCRIBED,HDAC,NOTABLY,RUNX,RUNX3
EACH,THERE
1960,2010,DATA,RESPONSES,RESULTS
176,177,8201,8805,CONCLUSION,CT0,CT20,D95,DIR,DOSE,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PLAN,PTV,RESULTS,THREE
169,2015,945,946,AAN,AKT,BRITAIN,COPYRIGHT,CTGF,GREAT,HOWEVER,IRELAND,JOHN,LTD,PAI,PTEN,PUBLISHED,SER15,SIMILARLY,SMA,SMAD3,SOCIETY,SONS,STZ,TGF,THUS,TUBULAR,UUO,WILEY
COMPETING,GRAPHICAL,MRE,MRES,RNAS,THEREFORE,UTR,UTRS,VIA,WHILE
169,2015,A549,AKT,CLEAVED,ERK1,EXPRESSION,FPPC,HOWEVER,LEC,LM2,VEGF,VEGFR
169,2015,ANEUPLOIDY,CDK2,CELLS,CP110,KRAS,LIVE,MECHANISMS,THUS
169,2015,8201,CDC20,CELL,INC,PLK1,SIXTY,WEBGESTALT,WILEY
169,2015,CONCLUSION,CXCR4,DEN,HCC,LABEL,LIVER,MMP,MMP10,MMPS,PREVIOUSLY,SDF1,UNLABELLED
100,BAX,CASPASE,CD95,CONCLUSION,FURTHER,GEME,H441,KLF5,LABEL,LUNG,METHODS,OBJECTIVE,PCR,RESULTS,UNDER,WESTERN
A549,ANNEXIN,BACKGROUND,FLOW,IAPS,LABEL,METHODS,PCR,RESULTS,SMAC,TAXOL,THERE,WESTERN
AKT,ALK,BRAF,DRUG,DUAL,EGFR,FRA1,RAF,THUS
HOWEVER,NSCLC
001,008,032,113,8805,FISH,GCN,GCNS,HIGH,INCREASED,LABEL,MATERIALS,METHODS,MYC,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SCC,TERC,UCCC,UNIVERSITY
AMONG,CHD1,EIF3L,KAP1,KRAS,RNAI,SUMO,THUS,UBC9
169,2015,231,BAPTA,BIOLOGY,CELL,ENO,GOLGI,INC,LPS,MDA,MOLECULAR,ORAI,ORAI1,SOCIETY,STIM,STIM1,THESE
152,170,200,247,274,280,291,300,320,690,956,AFTER,AKT1,CATLE,CDH1,EMT,ERK,ERK1,HIF1A,HMOX1,HPL,INC,INCREASED,INORGANIC,KRAS,MMP2,MT1A,MT2A,PTEN,PUBLISHED,SLC38A3,THUS,VIM
169,2015,COPYRIGHT,INC,MITF,PECOMAS,TFE,TFE3,THERAPY
CURRENTLY,ELISA,HOWEVER,SMOKING,THUS,TOF
BACKGROUND,CASE,CONCLUSION,FISH,LABEL,METASTATIC,METHODS,THEREFORE,URINE
ACR,COLLEGE,IIIA,INDUCTION,LITERATURE,LUNG,PANEL,PORT,RADIOLOGY,THERE
169,2012,2015,CONCLUSION,HIGH,HIPAA,III,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PATIENT,PURPOSE,RESULTS,RSNA
2002,945,BECAUSE,CMPT,CMPTS,HNF4,TEN,TTF
12A,169,2015,945,946,AMONG,CCL5,H1N1,INC,MRC,TNF,WILEY
2002,2005,2015,2098,BACKGROUND,IIA,IIB,IIIA,IIIB,ITALY,LABEL,METHODS,POPULATION,PRESS,PUBLISHED,RESULTS,RISK,THESE,UNIVERSITY
032,8201,AMONG,MALT,PFS,PRIMARY
169,2015,APMIS,CD34,CK19,DESPITE,EMA,INI1,INTRA,JOHN,LTD,MRI,PUBLISHED,PVNS,SONS,WILEY
169,183,2005,2011,2015,300,329,332,661,AFTER,BACKGROUND,COPYRIGHT,FEB,FUNDING,JULY,KARNOFSKY,LABEL,LTD,MERCK,METHODS,RESULTS,VORINOSTAT
169,2015,348,ACIDS,CBP,EZH2,FURTHER,H3K27,HOWEVER,K348,NUCLEIC,P300,PCAF,PRC2,PRESS,PTMS,PUBLISHED,SIRT1,T345,T487,UNIVERSITY
2005,2013,229,248,477,CELSIUS,IASI,INSTITUTE,JANUARY,JULY,LOCAL,MRI,RADIOLOGY
169,2015,FINALLY,G3BP1,SGS,UNDER,UTR
2007,2013,212,225,252,257,FNAC,MOST
COLORECTAL,DUE,EBOLA,EVEN,PREVENTION,PRITELIVIR
AREAS,BACKGROUND,COVERED,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,OPINION,PROTEOMIC
191,2012,2014,BENEFICIAL,CHINESE,FURTHER,PAIN,PARKINSON,PHYSICIANS,RCTS,TAI
115,169,2015,BAP1,COPYRIGHT,IONTORRENT,MALIGNANT,PUBLISHED,THERE
100,188,ACTIVIN,THEN,TNM
169,2015,A549,BIBX1382BS,CONCLUSION,COPYRIGHT,EGF,EGFR,FUNCTIONAL,H1299,H3122,H460,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SINCE,STRIKINGLY
005,007,023,027,033,046,10878,110,169,1991,2012,2015,331,808,ACCORDING,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,GROUP,IRELAND,LABEL,LTD,LUNG,MALIGNANCY,MASAOKA,METHODS,RECURRENCE,RELAPSE,RESULTS,WORLD
1115,169,2015,CONTINUOUS,HOWEVER,LDCT,LOW,LUNG,PRESS,PUBLISHED,SMOKING,TEST,THESE,UNIVERSITY
001,130,140,165,166,169,1991,2007,2015,313,529,852,977,AMERICANS,ASIAN,BACKGROUND,BECAUSE,CHINESE,CSM,DESPITE,END,FINE,GRAY,HAWAIIANS,KOREANS,LABEL,METHODS,PACIFIC,PAKISTANI,PRESS,PROGRAM,PUBLISHED,RESULTS,SOUTH,THESE,UNIVERSITY,VIETNAMESE
005,029,047,102,169,2006,2010,2015,222,508,578,896,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,HCC,INC,JANUARY,KOREA,LABEL,MEDICAL,MEIER,METHODS,PIVKA,RECURRENCE,RESECTION,RESULTS,SAMSUNG
169,2013,2015,231,233,6880,8329,BACKGROUND,CAUCASIANS,CHINA,CNKI,COPYRIGHT,DATA,FRAN,HOWEVER,KNOWLEDGE,LABEL,MEDLINE,METHODS,OVERALL,PUBLISHED,RESULTS,SAS,SOCI,STRATIFIED,THERE,THR241MET,TOTAL,XRCC3
BEIR,BIOLOGICAL,COMMITTEE,CONCLUSION,EFFECTS,END,EVEN,INCREASES,LABEL,LOSS,MATERIALS,METHODS,OBJECTIVE,RADIATION,RESULTS,SCREENING,SEER,VII
100,120,15TH,177,8805,CONCLUSION,FBP,FIFTY,FOUR,IMAGE,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,TEST
041,1323,141,177,242,CHEST,CONCLUSION,FOUR,HEALTHCARE,I30F,I70F,INDIVIDUAL,ITERATIVE,LABEL,MATERIALS,MAXIMUM,MEAN,METHODS,MICRODOSE,MIP,MIPS,OBJECTIVE,RESULTS,SIEMENS,SOFT,STELLAR,THESE
0001,0007,2004,2010,3018,339,8201,APM,COX,DATABASES,DPIN,DRUG,GNRH,JANUARY,NETWORK,PROGRAM,USING
239,947,CD28,CD4,CD80,IFN,MHC,STUDIES,THESE
174,CDK,CDK6,CDKS,IBRANCE,III,INSTITUTE,PHASE,USA
1183,148,169,2004,2010,2015,224,299,811,AMONG,BACKGROUND,COPYRIGHT,COX,END,III,INC,LABEL,METHODS,MPM,OVERALL,RESULTS
169,2015,COPYRIGHT,FURTHER,INC
100,168,169,2015,BACKGROUND,CONCLUSION,COPYRIGHT,CRLM,INC,LABEL,METHODS,RESULTS,RFS
169,2015,A549,ARDS,COPYRIGHT,IIA,LPS,PLA2,PLA2G2A,PRE
HARMS,LDCT
001,149,169,183,2000,2012,2015,285,8201,9185,BACKGROUND,BJS,CONCLUSION,GROUP,JOHN,LABEL,LTD,METHODS,PUBLISHED,RESULTS,SLLM,SOCIETY,SONS,TEN,WILEY
004,10TH,872,BACKGROUND,DATA,FREQUENTLY,LABEL,LAM,MEAN,METHODS,MORTALITY,NINTH,POPULATION,RESULTS,REVISIONS,THERE,THESE,TSC
0004,0007,009,169,2015,8201,ADC,BACKGROUND,GUIDELINES,HOWEVER,LABEL,LUNG,METHODS,NUCLEAR,RESECTIONS,RESULTS,SOCIETY
122,7721,AEG,AUF,HCC,PCR,REAL,SMMC,TAKEN,TREATMENT,WESTERN
169,2015,956,BIOLOGY,INC,MOLECULAR,NMR,SOCIETY,ZINC
RESTORING
III,MRI,PPB
100,APC,BRAF,CRC,FBXW7,KRAS,PTEN,SMAD4,SOMATIC,SYNE1,TP53
158,2009,221,8201,COHEN,INTERNS,JUNE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
162,169,179,2015,885,999,ALSO,AUC,AUTHORS,INC,MOST,NON,NSCLC,PIS,PSS,PUBLISHED,ROC,SMS,THESE,UICC,WILEY
1290,ANTAGOMIR,CD133,CSLCS,SRC,THESE
116,11C,18F,8804,FDG,LABEL,METHODS,OBJECTIVE,PET,REGARDLESS,RESULTS,SUV,THREE,VALUE
001,003,169,2005,2011,2015,496,635,8201,AMONG,BACKGROUND,EGFR,III,JANUARY,KARNOFSKY,KRAS,LABEL,MEIER,METHODS,PROGNOSTIC,RESULTS,SOCIETY,STAGE,TNM
CELL,EIGHT,SCP1833,SCP4175,THESE
001,005,011,2008,2012,AIM,CONCLUSION,CRC,FIVE,IPNS,LABEL,LUNG,METHODS,OBJECTIVE,PET,RESULTS,SERUM,SIX
169,454,BLEISWIJK,COPYRIGHT,EGFR,ION,KRAS,LABEL,LIFE,MACHINE,METHODS,NGS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,ROCHE,ROTOR,SEQUENCER,SOCIETY,TORRENT,VENLO
169,531,AFRICAN,AMERICANS,COPYRIGHT,HER2,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THESE
169,2015,8201,A549,COPYRIGHT,HACAT,HEPG2,JOHN,LTD,ROOTS,SONS,WHILE,WILEY
110,150,160,172,1992,2013,222,ADULT,CHINA,CLINICALLY,COLLEGE,CONCLUSION,JANUARY,LABEL,LANGERHANS,LCH,MEDICAL,METHODS,OBJECTIVE,RESULTS,SCIENCE,SICHUAN,TECHNOLOGY,THERE,UNION,UNIVERSITY,WEST
19TH,233,HYACINTHE,LAENNEC,PARIS,REN
114,2002,2010,BECAUSE,DFS,DIAGNOSTIC,INSTITUTE,JANUARY,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIOLOGY,RESULTS
105,112,120,149,151,18GY,2009,2013,8804,BED,CRC,CSS,DFPS,DFS,DPFS,EXCELLENT,FOUR,JULY,LABEL,LOCAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,THERE,THREE
004,007,100,1997,2012,217,3RD,CHT,EARLY,FORTY,HYPO,LABEL,LRFR,METHODS,MST,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SCLC,THESE,THREE
668,677,ARMS,CBS,CONCLUSION,EGFR,EPIDERMAL,FFPE,FNAC,FORTY,FPPE,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,TKIS
2010,2012,CONCLUSION,EGFR,JANUARY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SEVENTY
719,CONCLUSION,CRC,EGFR,EVALUATING,KRAS,LABEL,MCNEMAR,METHODS,OBJECTIVE,PCR,PFS,PURPOSE,RESULTS,WHILE
112,8197,BACKGROUND,BMJ,CARCINOID,DISEASE,GROUP,HIGH,IBT,ICEBERG,LABEL,LIMITED,METHODS,MINIMUM,PUBLISHED,PUBLISHING,RESULTS
169,2015,CK5,COPYRIGHT,IHC,INC,NSCLC,SCC,SCCS,SEVERAL,TTF
100,128,169,2015,ALK,BECAUSE,CDX2,CK20,CK7,COLLOID,COPYRIGHT,EGFR,INC,KRAS,SEVEN,THREE,TTF
CALCIUM,CD318,CDCP1,CUB,FUNCTIONAL,ORAI1,STIM1,STOCS,THESE,TRASK
22G,ASSESSMENT,BOTH,COMPARISON,CONCLUSION,COOK,GLOBE,GROUP,HITACHI,LABEL,MEDI,METHODS,OBJECTIVE,RESULTS,SEQUENTIAL,THUS
041,075,172,239,239PU,439,481C,590G,849,945,947,CONTROL,EXB,GSTM1,GSTP1,GSTS,GSTT1,HARDY,ILE105VAL,MAYAK,MAYAL,NAT,NAT2,THREE
ANP,B16,MOST,NPR1,THESE
945,947,ALTOGETHER,FBW7,HIGH,HOWEVER,MYC,SCF,SKP1,USP,USP36
100,8764,ALK,BACKGROUND,CONCLUSION,EGFR,HRS,LABEL,METHODS,NSCLC,PFS,RESULTS,TKIS
945,A549,AMD3100,BACKGROUND,CXCR,CXCR4,ENDOGENOUS,FINALLY,FUNCTIONAL,FURTHER,H1299,H460,HIF,IL24,LABEL,METHODS,PCR,PRINCIPAL,RESULTS,SDF,SDF1,SJA5
012,033,119,2002,2014,BACKGROUND,CASES,E1L3N,LABEL,METHODS,MPM,PD1,RESULTS,THERE
IMMEDIATE

500,946,EIGHT,H1299,ITGB3BP,NEK2,NIMA,SHC,SHC1,SRPK1,SRSF,USING
2014,ACADEMY,AWARD,BRINKER,DIMITRIOS,DOCTORATES,FOUNDATION,HARVARD,HONOR,INSTITUTE,KAROLINSKA,MEDAL,PRESIDENT,PREVENTION,PROFESSOR,UNIVERSITY
160,169,2015,293T,A549,COPYRIGHT,H3K4ME1,HISTONE,HOWEVER,INC,LSD2,OGT
BOTH,CDDP,CONCLUSION,LABEL,METHODS,OBJECTIVE,OCT,OCT6,OCTS,OHP,PCR,PURPOSE,RESULTS,WESTERN
HOWEVER,LDCT,LOW,NSCLC,VATS,VIDEO
100,693,8201,ADC,ADCS,ALU,CIMP,CPG,STAGE
125,125B,160,169,2015,COPYRIGHT,EXPRESSION,INC,MIR,MMP,NSCLC,PCR
001,012,017,169,2001,2013,2015,218,COPYRIGHT,INC,MEIER,NSCLC,OLFM4,OVERALL
109,149,169,2014,452,946,956,A549,AHR,COPYRIGHT,CZECH,EOM,EOMS,PM2,TGF,WNT
015,036,169,2014,215,ALSO,CHINESE,COPYRIGHT,GLU185GLN,HOWEVER,NBS1,PUBLISHED,THESE
000,100,169,2000,2002,2003,2005,2011,2015,90S,AMONG,LUNG,WHAT
106,169,2007,2012,2015,ABOUT,AIM,BRAIN,CNS,INSTITUTE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNLABELLED
169,1MM,1SD,2015,2MM,4MM,8MM,931,945,9MM,CONCLUSION,COPYRIGHT,GTV,III,INSTITUTE,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,SBRT,SIXTEEN
1625,1636,169,183,2015,264,276,298,304,364,374,BIOLOGY,CHIP,DDIT3,H3K9,HOWEVER,INC,JUN,K14,KAT2A,MOLECULAR,SOCIETY,THESE,TNFRSF10A,TNFRSF10B,TRAIL
169,179,1993,2004,2005,2008,2015,215,AMONG,CONCLUSION,COPYRIGHT,FIVE,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,SPHINCTER,UPFRONT
169,2015,AHR,COPYRIGHT,ICOS,ILC2,ILC2S,INC,STAT5,TH2,THUS,TYPE
020,024,030,067,072,100,113,121,128,141,169,177,2015,215,698,890,CONCLUSION,COPYRIGHT,ESTIMATED,INC,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PERCENTAGE,PURPOSE,RESULTS,THESE,USING
000,001,002,006,102,169,1ST,2013,2014,2015,2ND,3RD,440,4TH,5TH,956,ACUTE,ARIE,BACKGROUND,CHINA,CONCLUSION,COPYRIGHT,EGCG,III,IIIA,IIIB,INSTITUTE,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,RESULTS,RTOG,SEPTEMBER
169,2015,BAX,BENZO,CALU,CH27,CHK1,CHK2,CL3,COPYRIGHT,EMSA,EMSAS,ERK,EXPRESSION,H1299,H1355,H23,MYC,NSCLC,PD98059,PHOSPHO,SER15,SER20,TAKEN,WESTERN
100,2004,2011,8805,BACKGROUND,DATA,DLCO,FEV1,LABEL,METHODS,NINE,QOL,RESULTS,SABR,THERE
169,2015,AUTHORS,FK506,FKBPL,HOWEVER,IL8,LABEL,MOUSE,OBJECTIVE,RESULTS,VEGF
169,2015,392,946,BIOLOGY,ERK,INC,MH2,MOLECULAR,R175H,SER,SILENCING,SMAD2,SMAD3,SMAD4,SOCIETY,TGF
154,169,2011,2014,2015,AIM,COLLEGE,CONCLUSION,COPYRIGHT,ENGLAND,FIFTY,LABEL,LTD,MATERIALS,MAY,METHODS,MRI,NETWORK,NICE,OBJECTIVE,PUBLISHED,RESPONSES,RESULTS,ROYAL,THERE
169,2015,716751G,AFTER,ALK,AML,COPYRIGHT,INC,PCR,REVERSE
039,042,112,177,500,712,AUC5,BACKGROUND,ELISA,LABEL,METHODS,NSCLC,RESULTS,THERE
169,16S,177,2015,231,458,488,A549,BCL,COPYRIGHT,FOURIER,FTIR,HPLC,IC50,IRELAND,LTD,MDA,MPCAB,NMR,PUW5,THESE
169,2015,CD8,COPYRIGHT,SCIENCE
0005,163,169,2015,8201,964,CAII,FOS,GCTB,GIANT,INC,MEIER,MICROARRAY,MMP,NFIB,PROTEIN,PUBLISHED,RANK,RANKL,SOCIETY,WILEY
2009,2011,INTEGRATED,LDCT,MOLECULAR,ROLE
100,1114,1832,2004,2012,241,556,718,762,ADC,AIDS,BACKGROUND,BOTH,CUMULATIVE,FURTHER,HODGKIN,JANUARY,LABEL,METHODS,NADC,NNRTI,PIS,POISSON,RESULTS
006,015,027,10TH,169,2015,215,247,251,657,90TH,AFTER,BACKGROUND,BONFERRONI,COLORECTAL,LABEL,LUNG,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OVARIAN,PEARSON,RESULTS,SCREENING,SERUM,SOCIETY,TRIAL,USUAL
1334,169,2015,440,AMONG,ANXIETY,DEPRESSION,FOUR,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SCALE,UNIVERSITY
26B,CTGF,ERK1,KNOCKDOWN,LUCIFERASE,MMP2,SMAD1,UTRS
045,2004,2010,AMONG,BACKGROUND,CONCLUSION,COX,EFFORTS,LABEL,LUNG,METHODS,ORS,RESULTS,SEP
BACKGROUND,CHILE,CHILEAN,DISABILITY,HINDERING,LABEL,LIFE,METHODS,OBJECTIVE,OBJECTIVES,PERSISTENT,RESULTS,SOUTH,YEARS
EBUS,HOWEVER,IMAGING,TBNA
LUNG,NSCLC,RNAS
000,100,186,264,410,413,433,543,544,688,700,709,8201,993,BACKGROUND,BECAUSE,CXR,DANTE,DETECTION,HOWEVER,LABEL,LDCT,LUNG,MAIN,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SCREENING,SECONDARY,TECHNOLOGY,THEIR,TRIAL
A549,AFTER,BRDU,EGFR,ERBB1,FISH,LUNG,MNS
100,1000,101,1050,1575,210,315,CAC,CHD,CONCLUSION,COX,FIVE,HIPAA,IMAGE,LABEL,LUNG,MATERIALS,METHODS,NLST,OBJECTIVE,PURPOSE,RESULTS,SCREENING,TRIAL
500,RESECTION,SURGERY,VINCI
AUTOPSY,CD117,CD34,GASTRIC,HISTOLOGY,HOWEVER,III,NINE,RADIATION
ACTN4,BINDING,CONSISTENT,DESPITE,HCC,HDIS,HOWEVER,MDM2,MTBP,PLC,PRF,PROTEIN,THESE
1942,2011,2342,8197,BMJ,CALIFORNIA,CIS,COX,GROUP,HRS,INDEX,LABEL,LIMITED,METHODS,MORTALITY,NMRD,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR,SMRS,WORKERS
169,2015,ALK,AMONG,COPYRIGHT,INC,P2Y,P2Y1,P2Y2,P2Y6,PKC
2006,2010,2012,342,8197,8221,BACKGROUND,BMJ,DISEASE,GROUP,IARC,JULY,LABEL,LIMITED,METHODS,ORS,PUBLISHED,PUBLISHING,RESULTS,THERE
CUSHING
0001,2014,8201,FURTHER,NSCLC,OCTOBER,ODDS,ORS
169,2015,BASED,COPYRIGHT,CXR,DTS,INTER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
ANCHORAGE,CD31,H2009,SIMILAR,TIMP
001,002,10878,147,257,272,453,490,576,BACKGROUND,IQR,LABEL,METHODS,MPM,NEUTROPHIL,NLR,PET,RESULTS,SERUM,SEVENTY,TGV,TTP
006,012,BACKGROUND,BSC,C30,COMPLIANCE,EORTC,HRQOL,LABEL,LC13,METHODS,MPM,ONCE,PATIENT,QLQ,RESULTS,SEVENTY
174,8482,LUNG,RNAI,RNAS
125A,320,484,BACKGROUND,EXPRESSION,FRESH,HSA,INTEGRATED,LABEL,MET,METHODS,NOTCH,RESULTS,THESE
169,2015,5100,A549,CDK2,COPYRIGHT,EXOGENOUS,H1299,IRELAND,LTD,RAB6,THESE,USING,UTR
001,160,169,2015,3DCRT,COMBINING,COPYRIGHT,DIBH,HODGKIN,IMRT,INC,LABEL,LIFE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TREATMENT,V20GY
169,2013,2014,2015,ADVERSE,AMONG,APRIL,COPYRIGHT,FURTHER,GRADE,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RBE,RESULTS,V20,V95
027,074,169,1997,2012,2015,AFTER,CHEST,COPYRIGHT,HOWEVER,INC,INITIAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,RISK,THERE,WILMS
169,2015,AGA,AIMS,ANTI,BACKGROUND,BALB,CDH5,COLORECTAL,COPYRIGHT,CRC,CT26,EXPRESSION,INC,INSTITUTE,LABEL,LYMPH,METASTASES,METHODS,MICE,OBJECTIVE,PUBLISHED,RESULTS,STRATEGIES,VEGFC
169,2015,664,751,773,803,804,8201,830,860,973,ASIAN,BOTH,META,MORTALITY,PCBS,PCDFS,SMR,UICC,YUCHENG,YUSHO
1562,230,584,CYTOSCAPE,DATASET,DEGS,ENRICHMENT,EXPRESSION,INADL,LABEL,LIMMA,MAP,MATERIALS,METHODS,NSCLC,OBJECTIVE,OMNIBUS,PLCB3,PLCE1,PPI,PROTEIN,RELA,RESULTS
169,2015,A549,ADP,ALSO,BAX,BCL,COPYRIGHT,EGFR,GBA,H460,HOWEVER,JOHN,LEWIS,LTD,MCL,MYELOID,NSCLC,OVERALL,PARP,SONS,THUS,TUNEL,WESTERN,WILEY
003,016,047,946,BALF,BBS,BESNIER,BOECK,ELISA,HMGB,IIIB,LUNG,NSCLC,SCHAUMANN,SERUM,TGF
3P21,EARLY,FAM107A,LUNG,MSP,NSCLC,TOTAL,TSG,TSGS
169,2015,726,956,A549,B16,COLON,COMPLEX,COPYRIGHT,DFT,FTIR,IC50,IRELAND,LTD,LUNG,MDA
169,2015,945,946,CONCLUSION,COPYRIGHT,CSC,CSCS,DCC,DCCS,DLQ,FITTING,GBM,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLQ,SMALLER
000,1360,169,1744,200,2015,5327,569,6936,8364,ART,CONCLUSION,COPYRIGHT,CRT,ICER,ICUR,IIIB,INC,LABEL,LYS,MAASTRO,MATERIALS,METHODS,MODEL,NSCLC,OBJECTIVE,PET,PRIMARY,PURPOSE,QALY,QALYS,RESULTS
169,2015,A549,CELL,COPYRIGHT,EKR1,HSF1,HSP27,HSP70,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARP,PURPOSE,RESULTS,THESE,WESTERN
169,2005,2012,2015,359,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SASKATOON,SCLC,SEVENTY,WBRT
001,169,2007,2012,2015,8805,BECAUSE,COPYRIGHT,CRI,EASTERN,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PAIN,PRE,PRIMARY,PURPOSE,RESULTS,SCALE,SECONDARY,SPR,TREATMENT,VAS
001,1241,125,161,169,1995,2008,2015,202,COMPETING,COPYRIGHT,CUMULATIVE,CURRENT,IIIA,INC,LABEL,MATERIALS,MEIER,METHODS,NETWORK,NSCLC,OBJECTIVE,PORT,PURPOSE,RESULTS,THUS
169,2015,215,COPYRIGHT,EIGHT,LCHN,LUNG,OVERALL,THEREFORE
A549,BASED,FURTHER,H2SO4,MCF,PPH3,SKOV,SRB,VIS
AIM,BACKGROUND,LABEL,MATERIALS,METHODS,OBJECTIVE,PAIN,PVN,RESULTS,SCLC
0001,001,015,049,120,130,177,2001,2013,225,ANOVA,BACKGROUND,BETA,CONCLUSION,COX,FRONTAL,GKRS,GROUP,HOWEVER,LABEL,MATERIALS,MBT,MBTS,MEIER,METHODS,OVERALL,RESULTS
123,BRAF,F354L,FINE,FVPTC,HRAS,JEGHERS,KDR,KRAS,MET,N375S,NEXT,NRAS,PAPILLARY,PAX8,PEUTZ,PPARG,PTC,Q472H,RET,STK11,VEGF
BACKGROUND,CASE,CONTEXT,CTLA,FOUR,HOWEVER,LABEL,METHODS,PTS,SIX,TBII
001,2012,2014,225,323,ACTA,ACTIVIN,BACKGROUND,BODY,CNC,CONTEXT,GIVEN,JANUARY,LABEL,MARCH,METHODS,MSTN,MYOSTATIN,OBJECTIVE,OUTCOME,RESULTS,SETTING,SNAQ,THESE
100,149,177,2011,2014,407,BETWEEN,EBUS,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,TBNA
0149,169,2015,AIM,ALK,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,EML4,HOWEVER,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SDI
169,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DFS,DISTANT,INSTITUTE,JOHN,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,OUTCOME,RADIATION,RESULTS,SBRT
169,2002,2013,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,IIIB,INSTITUTE,JANUARY,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,177,2015,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,LOBAR,METHODS,NINE,OBJECTIVE,RESULTS
104,169,1996,2015,254,293,422,678,ACTN4VA,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,RESULTS,SCLC
169,2015,ANTICANCER,BACKGROUND,CASE,COPYRIGHT,DISCUSSION,EWING,INSTITUTE,JOHN,LABEL,METHODS,MOST,NMC,NUT
0001,0002,036,037,074,147,169,1999,2003,2010,2013,2015,745,AIM,ANTICANCER,BACKGROUND,BONN,CONCLUSION,COPYRIGHT,DATA,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVERSITY
001,169,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,K562,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2015,4945,945,A549,AIM,AKT,ANTICANCER,CALU,CELL,CK2,CONCLUSION,COPYRIGHT,FACSCAN,FITC,H1299,H358,HOWEVER,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PACLITAXEL,PARP1,RESULTS,TREATMENT
169,17A,2015,947,ANTICANCER,BACKGROUND,CD25,CD3,CD4,CONCLUSION,COPYRIGHT,HOWEVER,IFN,IL10,IL17A,IL6,INSTITUTE,JOHN,LABEL,METHODS,REGULATORY,RESULTS,ROR,TH17,THUS,TREG,TREGS
169,2015,A549,ANTICANCER,CHINESE,COPYRIGHT,HIGH,INSTITUTE,JOHN,NSCLC,SHH,SMO,SONIC,TNM1,TNM2,YANGZHENG,YZXJ
125A,169,199A,199B,2015,214,452,574,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FIVE,HEAD,HNACC,HNSCC,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MIR,OBJECTIVE,RESULTS
169,2015,4T1,APRIL,BCMA,CAML,ERK1,HER2,JNK1,KI67,PRESS,PUBLISHED,SILENCING,STUDIES,TACI,TLR,UNIVERSITY
AMONG,BASED,SIMULATING,SNOS,SYNTHETIC,UNTIL
8201,BULKY,CROSS,CUMULATIVE,DETECTION,INERTNESS,INNOVATIVE,POC
000,150,2006,2010,2011,3400,3800,4300,5000,800,8300,900,CORRECTED,COSTS,GAMMA,HODGKIN,LABEL,METHODS,OBJECTIVE,PER,RESULTS,VOTE,ZEALAND
021,103,151,2007,2012,209,236,339,564,599,938,AMONG,BIOMEDICAL,CONCLUSION,INNOVATION,INSTITUTE,JANUARY,JUNE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SMOKING,THYROID,UPPER
169,2015,405,624,CAS9,COPYRIGHT,INC,INDIVIDUAL,RNAS
0045,0062,0065,1997,2002,BACKGROUND,DFI,LABEL,LUNG,METHODS,POTENTIAL,RESECTION,RESULTS,THREE
0001,0101,0277,169,183,2015,3477,421,ASCOT,BACKGROUND,CARE,COPYRIGHT,DIET,FUNDING,INSTITUTES,JUPITER,LABEL,LTD,MALMO,METHODS,PROVE,RESULTS,SIMILARLY,TIMI
169,2015,COPYRIGHT,G12V,H1299,HELA,HOWEVER,IRELAND,LTD,MYC,Q61K,RAS
002,003,127,168,169,179,2015,215,315,341,849,925,AFRICAN,COPYRIGHT,GWAS,INC,MERGING,PUBLISHED,SOCIETY,STUDIES,TGSII
169,2014,945,AUTHORS,CD31,COPYRIGHT,EGFR,HIF,INC,MYC,NSCLC,PUBLISHED,THESE,VEGF
169,2015,916,968,A549,BAX,BCL,COPYRIGHT,H1299,HOWEVER,INC,NAC,PARP,ROS,THESE
064,100,2005,2011,875,8805,901,ANALYZING,COLON,CONCLUSION,DATA,JAPAN,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SURGERIES,USING
CHANGES,EGCG,ERK,INHIBITORS,JUN,MEK,MIGRATION,MTT,TAKEN,U0126,WESTERN
185,228,AECS,AFTER,AGNOR,BMF,HPLC,LPG,NO2,PM10,PM2,ROS,SOD
169,2015,945,ACCORDING,COPYRIGHT,IGFBP,INC,RESULTS,SERUM,VARIATIONS
8197,BACKGROUND,BMJ,GROUP,INSPECTION,LABEL,LIMITED,METHODS,POE,PUBLISHED,PUBLISHING,RESULTS,SPN,SPNS,THERE,TRIAL,USING
001,002,015,018,022,026,035,101,125,141,210,222,242,490,707,ADC,ADCS,LUNG,NSCLC,PCR,ROC,SCC,SCCS,THUS,TNM
169,2015,COPYRIGHT,FFF,FLATTENING,IRELAND,LTD
169,2015,215,635,BACKGROUND,COPYRIGHT,FDR,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RADIOMICS,RESULTS,UNIVARIATE
169,2015,8805,COPYRIGHT,DELETED,DIFFERENT,DLEC1,HNSCC,HOWEVER,PCR
BOB,CD15,CD30,HODGKIN,OCT,PAX5,PPHL,PRIMARY
100,956,A549,AUTOPHAGIC,AUTOPHAGY,BOTH,BPA,CASPASE,CDDP,CYTO,DETECTION,DHA,ENZO,EPA,GLO,KIT,PROMEGA,PUFAS,VIABILITY,XTT

2P23,ALK,BACKGROUND,CASE,EXPRESSION,IMT,IMTS,LABEL,METHODS,THERE
AFTER,ARA,CCK,CONCLUSION,DDP,EFFECTS,LABEL,LRP,METHODS,NPC,OBJECTIVE,PCR,RESULTS,TW03,WESTERN
169,2015,946,EMT,EPITHELIAL,OTHER,TGF
169,2015,946,CSC,FUNCTIONAL,IKBKB,IKK,NOTABLY,RNAI,TCF4,THESE,WNT
169,1801,2015,AACR,EGF,EGFR,FINALLY,MOUSE,MTEC,RES,STAT3,STUDIES,TAKEN
169,2015,233,8211,HOWEVER,PCR,THESE
AFTER,BALB,HB1,LUNGS
169,5046,945,946,BIOLOGY,IPF,LEUKOCYTE,ONO,SMA,SOCIETY,TGF,THUS,TREATMENT
CHEST,LABORATORY,PTHRP,TBLB
THREE
1ST,2ND,FOUR,HEMORRHAGE,STENT
CCTL,CLEAR,POST
ACTH,CUSHING,HORMONE,SINCE
177,ADHERENCE,AFTER,AREA,ASSOCIATED,AUC,AUCSS,CONCLUSION,ERLOTINIB,ESPECIALLY,LABEL,MEMS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY

AFTER,EVEN,HOWEVER,PARTIAL
HOWEVER,N0M0
2010,2011,2012,50S,AFTER,EGFR,HOWEVER,III,JANUARY,KRAS,MAY,PET,RFA
EIGHT,JOHNSON,SJS,STEVENS,THUS
2008,2012,GRADE,KRAS
500,BACKGROUND,CISPLATIN,CONCLUSION,EGFR,GRADE,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,THERE,THEREFORE
000,2014,20TH,CHIBA,CURRENTLY,DAV,HEAVY,HIMAC,HOWEVER,HSP90,INSTITUTE,IONS,NIRS,PARP,PROJECT
1983,BRAGG,CHARGED,HENCE,PBT,TSUKUBA,UNIVERSITY
2011,CONCURRENT,DISEASE,EAST,GRADE,GYE,NINE,NSCLC,PBT,V20
177,18F,197,251,FDG,FINALLY,FIVE,MTV,NSCLC,PET,SUV,SUVMEAN,THERE,TLG,TNM
8197,AFOP,AIMS,BMJ,COP,GOP,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SIXTY,WHILE

LEFT
CHEST,DIAGNOSING,EBUS,TBNA
ACTIVATION,BACKGROUND,EXPRESSION,HEY1,HOWEVER,KNOCKDOWN,LABEL,METHODS,MMP9,NOTCH,RESULTS,THEREFORE,YRPW
100,1094,2015,854,ACTIONABLE,AGENA,AUSTRALIA,BACKGROUND,BIOSCIENCE,LABEL,MASSARRAY,METHODS,MPS,OVERALL,PANEL,RESULTS,WHEREAS
328,543,ARG458X,BACKGROUND,BAX,FUNCTIONAL,LABEL,LYS469GLU,MDM2,METHODS,NEITHER,NSCLC,PPM1D,RESULTS,THEIR,THESE,WIP1
001,008,1996,2013,252,291,8201,CLEVELAND,DETAILS,DISTANT,HOWEVER,HPV,III,IMPORTANCE,IMPORTANT,IVB,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,OPSCC,RELEVANCE,RESULTS,SECONDARY,SETTING
001,002,115,947,ASA,BACKGROUND,CHEST,COLLEGE,EDUCATION,EVALUATION,FIFTEEN,LABEL,METHODS,PHYSICIANS,QUALITY,RELATIVELY,RESULTS,RISK,SECONDARY,SOCIETY,THERE,THESE
GRADUAL
104,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISK
2013,450,BIVARIATE,LABEL,METHODS,MODEL,OBJECTIVE,OBJECTIVES,RECURSIVE,RESULTS,TAIWANESE
PJP
001,143,170,210,221,246,414,8804,AFTER,AMONG,AREA,AUC,CONCLUSION,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,RESULTS
1063,118,120,162,169,200,2015,300,8805,956,CAD,COPYRIGHT,FALSE,FBP,IRELAND,LABEL,LTD,MDCT,METHODS,NOISE,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,SIMILARLY
945,946,PDGF,PDGFR,POSTMORTEM,PTTM,PULMONARY,THUS,TREATMENT
ABELSON,ABL1,ALK,ASP,EMAP,EML,EML1,EML2,EML4,H2228,MTS,NSCLC,RECURRENT,THESE,TRP,WD40
167,169,1980,2009,2015,291,BACKGROUND,BONE,COPYRIGHT,GCT,GIANT,JOINT,JOURNAL,LABEL,METHODS,RESULTS,SURGERY,THERE
169,2008,2012,2013,2015,AAPC,APC,APPROACHES,APRIL,AVERAGE,BACKGROUND,CAUTION,END,FIRST,INSTITUTE,LABEL,METHODS,MOST,RESULTS,SEER,SOCIETY
169,1996,2010,2015,7322,8411,BACKGROUND,BECAUSE,BLADDER,BOTH,HIV,LABEL,METHODS,ODDS,ORS,RESULTS,SOCIETY
263,311,500,ABT,AZD8055,BCL,BCL2,BH3,BIM,HOWEVER,MCL,RB1,SCLC,SCLCS,THEREFORE,TORC1,TP53,WHEREAS
001,169,2010,2013,2015,5106,8804,8805,APHASIA,BACKGROUND,COX,HEART,INC,INSTITUTES,LABEL,METHODS,OBJECTIVE,PNEUMONIA,PURPOSE,RECURRENCE,RECURRENT,RESULTS,SCALE,TIA
ANTI,DESPITE,LUNG,NSCLC,THEREFORE
001,305,CD133,COX,CSCS,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM,VEGF
169,2015,ALK,CD133,COPYRIGHT,EML4,EMT,ERK,ERK1,H1299,HOWEVER,INC,NSCLC,TAKEN,THUS
100,2011,8201,CONCLUSION,KNOWLEDGE,LABEL,METHODS,MILD,OBJECTIVE,OUTCOME,RESULTS,SBRT,SPLN
169,2015,COPYRIGHT,EOC,FIGO,HIGH,INC,LABEL,METHODS,OBJECTIVE,PCR,PFS,PRSS3,RESULTS,THERE,THESE
160,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STAT3
000,ICER,JAPAN,LDCT,LUNG,NLST,SCREENING
ERP29,HOWEVER,INHIBITION,LUNG,THESE
160,169,183,GEORG,HENCE,STUTTGART,YORK
160,169,183,ALK,EGFR,GEORG,GERMANY,ROS1,STUTTGART,YORK
160,169,183,DIAGNOSIS,GEORG,MOST,STUTTGART,WORLDWIDE,YORK
003,037,106,124,168,475,963,AMONG,BACKGROUND,CHEST,DATA,DIAGNOSTIC,ENGLISH,LABEL,METHODS,PROGRAMMES,RESULTS
2006,2010,645,749,AMONG,BACKGROUND,CRUDE,DATA,DIAGNOSIS,HODGKIN,LABEL,METHODS,RESULTS,SIMILARLY
222,BACKGROUND,LABEL,METHODS,RESULTS,SEA,SEAS,THERE
2012,2013,BACKGROUND,ENGLAND,FURTHER,LABEL,METHODS,NCRS,RESULTS,SERVICE,STAGE
001,2010,2012,AWARENESS,BACKGROUND,BCOC,CAM,CLEAR,ENGLAND,ENGLISH,GPS,LABEL,LIFESTYLE,MEASURE,METHODS,OCTOBER,RESULTS,STATISTICS
1140,1245,1246,1412,2012,355,486,ABC1,BACKGROUND,C2DE,DATA,ENGLAND,LABEL,MEN,METHODS,OVERALL,READ,RESULTS,THERE,UNPROMPTED
ALK,ATP,CD74,CNS,FIG,HOWEVER,MET,ONCOGENIC,ROS1,TAKEN,XALKORI
3Q26,BECAUSE,FRAGILE,FXR1,NSCLC,RELATED,SCC
160,169,2015,COPYRIGHT,INC
160,169,2015,8805,ATL,AUTHORS,BRITISH,GRADE,JOHN,JOURNAL,LTD,ORR,SEVERAL,SONS,WILEY
169,2015,AKT,CAF,LEWIS,PI3K
128,143,160,BASED,CHINESE,COX,DFS,ERCC1,HOWEVER,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RRM1

DESPITE,HOWEVER,INITIALLY
HOWEVER,SMALL
100,138,169,2015,30504,945,CONCLUSION,CROSS,GRADE,GROUP,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SCLC,SOCIETY,TEN,THREE
002,160,169,2015,231,233,AMONG,COPYRIGHT,FRAN,PUBLISHED,SAS,SOCI
0001,045,127,169,2015,219,411,8804,8805,ACCORDING,BACKGROUND,BASED,CEA,CONCLUSION,COPYRIGHT,CRLM,INC,LABEL,METHODS,NOTABLY,PDC,PDCS,RESULTS
BACKGROUND,CCRT,CISPLATIN,CONCURRENT,DISTANT,ECOG,III,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SIMILAR,SIX
2006,DRUG,FDA,FOOD,IIIB,NCCN,NON,NSCLC,OCTOBER,VEGFR
003,024,032,125,130,293,8201,ESCC,HIGH,HOWEVER,NSCLC,PCAT,PCR,RNAS
1993,2008,2013,AFTER,TAE
ALK,IMT,RECURRENCE
ANAPLASTIC,FOUR,SIX
BEV,CASE,CRC,DTX,THREE
18F,2006,2007,2011,2013,60S,FDG,JUNE,MALIGNANT,PARTIAL,PET
2008,2009,2010,2011,2012,AFTER,APRIL,FOLFIRI,JANUARY,JULY,LEUCOVORIN,MARCH,STAGE,THUS
178,185,8312,CDX,CHEST,CK20,CK7,EARLY,FDG18,HER2,LUNG,PET,STAGE,TTF
003,004,132,231,562
13TH,22ND,26TH,300,ARDS,CDDP,SINCE
5MM,AFTER,CDDP,CPT,KRUKENBERG,MST,QOL,STAGE
16B1,70S,IPMN,LIVER,PART
CASE,III,SBRT,SRT,STAGE
100,2012,2013,CK20,DIAGNOSIS,JULY,JUNE,MARCH,OCTOBER,PRE,SEPTEMBER,STAGEIB,TBLB,TTF
CBDCA,EOB,FIRST,HCC,HCCS,IIIB,MRI,PEM,STAGE,THERE
102,AFTER,BASED,FIRSTLY,HCC,HOWEVER,PRS,REMNANT,RFA,TACE,THERE
ICC,IVB,STAGE
AFTER,EVANS,GRADEIB,PVTT,RADIATION,SEVEN
AFTER,ERBITUX,FINALLY,FOLFIRI,HAI,HDHAI,HOWEVER,RFA,TAE
2011,2013,AFTER,EVALUATION,FOLFIRI,FURTHER,IVC,JANUARY,LEUCOVORIN,RESECTION,SOLID,UFT,UZEL,XELOX
2003,2006,2007,2009,2010,APRIL,GRADE,LEUCOVORIN,MARCH,MAY,POST,SEPTEMBER
2003,2005,2006,2009,2010,CURRENTLY,HOWEVER,SBRT,THESE
192,HMLN,NSCLC,PRS,TREATMENTS
APC,COPD,EIGHT,SCC

PDT,TODAY
HOWEVER
ADRIAMYCIN,AFTER,EMR,ENDOSCOPIC,ESD,FAP,UPPER
ACCORDING,AFTER,AMR,CBDCA,CDDP,CDGP,CHEST,CPT,HOWEVER,IVB,NGT,SMALL,STAGE,UPPER
AFTER,CDDP,CDGP,IVB,STAGE
2010,2012,2013,2014,AFTER,APRIL,BECAUSE,CRANIOTOMY,CRT,ESOPHAGEAL,IVA,JANUARY,JUNE,MARCH,MAY,MTLT,TXT
CASE,NITI,STM
HMB45,MALIGNANT,MELAN,PARTIAL,S100
2001,2006,215,JULY,MASTECTOMY,OCTOBER
2012,2013,JUNE,OCTOBER,PSVN,STAGE,THEREFORE,TREATMENT
2003,2007,2009,2010,2011,2012,JUNE,STAGEIV,T4BN1M1
215,CHEST,IIB,SUBSEQUENT,ULTRASOUND
AFTER,CARCINOMA,DESPITE,HER2,IIIA,RECURRENT,SIMILAR,T1CN2M0
2009,2013,AFTER,APRIL,CLINICIANS,HOWEVER,IIIB,LEUCOVORIN,SIX,STAGE,UNDER
ALOW,ASECOND,CPT,DELAYED,FOLFIRI,HOWEVER,QOL,XELOX
2010,DIGESTIVE,JAPAN,LEUCOVORIN,LIVER,MANEC,NEC,SEVERAL
5FU2,BILATERAL,BMAB,FOLFOX6
2009,2010,2011,2012,2013,2014,CUR,FOLFIRI,JANUARY,JUNE,MULTI,OCTOBER,SINCE
DEPARTMENT,HOWEVER,LOX,REMOVAL,SURGERY,THEREFORE,TREATMENT,XELOX
EVEN,FIVE,III,THEREFORE
187,2007,2010,2011,2012,2014,283,600,AFTER,CEA,IIIA,JANUARY,JULY,LEUCOVORIN,OCTOBER,SEPTEMBER,UFT,XELOX
EXTRA,LABEL,LIVER,LYMPH,MALIGNANT,METHODS,OBJECTIVE,OPERATIVE,PERITONEAL,PRIMARY,PROCEDURE,PURPOSE,RESULTS
DESPITE,FOLFIRI,HOWEVER,LEUCOVORIN,SEVEN,VIRCHOW
CARCINOMA,COLORECTAL,EVALUATION,FOLFOX6,GRADE,KRAS,METASTASIS,SIGMOID,SOLID

000,2012,304,420,BASED,TLDG
2012,2014,SEVEN,SRT
007,013,026,8197,8805,ACA,BMJ,CASP3,CD44,CD44S,CD95,DESPITE,EXPRESSION,FURTHER,GROUP,LABEL,LCC,LIMITED,METHODS,NSCLC,OBJECTIVE,OPN,PUBLISHED,PUBLISHING,RESULTS,RHAMM,THREE,UNION,WHILE
200,956,ANESTHESIA,CAD,DESPITE,THEN
BACKGROUND,CASE,DIAGNOSIS,DISCUSSION,FOUR,HOWEVER,LABEL,METHODS,PCR
0001,009,107,1909,1995,2010,2013,2660,3323,8447,AUTHORS,BACKGROUND,CANCERLIT,COLLECTION,DATA,IPD,LABEL,MAIN,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,SELECTION,SURGERY,THERE
107,108,169,2010,2013,2015,249,ADULT,ADVERSE,ALISERTIB,AMONG,BACKGROUND,COMPANY,COPYRIGHT,CZECH,ENROLMENT,EVALUATION,FEB,FUNDING,INC,LABEL,LIMITED,LTD,MAY,METHODS,MILLENNIUM,RESULTS,SERIOUS,SOLID,THESE,USA
121,169,2015,BCI,CRC,H3K4ME2,INC,MOST,RNAI,SMYD3,THESE,WILEY
169,2015,575,BLID,COPYRIGHT,FEDERATION,NSCLC,PUBLISHED,SOCIETIES,UTR
0001,169,2004,2013,2015,COPYRIGHT,COX,FDG,INC,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SEVENTY,SIXTY,SURGERY,UNIVARIATE
169,2015,A24,ANOTHER,ASIA,AUTHORS,BASED,CD4,CTL,CTLS,FURTHER,HLA,HNSCC,LPS,LTD,PTY,PUBLISHING,SCIENCE,SPS,TAA,TAAS,WILEY
001,002,003,028,120,169,2015,239,CONCLUSION,COPYRIGHT,ILA,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE,TKI
169,2014,500,956,A549,AFTER,COPD,COPYRIGHT,DF0,DF30,DF7,DOC,DPF,PAHS,RME,TA102,TA98,TAKEN
169,1ST,2006,2009,2015,31ST,5888,743,BACKGROUND,COPYRIGHT,DRUG,LABEL,LINKAGE,LTD,METHODS,OCTOBER,PRESCRIBED,RESULTS,SWEDISH,THESE
169,2015,COPYRIGHT,INC,META,NINE,NSCLC,PUBLISHED,SOCIETY,THESE
0002,001,017,0273,159,160,169,177,2003,2006,2015,967,BACKGROUND,BONFERRONI,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY,STUDENT,TAMS,TOPN
1930S,215,5CM,LARGE,LUNG,METASTASIS,PAROTID,PRIMARY,SMALL,THEN,THERE
DEPLETION,HIGH,HOWEVER,MIR,NAIF1,NEXT,NSCLC,NUCLEAR
169,2015,ABCG2,BIOMARKERS,BRAF,CD271,COPYRIGHT,IRELAND,JARID1B,LTD,MAPK,MMP,RESISTANT,V600E
169,2015,CD103,CD8,COPYRIGHT,CTL,HOWEVER,INC,NSCLC,TCR,THESE,TIL,TIM
169,2015,945,946,948,COPYRIGHT,EGFR,EMT,FINALLY,H1650,NOTABLY,NSCLC,PKC,SNAIL,SOCIETY,TKIS,TWIST,WHEREAS,ZEB2
2006,2012,NEURALGIA,SEVEN
169,2015,GROUP,HOWEVER,III,JAPAN,PHASE,POST,PRESS,PUBLISHED,STAGE,TNM,UFT,UNIVERSITY
001,005,009,034,114,115,296,525,8805,ACCORDING,DFS,OVERALL,SEX,THEREFORE,TNM
0001,005,027,046,121,2004,2013,356,ALCOHOLISM,BACKGROUND,DESPITE,EMERGENCY,GERMANY,LABEL,METHODS,RESULTS
IATROGENIC
CNS,HOWEVER,USA
945,BECAUSE,GLU81,LPMAB,MABS,OTS,PDPN,PLAG,PODOPLANIN,THR76,WESTERN
8201,CD147,FINALLY,MAB2,THESE
169,2015,BH3,COPYRIGHT,DYNAMIC,INC,PROFILING,THERE,WHILE
001,004,009,010,016,020,569,ADC,ADCS,BRAF,EGFR,HOWEVER,LIMITED,LUNG,STAS
ALK,EML4,FUSIONSEQ,HOWEVER,IMT,IMTS,NTRK1,RET,ROS1,TFG,THERE
001,169,2015,A549,BLOOD,CONCLUSION,FDG,FIVE,HOST,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PASTEUR,PET,RESULTS,SMALL,SOCIETY,SUV,UNLABELLED,WARBURG
169,2015,ACT,CONCLUSION,CORE,FDG,IMAGING,INC,INSURANCE,LABEL,METHODS,MOLECULAR,NUCLEAR,PEARSON,PERFORMING,PET,QABS,RESULTS,SOCIETY,UNLABELLED
100,169,ALK,BACKGROUND,CONCLUSION,D5F3,DRUG,EML4,FISH,FOOD,IHC,LABEL,MATERIALS,METHODS,NGS,PRESS,RESULTS,SCREENING,THREE
169,2015,COPYRIGHT,FINALLY,HDAC,HDACS,HISTONE,HOWEVER,IGF,IRELAND,LTD,MTT,NSCLC,OTHER,THESE,TREATMENT,USING
10TH,169,2015,20TH,AUTHORS,COPYRIGHT,HSF1,HSP70,HSP90,HSPS,IRELAND,LTD,NVP,NZ28,PUBLISHED,TREATMENT
001,021,145,169,2015,BACKGROUND,BASEL,CRT,IIIB,LABEL,METHODS,NSCLC,PFS,RESULTS,STAGE
169,2015,2OCL3,4RU,956,ADP,AG311,ATP,COPYRIGHT,HCO2,HMGB1,NH3,PARP,RU360,SOCIETY,THERAPY,THEREFORE
169,2015,BASEL,HEPATIC,HPVG,IIIA,SINCE
169,181,2015,A549,BACKGROUND,BASEL,CHINESE,DESPITE,FLOW,IC50,LABEL,LUNG,METHODS,MYRICANONE,RESULTS,THESE,TRITIATED
226,BACKGROUND,DAB2,HOWEVER,LABEL,LUNG,METHODS,NSCLC,PCR,RESULTS,WESTERN
0001,046,114,132,138,1999,2010,362,652,906,AUSTRALIA,BACKGROUND,CONCLUSION,CONTEXT,LABEL,LITERATURE,METHODS,OBJECTIVE,PTHRP,QUEENSLAND,RESULTS,SETTING,SOLID,THERE
154,159,3OST2,APC,BACKGROUND,FAM19A4,LABEL,LUNG,METHODS,PCR,PHACTR3,RASSF1A,RESULTS,THREE
107,120,169,1975,2000,2015,227,238,746,AMONG,ANXIETY,BACKGROUND,GUIDELINES,HODGKIN,HOWEVER,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SPM,SPMS,SURVIVORS,UNIVERSITY,VITAL
169,2015,945,CCR2,COPYRIGHT,INC,OSCAR,SFTPD,SURFACTANT,TNF
1995,1999,2000,2004,2005,2009,2011,AGE,ANZDATA,AUSTRALIA,CIS,COX,FIVE,HOWEVER,INDIGENOUS,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,RRT,SETTING,TRANSPLANT,UNADJUSTED,ZEALAND
001,191,2001,2007,2039,954,ABORIGINAL,AFTER,CONCLUSION,CROSS,LABEL,MAIN,MEASURE,METHODS,NSW,OBJECTIVE,OUTCOME,OVERALL,RESULTS,RRR,SETTING,SOUTH,WALES
169,2015,95D,A549,BDMC,BIOMEDICAL,BOARD,CCK,CDC,CHINA,CONCLUSION,COPYRIGHT,EDITORIAL,FLOW,GFP,GLI1,LABEL,LC3,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SAECS,SMO,WESTERN
129,A549,AKT,EGF,EGFR,H460,HOWEVER,MMP9,NSCLC,PI3K,TAKEN,THUS
004,005,17558,19385,2014,BACKGROUND,CAUCASIANS,CIS,HOWEVER,LABEL,METHODS,OCTOBER,ORS,RESULTS,TELOMERASE,TERT
2004,2006,AMERICANS,THEREFORE

120,129,1487,1973,2010,CCA,CCAS,DATA,END,HOWEVER,INCREASED,INSTITUTE,LOWER,RESULTS,SIR,SIRS
001,2011,2013,263,542,8202,953,AFFILIATED,AMONG,EGFR,FIRST,GUANGZHOU,HOWEVER,MEDICAL,NSCLC,PCR,UNIVERSITY
181,470,562,ACHE,ADR,ANNONACEAE,BASED,CAFFEIC,GI50,NCI,OVERALL,THIN,UA251
003,004,005,009,012,028,2009,2010,286,324,335,363,374,378,500,956,B12,BETWEEN,JUNE,PEMETREXED
2001,2013,ACUTE,CASES,CONCLUSION,CRT,FIVE,LABEL,LATE,MATERIALS,METHODS,OBJECTIVE,OVERALL,PFS,RESULTS,SCLN
084,177,714,918,AFTER,CONTINUED,CUMULATIVE,EARLIER,HOWEVER,LUNG
0043,15Q12,169,2015,215,BACKGROUND,DETECTION,DSBR,GABAERGIC,LABEL,LUNG,METHODS,PATHWAY,PRESS,PUBLISHED,RESULTS,RS73371737,SNPS,UNIVERSITY
169,2015,259,945,A549,ACTIVATION,BIOLOGY,ERK,ERKS,H1299,H89,INC,INHIBITING,MEK,MG132,MOLECULAR,PGE2,PKA,RAF,REDUCED,SER,SIRT6,SIRTUIN,SOCIETY,THEREFORE,TREATMENT,WESTERN
100,125,130,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNDER
120,180
000,001,100,154,163,2013,2014,222,260,353,CHEST,CVATL,EARLY,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
001,BACKGROUND,FEV,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
113,119,135,138,146,147,177,1ST,2010,2012,30TH,3RD,CONCLUSION,FIRST,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OPERATIONS,RESULTS,VAS,VATS,VIDEO
140,150,CONCLUSION,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OPERATION,RESULTS
1990S,2014,300,8217,CHINA,VATS
170,183,2013,2014,BACKGROUND,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,VATS,VIDEO
169,2015,ACADEMY,CIGARETTE,DICER,YORK
001,015,169,2015,432,AAG,ALLYLAMINO,AUTHORS,FOUNDATION,HOWEVER,JOHN,JOURNAL,LAC,LAST1,LATS1,LTD,MOLECULAR,SONS,TAKEN,WILEY,YAP
169,2015,CD74,COPYRIGHT,CXCR2,CXCR4,INC,MAPK,MIF,MSC,MSCS
123,1280,169,170,2015,COPYRIGHT,MDR,PARKINSON,PGP
100,115,134,169,2015,210,8201,BACKGROUND,CARCINOMAS,CBX,FNA,KRAS,LABEL,METHODS,RESULTS,SOCIETY,THERE
8197,BMJ,GROUP,IDC,LIMITED,METASTATIC,OESTROGEN,PUBLISHED,PUBLISHING
100,109,135,946,BACKGROUND,BAL,BALS,BASED,FUNGITELL,GROUP,IFI,LABEL,METHODS,MYCOSIS,RESULTS,TREATMENT
169,2015,BACKGROUND,COPYRIGHT,CT0,CTS,DOSE,DVH,EQUIVALENT,EUD,HOWEVER,IMPT,IRELAND,ITV,LABEL,LTD,METHODS,MFO,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,ROBUSTNESS
001,169,2015,5204,5284,AFFAIRS,AMONG,ASIAN,BACKGROUND,CANCORS,CARE,CHINESE,CONSORTIUM,ENGLISH,FURTHER,HISPANICS,LABEL,METHODS,NON,RESULTS,SOCIETY,SPANISH
CPG,IGE,THERAPIES
169,2015,ASIA,AUTHORS,HOWEVER,LTD,PTY,PUBLISHING,SCIENCE,WILEY
169,2015,8805,AIMS,BACKGROUND,COPYRIGHT,IHC,IMSS,INC,LABEL,MALIGNANT,METHODS,MEXICAN,MPM,OBJECTIVE,PUBLISHED,RESULTS
AKT,BIM,BRAF,ERK,FINALLY,HOMOLOG,MEK,NSCLC,RAF,SARCOMA,THUS,TRAMETINIB,V600,V600E,VIRAL
BALB,HER2,HOWEVER,WHILE
231,DESPITE,FINALLY,MDA,PROBING,SKOV,USING
DESPITE
0001,006,0495,1987,2007,BACKGROUND,BASED,CMV,KINGDOM,LABEL,METHODS,RESULTS,STATISTICS,THERE,TRANSPLANT
000,160,169,2015,427,600,BACKGROUND,CHINA,COPYRIGHT,INC,KNOWLEDGE,LABEL,LIBRARY,META,METHODS,PUBLISHED,RESULTS,SOCIETY
169,2015,COPYRIGHT,EPITHELIUM,ILC2,ILC2S,LTD,TH2
117,169,183,2012,2013,2015,BACKGROUND,BETWEEN,BRISTOL,COPYRIGHT,FUNDING,GERMANY,IGG4,IQR,ITALY,JULY,LABEL,LTD,METHODS,MYERS,NIVOLUMAB,NOV,RESULTS,THERE,THESE,USA
169,2015,BOTH,EPIGENOMIC,INCREASED,KCA,KCNN4,NSCLC,THUS,UICC
002,008,135,169,2015,4672,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RANDOMIZED,RESULTS,STERNAL,SURGERY
108,13433,AFTER,AIMS,BACKGROUND,DEGS,EXPRESSION,JAK,KEGG,LABEL,LUNG,METHODS,OBJECTIVE,OMNIBUS,RESULTS,STAT,TGF,WNT
AIMS,BACKGROUND,BONE,CASE,DISCUSSION,LABEL,METHODS,OBJECTIVE
101,143,2009,2013,8805,ACADEMY,AIMS,BACKGROUND,DEPARTMENT,DOSE,FIFTEEN,GULHANE,LABEL,MEDICAL,METHODS,MOST,OBJECTIVE,OCTOBER,RADIATION,RESULTS,THERE,TREATMENT
AFTER,EGFR,IMPORTANT,NSCLC,ORAL,TKIS
SIADH,SMALL
8220,8221,8805,ACUTE,CEF,CHT,CRT,GRADE,LABEL,LATE,MATERIALS,MEAN,METHODS,OBJECTIVE,POST,PURPOSE,RESULTS,SIXTY
AIMS,BACKGROUND,BRONCHIAL,DIAGNOSES,FIVE,LABEL,METHODS,OBJECTIVE,RESULTS
000,100,180,195,1997,1998,2002,2006,2008,217,239,AMONG,CONTINENTS,INCIDENCE,OVERALL,RESULTS,THERE,THYROID,USING
705,8851,988,AIMS,BACKGROUND,EARLY,LABEL,LOW,METHODS,OBJECTIVE,RESULTS
34B,448,520H,654,BAC,BACKGROUND,EXPRESSION,GEO,LABEL,METHODS,MICRORNAS,NON,NSCLC,OMNIBUS,RESULTS,RNAS,THEN
DRUG,FOOD,IRINOTECAN,TNBC
BASED,EARLY
025,130,8201,COMPARISON,EGFR,EPIDERMAL,GEHAN,IIIB,KIRSTEN,KRAS,NSCLC,PFS,SEVERAL,TKI,TKIS
1N9,2N6,4N6,5N3,ADC,BASED,COPD,FATTY,ROC,SCC,SCLC
1000,168,549,8764,945,A549,FINALLY,MPEG,MPT,PCL,PTX,TAXOL,TPGS
160,169,2014,2015,231,233,244,AIMS,ALPES,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,FRAN,GPS,INSTITUTE,LABEL,MAY,MCS,METHODS,OBJECTIVE,PCS,PRESENT,PUBLISHED,RESULTS,SAS,SOCI
AFTER,CISPLATIN,CONCLUSION,IIIB,LABEL,METHODS,NON,NSCLC,OBJECTIVE,ORR,PARTIAL,PURPOSE,RESULTS,THREE
107,145,190,2005,2013,215,275,348,535,AMR,BASED,EPNEC,JULY,LABEL,METHODS,OBJECTIVE,ORR,PATIENT,PFS,PRIMARY,PRIOR,PURPOSE,RESULTS
169,2015,COPYRIGHT,EGFR,EPIDERMAL,ERK,INC,MAPK,MAPKS,WILD
103,127,155,169,183,2009,2011,2015,304,312,315,318,500,633,800,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,EASTERN,ECOG,EGFR,ELI,ENROLMENT,FEB,FUNDING,GROUP,LABEL,LILLY,LTD,METHODS,NOV,NSCLC,RESULTS,SERIOUS,THERE
160,169,2015,A549,BACKGROUND,COPYRIGHT,CTC,CTCS,H1299,H460,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
169,2015,COPYRIGHT,INC,TOOLS
946,A549,ABCB1,BAX,BCL,DOCETAXEL,EMT,LUNG,MDR1,NSCLC,TGF
946,EMT,ERK,FOXM1,KNOCKDOWN,LENTIVIRUS,NSCLC,TGF,TRANSWELL,U0126
8201,AFTER,AKT,CELL,HOS,HOWEVER,KI67,TRAF4,U2OS
198,945,946,ESTROGENS,HOWEVER,IHC,LUNG,MICE,NSCLC,PCR,THESE,TMA,WESTERN
169,2015,947,CD3,CD4,CD8,COPYRIGHT,HFE,IFN,LTD,MHC,PBMC,PUBLISHED,THESE,TNF
CHEST,HOWEVER,IDIOPATHIC,IPF,SCLC,SMALL
HOWEVER,IIB,METASTASES,PATIENT,PROGNOSIS,SPLENIC,STAGE,SURGERY,T3BN0M0
138,AFTER,ALSO,CONSISTENT,EVEN,FINALLY,H2081,H2AX,LUNG,NCI,RESULTS,SCLC
AIMS,AMONG,BACKGROUND,DFI,ESCC,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS
ANTI,EGF,EGFR,ERBB,ERK,LAM,SNAIL,THESE,TSC
000,125,169,2015,CONCLUSION,GIP,GLP,HOWEVER,IMAGING,INC,LABEL,METHODS,MOLECULAR,NETS,NUCLEAR,RESULTS,SOCIETY,TYR,UNLABELLED,USING
001,169,177,179,2015,267,311,ANATOMY,CONCLUSION,DATA,FDG,FNA,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,SUV,THERE,UNLABELLED
HOWEVER,RAY,SMALL
009,014,015,084,099,1280,177,916,BACKGROUND,LABEL,METHODS,NON,NSCLC,PCR,RESULTS
162,A549,AKT,ERK,H460,LUNG,MEK,THUS
004,009,014,169,177,2015,946,A549EPOB40,BACKGROUND,CD1,DIFFERENT,FOXN1,HOLM,ICRNU,INHIBITION,LABEL,MEIER,METHODS,MSA,MSAS,PRESS,PUBLISHED,RESISTANCE,RESULTS,SIDAK,SW480,TREATMENT,UNIVERSITY,VEGF
169,2015,215,GEWIS,GWAS,INC,THROUGH,WILEY
011,076,1000,ACUTE,ALI,CONCLUSION,GREATER,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OPERATIVE,RESULTS
1998,2013,CHINA,CONCLUSION,JANUARY,JULY,LABEL,MATERIALS,MEDICAL,METHODS,MOST,MRI,OBJECTIVE,PROVINCIAL,RESULTS,THESE,WHILE
A549,AUNP,AUNPS,BAP,BAX,BCL,BENZO,CD44,COF,FITC,FOURIER,FURTHER,IAP,INCUBATION,THESE,THUS
169,2015,946,COPYRIGHT,MAST,MCS,SOCIETY,TGF,THESE,THROUGH,TRANSPLANT,TREG
CUTANEOUS,EPS,MOST
018,023,103,185,18F,8312,945,946,ANOTHER,CURRENTLY,FDG,FDHT,FES,ICRP,KETTERING,LOUIS,MBQ,PET,SEATTLE,SLOAN,SUV,UNIVERSITY,USING,WASHINGTON,YORK
AFTER,ANESTHESIA,CONCEALED,PARKINSON,PSVT,RECURRENT,VATS,WHITE,WOLFF,WPW
1994,238PU,BYSTANDER,CHIBA,HEAVY,HIMAC,HOWEVER,INSTITUTE,ION,MEDICAL,NOW,P53,PHASE,SINCE,THERE
ADT,CRPC,EVENTUALLY,FURTHER,GPCRS,KETTERING,MEIER,PCA,PTEN,SLOAN
101,COX2,DFS,EMT,EZH2,HCC,HCCS,HOWEVER,RAC,RHO,RNAS,ROCK2,STMN1,THESE
8202,BACKGROUND,CASE,HOWEVER,LABEL,METHODS,PET,SARC
AIM,BRIGHTVIEW,CONCLUSION,HEALTHCARE,LABEL,METHODS,NSCLC,OBJECTIVE,PHILIPS,RESULTS,SCLC,SPECT,WHOLE,XCT
000,006,100,140,153,1977,2011,2015,2020,272,368,604,652,695,759,775,777,BACKGROUND,CZECH,DATA,LABEL,METHODS,REGARDING,RESULTS
945,946,A549,BACKGROUND,CONCLUSION,EGFR,EPIDERMAL,GEFITINIB,LABEL,LAC,METHODS,PC9,RESULTS,TAMOXIFEN
001,007,027,239,CANCEROUS,CD133,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM
169,2015,ATP,BCL,COPYRIGHT,E1B,MIEAP,SINCE,SOCIETY,THESE,TP53,WHILE
169,2015,COPYRIGHT,NETWORK,PROPONENTS,SURGERY,VATS
169,2015,COPYRIGHT,NETWORK,VATS
8201,AFTER,BACKGROUND,CONCLUSION,DEPARTMENT,DUE,HIGH,LABEL,MEDICAL,METHODS,NEITHER,RADIATION,RESULTS,UNIVERSITY
0001,001,005,008,100,101,180,1998,2011,BACKGROUND,BRAF,CRC,DATA,FURTHER,JANUARY,KRAS,LABEL,METHODS,MOLECULAR,RESULTS
PAZOPANIB
2012,2014,ECOG
003,021,032,171,191,AIMS,BACKGROUND,DTI,III,LABEL,METHODS,OBJECTIVE,RDTP,REGARDLESS,RESULTS,SEVERAL
AIRO,GIOVANI,GROUP,HIGHLIGHTS,MEMBERS,WORKING,YOUNG
001,0235,169,189,2015,214,6668,ACRIN,BACKGROUND,CONCLUSION,COX,FDG,HIGH,III,LABEL,LRC,METHODS,MTV,NSCLC,PET,PRESS,PUBLISHED,RESULTS,RTOG,TGA,TIME,UNIVERSITY
169,2015,512,A549,COPYRIGHT,DOCK3,GEF,H1299,KNOCKDOWN,LTD,MICRORNAS,NSCLC,RAC1,RNAS
169,177,2015,956,CHINA,COPYRIGHT,FINE,GUANGZHOU,LTD,PAHS
1271,169,2015,628,8764,CCK,COPYRIGHT,HOWEVER,HOXA5,INC,MICRORNAS,NSCLC,RNAS,THUS,WESTERN
10877,139MONTHS,169,1FR,2015,30GY,311MONTHS,3FR,3MONTHS,48GY,4FR,60GY,8FR,ADVERSE,ARC,COPYRIGHT,CTCAE,ECOG,FIVE,III,LABEL,LTD,METHODS,MODULATED,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SBRT,STS,THERAPY,TREATMENTS,VOLUMETRIC
780,BABL,BACKGROUND,LABEL,LNCAP,MEAN,METHODS,NIRF,OATP1B3,RESULTS,RWPE,THERE
0001,001,002,007,008,320,593,8212,ASX,CONCLUSION,IIIB,INCIDENTAL,LABEL,METHODS,MORTALITY,NSCLC,OBJECTIVE,OVERALL,RESULTS
ENDOSCOPIC,PANCREATIC,PDAC,VARIOUS
CONCLUSION,LABEL,MATERIALS,MEIER,METHODS,MSTS,OBJECTIVE,PATIENT,PRIMARY,PURPOSE,RESULTS,SOCIETY,SURGERY
31042,8805,ADULT,AMERICA,CHEST,MPM,NORTH
100,1108,417,4299,483,ABCG5,ABCG8,CALIFORNIA,CNV,CNVS,DAVID,EXPRESSION,FINALLY,KO05223,LABEL,MATERIALS,MEANWHILE,METHODS,NUCLEOTIDE,OBJECTIVE,OMNIBUS,PENNCNV,RESULTS,SANTA,SNP,SNPS,UNIVERSITY
LN2,SEPARATOR,SMALLER,THESE,VAPOR
121,169,2015,ARMADILLO,ARVCF,INC,NSCLC,RHOA,WILEY
BACKGROUND,BCOR,CASE,CCNB3,CIC,DUX4,FOXO4,GENERALLY,LABEL,LUNG,METHODS,NEWER,RESISTANCE,THEIR
000,0028,169,1800,1990,1993,2001,2011,2015,AGA,AIMS,BACKGROUND,COLORECTAL,COPYRIGHT,CRC,GERMANY,INC,INSTITUTE,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PUBLISHED,RESULTS,RISK,SCREENING,SIMILAR,TRIAL
105,157,169,199,2015,434,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,CRC,LABEL,LTD,METHODS,RESULTS,RFA,THERE
001,1157,140,169,2015,643,683,BACKGROUND,COPYRIGHT,HIGH,LABEL,LTD,METHODS,NSCLC,RESULTS,SIX,THERE
169,2015,790,8594,A549,COPYRIGHT,CPG,EGFR,INC,NSCLC,PC9,T790M,TKI,TKIS
169,177,2015,945,946,947,956,A549,ATP,COPYRIGHT,F1F0,INCREASING,LTD,WHEREAS
169,2015,ATP,COPYRIGHT,III,IRELAND,LTD,PGP,THESE
169,2015,BIOLOGY,EGFR,GEFITINIB,H1650,HOWEVER,INC,LAD,MOLECULAR,ROS,SEVERAL,SOCIETY,TARCEVA,THESE,TKIS,WESTERN
169,2015,ACCORDING,AIS,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,HOWEVER,HRCT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MIA,RESULTS,THUS
169,177,2015,4DCT,COPYRIGHT,DEFORMABLE,FBCT,INC,LABEL,LCS,LUMPECTOMY,MATERIALS,METHODS,OBJECTIVE,POPULATION,PTV,PTVS,PURPOSE,RESULTS,SIMILARLY,SIXTEEN
120,169,2015,8805,COPYRIGHT,COX,DATA,FDG,INC,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
245,A549,AKT,DAPA,EGF,EGFR,ERK,ETS,H1299,INHIBITORS,MAD,MYC,SNP,THESE,USING
169,2015,AMERICANS,CCN2,CTGF,DRUG,DUE,LESIONS,NORTH,SINCE,THESE
169,2015,COPYRIGHT,INC
131,DTC,FDG,PET,SPET,WBS
372,643,E542K,FGFR,FGFR1,FGFR4,G12A,HOWEVER,HRAS,KDR,MUTATIONAL,MUTATIONS,P126S,PRIMARY,RAS,V550M,VEGFR
169,2015,500,AUTHORS,FOLLOWING,NAV3,NAVIGATOR,PUBLISHED
100,160,169,2015,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,MALIGNANT,METHODS,PUBLISHED,RESULTS,SOCIETY
118,169,185,2010,2012,2015,249,294,330,479,724,BACKGROUND,BETWEEN,BOARD,COMPLEX,COPYRIGHT,HOWEVER,INC,JUNE,LABEL,METHODS,MTB,OVERALL,PATIENT,PUBLISHED,RESULTS,SOCIETY
169,2015,4352,CONCURRENT,COPYRIGHT,CSR,DESPITE,DISCUSSION,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE,USING
004,021,037,045,046,177,8804,ADVERSE,CHOI,CONCLUSION,DISEASE,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
004,100,31CC,31G,31GG,9904341,PCR,PRESENTLY,RFLP
036,AFP,ASIAN,AUC,CA153,CCAT2,CPG,ESCC,ESOPHAGEAL,HEEC,KYSE410,NSE,RNAS
001,1546,210,5335,CCRCC,MALDI,NSCLC,TOF
008,009,021,024,030,128,COX,KLK13,MEIER,NSCLC,PCR,TATA,TOTAL
169,2015,722,AFTER,AMONG,BACKGROUND,CARE,LABEL,METHODS,RESULTS,SOCIETY,STILL
169,2015,ADVANCING,AIDS,BECAUSE,BLOOD,CARDIOLOGY,COLLEGE,COPYRIGHT,FOUNDATION,GROUP,HEART,HIV,HLB,INC,INSTITUTE,LUNG,NHLBI,PUBLISHED,WORKING
DECADES,THESE
169,188,2015,BACKGROUND,BOTH,CARE,CAREGIVERS,LABEL,MAIN,METHODS,NEEDS,NETWORK,PATIENT,PREDICTION,RESULTS,SOCIETY,SUPPORTIVE,THEREFORE
169,2015,ALCHEMIST,ALK,EGFR,ENRICHMENT,HOWEVER,INSTITUTE,LUNG,SEQUENCING,SOCIETY,TRIAL
CER,LUNG
169,2015,BIOMARKER,CELL,EFFORTS,III,LINE,LUNG,MAP,PHASE,S1400,SOCIETY,THERAPY
169,2015,AEF,AMONG,COPYRIGHT,HRCT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTWCS,OBJECTIVE,PURPOSE,RESULTS,THERE,THREE,UIP,WHILE
169,2015,AMERICA,INFECTIOUS,PRESS,PUBLISHED,SOCIETY,TAKEN,UNIVERSITY
160,169,2006,2012,2015,290,BACKGROUND,BASED,COPYRIGHT,EVEN,FLV,INC,JANUARY,LABEL,METHODS,RESULTS
CAF,CAFS,HOWEVER,MSCS,THUS
EGFR,NSCLC,TKI,TKIS
006,011,013,021,025,026,125,199,ASA,BACKGROUND,BMI,CA125,CA199,CEA,CYFRA21,FORTY,LABEL,LUNG,METHODS,NSE,PATIENT,PCIA,PVB,RESULTS,SCC,SERUM,SOCIETY,VAS
013,956,BACKGROUND,CELL,FACS,IGG1,LABEL,METHODS,PC9,RESULTS,THEREFORE,TUNEL,WST
A549,AFTER,BACKGROUND,EPIGENETIC,EXPRESSION,H1299,LABEL,LUCIFERASE,METHODS,MMP,MSP,PCR,RESULTS,WESTERN
ALK,ECHINODERM,EML4,MEANWHILE,MPC,NSCLC
250,ADVERSE,ALK,BACKGROUND,CONCLUSION,CRIZOTINIB,CTC,DISTANT,EVALUATION,FISH,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SOLID,TUMOURS
115,ALK,ANAPLASTIC,ARMS,BACKGROUND,D5F3,EGFR,EML4,FISH,IHC,LABEL,METHODS,NON,NSCLC,PCR,RESULTS,SCORPIONS,WHILE
172,ALK,AMONG,BACKGROUND,BESIDES,EGFR,FISH,IHC,LABEL,METHODS,NSCLC,RESULTS
ALK,EGFR,EPIDERMAL,LUNG,NON,NSCLC,THEIR,TKI,TKIS
ALK,CURRENTLY,NSCLC,THERE,THUS

FURTHER,SMALL,THERE
AIM,CONCLUSION,EGFR,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,RESULTS
2011,CHINA,DRUG,EGF,EGFR,FOOD,III,JUNE,NSCLC,PHASE,TREATMENTS
BROWN,FDG,IIIA,PET,SEVEN,THERE
100,8202,FDG,HOWEVER,PET,SUV,SUVS,WHOLE
500,BZDS,COX,DDD,HOWEVER,INSURANCE,LOE
8212,8217,DESPITE
CALRETININ,CD31,CD56,CEA,CELL,CK19,HEPATOCYTE,MOST,THUS,TTF,WT1
CD271,FURTHER,HOWEVER,METASTASES,PRIMARY
112,296,369,444,CARCINOMA,CUP,FDG,MBQ,PET,THERE
BACKGROUND,EXPRESSION,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,RNAS,THEN
100,AMONG,EGFR,HRM,NSCLC
001,012,021,022,026,032,143,960,GST,MNSOD,PRIMARY,ROS,TXNIP,UNIVARIATE
946,A549,AKT,DHA,FLOW,GSK,LUNG,MTS,NON,NSCLC,PCNA,SCC,SCLC,THESE
A549,ASTRAGALUS,FLOW,H23,MEANWHILE,MTT,NCI,NSCLC,SER15,SER20
0001,018,106,119,357,363,BACKGROUND,COX,DFS,ERCC1,HIGH,LABEL,MEANWHILE,MEIER,METHODS,NSCLC,PCR,RESULTS,THEREFORE
DESPITE,DIAGNOSIS
160,215,224,339,8764,BMI,FIVE,METABOCHIP,OBESITY,PATHWAY
160,215,224,459,BMI,BODY,PATHWAY
00019,00044,0058,012,017,107,181,8197,BACKGROUND,BMJ,CD4,CD8,DEE,GROUP,HOWEVER,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS
500,AIDS,DHA,EPA,HIV,NRF2,ONOO,OTHER,RAISING
100,2279744,309,309GG,309TT,EXPRESSION,MDM2,NON,PRESENTLY,T309G,TP53
108,ABBOTTABAD,AYUB,BACKGROUND,BRONCHIAL,CONCLUSION,DIAGNOSTIC,FOB,LABEL,METHODS,RESULTS,TBA,TBB
EBUS,INDIA,TBNA
THUS
169,2015,AKT,ASIAN,CAUCASIAN,FGFR1,PI3K,PRESS,PUBLISHED,RET,TARGETING,THESE,UNIVERSITY,WHILE
169,2013,2015,COPYRIGHT,CTV,EARLY,GROUP,HODGKIN,HOWEVER,ILROG,INC,LABEL,METHODS,OARS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SEVEN,TEN
106,120,168,169,2015,215,8805,916,AREA,AUC,AUCS,COPYRIGHT,INC,INDIVIDUAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGRESSION,RESULTS,ROI,ROIS,USING
0001,005,160,3720,BACKGROUND,CONCLUSION,HDL,INC,INCREASED,LABEL,LDL,LOW,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,2015,BECAUSE,DOPS,LUNG,RESULTS,SAPC,SAPOSIN,THESE,USING,VIABILITY
169,184,185,1989,2010,2014,412,617,BACKGROUND,COPYRIGHT,DATA,FUNDING,HOWEVER,HRS,LABEL,LTD,METHODS,RESULTS,SWEDISH,UNIVERSITY,VASALOPPET
000,146,160,169,172,2006,2011,2013,2015,400,BACKGROUND,COPYRIGHT,CRP,EASTERN,ECOG,GROUP,INC,JUNE,LABEL,METHODS,MPM,PERSISTENT,PLT,PUBLISHED,RESULTS,SOCIETY,VAT
100,150,169,400,600,BACKGROUND,CONCLUSION,EGFR,LABEL,METHODS,MTD,PI3K,PRESS,RESULTS,SAR245408,THERE
160,2003,2010,AUSTRALIA,BECAUSE,CONCLUSION,EMERGENCY,JULY,JUNE,LABEL,MAIN,METASTATIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS
ALK,CD20,COMPANION,EGFR,EGFRS,FINALLY,FISH,GISTS,HER2,HODGKIN,IHC,KIT,MOST,NON,RITUXIMAB,THUS
2012,500,60TH,FAX,JSLM,LABORATORY,SOCIETY,THEREFORE
061,638,8805,AMONG,BACKGROUND,COMBINING,DETECTION,EARLY,HOWEVER,LABEL,LUNG,MAIN,METHODS,NLST,OBJECTIVE,OBJECTIVES,PITTSBURGH,PLUSS,PROGRAM,RATIONALE,RESULTS,SCREENING,TRIAL
169,183,8202,CHURG,FIRST,GEORG,IMPORTANT,STRAUSS,STUTTGART,SUBSEQUENT,WEGENER,YORK
BAX,BCL
ATTRACTIVE,CTLA,EARLY
CDK4
125B,140,BACKGROUND,BOTH,KINESIN,KLC,KLC2,LABEL,METHODS,MIR,NSCLC,RESULTS
002,007,10877,ARF,BACKGROUND,LABEL,MALIGNANT,MDM2,MEIER,METHODS,MPM,MPMS,P14,P53,PFS,RESULTS,SCORE,UNTIL
A549,BACKGROUND,CELL,EMT,EPITHELIAL,FAS,HEPG2,LABEL,MCF7,METHODS,RESULTS
169,196,2015,213,374,929,ANTICANCER,CENTERS,CONCLUSION,CONTROL,COPYRIGHT,DISEASE,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NUTRITION,OBJECTIVE,PREVENTION,RESULTS
001,169,2015,375,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,COX,FORTY,INSTITUTE,JOHN,LABEL,METHODS,MPE,NSCLC,OBJECTIVE,PFS,RESULTS,SERUM,VEGF
002,007,169,2000,2009,2011,2015,361,970,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HOWEVER,INSTITUTE,JANUARY,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS,SEN,SEVENTEEN,SUN,YAT
008,145,169,2015,835,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,IIPS,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,RESULTS,SCLC
0002,0006,0008,0026,0387,169,2015,AIM,ANTICANCER,CNS,CONCLUSION,COPYRIGHT,CSF,EGFR,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,POST,PPS,RESULTS,T790M,TKI
100,123,169,2015,956,A549,ANTICANCER,CC50,CONCLUSION,COPYRIGHT,COUMARINS,INSTITUTE,JOHN,LABEL,MMP,MRC,PCFDA,RESULTS,ROS,THESE,UNLABELLED
169,2015,954,ALSO,ANTICANCER,B19,COPYRIGHT,CURCUMA,EPHB2,HDAC4,INSTITUTE,JOHN,SEPP1,STAT3
102,169,1992,2009,2015,929,AMONG,BACKGROUND,BROADER,CONCLUSION,COX,END,HOWEVER,LABEL,METHODS,OVERALL,PRESS,PRIOR,PUBLISHED,RESULTS,UNIVERSITY
A549,AFTERWARDS,GAS,NEITHER,SNIFFER,SOLID
169,2014,2015,FURTHER
150,169,2003,2015,567,CONCLUSION,DRUG,FOOD,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PATIENT,PFS,PURPOSE,RESULTS,SOCIETY,THERE
014,169,2006,2010,2015,483,633,798,850,8805,886,988,BASE,CONCLUSION,COX,DATA,LABEL,METHODS,NSCLC,OBJECTIVE,PORT,PURPOSE,RESULTS,SOCIETY
169,2015,ALK,BEST,CONCLUSION,CRIZOTINIB,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,ROS1,SOCIETY
169,2015,AKT,ALK,BRAF,COMPLETION,CONCLUSION,EGFR,ERBB2,HRAS,KIT,KRAS,LABEL,METHODS,NRAS,NSCLC,OBJECTIVE,PTEN,PURPOSE,RESULTS,SIX,SOCIETY
169,2015,CONVERSELY,COPYRIGHT,H1299,H358,HN30,HN6,SOCIETY,TAKEN,THESE,WHEREAS
029,169,566,669,749,ABCB1,ATP,B17,CYP2A13,FASEB,FOXA2,GATA,III,INHALED,MDR,P450,R257C,TAP,THEIR,UDP,UGT2B17
231,264,954,BMMS,BONE,EXTENSIVE,FINALLY,MAPK,MDA,MOUSE,QUE,RANKL,RAW,THEREFORE
169,2015,ACCORDING,CHROMATIN,CONSISTENT,COPYRIGHT,H1299,HOWEVER,INC,PCC,PRR11,TAKEN
001,166,169,177,2014,258,268,424,579,CONCLUSION,COPYRIGHT,LABEL,METHODS,NEUTROPHIL,NLCR,PARTNER,PUBLISHED,RESULTS,ROC,SOCIETY,UNLABELLED,URBAN
169,2015,A431,AGR2,AREG,BIOLOGY,CONSISTENT,EGFR,EGR1,FOS,H460,INC,MOLECULAR,NCI,REDUCED,SIMILAR,SOCIETY
100,169,2007,2009,2015,2987,ACCOUNTING,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,COX,END,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,RESULTS,STATINS
1991,2014,BMJ,DATA,ENGLISH,EXTRACTION,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PEER,PUBLISHED,PUBLISHING,RESULTS,SELECTION,SOURCES,SYNTHESIS,WATERPIPE,WTS
169,2005,2012,2015,567,BACKGROUND,BMI,CONCLUSION,COPYRIGHT,INC,LABEL,LOS,METHODS,NSQIP,OBESITY,OVERALL,POISSON,PROGRAM,QUALITY,RESULTS,WORLD
169,2015,231,233,COPYRIGHT,MOST,PUBLISHED,SAS,SFRO,SOCI
130,197,945,CD44,CONCLUSION,FOS,FRA,LABEL,MB231,MCF7,MDA,METHODS,OBJECTIVE,PURPOSE,RESULTS,SINCE,THESE,THUS,USING
DOCTORS,LIMITED,PULMONARY
954,BACKGROUND,CONCLUSION,CONTOURING,CTV,DESPITE,DR1,DR2,DRS,FDG,GTV,KAPPA,LABEL,MATERIALS,METHODS,NSCLC,OVERALL,PET,PLAN,RESULTS,THEREFORE,TVS
EPITHELIAL,GAIN,HLCC,HLCCS,HOWEVER,LCC,LCCS,LH2,UTILIZING,WAF1
945,GLUTAMINE,METABOLIC,NCOA2,SRC,SREBP,TCA
374,388,SHP
455,671,722,BACKGROUND,COLLEGE,CONCLUSION,FUNDING,INSTITUTES,LABEL,LDCT,LIMITATION,LUNG,METHODS,NLST,OBJECTIVE,PRIMARY,RADIOLOGY,RADS,RESULTS,SCREENING,SECONDARY,SETTING,TRIAL
8201,8764,956
2000,8805,998,LOD,LOQ,MSM,NSM,PSM,SEM,TYR
CD56,HOWEVER,SCLC,SMALL,THESE
169,2015,HOWEVER,PRESS,PUBLISHED,THUS,UNIVERSITY
000,001,100,1440,2010,2015,3480,3920,440,4470,7330,740,7760,8320,900,910,AIDS,AMONG,BACKGROUND,END,HIV,HODGKIN,LABEL,METHODS,NHL,POISSON,PRESS,PUBLISHED,RESULTS,UNIVERSITY
342,FINALLY,MICRORNAS,NSCLC,RAP2B,UTR
AET,MMC,SLCCS,TAKEN,USING,VX2
BOS,COP,HSCT,IPS,MAIN,TNF,WHILE
000,100,128,160,169,194,1996,2009,2015,482,510,767,860,923,AMONG,BACKGROUND,COPYRIGHT,ESRD,FACTORS,FOUNDATION,HISPANICS,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RATES,RESULTS,RISK,SETTING,SIR,THESE
169,2014,A549,AUHNS,COPYRIGHT,DOX,EGFR,LTD,NIR,PEGYLATED,TAKEN
176,AFTER,M1A,MEAN,MORBIDITY,MPD,MPM,SIX,WEDGE
2010,2014,AIM,CATANIA,CONCLUSION,INCLUSION,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,RESULTS
021,113,177,1986,2010,CUMULATIVE,SIZE,THERE
110,190,2008,2014,GUIDELINES,MARCH,MOST,PULMONARY,THERE,VATS
DESPITE,DIFFERENT
LUNG
PULMONARY,TYPICALLY,WHILE
300,PET,PULMICC
MOST,PULMICC,PULMONARY,UNTIL
169,2015,A549,AKT,COMBINING,COPYRIGHT,EGFR,ERK1,GEFITINIB,H1975,HOWEVER,HSP90,INC,MKK1,NSCLC,THESE,TKI,XRCC1
163,169,2015,COPYRIGHT,CXCR4,HSC,INC,R334X,WHIM
169,2015,COPYRIGHT,EMT,H460,INC,LCLC
110,130,140,169,2015,AUC,BIS,CONCLUSION,COPYRIGHT,DBONE,DWA,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,OBMS,REGIONS,RESULTS,SECT,VMS
0001,0015,0016,0019,104,120,160,169,2003,2009,2015,413,AFTER,BACKGROUND,COPYRIGHT,CSS,FORTY,INC,LABEL,METHODS,NSCLC,PROPENSITY,PUBLISHED,RESULTS,RFS,SBRT,SOCIETY,VATS
2014,8764,ABSTRACTED,BMJ,CHRONIC,DATA,EXTRACTION,GROUP,HOWEVER,LABEL,LIMITED,LUNG,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SELECTION,SOURCES,SYNTHESIS,THREE,WPS
116,169,16S,2015,COPYRIGHT,EIGHT,FIFTY,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PPI,PPIS,PRINCIPAL,RESULTS,THERE
169,1983,2000,2015,2877,303,532,682,915,COPYRIGHT,DATA,INDICATING,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMR,SMRS,STATISTICS
169,2014,CHANGES,COPYRIGHT,CROWN,G418,LUNG,MMP,MMP2,MMP9,MYPT1,PREVIOUSLY,PUBLISHED,RHO,RHOA,SAS,SPCA1,TAKEN,THROUGH
169,2014,954,A549,APOPTOSIS,COPYRIGHT,HDAC,HOWEVER,HSP90,NSCLC,RELA,ROMIDEPSIN,ROS,SAS,THESE
145,169,2015,BIOMARKERS,COPYRIGHT,DFS,ISH,NON,NSCLC,PCR,SAS,THESE
169,2015,A549,COPYRIGHT,DDP,DNMT,EGCG,GAS1,HDAC,HOECHST,ICAM1,MTT,NSCLC,PCR,SAS,TIMP4,WISP2
169,2014,520E,COPYRIGHT,MEANWHILE,MICRORNAS,MIR,SAS,TAKEN
0003,0020,0046,0056,0198,0219,1268,1311,160,169,177,2014,460,683,760,780,961,976,A549,CCL20,CCR6,CD4,COPYRIGHT,FOXP3,HOWEVER,IHC,III,MFI,NSCLC,PBMC,PCR,SAS,TIL,TREG
169,2014,BANCR,COPYRIGHT,ERK,JNK,LNCRNAS,LUNG,MAPK,RNAS,SAS,THESE,VISE
169,2014,ATP,CD3,CD56,CIK,COPYRIGHT,CRT,DOCETAXEL,HMGB1,HOWEVER,SAS,SPC
140,160,169,177,2014,210,6NM,8764,945,956,9NM,A549,ANOVA,CIS,CISPLATIN,CLSM,CONCLUSION,COPYRIGHT,DRUG,DSC,FTIR,GNS,HELA,HOWEVER,IC50,LABEL,METHODS,OBJECTIVE,PURPOSE,PXRD,RESULTS,SAS,THEREFORE
169,2004,2013,2015,ARRAY,COPYRIGHT,GENOTYPING,HIGH,HPV,INC,INK4A,PATHOLOGIC,ROCHE,SCLC,SMALL
2001,2010,BMJ,CARE,DUE,EXCELLENCE,GROUP,INSTITUTE,LIBRARY,LIMITED,MEDLINE,NICE,NSCLC,PFS,PUBLISHED,PUBLISHING,RCTS,THERE
147,169,2015,264,8MRNA,954,A549,BONE,CD147,COPYRIGHT,INC,RAW,TAKEN
169,EACH,NSCLC,PRESS,UNTIL
CURRENT,DESPITE,IDIOPATHIC,IPF
047,115,169,2004,2011,2015,992,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,LOCAL,METHODS,MOST,NSCLC,RESULTS,SRS
0005,0025,0123,148,169,2000,2012,2015,CONCLUSION,COPYRIGHT,DDLPS,DISTANT,IQR,LABEL,LOG,LTD,LUNG,MATERIALS,METASTATIC,METHODS,OBJECTIVE,RANK,RECORDS,RESULTS,RISK
ALK,AREAS,BACKGROUND,COVERED,CRIZOTINIB,FDA,HOWEVER,LABEL,MET,METHODS,NSCLC,OPINION,ROS1
AAH,ACTIVATION,AID,AT2,BASED,HOWEVER,INCREASED,LGR5,LGR6,MALL,MALLS,SIMILAR
001,003,023,1004,111,2001,2010,3143,386,AGGREGATE,GAMMA,KNIFE,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS,THEREFORE
FDA,IPILIMUMAB,MEDICINES
169,2015,AHR,ARNT,BOTH,COPYRIGHT,PER,SIM,SOCIETY,THEREFORE
001,007,169,261,649,AMONG,BACKGROUND,COMPARISON,CONCLUSION,EGFR,EGFRM,HRS,III,LABEL,LUNG,LUX,METHODS,NSCLC,OPTIMAL,PFS,PRESS,RESULTS,TKI,TKIS,UNIVARIATE,WJTOG3405
169,2015,AKT,BP1,COPYRIGHT,FAK,GBC,IHC,IRELAND,LTD,MMP,NOZ,THESE
169,2015,DISCOVERY,FLYNN
169,2015,231,233,ALK,COPYRIGHT,EGFR,PUBLISHED,SAS,SEVERAL,SFRO,SOCI
100,107,113,138,169,2010,2012,2015,500,AIM,COLLEGE,CONCLUSION,COPYRIGHT,FIVE,INCIDENTAL,JUNE,LABEL,LTD,MALIGNANT,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SEPTEMBER,THEREFORE
A549,ABI,ABII,BEAS,H12,H14,H17,RESULTS,THEIR,WESTERN
036,042,043,228,301,501,CHINESE,CTGT,HAN,HOWEVER,LUNG,ODDS,RS8042059,SEVENTEEN,SNPS,TCAC
20TH,ACUTE,PATIENT,PRIMARY
112,238,8321,8322,AVERAGE,BACKGROUND,CLOSE,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,THERE
CHRONIC,CLL
BACKGROUND,CELL,LABEL,MDPCR,METHODS,RESULTS,THERE
020,348,BACKGROUND,BASED,CHINESE,GRADE,III,LABEL,METHODS,OBJECTIVE,ORR,PFS,RESULTS,THERE
BACKGROUND,CCR2,CONCLUSION,FINALLY,LABEL,METHODS,NEXT,NOTABLY,RESULTS
GROWING,RNAS
CFM,GSH,IC50,ID8,L1210,L1210FR,NOVEL,OET,PET,RME,WI38
AFTER,AIR,ANTI,AUTOIMMUNE,BACKGROUND,CASE,CONCLUSION,LABEL,LABORATORY,METHODS,THESE
000,400,SHS,SIDS
AFTER,CHINA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SYNERGY,THERE,ZEALAND
BAC,NSCLC
100,2003,2011,8202,875,879,886,CHINA,EGFR,EPIDERMAL,FURTHER,JANUARY,LDA,NSCLC,PRIMARY,SOUTHWEST,SVM,USING
2008,2012,513,ASPIRATION,EBUS,HIV,LAD,METHODS,OBJECTIVE,POTENTIAL,RESULTS,TBNA,ULTRASOUND,VIRUS
001,036,037,121,EVEN,HOWEVER,NSCLC,PCR,THEREFORE,WNT,WNT7A
169,2015,CSC,LUNG,NPS,POOR,PRESS,PUBLISHED,RES,THESE,UNIVERSITY
160,8201,A549,AFTER,BACKGROUND,CD11C,CD123,CHI,CHINESE,CHUAN,CONCLUSION,DC11C,LABEL,METHODS,NKT,NSCLC,PBMC,PBMCS,PERIPHERAL,REGULAR,RESULTS,TAI,TCC,TRC,TRIAL
956,ANNEXIN,BOTH,CCK,CONCLUSION,DDP,FITC,LABEL,LRP,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,TW03,WESTERN
002,0035,005,012,014,015,017,026,177,BMJ,BRITISH,COPD,GD1,GOLD,GROUP,HOWEVER,LABEL,LIMITED,MACROPHAGE,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PRIMARY,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,SETTING,THERE,TOTAL,VANCOUVER
HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SURGERY,THESE,UNDERGOING
169,2015,ENGINEERS,MALIGNANT,OCT,OPTICAL,PHOTO,RAMAN,SOCIETY,SPIE
1000,284,2928,469,ADDITIONAL,LABEL,METHODS,MHD,MLD,OBJECTIVE,OVH,PRINCIPAL,PTV,PURPOSE,RESULTS
CARLO,DOSIMETRY,FURTHER,LABEL,LINAC,LORENTZ,LRBP,METHODS,MONTE,MRI,OBJECTIVE,ORIENTING,PTV,PURPOSE,RESULTS,TRBP
2001,DRX,LABEL,LUCY,METHODS,NEMA,NU2,OBJECTIVE,OSEM,PARTIAL,PET,PSF,PURPOSE,PVE,RESULTS,RICHARDSON,SNR
FIVE,HEALTHCARE,IMRT,INITIAL,LABEL,MEDICAL,METHODS,NUCLEAR,OBJECTIVE,OPTIMIZED,PHILIPS,PURPOSE,RESULTS,SUN,SYSTEMS,UIMAT,VMAT
174,CARLO,CHANGES,DVH,LABEL,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TREATMENT
177,CARLO,CBCT,CONE,DOSIMETRIC,LABEL,METHODS,MONTE,OBJECTIVE,PHASE,PURPOSE,RESULTS
A549,AGENT,BAX,BCL,BESIDES,METADHERIN,MTDH,MTT,NSCLC,TAKEN,WESTERN
8482,ARAB,AST,BACKGROUND,ELISA,FASN,GRECO,HILIT,KAN,LABEL,METHODS,PIGR,RESULTS,SAA1,SAFRA,SAVDA,SPP24
169,2015,8805,BACKGROUND,COPD,CURRENT,FRAMINGHAM,HIGHEST,LABEL,LUNG,METHODS,OFFSPRING,RESULTS,SOCIETY,THESE
169,2012,2015,BASED,LUNG,OTHER,RISK,SOCIETY
000,2013,600,ABOUT,AMI,AMONG,EVEN,ITALIAN,OBVIOUSLY,THEREFORE
954,DATA,JNK,KEY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,TNF,TNFIS,USING,WHEREAS
COEXISTENT,DVL2,HTR4,OPHN1,OTHER,PECOMAS,PSF,RRAGB,SFPQ,ST3GAL1,TFE3,TP53,TSC,TSC1,TSC2
ALK,EML4,GENOMIC,TRUP,UNIFIED
169,2015,BPE,CHRONIC,COLLEGE,CRT,IIIA,NSCLC,PHYSICIANS,ROYAL,THESE
001,169,2015,202,350,552,BACKGROUND,CD20,CD3,CD8,DIAMIDINO,HIGH,HOWEVER,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PRESS,PUBLISHED,QIF,RESULTS,STUDIES,TIL,TILS,UNIVERSITY,USING,YTMA140
169,2015,COPYRIGHT,CURRENT,III,IRELAND,LTD,MEDLINE,NSCLC,PEMETREXED,WHILE
169,198,2015,351,522,708,906,COPYRIGHT,CPG,DESPITE,EPIGENETIC,INC,LUNG,THERE,THESE,USING
000,169,1975,2010,2015,2020,900,BACKGROUND,BETWEEN,END,LABEL,METHODS,OVERALL,PREDICTING,RESULTS,SINCE,SOCIETY
169,2015,BRAIN,COPYRIGHT,PUBLISHED,SAS
169,2015,956,BACKGROUND,CAST,ECS,HEART,HOWEVER,INC,JAK,JANUS,LABEL,LOSS,METHODS,OBJECTIVE,RATIONALE,RESULTS,SMALL,SOCS3,STAT,STAT3,VEGF
169,2015,AFTER,AMONG,CAFS,HOWEVER,PDPN,RHOA,ROCK,THESE,UICC
024,107,176,ASN118ASN,C8092,ERCC1,THESE,XPD,XRCC1
141,183,2007,AMONG,BACKGROUND,HINTS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SMOKING
2009,2012,8201,8804,IIIB,JANUARY,JULY,NSCLC,THUS,TOXICITIES
C25,DR5,HOWEVER,MTS,SHORT,SOLUBLE,THUS,TRAIL
001,011,012,021,169,2015,8805,BACKGROUND,BSP,COPYRIGHT,CPG,EPIGENETIC,INC,LABEL,METHODS,MSP,NPTX1,PCR,QMSP,RESULTS,THESE,TNM
500,AMONG,CD8,ELISPOT,H1N1,H3N2,HLA,HOWEVER,IAV,IAVS,IC50,M13,PB1,PB2,POISSON,PR8,X31
003,169,2015,215,232,259,328,378,591,945,COMPARING,HOWEVER,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,S100B,THEREFORE,UNIVERSITY
CELL,ECM,HDFC
100,169,2014,COPYRIGHT,MPCE,PUBLISHED,THUS,ULTRASOUND
160,169,2015,215,COPYRIGHT,DISTANT,GIVEN,INC,TRANSPLANT
ACUTE,AFTER,AMONG,CONCLUSION,FIVE,KNOWLEDGE,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SBRT
169,2015,946,AKT,COPYRIGHT,EMT,INC,TGF
169,2015,945,BIO,BRITISH,CCL,IMMUNOLOGY,MDSC,MDSCS,MYELOID,NSCLC,PERIPHERAL,PLEX,RFA,SOCIETY,THERE,THESE,TNF,TREGS
169,2015,946,ADC,COLD,DOCK,DOCK4,LABORATORY,PRESS,PUBLISHED,RAC1,SMAD,TGF,THESE,THUS
169,1994,1996,1997,2012,2014,351,428,557,747,8805,AMONG,CONSISTENT,COX,JANUARY,JUNE,USING
111,169,2015,215,476,510,730,953,DISCOVERY,FDR,FFAR4,FOUR,GWAS,INC,LUNG,WILEY
IRELAND,LTD,LUNG,PUBLISHED,SEVERAL,THEREFORE
1998,2010,7204,BACKGROUND,BETWEEN,CALLS,CONCLUSION,DESPITE,FUNDING,HRS,INDIVIDUAL,INSTITUTE,LABEL,LIMITATION,METHODS,NURSING,OBJECTIVE,PRIMARY,PROXY,RESULTS,RETIREMENT,SETTING
1000,1250,169,2015,750,BACKGROUND,CETUXIMAB,DECREASED,DLT,DLTS,EGFR,ERBB2,FIFTY,FURTHER,JAK,LABEL,MAPK,METHODS,MTDS,PI3K,RESULTS,SOCIETY,STAT
169,2015,FORCE,LUNG,PREVENTIVE,SCREENING,SINCE,SOCIETY,TASK,TRIAL
169,2014,231,233,COPYRIGHT,FRAN,PEMETREXED,PUBLISHED,SAS,SOCI
ADDITIONAL,AFTER,BACKGROUND,CELLS,FINAL,LABEL,LUTS,PATIENT,PAZOPANIB,PEC,PSA,RESULTS,T1B,THERE,THEREFORE,THREE
160,169,2015,510,900,CHINA,COPYRIGHT,ELISA,GENOMIC,HOWEVER,IGG,IRELAND,LTD,PCR,PREVALENCE,RFLP,THREE,THUS,TOXOPLASMA,TYPE
169,2015,CONCLUSION,COPYRIGHT,DESPITE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,169,2014,4N0,7TH,AFTER,BACKGROUND,CCRT,CIRT,GRAY,GYE,IIA,IIIA,LABEL,LCR,METHODS,NSCLC,RESULTS,SHORT,SOCIETY,UICC
169,2015,COLORECTAL,COPYRIGHT,CPG,CUR,CURCUMA,DELETED,DLEC1,HDAC4,HT29,INC,KNOCKDOWN,MSP,TAKEN
169,2015,ASIA,AUTHORS,FURTHER,G3H,GFP,HGF,HOWEVER,LTD,MET,PTY,PUBLISHING,SCIENCE,SCLC,SMALL,THEREFORE,THESE,WILEY
169,2015,823C,ARG275TRP,COPYRIGHT,INC,PARK2,PARKINSON,PUBLISHED,RING,SOCIETY,THESE,UPON
001,016,042,045,100,127,130,135,212,334,AFTER,ALONG,BACKGROUND,HOWEVER,IIA,IIB,IIIA,IIIB,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SCLC
10G,BACKGROUND,GLN,LABEL,MATERIALS,METHODS,RESULTS,SIXTEEN
BACKGROUND,DISEASE,FDG,LABEL,MATERIALS,METABOLIC,METHODS,NSCLC,PERCIST,PET,PFS,RESULTS
BACKGROUND,DARUSSALAM,EGFR,HER2,HOWEVER,LABEL,LUNG,MATERIALS,METHODS,PROTEIN,RESULTS
103,183,188,2006,2011,205,285,388,BACKGROUND,BAL,LABEL,LUNG,MATERIALS,METHODS,NPV,PPV,RESULTS,TBLB
A549,HOWEVER,NSCLC,RAD51
000,100,109,112,138,150,2010,2012,2013,684,999,ABUL,ARAB,BACKGROUND,EAST,FAO,HOUSEHOLD,IRAQ,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS,SHATT,THESE
2006,2009,695,AMONG,BACKGROUND,IMAM,KERMANSHAH,LABEL,MATERIALS,MEDICAL,METHODS,RESULTS,REZA,SPSS,UNIVERSITY
169,2015,CTCS,GMBH,KGAA,VCH,WILEY
2CPE,963,A549,BIS,FINALLY,HAMMETT,IC50,INHIBITOR,PEG,WHILE
001,054,10540,169,178,1997,2010,2015,HCC,HIV,INC,INSURANCE,PWH,THERE,WILEY
169,2015,COPYRIGHT,HCC,INC,PUBLISHED,SOCIETY,TAE
169,2015,COPYRIGHT,INC,PUBLISHED,SOCIETY
CASE,DISCUSSION,DUE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCT,PET,SIX,STTA,SUB,TENON
169,2015,5AZA,A750,AKT,CDR,CONCLUSION,COPYRIGHT,CPG,E746,EGFR,EGR,GEF1,GEF2,ICAM,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PC9,PCR,PTEN,RESULTS,TKIS,TREATMENT
32P,AAI,AAN,BEN,CONCLUSION,DICOUMAROL,EXPRESSION,HOWEVER,LABEL,METHODS,NAD,NQO1,OBJECTIVE,OBJECTIVES,RESULTS,UNASSIGNED,WESTERN
001,169,2010,2015,8804,BACKGROUND,BASED,END,HODGKIN,HOWEVER,LABEL,LARGE,METHODS,MOST,PRESS,PUBLISHED,RESULTS,SEPARATELY,SMALLER,UNIVERSITY,YOUNGER
0046,460,8201,ALSO,CAT,FINALLY,GPX,GSEA,HAG,HOP,LCC,OXIDATIVE,SOD,THUS,TXNIP,USING
0001,004,1032,146,169,2006,2012,2015,8805,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS,ROBOTIC,UNIVARIATE
EARLY,FOOT,PALLIATIVE,WHOLE
169,2015,946,947,BAX,CELLS,COPYRIGHT,H2AX,INC,PCNA,SER
169,177,2015,COPYRIGHT,GENERAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PBS,PHANTOM,PMRT,PURPOSE,RESULTS,SURFACE
001,169,2015,ALSO,ARM,BCS,COPYRIGHT,DUE,GROUP,HOWEVER,IMN,INC,KROG,LABEL,MATERIALS,METHODS,MRM,OBJECTIVE,PURPOSE,RADIATION,RESULTS
169,2000,2015,CBCT,CBCTS,CONCLUSION,COPYRIGHT,DAVIS,FOUR,INC,KRESS,LABEL,MATERIALS,MAXE,METHODS,OBJECTIVE,PICCS,PURPOSE,RESULTS,RMSE,SMEIR,THEN,USING
0001,003,100,169,2015,945,COPYRIGHT,CTVS,EVALUATION,FDG,FIFTEEN,GTV,INC,LABEL,MAASTRICHT,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,RESULTS
0001,001,106,150,166,169,2003,2006,2015,215,498,945,946,AMONG,BED,COPYRIGHT,COX,HIGH,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SBRT
100,169,2015,8804,BECAUSE,COPYRIGHT,GRADE,INC,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
169,2015,231,233,ASSESSMENT,COPYRIGHT,PROGNOSTIC,PUBLISHED,SAS,SFRO,SOCI,THESE
169,2015,231,233,COPYRIGHT,INCA,PUBLISHED,SAS,SEVERAL,SFRO,SOCI,THESE
CHEMICALLY,CRE,FINALLY,FLP,INTRANASAL,MOST,NSCLC,SCLC,TET,THESE
LUNG,POTENTIAL,RAS
8201,LUNG,MALIGNANT,MPE,PLEURAL
HOWEVER
CETUXIMAB,EGFR,GROUP,III,INSPIRE,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOUTHWEST,SUMMARY
100,2030,BACKGROUND,BESIDES,CANCERS,EVEN,LABEL,LUNG,PREVENTIVE,WOMEN
176,A549,AFTER,CASPASE,CELL,DU145,H1299,HSP90,LABEL,MATERIALS,MCF7,METHODS,MRC5,OBJECTIVE,PC3,PURPOSE,RESULTS,T98G,U87MG,VIABILITY
946,MMP,RHOB,TGF,THEN,THEREFORE
2007,2011,EACH,END,FIFTY,FORTY,FRANKEL,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SELECTING,SRS,TRILOGY
2013,8805,AMONG,BOARD,CHECK,FORCE,HOWEVER,MEDICAL,PHE,PHES,PREVENTIVE,SERVICE,SINCE,SWISS,TASK,THEREFORE
549,A549,BACKGROUND,BF1,EXPRESSION,LABEL,METHODS,MIGRATION,MMP,MMP1,MMP2,MMPS,NSCLC,PCR,PRDI,RESULTS,RIZ,TIMP,TIMP1,TIMP2,TIMPS
1217,1292,18F,2012,2013,3255,BACKGROUND,BESIDES,FDG,JULY,LABEL,METHODS,PET,RESULTS,SPM,UNIVERSITY,ZHENGZHOU
026,056,1997,2011,870,8805,ACCORDING,BACKGROUND,COX,LABEL,METHODS,NEWLY,RESULTS,RISK,SIR,SIRS,SPM,SPMS
169,2015,BIOLOGY,HOWEVER,IAP,INC,MKN45,MOLECULAR,SOCIETY,THUS,TREATMENT,YM155
100,9P21,BAP1,BRCA,EMA,FISH,GLUT1,HOWEVER,IHC,IMP3,LOSS,VARIOUS
138,8322,8804,AUC,EBC,EXHALED,LUNG,NSCLC,THERE
160,2007,2008,2010,969,AIMS,ALSO,AMONG,BACKGROUND,CONCLUSION,DENMARK,GENERAL,HOWEVER,III,INITIATING,LABEL,METHODS,NON,OBJECTIVE,PATIENT,PHD,RESULTS,SD18,SERVICE,SPIROMETRY,STUDIES,UNIT,UNIVERSITY,UNLABELLED,WOMEN
ACUTE,FIVE,GRADE,HOWEVER,IGRT,III
8202,8764,CONFIRMED,FDG,MOST,OUTCOME,PET,PSP
120,1996,2010,2192,6073,8265,BECAUSE,COMPARING,COX,EGFR,HOWEVER,INSURANCE,PFS,PREDICTORS,THERE,TKI,TKIS
2003,2008,2010,399,BESIDES,CASES,COEXISTING,COPD,COX,HOWEVER,HRS,INSURANCE,TAIWANESE
103,332,BASED,LOW,NSCLC,PET,PULMONARY,STAGE,THERE,THREE
100,177,354,956,95C,CSPECIFIC,NUMERICAL,YOUNG
001,012,016,018,029,033,036,045,083,160,169,172,187,2015,371,433,546,558,568,681,976,991,BACKGROUND,COPYRIGHT,INC,LABEL,LUNG,METHODS,PROGNOSTIC,PUBLISHED,RESULTS,SOCIETY,SOLID
141,ECTOPIC,FINALLY,GASTRIC,HOWEVER,INCREASING,MIR,PDZ,TAKE,TAZ,THESE
001,048,187,AFTER,BACKGROUND,CONCLUSION,CRP,ESTIMATING,KI67,LABEL,METHODS,MPM,NLR,RESULTS,THUS
001,005,124,150,1980,2010,2013,3071,8805,AMONG,BACKGROUND,CONTEXT,ETE,LABEL,LARGE,METHODS,OBJECTIVE,PREDICTORS,PTC,RECURRENCE,RESULTS,RFS,SECULAR
ACETATE,AFTER,DECOCTION,INCREASED,LABEL,LCC,METHODS,NPY,OBJECTIVE,PCR,POMC,RATS,RESULTS,SERUM,THERE,THOSE,TOTALLY,XIAOYAN
956,ADM,ADRIAMYCIN,BUTYL,CELLS,CURCUMA,CWN,CWNAE,FCM,GCS,IHC,LABEL,LRP,MDR,METHODS,OBJECTIVE,RESULTS,SGC7901,VCR,VERAPAMIL,VP10,W20,W40,W80,WESTERN
HEP,MCF7,STEMONA,THESE
549,AMONG,COMPOUNDS,ESPECIALLY,HELA,THP,URSOLIC
0156,1000,125,2293,8201,956,A549,DAD,HPLC,INDIA
945,GROSS,HMB45,SINCE,THEREFORE
169,2015,231,ATTACHMENT,COPYRIGHT,FAK,FINALLY,FOCAL,LVC,MDA,MYOF,PAX,RNAI,SOCIETY,THESE,Y118,Y397
946,A549,ERK,FBS,FPP,HOWEVER,LUNG,MTT,RII,STATINS,TGF,THEREFORE,WESTERN
169,2015,COPYRIGHT,ECG,INC
946,A549,ALSO,ANTI,ERK,FAK,GSK3,MMP,ROS,SRC,SUPPRESSED,THUS
2004,2013,544,891,AIM,CENTRAL,CNS,HER2,LIVER,PFS,PPS,PROGNOSIS,RESULTS,THERE
100,116,205,549,87MG,956,COLO,H322,HCT,MCF,METHANOLIC,NCI,SPP,SRB,THP
145,956,A1CL3,A549,ALP,AMONG,ANTICANCER,CELL,CHLOROFORM,DRIED,FLAVONOID,IGR,MCF,OVI,PIPER,SGOT,SGPT,SRB,THP
BRG1,CONVERSELY,EGFR,EZH2,NON,PRC2,THESE
001,400,945,A549,BAX,BCL,FORTY,HIF,IHC,MYRICANOL,NUDE,PCR,THESE,TIR,TUNEL,VEGF
177,8201,ACCORDING,BSE,CBCT,CONCLUSION,EUCLIDEAN,GTV,LABEL,METHODS,OBJECTIVE,REFERENCE,RESULTS,SBRT,SOBEL
001,106,169,2014,2015,AFTER,AMONG,FORCEPS,INDIVIDUAL,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,18F,2015,216,609,8804,AMONG,LABEL,LY0V0PL0N0,METHODS,OBJECTIVE,PRESS,PUBLISHED,PURE,RESULTS,SMALL,SOLID,STAGE,UNIVERSITY
130,169,2014,2015,8804,ENDOSCOPIC,GRADE,III,MAY,PHASE,PRESS,PUBLISHED,SECONDARY,UMIN,UNIVERSITY
BMJ,DESPITE,GROUP,LDCT,LIMITED,PUBLISHED,PUBLISHING

BRAIN,DATA,HISTOLOGY,NSCLC
169,2015,535,956,COPYRIGHT,ESI,HOWEVER,HPLC,IMS,MNPS,THEREFORE,UNDER
2011,ANTI,KIF5B,LADCS,NSCLC,REARRANGED,RET,SEVERAL,TKIS
001,006,007,019,041,264,BACKGROUND,CONCLUSION,LABEL,METHODS,MTSS1,NSCLC,RESULTS,SCC,SCCS
169,2015,A549,ACTIVATION,AIMS,CDC2,CDDP,CELL,CISPLATIN,COPYRIGHT,CROSS,CYCLINB,FLOW,HOWEVER,INC,KEY,LABEL,MAIN,METHODS,OBJECTIVE,RESULTS,SEVERAL,TYR15
CARDIAC,THREE
GERD,MOST
090,169,2015,482,ADVERSE,AGREEMENT,CONCLUSION,EXAMINING,GIVEN,INSTITUTE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SOCIETY,SUBJECTIVE,TREATMENT
111,148,169,2015,261,CHINA,COMMITTEE,CONCLUSION,IASLC,JOINT,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX,SOCIETY,TNM
001,1005,1007,109,166,169,2015,253,275,7652,888,ALK,AMONG,CONCLUSION,CRIZOTINIB,DCR,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PROFILE,PURPOSE,RESULTS,SOCIETY,TTP
001,160,169,1997,2008,2015,APRIL,BACKGROUND,COPYRIGHT,FIVE,FURTHER,III,INC,KRAS,LABEL,MARCH,METHODS,PUBLISHED,RESULTS,SOCIETY
002,011,014,034,052,054,169,2015,945,AKT,BONE,CELL,COPYRIGHT,EDUCATION,FAK,INC,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,PTEN,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL,WESTERN
169,2015,COLLEGE,COMBINING,COPYRIGHT,EARLY,LTD,PUBLISHED,PULMONARY,ROYAL
2010,326,408,AMONG,CONCLUSION,CURRENT,DATA,INDICATORS,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SHS
0001,003,009,208,8201,8804,DFS,LCR,LNR,NCR,NSCLC,THEREFORE
169,2015,ATM,BIOLOGY,EPHA5,FINALLY,INC,LUNG,MOLECULAR,SOCIETY,UPON
100,160,169,2015,AGE,CONCLUSION,COPYRIGHT,CTPA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,PURPOSE,RESULTS,TEN,THESE
089,169,2015,481,577,AFTER,AMSTERDAM,COPYRIGHT,ERASMUS,GUIDELINE,IRELAND,LABEL,LTD,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,ROTTERDAM,SABR,UNIVERSITY,VATS
169,2015,ALTO,CBCT,CONCLUSION,COPYRIGHT,CROWN,IMAGE,LABEL,LAT,LTD,MATHWORKS,MEDICAL,METHODS,OBJECTIVE,ORGAN,PALO,PUBLISHED,PURPOSE,RESULTS,SYSTEMS,USA
038,048,152,196,ACCORDING,EVIS,LABEL,METHODS,NBI,OBJECTIVE,OLYMPUS,RESULTS,THERE,WLB
001,150,300,AIM,BACKGROUND,COLORECTAL,CONCLUSION,CRC,LABEL,METHODS,MINIA,OBJECTIVE,RESULTS,SEDENTARY
100,169,177,2015,8764,956,A549,AUC,BROMO,COPYRIGHT,HENCE,HOWEVER,INC,NEXT,NLPS,NOS,THEREFORE
122,HIGH,THESE
CARD9,CXCL1,CXCL2,CXCL5,EXOGENOUS,MYD88,TOLL,USING
DATA,ITALY
8322,EXOGENOUS,FAK,FOCAL,PHOSPHATE,S1P
003,014,021,145,8202,877,8804,8805,FDG,NSCLC,ROC
177,2005,2013,8202,BONE,DATA,FIVE,FURTHER,JANUARY,MALIGNANT,MFH,MRI,PATHOLOGY,PATIENT,THERE

169,2015,ADC,ALSO,COPYRIGHT,IHC,IRELAND,LARGE,LCC,LCNEC,LTD,NET,NGS,NOS,NSCLC,SCLC,SQC
001,028,143,160,169,1998,2007,2015,316,AMONG,BACKGROUND,BASED,BETWEEN,COPYRIGHT,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY
001,045,118,160,167,169,2015,347,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,PURE,RECURRENCE,RESULTS,SOCIETY
001,132,155,172,177,190,421,CCL18,CD14,CD25,CD4,CD80,CD83,CD86,CSF,FCM,FINALLY,FOXP3,HLA,LABEL,METHODS,MFI,MPE,NSCLC,OBJECTIVE,RESULTS,SIMILARLY
945,BORN,ERBB,GBSA,HER2,HOWEVER,L755P
CD133,CD29,CELL,CELLS,CTCS,EPCAM,EPITHELIAL,FIRSTLY,HOWEVER,NSCL,NSCLC,STEM,THESE,TSCS
967,BLOOD,EVALUATION,PBV,SOLID,SURFACE,THROUGH
004,006,945,A549,AKT,ANCT,LAC,LETP,MMP,MTT,PCNA,PENTRAXIN,PTX3,TAKEN,TRANSWELL
169,2015,COPYRIGHT,INC,THUS
95D,A549,AKT,CXCR4,FITC,LMWH,LOW,MILLICELL,MTT,PI3K,THEREFORE,TRANSWELL,WESTERN
946,A549,BAD,BAX,EMT,JUN,KNOCKDOWN,NSCLC,SHORT,THESE,USING,WESTERN
947,AFTER,ASSESSMENT,CONCLUSION,CONVERSELY,DCS,FACT,FUNCTIONAL,GPS,INF,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,TH1,TH2,TREATMENT
169,2015,786,945,AUC,BACKGROUND,BECAUSE,HOWEVER,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THEREFORE,UNIVERSITY
GCTB,GIANT,OPG,RANK,RANKL
169,2014,244,468,ACCORDING,ALPES,BACKGROUND,COPYRIGHT,LABEL,METHODS,PATIENT,PUBLISHED,RESULTS,SAS,SPLF,THEREFORE
107,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,MONITORING,PUBLISHED,SAS,SCLC,SIADH,SPLF
157,160,169,19KG,2008,2011,2014,37YEARS,BACKGROUND,CONCLUSION,COPD,COPYRIGHT,FIFTY,HBS,LABEL,LUNG,METHODS,POOR,PREVIOUSLY,PROTECTIVE,PUBLISHED,RESULTS,SAS,SPLF,VITAMIN
001,005,169,2015,CONCLUSION,COPYRIGHT,EGFR,EXPRESSION,FURTHER,HER2,IGF,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PROTEIN,RESULTS,TKI,TKIS,UNIVARIATE,VEGF
001,007,169,1796,2014,BACKGROUND,BESIDES,CONCLUSION,COPYRIGHT,EBSCO,HOWEVER,HRS,IRELAND,LABEL,LTD,METHODS,MPLC,OVID,RESULTS,THERE
169,2015,COPYRIGHT,IRELAND,LTD,PUBLISHED,THERE
169,2015,COPYRIGHT,ERK1,IRELAND,LTD,NSCLC,PTP1B,THESE
169,2015,A549,ATRA,BCL,CDK,COPYRIGHT,RESULTS,TNF
002,006,A549,HDACI,LABEL,LARGAZOLE,METHODS,OBJECTIVE,PURPOSE,RESULTS,TGI,THESE,USING
8482,ADP,AUSTRALIA,BRCA,CHINA,EWING,III,JAPAN,KOREA,SOUTH,USA
150,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TEN,THESE
1980,2012,BACKGROUND,BRIGHAM,DEPARTMENT,FAST,HOWEVER,LABEL,MALIGNANT,MATERIALS,MEDICAL,METHODS,MPM,RADIATION,RESULTS,STAGE,UNIVERSITY,WASHINGTON
1983,2012,4221,ASIA,BACKGROUND,CONCLUSION,GROUP,III,LABEL,MALIGNANCY,METHODS,RESULTS,STAGE,THERE,TYPE,WORLD
BACKGROUND,CONCLUSION,EBUS,LABEL,METHODS,RESULTS
143,169,2015,BASED,COPYRIGHT,DOWN,FEDERATION,LUCIFERASE,MYB,NCP,NPC,NPCS,PUBLISHED,SOCIETIES
001,045,169,172,2015,242,CMV,CSA,GVHD,INC,MMF,MTX,PSM,THERE,WILEY
ALK,EGFR,HODGKIN,KRAS,LUNG
177,197,ASSESSMENT,BRM,CNS,GPA,INTRABEAM,IORT,KARNOFSKY,LABEL,LOCAL,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SCALE,SIX,SURGERY
0144,177,4T1,AKT,DMBA,EVEN,IGF,IGFBP,IGFS,INSULIN,WHILE
3957,AMONG,CHANG,CLOSE,GUNG,MCT,MEDICAL,OTHER
169,181,2015,8482,954,A549,BACKGROUND,BASEL,CNS,CONCLUSION,EFFORTS,GI50,INSTITUTE,LABEL,METHODS,NCI,NSCL,PI3K,RESULTS,SCREENING,SRC,SRS06,STAT3,TRANSAM,WESTERN
2005,2006,BAC,CONCLUSION,FDG,GGO,HRCT,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SUV
201T,946,A549,BAD,BAX,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,STS,WESTERN
136,149,155,169,171,2001,2013,2015,285,AMONG,CENTERS,CONCLUSION,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
169,2015,215,CONCLUSION,FDG,HENCE,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SNR,SNRS,SOCIETY,SUPPORTED,SUVMEAN,UNLABELLED
169,2015,BACKGROUND,BASEL,CHIP,CONCLUSION,DUAL,H1299,H1568,HIGH,KRAS,LABEL,METHODS,MTT,MYC,NSCLC,PCR,RESULTS,TUNEL,WT1
250,AREA,BACKGROUND,C30,DEVIATION,EORTC,FURTHER,HRQOL,LABEL,METHODS,PEMETREXED,QLQ,RESULTS,SEVERAL,SOUTH,SWAMP,WEST
003,8201,BSP,HOWEVER,NSCLC,PCR,SOX1,TMA
001,002,007,008,170,196,343,665,8201,8805,HOWEVER,III
001,004,104,529,8201,A549,ANNEXIN,ARNT2,MTT,NSCLC,OVERALL,TAKEN
203,A549,ADP,BACKGROUND,CDDP,CFZ,H1299,H1993,H460,H520,IC50,LABEL,LC3B,METHODS,NSCLC,PARP,PHASE,RESULTS,SCLC,SHP77,WESTERN
100,120,169,2015,DAYS,GRADE,IRINOTECAN,LABEL,METHODS,NON,OBJECTIVE,ORAL,PHASE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
BACKGROUND,CASE,CONCLUSION,ILD,LABEL,METHODS,PTV,RADIATION,RTOG,SABR,SIX
1960,1996,992,CARLO,LABEL,LIMA,METHODS,MONTE,OBJECTIVE,OBJECTIVES,OHIO,RESULTS
1955,2011,2096,474,EARLIER,LABEL,LIMA,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
OPTIMAL
1999,SINCE
2015,AFTER,AMPUTATION,COPYRIGHT,FOUR,HOWEVER,III,SLACK
34C,DAC,ECTOPIC,HOWEVER,KNOCKDOWN,MET,NPC,PCR
DAC,DESPITE,NALP1,PCR,THEREFORE
163,2000,2010,AMONG,BACKGROUND,CONCLUSION,EGFR,EGFRS,ERLOTINIB,HIGH,KRAS,LABEL,METHODS,OBJECTIVE,RESULTS,THEREFORE
ADDITIONAL,AKT,BACKGROUND,CONCLUSION,EVEROLIMUS,LABEL,METHODS,MPM,OVERALL,PFS,PI3K,RESULTS,THERE
001,0012,939,ASSESSMENT,BACKGROUND,CHEMONAIVE,EASTERN,FACT,FUNCTIONAL,GENERAL,GROUP,III,IIIB,LABEL,LUNG,MEAN,METHODS,NSCLC,NTX,POINTBREAK,POST,QOL,RANDOMIZED,RESULTS,THERAPY,TREATMENT
005,100,127,138,BACKGROUND,BECAUSE,CORRECT,EACH,EBUS,KOREA,LABEL,METHODS,NPV,NSCLC,RESULTS,TBNA
2013,DRESDEN,EVALUATION,HOWEVER,IASLC,LUNG,POST,SOLID,WCLC,WORLD
PROGNOSIS,PULMONARY,RADIOLOGY
001,005,006,2001,2006,2007,2011,553,BACKGROUND,CONTEXT,LABEL,LBP,LBPS,METHODS,OBJECTIVE,PULMONARY,RESULTS
BACKGROUND,CONTEXT,DISEASE,IDR,LABEL,METHODS,OBJECTIVE,RESULTS
ADVERSE,DFS,EGFR,EPIDERMAL,III,LABEL,NSCLC,OBJECTIVE,PHASE,PURPOSE,RESULTS,SUMMARY,THERE,TKI,TKIS
1686,8202,AZD9291,EGFR,ERBB,HM61713,L858R,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,T790,THIRD,TKI,TKIS
169,2015,ACIDS,AKT,CLINICALLY,HDAC1,HOWEVER,NOTABLY,NUCLEIC,OC4,OCT4,PRESS,PTEN,PUBLISHED,SP1,THROUGH,TNC,UNIVERSITY
169,2014,231,233,BIOLOGICAL,COPYRIGHT,CPMHS,CPMRC,FRAN,HSMPC,MCRPC,PUBLISHED,SAS,SOCI
169,1999,2011,2015,231,233,254,APRIL,BACKGROUND,BRAF,CEA,COPYRIGHT,FASAY,FRAN,JANUARY,LABEL,LOUIS,METHODS,PFS,PUBLISHED,RESULTS,ROUTINE,SAINT,SAS,SOCI,THERE,TP53,V600
001,002,100,164,18F,202,442,555,662,963,BACKGROUND,BOTH,CONCLUSION,FDG,HOWEVER,LABEL,METHODS,MTV,PET,RESULTS,SCLC,THERE,TLG,VOLUMETRIC
045,083,092,102,178,19MT,21MT,441,639,644,653,665,682,967,EGFR,ELISA,EPIDERMAL,HOWEVER,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PROTEIN,RESULTS,SERUM,SPSS,THESE,THUS,TNM,TTF
088,093,102,109,131,136,139,148,150,155,178,179,199,203,205,220,223,237,241,243,253,255,260,310,410,435,446,498,528,567,656,697,741,831,893,919,967,999,CIGARETTE,CONCLUSION,ERAP2,HAN,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS,SNP,SNPS,THEN
101,119,139,163,172,177,181,431,556,589,633,655,725,AMONG,BOTH,COPD,EXPRESSION,LABEL,METHODS,OBJECTIVE,RESULTS,VAN
003,008,009,019,025,030,148,160,163,2010,227,558,8201,8804,8805,925,BACKGROUND,BOTH,LABEL,METHODS,PET,RESULTS,SOLID,TSCT,USING
946,BACKGROUND,DAL,EMT,EPITHELIAL,HSPA5,LABEL,METASTASIS,METHODS,PCR,RESULTS,STRIKINGLY,THESE
MTT
169,2015,MMP,RIBAVIRIN
100,BACKGROUND,CONCLUSION,DEFINITELY,FDG,FREQUENCY,HOWEVER,LABEL,MALIGNANT,METHODS,PET,RESULTS,THERE,WHILE
00001,005,160,2013,205,520,8804,8805,967,AAH,AIS,BACKGROUND,BETWEEN,GGNS,JANUARY,LABEL,METHODS,MIA,PEARSON,RESULTS,ROC,TSCT
114,AFTER,BACKGROUND,BLINDED,CARCINOMA,CELL,CONCLUSION,EBUS,EUS,F18,FDG,HOWEVER,LABEL,LUNG,METHODS,NEITHER,NON,NSCLC,PET,REFERENCE,RESULTS,SMALL,STAGING,THEREFORE
945,BACKGROUND,CELL,CELLS,CISPLATIN,EXPRESSION,H23,HDAC,HDAC4,HDACS,HIF,LABEL,LUNG,METHODS,MOST,NSCLC,PARP,RESULTS,THESE,TOXIC
461,682,BACKGROUND,CONCLUSION,DIFFERENT,LABEL,METHODS,OTHER,RESULTS
18F,FDG,HISTOLOGIC,PET,SUBSEQUENT
001,246,311,618,EGFR,EPIDERMAL,LABEL,LOW,MANN,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEVENTY,SUV,WHITNEY
001,100,18F,2009,2013,68GA,APRIL,BOTH,DEFINITIVE,DOTA,FDG,HISTOLOGY,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,SUV,TCS
13C,13C5,13C6,15N2,DUE,FRESHLY,GLS,GLS1,KREBS,NSCLC,THESE
JCI,SELLERS,TCA,THERE
100,EGFR,FURTHER,HOWEVER,IMPORTANCE,KERATOSIS,LABEL,METHODS,OBJECTIVE,RAF,RELEVANCE
LUNG,SKIN,SUBSEQUENT,THEREFORE
HOWEVER,NSCLC,PLGF,VEGF
169,2015,4T1,600,802,946,AMONG,BIOLOGY,EMT,EPITHELIAL,HIT,HOWEVER,HOXA,INC,KNOCKDOWN,MOLECULAR,NMUMG,RNAS,SOCIETY,TGF
BACKGROUND,CEA,CONCLUSION,EACH,HENCE,LABEL,LUNX,METHODS,PCR,RESULTS,THREE
174,8482,ACCURAY,CONCLUSION,FIF,HELICAL,INC,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,SBBC,SIB,SIMILARLY,SIX,SUNNYVALE,TOMODIRECT
8201,ASSESSING,BLAND,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,TOMO
000,009,018,028,2013,ADVERSE,COX,GEFITINIB,III,IIIB,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PFS,RESULTS
038,105,166,167,946,III,NSCLC,RAR,SIMILAR,SINCE,THESE
A549,BACKGROUND,CELL,CHINESE,EFFECTS,EXPRESSION,LABEL,MATERIALS,METHODS,MMP,MMPS,MTT,PARIS,PPSS,RESULTS,WESTERN
005,021,037,041,151,ACE,BACKGROUND,BLOOD,INDIA,LABEL,MATERIALS,METHODS,NORTHEAST,RESULTS,SMOKING
001,002,034,177,272,544,BACKGROUND,EAST,INDIA,LABEL,MANIPUR,METHODS,MIZORAM,NORTH,PRO,RESULTS
001,1077,177,552,619,680,813,ASIAN,BACKGROUND,EGFR,EPIDERMAL,ESPECIALLY,HOWEVER,LABEL,MATERIALS,METHODS,OVERALL,RESULTS
123,A549,DDP,HOWEVER,MDR,MRP1,MTT,PCR,REAL,RNAI,RNAS,TAKEN
339,365,570,663,756,BACKGROUND,CONSISTENT,HOWEVER,IHC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,ROC,SCLC,THREE,THUS,TNF,TNM,TRAF6
1ST,AGE,BACKGROUND,CONCLUSION,DEPT,LABEL,METHODS,MOST,OLOMOUC,PET,RESECTION,RESULTS,SURGERY,UNIVERSITY
169,2015,215,21H,23H,8201,945,CDS,CEA,COPYRIGHT,JOHN,LTD,NSE,SONS,WILEY
19A,8209,CONVERSELY,HOWEVER,NSCLC,PCR,SOCS1,STAT3,TAKEN,THUS,UTR
AREAS,BACKGROUND,CAR,CARS,COVERED,EWING,GD2,IGG,LABEL,METHODS,OPINION
169,2015,4T1,BV8,CSF,CXCR2,IFN,LLC,LUNG,METASTASES,MMP9,OVERALL,THUS,UICC
035,045,CONCLUSION,COX,IIIA,LABEL,METHODS,MLN,NSCLC,OBJECTIVE,RECURRENCE,RESULTS
COMPETING,RNAS,THERE
001,029,037,049,067,160,263,479,547,768,779,8805,CIORR,CIOS,CIPFS,CNKI,EGFR,ERLOTINIB,HROS,HRPFS,LIBRARY,MAIN,MEDLINE,NINE,NSCLC,ORR,OVID,PFS,RRORR,SCIENCE,STATA,TKI,TKIS,WEB
001,002,014,025,028,107,120,157,158,160,164,187,2014,279,321,338,374,374T,399,416,429T,470,499,541,686,732,746,757,818,821,823,82G,840,882,908,936,976,981,ASIAN,CAUCASIAN,LIBRARY,MEDLINE,OVERALL,RAGE,SCHOLAR,THUS
169,1980,1996,1998,2011,2014,801,803,BACKGROUND,BTMED,CAUSE,CONTINUED,COPD,DEPARTMENT,DOE,INC,LABEL,MEDICAL,METHODS,MORTALITY,PROGRAM,RESULTS,RISKS,SCREENING,SMRS,WILEY,WORKERS
KLF4,MICRORNAS,NANOG,OCT4,OCTAMER,POU,RNAS,SEVERAL,SOX2
ALK,EGFR,FGFR1,NGS,NSCLC,SEVERAL
CHINA,HOWEVER,LUNG,LYMPH,NON,NSCLC
001,115,961,AUC,BACKGROUND,CAIX,DETECTION,ELISA,FORTY,III,LABEL,METHODS,RESULTS,SERUM,TNM
001,014,025,031,038,041,120,BACKGROUND,CHI,COX,LABEL,MEIER,METHODS,P53,RESULTS,TP53
107,130,315C,70C,8805,BACKGROUND,BAOSHAN,CHINA,CIS,ESTIMATES,EX1,EX6,GST,GSTM1,HOWEVER,LABEL,LONGTAN,LUNG,METHODS,OGG1,ORS,PCR,RESULTS,THERE,XUANWEI
945,954,956,BACKGROUND,ERK1,EXOGENOUS,IKB,JNK,LABEL,METHODS,NSCLC,PCR,RESULTS,SPC,TLR5,TREATED,WESTERN,WHILE
000,163,177,689,9312,9313,99MTC,BACKGROUND,DYNAMIC,LABEL,METHODS,MOST,PET,RESULTS,ROI,SCLC
155,AFTER,ASCO,CBM,CNKI,CONCLUSION,ESMO,LABEL,META,METHODS,OBJECTIVE,RESULTS,SEVEN,STATA,VIP,WANFANG
169,2015,242,ABCG2,CISPLATIN,COPYRIGHT,DCR,HOWEVER,INC,INOPERABLE,MTT,PFS,QCR,USING
169,2015,ABCB1,ABCC1,ATP,CONVERSELY,COPYRIGHT,HDL,HOWEVER,INC,LDL,LRP,MDR,MDR1,MULTIDRUG
1494,2111,246,3198,327,345,5036,513,AMONG,AUDIT,BACKGROUND,CARE,DIAGNOSIS,ENGLISH,EXCELLENCE,GENERAL,INSTITUTE,IQR,KINGDOM,LABEL,METHODS,NICE,PRESENTING,PRIMARY,RESULTS
FINALLY,ICIS,III,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TARGETING
LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
138,169,2015,ALK,COPYRIGHT,EGFR,EML4,FISH,HOWEVER,IHC,IRELAND,LTD,NSCLC,PCR,TKI
001,169,1ST,2009,2015,232,2ND,330,8805,BACKGROUND,COPYRIGHT,CROWN,DESPITE,FURTHER,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,REASONS,RESULTS,STAGE
169,2015,945,946,BOTH,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SCC
169,2015,COPYRIGHT,DESPITE,FISH,HER2,IHC,IRELAND,LABORATORY,LTD,NGS,NSCLC,ONCOGENIC,SEVERAL
169,2015,239,ALK,ALSO,COPYRIGHT,CRIZOTINIB,IRELAND,LTD,NSCLC,TKI,TKIS
0001,004,110,121,147,160,166,169,185,200,2007,2011,2015,205,207,217,228,237,250,400,8805,AUC,BACKGROUND,BETWEEN,BOTH,BRISTOL,COPYRIGHT,FUNDING,III,INSTITUTE,IQR,LABEL,LTD,METHODS,MYERS,NOV,PET,RADIATION,RESULTS,THERE,USA
169,2015,BASED,COPYRIGHT,FURTHER,HER2,HOWEVER,IRELAND,LTD,SCLC,SMALL
169,2015,A549,BOTH,CELL,COPYRIGHT,H460,HDAC,INC,KISS1,LUNG,NON,NSCLC,SAHA,SINCE,SMALL,SRC
169,2015,ANTI,CONVERSELY,FUNCTIONAL,LUNX,NSCLC,THERE
169,2015,946,A549,CIGARETTE,E2F1,EMT,NSCLC,SCID,SRC,TAKEN,ZEB1,ZEB2
144,169,179,2015,956,ANTICANCER,CONSOLE,COPYRIGHT,DMC,EXPRESSION,H460,HOWEVER,INSTITUTE,JOHN,LUNG,MULTICHIP,NCI,RMA
146,AIMS,BACKGROUND,CONCLUSION,FACTORS,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PULMONARY,RESULTS,THERE
100,169,183,8202,AMONG,DIP,DUE,EXTENSIVE,GEORG,HISTOLOGIC,HISTOLOGY,IGG4,ONCE,STUTTGART,THERE,VO2,YORK
263,360,4356,485,824,993,AFRICAN,ARAB,ASIAN,DANES,EAST,EASTERNERS,EUROPEANS,HRS,IRANIAN,LOW,NORTH,ORDINAL,PANCREATIC,SOUTHEAST,SWEDISH,TURKISH,TURKS
169,2014,AFTER,BACKGROUND,CATHETERS,CONCLUSION,COPYRIGHT,CSF,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,TEXAS,THESE,UNIVERSITY
169,2014,945,946,AKT,AMPK,AUTHORS,CONVERSELY,DNMT1,ERK,ERK1,FOUNDATION,HOWEVER,JOHN,JOURNAL,LTD,METFORMIN,MOLECULAR,NSCLC,PD98059,RHIZOMA,SONS,SP1,TAKEN,WILEY
2010,2012,312,CONCLUSION,DATA,FACTORS,LABEL,METHODS,OBJECTIVE,ODDS,PREVALENCE,PREVENTION,RESULTS,TIANJIN
169,2015,COPYRIGHT,ECD,ESI,INITIAL,NARCISSUS,NMR
169,2015,BECAUSE,COPYRIGHT,HOWEVER,III,NSCLC,PUBLISHED,SUSTAINED,VEGF,VEGFS
169,2015,248,ACCORDING,ADF,COFILIN,COPYRIGHT,KNOCKDOWN,LIN28,LNA,MMPS,NEXT,NSCLC,PREVIOUSLY,TAKEN,TWIST
169,2015,COPYRIGHT,ERK1,FGF,HOWEVER,IRELAND,LTD,MAPK,THESE,VEGF
001,8805,CONCLUSION,EGFR,ELEVATION,FIRST,III,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PHASE,QOL,RESULTS,TIME
142,169,2015,251,651,8201,BIOMARKERS,CART,FDR,IL12A,IL13,IL16,IL1A,IL1B,IL8,INC,NSCLC,SNP,SNPS,THESE,WILEY
GPS,NSCLC,PET,PROJECT,SIGN,SMOKING,SURGERY,THOSE
025,169,2003,2012,2015,BACKGROUND,CD56,COPYRIGHT,FIFTY,INC,LABEL,LARGE,LCNEC,MARCH,METHODS,OVERALL,PUBLISHED,RECURRENCE,RESULTS,SOCIETY
A549,CAV,DEVD,FAS,FMK,HOWEVER,IETD,INHIBITION,P62,RSV
001,005,018,127,130,2000,2012,8201,ALSO,ARG399GLN,ASN118ASN,COX,ERCC1,ERCC2,LYS751GLN,MEIER,NSCLC,RFS,SNPS,TP53,XPD,XRCC1
0000,0001,002,183,8201,ERK,ERK1,HOWEVER,MEANWHILE,NSCLC,THERE,THEREFORE,THUS,TNM
2011,2014,ACTIS,BETWEEN,CRO,HAPPY,JANUARY,MEDICAL,OPDS,SYSTEMS,THEREFORE,TOSHIBA
106,8314,AES,AFTER,NSAI,NSAIS
2012,2013,ADVERSE,BETWEEN,CDDP,CTCAE,GRADE,JANUARY,LABORATORY,THERE
CGA,HOWEVER,JAPAN,LUNG,NSCLC,TREATMENT
169,2015,48H,500,769,BENZO,COPYRIGHT,FINALLY,INC,TEN,THESE,THREE,WESTERN
169,2015,AKT,EGFR,ERBB2,ERBB3,ERK,FINALLY,FOUR,GAB,GAB1,GAB2,L858R,MET,PI3K,SIMILAR
007,015,120,169,ALK,CNB,COPYRIGHT,EGFR,FNA,KRAS,LABEL,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,OBTAINING,PATHOLOGY,RESULTS,SOCIETY,UNIVARIATE
008,010,1377,1377G,196,2007,2011,379,8201,844,844C,844CC,844T,8805,AGE,APOPTOSIS,CHINA,FAS,FASL,HOWEVER,JULY,OCTOBER,PCR,RFLP,SNP,SNPS,SOUTH
215,APR,M1A,PBT,PERB,RBE,STAGE,THREE
012,033,8805,CCR,GRADE,THEREFORE
131,223,CD20,HODGKIN,III,STRONTIUM,THEREFORE,YTTRIUM,ZEVALIN
1994,FOUR,GUNMA,HEAVY,INSTITUTE,ION,JAPAN,MEDICAL,NIRS,PRIMARY,SCIENCE,UNIVERSITY
CRT,HCC,HOWEVER,JAPAN,SBRT,SEVERAL
160,A549,ANNEXIN,FITC,TREATMENT,WESTERN
169,2015,COPYRIGHT,DIAGNOSES,INC,MALIGNANT,NONE,PNSTS,SIX
1078,169,2015,891,946,A549,CDH2,CHIP,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LABEL,LTD,LUCIFERASE,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SMAD,SMAD3,SMAD4,SMADS,SPC,TGF,UPON,WESTERN
153,2014,364,6TH,ANY,DATA,GDP,HEALTHCARE,HOWEVER,LMI,LOW,MEDICAL,MEDLINE,MOST,NCD,NCDS,SCHOLAR,STUDIES
001,018,027,8197,ACCORDING,AIMS,AMONG,BMJ,CBC,CBCS,CNS,DMS,EMBC,EXPRESSION,GEMININ,GROUP,KI67,LABEL,LIMITED,MBC,MBCS,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,THERE

CURRENTLY,EPP,MALIGNANT,MPM,MST,THERE
100,169,2014,215,420,500,5000,597,956,BEH,C18,COPYRIGHT,DEUTERATED,ERLOTINIB,EXTRACTION,LLOQ,OSI,PRECISION,XBRIDGE,XEVO
1990,2013,AMONG,CCRT,DESPITE,FIVE,INITIAL,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,PREVENTION,RESULTS,SCC,SIX
001,004,005,018,042,046,051,100,111,2006,2010,FEDERATION,FIGO,GYNECOLOGY,III,LABEL,LRP,METHODS,MRP,MRP1,MRP3,MRP5,OBJECTIVE,OBSTETRICS,PGP,RELAPSE,RESULTS
122,136,155,169,2015,210,HOWEVER,LABEL,LDCT,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SPN,SPNS,USING
169,2015,26210,428,AACR,CLIN,CLINICALLY,DECREASED,DUSP1,EGFR,GEFITINIB,HDAC,HDAC1,HISTONE,HOWEVER,LABEL,METHODS,MTT,NON,NSCLC,OBJECTIVE,PCR,PROTEIN,PURPOSE,RES,RESULTS
169,2015,217,839,CONCLUSION,FIFTY,IMAGING,INC,LABEL,METHODS,MOLECULAR,MOST,NAF,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,UNLABELLED
100,169,2015,945,946,ASOS,CONSISTENT,COPYRIGHT,EMT,ESTRADIOL,INC,MALAT,PTBP2,SFPQ
002,169,185,2015,607,610,AMONG,COPYRIGHT,EIGHT,INC,REGULOMEDB,XRCC1
169,2007,2013,2015,AMONG,ASPIRATION,BACKGROUND,CHEST,COPYRIGHT,INC,LABEL,MAYO,METHODS,MINN,NONE,RESULTS,ROCHESTER,THESE
CXCR4,FINALLY,FURTHER,HOWEVER,LPS,ML171,MMP9,NADPH,NOX1,NSCLC,ROS,TLR4,TOLL
169,177,183,2014,50GY,72GY,COPYRIGHT,EPID,LEVENBERG,LTD,MARQUARDT,PDI,PDIS,USING
169,2015,A549,ALK,BACKGROUND,CLONOGENIC,COPYRIGHT,CRIZOTINIB,H3122,IRELAND,LABEL,LLC,LTD,METHODS,MVD,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS
1200,169,2014,COPYRIGHT,LTD,MICRORNAS,RNAS,THEREFORE,WHILE
100,138,143,A750,EGFR,INVADER,L858R,MUTATIONS,NSCLC,PCR,THUS
169,2015,CD4,HOWEVER,ILC,ILC2,INC,TH2,TYPE
1000,150,8805,AES,CHINA,CHINESE,EGFR,ERLOTINIB,FORTY,IIIB,PCR,SIXTY
1210477,263,ABT,BCL,BH3,BIM,HOWEVER,MCL
DUMON,PALLIATIVE,SEMS,UNDER
CRYOPROBE,CRYOPROBES
34TH,RIGID
100,182,1999,2012,561,8804,902,BACKGROUND,CAO,DESPITE,LABEL,METHODS,RESULTS
BACKGROUND,EBUS,HOWEVER,LABEL,METHODS,RESULTS,TBNA,THERE
0005,032,120,BACKGROUND,LABEL,METHODS,ONCE,RESULTS
181,183,8201,8202,A549,GEORG,IC50,MCF7,NMR,STUTTGART,YORK
0001,137,177,230,312,326,8226,854,900,935,AUC,BACKGROUND,CONCLUSION,DISCUSSION,HPLC,KYNA,KYNURENIC,LABEL,METHODS,NODAL,NPV,NSCLC,OBJECTIVE,PPV,RESULTS,ROC
954,BCL,CDK2,FURTHER,HES1,NOTCH,RBPJ,SKP2
8201,ALSO,CNS,CORONAL,DIFFUSION,FLAIR,IIC,ISSUE,ITSS,ITSSS,LABEL,MELANOTIC,METASTASIS,METHODICAL,METHODS,MRI,OBJECTIVE,PRACTICAL,STAGE
0015,023,111,113,169,2015,209,213,229,237,239,246,345,364,BACKGROUND,BOEHRINGER,COPYRIGHT,EGFR,FUNDING,HOWEVER,IIIB,INGELHEIM,IQR,LABEL,LEU858ARG,LTD,LUNG,LUX,METHODS,PREVIOUSLY,RESULTS,THESE
019,041,045,071,076,088,105,107,109,111,115,125,149,159,160,190,195,202,248,254,273,308,313,410,730,974,CYS,OGG1,OVERALL,SER,SER326CYS,WEIPU
001,160,182,290,384,470,652,920,946,961,COX,ESCC,LSCC,MYC,NPC,RBMS3,THEREFORE,TSG,WESTERN,WNT
001,006,008,121,2004,2012,BACKGROUND,CAREFULLY,CBM,CHINA,CNKI,FINALLY,HOWEVER,III,KNOWLEDGE,LABEL,LIBRARY,METHODS,MMP,ORS,RESULTS,SCIENCE,STATA,TNM,VERSION,WEB
114,159,8197,BMJ,BRAIN,COMMONEST,EPSCC,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PRIMARY,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,SETTING
231,H460,LNCAP,MCF,MDA,PCA,RAMAN
011,396,ALK,AP26113,ASP3026,BASED,CHALLENGES,CRIZOTINIB,FDA,III,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TSR
HOWEVER,RNAS,TAKEN,THERE
144,701,8201,BACKGROUND,BMI,CONCLUSION,COX,CUTOFFS,INITIATIVE,LABEL,METHODS,OBESITY,RESULTS,ROC,USING,WHR,WOMEN
177,RTP
169,2015,COPYRIGHT,EGFR,GRB2,PLA,SCIENCE,STRATEGIES,THUS
169,2015,8805,AMERICANS,HODGKIN,MARIJUANA,ORS,STUDIES,THERE,THREE
0001,036,169,2003,2006,2015,AMONG,BACKGROUND,COPYRIGHT,COX,IRELAND,LABEL,LTD,MEIER,METHODS,NOTX,OVERALL,RESULTS,SBRT
100,177,1986,1EP,2005,206,215,300,3BEP,4BEP,8805,AFP,CONCLUSION,HCG,INCLUSION,LABEL,LDH,METHODS,OBJECTIVE,PURPOSE,RESULTS,ULN
0002,0004,001,0015,0028,006,037,141,169,174,2015,259,279,456,950,ABCC4,ATP,BACKGROUND,CIPN,COPYRIGHT,GPX7,GST,LABEL,METHODS,MGMT,OTHER,RESULTS,SNPS,THESE
011,ACS,ASSESSMENT,CACS,COMPARING,CONCLUSION,FAACT,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,THERAPY
8209,947,APOPTOTIC,BCL,CELL,DERS,FIFTY,H1299,H460,IC50,INHIBITION,MAPK,MTT,NCI,NSCLC,ROS,TREATMENT,TUNEL
181,211H,ANNEXIN,BAX,BCL,BID,CONSISTENT,DAPI,FLOW,H28,HOWEVER,IC50,LCA,MALIGNANT,MCL,MPM,MSTO,SP1
2004,2012,AIMS,BACKGROUND,CK20,EUS,FNA,FOUR,JANUARY,LABEL,MCC,METHODS,OBJECTIVE,PET,RESULTS,THREE,TTF
0001,042,102,107,113,2005,2011,215,8209,DFS,FUKUSHIMA,HOWEVER,IHC,IMMUNOBLOT,JAPAN,MEDICAL,NSCLC,SCC,SPECIMENS,UNIVERSITY
107,169,2015,8201,ACCORDING,AGE,BACKGROUND,CR2,DATA,EWING,EWS,FIFTY,HDT,IFO,III,INC,ISG,LABEL,METHODS,POST,PROCEDURE,PRS,RESULTS,RFI,SSG,WILEY,WITHOUT
916,936,BET,BETULINIC,CYT,DCA,PDK,ROS,SELECTIVE,TAKEN,WARBURG
169,2014,215,CBCT,COPYRIGHT,EACH,FINALLY,FOUR,INC,LABEL,MARGINS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL
100,169,177,2014,8804,AAA,AXB,CALCULATED,CBCT,COPYRIGHT,D95,GTV,HOWEVER,INC,ITV,LABEL,MATERIALS,MEAN,MEIER,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SABR
FORTY,SPME
0001,100,2007,2011,675,BACKGROUND,BNP,LABEL,METHODS,RESULTS,RISK,SINCE
737,ABT,APOPTOSIS,BCL,MCL,MR29072,PYRIDOCLAX,SURFACE,WHEREAS,WITHOUT
169,2015,248,248C,277,277C,490,490C,501,501C,946,COPYRIGHT,GSH,H2O2,H358,INC,NADPH,SRC,TAKEN,TGF,THUS
160,169,2015,COPYRIGHT,INC,INCREASING,OVERALL,THUS,VERAPAMIL
169,2015,CELL,CILENGTIDE,COPYRIGHT,INC,VERAPAMIL,WONG
169,2015,946,AUTHORS,BLOOD,COPYRIGHT,ERG,ETS,FINALLY,INC,INDUCIBLE,PUBLISHED,THESE,VEGF,WNT
032,956,H2122,IC50,SNC
001,004,010,023,2015,805,CONCLUSION,COX,FDG,LABEL,MATERIALS,MEIER,METHODS,MTBWB,MTVWB,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,RSNA,TLGWB,TNM
001,119,136,140,2015,954,ACCURACIES,AGREEMENTS,CONCLUSION,FDG,LABEL,MATERIALS,MCNEMAR,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,RSNA,TNM
135,2015,228,676,ADVERSE,CONCLUSION,ELEVATION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,RSNA,SUV,SUV95,SUVS
COMPOUNDS,IAP,IAPS,XIAP
169,2015,239,276,8805,996,CONCLUSION,III,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
169,2014,INJECTIONS
169,2015,COPYRIGHT,GUIDELINES,NCCN,NETS,NETWORK
169,2015,COPYRIGHT,DOSE,GUIDELINES,LOW,LUNG,NCCN,NETWORK,REPORTING,SCREENING,STORAGE,THESE,TOMOGRAPHY
169,2015,BRAF,COPYRIGHT,HCL,MALIGNANT,NETWORK,V600E
001,049,10877,10878,13YEARS,169,201,2015,30MM,321,587,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PROGNOSTIC,PURPOSE,RESULTS,RFA,SBRT
169,2008,2014,2015,363,AES,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,IRELAND,JULY,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS,THERE,TKI,TKIS,UPFRONT
038,169,2007,2012,2014,234,264,424,494,984,ADDITIONAL,CONCLUSION,FORTY,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,PREFECTURE,PRESS,PUBLISHED,RESULTS,SEVENTEEN,THREE,UNIVERSITY
160,A427V,DEPENDING,ECH,G333C,G350S,G364C,G379D,G430C,G476R,ITC,KEAP1,KELCH,NMR,NRF2,R413L,R415G
169,2015,365,AUSTRALIA,CONCLUSION,COPYRIGHT,EXCLUDING,FOUR,INC,LABEL,METHODS,NINE,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,SOUTH,WALES
127,169,2015,622,947,956,A549,ACGS,BASED,COPYRIGHT,FIFTEEN,HOWEVER,IC50,LTD,MDR,TAXOL,THF,THOSE,VERAPAMIL
0004,001,003,006,142,169,2014,ACADEMY,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCL,SSC,UNDER
169,2014,5H1,AUTHORS,BESIDES,COPYRIGHT,E1L3N,LTD,NONE,PUBLISHED,SMALL,THUS,USING
158,169,2015,788,ALK,ATS,CHINESE,CONCLUSION,COPYRIGHT,EGFR,EML4,ERS,GGO,HISTOLOGIC,IASLC,IRELAND,KRAS,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,PULMONARY,RESULTS,SOCIETY,STUDENT,SURGICALLY,THESE,TNM
100,AE1,AE3,AMONG,CD117,CD99,EMA,EPITHELIAL,III,LABEL,METHODS,NINE,OBJECTIVE,PPB,RESULTS,SMA,TYPE
100,2011,2013,ALK,AMONG,FISH,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
BASED,CD56,CGA,CK7,CKPAN,FIVE,GROSS,LABEL,METHODS,MOST,NEC,OBJECTIVE,RESULTS,SYN,TTF
001,005,115,2013,2014,AIM,DATA,JANUARY,LABEL,LUNG,METHODS,MOST,OBJECTIVE,PEARSON,RESULTS,SPSS,SURGERIES
169,2015,A20,A925L,ALK,ASIA,AUTHORS,EML4,LTD,PTY,PUBLISHING,SCIENCE,WILEY
EARLY,VTE
1ST,4TH,6TH,BACKGROUND,FEV1,LABEL,LPS,MATERIALS,METHODS,NSCLC,PFTS,RESULTS,VRI,VRIXP
BACKGROUND,CONCLUSION,DESPITE,GROUP,IIA,IIB,III,IIIA,IIIB,LABEL,MATERIALS,METHODS,MRI,NSCLC,PET,RESULTS,SERUM,THERE,TNM,YKL
169,2015,3T3,946,956,A549,EC50,GMBH,KGAA,NIH,VCH,WILEY
169,2015,945,AAD,ALDH,ALDH7A1,ATP,COPYRIGHT,GBM,GSC,GSCS,HIGH,HNPCS,INHIBITION,JOHN,LTD,METABOLITE,NMR,NPCS,SONS,WILEY
FFA2,FFA3,FFAR2,FFAR3,TYPE
169,2015,ACS,ACT,AFFORDABLE,CARE,EACH,INTERVIEW,NHIS,SOCIETY
169,200,2015,916,936,956,APOPTOSIS,CELLS,CONCLUSION,DAPI,DIOC6,IC50,JOHN,LABEL,LTD,MATERIALS,MELATONIN,METHODS,MTT,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SONS,THESE,WILEY
169,2015,ABL,AES,BCR,BONE,FAERS,FDA,GAMMA,INC,ITEM,MOST,MULTI,POISSON,RARE,REPORTING,SIGNALS,THESE,WILEY
169,2014,7WT,85NM,960,COPYRIGHT,DOX,PEO,SEM,THUS
713,BACKGROUND,CONTROLLED,CURRENT,KNOWLEDGE,LABEL,LIBRARY,METHODS,MST,NSCLC,RESULTS,SBM,SPSS,SRS,STATA,THERE,WEB
160,170,2000,2014,363,CBM,CHINA,CNKI,FANG,JANUARY,NSCLC,PFS,SCIENCE,WAN,WEB
AKT,CISPLATIN,DDP,ERK,EXPRESSION,FACS,MDR1,MTT,SGC7901,SORAFENIB,WESTERN
ALK,COLLEGE,FISH,GIVEN,LUNG,MOLECULAR,PATHOLOGY,THEREFORE
160,169,2015,BECAUSE,COPYRIGHT,INC,METASTATIC,ORAL,PUBLISHED,RCCC,RENAL
169,2014,AKT,CDK6,COPYRIGHT,DUBS,ERK,FINALLY,HOWEVER,IRELAND,LTD,MG63,SEVERAL,THEN,THESE,UBIQUITIN,UCH,UCHL1
264,486,956,95D,DAVID,DEGS,EGR,NSCLC,PATHWAY,RNAS,TOTAL,VALIDATION,WNT
100,DETECTION,MONITORING,NON,USING
MOST,TIMP
016,026,039,500,8201,CHINESE,COX,HAN,MCT,MCT1,MCT2,MCT4,MCTS,MEIER,NINE,NON,NSCLC,RFS,SNP,SNPS
001,002,003,132,166,177,346,8201,8226,ALK,CHEST,EGFR,KEY,LABEL,LOWER,METHODS,OBJECTIVE,RESULTS,SOLID,TDR,TKI
CONCLUSION,EIGHT,LABEL,METHODS,MOTIVATION,OBJECTIVE,PURPOSE,RESULTS,RICOEUR
153,859,AFTER,EGFR,FOUR,HOWEVER,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,REGARDING,RESULTS,TKIS
169,2000,2015,ALK,BIOVIEW,COPYRIGHT,CRIZOTINIB,FISH,III,IKONISCOPE,INC,PHASE
169,2015,25A,BASED,BTG,BTG2,COPYRIGHT,INC,NSCLC,THEREFORE
2000,8201,JANUARY,PULMONARY,RESULTS,VARIOUS
0408,203,8197,BACKGROUND,BMJ,COMMITTEE,GROUP,LABEL,LIMITED,METHODS,MPM,PTM,PUBLISHED,PUBLISHING,SECONDARY,SMART,THERE,TRIAL
178,215,CASITAS,CBL,EGFR,GRB2,H1299,RING,SH2
001,002,005,049,130,170,198,2004,2013,238,445,485,789,815,8530,855,9388,950,954,961,ALK,CONCLUSION,EGFR,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS
1998,2013,APRIL,BASED,HOWEVER,LABEL,METHODS,OBJECTIVE,OCTOBER,OVERALL,RESULTS,UNIVERSITY
025,227,ACTB,CHINESE,DELC1,DLEC1,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
169,2015,ALSO,ATLAS,BACKGROUND,FURTHER,LABEL,MODEL,MOST,MOTIVATION,PRESS,PUBLISHED,RESULTS,SIMULATION,TCGA,UNIVERSITY
8209,A549,BIP,CDK4,CDKS,CHINESE,CKIS,E2F,ERP72,FLOW,H460,NCI,NSCLC,PERK,UPR,WESTERN
110,113,117,130,163,ALDH1,CD44,EGFR,FGFR1,HER2,HOWEVER,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOX2
169,2014,AKT,CBL,CHIP,COPYRIGHT,EGFR,GRB2,IRELAND,LTD,NSCLC,PI3K,RING,SH2,SPC,TARGETING,UPS
1BR3,8209,DIF,EGFR,FBS,NSCLC,PC9,SIMILARLY,VNR
112,121,177,2012,2013,233,767,870,BETWEEN,FEV,FVC,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
181,8209,946,A549,A549CIS,CALU1,CELL,DKK3,H460,H460CIS,LUNG,MMP7,PARP,WNT
001,169,177,2015,BACKGROUND,BASEL,FIVE,HCC,LABEL,MAM,METHODS,RESULTS,SIX,TEN
A549,AKT,BAX,BCL,ERK,FINALLY,HCPT,LUNG,MAPK,MAPKS,PD98059,PP2A,REGULATION,TAKEN,WHILE
001,140,160,320,916,AES,FORTY,IIIB,MWA,NSCLC,OBJECTIVE,PFS,TTLP
ANTI,EGF,EGFR,EGFRS,THREE,TKIS
8209,EMT,HES1,HEYL,HOWEVER,MEANWHILE,METASTASIS,NOTCH,NSCLC,OVERALL,STUDIES,WNT,WNT3A
008,047,129,2015,945,BASEL,FUT8,GMD,HIGH,LABEL,METHODS,OBJECITIVE,RESULTS,UNLABELLED,USING
104,130,160,191,205,224,230,269,271,8805,CED,DOSE,EVAR,LABEL,MATERIALS,MDCT,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS
GPS,ITALIAN,THEREFORE
181,AIF,ALONG,ARSENIC,ATO,BCL,BHA,CELL,DMS79,GSH,H187,H526,H69,H841,IC50,NAC,ROS,SCLC,SMAC,TRX1,WESTERN
169,2015,954,ERK,MMP9,OVERALL,RAGE,TNBC,TNBCS
169,2015,AREAS,CONCLUSION,FDG,HIGH,III,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SEVENTEEN,SOCIETY,UNLABELLED,VARIOUS
060,100,1038,160,169,198,200,2015,206,300,324,662,8804,BACKGROUND,CONCLUSION,COPYRIGHT,III,IIIB,INC,LABEL,METHODS,NSCLC,OVERALL,RENAL,RESULTS,UNTREATED
005,169,1ST,2006,2011,2015,BACKGROUND,CONCLUSION,COPYRIGHT,INC,JANUARY,LABEL,MARCH,METHODS,MOST,RESULTS,SBRT,SIGNS
956,A549,ADR,CELL,CONCLUSION,LABEL,LDH,MCF,METHODS,OBJECTIVE,RESULTS,WESTERN
177,2008,2013,321,336,341,361,378,399,423,457,500,771,916,942,ACCORDING,AMONG,CONCLUSION,FOUR,III,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,OPERATIVE,RESULTS,THERE,THREE,TOKUHASHI,VAS
ELCAP
ELECTRICAL,FREQUENCY,HOWEVER,RADIO,RFA,THEREFORE
AIDED,CAD,DIAGNOSIS
CTCS,ONCE,RESULTS
460,ARMA,CYBERKNIFE,EKF,FMKF,LCM,RESULTS,SVM
A549,CL1,THEREFORE
BNCT,BNCTS
2006,2011,2013,480,8201,FIVE,MOST,PATIENT,SIX,SURGERY
ZNO
215,INTENSE,SKULL
169,2014,2015,DATA,ENGLISH,LABEL,METHODS,OBJECTIVE,RESULTS,SELECTING,SOURCES,STUDIES,SYSTEMATIC
149,187,2006,2012,202,657,737,763,777,958,980,994,996,998,AOR,BACKGROUND,ESTIMATED,LABEL,MALIGNANT,METHODS,NPV,OVERALL,PET,RESULTS,SPECIMENS,TTNB,TTNBS
169,2015,BOARD,COPYRIGHT,THEREFORE
006,012,FACTORS,LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SIXTY,TNBC
652,AMONG,CD74,FISH,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,ROS1,SDC4,SLC34A2,TPM3
001,007,023,025,037,049,097,127,169,177,673,890,915,963,965,970,ADM,CCK8,DDP,H69,H69AR,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,SCLC,SELECTIVE,WESTERN,WIG
001,002,004,011,160,168,GSE3268,III,MEANWHILE,NSCLC,PCR,SOX4,UNIVARIATE,USING
0001,112,169,2002,2011,2015,8805,ABC,AFTER,BREATHING,COPYRIGHT,III,INC,INCIDENTAL,LABEL,LBC,MATERIALS,METHODS,MHD,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SECONDARY,SOCIETY,ULTIMATELY
10Q25,349,3Q28,457,5P15,609,6P21,6Q22,731,AMONG,ASIA,CLASS,COAL,CONSORTIUM,FLCCA,GWAS,HAP,HLA,HOUSEHOLD,LUNG,SNPS,SOUTHEAST,TP63
129,948,AZA,CPG,HOMO,HOWEVER,LUCIFERASE,PCR,THESE,VCP,WESTERN
032,174,174G,424,CYTOKINES,LUNG,NSCLC,PCR,REGARDING,RFLP,SNP
A549,ERK,FGF1,FGFR,FGFR1,INHIBITION,JNK,MAPK,MMP26,NSCLC,PI3K
AIM,BACKGROUND,CONCLUSION,COUNSELING,ECG,LABEL,LIMITATION,METHODS,OBJECTIVE,RESULTS,SCALE,TSC,USG
186,SIXTY
COPD,GOLD,LDCT,SIXTY,SPECT,SPIROMETRY,THREE
169,2007,2013,2015,459,AMONG,APRIL,BACKGROUND,DILD,DRUG,EGFR,ILD,LABEL,MARCH,METHODS,OBJECTIVE,POOR,RESULTS,TKI
001,1396,169,2015,8201,BACKGROUND,CARE,CONSORTIUM,CORRELATES,COX,EUROQOL,EXAMINING,HRQOL,LABEL,LUNG,MEIER,METHODS,RESULTS,SOCIETY,YOUNGER
169,2015,3432,AAS,AFRICAN,AMERICANS,BACKGROUND,CANCORS,CARE,CONSORTIUM,CRC,CURRENT,HISPANICS,LABEL,METHODS,RESULTS,SOCIETY
169,2015,2OH,946,AKT,BNPP1,BUB1,COPYRIGHT,EMT,KNOCKDOWN,MAPK,SCIENCE,SMAD,SMAD2,SMAD3,SMAD4,TGF,TGFBR,TGFBRII,THESE,UPON,USING
2008,2013,284,369,8805,COX,JANUARY,LABEL,METHODS,OBJECTIVE,OPIOIDS,OSAKA,PURPOSE,RESULTS,THERE,UNIVARIATE
134,169,1961,1975,1991,2005,2015,388,838,AIMS,DENMARK,FINLAND,HOPEFULLY,ICELAND,LABEL,METHODS,OBJECTIVE,RESULTS,SIR,SOCIETIES
106,1999,2013,ACADEMY,BOTH,CCMP,CHINESE,DFI,IIB,JANUARY,JUNE,LABEL,MEDICAL,METASTASES,METHODS,OBJECTIVE,PULMONARY,REGULAR,RESULTS
177,181,611,614,EGFR,H1975,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PCNA,RESULTS,T790M,THERE,WESTERN
0941,177,181,A549,ACCORDING,AKT,AZD6244,BAX,BCL,BOTH,ERK,GDC,LABEL,MEK,METHODS,MTT,NSCLC,OBJECTIVE,PARP,PI3K,RAS,RESULTS,WESTERN
169,2014,2YL,A375,A549,COPYRIGHT,ERK1,FACS,FURTHER,HENCE,LTD,MCF
ALK,EGFR,KRAS,LUNG,NSCLC
A549,BIOCOAT,CELL,CHAMBER,DECREASED,DPI,FINALLY,FURTHER,INCREASED,INHIBITION,ISOLATION,KIT,MMP9,NADPH,NOX,PRIMARY,PTEN
160,8805,AUC,CONCLUSION,ECOG,FORTY,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PURPOSE,RESULTS,SIXTY
0079,104,160,2002,2013,314,517,842,ILD,JUNE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
2010,2011,2012,AMONG,CHEST,INADEQUATE,JOB,LABEL,METHODS,OBJECTIVE,RESULTS,TELEPHONE
000,006,023,024,031,129,722,781,927,ALTERED,BACKGROUND,CD3,CD8,CHI,COX,LABEL,MEIER,METHODS,NSCLC,RESULTS,THUS
CARLO,CBCT,LABEL,METHODS,MONTE,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,SCATTERED
10000,11000,1600,2014,215,800,8901,DATA,EBT3,EPSON,FILMQAPRO,IMRT,LABEL,LRA,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCANNED,THESE,TRILOGY,VMAT
1400,8804,8805,916,AVERAGE,DOSE,EUCLIDEAN,FAST,FRAUNHOFER,LABEL,METHODS,MEVIS,OBJECTIVE,PRETHERAPY,PURPOSE,RESULTS,USING
135,8764,BASED,BEAM,HOWEVER,LABEL,METHODS,MSE,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,THESE,WHERE,XCAT
016,120,1745,177,1923,1925,8482,FRAME,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEQUENTIAL,TEN
130,400,752,ACCURATELY,DCT,DUE,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PCA,PURPOSE,RESULTS,SBRT,SINCE,SOA,USING
1564A,3073A,320,346,ARG194TRP,ARG399GLN,BOTH,CHINESE,DATA,LUNG,MDR1,SNPS,XRCC1
169,2015,945,947,948,954,A549,AKT,CLAUDIN,CLDN1,CONVERSELY,COPYRIGHT,FURTHER,INC,MAPKS,PGE2,PI3K,PKC,PPAR,SRC,TNF
100,AFTER,BACKGROUND,HOWEVER,LABEL,LUNG,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OCT,OPTICAL,RATIONALE,READERS,RESULTS,SCC
945,A549,BACKGROUND,CONCLUSION,EMT,LABEL,LISA,METHODS,RAC1,RESULTS,RHOGDI2,SLUG,SMA,SNAIL,THESE
155,AFFYMETRIX,EMT,FOXM1,INHIBITION,KNOCKDOWN,SNAIL
169,2015,BDP1,BORCK,BRF1,COLD,III,IIIB,LABORATORY,POL,PRESS,PUBLISHED,RNAS,TAKEN,TBP,WHOLE
174,214,DIEGO,EGFR,EPIDERMAL,FINALLY,G12C,HOWEVER,KRAS,MASSARRAY,NSCLC,RESPONSIVE,SAN,TKI,TKIS,USA
0001,0002,0007,0042,0049,0154,032,101,184,2001,2010,2082,2N0M0,AFTER,BACKGROUND,GENERALLY,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,VATS
ASIAN,CHINA
FINALLY,FIRST,SEVERAL,SINCE,VOCS
169,2015,AIM,ANTICANCER,BACKGROUND,BALF,CONCLUSION,COPYRIGHT,DELINASIOS,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,PROTEOMIC,RESULTS,S100
016,169,177,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DELINASIOS,EGFR,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,PCR,PFS,RESULTS,T790M,TKI
MIB
128,2012,ASSOCIATED,BACKGROUND,CELSIUS,CONCLUSION,IMMEDIATE,LABEL,LOCAL,LUNG,MARCH,MATERIALS,METHODS,RESULTS,THERE,UPON
0045,0287,0440,1298A,2014,5459,6533,ABCB1,AIM,CONCLUSION,ERCC1,IC50,LABEL,MATERIALS,METHODS,MTHFR,MTT,OBJECTIVE,PCR,RESULTS,RRM1,THERE,THESE
014,021,035,115,139,140,177,181,339,351,465,5849,AIM,CONCLUSION,CRP,FOUR,LABEL,METHODS,OBJECTIVE,OLV,PRE,RESULTS,THERE
001,0018,002,006,0078,148,169,2015,BAL,CENTRAL,CONCLUSION,CONTROLLED,ENGLISH,GUIDELINES,HOWEVER,HSCT,LABEL,LUNG,MEDLINE,METHODS,OBJECTIVE,OVID,PURPOSE,RESULTS,SOCIETY,STUDIES
022,118,169,200,2015,650,779,BOTH,CONCLUSION,HRS,IIIB,LABEL,LINIFANIB,METHODS,NSCLC,OBJECTIVE,PDGF,PFS,PURPOSE,RESULTS,SOCIETY,VEGF
1970S,1996,ANOTHER,DROSOPHILA,FDA,HOWEVER,PTCH1,SINCE,VISMODEGIB
000,100,169,2000,201,2011,2015,3587,8805,BACKGROUND,EARLIER,END,HNSCC,HOWEVER,LABEL,LUNG,MEDICAL,METHODS,PITTSBURGH,PLUSS,RANDOMIZED,RESULTS,SCREENING,SOCIETY
100,111,AIM,BACKGROUND,CONCLUSION,GH20,GP5,GP6,HOWEVER,HPV,HPVS,INFECTION,IRAN,LABEL,MASHHAD,MATERIALS,METHODS,OBJECTIVE,PCO4,PCR,RESULTS,SIXTY
169,2014,946,ACTIVIN,AUTHORS,COPYRIGHT,ERK,INC,MALIGNANT,MIGRATION,MIGRATORY,PUBLISHED,SMAD2,SMAD3,TGF,THESE
0005,169,181,2014,350,8201,900,AFTER,AUC,BACKGROUND,INC,LABEL,METHODS,MOL,MOST,PROCEDURE,RESULTS,SCA,WILEY
AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,METHODS,NSCLC,OPINION,SQCLC
1523,169,2014,233,403,CAD,COPYRIGHT,LIDC,LTD,LUNG,SVM
169,2014,ADDITIONAL,ALK,BACKGROUND,BOTH,EGFR,HOWEVER,KRAS,KRISTEN,LABEL,METHODS,RESULTS,SALIENT,SOCIETY
131,169,201,2014,APMIS,EGFR,JOHN,L858R,LMD,LTD,PCR,PUBLISHED,SAMPLES,SEVERAL,SONS,WILEY
169,2014,ADCC,CD98,PHASE,UICC,VARIOUS
169,2014,215,5FU,7DAYS,HOWEVER,HT29,LEWIS,LLC,SINCE,THUS,UICC,VEGF,VEGFA
BASED,LCRP,RELIEFF
045,1014O16,215,482,501G6,629,672F9,8805,AMONG,ARRAY,ARRAYSTAR,BACKGROUND,C14ORF132,CALCA,CALCB,CD24,CD81,CNC,GSEA,HCC,LABEL,MATERIALS,METASTASIS,METHODS,NCRNA00173,PCR,PSG2,PSG8,RESULTS,RNAS,RP11,RP5,SOST,USING
A549,BACKGROUND,BUFALIN,CCK,CELL,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,WESTERN
1772,BACKGROUND,ENDOMETRAL,HIF,HYPOXIA,LABEL,MATERIALS,METHODS,PCR,RESULTS,RFLP
010,098,101,168,170,195,370,452,578,798,806,A4T14,BACKGROUND,CHINA,CHINESE,CTPP,G4C14,HOWEVER,HRM,LABEL,MATERIALS,METHODS,NSCLC,PCR,RESULTS
001,019,036,111,139,298,409,BACKGROUND,BEV,FIRST,FOLFIRI,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,RESULTS,XELOX
001,2026,314,529,ACCORDING,HOWEVER,MEDLINE,NSCLC,OVERALL,PROQEST,RASSF1A,SCIENCE,SCLC,STATA,WEB
176,186,1ST,2002,2010,2011,221,319,31ST,424,5X109,BACKGROUND,BETWEEN,FEC,JANUARY,LABEL,MATERIALS,MBC,MEDICAL,MEIER,METHODS,MOST,NAUROIS,RESULTS,SPSS,TRD,UMMC,UNIVERSITY
001,003,177,1985,2012,264,290,606,ACCORDING,BACKGROUND,HODGKIN,IRAN,LABEL,MASHHAD,MATERIALS,METHODS,NON,OVERALL,RESULTS,SCREENING,THERE
BACKGROUND,FDG,HOWEVER,LABEL,MATERIALS,METHODS,PET,RESULTS,ROC,SEVENTY
947,950,ECTOPIC,HNSCC,HOWEVER,IFN,LPS,OSCC,STAT3,TAKEN
8197,RAYS,SIC,SIOX,THESE
ALECTINIB,ALK,CRIZOTINIB,CSF,FURTHER,MET
169,2015,COLD,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2015,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2015,AFTER,BOTH,COPYRIGHT,INC,PUBLISHED,SOCIETY
100,120,160,183,956,ABP,ANESTHESIA,ASA,BIS,BLOOD,CCO,CVP,ECG,FIO2,GANZ,GENERAL,LABEL,MAP,METHODS,OBJECTIVE,OLV,PAO2,RESULTS,ROCURONIUM,SGB,SVRI,SWAN,THERE,TLV
AMONG,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
0046,163,DFS,LABEL,METHODS,NSCLC,OBJECTIVE,OPN,RESULTS,THESE
100,169,17P13,2011,2014,2015,420,BACKGROUND,BETWEEN,BLOOD,CLL,COPYRIGHT,DEC,FOUNDATION,FUNDING,GRADE,HEART,INC,INSTITUTE,INSTITUTES,INTRAMURAL,IQR,JAN,LABEL,LTD,LUNG,MEDICAL,METHODS,NORDISK,NOVO,PROGRAM,RESULTS,SOCIETY,TP53,USA
169,2014,215,2YL,A549,BAX,BCL,CELL,COPYRIGHT,H2O,HOWEVER,INC,MTT,SGC7901,TBHP,WESTERN
000,1975,2011,547,592,689,7TH,DEC,IIA,IIB,IIIA,IIIB,JAN,TNM,TYPICAL
169,199,2014,363,COPYRIGHT,ELISA,HOWEVER,IL1A,INC,NON,NSCLC
169,1998,2009,2014,453,464,722,8320,8322,8327,8329,8331,AUTHORS,CIR,CONCLUSION,COPYRIGHT,LABEL,LIVER,LTD,MEIER,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,QALE,QALY,QALYS,RESULTS,WHILE
160,945,946,AAH,EGF,THUS
INCREASED,MOLECULAR
2012,2013,APRIL,BACKGROUND,CASE,LABEL,MAY,METHODS,S3C,SMPLC,SPMLC,THEREFORE
10A,123,169,2014,231,A459,A549,AMONG,COPYRIGHT,COUMARINS,CYTOTOXIC,DOCETAXEL,ESTER,INC,MCF,MDA,MMP,MRC,PC3,RHODAMINE,THESE,TMRM
00001,25800,31964,36883,41089,652,ASIAN,ASPARTATE,CASP8,CASPASE,D302H,FURTHER,HISTIDINE,HOMOZYGOUS,HOWEVER,OVERALL,THEREFORE
100,AUNPS,OVERALL
160,200,250,300,400,EGFR,FIFTY,HOWEVER,LABEL,METHODS,MTD,NSCLC,OBJECTIVE,PFS,PLANNED,PURPOSE,RESULTS,RP2D,THERE,THREE,TREATMENT,VORINOSTAT
ALSO,BECAUSE,LOCAL,STILL,THERE
0001,014,108,2005,2010,488,608,CARDIAC,CUMULATIVE,HER2,LVEF,MEAN,STRATEGIES,TIC
117,129,156,177,411,489,567,AIM,AMONG,BACKGROUND,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,RESULTS
382,AGE,CONCLUSION,ESS,FOUR,III,LABEL,MEIER,METHODS,MOST,OBJECTIVE,RESULTS,SIXTEEN
226
MPM,THESE
99MTC,ACCORDING,DIAGNOSTIC,MIBI,NPV,NSCLC,PNEUMONIA,PPV,SEN,SPECT
ALSO,DISBALANCE,HODGKIN,OPG,RANK,RANKL
BOTH,CA19,CD66C,CEA,CYFRA,FORTY,MPE,MPES,VARIOUS
215,954,CELL,EXPLANTED,H520,KNOCKDOWN,LABEL,METHODS,MTT,NCI,NUCLEAR,OBJECTIVE,RESULTS
PCR
FDG,HOWEVER,PET,THESE
HOWEVER,LARYNGEAL,METASTASES,PRIMARY
BASED,HOWEVER
001,002,003,009,043,110,222,241,277,279,292,299,365,550,643,735,AUC,FURTHER,HOWEVER,IRAK1,NSCLC,ROC,SCLC,TLR,TNM
2012,2014,967,COX,ELISA,FINALLY,JAN,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OCT,RESULTS,ROC,TLR1,TLR2,TLR3,TLR4,TLR5,TLR6,TLR7,TLR8,TLR9,TLRS,TOLL
018,123,206,ATS,EGFR,ERS,IASLC,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
001,045,115,119,121,130,LOSS,NSCLC,PER,PER1,PER2,PER3,PERIOD1,PERIOD2,PERIOD3,SIMILARLY,THESE,TNM
001,008,027,100,111,116,136,140,369,947,ALNS,COX,FURTHER,MMTV,PYMT,REG
001,016,019,031,047,162,EXPRESSION,GNMT,PIPOX,SARCOSINE,SARDH
ALSO,CDK2,DOWN,FINALLY,H510A,LABEL,LUCIFERASE,METHODS,MTT,OBJECTIVE,PCR,PURPOSE,RESULTS,SCLC,THEN
001,002,008,011,012,013,116,8804,CHA,DFS,NLCMA,THEN
AIMS,BCL,CD117,COLLEGE,COUGH,FIFTEEN,GFAP,LABEL,MEDICAL,METHODS,OBJECTIVE,P16,P53,P63,PUMCH,RESULTS,RFS,SMA,TACC,TEN,TTF,UNION
001,013,015,124,MEIER,NON,NSCLC,SEX,SOX,SOX8,SOX9,SRY
169,1999,2012,2015,AMONGST,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EHE,INSTITUTE,JANUARY,JOHN,LABEL,MARSDEN,METHODS,RESULTS,ROYAL,SURGERY,THERE
169,2015,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EIGHT,FHP,INSTITUTE,JOHN,LABEL,METASTATIC,METHODS,NINE,PMMA,RESULTS
169,2015,945,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HIF,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,RESULTS,VEGF
001,169,2015,267,AES,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,RESULTS
169,2015,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,FOXD1,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MICROARRAY,NSCLC,OBJECTIVE,RESULTS
1102,169,2015,A549,ADP,AIM,ANTICANCER,ANTITUMOR,BALB,BASED,CONCLUSION,COPYRIGHT,HDAC,HELA,HISTONE,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,ONCE,PARP,PAT,RESULTS
169,2015,945,946,956,AIM,ALSO,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DENDROBIUM,EMT,H460,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,SLUG,SNAIL
169,2014,5HTT,AUTHORS,BACKGROUND,CELLS,CHRONIC,HEART,INC,KI67,LABEL,METHODS,PUBLISHED,RESULTS,SM22,SMC,SMCS,TA65,TELOMERASE,TERC,TERT,WOLTERS
BECAUSE,BIOMARKERS,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,RNAS,THESE
EMC,FIVE

BOTH
HOWEVER,HOX,HOXA5,NSCLC,TNM
ACCORDING,KAZAKHSTAN,PROBLEM
BASAL,EIGHT,ENB,HOWEVER,KINOMIC,LABEL,METHODS,OBJECTIVE,PAMSTATION,PURPOSE,RESULTS,THUS
001,100,BACKGROUND,CONCLUSION,COX,DBF,FORTY,LABEL,MEIER,METHODS,NINE,OBJECTIVE,PRIMARY,RESULTS
A549,NANOG,OCT3,SOX2,THROUGH
008,123,130,174,175,190,2010,2013,595,722,BACKGROUND,BOTH,III,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SOUTHWEST,THERE,TOTAL
21V,946,ADTR,BHP18,CONVERSELY,DECREASED,FTI,FTIS,GTP,HDAC1,HDAC3,RHOB,THYROID,TRS
945,AFTER,BASED,EGF,RESAMPLING,TNF,TNFR
BENEFICIAL,THERE
DIFFERENT,THUS
177,8201,8805,GTV,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,SBRT,SMALL,WHILE
0001,104,161,235,396,980,ADC,ADCS,AMONG,ATLAS,CLCA2,HAMAMATSU,SCC,SCCS,TCGA,THESE,UNIVERSITY
169,2015,ANOTHER,COPYRIGHT,HEPOXILIN,HXA3,INC,LTB4,USING
8805,ADI,ASS,CELLS,LABEL,LCNEC,METHODS,OBJECTIVE,PEG,PNEC,PURPOSE,RESULTS,SCLC,SIXTY,THESE,TREATMENT
113,127,169,198,1991,2009,2014,242,555,561,871,AMONG,CONCLUSION,COPYRIGHT,COX,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SWEDISH
397,8201,BCR,BOTH,THERE
105,140,160,200,2004,2014,8201,BACKGROUND,BETWEEN,LABEL,METHODS,MOST,OCTOBER,RESULTS,SINCE,THERE,VIDEO
001,169,2001,2007,2014,362,573,844,CONCLUSION,FOUR,LABEL,MEIER,METHODS,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS,RISK,SEER,SOCIETY
FIRST,INCREASING,MDMX,NSCLC,TAKEN,USP22
160,8201,CONCLUSION,LABEL,LOW,METHODS,OBJECTIVE,PS1,PS2,PS3,PURPOSE,RESULTS,TNM,URINE
2014,AFFECTIVE,AIDS,BACKGROUND,BOOLEAN,CUSHING,DEPRESSION,ISI,LABEL,MANIA,MEDLINE,METHODS,PHYSICIANS,RESULTS,SCIENCE,WEB
100,BACKGROUND,BASED,CDC42,CHIP,CHROMATIN,HBL,LABEL,METHODS,MTLN3,RESULTS,SINCE,TOCA,TRANSDUCER
2009,2010,2014,APRIL,SURGERY,TEN,WEDGE
CRYSTAL,DISCOVERY,SCIENCE,TKI,TKIS
1891,2000,2009,2010,516,AFTER,FURTHER,HOWEVER,INSURANCE,NHI,SIR
156,1999,2007,238,ABL,AKT,BRAF,CDK,CHINESE,EFGR,EGFR,ERBB2,FGFR1,FGFR3,FLT3,HRAS,JAK2,KIT,KRAS,MET,MOLECULAR,NONE,NRAS,OTHERWISE,PCR,POLYGENIC,RET,SEVERAL,SIX,T790M,THERE,USING
169,2014,CCL5,CD11C,DCS,EMT,INC,MALAT,SNAIL,TADC,TADCS,WILEY
007,010,020,023,035,043,168,18F,324,439,506,537,695,897,916,953,973,BACKGROUND,EACH,EARLY,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,TLG,UNIVARIATE
EDDA,FDG,HYNIC,PET,SPECT,SPN,TOC,WHOLE
BACKGROUND,CONCLUSION,ECTOPIC,LABEL,METHODS,MTC,MYH13,OBJECTIVE,ONCOGENIC,RESULTS,RET,THREE
100,169,2014,946,99M,ASIA,CCA,EAST,LTD,PET,PTY,PUBLISHING,RESULTS,SOUTH,WILEY
A549,AKT,CPT,DII,ERK1,HB1,NDEPT,NSCS,OVERALL,VEGF
044,128,134,8201,ADC,CHEST,DATA,FEMALES,HPV,NSCLC,PCR,SAMPLES,SQC,THERE,TNM
001,010,013,016,025,105,272,766,CONCLUSION,DFS,HIGH,HOWEVER,LABEL,MACC1,METASTASIS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
FDA,INSURANCE
100,169,2002,2013,2015,241,572,859,967,996,ALT,COPYRIGHT,INC,LABEL,MARCH,METHODS,OBJECTIVE,ORAL,PUBLISHED,PURPOSE,RESULTS,SOCIETY
MALIGNANT,NECK,OCCASIONAL,RIGHT,THESE
2014,2487,3228,BACKGROUND,BIOLOGY,C677T,CBM,CHINA,CHINESE,CIS,CNKI,DATA,KNOWLEDGE,LABEL,LINK,METHODS,MTHFR,NORTH,ORS,OVERALL,OVID,RELATED,RESULTS,SERVICE,STUDIES,WANFANG
8209,8545,A549,BUN,CDDP,EGFR,NOTABLY,NSCLC,THESE
NNAL,NNK,THOUSANDS
234,716,AFRICAN,BACKGROUND,HOWEVER,LABEL,RESULTS
169,2012,2013,2014,COPYRIGHT,HRT,INC,INHALATION,PAH,PAHS,PM1,PM10,PM2,RESULTS,RISK,TEQ,THESE,THREE,UNIT

0001,0003,0006,0008,0014,0031,0169,0266,140,1987,1990,1995,1996,2001,2005,2010,BELARUS,CHERNOBYL,COMPARISON,CONCLUSION,FREEMAN,KRUSKAL,LABEL,MARCH,METHODS,NINE,OBJECTIVE,PEARSON,PTC,RESULTS,WHAT
100,169,2015,ACTIVATING,AE1,AE3,ATF1,BREAKPOINT,COPYRIGHT,EWING,EWSR1,HCCC,INC,SARCOMA
160,169,2015,AUTHORS,COPYRIGHT,DEPLETING,FINALLY,HGF,HUWE1,INC,PUBLISHED,RAC,THUS,TIAM1
169,2014,231,946,HER2,HOWEVER,HOXB7,INCREASED,MDA,MMTV,PCR,PROVIDING,SMAD3,TAKEN,TAM,TAMS,TGF
169,2014,3T3,A549,COPYRIGHT,GCMSN,GNPS,GOLD,LTD,MSNS,NMSNS,SERVING
169,2015,5GY,CARLO,CLINICALLY,COPYRIGHT,DOSE,DVH,DVHS,FOUR,GTV,INC,MEDICAL,MONTE,PTV,PUBLISHED,SBRT,STAGE,TCP,TCPS
169,2014,761,946,947,A549,AFTER,ATP,COPYRIGHT,H2AX,H596,HOWEVER,LABEL,LAP,LUNG,NAD,NQO1,NSCLC,PARP1,PEG,PLA,PRE,UNASSIGNED,UNLABELLED
169,2002,2004,2014,BACKGROUND,COPYRIGHT,EWS,EWSS,JULY,LABEL,METHODS,PUBLISHED,RESULTS,SIX,SOCIETY
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DECISIONS,DISCUSSION,FERRAND,GLIOMAS,LABEL,METHODS,OPTIC,RESULTS,SAS,THROUGH,TREATMENT,UNIVERSITY
001,160,169,201,2015,8804,AMONG,AUR,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RAREA,RATIONALE,RESULTS,ROC,SIXTY
SBRT
INSTITUTE,INTENTION,LABEL,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SETTING,VARIABLES
169,2005,2011,2015,9011,992,AMONG,BASE,COPYRIGHT,DATA,FURTHER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2004,2014,2015,COPYRIGHT,DISCUSSION,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SABR,SECONDARY
0001,002,004,2005,2013,8805,III,MEAN,MMP,NEUTROPHIL,NGAL,PROGNOSIS,SUR,TUMORAL,UNIVARIATE
A549,BRCA,CISPLATIN,DDP,FANCONI,HOWEVER
100,200,300,400,500,956,AGS,AKT,ANNEXIN,BAX,BCL2,CD44,ECM,FLUOS,OCT3,P53,PCNA,PCR,REAL
001,006,169,2014,A549,BCL,COPYRIGHT,H1299,HBE,INC,NSCLC,TAKEN,TIPE2,TNM
504,APC,HCL,HSP90,IPI,LOSS,MTA,NSCLC,PLK1,RNAI,SEVERAL,SILAC,SUPPORTING,THEREFORE,TREATMENT,XENOGRAFT
200,223,A549,CDH1,CHROMATIN,EMT,EZH2,H3K27,HISTONE,HT29,PRC2,TGF,ZEB
024,059,201,215,406,546,570,577,AFRICAN,AMERICANS,AMONG,ARIC,BACKGROUND,CHD,CONSORTIUM,COX,HEALTHABC,HOWEVER,INITIATIVE,LABEL,METABOCHIP,METHODS,MYC,RESULTS,RISK,SNP,SNPS,SORT1,WHI,WOMEN
945,946,CK2,HOWEVER,MEIER,PLOTTER,THERE,THESE
ATLAS,CREB,MYC,NOTABLY,TCGA,THESE,THUS,TTP,ZFP36
176,177,180,270,650,670,BASED,CBCT,CONCLUSION,DTS,FOUR,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
122,3UTR,HCC,HCCS,PKM2
169,1990,1998,2006,2012,2014,4403,571,661,676,800,801,970,BACKGROUND,COPYRIGHT,III,JAPAN,LABEL,LTD,METHODS,RESULTS
169,2014,A549,BCL,BIRC5,COPYRIGHT,DR4,DR5,FAS,HOWEVER,LTD,MICROARRAY,TNF,TRAIL
169,2014,AMONG,AZD6244,BCL,BIM,CISPLATIN,COPYRIGHT,ERK1,IRELAND,KRAS,LTD,MAPK,MEK1,NSCLC,THESE,USING
130,169,2000,2014,COPYRIGHT,CPG,DEEP,GIST,GISTS,KIT,SCIENCE,SDH,SDHA,SDHB,SDHC,SDHD,SDHX,SIX,SUCCINATE
1350,169,1995,2000,2004,2007,2008,2014,6561,AMONG,BACKGROUND,CONCLUSION,DIFFUSION,DOCETAXEL,EFFORTS,END,FDA,III,LABEL,MAY,METHODS,PRESS,PROGRAM,PUBLISHED,RESULTS,SEER,UNIVERSITY
169,2015,600,CNNM2,COPYRIGHT,MAGNESIUM,MAGT1,SOCIETY,TRPM6
BACKGROUND,COLORECTAL,CONCLUSION,INITIATIVE,KEY,LABEL,LARGE,LUNG,OVARIAN,PREVENTION,RESULTS,SCREENING,TRIAL,USING,VITAMIN,WHILE,WOMEN
160,HOWEVER,LWR,RCC,THEREFORE
HOWEVER,NSCLC,TFS
160,BACKGROUND,CASE,CONCLUSION,GOSERELIN,LABEL,METHODS
COPD,PPC
METASTATIC,SURGERY
LENTIVIRAL
PRIMARY
EGFR,MICRORNAS,NSCLC,TKI,TKIS
ARG,ASP,GLY,INTEGRINS,LUNG,RGD,SUSTAINED
ALK,AP26113,CH5424802,HOWEVER,III,NSCLC,RO5424802,SEVERAL
100,2009,2013,AGGRESSIVE,BACKGROUND,GGO,GGOS,LABEL,LUNG,METHODS,OBJECTIVE,OCTOBER,RESULTS,VATS
013,140,AMONG,BACKGROUND,LABEL,METHODS,NCCN,NETWORK,NSCLC,OBJECTIVE,PFS,RESULTS,THESE,TREATMENT,UNIVARIATE
023,519,BACKGROUND,EACH,EGFR,H1975,LABEL,LOWER,METHODS,NCI,OBJECTIVE,RESULTS,TKI,TKIS
A549,AD5,AFTER,ANNEXIN,BACKGROUND,CASPASE,CELL,F35,FACS,FITC,LABEL,LOW,METHODS,MOI,MTT,NULL,OBJECTIVE,PARP,PCR,RESULTS,WESTERN,XAF1
1988,CALCIFIED
412,CONCLUSION,DIAGNOSTIC,EWING,FDG,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,RESULTS
100,225,CONCLUSION,EXCLUSION,GIVEN,LABEL,MATERIALS,MDCT,METHODS,OBJECTIVE,RESULTS
001,004,009,011,012,750,CONCLUSION,DIAGNOSTIC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
0001,0013,100,111,1988,2010,306,876,929,AMONG,BACKGROUND,DATA,DSS,END,FIVE,HOWEVER,LABEL,MEIER,METHODS,OVERALL,PROGRAM,RESULTS
169,2014,A3B,BECAUSE,COPYRIGHT,HPV,IMPORTANCE,KNOCKDOWN,LABEL,OBJECTIVE,SEVERAL,TAKEN,TP53,UNLABELLED
169,16Q23,2014,8201,BIOLOGY,DESPITE,SOCIETY,WWOX
2014,ACADEMY,COPYRIGHT
169,2015,COPYRIGHT,FEW,FURTHER,INC
380,CASP8,CONCLUSION,DFS,LABEL,MEIRE,METHODS,OBJECTIVE,RESULTS,SRC,WESTERN
ACLY,AKT,ATP,COA,INCREASING,INHIBITION,OAA,STUDIES
231,231SHCXCR3,CONVERSELY,CXCR3,ERK1,MDA,TARGETING,THERE
AGE,BRONCHIAL,CASE,CD34,CD99,CHINESE,CNKI,CONCLUSION,COUGH,ENGLISH,FIBEROPTIC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,SMA,THESE,VIP,WANFANG
8226,916,936,A549,GSH,HDAC,HOWEVER,MMP,NAC,ROS,SBHA,TRX,TRX1,WHILE
934,945,BACKGROUND,CCL1,CCL2,CCR2,DOWNSTREAM,FAS,LABEL,LEWIS,LLC1,MAIN,METHODS,MIP1,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THESE
BOTH,CHK1,CUL4A,DDB1,DEPLETION,HOWEVER,TAKEN,XAF1,XIAP
160,AKT,BECAUSE,ERK,ESCC,FGFR,FGFR3,K508M,NPC,TACC3,TAKEN
AML,CD34,CD38,CELL,FOUR,HSCS,LSC,LSCS,MSCS,NSG,PRIMARY,PUBLISHED
BACKGROUND,ENZYMATIC,FUNCTIONAL,FURTHER,LABEL,LUNG,METHODS,PCR,PREDICTED,RESULTS,ULEX
002,007,2008,2010,202,494,BACKGROUND,KRAS,LABEL,LUNG,METHODS,OVERALL,RESULTS,TTLM
FINALLY,NSCLC,THERE
945,HIF,TAP73
1953,1954,DOLL,HOWEVER
2014,BMJ,DIGITAL,GROUP,INITIALLY,LTD,PALLIATIVE,PUBLISHING
003,029,045,123,124,136,169,177,2015,250,788,BACKGROUND,COPYRIGHT,FIFTY,IHM,INC,LABEL,MEAN,METHODS,RESULTS,WOMEN
169,200,2000,2005,2014,ACT,AFFORDABLE,CARE,CONCLUSION,DUAL,IIB,III,INSTITUTE,LABEL,METHODS,NETWORK,OBJECTIVE,PURPOSE,RESULTS,SEER,SOCIETY,STUDIES,USING
169,181,2014,842,CONCLUSION,FIVE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,PURPOSE,RESULTS,SES,SOCIETY
1199,169,2014,AUTHORS,BACKGROUND,C30,CONCLUSION,COPYRIGHT,EUROQOL,LABEL,LIFE,LTD,LUME,LUNG,METHODS,NSCLC,PATIENT,PRO,PROS,PUBLISHED,QOL,QUALITY,RATES,RESULTS,THERE,TIME,TREATMENT,VAS
160,2010,2013,GBM,LESS
001,0CM,1074,169,1881,2015,3CM,8GY,9CM,COPYRIGHT,DIBH,HVIF,INC,MEDICAL,MOST,OAR,OARS,OVERALL,PUBLISHED,REGRESSION,V20
000,023,024,042,1998,2005,471,629,759,885,928,ACCORDING,CHEST,COX,III,JANUARY,LABEL,LOGRANK,MEIER,METHODS,NINE,OBJECTIVE,QINGDAO,RESULTS,THEIR,TNM
115,125,177,215,8201,BACKGROUND,BOTH,BTV,D95,D99,DMAX,DSC,FDG,LABEL,METHODS,OARS,PET,PLANS,PTV,PTVCT,R100,R50,RESULTS,SBRT,SIB,VMAT
HOWEVER,PFS
2014,PET
000,169,2014,254,BACKGROUND,CIS,COLORECTAL,COX,HOWEVER,INCIDENCE,INSTITUTE,LABEL,LUNG,METHODS,NBP,NBPS,OVARIAN,PLCO,RESULTS,SCREENING,SOCIETY,SQX,TRIAL,WOMEN
169,2014,AUTHORS,COPYRIGHT,DESPITE,LTD,PUBLISHED,WHILE
176,HSA,INC,PET,PUBLISHED,RSA,TBAF,TFP,THESE
169,2014,945,COPYRIGHT,CROHN,EMPLOYING,HOWEVER,HT29,IEC,IECS,INC,MAPK,PARKINSON,PARP,TAKEN,TNBS,TNF,VPS4B
160,169,2015,AUTHORS,COPYRIGHT,DIETARY,HCD,INC,KRAS,PROVIDING,PUBLISHED,UNRESOLVED,UPR,WHOLE
169,2014,COPYRIGHT,GMBH,HCC,THESE,TNM
AIR,COHORTS,EFFECTS,POLLUTION
0001,0490,100,101,169,186,2015,3458,3559,400,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METHODS,NRI,OBJECTIVE,PUBLISHED,RESULTS,SMOKING,SOCIETY,TOMOGRAPHY
1015,CW2,H2052,HUHS,MKN45,NCI
001,169,2015,967,BECAUSE,CARCINOIDS,CASES,COPYRIGHT,DIFFUSE,DIPNECH,INC,NECH,NEP,THREE
HER2,HOWEVER,PERTUZUMAB
ANAPLASTIC,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS
CHINESE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TCM,UNDERSTAND,URINARY
1950S,A549,ANTICANCER,FITC,K562,MCF,MYC,SF5,THEREFORE
789,790,797,8209,947,BIMAS,CTL,CTLS,EGFR,ELISPOT,EPIDERMAL,H1975,HLA,HOWEVER,IFN,IMQLMPFGC,ITQLMPFGC,LUNG,NCSLC,NSCLC,PBMCS,T790M,TKI,TKIS,USING
124,A549,BEAS,DFS,FURTHER,H460,NCL,NSCLC,STAT3,TNM,UTR
125,164,169,2014,875,940,BACKGROUND,CA125,CA153,CONCLUSION,CYFRA21,GMBH,LABEL,METHODS,RESULTS,SCC,SCREENING,SPN,SPNS,THROUGH,USING
169,2014,451,AIM,CONCLUSION,LABEL,LITERATURE,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS
CDDP,DESPITE,LUNG,NSCLC
153,753,ATLAS,CD74,HIPPO,LUNG,MET,NF1,NRG1,THESE
100,119,ACA,ADJUNCTIVE,DAH,DIFFUSE,ICU,OVERALL,PRIMARY,TREATMENT
169,2014,A549,AKT,BDE,CAD,COPYRIGHT,EMT,ERK,FURTHER,GENERALLY,H358,HOWEVER,PBDE,PBDES,PD98059,PI3K,SILENCING,SNAIL,VIM
CRK,CRKL,CT10
HOWEVER,HYPOXIA,SINCE
AIM,BACKGROUND,CHINESE,CONCLUSION,LABEL,MATERIALS,MEDICAL,METHODS,NETWORK,NPC,OBJECTIVE,PREVIOUSLY,RESULTS,TCD6120,TRIAL,UNIVERSITY
945,946,AKT,BOTH,ERK1,FOCAL,H1299,H4K16,H661,IMMUNOBLOT,INTERGRIN,KINDLIN,LUNASIN,NSCLC,PROXIMITY,SILENCING
06H,15MG,169,2006,2014,50MG,5MG,70MG,AES,AZD1480,BID,COPYRIGHT,FOUR,IWG,JANUS,LTD,MRT
120,ARG753GLN,ASP299GLY,ELISA,IGE,IRANIAN,MSP1,NCO1,PCR,RFLP,TLR2,TLR4,TLRS,TOLL
BAL,COPD,CSF,FLOW,IEP
160,169,2010,2013,2015,AUDIT,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,LYMPH,METHODS,PUBLISHED,RESULTS,SOCIETY
169,2014,AMD3100,ANTI,CD8,CONCLUSION,CXCR4,HCC,HCCS,HOWEVER,INHIBITION,LABEL,LIVER,SORAFENIB,UNLABELLED,USING
AKT,HOWEVER,INHIBITION,NSCLC,SNAIL,SPHK1,TAKEN,THUS
100,169,2014,ASIA,AUTHORS,EPR,LTD,PREVIOUSLY,PTY,PUBLISHING,SCIENCE,SMA,THESE,THP,WILEY
169,2014,COPYRIGHT,EBC,FIRST,FURTHER,LTD,MET,SAR
140,169,2014,8201,AUTHORS,BACKGROUND,BECAUSE,CNB,CNBS,EGFR,FNA,FNAS,HOWEVER,INC,KIRSTEN,KRAS,LABEL,METHODS,MOLECULAR,NON,NSCLC,RESULTS,SOCIETY,WILEY
100,169,2014,ALK,BACKGROUND,CURRENTLY,FIFTY,FISH,IHC,LABEL,METHODS,MPE,NSCLC,PCR,RESULTS,SOCIETY,VENTANA
FTIR
169,183,2014,8201,967,BACKGROUND,BJS,CONCLUSION,CRC,FAILURE,FIFTY,JOHN,LABEL,LTD,METHODS,PUBLISHED,REDO,RESULTS,SOCIETY,SONS,THOSE,WILEY
ATG5,AUTOPHAGY,HOWEVER,SIMILARLY,TAKEN,WHILE
102,BECK,C30,DEPRESSION,EORTC,INVENTORY,LABEL,MATERIALS,METHODS,OBJECTIVE,QLQ,RESULTS,THOSE
954,AKT,CD27,FIRSTLY,MAP,NEXT,NSCLC,RNAI,SOMATIC,TAKEN
004,024,177,MOUSE,PROGNOSIS,RFP,SALMONELLA,THEREFORE
0001,0013,0399,102,169,2003,2006,2015,512,688,BACKGROUND,BASE,COPYRIGHT,DATA,FURTHER,III,INC,INCOMPLETE,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
169,183,2014,231,2HCL,A549,CLL,COPYRIGHT,FOUR,INC,MDA,MTT,NMR,PDCL2
169,2014,562,616,930,BIM,BIMS,BOTH,COPYRIGHT,GI50,H460,MCF7,NCI,NON,OVARIAN,OVCAR,SAS,TEN,USA
146,2005,2010,245,464,8201,8805,ACCORDING,AFTER,AIC,BACKGROUND,CONCLUSION,COX,CRITERION,EVALUATION,IQR,LABEL,METHODS,NSCLC,RESULTS,SOLID,TRIAL
2014,AIDS,BMJ,CD4,EPOCH,GROUP,HIV,HODGKIN,LTD,NHL,NON,PPL,PRIMARY,PUBLISHING,RISK
158,2014,241,6TH,AFRICAN,CKD,COPD,DATA,EASTERN,FINANCIAL,GIVEN,LATIN,LMIC,MEDLINE,NCDS,OOP,PACIFIC,RANDOMIZED,SCHOLAR,STUDIES,WESTERN
110,231,AFTERWARD,BACKGROUND,CHIP,FINALLY,LABEL,MCF,MDA,METHODS,MMP,PCR,PIT,POU,RESULTS,SCID,WESTERN
HOWEVER,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,WHEREAS
001,005,2006,2013,215,260,464,724,8201,HOWEVER,LDH,PNI,SCLC,UNIVARIATE
169,2014,COPYRIGHT,INC,MINIMALLY,VATS,VIDEO
169,2014,CONTINUED,COPYRIGHT,INC
169,2011,2014,COPYRIGHT,INC,LUNG,PROGNOSTIC,SOCIETY
169,2014,COPYRIGHT,DESPITE,INC,PUBLISHED,SLN,SLNS
169,2014,AFTER,COPYRIGHT,INC,MALIGNANT,RADIATION,SURGERY,THERAPY
025,030,042,058,098,100,114,134,150,234,90TH,956,ADDITIVES,AFTER,BACKGROUND,BENCHMARK,COMMITTEE,CONFIDENCE,DOSE,FAO,FOOD,GREEN,HCL,HGAAS,HOWEVER,INORGANIC,JECFA,JOINT,KEY,LABEL,LIMIT,LOWER,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THEIR,WORDS
2D3,APART,BACKGROUND,CALCITRIOL,HOWEVER,KEY,LABEL,LANGERHANS,RAAS,T2DM,THESE,UNLABELLED,VITAMIN,WORDS
160,169,2014,946,ACTIVATED,CD4,CONVERSELY,COPYRIGHT,INC,IRF3,RLR,SMAD3,TGF,TREG
COX,MOST,SPSS,THERE
001,002,008,012,022,1ST,290,2ND,3RD,8202,8804,AMONG,FDG,METABOLIC,NSCLC,PERCIST,PET,PFS,SOLID,UNIVARIATE
033,041,228,301,CHINA,CHINESE,CIS,CLPTM1L,FURTHER,GTTATCTGT,HAN,HAPLOTYPE,ODDS,ORS,SNPS
2007,2008,394,AMONG,EHRS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,VETERAN,VHA
143,169,1985,1990,1995,1999,2007,2010,8805,AGE,AHMEDABAD,BACKGROUND,C03,C33,C34,CONTEXT,GUJARAT,GUTKA,ICD,INDIA,LABEL,METHODS,MOUTH,RESULTS,USED,USING
600,ADDITIONAL,ALECTINIB,ALK,BACKGROUND,CURRENTLY,FDA,FOUR,LABEL,METHODS,NSCLC,OVERALL,RESULTS,THREE
100,105,131,160,205,6095,BRCA1,BRCA2,CHINESE,DICER,FOUR,HOWEVER,IVS11,IVS16,IVS19,IVS8,LOW,NONE,SIXTY,THREE
BACKGROUND,CONCLUSION,FOUR,LABEL,METHODS,PATIENT,RESULTS,SARCOID
545,601,622,627,670,742,ACCORDING,AUC,HOWEVER,MALAT,PCA,PSA,ROC
100,118,AIM,CONCLUSION,CYBERKNIFE,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,RESULTS,STUDIED,THREE
100,174,2014,400,MAY,MEETING,SBRT,SCIENTIFIC,SOCIETY,SRS,USA
ADVOCATES,COMMITTEE,DATA,FORCE,LDCT,LUNG,NLST,PREVENTIVE,SCREENING,TASK,TRIAL
HIF
8201,ALSO,BREATHING,DEBH,FIFTEEN,PTV
ACO,LUNG,OTSU,VARIANT
100,8202,826,882,954,A750DEL,ADX,ARMS,BACKGROUND,CONCLUSION,E746,EGFR,EPIDERMAL,EXCELLENT,IHC,L858R,LABEL,MATERIALS,METHODS,NSCLC,QDS,RESULTS,SINCE
040,064,114,119,129,134,159,169,177,2015,248,541,676,812,8804,CONCLUSION,DESPITE,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RECURRENCE,RESULTS,SOCIETY,SUV,T1A,T1B,TLG,UNLABELLED
169,170,2008,2015,237,406,CONCLUSION,CORE,CTN,DIFFERENT,IMAGING,INC,INDIVIDUAL,LABEL,METHODS,MOLECULAR,NETWORK,NUCLEAR,PET,PHANTOM,RESULTS,SCANNER,SINCE,SNMMI,SOCIETY,THESE,UNLABELLED
129,255,ADS,ADTAV,E1A,ONCOLYTIC,TAV
BOTH,FURTHER,MALIGNANT,MSC,MSCS,THESE,TRAIL,USING
2280,BACKGROUND,BASED,BEGG,BIOMEDICAL,CHINESE,CONCLUSION,ELECTRONIC,HRS,LABEL,LITERATURE,LOW,METHODS,NSCLC,OBJECTIVE,PFS,PROGNOSTIC,RESULTS,SCIENCE,THERE,WEB
008,011,030,039,077,118,120,133,146A,149,196A2,2014,217,300,357,8764,987,BACKGROUND,CIS,CNKI,FINALLY,HOWEVER,LABEL,MAY,METHODS,MIR,ORS,RESULTS,SCIENCE,SNP,THESE,WEB
946,AGE,BACKGROUND,CONCLUSION,DACT,DACT1,DACT2,LABEL,METHODS,OBJECTIVE,OSCC,PCR,RESULTS,TGF,THERE,THESE,WNT
8209,A549,AKT,CELECOXIB,CXB,MTT,NSCLC,PI3K,THEREFORE,THESE,TUNEL,XIAP
A549,AKT,CURRENTLY,LUNG,PI3K,PIP2,RTKS,SINCE,THUS
105,137,155,160,169,2015,AMONG,COPYRIGHT,DISCUSSION,INC,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SNS
169,2015,FOUNDATION,INITIALLY,JOURNAL,SOCIETY,STICHTING
181,A549,BCL,MICRORNAS,NSCLC,RNAS,TAKEN
2013,2014,946,A549,ALSO,CHINA,DECORIN,DEPARTMENT,HOWEVER,JINLING,MARCH,NANJING,NSCLC,P21,P53,PCR,SEPTEMBER,SURGERY,TGF,THROUGH,UNIVERSITY,VEGF,VIA,WESTERN
169,2014,COPYRIGHT,FINALLY,IRELAND,LTD,NSCLC,OVERALL,PLK1,POLO,SAC
100,8201,BACKGROUND,HUD,LABEL,METHODS,MOST,RESULTS,SCLC
169,2015,BACKGROUND,BASED,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OUTCOME,PATIENT,PURPOSE,PVP,RADIOLOGIC,RESULTS,THERE,UNDER,VAS
ENTROPY,LIEBLER
1970,1990,1999,2000,2001,2007,2011,AGE,BACKGROUND,CONCLUSION,END,INCIDENCE,INCREASES,JOINPOINT,LABEL,METHODS,MORTALITY,PROGRAM,REGRESSION,RESULTS,SEER,STAT,STATISTICS,TREND
0001,001,006,007,105,8201,BACKGROUND,CONCLUSION,FIVE,LABEL,LATER,METHODS,MOST,NULMS,OUTCOME,RESULTS,THEREFORE,ULMS,UNIVARIATE
8217,BACKGROUND,EPCAM,LABEL,RESULTS,SINCE,TROP1,TROP2
169,2014,BECAUSE,EGFR,ERLOTINIB,HGF,HOWEVER,MET,NSCLC,TKI
206,8209,AKT,EBC,EGFR,ERK1,EXPRESSION,MET,RTKS,SCC,THEREFORE,TKIS,UTRS
945,A549,BENG,C57BL,CHA,CONCLUSION,GAN,LABEL,METHODS,MONGOLIAN,OBJECTIVE,PGC,RESULTS
BCL,FLICE,FLIP,FURTHER,NSCLC,PUMA,ROS,TRAIL
001,2007,2009,750,8201,BACKGROUND,END,FURTHER,LABEL,MAIN,METFORMIN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PRIOR,PROPENSITY,RATIONALE,RESULTS,USING
CISPLATIN,EHRLICH,IRON,METAL,THERE,THESE
BACKGROUND,COPD,DETECTION,EARLY,LABEL,LUCSS,LUNG,MAIN,METHODS,OBJECTIVE,OBJECTIVES,PITTSBURGH,PLUSS,PROGRAM,RATIONALE,RESULTS,SCREENING,VALIDATION
003,956,AVERAGE,BACKGROUND,CNB,CNBS,CONTEXT,DIAGNOSTIC,DIFF,LABEL,METHODS,OBJECTIVE,OVERALL,QUIK,RESULTS,TOUCH,TPS
1747,BACKGROUND,G583R,GFP,LABEL,NON,NSCLC,POLA2,RESULTS,SNP,USING
ABOUT,AMONG,AUTOMATIC,BACKGROUND,FULL,INTEGRATED,LABEL,NON,NSCLC,RESULTS,THESE,THUS,TINAGL1
122,8201,AFFAIRS,AMONG,BACKGROUND,CARE,DEPARTMENT,EVENT,INCIDENTAL,LABEL,MAIN,MEASURE,MEDICAL,METHODS,OBJECTIVES,RATIONALE,RESULTS,RISK,SCALE
CONVERSELY,MCC,MCC13,MCC26,MKL,UISO,USING,WAGA,YET
DEFINITIVE,THESE
001,031,100,233,BACKGROUND,BIOVICA,DIVITUM,LABEL,METHODS,MOST,NSCLC,RESULTS,SCLC,THYMIDINE,TK1
224,ADC,ADCS,BACKGROUND,CONCLUSION,IHC,LABEL,METHODS,NOS,NSCLC,RESULTS,SIXTY,THESE,TTF
0007,BACKGROUND,EGFR,KRAS,LABEL,METHODS,NSCLC,PFS,PFS4M,RESULTS,RP2D,WESTERN
2012,COMMITTEE,DRUG,FOOD,INSTITUTE,LUNG,NCI,PROTOCOLS
BACKGROUND,CL1,DDA,EXTRACTION,FINALLY,LABEL,PEAK,RESULTS,WHILE
100,126,182,205,356,601,ALTERED,BACKGROUND,CONCLUSION,FZD3,LABEL,MENDELIAN,METHODS,OMIM,RESULTS,RPS6KA3,SCC,THESE
169,2014,EGFR,FIRST,NSCLC,SOCIETY,T790M,TKI,TKIS
1115,177,2002,2011,CONCLUSION,DESPITE,ECC,GROUP,JANUARY,LABEL,METHODS,NINE,OBJECTIVE,REF,RESULTS,TAB,TEN
1990,2000,2010,ASR,BACKGROUND,BPSP,LABEL,MATERIALS,METHODS,MPSP,MUSLIMS,NHL,OBJECTIVE,OBJECTIVES,PBSP,PMSP,POPULATION,RESULTS
BACKGROUND,CD3,CD56,CD56BRIGHT,CD56DIM,III,LABEL,MATERIALS,METHODS,NKT,RESULTS,TIM
100,190,2006,2010,245,BACKGROUND,DEPARTMENT,FACTORS,FNA,LABEL,MALIGNANT,MATERIALS,MEDICAL,MEIR,METHODS,OTHER,PATHOLOGY,RESULTS
006,180,2009,2013,ABO,BACKGROUND,JANUARY,LABEL,MATERIALS,METHODS,RESULTS,SPC,SPCS,TAIWANESE,THERE
150,193,664,665,805,CEA,CYFRA21,FOUR,LABEL,MATERIALS,METHODS,NSE,OBJECTIVE,PURPOSE,RESULTS,SERUM
946,HOWEVER,VARIOUS
AMONG,ORFS,RNAS,SIMILARLY,SINCE,THUS,UTR,UTRS
16953,ASIA,RESULTS,SINGAPORE,USING
JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHWAY,PUBLISHED,RISK,UNASSIGNED
EPIGENETIC,NMD,PTC,SMG1,UPF1
CLOSE,CRE,KRAS,LKB1,OWING
2014,20S,BMJ,GROUP,HOWEVER,LTD,PUBLISHING
2014,BMJ,GROUP,LTD,PUBLISHING
AEA,FAAH,FDA,H460,LOQS,OEA,PEA,USING
169,2014,8805,956,A549,ASPC,CAKI,FLT,IC50,PAZOPANIB,TKI,TKIS
110,AFTER,BAD,CLINICALLY,FINALLY,H460,HBE,MDM2,NSCLC,THEN,USP7
160,174,8482,956,AFFYMETRIX,AMP,BACKGROUND,CIC,CICS,EPISTEM,INITIAL,LABEL,MACS,MCF7,MICROARRAY,NSCLC,NUGEN,OVATION,PATHWAY,RESULTS,SEQ
169,2000,2015,COLD,HISEQ,HOWEVER,LABORATORY,PRESS,PUBLISHED,RPM,SMALL,SOCIETY,THESE
001,002,005,006,023,043,051,206,8201,966,AVERAGE,BACKGROUND,COX,GENERALLY,LABEL,METHODS,PATHOLOGIC,PULMONARY,RESULTS
233,AGE,BACKGROUND,BIRT,DUB,FINALLY,FLCN,FOUR,HOGG,LABEL,METHODS,MOST,RESULTS
1226,169,2014,8764,92A,945,CYP24A1,LUNG,NOTABLY,NSCLC
231,4T1,MDA,METASTASES,MVS,PCR,THESE
2007,2012,BACKGROUND,ECOG,FIFTEEN,III,JANUARY,LABEL,METHODS,RESULTS,STAGE,THERE,THREE,TREATMENT
026,038,047,051,054,061,069,073,074,115,121,124,125,172,475,566,575,669,769,787,817,850,875,878,975,A05,BCL,CONCLUSION,FAS,FASL,H446,LABEL,METHODS,NCI,OBJECTIVE,PCR,RESULTS,WESTERN
KNOWN
ACCORDING,ALSO,COPD,GLC,GROUP,LABEL,LRT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCFA
177,956,BACKGROUND,BIOLOGICAL,CIOCALTEU,CONCLUSION,COR,DPPH,FOLIN,FRAP,HELA,HPLC,IC50,L23,LABEL,LPS,MCF,METHODS,MRC,OBJECTIVE,RESULTS,SRB,SUNG,SXH,TEAC,THUS,TOTAL,W264,YET,YOD
177,688,956,BACKGROUND,CONCLUSION,CYTOTOXIC,H1688,HPLC,IC50,LABEL,METHODS,MRC,NCI,OBJECTIVE,PIPER,PLUMBAGIN,RESULTS,SIX,SRB,THAI,VLC
215,CONCLUSION,DIFFUSION,EIGHT,FUNCTIONAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
10878,1409,2006,2008,AGE,CXR,ELDERLY,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,VITAL
2008,2013,GREATER,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
2014,COPYRIGHT,GRANEHEIM,JOURNAL,LUNDMAN,PHYSICIANS
ASIAN,EGFR,ERBB,III,LUNG,LUX,NSCLC,OVERALL,PFS,PRIMARY,SIMILARITY,THERAPY,THERE,TKI,TKIS
MESH,MOST,SEVERAL,THESE
10Q,215,640,8201,AMONG,AWT,BACKGROUND,LABEL,MAGI2,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SNP,SNPS,THREE
BOTH,INCREASING,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SONIC,SUMMARY
530,650,PARKINSON,S18Y,SPR,UBIQUITIN,UCH
2014,215,457,493,536,8201,AMERICA,ASIAN,GOVERNMENT,GRS,GRSS,PUBLISHED,SNP,STRATIFIED,TERT,USING,WBC,WBCS,WOMEN
169,2014,A549,LABEL,TELOMERASE,THESE,THIO,TREATMENT,UNLABELLED
169,2014,BAL,COLLEGE,COPYRIGHT,HOWEVER,IDIOPATHIC,IPH,ROYAL
8209,945,A549,CDK,CDK6,CELL,FURTHER,HOWEVER,MTT
177,8209,A549,ANNEXIN,BLM,LUNG,MSC,MSCS,MTT,PARACRINE,RATS
001,CPG,EXPRESSION,KNOWLEDGE,SCC
320,954,ANNOTATION,CCAAT,CD36,CEBPD,COL11A1,DAVID,DEGS,DISCOVERY,ECM,EXPRESSION,GENOMES,GEO,INTEGRATED,KEGG,KYOTO,LABEL,MATERIALS,METHODS,OBJECTIVE,OMNIBUS,PATHWAY,PPAR,PPI,PURPOSE,REL,RESULTS,RETRIEVAL,TFS,TOOL
2005,2012,340,CALCIUM,CONCLUSION,DATA,INDEX,JANUARY,JUNE,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,POST,RESULTS,SEVENTEEN,SIXTY,VHI,VOICE
AKT,EGFR,ERK,FGFR1,FGFR2,ITK,LUNG,MEK,MOS,MST1R,NSCLC,NTRK1,NTRK2,ORF,PC9,PI3K,RAF1,SRC,TKIS
945,946,CAFS,CXC,CXCL6,SMA,THESE,TSPAN12
BESIDES,CURVE,FORESTS,HOWEVER,IFS,LADC,LOOCV,LUNG,MAXIMUM,MINIMUM,NSCLC,OPERATING,RECEIVING,REDUNDANCY,RELEVANCY,RFS,ROC,SCLC,SQCLC,TAKEN,THERE
169,2014,BACKGROUND,BOTH,COPYRIGHT,HPV,ICAHN,INC,LABEL,LMICS,METHODS,MOUNT,OBJECTIVE,ORGANIZED,PUBLISHED,RESULTS,SCREENING,SINAI,VIA
169,2014,BACKGROUND,COPYRIGHT,ICAHN,INC,LABEL,LMICS,MOUNT,OBJECTIVE,PUBLISHED,RESULTS,SINAI,WOMEN,WORLD
169,2014,ALCOHOL,BACKGROUND,CANCERS,CONCLUSION,COPYRIGHT,HICS,ICAHN,INC,LABEL,LMICS,MOUNT,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SINAI,TOBACCO
160,169,2012,2013,2014,2020,2025,ASIA,BACKGROUND,CONTINENTS,CONTROL,COPYRIGHT,FIVE,HBV,HPV,ICAHN,INC,INCIDENCE,LABEL,LMICS,METHODS,MOUNT,NCD,NCDS,OBJECTIVE,OBJECTIVES,PACIFIC,PAIN,PLAN,PREVENTION,PUBLISHED,RAPID,RESULTS,SINAI,VOL,WESTERN,WORLD,WPR
000,100,169,2012,2014,20TH,ASIA,ASIAN,ASR,BACKGROUND,BAHRAIN,CANCERS,COPYRIGHT,COUNTRIES,DATA,HIGH,IARC,ICAHN,INC,IRAN,IRANIAN,LABEL,LACK,LEBANON,METHODS,MOUNT,NINE,OBJECTIVE,OBJECTIVES,OMAN,PUBLISHED,QATAR,RESULTS,SAUDI,SINAI,THEREFORE,THESE,TURKISH,WEST,WESTERN
0502,101,160,184,186,213,291,292,296,625,733,8364,908,BACKGROUND,CONCLUSION,ERLOTINIB,GFPC,ICER,ICERS,IFCT,III,LABEL,METHODS,NSCLC,QALY,RESULTS,UTILITY
169,2014,295,945,ACC,AMP,AMPK,ATP,COPYRIGHT,INC,INDONESIA,MEFS,SER79,U87,ULK1
169,2014,945,COLLAGENS,COPYRIGHT,HIGH,IRELAND,LTD
EGFR,HGF,HOWEVER,NSCLC,SEVERAL,THESE,TKI,TKIS
EGFR,EPIDERMAL,MET,NSCLC,SEVERAL,T790M,TKIS
133,177,2013,2014,321,402,499,556,838,ACCORDING,DETECTION,ELISA,LABEL,MALIGNANT,MARCH,METHODS,OBJECTIVE,PROVINCIAL,RESULTS,ROC
030,044,048,2007,2014,297,8201,BACKGROUND,FXIII,JULY,LABEL,MARCH,METHODS,PAL,RESULTS,XIII
BACKGROUND,BECAUSE,CASE,CONCLUSION,LABEL,METHODS,OVERALL,PRIMARY
169,2014,COPYRIGHT,IRELAND,LTD,MWCNT,THERE,USING
0002,0003,001,010,162,169,177,193,248,386,395,398,492,600,642,961,CFD,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PRESURGERY,RESULTS,SOCIETY,TNM
CTC,CTCS,EPCAM,HOWEVER,KEY,PATIENT,VEGF
ACE,ACE2,AT1R,CAPTOPRIL,HOWEVER,HYPOXIA,LEWIS,LLC,RAS,THESE
FACTORS,HOWEVER
367,BACKGROUND,CASE,LABEL,MALIGNANT,MEN,METHODS,PILONIDAL,SPAIN
0495,2006,2011,550,666,APRIL,CONCLUSION,COUNCIL,LABEL,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
A431,EGFR,EPIDERMAL,HOWEVER,KIT,TAKEN,THESE
2CL2,A549,APOPTOSIS,BAX,CHANGES,DMSO,HELA,HEPG2,MCF,MTT,NOXA,PARP,PT2,PUMA
168,169,180,200,2014,A549,COPYRIGHT,DMAB,F127,PBS,PF127,PLGA,PVA
001,039,095,147,187,199,2000,2001,2014,253,298,303,408,ANXIETY,BACKGROUND,CBM,CHINESE,CNKI,CUMULATIVE,HOWEVER,INVENTORY,JANUARY,LABEL,METHODS,MODERATING,MODERATOR,RANDOMIZED,RESULTS,SCIE,SCIENCE,SMD,STAI,STATE,TRAIT,VIP,WANFANG,WEB
AFTER,BACKGROUND,BRDU,CASPASE,IFN,KSY,KUAN,LABEL,METHODS,MTT,PARP,RESULTS,SIN,TILS,TNF,TUNEL,UNDER,YIN
2004,2009,ASSESSMENT,BACKGROUND,CONCLUSION,DEPARTMENT,FACT,FUNCTIONAL,JANUARY,LABEL,LUNG,METHODS,NON,NSCLC,OBJECTIVE,QOL,RAJAVITHI,RESULTS,SURGERY,THERAPY,UNIT
111,2003,2011,251,263,369,415,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RAJAVITHI,RESULTS,TTF
128,956,BAX,BCL,CLONE,DHA,DIFFERENT,GLC,IC50,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,SER,WESTERN
8201,AML,COX,DCBCL,LASSO,SIMULATION
CONSORTIUM,EARLY,HOWEVER,IMAGE,INITIATIVE,LUNG,PHYSICIANS
169,2015,ASP,BIOLOGY,FINALLY,HHAT,HOWEVER,INC,MOLECULAR,SOCIETY
169,2014,CELL,COPYRIGHT,GUIDELINES,LUNG,NCCN,NETWORK,NON,NSCLC,SMALL,TREATMENT
169,2014,IMT,INC,VDA,WILEY,WILMS,XRT
169,2014,ANRIL,ATM,E2F1,HOWEVER,INK4B,KLF2,NSCLC,P21,PC9,PRC2,RNAS,THUS
079,169,2014,231,AKT,CXCR4,ERK,GTP,HODGKIN,IC50,LY2510924,MDA,SDF,U937
150,169,2014,800,8805,AFTER,DL1,DL2,DLT,MTR,PAZOPANIB
039,042,083,1B1,4326,4326C,4390A,967,COX,CYTOCHROME,FORTY,HISTOLOGY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,P450,PEARSON,PFS,PURPOSE,RESULTS,SEVERAL,SNPS
001,023,024,139,2013,2014,AIM,APRIL,ARSENIC,BETWEEN,CHINA,DCR,GUANGZHOU,JUNE,LABEL,METHODS,OBJECTIVE,ORR,RESULTS,TTP
169,2014,GMBH,KGAA,UTILIZING,VCH,WILEY
001,002,009,012,017,020,045,113,224,234,648,8209,945,HGF,LMVD,MET,NSCLC,VEGF
BACKGROUND,BECAUSE,EVERY,LABEL,METHODS,RESULTS,THEREFORE,THESE,THUS
CXCR4,METASTASIS,SBC,SCLC,SDF,STROMAL,THUS
BACKGROUND,EGFR,III,LABEL,METHODS,NSCLC,NSCLS,PFS,REGARDING,RESULTS,THEREFORE,THUS,TKIS
100,2010,2011,BACKGROUND,FORCE,HOWEVER,LABEL,LATE,LDCT,LUNG,MAJOR,METHODS,NLST,RESULTS,SCREENING,TASK,THESE,TRIAL
169,2015,4T1,8710,936,BACKGROUND,BASEL,BCL,CONCLUSION,FINALLY,LABEL,MDSCS,MEANWHILE,METHODS,RESULTS,ROS,THUS,YLT26
169,2009,2013,2014,ANTICANCER,BETWEEN,CONCLUSION,COPYRIGHT,COX,EGFR,INSTITUTE,JOHN,JUNE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,PFS,RESULTS,RISK
169,2014,544,ANTICANCER,BACKGROUND,CONSLUSION,COPYRIGHT,COX,INSTITUTE,JOHN,LABEL,NSCLC,PFS,RESULTS,UNASSIGNED
169,2014,AIM,ANTICANCER,BACKGROUND,BIO,CIS,CONCLUSION,COPYRIGHT,DETECTION,ELISA,GIF,HOWEVER,INSTITUTE,JOHN,LABEL,MATERIALS,MESOTHELIN,METHODS,MPM,OBJECTIVE,RESULTS,SMRP
169,2014,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GGNS,INSTITUTE,JOHN,LABEL,LUNG,METHODS,RESULTS,THREE
110,111,124,169,2014,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,DATA,DEVIATIONS,HOWEVER,IMAGE,INSTITUTE,JOHN,LABEL,LOWER,METHODS,MVCT,NEXT,NONE,OBJECTIVE,PTV,RESULTS,SBRT,SLOW,UPPER
169,2014,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,HER2,INSTITUTE,JOHN,LABEL,METHODS,RESULTS
049,169,2014,656,ANTICANCER,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,HRQOL,INSTITUTE,JOHN,LABEL,MELATONIN,METHODS,NON,NSCLC,RESULTS
169,2014,AFTER,ANTICANCER,AUTOPSY,BACKGROUND,BILATERAL,CASE,CONCLUSION,COPYRIGHT,DESPITE,IIIA,INSTITUTE,JOHN,LABEL,LITERATURE,METHODS,SINCE
030,043,100,169,2014,8804,8805,AIM,ANTICANCER,BASED,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,KARNOFSKY,KPS,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVEN,SRS
0083,025,0419,056,062,131,169,177,2014,ANTICANCER,BACKGROUND,CK19,CONCLUSION,COPYRIGHT,FOXP3,HIGH,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,PCR,REGULATORY,RESULTS,RLNS,TREGS
169,2014,945,946,AKT,ANTICANCER,ATP,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,FAK,GTP,H460,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MIGRATION,MTT,RAC,RESISTANCE,RESULTS,RHO
0003,0004,0005,0025,1082G,169,2014,358,592C,716,819C,ANTICANCER,COPYRIGHT,FURTHER,INSTITUTE,JOHN
169,2014,215,358,716,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TAIWANESE,XRCC7
169,2014,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MMR,MSH2,MSH6,MUTS,OBJECTIVE,RESULTS,TMA
0298,100,169,2014,205,3117,8482,ANTICANCER,CASKI,COLO,COPYRIGHT,CTG,H460,H69,HOWEVER,INSTITUTE,JOHN,TGI,THESE,TUMORGRAFT
169,2014,6D1,946,ANTICANCER,CELL,COPYRIGHT,FYN,INSTITUTE,JOHN,MCS,MOST,RAF,SCC,SCC9
169,2014,946,ANTICANCER,COPYRIGHT,INSTITUTE,JOHN,USING
169,2014,ANTICANCER,ARG,B1R,COPYRIGHT,INSTITUTE,JOHN,KLK1,KLK10,KLK11,KLK6,LYS
100,181,A549,APOPTOSIS,BACKGROUND,BAX,CODON,ERK1,HIGH,HOWEVER,KRAS,LABEL,LOVO,PRINCIPAL,RESULTS,THESE
ALK,CRIZOTINIB,EML4,H2228,H3122,HGF,HOWEVER,MET,NON,NSCLC,THESE
500,BACKGROUND,CASP8,CONCLUSION,D302H,LABEL,METHODS,MYCN,RESULTS,SNP,SNPS,TP53
AFTER,APOPTOSIS,DEPLETING,FIRST,HOWEVER,MTA1,NURD,SCLC
169,2014,239,500,8805,AUC,BASEL,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
A549,AUNPS,C225,CETUXIMAB,EGFR,FINALLY,H1299,HOWEVER,IGG,NSCLC,OVERALL
169,2014,811,AKT,AMYLOID,APP,CELLS,INC,IRES,NSCLC,PI3,PRECURSOR,PROTEIN,SINCE,THESE,WILEY
8212,BACKGROUND,III,LABEL,LUNG,METHODS,NON,NSCLC,RESULTS,THERE
946,ATP,BIM,DASATINIB,DESPITE,DRUG,EGFR,KNOCKDOWN,LUNG,NSCLC,SMAD2,SMAD3,TGF,THEREFORE,TKIS
660,A549,CIP1,DESPITE,H1299,H460,LT73,LUNG,MDM2,MICRORNAS,NCI,RNAS,TRANSIENT,WAF1
046,450K,778,A549,ADDITIONAL,AML,BRDU,CHOU,CPG,DNMT,DRUG,FURTHER,HL60,HTB56,LUNG,MGMT,NSCLC,TALALAY,THESE,THRB,U937,WHILE
DESPITE,PTH,PULMONARY
HOWEVER,KLF2,KRUPPEL,NSCLC,TNM
148,148A,148B,152,300,452,8201,AFTER,AUC,BLOOD,CURRENT,FURTHER,HENCE,HIGH,HOWEVER,LATE,LOW,LUNG,MICRORNAS,NSCLC,PCR,SERUM,STRATIFIED
001,003,101,1997,2010,565,CARDIAC,INSURANCE,LABEL,MALIGNANCY,MALIGNANT,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,THERE
34A,946,A549,BEAS,H1299,LUCIFERASE,MICRORNAS,NSCLC,PCR,SPCA,TGF,UTR,WESTERN
015,100,2012,2013,8202,AES,AFTER,ALK,ALT,AST,AUG,BACKGROUND,CHINESE,CRIZOTINIB,ECOG,EML4,FORTY,GRADE,HOWEVER,LABEL,MAY,METHODS,NSCLC,PFS,QOL,RESULTS,SIX
169,2014,945,946,AKT,CD24,CSC,CSCS,HOWEVER,MALIGNANT,MET,MYC,NK4,OCT4,THESE,UICC,WNT
2488,2576,77T,ASIAN,CIS,HOWEVER,ORS,XRCC1
132,165,2007,2009,2012,297,CHINESE,ERCC1,NSCLC,RRM1,SEPTEMBER
3761,3977,500,CHINA,HOWEVER,KNOWLEDGE,SCHOLAR,T241M,XRCC3
242,AMONG,COX,LYMPH,METASTASIS
001,003,005,036,045,2014,2E1,332,7028,9822,ASIAN,C1C1,C1C2,C2C2,CHINA,DATABASES,JULY,KNOWLEDGE,LIBRARY,P450,PROTECTION,PST,RSA,WANFANG
024,2003,2004,2008,219,759,AMONG,COEXISTING,COPD,COX,EFFECTS,HOWEVER,HRS,INSURANCE,SMCC,SQCC
002,019,107,209,4Q12,4Q21,4Q22,4Q31,4Q35,8202,DFS,DTCS,FISH,NEITHER,NSCLC,POSITIONS,USING
A549,CEACAMS,FURTHER,HNO,HOWEVER,THESE
169,2014,BRITAIN,COPYRIGHT,GREAT,INHERITED,IRELAND,JOHN,LTD,PPB,PUBLISHED,SOCIETY,SONS,THESE,WILEY
001,014,018,024,028,044,100,177,691,753,ACCORDING,ACS,CTP,LABEL,LCC,LCCS,MATERIALS,METHODS,MTT,NSCLC,OBJECTIVE,OBJECTIVES,PIMAX,PULMONARY,RESULTS,SCCS,THERE,UNION,USING
002,0053,0093,169,2015,415,555,CONCLUSION,COX,FDG,FOUR,IMAGING,INC,LABEL,MATV,MATVS,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SOCIETY,THESE,UNLABELLED
169,177,2015,293,360,947,99M,AFTER,BECAUSE,CCK2R,CONCLUSION,CRL,HEK,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,RESULTS,SOCIETY,SPECT,UNLABELLED
200,2011,2012,632,DUE,HOWEVER,INFECTIOUS,JULY,JUNE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEOUL,TREATMENT,UNIVERSITY
AUTOPSIES,PTTM,PULMONARY,TMA,TROUSSEAU
233,BHDS,BIRT,DUB,DUE,FLCN,HOGG
CHEST,HOWEVER
169,2014,BROADLY,COLLEGE,COPYRIGHT,ENGLAND,IIIB,LTD,MALTHUS,PUBLISHED,ROYAL
020,100,169,2015,8804,8805,AES,AIMS,BACKGROUND,CALIFORNIA,COLLEGE,COPYRIGHT,DIEGO,FORM,FURTHER,GROUP,HOWEVER,INC,LABEL,MCS,METHODS,PCS,PRIOR,PUBLISHED,QOL,RESULTS,SAN,SF36,SHORT,SHORTNESS,SOBQ,SURGERY,T1A,T1B,THERE,UNIVERSITY,VATS,Z4032
11A,11C,169,177,2014,956,A549,ADME,COPYRIGHT,FINALLY,HEPG2,IC50,MCF,NOTABLY,QSAR,SAR,SAS
003,169,177,2015,8804,8805,BACKGROUND,COPYRIGHT,DESPITE,EUROQOL,FIFTY,INC,IQR,LABEL,METHODS,RESULTS,RHO,THERE,VAS
169,2014,468,47D,495,562,568,956,CNS,COPYRIGHT,GI50,HOP,INSTITUTE,MDA,MOLT,MOTIVATED,RESULTS,SAS,SNB,USA
169,2014,COPYRIGHT,GI50,SAS,SRB
BMSC,BMSCS,MICROARRAY,SSCS,TBD,TERC,THESE,UPON
169,2014,COPYRIGHT,INC,MPM,NSCLC,PDT,SCLC,SIMILARLY
169,2014,CHORDOMAS,COPYRIGHT,HODGKIN,INC,LATE,THERE
169,2014,COPYRIGHT,INC,NSCLC,SBRT,SEVERAL
169,175,2015,31001,BACKGROUND,CALGB,COMPARISON,COPYRIGHT,FIVE,INC,LABEL,LACK,MCNEMAR,METHODS,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,THERE,VATS
042,096,169,2015,612,629,AFTER,BACKGROUND,BASE,COPYRIGHT,DATA,FINALLY,IIIA,INC,LABEL,MEIER,METHODS,NDCB,NEXT,OVERALL,PUBLISHED,RESULTS,SOCIETY,THERE,THESE,TREATMENT
030,038,169,1991,2013,2015,APRIL,BACKGROUND,CEA,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OWING,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,THERE
052,105,10878,128,134,169,2007,2011,2014,290,BACKGROUND,CHOI,COPYRIGHT,DUAL,EVALUATION,KAPPA,LABEL,LTD,METHODS,RESULTS,SOLID,TUMOURS,UNIVARIATE
100,1007,1009,169,183,2004,2009,2015,2016,409,432,841,BACKGROUND,BETWEEN,BLOOD,COPYRIGHT,FEB,FOCUS,FUNDING,HEART,INSTITUTE,IQR,JULY,LABEL,LIBERAL,LTD,LUNG,METHODS,RESULTS,THESE,TREATMENT,USA
169,2015,COPYRIGHT,INC,ISP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PHYSICIANS,PUBLISHED,RATIONALE,RESULTS,VOLUNTEERS
169,2014,CONVERSELY,COPYRIGHT,E16D,E94D,FINALLY,HOWEVER,IRELAND,LTD,LYS,OTU,OTUD5,PDCD5,PROGRAMMED
169,2014,945,954,A549,COPYRIGHT,H1299,H358,IRELAND,KRAS,LTD,SILENCING,THUS,V12
1523,169,176,2015,210,2CM,359,8CM,COPYRIGHT,D99,ECLIPSE,INC,MEDICAL,MUS,PTV,PTVS,PUBLISHED,SBRT,SIMS,V10,V100
0001,0003,1998,2008,454,8201,AMONG,BACKGROUND,BANK,CONCLUSION,COUNTRIES,DATA,ENGLISH,FACTORS,INITIATIVE,LABEL,LMC,LMCS,MEDLINE,METHODS,PROPORTION,RCTS,RESULTS,WORLD
169,2000,2010,2015,BLOOD,BOS,COPYRIGHT,FEV1,FIFTY,HSCT,INC,INSTITUTES,LUNG,PUBLISHED,SOCIETY
160,169,2015,322M,549,BACKGROUND,COPYRIGHT,H322M,HENCE,INC,LABEL,METHODS,MICE,MTT,NEWER,NSCLC,PAC,PROCASPASE,RESULTS,SIMILARLY,WESTERN
0001,0004,003,006,169,2015,AMBULATORY,ASPIRATION,CHANGES,COPYRIGHT,DYSPHAGIA,FIFTEEN,HNC,IMPAIRMENT,INC,INVENTORY,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PAS,PROFILE,PUBLISHED,RESULTS,SCALE,SETTING,SWALLOW,USING
169,2015,COPYRIGHT,HOWEVER,INC,LOW,PATHOLOGY,PUBLISHED,SOCIETY,TEC,TECS,THESE,VERAPAMIL
2014,BMJ,EARLY,GROUP,LTD,MALIGNANCY,PUBLISHING
131,169,177,2014,215,24HR,330,669,BBS,BBS7,BECAUSE,BMAX,COPYRIGHT,DOTA,GRPR,HIGH,INC,LABEL,LYS,METHODS,PRRT,RESULTS,TREATMENT,UNLABELLED
169,2014,AWARENESS,COPYRIGHT,IRELAND,LTD,NORTH,PRIORITIES,RADIATION,SABR
169,2014,2R4F,BLY,BOTH,COMPARING,COPYRIGHT,GMBH,GVP,H292,HMOX1,HOWEVER,HSP70,NCI,NRF2,REFERENCE,TPM
0MONTHS,169,2014,5MG,65MG,66GY,7DAYS,9MONTHS,CCRT,COPYRIGHT,FIFTY,III,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OVERALL,PFS,PRIMARY,PURPOSE,RESULTS
001,169,2014,BACKGROUND,CARDIAC,COPYRIGHT,DIBH,IRELAND,LABEL,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,WBI
169,2014,COPD,COPYRIGHT,GMBH,HOWEVER,MMP1,MMP1A,MMP1B,THESE,USING
106,2009,243,4108,946,BACKGROUND,BASED,CCL5,CELLS,CG200,DLS,H1N1,IFIT2,IFIT3,INF,LABEL,METHODS,RESULTS,SAEC,SG65,SG76,SLS,SMALL,ST3GAL4,ST6GAL1,SWCNT,THESE
169,2014,23A,CISPLATIN,COPYRIGHT,FIVE,IMIDAZO,KINASES,MOST,SAS
169,2015,COPYRIGHT,FURTHER,HOWEVER,INC,LOBECTOMY,NSCLC,PUBLISHED,SOCIETY
104,169,18F,2000,2011,2015,BACKGROUND,COPYRIGHT,FDG,IIA,IIB,INC,LABEL,METHODS,NSCLC,PET,PUBLISHED,RESULTS,SOCIETY,T1A,T1B,T2A,T2B,THERE
001,169,1701,177,2014,493,ASSOCIATES,BACKGROUND,CONCLUSION,COPYRIGHT,EACH,LABEL,LTD,METHODS,OPTIMIZING,PUBLISHED,RESULTS,THERE,THEREFORE,THESE,USING
10MG,169,2014,2DAYS,945,97L,BERBERINE,CONSISTENT,COPYRIGHT,HCC,HIF,MHCC,STRIKINGLY,USING,VEGF
100,169,2014,ALPPS,ASSOCIATES,BACKGROUND,BILIARY,COPYRIGHT,CRLM,DISCRETION,DISCUSSION,FLR,HEPATIC,HOWEVER,ISS,LABEL,LTD,MATERIALS,METHODS,PEER,PUBLISHED,PVL,PVO,RESULTS
169,2014,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,LABEL,PUBLISHED,RENAL,RESULTS,SAS,SPLF
169,2014,COPYRIGHT,HOWEVER,ICU,MOST,NSCLC,PUBLISHED,SAS,SCLC,SPLF,WESTERN
169,2014,CD4,COPYRIGHT,HIV,PUBLISHED,SAS,SPLF
169,2015,8805,CONCLUSION,COPYRIGHT,DIPNECH,ELECTRONIC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS
EBUS,LUNG,REAL,TBNA
3HE,BACKGROUND,CRT,CURRENT,DISCUSSION,EVERY,III,LABEL,METHODS,MRI,NSCLC,QOL,SECONDARY,STAGE,TRIAL
1998,2006,4944,BACKGROUND,CUBA,IIIB,JANUARY,LABEL,METHODS,NCRC,NONE,NSCLC,RESULTS,THERE
CIMAVAX,MAGE,NON,NSCLC,TECETOMIDE
001,008,8201,BACKGROUND,CONCLUSION,EASTERN,ECOG,GROUP,LABEL,METHODS,RESULTS,SINCE,TEN,TREATMENT
001,008,BECAUSE,CA125II,COLORECTAL,DATA,LUNG,MEAN,OVARIAN,PLCO,SCREENING,THESE,TRIAL
956,BACKGROUND,LABEL,NMRI,RESULTS,TAKEN
BACKGROUND,DATA,KIWI,LABEL,RESULTS,TOOLBOX
10442,10869,14289,7117,945,ASIAN,BACKGROUND,CIS,HIF,HOWEVER,LABEL,METHODS,ORS,RESULTS,SCIENCE,SIMILARLY,THEREFORE,WEB
BASED,CURRENTLY,DESPITE,NGS,NON,NSCLC
ANOVA,BACKGROUND,CELLTITER,GLO,INHIBITION,LABEL,MANN,METHODS,MYC,PCR,PRKDC,PROMEGA,RESULTS,RNAI,SYNTHETIC,WESTERN,WHITNEY
1617,208,215,231,AFTER,AUNC,AUNCS,CURRENT,EGFR,H1650,MPE,PCA,PRINCIPAL,RAMAN,SERS,SOMATIC,SVM,TKIS
001,003,014,032,046,118,181,199,2007,2012,239,257,326,329,345,357,360,381,383,389,460,508,846,BACKGROUND,CHINESE,FURTHER,LABEL,METHODS,NSCLC,PEMETREXED,PROPENSITY,REAL,RESULTS
240,CONTEXT,HOWEVER,IHC,LABEL,METHODS,NEN,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SCLC,SIMILAR,SSTR,SSTR1,SSTR5,SSTRS
000,100,1977,2001,2011,258,475,681,802,BACKGROUND,CNCR,CONCLUSION,CZECH,DATA,LABEL,METHODS,POPULATION,RECORDS,RESULTS
169,2014,945,946,947,CONFIRMING,IFN,IL10,IL4,IL6,TAKEN,TAM,TGF,TNF,USING
CURRENTLY,DWI,MRI
017,025,177,181,2009,2013,350,371,ACCORDING,ANY,BACKGROUND,BIOLOGICAL,BLOOD,BOTH,CHRONIC,CONCLUSION,FIFTY,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SCLC,TNM
120,160,7721,800,956,CD34,HCC,HIF,KEEPING,MMP,MMP2,MTDH,MVD,PCNA,PRESENTLY,SMMC,SP1,STAT3,TAKEN,TUNEL,VEGF
160,A549,CCL2,CHEMOKINE,OVERALL,THUS
AFTER,CHEST,GENERALLY,GMA,PULMONARY,SEVEN,SINCE,WEGENER
947,BASIC,BATF,CD25,CD4,CTLA4,DOWNSTREAM,FOLR4,FOXP,FOXP3,ICOS,IL10,IL21,IL6R,INTRANASAL,LAG3,RAR,ROR,RORC,STAT3,TH17
100,160,169,2015,955,AUR,COPYRIGHT,DESCT,INC,LABEL,MATERIALS,METHODS,NIC,NICS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,ROC,SIXTY
169,2008,2012,2014,394,441,477,786,8201,918,AMONG,BACKGROUND,CASES,CRC,KRAS,LABEL,METHODS,NRAS,RAS,RESULTS,SOCIETY
HOX,RNAS
1GIMNSS,ATLAS,BACKGROUND,CARLO,CHAIN,HOWEVER,LABEL,LACKING,MCMC,MMSE,MONTE,MOST,OBC,POISSON,RESULTS,SEQ,SEQUENCING,TCGA,THROUGH,THUS
001,047,169,2006,2011,2014,322,437,BACKGROUND,CHINESE,CONCLUSION,COX,CRP,HOWEVER,JULY,KAILUAN,LABEL,METHODS,RESULTS
00006,004,006,009,116,8201,ANXIETY,BACKGROUND,DEPRESSION,INVENTORY,LABEL,METHODS,RESULTS,SCALE,SYMPTOM,TAIWANESE
169,2014,COPYRIGHT,INC,MYC,SCLC,SMALL,THZ1,USING
169,2014,CDK7,CELL,COPYRIGHT,INC,SCLC,SMALL,THZ1,USING
169,2014,AKT,BOTH,COPYRIGHT,HOWEVER,HSP90,INC,MSH2,MUTS,NSCLC,PI3K,THEREFORE,THESE
2010,2013,313,8201,CHANGES,CONCLUSION,GODDARD,JAPAN,KNOWLEDGE,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SBRT,STAGE,THERE,TOKYO,UNIVERSITY
ACRAL,CARCINOMA,HOWEVER,METASTASES,ORTHOPEDIC,THERE
001,049,151,178,329,8805,BACKGROUND,COX,EXTENSIVE,GROUP,HRS,LABEL,METHODS,PFS,PROGNOSTIC,RECURSIVE,RESULTS,SCLC,SOUTHWEST,SUBSEQUENT,THESE,VALIDATION
0001,009,045,049,133,143,177,189,AUC,BACKGROUND,BOTH,EFFECTIVE,ELISA,GM2,GM2AP,LABEL,METHODS,RESULTS,SERUM,THERE,USING,WESTERN
CIGARETTE,CONSISTENT,COPD,FOS,FRA,HEIGHTENED
169,183,ANTI,GEORG,HOWEVER,NSCLC,STUTTGART,VEGF,YORK
169,2014,215,956,COPYRIGHT,DATA,INC,LABEL,MET,METHODS,OBJECTIVE,OBJECTIVES,PCR,PUBLISHED,RESULTS,SERUM,SOCIETY,SPSS,TNM
169,1997,2008,2015,382,953,AUSTRALIAN,HODGKIN,LABEL,METHODS,OBJECTIVE,READERS,RESULTS,SIRS,SMRS,TYPE
088,091,092,160,169,2015,954,AUR,BECAUSE,CLOUD,COPYRIGHT,EVALUATION,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,REFERENCE,RESULTS,RIDER,SOLID,THESE,VBR
169,2003,2006,2015,929,BACKGROUND,BASE,COLLEGE,COMMISSION,COPYRIGHT,COX,DATA,DIMINISHED,INC,LABEL,METHODS,PUBLISHED,RESULTS,SEVERAL,SOCIETY
169,177,2015,946,GMBH,K562,KGAA,NCAL,VCH,WILEY
169,2015,A549,ADDITIONAL,AKT,COPYRIGHT,CYTOSCAPE,DOCK1,GEFITINIB,H1975,LOW,MOLECULAR,PAGE,PROTEIN,PROTEOMICS,SDS,SOCIETY,TRANSWELL,WESTERN
169,2010,2015,777,BRITAIN,CONTINUED,COPYRIGHT,GREAT,INC,LABEL,METHODS,OBJECTIVE,PAF,PAFS,PURPOSE,RESULTS
ELECTRONIC,FENO,FINALLY,ISI,LABEL,MATERIALS,METHODS,NON,OBJECTIVE,RESULTS,STUDIES
LABEL,MATERIALS,METHODS,OBJECTIVE,RADIATION,RESULTS
001,005,015,021,053,177,916,COPD,CTL,DATA,FEV1,FVC,GROUP,KEOWN,LABEL,MEAN,METHODS,OBJECTIVE,POPC,POPCS,RESULTS,SIMILARLY,THESE
169,2014,932A,945,AMONG,CDP,CHKA,CHOK,CHOLINE,RSM
134,947,H2AX,K134,OVERALL,SUV39H2
24H,AKT,ERK,FACS,FISH,GLC,H1184,K252A,MEK,MYC,PI3K,PROCESS,SCLC,THESE,UCN
14MONTH,169,2014,COPYRIGHT,HISTOLOGY,INC,PRIMARY,WILMS
038,045,132,169,1758,177,1805,1980,1980S,1989,1990,1999,2000,2000S,2009,2014,2064,948,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
160,190,217,793,8804,AMONG,APOA5,III,LDL,LDLR,MYOCARDIAL,PREVIOUSLY
578,AXL,BACKGROUND,EGFR,ESRP1,GREATER,HOXB4,LABEL,RESULTS
CAM,CD326,CD45,CTC,CTCS,PDT
946,ATRS,CCND1,EGF,EGFR,FINALLY,IFN,LAC,MMP2,PML
FEV,LABEL,MEANS,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
ARF,E2F1,MDM2,PERIOSTIN,STRIKINGLY,THESE
3MA,4945,ATG7,CK2,EGFR,GFP,HOWEVER,LC3,PROTEIN,RESISTANT,T790M,TKI
173,317,BRCA2,DEFECTS,PRO
0199,169,199,2014,263,ABT,BAK,BCL,BH3,COPYRIGHT,GDC,INC,MCL,MOST,RNAS,SMALL,THUS
1120,17MS,CONCRETELY,UPON
CURRENT,HOWEVER,PCA,THEREFORE,TOMOGRAPHY
002,100,169,2014,ACCORDING,COPYRIGHT,LABEL,LIBRARY,MATERIALS,MEDLINE,METHODS,NCA,NEOPLASTIC,OBJECTIVE,RESULTS,SCHOLAR,SCIENCE,WEB
169,2014,30A,A549,AEG,COPYRIGHT,GMBH,RNAS,SNAIL,THEREFORE,THESE
111,125,8805,ANTI,CONSISTENT,DELTA,DLL4,DOSE,IGG1,MAXIMAL,MV522,THESE
ANTI,LA1,VEGF

009,8209,BRAF,EGFR,EMT,H1975,HOWEVER,KIRSTEN,KRAS,L858R,NCI,NON,NSCLC,RAF,T790M,THESE,TKI,TKIS
145,8209,946,A549,EMT,OCT4,WNT,WNT3A
BLP25,CD4,CD8,III,TECEMOTIDE,TH1,TREATMENT,TREG
ADDITIONAL,III,IIIA,IIIB,MUC1,NSCLC,PHASE,TAA
5T4,CURRENTLY,DESPITE,KRAS,MVA,THERE

A2B1,HSC,LDHA,LUNG,PKM2,THEREFORE
181,211H,BECAUSE,H2052,IC50S,MALIGNANT,MET,MPM,MSTO
115,218,333,ABO,BACKGROUND,CEA,LABEL,METHODS,NSCLC,RESULTS,STUDIES
CDK,CHIP,CIP1,HDAC1,HOWEVER,MICROARRAY,NSCLC,SP1,STRAP,THESE,USING
945,CONSISTENT,EVEROLIMUS,GLUT,HIF,VEGF
309T,444,461,461C,ADVERSE,MDM2,NSCLC,PCR,RFLP,SNPS,THIRD
013,HMPL,PHASE,VEGF,VEGFR
004,011,040,045,114,131,142,466,8209,ANGPTL2,ANGPTL5,ANGPTLS,ILT4,NSCLC,THEREFORE,UPON
950,A549,HAIYPRH,IC50,PEG,PTX,TAT
587,731,8209,936,EGFR,LNCRNAS,NSCLC,RNAS,SEVERAL,SIX,TKIS
SOLID,VOCS
1037,1294,169,2014,946,COPYRIGHT,EGF,EGFR,ELK,INC,MAPK,MEK,RAS,SMAD3,TGF,U0126
AKT,IGFBP,NSCLC,PI3K
AKT,BRAIN,HOWEVER,MAPK,MOST,MST1,OTHER,RAF,RASSF,RASSF1A,THUS,V600E
712,954,A549,CDK,CKD,G2M,MMP,TAKEN,THI,VEGF
169,1998,2007,2014,231,397,944,COLLEGE,COPYRIGHT,LTD,ONTARIO,OVERALL,PALLIATIVE,PRT,PUBLISHED,ROYAL
169,2007,2012,2015,8805,ACUTE,CONCLUSION,COPYRIGHT,EASTERN,FIFTY,GROUP,HYPOTRT,INC,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC
169,2015,AUR,CONSENSUS,COPYRIGHT,CTP,DCE,HILL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PERFUSION,PUBLISHED,RATIONALE,RESULTS,ROI,ROIS,TCC,TCCS
001,004,018,126,160,8201,8805,FINALLY,HOWEVER,PCR,RNAS,USING
169,2014,AKT,ANTI,BASED,BESIDES,CELL,COPYRIGHT,ERK1,HUVEC,INC,INVERSELY,K20E,LLC1,MEK1,VECS,VEGF,VEGFR
0001,125,130,151,169,2014,255,AIS,APA,ATS,CONCLUSION,COPYRIGHT,COX,ERS,FDG,IASLC,IIA,IIB,IIIA,IMA,IRELAND,LABEL,LPA,LTD,MATERIALS,MEIER,METHODS,MIA,MPA,MPP,OBJECTIVE,OBJECTIVES,OVERALL,PET,PPA,RESULTS,SPA,THEREFORE
8201,BACKGROUND,FOLLOWING,HOWEVER,LABEL,METHODS,RESULTS,SABR
169,2015,COPYRIGHT,CTLA4,INC
CELL,CONCLUSION,DOWN,H1299,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,UBB,UBC,WESTERN
181,CHROMATIN,COX,INHIBITION,NSCLC,RFPL3,THESE,UNIVARIATE
169,2014,BACKGROUND,CODE,CONCLUSION,CONSORTIUM,CONTACT,FEDERATION,FINDING,HOWEVER,IMMUNOLOGY,LABEL,METHODS,MOTIVATION,PRESS,PROJECT,PUBLISHED,RESULTS,SOCIETIES,UNIVERSITY
136,169,2010,2011,2012,2014,8804,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,PRESS,PROVISION,PUBLISHED,RECEIPT,RESULTS,SOCIETY,STAGE,UNIVERSITY
018,029,033,046,067,069,079,169,2014,375,436,461,973,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
008,049,169,2014,516A,CXCR2,HOWEVER,IL8,MAPK,ORTT,SNP,SNPS,THUS,USING,UTR
790,945,A549,BEAS,CAD,CCK,EMT,ERR,MCF,PCR,SILENCING,SLUG,SNAIL,TARGETING,TRANSWELL,TWIST,VIM,WESTERN,XCT,ZEB1
10877,169,2014,239,CONCLUSION,COPYRIGHT,CTC,CTCAE,DOSE,EFFECTS,FATIGUE,FOUR,GRADE,III,LABEL,LTD,METHODS,MGN1703,OBJECTIVE,PURPOSE,RESULTS,SAE,SIX,THERE,TLR9,TWICE
A549,ACTIVATION,BACKGROUND,BAX,BID,DSBS,INDIVIDUAL,LABEL,METHODS,MMP,RESULTS,SSBS,THESE,U87MG
EXPRESSION,HOWEVER,PCR,RNAS,SMALL
0001,001,106,160,177,8201,ELISA,MEIER,NSCLC,TNM,UNIVARIATE,USING
007,016,022,169,2014,20MM,8805,CONCLUSION,COPYRIGHT,DIFFUSE,FIFTEEN,FOUR,IIA,IIB,IIIA,IIIB,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM,USING,ZEB1
8320,8325,A549,A750,ABCG2,AKT,BCRP,DELE747,EGFR,FINALLY,G12S,H1650,H292,KO143,MDR,PI3K,RAS,REMARKABLY,THESE,WHILE
189,2835,896,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SWEDISH,THERE,WORKERS
279,ANIMALS,BACKGROUND,CONCLUSION,E26,ERG,ETS,ETV1,EXPRESSION,GLYATL2,INHIBITION,LABEL,LNCAP,METHODS,MMP7,RESULTS,SCID,THEREFORE
169,2014,CONCLUSION,COPYRIGHT,DISCS,DLG5,HOWEVER,INC,KNOCKDOWN,LABEL,MEIER,THESE,UNLABELLED
954,BELGIAN,CAD,COHEN,DUTCH,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
8211,BACKGROUND,CONCLUSION,LABEL,LUME,LUNG,METHODS,NINE,NINTEDANIB,RESULTS
183,2009,2014,8764,BACKGROUND,CASE,CONCLUSION,GEORG,LABEL,METHODS,MINIMALLY,MIS,RESULTS,STUTTGART,WILMS,YORK
169,2014,946,ANXA2,CONVERSELY,H3K9,KMT1E,RESTORING,SMAD2,TGF
169,2014,AZD9291,EGFR,FOUR,METASTATIC,T790M,TKIS,USING
008,010,042,169,2006,2013,2014,AGGRESSIVE,BACKGROUND,COPYRIGHT,DFS,HOWEVER,LABEL,LRFS,LRRC,LTD,METHODS,OCTOBER,PREVENTING,RECURRENCE,RESULTS,SACRECTOMY,STUDIED,THREE
169,2015,6014,ADULT,COPYRIGHT,LOSS,LOY,MEN,SCIENCE,SENIORS,TOBACCO,UPPSALA
109,160,169,2014,AUNP,AUNPS,COPYRIGHT,DESPITE,LTD,MRC5,NPS,SAECS,SILAC,THERE
0236,169,2014,RTOG,UPDATED
169,2014,BRAF,HER2,WHILE
A549,CELL,DEPLETION,HOWEVER,INHIBITION,MODULATION,NSCLC,PDCD4,REDUCED,WESTERN
EMT,NOTCH,NSCLC,THROUGH
018,120,150,169,177,2007,2014,BETWEEN,BOTH,JULY,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RATS,RESULTS,SEVENTY,SURGERY,UNIVERSITY,VATS
145,169,182,2012,2013,2014,FOUR,LABEL,LOBECTOMY,MALIGNANT,MARCH,MAY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY,VATS
115,169,2014,9933,9999,COPYRIGHT,FINALLY,SATISFIED,TEST,UNDER
169,2014,231,945,946,954,A549,CHINESE,COPYRIGHT,ECM,FINALLY,HEP1,IRELAND,LTD,MCF,MDA,MMP,MORUS,MORUSIN,STAT3,THESE
231,BACKGROUND,CK5,EWD8,FOUR,LABEL,LUMINAL,MCF,MDA,METASTATIC,METHODS,RESULTS,SIMILAR,THEIR,WHILE
BACKGROUND,CURRENT,DESIRABLE,LABEL,OVERALL,RESULTS
8201,8804,8805,C30,EASTERN,ECOG,ELD14,EORTC,GROUP,HRQOL,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,QLQ,RESULTS,SIX,UICC,UNION
153,169,2014,COPYRIGHT,FURTHER,HOWEVER,INC,KNOCKDOWN,LUCIFERASE,MIR,NSCLC,PCR,TAKEN,USING,UTR
169,2015,3270,6780,COPYRIGHT,INC,UNREPORTED
1970,1970S,1980S,1988,1990S,2011,3187,4220,AUSTRALIA,CHINA,GDP,INDUSTRIAL,ITALIAN,ITALY,JOURNAL,SIX
2000,2004,2009,500,523,888,AAA,BACKGROUND,CENTRAL,EMR,EMRS,ESTIMATES,GEISINGER,JANUARY,KNOWN,LABEL,METHODS,PERIPHERAL,RESULTS,SIMILARLY,USING,VARIABLES
169,2015,COPYRIGHT,INC,INCREASING,IRS
169,2014,600,8764,COPYRIGHT,EXPOSED,NO2,PAHS,PUBLISHED,STUDIES,THESE,TODAY
ALA119SER,ASN453SER,CAUCASIANS,LEU432VAL
169,2015,BONE,COPYRIGHT,INC
DIAGNOSIS,EWSR1,PNET,PNETS,PRIMARY
169,178,2011,2012,2014,AIM,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,DATA,DESPITE,IMPROVING,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PATIENT,RESULTS,THERE,THESE
0001,001,002,006,169,2015,947,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS

AFTER,CK7,DIAGNOSIS,FDG,LUNG,NKX2,PET,TTF
FGFR,FLT,III,IPF,NINTEDANIB,NSCLC,PDGFR,SRC,VEGFR
8594,A549,AKT,CELL,EGFR,ERK,HRM,IGF,INDEX,LABEL,MECHANISM,METHODS,MTT,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,TKIS
A549,CONVERSELY,FURTHER,H460,NSCLC,PDX,PRIMING,TAKEN,THERE,USING
CTCS,NEXT,TP53
OHP
AFTER,CHB,HBIG,HCC,HOWEVER,THESE
001,085,169,2001,2007,2009,2014,327,389,8201,AMONG,CUMULATIVE,END,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,USING,VALIDATED
122,CCNG1,HOWEVER,MEF2D,OLEANOLIC,RESTORING
945,946,947,A549,BACKGROUND,LABEL,METHODS,NUCLEAR,RESULTS
177,8201,EPID,IMRT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TPS
1050,750,AUC,CAD,FALSE,MACHINE,ROC,SUPPORT,SVM,SVMFEATURE,THREE
121,177,2010,2012,3250,8201,BACKGROUND,DEPARTMENT,EARLY,INCOMPLETE,LABEL,MARCH,METHODS,RADIATION,RESULTS
001,055,068,118,2014,254,8201,BACKGROUND,CITY,CRCL,HIGH,LABEL,MAY,METHODS,OSAKA,REGISTERED,RENAL,RESULTS,SERUM,THERE,TRIAL,UNIVERSITY
CAUCASIANS,HENCE,OVERALL
2008,2013,UNIVERSITY,WARTHIN
ALTO,CARLO,CTV,DAO,ECLIPSE,FINALLY,FURTHER,HOWEVER,LABEL,MEDICAL,MERT,METHODS,MONTE,OAR,OARS,OBJECTIVE,PALO,PLAN,PTV,PURPOSE,REGARDING,RESULTS,SMCP,SWISS,SYSTEMS,THEN,THESE,TPS
177,250,300,COLLECTION,HOWEVER,LABEL,METHODS,OBJECTIVE,PRECISE,PURPOSE,RESULTS,SIMILAR
4DCT,BEV,DRR,DRRS,EOE,EPID,GTV,HOUNSFIELD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,THROUGH,USING
169,2014,8201,919,ABSTRACTS,AES,ALSO,ASCO,CENTRAL,CONTROLLED,EFGR,EGFR,ESMO,HOWEVER,INCREASED,MEDLINE,NSCLC,RCTS,TREATMENT,UICC,VEGF
169,2014,945,946,BASED,CD34,CSF,HUVEC,PRE,TNF,UICC
EXTENSIVE,FIVE,HPF,IGE,IGG,IGG4,LABEL,MAXVISION,METHODS,MULTI,OBJECTIVE,OTHER,RESULTS
CONCLUSION,DOWN,H69,H69AR,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SALL4,SCLC,WESTERN
005,105,178,2012,2013,877,967,AG85B,BEIJING,CAPITAL,CHEST,CONCLUSION,IHC,JANUARY,JULY,LABEL,MEDICAL,METHODS,NEELSEN,OBJECTIVE,RESULTS,UNIVERSITY,ZIEHL
2012,AFRICAN,ASIAN,BACKGROUND,CAUCASIAN,III,LABEL,METHODS,NINE,RESULTS,WHILE
169,2014,AMONG,BACKGROUND,BASEL,LABEL,METHODS,RESULTS,TEN,THERE,URACHAL
LUNG,RNAS,THEREFORE,THUS
010,015,018,032,059,380,461,502,519,589,649,684,688,697,912,914,969,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,RFS
HER2,HOWEVER,III,MBC,PHASE
001,1014,250,343,500,ALK,BACKGROUND,CRIZOTINIB,CROSSOVER,LABEL,METHODS,NSCLC,OBJECTIVE,PROFILE,RESULTS
4DCT,8201,CONCLUSION,GREATER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PEAK,RESULTS,SCAN
177,60CO,947,956,A549,HOWEVER,IC50
231,A549,BAD,BAK,BAX,BCL,FADU,GAS,HEP,LNCAP,MDA,OVERALL,RL95,SOE,TREATMENT
039,160,169,2014,AUTHORS,BRAF,DFS,EGFR,FGFR1,HOWEVER,JOHN,KRAS,LTD,MEK1,MET,NRAS,NSCLC,PATIENT,PDX,PTEN,SONS,WILEY
169,2014,945,946,BRITAIN,COPYRIGHT,GREAT,IRELAND,JOHN,LTD,MMP2,MMPS,OVERALL,PCR,PLACING,PUBLISHED,SOCIETY,SONS,TGF,THUS,WILEY
001,005,016,024,160,169,17A,2014,330,382,420A,73G,73GA,73GG,APMIS,FURTHER,HOWEVER,JOHN,LTD,LUNG,NSCLC,PUBLISHED,SONS,WILEY
001,002,2578C,460C,460TT,BACKGROUND,BASED,CAUCASIANS,HOWEVER,LABEL,METHODS,RESULTS,SIMILAR,SNPS,THESE,VEGF
169,1990,2012,2014,CONCLUSION,COPYRIGHT,EATON,EQUAL,FOUR,INC,JANUARY,LABEL,LAMBERT,LEMS,MAIN,MAJOR,METHODS,OBJECTIVE,RESULTS,SETTING
169,2014,BECAUSE,COPYRIGHT,MOST,NSLCC,PUBLISHED,THROUGH
ADVANCE,HELPING,HIGH,THERE,WHILE
1055,1275,146,169,2014,ADC,ADCS,AMONGST,BACKGROUND,COPYRIGHT,HER2,HIGH,IRELAND,LABEL,LTD,METHODS,RESULTS
120,132,140,145,169,177,200,2014,364,COPYRIGHT,EGFR,FINALLY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SUCCESSFUL
169,2014,ACTIVATION,CAR,COPYRIGHT,CTL,IRELAND,LTD,RECOVERIN,SCLC,SUBSEQUENT
011,050,169,2014,236,250,946,AMONG,CONCLUSION,COPYRIGHT,COX,DFS,DPD,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OPRT,PCR,RESULTS
001,039,169,2007,2010,2014,CIR,COMPETING,CONCLUSION,COPYRIGHT,CRT,FDG,III,IRELAND,LABEL,LOW,LTD,METHODS,MTV,MTV_LES,MTV_PAT,NSCLC,OBJECTIVE,PATIENT,PET,PFS,POST,PRE,PURPOSE,RESULTS,SELECTIVE,SUV,SUVMAX_PAT,USING
169,2014,BAP1,BRCA1,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MPM,OBJECTIVE,RESULTS
110,169,2014,COPYRIGHT,HOWEVER,INCREASED,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,ROMO1
169,2015,ALK,COPYRIGHT,CTC,EGFR,EML4,HER2,INC,PREDICTIVE,PROGNOSTIC,THESE
169,2014,COPYRIGHT,INC,MEANWHILE,PUBLISHED,SOCIETY
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY,SVC,WHILE
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2014,COPYRIGHT,FETAL,INC,PUBLISHED,SOCIETY
001,169,2012,2013,2014,CAIRO,COMBINING,CONCLUSION,COPYRIGHT,DOPPLER,EGYPT,FEDERATION,FLV,FLVS,GYNECOLOGY,IRELAND,JANUARY,JULY,LABEL,LTD,METHODS,OBJECTIVE,OBSTETRICS,PUBLISHED,RDS,RESULTS,RIS
160,169,2015,ALK,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,ERBB2,FISH,HER2,IHC,INC,KRAS,LABEL,MATERIALS,METHODS,PCR,PUBLISHED,RESULTS,RET,ROS1
160,169,2007,2013,2015,8805,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,III,IMRT,INC,INTENSITY,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SIB
0501,131,169,177,2015,231,233,BACKGROUND,CANC,CAV,CONCLUSION,COPYRIGHT,FRAN,INC,LABEL,METHODS,PFS,RESULTS
000,169,183,1995,2005,2009,2015,279,AGAINST,AMERICA,ASIA,ATLANTA,AUSTRALIA,BACKGROUND,BELFAST,BERN,CENTERS,CONTINUOUS,CONTROL,COPYRIGHT,DEC,DISEASE,ECUADOR,ESTIMATES,FOCUS,FUNDING,INDIVIDUAL,INSTITUTE,IRELAND,JAPAN,KOREA,LABEL,LEXINGTON,LIVER,LTD,METHODS,NORTH,OPEN,PREVENTION,PUBLISHED,RESULTS,RICO,SOUTH,SWISS,TORONTO,UNIVERSITY,USA,WALES,WORLDWIDE
1000,109,169,2014,8201,956,A549,COPYRIGHT,FINALLY,HPLC,PTERIDINES,QTOF,QUANTIFIED,RSD,WHILE
100,169,2015,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,UPRIGHT
10C,169,2014,231,946,A549,AKT,AMONG,BCL,COPYRIGHT,COX,ERK,H1299,LTD,MCF,MDA,MMP,MRC
169,2014,COPYRIGHT,LTD,MALIGNANT,MOST,MPM,PROGNOSIS
169,2014,COLLEGE,COPYRIGHT,FURTHER,HENCE,HOWEVER,LTD,LUNG,MODELLING,PATIENT,POPULATION,PUBLISHED,ROYAL,WHITE
112,129,142,160,184,2012,284,INITIAL,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROBOTIC,SEPTEMBER,THERE
128,169,177,1793,2010,2014,210,BACKGROUND,CBCT,COPYRIGHT,IRELAND,ITAC,ITACS,LABEL,LIGHT,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TRAFFIC,TYPES
127,169,2015,A549,AFTER,COPYRIGHT,COX,EXPRESSION,GLC,H358,HOWEVER,INC,LAK,MEIER,PBK,PDZ,THEREFORE,TNM,TOPK,WESTERN
169,2004,2011,2014,AUTHORS,BELGIAN,BELGIUM,COPYRIGHT,HOWEVER,INCIDENCE,LTD,POISSON,PUBLISHED,THESE,WORLD
169,2014,BRAF,COPYRIGHT,IRELAND,LTD,NSCLC
012,026,101,155,169,2014,221,BACKGROUND,COPYRIGHT,CRT,HIGH,HOWEVER,IIIB,IRELAND,LABEL,LTD,METHODS,MICRORNAS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,RIET,RNAS,V50
0001,0008,169,183,198,2014,3365,APRIL,BACKGROUND,CENTRAL,CONTROLLED,COPYRIGHT,FUNDING,INDIVIDUAL,LABEL,LTD,LUNG,MEDLINE,METHODS,NONE,OVERALL,RESULTS,SCIENCE,SOCIETY,WEB
100,239,4EBP1,AKT,ALK1,BACKGROUND,BRAF,CELL,EGFR,KRAS,LABEL,LUNG,METHODS,NON,NSCLC,P7170,RESULTS,SMALL,THEREFORE
169,2014,969,A549,COPYRIGHT,LTD,THESE
169,2014,A549,CARB,COPYRIGHT,DIVERSE,FCP,HELA,LOVO,LTD,MCF
002,006,169,188,2014,398,BACKGROUND,BROAD,CHALLENGE,CHIP,CONCLUSION,COX,CREB,CRTC1,INSTITUTE,LABEL,LKB1,MAP,METHODS,PGE,PGE2,PRESS,PUBLISHED,RESULTS,SOMATIC,TCGA,THESE,UNIVERSITY
169,2014,ARB,ARBS,BASED,COPYRIGHT,DESPITE,FDA,HOWEVER,IRELAND,LTD,PUBLISHED
169,2014,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS
048,105,169,183,2010,2012,2014,BACKGROUND,BETWEEN,CHRONIC,COPYRIGHT,DISEASE,FUNDING,HIGGINSON,INSTITUTE,LABEL,MASTERY,METHODS,NIHR,OCT,OPEN,PUBLISHED,RESULTS,SEPT,SOUTH,UNIT
METASTATIC,PITUITARY,PROGNOSIS
5000,BECAUSE,COLLEGE,LUNG,ROYAL,TREATMENT
169,2015,954,BECAUSE,COPYRIGHT,EXTRACTED,INC,LVSE,SGP40,SGP65,SGPS,THESE,TREATMENT
231,4T1,BESIDES,CE6,CHLORIN,FURTHER,MCF,MDA,MMP,MTT,NAC,PDT,PROPIDIUM,ROS,SDT,SONO,SPDT,THESE,TUNEL,VEGF
169,177,2014,ADDITIONAL,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SELF,SOT
2012,26TH,7TH,BASED,FIVE,JULY,MODEL,RESILIENCY
BECAUSE,DTC,LUNG,THEREFORE
169,2014,24H,A549,AKR,AKR1B10,COPYRIGHT,ERK,HOWEVER,IRELAND,JUN,LTD,MAP,MEK1,THESE,TPA,U0126
10001,1966,333,APART,DESPITE,MEDICAL,PERFORMING,PUBLISHERS,SEVENTH,THESE,USA,YORK
10001,333,DESPITE,MEDICAL,PERIPHERAL,PUBLISHERS,SEVENTH,USA,VIRTUAL,WHILE,YORK
10001,333,BECAUSE,EBUS,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,USA,YORK
169,2015,COPYRIGHT,FURTHER,H202,H460,HOWEVER,ISSUE,KNOCKDOWN,MEDICAL,PCR,PROTEOMIC,PROTEOMICS,PUBLISHED,ROS,SPECIAL,STC2,THESE,WESTERN
116,169,2014,460,549,COMPOUNDS,COPYRIGHT,EGFR,HCT,INC,MOLECULAR,SAR
160,169,2014,33258,803,BAX,BCL,COPYRIGHT,DHA,H460,HELA,HOECHST,MGC,MTT,NCI,ROS,SAS,TUNEL
0118,160,169,177,2014,CALIXARENE,COPYRIGHT,FOLLOWING,HPLC,HUVEC,MA148,PEG3,SAS,STILL,WHILE
145,160,169,2014,956,A549,AKT,ALSO,AMONG,CELL,COPYRIGHT,FIVE,FURTHER,HELA,HEPG2,HOECHST,IC50,MCF,PKB,SAS
169,2014,ATP,AUTHORS,CELL,COPYRIGHT,CYS,DIMINISHED,DRP1,FOXM1,PRX3,PUBLISHED,USING
001,404,425,BACKGROUND,DEPARTMENT,ENGLAND,LABEL,METHODS,MOST,RESULTS
BACKGROUND,DEPENDING,HOWEVER,INCREASED,LABEL,LEAD,MEAN,METHODS,RESULTS,SLT,SYMPTOM,THESE,TIME,TIMES
160,169,2015,239,446,ACADEMY,ASSESSMENT,BACKGROUND,CACS,CHRONIC,CONCLUSION,CONTEXT,COPYRIGHT,EASTERN,FACT,FATIGUE,FUNCTIONAL,GENERAL,GROUP,HOSPICE,ILLNESS,INC,KARNOFSKY,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,QOL,RESULTS,THERAPY,VISIT
130,169,2015,AGA,AIMS,BACKGROUND,COPYRIGHT,EMAST,EXPRESSION,IL6,IL6R,INC,INCUBATION,INSTITUTE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,STAT3
169,170,2014,ALK,BASED,COMPOUNDS,COPYRIGHT,IC50,KIST301072,ROS1,SAS
169,2015,A549,COPYRIGHT,INC,LABEL,THESE,UNASSIGNED,UNLABELLED
001,0151,100TH,143,184,255,291,30TH,327,452,65TH,711,754,8805,963,BACKGROUND,COLORECTAL,CURRENTLY,CXR,EDITORS,FORCE,LABEL,LUNG,METHODS,NLST,NONE,OVARIAN,PLCO,PPV,PPVS,PREVENTIVE,RESULTS,RISKS,SCREENING,SMOKERS,SUMMARY,TASK,TRIAL
169,1PM,2014,2573,AUNPS,COPYRIGHT,EGFR,MOST,NEANA,THEN
169,2014,AHRR,ASSESSMENT,BEAS,COPYRIGHT,H2AX,INC,INORGANIC,LEBANON,PM2,URBAN,USING
945,956,A549,AFTER,BCL,HIF,THESE,VEGF
175,18F,2012,459,960,CELL,CENTERS,CHINA,CHINESE,CNY,CONCLUSION,DATA,FOUR,GDP,GUIDELINES,LABEL,LIFE,LUNG,METHODS,MODEL,NCCN,NON,NSCLC,OBJECTIVE,PET,RESULTS,ROBUSTNESS,SMALL
169,2014,552,COPYRIGHT,GAB,GAB1,INC,MAP,MAPK,PI3,PI3K,PIP3,PLC,PREVIOUSLY,RHO
169,2014,8805,COPYRIGHT,FEW,HOWEVER,IRELAND,LTD,PUBLISHED,RDI,STUDIES
169,2014,COPYRIGHT,CROWN,CTC,CTCS,FURTHER,IRELAND,LTD,ONGOING,PUBLISHED,THERE
000H,140,169,2014,CARLO,COPYRIGHT,CPU,GATE,IRELAND,LTD,MONTE,NCAT,PET
169,2014,COPYRIGHT,LUNG,SAS
169,2014,ASIAN,BMI,CAUCASIAN,COPYRIGHT,HCC,HIGH,LIBRARY,SAS,STUDIES
169,2014,COPYRIGHT,FOLLOWING,HOWEVER,LTD,THEREFORE,WHILE
001,015,029,160,169,2000,2005,2012,2015,ACT,AMENDMENTS,ARIZONA,ASSESSMENT,BACKGROUND,BECAUSE,CENTERS,CONCLUSION,CONTROL,COPYRIGHT,DATA,DISEASE,EDUCATION,HIGH,INC,LABEL,LOW,LUNG,MATERIALS,METHODS,PREVENTION,PROGRAM,RADIATION,RESEP,RESULTS,SCREENING,SOCIETY,THESE,TOBACCO,TOTAL,UTAH,VARIATIONS,YET
169,2015,ALK,COPYRIGHT,III,INC
160,169,2015,500,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTEEN,INC,LABEL,METHODS,NSCLC,PFS,RESULTS
169,2014,945,946,99M,COPYRIGHT,CURRENTLY,EC145,EC20,FOLIC,LTD,PHASE,THEREFORE,VINCA
169,2014,ASIA,AUTHORS,AUTOPHAGY,BECLIN1,BEV,C26,HSA,JNK1,LTD,PTY,PUBLISHING,SCIENCE,SIMILAR,SNO,THEREFORE,WILEY
112,146,169,2015,COPYRIGHT,CTNB,CTNBS,INC
169,2014,BESIDES,COPYRIGHT,MEANS,RIGHT,SAS,TDM,THUS,TNM
001,024,113,169,1989,2010,2014,967,ANTIFUNGAL,BACKGROUND,CONCLUSION,COPYRIGHT,FIVE,JANUARY,LABEL,METHODS,RESULTS,SAS
100,169,2014,8764,A549,COPYRIGHT,PLGA,PTX,TENPS,TPGS,VITAMIN
169,177,2014,334,604,946,956,A549,BESIDES,COPYRIGHT,DSBS,GI50,HENCE,IETD,SAS,SSBS,THESE,U87MG
A549,APPROACHES,MA148,MSCS,NANO,POOR,PUBLISHED,THESE
039,169,2014,467,8805,ASIAN,BACKGROUND,C216T,C228A,C228T,C229G,C250T,C295T,COPYRIGHT,EAST,EGFR,G233C,G267C,IHC,IRELAND,KRAS,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,RFS,TERT,TNM
169,2014,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,EMT,H1688,H69,H69AR,IRELAND,JAK3,LABEL,LTD,MATERIALS,METHODS,NICD,NOTCH,OBJECTIVE,RAG2,RESULTS,SBC3,SCLC
500,ALPHA,BETA,COMPARING,CONCLUSION,COX,DBP,HRS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PREVENTION,PUBLISHED,RESULTS,SERUM,THERE,TOCOPHEROL,VITAMIN
169,2014,AKT,ASIA,AUTHORS,ERK,HOWEVER,LTD,METASTASIS,PI3K,PTY,PUBLISHING,RAF,RAS,SCIENCE,SLUG,TREATMENT,WILEY
169,2014,A549,ABC,ANNEXIN,BACKGROUND,CACO,COPYRIGHT,DCM,DNR,FURTHER,HELA,INDIA,IRELAND,LABEL,LESS,LTD,MATERIALS,MCF,MDR,METHODS,PET,RELEVANCE,RESULTS,SIMILARLY,SRB,THUS
169,2014,COPYRIGHT,HOWEVER,LATE,LTD
100,169,183,2009,2011,2014,8805,APRIL,BACKGROUND,BETWEEN,COPYRIGHT,EGFR,EVALUATION,FUNDING,HOWEVER,LABEL,LTD,MARCH,METHODS,RESULTS,SOLID
169,2014,COPYRIGHT,FOURIER,FRDS,LTD
169,2014,ALK,AUTHORS,CAS9,COPYRIGHT,EML4,GEMMS,GENERATION,GENOMIC,INC,PUBLISHED
001,100,143,169,177,2014,217,BACKGROUND,COPYRIGHT,FDG,LABEL,LTD,MATERIALS,METHODS,PET,PUBLISHED,REGARDING,RESULTS,SUV,THROMBOSIS,VTE
100,169,1995,2012,2015,BACKGROUND,CANDIDA,COPYRIGHT,COX,DELAYED,GROUP,HEART,IFD,INC,LABEL,LUNG,METHODS,MYCOSES,OKT3,PERI,PUBLISHED,RESULTS,SOCIETY,THERE,THREE,TREATMENT
1MET,8211,8216,8217,ANTI,BECAUSE,HOWEVER,MDM2,MDM4,OTHER,PRESENTLY,PRIMA,THESE,TP53
169,2015,ACR,COLLEGE,COPYRIGHT,FORCE,INC,LUNG,NETWORK,PREVENTIVE,PUBLISHED,RADIOLOGY,RADS,SCREENING,TASK
001,0014,005,110,134,160,169,177,1993,2010,2014,340,450,8805,COPYRIGHT,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,946,CACO,CAV3,COPYRIGHT,FEDERATION,FINALLY,IKB,IKK,LARGE,MCF,MLL,PC3,PKC,PUBLISHED,RAPID,SOCIETIES,SW620,TARGETING
169,1984,2014,215,956,AIR,BOARD,CALIFORNIA,COMMISSION,COMMITTEE,COMPANY,COPYRIGHT,DESPITE,DUTCH,EPA,GIVEN,INTEGRATED,IUR,IURS,LTD,MONTANA,PROTECTION,QUALITY,RESOURCES,RISK,SINCE,TEXAS,USING,WASHINGTON
130,138,147,169,1932,1993,2000,2011,2014,AMONG,BASED,BRONI,COPYRIGHT,FEW,ITALIAN,LTD,STRADELLA
003,1120,149,169,177,2014,284,3181,4010,433,8805,915,ADVERSE,AGE,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,MEAN,METHODS,MHD,MLD,OBJECTIVE,OBJECTIVES,PORT,PTV,RESULTS,V20
019,048,169,2010,2013,2014,CONCERNING,COPD,COPYRIGHT,DIFFERENT,EACH,EGFR,IRELAND,KRAS,LABEL,LTD,MATERIALS,METHODS,MIB1,OBJECTIVE,OBJECTIVES,RESULTS
169,1ST,2013,2014,468,762,BACKGROUND,COPYRIGHT,DESPITE,FIVE,HOWEVER,IRELAND,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,RRS,THERE
169,2014,COPYRIGHT,LCMS,NLLGLIEAK,PEPTIDE,ULTIMATELY
169,2014,COPYRIGHT,IMPORTANT,INC
001,1029,160,169,2015,433,740,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,EGFR,ELECTRONIC,HOWEVER,INC,LABEL,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,SMOKING,TKI,TKIS
169,2015,CONTINUED,COPYRIGHT,INC
100,169,2014,231,8764,COPYRIGHT,DPB,FRET,LTD,MDA,PEG,PEGYLATION,RESULTS,THESE
002,169,183,2014,292,AMONG,CLINICO,COPYRIGHT,EGFR,GPA,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,WHILE
0001,169,1998,2011,2014,617,727,8804,ADVANCE,COPYRIGHT,EVTE,III,IRELAND,LABEL,LATE,LTD,LVTE,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCLC,STAGE,VTE
001,005,014,126,169,193,2003,2009,2014,339,ACCORDING,BETWEEN,BMFS,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PCI,RESULTS,SCLC
113,169,2014,A750,BACKGROUND,BRAF,CD56,COPYRIGHT,D102Y,D990N,EGFR,FIVE,IRELAND,ITALIAN,KIT,KRAS,L858R,LABEL,LTD,MATERIALS,MET,METHODS,OVERALL,R988C,RESULTS,SAMPLES,SCLC,TARGETABLE,THEIR,TTF
169,2014,801,ADC,ADCS,BACKGROUND,CK19,COPYRIGHT,CTS,EXPRESSION,IRELAND,LABEL,LCC,LCCS,LCNEC,LTD,METHODS,MOST,NSCLC,OSNA,PCS,RESULTS,SCC,SCCS,SQC,SQCS,THESE,TMAS
169,2014,945,A549,COPYRIGHT,HELA,LTD,MCF,NATURAL,PALLADIUM,SCREENING
177,8320,8325,946,956,A549,BASED,EG5,HELA,HR22C16,MCF,ME180,MOLECULAR,MTT,THESE
169,2014,25MG,AMONG,BACKGROUND,COPYRIGHT,ENDPOINTS,IIIB,IRELAND,LABEL,LTD,MEANWHILE,METHODS,NSCLC,RESULTS,THERE,THEREFORE
013,048,049,100,159,169,2014,250MG,250ML,8805,AMONG,AUTHORS,BACKGROUND,CHINESE,CHM,COPYRIGHT,EGFR,FUZHENG,IIIB,KANG,LABEL,LTD,METHODS,MST,NSCLC,PFS,PUBLISHED,RESULTS
169,2014,239,BAGGING,BAYES,BPNN,CISL,CISLS,COPYRIGHT,LTD,SVM,THEN,THESE
169,2014,ASIAN,BCL,BCL2L11,BH3,BIM,COPYRIGHT,EAST,EGFR,EMT,GEFITINIB,HOWEVER,PUBLISHED,SOCIETY,TKI,TKIS
169,1990S,2014,COPYRIGHT,III,JAPAN,PUBLISHED,SOCIETY
169,2014,ALK,ANAPLASTIC,COPYRIGHT,CRIZOTINIB,EML4,HOWEVER,III,NSCLC,PUBLISHED,SOCIETY,TKI,TREATMENT
169,2014,ALONG,COPYRIGHT,CURRENTLY,JAPAN,MEANWHILE,PUBLISHED,SOCIETY,THESE,VATS
169,2004,2010,2012,2014,2016,COMMITTEE,COPYRIGHT,JAPAN,JOINT,LUNG,PREVIOUSLY,PUBLISHED,SOCIETY,TNM
CONSISTENT,EGFR,HER1,PROTEIN,USING
916,A750,E746,HER1,MB231,NSCLC,SW620,T790M,TKI,TKIS
169,2014,AIM,BACKGROUND,BRITISH,CARE,CONCLUSION,ENGLAND,EXCELLENCE,GENERAL,GPS,INSTITUTE,JOURNAL,LABEL,METHODS,NICE,OBJECTIVE,RESULTS,SETTING
101,142,169,193,2014,400,500,8805,APRICOXIB,CONCLUSION,COX,DOCETAXEL,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PGE,PGE2,PURPOSE,RESULTS,SOCIETY
CDK5,DLC1,GAP,HOWEVER,RHO
169,2014,2100,CARLO,DOSIMETRIC,MONTE,PRESS,PUBLISHED,RESULTS,TPS,UNIVERSITY
169,2013,2014,34S,COPYRIGHT,CRC,FURTHER,HCC,NPC,NSCLC,PCA,SCIENCE,THEREFORE,ULTIMATELY,WEB
1523,169,2014,APE1,COPYRIGHT,CROWN,GSTM1,HMOX1,IMPORTANT,INC,NRF,PUBLISHED,THESE,USING
001,002,018,169,2006,2008,2014,225,292,877,APRIL,BACKGROUND,CD44,CERTAIN,COPYRIGHT,COULTER,COX,III,LABEL,METHODS,NSCLC,RESULTS,WBC,WBCS,ZPCH
181,BXPC,H1299,IC50,IND,INDANONES,INHIBITORY,MASS,MTT,NMR,RWPE
2014,3540C,CHINESE,HOWEVER,PPB,REMARKABLY,SAS,SERTOLI,TYR1180
169,1974,2014,30GY,40GY,6MONTHS,BACKGROUND,CHOROIDAL,COPYRIGHT,DEPENDING,DISCUSSION,FOCALIZED,HOWEVER,LABEL,LTD,METHODS,RADIATION,RESULTS
0001,0025,0042,0096,169,2015,COPYRIGHT,DIFFUSING,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,THERE,TREATMENT
169,197,2014,BASED,BH3,CHOP,COPYRIGHT,EBP,FOXJ2,H460,HMGCR,IDI1,LNA,NAC,NCI,PREVIOUSLY,ROS,STAT6,UTR
000,8201,956,PET,THERE
CURRENTLY,NEXT,NGS,SELECTIVE,THESE
169,2014,COPYRIGHT,IRELAND,LTD,TCGA,THESE,THUS
169,2014,945,A549,COPYRIGHT,H23,NSCLC,THESE
100,169,171,2013,2014,2015,206,8804,8805,AGENZIA,AIFA,BACKGROUND,COMMITTEE,CONCLUSION,COPYRIGHT,DATA,EASTERN,FARM6PMFJM,FARMACO,GOIRC,GROUP,III,INC,JULY,LABEL,MAJOR,METHODS,MONITORING,SCLC,SECONDARY,SEPTEMBER,TREATMENT
15D,169,2000,2009,2011,2015,276,586,BACKGROUND,C30,CENTRAL,COPYRIGHT,EORTC,HRQOL,INC,JANUARY,JUNE,LABEL,LC13,METHODS,NSCLC,QLQ,RESULTS,UNIVERSITY
169,2015,CHT,COPYRIGHT,III,IIIA,INC,NSCLC,SIMILARLY
169,1990,2014,2015,685,COPYRIGHT,DATA,FIFTEEN,III,IMPROVING,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PEARSON,PURPOSE,RESULTS,THERE
001,017,036,100,124,169,2015,310,809,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EGFR,HOWEVER,INC,LABEL,METHODS,RESULTS,T790M,THERE,TKI
169,2015,COPYRIGHT,EGFR,FORTY,GRADE,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,TKI,TKIS,TREATMENT
169,2015,673,946,ACEI,ACEIS,ARBS,ASPIRIN,BACKGROUND,CONCLUSION,COPYRIGHT,COX,DFS,DMFS,III,INC,INCIDENTAL,LABEL,LRPFS,METHODS,NSCLC,RESULTS
0022,169,2009,2012,2015,215,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,COX,CSS,EASTERN,FFR,FINE,GENOTYPING,GRAY,GROUP,INC,KRAS,LABEL,MEIER,METHODS,MOST,NSCLC,RESULTS,SBRT,SEVEN,T1A
018,160,169,2004,2007,2015,2790,710,816,8805,983,BACKGROUND,COPYRIGHT,INC,INSURANCE,LABEL,MEDICATION,METHODS,OLDER,OVERALL,RESULTS,SCC
169,177,2014,956,AKT,BOTH,COPYRIGHT,CXCR4,DOX,HOWEVER,LIP,METASTASIS,MIGRATION,PEGYLATED,PEPTIDE
169,2014,A549,ALPHA,COPYRIGHT,FINALLY,H1299,INC,MOTIF,NSCLC,SAMD9,STERILE
132,169,2014,ADDITIONAL,COPYRIGHT,HN1,INC,MIR,TAKEN,UTR
GIVEN,LUNG,SERUM
956,CONCLUSION,CYFRA21,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,SIXTY
1A1,2012,2013,CONCLUSION,FNX01,IRINOTECAN,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,ORR,PFS,RESULTS,SCLC,THERE
65U,8804,945,BACKGROUND,BASED,CA125,CA199,CA242,CA724,CONCLUSION,COX,ESCC,LABEL,MATERIALS,MEIER,METHODS,RESULTS,SERUM,THEN,TMS,UNIVARIATE
013,045,058,145,176,363,403,529,575,AIM,CENTRAL,CONCLUSION,DOR,HOWEVER,LABEL,METHODS,NLR,OBJECTIVE,PLR,RESULTS,SEVEN,SROC,STUDIES,SUMMARY,THUS
1649,8805,ASIAN,BACKGROUND,CRP,DATA,EIGHT,ENGLAND,HRS,LABEL,MANAGER,MATERIALS,METHODS,NSCLC,RELATED,RESULTS
131,265,396,AMONG,CONCLUSION,EGFR,HOWEVER,IIIB,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
000,185,257,318,710,BRAF,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,REAL,RESULTS
500,590,AIM,CHINA,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,THESE
049,4221,AFTER,CNKI,CONCLUSION,CYFRA21,LABEL,MEDLINE,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2014,A549,COPYRIGHT,EPCAM,HOWEVER,NOTABLY,PSS,SKOV,THUS
1337,169,2014,616,8201,COPYRIGHT,COX,IRELAND,LTD,NSCLC,PROTEIN,STROMAL,THEREFORE
169,2014,946,COCL2,COPYRIGHT,GLYCOLYSIS,HYPOXIC,IRELAND,LTD,NADPH,ROS,SINCE,SRC,THESE,THUS,VEGF
169,2014,COPYRIGHT,GLI2,IRELAND,KNOCKDOWN,LTD,PCR,REAL,RPS3,THESE
105,169,2014,8201,COPYRIGHT,CTC,CTCS,CVB,IRELAND,LTD,MBC,PVB,TCE
169,2014,3LL,ALDH1A1,COPYRIGHT,CSC,CT26,ERK1,HIGH,ID1,ID1A,ID1B,INCREASED,IRELAND,LTD,NOTCH,OCT,PKH26,SCA,SOX,TERT,THROUGH,USING
169,2014,945,946,A549,AKT,COPYRIGHT,DRUG,FOOD,FURTHER,HGF,HOWEVER,IRELAND,LTD,MET,PC3,SAHA,SILENCING,THESE,XL184
169,2014,505,551,COPYRIGHT,EACH,EOC,INC,INHIBITION,NER,NSCLC,PROTEIN,RPA,TDRL,THESE
169,2014,AUTHORS,BOTH,CISPLATIN,COPYRIGHT,CURRENT,HOWEVER,LTD,NSCLC,PRODUCTION
169,2014,ACCOUNTING,ADC,AKT,COPYRIGHT,ERK,INC,LOH,LUNG,MEK,NAC,NSCLC,PI3K,PTEN,RAF,RAS,SCC,THESE
169,2014,A549,COPYRIGHT,FINALLY,INC,LUNG,MRC5,TAKEN
169,2014,COPYRIGHT,HOWEVER,INC,THESE
169,2014,946,COPYRIGHT,INC,PE38,PIPP,WORK
169,2014,946,COPYRIGHT,FEDERATION,FERM,FRMD5,HOWEVER,PUBLISHED,ROCK1,SOCIETIES,TAKEN
169,182,2007,2011,2014,ASSOCIATES,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,CTS,DISCUSSION,FOUR,III,LABEL,LTD,METHODS,PRE,PUBLISHED,RESULTS,ROUTINE,THERE
169,2014,945,946,954,956,AKT,BCL,BEAS,CAT,COPYRIGHT,COX,FAK,HEXAVALENT,HIF,INC,INHIBITION,MAPK,MMP,NADPH,NOX,NUDE,OVERALL,ROS,SOD2,STAT,TNF,TREATMENT,VEGF,WESTERN
169,2014,231,4T1,945,946,COPYRIGHT,EMT,ERK1,IC50,INHIBITION,LTD,MDA,MEK1,METASTATIC,PD0325901,TGF,THEREFORE,TNF
10000,169,2014,BACKGROUND,CONCLUSION,ENGLAND,GPS,LABEL,METHODS,OBJECTIVE,ONGOING,PRESS,PUBLISHED,RATS,RESULTS,THESE,UNIVERSITY
169,2014,A549,COPYRIGHT,DE3,LATCRIPIN,LENTINULA,MTT,ROSETTA,SIMILARLY,TEM
125,150,169,2014,BACKGROUND,COPYRIGHT,DISEASE,IIIB,LABEL,METHODS,NSCLC,PRIOR,RESULTS,THREE
169,2014,AAA,ATPASES,COPYRIGHT,G780AGPSQ,PAGET,VALOSIN,VCP
ALK
169,2014,CELL,CISPLATIN,COPYRIGHT,FEDERATION,IC50,MAJOR,MVP,NON,NSCLC,PROTEIN,PUBLISHED,SMALL,SOCIETIES,THEREFORE,VAULT,WILMS,WT1
169,2014,327,8811,AHR,COPYRIGHT,CYP1,GGGGC,INC,STATE,THESE,YORK
169,2014,24H,CHIP,COPYRIGHT,CSCS,CSE,EMT,HBE,HOX,INC,STAT3,THESE,THUS
169,2014,243,AKAP,AMONG,CONVERSELY,COPYRIGHT,CRC,PRKA,THESE
160,169,2014,APCS,BATF3,CD103,COPYRIGHT,CSF,CTL,DCS,FLT3L,INC,IRF8,REGRESSING,THESE
169,2014,945,AKT,BAX,BCL,CD34,CHINA,COPYRIGHT,DHTMF,DIHYDROXY,H522,HIF,IRELAND,KOREA,LTD,TAKEN,THESE,VEGF,VITEX
028,087,ALDH1,AMONG,BCRP,CAFS,CD204,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,TAMS,THESE
169,2014,COPYRIGHT,CSCS,INCREASING,PUBLISHED
169,2014,COPYRIGHT,EMT,HOWEVER,INC,LOW
169,2014,945,946,A549,COPYRIGHT,EMT,EPITHELIAL,FINALLY,HCC2935,HIF1,HYPOXIA,IGF,IGF1,IGF1R,INC,INHIBITION,INSULIN,NSCLC,PCR,TGF,THESE
A549,CONVERSELY,EMT,EXOGENOUS,GROUCHO,HDAC,HDACS,INC,PUBLISHED,THESE,THROUGH,TLE1,TSA
169,2014,APOPTOSIS,BIM,CETUXIMAB,COMBINING,COPYRIGHT,EGFR,EGFRS,HOWEVER,INC,K562,L858R,T790M,TKI,TKIS,WHILE
8220,8221,AFRICAN,ASIAN,COPD,LEGUMES,LUNG,PAST,SOCIETY,STATISTICS,WHILE
169,2014,231,ABC,CAS,CD44,COPYRIGHT,CSGALNACT1,EXOGENOUS,GD3G7,HCC38,HEF,INC,MDA,MICROARRAY,NEDD9,SERGLYCIN,THERE,THESE
169,177,2014,337,340NM,3DAYS,598,678,8MG,BALB,COPYRIGHT,DOX,H226,HSA,TRAIL
8211,III,MOST,ROSSI
169,176,177,2015,267,CONTINUOUS,COPYRIGHT,DOF,INC,KIM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,VARIOUS
027,043,063,087,093,169,2014,208,224,227,340,355,447,586,604,686,808,844,856,948,AMONG,COLLEGE,COPYRIGHT,EGFR,ENGLISH,JANUARY,KRAS,LIBRARY,LTD,NSCLC,PUBLISHED,ROYAL,STUDIES,THEREFORE,THESE
169,2014,327,ACCORDING,ACTB,BASED,BESTKEEPER,BRCA1,COPYRIGHT,EGFR,ERCC1,GAPDH,GUSB,HER2,INC,NORMFINDER,PCR,RPLPO,RRM1,STMN1,TFRC,TOP2A,TUBB3,TYMS,USING
0001,169,1995,1999,2000,2003,2004,2007,2015,563,BLOOD,COPYRIGHT,RISK,SOCIETY,TRANSPLANT
164,169,174,1998,2011,2015,582,ASA,COPYRIGHT,COX,DEFINITIVE,ECOG,EDUCATION,GLEASON,HOWEVER,INC,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2014,302,ANIMALS,COPYRIGHT,CROWN,HOWEVER,IPM,IRELAND,LTD,PUBLISHED
169,2014,945,AMD3100,COPYRIGHT,CXCR4,F5M2,HIF,IRELAND,KC7F2,LTD,THESE
169,2014,946,AEROBIC,AKT,COPYRIGHT,ERK,GSK3,HOWEVER,IRELAND,LTD,NSCLC,PDK1,PKM2,SILENCING,THESE
169,192,2014,215,A427,A549,CONVERSELY,COPYRIGHT,FINALLY,FUNCTIONAL,H1299,H460,IRELAND,LTD,R273H,TAKEN,XIAP
169,2014,202,293,315,8805,ALK,ATM,BAI3,COPYRIGHT,EGFR,EP300,HGF,IRELAND,KDR,KRAS,LTD,MLL3,MOLECULAR,OTHER,PDX,PDXS,RUNX1,SETD2,STK11,TP53
169,2014,945,954,CD163,COPYRIGHT,ICAM,IRELAND,LTD,MIP,SOX2,STAT3,TAMS
169,180,2014,210,916,A549,BECAUSE,COPYRIGHT,FURTHER,HOWEVER,IRELAND,LTD,PDCD5,THUS
169,2014,COPYRIGHT
8212,FINALLY
001,ASP,BACKGROUND,COX,FDG,LABEL,MEIER,METHODS,MTV,NCSLC,NONE,NSCLC,OAS,PET,PFS,RESULTS,ROVER,SUV,TLG,UNIVARIATE
2004,2009,BACKGROUND,CONCLUSION,DUE,JANUARY,LABEL,METHODS,OBJECTIVE,ONCE,PURPOSE,RESULTS
169,2014,COPYRIGHT,PUBLISHED,REAL,SEPAR
169,177,2014,5TH,8325,95TH,BACKGROUND,CONCLUSION,COPYRIGHT,CTV,FURTHER,IRELAND,LABEL,LTD,ME95,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,RTTT,SBRT,VERO
169,177,18F,2014,COPYRIGHT,DEVIATIONS,DPBC,DPBN,FDG,GTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,QFS,RESULTS,RMS,SIX,SIXTEEN,SUV,SUVPEAK,SUVS
169,183,2014,956,A549,AIM,B16,BALB,CHINA,CONCLUSION,COPYRIGHT,CSF,CTX,IC50,ICR,LABEL,METHODS,MULTI,OBJECTIVE,PUBLISHED,QGY,RESULTS,S180,THESE,UNIVERSITY,WBC
169,2005,2013,2014,AMONG,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
001,019,169,2001,2005,2014,8805,BORDERLINE,COPYRIGHT,COX,DISABILITY,END,IRELAND,LABEL,LTD,METHODS,MOST,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
160,169,2014,BACKGROUND,CONVERSION,COPYRIGHT,HOWEVER,INC,JANUARY,LABEL,MARCH,METHODS,OPERATIVE,PUBLISHED,RESULTS,SOCIETY,UNIPORTAL,VATS
0000,0018,004,0088,031,041,042,160,169,1995,2009,2014,BACKGROUND,BILATERAL,COPYRIGHT,DATA,HOWEVER,INC,LABEL,LOBECTOMY,METHODS,PUBLISHED,RESULTS,SOCIETY,SPLA,SURGERY,THERE
100,108,114,160,169,1992,2011,2014,BACKGROUND,BRONCHIAL,COPYRIGHT,ENDOSCOPIC,INC,LABEL,MEAN,METHODS,PUBLISHED,REGULAR,RESULTS,SIXTY,SOCIETY,THERE
119,146,160,169,2004,2009,2014,ADVERSE,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NCDB,NSCLC,OVERALL,PRIMARY,PUBLISHED,RESULTS,SOCIETY
017,039,102,160,169,1999,2011,2014,247,300,514,AFTER,BACKGROUND,CAREFUL,COPYRIGHT,INC,LABEL,LUNG,MEIER,METHODS,MORTALITY,NETWORK,OCTOBER,ORGAN,PROPENSITY,PUBLISHED,RESULTS,SHARING,SOCIETY,THERE,UNOS,USING
013,160,169,2014,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,FIRST,INC,LABEL,MATERIALS,METHODS,RESULTS
022,023,111,1364,160,169,1999,2010,2014,AFTER,AMONG,BACKGROUND,BMS,CLINICIANS,CONCLUSION,COPYRIGHT,COX,CRC,INC,INCREASED,JANUARY,JAPAN,KINKI,LABEL,LOG,MATERIALS,METHODS,MST,RESULTS,THERE,UNIVERSITY
HOWEVER,IMAGING
169,2014,AUR,BOOSTED,CBCF,CONSORTIUM,CONTENT,COPYRIGHT,FILTERING,IDRI,IDRL,IMAGE,INC,INITIATIVE,LABEL,LIDC,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
15A,169,2015,954,A549,COPYRIGHT,FINALLY,FIRST,H358,HOWEVER,INC,LABEL,MATERIALS,METHODS,NEXT,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TLR1,TOLL,UTR
100,102,169,177,2015,215,CARLO,COPYRIGHT,FILM,IMRT,INC,IONIZATION,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TPS,VIEWRAY
169,2010,2012,2015,ADULT,ASSESSMENT,BETWEEN,BRAIN,COPYRIGHT,FIFTY,FUNCTIONAL,GTV,HOWEVER,INC,INDIVIDUAL,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,MINI,MRI,OBJECTIVE,PARTS,PTV,PURPOSE,RESULTS,SECONDARY,SRS,STATE,TEST,THERAPY,THREE,TRAIL
100,110,119,132,169,196,2005,2011,2015,229,3N0M0,8805,945,946,967,ADVERSE,AES,CENTRAL,CONCLUSION,COPYRIGHT,GRADE,GRAY,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PFT,PTV,PULMONARY,PURPOSE,RESULTS,SBRT
043,045,169,198,2001,2010,2015,274,528,AFTER,BETWEEN,COPYRIGHT,CRT,EGFR,III,INC,JANUARY,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUFFICIENT
169,2009,2013,2015,ADVERSE,COPYRIGHT,EPP,GRADE,IMRT,INC,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,PFS,PULMONARY,PURPOSE,RESULTS
169,2014,945,956,A549,AMONG,COPYRIGHT,IC50,LTD,MICROWAVE
169,2014,259,722,771,916,981,AMONG,BASED,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,SIX,THERE
008,169,2014,CONCLUSION,COPYRIGHT,CTS,DAILY,IGRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,V50,V95,WBI
169,2002,2012,2014,ACUTELY,COPYRIGHT,INC,JUNE,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RADIATION,RBE,RESULTS
0002,001,003,006,013,023,025,081,169,177,2014,5CAC,5FC,5HMC,5MC,BACKGROUND,CONCLUSION,COPYRIGHT,EIA,GROWING,HRP,LABEL,METHODS,PUBLISHED,RESULTS
150,169,2014,COPYRIGHT,INC,PUBLISHED,SEVERAL,SOCIETY
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2014,COPYRIGHT,INC,LUNG,PUBLISHED,SOCIETY
160,169,2014,COPYRIGHT,HISTOLOGIC,INC,PUBLISHED,PULMONARY,SOCIETY
169,2014,BASED,BRAIN,COPYRIGHT,INC,PITUITARY,PUBLISHED,SOCIETY,SUBSEQUENT
169,2014,450,945,947,954,ACADEMY,ALLERGY,BACKGROUND,CD28,CD3,CD4,CELL,CONCLUSION,COPYRIGHT,GATA3,IFN,IGE,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,OVA,PKCS,PUBLISHED,REMARKABLY,RESULTS,TH1,TH2,THESE,TNF
001,002,011,10878,110,115,169,2002,2012,2014,68L,73L,94L,AUTHORS,COPYRIGHT,DMFS,FEV1,FIVE,IRELAND,JANUARY,LABEL,LRRFS,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PORT,PUBLISHED,PURPOSE,RATIO,RESULTS
105,12MM,169,2014,50GY,75GY,COPYRIGHT,CRC,CTS,IRELAND,LABEL,LRS,LTD,METASTASES,METHODS,OBJECTIVE,PET,PTV,PURPOSE,RESULTS,SBRT
169,2014,COPYRIGHT,HOWEVER,LTD,MULTI,SWEDISH,USING
169,1996,2008,2014,2015,376,425,BACKGROUND,CASE,COPYRIGHT,DECREASES,DEPARTMENT,INC,JOURNAL,LABEL,METHODS,MULTILEVEL,OBJECTIVE,OHIO,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS
A549,BACKGROUND,BOTH,EGFR,LABEL,LENTIVIRAL,METHODS,NSCLC,PCR,RBM5,REAL,RESULTS,SALMONELLA,TY21A,WESTERN
169,2014,ACA,AIS,ALK,ASIDE,COPYRIGHT,EGFR,INC,ISHLT,LAS,LUNG,MIA,THOSE
169,2014,CARINAL,COPYRIGHT,HOWEVER,INC,NSCLC,THESE
169,2014,ADDITIONAL,COPYRIGHT,EPP,INC,NSCLC
169,2014,COPYRIGHT,INC,VATS
ACQUIRING,CURRENT,HOWEVER,IIIA,IIIB,INC,LOCALIZED,NETWORK,PROGNOSIS,PUBLISHED,THEREFORE
169,2014,COPYRIGHT,IIIA,INC,NSCLC,THERE
DISCOVERY,INC,LUNG,PUBLISHED,SVC
169,2014,CAREFUL,CENTRAL,COPYRIGHT,INC,LIMITED,NSCLC,OPERATIONS,SBRT,WEDGE
169,2014,COPYRIGHT,GENERALLY,INC,NOMS,NSCLC,SEPARATION,SRS
169,2014,COPYRIGHT,INC,LOBECTOMY
169,2014,COPYRIGHT,INC,MOST,SCLC,SMALL
169,2014,COPYRIGHT,INC
169,2014,COPYRIGHT,INC,MORBIDITY,OBTAINING,WHILE
169,2014,ASSESSMENT,CAREFUL,COPYRIGHT,INC,OPERATIVE
169,2014,CAREFUL,COPYRIGHT,INC,MIS,VATS
169,2014,COPYRIGHT,CURRENT,DEVELOPING,FINALLY,LTD,MOST,PUBLISHED,THERAPIES,THESE
169,2011,2014,AWARENESS,CONTINUED,COPYRIGHT,INC,LUNG,PERSISTENT,SOCIETY
169,2007,2011,2014,AMONG,BACKGROUND,COPYRIGHT,HMPV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
8217,8722,CA755,INSTITUTE,NSC,USA
169,2014,ANTI,BECAUSE,COPYRIGHT,EWING,GD2,INC
160,166,169,1990,2011,2014,ACADEMY,BACKGROUND,COPYRIGHT,FOUR,INC,INCREASING,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIROLIMUS,SKIN
169,2013,2015,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,METHYLENE,OCTOBER,PUBLISHED,PULMONARY,RESULTS,SOCIETY,THERE,VATS
169,2004,2010,2015,663,8804,AMONG,BACKGROUND,COPYRIGHT,FIVE,GGO,INC,LABEL,METHODS,OVERALL,PUBLISHED,RADIOLOGIC,RESULTS,SOCIETY,WEDGE
001,169,2015,227,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PUBLISHED,PULMONARY,RESULTS,SOCIETY,THREE,VATS,VIDEO
106,125,169,175,2003,2006,2015,3124,333,344,356,438,4N2M0,649,949,BACKGROUND,COPYRIGHT,COX,III,INC,LABEL,METHODS,NCDB,NSCLC,PUBLISHED,RESULTS,SOCIETY
112,120,158,169,2015,209,256,313,BACKGROUND,COPYRIGHT,DISSECTION,INC,LABEL,METHODS,OPERATIONS,PUBLISHED,PULMONARY,RESULTS,ROUTINE,SOCIETY,SUBGROUPS,UNEXPECTED
169,2014,CD28,COPYRIGHT,FURTHER,LTD,MONOCLONAL,NSCLC,RCC
0001,0006,0036,006,014,160,169,2015,A549,COPYRIGHT,CTEN,EPIDERMAL,FOUR,H125,H358,H441,INC,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROTEIN,PUBLISHED,RESULTS,THESE,WESTERN
0001,0038,022,160,169,1763,2000,2009,2015,COPYRIGHT,IIA,IIB,IIIA,IIIB,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY,WEDGE
160,177,2008,2013,FURTHER,INC,JANUARY,JULY,LABEL,MEAN,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SELECTIVE,T1N0,T2N0
001,1227,160,169,194,2004,2012,2015,336,517,623,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PLANNED,PUBLISHED,RESULTS,SURGERY,VALIDATING,VATS
169,2014,COPYRIGHT,LOCAL,LTD
0001,001,041,049,169,183,185,2009,2013,2014,239,240,477,480,506,8805,BACKGROUND,BETWEEN,COPYRIGHT,DEC,EGFR,FUNDING,HOWEVER,INSTITUTE,IQR,JANUARY,JUNE,KRAS,LABEL,LTD,METHODS,RESULTS,SOCIETY,TREATMENT
022,104,134,150,169,183,2011,2013,2014,229,253,256,263,439,587,802,834,878,941,ASIAN,BACKGROUND,BETWEEN,COPYRIGHT,EASTERN,ECOG,EGFR,FUNDING,FURTHER,GROUP,JUNE,KRAS,LABEL,LTD,MARCH,METHODS,RESULTS,SERIOUS,TREATMENT
169,2014,COPYRIGHT,LTD,VIEW
001,005,009,011,018,027,033,160,169,2003,2013,2015,304,310,4498,615,AFTER,COPYRIGHT,EPITHOR,INC,INDUCTION,LABEL,METHODS,NONE,OBJECTIVE,OPERATIVE,OVERWEIGHT,PUBLISHED,RESULTS,SEVERAL,SOCIETY,SURGERY,THEN
008,018,019,1114,169,1706,2006,2009,2014,592,692,8805,AGE,BCP,COPYRIGHT,COX,IIIB,IRELAND,IRR,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,SEER
0001,1373,169,2009,2014,417,748,8805,BACKGROUND,BRITISH,COPYRIGHT,COX,ECOG,HAZARDS,HISTOLOGY,IIIB,IRELAND,JANUARY,LABEL,LTD,MEIER,METHODS,NOS,NSCLC,PATIENT,PREDICTORS,RESULTS,STRATEGIES,THERE
169,2014,COPYRIGHT,CROWN,DLBCL,INC,PUBLISHED
169,1919,2014,849,ACADEMY,ALLERGY,ATOPY,BACKGROUND,CIS,CONCLUSION,COPYRIGHT,COX,HOWEVER,IGE,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
169,2007,2010,2014,3043,8805,AUTHORS,BACKGROUND,BFC,COHORTS,COPYRIGHT,FSC,INC,JUNE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEPTEMBER
169,2014,CELL,COPYRIGHT,FINALLY,GRIDMOS,HOWEVER,IRELAND,LTD
148,20MM,CONCLUSION,INC,LABEL,MALIGNANCY,METHODS,OBJECTIVE,PUBLISHED,RATE,RESULTS
AAS,ACCORDING,HCT,NEITHER,RBC,WBC
KRAS
001,117,197,2003,2005,379,475,6835,AFFAIRS,BACKGROUND,CHARITABLE,CONCLUSION,DEPARTMENT,DORIS,DUKE,FOUNDATION,FUNDING,GEOGRAPHIC,LABEL,LESS,LIMITATION,METHODS,MULTILEVEL,OBJECTIVE,OLDER,PER,PRIMARY,RESULTS,SETTING
BESIDES,EMPLOYING,HOWEVER,PHGDH,PSAT1,PSPH,SHMT,SHMT2,THEREFORE
111,177,355,403,543,705,BACKGROUND,DVL,FIVE,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,WNT,XENOPUS
COLORECTAL,CORRECT,CRC,ERUS,MDCT,MPR,MRI,PET
005,006,008,110,8804,CD11B,CD14,CD15,CD33,CD4,HLA,INCREASED,LIN,MDSCS,MYELOID,NSCLC
7901,BACKGROUND,CHINESE,CONCLUSION,ETHANOL,FOUR,LABEL,MATERIALS,METHODS,NMR,ODS,OPTICAL,RADIX,RESULTS,SGC
169,1ML,2014,CAP,CD45,COPYRIGHT,CTCS,EPCAM,FINALLY,H1650,MCF,NCI,THEIR
169,2014,BCL,COPYRIGHT,DESPITE,HOWEVER,INC,NON,PACLITAXEL,PREVIOUSLY
100,115,120,121,CACTTTG,ECTOPIC,OVERALL,SOX,SOX30,SRY
100,116,169,2014,539,549,8320,8325,956,CCRF,CELL,CEM,CNS,COLON,COPYRIGHT,GI50,H522,HCT,LTD,LUNG,MALME,NCI,NON,NSC,OVARIAN,OVCAR,RENAL,SMALL
132,212,A549,CELLS,CONVERSELY,H1299,LUNG,RNAS
CURRENTLY,EGFR,ERBB,ERBB1,ERBB2,ERBB3,ERBB4,FINAL,HER1,HER2,HER3,HER4,III,LAPATINIB,NSCLC,PHASE,THESE,THREE,TKI,TKIS
946,956,A549,AIM,BAK,BAX,CELL,CONCLUSION,DAPI,DMAS,FMK,IC50,LABEL,METHODS,MTT,OBJECTIVE,PARP,RESULTS,TREATMENT,VAD,WESTERN,XIAP
100,2001,2013,BECAUSE,GAMMA,GKS,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PER,RESULTS,SUBSEQUENT
009,110,2001,2007,2412,289,3220,4360,AVERAGE,CRITICS,DESPITE,KARNOFSKY,KPS,LABEL,MAY,MEIER,METHODS,MVA,OBJECTIVE,OVERALL,RESULTS,SALVAGE,SCALE,SRS,TREATMENT,WBRT
008,012,024,2007,2013,8805,CLASS,COX,DISTANT,FOLLOWING,GAMMA,KNIFE,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PROGNOSTIC,RESULTS,SALVAGE,SRS,WBRT,WHILE
003,006,110,2004,2013,625,817,ACCORDING,ACTUARIAL,COX,FACTORS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OPTIMAL,PENDING,RESULTS,RISK,SCALE,SHERBROOKE,SRS,UNIVARIATE,WBRT
215,BEDS,CNS,EVEN,FIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SRS,WBRT,WHOLE
0001,1011,1143,134,1604,176,178,1868,204,2089,219,268,2838,302,305,318,355,382,749,792,825,8804,ACCORDING,BASIC,BRAIN,BSBM,HOWEVER,LABEL,LORENZONI,METASTASES,METHODS,MRI,NPS,NPSS,OBJECTIVE,RESULTS,SCORE,SRS,SUBGROUPS
03GY,110,116,11GY,130,150,169,176,180,2015,210,230,250,3DCRT,45GY,4GY,66GY,COPYRIGHT,IMRT,INC,MEDICAL,OAR,OARS,PHYSICS,PROGRAMME,PUBLISHED,RADIATION,VMAT
COLORECTAL,CRC,HCT16,HOWEVER,THESE,USING
10878,169,2014,BACKGROUND,CHRT,CONCLUSION,COPYRIGHT,FAZA,FHV,FHVS,HNSCC,IRELAND,LABEL,LTD,METHODS,NSCLC,PET,RESULTS,TEN,THEREFORE
A549,ERCC1,EXPRESSION,FCM,FIRSTLY,FLOW,H1299,HPLC,MRP,MTT,NSCLC,RNAI,THEN,THEREFORE
8209,BPS,LEWIS,LLC,PGI2
001,1160,AGE,ALK,EGFR,EML4,NSCLC,ROC,THESE
BMP,CHEST,EXCISIONAL,HISTOLOGIC
AFTER,HEPARIN,HIT,HOWEVER,JAPAN,LOW,PCPS,PF4,PLATE,WESTERN
215,5MM,AFTER,BOTH,CHEST,FOUR,III,PET,SUBSEQUENT,THERE
HOWEVER,ROBOTIC,WHILE
169,2014,A549,COPYRIGHT,GMBH,MEIER,NSCLC,NTC31,SYF2,TAKEN,WESTERN
169,2014,COPYRIGHT,EGFR,FINALLY,IARC,IRELAND,LFS,LTD,TKI,TP53
000,001,028,037,169,1798,2014,259,416,615,877,959,961,BACKGROUND,CONCLUSION,COPYRIGHT,CURRENT,FGFR1,FISH,IRELAND,LABEL,LIBRARY,LTD,METHODS,PEARSON,PFS,RESULTS,SCHOLAR,SCI,SQCC,USING,WEB,WHETHER
0001,033,169,2014,4104,8804,8805,916,ANXIETY,BACKGROUND,BEHAVIOUR,BOTH,COPYRIGHT,COS,DEJECTION,DLCST,FOCUS,HARM,HEALTHY,HEAVY,INTROVERT,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SELF,SMOKING,THERE,TRIAL
169,177,2013,500,B12,BACKGROUND,CLEA,CONCLUSION,COPYRIGHT,EPO,LABEL,NSCLC,PUBLISHED,RATIONALE,RESULTS,SAS,SPLF
0001,0008,10YEARS,119,169,1ST,2000,2010,2013,31ST,6083,BACKGROUND,BOTH,COLLEGE,COMPARISON,COPYRIGHT,CPHG,EGFR,GENERAL,JANUARY,KBP,LABEL,METHODS,NSCLC,PHYSICIANS,PUBLISHED,RESULTS,SAS,SPLF,THEIR,VARIOUS
177,200,500,507,577,617,730,838,864,956,A549,BACKGROUND,DPPH,GAE,GRAM,IC50,LABEL,MIC,RESULTS,SCA5
946,A549,APOPTOSIS,EXPRESSION,GAL,INJURED,LCC,LCCS,LCPD,PLEURAL,PMC,PMCS,TGF,WESTERN
1089,1444,3882,8201,960,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,USAGE
169,2014,945,946,BIOLOGY,COPYRIGHT,EDA,EDB,PUBLISHED,SOCIETY,THESE
001,002,004,012,1686C,169,2014,391,398,482C,COPYRIGHT,CRS,GROWING,PCR,RFLP,SNPS,THESE,XRCC1
001,160,8201,AMONG,CONCLUSION,DSS,FDG,III,INITIAL,LABEL,METHODS,MORTALITY,NAC,OBJECTIVE,PET,PURPOSE,RESULTS,TNBC
14097,169,2014,8804,937,BACKGROUND,CDDP,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SEER,THESE,TRIAL,UNIVERSITY,USING,VP16
169,2014,5584,945,946,CONSISTENT,CSC,PI3K,RNAI,TAKEN
169,2014,946,954,ACTIVIN,CIC,CICS,EMT,INHBA,NSCLC,SOLUBLE,TGF,USING,WORK
A549,CDC42,NSCLC,PCR,THEN
160,954,956,CELL,ELISA,ERK,ERK1,GLC,H2O2,LUNG,MMP,MTT,MYD88,OXIDATIVE,THEREFORE,TRADD,TRAF2,TRAF6,TUNEL,WESTERN
FOLLOWING,GTP,MHC,NATURAL,NCR1,NCRS,NKP46,RAL,RALA,RALB,RAS,THESE,YET
161,ACT,CERTAIN,CONCLUSION,IMAGING,INSURANCE,KNOWLEDGE,LABEL,METHODS,MRI,OBJECTIVE,PLEURAL,PRIMARY,RECURRENT,RESULTS,SMALLER,SSS
946,MSH2,RED,THESE
A549,ARSENIC,AS2O3,FAS,FASL,HOWEVER
945,AKT,HOWEVER,KNOCKDOWN,LENTIVIRUS,METASTASIS,MMP,PCNA,PI3K,PI3KP85,RNAS,SAO2,TAKEN,THEN,THESE
0001,002,107,2010,2014,408,8201,998,AMERICA,CIS,COLORECTAL,COX,GOVERNMENT,HRS,LUNG,OVARIAN,PUBLISHED,RCC,SCREENING,TRIAL
169,2014,309G,309GG,331,501,532,717,749,8201,830,AUTHORS,CONSISTENT,INC,MDM2,PUBLISHED,SNP285C,SNP285G,SNP309T,SNPS,UICC,WILEY
169,2014,945,946,BRITAIN,COPYRIGHT,DATA,GREAT,IIB,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,WILEY
807,945,BACKGROUND,CHINA,DATA,HLA,KNOWLEDGE,LABEL,METHODS,OVERALL,RESULTS,TEN,WANFANG
124,131,200,APOPTOSIS,CELL,CURRENTLY,FDG,FLT,HOWEVER,PET,SURGERY,THREE
0001,104,235,3782,380,AIMS,BMJ,BRAF,EGFR,FFPE,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PCR,PUBLISHED,PUBLISHING,QUBIT,RATE,RESULTS,RING
AIMS,BMJ,FFPE,GENOMIC,GROUP,HER2,KRAS,LABEL,LIMITED,METHODS,MILLISECT,OBJECTIVE,PROTEOMIC,PUBLISHED,PUBLISHING,RESULTS,SLIDE
0044,134,8201,CONCLUSION,COX,HOWEVER,LABEL,LSMI,LSMIS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,002,005,015,046,100,AMONG,BACKGROUND,COX,DESPITE,III,INHIBITION,LABEL,METHODS,NON,NSCLC,PCR,RESULTS,SENP1,SIXTY,SUMO,TNM,VEGF
174,2014,BOEHRINGER,COMMITTEE,INGELHEIM,IPF,MEDICINAL,MEDICINES,NINTEDANIB,OCTOBER,OFEV,PHASE
001,003,177,489,665,CD11B,CD14,CD33,FLOW,HLA,LABEL,MDSCS,METHODS,OBJECTIVE,RESULTS,SCLC
BOTH,CD31,LABEL,METHODS,OBJECTIVE,RESULTS,SURGICALLY
8594,ATLAS,CLUSTERING,HOWEVER
100,500,8201,BACKGROUND,CONCLUSION,ECOG,GRADE,LABEL,METHODS,ORR,PEMETREXED,PFS,RESULTS,SECONDARY,SEVEN
001,118,2006,EMT,EPITHELIAL,EXPRESSION,HOWEVER,THERE,TWIST
132,2005,2014,339,365,386,672,753,788,EASTERN,GROUP,INDWELLING,IPCS,JANUARY,LABEL,LENT,MALIGNANT,METHODS,MOST,MPE,OBJECTIVE,RESULTS,SIXTY,THERE
956,AMONG,COOH,FOURIER,MWCNT
001,138,8201,947,966,ADIPOSE,ADSCS,ANOVA,BACKGROUND,C31,CAOV,CD25,CD4,CD8,DATA,FOXP3,IFN,JAK,LABEL,MCF7,METHODS,MSCS,RESULTS,STAT1,STUDENT,TRAIL,TREATMENT,TREGS
160,174,300,ALECTINIB,ALK,CNS,JAPAN,NSCLC,PATIENT,TREATMENT,WHILE
1996,2006,2011,BMJ,COPD,GROUP,IMPORTANCE,LABEL,LIMITED,MAIN,METHODS,MORTALITY,OBJECTIVE,ONTARIO,POPULATION,PUBLISHED,PUBLISHING,RELEVANCE,RESULTS,SETTING
104,ACCORDING,CHINESE,DRAFT,EVALUATION,III,KAPPA,KARNOFSKY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,REC,RESULTS,SOLID,TCM,WESTERN
158,181,2012,2014,204,362,EGFR,EXON,JANUARY,L858R,LABEL,LBC,LBCS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
2014,8197,BMJ,GROUP,LTD,PUBLISHING
ALCOHOL,ALDH2,CURRENTLY,GROUP,HOWEVER,IARC,THUS
100,157,282,439,AP11,BALB,CEACAM6,CEACMA6,SMALL,THUS
HIGH,LABEL,METHODS,OBJECTIVE,RESULTS,SMOKING
BACKGROUND,CONTEXT,DATA,DIAGNOSTIC,KNOWING,LABEL,LITERATURE,METHODS,OBJECTIVE,SOURCES
HEPATOCYTE,HGF,MET
946,AMONG,COX,FOXHEAD,FOXM1,GNM,HOWEVER,HPV,INDUCTION,LABEL,MEIER,METHODS,MZF1,NKX2,OBJECTIVE,PURPOSE,RESULTS,RFS,WNT
160,4T1,BACKGROUND,BALB,CD4,CD8,CNB,CONCLUSION,CTC,CTCS,EMT,EZH2,INCISIONAL,LABEL,MDSCS,METHODS,MICE,RESULTS,SOX4
177,244,471,ATLAS,CONSORTIUM,CUP,METASTATIC,SEQ
100,160,CRE,INHIBITION,METASTASIS,NEUROG3,RELAPSE,THUS,TSC,TSC1
169,2014,AUTOPSY,DESPITE,PRESS,PUBLISHED,UNIVERSITY
136,169,2014,CYFRA21,LABEL,LUNX,METHODS,OBJECTIVE,PLEURAL,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,2015,CDK6,COPYRIGHT,DAI,DLC1,LOW,SNP,THESE
145,945,ADP,ATF,ATF4,BIP,BORON,DIETARY,GRP78,LOW,MILD
017,027,035,106,123,128,2000,2010,312,316,8201,919,AIMS,BETWEEN,BRAIN,CI95,CONCLUSION,DFS,IC95,IIB,IIIA,IIIB,LABEL,LOCAL,MATERIALS,MEAN,METHODS,MOST,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE
A549,AKT,BOTH,ERK,HOWEVER,MAPK,MMP9,NSCLC,PI3K,THESE,THUS,USING,VEGF
946,BACKGROUND,EMT,HOKS,LABEL,METHODS,MMP,MMP7,OSCC,OSCCS,RESULTS,SIRT1,SMAD4,TGF,THESE
8201,8805,BACKGROUND,BELIEFS,CONCLUSION,DATA,LABEL,METHODS,RESULTS,SEVERAL,SMOKERS,USING,WHEREAS
109,119,121,133,141,145,2001,2011,AVERAGE,BACKGROUND,CONCLUSION,DESPITE,HOWEVER,LABEL,METHODS,OBJECTIVE,QUESTIONS,RESULTS
215,7721,947,954,AKT,BALB,CD147,HAB18,HUH,IGG1,PI3K,SMMC,THESE
ANAPLASTIC,ATC,BACKGROUND,CONTEXT,DESPITE,ERK1,JNK,LABEL,METHODS,OBJECTIVE,RAGE,RESULTS,RNAI,THESE,USING
FDG,PET,THROUGH
FDA,FDG,FDOPA,MRI
HPV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TREATMENT
AEROSOL,AREAS,BACKGROUND,COVERED,EFFICIENT,FINALLY,LABEL,LUNG,MEANWHILE,METHODS,OPINION,PEGYLATION,VIRAL
430,500,520,955,FURTHER,HPLC,MOST,THESE,THIOL
916,C57BL,HOWEVER,LPS,MSBB,NOD1,NOD2,SALMONELLA,SIMILARLY,TLR2,TLR4
A549,EXPRESSION,GFP,HELA,INHIBITOR,MIIYRDLISH,NH2,PTD,PTDS,TCTP
070,177,8201,BACKGROUND,CONCLUSION,LABEL,LATE,METHODS,PREFS,PRS,RELAPSE,RESULTS,SIXTEEN,THERE
486,538,572,8201,ALCOHOL,BACKGROUND,HEAVY,HODGKIN,LABEL,METHODS,NON,RESULTS,RRS,THERE
001,0022,0246,169,2001,2010,2014,499,842,AFTER,CONCLUSION,COX,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TREATMENT
169,2014,ALTOGETHER,CDC42,DDR1,DISCOIDIN,FINALLY,GEF,JUIN,RHOGTPASE,SRC,TUBA
169,2014,AIM,ANOTHER,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DELINASIOS,INSTITUTE,JOHN,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROC,SCC
2014,ANTI,BMJ,CAR,CRMP,CRMP5,CV2,GROUP,LTD,PUBLISHING,SMALL
2014,BMJ,GROUP,HIV,LTD,PUBLISHING,SYPHILITIC
120,ASA,CCO,CGRP,CVP,ELISA,FORTY,HEART,LABEL,MAP,MATERIALS,MEANWHILE,METHODS,MPAP,OBJECTIVE,OLV,RESULTS,SGB,SOCIETY,TOTAL
2005,2011,4065,CONCLUSION,IRAN,KHUZESTAN,LABEL,METHODS,PREVALENCE,PROVIDENCE,RESULTS,SHAFA,SPSS,THEREFORE,UNLABELLED
120,128,135,CEA,CRP,CYFRA21,GEP,GEP2,GEP3,LDH,NSCLC,NSE,SCLC,SERUM
AIM,ASIA,ASIAN,BACKGROUND,C677T,CIS,LABEL,MATERIALS,META,METHODS,MTHFR,OBJECTIVE,ORS,RESULTS
062,199,364,611,673,835,BACKGROUND,CHINESE,CLPTM1L,GWAS,HOWEVER,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,RS31489,SENSITIVE,THUS
001,003,031,042,053,056,1000,178,241,359,365,382,419,587,768,841,916,930,974,BESIDES,DRAI,HAN,INNER,LABEL,LUNG,MATERIALS,METHODS,MONGOLIAN,NAT2,OBJECTIVE,PCR,PSTI,PURPOSE,RESULTS,RFLP,RSAI,SMOKERS
1297,COX,CRC,CYCLO,LOVO,MICRORNAS,MIR,THEREFORE,THESE,UTR
CARE,JAPAN,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,PALLIATIVE,PROGRAM,PURPOSE,RESULTS,SCALE
636,AUC,BACKGROUND,DKK1,LABEL,MATERIALS,METHODS,RESULTS,ROC,SERUM,THEN
AUTOPHAGY,CONCLUSION,DESPITE,III,LABEL,METHODS,OBJECTIVE,PURPOSE,REGULATION,RESULTS,THESE
109,142,2006,2010,222,250,437,670,802,AMONG,EGFR,LABEL,MARCH,MAY,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,TKI,TKIS
956,ANOTHER,HOWEVER,NPS,TIO2
A549,ADSORPTION,HACAT,HENCE,MTT,PVP,ROS,THEN
945,A549,CELL,EACH,LD50,TUNEL
001,160,169,2014,598,658,APMIS,CAUCASIAN,EGFR,JOHN,KIT,LTD,MUTATIONS,NSCLC,PCR,PUBLISHED,RGQ,SONS,WILEY
CHALLENGES,CPG,EPIGENETIC,GBM,HTB,K27,KIF23,LOX,MSCC,PBK,THERE
AIDS,BOTH,CURE,DRUG,EPIGENETIC,FOOD,GROUP,HAART,HIV,HODGKIN,HOWEVER,INSTITUTES,NHL,NIH,NOW,PAST,SCIENTIFIC,SOCIETY,WORKING
CPG,DESPITE,LUNG,THUS
169,2014,211H,8962,ASIA,AUTHORS,BIW,FIFTY,GM2,HOWEVER,LTD,MALIGNANT,MPM,MSTO,PTY,PUBLISHING,SCIENCE,THEREFORE,THESE,WILEY
160,1899,194,268,8201,8252,BACKGROUND,DISEASE,ENGLAND,EPIC,LABEL,METHODS,NORFOLK,ODDS,RESULTS,SELF,THOSE
169,2014,CD11B,IL6,LABEL,METASTASIS,ST6GALNAC4,THOMSEN,UNLABELLED
DIFFERENT,III,PHASE
2004,2013,BACKGROUND,CONCLUSION,COURT,JAPAN,LABEL,METHODS,OBJECTIVE,PLAINTIFFS,RESULTS,SUPREME
169,175,2014,8805,ANY,EASTERN,GROUP,KETTERING,LABEL,LIVER,LUNG,METHODS,OBJECTIVE,PHASE,PRESS,PUBLISHED,RESULTS,SLOAN,UNIVARIATE,UNIVERSITY
8209,946,EMT,EPITHELIAL,MORTALITY,OCT4
549,945,946,NAUCLEA,NMR,THEIR
BAL,CSF,HRCT,INHALATIVE,PAP,SECONDARY,SEVERAL,WHOLE,WLL
107,160,169,2014,AUTHORS,CIN1,CIN2,CIN3,EPIGENETIC,HPV,JOHN,LTD,PCDH,PCDHA13,SONS,TESTING,WILEY
2013,450,AIDS,BECAUSE,HIV,HODGKIN,INCA,INSTITUTE
001,002,003,010,018,020,1039,158,186,291,876,EGFR,III,PRS,RFS,SOLID,TKIS
21ST,8TH,EGFR,GEFITINIB,NSCLC,TEN,TKI,TOXIC,TREATMENT
1AT,945,EMPHYSEMA,GLU342LYS,SAXS
1960,1960S,2000,2010,449,708,AMONG,BACKGROUND,CVD,INDEX,INEQUALITY,LABEL,METHODS,NORWEGIAN,RESULTS,RII,SII,SLOPE,STILL
EPHA2,HOWEVER,HRS,SCIENCE,WEB
169,1967,1995,2000,2014,4000,4499,AUTHORS,BACKGROUND,BIRTH,FINALLY,JOHN,LABEL,LTD,MEDICAL,METHODS,MOTHERS,PAEDIATRIC,PERINATAL,PUBLISHED,RESULTS,SIMILARLY,SONS,WILEY
2011,2013,500,B12,BETWEEN,BEV,CHINESE,DISEASE,NSCLC,OCTOBER,OVERALL,PFS,TOXICITIES
239,ATP,BASED,EGFR,EPIDERMAL,FIRST,HER2,HER4,LUNG,LUX,NSCLC,TKI,TKIS
0001,181,2003,2009,316,690,CONCLUSION,CONTINUED,END,INDIANS,LABEL,METHODS,OBJECTIVE,RESULTS,SEER,WHILE,WHITE
2012,2014,BACKGROUND,BOTH,CONCLUSION,END,LABEL,METHODS,OBJECTIVE,PRESS,PROGRAM,PUBLISHED,RESULTS,SEER,UNIVERSITY,USING
169,2000,2009,2010,2014,BACKGROUND,CONCLUSION,END,FIVE,INSTITUTE,JANUARY,LABEL,METHODS,PRESS,PROGRAM,PUBLISHED,RESULTS,SES,SLT,UNIVERSITY,USLT
001,003,025,171,188,LMR,SCLC
EMT,FRIZZLED2,FYN,FZD2,STAT3,WNT,WNT5A
001,8201,8226,CONCLUSION,DLP,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,PRECISION,PROCEDURE,RESULTS,ROBOT,SIZE
001,007,010,050,102,116,2010,2012,372,8201,BACKGROUND,COX,CRRT,EASTERN,ECOG,GROUP,HOWEVER,ICU,INTENSIVE,JANUARY,LABEL,LUNG,METHODS,RESULTS,SEVERANCE,SIXTY,UNIVERSITY
001,005,011,015,028,8201,ANXIETY,AUC,BORG,CHANGES,CHRONIC,CONCLUSION,DEPRESSION,DISEASE,FEV1,FORTY,FVC,IMT,LABEL,MATERIALS,METHODS,NRS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,RESULTS,SCALE,SEVENTY,THESE
116,169,2014,945,946,GRP94,H1975,HSP90,NCI,NVP,ORAL,TAS,TRAP1
001,002,003,004,006,008,177,8201,BACKGROUND,ELISA,HOWEVER,LABEL,METHODS,NSCLC,OPN,PRE,RESULTS,SIXTY
169,172,2014,AKT,EMT,EPITHELIAL,FINALLY,HOWEVER,JAM,JUNCTIONAL,NPC,PI3K,PRESS,PUBLISHED,TAKEN,THESE,UNIVERSITY
002,169,2014,407,494,AFRICAN,AMERICANS,COMMUNITY,LUNG,PRESS,PREVIOUSLY,PUBLISHED,THESE,UNIVERSITY
100,169,1RA,2014,242,IGFBP,NSCLC,THESE,URINE
NON,THERE
100,2012,JANUARY,TRANSIENT
000,500,ADVERSE,GRADE,MEIER,PFS,RTOG,SBRT,SCLC
088,099,170,187,226,229,455,515,904,CHINESE,MET,N375S,PCR,PFS,SCLC,SNP
0001,001,002,004,005,006,008,015,2002,2005,242,484,BACKGROUND,CONCLUSION,DESPITE,GENERALLY,IRAN,LABEL,METHODS,OCTOBER,RESULTS,TRAINED
2010,2013,22G,8201,BACKGROUND,EBUS,FIVE,FURTHER,LABEL,MALIGNANCY,METHODS,NINE,NON,RESULTS,SEVEN,TBNA,THERE
281,SIRS,STUDIES,SWEDISH
CONCLUSION,CUMULATIVE,IMAGING,LABEL,OBJECTIVE
PROTONS
CURRENT,LUNG,NSCLC,RADIATION
215,8202
128,2700,292,ACTIVATION,AUC,GEO,ONCOFINDER,PAS,PATHWAY,SIGNALING,THESE
177,185,212,BACKGROUND,CHEST,FORTY,LABEL,LATISSIMUS,MESH,METHODS,OPERATIVE,RESULTS
120,132,AFTER,EITC,GRADE,III,METHODS,RESULTS,SINCE,THEREFORE
169,2014,BACKGROUND,HIGH,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,SAMNETWEB,SUMMARY,THESE,THROUGH,UNIVERSITY
169,2014,ACIDS,CHIP,CHROMATIN,DISRUPTION,EHF,ETS,NUCLEIC,PRESS,PUBLISHED,THESE,UNIVERSITY
169,2014,946,AKT,FUNCTIONAL,III,NSCLC,OVERALL,PTEN,TUBB3,TUBULIN
169,2014,ASIA,AUTHORS,KNOCKDOWN,LTD,NSCLC,PTY,PUBLISHING,SCIENCE,TFPI,TMPRSS4,WILEY
177,8201,8226,957,968,978,AGREEMENT,BACKGROUND,BLAND,CONCLUSION,DATA,ICC,INTERSCAN,IQR,KEY,LABEL,MANN,METHODS,RATIONALE,RESULTS,SEMI,SSN,SSNS,VOLUMETRIC,WHITNEY
0001,001,084,112,152,169,177,184,194,1996,2012,2014,359,403,665,8805,BECAUSE,BETWEEN,LABEL,LNR,METHODS,MULTIMODAL,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RATIO,RESULTS,SURGERY,UNIVERSITY
AKT,BACKGROUND,CUL4A,EGFR,EXPRESSION,LABEL,METHODS,MTT,NSCLC,PCR,RESULTS,WESTERN
001,003,037,057,110,132,169,2004,2011,2015,ANY,CENTRAL,CNS,COPYRIGHT,COX,FACTORS,FIFTEEN,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RADIATION,RESULTS,SCLC,SOCIETY,SRS
1001,1005,1007,1014,8482,ALK,CRIZOTINIB,MET,OPTIMIZING,PROFILE,ROS1,WHILE,XALKORI
134,1990,2009,946,BACKGROUND,CARCINOID,CONCLUSION,EMT,EPITHELIAL,FOXC2,LABEL,LCNEC,METHODS,NETS,PULMONARY,RESULTS,SCLC,SNAIL,TRANSITION,TWIST,TYPICAL
001,002,006,017,157,8201,COX,HOWEVER,MEIER,NSCLC,PCR,PPM1D
2009,2013,370,624,BETWEEN,CENTRAL,THERE,TPN,TREATMENTS
AFTER,ANFIS,CYBERKNIFE,FINAL,SYNCHRONY
2014,945,CDDP,CHRONIC,FASL,FLICE,FLIP,GOVERNMENT,KNOCKDOWN,PASSAGE,PRESS,PUBLISHED,SOCIETY,SWCNT,TNF,TOXICOLOGY,UNIVERSITY,WHOLE
169,2004,2010,2012,2014,344,6TH,797,7TH,ABOUT,AJCC,BACKGROUND,COLLECTION,COMMITTEE,CSV2,DATA,END,IIA,IIIB,JOINT,LABEL,METHODS,OVERALL,PROGRAM,RESULTS,SEER,SOCIETY,SSFS,STAGE,TNM,VERSION
SHMT,SHMT1,SHMT2,WHILE
177,8209,CD4,H446,NCI,PBMCS,PNS
204,AKT,BACKGROUND,BOTH,BP1,CHEMOTAXIS,FINALLY,INCREASED,KNOCKDOWN,LABEL,LUCIFERASE,LUNG,METHODS,NSCLC,NUAK1,PCR,REAL,RESULTS,SCRATCH,THERE,UTR,WESTERN
8320,8321,8325,956,A549,ALSO,CELL,III,TAKEN
0001,0004,1995,2004,300,600,MONTEVIDEO,THESE,URUGUAY
945,BACKGROUND,BASED,BOTH,HMB,LABEL,LAM,METHODS,RESULTS,TSC,TSC1,TSC2,WESTERN,WHEREAS
169,2014,490,705,METASTATIC,PRESS,PUBLISHED,SILENCING,STAT3,TAKEN,TYR,UNIVERSITY
10A,169,2014,231,BT20,HOWEVER,MCF,MDA,NAD,SEVERAL,SIRT1,SRT1720,THUS
000,169,2015,8764,COPYRIGHT,CTCS,CTM,GEOMETRIC,HOWEVER,SEVERAL,SINGLET,SOCIETY,THESE,THROMBOTIC,VTE,VTES
169,2015,ALDH1A1,CAV,CD133,COPYRIGHT,CSC,CSCS,EVEN,H292,H460,LAST,RAPID,SOCIETY,THESE
169,2014,BACKGROUND,CONTACT,DEG,DEGS,LABEL,METHODS,MOST,MOTIVATION,NMF,PRESS,PUBLISHED,RESULTS,TREMENDOUS,UNIVERSITY
169,2015,ATLAS,BINDING,BIOLOGY,INC,MOLECULAR,MUTATIONS,RING,SCCRO,SOCIETY,UBA
119,149,169,189,192,196,2015,370,945,946,ACH,ACTIVATION,ARG,BIOLOGY,CONUS,CYS,IC50,INC,MOLECULAR,N11A,N12A,PHE,SER,SOCIETY,TRP,TYR
169,181,2014,344,8805,ADVERSE,BACKGROUND,CMAX,EXPOSURES,FOUR,INSTITUTE,LABEL,METHODS,MTD,RESULTS,SOCIETY,THERE
001,004,005,008,009,8201,B4W,BACKGROUND,BLOOD,EGFR,GEFITINIB,LABEL,METHODS,MUC1,NSCLC,PCR,PFS,RESULTS,VEGF
001,119,127,281,AMONG,BACKGROUND,CONCLUSION,ECOG,EGFR,FURTHER,IIIB,KOREA,LABEL,METHODS,NSCLC,RESULTS,TKIS
100,15MM,20MM,ALONG,HOWEVER,MRI
17MM,37MM,EACH,LABEL,METHODS,NEMA,OBJECTIVE,PET,RESULTS,STATIONARY,TBR,TBRS
177,CONCLUSION,DISCUSSION,DOSE,IMRT,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,VMAT,VOLUMETRIC
160,1683,2005,2010,CHINA,HEAVY,HOWEVER,POISSON,RESULTS
200
169,BACKGROUND,COMMITTEE,CONCLUSION,END,FT4,JOINT,LABEL,METHODS,PRESS,RESULTS,SERUM,TSH
2009,2013,225,ANTIBIOTIC,APRIL,CDI,CONVERSELY,CURIOUSLY,HOWEVER,INPATIENT,JANUARY,LABEL,LATER,METHODS,OBJECTIVE,OCTUBRE,PURPOSE,RESULTS,TYPE,UNIVERSITY
231,IGF1R,MDA,MET,METASTASIS,TCM
946,BACKGROUND,CAUCASIANS,CIS,HOWEVER,LABEL,METHODS,NSCLC,ORS,OVERALL,RESULTS,SUMMARY,THUS
EARLY,METASTATIC,MOST,ONCE
001,012,072,086,2000,2007,8804,BACKGROUND,CRT,JANUARY,LABEL,METHODS,NEITHER,OTHERWISE,PRECISE,RECURRENCE,RESULTS
001,004,024,1999,2009,927,AFTER,BACKGROUND,BLACK,FINALLY,LABEL,METHODS,RESULTS,THESE,WHITE
946,EMT,PCC,SMAD3,TAKEN,TGF,ZEB1,ZEB2
001,013,016,121,8202,AGE,AIDS,BACKGROUND,CD4,CHEST,CROSS,HIV,LABEL,METHODS,OVERALL,PITTSBURGH,RESULTS,UNIVERSITY
AFRICAN,ALA,CAP,FURTHER,LNCAP,R1881,T877A
A431,ACRYLAMIDE,ALSO,EGFR,GATEKEEPER,H1975,L858R,MICHAEL,NSCLC,ORAL,SW620,T790,T790M,THESE
946,AMS,ATP,CONVERSELY,FURTHER,LIPID
945,946,BROAD,PTEN,THERE
AIM,BACKGROUND,CEACAM6,CONCLUSION,HOWEVER,IHC,LABEL,MEIER,METHODS,PDAC,RESULTS
100,109,148,2008,2013,AMONG,BACKGROUND,CONCLUSION,DFI,DISCUSSION,LABEL,PROGNOSTIC,RESECTIONS,RESULTS
179,1994,2011,INDUSTRIAL,INSURANCE,LAW
2452,ADP,BCL,MCL,MG132,PCR
NOR,TNM
HOWEVER,NUCLEASES,RNAS,ZFNS,ZINC
015,150,189,1A1,8734,AUC,AUCT,BACKGROUND,BLOOD,BOTH,CYP,ERLOTINIB,KOREA,LABEL,METHODS,OBJECTIVE,P450,RESULTS,THERE
356,ALK,BACKGROUND,CHINESE,EGFR,EML4,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,STUDIES,THUS,TKI,TKIS
005,1FX,CTV,IMPT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN
110,177,AVERAGE,DOSIMETRIC,GREATER,LABEL,MATERIALS,METHODS,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,ROTATIONAL,V95
ALTO,API,CONTOUR,IMRT,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PALO,PURPOSE,RESULTS,SYSTEMS,THESE,TPS,USER,XML
AGNC
CELL,PLA,PLG
001,005,169,2014,343,446,8201,897,CHD4,D140E,E139D,INC,NINE,SNV,SNVS,THERE,WILEY
160,2009,2013,284,AMONG,BACKGROUND,BETWEEN,CONCLUSION,FOLFIRINOX,III,JANUARY,LABEL,METHODS,NONE,PDAC,RADICAL,RESECTION,RESULTS
161,945,946,BACKGROUND,DOX,DRZ,DSB,H9C2,ICRF,LABEL,METHODS,RESULTS,TAKEN,TOP2A,TOP2B
169,1987,2013,2014,AIMS,AUTOPSY,FORTY,JOHN,LABEL,LTD,MAY,METHODS,OBJECTIVE,RESULTS,SONS,UNUSUAL,WILEY
001,047,086,178,2009,2013,314,324,330,356,AMONG,BACKGROUND,HOWEVER,JANUARY,LABEL,METHODS,OCTOBER,PCNA,PCNB,RESULTS,VATS
005,100,169,2005,2012,2014,225,6359,8201,ACTA,AMONG,BACKGROUND,CONCLUSION,FDG,FOUNDATION,FOV,LABEL,LUNG,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SMM,TORSO
001,007,015,044,135,239,8202,AMONG,ARMS,BACKGROUND,CONCLUSION,DETECTION,DHPLC,EGFR,LABEL,MATERIALS,MET,METHODS,NSCLC,PCR,PFS,REAL,RESULTS,T790M,TKI
016,021,024,028,029,031,035,042,046,048,412,GENOTYPES,RS16904853,RS2929946,WISP1
A549,ABCC1,ABCC4,CMPK,ERCC2,FOLH1,LC6,LMO7,LU130,LU99,PRSS3,SCID,SHMT1,TGI,TK1,TST,TXN
ATLAS,FINALLY,INTEGRATED,MUTATIONS,RADIA,TCGA
001,2014,375,CIS,HRS,LABEL,LIBRARY,MAY,METHODS,NSCLC,OBJECTIVE,RESULTS,STUDIES
169,2014,DISRUPTION,ECM,MMP,MT1,ORAI1,SRC,STIM1,SUN
519D,AMP,AMPK,MMP,TAKEN,THEREFORE
0001,106,169,2014,387,946,BRITAIN,COPYRIGHT,GREAT,IRELAND,JOHN,LTD,NSCLC,P53,PUBLISHED,SOCIETY,SONS,WILEY,WNT
LUNG,MOLECULAR,NSCLC
BCL,BH3,BIM,LUNG,NON,NSCLC,THEREFORE
CONSISTENT,STUDIES,THUS
113,177,BACKGROUND,COLLECTED,EGFR,HOWEVER,III,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,REAL,RESULTS,SPSS,STUDIES,THERE,TKIS
001,040,050,AFB,BACKGROUND,DISEASE,HGD,LABEL,LGD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILARLY,SPSS,YUV
001,004,005,014,017,032,048,2009,2012,604,APTT,BACKGROUND,DATA,FIB,FIFTY,HEBEI,III,INR,JANUARY,LABEL,MEDICAL,METHODS,NON,NSCLC,OBJECTIVE,PLT,PROLONGED,PTA,RESULTS,SPSS,TNM,UNIVERSITY
100,946,A549,ADD,AFTER,ALTERATION,BACKGROUND,CASPASE,CCK,FCM,LABEL,METHODS,NSCLC,OBJECTIVE,P53,PCR,RESULTS,WESTERN
A549,AFTER,BACKGROUND,DMAG,EGFR,H1975,HSP90,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,TKI,WESTERN
ADM,BACKGROUND,CCK8,DDP,FIRSTLY,H69,H69AR,LABEL,LUNG,MDR,MEANWHILE,METHODS,OBJECTIVE,PCR,QRT,RESULTS,SCLC,SPHK1,THEN,WESTERN
248,8201,984,AMONG,BACKGROUND,CDE,CHILDHOOD,CROSS,CSES,DATA,GENERALLY,LABEL,LOG,LOW,METHODS,MOST,MTE,NDE,NIE,PARAMED,RESULTS,RRS,STATA,THESE,TROMS
169,1998,2014,462,501,539,8201,963,AFTER,AUTHORS,COX,DIETARY,FURTHER,HORDALAND,HUSK,INC,PAR,PLP,PUBLISHED,PYRIDOXAL,UICC,WILEY
169,2014,AGC,CALCIUM,CMGC,EGF,EGFR,EGFRS,FINALLY,GMBH,JANUS,KGAA,L858R,MUTATIONS,PXD001101,S623,SILAC,STE,T790M,TKI,TOP,ULK1,VCH,WILEY
2000,2010,AFTER,BETWEEN,CHRONIC,CONSENSUS,ELDERLY,FURTHER,GROUP,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,CHOMP,GMBH,KGAA,VCH,WILEY

100,200,MRC,OVERALL,TAXOL,THEIR
160,MPM
169,181,2014,AMONG,JULY,RRS,UICC
III,MEN,REGARDLESS
109,231,AHR,CHIP,HSP70,MDA,NOTABLY,TAKEN,TNBC
169,2014,947,948,956,ALT,AST,BOLUS,CD8,CONCLUSION,DOSE,FLOW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
1959,2009,APC,BLACK,HOWEVER,THESE
HOWEVER,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THESE
ACTIVATION,BAK,BAX,BID,CASPASE,CYT,H2O2,NOXA,PUMA
FURTHER
001,169,2008,2012,2014,222,344,AMONG,ATTENDING,BACKGROUND,BASEL,CONCLUSION,DIAGNOSING,EBUS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,TBNA,TBNAS,THESE
169,2013,2014,8804,BASEL,EBUS,TAKEN,THESE,USING,VBN,VIRTUAL
169,2014,204,260,464,A549,BACKGROUND,BASEL,CALU,CONCLUSION,H23,H292,H460,IGF,IGF2R,INSULIN,LABEL,MEANWHILE,METHODS,NCI,NON,NOTABLY,NSCLC,RESULTS
143B,169,2014,945,BACKGROUND,BASEL,CXC,CXCR4,INFLIXIMAB,LABEL,METHODS,RESULTS,RHO,SCID,THESE,TNF
100,104,175,1982,1993,1995,2002,2007,2008,2009,239,386,526,AARP,ADVENTIST,AFRICAN,AMERICANS,AMONG,BLACK,BMI,COLORECTAL,COMMUNITY,COX,EAST,HRS,LUNG,NIH,OBESITY,OVARIAN,PREVENTION,SCREENING,TRIAL,WOMEN
169,2014,BASEL,PROBE
946,AMONG,ARRB1,CHALLENGE,DATA,E2F1,GPCRS,KIT,LUNG,NSCLC,SCF,SET,STEM,THESE
A549,AB11,CURRENTLY,EGFR,ERK,FURTHER,H1299,HOWEVER,MIG,NON,NSCLC,THERE,THESE
032,107,177,A549,CDK8,HOWEVER,MTT,NSCLC,PCR,WESTERN
CHEST,IHC,PBML,PULMONARY
CD44,CSF,DESCENDING,FURTHER,HOWEVER,UPON,WHILE
044,FACS,HOWEVER,IHC,MEANWHILE,NKP30,NSCLC,SIMILARLY,THREE
BACKGROUND,INCREASED,INCREASING,LABEL,METHODS,MTT,NON,NSCLC,PCR,PVT1,REAL,RESULTS,RNAI,RNAS
001,004,029,033,080,090,2001,2013,AGE,APRIL,CEA,HIGH,LYMPH,MAY,PFS,PMEC,PULMONARY,TNM
025,2008,2012,267,494,913,BACKGROUND,COX,JANUARY,LABEL,LDH,METHODS,NQO1,PARP1,RESULTS,SCLC,SMALL,SOD2
002,045,157,294,427,CNKI,DFS,EVER,HRS,IGF1R,MEDLINE,NSCLC,ORS,OVERALL,OVID,THUS
AXL,EGFR,EMT,MTT,NSCLC,RTKS,THOSE,TKI,WESTERN
001,013,015,124,MEIER,NON,NSCLC,SEX,SOX,SOX8,SOX9,SRY
ABDOMINAL,AMENORRHEA,ENDOSCOPIC,PNET,PNETS
CHINA,DESPITE,EARLY,HOWEVER,PANCREATIC,PET,SURGERY,WHAT
130,160,1901,1966,1980,2000,2013,2018,ABOUT,ACCORDING,AUTHORS,BACKGROUND,BASICALLY,CENTRAL,CETUXIMAB,CIS,COLLECTION,CONTROLLED,DATA,EASTERN,EGFR,GROUP,HRS,ISSUE,LABEL,LIBRARY,LUNG,MAIN,MANAGER,MEDICAL,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RCTS,RESULTS,RRS,SELECTION,SOCIETY,THERE,WORLD
200,HOWEVER,THORACO

PDGF,PTTM,PULMONARY,THESE,VEGF
046,2006,2014,557,587,AFFILIATED,APRIL,EGFR,FUDAN,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,RESULTS,TKI,UNIVERSITY,ZHONGSHAN
001,004,005,012,178,185,200,2006,2007,215,250,290,422,645,8315,8805,ACCORDING,CHINESE,COX,EGFR,GENERAL,GUANGDONG,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,ORR,PFS,RESULTS,SEPTEMBER,TKI
038,114,181,2010,2013,313,677,AMONG,CEA,EGFR,HOWEVER,IIIA,IIIB,JULY,JUNE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
001,014,022,030,036,167,170,181,2010,2013,344,357,444,578,622,840,8805,903,BETWEEN,CEA,CHEST,CLOSE,CYFRA21,DCR,EGFR,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RESULTS,SEPTEMBER,THOSE,TKI,UNIVARIATE
169,2014,INC,LYMPHATIC,VEGF,WHILE,WILEY
951,C1B,NSCLC,PKC,PKCS,PROTEIN,THUS
150,BACKGROUND,BEV,BPFE,CASE,LABEL,METHODS,PHLNM,RECURRENCE,SVCS
MOST,TEN,TOXIC
350,397,500,AIMS,CHINESE,CONCLUSION,MAF,METHODS,NSCLC,PHACTR2,RESULTS,SNPS
102,141,169,2014,DUE,FIVE,FOUR,PRESS,PUBLISHED,STUDIES,SURGERY,UNIVERSITY
2014,BALTOMA,BMJ,GROUP,LTD,MALTOMA,PUBLISHING
169,2014,ANTICANCER,COPYRIGHT,CPET,DLCO,FEV1,HOWEVER,INSTITUTE,JOHN,LUNG,NSCLC,OVERALL,VARIOUS
000,100,169,4T1,8430506,8804,956,COMBINING,FASEB,HEPG2,IC90,KI16425,KNOCKDOWN,LPA,LPA1,LPA2,NRF2,ONO
GINS,HOWEVER,PARTNER,PCR,PSF1,WESTERN
169,2006,2014,947,A549,CAKI,FLOW,GROUP,H2AX,HEP3B,IARC,NPS,OVERALL,PRESS,PUBLISHED,ROS,SOCIETY,TOXICOLOGY,UNIVERSITY
102ND,169,2014,ALECTINIB,ALK,LABORATORY,PHASE,PRESS,PUBLISHED,STAGE,THERE,UNIVERSITY
2014,3377,BMJ,FORMULA,FURTHER,GROUP,JULY,LIMITED,MEDLINE,OUTCOME,PAH,PAHS,POLYCYCLIC,POPULATION,PUBLISHED,PUBLISHING,WHILE
ASK,LUNG,STOP,THERE
ALTOGETHER,EFIRM,ELM,ELMS,GAPDH,GFP,H460,NUDE,RNAS,THESE
000,2005,2010,226,3127,578,859,885,DATA,FIVE,NEUCH,REGISTRIES,SHN,SWISS,THESE,VAUD
EGF,NON,NSCLC
143,946,A549,AZA,CATENIN,DUAL,NSCLC,PCR,SPC,SUBSEQUENT,TNM,WNT,WNT3A
00027,0050,215,650,85TH,BACKGROUND,CCP,COX,LABEL,METHODS,RESULTS,USING
176,BACKGROUND,CASE,INCREASING,LABEL,METHODS
ACADEMY,COMMITTEE,FACTORS,GROUP,HEAD,IASLC,ITMIG,LUNG,LYMPH,MALIGNANCY,NECK,PROGNOSTIC,SOCIETY,STAGING,SURGERY
105,808,8TH,COMMITTEE,CONTROL,DESPITE,GROUP,JOINT,LUNG,SIZE,STAGING,UNION
8TH,GROUP,LUNG,TNM
ANNEXIN,BACKGROUND,CELL,CONCLUSION,LABEL,MATERIALS,MES,METHODS,MTT,OPUNTIA,P53,PTEN,RESULTS,WESTERN
2014,BMJ,CARCINOMA,GROUP,LTD,METASTASES,PLEURAL,PUBLISHING
141,222,CSF,FIFTY,FOXL1,POU,RFX1,SNPS,SP1,THESE,USF1
001,078,161,594,BOTH,CTX,FURTHER,GCT,IPFSG,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SALVAGE
8209,A549,DESPITE,HDAC,HDAC4,MDR1,NOTABLY,STAT1,THESE,TSA
1145,1149,180,2014,BLOOMBERG,EPIDEMIOL,GOVERNMENT,HOPKINS,JOHNS,METRICS,PRESS,PUBLISHED,ROTHMAN,UNIVERSITY,USING
169,181,1982,2014,25TH,75TH,BLOOMBERG,ESTIMATES,HOPKINS,HOWEVER,JOHNS,PRESS,PREVENTION,PUBLISHED,UNIVERSITY
ASPIRATION,BOTH,EBUS,ESOPHAGEAL,FINE,TBNA,ULTRASOUND
AFTER,BARR,EBV,EPSTEIN,MMP,PAH,PTSMT,THESE,USING
470,8201,AFTER,ASSAY,CFI,CHINESE,COMPLEMENT,GENOTYPING,GOLD,HAPLOVIEW,MASSARRAY,NSCLC,ORS,SNPS,THERE,TOTALLY
33342,945,946,954,A549,AKT,BCL,CHANGES,DDP,FAF1,FAK,FAS,FASL,FINALLY,HOECHST,HUVEC,MRP,MTS,PI3K,VBMDM
169,2014,ALK,COPYRIGHT,EGFR,FGFR,FGFR3,MAPK,MEK,SCIENCE,SRC
102,109,242,385J1,586,8209,8805,AMONG,HOWEVER,NSCLC,RNAS,RP11,SEVERAL,USING
AUSTRALIA,CHEST,INTERVIEWS,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROYAL,SEMI,SOUTH,SUPPORT
169,16HBE,2014,AUTHORS,BCI,EMP1,ERK,GEFS,MEK,NS1,RAS,RNAI,SOS1
003,032,033,044,046,DFS,III,INCREASING,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OVERALL,OVERSIZED,PURPOSE,RESULTS,RFA,SEX,TREATMENT
0001,0207,0374,143B,312H,CELL,EXPRESSION,FOLLOWING,GFP,HOS,KHOS,MG63,NIS,SJSA1,VIRAL
169,2014,8201,ASIA,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
123,8209,954,960,A549,ABCA2,ABCA5,AKT,ATP,CHINA,DDP,ERK,HOWEVER,LUNG,MDR,MULTIDRUG,STAT,STAT5
1171,A20,ALK,EML4,H21,H28,H30,HIP1,HOWEVER,HUNTINGTIN,NSCLC
001,1092,165,2010,2014,927,ALK,BACKGROUND,BETWEEN,FISH,LABEL,METHODS,NSCLC,RESULTS,SPAIN,SPANISH,THUS
2008,2012,8201,AMR,BACKGROUND,CBDCA,FURTHER,LABEL,METHODS,OCTOBER,ORR,RESULTS,THERE
1981,1999,2004,2011,2015,COMMITTEE,IASLC,LUNG,PATHOLOGY,SOCIETY,WORLD
000,100,1616,1656,185,1946,1974,2013,2328,2823,400,465,679,8312,8805,APRIL,AUTHORS,BACKGROUND,CARE,COLLECTION,DATA,EXCELLENCE,FDG,HSROC,INSTITUTE,JULY,LABEL,LIBRARY,MAIN,MEDLINE,METHODS,NICE,NONE,NSCLC,OBJECTIVE,OBJECTIVES,OTHER,PET,PREMEDLINE,RESULTS,RISK,ROC,SELECTION,SROC,THERE,UNDER
163,193,266,283,549,CHINA,MIXED,PAH,PAHS,THESE,XUANWEI
035,103,AMONG,BACKGROUND,EBUS,LABEL,METHODS,RESULTS,TBNA
0001,0006,001,002,004,013,8202,8804,BPM,CCR,DPM,MCM,PCI,PERITONEAL,SOLID,THERE,TPM,WDPM
215,ADENOSINE,FE3O4,RAMAN,SERS,THROUGH
001,019,705,805,8202,AMONG,AUC,BACKGROUND,COX,FURTHER,GLASGOW,GPS,HOWEVER,LABEL,METHODS,NLR,NPC,PLR,PROGNOSTIC,RESULTS,SCORE,SEVERAL
ADC,AMONG,BACKGROUND,BASED,COX,DFS,FDG,HOWEVER,LABEL,METHODS,PET,RESULTS,SQC
001,002,004,017,029,100,169,2014,380,437,ALK,BOTH,EGFR,MSI,ROS1,SIMILARLY,TIL,TILS,TNBC,TP53
181,8804,A549,HOECHST,HOWEVER,IC50,LABEL,MATERIALS,METHODS,MHMD,MTT,OBJECTIVE,RESULTS,TYPICAL,VAD
160,ADR,AFTER,BACKGROUND,DDP,DIA,IFO,LABEL,MEIER,METHODS,MMIA,MTX,RESULTS
2014,BMJ,FDG,FINALLY,FOUR,GROUP,KI67,LTD,OWING,PET,PUBLISHING,THREE
65292,65310,946,AFTER,INF,SIX,UNDER
GASTRIC,ORAL,RCC
169,193A,2015,BECAUSE,BIOLOGY,ERBB,ERBB4,INC,MOLECULAR,SOCIETY,TAKEN,UTR
000,002,177,3DCT,4DCT,8201,CONCLUSION,GTV,GTVA,GTVS,LABEL,MATERIALS,METHODS,MIP,OBJECTIVE,OBJECTIVES,RESULTS,SPL,THERE
100,20MM,ACUTE,BASED,CLINICALLY,PROGNOSIS
AFTER,BARR,CHEST,EBER,EPSTEIN,FDG,LELC,MALT,PET,S10

CHEST,VATS
AKT,BAX,BCL,CAV,DENDROBIUM,ERK,GTP,H460,MCL,RAC,RESISTANCE,RHO,TAKEN,WESTERN
183,956,CALU,CELL,FITC,GSH,HOWEVER,IC50,NAC,ROS,TRX
954,HOWEVER,LARGE,LATS2,NSCLC,TAKEN
1607,1G1G,1G2G,2014,2G1G,2G2G,640,915,ASIAN,CIS,CRUDE,GROWING,MMP1,ORS,SEPTEMBER,STATA,THUS
231,4T1,DOWN,HIGH,MDA,STC1,SUBSEQUENT
231,4T1,AKT,BACKGROUND,BALB,EGF,ERK,FINALLY,LABEL,LUC,MDA,METHODS,MLC,PIV,PULL,RAC1,RESULTS,RHOA,VAV2,WESTERN
95D,CCNG2,DEPLETION,ECM,MICROARRAY,NUPR1,PCR,PTEN,THESE,TIMMDC1,TIMP3
CRAN,EMT,ENA,GRNS,HOWEVER,REVERSE
BACKGROUND,CLINICIANS,EARLY,LABEL,METHODS,RESULTS,THESE
100,169,BC12,COPYRIGHT,IP64,LABEL,METHODS,NONE,OBJECTIVE,OBJECTIVES,PATHOLOGY,PAX,RESULTS,SOCIETY,SP1,SPT24,TTF,USING
169,199A2,2014,945,BINDING,BIOLOGY,CHIP,ENDOTHELIN,HIF,HOWEVER,INC,MOLECULAR,PLGF,PPAR,SCD,SOCIETY,UTR
132,169,2014,ALR,ATG5,AUTHORS,BREFELDIN,CONNEXINS,CX31,FOUNDATION,H1299,HOWEVER,JOHN,JOURNAL,KNOCKDOWN,LC3,LTD,MOLECULAR,SONS,TAKEN,UNDER,UPS,WILEY
169,2014,737,A549,ABT,AUTHORS,FOUNDATION,H1299,JOHN,JOURNAL,LTD,MOLECULAR,REGULAR,SONS,WILEY
200,247,ARMS,CONCLUSION,CYPS,GSTM1,GSTP1,GSTT1,ILE462VAL,LABEL,MATERIALS,METHODS,NAT2,OBJECTIVE,OBJECTIVES,PCR,PORTUGUESE,RESULTS,RFLP,TOBACCO
051,053,162,164,608,612,749,750,BACKGROUND,BETA,C30,CARLO,CLAD,CONCLUSION,DATA,EORTC,LABEL,LIFE,MEAN,METHODS,MONTE,QALY,QLQ,QUADRATIC,QUALITY,RESULTS,RMSE,TOBIT,TOPICAL,YEARS
106,169,2014,CAF,CAFS,EGFR,EPIDERMAL,ERK,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PODOPLANIN,PURPOSE,RESULTS,TKI,TKIS
001,028,169,2014,ACTIVATION,AYCC,HIPPO,III,IYCC,KRAS,LABEL,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,STRATIFIED,YAP1
BACKGROUND,BASED,CASE,CONCLUSION,HOWEVER,LABEL,METHODS,THESE,THREE,THYROID
CURRENTLY,LUNG,NON,NSCLC,USING
1993,2008,ABL,BCR,CD34,CD38,CD90,CML,HLA,LINEAGE,PRS,SCT,SCTS,TKI
III,PHASE,STUDIES
001,8201,BACKGROUND,EACH,FOUR,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OLDER,RATIONALE,RESULTS
154,892,957,HOWEVER,LNA,LUNG
AKT,APS,ASTRAGALUS,BACKGROUND,C57BL,HOWEVER,LABEL,METHODS,PI3K,RESULTS,ROS,THESE,TREATMENT,TUNEL,WESTERN
PROBIOTICS,SPECIES,WORLD
001,170,1995,1999,2000,2004,232,442,469,984,999,AFTER,AMERICA,BACKGROUND,CALI,CASES,EST,FIVE,FOLLOWING,LABEL,LATIN,METHODS,OBJECTIVE,RESIDENTS,RESULTS,SES,SITES,THERE
169,2015,BENEFIT,EVEN,GEP,IDEAL,INTRA,NET,NETS,SOCIETY,TACE,TAE,THESE
169,179,2014,386,552,8805,967,CONCLUSION,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,THESE
169,2014,276,ADS,CONCLUSION,DISCREPANT,GENOMIC,LABEL,LASER,LUNG,METHODS,MULTIFOCAL,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SQCC,SQCCS,USING
001,003,004,018,043,047,169,170,2014,223,637,759,802,880,8805,AMRUBICIN,CONCLUSION,GRADE,III,LABEL,METHODS,NQO1,OBJECTIVE,ORR,PFS,PRIMARY,PURPOSE,RESULTS,SCLC,SOCIETY
1106,16S,181,2618,946,A549,ATCC204508,ENDOPHYTIC,FDC83,GRAM,IC50,INDOLES,KOCURIA,LGMB259,NRRL,PC3,R5A,VINYL
954,C57BL,CHINESE,EUPATORIUM,FURTHER,HOWEVER,HUVEC,JNK,MMP,TAKEN,VEGF,WEF
211H,8209,FOUR,H2052,H2452,H28,MPM,MSTO,NPE6,PDT,PEMETREXED,WST
100,1162,160,2010,2013,267,ACTUARIAL,AMONG,D95,ITVS,KARNOFSKY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OVERALL,PTV,PURPOSE,RESULTS,SBRT,SIX,T1A,T1B,THERE,TREATMENT,VMAT
100,8209,ADAM,H23,MMP,MMP2,MMPS,NCI,NKG2DLS,PREVIOUSLY
ADDITIONAL,DRUG,FDA,FOOD,HODGKIN,MPDL3280A
007,ASIAN,CHINA,CHINESE,COX,FGFR1,III,JAPAN,SOX2,SQCC
26S,947,FURTHER,LOSS,MG132,R175H,THESE
126,128,15A,2009,210,34A,8201,EXPRESSION,HOWEVER,LUNG,NSCLC,PCR,REST,SAMPLES,SCC,SPSS,TNM
169,2014,HOWEVER,RSNA
1BBL,945,947,CCR5,CCR7,CD54,CD62L,CD86,CROSS,CXCR3,CXCR4,IFN,MCP,MIP,OX40L,TANS
120,212,765,942,ASIAN,BACKGROUND,BIM,CONCLUSION,EGFR,HOMOZYGOTE,HOWEVER,LABEL,METHODS,RESULTS
100,2008,2011,AUC,BACKGROUND,BASED,HOWEVER,III,IIIA,IIIB,LABEL,MARCH,METHODS,MOLECULAR,OCTOBER,PFS,RESULTS,SEVENTY,TREATMENT
BACKGROUND,CCDC6,CONCLUSION,HCC78,LABEL,METHODS,NSCLC,RESULTS,RET,ROS1,SLC34A2
790,946,BACKGROUND,CATENIN,CONCLUSION,EGFR,LABEL,METHODS,NSCLC,RESULTS,T790M,TKI,TKIS,WNT
001,003,022,033,113,247,320,825,FINALLY,HOWEVER,MEIER,NSCLC,PCR,STMN1,TNM
100,319,986,AMP,ARHGEF2,BRAF,CHTOP,CREB5,FFPE,FGFR2,MSN,NRG1,NTRK1,PCR,PPL,RET,ROS1,RUFY2,TPM3,TRIM4,VALIDATION,VAMP2
2003,2005,402,BACKGROUND,CHEST,COX,LABEL,LUNG,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PLEURAL,RATIONALE,RESULTS
CASE,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
1000,119,266,648,BACKGROUND,CHEST,CME,CONCLUSION,CONTINUING,EARLY,EDUCATION,GPS,HALF,LABEL,LDCT,MEDICAL,METHODS,RESULTS,THERE,TRIAL,WHETHER
BACKGROUND,LABEL,MCC,METHODS,RESULTS,USING
945,949,A549,BOTH,MCF,NAD,SAR,SIRT2,SIRTS
790,ACTIVATING,DUE,EGFR,HTS,JAK2,L858R,T790M,TYK2
111,8805,BACKGROUND,FURTHER,GRADE,HOWEVER,IPN,IPNS,LABEL,METHODS,PPLC,RESULTS,T1A,T1B,T2A
007,106,2007,2011,406,534,IQR,MEIER,MEM,THERE
169,2014,ERK1,INC,MEK,PP2A,RAS,SMYD3,THESE,WILEY
002,125,BACKGROUND,BCS,LABEL,METHODS,MOST,OWING,RESULTS,THEREFORE
169,2014,CASPASE,EGFR,FINALLY,H1975,HDAC,HISTONE,HOWEVER,SAHA,T790M,TKI,TKIS,UICC,WHILE
169,2014,COPENHAGEN,DENMARK,DEPARTMENT,DESPITE,FOLLOWING,LABEL,METHODS,OBJECTIVE,OUTCOME,PURPOSE,RELEVANCE,RESULTS,SURGERY,UNIVERSITY
2ND,3RD,EGFR,EPIDERMAL,MET,NSCLC,TKI,TKIS
ALK,HGF,HOWEVER,MET,THERE,THESE
2008,A2780,A431,A549,AKT,CDK2,CHK1,CONCLUSION,EGFR,EPHA1,ERBB4,ERK,ERLOTINIB,FGF,JM118,JM216,LABEL,PTEN,RAS,STAT3,UNLABELLED,VEGFR,WIDR
ALK,AREAS,BACKGROUND,CERITINIB,CONTINUED,COVERED,CRIZOTINIB,EGFR,III,LABEL,METHODS,NSCLC,OPINION,PHASE,SEVERAL,TKI,TKIS,TREATMENT
EZH2,INTRAVITAL,KIF22,KIF2C,NOTCH,OCA2,SRF,SUBSEQUENT
AMOT,ANGIOMOTIN,CL1,CYR61,FURTHER,HOWEVER,KNOCKDOWN,LEWIS,LUNG,PDZ,RESULTS,TAZ,THESE,YAP,YES
3RDS,637,BACKGROUND,DESPITE,IPF,LABEL,METHODS,RESULTS
2010,FAILURE,FINALLY,LCS,LUNG,NLST,RCT,RCTS,SCREENING,TRIAL
947,948,CYTOTOXIC,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
946,A549,BACKGROUND,CONCLUSION,EMT,EPITHELIAL,GC7,H1299,LABEL,METHODS,NCI,NSCLC,RESULTS,TGF
160,CONCLUSION,FOUR,LABEL,MATERIALS,METHODS,NEXT,OBJECTIVE,PURPOSE,RESULTS
100,231,549,945,956,ABTS,BHA,FURTHER,HELA,IC50,MDAM,MTT
956,AGS,AMPS,CELL,DUE,FLOW,GASTRIC,HOWEVER,IC50,LC3,PARP,THESE,WESTERN
0571,0716,169,1973,2010,2014,556,ACTUARIAL,BAP1,BRCA1,END,FIVE,PRESS,PUBLISHED,RESULTS,SEER,TEN,UNIVERSITY
BACKGROUND,CASE,CRIZOTINIB,CYFRA21,INCREASES,LABEL,METHODS
0040,0267,0954,120,177,2006,2011,472,9177,AFTER,AIM,AMONG,BACKGROUND,COMPARISON,CRM,DFS,LABEL,LOCAL,MEAN,METHODS,OBJECTIVE,RESULTS
CELLS,CNE1,CONCLUSION,H1299,HEP3B,HIGH,INHIBITION,LABEL,MATERIALS,MCF,METHODS,MGC,NCI,OBJECTIVE,OP18,PURPOSE,RESULTS,TAXOL
014,120,258,531,AFTER,AIMS,BACKGROUND,CRD,EMG,FURTHER,IIM,ILD,LABEL,METHODS,OBJECTIVE,RESULTS
077,112,169,2014,8804,8805,BOTH,C000000146,COMMITTEE,CTR,DATA,ECOG,ELDERLY,FURTHER,LABEL,METHODS,MONITORING,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIXTY,UMIN,UNIVERSITY
169,200,2014,AFTER,CAR,CD28,CD4,CD8,COPYRIGHT,M28Z,SCIENCE
BMJ,GROUP,INCREASING,LIMITED,PUBLISHED,PUBLISHING,RNAS
114,187,196,8364,AIMS,BMJ,BRAF,COLON,EGFR,GROUP,ION,KRAS,LABEL,LIMITED,LUNG,METHODS,NGS,NRAS,OBJECTIVE,PANEL,PUBLISHED,PUBLISHING,RAS,RESULTS,TAT,TORRENT
169,2014,217,3112,3687,385,536,552,573,ACIDS,CHIP,EGFR,H3K27AC,H3K4ME1,H3K4ME3,NUCLEIC,PRESS,PUBLISHED,SEQ,UNIVERSITY
169,2002,2014,322,ACIDS,CHIP,DBTSS,NUCLEIC,PRESS,PUBLISHED,RELEASE,SINCE,SNV,TSS,TSSS,UNIVERSITY
169,2014,947,A549,ACIDS,ADP,BER,EXOG,NUCLEIC,PARP1,PARYLATED,POL,PRESS,PUBLISHED,UNIVERSITY
375,MALT,PULMONARY,RITUXIMAB,THERE,TREATMENT
2009,2012,2PATIENTS,AIM,LABEL,LIFE,METHODS,OBJECTIVE,QUALITY,RESULTS,UNIVERSITY,WASHINGTON
169,2014,ALK,BACKGROUND,BASEL,EBUS,EGFR,KRAS,LABEL,LIBRARY,MAIN,METHODS,MOLECULAR,NEITHER,OBJECTIVE,OBJECTIVES,OBTAINING,RATIONALE,RESULTS,REVIEWS,SYSTEMATIC,TBNA,THERE
036,169,2000,2011,2014,245,271,298,307,407,453,507,672,699,870,897,AAPC,BACKGROUND,COLORECTAL,DESPITE,HIGH,INCIDENCE,INPATIENT,LABEL,METHODS,NATIONWIDE,RESULTS,SOCIETY
032,132,140,169,180,2010,2011,2014,8201,BACKGROUND,LABEL,METHODS,NSCLC,OCTOBER,PFS,RESULTS,SOCIETY,TREATMENT,VEGF
169,2014,A2A,A2AR,A2ARS,ADORA2A,CD44,CD8,DCS,DEPLETION,HIGH,IL10,IL12,LEWIS,LY6C,LY6G,LYSMCRE,MDSC,MDSCS,MHCII,MYELOID,OVERALL,REDUCED
0008,169,183,1998,2013,8202,DUE,FIVE,GEORG,GRAFT,LOCAL,MAJOR,NSCLC,RADICAL,STUTTGART,SVC,YORK
024,036,094,691,709,726,775,8201,892,910,945,988,COX,FURTHER,MEIER,NSCLC,POMC,ROC
8209,BONE,CD105,CD106,CD31,CD34,CD45,HBMMSCS,LIPID,MYOD1,P10,P25,P57
096,149,157,169,2014,217,254,IQR,LABEL,LEPIDIC,LOCAL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THESE,UNIVERSITY
169,2014,A549,ADCC,CD147,CHINA,H520,IGG1,METUZUMAB,MICE,NCI,NSCLC,SPRAGUE,THESE
169,2014,5ENVE,BAI1,BRAIN,FINALLY,GPCR,TREATMENT
2000,222,301B,338,577,597,615,696,8209,8805,891A,944,FURTHER,HISEQ,LUNG,MICRORNAS,NSCLC,RNAS,SEQ,SINCE,TARGETS,THERE
014,048,099,137,214,299,335,914,BACKGROUND,DDR2,EGFR,EPIDERMAL,GENOMIC,LABEL,LUNG,METHODS,NSCLC,RESULTS
2000,2010,BACKGROUND,LABEL,METHODS,MULTILEVEL,RESULTS,SWEDISH,THERE
001,020,157,1YEAR,8805,BACKGROUND,GR2,GR3,ILD,LABEL,METHODS,PRE,RESULTS,SBRT
NUR77,TR3
ALZHEIMER,LIPIDOMICS
160,1993,2008,BACKGROUND,IMPLANT,LABEL,MEAN,METHODS,OVERALL,RESULTS
169,188,2014,368,854,AUSTRIA,BASEL,BURKITT,DLBCL,DUE,HODGKIN,LUNG,MOST,PRIMARY,RICHTER
000,072,100,2001,2006,2011,2012,242,286,363,480,554,612,654,725,787,8805,BACKGROUND,COPD,DATA,DEPARTMENT,DESPITE,EMERGENCY,INPATIENT,LABEL,METHODS,NATIONWIDE,NEDS,NIS,NUMBERS,RESULTS
1129,8202,ERCC1,HOWEVER,ODDS,ORR,PFS,SCIENCE,SCLC,THEREFORE,WEB
223,AFTER,AKT,ALK,CHK,CSCS,EGFR,EML4,ERK1,FAK,INHIBITION,KRAS,LKB1,LYN,METF,METFORMIN,NSCLC,PHOSPHO,REMARKABLY,SAL,SRC,THEREFORE,TKIS,YES
140,2003,2012,BACKGROUND,CELSIUS,CONCLUSION,ESOPHAGEAL,FIRST,IASI,LABEL,METHODS,OVERALL,RESULTS,TECHNIQUE
110,2005,2010,2013,678,LABEL,MAY,MEDICAL,METHODS,MRI,MRIS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,TMC,TUFTS
000,2030,500,POLES
AFTER,ASKIN,PNET
001,011,023,035,041,043,046,048,104,2008,2011,8805,CCRT,DFS,DISEASE,IIIA,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,SIZE,SUV,WHILE
160,BEST,FIFTY,FOUR,GRADE,III,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE
001,003,006,008,357,375,ALK,CNG,DFS,NSCLC,ROS1,THERE
156,1945,2012,BACKGROUND,CARCINOID,CTS,CURE,FOUR,LABEL,MEAN,METHODS,MOST,NATIONWIDE,NONE,OBJECTIVE,OHIO,PURPOSE,RESULTS,SPM,SPMS,THREE
177,179O,300OCCW,3DCRT,5000CGY,6MV,90O,BACKGROUND,CBCT,DIBH,DOSE,HOWEVER,LABEL,MATERIALS,METHODS,OAR,PTV,RESULTS,RPM,TEN,V20GY,V30GY,VMAT
100,956,A549,CONCLUSION,LABEL,LYS,METHODS,MNPS,MRI,OBJECTIVE,RESULTS,TEM,THEN,UNDER,VSM,ZETA
BACKGROUND,CALU,LABEL,MAA,MATERIALS,METHODS,MTT,PCR,PINX1,RESULTS
003,004,007,008,022,029,036,039,045,177,BACKGROUND,HIGH,IIIA,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SPARC,STAGE
634,765,BACKGROUND,BCL,CIS,DFS,FURTHER,HIGH,HRS,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
BACKGROUND,LABEL,MALIGNANT,MATERIALS,METHODS,ORAL,RESULTS,UNDER
113,116,17A,17F,469,7488A,832G,BACKGROUND,LABEL,MATERIALS,METHODS,PCR,RESULTS,RFLP
1640,A549,AFTER,ASSESSMENT,BACKGROUND,CELLS,DMAG,FBS,FOURIER,HSP90,IC50,LABEL,MATERIALS,METHODS,MTT,OTHER,PCR,PEG,PLGA,RESULTS,RPMI,THEREFORE
2000,A549,EXPRESSION,GSTA1,MRC,MTT,PCR,REAL,RESULTS,SIRNA,THREE,WESTERN
ADVERSE,AFTER,CONTROL,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
160,200,2011,2013,ACCEPTABLE,BACKGROUND,BEZMIALEM,CISPLATIN,DEPARTMENT,ECOG,FACULTY,GRADE,HOWEVER,IIIB,LABEL,LUNG,MATERIALS,METHODS,NSCLC,RADIATION,RESULTS,STAGE,TEN,UNIVERSITY,VAKIF
945,946,947,948,AMONG,BASED,DUSP1,ERK,ERK1,ERK2,ERK3,ERK4,ERK5,HOWEVER,JNK,JUN,MAP,MAPK,MEK,MITOGEN,RAF,RAS,SAPK,SEVERAL,THERE
2013,ACCORDING,CHINA,HOWEVER,PROTEOMICS
A549,CCK,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THEIR
338,8209,ECTOPIC,HOWEVER,NSCLC,RAB14,RAS,THEREFORE,THESE
045,049,176,562,946,967,BACKGROUND,CHI,IIIA,INCREASING,LABEL,MEIER,METHODS,RESULTS,SMAD,SMAD2,TGF,THERE,THEREFORE
ALK,BRAF,EGFR,HOWEVER,IHC,MET,OTHER,ROS1,V600E
MEDICAL,RADIOLOGY,SOCIETY,SPANISH,TNM
0015,133,248,8804,916,A549,HIGH,NSCLC,RISK
0001,AFFAIRS,BACKGROUND,COMPARE,COMPOSITE,FOUR,LABEL,METHODS,OBJECTIVE,RESULTS,WEAK
8209,ADP,BCL,CHINESE,FORSYTHIA,FSEER,FSFEE,FSLEE,FSREE,JANUS,THESE
129,155,BACKGROUND,CHIP,DSG2,EMT,FURTHER,HOWEVER,LABEL,MCRS1,METHODS,MICROARRAY,MIR,NSCLC,PCR,RESULTS,RETROVIRUS,SYSTEMATIC,UTR
001,004,396,AES,CONCLUSION,DCR,DCRS,ELECTRONIC,FURTHER,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,ORRS,PFS,PURPOSE,RCTS,RESULTS
100,210,789,BACKGROUND,BOTH,CONCLUSION,CTC,CTCS,DESPITE,DTCS,HENCE,HOWEVER,HT29,LABEL,LUNG,METHODS,PRIMARY,RESULTS
AMONGST,PROSTATIC
200,LUNG,RNAS
CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESULTS
1999,2006,416,ADDITIONAL,BACKGROUND,BETWEEN,DESPITE,EXPOSURES,LABEL,MAIN,METHODS,MOST,REGRESSION,RESULTS,UNITS
003,004,014,226,261,268,8201,BACKGROUND,BIOMARKERS,CBQ,COPD,DENMARK,FEV1,LABEL,LIFE,MAIN,MEASURE,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RATIONALE,RBM,RESULTS,THERE,TOMOGRAPHY,WESTERN
000,0088,0154,0201,0314,0316,0478,106,186,557,631,709,BACKGROUND,COSTS,HOWEVER,ICERS,INSTITUTE,LABEL,LUNG,METHODS,NLST,QALY,QALYS,QUALITY,RESULTS,SCREENING,TRIAL
A549,H358,H520,HES1,LUNG,NICD,NOTCH,NSCLC,RHO,RHOE,RND3,WEST
AKT,ALK,EGFR,ERK1,HOWEVER,MER,NSCLC,STAT6,THESE,TOTAL,TREATMENT
100,8805,AMONG,CANDIDA,PCR,RAPD
001,120,466,CAP1,MEIER,NSCLC,ROC,THESE
8209,8898,A375,ARSENIC,AS4S4,CELLS,CHINESE,HEPG2,L02,LEWIS,MKN45,THESE
169,2014,946,HOWEVER,INC,NKX2,PI3K,TGF,THEREFORE,WILEY
100,BACKGROUND,CHINA,CHINESE,HABIT,LABEL,METHODS,MOST,RESULTS,SMOKING,TOBACCO
100,169,181,2007,2010,2014,288,AFTER,ARSENIC,BLOOMBERG,CHILE,HOPKINS,JOHNS,MEAN,PRESS,PREVIOUSLY,PUBLISHED,THESE,UNIVERSITY
0001,0012,0307,0427,119,166,177,274,293,341,720,747,8209,946,947,CCL17,CCL20,ELISA,FOXP3,HOWEVER,MPE,PCR,PPE,ROR,TGF,TH17,THEIR,TREG,TREGS
109,A375,A549,BASED,ECA,HEL,MTT,THESE
0001,2003,2011,822,BACKGROUND,CONCLUSION,HISPANICS,LABEL,METHODS,NOTX,NSCLC,RESULTS,SBRT,THERE,THESE,TREATMENT
2005,2011,552,APART,BACKGROUND,CENTRAL,CONCLUSION,COX,DATA,DENMARK,DUE,INITIAL,LABEL,LUNG,METHODS,PATIENT,POPULATION,RESULTS,TREATMENT,WOMEN
176,179,182,200,500,8805,BACKGROUND,BEV,BOTH,COMMITTEE,DCR,EASTERN,G4PFS,GROUP,JOINT,LABEL,METHODS,NSCLC,ORR,PAC,PEM,PFS,PRONOUNCE,RESULTS,SECONDARY
133,142,196,2010,2013,8804,8805,BACKGROUND,CONCLUSION,EBUS,HOWEVER,LABEL,LYMPH,MARCH,METHODS,RESULTS,TBNA,THREE,USING
DENMARK,FINALLY,FURTHER,HOWEVER,PAPER,THESE
CASE,CLINICIANS,LABEL,METHODS,PEMETREXED,TTP
945,A549,ERK,FOLLOWING,HOWEVER,LUNG,NSCLC
231,ELISA,ERK,ERK1,MDA,MMP,THESE,TIMP,TRANSWELL,WESTERN
ISOTROPIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOMETIMES,THEIR,THEN
177,BAA,HOWEVER,IMAGE,LABEL,METHODS,OBJECTIVE,OPAST,PURPOSE,RESULTS,SAA,SBDX,THEIR
001,150,DICE,DSI,FDG,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PROGRESSOR,PURPOSE,RESULTS,ROOT,SIXTEEN,SUV
176,CARLO,D95,DOSE,DVH,DVHS,HOWEVER,LABEL,METHODS,MONTE,MRI,OBJECTIVE,PURPOSE,RESULTS,SITES,V20
117,4DCT,CTV,DESPITE,ITV,LABEL,MAO,METHODS,OAR,OARS,OBJECTIVE,PHANTOM,PURPOSE,RESULTS,THROUGH,V20,V25,V30,WHILE
142,160,177,179,4DCT,DICE,DSC,FOUR,HIGH,INDIVIDUAL,ITV,LABEL,LUCAS,METHODS,MRI,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,SBRT,THEIR
001,282,803,ARID2,BAF,BRD9,CALU,CATALOGUE,MUTATIONS,PEARSON,SMARCA4,SNF,SOMATIC,SWI,THEREFORE,TP53
T2TMETS
8209,A549,AKT,CISPLATIN,EGFR,ERK1,H1299,H1975,HOWEVER,NSCLC,TKIS
001,1000,177,CASES,CONCLUSION,CURRENT,CVD,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SCREENING,TRIAL
100,169,195,2014,720,COLLEGE,DDIS,ICU,LEXI,LUNG,METABOLISM
001,011,177,8201,8710,BACKGROUND,BONE,CONTROL,LABEL,METHODS,REAL,RESULTS
001,177,3360,380,455,677,718,768,813,927,985,998,AIF,AIFS,BLAND,CONCLUSION,ICC,ICCMANUAL,ICCS,KCC,KENDALL,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROI,ROIS,THREE
156,169,2015,8201,BACKGROUND,FNAB,FNABS,KNOWLEDGE,LABEL,METHODS,RESULTS,SCCS,SECONDARY,SNTG,SNTGS,SOCIETY
SOLID,THESE
BOTH,EFFECTIVE,FORCE,LDCT,LUNG,PREVENTIVE,SCREENING,TASK,TRIAL
10001,333,ASIA,HCC,JAPAN,MEDICAL,PUBLISHERS,RISK,SCREENING,SEVENTH,SPECIAL,THERE,USA,YORK
095,169,2014,224,549,BACKGROUND,COMPONENT,DATA,EMOTIONAL,END,FORM,HODGKIN,HRQOL,ITEM,LABEL,MCS,METHODS,PCS,RAND,RESULTS,ROLE,SCALE,SHORT,SOCIETY,SUMMARY,SURVIVORS
COPD,EPIGENETIC,HATS,HDAC4,HDACS,MEF,MEF2C,SUMO,THESE,WHETHER
10TH,116,CA224,CDK1,CDK4,H460,HCT,MTD,NCI,SCID,SV40,WESTERN
169,1990,1996,2010,2014,AANHPIS,AGE,AMERICANS,APC,ASIAN,BACKGROUND,CHINESE,HAWAIIANS,ISLANDERS,JOINPOINT,LABEL,LUNG,METHODS,PACIFIC,RESULTS,SCC,THESE
0001,0002,169,2014,584,8805,AMERICANS,BACKGROUND,DHBMA,GSTT1,HAWAIIANS,HOWEVER,LABEL,MEAN,METHODS,MHBMA,RESULTS,THESE
169,2015,954,BRMS1,COPYRIGHT,EMT,K310,KNOCKDOWN,NSCLC,RELA,SOCIETY,THESE,USING
169,2014,8805,CTV,DVH,GYE,IIB,IIIA,IIIB,JAPAN,NSCLC,PBT,PLANS,PRESS,PUBLISHED,RADIATION,SOCIETY,TNM,UNIVERSITY,V20,V50,XCRT
169,2014,745,762,793,855,ADP,AKT,AKT1,ASP,ATP,BCL,BIM,BIOLOGY,EGF,EGFR,ERK1,ERK2,GLU,H1975,ILQ,INC,L858R,LYS,MET,MOLECULAR,NON,NSCLC,SOCIETY,T790M,TAKEN,TKI,TREATMENT
051,169,2007,2012,2014,445,8805,AIM,ANTICANCER,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EASTERN,ECOG,GROUP,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,MOST,OBJECTIVE,OLDER,PRT,RESULTS,SHORT,UNI
0001,138,169,2010,2014,2ND,376,ANTICANCER,BREAK,CONCLUSION,COPYRIGHT,DATA,DRUG,INDIVIDUAL,INSTITUTE,JOHN,LABEL,METHODS,RECORDS,RESULTS,UNLABELLED,UPON
169,2014,250,956,AIM,ANTICANCER,BACKGROUND,BIS,COMPOUNDS,CONCLUSION,COPYRIGHT,DENDROBIUM,EACH,H292,INSTITUTE,JOHN,LABEL,LH20,MATERIALS,METHODS,OBJECTIVE,RESULTS,TANG,TEN,THESE,WANG
169,2014,956,A549,AIM,ANTICANCER,CELL,CONCLUSION,COPYRIGHT,DSBS,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE,VPA,WAF1
169,2014,A549,ACF,ADP,AIM,ANTICANCER,BAX,BCL,CONCLUSION,COPYRIGHT,DATA,FLOW,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MTT,NSCLC,PARP,RESULTS,THESE,TREATMENT,UNLABELLED
169,2014,ADC,ANGLE,HIGH,LUNG,MAGIC,NMR,NOTABLY,NUCLEAR,OTHER,OVERALL,PRESS,PUBLISHED,RESOLUTION,RESONANCE,SQCC,UNIVERSITY
169,2014,945,946,A549,ARS,BOTH,CARVEDILOL,DMBA,EGF,EGFR,GRK,HOWEVER,JB6
000,169,2014,CROSSROADS,CTLA,IMMUNOLOGY,METASTATIC,PLUP
169,2014,EGFR,NSCLC,PFS
169,2014,EMT,LABEL,LUCAS,MET,SUMMARY,TMPRSS2
169,2014,RBM4
001,003,008,011,018,019,2009,2012,8201,DATA,LINKS,NUTRITION,SURVEYS,THERE,THEREFORE,URINARY
002,ABCB4,ATP,CPG,EPIGENETIC,SILENCING
BARR,EBV,EPSTEIN,HIGH,HLA,NPC
191,ELISA,HOWEVER,LABEL,METHODS,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,USING
DUKE,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFA,VIRTUAL
001,AGES,ALA,CERTAIN,ESI,HOWEVER,ILE,LEU,UPLC,VAL
945,ATP,HOWEVER,LIMAPROST
163,2012,COX,ERCC1,NSCLC
00001,0051,0187,0238,024,177,2011,2012,BRAC1,BRAF,EGFR,IHC,III,KRAS,LCT,NSCLC,OCTOBER,RRM1,SEPTEMBER,STMN1,TNM,TOP2A,TTF,TUBB3,TYMS
EGFR,GEFITINIB,NSCLC
119,195,318,796,ADJUSTMENT,CONCLUSION,HISTOLOGY,LABEL,METHODS,NONE,OBJECTIVE,RESULTS
215,A549,CY5,DISCOVERY,M13,NOVEL,THEN
AFRICAN,BACKGROUND,CASE,IIB,LABEL,METASTASES,METHODS,NORTH,SPLENIC
160,2004,2015,ACCORDING,DIPNECH,LCNEC,NET,NSE,SCLC,WORLD
2015,BASED
174,2003,2012,APRIL,HCC
BACKGROUND,BODY,DOSE,EACH,FIFTEEN,HOWEVER,IMAT,INTENSITY,LABEL,LARGE,LIMITED,METHODS,MLC,MUS,NSCLC,OAR,OARS,PTV,RESULTS,SBRT,SIMULATED,THERE,TOMOGRAPHY,V90,V95,WHILE
007,011,188,2005,2011,7TH,8201,COMMITTEE,DFS,IIA,JANUARY,JOINT,LNR,NSCLC,RISK,UNDER
176,ACCORDING,AREAS,BACKGROUND,LABEL,LUNG,METHODS,RECURRENCE,RESULTS,ROCS,TUMOURS
956,A549,BAX,BCL,FLAVONOIDS,FURTHER,GYNOSTEMMA,H460,IC50,THESE
1990S,A549,DESPITE,DRUG,FOOD,RESULTS
G12,H28,IST,MERO,MES2,MET,NCI,OTHER,PAR1,PARS,REN,SIMILARLY,THESE,THUS
192,CPG,G12D,KRAS,LA2,MNU,NEXT,Q61L,Q61R,THESE
446,ESI,HELA,LIGULARIA,NCI,NMR
DRUG
169,2001,2006,2014,AFTER,ANTICANCER,APRIL,BACKGROUND,DRUG,FOOD,JAPAN,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,REGARDING,RESULTS,SOCIETY,UNIVERSITY
104,169,2012,2014,8805,AAH,AIS,ALK,AMONG,BACKGROUND,EGFR,GGN,GGNS,HER2,HOWEVER,INCIDENCE,KRAS,LABEL,MEDICAL,METHODS,MIA,PRESS,PUBLISHED,PULMONARY,QUADRUPLE,RESULTS,SOCIETY,THREE,TIME,UNIVERSITY
169,2014,AKT,AKT1,CABLES1,CDK2,CLINICALLY,ECTOPIC,MUTAGENIC,T150,T44
000,177,348,855,8805,917,979,CD45,CHANGES,CORRECTED,CTCS,DETECTION,III,PFS,ROC,THEREFORE
0001,BMJ,C30,COMPLIANCE,DATA,EORTC,EUROQOL,GROUP,HOWEVER,HRQOL,LABEL,LIMITED,LUNG,LUX,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PUBLISHED,PUBLISHING,QLQ,RESULTS,THESE,TREATMENT
215,BACKGROUND,CASE,CONCLUSION,HOWEVER,IMAGING,LABEL,LARGE,METHODS,SRI
00001,1997,2013,BACKGROUND,CENTRAL,ENGLISH,FIVE,FOUR,JADAD,LABEL,MARCH,MEDLINE,METHODS,PCI,RANDOMIZED,RESULTS,SCIENCE,SCLC,SMALL,THREE,WEB
169,2014,COPYRIGHT,NETWORK,NSCLC,SBRT
129,169,1983,1995,BACKGROUND,BOOP,CHEST,CONCLUSION,ITEMS,LABEL,MATERIALS,META,METHODS,MOST,PREFERRED,PRESS,RADIATION,REPORTING,RESULTS,REVIEWS,SYSTEMATIC
000,110,1916,1960,1980S,1984,1990S,1997,2000S,2006,374,ADDITIONAL,EVERY,EXTENSIVE,MAJOR,REFINED
946,A549,ATP,GSK,H1395,HOWEVER,LDH,NSCLC,ROS,TAKEN
BRAF,CURRENT,RAS,REDUNDANT
00001,0001,2014,4511,8202,ALK,BACKGROUND,CONCLUSION,EGFR,EGGER,EML4,JULY,LABEL,METHODS,NSCLC,RESULTS,SEVENTEEN
177,2010,2012,AFTER,DEPARTMENT,GAZI,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,UNIVERSITY
HOWEVER,INFANTILE

169,2014,AGING,AMERICA,CCI,DISCUSSION,DUE,INDEX,LABEL,LIFE,METHODS,NCI,NSHAP,OBJECTIVE,PRESS,PROJECT,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY,WAVE
169,BIOLOGY,CAREFUL,DESPITE,ECMS,LEUKOCYTE,SOCIETY,THUS
CD34,CD4,CD8,GATA2,GERM,USING
001,055,114,169,181,196,2014,389,408,450,475,505,680,AFTER,AMONG,GIVEN,LAR
145,15A,169,19B,2014,203,294,295,483,615,ADENO,ADV,AFTER,AMONG,CD34,CRE,FOUR,G12D,INC,KRAS,LEWIS,LOX,LSL,LUNG,MIR,MIRNA,MMP3,PCR,SCA,UTR,WILEY
231,946,CULTURE,GLI2,HOWEVER,LICL,MDA,PCR,PTHRP,RWGT2,SMAD,STROMAL,TCF,TCF4,TGF,THEREFORE,THESE,WHILE,WNT,WNT3A
169,2014,8201,ALTOGETHER,ATF2,CDDP,CELASTROL,HIGH,JNK,LOG2,NSCLC,THESE,UICC
100,160,169,2014,ECM,JOHN,LTD,NSCLC,SONS,THERE,THOSE,WILEY
001,169,177,946,AKT,CRC,CXCR4,FASEB,FOLLOWING,G12V,G13D,KIRSTEN,KRAS,SERPINE,SW48,VEGFA
100,ALSO,BAX,BCL,FURTHER,THEREFORE
2ORG,2RST,946,ANNEXIN,ERK1,HOWEVER,JNK1,MAPK,MAPKS,TGF
000,2012,215,AMONG,CONCLUSION,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN
100,1138,122,2012,2022,3121,7970,8197,8805,BMJ,CIS,ENGLAND,GROUP,HODGKIN,LABEL,LIMITED,METHODS,MORTALITY,NOR,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,SMR,SMRS,WALES
701,ASSESSMENT,C30,CCD,CHINA,EORTC,FACT,FUNCTIONAL,GENERAL,LABEL,LCSS,METHODS,OBJECTIVE,PURPOSE,QLQ,QOL,RESULTS,THERAPY,TREATMENT
ARRAY,BACKGROUND,EXPRESSION,LABEL,METHODS,NRP2,RESULTS,ROS,SOD3,TIC,VEGF
0027,HOWEVER,MALIGNANT,MPM,MPMS,RMPS
0001,004,005,051,082,106,162,169,180,2014,256,296,337,395,565,687,841,8805,CEA,CRC,DATA,LABEL,LNI,LNR,METHODS,OBJECTIVE,OBJECTIVES,OTHERWISE,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
169,2014,BACKGROUND,BASEL,FIVE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS
001,102,148,362,BACKGROUND,CONCLUSION,GRADING,HOWEVER,LABEL,METHODS,NEN,RESULTS,SEVENTEEN,THUS
170,250,265,387,425,549,558,907,946,955,A549,EQULLIBRIA,HCPT,K562,UPON
115,183,187,947,ASA,BACKGROUND,BORG,CLINICALLY,FIFTEEN,GREATER,HRQOL,LABEL,METHODS,RESULTS,SECONDARY,SOCIETY,TECHNICAL,THERE
AVERAGE,BACKGROUND,LABEL,METHODS,PULMONARY,RESULTS,SIZE
ATS,CHEST,COLLEGE,HIGH,LUNG,NETWORK,NINE,PHYSICIANS,PREVENTIVE,SOCIETY,STATEMENTS,SURGERY
EMT,FOXQ1,HIGH,NSCLC
954,956,A549,BAX,BCL,CALU,CYTOTOXIC,FAK,H3255,JNK,MMP,NSCLC,PCA,RESULTS,THESE
NSCLC,SENSITIVE,THESE
CRLM,IVA,MWA,REGULAR,SEG
1950S,1980S,1990S,RANDOMISED,RCTS
169,2014,A549,ACCORDING,ADP,BAX,BCL,CL1,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
054,169,2014,294,372,391,456,471,566,645,709,8482,888,914,BACKGROUND,EGFR,EPIDERMAL,FIFTY,G719A,HOTSPOT,KOREA,L858R,LABEL,MEDICAL,MET,METHODS,NEVER,ONCE,OTHER,PANEL,PRESS,PTEN,PUBLISHED,RB1,RESULTS,SCLC,SMAD4,SOCIETY,TP53,UNIVERSITY
008,075,086,169,177,2014,AMONG,ANOTHER,BASED,CEA,CK19,HOWEVER,PRESS,PUBLISHED,SURGERY,UNIVERSITY
IIIA,LOCALLY,MEANWHILE,NSCLC,SEVERAL,STAGE
1996,2008,2013,CPT,EFFORTS,FDA,FIRST,OTHER,TPT
169,2014,AUTHORS,BASED,ILBC,JOHN,LTD,METASTASIS,OTHER,SONS,WILEY
101,155,169,199,2014,HOWEVER,MAX,PRESS,PUBLISHED,SMARCA2,SMARCA4,SNF,SWI,UNIVERSITY,UTRS
0001,011,013,169,2014,949,956,MPG,OGG1,PRESS,PUBLISHED,UNIVERSITY
18F,2012,2013,CONCLUSION,FDG,HRCT,LABEL,MAY,METHODS,NEGLECTING,OBJECTIVE,OTHER,PET,RESULTS,THERE
DONABEDIAN,LCSDP,LUNG,PROJECT,SCREENING,THROUGH,WHILE
16HBE,COPD,CSE,HEAT,HFL,HSP,HSP10,HSP60,NOTEWORTHY,VARIATIONS
163,169,2014,509,8201,8804,ASIA,LNT,LNTS,LTD,MOST,PATHOLOGY,PTY,PUBLISHING,SOCIETY,THESE,WILEY
169,2014,ASIA,ENDOSCOPIC,FORCE,JAPAN,LTD,PTY,PUBLISHING,SOCIETY,SURGERY,TASK,THEREFORE,WILEY
COPD,USING
000,111,113,2006,2012,224,BACKGROUND,BETWEEN,BLOOD,GVHD,HEART,HLA,HOWEVER,III,INSTITUTE,LABEL,LUNG,METHODS,RESULTS,SIMILAR,THEREFORE,TREATMENT,UMBILICAL
954,CONCERNING,GROUP,LABEL,METHODS,MPM,OBJECTIVE,PET,PURPOSE,RESULTS,SIXTY,TNM
160,640,8209,8X60K,AGILENT,AMONG,ARRAY,BEAD,C10ORF116,EGFR,EXPRESSION,PC9,S100P,SUREPRINT,TKIS
015,020,022,028,169,2014,4Q12,CDR,DTC,HERC5,LUNG,NSCLC,PCR,QRT,SEVEN,STAGE,UICC
001,010,026,042,EAS,EHE,MALIGNANT,WWTR1
160,FGF,FGF10,FGF2,FGF9,FGFS,H146,H69,H82,NSCLC,PC9,SCLC
169,2014,A549,COPYRIGHT,DRUG,FOOD,FURTHER,HUVEC,NSCLC,PAT,REMARKABLE,SOCIETY,SRC,TAKEN
022,215,439,559,709,907,CONCLUSION,ILDS,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,UIP
A549,CD40,CD40L,HOWEVER,THESE
181,8209,A549,ADM,CDDP,CDDPR,ETHYL,H1299,H460,MERM1,MMC,PTX,WBSCR22
8209,99A,DU145,FOLLOWING
MOST,NON,NSCLC,THESE
020,022,023,026,035,037,313A,313GG,351,8201,NSCLC,PFS,SIPA1
169,2014,947,BRAF,CD69,ERK1,IFN,IL2,INHIBITION,MAPK,NKP30,OVERALL,PLX4720,V600E
2MAPK,8209,A549,AKT,CD151,ERK1,FAK,FINALLY,LAC,MEK,MMP9,MMPS,MTT,PI3K,REDUCED,RNAI,TAKEN,THUS,VEGF
169,2014,ALK,CD74,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RET,ROS1,THUS,TKI,VEGFR,XL184
160,203,477,ADDITIONAL,ASSESSMENT,CACS,CHRONIC,EVALUATION,FAACT,FACIT,FATIGUE,FUNCTIONAL,HCL,III,ILLNESS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,QOL,RESULTS,SEA,SEF,SIMPLIFIED,THERAPY,THESE
169,1787,1971,2014,BRITAIN,COPYRIGHT,FOLKMAN,GREAT,HOWEVER,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,THESE,WILEY
CD4,HOWEVER,KEY
CAV,H460,HOWEVER,H_AR1,H_AR2,KNOCK,RESULTS,SHRNA,THESE
000,012,026,048,111,177,178,2011,2012,208,224,227,967,CONCLUSION,ENB,LABEL,MAY,METHODS,OBJECTIVE,PATHOLOGIC,RESULTS,SEPTEMBER,SEVENTEEN,TBLB,THEN
169,2014,ALK,COPYRIGHT,ERK5,MYC,MYCN,SCIENCE,SIGNALING
2011,MEDICAL,MOST,PATHOLOGY,SOCIETY,SPANISH
CAPS,INSTITUTE,JANEIRO,RIO,THROMBOSIS
EMT,HIPPO,ITCH,LATS1,WW1,YAP
177,183,376,490,6MWT,967,BACKGROUND,CPET,DOPPLER,FEV1,FUNCTIONAL,HOWEVER,LABEL,METHODS,MOST,PFT,PFTS,PULMONARY,RESULTS,SEVENTEEN,SFTS
177,BACKGROUND,HOWEVER,IMRT,LABEL,MEAN,METHODS,NTCP,RESULTS,TCP,TREATMENT
105,248,ALTOGETHER,AMONG,AUTHORITY,BACKGROUND,INSPECTION,LABEL,LUNG,METHODS,MOST,NAV,NORWEGIAN,RESULTS,WELFARE
103,105,160,169,177,1997,2013,ACADEMY,AIDS,APRIL,BACKGROUND,CHINA,CKS,HHV,JANUARY,JEWS,LABEL,MEAN,METHODS,MOST,NORTHWEST,OBJECTIVE,OBJECTIVES,RESULTS,THERE
BACKGROUND,CONCLUSION,LABEL,PFGE,RESULTS,SALMONELLA,TOPIC
100,1000,895,AFTER,CONCLUSION,EARLY,LUNG,MATERIALS,METHODS,OBJECTIVE,PROGRAM,RESULTS
0001,001,005,006,125,ALK,BACKGROUND,EGFR,KRAS,LABEL,METHODS,NSCLC,PD1,RESULTS,TTP
HOWEVER,THERE,USING
169,2014,ALECTINIB,ALK,CH5424802,KIF5B,NSCLC,RET,ROS1,THUS,V804L,V804M
001,169,2014,CHEMOTAXIS,CXCL1,CXCR2,HOWEVER,INCREASED,MPE,NSCLC,TREG,TREGS
169,2014,AFTER,CONCLUSION,EGFR,LABEL,LUNG,METHODS,MOST,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SBRT,SOCIETY,ZERO
169,2014,AMONG,BOEHRINGER,CONCLUSION,COPYRIGHT,EGFR,EGFRT790M,III,INC,INGELHEIM,LABEL,NSCLC,OBJECTIVE,OTHER,PHASE,PURPOSE,SOCIETY,SUMMARY,T790M,TKI,TKIS
169,188,2014,947,BMEDA,CONCLUSION,EXM,H292,IMAGING,INC,LABEL,METHODS,MOLECULAR,NCI,NON,NSCLC,NUCLEAR,PEG,PEGYLATED,RESULTS,SOCIETY,SPECT,UNLABELLED,WINNONLIN
169,2014,BIOLOGY,CAND1,DCUN1D1,EXPRESSION,INC,MOLECULAR,NEDD8,PONY,RING,ROC1,SCCRO,SOCIETY,TAKEN,UBC12
169,2014,DISEASE,EMD,FORTY,FURTHER,IGM,INC,MOST,NINE,WILEY
169,2014,AKT,CONVERSELY,DDR2,EGFR,ERK,GAB1,IGF1R,IRS2,MET,OVERLAYING,RTK,SCC,SRC
BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,RFA,TAE,THERE
129,160,2011,2012,8804,AKT1,ALK,ASIAN,BACKGROUND,BASED,BRAF,DDR2,DESPITE,EGFR,EML4,FGFR1,FGFR2,HER2,JULY,KIF5B,KRAS,LABEL,LUNG,MEK1,MET,METHODS,NRAS,PCR,PTEN,RESULTS,RET,ROS1,THESE
169,2014,KEY
001,218,CEP17,HER2,TNM
169,2014,CD8,GAL,INHIBITION,THESE
001,003,231,420,442,468,691,8804,906,GINS,GINS2,GSEA,HIGH,MDA,MEIER
1229,1463,169,185,1969,1995,2013,2014,2492,369,5010,560,8805,894,BACKGROUND,CIS,COX,CR40,CURRENT,LABEL,METHODS,RESULTS,SIR,SIRS,SOCIETY,STUDIES,WILMS
CD8,FINALLY,IGG1,LEWIS,ROBO4,THESE,VACCINATED
200,CD8,EMT,THESE,TIL,ZEB1
169,2014,707,834,844,905,919,945,A1AT,ADC,AUC,ELISA,FURTHER,GLYCANS,LUNG,NSCLC,PRESS,PUBLISHED,SCLC,THUS,UNIVERSITY
157,169,2014,ASIA,EMT,LTD,OVERALL,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY,ZEB1
129,FINALLY,SINCE,SRC
23A,946,BLIMP,CD8,CTL,CTLS,FUNCTIONAL,TGF
956,CHRONIC,H460,MTM,PMCON,PMMTM,THESE,XENOGRAFT
2009,2014,ALP,CONCLUSION,DETECTION,ESR,GENERAL,LABEL,LDH,METHODS,OBJECTIVE,PLA,RESULTS
001,011,036,120,169,2014,ADC,AGAIN,BRITAIN,COPYRIGHT,GREAT,HOPX,HOWEVER,IRELAND,JOHN,LTD,MAPK,MDM2,PUBLISHED,RAS,SCC,SOCIETY,SONS,TAKEN,WILEY
115,2011,2012,215,8201,BAP,DUST,FINE,HPLC,LOD,PAH,PM10,SOUTHWEST,SPAIN
A549,ALSO,B23,BACKGROUND,BCL,CAM,CELL,CHIJONGDAN,FACS,FMK,H1299,H460,IPO7,KOREA,LABEL,METHODS,MTT,NPM,NSCLC,PANAX,PARP,PERSICARIA,REALGAR,RESULTS,RHUS,THESE,THUS,UBF,USA,VAD,WESTERN
200,460,956,AKT,ALSO,BACKGROUND,CD44,CELL,CONCLUSION,COX,EEOS,EGFR,H460,LABEL,METHODS,MMP,MTT,NCI,OPN,OVERALL,PCR,PI3K,RESULTS,VEGF
AREAS,BACKGROUND,CLASS,COVERED,EGFR,GIVEN,III,LABEL,METHODS,NSCLC,OPINION,PHASE,SIX,TKIS
1318,169,2000,2014,209,215,2500,381,AGILENT,AMENDMENTS,BACKGROUND,BRAF,COLLEGE,EXCISIONAL,FFPE,FIVE,HISEQ,KRAS,LABEL,LABORATORY,METHODS,MISEQ,NGS,NSCLC,RESULTS,SEQUENCING,SOCIETY,SURESELECT,TAT
169,2007,2012,2014,365,COX,CPFE,DFS,HRCT,INSTITUTE,JANUARY,KOFUKAI,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THEREFORE,UNIVERSITY
160,1637,1656,169,2014,945,946,ALTERATION,ANTI,DAPI,FOURIER,FTIR,HIGH,JOHN,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SECONDARY,SONS,THUS,WILEY
1997,2006,CONCLUSION,CSF,HIGH,HODGKIN,LABEL,METHODS,NHL,OBJECTIVE,OVERALL,RESULTS,ROUTINE,SIRIRAJ,THREE
002,007,009,1000,109,125,169,1998,2011,2014,8805,CYBERKNIFE,JAPAN,PRESS,PUBLISHED,RADIATION,SOCIETY,SRS,SRT,UNIVERSITY
HOWEVER,ID1,MEIER,NSCLC
A549,AKT,CALU,EGFR,HOWEVER,IGF1,IGF1R,OTHER,PI3K,PTEN
EACH,HOWEVER,LEUKOCYTES,THERE,WHILE
ADT,CRPC,CTL,CURRENTLY,DESPITE,FAILURE,FUNCTIONAL,NAIP
946,ENPP1,IFN,STING,STUDIES,THP1,TMEM173
A549,EGFR,ELISA,ERLOTINIB,H157,H1975,H460,LABEL,METHODS,MOUSE,MTS,NSCLC,OBJECTIVE,PC9,PURPOSE,RESULTS,THESE,TKI,VEGF
007,009,1000,1295,1971,1991,2000,2010,2012,2013,205,2245,246,2527,3120,461,473,6942,8201,AGE,DIET,FRAMINGHAM,GRS,GRSS,HDL,HEART,IMPORTANCE,LABEL,LDL,MAIN,MALM,MDCS,MENDELIAN,METHODS,MULTI,OBJECTIVE,RELEVANCE,RESULTS,REYKJAVIK,SETTING,USING,WHETHER
0001,004,022,169,2014,232,693,762,771,792,817,8201,824,ACTA,BACKGROUND,CONCLUSION,DFS,FOUNDATION,GGO,HRCT,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLW,THERE,USING,WTLW,WTMW
000,300,450,BACKGROUND,CELL,CONCLUSION,DUE,INITIAL,LABEL,LUNG,MAIN,METHODS,NAMI,NON,NSCLC,RESULTS,SMALL
169,176,2014,ALK,BACKGROUND,EGFR,FISH,FIVE,IHC,KRAS,LABEL,MEDICAL,MET,METHODS,PRESS,PUBLISHED,RESULTS,ROS1,SEVEN,SOCIETY,THREE,UNIVERSITY
169,2014,HOWEVER,MEDICAL,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
108,221,3Q28,AFTER,ASIAN,CAUCASIANS,EAST,HOWEVER,OVERALL
169,17P,2014,947,956,CHRONIC,CLL,IGM,NEXT,NOD,NOTABLY,NSG,SCID,THREE
0001,149,152,160,796,8201,ANXA1,IGG,PEARSON,ROC,STUDENT
001,002,003,010,8201,EXPRESSION,GEO,HIGH,HMGA1,III,MEANWHILE,N0N1,NSCLC,OMNIBUS,PCR,USING
049,177,8201,DUAL,DUSP6,ERKS,MKP,NSCLC,OCTUBRE,PCR,UNIVERSITY,USING
1287,AKT,BACKGROUND,CETUXIMAB,CTX,CTXR,CTXS,EGFR,FIRST,H226,HER2,HER3,HOWEVER,INCUBATION,KI67,LABEL,MAPK,NEXT,NSCLC,PI3K,RESULTS,SINCE,THESE,TREATMENT
AUSTRALIA,BACKGROUND,CHRISTMAS,EAST,EASTERN,ENGLAND,HOWEVER,IRCO,LABEL,LATE,METHODS,NORTH,RESULTS,SYMPTOM,WESTERN
169,2014,AS2O3,COPYRIGHT,GSH,GSSG,HOWEVER,NRF2,TRIVALENT
ADDITIONAL,ANTI,CTLA
104,107,160,239,COEXISTENT,DESPITE,FOLLOWING,IRIS,LABEL,MANAGEMENT,METASTATIC,METHODS,OBJECTIVE,PURPOSE,RESULTS
172,AIMS,BACKGROUND,CALRETININ,FOCAL,HOWEVER,LABEL,OBJECTIVE,RESULTS,THESE
1A1,526,65285,AIMS,BACKGROUND,CHINESE,CYP,CYTOCHROME,ILE,ILE462VAL,LABEL,METHODS,OBJECTIVE,P450,RESULTS,VAL
0036,0071,029,048,2004,2012,AIMS,BACKGROUND,BMI,LABEL,LDH,METHODS,OBJECTIVE,OVERALL,RESULTS,SCLC,TTP
0001,002,150,2008,2011,645,ADHERENCE,AIMS,ASCO,BACKGROUND,CORRECT,DATA,ESMO,ITALIAN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THESE
BECAUSE,GAIN,GSC,HCC,HIGH
005,013,021,074,124,165,169,172,179,2011,2013,2014,282,309,316,432,852,AMONG,CLAVIEN,DINDO,GRADE,HIGH,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,PULMONARY,RESULTS,SURGERY,THERE,UNIVERSITY,VARIOUS,VATS
001,019,026,101,486,504,8201,BACKGROUND,BLOT,EGFR,LABEL,NSCLC,PCR,PIM,REDUCED,RESULTS,UTR,WESTERN
A549,ANNEXIN,APOPTOTIC,BACKGROUND,BAX,BCL,CFSE,DIOSCOREA,FITC,LABEL,METHODS,NSCLC,RESULTS,SCLC,SRB,VAD
009,010,023,031,169,2014,230,361,8805,ASPIRIN,BACKGROUND,COLORECTAL,LABEL,LUNG,MEN,METHODS,OVARIAN,PLCO,RESULTS,SNPS,THESE,TRIAL
018,169,2014,A549,AKT,CONCLUSION,FDG,GLUT1,HK2,HOWEVER,IMAGING,INC,KNOCKDOWN,LABEL,LACTATE,LDHA,MAXIMUM,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,THESE,UNLABELLED
102,160,8201,AMONG,BACKGROUND,DISTANT,ECOG,EMA,III,LABEL,METHODS,RESULTS,TCCU,TIME,VINFLUNINE
BACKGROUND,BASED,CIGARETTE,LABEL,LUNG,METHODS,MICRORNAS,RESULTS
169,2015,99M,DIFFUSE,IMAGING,INC,MOLECULAR,NUCLEAR,SOCIETY
945,A549,AKT,BAD,BECAUSE,CONCLUSION,ERK,HOWEVER,KRAS,LABEL,MEK,MEK1,METHODS,NSCLC,OBJECTIVE,PI3K,PURPOSE,RESULTS,TAKEN,THEREFORE
PPL,PRIMARY
NANO
EGFR,HGF,HOWEVER,LUNG,MET,NSCLC,TKI
ASCO,LUNG,NSCLC,SOCIETY
MDR,THEREFORE
ACTIVATION,CURRENTLY,DESPITING,LUNG,NSCLC
945,BACKGROUND,CRP,LABEL,METHODS,OBJECTIVE,RESULTS,THEN,TNF,VATS
BACKGROUND,CONTINUOUS,CTC,CTCS,ENRICHMENT,INHIBITORY,LABEL,METHODS,MLVD,NSCLC,OBJECTIVE,RESULTS,THERE,USING,VEGF,VEGFR
614,ALTERED,BACKGROUND,BRDU,CCK8,LABEL,METHODS,MICRORNAS,MIR,OBJECTIVE,PCR,PGCL3,PGLH7,PSA,REAL,RESULTS,TRANSWELL,UTR,WESTERN
EGFR,NSCLC,TKIS
169,2003,2013,2014,930,BASEL,CONCLUSION,LABEL,METASTATIC,METHODS,MOST,NONE,OBJECTIVE,RESULTS
1954,2013,BACKGROUND,CONCLUSION,JANUARY,LABEL,LEADING,METASTATIC,METHODS,RESULTS,THEREFORE,TMJ
100,8805,AUC,CONCLUSION,FORTY,LABEL,METHODS,OBJECTIVE,RESULTS,WHOLE
CXCL4,CXCR4,CXCR7,HCC,MAPK,TARGETING,TP53,U0126
A549,BCL,H1299,H460,MCL,MIGRATION,NSCLC,ROS,THESE,VDAC,VDAC1,VDAC2
188,A549,HOWEVER,IGG,KRAS,RNAI,THESE
THEREFORE
30C,EMT,FHIT,FINALLY,FN1,FRAGILE,HIGH,HISTIDINE,HMGA2,METADHERIN,METASTASIS,MTDH,TRIAD,VIM
ABCB1,ABCC1,ABCG2,AFTER,AIM,CONCLUSION,ERCC4,GENOMIC,IIIB,LABEL,LUNG,MATERIALS,METHODS,NQO1,NSCLC,OBJECTIVE,RESULTS,SNPS,XPC
111,1987,2009,857,BACKGROUND,CD3,CONCLUSION,HODGKIN,INDUCTION,LABEL,MATCH,METHODS,MUROMONAB,NHL,POISSON,POLYCLONAL,RECIPIENTS,REGISTRIES,RESULTS,SCIENTIFIC,STUDIES,TRANSPLANT
000,4000,BOTH,RADIOLOGY
RADIOLOGIC
000,2013,BACKGROUND,EGGER,JANUARY,LABEL,MEDLINE,METHODS,RESULTS,SIXTEEN,THERE
158,176,HISTORY,LABEL,METHODS,PARTIAL,PERTINENT,THERE
NET
100,123,160,200,8201,956,A549,DAPI,FLOW,FURTHER,MTT,NPS,PCR,TAKEN,TIO2,TYPICAL
160,33258,CNE,DDP,HOECHST,INDUCIBLE,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,SMT
174,181,A549,BIOCHIP,HALF,IC50,MICROARRAY,PARAFLO,PROTEIN,REAL,THERE
090,110,169,2014,270,444,513,620,716,929,959,977,ASIAN,BACKGROUND,CONCLUSION,DOR,EGFR,LABEL,LIBRARY,METHODS,NSCLC,RESULTS,ROC,SCIENCE,SROC,WEB
106A,A549,ABCA1,DDP,FEWER,MICRORNAS,NSCLC,REVERSE
155,ANX,ANX7,FLOW,MICRO,MTT,RNAS
138,169,2014,CLINICALLY,EPIGENETIC,EZH2,GATA3,LUNG,NOTABLY,PATIENT,PDX
169,2014,KRAS,NRF2,NSCLC,ONCOGENIC,RNAI,TPA,TRE
180,180MG,60MG,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
001,010,066,087,1449,179,186,287,297,481,580,838,861,ASIAN,CHINESE,CIS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ORS,RASSF1A,RESULTS
001,019,022,287,310,696,AIMS,BOTH,CONCLUSION,COX,LABEL,METHODS,MPE,OBJECTIVE,RESULTS,THERE,USING,VEGF
0001,440,CIS,CTCS,FURTHER,HOWEVER,SCLC
1993,2012,BACKGROUND,FACULTY,KAEN,KHON,LABEL,MATERIALS,METHODS,NORTHEAST,RESULTS,THYROID,UNIVERSITY
105,153,156,2004,2008,893,ASR,ASR12,ASR13,BACKGROUND,DATA,INCIDENCES,IRAN,IRANIAN,IRAQ,KHUZESTAN,LABEL,MATERIALS,METHODS,RESULTS,SPSS
263,BACKGROUND,INDIA,KARNATAKA,KSRTC,LABEL,MANGALORE,MATERIALS,METHODS,RESULTS,ROAD,SMOKING,STATE,THESE,TOBACCO,TRANSPORT,TWLS
001,004,064,2014,841,8805,BACKGROUND,CRPC,LABEL,MARCH,MATERIALS,META,METHODS,ORR,PFS,PSA,RESULTS,SCIENCE,SIMILARLY,SOCIETY,STUDENT,VEGF,WEB
000,002,030,194,565,874,946,LEICA,NSCLC,TGF,THUS,TNM,UNIVARIATE
EARLY,GASTRIC,HOWEVER,MICROARRAY,NGS
1195G,COX,HOWEVER,NSCLC,SNP,SNPS,TREG,TREGS
140,225,315,ACCORDING,EGFR,ELISA,HGF,MBP,MONITORING,PCR,T790M,TKIS
169,2014,COPYRIGHT,RNAS,SCIENCE,SIMILAR,TOPK
AIM,CBA,FDA,HENCE,HIGH,LABEL,MCA,MCF,NAMI,OBJECTIVE,RESULTS
1434,169,2002,2008,2012,2014,945,946,A549,ASIA,AUTHORS,EGFR,ERK,JANUARY,LTD,MEK,PE089,PTY,PUBLISHING,SCIENCE,WILEY
169,2014,AGAINST,EGFR,FINALLY,JOURNAL,LUNG,THUS
CCR7,CD1A,CD83,CIGARETTE,COPD,DCS,EIGHT,EVIDENT,EXCESSIVE,LUNG,MYELOID,USING
2000,2014,JANUARY,MARCH,SCIENTISTS
160,177,231,956,BLUME,DUNAL,HEPG2,IC50,LNCAP,MCF,MDA,MKN7,NMR,SW480,THEIR,VIETNAM
BACKGROUND,CD31,CD34,CD45,CONCLUSION,CSC,CSCS,HEP,LABEL,METASTASIS,METHODS,MSC,PRINCIPAL,RESULTS,THUS
178,8314,946,CD8,MHC
146A,149,196A2,499,ASIAN,BACKGROUND,CAUCASIAN,CELL,CONFIDENCE,DISEASE,INTERVALS,LABEL,LUNG,METHODS,NON,OVERALL,RECURRENCE,RESULTS,SMALL
CAS9,CRE,G12D,HOWEVER,KRAS,USING
ERSPC,NOW,PLCO,PSA,RANDOMIZED,SCREENING
05009,100,946,954,A549,ATP,CONTINUING,EMT,ERK,FAK,JNK,MAP,NCK,SINCE,SMAD,SRC,TGF,TNIK,TRAF2,WNT
AXL,EMT,GAS6,TARGETING
100,215,AFTER,AIMS,CONCLUSION,FOCAL,HEMORRHAGE,HMB45,LABEL,MELAN,METASTATIC,METHODS,OBJECTIVE,RESULTS,SMA
ABDOMINAL,CA19,HOWEVER,MRI,THEREFORE
176,HODGKIN,HOWEVER,LDH,LUNG,PPD,PRIMARY
100,AMGA,CARCINOMA,CHINESE,DCIS,DESPITE,HER2,MGA,MGACA,MPC,NST,P63,PAS
110,ECM,HIGH,IHC,LOX,LYSYL,MEIER,MMP2,MMP9,NSCLC,PCR,UNIVARIATE
956,A549,AIMS,AKT,DMSO,EGFR,GRANDININ,HOWEVER,LABEL,MALIGNANT,MELALEUCA,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THESE,WESTERN
002,006,016,021,037,ACCORDING,BEAS,BOTH,EMT,LU1,MES1,MMP2,MMP9,SCC,SLUG
108,394,487,CK5,CONSISTENT,ICC,IMP3,LAC,MAC,NLAC,PCR,RMS,TTF1
786,BACKGROUND,COX,HOWEVER,IT1,LABEL,MEIER,METHODS,PCR,RESULTS,RNAS,SMALL,SPRY4
002,006,324,471,COPD,COX,HRADJ,MEIER,NETWORK,WHILE
956,CUP,DEPENDING,DIFFERENT,ERLOTINIB,PULMONARY,THERE,TREATMENTS
001,169,193,2014,386,425,660,CONCLUSION,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THROUGH
000,169,1970S,2014,DESPITE,NSCLC,SCLC,SMALL,SOCIETY
169,2014,946,954,BRAF,CCL11,CD8,DEPLETING,IKK,MHC,MYELOID,PTEN,TH2,THUS,V600E
169,2014,APC,ATROGIN,HOWEVER,LEWIS,LLC,MAFBX,MIN,MURF1,MYOSTATIN,NOTABLY,TAKEN
110,127,160,237,448,663,AUC,CONCLUSION,HOWEVER,III,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,POPULATION,PURPOSE,RESULTS
074,093,508,828,DRAI,HENCE,HOWEVER,OVERALL,RSAI,THERE
2013,2014,BACKGROUND,DISCUSSION,ELECTRONIC,GOVERNMENT,INSTITUTES,LABEL,OBJECTIVE,PRESS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THEIR,THESE,TOBACCO,UNIVERSITY
140,169,2014,8201,AUSTRALIAN,BACKGROUND,COLLEGE,FDG,LABEL,METHODS,MICROWAVE,MWA,NSCLC,PET,RESULTS,ROYAL,SEVEN,THERE,THREE,ZEALAND
006,016,017,042,248,257,312,532,936C,BACKGROUND,HOWEVER,HRS,INTENSIVE,LABEL,METHODS,OBJECTIVE,ORS,RESULTS,VEGF
945,BACKGROUND,CIS,CONCLUSION,CRP,HOWEVER,HRS,INCREASED,LABEL,METHODS,NSCLC,RESULTS,TNF
001,012,046,ACCORDING,ADC,AMONG,BACKGROUND,CD44,CSCS,INCREASED,LABEL,LCC,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,SCLC,UNIVARIATE
AFTER,BECAUSE,CDDP,FIRST,HER2,HOWEVER,STAGE
107,2009,2013,215,292,313,8805,DCR,DCS,EVALUATION,MAY,MST,MUC,OCTOBER,OVERALL,PARTIAL,SOLID,THESE,WILMS,WT1
2005,2013,309,939,JULY,OVARIAN,THERE
500MG,AFTER,AUC,BEV,CBDCA,PEM,RIGHT
001,004,009,023,027,1758,176,2000,2008,AIM,BONE,CONCLUSION,HER2,IDC,IDCS,ILC,ILCS,LABEL,METHODS,OBJECTIVE,RESULTS
A549,CELL,CONCLUSION,FCM,LABEL,LAP,METHODS,MTT,OBJECTIVE,PCR,REAL,RESULTS
160,181,211H,ANNEXIN,ARSENIC,ATO,BAK,BCL,E2F1,H2052,H226,H28,JUN,MALIGNANT,MTT,THERE,TYMS
AMONG,BACKGROUND,CONCLUSION,COORDINATE,LABEL,MOST,NSCLC,RESULTS,SCC
2008,AIR,DESPITE,DIRECTIVE,HENCE,HOWEVER,IARC,NO2,NOX,QUALITY,SEVERAL
160,4T1,64258,BMDCS,FACTORS,PGE2,PRIMARY,SUBSEQUENT,THESE,TREATMENT,VEGF
453,8209,950,AMAXA,CD28,FACS,MDA,MHC,PCR,SEVERAL,SKBR3,THESE
A549,CELL,HOWEVER,NSCLC
001,005,041,123,150,740,CIGARETTE,COX,IHC,MEIER,NON,NSCLC,TMAS,UNIVARIATE
HAYASHI,HOWEVER,YOMO
III,MOST,NET,NETS
500,946,CD24,CD44,CDKL2,EMT,NOTABLY,SUBSEQUENT,TAKEN,ZEB1
945,946,947,A549,ADP,AMP,AMPELOPSIN,ANNEXIN,BCL,CELL,CERTAIN,FBW,FBW7,FOLLOWING,GSK3,HDAC,HDAC1,MTT,MYC,SKP2,THR58
ANY,FINALLY,METASTASES
MAX,MYC
124,131,168,169,2014,300,8804,ADS,CONCLUSION,IMAGING,INC,LABEL,LMS,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SMALL,SOCIETY,THEIR,TRS,UNLABELLED
169,2013,2014,370,III,JAPAN,PHASE,PRESS,PUBLISHED,UMIN,UNIVERSITY
169,2014,287,471,581,ELISA,GMBH,KGAA,MMP9,S100,SOD3,VCH,WILEY
2003,2007,255,3040,CENTRAL,DATA,JANUARY,LABEL,LHD,MAIN,METHODS,NSCLC,NSW,OBJECTIVE,OUTCOME,POTENTIAL,RESECTION,RESULTS,SETTING,SOUTH,THOSE,WALES
169,2014,946,A549,BIOLOGY,C459S,DOWN,E76V,EMT,HOOK1,HOWEVER,INC,MOLECULAR,PHPS1,SH2,SHP2,SOCIETY,SRC,TGF,THESE,USING
169,174,2014,AIM,ANTICANCER,APC,ASSAY,BACKGROUND,CONCLUSION,COPYRIGHT,DELINASIOS,EPI,GERMANY,INK4A,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,QMSP,RAS,RASSF1A,RESULTS,SHOX2
169,2014,569,598,9090,945,GMBH,KGAA,PGC1,SMALL,THEREFORE,VCH,WILEY
032,043,131,1991,2013,5367,BACKGROUND,CONCLUSION,COX,DTC,HFDM,JANUARY,JUNE,LABEL,MEIER,METHODS,PTC,RESULTS,SERUM
160,169,2014,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IRELAND,LABEL,METHODS,MOST,NIH,OBJECTIVE,RESULTS,SOCIETY,TRIAL
000,001,042,051,178,181,203,300,437,450,454,465,485,491,494,499,946,A549,ACCORDING,CYSTEINYL,DMSO,GDP,IMAGE,LABEL,METHODS,MTT,OBJECTIVE,QUANT,RESULTS,RHO,WESTERN
009,024,110,116,187,2002,2007,579,787,AGE,AMONG,CHINA,CONCLUSION,LABEL,METASTATIC,METHODS,OBJECTIVE,REGRESSION,RESULTS,SEPTEMBER,TNBC
169,2014,372,BRAIN,BRESLOW,CLARK,COX,HOWEVER,LATE,LEVEL,RECURRENCE,SEVENTY,STAGE,THESE,UICC
041,042,045,047,125,175,177,2011,2013,494,633,664,711,CEA,CONCLUSION,CYFRA21,FIRST,JAN,LABEL,METHODS,NSE,OBJECTIVE,RESULTS,ROC,SCC,SPN,SPSS,THERE,UNIVERSITY
BACKGROUND,CRS,DEFINITIVE,HIPEC,LABEL,MALIGNANT,METHODS,MPM,MRI,PET,PROGNOSTIC,PROMISING,RESULTS,SV40
002,012,30GY,CTV,GTV,OAR,OARS
946,CELL,CONVERSELY,GSK,HOWEVER,NSCLC,S1P,SPNS2,STAT3,THESE
001,253,467,BACKGROUND,CONCLUSION,COX,DATA,HARRELL,HOWEVER,LABEL,METHODS,OTHER,RESULTS,SEVERAL,THOSE
003,568,8201,ASIAN,COMPARING,CONCLUSION,CURRENTLY,DESPITE,EGFR,FURTHER,III,LABEL,METHODS,NSCLC,OBJECTIVE,ORS,PURPOSE,RCTS,RESULTS,SCIENCE,WEB
011,15Q25,177,400,491,8202,BACKGROUND,CHINESE,HAN,HOWEVER,LABEL,METHODS,NPC,RESULTS,THERE,UNIVARIATE
2009,2012,ADJUSTMENT,AREA,BACKGROUND,CARE,CATALONIA,IRR,LABEL,MEDEA,METHODS,OBJECTIVE,POISSON,PRIMARY,RESULTS,SPAIN,SPANISH,THERE,THESE
001,025,104,177,BACKGROUND,CYST,DESPITE,FEV1,LABEL,LUNG,MAIN,METHODS,MOST,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SIROLIMUS,THEN
009,COMPLIANCE,EPA,LUNG,SERUM,SIXTY
EARLY,HMB45,S100
005,006,054,106,10834,BACKGROUND,DCR,ELECTRONIC,HOWEVER,III,LABEL,MATKI,METHODS,MULTI,NSCLC,ORR,OVERALL,PFS,RCTS,RESULTS
MAIN,TLH
029,199,2007,2012,319,342,377,690,8805,ACADEMY,ACCORDING,AFTER,BESIDES,CHINA,CHINESE,EARLY,ELCAP,JULY,JUNE,LABEL,LDCT,LUNG,MEDICAL,METHODS,NCCN,NETWORK,NSCLC,OBJECTIVE,PROGRAM,RESULTS,SCLC,TNM
001,138,189,2012,2013,236,245,270,8804,APART,CHI,DATA,GGO,HOWEVER,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,RESULTS,USUALLY
2000,2008,711,8805,COX,IIA,IIB,IIIA,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM
LABEL,METHODS,NINE,OBJECTIVE,RESULTS,SEVEN
001,003,100,177,180,194,205,227,236,287,334,354,510,8314,8315,AMONG,ARMS,BEIJING,EGFR,FFEP,FFPE,FORTY,FPS,GEFITINIB,HIGH,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SEQ
009,250,AMONG,CIV,LABEL,METHODS,OBJECTIVE,PRODROMES,RESULTS
005,044,047,100,AMONG,DISEASE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,RRM1,UNIVARIATE
ALK,AMONG,BOTH,D5F3,FFPE,FISH,IHC,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTY,THERE,VENTANA
HOWEVER,PROTEIN,THEN
100,215,987,ANN,AUC,NEXT,PACS,ROC,VOI
121,122,142,ANN,BONE,CONCLUSION,INDEX,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SCAN
AMONG,HOWEVER,RIF1,RIF2,SEVERAL,SINCE,TDD,TED
000,100,160,AFTER,FIRST,GBP,GBPS,HOWEVER,THEREFORE
160,198,8201,EGFR,EGFR2,ERBB2,HER2,KRAS,MBC,MUTATIONS,NEU
160,BACKGROUND,CASE,CD34,CONCLUSION,FDG,LABEL,METHODS,PET,PPSS,PRIMARY,RESECTION
11598,169,18141,2014,4MM,BACKGROUND,CONCLUSION,LABEL,LUNG,METHODS,NLST,PRESS,PUBLISHED,RAISING,RESULTS,SCREENING,THERE,TRIAL,UNIVERSITY
2014,3RD,BMJ,GROUP,HOWEVER,LTD,MOST,PUBLISHING
169,2014,CD4,CD8,COPYRIGHT,INC,ORIGINALLY,TH2,THESE,TSLP
ANTI,BACKGROUND,COMBINING,CPG,CT26,DA3,DART,LABEL,METHODS,MICE,MOST,RESULTS
A549,APOPTOSIS,BACKGROUND,BID,CELLS,CK2,HELA,LABEL,LNCAP,LOW,METHODS,MTT,NONE,PC3,RESULTS,TAT,THEREFORE,TRAIL,WESTERN
13TH,157,ATTRITION,FUNCTIONAL,HRQL,LABEL,METHODS,MISSING,OBJECTIVE,PURPOSE,RESULTS,SEM,T12,T13,T24
000,148,153,186,1999,2008,217,231,280,300,301,326,422,52ADS,5ADS,8197,ADS,AIR,BMJ,CITY,DATA,DIRECTIVE,GROUP,GUIDELINES,LABEL,LIMITED,LUNG,MAIN,METHODS,OBJECTIVE,OUTCOME,PM10,PM2,PUBLISHED,PUBLISHING,QUALITY,RESULTS,SETTING,SOURCES,SPAIN,TADS,VALLADOLID
1890,1893,1894,1915,1927,1930,1934,1940,1949,1950,1950S,1954,1965,1970,1992,1993,1994,2000,2011,2013,8197,AFTER,AGE,AMONG,BMJ,CURRENT,GROUP,LABEL,LIMITED,MEASURE,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PREVIOUSLY,PRIMARY,PROVIDING,PUBLISHED,PUBLISHING,RESULTS,SETTING
368,8804,AP1M2_1,BASED,CUL7,FAD,FLAD1,GENMAPP,GOLGI,KEGG,PEARSON,THUS
169,2014,947,949,BECAUSE,CD16,COPYRIGHT,FCR,IGS,INC,IVIG,RIII,RIV,THEREFORE
001,1715,1998,2006,2562,3430,482,552,784,9847,BACKGROUND,HISTOLOGY,IIIA,LABEL,METHODS,NSCLC,OVERALL,PORT,RESULTS,THERE
1970S,1980S,2015,CONFERENCE,LUNG,THESE,WORLD
2009,899,911,BACKGROUND,CCL22,CCR4,CD127,CD25,CD28,CD3,CD4,CD56,CD8,FOXP3,LABEL,MDC,METHODS,PBMCS,RESULTS,TH17,TH2,TILS,TREG,TREGS
BACKGROUND,BOTH,CONCLUSION,DIFFUSION,FOLLOWING,LABEL,METHODS,RESULTS,VOXEL
100,103,114,124,143,157,990,992,CONCLUSION,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,ONCE,OVERALL,PURPOSE,RESULTS
2000,2011,BACKGROUND,CONCLUSION,DISCUSSION,EPA,GST,HODGKIN,INTEGRATED,IRIS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PBPK,RISK
0175,169,2014,BOTH,CONCLUSION,DYNAMIC,FAZA,ICC,IMAGING,INC,LABEL,LOGAN,METHODS,MOLECULAR,NEXT,NLR,NUCLEAR,PET,RESULTS,SOCIETY,SUVR,TIME,UNLABELLED,VOIS
100,169,2014,700,800,956,99M,AFTER,CONCLUSION,FMS,IMAGING,INC,LABEL,METHODS,MOLECULAR,NIR,NUCLEAR,OPTIMIZED,RESULTS,SOCIETY,SPECT,UNLABELLED,USING
169,2014,ACIDS,BCL,FGF,FIBROBLAST,IRES,K183,NUCLEIC,PRESS,PUBLISHED,S6K2,SER4,UNIVERSITY,XIAP
945,946,ACH,ACHR,AKT,DEPENDING,EFFECTIVE,EPITHELIAL,ERK,INHIBITION,RAF,RAS,TIOTROPIUM
2206,AKT,BOTH,EGFR,H1975,HGF,KRAS,LABEL,MAP,MEK,MET,METHODS,OBJECTIVE,PD0325901,PURPOSE,RESULTS,T790M,THESE
AUTOPHAGY,CONCLUSION,LABEL,LC3B,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,WESTERN
169,2014,CTL,CTLA,CURRENT,DESPITE,DRUG,EFFORTS,FOOD,IMMUNOLOGY,IPILIMUMAB,SOCIETY
104,108,110,15CM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PTNB,PURPOSE,RESULTS,THERE
CID,COMBINING,E1A,FOUR,HOWEVER,KNOCKDOWN,MSC,MSCS,NSCLC,SCID,THESE,THUS,TREATMENT,XIAP
ECTOPIC,ISH,MTDH
001,002,006,007,012,015,177,1RM,8197,BACKGROUND,BMJ,GROUP,LABEL,LIMITED,LUNG,METHODS,OTHER,PUBLISHED,PUBLISHING,QOL,RESULTS,TLCO,TRIAL
196,383,673,8226,AFTER,COX,FOLLOWING,FURTHER,HOUNSFIELD,KEY,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNITS,VERTEBRAL
DATA,LCSCR
123,960,A549,AKT,DDP,E2F,FURTHER,LUNG,MDR,MDR1,MPR,RHODAMINE,SEVERAL,TWIST
2014,8197,BMJ,CLINICALLY,GROUP,LTD,PEARSON,PUBLISHING
165,169,192,2014,2096,550,ERS,PCV,PCV13,PCVS,TYPE
169,2014,946,A549,AD5,BACKGROUND,BASEL,GFP,INF,L1C2,LABEL,LACZ,LOCAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PILOT,RESULTS,SIMILAR,STENT,THESE
946,A549,CYT,EMT,EPITHELIAL,NSCLC,RESULTS,TGF
143,8209,ATG2B,CELL,H1299,HOWEVER,KNOCKDOWN,NSCLC,PREVIOUSLY,RNAS,THESE
001,003,004,047,070,149,169,174,1980,2014,227,231,263,402,417,502,530,542,556,671,780,808,8201,856,8804,8805,926,BACKGROUND,CSS,INC,LABEL,METHODS,NSCLC,RESULTS,RFS,VATS,WILEY
042,100,1990,2013,588,HOWEVER,JANUARY,MAY,MGCT,SUN,THERE,THESE,TREATMENT,UNIVERSITY,YAT
64257,64258,A549,AVULAVIRUS,EARLY,FMK,HOWEVER,MTT,NDV,NEWCASTLE,PCR,RVG,THEREFORE,VAD
AUTOSOMAL,CHINA,COMMITTEE,MEDICAL,THERE,VANISHING,ZHANGYE
730,ANNEXIN,BAX,BCL,HOECHST,HOWEVER,MTT,NSCLC,PARIS,PSI,RHIZOMA
011,101,37440,396,ALK,AP26113,ASP3026,CANCERS,CEP,CH5424802,MET,NSCLC,RESISTANCE,RO5424802,ROS1,RXDX,TSR
AKT,EGFR,IAP,IAPS,MAPK,MAPKS,NSCLC,XIAP
CRT,ESCC,ESCCS,FACTORS,HOWEVER,NHEJ,PC4,THESE,XLF
HOWEVER
CD4,CD68
HISTOLOGIC,THESE
BOTH,DIFFUSE,DIPNECH,THERE,THESE
0001,0011,0015,004,0052,0120,0167,0271,0454,ALSO,BACKGROUND,III,LABEL,METHODS,MMP,NON,NSCLC,RESULTS,SCLC,TOTAL
00001,0001,001,147,BACKGROUND,BECAUSE,DESPITE,DIAGNOSTIC,EBUS,INADEQUATE,LABEL,METHODS,OVERALL,RESULTS,TBNA
2001,2011,BACKGROUND,FNA,FORTY,LABEL,METHODS,RESULTS
100,122,1995,2010,BARR,CLINICALLY,EBV,EPSTEIN,GRADING,INSTITUTE,LYG
001,004,008,2003,2009,2012,9093,AHR,END,HOWEVER,IMPORTANCE,JANUARY,LABEL,LOBECTOMY,MAIN,METHODS,NSCLC,OBJECTIVE,OVERALL,PROPENSITY,RELEVANCE,RESULTS,SABR,SETTING,UNADJUSTED
008,124,131,216,268,333,344,357,AFTER,AIM,CONCLUSION,DEPARTMENT,HOWEVER,LABEL,LUNG,LYMPH,MATERIALS,MEDICAL,METASTASIS,METHODS,NUCLEAR,OBJECTIVE,PET,RAI,RESULTS,UNIVERSITY
100,111,2007,2011,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MAY,METHODS,NEWLY,NOTABLY,OCTREOSCAN,RESULTS,SCLC,SMALL,SSRS,SSTR,SSTRS
945,BACKGROUND,CEA,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEX,SPNS,THEREFORE,TNF
945,ENZYMES,GLUT1,HIF,INCREASED,MIA,MKN45,NUGC3,PACA,PANC1,PFKFB,PSN,THUS,VEGF
0001,001,0401,100,169,2014,EGFR,FINALLY,IFCT,IHC,L858R,LABEL,LOSS,METHODS,NEXT,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RHOB
169,2014,8201,B16,BRITAIN,C26,C38,COPYRIGHT,FINALLY,GREAT,HT25,III,INSTEAD,IRELAND,JOHN,LTD,MAT,PUBLISHED,SOCIETY,SONS,THESE,WILEY
BOLTZMANN,OES,ROS
169,2014,AKT,BAK,BAX,ERK,FURTHER,JNK,NSCLC,PARP,SCREENING,THESE,THUS
AFTER,THERAPY
2476,2500,621,BACKGROUND,BASE,COX,CURRENT,DATA,FIVE,III,IIIA,LABEL,LOBECTOMY,MEIER,METHODS,NCDB,RESULTS,SCLC,THESE
ALSO,MUC1,SEVERAL,THUS
169,2015,BACKGROUND,CASES,FIFTY,LABEL,METHODS,ONCE,RESULTS,SARCOID,SOCIETY,THESE,TYPICALLY
2006,2007,BACKGROUND,CONCLUSION,EBUS,FALSE,IIIA,IIIB,LABEL,MARCH,METHODS,RADICAL,REF,RESULTS,SEPTEMBER,TAB,TNM,ULTRASOUND
945,A549,BECLIN1,CLONOGENIC,EGFP,H1299,HIF,HYPOXIA,JUN,LC3,NH2,PCR,REDUCED,UNDER,WESTERN
PULMONARY,THESE
DANG,NSCLC,TAKEN
CHEST,LEFT
BECAUSE,MALIGNANT,MPM,PMT
CCL2,CCR2,EMT,NSCLC,STAT3,THUS,TWIST
169,2014,AUC,COPYRIGHT,DIAGNOSTIC,JOHN,LTD,PARAMETRIC,ROC,SONS,WILEY
169,2013,2015,211,257,276,A549,ABS,ADRAGNA,ALTER,BAK,BAK1,BCL,BCLXL,BH1,BH3,BIOCHEM,BROWN,CELL,COPYRIGHT,FHLCS,HEINY,LAUF,NKA,NOTABLY,PHYSIOL,SOCIETY,THESE
163A,AKT,BACKGROUND,FINALLY,FURTHER,LABEL,MAIN,METHODS,MPS,NEXT,OBJECTIVE,OBJECTIVES,PSD,RATIONALE,RESULTS,S159,THESE,THROUGH,USING
ACT,AFFORDABLE,CARE,CENTERS,CMS,FORCE,LEGITIMATE,LUNG,PREVENTIVE,SCREENING,SINCE,TASK,THESE,TRIAL
BACKGROUND,DETECTION,EFIRM,EGFR,FINALLY,L858R,LABEL,MAIN,METHODS,MUTATIONS,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SABER
BACKGROUND,CASE,FOLLOWING,FORTY,HOWEVER,NSCLC,THREE
180,GROUP,HIGH,IIA,LABEL,METHODS,OBJECTIVE,RESULTS
CELL,ERK5,HOWEVER,LABEL,MATERIALS,METHODS,MMP,MTT,OBJECTIVE,PCR,RESULTS,SLUG,U2OS,WESTERN
8211,FURTHER,IMPORTANCE,KIT,RAF,RAS,RELEVANCE,S628N,THEREFORE,USING
CTC,CTCS,DUE,EPCAM,HOWEVER,MCF,OVERALL,UNDER
2013,ACT,AFFORDABLE,CARE,CENTERS,CMS,FORCE,LUNG,NLST,PREVENTIVE,SCREENING,TASK,TRIAL,UNDER,UNTIL
169,2014,CONCLUSION,FDG,GTV,HX4,HYPOXIC,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,REMARKABLY,RESULTS,SUV
0001,001,007,169,2014,247,695,749,761,813,945,ALTERED,ELISA,HSP90,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,USING
169,1993,1999,2014,304,676,8805,901,AMONG,BACKGROUND,COX,CURRENT,GOV,HOWEVER,INITIATIVE,LABEL,LUNG,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVERSITY,WHI,WHILE,WOMEN
METASTASIS,MTA,MTA1
024,177,258,267,5TH,908,AVAPS,NIMV,PACO2,PAO2,SAO2,THERE
177,8201,8322,AHI,CD40,CD40L,OSA,SAO,THERE,URIC
002,128167809,128393157,128498051,145,169,2014,215,8Q24,961,CAUCASIAN,CHR8,CHROMOSOME,COLORECTAL,CPG,FDR,LUNG,MYC,OVARIAN,POU5F1B,SCREENING,SNP,SNPS,THESE,TRIAL
174,2005,AVASTIN,III,RESULTS
AFTER,BASED,HOWEVER,RADIATION
009,125,127,229,340,8202,868,8805,BACKGROUND,COX,LABEL,METHODS,OBJECTIVE,PLACENTAL,PURPOSE,RESULTS,THERE,TRIAL
116,181,215,250,2YL,A375,A431,A549,AGILENT,C18,COLON,DAD,EPIDERMOID,FINALLY,H322,HCT,HPLC,IC50,MTT,NCI,PRANGOS
788,BACKGROUND,LABEL,METHODS,REGISTERS,RESULTS,SIR,SIRS,SWEDISH
026,168,174,2011,2013,BOARD,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PATHOLOGY,PROXIMITY,PURPOSE,RESULTS,THESE
145,169,2014,956,A549,AMONG,ANNEXIN,FITC,FLOW,GMBH,HELA,HOECHST,IC50,KGAA,MCF,THESE,VCH,WILEY
215,FONTANA,HMB,MALIGNANT,PATHOLOGIC,STOMACH

231,ANOVA,BACKGROUND,CELL,CONCLUSION,DAPI,DEVELOPING,H1299,LABEL,MATERIALS,MDA,METHODS,MTT,RESULTS,SPSS,TAMOXIFEN,TREATMENT
001,046,178,279,967,998,AIM,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
011,021,0210,324,634,828,FSRT,LABEL,MATERIALS,METHODS,OBJECTIVE,RECURSIVE,RESULTS,SALVAGE,SCLC,THERE
1999,2009,AIMS,BACKGROUND,DISEASE,JANUARY,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,THERE
ADDITIONAL,CSF1,ERK,FINALLY,H358,NOD,SCID,VAV1
CD209,CELL,ERK,HOWEVER,HYPOXIA,LEWIS,LLC,LUNG,NON,NSCLC,SMALL
169,2014,BACKGROUND,COLON,CXR,DATA,END,LABEL,LUNG,METHODS,MPST,MPSTS,NLST,OVARIAN,PLCO,RESULTS,SCREENING,SEER,TRIAL
169,2014,ALK,COPYRIGHT,EGFR,IRELAND,L858R,LTD,NSCLC,ONCOGENIC
005,127,169,2014,5CM,953,969,ALK,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,METHODS,RESULTS,WHILE
169,2014,945,946,A549,BPA,COPYRIGHT,EGFR,ERFR,ERK1,FURTHER,GPER,LUNG,MMP,MMPS,SAS
169,2014,BECAUSE,BFD,COPYRIGHT,DR4,H460,INDEX,LUNG,NCI,ROS,SAS,TRAIL
125,177,215,435,8764,945,946,99M,A549,FITC,GALACTO,HT29,IC50,MDA,RGD,RGD2,SINCE,SIX,THERE,THESE,THREE,U87MG
0001,162,2008,2012,BACKGROUND,CEA,CONCLUSION,CYFRA,LABEL,METHODS,NSE,RECURSIVE,RESULTS
177,2003,2013,2014,AFTER,AMONG,APRIL,DVT,DYSPNEA,JANUARY,LABEL,METHODS,MOST,OBJECTIVE,PTE,RESULTS,THERE,VTE
169,2014,AKT,ALREADY,COPYRIGHT,DESPITE,LTD,PI3
169,2014,215,BALB,CALU,CD105,CD117,CD13,CD133,CD14,CD34,CD44,CD45,CD73,CD90,CELL,CONTROL,ETS1,LABEL,MCS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PRIMARY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
522,725,ARG,ASIAN,CHINESE,HIS139ARG,ODDS,STRATIFIED,THESE,TYR,TYR113HIS
108,155,160,169,1994,2010,2015,ANGELES,CALIFORNIA,COPYRIGHT,INC,LABEL,LOS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SARCOMA,SURGERY,UNIVARIATE,UNIVERSITY
001,002,011,100,123,169,2015,224,945,946,COPYRIGHT,IGF,IGFBP,INC,LABEL,MANN,MAYO,METHODS,OBJECTIVE,PUBLISHED,REFINEMENT,RESULTS,RUSH,SURGERY,THESE,UNIVERSITY,UPON,WHITNEY
160,BACKGROUND,CELL,CONCLUSION,EGF,EGFR,IHC,LABEL,METHODS,NSCLC,RESULTS,THUS,Y317,Y320,Y347,Y350
169,2014,252,COPYRIGHT,FEDERATION,FOXO1,NSCLC,P21,P27,POK,POZ,PUBLISHED,SOCIETIES,THEREFORE
169,2014,549,929,CD2,COMPLEX,COPYRIGHT,DIC,DICLOFENAC,FRIDOVICH,H2O,IC50,MCF,MEOH,T24
142,2000,2013,8197,8805,BACKGROUND,BMJ,CXR,CXRS,GROUP,INDIVIDUAL,LABEL,LIMITED,LUNG,METHODS,NETWORK,PUBLISHED,PUBLISHING,RESULTS
A549,ALSO,BACKGROUND,BRDU,HMC,KIT,LABEL,METHODS,PCR,PKH67,RESULTS,SCF,WESTERN
251,251A,265,607,HOWEVER,OVERALL
116,HCT,HOWEVER,PAS,POLYAMINES,SSAT,SW480,THEREFORE
169,2014,ALK,AMP,ASCO,CAP,COLLEGE,CONCLUSION,DISCUSSION,EGFR,IASLC,LABEL,LUNG,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PURPOSE,RESULTS,SOCIETY
169,2014,945,COPYRIGHT,HOWEVER,LIPOSOMAL,NSAID,NSCLC,PHOSPHO,PIA,ROS
200,4T1,946,EBP,EO771,MICE,PRIMARY,REDUCED,STAT6,TAKEN,TCM,YM1
568,BACKGROUND,COMPLEX,CONCLUSION,EMT,H3K27,H3K4,LABEL,LSD1,METHODS,NFAT5,NUCLEAR,PRC2,REPRESSIVE,RESULTS,RNAS,VEGF
169,2014,451,946,COPYRIGHT,DTX,EMT,EPITHELIAL,ERK,GSK,H1299,HOWEVER,LAD,LTD,MET,MIR,MYC,SPC
CB1A,DOCETAXEL,MICE
HOWEVER,LESS,PULMONARY,THESE,VARIOUS
HOWEVER,METASTASES,METASTATIC,MOST,THEREFORE
COMMITTEE,GROUP,HOWEVER,JOINT,LUNG,SCLC,SMALL,VALSG
GROUP,HOWEVER,MALIGNANT,MPM,PET
CONSISTENT,DRESLER,IASLC,LUNG,SOCIETY
BECAUSE,FLEISCHNER,FURTHER,PET,SEMISOLID,SPN,SPNS
AUTOPSY,ITALY
EGFR,KOREA,MET,NOTABLY,NSCLC,PULSATILLA,SB365,THEREFORE,TKIS
160,226,468,692,A24,A26,AMONG,CTL,HLA,IGG,NSCLC,PPV,THEREFORE,THESE
AROMATASE,CYP19A1,ELISA,ERS1,ERS2,ESR1,NSCLC,PCR
0001,005,198,A549,BASED,H1703,H522,HOWEVER,IHC,IMR,LCC,NCI,NSCLC,SOX18,SQC
107,175,1997,2011,322,643,8202,BIAGINI,BORIANI,JANUARY,KARNOFSKY,LABEL,LOG,LUNG,MEIER,METHODS,OBJECTIVE,RANK,RESULTS,SCORE,WALKING,WEINSTEIN
8209,CRTX,JUN,NOTABLY,SOUTH,SPCA,THEREFORE
LUNG,MICRORNAS,RNAS,SEVERAL
1000,158,169,2014,3NM,945,A549,COPYRIGHT,CRIZOTINIB,HOWEVER,PLA,SILDENAFIL,THESE,TPGS
100,160,EDX,LEAD,LUNG,MANGANESE
169,2014,231,233,A549,ART,AVOS,COPYRIGHT,CYT,INHIBITION,MDA,MOL,NAC,POTENCY,PRE,ROS,SCAVENGING,SCC25,SFBBM,SIMILAR,SOCI,WI38
956,DOX,H1299
1964,21ST,EXACTLY,GENERAL,SURGEON
MEN,MTC,PAPILLARY,PTC
169,2014,A549,COPYRIGHT,FURTHER,HOWEVER,INC,MTT,THESE,THUS,TUNEL
169,2014,8201,BARR,COPYRIGHT,EPSTEIN,HALF,HLA,PTLD,PTLDS,SOCIETY,SOT,TRANSPLANT
150,306,945,DESPITE,MEIER,RNAS

ALZHEIMER,GWAS
226
175,BACKGROUND,CASE,CAUCASIAN,CEA,CONCLUSION,LABEL,METASTASES,METHODS,SERUM
516,ALONG,CME,EVIDENCED,MET
001,114,15TH,388,588,8201,8804,910,950,AGER,AGONIST,AUC,BACKGROUND,CCL20,CDH,CDH1,CHRONIC,COPD,EMPHYSEMA,FEV1,HIGH,HRCT,ICAM,ICAM1,LAA,LABEL,LP15A,METHODS,OTHER,RAGE,RATIONALE,REGRESSION,RESULTS,SELECTIVE,TESRA,TREATMENT,ULTIMATELY,USING,VALIDATION
18F,AXILLAR,BACKGROUND,CASE,CONCLUSION,FDG,LABEL,METHODS,PET,SCHWANNOMA
ADP,CBP,H2B,K12,K120,PARP,THROUGH,USING
169,2014,ASP,CNP,COPYRIGHT,FITC,MTX,THERE
0001,001,008,118,169,2012,2013,2014,226,294,654,8805,APRIL,BNP,BNPS,FOLLOWING,HOWEVER,IQR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
BUDS,EVEN
169,2014,211,252,331,9508,AMONG,COPYRIGHT,COX,GPA,GROUP,INC,LABEL,MATERIALS,METHODS,MST,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,SRS,THERAPY,TREATMENT,WBRT
140,160,169,2013,2015,AAGL,COPYRIGHT,FORCE,INC,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,OLDER,OUTPATIENT,PUBLISHED,RESULTS,RISK,SETTING,TASK,THESE,UNIVERSITY
001,169,2014,327,AUTHORS,CLINICALLY,CONTROLLED,COPYRIGHT,CRT,DOSE,GTV,INC,LABEL,MATERIALS,METHODS,NTCP,OBJECTIVE,PTV,PTV2,PUBLISHED,PURPOSE,RA50,RA62,RANDOMISED,RESULTS,SIB,TCP,THESE
1296,169,2014,237,AMONG,BACKGROUND,BPD,BPDS,COPD,COPYRIGHT,CYFRA,E170,ECL,HOWEVER,LABEL,MANN,METHODS,NSCLC,RESULTS,ROC,SERUM,THEREFORE,WHITNEY
119,CAFS,EZRIN,LABEL,LUNG,METHODS,OBJECTIVE,PDPN,PURPOSE,RESULTS
8201,WORLD
2010,495,IASLC,LUNG,THESE,TNM
043,130,169,2014,55GY,682,BACKGROUND,CELL,CONCURRENT,COPYRIGHT,CURE,III,LABEL,LTD,LUNG,METHODS,NON,NSCLC,PUBLISHED,RESULTS,SECONDARY,SEQUENTIAL,SMALL,STAGE,TREATMENT
8201,ABC,ADDITIONAL,DCN,DPT,EXPRESSION,GCTB,GIANT,LUM,PCR,VALIDATION
169,2014,946,LCFA,MMTV,OBESITY,PYMT,SRC,STAT3,T2D,THESE
110,1123,160,ATI,FIBONACCI,LABEL,METHODS,MTD,OBJECTIVE,PHASE,PKS,PURPOSE,RESULTS
022,024,105,169,19S,2005,2012,2014,AMONG,BACKGROUND,BETWEEN,COPYRIGHT,DEL,DELETIONAL,E746,EFFICACIES,EGFR,EXON,INSERTIONS,IRELAND,JULY,L747,L858R,LABEL,LTD,METHODS,PFS,RESULTS,TKI,TKIS
8201,CD34,HOWEVER,INCREASING,MVD,NSCLC,PCR
169,2014,EGFR,FDA,HER2,HOWEVER,MET,SEVERAL,T790M,THERE,TKI,TKIS
004,177,2009,2011,AIR,EGFR,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
116,169,2014,8805,COPYRIGHT,EGFR,INC,RET
103,108,169,2014,8805,AMONG,BED,COPYRIGHT,COX,DOSIMETRIC,ESOPHAGEAL,GTV,INC,INCIDENCE,LABEL,LOCAL,MATERIALS,METHODS,MVA,NFZ,NONE,OBJECTIVE,PBT,PTV,PURPOSE,RESULTS,SBRT,SIXTEEN,THERE,USING
169,2014,A549,COPYRIGHT,H1299,HOMOLOGUE,HOWEVER,PARP,RNAI,SCIN,SILENCING,THESE
PDGF,PDGFS
169,2014,A549,BOTH,ESMS,GMBH,H1435,KGAA,NCI,NMR,USING,VCH,WILEY
2009,2012,CASES,FIVE,JANUARY,LABEL,METASTATIC,METHODS,MRI,OBJECTIVE,RESULTS,THESE
AKT,FINALLY,KRAS,MAPK,ONCOGENIC,PI3K,RAF,RAL,RAS
169,2014,AMONG,CAD,COMPARISON,CONSORTIUM,COPYRIGHT,FPS,IMAGE,LAPLACIAN,LIDC,LTD,LUNG,THEN,THESE
169,2014,8201,8804,CCDC6,FINALLY,NON,NSC,NSCL,NSCLC,PARP,PARP1,RAD51,REMARKABLY,TMA,UICC
169,2014,AMINOBENZ,ESMS,GMBH,H460,ICP,KGAA,NCI,NSCLC,VCH,WILEY
0001,110,169,1990,2012,2013,270,290,8201,BACKGROUND,BECAUSE,BETWEEN,LABEL,METASTATIC,METHODS,RESULTS,SOCIETY,STUDIES
102,468,A549,ABTS,ALSO,AMONG,ATCC,FINALLY,GI50,H322M,H460,INSTITUTE,MDA,NCI,STRUCTURE,THESE
EGFR,HOWEVER,NON,NSCLC,T790M,TKIS
1996,2008,955,ALSO,BACKGROUND,BOTH,CONCLUSION,III,LABEL,METHODS,PHASE,RESULTS,THESE
BACKGROUND,BMJ,CROSS,DEG,FURTHER,GROUP,GSEA,HOWEVER,LABEL,LIMITED,MEANWHILE,METHODS,PUBLISHED,PUBLISHING,RESULTS,SEQ,THUS,UNASSIGNED
169,2014,7721,A549,BOC,COPYRIGHT,DDP,IC50,LTD,MCF,SMMC
ADENOVIRUS,E1A,GP78,HAT,HSPA5,K353,YANG,YING
1775,ATR,AZD7762,CDK1,CHK1,H39,SER10,SMALL,THESE,TYR15,WEE1
AMONG,BACKGROUND,CONVERSELY,HDAC,HDACI,ITF2357,LABEL,LCSC,NON,NSCLC,OVERALL,PEMETREXED,RESULTS,SIMILARLY,SINCE
169,2014,CANCERS,COPYRIGHT,ITH,SCIENCE,THESE,WES
169,2014,COPYRIGHT,DESPITE,NSCLC,SCIENCE,SPATIAL,THERE
169,2014,945,BASEL,FAS,FASL,H2052,NAFTOPIDIL,NCI,TNF
169,2014,5A1,6A1,COPYRIGHT,GLC,IRELAND,LTD,OATP,OATP4A1,OATP5A1,OATP6A1,OATPS,SCLC,SCLCS,TREATMENT,WESTERN
160,663,956,BCL,H3255,H460,HOWEVER
004,039,655,715,8201,EGFR,HOWEVER,ORR,PFS,SIXTY,TKIS
160,169,2014,2M0,3N0M0,4N1,ADDITIONAL,BACKGROUND,COPYRIGHT,FIVE,INC,LABEL,LUMINEX,METHODS,PUBLISHED,RESULTS,SIMILARLY,SOCIETY,T1A
945,946,A549,AIMS,AKT,BACKGROUND,CONCLUSION,CXCL1,CXCR,ELISA,HOWEVER,JNK,LABEL,MAP,MAPK,METHODS,OBJECTIVE,PCR,PI3K,RESULTS,TGF,TNF,TRANSWELL
A750,BACKGROUND,CASE,CAUCASIAN,E746,HOWEVER,LABEL,METHODS,THESE,TREATMENT
AFTER,AGAIN,ALDH,ALDHBRIGHT,ANTI,BACKGROUND,CD133,CD24,CD44,CSC,CSCS,FEW,INCREASING,LABEL,METHODS,PARAMETRIC,RESULTS,TKI,TKIS,TMA
171,174,BACKGROUND,C2P,CONCLUSION,COX,EVEN,LABEL,LUNG,METHODS,RESULTS,THUS
956,BACKGROUND,CD9,CDCP1,CELL,COLO320,CUB,DETERGENT,DUAL,ENGINEERED,LABEL,METHODS,REAL,RESULTS,SW480,TIME,TREATMENT,WESTERN
ALK,ANAPLASTIC,AREAS,AVAILABLE,BACKGROUND,COVERED,III,LABEL,METHODS,NOVEL,NSCLC,OPINION,PHASE
946,ECTOPIC,EMT,EPH4,EPITHELIAL,FOS,FRA,INHIBITING,MOLECULAR,SLUG,TGF,THUS,ZEB1,ZEB2
001,100,107,169,177,2014,215,5493,ACADEMY,AFRICAN,ALLERGY,AMONG,BACKGROUND,CHILDHOOD,CONCLUSION,COPYRIGHT,FEV1,IMMUNOLOGY,LABEL,LATINOS,METHODS,OBJECTIVE,ODDS,RESULTS,THESE
001,004,010,015,044,048,075,158,216,284,287,296,491,510,597,8201,936,975,BACKGROUND,CAUCASIAN,EGFR,HOWEVER,IIIB,ITALIAN,LABEL,METHODS,PCR,PFS,RAS,RESPONSES,RESULTS,SIXTY,TKI,TKIS
946,AIM,CONCLUSION,ELISA,HOWEVER,HSP90,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS
001,007,129,164,169,2000,2012,2014,281,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,GROUP,LABEL,LOCAL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SARCOMA,SURGERY
004,073,100,169,2015,BLOOD,CARDIAC,COPYRIGHT,HSCT,INC,PUBLISHED,SEVENTEEN,SOCIETY,THESE,TMA
169,2014,AUR,COPYRIGHT,CTP,EACH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,TCCS
BACKGROUND,CONCLUSION,LABEL,METASTATIC,METHODS,MSM,PANCREATIC,RADIATION,RESULTS,SMAD4,THERE,WHIPPLE
169,1958,1980,2014,COPYRIGHT,CSF,DESPITE,IDIOPATHIC,KING,PAP,PAS,PUBLISHED,PULMONARY,ROSEN,SINGH,SPECIALIST,WHOLE
169,2014,BRCA1,CNS,COLLEGE,COPYRIGHT,FINALLY,HER2,LTD,PUBLISHED,ROYAL,THERE,TNBCS
AFTER,HOWEVER,JANUS
8197,945,947,AMPAR,BACKGROUND,BARCELONA,BMJ,DATA,DISCUSSION,EEG,FIVE,GABA,GROUP,LABEL,LIMITED,MAYO,METHODS,MRI,NONE,PUBLISHED,PUBLISHING,RESULTS,SCLC,SERUM,THREE
169,2014,440,500,610,679,BACKGROUND,BASEL,BIOMARKER,EGFR,L858R,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,THEIR
169,2014,BACKGROUND,BASEL,EXPRESSION,FIFTY,IHC,LABEL,LUNG,METHODS,MMP,OBJECTIVE,OBJECTIVES,PCR,PSP,RESULTS,THESE,TIMP
169,1MM,2014,A549,ATII,COPYRIGHT,DFT,NMR,PET,THERE,TURN
800,ACCORDING,RDA,VITAMIN
AKT,BET,BETI,ENDOGENOUS,MYC,PANNETS,THESE
8482,ALK,CRIZOTINIB,DIETARY,DIGESTIVE,MET,MONITORING,PROFILE,ROS1,XALKORI
100,A549,BASED,CD44,H1299,HFL1,HOWEVER,NSCLC
018,025,036,042,044,046,151,1995,2008,473,BACKGROUND,CIS,COX,HRS,LABEL,METHODS,NSCLC,RESULTS,RTL,WOMEN
001,146,149,250,BACKGROUND,BASED,CONCLUSION,LABEL,MEIER,METHODS,NLR,PLR,RESULTS,ROC,THERE
100,150,200,8805,AMONG,BACKGROUND,BSA,CONCLUSION,CONTINUOUS,DOSE,DRUG,FORTY,LABEL,METHODS,RESULTS
001,736,828,909,ACCORDING,ACTN4,BACKGROUND,CL1,LABEL,METHODS,NSCLC,RESULTS,THESE,THUS
169,200,2014,AUTHORS,BECAUSE,FOUNDATION,JOHN,JOURNAL,LTD,LUNG,MOLECULAR,NON,NSCLC,RNAS,SONS,WILEY
215,ILCR,MODEL,PAH,PAHS,STILL
169,2014,215,8764,ATLAS,BACKGROUND,LABEL,MOST,MOTIVATION,PRESS,PUBLISHED,RESULTS,TCGA,THESE,THETA,UNIVERSITY,WGS,WXS
BCG
0001,ACS,CCL25,CCR9,DESPITE,EXPRESSION,LUCA,NSCLC,POOR,SCC,SCCS,SIMILAR
169,2014,369,545,577,766,912,961,987,AUTHORS,DATA,FURTHER,IGE,JOHN,LTD,SIR,SIRS,SONS,THERE,WILEY
BPF,PRIMARY
001,003,042,ASSESSMENT,BACKGROUND,ELISA,LABEL,METHODS,RCAS1,RESULTS,SERA,SERUM,SISO,UNIVARIATE
000,100,2000,2006,2009,231,241,262,311,AAPC,AGE,AIMS,ASRW,ASRWS,AVERAGE,COLORECTAL,DATA,DCO,JOINPOINT,METHODS,OVERALL,RESULTS,SOFIA
1686,ATP,AZD9291,CLASSIC,EGFR,L858R,LUNG,NON,NSCLC,ONGOING,T790M,TKIS
791,8202,IIIA,LABEL,MANAGER,MEDLINE,META,METHODS,MLND,MLNS,NSCLC,OBJECTIVE,RESULTS,SYSTEMATIC,THERE,VERSION,WHETHER
CRAN,SIGNATURES,SNPS,THESE
0MG,2007,2011,666,CONCLUSION,DIET,DISEASE,FOUNDATION,GROUP,HOWEVER,JANUARY,LABEL,MDRD,METHODS,OBJECTIVE,RENAL,RESULTS,WORKING
SBRT,THEREFORE
BIOMARKERS,CURRENT,EVS,LUNG,MICRORNAS,REMARKABLY,RNAS,THEIR
169,2014,ATM,ATMIN,BIOLOGISTS,COMPANY,DEPLETION,DYNC2H1,EXPRESSION,H210Q,IFT,INITIALLY,LC8,LTD,PUBLISHED,WDR34
0001,109,169,2014,AKI,ATP,BACKGROUND,CHEMISTRY,COX,LABEL,MEIER,METHODS,PCR,PREDICTING,RESULTS,RNAS,TAPSAKI,TRANSCRIPT
169,2014,576,ASIAN,CAUCASIAN,EGFR,EXPRESSION,FGFR,FGFR3,HOWEVER,IL3,LABEL,METHODS,NGS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TACC3,TARGETABLE,THESE
CBP,CHROMATIN,CONVERSELY,HOWEVER,INHIBITION,SP1
108,162,169,2014,COMPONENTS,CONCLUSION,COPYRIGHT,FEAR,HOWEVER,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PARTIAL,PIC,RESULTS
038,047,160,215,500,CBDCA,EPIDERMAL,FORTY,FURTHER,LABEL,METHODS,MTHFR,NSCLC,OBJECTIVE,PEM,PURPOSE,RESULTS,TYMS,VNTR
2000,8201,8805,FOLLOWING,LUNG,PULMONARY
132,169,2013,2014,8201,ACTA,BACKGROUND,CONCLUSION,FINAL,FLEISCHNER,FORTY,FOUNDATION,INTER,LABEL,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,RESULTS,SOCIETY,THERE,THREE
155,169,2014,215,239,241,311,364,437,453,490,4Q13,674,802,892,AFRICAN,AMERICANS,AMONG,BACKGROUND,EVALUATING,FIFTEEN,HAWAIIANS,LABEL,LATINOS,METHODS,RESULTS,SNP,SNPS,UGT2B10,URINARY
0001,0002,049,142,169,1ST,2014,292,301,3RD,ALPHA,ATBC,BACKGROUND,BETA,CLL,COLORECTAL,GREATER,HODGKIN,LABEL,LUNG,METHODS,NHL,OVARIAN,PLCO,PREVIOUSLY,RESULTS,SLL,THESE,TOCOPHEROL
0001,169,2014,2977,8805,AACR,ALPHA,ASIA,ATBC,BACKGROUND,BETA,BIOMARKERS,COLORECTAL,EPIDEMIOL,LABEL,LUNG,MATERIALS,METHODS,ORS,OVARIAN,OVERALL,PLCO,PREV,RESULTS,SWHS,TOCOPHEROL,WOMEN
AFTER,ANOTHER,HOWEVER,RADICAL
945,947,BASED,LABEL,LUNG,METHODS,OBJECTIVE,PLS,PURPOSE,RESULTS,SAMPLES,SERUM
8201,AWARENESS,BACKGROUND,KEY,LABEL,METHODS,RESULTS
001,003,100,160,169,177,2010,2012,2015,COILS,COPYRIGHT,CROWN,GROWING,INC,JUNE,LABEL,MARCH,METHODS,NODULES,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PUBLISHED,RESULTS,SIXTY,THERE,VATS
160,AMPLITUDE,BACKGROUND,BOTH,FDG,GATED,ITV,ITVS,LABEL,MATERIALS,METHODS,MIP,MIPS,NON,OBJECTIVE,OCVS,PET,PURPOSE,RESULTS,UNIFORM
160,325,AFFYMETRIX,AGGRESSIVE,CDH1,CDH2,COCULTURE,EMT,EPITHELIAL,EXPRESSION,FORTY,GENERATED,MCF,MG63,PCR,PROTEIN,TWIST,VIM
MRI,SURGERY
382,CSC,EMT,LUNG,TAKEN
AMONG,CHRONIC,COPD,LABEL,MATERIALS,METHODS,MMP1,MMP12,MMP2,MMP3,MMP9,MMPS,OBJECTIVE,RESULTS,THERE,TIMP1
947,DR5,FADD,H226,H322M,HOWEVER,IDO,IFN,INTERFERON,NCSLC,NOTABLY,NSCLC,THESE
001,117,238,355,BLOOD,HEART,INSTITUTE,LABEL,LUNG,MATERIALS,METHODS,METS,OBJECTIVE,PURPOSE,RCC,RENAL,RESULTS,RISK
101,2010,2013,434,ACTIVATING,ADX,AMONG,ARMS,BACKGROUND,EGFR,HOWEVER,LABEL,LBC,MARCH,MATERIALS,METHODS,NSCLC,REFRACTORY,RESULTS,TKI
A549,AD5,ADENOVIRUS,AFTER,CONCLUSION,CTRL,F35,FITC,LABEL,METHODS,MOI,MTT,NULL,OBJECTIVE,PARP,PCR,RESULTS,THEREFORE,WESTERN,XAF1
000,011,017,018,168,267,379,513,552,577,897,967,APAI,BACKGROUND,CHINESE,IGF2,LABEL,LOI,MATERIALS,METHODS,PCR,RESULTS,RFLP
2014,5TH,623,865,APRIL,BIOLOGY,CBM,CHINA,CHINESE,CNKI,DATA,GSTM1,KNOWLEDGE,LINK,OVERALL,OVID,RELATED,SERVICE,WANFANG
011,2000,2013,401,544,586,688,AKDENIZ,AUC,BACKGROUND,BECAUSE,JANUARY,LABEL,MATERIALS,METHODS,NACT,NLR,NPV,PCR,RESULTS,SIXTEEN,UNIVERSITY
A549,AIM,ATPR,ATRA,ERK,ERK1,EXPRESSION,LABEL,MAPK,MAPKS,MATERIALS,METHODS,MLC,MLCK,MTT,OBJECTIVE,PD98059,PMA,RESULTS,WESTERN,WOUND
003,048,061,063,068,275,381,486,508,523,670,697,719,806,851,888,909,931,952,970,985,992,993,998,BACKGROUND,CHINESE,CIS,CNKI,ERCC4,HOWEVER,KNOWLEDGE,LABEL,LITERATURE,MATERIALS,METHODS,ORS,RESULTS,SCIENCE,THERE,WANFANG,WEB
001,CURRENTLY,DFS,NSCLC,THEREFORE,TNM
AMONG,BACKGROUND,EGFR,LABEL,METHODS,MST,NSCLC,PCR,RESULTS,THESE
BACKGROUND,CA199,CEA,EGFR,LABEL,METHODS,NSCLC,RESULTS,SERUM,TKI
137,1995,2012,478,8805,ALTOGETHER,BACKGROUND,CONCLUSION,HOWEVER,JUNE,LABEL,METHODS,NSCLC,RESULTS
2009,2012,8805,BACKGROUND,BASED,BETWEEN,BOTH,CONCLUSION,JANUARY,LABEL,LATE,MAY,METHODS,NSCLC,PBT,PFS,RBE,RESULTS,SEX,THERE
169,2014,APOB,COPYRIGHT,LDL,LUC,MCF,PGA,VLDL
123,164,169,2000,2014,956,A549,ACTIVATION,APOPTOSIS,BCL,COLO320DM,COPYRIGHT,CYTOTOXIC,IRELAND,LTD,MOLECULAR,MTT,THESE,TREATMENT,VERO
169,1B10,2014,3MA,A549,AKR,AKR1B10,BHQ,BOTH,COPYRIGHT,IRELAND,LC3,LTD,NEITHER,TBE,TBEH,TBQ
002,011,100,600,800,ADC,ADCS,ANOVA,CHANGES,COMMITTEE,CONCLUSION,IMAGING,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,RESULTS,TREATMENT
001,003,013,17A,322,366,DATA,NSCLC,SNPS,THESE
000,169,2014,CASE,CONCLUSION,DISCUSSION,FURTHER,HIGH,LABEL,METHODS,OBJECTIVE,OLHDE,OPTIONS,SUMMARY,VTE
169,2014,BIOLOGY,C6H4,ENDOGENOUS,HNE,I217R,INC,MOLECULAR,PR3,SOCIETY,THESE,WEGENER
001,002,169,1MONTHS,2014,957,ASCO,BACKGROUND,CIS,COPYRIGHT,EGFR,JANUARY,LABEL,LTD,METHODS,NSCLC,RCTS,RESULTS,TREATMENT
AAVS1,CD34,CGD,THERE,USING,ZFN
AKT,AKT2,BACKGROUND,CONCLUSION,FUNCTIONAL,LABEL,METHODS,MTT,PCR,RESULTS,S473,SHORT,TARGETSCAN,UTR
169,2014,COPYRIGHT,INC,STRATAKIS,VON
169,2014,ALK,ASIAN,BECAUSE,BRAF,COPYRIGHT,EAST,EGFR,INC,KRAS,KRISTEN,LUNG,NSCLC,RAF
2012,BACKGROUND,DESPITE,DISCUSSION,EGFR,ESO,EUDRACT,GRADE,LABEL,METHODS,MUC1,NSCLC,THREE,TRIAL
00001,005,4608,4617,CHINESE,FIVE,THUS

ALK,BRAF,CMET,CNS,CTLA4,EGFR,ESMO,FGFR1,HER2,MEDICAL,METASTASES,NCCN,NETWORK,RAS,ROS1,SOCIETY
169,2014,CACO,INC
0016,0029,160,169,2007,2009,2014,277,360,429,8804,ASIA,AUTHORS,CONCURRENT,COX,EASTERN,ERLOTINIB,GROUP,ILD,JAPAN,LTD,ML21590,OCTOBER,OVERALL,POLARSTAR,PRIMARY,PTY,PUBLISHING,SCIENCE,THESE,WILEY
946,CELL,CHROMATIN,EMT,EPITHELIAL,EPRAS,FOXQ1,HELA,NOTABLY,PCR,TGF,WOUND
115,130,300,8201,8226,CONCLUSION,DIAGNOSIS,FLEISCHNER,HOUNSFIELD,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY
000,100,169,2014,2260,46XX,46XY,ANOTHER,CASE,CONCLUSION,COPYRIGHT,EARLY,EMA,FETAL,HCG,LABEL,METHODS,OBJECTIVE,PUBLISHED,THERE
A549,DUAL,FINALLY,FOXO3,MICRORNAS,MIR,NSCLC,PCR,SPC,THEREFORE,TRANS,UTR,WESTERN
495,KRAS,MICRORNAS,NSCLC,THESE
100,215,A750,EGFR,EPIDERMAL,IHC,L858R,PCR
027,1143,1332,1730,AFTER,CCT,CTF,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEREAFTER
2011,2013,2014,APRIL,COMMITTEE,FORCE,HOWEVER,LDCT,LUNG,PREVENTIVE,SCREENING,SINCE,TASK,TRIAL
001,177,7667,945,946,947,99M,A549,CONCLUSION,H446,LABEL,MATERIALS,METHODS,MICRO,NCI,OBJECTIVE,PURPOSE,RESULTS,RGD2,SPECT
160,169,2014,231,233,COPYRIGHT,FINALLY,FIRST,IIA,III,MOL,SEVERAL,SFBBM,SOCI,THERE
956,COUNSELING,EXCESSIVE,PM2,SHORT,WESTERN,WORLD
148,2006,2011,234,BACKGROUND,DISTANT,LABEL,MAIN,MEIER,METHODS,OBJECTIVE,OUTCOME,PULMONARY,RESULTS,THERE,THREE
169,2014,3MA,A549,AKT,BESIDES,COPYRIGHT,H157,INC,P53,ROS,SPC,SUBSEQUENT,THEN,THESE,THUS
181,CD133,CD177,CELL,CSCS,ISOLATING,NANOG,OCT4,OVCA429,PROM1,SKOV3,SURVIVING,THEREFORE
000,134,1993,1995,2008,2010,491,501,ADVANCING,AMBULATORY,AUTHORS,BACKGROUND,BETWEEN,BLOOD,CARDIAC,CARE,CONCLUSION,CROSS,FUNDING,HEART,INSTITUTE,LABEL,LIMITATION,LUNG,MEDICAL,METHODS,OBJECTIVE,PHYSICIAN,PRIMARY,RESULTS,SETTING
001,106,386,BACKGROUND,CHART,FIFTY,FORM,FUNCTIONAL,HOWEVER,LABEL,METHODS,MORTALITY,REGRESSION,RESULTS,SHORT
200,2ND,945,946,956,AKT,ARP2,CAFS,EMT,FAK,GTPASES,MOLECULAR,PC3,PCA,PREVENTING,SILIBININ,SRC,TRANSWELL
2000,2014,ANHUI,ANOTHER,CHEST,CONCLUSION,FIRST,FIVE,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
143,177,946,AFTER,AICAR,AMPK,APOPTOSIS,BAX,BCL2,CONCLUSION,FURTHER,LABEL,METHODS,MRC,MTT,OBJECTIVE,PEE,RESULTS,THESE,TUNEL
169,2014,203,AUTHORS,COPYRIGHT,EXPRESSION,HNSCC,INC,INDUCIBLE,LASP1,METASTATIC,NUAK1,PUBLISHED,SPARC,USING
169,2014,AUTHORS,BRD4,COPYRIGHT,GILFORD,HGPS,HUTCHINSON,INC,PUBLISHED,RESISTANCE
231,AKT,EMT,ERK,HOWEVER,MDA,MMP2,MMP9,PCR,PEDF,PIGMENT,SKBR3,THESE,WESTERN
946,EMT,FASN,HOWEVER,METASTATIC,TGF,THESE
CLINICALLY,DUB,FURTHER,HOWEVER,MYC,THUS,UBIQUITIN,USP37,USPS,WARBURG
ARSENIC,DATA,HOWEVER,INORGANIC,KOREA,SOUTH,THERE,WHILE
177,3127,A549,ABL,ABL1,ERK,G12,H292,NSCLC,RAS,REDUCED
031,069,1484,169,1995,2008,2014,8201,BACKGROUND,CURRENT,INCREASING,LABEL,METHODS,NSCLC,OVERALL,RATES,RESULTS,SOCIETY,SPLC,SPLCS,THERE,TOBACCO
B54,CHRONIC,DESPITE,DPB,HLA,KV1,TEN
001,160,169,2014,AMIODARONE,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,MEDICAL,METHODS,PUBLISHED,RESULTS,SOCIETY
169,181,2014,231,GMBH,H1299,H460,KGAA,MDA,MEL,MRC,NCI,THREE,VCH,WILEY
169,2014,ABUNDANCE,AUTHORS,GMBH,INSTEAD,KGAA,PROTEOMICS,PUBLISHED,VCH,WHILE,WILEY
169,2014,947,ADDITIONAL,AFTER,AMYLOID,APP,BP1,COMPLEX,GSI,HYPOXIC,INC,IRES,KEY,NOTCH,NSCLC,POST,PRECURSOR,PROTEIN,RAPAMYCIN,STYX,TARGETING,TORIN,UPON,WILEY
946,A549,BACKGROUND,BAX,BCL,HOUTT,LABEL,LUNG,METHODS,MTT,RESULTS,RUMEX
169,2014,954,AIMS,COPYRIGHT,DIAGNOSTIC,INC,KEY,LABEL,MAIN,METHODS,MIDKINE,MNG,NUCLEAR,OBJECTIVE,PROTEIN,PTC,RESULTS,ROC,WESTERN
2006,2012,530,ANTI,CONCLUSION,IIIA,LABEL,MAC,METHODS,OBJECTIVE,OBJECTIVES,PHYSICIANS,RESULTS,SIX
AFTER,AKT,ALONG,AMONG,BUZHONG,CISPLATIN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,PI3K,RESULTS,TOTALLY,YIQI
100,169,2014,ACCORDING,BEL,BRAIN,COMPONENT,COPYRIGHT,EMOTIONAL,HGG,LTD,PCA,PRINCIPAL,THEREFORE,THUS
169,2014,ABCG2,BCL2,BCRC5,CD133,CD44,COPYRIGHT,EMT,HOWEVER,LTD,MDR1,MMP2,MMP9,NANOG,NSCLC,SOX2,THESE
001,008,014,168,169,2015,BACKGROUND,COPYRIGHT,EXHALED,INC,LABEL,METHODS,PNEUMONIA,RESULTS
100,169,183,2014,300,400,600,7155,8805,9681,ACCP,BACKGROUND,CHEST,COLLEGE,COPYRIGHT,FONDS,FUNDING,IMMEDIATE,LABEL,LTD,LUNG,MANAGEMENT,METHODS,NEDERLAND,PHYSICIANS,RESULTS,SMALL,WILHELMINA
0001,003,005,102,169,183,187,196,2014,7155,7907,7915,822,BACKGROUND,COPYRIGHT,CTS,FONDS,FUNDING,HOWEVER,III,INITIALLY,IQR,LABEL,LOW,LTD,LUNG,METHODS,NEDERLAND,RESULTS,SCREENING,WILHELMINA
160,169,2014,COPYRIGHT,INC,MYCOLOGIC,PUBLISHED,RADIOLOGIC,RESOLUTION,SOCIETY
169,2014,COPYRIGHT,INC,LUNG,PUBLISHED,SOCIETY,VHL
169,1995,2010,2014,ADHERENCE,BACKGROUND,CHEST,COPYRIGHT,COVARIATES,CURRENT,CXR,EFFORTS,END,IMAGING,INC,LABEL,METHODS,MOST,NCCN,NETWORK,NSCLC,PET,PUBLISHED,REDUCED,RESULTS,SEER,SOCIETY
128,136,160,169,2005,2011,2014,505,BACKGROUND,CHF,CIS,COPYRIGHT,COX,DATA,HRS,IHM,INC,LABEL,METHODS,ODDS,ONTARIO,ORS,PATIENT,PDM,PUBLISHED,RESULTS,SOCIETY
000,253,288,423,500,697,700,8764,946,SNPS,USING,WNT
144,177,500,8321,CT1,DICE,DSC,FIVE,HAUSDORFF,INCREASING,LABEL,MBQ,METHODS,OBJECTIVE,ORGAN,PET,PURPOSE,RESULTS,SEMI,SIMPLIFIED,VOI,VOIS,VOLUMES,ZIRCONIUM
0001,AGREEMENT,CBCT,EACH,IMAGE,IRB,LABEL,LINAC,METHODS,NCC,OBJECTIVE,PROJECTION,PURPOSE,RCCT,RESULTS,RMC,USING
075,1642,215,8482,AP19,BECAUSE,EPID,FAST,FFT,KODAK,LABEL,LANEX,LAPLACIAN,LARGEST,METHODS,OBJECTIVE,PI200,PURPOSE,RESULTS,RMSE,VISICOILS,XRD
176,2013,8804,ACDS,AUSTRALIA,AUSTRALIAN,DOSIMETRY,FAIL,LABEL,LEVEL,METHODS,OBJECTIVE,OPTIMAL,PASS,PURPOSE,RESULTS,SCORING,SERVICE,TOLERANCE
000,175,256,8201,947,COMBINING,CPU,DATA,GPU,GPUS,LABEL,METHODS,NVB,OBJECTIVE,PURPOSE,REAL,RESULTS,THERE
BOTH,EVALUATION,IMAT,LABEL,METHODS,MLC,OBJECTIVE,PURPOSE,RESULTS
169,2014,240BP,CCAAT,COPYRIGHT,FOS,FURTHER,GIVEN,HOWEVER,LNCAP,PKC,PMA,PRMT5,PROTEIN
001,077,108,157,161,169,2009,2012,2014,250,500,6VERSUS,877,ARMS,BACKGROUND,COMMITTEE,CTONG0806,EGFR,IDENTIFIER,IRC,LABEL,MEDICAL,METHODS,NSCLC,PFS,PFSS,PRESS,PUBLISHED,QUALITY,RESULTS,SOCIETY,UNASSIGNED,UNIVERSITY
169,2014,PRESS,PUBLISHED,SURGERY,UNIVERSITY
169,2014,AZD3965,INHIBITION,MCT1,SCLC,THESE,THUS
169,2014,CDDP,DESPITE,DOPC,HCP1,KRAS,USING,VARIOUS
169,2014,A549,CDK2,COPYRIGHT,D165,FINALLY,INC,MCF7,YAVD
008,124,169,2014,427,8764,BACKGROUND,CCI,CONCLUSION,COPYRIGHT,FEV1,LABEL,LTD,METHODS,NSCLC,PROPENSITY,PSM,RESULTS,SBRT,SLR
019,031,169,177,2014,AGGRESSIVE,AGING,BLOOD,CONCLUSION,COPYRIGHT,DEFICIENCY,HEART,INC,INSTITUTE,LABEL,LOH,LUNG,MATERIALS,METHODS,METS,OBJECTIVE,PCA,RESULTS,THERE,THESE
0001,001,169,2014,AFRICAN,CHRNA,CHRNB,DRD1,FURTHER,GIVEN,LUNG,SNP,SNPS,UTR
BACKGROUND,BNA,CDSR,CIS,DISCUSSION,ITEMS,LABEL,MEDLINE,META,METHODS,MOOSE,ORS,OVERALL,PREFERRED,REPORTING,REVIEWS,RISK,SIRS,SMRS,STUDIES,SYSTEMATIC
169,2014,946,ADC,ERK1,FAK,HOWEVER,LABEL,NSCLC,SCC,TAF,TAFS,THESE,UNLABELLED,Y204
169,2014,A549,CDDP,COPYRIGHT,L929
150,169,2014,300,ANTISENSE,ASSOCIATED,EXPRESSION,FUNCTIONAL,HOX,INTERGENIC,LUNG,METASTASIS,MKN45,PCR,PRESS,PUBLISHED,RNAS,SIRNA,TRANSCRIPT,UNIVERSITY
946,ATLAS,ATTENUATED,BACKGROUND,CD11B,CONCLUSION,CXCL1,DNIIR,GR1,HER2,HOWEVER,LABEL,MAMMARY,METHODS,MMTV,MMTVNEU,NEU,PREVIOUSLY,PYMT,RESULTS,RII,TCGA,TGF,VEGF,VEGFA,WHOLE
135,148,169,1815,1911,2007,2009,2014,7701,7848,8804,8805,9651,9907,AUTHORS,COPYRIGHT,ERLOTINIB,ILD,IRELAND,JAPAN,LABEL,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,OTHER,PFS,POLARSTAR,PUBLISHED,RESULTS
AKRS,ALDO,EVALUATION,MICHAEL,NAD,NADPH,PAH,ROS,THESE,USING
1996,2007,234,522,681,780,BACKGROUND,DESPITE,INSURANCE,LABEL,NHI,PRINCIPAL,RESULTS,THEREFORE
18F,FDG,FIVE,III,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS
18F,8201,BACKGROUND,CONCLUSION,COPD,FDG,FEV1,FVC,LABEL,METABOLIC,METHODS,PET,RATIONALE,RESULTS,SUV,SUVS,THERE
001,177,1952,1986,2009,588,800,942,AMONG,BACKGROUND,CAH,CONTEXT,CYP21A2,DATA,INCLUDING,LABEL,MAIN,MEAN,METHODS,MORTALITY,OBJECTIVE,OUTCOME,REPORTS,RESULTS,SETTING,THERE
122,124,169,2014,450K,695,BEADARRAYS,HOWEVER,KEAP1,KRAS,LABEL,LCNEC,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC,SMARCA4,SQCC,SQCCS,STK11,SUBGROUPS,TP53,WHOLE
1250,160,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DAYS,DCR,EPC,IAP,LABEL,METHODS,NUCLEOTIDE,PUBLISHED,RESULTS
169,2014,409,AIMS,AKT,BACKGROUND,BASEL,COX,FUNCTIONAL,LABEL,LAD,LOW,MET,METHODS,MIR,NEXT,OBJECTIVE,PCR,RESULTS
ACCORDING,BACKGROUND,CONCLUSION,FIO2,HCO3,LABEL,METHODS,RESULTS,SAMPLES
1195,169,2007,2009,2014,4715,6008,CONCLUSION,END,INFLUENCE,LABEL,MAIN,MEASURE,METHODS,OBJECTIVE,OUTCOME,PAUL,PROPENSITY,RESULTS,SEER,SETTING
004,2014,317,394,711,BACKGROUND,HOWEVER,JANUARY,LABEL,METHODS,MLS,NSCLC,RCT,RESULTS,SML,THERE,THESE
8201,ANXIETY,DATA,FEW,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,USING
169,2014,COPYRIGHT,KALA,LTD,LUNG,MSNS,PEGYLATION,PEI,RNAI,TAKEN,VEGF
946,BACKGROUND,CD1,LABEL,MET5A,METHODS,RESULTS,SELECTIVE
169,2014,293T,AKT,CDK1,COPYRIGHT,FOXA2,FURTHER,INC,KNOCKDOWN,MEP50,MICROARRAY,MYC,PI3K,PRMT5,RAC1,RAS,VASP,WESTERN
169,2014,4500,ASO,BACKGROUND,BASEL,CELL,DUAL,FACS,HIGH,LABEL,LOW,LUCIFERASE,LUNG,MEIER,METHODS,MIR,MTT,NON,NRAS,NSCLC,PCR,RESULTS,WHETHER
006,169,2014,A549,AUNP,AUNPS,BIO,COPYRIGHT,DELFTIA,KCM,RSV
AKT,CDK4,HOWEVER,MAPK,MEK,NRAS,ONCOGENIC,PI3K,RAT,SARCOMA,SIGNALING
150,2008,200C,2012,AKT,DCR,EGFR,ERK,MEK,NSCLC,OVERALL,PFS,PI3K,SEPTEMBER,SEVERAL,TKIS
946,A549,BOX,CREB,FURTHER,GROUP,HIGH,HMGB1,PKA
1138,4421,BACKGROUND,DISCUSSION,GALLIUM,H2AX,INCREASING,LABEL,MAA,MACCALLUM,METHODS,NON,NSCLC,PET,PETER,RADIATION,THESE,TRIAL,U1111,UNIVERSAL,UTN
117,169,171,2014,215,8201,A549,BASED,BECAUSE,COPYRIGHT,JOHN,LTD,SMFS,SONS,WILEY
169,2014,280,C60,COPYRIGHT,III,JOHN,LTD,MULTIMODE,SONS,WILEY
ACCORDING,BASED,CHINESE,CONCLUSION,LABEL,MEDICINAL,MEDICINES,METHODS,OBJECTIVE,RESULTS,TCM,THEN
ALDH,CSCS,NANOG,OCT,STUDIES,THOSE
ADDITIONAL,AMONG,BACKGROUND,CURRENT,DIPNECH,FEV1,FORTY,HRCT,LABEL,METHODS,RESULTS
122,1453,152,190,2006,2011,275,338,520,522,556,718,816,824,946,DFS,INCREASING,LMR,NSCLC,UNIVARIATE
001,004,014,033,034,049,054,131,133,151,171,177,230,311,336,435,456,628,813,974,984,995,AGING,BACKGROUND,CURRENT,DISEASE,DUST,FVC,GROUP,HOWEVER,IPF,LABEL,LUNG,METHODS,RESULTS,THESE
17P,233,8201,AKT,BIRT,DUB,ERK,FLCN,HOGG,MAPK,PI3K,RENAL
127,176,946,DRUG,DSC,EACH,F127,FOURIER,FRANZ,HYDROGELS,MTT,PBS,PEO,PF127,SEM,XRD
18F,ERLOTINIB,FDG,MOST,PET
004,086,170,295,391,531,877,950,ATS,BACKGROUND,DFS,DRESLER,IASLC,LABEL,LNS,LUNG,MEIER,METHODS,NSCLC,RESULTS,SOCIETY
169,2014,226,AIM,ANTICANCER,ARM,CELL,CONCLUSION,COPYRIGHT,FIFTY,INSTITUTE,JOHN,LABEL,LUNG,METHODS,NON,NSCLC,OBJECTIVE,ORR,PFS,RESULTS,SMALL,THERE
169,2014,946,ADC,ADCS,AIM,ANTICANCER,CAS,CONCLUSION,COPYRIGHT,FIFTY,INCREASED,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,XVII
169,2014,945,946,ACCORDING,ANCHORAGE,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,H460,HOWEVER,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MTT,OUABAIN,RESULTS
123,169,2014,A549,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INSTITUTE,JOHN,LABEL,LUNG,MATERIALS,METHODS,MPP,NSCLC,RESULTS
169,2014,ANTICANCER,ANY,COPYRIGHT,INSTITUTE,JOHN,MRI,REGULAR,STS
169,2014,ANTICANCER,COPYRIGHT,DESPITE,INSTITUTE,JOHN,LUNG
169,2014,ANTICANCER,CLASSICAL,COPYRIGHT,INSTITUTE,JOHN
004,009,016,060,160,197,304,501,8201,8226,8804,CONCLUSION,DFS,DISEASE,GGN,GGNS,KEY,LABEL,MAXIMAL,METHODS,OBJECTIVE,PART,RESULTS
1819,1RA,2014,414,548,946,BACKGROUND,CCL,CCL11,CCL17,COLORECTAL,CRP,CURRENT,EOTAXIN,LABEL,LUNG,METHODS,ORS,OVARIAN,PLCO,PRESS,PUBLISHED,RESULTS,SCREENING,SMOKING,TARC,THESE,TRIAL,UNIVERSITY
546,INITIAL,THUS
169,2014,8201,AFTER,DUE,EPHB4,MFH,NVP,SEVERAL,SILENCING,SIZE,SOFT,STS,THEREFORE,UICC
BACKGROUND,BASED,CASE,LABEL,METHODS
000,BASED,GWAS,GWASS,LOG,MINUS,OTHER,SELECTING,SNP,SNPS,SUCCESSFUL
MOST
100,160,46EC,4A2B,4C71,945,A448,A478,ABF0,BACKGROUND,BRONCHIAL,CD1,CD20,CD3,HOWEVER,IGH,LABEL,METHODS,PAX5,PCR,PPL,PRIMARY,RESULTS,UNASSIGNED,VIA,VIRTUAL
001,003,045,169,2014,733,8201,945,951,AKT1,ALK,AMONG,BACKGROUND,BRAF,CONSORTIUM,DATA,EGFR,HER2,KIRSTEN,KRAS,LABEL,LUNG,MEK1,MET,METHODS,NRAS,RAS,RESULTS,SOCIETY,THESE,V600E
037,045,047,051,8201,DATA,FURTHER,MENDELIAN,OVERALL,THERE,TOTAL,USING,WMD
HOWEVER,MED23,NSCLC,RAS,TCF
126,160,179,2008,956,AIR,BACKGROUND,BEIJING,BTDAS,CHINA,CONCLUSION,ELEMENTAL,FEV1,FVC,HOWEVER,IQR,LABEL,METHODS,POLLUTION,RESULTS,TRUCK

EGFR,H292,NON,NSCLC,PI3K,STAT3,THESE,VEGF,WHILE
CELL,DESPITE,HOWEVER,LIVER,THESE
BRIEFLY,CADMIUM,THUS
AZD9291,DESPITE,EGFR,EGFRM,EPIDERMAL,FOLLOWING,NSCLC,T790M,TKI
001,006,100,1184,1188,1191,1195,1197,194,2388,2400,393,409,442,464,BACKGROUND,CALORIC,CONTROLLED,CURRENT,ENGLISH,INSTITUTE,KINGDOM,LABEL,METHODS,RESULTS,THERE
001,110,1271,130,142,170,185,8209,ACS,AFTER,CXCR5,H1915,LUCA,LUNG,NCI,NUCLEAR,SCC,SCCS,SERA,SERUM,THESE
100,120,169,2015,215,945,AMGEN,BAL,BLOOD,COPYRIGHT,IDIOPATHIC,INC,IPS,OAKS,OVERALL,PUBLISHED,SOCIETY,TNF
169,2014,ALTERED,BECAUSE,BIOLOGY,DEFECTIVE,HCO3,MOLECULAR,SLC26,SLC4,UNION,ZIP
954,A549,AKT,COX,HOWEVER,MAPKS,MMP,PFIO,PI3K,THESE
169,2014,ANZSCTS,AUSTRALIA,AUSTRALIAN,BOTH,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,VATS,ZEALAND
DOTA,III
ECM,SIZE,THREE,VARIOUS
FURTHER,HOWEVER,MALAT,PANCREATIC,THEREFORE
169,2014,344,GUA,HPB,METASTASIS,NNAL,NNK,PHB,POB,PRESS,PUBLISHED,PULMONARY,SIMILAR,TOTAL,UNIVERSITY
ACCORDING,DOTATOC,GLP1,MIBG,USA
169,2014,946,AUTHORS,GCN5,H3K9,HAT,HOWEVER,IFN,IFNB,INSTEAD,KAT2A,KAT2B,PCAF,TBK1,VIRAL
BASED,CRF,CURRENT,CVD,INC,NON,PUBLISHED
160,169,2014,72H,956,A549,ADP,CDK,CDK2,CDK4,CDK6,CELL,CELLS,CIP1,COPYRIGHT,H661,INC,KIP1,MTT,PARP,PHELLINUS
A549,CDK1,CELL,CENTROSOME,EG5,IGF,NSCLC,PLK1,PPP,THESE
005,006,8202,AES,BACKGROUND,CIK,CIS,DCR,DISEASE,EFFICIENCY,HOWEVER,LABEL,LUNG,METHODS,NSCLC,ORR,PFS,RESULTS,RRS,SIX,TEMPORARY,THEREFORE
916,CNR,COMMITTEE,CONCLUSION,DRR,DUAL,EPL,GTVS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DUE,FURTHER,HENCE,NPS,THESE,TOXIC
023,041,1559,1679,CHINESE,LOW,PXR,SNPS,THESE,UTR
945,BASED,CCDC131,CSRC2,DROSOPHILA,ERCC1,HELA,LU99,THUS,TNF
108,10878,177,2010,2012,BACKGROUND,EARLY,FURTHER,JULY,LABEL,MEAN,METHODS,OCTOBER,RESULTS,TREATMENT
160,169,183,AFTER,CONCLUSION,CONSISTENT,GEORG,HISTORY,LABEL,METHODS,SERUM,SIADH,STUTTGART,TREATMENT,YORK
FINE,GIVEN,RCC,THEREFORE
169,2014,519,ACTA,AFP,BACKGROUND,CONCLUSION,EIGHT,FOUNDATION,HCC,ITPA,ITPAS,LABEL,MDCT,METHODS,MULTI,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,THEIR,THESE
169,2003,2006,2014,613,831,ACT,AFFAIRS,AFTER,CARE,CENTERS,CHANGES,CONCLUSION,CONSORTIUM,CRC,DRUG,FFS,IHN,IHNS,IMPORTANT,LABEL,MEDICAL,METHODS,MMA,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
8211,AFTER,ALK,EGFR,IIIA,KRAS,LMWH,NSCLC,ONCHEST,ROS1
1000NMOLL,169,2014,8805,998,COPYRIGHT,EACH,IMPRINTED
000,AGGRESSIVE,AMONG,ASCL1,CHIP,CLL,NSCLC,SCLC,SEQ
0001,169,2004,2006,2012,2014,221,3354,453,672,679,845,860,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RATES,RESULTS
169,1997,2007,2014,356,AFTER,CHINESE,COPYRIGHT,INDEX,INSURANCE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOTALLY
945,A549,AUTOCAD,EOV,GRAM
946,AP4,HEPG2,NSCLC,SINCE,SMAD2,TAKEN,TGF,USING
A549,AFTER,AKT,BOTH,GDP,HOWEVER,MMP,PI3K,RHO,RHOGDI2,VERIFYING
169,1980,2013,2014,ACADEMY,AFFILIATED,AIM,CAREFUL,COPYRIGHT,LABEL,LTD,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,RIS,SKIN
8201,BACKGROUND,HOWEVER,LABEL,MCF7,METHODS,RECURRENCE,RESULTS,SRC,STAT3,T47D,TFF3,TREFOIL
HOWEVER,LABEL,MALIGNANT,MPM,OPINION,SEVERAL,STATEMENT,UNASSIGNED
ALK,CURRENTLY,HGF,LABEL,LUNG,MET,OPINION,PROLONGED,STATEMENT,UNASSIGNED
AFTER
BARR,CLEARANCE,CMV,CTL,E2A,EBV,EPSTEIN,FISH,FOUR,PHA
100,A549,BACKGROUND,DOX,EGF,EGFR,EGNP,GNP,H226,INHALATION,LABEL,MICE,MMP,OVERALL,RESULTS
100,119,158,177,1999,2001,2012,8201,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,SINCE,SURGERY,USING
GIVEN,PROVIDING
143,183,2007,2010,336,341,8202,8758,APRIL,ASSESSMENT,BACKGROUND,BETWEEN,BOTH,CONCLUSION,EARLY,INTERVIEWS,LABEL,MARCH,METHODS,MINI,MNA,OBJECTIVE,RESULTS,TRIAL
1997,2000,2001,2004,2005,2009,500,504,956,AGE,AIDS,AMONG,CD4,CONCLUSION,FHDH,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
PSA,SCREENING,SEVERAL
2002,2011,BASED,CHRONIC,IARC,RCF,SCOEL,THEREFORE
913,924,A549,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
001,003,018,028,046,069,608,613,710,CEA,EGFR,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,ROC,SERUM
10TH,183,8201,8202,ALSO,BACKGROUND,DATA,GEORG,HOWEVER,LABEL,METHODS,MINIMALLY,NAS,NSC,PDK,PIRITRAMID,REGARDLESS,RESULTS,ROPIVACAIN,STUTTGART,SUFENTANIL,VATS,YORK
250,ALK,AMONG,BACKGROUND,CRIZOTINIB,LABEL,MET,METHODS,NSCLC,RESULTS,ROS1
169,2014,228,ASPCR,CONCLUSION,COPYRIGHT,EBUS,EGFR,EPIDERMAL,FFPE,FNA,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RGQ,TBNA,THEREAFTER
001,030,114,169,2014,324,3CM,8804,8805,CONCLUSION,COPYRIGHT,COX,DISEASE,FDG,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,THUS,TSCT
001,002,135,169,2014,203,239,259,CONCLUSION,COPYRIGHT,COX,EGFR,EPIDERMAL,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,THESE,TKI,TKIS
AIB1,AMPLIFIED,ATOH1,BESIDES,CRC,HES,HES1,HES5,HOWEVER,MASTERMIND,MUC2,NCOA3,NOTCH,THUS
DROSOPHILA,EGFR,EPIDERMAL,EPS15,FERM,PDZ,PTPN3,RAS,TAKEN,USING
210,945,A549L,ACTIVATION,AKT,CD63,DOWNSTREAM,E2F3,HIF,P110,P85,PI3K,RAD52,SDHD,THESE,TIMP,UPON,VMP
169,2014,946,AXIN,DVL,GSK3,HBE,HEK293T,HOWEVER,INC,INCREASED,KI67,P120CTN,THESE,TNM,WESTERN,WILEY,WNT,ZBED3
100,177,179,181,185,CHLORAMINE,CONCLUSION,HPLC,LABEL,METHODS,OBJECTIVE,RESULTS,ROI,SPECT,THESE,ZEALAND
185,2402,8309,8314,945,946,CD8,CONCLUSION,HLA,LABEL,METHODS,OBJECTIVE,RESULTS,TCR,THESE,WT1
120,169,2014,215,A549,AAT,AATS,AMINO,BACKGROUND,COPYRIGHT,DU145,FAMP,INC,LABEL,MB468,MDA,METHODS,PET,RESULTS,SIMILAR,SKOV3,THESE,U87
100PG,169,174,2014,35PG,38PG,39PG,40PG,72PG,84PG,ARCHITECT,BACKGROUND,CHINA,CHINESE,COPYRIGHT,ELECSYS,INCREASED,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,THERE
100,185,2003,2013,8312,CHEST,CHINESE,FDG,GENERAL,HODGKIN,LABEL,METHODS,NHL,OBJECTIVE,PET,PLA,PPL,RESULTS,SINCE,SPL,SUV,THERE
169,2014,CEM,COMPOUNDS,COPYRIGHT,EFFICIENT,GI50,H522,HELA,L1210,LTD,NCI
156,169,2014,204,360,COPYRIGHT,COX,DFS,EZH2,IIIB,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
169,2014,CDCS,COPYRIGHT,LTD,MALIGNANT,MPM
ABCG2,ATP,CD133,CD44,CSC,CSCS,PRIMARY
0013,0020,0027,103,176,2007,2012,229,423,762,APRIL,BETWEEN,III,JULY,LABEL,METHODS,OBJECTIVE,PURPOSE,RCT,RESULTS,THOSE
001,002,003,018,035,133,154,169,2003,2013,2014,514,8804,AMMS,BIOLOGY,CHINA,CNB,COLOR,COPYRIGHT,DOPPLER,FEDERATION,FINE,HOWEVER,INC,MEDICAL,PUBLISHED,REAL,ULTRASOUND,UNIVERSITY,WORLD
169,2014,CHEST,COPYRIGHT,LTD,MANAGEMENT,PATIENT
169,2014,CCL2,CCR2,COPYRIGHT,CXCL8,HCMV,HEL,IE1,INC,THUS,UL54
5819,8068,ASIAN,CAUCASIAN,CONCLUSION,K109R,LABEL,LEPR,METHODS,OBJECTIVE,ORS,OVERALL,PURPOSE,RESULTS,SNP,THESE
BOOP,CHEST,CONCLUSION,DUE,HISTOLOGY,LABEL,METHODS,OBJECTIVE,PET,PULMONARY,PURPOSE,RELATIVELY,RESULTS,SUV
131,185,99M,99MTC,CONCLUSION,CTV,DIAGNOSTIC,DRRS,EBRT,GTV,LABEL,MBQ,MDP,METHODS,MIBI,OBJECTIVE,PET,PURPOSE,RESULTS,SLNS,SPECT
A549,CONCLUSION,LABEL,LIVIN,METHODS,MTT,OBJECTIVE,PCR,PURPOSE,REAL,RESULTS,TUNEL,WESTERN
017,020,177,AFTER,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,STUDENT,TREATMENT
001,338,368,403,486,552,8805,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OPN,PEARSON,PFS,PURPOSE,RESULTS,SPSS
169,2014,AGS,CD8,COPYRIGHT,CTLA,HLA,INC,THEIR,THESE
001,025,169,2014,BRITISH,COMMITTEE,CONFERENCE,DIAMOND,HILTI,HYGIENE,HYGIENISTS,INDUSTRIAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RCS,RESPIRABLE,RESULTS,SCIENTIFIC,SOCIETY,TOTAL,UNIVERSITY
002,051,080,169,2014,220,327,362,419,537,663,796,CONCLUSION,COPYRIGHT,HOWEVER,HSP70,IIA,IIIA,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
125,1571,169,2011,2012,2014,327,5549,6000,6087,614,665,ADRS,BACKGROUND,BETWEEN,CHINA,COPYRIGHT,DCR,DRUG,EGFR,FOOD,ILD,IRELAND,LABEL,LTD,METHODS,NSCLC,ORR,PFS,RESULTS
160,A549,DESPITE
100,169,2014,947,BEAM,COPYRIGHT,IMPT,IMRT,INC,INTENSITY,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,PATIENT,PLAN,PSPT,PURPOSE,RBE,RESULTS,V20,V40,V60
1157,142,169,2014,934,AFTER,BONE,CONCLUSION,COPYRIGHT,COX,DUTCH,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METASTASIS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VAS,VRS
000,169,350,500,8805,956,AFTER,B12,BACKGROUND,CONCLUSION,LABEL,METHODS,PRESS,PRIOR,RESULTS
ACUTE,BACKGROUND,HOWEVER,ILM,IPV5,LABEL,LOCAL,METHODS,NSCLC,OTHER,PEARSON,PFS,PTV,RESULTS,SBRT
100,169,2014,955,956,BARRETT,CACO3,CAR,COPYRIGHT,DOX,FOURIER,FTIR,HALENDA,RAMAN
BASIS,BEST,DISCOVERY,MEANWHILE
000,20TH,480,COPD,DESPITE,SINCE,TODAY,WOMEN
014,020,042,8202,916,9FL,COX,DFS,MEIER,NEXT,NSCLC,THESE
001,003,169,2014,916,936,956,A549,COPYRIGHT,IC50,ROS,SAS,SRB
114,169,1974,2014,239,400,750,8805,ALK,CERITINIB,DATA,EXTRACTION,JULY,LABEL,LITERATURE,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,SCHOLAR,SELECTION,SOURCES,SYNTHESIS
169,177,2014,BACKGROUND,CONCLUSION,COPYRIGHT,IIA,INC,LABEL,METHODS,MOLECULAR,NCCN,NSCLC,RECURRENCE,RESULTS
025,077,135,169,2014,753,ACCORDING,CHI,COPYRIGHT,DESPITE,GMBH,GSTP1,KRUSKAL,MANN,MRP1,NEXT,NSCLC,TNM,WHITNEY
8805,BACKGROUND,CAREFUL,DLCO,FEV,LABEL,MEDICAL,METHODS,PREDICTED,RESULTS,THESE
091,138,234,326,462,967,DFS,GLASGOW,GPS,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SIMILAR
105,2014,BMJ,CTPA,GROUP,LTD,PUBLISHING,THERE
169,2014,COPYRIGHT,ERK,HOWEVER,IRELAND,KRAS,LTD,MEK,MEK1,NSCLC,OTHER,RAF,RNAS,TRAMETINIB
0001,0226,160,187,AGE,HER2,PGR,SIMILARLY,TNM
118,HIGH,NOR
145,169,199A,2014,495,COPYRIGHT,EGF,EGFR,HOWEVER,INC,LOOCV,MICROARRAY,NSCLC,PTK2
CARLO,GSA,MONTE,THERE
DELAYED,DESPITE,IPA,MWA,THREE
TECHNIQUES
001,160,359,460,8201,8804,8805,CRP,GLASGOW,HOWEVER,LDH,PROGNOSTIC,SCLC,SCORE,UNIVARIATE
200,272,318,8805,CD133,CREB,CRTC2,NSCLC,NSCLS,PCR,PREVIOUSLY,PROM1,RFLP,THEN
169,2014,FGF,JOHN,LTD,PUBLISHED,RGP,SLUG,SNAI2,SONS,THESE,TSP,VEGF,VEGFR,WILEY
956,AF4,CELL,FURTHER,HEPG2,OVERALL,SORAFENIB,SPY,TREATMENT,WESTERN
169,2014,BACKGROUND,CASE,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE
A549,CONTROL,EGFR,MAD2,RNAS
169,2002,2008,ACT,AFFORDABLE,CALIFORNIA,CARE,CCR,COLLECTION,CONTINUOUS,DATA,DISCHARGE,EXPANSION,EXTRACTION,LABEL,METHODS,OBJECTIVE,PATIENT,PDD,PRINCIPAL,RESULTS,SOURCES,TRUST
160,1980,2012,AFFILIATED,BACKGROUND,CHINA,CONCLUSION,FIRST,HYPO,LABEL,MEDICAL,METHODS,OCTOBER,PANCREATIC,PMS,RADICAL,RESULTS,SEVEN,THREE,UNIVERSITY
050,169,2014,9596,BAY,BOARD,CONCLUSION,FDG,FIFTY,FMT,FURTHER,HNSCC,IMAGING,INC,LABEL,LAT,METHODS,MOLECULAR,NSCLC,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,UNLABELLED
169,2014,III,IMAGING,INC,MOLECULAR,NUCLEAR,PEPTIDE,SOCIETY
8764,AREAS,BACKGROUND,COVERED,HOWEVER,LABEL,LIMITED,METHODS,OPINION,SCLC,SIMILARLY,SMALL
945,946,954,EGFR,KRAS,RALB,TARGETING
169,2014,240,384,946,ACR,ACRS,AKT,BOTH,BRITAIN,CCL19,CCL21,CCR7,CCRL1,CLINICALLY,COPYRIGHT,GREAT,GSK3,HCC,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,WILEY
28A,946,AD5,ADF35,BACKGROUND,CAR,CD46,EXPRESSION,LABEL,METHODS,MSCS,RESULTS
001,160,169,2000,2012,2015,216,979,BACKGROUND,COPYRIGHT,INC,JANUARY,JRS,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,SOCIETY,THERE,UNIVERSITY
00049,169,177,2005,2013,2014,COPYRIGHT,INC,JANUARY,JUNE,LABEL,MATERIALS,MEAN,METASTASES,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEVEN,SIR
BACKGROUND,COPD,FIBULIN,LABEL,METHODS,RESULTS
ONCE
45TH,8805,AFTER,GRADE,IHC,LABEL,LND,LNS,LNU,MEIER,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS,RFS,THEREFORE
946,A549,AUNPS,AZO,AZOBENZENE,FERROCENE,GFP,GOLD,HOWEVER,USING
ACA,ALK,BACKGROUND,BEST,BRAF,CONTEXT,DATA,EGFR,ERBB2,KRAS,LABEL,METHODS,OBJECTIVE,RET,ROS1,SOURCES
231,2BS,630,A549,CDC7,CIS,DDIT4,EP300,H1299,HELA,HOWEVER,MCF7,MDA,PARP3,THESE,UTR
0048,017,029,031,045,5P15,967,CHINESE,HAN,LUNG,TERT
DURAL,ESOPHAGEAL,FOUR,THERE
384,ADJUSTING,BACKGROUND,CELLS,ERCC1,GENERAL,LABEL,METHODS,PLEURAL,PRIMARY,RESULTS,RRM1
13072,169,2014,207,BACKGROUND,EASTERN,END,FIFTY,FORTY,GROUP,LABEL,METHODS,PRESS,PRIOR,PUBLISHED,RESULTS,SEER,UNIVERSITY
160,177,2010,2013,207,614,BACKGROUND,CHRONIC,COPD,DIAGNOSIS,JAPAN,JULY,LABEL,MARCH,METHODS,PHYSICIANS,PROCEDURE,RESULTS
AREAS,BACKGROUND,COVERED,LABEL,METHODS,NSCLC,OPINION
160,2006,2011,BETWEEN,BSA,HOWEVER,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,THERE,THREE
BACKGROUND,BTBD7,DISORDERS,HOWEVER,INCREASED,LABEL,MDCK,METHODS,RESULTS,WESTERN
CHEST,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
001,002,015,017,022,023,031,033,039,045,8201,COX,HUR,NSCLC,RNAS
DATA,KI67,MORPHOLOGY,S6K
000,100,BECAUSE,EGFR,INHIBITION,METHODS,REGARDING,THERE
20TH,BASED,CURRENTLY,SIMILAR,SVCS
169,191,2014,946,BASP1,CSC,EMT,HBE,HIGH,INC,LUNG,THERE,THUS,WILEY,WNT,WT1
169,2014,332,ALK,ANAPLASTIC,BAR,BOTH,CLB,ERK,GAIN,HOWEVER,INC,MYCN,NONE,PC12,SAMPLES,STAT3,TAKEN,THESE,WHEREAS,WILEY
126,169,1999,2008,2014,BACKGROUND,HB99,III,INC,LABEL,METHODS,PRETEXT,PROCEDURES,RESULTS,WILEY
177,300,600,8201,CONCLUSION,DELIVERED,FORMULA,IMRT,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,REDUCED,RESULTS
023,107,169,1980,2012,2014,BACKGROUND,CONCLUSION,EWING,EWS,INC,LABEL,METHODS,PROCEDURE,RESULTS,WILEY
BACKGROUND,LABEL,LUNG,MAIN,METHODS,MMP,MMP19,MMPS,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,TAKEN
003,749,779,8805,887,953,954,BACKGROUND,FOLD,LABEL,LNCRNAS,METHODS,NUCLEOTIDE,PATHWAY,PCR,RESULTS,THERE
030,239,870,ABO,ADC,BACKGROUND,CHROMOSOME,CLUSTER,COX,DIAGNOSTIC,IHC,IIIB,IL1R2,LABEL,METHODS,NCK,NINE,NK2,NSCLC,PFS,PHASE,PREVIOUSLY,RESULTS,THESE,TRAF2,TREATMENT
1880,257,270,366,449,CONCLUSION,IMD,IMDS,LABEL,METHODS,NLP,OBJECTIVE,PURPOSE,RESULTS,ROC
946,ANIMALS,CELL,DYING,MECS,MERTK,TGF,THESE,USING
118C,630,643,72ARG,896,909,BACKGROUND,CART,CISPLATIN,ERCC1,FRAMINGHAM,LABEL,METHODS,OTHER,RESULTS,RIFLE,SCR,TAIWANESE,TP53
100,CONCLUSION,DISCOVERY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIX,STE,SUV
169,2014,ACIDS,ATM,CUL1,DSBS,FBXL5,HOWEVER,NUCLEIC,PRESS,PUBLISHED,SCF,SKP1,T117,THEREFORE,UNIVERSITY
100,169,2014,382,530,ACIDS,CHIP,MSG,MSGS,NME1,NME2,NUCLEIC,PRESS,PUBLISHED,REDUCED,UNIVERSITY
389,EGF,EGFR,HER2,HER3,HERS,III,MMP1,NEUREGULIN,NTS,NTSR1
169,2010,2011,2014,COPYRIGHT,DCR,EGFR,EPIDERMAL,ERLOTINIB,EXPRESSION,FORTY,G719X,HGF,HOWEVER,IRELAND,L858R,LABEL,LNA,LTD,MARCH,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PCR,PFS,PNA,RESULTS,SIX
169,2014,COPYRIGHT,IRELAND,LARGE,LTD,UNTIL
169,2014,409,CONCLUSION,COPYRIGHT,DDR2,IGF1R,INGENUITY,ION,IRELAND,KIT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PANEL,PGM,PROVEAN,RESULTS,ROS1,SEQUENCER,SIFT,THERE,VARIANT
167,ANXIETY,FCS,HOWEVER,IL1,IL1R2,LABEL,METHODS,NFKB2,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,TNFA,USING,VARIATIONS
30B,30C,A549,BACKGROUND,BOTH,CDS,DOWN,H23,INCREASING,KNOCKDOWN,LABEL,LUCIFERASE,METHODS,MICRORNAS,MTT,NSCLC,PCR,RAB18,RESULTS,RNAS,THESE,WESTERN
125,169,2014,703,8805,BACKGROUND,BMI,CCL13,CCL19,CCL2,COLORECTAL,CRP,CXCL5,CXCL6,ENA,FDR,GCP2,HOWEVER,LABEL,LUNG,MARKERS,MCP,METHODS,MIP,ORS,OVARIAN,RESULTS,SCREENING,SDF,TRIAL
169,2014,BRITISH,CONTACT,COPYRIGHT,LENS,LTD,PUBLISHED
DNAS,IRASA,THEN
003,011,013,040,044,114,COX,LABEL,LYMPHATIC,METHODS,OBJECTIVE,RESULTS,THERE
ADVERSE,CDDP,HER2,STAGE
5MM,HCC,HOWEVER,III,IVC,LOW,THEREFORE
177,18F,197,251,FDG,FINALLY,FIVE,MTV,NSCLC,PET,SUV,SUVMEAN,THERE,TLG,TNM
050,062,100,177,956,A549,ALKYL,CD31,EPC,EPCS,IRON,MRI,PEI2K,SEVEN,SPIO
160,EPOXIDE,HOWEVER,THUS
239,8594,CONCLUSION,EMA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,RESULTS,SEQUENCES,WEIBULL,WHILE
177,8804,AHI,ECG,HEART,HRV,OSA,PACO2
100,5A4,ALK,BACKGROUND,BASED,BIOVIEW,D5F3,FDA,FISH,FORTY,HOWEVER,IHC,LABEL,METHODS,NOVOCASTRA,NSCLC,RESULTS,THERE,VENTANA,VYSIS
001,177,AFTER,BELGIAN,CONCLUSION,DUTCH,FIFTY,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,SCREENING,THIN,TRIAL,WALL
CONCLUSION,IMAGING,LABEL,OBJECTIVE
104,CONCLUSION,EARLY,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PROGRAM,RESULTS,THREE
184,AGE,BECAUSE,ELECTRONIC,GIVEN,HOWEVER,SURVEYS,TOBACCO,UNTIL,YOUTH
ABOUT,HOWEVER,OVERALL,THUS
1923,2000,2014,257,5105,8201,8511,ABSTRACTS,APRIL,DATA,DATABASES,EXTRACTION,FDG,IMPORTANCE,LABEL,LOWER,MAIN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OUTCOME,PET,RELEVANCE,RESULTS,SCIENCE,SELECTION,SEVENTY,SOURCES,STUDIES,SYNTHESIS,THERE,THESE,WEB
169,2014,BACKGROUND,BASEL,GAMMA,GKSR,KNIFE,LABEL,LEKSELL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,PLAN,RESULTS,TEN,USING
004,108,131,173,177,BACKGROUND,COX,EVALUATION,FIFTY,LABEL,MEIER,METHODS,NSCLC,PERM,RESULTS,SCLC,SOLID
12MS,150,175,8805,AES,AFTER,BACKGROUND,BORTEZOMIB,DESPITE,DOSE,GRADE,HOWEVER,III,LABEL,METHODS,RESULTS,RP2D,SECONDARY
2004,ALK,CRIZOTINIB,DRUG,EGFR,EML4,FOOD,HER2,NSCLC,SINCE
100,120,2010,2013,395,541,573,BACKGROUND,CNS,CONCLUSION,DATA,EGFR,FIRST,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,SIXTY,TKI,TKIS
2011,2014,AGE,AIM,APRIL,BCA,FIFTY,FURTHER,JANUARY,LABEL,METHODS,OBJECTIVE,PET,RESULTS,TNM
18F,FDG,PET,PULMONARY,STOMACH
BOTH,NEITHER,PRIMARY,TTF

2003,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,SEVERAL,SINCE,WHILE
0185,028,169,2014,3258,677C,BACKGROUND,CONCLUSION,COPYRIGHT,ERCC1,EXPRESSION,FIFTY,GENOMIC,GREATER,HOWEVER,INC,INSERTION,LABEL,METHODS,MOST,MTHFR,PEMETREXED,PFS,RESULTS,SNP,USING,UTR
001,003,106,124,169,2007,2012,2015,272,318,507,544,8805,BACKGROUND,BECAUSE,CONCLUSION,CONCURRENT,COPYRIGHT,COX,ERLOTINIB,FACTORING,FURTHER,IIIB,INC,LABEL,METHODS,NSCLC,PERTINENT,PFS,RECORDS,RESULTS,STAGE,TKI,TKIS
169,2014,COPYRIGHT,DESPITE,III,INC,NSCLC,STUDIES
169,2015,COPYRIGHT,INC,NEWLY
001,004,169,2014,225,706,706C,AIM,COPYRIGHT,EACH,III,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,RFLP,SNP
ADM,HOWEVER,OSM,STAT,THESE
954,956,A549,COX,EGFR,ERK,FURTHER,HIGH,MG132,RESULTS,U0126
169,2014,COPYRIGHT,IMAGING,INC
169,2014,CANDIDATES,COPYRIGHT,INC,MELANOMAS,METASTATIC
169,2014,ACIDS,MIZ,MIZF,NUCLEIC,POK,PRESS,PUBLISHED,SHORT,UNIVERSITY,ZNF509L
060,160,2008,2013,476,659,772,APRIL,ILD,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,OPTIMAL,PURPOSE,RESULTS,THEIR,THEREFORE
004,169,2014,947,HOWEVER,NTCU,P63,PPAR,SCC,SCCS
CHEST
BACKGROUND,CONCLUSION,GENITAL,HPV,LABEL,METHODS,THESE
169,1994,2003,2014,945,961,COPYRIGHT,HIGH,HMGA2,INC,KIT,UNIVARIATE,USING
A549,H23
001,2004,2007,610,8201,8805,ANDALUSIA,BACKGROUND,DATA,III,LABEL,LUNG,METHODS,RESULTS,SPAIN,THERE,THESE,VARA
100,108,2002,2010,8201,8804,8805,ACUTE,APRIL,BACKGROUND,BETWEEN,CHART,CONCLUSION,DART,KARNOFSKY,LABEL,METHODS,NSCLC,RESULTS,SBRT,THERE,TOTAL,WHILE
169,180,2004,2007,2014,808,AFFAIRS,CENTRAL,COLLEGE,CONCLUSION,DEPARTMENT,IIB,IIIA,IIIB,LABEL,METHODS,NETWORK,OBJECTIVE,OPTIMIZING,OVERUSE,PET,PURPOSE,RADIOLOGY,RECEIPT,RESULTS,SOCIETY,WIDE
200C,203,8594,A549,AKT,AQA,CQC,EMT,G12S,H460,KRAS,LOSS,MEK,MUC1,NON,NSCLC,Q61H,THESE,ZEB1
HISTONE,HOWEVER,KDM2A,PDCD4,TAKEN
ATAP,BFL,RGD,SV129
001,169,182,2004,2008,2014,237,576,70YEARS,8805,AGE,CCI,CIGARETTE,CONCLUSION,COPYRIGHT,DATA,EGFR,FOUR,IIIB,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECEIPT,RESULTS,SCS,THEIR,THERE,TKI
548L,AKT1,CONCLUSION,FUNCTIONAL,FURTHER,LABEL,LUCIFERASE,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE,WESTERN
169,1950,2004,2005,2014,AMONG,BLOOMBERG,HOPKINS,JOHNS,PLATEAU,PRESS,PUBLISHED,UNIVERSITY,WORKERS
ANNA,BACKGROUND,CASE,CONCLUSION,HOWEVER,LABEL,METHODS,NEN,PNS,SPECIAL,TACE
000,AFRICAN,COLLEGE,COLORECTAL,EACH,EVERY,HOWEVER
8804,945,ATP,IC50,NEO,THUS
1092,279,316,948,AAL,ALEURIA,CONA,FIRST,HHL,NSCLC,PNA,THUS
ABOVE,HOWEVER,LEWIS,MMP
001,005,016,028,208,221,788,ALK,EGFR,KRAS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PET,RESULTS,THEREFORE,TTF
169,2014,ASIA,BECAUSE,CLASS,HOWEVER,III,LTD,NEUROD1,NSCLC,PATHOLOGY,POU,PTY,PUBLISHING,SCLC,SOCIETY,THESE,WILEY
COMPARISON,FEV1,FORTY,FVC,GVHD,PERIPHERAL,PIU,PTERYGIUM
100,169,2014,BECAUSE,BONFERRONI,CONCLUSION,LABEL,MATERIALS,MCNEMAR,METHODS,MPD,MPDS,MPM,OBJECTIVE,PLEURAL,PURPOSE,RESULTS,RSNA
8201,945,AFTER,BILATERAL,HEPATIC
169,2014,A549,AUCL3,COPYRIGHT,GOLD,HOWEVER,III,INC,THESE
BOTH,CDC45,CMG,GINS,MCM,MCM2,MUTATIONS
169,2015,BACKGROUND,CONCLUSION,COPYRIGHT,DUTCH,EGFR,EPIDERMAL,EVALUATION,INC,IRENE,LABEL,METHODS,NSCLC,NVALT,PFS,RESULTS,SECONDARY,SEVERAL,SOLID,TKI,TKIS,VERISTRAT
001,169,2014,ACCORDING,AES,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,INC,JACKMAN,LABEL,MATERIALS,METHODS,NSCLC,OUTCOME,PFS,RESULTS,T790M,TKIS
169,2014,2015,BASED,COPYRIGHT,EUDRACT,INC,LUNG,METAL,METFORMIN,SECONDARY
001,104,169,1996,2001,2008,2009,2014,312,315,375,8201,997,CENTRAL,CRC,DATA,JANUARY,RECORDS,SEER,SEPTEMBER,SIR,SMR,SOUTH,UICC,USA,VITAL
8209,FINALLY,FURTHER,MIA,NOVEL,NSCLC,NUAK1,PACA,TARGETSCAN,UTR
138,169,2003,2005,2010,2014,8201,852,AGE,CASES,CHINA,ESTIMATES,FOLLOWING,LIMITED,UICC,WHILE
160,169,2014,AUTHORS,BCL2,BCL2L15,COPYRIGHT,HOWEVER,INC,PROX1,PUBLISHED,THESE,WNT
110,130,160,169,2014,599C,CHINESE,COPYRIGHT,HOWEVER,IL6ST,INC,KRAS,LUNG,PCR,PROTEIN,STAT3
160,A549,APOPTOSIS,CUB,NATURAL
0001,069,169,2014,BACKGROUND,BRCA1,COHORTS,DLC1,HIF1A,LABEL,METHODS,RESULTS,THESE,XPO1
001,159,169,2014,3919,8764,AUTHORS,BACKGROUND,COPYRIGHT,DSS,ESPECIALLY,IIIA,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,STAGE
001,169,2014,571,BACKGROUND,CTC,CTCS,HOWEVER,LABEL,METHODS,NSCLC,PERIPHERAL,RESULTS,SEQUENTIAL,SOCIETY
2001,2012,ACADEMY,CHINESE,JANUARY,LABEL,MEDICAL,METASTASIS,METHODS,OBJECTIVE,RESULTS
177,8314,CD39,CD4,CTLA,FCM,FURTHER,III,LABEL,LAG,METHODS,NSCLC,OBJECTIVE,RESULTS
112,161,177,178,610,95C,95D,BRDU,CCK,CELL,CONCLUSION,DUAL,GJA3,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,THESE,TRANSWELL,WESTERN
100,181,786,8209,8804,KFEE,LDL,MTT,RCC,REDUCTION,SI3
169,176,177,1PA,2014,231,400,945,956,A549,ASP,COPYRIGHT,D9K,G17,G21,GXXXG,INC,INCREASING,LC50,LYS,M28,MDA,NH2,PIPIDAE,THUS
COPD,PULMONARY
LABEL,OBJECTIVE,RESULTS,WHILE
0915,101,10GY,176,GROUP,INC,PHYSICISTS,PUBLISHED,RADIATION,SBRT,TASK,THERAPY,TREATMENT,USING
101,1060,127,169,177,2000,2011,2014,2102,228,245,857,BACKGROUND,CONCLUSION,COPYRIGHT,HER2,KI67,LABEL,LOSS,LTD,METHODS,RESULTS
100,100UG,169,1989,200,200UG,2014,400,400UG,500UG,ABOVE,BACKGROUND,BFD,BLACKFOOT,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,POISSON,RESULTS,RISK,THERE,USING
031,102,169,2002,2012,2015,382,748,COPYRIGHT,COX,EDUCATION,HARRELL,HOWEVER,INC,IQR,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RENAL,RESULTS,UROLOGICAL
169,2014,251,BACKGROUND,COPYRIGHT,DIF,HOWEVER,LABEL,METHODS,PATIENT,PHQ9,RESULTS,SOMATIC
169,2014,COPYRIGHT,DESPITE,ISSUE,OXYGENATED,PUFA,SPECIAL,THERE,THESE
001,002,120,160,177,8201,8804,8805,BACKGROUND,CONCLUSION,EASTERN,GROUP,III,LABEL,METHODS,NINE,RESULTS,SCORING,SIX,THREE,WBI
169,2014,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COMPLEX,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,ZEALAND
1000,169,1999,2010,2014,720,BASED,BONE,CONCLUSION,COPYRIGHT,COX,DENMARK,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,MRR,MRRS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCLC,SRE,SRES
001,019,035,169,2014,673,8806,BACKGROUND,COPYRIGHT,EGFR,FIFTY,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,RFA,WHETHER
169,2014,AMP,AMPK,CONCLUSION,COPYRIGHT,EGFR,ERLOTINIB,H1299,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,RPPA,WESTERN
169,2014,ALK,COPYRIGHT,EGFR,PARTNER,PUBLISHED,ROUTINE,URBAN
122,BACKGROUND,BASED,COX,FINALLY,LABEL,NEXT,NON,NSCLC,RESULTS
536,954,ASS,BACKGROUND,CURRENTLY,LABEL,METHODS,PANC,PANCREATIC,PCR,RESULTS,TREATMENT
169,2014,BAX,COPYRIGHT,FIRST,INC,LM3,THERE
169,2012,2014,215,ARGENTINA,COPYRIGHT,CORDOBA,HOWEVER,HPLC,LTD,MEAN,PAH,PAHS,PM10,SAMPLES,THEIR
001,2014,215,2252,7619,8804,9P21,AS1,ASSET,BRC,ESCC,GWAS,IFNW1,PRC,PRESS,PUBLISHED,RCC,RS10511729,SNP,SNPS,TUSC1,UNIVERSITY
169,2013,AFTER,BACKGROUND,COPYRIGHT,DISCUSSION,EGFR,ERLOTINIB,HFS,HOWEVER,LABEL,METHODS,PUBLISHED,SAS,SEVERAL,SPLF,TKI
169,2013,COPYRIGHT,NF1,PUBLISHED,SAS,SPLF,THERE,TYPE
169,2013,239,ALPES,BACKGROUND,CONCLUSION,COPYRIGHT,DEPARTMENT,LABEL,METHODS,NSCLC,PACLITAXEL,PUBLISHED,RESULTS,RHONE,SAS,SINCE,SPLF,TEN,THEIR,THERE
169,2014,ALSO,ANN,BOTH,CD147,CD9,CONCLUSION,COPYRIGHT,HLA,LABEL,METHODS,OBJECTIVE,P4E6,RESULTS,ULTRA
120,135,250,AUC,BACKGROUND,CTONG1002,DISCUSSION,HOWEVER,III,LABEL,METHODS,TRIAL,UNASSIGNED
169,2014,5MM,646,BASED,CONCLUSION,COPYRIGHT,IRELAND,KINGDOM,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THOSE
003,013,017,039,126,2003,2009,8201,924,BACKGROUND,CONCLUSION,COX,HOWEVER,III,LABEL,LVI,MEIER,METHODS,PCI,RESULTS,SCLC,TNM
160,2011,ALK,BACKGROUND,CRIZOTINIB,DRUG,FOOD,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS,SIX
140,CURRENTLY,LOCAL,LUNG,PRESENTLY,SBRT
001,004,006,169,2004,2010,2014,255,332,8805,APRIL,CHEST,CONCLUSION,COPYRIGHT,FIRST,FURTHER,HNC,HOWEVER,INITIAL,IRELAND,LABEL,LTD,LUNG,MARCH,METHODS,OBJECTIVE,RESULTS,THIRD,USING
3DMCO,4DMCO,4DMCRECAL,4DMCRENORM,8201,8805,ACCURAY,CARLO,COMPARISON,CONCLUSION,CYBERKNIFE,DOSE,EACH,GTV,INC,LABEL,MATERIALS,METHODS,MONTE,OAR,OARS,OBJECTIVE,PTV3,PTV5,PURPOSE,RESULTS,SBRT,SUNNYVALE,THREE
169,2014,ALK,BAL,COPYRIGHT,EML4,FISH,GMBH,IHC,PCR,USING
169,2010,2012,2014,AFTER,COPYRIGHT,DANESHVARI,FFPE,GMBH,IRAN,MARCH,MASIH,MCC,MCPYV,NSCLC,PCR,REAL,SCLC,SIMILARLY,SMALL
160,956,A549,ERK1,HOWEVER,LINN,LUNG,MAPKS,MMP2,MMP9,MTT,NIGELLA,P16,PCNA,PCR,PD98059,WESTERN
174,2014,BACKGROUND,CURRENT,DATE,DISCUSSION,JANUARY,KINGDOM,LABEL,MALIGNANT,METHODS,SECONDARY,TRIAL,WHILE
665,673,8805,897,BACKGROUND,CARE,CONCLUSION,DATA,HOURS,INSURANCE,KOS2011,LABEL,LVKOS2011,METHODS,OOH,PRIMARY,RESULTS,RFE,SERVICE,THESE,YET
000,A549,CETUXIMAB,EGFR,EXCELLENT,KRAS,LUNG,SCID
231,945,ATP,BMDC,BMDCS,CD11B,FINALLY,HIF,LOX,MDA,P2Y2,P2Y2R,THEREFORE,THESE,THP,UTP
9F1,ADDITIONAL,CD146
001,013,212,292,946,ECTOPIC,HOWEVER,MEIER,NSCLC,WNT
AKT,EGFR,ERBB2,T798I
ALK,H2228,H3122,PI3K,SINCE,TREATMENT
A549,INFLUENCE,LNCAP,U251
DRUG,H2O2,HOWEVER,METASTATIC,PRODRUG,THUS
162,1765,178,2DLC,946,AMONG,CD105,ECS,THESE,TOTALLY,USING
THESE
FOXF1,MSC,MSCS,SEVERAL
011,016,019,020,025,030,043,051,054,067,078,087,140,141,148,150,167,169,200MG,2014,207,347,373,533,597,989,AAD,AUTOIMMUNE,AXIS,BACKGROUND,BILIARY,BOWEL,BRONCHIAL,CARDIAC,CHRONIC,CONCLUSION,CONDITIONS,COPD,COPYRIGHT,DERMATITIS,DIAGNOSTIC,DISORDERS,DSM,GENERAL,GMC,GMCS,INTERVIEW,IRRITABLE,LABEL,LITHIASIS,LUNG,MEDICAL,METABOLIC,METHODS,MOOD,OBESITY,PSORIASIS,RESULTS,REVISED,RHINO,SCID,SEBORRHEIC,SEMI,SIMD,STRUCTURED,URTICARIA,VERSION
DETECTION,DKC1,TELOMERASE,TELOMERES,TERC,TERT
169,2006,2011,2014,571,899,AMONG,BACKGROUND,COPYRIGHT,DATA,HODGKIN,INC,ISPOR,LABEL,METHODS,MOST,NETWORK,NHL,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SOCIETY,VHA
169,175,2014,AES,AUC,CONCLUSION,COPYRIGHT,IDENTIFIER,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RANDOMIZED,RESULTS,SIMON,TREATMENT,UNASSIGNED
001,002,161,169,2007,2012,2014,248,8805,ATS,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,EGFR,ERS,IASLC,IRELAND,LABEL,LAC,LTD,LUNG,MAY,METHODS,MPP,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS,SOCIETY,THERE,THESE,TNM,USED
0001,120,169,2014,BACKGROUND,BRITISH,CO2,COPD,FEV1,JOURNAL,LABEL,MEF50,METHODS,MIF50,PRESS,PUBLISHED,RESULTS,ROBOTIC,THEREFORE,UNIVERSITY
160,169,2014,231,233,945,946,CELL,COPYRIGHT,CRGDK,H460,HOWEVER,MCF,MOL,RGPD,SFBBM,SOCI,SUBSEQUENT,THESE,TP5
169,2014,864,COPYRIGHT,CSS,DFS,HOWEVER,IRELAND,LABEL,LIBRARY,LTD,MEDLINE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,SIX
169,2014,COPYRIGHT,DOSE,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PURPOSE,RESULTS,SBRT
101,145,169,181A,2014,212,494,ARRAY,COPYRIGHT,COX,ETS1,FZD4,FZDA,INC,MAPK1,MPM,PCR,PLEURAL,USING
163,169,18B,2014,2158,428,8805,BACKGROUND,CDCA3,FINALLY,GBA,HCC,LABEL,MOTIVATION,PCR,PEARSON,PRESS,PUBLISHED,THEREFORE,THUS,UNIVERSITY
EGFR,ERBB,TKI,TKIS
136,160,169,2001,2011,2015,ANESTHESIA,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,RESULTS,RML,SOCIETY,WHEREAS
169,1994,1995,1996,2002,2006,2009,2015,BACKGROUND,BETWEEN,COPYRIGHT,END,HOWEVER,INC,LABEL,MATERIALS,METHODS,PRIOR,PROCEDURES,RESULTS,THESE,USING
169,2015,344SQ,393P,A549,BACKGROUND,COPYRIGHT,CTCS,CURRENTLY,H1299,INC,ITGB4,LABEL,MATERIALS,METHODS,MOST,RESULTS
169,2014,945,BASED,COPYRIGHT,GIVEN,HIF,HOWEVER,INC,MYC,PREVIOUSLY,PRMT5,UTRS
001,100,217,A549,FINALLY,HOWEVER,KRAS,MIR,PCR,SPC,TARGETSCAN,WESTERN
0001,0099,169,2014,2A6,2B10,311,364,437,453,674,AFRICAN,P450,PRESS,PUBLISHED,THERE,TOTAL,UDP,UGT,UGT2B10,UNIVERSITY,WHITE
CTLA,CTLA4,FINALLY
100,12R,DEPSIDE,ESI,H460,HELA,MCF,NCI,NMR,THEIR,THREE,USNEA,USNIC
003,007,215,347,661,8202,ALSO,CLPTM1L,GWA,HOWEVER,LUNG,RESULTS,SEVERAL,SNPS,TERT,TP53
003,006,021,049,148,157,BACKGROUND,DCR,LABEL,METHODS,NSCLC,PCR,PFS,PKM2,RESULTS,THERE
169,2014,COPYRIGHT,CROHN,PULMONARY
169,2014,COPYRIGHT,DESPITE
169,2014,956,A549,ATCC,CELL,COMPOUNDS,COPYRIGHT,H460,HDAC,HDAC1,HDLP,HEPG2,IC50,IIB,IIC,IIF,IIIA,IIIB,IIIG,INC,LUNG,MOLECULAR,NCI,NON,QSAR,SMALL,VIA,VIIA,VIIIA
1096,2014,8202,AMONG,FISH,JANUARY,LABEL,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS
954,BCL,SCLC,THESE
169,2009,2013,2014,DIAPHRAGM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PRESS,PRIMARY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
0007,076,1139,152,169,173,183,2014,411,416,419,568,571,ANAEMIA,BACKGROUND,COPYRIGHT,FIVE,FUNDING,HOWEVER,LABEL,LTD,METHODS,NONE,OVERALL,RESULTS,SECONDARY,SIX,THEREFORE
001,011,032,036,049,2012,2013,8804,CONCLUSION,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPSS,WALKING,WIN
BMJ,FOLLOWING,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,PUBLISHING,RESULTS
2000,2012,8197,BMJ,GROUP,IARC,LABEL,LIMITED,METHODS,OBJECTIVE,OTHER,PUBLISHED,PUBLISHING,RESULTS,THESE,VILLAGE
14Q32,211H,379,411,BASED,HDAC,JAPAN,LUCIFERASE,MALIGNANT,MESO1,MPM,PATHWAY,PCR,PEM,SAHA,THESE
1350,8197,APPROACHES,AUSTRALIA,AUSTRALIAN,BACKGROUND,BMJ,DIAGNOSTIC,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,SECONDARY,TOTAL,TRIAL,UNIVERSITY,WESTERN,WHILE,ZEALAND
169,2014,500,AMATUXIMAB,LABEL,METHODS,MPM,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESPONSES,RESULTS,SECONDARY,SIX
103,169,2014,BAP1,INC,INHERITED,KNUDSON,USING,WILEY
VGIIB
001,019,033,042,045,115,8209,967,CHI,COX,FURTHER,HOWEVER,IHC,LABEL,MEIER,NAD,NQO1,PCR,SCLC,UNASSIGNED
001,177,8201,BATHO,BEAM,CONCLUSION,EQUIVALENT,ETAR,KENDALL,LABEL,METHODS,NOVEL,OBJECTIVE,PBC,POST,PURPOSE,RESULTS,SHAPIRO,THESE,WILKS
169,2014,AMERICA,HPYV7,HPYVS,INFECTIOUS,PRESS,PUBLISHED,ROLLING,SOCIETY,UNIVERSITY
REGUCALCIN
001,004,066,169,2009,2012,2015,247,248,498,BACKGROUND,BELGIUM,CKTO,COPYRIGHT,DEC,DUTCH,FEB,FUNDING,GROUP,HOWEVER,LABEL,LTD,LUNG,MANCHESTER,MEAN,METHODS,MOST,NEDERLANDS,NETWORK,NTR1527,OVERALL,RESULTS,SCIENCE,SCLC,SECONDARY,SOCIETY,THREE,TRIAL,UNIT
EMBRYONAL,FINE
155,LAN,LUNG,MOLECULAR,THEREFORE
112,2011,AFTER,BELO,CONCLUSION,HORIZONTE,JANUARY,JULY,LABEL,METHODS,MINAS,OBJECTIVE,RESULTS,THESE
A549,DU145,HELA,MCF
IC50,ML323,PCNA,UAF1,ULTIMATELY,USP1
160,AMONG,LOIRE,PAPILLOMA
BECAUSE,FIFTEEN,HCC,REMARKABLY,TACE
000,169,2014,AYA,AYAS,BASEL,THEREFORE,USA
169,2014,ALK,BOTH,CAFEE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TKI,TKIS,TREATMENT
169,2014,ALK,DIFFERENT,MUTATIONS
160,ANTI,LABEL,METHODS,MICE,OBJECTIVE,PURPOSE,RESULTS,SN38,SUSTAINED,TGD
169,2014,AIMS,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,DATA,EGFR,EPIDERMAL,JOURNAL,LABEL,METHODS,NSCLC,OBJECTIVE,PHYSICIANS,RARE,RESULTS,ROYAL,SAMPLES,THERE,TKI
ALK,DESPITE,EGFR,LABEL,LUNG,NSCLC,OPINION,STATEMENT,UNASSIGNED
A549,BACKGROUND,BASED,BAX,BCL,CCNG1,CENP,CHK2,CKS1,CONCLUSION,DOWN,LABEL,METHODS,RESULTS,SKP2,WESTERN
BACKGROUND,BASED,CDK,CDK2,CONCLUSION,DESPITE,EGFR,EXPRESSION,GEFITINIB,LABEL,METHODS,NSCLC,RESULTS
FUNCTIONAL,HOWEVER,MDM2,SCY1,TAKEN
100,125,AUC,CBP,CONCLUSION,DCR,DDP,FORTY,III,LABEL,METHODS,NAB,NSCLC,OBJECTIVE,ORR,PFS,RESULTS
3DCRT,8805,BACKGROUND,CONCURRENT,DVH,DVHS,GRADE,GTV,IPSI,LABEL,MATERIALS,METHODS,PTV,RESULTS,V13,V20,V30,V45
135,144,DCR,ERCC1,LABEL,LRP,MATERIALS,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,RRM1,SHORT,TTP
100,177,200,400,A549,ADENOVIRUS,BAL,BAX,CLEAVED,CONCLUSION,CONTROL,FLOW,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,SER,SIRT6,WESTERN
1000,10TH,125,19DEL,234,274,2C19,4TH,627,672,680,ADR,BACKGROUND,BLOOD,CYP,CYP2C19,EGFR,HPLC,III,LABEL,LIVER,M20,M23,M24,M26,MATERIALS,METHODS,NSCLC,PFS,RESULTS,SAS,SPSS
A549,BACKGROUND,BBSKE,CHOU,DCFH,DOSE,DRI,DTNB,GSH,IC50,LABEL,MATERIALS,METHODS,OBVIOUS,RESULTS,ROS,SRB,TALALAY
480,BACKGROUND,BRIEFLY,COBAS,DEL,EGFR,G718X,L858R,LABEL,MATERIALS,METHODS,PAKISTANI,PCR,RESULTS,S768I
500,ACACA,ACLY,COX,DNL,EIGHT,FASN,FURTHER,HOWEVER,MEIER,NSCLC,SNP,SNPS,UNDER
CERTAIN,HPV,HPV16,HPVS,IRAN,IRANIAN
0001,004,095,104,126,138,163,2012,2013,208,316,335,418,429,485,508,5603,667,707,8872,924,ACCORDING,BACKGROUND,BANGLADESH,JANUARY,LABEL,MATERIALS,METHODS,MOST,RESULTS,SEPTEMBER,SMOKING,SOCIO,SPSS
013,058,073,088,2009,2011,8804,APRIL,BACKGROUND,COX,KRUSKAL,LABEL,MALIGNANT,METHODS,PFS,RESULTS,STUDIES,TEST
0001,001,002,005,008,014,017,018,023,024,025,034,038,0385,039,041,083,214,8201,946,BRCA1,ERCC1,NSCLC,RRM1,RRM2,THERE
239,8201,BACKGROUND,COMPANY,DISCUSSION,ELI,FOLLOWING,GIVEN,HRQOL,III,ITEMS,LABEL,LILLY,META,METHODS,NSCLC,PREFERRED,RCTS,REPORTING,RESULTS,REVIEWS,SYSTEMATIC,THERE
001,18C9,1E1,206,31G7,8201,8804,8805,BACKGROUND,CONCLUSION,DAKO,EGFR,EPIDERMAL,FISH,HIGHEST,IHC,LABEL,METHODS,OVERALL,PHARMDX,PROTEIN,RESULTS,SP84,UNASSIGNED,VIRTUAL
A549,NON,NRF2,NSCLC,PCR,RNAI,THUS,USING
BASED,HESSIAN,LUNG,RBC,RULE
DICE,EXTRACTION,INITIALLY,NEXT,OTSU
EVEN,PET,SUV,THEREFORE
001,004,005,030,DFS,FDG,MTV,MTV2,NSCLC,PET,SUV,T1N0,T2N0,THEREFORE,UNIVARIATE
ARTIFICIAL,CAD,FINALLY,FPS,MASSIVE,MTANN,NETWORK,THEN
109,BIOLOGICAL,CCCR,COLE,EIT,ELECTRICAL,IMPEDANCE,TOMOGRAPHY
2012,209,DEC,EGFR,EPIDERMAL,EXON,FNA,IRISH,IVD,L858R,MAR,PCR,RESECTION,SAMPLES
494,H446,H69,H69AR,HOWEVER,SCGN,SCLC,THEN,THESE
003,100,1302,ALK,ATS,BACKGROUND,BOTH,BRAF,EGFR,ERS,HER2,HOWEVER,IASLC,III,KRAS,LABEL,METHODS,MPC,MPP,OBJECTIVE,RESULTS,RET,RFS,ROS1,TKIS
2002,2009,8805,AMONG,BACKGROUND,COX,HOWEVER,III,IMRT,LABEL,METHODS,NSCLC,OVERALL,PROPENSITY,RESULTS,SEER,USING
280,AMONG,BACKGROUND,CONCLUSION,HIGH,LABEL,METHODS,RESULTS,RFS,SCC,SQCCS,T2A
0005,0073,150,BACKGROUND,CONCLUSION,DATA,EGFR,FDG,FLT,LABEL,METHODS,NSCLC,PET,RESULTS
BACKGROUND,CONCLUSION,EXOME,LABEL,METHODS,PULMONARY,RESULTS,THERE,THREE,WESTERN
001,002,003,047,111,137,3324,BACKGROUND,CONTEXT,COX,CVD,FAT,FRAMINGHAM,HEART,HOUNSFIELD,LABEL,MAIN,METHODS,NON,OBJECTIVE,RESULTS,SIMILAR,THERE,THESE,VAT
169,2014,COPYRIGHT,FIVE,H23,NCI,SAS
181,22RV1,361,8776,945,946,A2780,A549,ANTI,AURANOFIN,COMPLEXES,HELA,HLN,HOS,IC50,MCF7,NMR,PPH3,THP,TNF
027,068,100,109,119,139,141,142,162,235,246,365,420,484,520,564,676,691,ARDS,BACKGROUND,CHINA,ICU,ICUS,LABEL,METHODS,RESULTS
8013,ADDRESSING,BACKGROUND,CBX2,FOUR,LABEL,METHODS,OVERALL,PCG,RESULTS
001,003,006,016,020,021,027,031,335,8593,8595,BACKGROUND,DSS,IIIA,LABEL,MCT1,MCT2,MCT3,MCT4,MCTS,METHODS,NSCLC,RESULTS,TMAS
013,015,018,027,042,045,188,217,240,489,528,543,566,595,625,637,643,645,AFTER,CHINESE,LABEL,METHODS,OBJECTIVE,PARP,RESULTS
070,138,169,2014,571,8212,8805,ADJUSTMENT,CIS,COLORECTAL,CONCLUSION,COX,GLEASON,HOWEVER,HRS,III,LABEL,LUNG,METHODS,OBJECTIVE,OTHER,OVARIAN,PLCO,PURPOSE,RESULTS,SCREENING,SOCIETY,THEREFORE,TRIAL
CD33,CERTAIN,HOWEVER,SIGLECS,SUPPORTING,THUS
169,2014,947,A549,BIOLOGY,CALU,FAP,FAS,HOWEVER,INC,MOLECULAR,PEDF,PIGMENT,SIMILARLY,SOCIETY
002,003,007,023,040,071,073,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MEAN,METHODS,NSCLC,RESULTS,SARCOPENIA,SIXTEEN,SMCA,STAGE,THERE,THUS
8547,BRA,SEVERAL,UPON
BALB,EGFP,JAK3,M213,NUDE,RAG,THESE,THUS
126,169,2014,BRAF,HCC,IL8,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RCC,RESULTS
000,001,002,007,039,169,174,1990,2009,2014,250K,295,832,ABI,AFFYMETRIX,AGILENT,ARRAY,AUTHORS,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,INTEGRATED,IRELAND,KRAS,LABEL,LKB1,LOWER,LTD,MAPPING,MATERIALS,METHODS,NORTH,NSCLC,PUBLISHED,RESULTS,ROC,SNP,STY,UNIVERSITY,WIDE
130,3T3,COFE2O4,HACAT,HELA,MRI,RITC,THESE
CHINA,HOUSEHOLD,OVERALL,XUANWEI
169,178,1993,2010,2014,2895,844,AMONG,BACKGROUND,CENTRAL,KCCR,KOREA,LABEL,METHODS,RESULTS,SEER,SIRS,SOCIETY,STAT,THYROID
286,AFTER,CONCLUSION,EGFR,LABEL,LOD,METHODS,OBJECTIVE,PCR,RESULTS
0001,114,160,169,1990,1990S,1997,2015,2796,3719,6515,BACKGROUND,BCSS,CCS,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,RESULTS,SEER,T1AN0,THERE
001,019,8202,BACKGROUND,BASED,COMPARISON,EGFR,HOWEVER,HR19,HRTKI,L858,L858R,LABEL,METHODS,NSCLC,PFS,RESULTS,TKIS
108,600,CIGARETTE,DNMT1,EGFR,EPIDERMAL,ERK1,KIRSTEN,KRAS,MET,NAD,NQO1,NSCLC
1999,2010,21E,536,8202,A549,ATLANTA,CAV1,COX,CPG,EKVX,FDR,GOLDENGATE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SILENCING,VAMC
B72,BAP1,CAM,CD10,CD117,CD15,CD30,CEA,DIFFUSE,EMA,PAS,PLAP,S100,TFE3
001,0980,177,197,AKT,ARQ,BOTH,CELL,GDC,MALIGNANT,MAPK,MET,MPM,NVP,PI3K,STUDIES,WHILE
005,025,101,149,169,2014,8201,ACCORDING,COX,ESCC,GASC1,KLF4,MDM2,MYC,NANOG,PPARG,ROC,SOX2,THEREFORE,UICC
169,2014,231,233,916,966,A549,APOPTOSIS,BAX,CELL,COPYRIGHT,DEPLETION,H460,MOL,NSCLC,ROS,SFBBM,SOCI,THERE,THESE,WESTERN,ZERUMBONE
000,169,2012,2014,723,745,ESTIMATES,OVERALL,UICC
169,2014,BASED,BONE,COPYRIGHT,THESE
169,2014,COPYRIGHT,CTC,CTCS,EFFICIENT,INTRA,MCA,UNDER
102,169,2014,8805,CONCURRENT,COPYRIGHT,DMFS,EASTERN,EQD2,GROUP,HOWEVER,INC,INTENSITY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,POOR,PURPOSE,RESULTS
005,046,169,177,2014,8764,CCC,CCCS,COPYRIGHT,COX,CPFS,FFDM,HISTOGRAM,III,INC,LABEL,LRC,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PENALIZED,PREDICTIVE,PURPOSE,RESULTS,T50
183,956,A549,AIM,AUTOGRAFT,B16,CELL,COLON26,CONCLUSION,IC50,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,S115,S180,TOB2,TREATMENT,WESTERN
169,2014,AKT,AUTHORS,COPYRIGHT,DIFFERENT,ERBB2,INC,PUBLISHED,RELAPSE
169,2015,2AN2,COPYRIGHT,III,INC,NSCLC,STAGE,T1A,T3N1,T4N0
128,169,2008,2011,2014,BACKGROUND,CONCLUSION,COPYRIGHT,EBUS,INC,KINGDOM,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SABR,TBNA
169,2014,220,34A,CD44,COPYRIGHT,PCS,PTX
169,2014,AFRICAN,AMERICANS,AUTHORS,CULTURALLY,FIRST,JOHN,LTD,LUNG,RACE,SONS,THEN,WILEY
169,17Q,2014,AUTHORS,CHGA,INC,MYCN,NPY,PDX,PDXS,PUBLISHED,SYP,THUS,UICC,WHOLE,WILEY
007,169,2001,2003,2003_VS,2004,2005_VS,2006,2006_VS,2010,2012,2012_VS,2014,428,64_VS,8804,8805,BESIDES,COX,EINDHOVEN,HRMALE_VS,HROTHER_VS,NSCLC,UICC,_2001,_2010,_FEMALE,_LOW
675,AMONG,BACKGROUND,EXPRESSION,GEO,INGENUITY,LABEL,LUNG,MATERIALS,METHODS,MICRORNAS,OMNIBUS,RB1,RESULTS,TEN
AREAS,BACKGROUND,COVERED,EGFR,EIGHT,III,LABEL,METHODS,NSCLC,OPINION,PHASE,TKIS
169,2014,231,233,COPYRIGHT,DOSIMETRIC,HOWEVER,INTENSITY,METHODS,PUBLISHED,SAS,SEVERAL,SFRO,SOCI
ALSO,AREAS,BACKGROUND,COVERED,CURRENT,LABEL,MDA,METHODS,OPINION,ORIGINALLY,PDZ,THROUGH
CDDP,DEX,IHC,MKP,MTT,PCR,SGK,SPC
000,4294A,AGLIENT,COMPANY,EIT,HOWEVER,MHZ,THEN
0005,001,147,15N,169,2014,695,809,908,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,NSE,OBJECTIVE,OBJECTIVES,PCT,PUBLISHED,RESULTS,SERUM,SOCIETY,THUS
945,946,THESE,USING,VEGF
ATR,BRCA,BRCA2,CDK2,GENOMIC,HIPPO,LATS1,RAD51,RASSF1A
046,160,169,2000,2013,2015,232,322,554,603,639,958,AFTER,APRIL,COPYRIGHT,COX,INC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SUCCESSIVE,SURGERY,THERE
169,2014,8201,AUTHORS,BCL6B,CLL,COPYRIGHT,ECTOPIC,HCC,HEPG2,HIV,HUH7,IRELAND,LOSS,LTD,MHCC97L,PARP,PUBLISHED,TAT,VEGFA
0A549,8482,961,A549,CONCLUSION,CY5,DAVID,DEGS,E2F1,GENOMES,KEGG,KYOTO,LABEL,MAX,METHODS,MYC,NINE,OBJECTIVE,PURPOSE,RESULTS
169,1990,2012,2014,300,COPYRIGHT,DCR,IIB,III,IIIA,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PFS,RESULTS,THESE,TREATMENT
169,2014,945,946,954,956,A549,ASTRAGALI,COPYRIGHT,ELISA,ERK,ERK1,HOWEVER,METASTASIS,MMP,MTT,PDTC,PKC,PUBLISHED,RADIX,TGF,TNF,U0126,WESTERN,WOUND
177,198,215,480,565,CNS,IRANIAN,JCV,PCR,WBC
001,BRAIN,EMT,FURTHER,H1915,HOWEVER,METASTASIS,NSCLC,PCR,THEREFORE
1114,169,2014,2173,287,7887,AFRICAN,AMONG,ASIAN,BACKGROUND,ENROLLMENT,III,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,STRATEGIES,UNIVERSITY
001,2014,29321,BACKGROUND,CIS,COLORECTAL,CONCLUSION,COX,HRS,LABEL,LUNG,METHODS,OVARIAN,PLCO,PRESS,PUBLISHED,RESULTS,TVU,UNIVERSITY
169,2014,946,954,BIOLOGY,EXPRESSION,HOWEVER,INC,MOLECULAR,RAS,SCF,SOCIETY,TRCP,WNT
0001,169,2014,ALK,BACKGROUND,EGFR,GEC,HER2,HOWEVER,IHC,IHC2,INSTITUTE,ISH,LABEL,MCNEMAR,METHODS,MOLECULAR,NCI,NSCLC,PRESS,PUBLISHED,RESULTS,TESTING,UNIVERSITY
169,2014,NSCLC
001,169,2014,946,BALB,BERBERINE,COPYRIGHT,EMT,METASTASIS,SELECTIVE,SIHA,SOCIETY,TAKEN
112,8201,COX,DFS,ERCC1,HOWEVER,MEIER,MTT,NSCLC,OVERALL
1011,124,137,1475,169,2000,2014,203,323,544,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MAIN,MALIGNANT,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PARTIAL,RATIONALE,RESULTS,STUDIES
169,2014,A549,AUNP,AUNPS,COPYRIGHT,DENSITY,DRUG,EGFR,FOOD,GEFITINIB,H1975,H460,NCI,RAMAN
001,004,005,390,945,BANK,BIO,HIGH,NSCLC,PROVINCIAL
0001,001,112,198,273,AMONG,CFE,COOKING,EGFR,EPIDERMAL,KNOWLEDGE,NSCLC,OBJECTIVE,ORR,ORRS,PFS,TKI,TKIS
177,384,AMONG,FIRST,GROUP,HOWEVER,IIIB,MOST,NON,NSCLC,THEN
000,001,004,008,016,018,105,133,AMONG,HER2,PRS,RML
169,1998,2012,2014,8804,CLT,COPYRIGHT,COX,FACTORS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PROPENSITY,PURPOSE,RESULTS,ULTIMATELY
169,2008,2010,2014,8805,BACKGROUND,CONCURRENT,COPYRIGHT,CRT,EASTERN,ECOG,EIGHT,GROUP,HOWEVER,IIA,IIIB,INC,LABEL,MATERIALS,MAY,METHODS,NSCLC,ORR,PFS,RECURSIVE,RESULTS,SECONDARY,THREE,UPON,XRT
HOWEVER,MEDICINAL,SYSTEMATIC
024,1747,1978,2011,368,8201,BETWEEN,CONCLUSION,HODGKIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SIRS,USING
0001,8201,8226,AUC,FORTY,GREY,KEY,LABEL,MANN,METHODS,OBJECTIVE,RESULTS,ROC,TEXTURE,USING,WHITNEY
149,177,2011,2014,BACKGROUND,ERAS,JANUARY,LABEL,MEAN,METHODS,PRIMARY,RESULTS,SGA,SUBJECTIVE,THERE
169,177,18F,2014,50MM,COPYRIGHT,FDG,IDC,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,VARIOUS,VCT,VOIS,VPATH,VT30,VT50
005,012,013,022,037,050,071,091,177,181,214,239,397,662,668,815,8201,938,ATS,BACKGROUND,COX,ERS,IASLC,LABEL,LUNG,LVI,METHODS,RESULTS,RFS,SOCIETY,T1AN0M0
160,ALDOA,MMP
C21,EGFR,MARSDENIA,NMR,THEIR,TKI
12074,181,4600,4710,A549,AHR,ASSAY,BAP,BENZO,FURTHER,MTT,NPS,PAH,PAHS,POLYCYCLIC,ROS,TIO2
002,018,177,946,ALSO,BACKGROUND,CONTEXT,ESTRADIOL,ESTRONE,FURTHER,HOWEVER,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SERUM,SETTING
160,8209,A375,CADM1,CELL,HOWEVER,INCREASING,MMP,PCR,TSLC1
261,598,996,ARMS,BACKGROUND,COBAS,CROSS,EGFR,GROUP,LABEL,MALDI,METHODS,MTS,RESULTS,SCORPIONS,TKIS,TOF
A549,ADMET,FINALLY,FOLLOWING,PKM2,ROS,SIX,THESE,THUS,ZINC
169,2014,CONCLUSION,COX,FDG,HOWEVER,IMAGING,INC,LABEL,MEIER,METHODS,MOLECULAR,MTV,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,SUV,SUVS,UNLABELLED
008,169,2014,EGFR,H1975,IBRUTINIB,MEIER,NSCLC,PRESS,PUBLISHED,T790M,UNIVERSITY,Y1068,Y1173
169,2014,AUTHORS,EMT,EPITHELIAL,PUBLISHED,YET
100,169,2012,2013,2014,CONCLUSION,COPYRIGHT,EGFR,GUIDELINES,IRELAND,LABEL,LTD,MAY,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SECONDARY
150,169,2014,COMBINING,COPYRIGHT,DESPITE,FREQUENCY,INC,LEWIS,NON,NSCLC,PUBLISHED
2014,BMJ,BOTH,GROUP,LTD,PES,PUBLISHING
181,A549,DDP,DIFFERENT,FINALLY,H1299,H2347,IC50,JAK,JAK2,NSCLC,STAT,STAT3
005,ANTI,GBM,GSC,GSCS,MGG4,THESE,U87
2000,23A,ABL,BCR,CML,ECTOPIC,H157,K562,MIR,PCR,REAL
001,002,177,183,BETWEEN,CO2,NREM,PET,TEN,TORR
169,2014,BAMHI,BARR,BART,BART3,BART7,EBV,EPSTEIN,III,MUTU,NPC,SYSTEMATIC,THESE,UICC
169,2014,CD21,COPYRIGHT,CTLA,CTLA4,CYTOTOXIC,FOXP3,INHERITED,SCIENCE,TREG,WHEREAS
000,169,2014,811,904,972,983,993,AUC,BASED,CH2,CH3,CHRONIC,CIGARETTE,COPD,COPYRIGHT,DECREASED,III,NMR,NOVEL,OPLS,THEN,THUS,TNM
169,2014,8211,8764,ALIKE,BIOLOGY,CELL,COMMONS,DRUG,FOOD,HOWEVER,LICENSE,PACLITAXEL,SHARE,SOCIETY,TAXOL
4T1,BACKGROUND,EPC40,EPRAS,HOWEVER,ILEI,LABEL,METHODS,NONCLEAVED,PROTEASES,RESULTS,WESTERN
160,BACKGROUND,E1A,HER2,HSPA5,LABEL,METHODS,RESULTS,THERE,THUS,TNBC
326,BACKGROUND,CTTN,ESCC,HOWEVER,KNOCKDOWN,LABEL,METHODS,RESULTS,SRC,THESE,VEGF,WESTERN
2006,2011,823,BACKGROUND,BETWEEN,FEW,JANUARY,JUNE,LABEL,METHODS,RESULTS
169,2014,231,233,COPYRIGHT,DEDICATED,HADRONS,PUBLISHED,SAS,SFRO,SOCI,THESE
016,169,2014,750,8764,956,BEER,CMPD,GIVEN,III,INC,INITIAL,NIH,SN29751,SN30000,WILEY
100,101,129,158,177,2010,2013,294,593,637,772,908,AGE,BETWEEN,CONCLUSION,FURTHER,IRE,JANUARY,LABEL,MANN,MATERIALS,MEAN,METHODS,MRI,NANOKNIFE,OBJECTIVE,OVERALL,POST,PURPOSE,RESULTS,TEN,WHIPPLE,WHITNEY
8201,BACKGROUND,CRT,FDG,GRADE,HIGH,LABEL,LIVER,METHODS,MRI,PET,RESULTS
100,BACKGROUND,LABEL,METHODS,NPV,RESULTS,TEN,TRIAL,URL
157,181,2005,2009,268,BACKGROUND,FURTHER,FVC,GAP,HOWEVER,IPF,LABEL,METHODS,RESULTS,SEOUL,UNIVERSITY,WESTERN
BRAZILIAN,MALIGNANT
001,022,113,CERTAIN,DATA,IPN,IPNS,LABEL,METHODS,MOST,OBJECTIVE,PNS,PTNB,RESULTS,STUDENT,VARIABLES
101,CDH1,CONSISTENT,ECTOPIC,THESE,UTR
DRUG,MTT,NON,NSCLC,SETS
2013,2014,ATTENDEES,BLOOD,HEART,HOWEVER,INSTITUTE,LUNG,MARCH,NCI,NHLBI,PRESS,PUBLISHED,UNIVERSITY
169,2006,2014,BECAUSE,CETUXIMAB,GRADE,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIXTY,TEN,THERE,UNIVERSITY
0001,169,2014,8201,8805,BACKGROUND,CONCLUSION,EIGHT,LABEL,LARGE,METHODS,RESULTS,SDT,SOCIETY,SOLID,THESE
0001,103,108,177,2014,300,3093,396,956,ALT,BACKGROUND,DESPITE,GOVERNMENT,HEPATIC,HOWEVER,INITIAL,LABEL,LABORATORY,MEAN,METHODS,OVERALL,PHLEBOTOMY,PRIOR,PROVIDING,PUBLISHED,RBC,RESULTS,TIO,USA
0002,0061,169,2014,350,435,8201,BACKGROUND,DFS,DISEASE,III,LABEL,METASTATIC,METHODS,PPB,RESULTS,SIXTY,SOCIETY,THERE
169,2012,2014,ASIA,ASIAN,COLORECTAL,COPYRIGHT,CRC,HENCE,HONG,INC,KONG,KRAS,UFT
127,169,1999,2009,2014,325,8805,ACR,COLLEGE,OSLO,OVERALL,SLE,SMR,YPLL
CONCLUSION,COT,FISH,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,ROS1,SNR,THERE
2009,2013,AE1,AE3,CD34,CLINICALLY,DIAGNOSIS,HOWEVER,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,OVERALL,RESULTS,SEPTEMBER,SINCE,SMM,THERE,TTF,WT1
000,2002,2009,253,300,382,504,600,800,877,ASBESTOSIS,CHEST,ECOG,HALF,LDH,MALIGNANT,MOST,WBC
0001,0005,0015,0037,009,019,020,022,037,108,197,779,8804,AMONG,EGFR,NSCLC
426,8201,891,AIMS,CIS,DATA,HYPOTHESIS,LABEL,LIBRARY,METHODS,OBJECTIVE,OVERALL,RESULTS,RRS,THERE
BACKGROUND,CASE,CHEST,HOWEVER,LABEL,LOBECTOMY,METHODS,PART,POST
169,2014,EACH,IMAGE,RSNA,STAYING,SUGGESTED,TREATMENT,ULTIMATELY
CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,NON,NSCLC,OBJECTIVE,RESULTS
008,1298,1960,1979,1980,2014,CISPLATIN,CNKI,CONCLUSION,DDP,HIGH,LABEL,MATERIALS,META,METHODS,OBJECTIVE,ORR,RESULTS
000,CHINESE,CNKI,CONCLUSION,ELECTRONIC,FINALLY,KANGLAITE,KARNOFSKY,KLT,KNOWLEDGE,KPS,KSP,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,STATA11,WANFANG
3MM,947,DVH,IMRT,M3D,RTOG,TPS,VMAT
001,2008,2011,ACCOUNTING,BODYFIX,CBCT,EACH,LESIONS,SBRT
0236,0813,0915,CRT,DCAT,GROUP,HIGH,IMRT,MEAN,MONITOR,NSCLC,OARS,PTV,RADIATION,RTOG,SBRT,THERAPY,V20,VMAT
CHANGES,DVH,GTV,HOWEVER,III,THEREFORE
2MM,3DVH,3MM,AGILITY,DVHS,DYK,MLC,MLCI,RAYSTATION,TPS,TREATMENT,VAN
AFTER,COMPARISON,HIGH,SYNERGY,VMAT
003,004,006,011,019,026,029,031,034,039,042,043,2011,402,445,553,575,ASIAN,BCT,CTA,CTV,D95,DMAX,DMEAN,DOSE,HOWEVER,IMAGE,IMRT,JANUARY,LAD,LUNG,PLANS,PRV,PTV,SIMILARLY,USING,V10,V20,V25,V30,V40
169,2010,2014,945,BCPT,CTLA,DESPITE,DRUG,EMA,FDA,FOOD,HLA,IDO,IFN,MEDICAL,NEXT,NSCLC,PHD,SOCIETY,THUS,TMZ
001,025,093,177,DICE,DISTANCES,DRS,FDG,GROUP,HENCE,NSCLC,PET,SUCCESSFUL
60012,CC13,DOSE,ECLIPSE,EDGE,FINALLY,IBA,MLC,NEXT,NUCLEAR,PTW,SBRT,SUN,THESE,USING,VERSION,VMAT
2006,8805,947,EPID,GAMMA,PIERMATTEI,SOLID,USING,WATER
0709,0794,120,176,210,513,562,660,8805,ADVERSE,CBCT,CTCAE,GRADE,MUS,PATIENT,PET,PLANS,PULMONARY,SBRT,STEP,VMAT
176,177,3DVH,ACPDP,BOTH,CVSP,DELIVERED,DOSE,DVH,MACHINE,OAR,OARS,PINNACLE3,PLANNED,PTV,SBRT,SRS,TPS,TREATMENT,VIE,VMAT
1980,1999,2002,AUSTRALIA,CHINA,ECOLOGICAL,FRANK,GARLAND,HILL,JAPAN,SPAIN,UVB
169,2014,AFTER,DESPITE,EMT,INC,MALIGNANT,MPES,THEREFORE,WILEY
169,2014,8804,8805,ASIA,AUSTRALIA,HPV,KINGDOM,OPC
ALECTINIB,ALK,CACO,CH5424802,EML4,H2228,LABEL,METHODS,NCI,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
112,169,2014,231,233,COPYRIGHT,DLCO,EARLY,FCV,FEV1,FOUR,HOWEVER,INCLUSION,PUBLISHED,PULMONARY,SAS,SFRO,SOCI,TLCO
160,250,AFTER,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS
ACCORDING,AFTER,BACKGROUND,CASE,CONCLUSION,DYSPNOE,III,LABEL,MEDICAL,METHODS,NYHA,PFO,PLATYPNEA
169,2014,946,CDK,MAPK,SMAD3,TGF
169,2014,946,A549,BABL,BACKGROUND,BCL,BLUE,CHINESE,CONCLUSION,COPYRIGHT,ELEMENE,FLOW,FURTHER,IRELAND,LABEL,LTD,METHODS,MTT,P53,PCR,RESULTS,WESTERN,XENOGRAFT,ZEDOARY
121,169,2014,2015,500,817,827,AMIGO,IMAGE,OPERATING,SOCIETY
A549,FIRST,LUNG,MTT,NNMT,NSCLC,PCR,REAL,SUCCESSFUL,TIME,WESTERN
ALCOHOL,AQP1,CEA,CONCLUSION,CX43,GJIC,LABEL,LEWIS,METHODS,MTT,OBJECTIVE,RESULTS,SEMEN,WESTERN
101,118,131,181,1988,2011,224,529,AMONG,BACKGROUND,EPP,LABEL,MARS,MEIER,METHODS,MPM,OBJECTIVE,OUTCOME,RADICAL,RESULTS,SURGERY
BPS,CURRENTLY,ZOLEDRONIC
169,183,2012,8202,8805,BACKGROUND,CONCLUSION,EGFR,GEORG,LABEL,METHODS,NSCLC,RESULTS,STUTTGART,THESE,TKI,YORK
2006,2010,733,BACKGROUND,ENGLAND,EPISODE,INTERIM,LABEL,LATE,METHODS,NHS,OLDER,PLAN,RESULTS,STATISTICS,YORKSHIRE
162,1999,2009,224,256,994,BACKGROUND,JANUARY,LABEL,MEIER,METHODS,NSCLC,OCTOBER,RESULTS,RFS,T1A,T2BN0M0
169,2014,BCL,COPYRIGHT,HOWEVER,INC,RBM4,SRSF1,STRIKINGLY
169,2014,COPYRIGHT,EMT,INC,METASTATIC,PKD1,SCF,SER,SNAIL,THESE
0001,0006,133,169,198,2014,218,8804,CONCLUSION,DYNAMIC,FDG,FINALLY,LABEL,MATERIALS,MCNEMAR,METHODS,NEXT,NODULES,OBJECTIVE,PET,PURPOSE,RESULTS,RSNA,THEN,TOTAL,TUKEY
111,126,198,293,A750,BACKGROUND,CONCLUSION,DATA,DOR,E746,EGFR,FIFTEEN,KNOWLEDGE,L858R,LABEL,METHODS,MOLECULAR,NLR,NSCLC,PLR,RESULTS,SCHOLAR,SROC,VARIOUS,WEB
000,2011,2012,CENTRAL,CONCLUSION,DLCO,FEV1,FVC,ICU,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SIXTY,SOUTH,UNIVERSITY,XIANGYA
2000,2012,CAMBRIDGE,CENTRAL,CONTROLLED,ECONLIT,INPATIENT,JANUARY,JSTOR,MEDLINE,SCIENCE,VTE
150,169,2014,250,372,AFTER,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,EGFR,ERLOTINIB,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,NONE,NSCLC,OBJECTIVE,RESULTS,THEREFORE
002,003,020,026,163,169,2014,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,EGFR,HIGH,IIIB,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,NSE,OBJECTIVE,PFS,RESULTS,TKIS
169,2007,2009,2014,3DCRT,AIM,ANTICANCER,CCHIA,CONCLUSION,COPYRIGHT,FURTHER,III,IMRT,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE,USING
169,2010,2011,2014,AIM,ANTICANCER,BETWEEN,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,JULY,LABEL,MAY,METHODS,MILD,NSCLC,NSQ,OBJECTIVE,RESULTS
014,031,169,2014,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,EBC,FORTY,FURTHER,IIIB,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2014,4FR,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,RBE,RESULTS,SBRT
169,2000,2010,2013,2014,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,GRADE,INSTITUTE,IRINOTECAN,JOHN,LABEL,METHODS,NEC,PFS,RESULTS,WORLD
169,2014,655,8804,A549,ANTICANCER,BACKGROUND,CLONOGENIC,CONCLUSION,COPYRIGHT,EGFR,FOUR,H1650,INSTITUTE,JOHN,LABEL,LUNG,MATERIALS,METHODS,MMTV,NCI,PDGF,RESULTS,SEVENTY,TGFB,THOSE,WNT
169,2014,ANTICANCER,CDK1,COPYRIGHT,CUCD,DESPITE,ECBALLIUM,INSTITUTE,JOHN,NSCLC,PCR,THUS
169,174,2014,293,ANTICANCER,BOTH,COPYRIGHT,CRIZOTINIB,DOSE,HEK,IC50S,IKR,INSTITUTE,JOHN,KV11,LIPOSOMES,QTC,RABBITS,TASIGNA,XALKORI
169,1AND,2014,ANTICANCER,COPYRIGHT,ICAM,INSTITUTE,JOHN
ABROGATION,ARG1,DESPITE,HOWEVER,LUNG,MTB,NOS2
1498,169,2014,3433,503,646,786,8805,BOARD,CONCLUSION,COPYRIGHT,DATA,LABEL,MEN,METHODS,OBJECTIVE,PURPOSE,RESULTS,WOMEN
012,167,2012,226,227,307,348,517,537,582,674,800,888,935,963,AUC,DOR,EGFR,EPIDERMAL,HOWEVER,NLR,NSCLC,PLR,SROC,TKI,TRUE
169,2014,A549,COPYRIGHT,CSA,CYP,DUE,H460,HTB,INC,LUNG,MMP,SFA,THUS,USING
0001,0118,169,2009,2011,2014,733,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,MAJOR,MCNEMAR,METHODS,MORTALITY,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE,THESE,WEDGE
169,2010,2013,2014,8804,8805,ALT,AST,BETWEEN,CONCLUSION,COPYRIGHT,DCR,IIIB,IRELAND,LABEL,LTD,MATERIALS,MECHANISMS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PAZOPANIB,RESULTS,SIMON,STAGE,VEGF
169,2014,945,COPYRIGHT,DESPITE,HIF,IRELAND,LTD,SCLC,SMALL,THERAPY
100,945,CD34,CD99
MPNST
1999,2010,AFTER,LAPAROTOMY,MEANWHILE,OGCT
112,169,2014,GMBH,KGAA,LUNG,MRI,PREVIOUSLY,THESE,THUS,USRPS,UTE,VCH,WILEY
CSC,CSCS,DESPITE,EXTENSIVE,FURTHER,MDM2,STUDIES,THEREFORE,THESE
6MWT,DDR,DLCO,FEV1,FVC,LABEL,LAM,METHODS,MMP,MMPS,OBJECTIVE,PFTS,PURPOSE,RESULTS,SERUM,THERE,VEGF
169,2014,549,8243,COPYRIGHT,GRAM,HELA,PERFORMED,SAS,T47D
160,169,2014,ALK,COPYRIGHT,NPM,SAS,SUP
111,119,169,1999,2012,2014,206,258,269,646,AMONG,BACKGROUND,BECAUSE,CIS,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MORTALITY,OPERATIVE,PUBLISHED,RESULTS,SOCIETY
EXTRA,GENERALLY,PULMONARY
8209,A549,ABCG2,H460,PKH,TAKEN
001,419,508,8764,8804,945,947,AFTER,ALSO,CCK,CONCLUSION,ELISA,FCM,IC20,IFN,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SPCA,TH1,TH2,TNF,TREATED
160,946,A549,HCC,MMP,PATERNALLY,PEG10,TNM
169,2014,946,A549,CDK4,COPYRIGHT,FURTHER,GINSENG,H460,ORAL,PANAX,PPD,TAKEN
169,2014,231,233,COPYRIGHT,FINALLY,FIRSTLY,LUNG,N0M0,PET,PUBLISHED,SAS,SFRO,SOCI,THEN
169,2014,AUTHORS,BRAF,COMPOUNDS,COPYRIGHT,ERK,INC,KRAS,MEK,PROLONGED,PUBLISHED,RAF,RAF1,RAS,SMALL
169,2014,AIMS,AKT,BACKGROUND,BAD,BASEL,BCL,CDK4,EGFR,H1975,HOWEVER,LABEL,MELATONIN,METHODS,NSCLC,NSCLS,OBJECTIVE,RESULTS,T790M,THUS,TKI,TKIS,TREATMENT
169,2014,40S,A549,COPYRIGHT,FURTHER,H520,HOWEVER,IRELAND,LTD,NSCLC,RFS,RIBOSOMAL,SUBSEQUENT
001,018,039,612,7110,8805,BACKGROUND,CONCLUSION,FIVE,FUNDING,INSTITUTES,LABEL,LDCT,LIMITATION,LUNG,METHODS,NLST,OBJECTIVE,PPV,PREVALENCE,PRIMARY,RESECTION,RESULTS,SCREENING,SECONDARY,SETTING,TRIAL
SINCE
CURRENTLY,LAM,RAPAMYCIN,TSC2,WOMEN
1975,ALTOGETHER,INITIATING
A549,ERK,FOLLOWING,GEFITINIB,HPLC,IGF,III,SRC
116,1C8,205,B16MELF10,BALB,CEA,COLO,HCT,IGG2A,MCF7,NEEM,NLGP,SIHA,WESTERN
001,002,057,260,8211,8242,ATM,BREAK,CHINESE,DDR,DSBS,MDC1,SNP,SNPS
CELL,CNV,FINALLY,LINE,PLK,PROJECT,REMARKABLY,SCLC,TAKEN,THERE,THUS,USING
1706,1759,2011,282,555,990,BETWEEN,DISCHARGE,HOWEVER,JANUARY,PATIENT,SCORE
CHOP

1998,2012,251,BACKGROUND,CHINA,CONCLUSION,FIFTEEN,FINALLY,HLS,HODGKIN,HOWEVER,IPS,LABEL,MCCHL,METHODS,MOST,NSCHL,PRISM,RESULTS,SPSS
001,004,005,006,017,025,087,130,336,594,CHI,COX,DEK,IHC,MEIER,SCLC
ALCL,ALK,CD30,EMA,FURTHER,HOWEVER,MFH,SMA,SUBSEQUENT,TIA
CURRENT,HOWEVER,III,MTT,NAD,NSCLC,SIRT6,TAKEN
AHR,ASICS,OGR1,TRPV1
169,2015,8197,956,A549,G2M,GMBH,HELA,INITIALLY,KGAA,MCF7,MOST,NEXT,PBD,PLK1,POLO,VCH,WILEY
177,8201,8226,A549,AFTER,CONCLUSION,CY5,DOTA,EPO,EPOR,HOWEVER,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PROBE,RESULTS,THEREFORE,THUS
169,2014,215,289,748,A549,COX,FIRST,H460,ITALY,NCI,PTPRG,SNP,SNPS,THESE,UICC
004,028,045,058,113,169,2006,2012,2014,BASEL,CONCLUSION,FURTHER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2014,946,BARR,DAPK1,EARLY,EBV,EPSTEIN,HIGH,HOWEVER,HRM,NPC,RAR,RASSF1A,SINCE,TSGS,UICC,VIRUS,WIF1
0001,169,2000,2007,2014,221,AGE,COPYRIGHT,END,FORTY,FURTHER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PALLIATIVE,POISSON,PURPOSE,RATES,RECEIPT,RESULTS,SEER
DESPITE,TLS
2002,2009,31ST,ABOUT,BACKGROUND,BCS,BRONCHIAL,CENTRAL,JANUARY,LABEL,METHODS,RESULTS
AFTER,CASE,HOWEVER,ISONIAZID,OWING
2012,JULY,THERE
160,918,HRS,MANAGER,META,MMP,MT1
169,2014,231,233,COPYRIGHT,PUBLISHED,SAS,SFRO,SOCI
169,2014,233,BHD,BIRT,COPYRIGHT,DUB,FLCN,HOGG,HPV,HPYV,HPYVS,INC,KAROLINSKA,PCR,SEVEN,UNIVERSITY
AFTER,HOWEVER,OTHER,SCIENTIFIC,STAGE,THERAPY
100,169,177,2014,COPYRIGHT,CSI,DOSE,EXCLUSIVE,FIELD,IMPT,INC,LABEL,MATERIALS,METHODS,OARS,OBJECTIVE,PSPT,PURPOSE,RESULTS,TEN,V95
169,200,2014,CONCLUSION,COPYRIGHT,EPIGENETIC,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MGMT,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SCLC,SCLCS,SMALL
041,169,1966,2014,396,664,BIOMEDICAL,BOTH,CHINA,CHINESE,CIS,CONCLUSION,COPYRIGHT,EGGER,INC,JANUARY,JAPAN,LABEL,LIBRARY,METHODS,NEWCASTLE,OBJECTIVE,OVERALL,QUALITY,RESULTS,SCALE,SCHOLAR,SCIENCE,SUMMARY,TEA,WANFANG,WEB,WESTERN

169,2004,2010,2014,ACTUARIAL,CIDR,CILR,CILRR,CIRR,COPYRIGHT,CRT,ENR,IFRT,IMAGING,INC,INR,LABEL,LOCAL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THESE
100,169,2014,750,8804,AUTHORS,COPYRIGHT,DESPITE,GIVEN,IGRT,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SEVEN,THERE
169,2014,CBCT,COPYRIGHT,D10,ESTIMATES,FIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRACTICAL,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERAPISTS,TREATMENT,V10,V20,V30
169,189,2014,945,946,BACKGROUND,CONCLUSION,DOSES,EVALUATION,FGF,FGF3,FGFR,FGFR1,IIA,LABEL,LUCITANIB,MEDICAL,METHODS,MTD,PFS,PGFR,PRESS,PUBLISHED,RESULTS,SEVENTY,SEVERAL,SIXTY,SOCIETY,SOLID,THERE,UNIVERSITY,VEGF,VEGFR
001,003,008,132,1687,169,1867,2014,BACKGROUND,BECAUSE,CONCLUSION,IALT,LABEL,LUNG,MEDICAL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,SOCIETY,TRIAL,UNIVERSITY
RENAL,RNPV,RPNV
12V4,160,169,2014,A549,AFTER,AIMS,BACKGROUND,CHANGES,CONCLUSION,COPYRIGHT,H2O2,H358,HOWEVER,IMSS,INC,LABEL,LDH,METHODS,MMP,NCI,NSCLC,OBJECTIVE,PUBLISHED,QUERCITRIN,RESULTS,THERE,THESE,TIME,WST
CCA,CCA1,CSA,CSAS,MUTATIONS,RNAS,SIFD,TRNT1,USING
200,ABL,EGFR,EMT,EPITHELIAL,FAK,NSCLC,RNAI,SRC,THESE
CAS9,DSB,GENOMIC,HOWEVER,NGS,NHEJ,PUBLISHED,WHILE
00001,581,8201,CONCLUSION,DATA,EVENT,FDG,III,INCLUSION,LABEL,MANAGER,MEDLINE,METHODS,MTV,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,TLG,TNM,VOLUMETRIC
100,105,2009,2020,235,362,8201,AFTER,AUSTRIA,BACKGROUND,HOWEVER,LABEL,METHODS,PREDICTION,RESULTS,STATISTICS,THEREFORE,TYROL
169,2014,945,946,COPYRIGHT,D1A,D1B,FURTHER,HOWEVER,HOXD3,IRELAND,LTD,MCF,NOTABLY,THESE
169,2014,945,946,ALCL,ALK,EBP,EGFR,FINALLY,HIF,HIF1,HIF2,HIFS,NSCLC,RAS,STAT3,VEGFA
169,2014,946,954,ACTIVATION,AEG,AKT,BECAUSE,DEN,ERK,HCC,HOWEVER,IL6,LYRIC,MTDH,OVERALL,STAT3
169,183,2014,AIR,CHRONIC,COMMISSION,COPYRIGHT,LTD,THESE,WOMEN
169,2014,COPYRIGHT,INC,PUBLISHED,RESULTS,SOCIETY
169,2014,COPYRIGHT,INC,PATHOLOGIC,PUBLISHED,SOCIETY,THREE
169,2014,AKT,ANG,ANGIOGENIN,COPYRIGHT,FINALLY,FRET,GST,HOWEVER,INC,LRRS,PI3K,RNASE,TAKEN,THEREFORE
1080,160,177,24GY,3GY,9GY,AAA,BACKGROUND,CONCERNING,CTV,D99,DOSE,DVH,LABEL,METHODS,PTV,RESULTS,SABR,SABRT,VMAT
0008,0075,0131,0198,0269,0372,107,119,145,226,3347,6929,COX,EGFR,IIB,IIIA,INCREASED,PCR
169,2014,956,A549,COLCHICINE,COPYRIGHT,FURTHER,HOECHST,IC50,LTD,MOST,ROS,SAR
160,172,181,197,2013,238,252,255,492,516,BACKGROUND,DATA,DISEASE,LABEL,METHODS,RARE,RESULTS,STUDIES,THERE,THESE,WDTC
0002,008,160,1992,2006,2N1M0,781,784,BACKGROUND,COX,END,FACTORS,LABEL,MEIER,METHODS,NSCLC,OVERALL,RESULTS,THESE
134,135,1950,1964,2005,275,617,BACKGROUND,ESTIMATING,LABEL,LUNG,METHODS,MINE,PLATEAU,RESULTS,THERE,URANIUM,WORKERS
EPAS,FBI,IST,THUS
115,241,A549,CAP67,DESPITE,GALXM,GXM,MP84,MPS,PC3,THESE
152,FGF2,FIBROBLAST,MICRORNAS,NSCLC,OVERALL,THESE
200,CLT,CODONOPSIS,HEMSL,KOIDZ,METASTASIS,MMP,MMPS,RUNX2
012,160,2006,2011,437,841,967,BACKGROUND,COLORECTAL,CONCLUSION,CRC,GROUP,INTER,IPN,KAPPA,LABEL,MANN,METHODS,PATHOLOGY,PATIENT,PRIMARY,RESULTS,WHITNEY
160,DEEP,SMALL
181,200,800,BACKGROUND,HELA,INCUBATION,LABEL,LOW,MEFLOQUINE,MRC,NTS,RESULTS
BIOLOGICAL,DATA,FURTHER,KINDS,LABEL,METHODS,OBJECTIVE,RESULTS,SCIENCE,SOURCES,VARIOUS,WEB
1999,2013,DATA,IPF,LABEL,LUNG,MEDLINE,METHODS,OBJECTIVE,RADIOLOGIC,RESULTS,SELECTION,SOURCES,THESE
001,004,006,018,025,035,116,503,612,BACKGROUND,CONCLUSION,GCS,HIGH,LABEL,LRP,MDR,METHODS,NSCLC,RESULTS,THERE
001,029,045,100,112,160,8209,ACID,AFB,BACILLI,CK5,EBUS,EGFR,EIGHT,FAST,KRAS,SUBSEQUENT,TBNA,TTF
169,2014,ANTICANCER,BOTH,COPYRIGHT,FURTHER,INSTITUTE,JOHN,SINCE,STUDIES,SUBSEQUENT,WILMS,WT1
946,BCA,K63,LOSS,METASTATIC,SMAD,TAK1,TGF,UBC13
ADDITIONAL,BREAK,FISH,HOWEVER,NEXT,TP53,TP63
AREAS,BACKGROUND,COVERED,IGF,LABEL,METHODS,OPINION,SCLC,SMALL
106B,128,252,375,CHO,DRUG,EACH,GUO,HOWEVER,LARYNGEAL,LAST,LIANG,LUNG,NON,PROJECT,RNAS,THEIR,THEREFORE,THESE,THUS,WANG
100,169,2014,AMPK,ILK,MAPK,SEVERAL,TBK1,THESE,THUS,USING,WHILE
169,2014,AMONG,ASIAN,EGFR,TAKEN,THERE,THUS,TP53
118,169,2014,438,COPYRIGHT,DLS,DYNAMIC,EDX,ERYTHRINA,FOURIER,FTIR,GRAM,HIGH,NPS,SURFACE,TEM,TRANSFORM,ULTRA,VARIOUS,VIS,XRD
169,2014,CD8,GAL,INHIBITION,IRRADIATED,LABEL,LEWIS,LLC,LYMPHOCYTE,MATCHED,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,TDG
169,2014,203,8594,A750,AKT,AQA,CQC,EGF,EGFR,ERK,H1975,L858R,LABEL,MEK,METHODS,MUC1,NON,NSCLC,OBJECTIVE,PC9GR,PURPOSE,RESULTS,SIMILAR,T790M,TARGETING,THESE
169,2014,533,CONCLUSION,IVL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC,SCCS,SOX4,SUPERVISED,USING
169,2014,IMAGING,INC,MOLECULAR,NUCLEAR,RECEPTORS,SELECTIVE,SOCIETY
2011,8226,CTS,KEY,LUNG,NLST,RADIOLOGY,SCREENING,TRIAL
BACKGROUND,CAFS,FAP,FIBROBLAST,LABEL,METHODS,NONE,PARA,RESULTS,SIMILAR,SMA,TGF,TWIST
BACKGROUND,EXPRESSION,FGF,FGF18,FGF2,FGFR1,FGFS,FIBROBLAST,INHIBITION,LABEL,MAIN,MALIGNANT,METHODS,MOUSE,OBJECTIVE,OBJECTIVES,RATIONALE,REDUCED,RESULTS,SEVERAL
106,131,181,ANOTHER,BACKGROUND,CONCLUSION,CONTEXT,DISCUSSION,EVEN,INITIAL,LABEL,MALIGNANCY,MATERIALS,METHODS,PGL,RESULTS
FDG,INTENSE,PET
AGE,AIM,CONCLUSION,FIVE,LABEL,LNS,MEAN,METHODS,NINE,NONE,OBJECTIVE,PET,RESULTS,SIX,T1A,T2B,TNM
CONVERSELY,H1299,LAMP1,METHODS,THESE,THUS,USING
951,PACT,PDT,TRANSITION
026,2013,232,407,838,ASSESSMENT,BACKGROUND,DIAGNOSTIC,FDG,JUNE,LABEL,LIBRARY,METHODS,PET,QUALITY,RESULTANT,RESULTS,STUDIES
001,015,048,2002,2009,400,910,AGE,BACKGROUND,BOARD,COX,DUST,ECOG,EORTC,EPP,III,INDEX,LABEL,MEIER,METHODS,MPM,NLR,NSW,PROGNOSTIC,RESULTS,TREATMENT
198,A549,ALSO,BACKGROUND,CONCLUSION,DIFFERENT,DOX,LABEL,METHODS,NLC,RESULTS,SLN,THEIR
169,177,2014,MALIGNANT,PRESS,PUBLISHED,UNIVERSITY
169,2014,215,3109,414,6050,8764,8804,945,949,AAS,AFRICAN,AMERICANS,APOE,CRP,DESPITE,EAS,ESP,HNF1A,IL6R,NHLBI,PRESS,PUBLISHED,RORA,UNIVERSITY
15Q25,169,2014,215,3151,339,363,420,5P15,6P21,APOM,CANADIANS,MOST,PRESS,PUBLISHED,SNPS,UNIVERSITY
169,2014,APOPTOSIS,BCL,COUMARINS,HOWEVER,INHIBITION,JNK,JUN,MAPK,MOLECULAR,NUR77,PRESS,PUBLISHED,UNIVERSITY
0126,0322,206,CHI,CONCLUSION,COX,ELF2,ETS,LABEL,METHODS,NSCLC,OBJECTIVE,PBX2,RESULTS,UNIVARIATE,VCP
215,65294,969,A42,A64,A83,AUC,CONCLUSION,HOWEVER,LABEL,METHODS,NINE,OBJECTIVE,RESULTS
169,2014,8764,A549,ADP,AKT,CIP2A,COPYRIGHT,EGFR,H358,H441,H460,NSCLC,OKADAIC,PP2A,SOCIETY
8226,BELGIUM,DETECTION,DUTCH,KEY,LABEL,METHODS,NONE,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,THESE
169,2014,99A,AKT1,DOWN,FURTHER,INC,MICRORNAS,NSCLC,WILEY
104,124,1418,169,2008,2011,2014,228,394,445,479,AMONG,BACKGROUND,EACH,EBUS,FNA,LABEL,LNS,METHODS,NPV,NPVS,RESULTS,SOCIETY,STUDIES
398,A549,COX,LPS,NSCLC,THESE
AE1,AE3,CD15,CEA,GCDFP,HBME,MITOTIC,MOST,OTHER,TTF
1996,2012,BACKGROUND,CONCLUSION,FUNDING,JUTLAND,LABEL,METHODS,RESULTS,TIME,TRIAL,WOMEN
100,1286,1388,514,8764,CONTINUED,EARLY,LABEL,METHODS,OBJECTIVE,PCF,PURPOSE,RAMAN,RESULTS,SNR
111,543,553,563,586,588,601,CAD,CHAN,CONSORTIUM,DMEAN,FCM,FINALLY,GMM,IMAGE,JACCARD,LABEL,LBF,LUNG,METHODS,OBJECTIVE,OTSU,PURPOSE,RESULTS,SIX,THEREFORE,VESE
169,180,1992,2005,2014,639,8201,AGENT,BACKGROUND,COX,FURTHER,JANUARY,LABEL,METHODS,OVERALL,PRESS,PUBLISHED,RESULTS,TCDD,UNIVERSITY,VARIOUS,VIETNAM,WAR
DAD,MAMMALIAN
169,2014,COPYRIGHT,DATA,LTD,SABR
169,2014,231,946,COPYRIGHT,CSE,HMVEC,IMMUNOBLOT,INCUBATION,MDA,PAF,POTENTIAL,SIMILARLY,SOCIETY,TAKEN
120,2010,2012,AFTER,FIRST,NINE,SAA
169,2014,GSH,HMOX1,INDUCTION,INHIBITORS,LABEL,ROS,TSC,TSC2,UNLABELLED,USING
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
CDBT,CRAF,ERBB2,HSP90,NSCLC,THROUGH
169,2014,BACKGROUND,CENTRAL,CONTINUED,COPYRIGHT,DESPITE,ENGLISH,LABEL,LIBRARY,MEDLINE,METHODS,RESULTS,SMOKING,THERE
169,2015,COPD,COPYRIGHT,INTUBATION

109,1992,2002,BACKGROUND,CONCLUSION,CUTANEOUS,DATA,JANUARY,LABEL,LACTATE,METHODS,OBJECTIVE,RESULTS,SIXTY,SKIN
346,EGF,EGFR,ERLOTINIB,GEFITINIB,HOWEVER,NOMINALLY,THESE,UNREPORTED
946,AKT,H1299,NAD,NSCLC,OVERALL,SIRT1,THESE
AUTOPSY
GTPASES,HOWEVER,LUNG,MMP9,RAB,RAB37,RABS,TIMP1
BRAF1,CURRENTLY,DESPITE,EGF,EGFR,FGFR,MEK,PDGFR,PIK3A,SEVERAL,VEGFR
10YEARS,169,2014,BOHAN,CONCLUSION,COPYRIGHT,COX,DIAGNOSIS,LABEL,MEIER,METHODS,MORTALITY,OBJECTIVE,PETER,PROGNOSTIC,RESULTS
BACKGROUND,CHEST,JAPAN,LABEL,LEVEL,MEDICAL,MEDLINE,METHODS,MINDS,NETWORK,NSCLC,RESULTS,SERVICE,SURGERY,VATS
150,169,2014,266,300,COPYRIGHT,HOWEVER,KRAS,LTD,NSC,THROUGH
343,400,795,8226,893,AUC,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SPN,SPNS,USING,VDT
000,0001,005,014,015,023,024,034,046,058,076,080,100,184,269,573,8226,985,986,992,999,AGE,COX,DATA,FATAL,FEV1,FVC,KEY,LABEL,METHODS,NRI,OBJECTIVE,PULMONARY,RESULTS,SPIROMETRY,THESE
169,2014,231,233,COPYRIGHT,PUBLISHED,SAS,SFRO,SOCI,THEIR
APO2L,DERIVED,HPLC,HUVEC,IAP,IC50,IEC,ION,O53,SEC,SMAC,TRAIL,WHILE,XIAP
2008,2012,31MARCH,759,818,AUDIT,BMJ,CROSS,ENGLAND,ENGLISH,EPISODE,GROUP,LABEL,LIMITED,LUNG,MAIN,MEASURE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ODDS,OUTCOME,PUBLISHED,PUBLISHING,RESULTS,SETTING,STATISTICS
1111,169,BACKGROUND,BMJ,CD22,COPD,CST3,DIFFERENT,FEV,FVC,GROUP,HIGH,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEVERAL,SIGNALLING,SNP,SNPS
2012,CRPC,DESIGNING,FDA,HCC,HEPATOCYTE,MEDULLARY,MET,MTC,RCC,SCLC,THYROID,VEGF,XL184
ACAM,RAMAN,SERS,SINCE,THEREFORE
169,176,178,2010,2013,2014,239,8201,AIM,AUTHORS,CLAVIEN,CONCLUSION,CRS,DINDO,FIVE,FOUR,GYNECOLOGY,HIPEC,III,JAPAN,JOURNAL,LABEL,METHODS,OBJECTIVE,OBSTETRICS,OGCT,RESULTS,SOCIETY
ALTERATION,KLF4,MICRORNAS,RNAS,TAKEN,THUS
BACKGROUND,HOWEVER,LABEL,LRIG,LRIG1,LRIG2,LRIG3,METHODS,OPTIMAL,RESULTS,SEVERAL
009,017,021,025,032,038,046,048,120,BACKGROUND,CHI,COX,HOWEVER,LABEL,METHODS,NSCLC,PCR,REAL,RESULTS,THOP1,TIME,TNM,UNIVARIATE

946,CAV1,EMT,ERK1,HCC,MMP,THERE,WNT
12TH,176,8764,HOWEVER,IGF1,KRAS2,PNA,THUS
COLLEGE,EARLY,LUNG,NSCLC,PANEL,RADIOLOGY
182,CTCS,METASTASIS,MICRORNAS,NOTABLY,THESE
AFTER,EFFICIENT,GDP,GTP,LKB1,NRP,RAB7,TMR,TMRS
AIM,BACKGROUND,DATA,DISCUSSION,FOUR,III,LABEL,METHODS,MOMENTS,OBJECTIVE
BASED,BAYES,CART,HOWEVER,NIM
240,300,8201,BMP2,CALM1,CNAQ,CSF3,FIFTEEN,FINALLY,FIRST,GRIA2,III,IL3RA,IL6ST,LIFR,MYL9,MYLK,NSCLC,PCR,PLCB4,RAC3,ROCK2,THBS1,THESE,WESTERN
015,027,042,048,073,160,360,373,8201,AFTER,CHINESE,GENOMIC,HOWEVER,PARP,VAL762ALA
169,2014,AIM,COPD,COPYRIGHT,EBC,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2014,AKT,BIOLOGISTS,COMPANY,EMT,ERK1,HOWEVER,LTD,MEIER,NIR2,PI3K,PITPNM1,PUBLISHED,THESE
000,014,020,121,1220,169,2014,900,956,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,CSF,ENGLISH,HOWEVER,ICHUSHI,JAPAN,LABEL,LTD,MATERIALS,MEDICAL,MEDLINE,METASTASIS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,SOCIETY,WEB
169,2014,ALTOGETHER,COPYRIGHT,DELIVERING,FIRST,METABOLIC,PET,PUBLISHED,SAS
100,175,177,950,ANC,BSA,FURTHER,HNC,HOWEVER,IC50,ONC,PCA,PCR,REN,TAGUCHI,THESE,TPP
204,CHRONIC,LAST,SNP,SNPS,STUDIES
000,160,AFTER,ALONG,BACKGROUND,CONCLUSION,EMT,FINALLY,HER2,LABEL,METHODS,P2J,RESULTS,SNAIL,TUBO
001,003,169,195,1ST,2014,8805,945,BACKGROUND,CASES,COLORECTAL,GLEASON,III,INDIVIDUAL,LABEL,LUNG,METHODS,OR4TH,ORS,OVARIAN,RESULTS,RISK,SCREENING,TRIAL
102,125,177,2005,2008,HIGH,PTX,SCLC,SCLCS
1513,BACKGROUND,BASED,GLU496ALA,LABEL,NSCLC,P2X7,RESULTS,SNP,UNTIL
1652,169,177,2005,2009,2011,2012,2014,518,AUTHORS,BETWEEN,CONCLUSION,COPYRIGHT,EUROQOL,INTERVIEW,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,QALE,QALY,QOL,RESULTS,STATISTICS,VITAL
945,CCL5,HIF,IL6,JUN,LECS,LVS,STAT3,TNBC,VEGF
ALK,BACKGROUND,CASE,CELL,CONCLUSION,DESPITE,EML4,LABEL,LUNG,METHODS,NON,NSCLC,SMALL
169,2014,BAX,BCL,CHINESE,ERK1,GSTS,INC,JNK,KEAP1,NQO1,NRF2,PARP,PRO,PYDDT,ROS,SW620,TAKEN,THERE,WILEY
215,8201,A549,AFTER,GSH,MSA,NA2SEO3,REDUCED,THEREFORE,THESE
169,2014,DESPITE,EGFR,ERS,NSCLC,T790M,TKIS
169,2014,AUTHORS,COPYRIGHT,INC,MMP,MT1,PUBLISHED,TKS4,TKS5
160,169,2012,2013,2015,296,432,464,760,8805,COLLEGE,CONCLUSION,COPYRIGHT,GUIDELINES,INC,JANUARY,LABEL,LUNG,METHODS,NCCN,NETWORK,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SCREENING,SIMILAR,TRIAL
6FL,8209,945,LOSS,TARGETING,TEM,TEMS,THESE,TIE1,TIE2,TIE2CRE
169,1994,2012,2014,APRIL,BACKGROUND,BCOR,CCNB3,DATA,DIAGNOSIS,EWING,FIVE,INC,INDUCTION,LABEL,LOCAL,METHODS,MOST,PROCEDURE,RESULTS,SIXTEEN,WILEY
160,8209,COL6,TAKEN,TYPE
116,2YL,435,7404,BEL,DU145,ETHYL,H460,HCT,HOWEVER,LINN,MDA,MTT,SURGERY,ZCD
169,2014,A549,COPYRIGHT,DU145,HELA,LTD,MCF,PUBLISHED,UGI
160,181,8209,ANNEXIN,BAX,BCL,LA795,MTT
181,401,BASED,CD45,CTC,CTCS,GFP,HOWEVER,OBP,SEVEN,THEREFORE,WBCS
AUTOCRINE,CONCLUSION,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THESE,TYPE
160,169,2012,2014,235,238,500,BNCT,BORON,CANC,CAPTURE,CELLS,CONF,CONTROL,COPYRIGHT,INT,LTD,LUNG,NEUTRON,NON,NSCLC,PUBLISHED,SEMI,SINCE,SMALL,TCP,TCPS,THERAPY,TREATMENT
106,160,8209,945,946,BED2,ERGO,OBJECTIVE,OBRGT,RECURRENCE,SEVEN,SRS,VMAT
0001,100,169,2014,COL11A1,COPYRIGHT,CORE,DCIS,FORTY,GMBH,P63,VARIOUS
160,8209,A549,BAX,BCL,CELL,FLOW,FOLLOWING,MYD88,THESE,THUS,WST
169,2014,945,CD3,CD4,CD8,COPYRIGHT,ORAL,TNF,WATER,WSC
EGFR,HOWEVER,MOST
001,142,8209,BECLIN1,LIVER,LKB1,NSCLC,PCR,REDUCED,TNM,UNIVARIATE
4T1,954,AMONGST,GIVEN,HIRSUTINE,MMP,NUCLEAR
001,160,169,2003,2012,2014,AMONG,BACKGROUND,BUNDANG,COPYRIGHT,HOWEVER,IDIOPATHIC,IPF,LABEL,LTD,MATCHED,METHODS,RESULTS,SEOUL,SEVENTY,UNIVERSITY
143,8209,946,A549,ALTERED,CD44,NSCLC,PCR,RAS,SMAD3,TGF
000,100,106,110,1986,1990,1996,2006,2010,8201,AGE,ALGERIA,APC,APCS,ARAB,ASR,BACKGROUND,BETWEEN,INCIDENCE,INSTITUTE,LABEL,METHODS,RESULTS,SETIF,STATISTICS
087,169,1738,2014,250,50MG,ASPIRIN,AUSTRALIA,BECAUSE,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,MATERIALS,METHODS,NON,NSAID,OBJECTIVE,OBJECTIVES,RESULTS,WESTERN,WITTENOOM
169,2014,AIM,COPYRIGHT,DATA,FDG,FINALLY,IRELAND,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PET,RESULTS,TETS,WMD
MALIGNANT,MPM,THERE
0015,150,154,169,183,2011,2012,2014,BACKGROUND,BETWEEN,COPYRIGHT,EASTERN,EGFR,ERLOTINIB,FEB,FUNDING,FURTHER,GROUP,IIIB,JAPAN,LABEL,LTD,MARCH,METHODS,NSCLC,RESULTS,SERIOUS
131,142,169,183,2009,2011,2014,AVERAGE,BACKGROUND,CHECKLIST,CHIEF,CONTROLLED,COPYRIGHT,CURRENT,DEPRESSION,FUNDING,GOVERNMENT,JAN,LABEL,LTD,MANAGEMENT,METHODS,RESULTS,SCALE,SCIENTIST,SCL,SELF,SEPT,SMART,SYMPTOM,TRIAL,USUAL
160,BACKGROUND,C30,CONCLUSION,CONCURRENT,CTC,EORTC,IMRT,LABEL,LOCO,METHODS,N35,OG25,QLQ,QLQS,RESULTS,SEVEN
169,2007,2012,2013,2014,ABDOMINAL,APRIL,BACKGROUND,CCSK,CLEAR,CONCLUSION,EGYPT,III,INC,JULY,LABEL,MARCH,MEAN,METHODS,OVERALL,PROCEDURE,RESULTS,SURGERY,USA,WILEY
100,106,169,2013,2014,2GY,945,946,ACUTE,AIMS,BED,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RECURRENCE,RESULTS,ROYAL,SRS,VMAT
CK7,CLCA2,CTC,CTCS,CURRENTLY,DETECTION,HMMR,HOWEVER,PCR,THEN,THESE
160,8209,946,954,BLM,HOWEVER,LPA,SIMILARLY,TGF
169,2014,COPYRIGHT,NSCLC,PROTEOMICS
160,2002,2008,300,318,8805,ADVERSE,BACKGROUND,BETWEEN,CONCLUSION,CONCURRENT,CRT,CTCAE,III,LABEL,MAIN,METHODS,NSCLC,OVERALL,PFS,RESULTS,STAGE,THERE,TREATMENT
169,2015,AFTER,BACKGROUND,BOARD,CONCLUSION,COPYRIGHT,ELBOW,INC,JOURNAL,LABEL,METHODS,MSTS,PUBLISHED,RESULTS,SOCIETY,SURGERY
700,SMOKING
169,2014,CONCLUSION,EMT,HOWEVER,JOHN,LABEL,LTD,MATERIALS,METADHERIN,METHODS,MIGRATION,MTDH,OBJECTIVE,OBJECTIVES,RESULTS,SONS,SOSP,TAKEN,U2OS,WILEY
004,169,2014,769,8201,939,INC,MTS,THESE,WILEY
169,2014,CD97,CTF,FEBS,GPS,NTF
100,169,2014,8805,956,BASED,COPYRIGHT,DATA,FURTHER,INHALATION,IRELAND,LTD,MOA,MOAS,ONCE,SUBSEQUENT,THERE,THESE
KRAS
CDC42,CIP4,EGF,EGFR,ERK,H1299,MMP,NSCLC,ZEB1
181,ARSENIC,ATO,BAK,BAX,BCL,BID,CELL,DRUG,E2F1,FOOD,H23,H358,JUN,LUNG,PARP,TREATMENT,USING
SPLENIC
169,2003,2012,2014,AKT1,APC,BACKGROUND,BRAF,COPYRIGHT,EGFR,FGFR1,FGFR2,FURTHER,HER2,IRELAND,KRAS,LABEL,LTD,MEK1,MET,METHODS,MPM,NRAS,PTEN,RESULTS,TP53,VHL
181,8209,8805,DRP1,HOWEVER,LIVE,MDIVI,RED,THEREFORE,TRAIL
169,2014,AFTER,CONSORTIUM,COPYRIGHT,FIRST,IDRI,IMAGE,INITIATIVE,LIDC,LTD,LUNG
006,100,169,1998,1999,2004,2006,2014,216,ACSS1,AFFILIATED,AGA,AGS,AIMS,AKT2,BACKGROUND,BARR,CCNA1,CHINA,CHINESE,COPYRIGHT,EBV,EPSTEIN,FAM3B,FIRST,GUANGZHOU,HONG,IHH,INC,INSTITUTE,INTEGRATED,KONG,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SUN,TEN,THESE,TRAB,TRABD,UNIVERSITY,WALES,WHOLE,YAT
BJE,COLORECTAL,CRC,INSTEAD,LOW,MAPKS
143,ABL,ACCORDING,ADSCC,ASP,BRAF,CNS,DDR,DDR2,DISCOIDIN,EGFR,FLA,G12C,HER2,KRAS,NSCLC,PCR,S768R,SRC
169,2014,945,946,947,A549,COPYRIGHT,INHIBITING,JNK,JUN,NAG,SPAK,STE20,THESE
103,8805,BACKGROUND,BSA,EGFR,EXON,L858R,LABEL,METHODS,MST,NSCLC,PFS,RESULTS,THERE
169,2014,CD25,CD3,CD4,COPYRIGHT,INC,PNS,SCLC,THESE,TREG
ALK,CONSISTENT,CRIZOTINIB,IGF,IRS,SIMILAR,TKI
001,073,169,2004,2014,217,4171,COMMITTEE,CONTROL,COPYRIGHT,IIIA,INC,IPLCC,JOINT,LABEL,LUNG,METHODS,OBJECTIVE,PLC,PLEURAL,PROGNOSES,PUBLISHED,RESULTS,SURGERY,T2A,THESE,TNM,UNION
100,443,BACKGROUND,CHINESE,ENGLISH,HCC,LABEL,METHODS,RESULTS,THERE
0001,169,2014,239,272,468,506,511,527,995,AUC,BACKGROUND,CBMN,EXCELLENT,EXTENSION,GENERAL,HOUSTON,LABEL,METHODS,NPB,RESULTS,SPITZ,THERE
169,2014,945,A549,ARES,CONVERSELY,COPYRIGHT,ECH,INC,KEAP1,KELCH,KNOCK,NEH7,NRF2,P45,RXR
169,177,2014,231,956,A549,ALDER,CH3CN,COPYRIGHT,DIELS,EDDA,FURTHER,HELA,IC50,LTD,MCF,MDA
169,185,2014,A549,CCL,COPYRIGHT,DU145,HELA,HTB,LTD,MCF7
1128,115,165,169,197,2014,238,2920,509,9406,COPYRIGHT,EPCAM,FORTY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,VATS
1233,124,169,2007,2011,2014,418,BASE,COPYRIGHT,DATA,HOSPITALS,INC,LABEL,MAJOR,METHODS,MORTALITY,OBJECTIVE,OTHER,PUBLISHED,RESULTS,SIMILAR,SURGERY,THERE
169,2014,60GY,ALSO,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,NSCLC,PARTIAL,RESULTS,TOXICITIES,TRT
003,169,2014,266,946,CHANGES,CONCLUSION,COPYRIGHT,FURTHER,IIIA,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,UNIVARIATE
CDC,CONCLUSION,END,HISPANICS,HISTOLOGIC,INSTITUTE,IRELAND,LABEL,LTD,MATERIALS,METHODS,NPCR,OBJECTIVE,PROGRAM,PUBLISHED,RATE,REGISTRIES,RESULTS,SEER,TREND,USA
1235,169,2014,247,BACKGROUND,CRI,DEVON,LABEL,METHODS,MOST,PRESS,PUBLISHED,RESULTS,SLT,SYMPTOM,UNIVERSITY
SH2,SIMILAR,SOCS,SOCS6,THEREFORE
CHINA,RESULTS
135,169,2014,454,610,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,FLX,IGE,IGG,IGH,IGHV1,IGHV5,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
169,2013,29A,CEACAM6,COPYRIGHT,FEDERATION,PUBLISHED,SOCIETIES,THEREFORE
169,1735T,2014,594,605C,AIM,ALSO,BASEL,CONCLUSION,HOWEVER,IIIA,IIIB,LABEL,METHODS,NON,NSCLC,OBJECTIVE,RESULTS

122,169,2014,5NGL,COPYRIGHT,MEANWHILE,UNDER
171,AFTER,BACKGROUND,GCMS,LABEL,MARKERS,METHODS,OBJECTIVE,PNMD,PRINCIPAL,RESULTS,ROC,SPME,THEIR,THROUGH,VOCS
100,BACKGROUND,CTA,CTAS,GAGE1,LABEL,METHODS,OBJECTIVE,RESULTS,TAAS
0005,001,002,011,035,054,076,100,134,161,177,180,186,215,257,356,483,694,8201,880,AFTER,COMMITTEE,PET,PNS,RIS,RIX,SUV,SUV1,SUV2,THERE
169,2014,COPYRIGHT,CTC,CTCS,INC,THUS,USING
169,2014,COPYRIGHT,DPYD,EMT,FACS,INC,MMS,THUS
169,2014,INC,THESE,WILEY
003,055,063,064,177,215,427,727,CISPLATIN,GROUP,HENCE,HOWEVER,SEM,THESE,THUS
AMONG,BCL6,FOXM1,SRC,TP53
130,135,177,2009,2012,2229,263,8804,BACKGROUND,CONCLUSION,DUE,JULY,LABEL,METHODS,RAI,RESULTS,THREE
2011,956,BACKGROUND,EBUS,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TBNA
ASSESSMENT,BACKGROUND,BOTH,CHARTIS,HOWEVER,HRCT,ILF,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
001,226,492,AFFAIRS,AUC,BACKGROUND,BEST,BRIER,CONCLUSION,EVALUATION,LABEL,MAYO,METHODS,RESULTS,TREAT,TREATMENT,VANDERBILT,VETERAN
016,108,BACKGROUND,BIOLOGICAL,CAIX,CONCLUSION,DFS,FDG,GLUT1,HIGH,IIIA,LABEL,MCT1,MCT4,METABOLIC,METHODS,NSCLC,PET,RELEVANCE,RESULTS,THESE,TLG
SURGERY
BACKGROUND,BDI,BECK,CONCLUSION,DATA,DEPRESSION,INVENTORY,LABEL,METHODS,NON,NSCLC,RESULTS,SES,TREATMENT
0059,0392,0429,200,2GENE,BACKGROUND,CONCLUSION,FGFR,LABEL,METHODS,NSCLC,PFS,RESULTS,SNP,THERAPY,THESE
001,003,009,179,BACKGROUND,COX,DFS,G12C,KRAS,LABEL,METHODS,RESULTS,USING
ALK,BACKGROUND,DIAGNOSTIC,EQA,FISH,ITALIAN,LABEL,MEDICAL,METHODS,NSCLC,OVERALL,PATHOLOGY,RESULTS,SEVERAL,SOCIETY,TEST
002,005,007,548,945,946,BACKGROUND,BIOMARKERS,COLORECTAL,LABEL,LUNG,METHODS,OVARIAN,PRESENTLY,RESULTS,THESE
ALK,BACKGROUND,CONCLUSION,FIFTY,IHC,ISH,LABEL,METHODS,NSCLC,REMARKABLY,RESULTS
169,176,2014,A549,COPYRIGHT,INC,NIPAM,TAT,WHILE
001,006,BOTH,IMRT,LABEL,LIMITED,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS
169,2014,ABC,ALK,AP26113,BALB,BECAUSE,CELLS,EML4,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,THEREFORE,UNIVERSITY
169,2014,2285,AACR,BIOMARKERS,EPIDEMIOL,HE4,PREV,YET
A501,FLOW,MTT,NSCLC,WESTERN
2013,ADMS,BEGG,CHINA,CIS,CNKI,CONFERENCE,CPCI,EGGER,FIXED,HIGGINS,INDEX,KNOWLEDGE,LABEL,MATERIALS,META,METHODS,OBJECTIVE,OBJECTIVES,ORS,RESULTS,SCIENCE,SEVERAL,SUS,THERE,TZDS,WEB
0244,100,BACKGROUND,DETECTION,DIFFUSION,DWI,EACH,LABEL,METHODS,MRI,PET,RESULTS,WHILE
001,002,017,021,2005,2010,541,578,626,745,751,772,781,815,BACKGROUND,CHINA,ECOG,JULY,LABEL,MATERIALS,METHODS,NSCLC,ORR,PD2,PFS,PULMONARY,RESULTS,SEPTEMBER
00001,004,1946,2014,921,BACKGROUND,CD44,CIS,HRS,JANUARY,LABEL,MATERIALS,MEDLINE,METHODS,NSCLC,OVERALL,RESULTS,STATA,THEREFORE,THUS
A549,AIMS,APOPTOSIS,ASSAY,BACKGROUND,FLOW,HDAC,HDACI,KLF,KRUPPEL,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,PCR,RESULTS,SKOV,SKOV3,TAKEN,TSA,VYBRANT
169,221,AGER,ALTOGETHER,AMONG,EMP2,FASEB,LAMP3,NAPSA,NKX2,NSCLC,SFTPB,SFTPC,SFTPD,SLC34A2,TRANSCRIPT
946,947,CH27,EGFR,EMT,H460,JW67,MET,NSCLC,PPAR,SIGNALING,TGF,THESE,U373
169,175,2014,8GY,AMONG,COPYRIGHT,CRT,DVHS,IMRT,INC,MEDICAL,OARS,OVERALL,PUBLISHED,REGARDING,SIMILARLY,THESE
169,2014,COPYRIGHT,COX,FLS,IRELAND,LTD,THUS,TXA2
8201,HMGB1,MMP,MTT,PCR,RESULTS,TAKEN,THEN,WESTERN
4DCT,CONCLUSION,CTV,FTV,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PACS,RESULTS,THESE,TPS,TREATMENT
8764,956,MOST,SVFS,WHILE
027,043,100,169,2014,ACTA,AUC,BACKGROUND,CONCLUSION,FIVE,FOUNDATION,GENERAL,LABEL,LCD,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,T1A,T1AN0M0,THERE
030,100,150,177,2012,2013,JANUARY,JULY,LABEL,MAY,METHODS,OBJECTIVE,PAIN,POD,RESULTS,THERE,THREE,VAS
212,369,CD9,CD91,ELISA,EXOSOME,HOWEVER
001,169,1999,2009,2015,502,710,BACKGROUND,BETWEEN,COPYRIGHT,INC,INCREASING,INDEX,INPATIENT,LABEL,MCS,METHODS,NATIONWIDE,ODDS,RESULTS
105,106,123,147,160,169,2007,2011,2014,205,209,257,525,865,8804,982,AGE,BACKGROUND,COPYRIGHT,HOWEVER,INC,JANUARY,LABEL,MAJOR,METHODS,RESULTS,RISK,UNIVARIATE,VATS,VIDEO
100,BACKGROUND,CASES,DIAGNOSIS,DIFFERENT,LABEL,METHODS
001,177,412,635,AFTER,BACKGROUND,DLCO,FEV1,LABEL,LAM,METHODS,RESULTS,SIROLIMUS,THERAPY
8805,DESPITE,HOWEVER,LEWIS,THESE
001,052,158,181,186,260,AMONG,BACKGROUND,DESPITE,DIAGNOSIS,IPF,LABEL,LUNG,METHODS,PREVALENCE,RESULTS
7721,946,A549,BALL,COMPOUNDS,HELA,HOWEVER,HUANG,MURRAYA,NMR,SMMC,THESE
171,217,247,CHIHUAHUA,CITY,IDW,INVERSE,KRIGING,MORAN,THROUGH,WEIGHTING
136,169,2014,AKT,BRAF,DDFS,IIIB,IIIC,LABEL,LOSS,MBM,METHODS,NRAS,OBJECTIVE,PI3K,PTEN,PURPOSE,RESULTS,V600
169,2014,BACKGROUND,LABEL,MATERIALS,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THUS,UNIVERSITY
002,003,004,169,2014,215,8805,930,AUTHORS,BACKGROUND,BLACKWELL,COHORTE,ELY,FENLAND,FRAMINGHAM,HEART,INC,LABEL,LIFE,LOSMAPIMOD,METABOLIC,METHODS,OBESITY,OVERALL,POPULATION,PUBLISHED,RESULTS,RS2859144,WILEY
124,169,2014,ACCRUAL,ASIAN,BACKGROUND,BRCA1,BREC,CAUCASIAN,CHINA,CHINESE,CONCLUSION,GECP,GROUP,HOWEVER,III,IIIB,LABEL,LUNG,MEDICAL,METHODS,NSCLC,PFS,PRESS,PUBLISHED,RAP80,RESULTS,SLCG,SOCIETY,SPANISH,TRC,TRIAL,UNIVERSITY
169,2014,BECAUSE,COPYRIGHT,HOWEVER,III,JOHN,LTD,ROC,SELECTION,SONS,USING,WILEY
001,1354,169,2014,579,775,BACKGROUND,COPYRIGHT,LABEL,LTD,METHODS,OVERALL,RESULTS
2006,2011,8805,929,AFRICAN,BMJ,CROSS,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PERSONNEL,PUBLISHED,PUBLISHING,RESULTS,SETTING,SURVEYS,USING
PFAA,PFAAS,TFAAS,THUS,VARIATION
169,1996,2004,2014,AMONG,BACKGROUND,BRAZILIAN,DISCUSSION,HODGKIN,INC,LABEL,METHODS,MOR,MORS,RESULTS,WILEY
169,2014,946,CATENIN,EGFR,HOWEVER,L858R,T790M,THESE,TKI,TKIS
169,2014,BCSC,BCSCS,MICA,MICB,NKG2D,PRIMARY
112,8805,ACTUARIAL,BACKGROUND,GTV,LABEL,METHODS,PFS,PRIMARY,RESULTS,SABR,SECONDARY,UNIVARIATE
169,2014,8201,AKT,BENZO,HOWEVER,IGF,INC,INSULIN,LUNG,MAPK,PPP,TREATMENT,WILEY
00073,169,2000,2009,2014,8201,BACKGROUND,COX,EFS,EWING,FACTORS,HOWEVER,INC,LABEL,MEIER,METHODS,OVERALL,PROCEDURES,RESULTS,SUCCESSFUL,THERE,TREATMENT,VALIDATION,WILEY
144,154,174,2008,2013,364,394,538,8804,8805,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,SEPTEMBER,SIMILARLY,TTFNA
169,2014,HEMATOLOGY,JMML,MDS,MPN,RAS,SOCIETY,TREMENDOUS,WORLD
169,2014,946,A549,COPYRIGHT,FINALLY,SERUM,SOCIETY,SRC,TGF,THESE,WHILE
064,110,131,160,177,187,2008,282,283,287,327,387,405,408,462,529,586,663,673,697,722,8201,824,917,977,998,BACKGROUND,DIFFERENT,HODGKIN,LABEL,METHODS,RDS,RESULTS,RHEUMATIC,SIR,SIRS,SLE,SSC,THUS
AFTER,HISTOLOGIC,PULMONARY
116,181,183,295,435,FIVE,H358M,HCT,IC50,MDAMB,NCI,OVCAR,PBMC,PC3
2013,6942,BACKGROUND,DVT,LABEL,LMWH,META,METHODS,OCTOBER,PRIMARY,RCTS,RESULTS,SECONDARY,THERE,VTE
3337,8202,BACKGROUND,CONCLUSION,DFS,EGFR,LABEL,LIBRARY,METHODS,NSCLC,RESULTS,STUDIES,THERE
001,ASB,BACKGROUND,CONCLUSION,DETECTION,EOTAXIN,IFN,LABEL,LUMINEX,MALIGNANT,MANN,MCP,METHODS,MULTIPLEX,NGF,NOTABLY,PANEL,PCR,RESULTS,SV40,TAG,TECHNOLOGY,TNF,WHITNEY
001,028,030,033,034,037,040,044,048,102,8202,945,AKT,BACKGROUND,CD34,H1975,HIF,LABEL,MES,METHODS,MVD,NSCLC,PCR,PI3K,RBP2,RESULTS,THESE,VEGF
7721,956,AMONG,H1299,IC50,MCF,SMMC,THEIR,THESE
NETS,SEVERAL
947,MAP,MDP3,THESE
1000,169,2014,ATLAS,AUC,BACKGROUND,CALLING,CONSORTIUM,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,ROC,TCGA,UNIVERSITY,USING,VARIANT,VCF
169,2014,982,AREA,AUC,BACKGROUND,COLLECTED,CURVE,HOWEVER,LABEL,LUAD,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THEREFORE,UNDER,UNIVERSITY,WEB
160,177,FALSE,FINAL,FORTY,LABEL,MEAN,METHODS,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,STUDENT,SUV
169,1997,2005,2010,2014,APC,AUSTRALIAN,COPYRIGHT,DATA,INC,JOINPOINT,LABEL,MATERIALS,METHODS,NCP,NORWEGIAN,OBJECTIVE,PLAN,PURPOSE,RADIATION,RESULTS,RUR,RUR1Y,RUR5Y,RURS,TCI,TCIS
169,176,177,2014,270,BEV,CARLO,CEPR,COPYRIGHT,DICE,GTV,IGPT,INC,LABEL,MATERIALS,METHODS,MICHELSON,MONTE,OBJECTIVE,PURPOSE,RESULTS,SIX
103,116,208,213,222,876,DON,FURTHER,GIRLS,HEARD,JAPAN,LABEL,METHODS,NEVER,OBJECTIVE,RESULTS,UNDERSTAND
100
0001,126,169,2014,458,8201,8804,8805,DEEP,NSCLC,PCR,RNAS,SIX,STAGE,UICC
169,2014,AFTER,ASSOCIATES,BPF,BRONCHO,COPYRIGHT,LTD,NSCLC,PUBLISHED
2008,4040,AGE,BACKGROUND,BASED,BIVARIATE,KOREA,KOREANS,LABEL,METHODS,ODDS,RATIO,RESULTS,THOSE
000,169,2014,252,946,AMH,BECKMAN,COLORECTAL,COULTER,CURRENT,DESPITE,DIFFERENT,ELISA,GEN,LUNG,MEANWHILE,ORQ4,ORS,OVARIAN,PLCO,PSA,SCREENING,TGF,THUS,TRIAL
13R,169,2014,945,CD8,COPYRIGHT,HIV,LTD,PUBLISHED,TH1,TH2
001,004,613,8201,AVERAGE,BED10,CONCLUSION,DOSES,III,LABEL,LOCAL,MATERIALS,MEIER,METHODS,MORTALITY,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SBRT,STAGING,UICC
169,2014,ATX,AUTOTAXIN,ENPP2,GPCR,HOWEVER,LABEL,LPA,LPA1,LPA2,LPA5,RNAI,THESE,UNLABELLED
CONTINUOUS,FINALLY,HOWEVER,INITIAL,LUNG
168,AFTER,CALIFORNIA,FCS,GMM,IL1R2,KNOWLEDGE,LABEL,MAIN,METHODS,NFKB2,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SETTING,SNPS,VARIABLES
ENGLISH,FOUR,GENERAL,IIIB,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PETER,PURPOSE,RESULTS,SETTING
ACTIVATION,GAPS,LABEL,MYONUCLEAR,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
BENEFIT,CEA,EBC,LOVE,NSE,RESULTS,SCC,THESE
A549,COA,HMG,HOWEVER,MDA,MTT,ROS,SOD,SOD2,THESE,TREATMENT
107,2002,2012,ACC,FOUR,III,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
108,116,8804,CRC,DATA,EGFR,EXCLUDING,HOWEVER,KRAS,LUNG,NSCLC,THESE
008,149,945,CIS,COLORECTAL,CONCLUSION,CRP,INC,INCREASED,LABEL,LIMITED,LUNG,METHODS,OBJECTIVE,ODDS,ORS,OVARIAN,PRE,PRO,PUBLISHED,RESULTS,SCREENING,THESE,TNF,TRIAL
AFTER,AH2,DBCO,IDEPT,PCA,PEG4,PSMA,TG97,THEREFORE
107
105,170,75TH,BACKGROUND,EVALUATION,HOWEVER,LABEL,LUNG,METHODS,RESULTS,SITES,SOLID,SYSTEMATIC
023,101,1998,2001,2006,2007,720,BACKGROUND,ECOG,IIIB,LABEL,METHODS,NOS,RESULTS,STAGE
001,492,ALK,ASIAN,BACKGROUND,CD74,DUE,EAST,EGFR,EML4,KRAS,LABEL,METHODS,MULTIPLEX,RESULTS,ROS1,THEIR,THERE,THESE
BACKGROUND,CONCLUSION,CPFE,GERM,LABEL,LUNG,METHODS,ORPHELINES,OVERALL,RECHERCHE,RESULTS,VIRTUALLY
125,178,182,200,2007,2008,2012,2829,2836,8226,AMONG,ARM,ARMS,BACKGROUND,CLIN,ENROLLMENT,IIIB,JULY,LABEL,METHODS,MOTESANIB,NSCLC,ONCOL,RESULTS,SCAGLIOTTI,THREE,TREATMENT
239,500,BACKGROUND,CONCLUSION,EASTERN,FIFTY,GROUP,HOWEVER,IIIB,KDR,LABEL,METHODS,PFS,PFS6,PRIMARY,QOL,QUALITY,RESULTS,THERE,THREE,TREATMENT,VEGFA
132,2004,2010,213,243,663,BACKGROUND,BECAUSE,COMMITTEE,IIA,IIB,IIIA,JOINT,LABEL,LUNG,METHODS,RESULTS,SCLC
2004,2010,269,702,BACKGROUND,BAL,CONCLUSION,DIAGNOSTIC,EGFR,FAILURE,FURTHER,GENERAL,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,TBNA,TTNA
001,002,104,18F,AREA,AUC,BACKGROUND,CD45,CONCLUSION,CTC,CTCS,CTM,CURVE,DAPI,FDG,FIRST,HOWEVER,LABEL,METHODS,NSCLC,PET,RESULTS
ADP,ANTITUMOR,BACKGROUND,CD46,CELLS,EDMONSTON,LABEL,METHODS,NSCLC,ONCOLYTIC,RESULTS,THEREFORE,THESE
954,BACKGROUND,CONTINUAL,CSE,GRP78,HEAVY,HOWEVER,LABEL,METHODS,PI3K,RESULTS
0001,004,016,151,1988,2009,3529,628,BACKGROUND,COX,LABEL,METHODS,NSCLC,RESULTS,SEER,WOMEN
CATALDO,CLCSS,LUNG,RESULTS,SCALE
141,169,2014,204,COPYRIGHT,MIR,NSCLC,PUBLISHED,SIX1,THUS
169,2014,AMERICA,AMONG,NORTH,PRESS,PUBLISHED,SCATTERED,SIMILAR,THEREFORE,UNIVERSITY
946,ALONG,BOTH,EMT,EPITHELIAL,FINALLY,FOS,FRA,NSCLC,PBX,PBX1,PRE,PREP1,PREVIOUSLY,SMAD3,TGF,THESE
946,ATP,EMT,MECHANISMS,SURPRISAL,TGF,USING
169,2014,BCL,BEAS,BIOLOGY,CADMIUM,GFP,INC,LC3,MOLECULAR,NRF2,ROS,SOCIETY,SOD,SOD1,SOD2,TAKEN,THESE
001,169,2014,ADVERSE,COPYRIGHT,ESTIMATED,GRADE,INC,INSTITUTE,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SECONDARY,SIR,THERE,VERSION
100,956,EGFR,EPIDERMAL,EXONS,FIFTY,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
169,2014,7082,8201,8594,945,954,BAY,DVL,INC,NSCLC,PAX2,SP1,THESE,TREATMENT,WILEY
0001,0236,123,1426,1445,169,2000,2013,2014,3779,4431,4554,5335,7239,AMONG,BASED,BETWEEN,COX,III,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
008,1634,1678,169,2014,307A,8201,922,APE1,APEX1,ASP148GLU,CHINESE,INC,PAH,PAHS,POLYCYCLIC,SNP,WILEY
160,177,AMONG,CD24,CD44,HOWEVER,JIKEI,METASTATIC,OMBC,PFS,PULMONARY,UNIVERSITY
160,231,ATP,BACKGROUND,CONCLUSION,ECS,HOWEVER,ICAM,LABEL,MCF,MDA,METHODS,MMP,P2Y2,P2Y2R,RESULTS,THEN,UTP,VCAM,VEGF
1A1,1B1,1B10,1C1,1C2,1C3,26S,A549,AKR1B10,AKRS,CCAAT,CDDP,LOVO,MONITORING,NONOATE,PC3,ROS,TREATMENT
127,145,150,169,2006,2009,2014,AMONG,ASIA,BASED,CBM,CCTS,CHINA,CHINESE,CNKI,COMMISSION,DATA,HELICAL,HTAS,LABEL,LIBRARY,LTD,METHODS,OBJECTIVE,OBJECTIVES,PTY,PUBLISHING,RESULTS,SICHUAN,UNIVERSITY,VIP,WANFANG,WEST,WILEY
100,169,183,2014,549,956,CELL,CHINA,COLON,COPYRIGHT,DPPH,FECR,HCT,HELA,LC50,LUNG,PROSTRATE,PUBLISHED,SRB,THP,UNIVERSITY,WMI
169,2014,476,8201,ADJUSTING,CIS,COLORECTAL,DBP,LUNG,NEITHER,ORS,OVARIAN,SCREENING,TRIAL,UICC
0839,DESPITE,DOSE,III,LOCAL,NETWORK,NSCLC,RTOG,SBRT
000,100,169,2000,2004,2008,2010,2014,AGE,APC,AUTHORS,BACKGROUND,BRAIN,CENTRAL,CNST,HODGKIN,INC,LABEL,METHODS,RESULTS,SOCIETY,STATISTICS,TIME,WILEY
BACKGROUND,CASE,CONCLUSION,FIRST,LABEL,LITERATURE,MANAGEMENT,METHODS
169,2014,945,CASTRATION,COPYRIGHT,CRPC,CURRENT,FGF,FGF23,FGFR,FGFR1,FGFRI,LTD,TIO,WHILE
169,2014,METASTASIS,NIR,THEREFORE,UICC,WHILE
004,008,131,160,2014,8804,BACKGROUND,CD31,COMPARISON,CONCLUSION,HOWEVER,KUNZ,LABEL,LOW,MEIER,METHODS,MOST,MVD,NOVEL,PLOS,RESULTS
100,120,159,160,177,2124,2882,99M,EIGHT,GALLIUM,LABEL,METHODS,MSA,OBJECTIVE,PET,PURPOSE,RESULTS
001,005,010,016,022,043,089,112,114,130,136,184,185,2004,2013,215,228,270,273,335,366,514,571,574,688,726,738,820,833,879,8805,890,936,957,968,999,ALT,AMONG,CERTAIN,CHINESE,IIIB,JANUARY,JULY,LABEL,METHODS,NSCLC,OBJECTIVE,POOR,PURPOSE,RESULTS,THERE,VTE
0001,107,169,2004,2014,770,8201,989,ASCO,DATA,DESPITE,MEETING,NSCLC,PFS,PHASE,SOCIETY,THESE
08052,169,2014,523,BACKGROUND,CONCLUSION,COPYRIGHT,EORTC,EVALUATION,GROUP,INDIVIDUAL,LABEL,LCG,LTD,LUNG,METHODS,MPM,PFSR,RESULTS,SOLID,TREATMENT,TUMOURS,WORLD
107,115,2004,2013,AIP,DATA,IGG4,LABEL,MALIGNANCY,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,ORGAN,RESULTS,TYPE
0CM,15CM,169,177,2015,215,35CM,50CM,5CM,8CM,COPYRIGHT,DATA,FIELD,GROUP,INC,ITV,MEDICAL,PTV,PTVS,PUBLISHED,RADIATION,SBRT,THERAPY
005,118,169,2014,8804,BACKGROUND,KRAS,LABEL,MEIER,METHODS,MUT,RESULTS,RFS,SOCIETY
007,016,160,309,310,5P15,8201,967,CHINESE,CLEFT,CLPTM1L,HAN,SNP,SNPS
1498,15MG,169,2014,2578,303,405,460,5MG,634,936,ABIGAIL,BOR,COPYRIGHT,FOUR,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SNPS,THESE,THREE,UNASSIGNED,VEGF,VEGFR
169,2014,CHRONIC,COPYRIGHT,HOWEVER,LESIONS,PUBLISHED,SAS
160,2006,2011,3DCRT,BACKGROUND,CONCURRENT,D95,III,IMRT,INTENSITY,LABEL,LRF,LRFS,METHODS,MODULATED,NSCLC,PET,RESULTS,SEVENTY,SIXTY,THERE
2005,2006,346,CONCLUSION,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PRIMARY,RESULTS
0022,146A,CHINESE,NSCLC,PCR,RFLP,SNP

EXPAR,RAMAN,SERS
160,315,391,542,891,CAUCASIANS,F31I,HENCE,OVERALL,STK15,V57I
169,2014,COPYRIGHT,DOSE,DTT,GTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPHERICAL,T2A
AMONG,RECURRENT,SIADH,THEREFORE,TYPICALLY
001,002,014,180,2004,2012,237,240,251,425,720,ACADEMY,CHINESE,INSTITUTE,MEDICAL,PBCT,TNBC
DMAG,HOWEVER,HSP90,LUNG,NSCLC
193,CONCURRENT,COX,FORM,GVHD,HCP,KARNOFSKY,KPS,LACK,LEE,LFS,NIH,PATIENT,PCS,SF36,SKIN,THESE
2014,COPYRIGHT,DECISIONDX,HOWEVER,SLACK
126,169,2014,217,300,600,900,947,ALECTINIB,ALK,AUC0,BACKGROUND,CNS,COPYRIGHT,DOSE,EVALUATION,FUNDING,HOWEVER,IQR,LABEL,LTD,METHODS,MRI,NSCLC,RESULTS,ROCHE,SOLID,THREE
A549,ABOUT,ATTENUATED,CSCS,DECREASED,LABEL,LUC,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
0001,100,121,174,259,271,ALK,ALK3,ALK5,ANAPLASTIC,AQUA,BAT,FISH,IHC,NSCLC,OVERALL,TEST,UPON
2014,368,553,581,857,BACKGROUND,CIS,CONCLUSION,HODGKIN,HOWEVER,LABEL,MARCH,METHODS,RESULTS,RRS,SEDENTARY
2000,2007,2008,2011,BACKGROUND,BLACK,CDC,CENTERS,CONTROL,DATA,DISCUSSION,DISEASE,INSTITUTE,LABEL,METHODS,NPCR,PREVENTION,PROGRAM,REGISTRIES,RESULTS
8482,8HQ,956,AROMATASE,CONCLUSION,CYP19,ESTROGENS,GENTEST,IC50,LABEL,METHODS,MRC,MTT,OBJECTIVE,PURPOSE,RESULTS
169,2014,AMONG,BASED,COPYRIGHT,ITC,PEITC,PHENETHYL,PRE
169,2014,COPYRIGHT,DNRG1,EMT,INC,NDRG1,PP2A,SET
CHEST,COLLEGE,FLEISCHNER,PHYSICIAN,RISK,SOCIETY,THERE
008,014,100,178,185,2006,2008,359,388,8201,BACKGROUND,EGFR,HOWEVER,JAPAN,KRAS,LABEL,METHODS,MUTATIONAL,NSCLC,RESULTS
009,019,025,029,165,189,262,393,447,464,514,579,586,634G,645,651,704,743,801,873,898,948,953,965,ADDITIONAL,AFTER,BACKGROUND,CCCCC,CONCLUSION,HAPLOTYPES,HAPLOVIEW,HOWEVER,LABEL,METHODS,OCCURRENCE,RESULTS,SEVEN,UNIVARIATE,UTR,VEGF
169,2014,8764,A549,COPYRIGHT,COS,DOCA,DUE,PDLLA,PEG,POLY,PTX,TAXOL
945,954,BACKGROUND,CL1,HIGH,HOWEVER,LABEL,LOSS,MAIN,METABOLIC,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SQS,TARGETING
945,946,EMT,FINALLY,MYC,SILENCING,SLUG,SRC,STRIKINGLY
221,222,340,CDH1,CDK,CDKS,FINALLY,HOWEVER,KIP1,MET,MICRORNAS,NSCLC,PUM1,PUM2,PUMILIO,RHOA,ROCK1,SCF,SKP2,THEREFORE,THESE,UTR
1300,CSC,EACH,HIGH,JAK2,MYC,NOTABLY,SOX2,STAT3,THUS,TNBC,VEGF,VEGFR
001,046,049,056,169,174,2014,ADVERSE,CONCLUSION,COPYRIGHT,CROWN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SIMILAR,SKIN,THERE
0001,0005,001,1990,2013,AGE,AMONG,FURTHER,GYN,SEVERAL,UNIVERSITY
001,134,169,2014,ADC,BACKGROUND,COPYRIGHT,FRACTAL,HOWEVER,LABEL,LTD,MEAN,METHODS,NSCLC,PUBLISHED,RESULTS,ROC,SCC
AFTER,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,SVC
CAF,CAFS,NOTCH,RHOA,THUS,TIMP,TIMPS
11Q,169,17P,183,2012,2014,375,420,BACKGROUND,BETWEEN,BTK,CLL,COPYRIGHT,DIARRHOEA,FEB,FIVE,FUNDING,HOUSTON,IBRUTINIB,INC,INSTITUTE,LABEL,LTD,METHODS,PFS,PREVENTION,RESULTS,SEPT,SOCIETY,TEXAS,TP53,USA
1552,169,1878,2002,2009,2014,BACKGROUND,CONCLUSION,COPYRIGHT,CRT,END,III,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RATES,RESULTS,THERE,THESE
001,007,020,046,103,151,167,172,191,1990,2011,645,945,946,CHI,EXPRESSION,FURTHER,HIF,INTEGRINS,KI67,MANN,NSCLC,WHITNEY
451,A549,CXCR4,HOWEVER,MICRORNAS,MIR,MMP,MTT,NOS2,PCR,PSMB8,RESULTS,RNAS,THEREFORE,TRANSWELL,VEGF,WESTERN
1993,2001,2014,562,905,ALCOHOL,BLOOMBERG,COLORECTAL,COX,GOVERNMENT,HOPKINS,JOHNS,LUNG,OVARIAN,PRESS,PUBLISHED,SCREENING,TRIAL,UNIVERSITY,WHETHER
038,169,1970,1989,1990,1999,2000,2008,2014,354,441,BACKGROUND,BOARD,CAIRO,CONCLUSION,COPYRIGHT,DEPARTMENT,DOCTORATE,III,INSTITUTE,IRB,LABEL,MEDICAL,METHODS,MOST,NCI,OBJECTIVE,PRODUCTION,RESULTS,UNIVERSITY,WHILE
2002,2012,AAA,BACKGROUND,CAS,DISCUSSION,ENGLISH,FORCE,LABEL,METHODS,OVERALL,PREVENTIVE,RESULTS,SIXTY,SYSTEMATIC,TASK
125,144,169,2000,2011,2015,267,469,BETWEEN,COPYRIGHT,CROSS,EIGHT,INC,IQR,LABEL,METHODS,MOST,OBJECTIVE,PLANNED,PUBLISHED,RESULTS,SOCIETY,SURGERY
177,2000,2009,AGE,BRONCHIAL,CELSIUS,LABEL,METHODS,RESULTS,THERE,THESE,TNM,UNLABELLED
102,136,167,1999,2012,303,BETWEEN,CELSIUS,JANUARY,NLH,VAMS
150,ATF3,CISPLATIN,COX,DFS,ESCC,FINALLY,MDM2,MMP,P53,RESULTS
946,A549,AKT,C57BL,CL1,ERK1,FAK,LLC1,SMAD,SMAD2,SMAD7,TGF,TGFR,TGFRI,TGFRS,UPP
BAG3,H446,H69,HSP70,SCLC,SCLCS,TREATMENT
A549,AKT,FURTHER,H460,LICA,MMP,PI3K,SP1,THESE,THUS
100,106,113,169,2008,2013,2014,AFTER,BACKGROUND,CHIBA,COPYRIGHT,EBUS,FINAL,FURTHER,HOWEVER,INC,INTEGRATED,LABEL,MAY,METHODS,PET,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY,TBNA,THERE
169,181,2014,8320,8325,BACKGROUND,CONCLUSION,COPYRIGHT,COR,DIOSCOREA,HELA,HEPG2,IC50,IRELAND,L23,LABEL,LTD,MATERIALS,MCF,METHODS,MRC,PC3,RELEVANCE,RESULTS,SRB,THAI,THUS,TTM
00714,169,170,2014,319,BONFERRONI,CONCLUSION,DESPITE,EQUATIONS,ESTIMATING,FEV1,FOLLOWING,FURTHER,FVC,GEN,HEART,LABEL,MEAN,METHODS,OBJECTIVE,PRE,PURPOSE,RESULTS,THEREFORE,VO2
013,082,106,119,120,142,153,189,1990,234,481,549,596,643,735,857,GISTS,INCLUSION,KNOWLEDGE,LABEL,MEDLINE,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERE,USING,WEB
CTLA4,HOWEVER,III,PD1,PDL1,PHASE
946,BXPC,EXTENSIVE,HAS2,HAS3,PEGPH20,TREATMENT
AIM,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SOLUBLE,USING
160,169,2014,956,AMONG,COPYRIGHT,FURTHER,H1299,IC50,M10,MCF,MECHANISM,MTT,SAS
2014,AZA,COPYRIGHT,DRUG,EPIGENETIC,FOOD,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TREATMENT,UVEAL
011,169,2014,956,A549,GI50,GMBH,HELA,IC50,INSTITUTE,KGAA,MCF,MICHAEL,MOLECULAR,VCH,WILEY
AMONG,BACKGROUND,EGFR,KOREA,LABEL,METHODS,NSCLC,RESULTS,THREE,TKI
100,169,2014,252,264,299,381,956,A549,ACTA,AMONG,AZ521,BARR,CHIMICA,CHINABERRY,COPYRIGHT,COX,EBV,EPSTEIN,HELVETICA,HL60,IC50,LPS,MELIA,MELIACEAE,NINE,RAJI,RAW,TPA,WESTERN
192,ABOUT,ALTERED,LUNG,MICRORNAS,NON,NSCLC,RNAS,THREE
001,002,046,1161G,1779C,420,425,967,CHINESE,HAN,PCR,RFLP,TAKEN,XRCC1
141,2009,2010,ALSO,INSTITUTE,JANUARY,SURGERY
025,026,028,048,102,163,169,2002,2012,2014,8201,AFTER,BACKGROUND,CIS,CRLM,FOLLOWING,INC,JANUARY,LABEL,LIVER,LUNG,METHODS,OTHER,RESULTS,WILEY
DESPITE,FK866,N39,NAMPT
169,2014,ACUPOINTS,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FATIGUE,FURTHER,HEGU,LABEL,LI4,LTD,METHODS,OUTCOME,RESULTS,SP6,ST36,ZUSANLI
2014,8197,BMJ,GROUP,LTD,PUBLISHING,RECURRENCE,THESE
169,2014,A549,CONVERSELY,GMX,GMX1777,GMX1778,H1299,NAD,NAMPT,NSCLC,PARP,PARPS,PEMETREXED,THESE,USING
160,215,327,365,703,906,BACKGROUND,CHINA,CHINESE,COX,GWAS,LABEL,LUNG,METHODS,NANJING,NSCLC,RESULTS,SNPS,STUDIES,THESE
0001,004,025,117,276,AIM,CONCLUSION,DCR,DISEASE,LABEL,METHODS,OBJECTIVE,RESULTS
EGFR,HOWEVER,III,NON,NSCLC,PHASE,SEVERAL,THESE,TKI,TKIS
000,100,1996,1997,2002,2006,2007,AIM,AUSTRALIA,AUSTRALIAN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SIMILAR,SUMMARISED,UNTIL,WORLD,ZEALAND,ZEALANDERS
100,2013,734,8197,829,8938,937,BEGG,EGGER,FANG,KNOWLEDGE,MED,PERTINENT,WAN,WEB
000,100,10TH,110,119,2001,2009,BARANJA,C30,C34,C39,FEMALES,FIVE,HOWEVER,ICD,INSTITUTE,OBC,OTHER,RELATED
127,2003,2007,237,238,250,CUMULATIVE,LCNEC,SCLC,SMALL,UNIVERSITY
CELL,HOWEVER,OVARIAN,OVCA,SELEX,THEREFORE,USING
BASCS,GLUT1,INDUCIBLE,NOTABLY,NSCLC,ONCOGENIC,RAS,STZ
8201,956,CO3AP,THEREFORE
225,947,BACKGROUND,BRCA1,CDC2,CDK1,CELL,CHK1,CONCLUSION,EGFR,H2AX,LABEL,LC3B,METHODS,PARP,PROTEIN,RESULTS,SUB,WESTERN
BMJ,CIS,GROUP,LIMITED,META,OVERALL,PUBLISHED,PUBLISHING,SIR,SMR,WORKERS
169,2014,CH3,FURTHER,GR6,IMMUNOPET,MET,NSCLC
169,2014,99M,ABC,ATP,H1299,MDR,MIBI,MULTIDRUG,THESE
169,2014,HDAC,III,KIP1,LABEL,NSCLC,P27,SIRT,SIRT1,UNLABELLED
169,200,2014,946,AUTHORS,CATENIN,GIVEN,IVERMECTIN,PUBLISHED,SELAMECTIN,TCF,VP16,WNT
169,2014,ALGORITHM,ALIGNMENT,FACTERA,LABEL,MAP,METHODS,PRESS,PUBLISHED,UNIVERSITY,UNLABELLED
169,2014,ASCL1,ASIA,BOTH,BRN2,DNTF,DNTFS,FURTHER,HGNET,KI67,LTD,MEN1,P53,PATHOLOGY,PTY,PUBLISHING,RB1,SOCIETY,TTF1,WILEY
001,002,003,006,009,010,015,018,019,120,177,181,185,272,294,353,422,432,688,911,A490,A549,AFTER,AKT,BCL,CONCLUSION,EGFR,EMT,ERK,ERK1,LABEL,METHODS,MTS,OBJECTIVE,RESULTS,WESTERN
169,2014,FINALLY,FOCUS,FOXA2,HCC,HEPG2,MMP,PRESS,PUBLISHED,UNIVERSITY
CD3,ENG,EPHA2,HOWEVER,SCID,WHILE
169,2014,286,946,E2F,GSK,LOSS,NSCLC,PSAT1,THESE,UICC
400,450,520,AMONG,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,PDD,RESULTS
0069,0214,029,044,047,130,135,2003,2013,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,SEVERAL
001,113,2000,2012,AGE,CONCLUSION,COX,DISTANT,FEDERATION,FIGO,GYNECOLOGY,LABEL,LOCAL,LOG,LUNG,METHODS,OBJECTIVE,OBSTETRICS,PREDICTORS,RESULTS,STAGE,ULMS
169,2014,904,COMBINING,CONCLUSION,LABEL,LADC,METHODS,MICROARRAY,OBJECTIVE,PCR,PURPOSE,RESULTS,TP53
174,CTC,CTCS,H460,RFP,THESE
169,2014,947,AUTHORS,FUNCTIONAL,MDM2,R273H,SLUG,THESE,WAF1
011,020,8201,BACKGROUND,GLI1,HOWEVER,LABEL,LYVE,METHODS,NSCLC,RESULTS,SHH,THUS,VEGF
12P,ANAPLASTIC,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,OCT,PLAP,SALL4
0027,006,0063,007,017,018,045,117,125,282,8202,ADC,ADC_CICAMS,ADC_NCI,ASIAN,CHINESE,PTN1,PTN27
001,005,101,214,8202,BOTH,BRAZILIAN,DESPITE,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM,TREATMENT,USING
8482,ANTIGENIC,BLAST,DESPITE,FORTY,WESTERN
148,2013,2433,389,730,810,BACKGROUND,BODY,CONCLUSION,EXCLUSION,FOLLOWING,GRADE,ITEMS,LABEL,LOCAL,MARCH,MEDLINE,META,METHODS,OVERALL,PREFERRED,RCC,REPORTING,RESULTS,REVIEWS,SABR,SYSTEMATIC,THERE,TREATMENT
203,BECAUSE,ERK,FINALLY,RAS,SRC,UTR
160,169,2014,231,246,A549,COPYRIGHT,HAACK,MDAMB,SAS,VILSMEIER
0617,COLLEGE,CONCURRENT,GROUP,HOWEVER,III,NSCLC,RADIATION,RADIOLOGY,THERAPY,THREE
AFTER,BLOOD,FDG,PET
18F,BASED,FDG,PET,USCS
FDG,LIVER,MRI,PET
001,2004,2010,BACKGROUND,CD56,CONCERNING,CONCLUSION,DEPARTMENT,LABEL,METHODS,PATHOLOGY,RESULTS,SIXTY,SPSS,WORLD
946,HOWEVER,OXIDATION,SEVERAL
004,005,006,046,169,188,2014,385,626,8804,8805,BACKGROUND,EMBP1,FIXED,FPRP,GWAS,IMPC,INITIATIVE,INSTITUTE,LABEL,MEC,METHODS,MPC,NHGRI,PAGE,POPULATION,RESULTS,THESE,TOX3,WHI,WOMEN
169,2014,460,47D,549,DCFDA,GMBH,KGAA,MCF,VCH,WILEY
00001,0001,0002,169,2014,409,AFTER,ASCO,BACKGROUND,CENTRAL,CETUXIMAB,COPYRIGHT,III,IRELAND,LABEL,LTD,MEDLINE,METHODS,ORR,PFS,RESULTS
169,2014,AIM,COPYRIGHT,COX,EP1,INC,INCREASES,KEY,LABEL,MAIN,METHODS,OBJECTIVE,PGE2,RESULTS
8482,956,AEROSOL,ATR,DPIS,DPPC,DPPG,FOURIER,FTIR,GENERATION,INHALABLE,MMADS,NEXT,NGI,PTX,TEER,THESE,VIS
160,223,BASED,CTLA,CURRENT,CURRENTLY,SEVERAL
ASIAN,BACKGROUND,CASE,LABEL,METHODS,PULMONARY,THERE
1250,169,2014,545,8804,ADP,BACKGROUND,GCI,GRADE,IDENTIFIER,IMBALANCES,LABEL,MEDICAL,METHODS,NSCLC,ORR,PARP,PFS,PRESS,PUBLISHED,RESULTS,SECONDARY,SOCIETY,TRIAL,UNIVERSITY
737,ABT,BAK,BAX,BCL,BOTH,HNSCC,HPV16,MCL1,MEAYAMYCIN,PCR,SF3B1,WESTERN
186,216B,337,760,945,946,CIP1,CK2,IMR,ROS,TAKEN,UTR,WAF1
001,004,005,010,035,037,039,DFS,NSCLC,RESULTS,THESE,TNM
GCTB,GIANT,HIGH,HOWEVER,PULMONARY
ICG,THERE,VATS

2002,8805,CTCAE,DELAYED,PCLT,THOSE,THREE
HOWEVER,NOW
CENTRAL,EACH,HOWEVER,LASER,STENT,YAG
AFI,EBUS,ENDOSCOPIC,FICE,FUJI,HOWEVER,KNOWLEDGE,LUNGPOINT,NAVI,NBI,TBNA
DWI,MDCT,MEDICAL,MRI,PET,THEREFORE
177,219,414,741,764,8201,956,AFLP,APE1,ERCC1,IC50,LDH,PM2,SALMONELLA,TA98,THESE,XPA,XPF,XRCC1,XTT
169,2014,2LL,947,AFTER,CD25,CD4,CD8,COPYRIGHT,EGFP,FOXP3,HOWEVER,IDO,IFN,INCREASED,JAK,JAK1,LDH,STAT1,THESE,TREG,TREGS,WESTERN
169,189,2014,BACKGROUND,CCAT,CONCLUSION,CSI,DISCLOSURE,GAD,GMBH,LABEL,METHODS,PHQ,QSC,R10,RESULTS,SCNS
169,2014,5000,AMONG,COPYRIGHT,DOTAP,OPTIMIZED,THESE
100,169,2014,A549,BCL,CELL,COPYRIGHT,DTX,H226,MDR,OVERALL,PEGYLATED,PUBLISHED
160,2008,2010,BACKGROUND,CONCLUSION,EGFR,FGFR,FGFR1,FIBROBLAST,JULY,LABEL,MEAN,MPM,REGARDING,RESULTS,TKI
954,A549,AKT,EGFR,HENCE,LEWIS,LLC,NSCLC,TEC,TFC,TMC,TNC,VEGF,VEGFR
169,2014,A549,COPYRIGHT,DNC,ROS,SAS,THESE
DESPITE,KEY,MRI
DIAGNOSIS
PALLIATIVE,PATHOLOGY,PET,PULMONARY,UNDER
NTM,SINCE
100,HOWEVER,JAPAN,T1AN0M0
CD31,CD34,METASTATIC,VIII
005,454,8202,ASSESSMENT,BACKGROUND,BLOOD,CELLSEARCH,CTC,CTCS,EGFR,LABEL,METHODS,NGS,NSCLC,RESULTS,ROCHE,THESE,TRIGGER,VERIDEX
0008,002,017,034,041,045,048,049,755,8202,ALSO,COX,HIGH,NSCC,NSCLC,PCR,PIAS3,SCC,STAT5,STATS,T1A,T1B,T2A,T2B,THERE,TOTAL
183,1999,2009,BACKGROUND,BETWEEN,BRAIN,DESPITE,GEORG,HISTOLOGY,JANUARY,LABEL,MATERIALS,METHODS,NONE,NSCLC,RESULTS,STUTTGART,YORK
BASED,FDA,FINALLY,ONCOGENIC,RAS,THUS
8201,AFTER,ASSESSMENT,CONCLUSION,EOS,FDG,FTP,HOWEVER,HPLC,LABEL,MBQ,METHODS,OBJECTIVE,PET,RADIO,RESULTS,TLC
NSCLC,SABR
169,2014,5152,AACR,AXL,CETUXIMAB,CTX,EGFR,HNSCC,JUN,MAPK,NOTABLY,NSCLC,RES,RNAI,USING
045,100,100TH,169,1993,2010,2014,ABOUT,AMERICA,AMONG,BACKGROUND,DATA,DISEASE,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,RETIREMENT,SOCIETY,UNIVERSITY,WHILE
001,007,012,112,169,2014,218,64257,8804,BLOOD,III,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STAGE,UNIVERSITY
TOBACCO
A549,CORDYCEPS,CULTURE,HEPG2,IC50,MAXIMUM,MCF
CD95,FAS,THESE
33258,A549,ANNEXIN,BCL,CDK2,EPIMEDIUM,ERK,GENUS,HOECHST,HOWEVER,MAPK,MTT,PCR,ROS,THESE,WESTERN
A549,AKT,CELL,ENDOGENOUS,FIRSTLY,INHIBITION,MTT,NSCLC,PROTEIN,RESULTS,SEMAD,THESE,TRANSWELL,WESTERN
202,211,282,954,BACKGROUND,CCI,COMPOSITE,CONCLUSION,CSCS,ESRD,FURTHER,INDEX,KAPPA,LABEL,METHODS,NAGELKERKE,OBTAINING,RESULTS,SCORE,SELF
160,LUNG,MICRORNAS,NSCLC,SCLC,THERE
ACTIVATING,ALK,AP26113,CH5424802,HOWEVER,NSCLC,THERE
EMERGENCY,SEVERAL
169,2014,CCND1,CHROMATIN,COPYRIGHT,EGF,EGFR,HDAC1,IRELAND,LTD,THESE,TIP30
004,1420,169,1781,2014,788,AIM,ASIA,CONCLUSION,DATA,EGFR,EIGHT,HOWEVER,HRS,LABEL,LTD,METHODS,OBJECTIVE,PFS,PTY,PUBLISHING,RCTS,RESULTS,SCC,SCCS,THERE,TKIS,WILEY
101,2006,2009,226,237,BAL,COUGH,DOSE,ILD,JANUARY,MEDICAL,TOR
001,102,160,169,1999,2008,2014,436,532,BACKGROUND,COPYRIGHT,COX,EXCLUSION,INC,LABEL,METHODS,NSCLC,PATIENT,PROCEDURES,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,T2B
025,033,037,039,143,160,169,2006,2011,2014,203,AGE,BACKGROUND,COPYRIGHT,COX,INC,JANUARY,LABEL,MEIER,METHODS,MSPLC,OPERATIVE,OWING,PREDICTORS,PUBLISHED,RESULTS,SOCIETY,TNM
169,2014,231,BACKGROUND,BRITISH,CELL,CERK,FINALLY,FLOW,H358,KEY,LABEL,MCF,METHODS,NCI,NVP,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,WESTERN
215,ACCIDENTS,BACKGROUND,DESPITE,INSTITUTE,INSURANCE,ITALIAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROSECUTOR,RESULTS
945,946,954,ADRB2,COPD,FDA,IKK,LABA,MMP,TNF
CREB1,EWSR1,FISH,HOWEVER,OTHER,PCR,PPMS,PRIMARY,THESE
001,003,005,008,8201,ACID,ADDITIONAL,FORTY,FULL,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RELEVANCE,RESULTS,SETTING,THERE
169,2014,945,AUTHORS,CLEC,JOHN,KM10,LTD,OTS,SONS,THEREFORE,THESE,WILEY
946,ANNOTATION,DAVID,DISCOVERY,ID1,INTEGRATED,PPARG,SEVERAL,TGF,THEREFORE,THESE
0001,001,111,169,2014,652,749,846,AUC,COLLEGE,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,POPULATION,RESULTS,ROYAL,SETTING,THERE,THESE,WEST,WOMEN
100,33258,956,AIM,ANNEXIN,CELL,CONCLUSION,CRTX,FITC,HOECHST,LABEL,LC3,MES,METHODS,MTT,OBJECTIVE,PCNA,RESULTS,SOUTH,WESTERN
100,1981,2014,252,GROSS,INSTITUTE,MEAN,MULTIFOCAL,PAPILLARY,RADIOLOGY,TOTAL
133A,137,169,2014,449A,ALSO,COPYRIGHT,HOWEVER,JOHN,LTD,LUNG,MRE,MRES,SONS,TRAIL,WILEY
20MG,80MG,AFTER,CASE,CDDP,LABEL,METHODS,RFA,WIDESPREAD
DIAGNOSTIC,PERITONEAL
CASES,CONCLUSION,FIFTEEN,LABEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
HOWEVER,III,NSCLC,SEVERAL,THEREFORE
144,169,2015,267,416,ACADEMY,ANXIETY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,DEPRESSION,ENGLAND,FLOOR,FOUR,GDS,GERIATRIC,GERMANY,HADS,HOSPICE,INC,ITEM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PALLIATIVE,POS,PREVALENCE,PUBLISHED,RESULTS,ROC,SCALE
BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PEMETREXED,RESULTS
169,2014,8201,AUTHORS,FURTHER,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY
169,2014,AUSTRALIA,AUSTRALIAN,LUNG,METASTASES
169,2014,5476423,7919469,A549,ANTI,AXL,COMPOUNDS,COPYRIGHT,IC50,LTD
ALK,CHINESE,CONCLUSION,EGFR,EIGHT,FFPE,FISH,IHC,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2014,COPYRIGHT,FEW,HOWEVER,SAS,VIDEO
169,2014,AMONG,BACKGROUND,COPYRIGHT,FIVE,LABEL,LUNG,METHODS,RESULTS,SAS,SURGERY,TNM
0020,0065,013,1439,169,1713,196,1979,2010,2014,2329,561,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,NSCLC,PLI,PPLI,RESULTS,SAS,VPLI,WPLI
000,016,021,030,124,967,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,POCT,PORT,RESULTS,THERE
169,2014,945,947,APH1,AUTHORS,COPYRIGHT,DESPITE,HIF,INC,NOTCH,PEN,PUBLISHED,SECRETASE
LUNG,NEK9,NIMA
169,177,2014,373,769,946,956,A549,AFTER,APMIS,CATENIN,CISPLATIN,DDP,ENDOGENOUS,FLOW,IC50,JOHN,LTD,MTT,MYC,PUBLISHED,SONS,WILEY
AKT,CISPLATIN,PI3K
HGF,MET,ONCE
BRAF,DDR2,EGFR,FGFR1,IGF,LUNG,MET,PTEN,SQCLC
002,363,370,634,643,946,967,ABI7500,ALSO,BACKGROUND,CIS,GENOMIC,LABEL,METHODS,ORS,PCR,RESULTS,THERE
001,083,127,186,2012,2013,204,240,451,APRIL,ARMS,BACKGROUND,DESPITE,EGFR,EPIDERMAL,JUNE,LABEL,METHODS,NSCLC,RESULTS,THEREFORE,USING
BACKGROUND,CNKI,EMBSE,LABEL,MEDLINE,METHODS,MGMT,NSCLC,RESULTS,WANFANG
108,119,176,244,352,528,BACKGROUND,CASES,LABEL,LEVF,METHODS,NSCLC,RESULTS
2006,2012,BACKGROUND,COX,EASTERN,ECOG,FPS,GROUP,IIIA,IIIB,LABEL,LIMITED,MEIER,METHODS,PFS,RESULTS,SCLC,SMALL,TNM,UNIVARIATE
177,2000,946,A549,BACKGROUND,BIII,III,INCREASED,LABEL,METHODS,MTT,NSCLC,PACLITAXEL,PCR,REAL,RESULTS,TAXOL,TAXOLCELL,THREE,WESTERN
169,2014,BECAUSE,COPYRIGHT,JOHN,LTD,SONS,WHILE,WILEY
ADAM,CTGF,IGFBP,PSGL,STUDIES,WILLEBRAND
154,160,169,184,186,2014,ACM,ADC,ADDITIONAL,AIMS,CK5,CK7,IHC,JOHN,LABEL,LTD,METHODS,NEED,NSCLC,OBJECTIVE,RESULTS,SCC,SCM,SONS,TTF,WILEY
169,2014,ANATOMY,BRITAIN,CDC42,COPYRIGHT,EXOGENOUS,EXPRESSION,GREAT,HCII,HIGH,IRELAND,JOHN,LTD,NSCLC,PI3K,PROJECT,PUBLISHED,RAC1,SAGE,SOCIETY,SONS,USING,WILEY
1523,169,2014,CAUCASIAN,COPYRIGHT,CTA,DESPITE,DIAGNOSIS,INC,LABEL,METHODS,NSG,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PATHOLOGY,RESULTS
169,2014,COPYRIGHT,DESPITE,LTD,MSS,SMOKING,WATER,WORLD,WPS
169,177,2014,8805,AMONG,BACKGROUND,CONCLUSION,DOPPLER,INC,IVA,LABEL,LEFT,METHODS,MRI,PROCEDURES,RESULTS,THERE,WILEY
443,799,EGFR,L858R,MOST,NSCLC,TKI
169,2014,FIVE,JOHN,LTD,SONS,THESE,WILEY
169,2014,COPYRIGHT,DIFFUSE,INC,TGCT,TGCTS
001,113,169,2014,347,548,ANZSCTS,AUSTRALIA,AUSTRALIAN,BACKGROUND,CARDIAC,COPYRIGHT,CSANZ,FURTHER,LABEL,MEIER,METHODS,NON,NSCLC,PUBLISHED,RESULTS,RISK,SOCIETY,THESE,YOUNG,YOUNGER,ZEALAND
CD34,CGA,CKPAN,EMA,SHL,SMA,SPB,SYN,TTF
001,011,105,128,169,2007,2009,2014,8804,AMONG,COPYRIGHT,END,LABEL,LOWER,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIR
BARR,EPSTEIN,GRADE,LYG
ADULT,AOSD,STILL
DIC,TROUSSEAU
AFTER,BRAIN,WBRT
001,0201,090,169,2014,2ND,6TH,CONCLUSION,COPYRIGHT,FORTY,HLA,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PEPTIDE,PFS,RESULTS,TERT,TERT572,THREE
169,2002,2010,2014,431,BONE,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LIVER,LTD,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SWEDISH,WOMEN
0001,0024,085,101,125MEQUIV,126,130,130MEQUIV,134MEQUIV,135MEQUIV,169,2014,463,5037,564,631,CONCLUSION,COPYRIGHT,COX,DATA,FINAL,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NAPL,OBJECTIVE,OBJECTIVES,RESULTS,SCLC,UNIVARIATE
107,169,2014,COPYRIGHT,FOUR,FOURIER,III,INC,JUDICIOUS,LABEL,MARKERS,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SURGERY
007,169,2014,956,A549,CISPLATIN,COPYRIGHT,CTC,CTCS,H1299,H460,INC,LABEL,METHODS,MMP,MOSBY,OBJECTIVE,PETRI,PUBLISHED,RESULTS,SURGERY
0099,0525,10878,169,190,195,2014,212,2278,343,385,ADVERSE,BACKGROUND,COPYRIGHT,COX,EPO,INDUCTION,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RBC,RCHT,RCTH,RESULTS,TVES
100,ANNA1,INTRAVITAL
CARLO,DESPITE,HOWEVER,INHIBITION,MEANWHILE,NSCLC,RNAS,THUS
169,2014,ACCORDING,CONCLUSION,COPYRIGHT,EBUS,ENGLISH,EUS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEMLA,VAMLA
119,169,171,2000,2012,2014,613,665,784,AMONG,AMSTERDAM,ATE,CONCLUSION,COPYRIGHT,FORTY,HISTORY,IRELAND,LABEL,LTD,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,SIX,UNIVERSITY,VTE
123,150MG,169,174,2014,327,CONCLUSION,COPYRIGHT,DISEASE,EASTERN,ECOG,EGFR,ERLOTINIB,GROUP,IIIB,IRELAND,KRAS,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,SECONDARY,TARCEVA,THERE,THREE,TKI
0001,00035,0088,166,169,183,2014,3790,8804,955,BACKGROUND,BHASKARAN,BMI,COPYRIGHT,COUNCIL,COX,EACH,FUNDING,HIGH,INSTITUTE,LABEL,LTD,MEDICAL,METHODS,OPEN,PUBLISHED,RESULTS,TRUST
001,002,021,169,2014,390,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,DIFFERENT,IVIG,LABEL,METHODS,MYASTHENIA,OBJECTIVE,RESULTS
160,NASAL,NCMH,PPB
FOLFIRI,INTRA,PRIMARY,STAGEIV,THERE,UICC,XELOX
100MG,500MG,BACTERIAL,EARLY,HOWEVER,STAGE,T4BN2M1
ACD,ANTICANCER,DRUGS,HOWEVER,INCREASING,PEMETREXED,QOL,TREATED
DISEASE,HOWEVER,ZOLEDRONIC
0013,0028,100,1000,160,300,382,789,961,964,ATLAS,COMPARISON,LCM,MACRO,PATHWAY,THUS
169,2014,BOTH,COPYRIGHT,DISULFIRAM,DSF,HELA,IC50,PEVA
169,2014,BFT,BIOLOGICAL,BTV,BTVS,COPYRIGHT,DUE,ECM,EVIDENTIAL,FDG,FINALLY,FLT,FMISO,MEANS,PET,THEN,VOLUMES
169,2014,COPYRIGHT,DUE,ESS,IRELAND,LTD,UES
169,2014,COPYRIGHT,CPB,DIATHERMY,GASEOUS,OPCAB,PULMONARY,SKIN,SOCIETY,THEREFORE
169,2014,8594,A549,ALSO,COPYRIGHT,H460,MOST,MRC,NCI,THEN
169,2014,COPYRIGHT,IRELAND,LTD,MSCS,TME
000,0001,1201,125,169,2014,818,COLORECTAL,CONCLUSION,CONTROLLED,COPYRIGHT,INC,INSTITUTE,LABEL,LUNG,MENOPAUSAL,METHODS,NCI,OBJECTIVE,OVARIAN,PLCO,RANDOMIZED,RESULTS,SCREENING,THERE,TRIAL,WOMEN
169,2014,AARP,CTT,H22,HOWEVER,LEWIS,LLC,MMP,RK5,TAKEN
BACKGROUND,FESB,FMOB,FOUR,IMRT,LABEL,METHODS,NSCLC,PEAK,PULMONARY,RESULTS,V10,V20,V30
169,2014,231,233,8217,CANDIDA,COPYRIGHT,DIAGNOSIS,PUBLISHED,SAS,SFAR,SOCI
110,150,2003,2011,210,320,8201,8805,BACKGROUND,BED10,FURTHER,GYE,GYE10,LABEL,LOCAL,METHODS,MEV,PATIENT,PBRT,PRBT,RESULTS,THERE,UNIVARIATE
177,8201,954,956,A549,AMEAE,BACKGROUND,BAX,BCL,CELL,FLOW,HCS,HIGH,HOWEVER,IC50,LABEL,LDH,METHODS,MMP,MTT,PCR,RESULTS,ROS,TREATMENT
ADP,BACKGROUND,CD24,CD44,CELL,CSC,CSCS,DR4,DR5,ELISA,HELA,HOECHST,LABEL,LUNG,METHODS,NOD,PEITC,RESULTS,SCID,TRAIL
004,013,018,100,1008,215,992,CCGCC,CHINESE,FURTHER,HAN,HARDY,HOWEVER,LABEL,METHODS,OBJECTIVE,RBBP6,RESULTS,SNPS,TEN,THEREFORE,THESE,WHAT
1990,2012,BRAIN,FIFTY,HOWEVER,LABEL,MEIER,METASTASIS,METHODS,OBJECTIVE,RESULTS,TEXAS,THOSE,UNIVERSITY,UNTREATED
169,2014,EMT,JAK2,NOTABLY,PAK1,SER,SNAIL,TAKEN,THR
169,2014,643,AXL,EGFR,EMT,EPITHELIAL,HOWEVER,THESE,TKI,TKIS
169,2014,947,ALDH,EGFR,HOWEVER,MUTATIONS,NOTCH
169,177,ACS,CK5,CONCLUSION,COPYRIGHT,IHC,LABEL,LCNEC,METHODS,OBJECTIVE,PATHOLOGY,PULMONARY,RESULTS,SCLCS,SIXTY,SOCIETY,TCS,TTF
160,169,2014,946,ASP,BASED,BIOLOGY,CD31,FLK,GLU,H460,KDEL,KDR,KDRSCFV,KPLK,LEU,LYS,NSCLC,SOCIETY,THESE,VEGFR
0001,0058,177,8201,CONCLUSION,DOTA,GIVEN,H69,LABEL,METHODS,NCI,OBJECTIVE,PET,PRCRT,PRRT,PURPOSE,RESULTS,SCLC,SMALL,SMCC,SSTR,SSTR2
169,2014,231,AUTHORS,CD31,CDK2,FGF,FOUNDATION,JOHN,JOURNAL,LTD,MCF,MDA,MOLECULAR,SONS,THUS,WILEY
169,2014,CONCLUSION,GRADUAL,INDEX,LABEL,METHODS,OBJECTIVE,RESULTS,VOICE
946,A549,AKT,BOTH,EGF,EGFR,EMT,GSK,HOWEVER,PI3K,PKC,SNAIL,TAKEN
169,2014,BACKGROUND,EACH,INC,LABEL,UNLABELLED,WILEY,WIRES
001,169,2014,EGFR,GAGED2A,LABEL,METHODS,OBJECTIVE,PHENOTYPIC,PURPOSE,RESULTS,TKI,XAGE1
058,169,2014,5124,AACR,CLIN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PIAS3,PURPOSE,RES,RESULTS,STAT3,THESE
169,2014,COPYRIGHT,EPIGENETIC,HOWEVER,INC
CCNE1,E2F1,SET7,THESE,TP73,TRITHORAX,ZESTE
048,169,2014,672,8805,ADP,AUTHORS,DMS53,GLS,H128,H146,H187,H209,H526,H69,HACL1,IC50,JOHN,LTD,MECHANISMS,MSI2,MTS,PARP,PKCS,POLY,SCLC,SONS,UBEC2,VELIPARIB,WILEY
001,012,026,033,037,126,200C,8201,8804,HIGH,MICRORNAS,NSCLC,PCR,RNAS,THERE
1999,2013,207,217,247,BMJ,GROUP,JANUARY,LIMITED,PET,PUBLISHED,PUBLISHING,RESULTS
BACKGROUND,CASE,CD8,CONCLUSION,LABEL,LUNG,METHODS,THERE
A549,BACKGROUND,EXPRESSION,H1299,KNOCKDOWN,LABEL,LENTIVIRUS,METHODS,MG2,MN2,MTT,PCR,PPM1D,RESULTS,RNAI,THEREFORE,THESE,WESTERN
100,160,3DCT,4DCT,8201,BACKGROUND,CONCLUSION,FDG,GROSS,GTVPET2,GTVS,IGTV,LABEL,METHODS,NONE,NSCLC,PET,RESULTS,THEN
001,118,169,177,2014,8201,ASIAN,BACKGROUND,BALB,CD4,CD8,LABEL,MCP,METHODS,MICE,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,TREATMENT
001,127,151,169,2014,299,445,5227,633,BACKGROUND,COLORECTAL,CONCLUSION,COPYRIGHT,CXR,IRELAND,LABEL,LTD,LUNG,METHODS,OVARIAN,POTENTIAL,RESULTS,SCREENING,TRIAL,TRUE
284,CONCLUSION,CRT,HNC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RID,WHEREAS,WHILE
169,2014,946,ABCG2,ADULT,COPYRIGHT,FINALLY,GENESIS,HOWEVER,MSC,NG2,SOCIETY,TGF
169,COLLEGE,CONCLUSION,COPYRIGHT,DATA,LABEL,MEDLINE,METHODS,OBJECTIVE,PHYSICIANS,RESULTS,SELECTION,SOURCES,SYNTHESIS,UPDATED
169,CARE,COLLEGE,COMMITTEE,CONCLUSION,COPYRIGHT,DISEASE,EARLIER,FPS,GROUP,LABEL,LUNG,METHODS,NETWORK,OBJECTIVE,ONTARIO,PHYSICIANS,PRIMARY,PROVINCIAL,SITE,THESE,UNASSIGNED
000,150,169,2013,2014,36245,BIOLOGY,INC,MOLECULAR,NON,NSCLC,OVERALL,PHF,PI3K,SOCIETY
10001,333,MEDICAL,PAI,PUBLISHERS,SEVENTH,THUS,USA,YORK
APPLIED,ATLAS,DATA,DIFFERENT,MATCHER,MODMATCHER,MULTI,OMICS,TCGA
0105,0139,177,190,485,743,914,ATLAS,BACKGROUND,EGFR,FISH,HOWEVER,IHC,KRAS,L858R,LABEL,METHODS,NSCLC,PFS,RESULTS
001,002,019,177,360,AFTER,AMONG,CAUCASIAN,EASTERN,EGFR,FFPE,GENOMIC,GROUP,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,SMOKING
0001,123,195,2011,2013,354,BACKGROUND,DISCUSSION,EBUS,JANUARY,JUNE,KINGDOM,LABEL,MANCHESTER,METHODS,NETWORK,RESULTS,SOUTH,UNIVERSITY
133,2005,2012,381,398,BACKGROUND,BETWEEN,CONCLUSION,DMAX,LABEL,METHODS,OARS,RESULTS,TOLERABLE
0001,001,0271,0314,0636,127,1772,185,312,BACKGROUND,CONCLUSION,DESPITE,DFS,DISEASE,EGFR,G12C,G12V,KRAS,LABEL,METHODS,MUT,NSCLC,RESULTS
2004,954,ADC,BACKGROUND,CONCLUSION,FIRST,KAPPA,LABEL,METHODS,RESECTION,RESULTS,SQCC,WORLD
100,1033,1060,118,224,250,652,784,803,859,AVAILABLE,BACKGROUND,CAUCASIAN,CONCLUSION,EGFR,LABEL,MANDATORY,METHODS,OBJECTIVE,POST,PREPLANNED,RESULTS
1967,2006,2009,252,ARIES,AVASTIN,BACKGROUND,CONCLUSION,DRUG,FOOD,INCIDENCES,LABEL,METHODS,NSCLC,RESULTS,THERE
130,209,639,AKT,AKT2,AKT3,BACKGROUND,III,LABEL,METHODS,MYC,PI3K,PTEN,RB1,RESULTS,SCLC,THEREFORE,TP53
BACKGROUND,COUPLED,ERK,FURTHER,H1048,LABEL,M918T,METHODS,MYC,PRIMARY,RESULTS,RET,SCLC,THERE
166,173,242,249,BACKGROUND,CLINICALLY,HOWEVER,KNOCKDOWN,LABEL,MDM2,MEIER,METHODS,NOTE,RESULTS
103,157,8805,BACKGROUND,CONTINUOUS,FAK,FOCAL,LABEL,METHODS,NORTH,NSCLC,RESULTS,THERE,TMA
107,ADAMTS8,APC,BACKGROUND,CDH13,CONCLUSION,DAPK1,GSTP1,IIIA,LABEL,METHODS,METHYLIGHT,MGMT,PRIMARY,RESULTS,RFS,SOCS3,WHILE,WIF1
013,025,038,160,698,ABCB1,ATP,BACKGROUND,GSTP1,III,INHERITED,LABEL,METHODS,RESULTS,SNP,SNPS,USING
100,373,411,5A4,ALK,ALK1,AMONG,BACKGROUND,CALK,D5F3,FACTORS,FISH,IHC,INITIAL,LABEL,METHODS,POST,RESULTS,THREE,VYSIS
003,191,2008,2011,352,AFTER,BACKGROUND,CITY,CLINICIANS,CONCLUSION,LABEL,METHODS,OTHER,PATIENT,RESULTS,THESE,THREE,UNADJUSTED,YORK
297,363,660,BACKGROUND,LABEL,METHODS,PRO,PROS,RESULTS,THESE
169,2014,228,455,AMONG,AMPK,LKB1,PDE4,PDE4D,STK11,THUS
100,169,2014,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEVENTY,TYPE,UNIVERSITY
EGFR,GFP,JNK,JUN,MEF,MEFS,REDUCED,T24,T24T
000,001,003,007,008,029,107,137,177,2078,3953,4676,BACKGROUND,CONCLUSION,COX,FISHERS,LABEL,LOW,MEIER,METHODS,MICRORNAS,NSCLC,PCR,PFS,RESULTS,RNAS,TNM
ACUTE,AFOP,LOBECTOMY
100,115,2573T,A750,ARMS,ASSESSMENT,E746,EGFR,IHC,L858R,LEU858ARG,NSCLC,REFRACTORY,THERE,VALIDATION
BACKGROUND,EXPRESSION,GAS5,HCC,HOWEVER,LABEL,MEIER,METHODS,PCR,RESULTS,RNAS
100,916,ACS,CK5,FORTY,LCCS,NOS,NP63,NSCLC,SCC,SCCS,SUBTYPING,TTF,WORLD
945,EMT,PULMONARY,RELATED,SLUG,SMA,SNAIL,THESE,ZEB1
CXCR4,H446,HOWEVER,SCLC,UROKINASE
DELTA,RHO,RHOA
1772,2014,2167,BACKGROUND,CD44,CHINA,CNKI,CONCLUSION,DATA,HOWEVER,III,KNOWLEDGE,LABEL,LARGE,METHODS,NSCLC,PROGNOSTIC,RESULTS,SCC,SINCE,STUDIES,SUMMARY,TMN,VALUE
001,008,2004,2011,JANUARY,MAY,MEDICAL,MOST,NSCLC,PERCENTAGE
2007,2011,233,943,AMONG,FIFTH,INFLUENZA,KOREA,NUTRITION,SURVEYS
106,160,174,8209,ARAB,EGFR,HRM,KIRSTEN,KRAS,L858R,LUNG,MOLECULAR,PCR,RGQ,ROTOR,STRIPASSAY,THEREFORE
A549,AMINO,H22,HEPG2,ICD,S180,SGC7901
627,646,823,AUC,COHEN,CONCLUSION,FDG,FIFTY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC,TNM
001,125,151,153,239,318,330,648,8201,ACUTE,AFTER,ANTIEMESIS,ASIA,AUSTRALIA,CARE,CHINA,CINV,HEC,INDIA,KOREA,LABEL,MASCC,MEAN,MEC,METHODS,OBJECTIVE,OVERALL,PACIFIC,PURPOSE,RESULTS,SEQUENTIAL,SINGAPORE,SOUTH,SUPPORTIVE,THERE,TOOL
1302,1980,2011,269,6656,742,BACKGROUND,CONCLUSION,HODGKIN,LABEL,METHODS,RESULTS,SIR,SIRS,WHETHER
169,2014,A549,BINDING,CELL,COPYRIGHT,CXCR4,DOX,NPS,PLGA
2008,2013,227,CA125,CA153,CA199,COX,CYFRA21,FIRST,GENERALLY,LUNG,MEIER,THEN
196,2012,209,COMPARING,CONCLUSION,CONTROLLED,EBUS,LABEL,MAY,METHODS,MINOR,NASAL,OBJECTIVE,OCTOBER,PROCEDURE,PURPOSE,RESULTS,THERE
30C,8209,A549,EMT,HOWEVER,NSCLC
021,024,026,483,946,BIOMARKER,ERCC1,GROUP,III,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,RRM1
III,NINTEDANIB,PHASE
A549,CA125,MPF,MSLN,THESE
110,177,1992,2012,BACKGROUND,JUNE,LABEL,LCDD,LUNG,MAIN,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SEPTEMBER,THREE
100,GIT,NINE,PULSE,SITES
005,028,2006,2013,3345,973,AMONG,BACKGROUND,BONE,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,RESULTS
AIMS,BACKGROUND,BRAIN,CONCLUSION,CONTEXT,DATA,EVEN,HENCE,IHC,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,RESULTS
FIVE,LASER,LOCAL,NASAL,NCMH,NINE,PATHOGENIC,PPB,PRESENTING,THREE
950,BACKGROUND,HIF,HIFS,HOIL,HOIP,HOWEVER,HYPOXIA,INCREASED,IRP2,LABEL,LUBAC,LYS,MAIN,METHODS,OBJECTIVE,OBJECTIVES,PKC,PROTEIN,RATIONALE,RESULTS,SHANK,SHARPIN,THESE,WESTERN

2011,CHINESE,FINE,JUN,MAMMOGRAMS,MAY,MODERATELY,MRI
27632,CELL,HOWEVER,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,RESULTS,RHO,SKOV3,THEN,TREATMENT
222,BRAIN,EMA,GTN,OVERALL
309,AIMS,BMJ,EGFR,GROUP,HIGH,IGF1R,INSULIN,KRAS,LABEL,LIMITED,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SCC,SCCS,THERE
100,1000,1427,169,2012,2014,AIM,BACKGROUND,CONCLUSION,DEPARTMENT,DIFFERENT,EMERGENCY,ENGLISH,FURTHER,GIVEN,LABEL,MEDLINE,METHODS,OBJECTIVE,RESULTS,SCHOLAR,THERE,THREE
023,169,2014,943,AREAS,BACKGROUND,FORCE,HSA,HSAS,LABEL,METHODS,NEWLY,OBJECTIVE,OBJECTIVES,PREVENTIVE,RESULTS,SCALING,SERVICE,TASK
945,946,954,A549,ICAM,THESE,TNF
005,046,10878,2004,2006,8201,BACKGROUND,DOSIMETRIC,FOUR,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RADIATION,RESULTS
0001,0014,032,169,2014,ASIA,AUTHORS,CCR7,CD4,CD8,ENRICHMENT,HOWEVER,IGG,LTD,PBMCS,PD1,PTY,PUBLISHING,SCIENCE,SEVENTY,THESE,WILEY
169,2014,AKT,ASIA,AUTHORS,DESPITE,EGFR,ERBB2,ERBB3,HSP90,LTD,MET,NSCLC,PTY,PUBLISHING,SCIENCE,SINCE,T790M,TKIS,TREATMENT,WILEY,WK88
3079,CONCLUSION,FDG,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PET,RESULTS
AUC,CADX,CONSORTIUM,GABOR,GAIN,IMAGE,INITIATIVE,LUNG,SVM,TEXTURE,THESE,WHILE
100,120,177,RFA,THERE
893,CK7,LYMPH,TTF
078,088,A549,ASODN,IRON,IRP2,PCR,SCODN,TFR,WESTERN
100,215,5600,CURVE,ESI,FASN,FFA,HMDB,LIPIDVIEW,METABOLOME,MWAS,MWSL,OPERATING,ROC,SCIEX,TRIPLETOF,UNTARGETED,USING,WIDE,XCMS
001,002,169,2002,597,AFTER,BACKGROUND,CHINA,CONCLUSION,COX,DIFFERENT,INSURANCE,LABEL,METHODS,PRESS,RESULTS
000,001,118,120,139,140,173,175,1992,2005,201,373,756,BACKGROUND,EFFORTS,END,ICU,ICUS,LABEL,METHODS,NINTH,RESULTS,SEER
000,111,324,567,BACKGROUND,DUE,FUNCTIONAL,HOWEVER,LABEL,LCAL1,LCALS,RESULTS,RNAS,THROUGH
169,2014,945,ANNEXIN,APOPTOTIC,CPG,DMS79,FLOW,INC,RU486,SCLC,SMALL,THESE,WILEY
A549,COLLAGENS,LTD,M13,PUBLISHED
504,945,946,AKT,CD133,HOWEVER,HSP90,IPI,THESE
DCS,NSCLC,THESE
18F,408,8202,AMONG,BACKGROUND,CONCLUSION,DISCOVERY,FDG,FIVE,FOUR,HEALTHCARE,HNSCC,LABEL,METHODS,PET,RESULTS
188,2002,8202,ACCEPTABLE,BACKGROUND,BMI,CONCLUSION,CRP,INITIAL,LABEL,METHODS,MOST,NRS,RESULTS,RISK,SCREENING
100,174,8202,AIM,BACKGROUND,CERVARIXTM,CONCLUSION,CURRENTLY,CZECH,GENERALLY,HPV,LABEL,LARGE,OBJECTIVE,OVERALL,PERSISTENT,SILGARD,THERE,WHILE
000,150,956,ARSENIC,SEVERAL,SINCE,WORLD
100,181,946,A549,ERK1,H2O2,HECOGENIN,MMP,THESE,TREATMENT
001,1032,169,1986,1999,2000,2008,2014,22YEARS,2MONTHS,3MONTHS,410,622,69YEARS,70YEARS,CIS,CONCLUSION,COPYRIGHT,COX,HRS,INSTITUTE,IRELAND,LABEL,LEE,LTD,MATERIALS,MEIER,METHODS,MOFFITT,OBJECTIVE,OBJECTIVES,RESULTS,SCLC
BAK,BAX,BCL,G13289A,ND5,ROS,STUDIES
6BP,ATP,LAST,PFK,TAKEN
ALK,CRIZOTINIB,DESPITE,EML4,NSCLC
169,2014,BRG1,NSCLC,SNF,SWI
169,2014,316,658,CASES,COLORECTAL,GBV,HODGKIN,LUNG,NHL,OVARIAN,PLCO,SCREENING,TRIAL
215,8201,AFTER,BACKGROUND,CARDIAC,CASE,CONCLUSION,LABEL,LUNG,METHODS
000,100,120,2010,2013,2020,733,DUTCH,EUR,FIRST,KWF,SOCIETY,THESE
THESE,THREE
001,059,127,8805,CCI,ECOG,FCI,HOWEVER
150,2002,2004,250,BOTH,EGFR,ERLOTINIB,GEFITINIB,JAPAN,NSCLC,PHASE,SIMILAR,TKI,TKIS
169,2014,GHANA,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,PURPOSE,RESULTS,SOCIETY,TOBACCO,UNIVERSITY,WARNING
34A,KIRSTEN,KRAS,MAPK,MICRORNAS,THESE
ECTOPIC,GLUT1,RRAD,TAKEN,UNDER
169,2014,8804,ADVERSE,ANY,BACKGROUND,CONCLUSION,CTCAE,INSTITUTE,LABEL,MEDICAL,MEIER,METHODS,NCI,NSCLC,OVERALL,PERCIST,PET,PFS,PRESS,PUBLISHED,RESULTS,SBRT,SIDE,SOCIETY,SOLID,UNIVERSITY
169,2010,2014,COPYRIGHT,DATA,JAPAN,LTD,RISK
160,169,2014,7402,803,956,A549,BEL,CNE,COPYRIGHT,IC50,MGC,MOST,SAS
169,1YL,2014,946,956,A549,CHN,COMPLEXES,COPYRIGHT,ESI,FURTHER,HELA,IC50,ICP,INC,MCF,NMR
169,1951,2014,LARS,LEKSELL,LITERATURE,SOCIETY,SRS
169,2014,GIVEN,HOWEVER,SBRT,SOCIETY
169,1977,1990S,1992,2005,2006,2010,2014,ALK,ASIAN,BACKGROUND,EGFR,END,HISPANICS,ISLANDERS,LABEL,LUNG,METHODS,PACIFIC,RESULTS,SEER,SOCIETY
0001,044,177,200,8201,8473,916,ALSO,COX,HOWEVER,III,NSCLC
103,178,224,398,8201,HENCE,LYS751GLN,OVERALL,XPD
946,CHRONIC,COPD,EMT,HOWEVER,SMADS,TFS,TGF,THUS,TWIST,WNT
169,2014,947,948,950,A549,CONSISTENT,COPYRIGHT,DESPITE,FEDERATION,H2AX,HOWEVER,PUBLISHED,REV3,RNAI,RNR,RPA,RRM1,SOCIETIES,SSL,TREATMENT
AFTER,BACKGROUND,CASE,LABEL,METHODS
105,954,CHINESE,JAK,LUNG,MLL2,NOTABLY,NSCLC,STAT
008,009,015,159,169,191,2014,609,800,COPYRIGHT,COX,DATA,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,RFS,SURGERY
AES,HOWEVER,INCREASED
169,200,2000,2014,A549,BLANK,DSPE,HACE,INC,PEG,RG3,THUS,WILEY
0001,002,0039,010,011,013,033,17RA,945,946,A549,H460,NSCLC,TNF
169,2014,386,414,A549,ATII,BESIDES,GMBH,GSH,KGAA,MOST,NCS,VCH,WILEY
169,2014,3ATA,946,ABC,ABCC1,ADR,AUTHORS,COPYRIGHT,GLC4,GSH,GST,MDR,MRP1,PUBLISHED,REGARDING
CBCT,FFF,ITV,LINAC,SBRT,VMAT
001,144,177,216,AIM,AKT,ASPIRIN,BON1,CONCLUSION,FURTHER,GOT1,H727,LABEL,METHODS,NCI,NET,NETS,OBJECTIVE,PROPIDIUM,RESULTS,STUDENT,SYBR,THESE,TREATMENT,WESTERN
945,COLORECTAL,CRC,HOWEVER,MAPK,RESISTANCE,STUDIES
0005,001,002,169,2014,251,BACKGROUND,BPF,COPYRIGHT,EMPYEMA,EPP,FVCEX,INC,LABEL,MAJOR,METHODS,MPM,PUBLISHED,RESULTS,SEVERAL,SOCIETY
045,153,157,169,181,190,2004,2009,2014,257,294,346,640,BACKGROUND,COPYRIGHT,DISTANT,IIIA,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,STAGE,YET
160,169,2009,2012,2014,BACKGROUND,COPYRIGHT,FIVE,FORTY,HOWEVER,IIB,IIIA,INC,INDUCTION,JANUARY,LABEL,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY,T3N0,T3N1
160,169,1999,2010,2014,242,276,290,BACKGROUND,COPYRIGHT,INC,LABEL,LEAVING,LIMA,LUL,METHODS,OVERALL,PUBLISHED,RESULTS,SOCIETY,THERE
946,CPG,MIRA,RAR
160,169,2014,527,COPYRIGHT,FIVE,HOWEVER,INC,LUNG,TP53,TP63
001,280,555,8201,BACKGROUND,BASED,CONCLUSION,EXON,LABEL,RESULTS
123,954,A549,AKT,BCL,DDP,ERCC1,ERK,SNAIL,SUNITINIB,THEREFORE,TWIST
8209,A549,BAX,BCL,BCL2,FIRST,LUNG,NEXT,PDC5,PDCD5,THEREFORE
161,215,BACKGROUND,CASE,CYFLA21,DIAGNOSIS,FINAL,HOWEVER,LABEL,MEDICATION,METHODS,OBJECTIVE,PATIENT,PROCEDURE,PULMONARY,RARE,SPECIALTY,THEREFORE
AKT,CANCEROUS,CIP2A,HOWEVER,INITIALLY,NOTABLY,PP2A,S473,TAA,THEREFORE
AREAS,BACKGROUND,COVERED,CURRENTLY,FURTHER,III,JAPAN,LABEL,METHODS,NSCLC,OPINION,PHASE
169,1973,1980S,1990,1990S,1995,1998,2000S,2005,2009,2014,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,INC,INCIDENCE,LABEL,LUNG,METHODS,RESULTS,SEER
169,2014,BACKGROUND,COPYRIGHT,ENDPOINTS,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SABR,V50,VOLUMETRIC
169,2004,2010,2014,26GY,41GY,47CM,7CM,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,GAMMA,JANUARY,KNIFE,KPS,LABEL,LILLE,METHODS,MRI,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SRS,TEN,UNIVERSITY,WBRT
0001,2009,2013,8804,HOWEVER,INDEX,PALLIATIVE,PPI,PROGNOSTIC
012,133,864,BRAIN,HOWEVER,OVERALL
INC,PFO,PLATYPNEA,PUBLISHED
177,945,956,BASED,CONCLUSION,COPD,ELISA,FEV1,FVC,HIF,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SERUM
EARLY,HOWEVER,LUNG,NLST
1000,169,2014,8805,996,COPYRIGHT,LLOQ,MMST,MMSTS,SEVERAL,TYR
000,AWARENESS,BACKGROUND,BELIEFS,DENMARK,HOWEVER,LABEL,METHODS,PREVALENCE,RESULTS,STATISTICS
169,2014,208,946,BECAUSE,CONCLUSION,FINALLY,FIRST,LABEL,METHODS,OBJECTIVE,PURPOSE,RANKL,RESULTS,SD208,SMAD,SMAD3,SMAD7,TAKEN,TGF
0001,0002,001,006,169,1795,2001,2011,2014,215,2695,8201,AIM,CONCLUSION,COX,LABEL,LUNG,METASTATIC,METHODS,OBJECTIVE,OCTOBER,RESULTS,SEPTEMBER,THERE,UNIVARIATE
123,169,1991,2011,393,COPYRIGHT,FERRATA,FOUNDATION,THERE,THUS
169,2014,3DAYS,A549,CONVERSELY,COPYRIGHT,PLGA,SAHA,SAS
169,174,177,2009,2011,2014,APRIL,BASIC,COMPARISON,COPYRIGHT,DEPARTMENT,FEV1,INC,LABEL,MAIN,METHODS,MOST,OBJECTIVE,PAIN,PAINBUSTER,POD,POD1,POD4,RESULTS,SEPTEMBER,SETTING,SUFFICIENT,SURGERY,TEA,THERE,UNTIL
169,2014,COPYRIGHT,DESPITE,INC,SMALL,THESE
169,2014,ADP,BCL,BH3,CDDP,COPYRIGHT,HENCE,INC,KNOCKDOWN,MCL,PAR,PARP1,SIX,THUS
004,008,016,030,040,APE1,BRCA1,CONCLUSION,DRUG,ERCC1,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIMILARLY,TUBB3
116,169,2013,2014,ADVERSE,AGREEMENT,ANXIETY,BACKGROUND,CLINICIANS,COPYRIGHT,CTCAE,DEPRESSION,HADS,IRELAND,JANUARY,JUNE,LABEL,LIFE,LTD,METHODS,MOST,OBJECTIVE,OUTCOME,PATIENT,PRO,PROS,PURPOSE,QOL,QUALITY,RESULTS,SCALE,THERE,TREATMENT
001,003,102,169,177,2006,2010,2014,383,8320,8321,BACKGROUND,BED,BETWEEN,COPYRIGHT,DOSES,GRONINGEN,GTV,GTVS,IRELAND,LABEL,LOCAL,LTD,METHODS,NSCLC,OBJECTIVE,OSAKA,PTV,PURPOSE,RESULTS,SABR,SUFFICIENT,UNADJUSTED,USING,WESTERN
1988,2013,3399,ANATOMICAL,BACKGROUND,CONCLUSION,ICD,LABEL,METHODS,RESULTS,THEREFORE,TUMOURS
003,008,014,1999,2001,2006,2010,321,AWARENESS,BACKGROUND,CHRONIC,CONCLUSION,COPD,DESPITE,DISEASE,F4L,GERMANY,HRQL,INITIATIVE,KORA,LABEL,LLN,LUNGS,MCS,METHODS,PCS,PULMONARY,REGARDING,REGRESSION,RESULTS,USING
946,AMONG,BACKGROUND,CAFS,LABEL,LENTIVIRAL,METHODS,RESULTS,RNAI,TGF,THEREFORE
119,169,2014,5271,633,BMI,CAREFUL,COPYRIGHT,COX,HRCT,ICD,IRELAND,IRREGULAR,LABEL,LTD,LUNG,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS,SEVERAL,SUBSEQUENT
102,160,169,2014,COPYRIGHT,H460,LIVER,LTD,LUNG,PEG,THESE
0001,0002,001,120,125,130,160,169,178,199,1998,2008,2014,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NODAL,PUBLISHED,RAS,RESULTS,SOCIETY
000,160,169,2014,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NIR,PUBLISHED,RESULTS,SMALL,SOCIETY
100,106,2011,2013,255,CONCLUSION,FDG,IMMEDIATE,INTRA,LABEL,LESIONS,MBQ,MEAN,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
ANTI,BACKGROUND,CASE,LABEL,METHODS,NMDA,OVARIAN
BESIDES,GERMANY,LUNG,WHILE
BACKGROUND,COMDP,HOWEVER,LABEL,RESULTS,THEN,THEREFORE
169,2014,COPYRIGHT,FEDERATION,HOWEVER,PUBLISHED,SOCIETIES
ALDEFLUOR,ALDHLOW,BACKGROUND,CD8,CSC,CSCS,CURRENTLY,FURTHER,H460,LABEL,METHODS,RESULTS
061,200,2059,254,344,400,453,505,553,792,935,AMERICANS,BACKGROUND,CONCLUSION,DETECTION,EARLY,LABEL,LDCT,LUNG,METHODS,NORTH,PAN,RESULTS
139,204,APOA1,BACKGROUND,CO4A,CRP,FIRST,GSTP1,LABEL,METHODS,RESULTS,SAMP,STMN1
176,177,2006,2011,AFTER,BACKGROUND,CONCLUSION,CRC,ILUP,LABEL,LOCAL,LUNG,MEIER,METHODS,OPERATIVE,RESULTS,THESE
493,E2F1,HOWEVER,NSCLC
CALOCEDRUS,DESPITE,EGFR,FURTHER,H1975,PC9,TKI
169,2014,ADI,ALSO,BIOLOGY,LEUKOCYTE,PEG20,PMN,PMNS,ROS,SOCIETY,THESE
005,169,177,2014,500,539,8805,ADVERSE,AUTHORS,BACKGROUND,BEST,BLIND,BSC,CARE,CELL,CISPLATIN,CONCLUSION,CONTROLLED,COPYRIGHT,CTCAE,ECOG,EUROQOL,FOLLOWING,HOWEVER,INC,INDUCTION,LABEL,LUNG,MATERIALS,METHODS,NON,NSCLC,OVERALL,PARAMOUNT,PEMETREXED,PHASE,PLACEBO,PLUS,PUBLISHED,QOL,RESULTS,SMALL,SUPPORTIVE,TREATMENT
002,1237,129,8201,BACKGROUND,CGS,CIS,CONCLUSION,CPRD,HOWEVER,KINGDOM,LABEL,METHODS,OVERALL,RATE,RESULTS,RRS,THUS
2001,2008,8201,8805,BACKGROUND,COX,DFS,DISEASE,EVALUATION,EXACT,FEV1,FISHERS,FURTHER,HEIDELBERG,III,LABEL,MARCH,MEIER,METHODS,NSCLC,OVERALL,RESULTS,TREATMENT,UNIVERSITY
COX,EGFR,FEW,NSCLC,PFS,SEVENTY,SINCE,TKI,TKIS,UNIVARIATE
AFTER,BACKGROUND,BRISTOL,CANCERS,CHI,CONCLUSION,EFFORTS,INDIA,KASHMIR,LABEL,MATERIALS,METHODS,PACKAGE,PEARSON,PRESENT,RESULTS,UNIVERSITY
001,002,003,004,009,012,016,022,027,030,031,1801133,215,HOWEVER,MTHFR,NSCLC,PFS,SNPS
292,946,A549,AMP,AMPK,BESIDES,BETULIN,BRDU,MTT,NCI,TAKEN
049,076,169,177,2014,COPYRIGHT,DICE,DSC,DSCS,FEV1,FVC,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PFT,PURPOSE,RESULTS,SPECT,V4DCT
000,169,2014,841,AMONG,COPYRIGHT,HODGKIN,INC,LABEL,LDCT,LDCTS,LUNG,MATERIALS,METHODS,OBJECTIVE,POPULATION,PURPOSE,QALY,QALYS,RESULTS,SCREENING,TRIAL,WTP
RESECTION,RIGHT
007,035,142,169,2014,452,5197,526,BACKGROUND,CAUCASIAN,CHINA,CHINESE,GENERAL,GWAS,HAN,HOUSTON,LABEL,METHODS,MICRORNAS,NANJING,NSCLC,RESULTS,SNP,SNPS,TEXAS,THESE,UNIVERSITY
001,0012,0030,0062,0074,057,102,8201,BACKGROUND,EXPRESSION,GLI,GLI1,GLI2,GLI3,III,LABEL,METHODS,RESULTS
DMR,DMRS
0008,001,004,009,049,113,177,AFTER,BACKGROUND,COX,ENGLAND,LABEL,MEIER,METHODS,RESULTS,SCORE,SFTP,SFTPS,TIME,VALIDATION
169,2014,344,ADDITIONAL,BACKGROUND,BLOOD,EGFR,LABEL,METHODS,MOST,NSCLC,RESULTS,SOCIETY,T790M,THESE
CEA,EARLY,PATTERN,RAS,RECURRENCE,SITE
169,2014,ALK,EGFR,ERS,NSCLC,THEREFORE
1999,2008,ACCORDING,BACKGROUND,CLINICALLY,COX,DFI,LABEL,MEIER,METHODS,NSCLC,OVERALL,POTENTIAL,RCC,RESULTS
100,AFTER,ALSO,CHINESE,CONCLUSION,GROUP,HFS,LABEL,METHODS,OBJECTIVE,RESULTS
ELCWP,PCI,SCLC,WHAT
ELCWP,SCLC,THESE,WHAT
ELCWP,THESE,WHAT,WHICH
2014,DOES,ELCWP,III,NSCLC,PCI,WHAT
ELCWP,IIIA,NSCLC,WHAT
001,002,014,016,039,169,2014,436,546,954,CONCLUSION,DIXON,FURTHER,HEALTHCARE,HOWEVER,LABEL,LAVA,MATERIALS,METHODS,OBJECTIVE,PET,PRIMARY,PROPELLER,PURPOSE,READERS,RESULTS,RSNA,STIR,WIS
092,169,177,2005,2011,2014,319,981,ANNS,CONCLUSION,EACH,GGN,GGNS,IPAS,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PATHOLOGIC,PURPOSE,RESULTS,RSNA,THREE
191,5TH,75TH,780,AIS,AISS,CONCLUSION,LABEL,METHODS,MIA,MIAS,OBJECTIVE,OBJECTIVES,RESULTS
1017,120,288,480,576,DESPITE,OME,PCA,THEN
2013,AIDS,BARR,CALIFORNIA,EPSTEIN,FRANCISCO,HIV,HODGKIN,IAS,MARCH,MITSUYASU,MORTALITY,SAN,USA
2014,ALK,BRAF,CONSORTIUM,COPYRIGHT,EGF,EGFR,HER2,KRAS,LUNG,MEK,MET,NETWORK,NSCLC,PROUS,SCIENCE,THERE,THESE,VEGF,VEGFR
2014,378,ALK,CERITINIB,COPYRIGHT,CRIZOTINIB,DRUG,FOOD,LDK,NON,NSCLC,OVERCOMING,PROUS,SCIENCE,SEVERAL
169,2014,CDC6,HOWEVER,LABEL,THESE,UNLABELLED
169,2014,938,BACKGROUND,CROSS,CURRENT,FORTY,LABEL,METHODS,MOST,RESULTS,ROUGHLY,SMOKING
129,130,228,319,467,549,BACKGROUND,BASED,BMJ,COX,EASTERN,ECOG,GROUP,IQR,LABEL,LENT,LIMITED,MALIGNANT,METHODS,MPE,PUBLISHED,PUBLISHING,RESULTS,RISK,THREE
2001,2004,202,608,8201,897,ADJUSTMENT,AFFAIRS,AOR,BLACK,CRT,III,IMRT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHITE
000,169,1802,2014,731,984,AUTHORS,BOTH,DATA,EGFR,FOUNDATION,GIVEN,III,JOHN,JOURNAL,LTD,MOLECULAR,NSCLC,PFS,POOLING,SONS,TKI,TKIS,WILEY
181,1994,2004,240,676,8805,BACKGROUND,BILIRUBIN,CIS,CONCLUSION,COX,CURRENT,HRS,LABEL,METHODS,PROMOTION,RESULTS,SERUM,SEVERANCE,SMOKING
140,200,2013,225,500,FINALIZING,FORTY,LABEL,LDCT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIOLOGY,RESULTS,SOCIETY
001,005,007,019,024,026,027,029,126,2006,2008,300,404,445,470,659,DLCO,FEV1,FVC,JANUARY,NSCLC
CBL,HOWEVER,KNOCKDOWN,NH4CL,PROLINE,PYK2,THESE,TRYPSIN
160,2007,2011,ACCORDING,BACKGROUND,BETWEEN,EPIPHYSEAL,IIA,IIB,ISOLS,JULY,LABEL,LIMB,MAY,METHODS,RESULTS,SALVAGE,SOCIETY,THERE
118,1241,169,2006,2014,231,E362A,ECM,HOWEVER,INT,KNOCKDOWN,MCF,MDA,SEVERAL,THESE,TYPE,UICC,VIA
100,956,DEVELOPING,HOWEVER,IGF,USING
129,169,2014,2P23,ALK,BACKGROUND,CURRENT,D5F3,DRUG,FISH,FOOD,IHC,LABEL,METHODS,MINIMALLY,RESULTS,SOCIETY
4A1,BIS,DIM,DIMS,NR4A1,NUR77,THUS,USING
FINALLY,PARTICULAR,QUESTIONS,THREE
0001,032,109,2003,2013,282,EGFR,L858R,NSCLC,SRS,TKI,WBRT
161,177,1998,2007,60S,8201,8805,AGE,CONCLUSION,CRT,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
EGFR,THESE
130,945,ESI,HOWEVER,METABOLIC,NABH4,NNK
169,2014,ABBS,ACADEMY,BIOLOGICAL,BIOLOGY,BONE,CELL,CHINESE,EDITORIAL,INSTITUTE,INSTITUTES,LUNG,MICE,NON,NSCLC,PRESS,PUBLISHED,UNIVERSITY
ADC,APOE,LNM
2012,EFFORTS,III,NSCLC,SINCE,THERAPIES
1996,2007,541,ASIAN,CARE,CIS,CLINICIANS,COX,DATA,DISCUSSION,ETHNICITY,EVEN,FINALLY,FLORIDA,FLORIDIAN,HOWEVER,HRS,ISLANDERS,LABEL,MEIER,METHODS,NON,NSCLC,OBJECTIVE,PACIFIC,PAKISTANI,PURPOSE,RACE,RESULTS,SES,THUS
000,006,113,139,153,175,384,574,639,693,713,739,903,976,BACKGROUND,DATA,DFS,GROWING,LABEL,MAJOR,MATERIALS,METHODS,NON,NSCLC,RESULTS
110,AWS,POD,POD20,UNDER
RIGHT,TOTAL
MOST,SCLC
000,100,110,128,169,2001,2011,2014,248,3501,360,5149,BANS,BINSWANGER,CENTERS,CONTROL,DATA,DISEASE,JUSTICE,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,POISSON,PREVALENCE,PREVENTION,PRISONS,RESULTS,SETTING,SMOKING,STATISTICS,THESE
169,2002,2012,2014,CONCLUSION,HOWEVER,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEVERAL,THERE,UNIVERSITY
8201,ARTIFICIAL,CONCLUSION,CXR,FREE,FROC,GGO,KEY,LABEL,LDCT,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
AMPLITUDE,FDG,KEY,LABEL,LESIONS,METHODS,OBJECTIVE,OBJECTIVES,ORG,PET,RESULTS,SUVMEAN,WHOLE
169,2014,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,EGFR,EMPIRICAL,ICU,ICUS,IRELAND,LABEL,LTD,LUNG,METHODS
169,2014,ASIAN,CAUCASIAN,CHRONIC,COPYRIGHT,IRELAND,LTD,TREATMENT
100,149,169,2014,AUR,BOARD,COPYRIGHT,CTS,ETHICAL,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,THEREAFTER
169,2014,ACCORDING,AUR,COPYRIGHT,EVALUATION,INC,LABEL,MEIER,METHODS,NCECT,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,ROC,SOLID
160,211,A549,BCL,BIM,COA,HMG,HOWEVER,IAP,MSTO,NAC,NSCLC,PEMETREXED,ROS,STATINS,THESE
4736,CTLA,CYTOTOXIC,LABEL,LUNG,MEDI,MPDL3280A,NSCLC,ONGOING,OPINION,PROMISING,SCLC,STATEMENT,THESE,UNASSIGNED
011,169,2014,301,342,BACKGROUND,III,LABEL,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,STUDIES,TAKEN,THERE,UNIVERSITY
169,2014,621,BIOLOGY,BXB,HOWEVER,INC,MAPK,MOLECULAR,RAF,RAFS,RAS,SER,SOCIETY,TAKEN
CTL,FFPE,GP1R,PD1,PLATELETS,SAMPLES,STUDIES,THESE
ALK,EML4,EMT,H3122,HOWEVER,HYPOXIA,MTT,NSCLC,REGARDING
160,8804,ALND,BACKGROUND,DOSE,HTGF,III,LABEL,METHODS,RANDOMIZED,RESULTS,SLN,SLNB,SLNBA,SNLBA,STGF,TGF,THERE
169,2014,946,BESIDES,CDH1,CHALLENGES,COPYRIGHT,EMT,GIVEN,HEF1,LUNG,NEDD9,SOCIETY,TGF,TGFB1,WHILE
169,2014,850,8805,AFTER,BACKGROUND,BIRTH,CONCLUSION,COPYRIGHT,COX,INITIATIVE,LABEL,LTD,METHODS,RESULTS,WOMEN
107,160,194,9607,BOTH,CDH2,IGF1R,LUCIFERASE,PCR,POTENTIAL,SOSP,STUDIES,USING
000,2014,AFRICAN,FINALLY,GOVERNMENT,GWAS,PRESS,PRIOR,PUBLISHED,SNPS,TEN,UNIVERSITY,USING,WBC,WHITE
A549,CALU,ERK,HOWEVER,JNK,MAPK,MMP9,NSCLC,PI3K,SEMAPHORIN
DIAGNOSING,DIAGNOSIS,LITERATURE,ORAL
1970S,HOWEVER,TODAY,YET
169,2014,231,241,308,458,549,AKT,ANOIKIS,CONVERSELY,COPYRIGHT,COX,CYP,EP4,FLAVONOIDS,HETE,INC,ISL,MDA,NOTABLY,P450,PDK,PGE2,PI3K,SER,THR,TYR
100,200,400,738,AUSTRALIA,CONTINUOUS,COX,LATENCY,STATINS,WESTERN,WITTENOOM
169,2014,815,CONCLUSION,COPYRIGHT,EXPRESSION,GPC5,HSPGS,LABEL,LTD,METHODS,MTT,OBJECTIVE,PCR,REAL,RESULTS,SACC,TIME,WESTERN
010,015,24RGD,916,AD5,E1A,EVALUATION,IMPROVING,ONYX,ORCA,RGD
BACKGROUND,FINALLY,LABEL,METHODS,NVP,RCC,RESULTS,SMO,SMOOTHENED,SUR,THEREFORE,THUS
DESPITE,EFM,EFMS,METABOLISM,RESULTS,THEREFORE
100,152,169,BACKGROUND,EARLY,ELISA,HCC,HEPATITIS,IGG,INADEQUATE,LABEL,LUNG,METHODS,RESULTS,SERUM,TAAS,VARYING
167,BACKGROUND,CNVS,COLORECTAL,COPY,EAGLE,FINALLY,FUNCTIONAL,LABEL,LUNG,OVARIAN,PLCO,PRINCIPAL,RESULTS,SCREENING,SNP,TRIAL
143,177,DESPITE,DOCETAXEL,THESE,USING
136,169,2014,231,339,689,945,AMONG,CBX5,CHIP,H3K9ME3,HELA,HOWEVER,HP1,KAP1,LABEL,MDA,RRP1B,UNLABELLED
169,2014,AKT,ALI,DESPITE,HOWEVER,INCREASED,KUMAR,PI3K,RAP1B,SHP,THUS
169,2011,2014,ASCO,BRISTOL,CHECKPOINT,CTLA,FDA,MARCH,MYERS,SOCIETY
169,2014,UZUNBAS,YANG
HOWEVER,LABEL,LARGELY,NET,NETS,OPINION,PFS,RESULTS,STATEMENT,TARGETING,UNASSIGNED,UNTIL,VEGF
15B,169,2014,ATM,ATR,BIOLOGY,CELL,CHEK1,HOWEVER,INC,MICRORNAS,MOLECULAR,PCR,PPM1D,RAD,RNAS,SOCIETY,WIP1
2000,2012,390,860,ACC,ADRENAL,BACKGROUND,CONCLUSION,JANUARY,LABEL,MEIER,METASTASES,METASTATIC,METHODS,NETWORK,OPERATIVE,RESULTS,SEX
169,2014,ALSO,COPYRIGHT,INC
PREVIOUSLY,T12
CERTAIN,HOWEVER,SECRETORY
01382,03256,148,520,555,5726,733,8201,849,9393,946,967,AXIN2,AXIS,CHINESE,CIS,GENOTYPING,HAN,ORS,SNP,T148C,WNT
8197,EGFR,G719S,NSCLC,T790M
134,945,COA,FOURIER,SIX
169,2009,2014,8201,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,GEELONG,LABEL,LOWER,METHODS,RESULTS,ROYAL,RURS,SOUTH,TIME,WESTERN,WHETHER,ZEALAND
029,034,160,2003,2012,8201,BACKGROUND,CONCLUSION,FIFTEEN,JANUARY,LABEL,METHODS,OCTOBER,OVERALL,RESULTS
A549,CISPLATIN,CYTOTOXIC,FE3O4,FOURIER,IC50,MTT,NPS,PEG,PEG6000,PLGA
411,BCL2,BIM,CML,EGFR,GCS,GIVEN,TKI,TKIS,UNDERLYING
947,CD34,CELL,EFFICIENT,GFP,HSCS,IL2R,NOD,SCID,SIMILAR,UTILIZING
105,5HMC,767,DECREASED,TET,TET1,TET3
100,109,420,586,8805,AMONG,BACKGROUND,HOWEVER,LABEL,PCR,PRINCIPAL,RESULTS,RNAS,RPLP0P2,SEVERAL,USING
946,C1GALT1,ECM,HCC,HOWEVER,RNAI,THESE
1013,169,2014,969,A549,AFM,COPYRIGHT,FOURIER,FTIR,LDHS,MTT,MTX,PBS,REVERSE,TEM,THEN,XRD
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,FURTHER,KI67,LABEL,LTD,METHODS,NET,NETS,PRIMARY,RESULTS,SIXTEEN,SUNNYBROOK,WORLD
00001,003,117,169,2014,346,500MG,75MG,979,COPYRIGHT,COX,III,IRELAND,JMDB,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PARAMOUNT,PFS,PUBLISHED,RESULTS
169,2014,203,CARDIAC,CENTERS,CENTRAL,COPYRIGHT,EARLY,EAST,ELCAP,EXCELLENCE,IRELAND,LABEL,LDCT,LOCATIONS,LTD,LUNG,MATERIALS,METHODS,NLST,NORTH,NORTHEAST,OBJECTIVE,OBJECTIVES,PROGRAM,RADIOLOGY,RESULTS,SCREENING,SOCIETY,TRIAL
169,2014,236,COPYRIGHT,CSC,DEPENDING,LTD,MAPK,MOST,PI3K,PTEN
HOWEVER
169,2014,220,348,8201,AUSTRALIA,AUSTRALIAN,BACKGROUND,BURNOUT,COLLEGE,CORRECTION,CPD,FOUR,FURTHER,HSS,INVENTORY,LABEL,LUNG,MASLACH,MBI,METHODS,RESULTS,ROYAL,SPECIALIST,THERE,THOSE,ZEALAND
AFTER,NEN,NENS,SURGERY
158,169,2014,288,767,ACCP,AUC,BACKGROUND,INC,LABEL,MAYO,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,WILEY
116,169,2014,205,549,956,COLO,COPYRIGHT,HCT,IC50,LTD,MTT
169,2014,ACADEMY,BASED
139,154,157,158,161,169,2014,8201,AUSTRALIAN,COLLEGE,CONCLUSION,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROYAL,TECHNICAL,THERE,VATS,ZEALAND
169,2014,946,BECAUSE,COPYRIGHT,EMT,H2DCF,H2O2,ICW,INC,MEASURING,MET,NADPH,NOX4,PCA,PHENOTYPE,PRINCIPAL,SMAD,SMAD2,SMAD3,SMAD4,TGF,WESTERN
945,ARSENIC,AS2O3,DLL4,HIF,HOWEVER,NOTCH,NSCLC,SCLC,THESE,VEGF,VEGFR
947,HOWEVER,THOSE
169,2014,ALZHEIMER,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SCHOLAR,SCIENCE,SOCIETY,UPLC,WEB
A549,AIF,FLOW,GNA,RIP1,THESE,VDAC
160,169,2014,BACKGROUND,BOTH,COPYRIGHT,FDG,FNA,INC,LABEL,METHODS,PET,PUBLISHED,QUALITY,RESULTS,SOCIETY,VATS
169,2006,2014,655,BACKGROUND,CLINICALLY,COPYRIGHT,DATA,HOWEVER,INC,LABEL,METHODS,PUBLISHED,REAL,RESULTS,SOCIETY,THROUGH,TSP
169,2014,COPYRIGHT,GADD45A,INC,SEVERAL,TARID,TCF21
169,2014,COPYRIGHT,HOWEVER,INC,PUBLISHED,SOCIETY,TYPICALLY
169,2014,COPYRIGHT,HOWEVER,INC,LUNG,MOLECULAR,PUBLISHED,SOCIETY,THESE
169,1993,1995,2006,2010,2014,283,792,952,AARP,COLORECTAL,COPYRIGHT,COX,DIET,INC,INSTITUTES,LUNG,NIH,OVARIAN,PLCO,SCREENING,SIMILAR,TRIAL,WOMEN
169,2014,204,313,399,517,789,AFRICAN,AMERICANS,ARMD,BLOOD,COPYRIGHT,EVERY,EXOME,HEART,HGMD,INC,INSTITUTE,LUNG,MENDELIAN,NBS,OMIM,PGX,PROJECT,PUBLISHED,SEQUENCING,SOCIETY,THESE
169,2002,2012,2014,CONCLUSION,COPYRIGHT,HER2,INC,LABEL,METHODS,OBJECTIVE,RESULTS
008,037,046,239,250,AMONG,ASSESSMENT,BACKGROUND,CONCLUSION,EGFR,FACT,FIRST,FUNCTIONAL,GRADE,IIIB,LABEL,LCS,LUNG,METHODS,NSCLC,OVERALL,RESULTS,THERAPY
0001,003,177,215,221,269,2D3,319,379,580,A549,BETWEEN,CCK,DDP,FURTHER,H1650,PC9,SPC,TABLE,VITAMIN
138,312,450,BACKGROUND,CAUCASIAN,CONCLUSION,DELETIONS,EGFR,L858R,LABEL,METHODS,NSCLC,PCR,RESULTS,TESTING,TTF1
1997,946,BACKGROUND,EPIGENETIC,HCC,LABEL,METHODS,RESULTS,WNT
169,2007,2012,2014,ASSESSMENT,COPYRIGHT,INC,INCREASED,LABEL,LSF,LUNG,MATERIALS,MAY,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,SIRT
169,2014,ACR,COLLEGE,COPYRIGHT,INC,PUBLISHED,RADIOLOGY
164,967,BACKGROUND,IIIA,IIIB,LABEL,MEIER,METHODS,RESULTS,THERE
132,160,169,2009,2012,2014,APRIL,BACKGROUND,BRIEF,COPYRIGHT,FORM,INC,INDEX,ITEM,LABEL,MAY,MEDICAL,METHODS,MINIMALLY,PAIN,PATIENT,PUBLISHED,RESULTS,SHORT,SOCIETY,VATS
004,015,027,160,169,1985,2012,2014,287,545,626,698,BACKGROUND,BETWEEN,COPYRIGHT,COX,DISEASE,FIVE,INC,LABEL,LUNG,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE,THESE
005,009,045,231T,AFTER,ARHGDIB,BRMS1,CASP8,CD44,CD82,CDH1,CDH11,CDH2,DNM3,DRG1,FIVE,GSN,KISS1,MCF7,MDA,METASTASIS,MSG,MSGS,NME1,OAS1,PDE5A,PEBP1,RRM1,UGT1A
129,169,2009,2014,ANZSCTS,AUSTRALIA,AUSTRALIAN,BACKGROUND,BPF,CARDIAC,CONCLUSION,COPYRIGHT,CSANZ,EARLY,FOLLOWING,FORTY,IIIA,LABEL,MEAN,METHODS,NSCLC,OCTOBER,PUBLISHED,RESULTS,SOCIETY,ZEALAND
169,2014,981,985,COPYRIGHT,EXCELLENT,FINALLY,LUNG,PREDICTION,USING
BOTH,CATHEPSIN,HIGH,JAM,METASTASIS,WHILE
001,033,042,081,123,139,369,8201,DFS,FGFR,FGFR1,GCN,HOWEVER,NSCLC,SQCC,THESE
169,2014,A549,BESIDES,COPYRIGHT,GMBH,HIGH,HTRA2,NSCLC,THEN,THUS,WESTERN
HSCT,MIXED,MUCORALES
215,279,919,ADC,ATC,BACKGROUND,DIFFUSION,DWI,LABEL,MAPS,METASTASES,METHODS,MRI,PATIENT,RESULTS,THERE
LABEL,METHODS,MRI,OBJECTIVE,PDACS,PURPOSE,RESULTS,THESE
933,ALGORITHM,BOTH,DICE,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,VOIS
100,124,176,177,215,221,358,AAA,ALTO,AXB,CARLO,ECLIPSE,GERMANY,ITV,LABEL,MEANS,MEDICAL,METHODS,MONTE,NOVALIS,OBJECTIVE,PALO,PTV,PURPOSE,RESULTS,SBRT,SYSTEMS,THEN,WATER,XVMC
177,4DCT,CARDIAC,DIR,DVFS,EIGHT,EPID,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,SBRT,SPATIAL,TORSO,XCAT
177,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
4DCT,AAA,AVG,AVGP,CURRENT,FBP,ITVP,LABEL,MCSV,METHODS,MLC,OBJECTIVE,PTVP,PURPOSE,RESULTS,SBRT,THESE,VOLUMETRIC
169,2014,ALSO,APA,CCAGSCTGG,COPYRIGHT,FOUR,LTD,PASS,RGYRYRGTGG,RNAS,SVM
001,003,009,035,042,083,2002,2012,ATTEMPTING,BACKGROUND,COMPLETION,FORTY,ICU,III,ITT,JANUARY,LABEL,METHODS,RESULTS,SUCCESSFUL,THERE,VATS
169,2014,LUNG,PRESS,PUBLISHED,RFA,SURGERY,UNIVERSITY
169,2014,A549,BIOLOGY,CDC42,CONVERSELY,GDP,GTP,GTPASES,HIGH,INC,LIM,MOLECULAR,RAC1,RHO,RHOA,SCID,SOCIETY
169,2014,551B,AKT,COX,DECREASED,EGFR,FINALLY,FLIP,FURTHER,KNOCKDOWN,MUC1,MUCIN,PRESS,PUBLISHED,ROS,SCAVENGING,THUS,UNIVERSITY,USING,WHILE
109,406,533,586,8805,AMONG,EGFR,HOWEVER,LOC440905,LUNG,PCR,RNAS,RP11,STUDIES,USING
100,160,169,2008,2011,2014,240,254,311,8805,AIMS,AMONG,COLLEGE,COPYRIGHT,CRC,LABEL,LOCAL,LTD,LUNG,MATERIALS,METHODS,NSCLC,OBJECTIVE,POTENTIAL,PREDICTORS,PTV,PUBLISHED,RESULTS,ROYAL,SABR,V100
169,2014,ATRT,ATRTS,COPYRIGHT,HOX,HOXC,HOXD,HOXD8,INC,INI1,JPAS,PEDIATRIC,RESULTS,RNAS,SMARCB1,THESE
A427,A549,CCAR2,MELATONIN,NSCLC,ORDINARILY,SIRT1,THESE,TREATMENT
001,016,066,160,164,169,2001,2012,2014,BACKGROUND,COPYRIGHT,COX,HOWEVER,INC,LABEL,METHODS,OVERALL,PUBLISHED,RESULTS,SBRT,SOCIETY,THERE,UNIVARIATE
002,009,169,2014,601,BACKGROUND,COPYRIGHT,INC,LABEL,LCC,LCNEC,LELC,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE
0003,0226,170,2004,2013,246,254,670,716,BASED,BETWEEN,LABEL,MARCH,MAY,METHODS,OBJECTIVE,RESULTS,SMOKERS,THERE,UNIVARIATE
169,2014,BRITISH,COPYRIGHT,EIGHT,III,LTD,ORAL,PUBLISHED,RESECTION,SCC,TNM
2004,2008,371,496,CASES,DIET,LUNG,SPANISH
169,2014,5127,AACR,HOWEVER,NADPH,NOTABLY,OVERALL,RES,ROS,THESE,TIGAR
00001,015,250,BACKGROUND,CONCLUSION,LABEL,LNS,MANAGER,MEAN,METHODS,OUTCOME,RESULTS,STATA,VATS,WHILE
100,101,117,166,177,400,401,576,719,CAC,CONCURRENT,ECG,LDCT
001,004,010,241,AKT,ALSO,BACKGROUND,BOTH,CD147,CD98,LABEL,METHODS,NSCLC,PI3K,RESULTS,WESTERN
001,0KG,169,1978,1993,1ST,2008,2014,358,5TH,6729,8805,BMI,CONCLUSION,COPYRIGHT,COX,FOLLOWING,INVERSE,IRELAND,LABEL,LITHUANIAN,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,TSC
001,009,044,169,1998,2011,2014,228,335,401,700,8805,BETWEEN,CEREBELLAR,COPYRIGHT,COX,GAMMA,INC,JUNE,KNIFE,LABEL,LOCAL,MATERIALS,MAY,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SRS,THERE,THESE
BACKGROUND,BCL,BEAS,CHINA,CITY,FINALLY,GEJIU,H157,HOWEVER,LABEL,LUNG,NCI,NSCLC,PRINCIPAL,PTEN,RECK,RESULTS,SOUTH,YTMLC
169,183,201,2014,384,AIMS,AMONG,CONCLUSION,COPYRIGHT,EACH,FFPE,FIVE,FOUR,HOWEVER,ICC,IHC,INC,LABEL,METHODS,OBJECTIVE,RESULTS,S1PR,S1PR1,S1PR2,S1PR3,S1PR4,S1PR5,S1PRS,STUDENT,THEN,TMA,TMAS
ALSO,CONVERSELY,KIT,THEIR
ADULT,CARDIAC,EVALUATION,GENERAL,INDEX,LABEL,LMA,METHODS,MORBIDITY,OBJECTIVE,RESULTS,REVISED,RISK,SOCIETY,THERE
215,T2B,TEMLA,THERE,ULTIMATELY
169,2014,COPYRIGHT,DESPITE
160,169,2014,946,CAF,CAFS,COPYRIGHT,HSF1,INC,SDF1,STROMAL,TGF,THUS
183,1979,2010,2012,2013,217,237,8202,967,APRIL,BACKGROUND,DEB,DISEASE,DRUG,EBSCO,FIVE,LABEL,LIBRARY,METHODS,RCTS,RESULTS,SCHOLAR,SCIENCE,TACE,THERE,WEB,WILEY
169,2014,956,A549,BAX,BCL,COPYRIGHT,DR3,EMSA,EXPRESSION,FAS,H460,HOWEVER,IRELAND,LTD,NCI,NSCLC,PULL,STAT3,WESTERN
1716,1751,7449,BACKGROUND,BRIEF,INVENTORY,LABEL,METHODS,OLDER,OUTCOME,PAIN,RESULTS,SECONDARY,SYMPTOM
EUS,GUIDELINES,IPMN,IPMNS,THERE
116,169,2014,946,ARG,ASP,BAX,BCL,FOCAL,GLY,HCT,III,KP46,LOSS,RAPID,RGD,TRIS
140,169,1981,1986,1999,2003,2005,2009,2014,28000,AIMS,AML,AMONG,BACKGROUND,CIS,FURTHER,LABEL,METHODS,NORWEGIAN,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SIR,SIRS,SOCIETY,UNIVERSITY
BASED,BEIR,BIOLOGICAL,CARLO,COMMISSION,EFFECTS,FINALLY,FIRST,ICRP,IMRT,MONTE,PROTECTION,RADIATION,SOMETIMES,THEN,VII
169,177,2014,956,A549,COPYRIGHT,OVERALL,PLGA
169,2014,ERK1,INCUBATION,LUNG,MAPK,NSCLC,SURGERY,THESE,TLR,TLR4,TOLL,UICC,USING
272,274,CTPA,CTPAS,EACH,LOW,REFERRING,WHILE
147,150,169,177,2014,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,ORR,PFS,PFS15,RESULTS,SECONDARY,SEQUENTIAL,SIMON
023,045,1252,126,130,169,2014,256,500MG,75MG,822,980,996,ASIAN,CHINESE,CONCLUSION,COPYRIGHT,EAST,IIIB,IRELAND,JMDB,JMIL,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PATIENT,RESULTS
171,187,239,BECAUSE
169,193,2014,6977,COPYRIGHT,GGO,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPE,THEREFORE
2014,ALSO,ASSESSMENT,BACKGROUND,BMJ,CHINESE,DATA,DIAGNOSTIC,ENGLISH,GROUP,ISI,LABEL,LIMITED,MAY,MEDLINE,METHODS,MINIMALLY,NIHR,PUBLISHED,PUBLISHING,QADAS,QUALITY,RESULTS,REVIEWS,SCIENCE,SINOMED,SYSTEMATIC,TRIAL,WEB
169,2014,ATO,DRUG,FOOD,GLI2,INHIBITION,KNOCKDOWN,UICC
MOST,WORK
005,018,038,102,8201,BACKGROUND,COX,HIGH,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS
169,2014,320,DYNAMIC,EIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,SVC,UNIVERSITY
169,2014,APOPTOTIC,BACKGROUND,BAX,BCL,CCK,CDK,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MMP,OBJECTIVE,PURPOSE,RESULTS
2007,METASTATIC,THESE
100,169,2014,956,A549,ANTI,CONCLUSION,HEP3B,JOHN,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PARP,PC3,RESULTS,SONS,STIRT,SUCCESSFUL,THUS,USNEA,WILEY
115,HOWEVER,IGF,INSULIN,LABEL,METHODS,NSCLC,NVP,OBJECTIVE,PCR,PURPOSE,RESULTS,SIGNALLING,THERE,THESE
2009,2013,28TH,5TH,APRIL,CHINESE,DCR,EASTERN,ECOG,GENERAL,GROUP,JUNE,LABEL,MAY,METHODS,NSNSCLC,OBJECTIVE,OBJECTIVES,ORR,PFS,PLA,RESULTS
087,104,105,122,147,163,188,1982,2000,2009,209,236,271,305,320,445,641,888,904,982,984,AGE,APC,ASIRC,ASIRW,CHINA,CHINESE,CONTROL,LABEL,LUNG,METHODS,OBJECTIVE,OVERALL,PREVENTION,PROVINCIAL,RESULTS,SEGI
300,806,967,CD31,IHC,LABEL,MATERIALS,METHODS,MVD,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,021,043,532,899,BACKGROUND,EXPRESSION,GOLGI,HIGH,HOWEVER,LABEL,MATERIALS,METHODS,MVD,NSCC,NSCLC,RESULTS
064,141,437,447,842,8804,BACKGROUND,FORTY,IGF1R,LABEL,MATERIALS,METHODS,RESULTS,THERE
LABEL,METHODS,OBJECTIVE,PFS,RESULTS,SCLC,THERE
748,ABSTRACTS,ASCO,BACKGROUND,DCR,EGFR,ESMO,FURTHER,GRADE,HFSR,HOWEVER,LABEL,METHODS,NSCLC,PFS,RCTS,RESULTS,SBT,SORAFENIB,TKI
2013,CHENNAI,CONCLUSION,INDIA,LABEL,METHODS,OBJECTIVE,PREVALENCE,RESULTS
383,456,657,665,691,792,968,984,BACKGROUND,CAUCASIANS,LABEL,MATERIALS,METHODS,RESULTS,THERE
AFTER,CCK,CELL,DEPLETION,LABEL,MB231,MDA,METHODS,MMP,MTA2,OBJECTIVE,PCR,RESULTS,TRANSWELL,WESTERN
000,158,2012,2013,288,8805,AGE,BACKGROUND,CANDIDA,ICU,JANUARY,LABEL,LUNG,MAJOR,MATERIALS,METHODS,MRSA,RESULTS,VAP
169,2014,BRITAIN,BUDDING,COPYRIGHT,EMT,GREAT,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,WILEY,ZEB1
001,169,2014,279,326,571,COPYRIGHT,GRIM,GRP78,HOWEVER,INC,NSCLC,SIMILARLY,TNM,USING
001,2006,2010,215,256,8201,8805,ALC,AMC,BETWEEN,COX,HOWEVER,JANUARY,LMR,NPC,PRE
001,014,018,145,COX,GOLGI,HIGH,HOWEVER,MEIER,NSCLC,TNM
001,002,1349,141,2014,BOTH,DATA,HAP1,HOWEVER,MARCH,STUDIES
0001,001,031,042,131,517,CASES,COX,CURRENT,FACTORS,HOWEVER,LABEL,MARTINI,MELAMED,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS
169,2014,ACIDS,NUCLEIC,PRESS,PUBLISHED,RESULTS,TFS,THEREFORE,THESE,UNIVERSITY
946,EMT,NOTCH,NSCLC,TGF,WESTERN,ZEB
169,2014,945,AMP,AMPK,CONSISTENT,KRAS,LKB1,NSCLC,THESE,UICC
100,14Q21,169,17Q11,2014,336,ASIAN,OPG,PRESS,PUBLISHED,TNFRSF11B,UNIVERSITY
001,106,AFTER,BASED,FDG,HOWEVER,LABEL,METHODS,OBJECTIVE,PARTIAL,PET,PROCEDURES,PURPOSE,PVE,REGRESSION,RESULTS,SUVMEAN,TLG,VOLUMETRIC
169,2014,650,8201,8805,BACKGROUND,COPYRIGHT,DISEASE,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SONS,THEREFORE,WILEY
230,EGFR,ERBB2,HIGH,MAPK,MET,MGA,MYC,NF1,RBM10,RIT1,THESE
655,BACKGROUND,CASE,CLINICIANS,CNS,INCLUSION,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SCIENCE,SEVEN,SURGERY,WEB
1995,2007,2008,441,727,AMONG,CALIFORNIA,CONFIDENCE,COX,EXCLUSIVE,INTERVALS,JANUARY,MHT,SMOKING
001,183,275,ABCB1,ABCC2,ABCG2,AUC0,BCRP,BMS,HOWEVER,LLCPK,MDR1,MDR1A,MRP2,ORAL,PGP,PPI,PPIS,PROTEIN,RESISTANCE,RESULTS
A549,AKT,ATG5,BACKGROUND,DDP,FMW,GFP,HOWEVER,LABEL,LC3,METHODS,NDV,NEWCASTLE,ONCOLYTIC,PI3K,PTX,RESULTS,THESE
ACTIVATING,ATF4,BACKGROUND,ESCC,HOWEVER,LABEL,MMP,PRINCIPAL,RESULTS
021,673,AFTER,CRT,DT50,GTV,GTV1,GTV2,NSCLC,PLAN,RADIATION,THERE
108,2008,2009,269,377,946,BRCA1,HRS,JANUARY,PFS,RRM1,THESE
6D4,8202,AAD,ANNEXIN,BACKGROUND,CD16,CD3,CD326,CD4,CD56,CD8,COPD,FEV1,FIRST,GREATER,LABEL,LUNG,MICA,MICB,NKG2D,NKP44,THESE,TRIAL,UNLABELLED,WHETHER
009,099,146A,149,196A2,2014,499,705,ASIAN,EAST,INSTITUTE,ISI,MAY,REFERENCES,SCIENCE,SCIENTIFIC,SEVEN,WEB
CD8,G12D,HRAS,KIRSTEN,KRAS,L858R,LUNG,N17,OVA,OVERALL,RAS
124,144,159,2008,2013,211,370,BMJ,GROUP,JANUARY,LIMITED,PRESTON,PUBLISHED,PUBLISHING
125,137,141,156,1998,2010,DISCUSSION,FOUR,III,JAPAN,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
160,ADRENAL,BACKGROUND,CASE,CONCLUSION,CUSHING,HHV,HIV,IMAGING,LABEL,METHODS,POST,PULMONARY,SUBSEQUENT
1513,500,900,916,AMONG,BACKGROUND,BESIDES,CSF,LA1,LABEL,NON,NONE,NSCLC,R172H,RESULTS,SINCE,SPP1,THUS
231,ATM,ATR,CHK1,CHK2,ERK,FURTHER,HOWEVER,JNK,MAPK,MAPKS,MCF,MDA,NAC,ROS,SINOMENINE,SINOMENIUM
169,177,2014,27853,A549,ATCC,BACKGROUND,CHINESE,COPYRIGHT,ETHYL,IRELAND,LABEL,LTD,MATERIALS,MBC,METHODS,MIC,MTT,RELEVANCE,RESULTS

2002,2011,351,ACCORDING,AFTER,AIM,ASSESSMENT,BMI,JULY,LABEL,METHODS,NRS,OBJECTIVE,RESULTS,RISK,SCREENING,SEPTEMBER,SGA,SUBJECTIVE,SURGERY,TTR
001,005,2012,2014,AIM,CHICAGO,DATA,FOUR,IASI,IIIA,IIIB,INC,INSTITUTE,IRCI,LABEL,MATERIALS,MAY,METHODS,MOST,NSCLC,OBJECTIVE,PEARSON,RESULTS,SEX,SPSS,SURGERY,USA
AMONG,ASSESSMENT,C30,CHEST,EORTC,FACT,FUNCTIONAL,GENERAL,LCSS,LUNG,QLQ,QOL,SCALE,SYMPTOM,THERAPY,TREATMENT
1604,2014,GIVEN,IGF,MEETING,OLDER,SCHMIDT,SOCIETY
BACKGROUND,CONTEXT,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POSITIVITY,RESULTS,SIXTEEN
EGFR,ERLOTINIB,NSCLC,THEREFORE
1429,556,873,AFTER,AIMS,ANNOTATION,BACKGROUND,CCNB2,CDC20,CDC45,CONCLUSION,DATA,DAVID,DEGS,DISCOVERY,EXPRESSION,FEN1,HOWEVER,INTEGRATED,LABEL,MCM2,MCM4,METHODS,OBJECTIVE,OMNIBUS,PTTG1,RESULTS,RETRIEVAL,SET,TOOL,TOOLKIT,WEB,WEBGESTALT
007,124,AIMS,BACKGROUND,CRANIAL,FIFTY,INSTITUTE,LABEL,METHODS,OBJECTIVE,RESULTS,SMALL
0001,047,142,145,177,2010,212,276,807,AFTER,AIMS,COST,CRAIG,LABEL,METHODS,OBJECTIVE,PROLONGED,RESULTS,SEVENTY,TRIAL
FEATURING
169,2014,ANTICANCER,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,DESPITE,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,SIMPLEX,TEN,VIRUS
169,2014,AGE,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,ELDERLY,GRADE,GROUP,IIIB,INDUCTION,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,RESULTS
133,140,169,2014,ANTICANCER,CA19,CONCLUSION,COPYRIGHT,DFI,INSTITUTE,JOHN,LABEL,METHODS,RESULTS,THOSE,TPS,UNLABELLED
0001,001,0054,026,029,039,169,191,2014,945,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EXPRESSION,INSTITUTE,JOHN,LABEL,LOW,MATERIALS,METHODS,NGBR,NOGO,NSCLC,RESULTS,SQC,STAGE
169,2014,AIM,ANTICANCER,ANTITUMOR,BACKGROUND,CD4,CD8,CLUSTER,CONCLUSION,COPYRIGHT,DCS,HOWEVER,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MHC,MUC1,OBJECTIVE,RAG2,RESULTS
936,HENCE,HOWEVER,TP53
000,002,2013,ASCO,BACKGROUND,BIOMEDICAL,CBM,CHINA,CHINESE,CNKI,CONCLUSION,CONFERENCE,DATA,DCR,EGFR,EGGER,ENGLISH,EPIDERMAL,ESMO,EXTRACTION,INCLUSION,JADAD,KARNOFSKY,KNOWLEDGE,KPS,LABEL,LIBRARY,LITERATURE,LUNG,MEDICAL,METHODS,NSCLC,OBJECTIVE,OCTOBER,ORR,OTHERWISE,RESULTS,RISK,SOCIETY,TCMH,TCMHS,TKI,WCLC,WORLD
128,153,226,BOTH,RASMUSSEN
169,2004,2013,2014,899,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS
2435,3240,3540,8197,871,AIMS,BACKGROUND,BMJ,COX,GREATER,GROUP,HOWEVER,LABEL,LIMITED,LUNG,METHODS,NASH,NSCLC,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,THESE
001,004,005,013,021,034,038,041,107,262,369,8201,8805,ADVERSE,AMONG,BACKGROUND,III,LABEL,MATERIALS,METHODS,RESULTS,STAGE,THERE,WHETHER
169,2014,5008,AACR,C57BL,NOD,RES,SCID,TLR,TLR7,TLRS,TOLL
169,17Q,2014,COPYRIGHT,INC,NEC,PRIMARY,RECURRENT
290,522,ASIAN,CIS,DATA,ORS,RESULTS,STATA,THERE,USING
BASED,BSF2,CAUCASIAN,CIS,CNKI,MEDLINE,ORS,STUDIES
169,2014,BROAD,CELLS,CHIP,COMPARABLE,CTC,CTCS,GMBH,H1650,KGAA,MCF7,VCH,WILEY
007,169,2014,3CM,5CM,ADVERSE,BACKGROUND,CONFORMAL,GTV,LABEL,METHODS,NSCLC,OVERALL,PRESS,PTV,PUBLISHED,RESULTS,TOXICITIES,UNIVERSITY
BACKGROUND,CASE,HOWEVER,LABEL,LEFT,MALIGNANT,METHODS,SUGGESTED
169,2004,2013,2014,8805,AFTER,COPYRIGHT,DISTANT,FIVE,FORTY,IMRT,INC,INCREASING,LABEL,MATERIALS,MAY,METHODS,MPM,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERE
10R,169,2014,ALK,CD74,COPYRIGHT,EC50,EC60,EML4,H3122,PF06463922,ROS,ROS1,SOCIETY,THUS,USING
DUE,EARLY,HOWEVER,METASTATIC,VARIOUS
0001,003,005,169,2014,CIK,CNKI,CONCLUSION,COPYRIGHT,DCS,FURTHER,HRQOL,LABEL,MEDLINE,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESULTS,SECONDARY,SIX,THERE,WEIPU
0001,ANALOGOUS,BACKGROUND,CD4,EFFECTIVE,FLOW,INCREASED,LABEL,MAIN,METHODS,MICROARRAY,NORMALIZED,OBJECTIVE,OBJECTIVES,PDCD1,RATIONALE,RESULTS
159,160,1994,2002,946,956,MAX
001,120,134,135,BACKGROUND,FOUR,INDUCTION,LABEL,MEDLINE,METHODS,NSCLC,OBJECTIVE,OVERALL,RESULTS,SIX,SPINE,UNIVARIATE
BACKGROUND,FDA,HOWEVER,ICG,LABEL,METHODS,NIR,OPTICAL,RESULTS
00001,004,718,8202,CIS,CONCLUSION,HOWEVER,HRS,LABEL,META,METHODS,NSCLC,OBJECTIVE,ORS,PCI,PURPOSE,RCTS,REMAN,RESULTS
0001,003,215,247,521,946,AFRICAN,AMERICANS,BACKGROUND,BECAUSE,BEHAVIORAL,COPD,EXHALED,FAGERSTROM,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OMNI2,RATIONALE,RESULTS
FTICR,HIGH,IMS,MALDI,USING
169,2014,CONCLUSION,EFFECTIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SURGERY,TREATMENT
022,100,169,2014,281,ALK,CONCLUSION,FISH,IHC,LABEL,LUNGSCAPE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TESTING
8211,BECAUSE,DESPITE,LUNG
169,2014,AIM,BACKGROUND,BRITISH,CONCLUSION,GENERAL,INDICATORS,JOURNAL,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,THEIR
163,8197,8805,956,DHA,PEG,SUBSEQUENT
CDDP,DESPITE,HOWEVER,III,LUNG,NAD,NRF2,NSCLC,SIRT5,TAKEN
160,945,946,960,BOTH,CLARIFYING,DKK,GST,MDR,NSCLC,SFRP,TOPO,WNT
160,181,ATP7A,BCPS,CELL,CTR1,CUCL2,GIVEN,H196,H889,MRC,NAC,NCI,PDTC,ROS,SCLC,THESE
8209,ABC,ABCE1,ATP,HOWEVER,MCF,MTT,RNASE,STUDIES,THESE,TRANSWELL
8201,947,BACKGROUND,CLASS,EBT2,FFF,GAMMA,LABEL,MAPCHECK2,METHODS,MLC,MLCS,PATIENT,QAS,RESULTS,SBRT,SHIFT,THREE,VMAT
CELL,CONCLUSION,EGFR,FIFTY,FISH,HIGH,LABEL,LN6216C,METHODS,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,ASSESSMENT,CONCORDANT,DAPK,HRM,MCNEMAR,MSP,PCR,RASSF1A,RESULTS,SEVERAL
9P21,FISH,HOWEVER,MMS,THESE
160,AKT,ERK1,LAM,PROTEIN,THUS,TSC2
18A,231,945,AGO2,BACKGROUND,DMFS,ECTOPIC,HIF1A,HOWEVER,LABEL,LAST,LUCIFERASE,MDA,METHODS,MIR17HG,MODULATING,PCR,RESULTS
127,1567,160,169,2003,2012,2014,AMONG,BACKGROUND,BRAF,CONCLUSION,COPYRIGHT,DESPITE,HOWEVER,INC,LABEL,MAY,MEIER,METHODS,PFS,RESULTS
100,169,2014,ADVERSE,BACKGROUND,COPYRIGHT,IIIA,IIIB,INC,LABEL,METHODS,NSCLC,RESULTS,SECONDARY,THESE,TMZ
004,028,050,169,193,1991,2011,2014,AFTER,BACKGROUND,COPYRIGHT,FIFTY,INC,LABEL,LOBECTOMY,METHODS,NSCLC,PATHOLOGIC,PUBLISHED,RESULTS,SIXTY,SOCIETY,UNIVARIATE
169,2014,BACKGROUND,COPYRIGHT,EBUS,INC,LABEL,METHODS,PATIENT,PUBLISHED,RESTAGING,RESULTS,SOCIETY,THERE,THUS
000,100,1992,2001,2011,2025,240,2645,457,MALIGNANT,MEDIANS,MOST,NOW,THESE,UKRAINE
BEAM,MARGINS,RANGE
169,2014,916,A549,ALTOGETHER,BEAS,CB1,CB2,CBD,COPYRIGHT,FINALLY,H460,ICAM,INC,INCREASED,LAK,LFA,THC,THESE,USING
161,169,2014,8201,BIOMARK,COPYRIGHT,ERCC1,ERCC2,ERCC3,ERCC4,ERCC5,III,IIIA,IIIB,IRELAND,LTD,NSCLC,SNP,SNPS,XPA,XRCC1,XRCC2
169,2014,AMONG,COPYRIGHT,HOWEVER,LTD,PROMISING,ROR1,RTK,RTKS,TKI
954,956,A549,BAX,BCL,CELL,CONSISTENT,DAPI,DR3,DR6,DRS,EMSA,EXPRESSION,H460,HOWEVER,NCI,THESE,TNF,TUNEL,WESTERN
1ST,2003,2012,246,35TH,AMONG,CHINA,CHINESE,ESR,EXTENSIVE,ILD,LABEL,LUNG,METHODS,NPC,OBJECTIVE,OBJECTIVES,RESULTS
195,956,A2780,A549,ESI,G361,HELA,HOS,IC50,LNCAP,MCF7,NMR
A431,A549,DMSO,EVALUATION,HEPG2
105,169,176,2014,233,945,946,A549,ASTERACEAE,BACKGROUND,BEH,CHINA,COMPOUNDS,COPYRIGHT,ETHANOLIC,HSS,INDIA,IRELAND,JAPAN,LABEL,LTD,MATERIALS,METHODS,RELEVANCE,RESULTS,SAUSSUREA,THEIR,UPLC
SHH,THERE,WHAT
GRAM,HACEK,PULMONARY
160,MSCS,SIMILARLY,UNDER
169,2014,946,A549,AMONG,ASIA,COPYRIGHT,EAST,HELA,HOWEVER,LTD,NMR,SOUTH,THEIR
001,160,169,2014,945,ALSO,BACKGROUND,CELLS,COPYRIGHT,EMT,IPF,LABEL,LTD,METHODS,RESULTS,SMA,SRIF,THESE,THREE,TTF1,UIP
COMPARING,ERR,LABEL,MATERIALS,MAYAK,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RBE,RESULTS
169,2008,2014,219,241,288,306,312,628,798,8364,850,CENTRAL,CNS,COSTS,EASTERN,EVERY,HODGKIN,LOST,PREMATURE,STOMACH,THESE,UICC,WESTERN,YEARS,YPLL
169,2014,AUTHORS,BARR,BOTH,BRITISH,CELLS,CTL,CTLS,EBV,EPSTEIN,HLA,JOHN,JOURNAL,LTD,NEITHER,PTLD,SINCE,SONS,THUS,WILEY
153,169,2014,AKT,AKT1,AMO,IC50,KNOCKDOWN,LUCIFERASE,LUNG,UICC,UTR
001,052,160,2005,2007,DIAGNOSIS,END,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SEER,USING
106,169,2014,215,321,ACCORDING,ASIA,CNKI,COLLEGE,COPYRIGHT,CSSCI,EAST,LABEL,LIBRARY,MEDICAL,MET,META,METHODS,OBJECTIVE,PUBLISHED,RELATED,RESULTS,THR,THR241MET,XRCC3
169,2014,946,A549,BCL,CAFS,COLLEGE,COPYRIGHT,EXPRESSION,GFP,ITGB1,ITGB3,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS
169,2014,AUTHORS,BOTH,COPYRIGHT,ETC,INC,METASTATIC,PUBLISHED,PYK2,SRC,THUS
169,2014,AIMS,ALK,BRAF,CDX2,CK7,CONGENITAL,CPAM,EGFR,G12V,HER2,JOHN,LABEL,LTD,METHODS,MUC1,OBJECTIVE,RAS,RESULTS,SONS,STOCKER,TTF,VE1,WILEY
169,2014,COPYRIGHT,INC,PET,SCLC,THROUGH
169,2014,BECAUSE,COPYRIGHT,FURTHER,INC,LARGE,LCNEC,NSCLC
169,2014,CARCINOID,COPYRIGHT,INC
169,2014,COPYRIGHT,INC
169,2014,BOTH,COPYRIGHT,DOTA,FDG,INC,PULMONARY,TYPICAL
169,2014,COPYRIGHT,INC,LARGE,SMALL
169,2014,COPYRIGHT,INC,LCNEC,SCLC
169,2014,239,COPYRIGHT,INC,SIMILARLY
BONE
169,2014,ALK,COPYRIGHT,EGFR,FGF,FGFR,HER2,INC,JAK,KRAS,MEK,MET,PATHWAY,STAT3,THESE
169,2014,COPYRIGHT,H3K4ME3,H3K9ME1,INC,JMJC,NSCLC,PHF8,TSSS
1024,1381,169,1947,2014,2812,344,8201,865,ACRIN,ANXIETY,AUTHORS,BACKGROUND,COLLEGE,CXR,FORM,HRQOL,INC,INVENTORY,LABEL,LDCT,LOW,LUNG,METHODS,NLST,RADIOLOGY,RESULTS,SCREENING,SHORT,SIF,SIFS,SOCIETY,STATE,TRAIT,TRIAL,WILEY
CCN1,CYR61,FGF2,PECAM,SPARC,TAKEN,THESE,THUS,USING,VEGF
0001,001,002,004,6MWT,ANOVA,BACKGROUND,BOTH,CHANGES,CHEST,CONCLUSION,CONTROLLED,CPT,CURRENT,EACH,LABEL,METHODS,NSCLC,PULMONARY,RBR,RESULTS,TEST,THERAPY,TRIAL,WALK
169,2014,BINDING,CLINICALLY,COPYRIGHT,EATON,FEDERATION,IRELAND,LAMBERT,LEMS,LTD,NMJ,PUBLISHED,SCLC,THESE,VGCC,VGCCS
169,194,1999,2011,2014,219,BACKGROUND,COPYRIGHT,DECREASED,ENGLAND,FURTHER,INCREASED,LABEL,LTD,METHODS,PARKINSON,RESULTS,RRS,THERE
CLEAR
169,2014,945,CIP1,CK2,COPYRIGHT,FEDERATION,IMR,KNOCKDOWN,NADPH,PLD1,PLD2,PUBLISHED,ROS,SOCIETIES,TAKEN,WAF1
001,002,100,138,NOTABLY,NSCLC,PCR,PDK1,TNM
001,006,012,018,169,2014,702,ACADEMY,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SMOKING,SPANISH
201,227,587,8201,ARG194TRP,CAUCASIANS,HENCE,OVERALL,XRCC1
001,10877,10878,125,169,2014,5CC,8320,8321,8325,945,946,BACKGROUND,BED,CONVERTING,COPYRIGHT,DMAX,DOSE,INCIDENCE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,USING
169,2013,2014,404,874,BASED,COPYRIGHT,HENCE,IRELAND,JULY,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RRR,THEREFORE,THESE
169,2014,DRUG,FOOD,KIF5B,ONCOGENIC,PRESS,PUBLISHED,RET,SPC,TREATMENT,UNIVERSITY
946,BALB,EGFP,LEWIS,MICE,NUDE,PLK1,SPF,TGF,XENOGRAFT
ARNTL,BMAL1,CLARA,CXCL5,MOP3,THESE
145,160,173,177,2000,2012,8201,BACKGROUND,BAT,CHEST,CONCLUSION,LABEL,MEAN,METHODS,PLT,PLTS,RESULTS,TOTAL
BACKGROUND,CASE,CORRESPOND,DUE,HER1,HER2,LABEL,METHODS,THERE
083,177,BACKGROUND,LABEL,MALIGNANT,MEAN,METHODS,MODEL,OBJECTIVE,RESULTS
001,100,169,208,COPD,FASEB,LYMPHOCYTE,OLIVE,OTM,OTMS,RESPONSES,ROC,UVA
169,2014,945,CD133,COPYRIGHT,FINALLY,G6PD,H2O2,HIF1,INHIBITION,SM22,SOCIETY,THEREFORE,THESE
AMONG,H3K9,H3K9ME3,SUV39H1,THUS
373,A549,ADDITIONAL,CALU,EPIGENETIC,HDAC,IRAK2,IRELAND,KNOCKDOWN,LAMP1,LTD,NSCLC,PCR,PUBLISHED,SAHA,TREATMENT
001,003,004,007,033,169,2014,214,239,340,BMI,COPD,COPYRIGHT,GIT,GOLD,HOWEVER,IRELAND,LABEL,LTBI,LTD,LUNG,MEIER,METHODS,NEWLY,NON,OBJECTIVE,OBJECTIVES,QFT,RESULTS,TUBE
015,100,105,111,143,169,2014,340,811,946,CK34,CK5,CK7,COPYRIGHT,CROWN,E12,GMBH,MOST,PUBLISHED,SCC,THERE,TTF,UNIVARIATE
110,169,2013,2014,418,BACKGROUND,CENTERS,COPYRIGHT,DESPITE,EHR,FIFTY,FORCE,INC,JANUARY,LABEL,LACK,LCS,LDCT,LUNG,MEANINGFUL,METHODS,NCCN,NETWORK,PREVENTIVE,PUBLISHED,RESULTS,SOCIETY,TASK,THREE,USPTF
100,177,2010,8201,ASSESSMENT,CINV,CONCLUSION,HEC,JAPAN,LABEL,MAY,MEC,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
100,169,2014,CIGARETTE,EIGHT,ERS,FINALLY,FURTHER,IIP,PHASE,SMOKING
169,2014,4EBP1,A549,AKT,COLLEGE,COPYRIGHT,EGFR,FLOW,LABEL,MEDICAL,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PTEN,PUBLISHED,RESULTS,TKI
10B,169,2014,COLLEGE,COPYRIGHT,KLF4,LABEL,MEDICAL,METHODS,OBJECTIVE,PCR,PUBLISHED,REAL,RESULTS,TRANSWELL,WESTERN
149,160,187,206,8805,BAL,FOB,HSCT,NPV,PPV,PULMONARY,THERE,TREATMENT
169,183,AFTER,AREAS,GEORG,PRIMARY,SINCE,STUTTGART,THEREFORE,WILMS,YORK
AFTER,THERE
116,169,2014,205,431,923,936,956,A549,COLO,COPYRIGHT,H322,HCT,IC50,MTT,NCI,SAS,SKIN,T47D
006,035,2011,2012,APRIL,BACKGROUND,CONCLUSION,EDAC,EDAP,LABEL,METHODS,MPS,NSCLC,PDAC,PDAP,RESULTS
169,DESPITE,EPP,GIVEN,HOWEVER,MALIGNANT,MPM,PEMETREXED,PRESS,THESE
AGE,ELISA,EPCAM,NSCLC,SERUM,SIMILARLY,THERE
2012,AMONG,BACKGROUND,BASED,CARE,CASE,CDSR,CONCLUSION,DARE,ECONLIT,EXCELLENCE,HTA,INSTITUTE,JULY,LABEL,LYS,MEDLINE,METHODS,NICE,OBJECTIVE,OBJECTIVES,OTHER,QALYS,REFERENCE,RESULTS,SIMILARLY,STUDIES,USA
1989,2008,233,8073,BACKGROUND,BESAG,CASE,CONCLUSION,LABEL,METHODS,MOLLI,RESULTS,SPAIN,YORK
169,2014,ABL,ADAM9,CDCP1,SRC
086,160,508,727,AMONG,BACKGROUND,CONCLUSION,END,GINET,INCREASING,LABEL,METHODS,NET,PNET,RESULTS,SEER,STUDIES,USING
8209,A549,AKT,ERK,ERK1,FIRSTLY,KDR,MTT
169,2014,RAPID
2006,2012,ACUTE,MRIS,SEVENTY,SRS,SRT
008,028,046,8804,EGFR,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PACLITAXEL,PFS,PURPOSE,RESULTS,SIXTY
MINI,MMSE,STATE,UFPS
169,2014,CISPLATIN,COPYRIGHT,HOWEVER
CUTANEOUS,DIAGNOSTIC,HOWEVER,PHYSICIANS
2003,2013,8805,COPD,FEV1,LOBAR,NSCLC,THERE
169,2014,AMONG,AUTOMATED,COPYRIGHT,DUE,GAMMA,GOODMAN,INC,KRUSKAL,OVERALL
945,A549,AKT,BACKGROUND,ELISA,H460,HIF,HPV,JNK,JUN,LABEL,METHODS,NCI,NSCLC,OBJECTIVE,OBJECTIVES,PCR,PI3K,REAL,RESULTS,VEGF,WESTERN
003,100,111,211,219,8202,ALK,FISH,IHC,ROS1
2003,2004,2005,2006,2007,2008,2009,2010,759,8201,BACKGROUND,FEMALES,FOUR,HPV,LABEL,METHODS,NUTRITION,ORADJ,RESULTS
100,1058,140,2004,2013,215,220,225,300,639,8201,AMONG,BACKGROUND,FIFTEEN,FURTHER,HSCT,IDENTIFIER,IMPORTANCE,JULY,LABEL,MAIN,METHODS,OBJECTIVE,OCTOBER,RELEVANCE,RESULTS,SETTING,THERE,TRIAL
ASKIN,FDG,FIFTEEN,PET,SEVENTEEN
AKT,BESIDES,DFS,EGFR,ERK,NSCLC,PTEN,RESISTANCE,TKI,TKIS
001,AFTER,BACKGROUND,COX,EFFECTS,EXPRESSION,HGF,LABEL,MAPK,MET,METHODS,NSCLC,RESULTS,TARGETING,TRANSGENIC
BACKGROUND,EGFR,L858R,LABEL,METHODS,RESULTS,T790M,THESE,TKI,TKIS,V843I
002,004,005,016,039,050,120,153,204,AMONG,ASIAN,BACKGROUND,BCL,BIM,EGFR,LABEL,METHODS,NSCLC,PFS,RESULTS,TKIS
100,23ANDME,ALSO,AMONG,BACKGROUND,BIO,DNALINK,HELLOGENE,HOWEVER,INSTITUTE,KOREA,LABEL,MATERIALS,METHODS,OPTIMUS,RESULTS,SNP,SNPS,THESE
100,1391,169,2014,570,958,AFTER,BACKGROUND,EGFR,FISH,HIGH,III,IIIB,KRAS,LABEL,MEDICAL,METHODS,NSCLC,PFS,PRESS,PUBLISHED,RESULTS,SIMILARLY,SOCIETY,THERE,UNASSIGNED,UNIVERSITY
169,2014,239,HOWEVER,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,PULMONARY,RESULTS,UNIVERSITY,WHILE
100,125,169,2003,2012,2014,350,APRIL,DAYS,EAST,EASTERN,FIFTY,GRADE,GROUP,HOWEVER,IRINOTECAN,JUNE,LABEL,LOW,METHODS,OBJECTIVE,PRESS,PUBLISHED,RANDOMIZED,RESULTS,UNIVERSITY
0035,049,144,159,169,2014,214,235,ASIA,FURTHER,HISTOLOGIC,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,STUDIES,THERE,UNIVERSITY,USA
99M,CONCLUSION,LABEL,METHODS,METHYLENE,NSCLC,OBJECTIVE,RESULTS,SIXTY,SLN,SLNS
177,181,946,A549,AFTER,ARF,BMI,CISPLATIN,CONCLUSION,DDP,H2AK119,IC50,INK4A,LABEL,METHODS,MTT,OBJECTIVE,P14,P16,P21,P53,RESULTS,SILENCING,WESTERN
160,169,2014,8211,945,ALIKE,BIOLOGY,CELL,CHATURVEDI,COMMONS,EWING,EWS,FLI,HOFFMAN,LICENSE,SHARE,SILENCING,SOCIETY,USING
169,2014,COPYRIGHT,DEPENDING,EXOGENOUS,IMPORTANCE,LABEL,OBJECTIVE,ONCOLYTIC,SOCIETY,THEREFORE,UNLABELLED
FURTHER,NON
231,AKT,MDA,PI3K,STC,TAKEN
BMSCS,EPCAM,LUNG,OPN,TAKEN
120,169,2014,495,617,BRCA1,CCND1,CHUNG,CUL3,CURRENTLY,DDR2,DDX3X,EGFR,EPHA2,FGFR,FGFR1,FGFR2,FGFR3,HNSCC,HPV,KRAS,KRIGSFELD,LABEL,METHODS,MLL2,MUTATIONS,NOTCH,NSD1,OBJECTIVE,PI3K,PURPOSE,RESULTS,S249C,TP53
2014,8197,BMJ,EGFR,GROUP,HOWEVER,LTD,PUBLISHING,THESE
HOWEVER,META,RRA,THEREFORE
120,127,145,280,300,440,FOCUS,THERE
500,CARL,INTRABEAM,IORT,NBS,PRS,THERE,ZEISS
BRAIN,PCI,SCLC,WBRT
ASIAN,EAST,EGF,EGFR,NSCLC,ORAL
DISCUSSED,NON,NSCLC
739,945,BACKGROUND,CHRONIC,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SYNERGY
201,220,277,930,AFTER,DDX58,DEFINITIVE,HOWEVER,III,PRKCE,THREE,VALIDATION
001,177,5CM,ASA,ASSESSMENT,BACKGROUND,CONCLUSION,DBP,END,FURTHER,GII,H2O,IVOR,LABEL,LEWIS,MAP,METHODS,OBJECTIVE,OBJECTIVES,OLV,PACU,PCA,PEEP,RESULTS,SBP,SETTING,SOCIETY,TABDO,TBASELINE,TEA,THERE,TOLV,TPOSTOP20,VAS
MRI
001,008,169,172,2005,2012,2014,ALK,BACKGROUND,EGFR,KRAS,LABEL,METHODS,NEURO,NSCLC,OVERALL,PRESS,PUBLISHED,RECEIPT,RESULTS,SOCIETY,SUBSEQUENT,UNIVERSITY
169,2014,CDDP,MICROARRAY,MPM,NRF2,NSCLC,THESE,WESTERN
000,169,2014
169,1970S,1982,2011,2014,5TH,AIRSTREAM,ARCHIVE,BECAUSE,BRITISH,EXECUTIVE,FIVE,FREEDOM,HYGIENE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PAH,PRESS,PUBLISHED,RESULTS,SOCIETY,STEEL,UNIVERSITY
130,169,1999,2012,2014,506,AIM,BECAUSE,BRONCHIAL,IDIOPATHIC,LABEL,METHODS,OBJECTIVE,RESULTS,WHEREAS
AMERICA,NORTH,THESE
AUC,DOR,HOWEVER,LUNG,NLR,PLR,SEN,SPE,SROC,STATA,THUS,WHILE
169,1995,2010,2014,258,415,AMONG,CIS,COX,DRUG,EHR,EHRS,HRS,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY,USING,VANDERBILT
AVAILABLE,COLLEGE,CURRENTLY,EGFR,LADC,LSQC,LUNG,MEDICAL,MOLECULAR,NETWORK,PATHOLOGY,SOCIETY,THERE,THEREFORE,TKI
169,2014,8226,956,APOPTOTIC,CONCLUSION,GSH,HIGH,JOHN,LABEL,LTD,MATERIALS,MELATONIN,METHODS,OBJECTIVE,OBJECTIVES,PBMC,RESULTS,SONS,UNDER,WILEY
169,2014,DEFORMABLE,DIR,HOWEVER,INSIGHT,ITK,JAPAN,PARAMETER,PRESS,PUBLISHED,RADIATION,SOCIETY,TOOLKIT,UNIVERSITY
A549,BEAS,CASPASE,CONVERSELY,EGFR,ERBBS,ERK1,MUC1,MUCIN,NEU,SINCE,THESE
169,2014,916,946,ALTERED,BMP,FURTHER,HTY,NOTABLY,PC3,RUNX2,SMAD,SMADS,TGF,THUS,UICC
IMAGING,THEREFORE
CURRENTLY,DUE,HER2,SINCE
160,3RD,5TH,ACUTE,BACKGROUND,CARDIAC,CONCLUSION,CTCAE,CTVS,DOSE,III,IMN,IMRT,LABEL,METHODS,MOST,OBJECTIVE,PTV,PURPOSE,RESULTS,SKIN,TRIAL
169,2000,2012,2014,4850,7071,AFTER,COPYRIGHT,DFS,ENGLISH,FORTY,INC,LABEL,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT
100,169,2014,CONVERSELY,EGFR,FLT,H1993,H820,IMAGING,KI67,LABEL,MET,METHODS,NSCLC,NUDE,OBJECTIVE,PET,PURPOSE,RESULTS,TKI,TKIS
100,108,160,177,8201,8226,8805,AUTOMATED,CAD,CONSORTIUM,EUCLIDEAN,IMAGING,IQR,KEY,LABEL,LIDC,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THUS
001,009,169,2000,2012,2014,DELTA,FINALLY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
131,341,436,ADVERSE,CONCLUSION,GGO,HOWEVER,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RESULTS,TEST,TNB
AUC,HE4,SCLC,SERUM,THESE,USING
031,1995,2013,504,778,851,8804,956,998,COX,MEIER,MPM
AFTER
0018,169,177,2014,62Y,COPYRIGHT,DESPITE,FIM,FURTHER,INC,LABEL,MAIN,MEAN,MEASURE,MEDICAL,METHODS,OBJECTIVE,OUTCOME,PRIMARY,PUBLISHED,RESULTS,SETTING
120,A375,PTHRP
100,BACKGROUND,DFA,HBEC,KRAS,LABEL,METHODS,RESULTS,TP53,V12,VOC,VOCS
004,007,1065,184,233,ADC,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,SQCC
160,A549,CELL,LENTIVIRUS,MIGRATION,NEDD9,PCR,THESE
169,2014,346,BECAUSE,COLLEGE,COPYRIGHT,EGFR,FURTHER,INC,MOLECULAR,PATHOLOGY,PCR,PNA,PUBLISHED,SIX,SOCIETY,THESE
004,019,028,070,114,115,185,218,229,237,389,846,BACKGROUND,CONCLUSION,CRC,LABEL,METHODS,PFS,RESULTS
BRAIN,DOPS,SAPC,SAPOSIN,TAKEN,THESE,THIRD

3840,4712,AIMS,BEGG,CIS,CNKI,DATABASES,ERCC1,EUROPEANS,FURTHER,LABEL,META,METHODS,OBJECTIVE,ORS,OVERALL,RESULTS,SCHOLAR,SUMMARY
160,252,8594,945,A549,GIVEN,HIF,HOWEVER,HYPOXIA,KLF5,USING
11Q13,11Q15,13Q11,15Q11,18P11,19P13,19Q11,1Q21,20P13,20Q11,2P25,2Q11,3P26,5P15,6P25,7P22,7Q11,8P23,8Q11,9P24,9Q12,ARRAY,CONGENITAL,PATIENT
946,EMT,EPITHELIAL,ERM,HOWEVER,TGF,THEREFORE
169,16HBE,2014,BPDE,CELL,COPYRIGHT,HOWEVER,IRELAND,LTD,LUNG,PCR,RNAS,USING
100,1990,2010,BACKGROUND,BETWEEN,EIGHT,FIFTY,HONG,JANUARY,KONG,LABEL,METHODS,PROCEDURE,PROGNOSTIC,PULMONARY,RELATIVELY,RENAL,RESULTS,WILMS
DECREASED,REGUCALCIN
945,946,947,948,949,A549,ACTIVATING,CSC,CUMULATIVE,H1299,H446,NCI,USING,WESTERN
1979,2000,2007,2010,956,PM2,THESE,USA,WORLD
EGFR,KRAS,RNAS,SMALL,THESE
2005,2010,8201,ASIAN,BACKGROUND,EGFR,IIIB,JANUARY,JUNE,LABEL,METHODS,NSCLC,RESULTS,TKI,TKIS
ACTIVATING,ATF2,FOS,JUN
0MM,169,2014,2MM,BASED,CONCLUSION,COPYRIGHT,CTV,GTV,IRELAND,ITV,LABEL,LTD,MATERIALS,METHODS,NSCLC,NTCP,OAR,OBJECTIVE,PTV,PURPOSE,REDUCTION,RESULTS,RTTT,SBRT,TOTAL,VERO
125,340,AFTER,KPS,MALIGNANT,TAKEN
8211,99M,AMEDIAN,METHYLENE
029,032,043,048,101,ALPHA,COX,CRYAB,HOWEVER,IHC,MEIER,NSCLC,TNM,WESTERN
100,169,2014,COPYRIGHT,ENDOSCOPIC,EUS,FNA,HISTOLOGIC,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
AXIAL,B13,BRUNNER,FLAIR,GERMANY,MRI,SIEMENS,TESLA,VOLUMES,WMH
FISHERS,FLDA,FORMULA,HIGH,HOWEVER,LUNG,POMEROY,THEREFORE,WANG,WHILE
169,2014,COPYRIGHT,IIIB,IRELAND,LTD,NSCLC
100,200,956,AKT,CD31,ERK,KI67,MET,PSB
BACKGROUND,CD31,CD45,EPC,EPCS,FLK,FLOW,GIVEN,HIGH,HOWEVER,KIT,LABEL,METHODS,RESULTS
001,169,2014,243,CASES,CONCLUSION,COPYRIGHT,DISH,EGFR,FISH,HER2,IHC,IRELAND,KRAS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHILE
169,1MO,2014,239,25MG,3MO,4MO,8805,ADVERSE,ARM,BACKGROUND,BASED,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MPM,PATIENT,PFS,RESULTS,WHILE
169,2014,CAUCASIAN,COPYRIGHT,CROWN,EGFR,IRELAND,LTD,PUBLISHED,TP53
BACKGROUND,CHINESE,KIF5B,LABEL,LUNG,MAPK,METHODS,NSCLC,PCR,RESULTS,RET,STAT3
2013,BASED,DCG,FIRST,FUSHING,PLOS
169,2014,ASIA,CK5,CMPT,EGFR,FOUR,KRAS,LTD,P63,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
520H,954,ARSENIC,ATO,BACKGROUND,CXCR4,IKK,LABEL,METHODS,PP2A,RESULTS
2002,2004,2011,439,8805,991,FINLAND,FINNISH,HODGKIN,LABEL,LIFESTYLE,METHODS,NHL,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SIRS,THERE
1980,2010,559,718,8202,BACKGROUND,CONCLUSION,INCREASED,LABEL,METHODS,PCA,RESULTS,SIR,SIRS,SITE,THERE
146A,169,2014,COLD,CONVERSELY,CORNETT,COX,LABORATORY,LUTZ,MICRORNAS,PRESS,PUBLISHED,SINCE,SOCIETY,THEREFORE,UTR
1640,CONCLUSION,LABEL,METHODS,OBJECTIVE,P16,PCR,RB1,RESULTS,RPMI,THERE,UNDER
ALTERATION,CYTOLOGIC,P450S,SMOKING,THESE,USING
100,106,1290,162,169,2014,229,2448,268,300,429,4790,539,805,8805,AIMS,AUTHORS,BNP,CAD,CARDIOLOGY,CONCLUSION,COX,FAILURE,FRAMINGHAM,HEART,HFPEF,IMPORTANT,INCLUSION,JOURNAL,KAREN,KAROLINSKA,KNOWN,LABEL,LVEF,METHODS,OBJECTIVE,PREDICTORS,PROGNOSIS,RENIN,RESULTS,SOCIETY
AIM,CONCLUSION,EGF,LABEL,MATERIALS,METHODS,OBJECTIVE,RAMAN,RESULTS,SERS
3LP,99A,A549,CDK2,CDK4,D261,H460,MICRORNAS,NCI,NSCLC,REGULATING,THESE
00038,00040,0024,114,123,8805,954,ACS,ADDITIONAL,HOWEVER,PULMONARY,TCS
169,2014,BRAIN,CLDN1,TAKEN,UICC
BASAL,BASED,HCQ,HOWEVER,PDAC,PDX,RNAI,TP53,TRP53

947,CD3,CD8,IFN,PBMCS,PMA,THESE
169,2014,AUC,AUTHORS,ELISA,ERC,HOWEVER,JOHN,LTD,PLEURAL,SONS,WILEY
169,181,2014,2800,300,5000,8805,AFTER,AJCC,BACKGROUND,LABEL,METHODS,MOLECULAR,MULTIGENE,NGS,RESULTS,SOCIETY,SPECIMENS
00001,00033,028,145,167,169,2014,309,381,880,BACKGROUND,EGFR,KI67,LABEL,MCM6,MCM7,METHODS,NSCLC,RESULTS,SCLC,SOCIETY,TP53,TP63,UHR1
169,2014,COPYRIGHT,HOWEVER,JOHN,LTD,SONS,THEREFORE,WILEY
169,2014,252,AE1,AE3,BACKGROUND,BECAUSE,LABEL,METHODS,RESULTS,SOCIETY,WILMS,WT1
169,2014,252,8197,956,A549,ACTA,AZ521,CHIMICA,COPYRIGHT,HELVETICA,HL60,IC50,MELIA,MELIACEAE,THESE,THREE
169,2014,COPYRIGHT,HODGKIN,JOHN,LTD,SONS,TYPE,WHEREAS,WILEY
100,169,177,2014,8201,956,A549,BIOLOGY,CELL,COMBINING,EGFR,FEDERATION
0001,160,169,186,2014,AUROC,AUTHORS,BIOMARKERS,C1M,COPD,ECM,ELM,IMF,IPF,JOHN,LTD,MMP,SONS,VICM,WILEY
001,011,028,169,1985,2012,2015,853,967,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,COX,ENHANCING,INC,LABEL,MEAN,MEIER,METHODS,PMGCT,PMNSGCT,PRIMARY,RESULTS
001,033,089,116,169,176,2009,2012,2014,484,590,607,627,793,7TH,810,824,8804,881,967,ACCORDING,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,GUANGDONG,III,INC,INSTITUTE,JANUARY,JULY,LABEL,LUNG,M1A,M1B,METHODS,NSCLC,OVERALL,RESULTS,TNM,USING
169,2014,4000,8804,8805,BACKGROUND,CONCLUSION,COPYRIGHT,III,INC,KRAS,LABEL,MATERIALS,METHODS,RESULTS,TEN
001,160,169,2014,340,8805,COPYRIGHT,FIVE,HNSCC,INC,LABEL,OVERALL,PAIN,PUBLISHED,SOCIETY,THEREFORE,UNLABELLED
001,146,169,1934,197,2014,434,438,566,711,838,875,947,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,FURTHER,HRS,IRELAND,LABEL,LTD,METHODS,NSCLC,ORR,ORRS,PFS,RESULTS,THERE
001,021,029,080,132,169,2014,210,259,644,902,923,AMONG,BACKGROUND,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WILEY
AFTER,APART,AUTHORS,BACKGROUND,CUTANEOUS,FINAL,KEY,LABEL,LUNG,METASTASES,METASTATIC,PATIENT,SKIN,UNLABELLED,WORDS
169,2014,AFTER,CONCLUSION,COPYRIGHT,DEFINITIVE,HOWEVER,IIIA,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PARTIAL,PFS,RCT,RESULTS
0001,0063,0258,032,071,169,2014,263,302,339,430MM,627,765,910,CD68,CONCLUSION,COPYRIGHT,COX,HOWEVER,INCREASING,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RFS,ROC,TAMS
100,108,1212,169,2014,303,611,BACKGROUND,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,METHODS,PEROXISOME,PPARD,PPARG,PPARS,RESULTS,SNPS,UADT
169,2014,2390,2993,8201,AMONG,BACKGROUND,CARE,CURRENT,LABEL,LIMITED,METHODS,NEVER,RESULTS,SMOKING,SOCIETY,THERE
169,2012,2013,2014,COPYRIGHT,EAST,HOWEVER,INC,NSCLC,SEPTEMBER
120,169,2014,627,645,8804,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ILD,INC,LABEL,METHODS,PRE,PUBLISHED,RESULTS
169,2014,ACC,ADENOID,AFTER,CONCLUSION,COPYRIGHT,DISTANT,FIVE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ORAL,PUBLISHED,PURPOSE,RESULTS
ABOUT,LEWIS,PTHRP,THUS
008,169,2014,COPYRIGHT,EGFR,FISH,HOWEVER,IHC,III,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SPECIMENS,TTP
169,2014,COPYRIGHT,IRELAND,LTD,LUNG,WNT
1659,1673,169,2014,954,ATP,CHROMATIN,CONCLUSION,EMT,HCC,HEPATOLOGY,HOWEVER,IF1,LABEL,LIVER,NIK,SNAI1,THERE,TNF,TRAF1,TRAF2,UNLABELLED,VEGF
169,2014,AMPK,COPYRIGHT,FAK,INC,LKB1,MARK1,MARK4,SIMILAR,SNAIL
169,2014,6PGD,ACAT2,COPYRIGHT,DLAT,EGF,EXPRESSING,HDAC4,INC,K294,K76,NADP,NADPH,ROS
145,C228T,DESPITE,FFPE,GENOMIC,NEITHER,PCR,SCC,SCLC,SMALL,TERT
169,2014,290,375,BF4,CLO4,COPYRIGHT,FOUR,HNOR,INC,MECN,MEOH,NO3,NOTABLY,PF6
169,2014,8804,BACKGROUND,CCR0,CONCLUSION,CRS,FOLFOXIRI,FOUR,GYMS,HIPEC,INC,INDEX,LABEL,MAXIMAL,METHODS,PCI,PERITONEAL,RESULTS,SEVENTEEN,WILEY
169,2014,BAYES,BFS,BOTH,COPYRIGHT,FBF,FINALLY,IBF,JOHN,LTD,MTS,MTSS,SONS,UNDER,WILEY
001,140,169,2014,601,BACKGROUND,EEC,EECS,JEGHERS,LABEL,LIVER,LKB1,METHODS,MUTATIONAL,MUTATIONS,PEUTZ,RESULTS,SOCIETY,STK11,WESTERN
169,2014,257,8804,8805,COPYRIGHT,EVEN,INC,NOTABLY,SALIA
169,2014,498,947,A549,ATF,ATM,COPYRIGHT,DOWNSTREAM,H2AX,INC,JNK,MRN,PRE,SOLUBLE,THR69
0001,026,117,151,364,402,BACKGROUND,CD146,CEC,CECS,HIGH,HOWEVER,INCREASED,LABEL,METHODS,NSCLC,RESULTS
001,169,2014,ACUTE,COX,FEV1,FVC,GVHD,HSCT,JOHN,LTD,PUBLISHED,SCHEDULED,SONS,WILEY
AMONG,ENDOGENOUS
000,002,023,165,609,8805,ANN,AUC,CHI,IIIB,MANN,ROC,STUDENT,VARIABLES,WHITNEY
000,100,2011,291,293,998,AQI,BACKGROUND,CHINA,DATA,GEOGRAPHIC,HIGH,LABEL,LUNG,MATERIALS,METHODS,NANHU,RESULTS,THEREFORE,YUEQING,YUYAO
103,122,131,155,2002,2012,258,273,380,4417,494,673,744,855,BACKGROUND,INSURANCE,KOREA,LABEL,MATERIALS,METHODS,RESULTS,USING
004,007,008,014,411,471,AGE,CAA,CHINESE,NOGO,NSCLC,RTN4,SNPS,UTR
112,946,EPIGENETIC,FHIT,HOWEVER,III,MSP,PCR,RAR,RASSF1A,SIMILAR,THERE,THESE
000,001,055,107,144,194,284,290,322,390,456,467,573,578,631,762,884,893,BACKGROUND,CHINA,GSTM1,GSTM3,GSTP1,GSTT1,HAN,ILE,INNER,LABEL,MATERIALS,METHODS,MONGOLIAN,MONGOLIANS,MSP1,PCR,RESULTS,RFLP,SIMILARLY,THERE,VAL
014,2013,AFTER,BACKGROUND,CPS,EGGER,FIVE,LABEL,MATERIALS,METHODS,PAS,RESULTS,SCHOLAR,SMR,TCDD,WEB
BACKGROUND,BIOMEDICAL,CHINESE,CIS,CNKI,DATABASES,FURTHER,HARDY,HOWEVER,HWE,LABEL,LITERATURE,MATERIALS,METHODS,ORS,OVERALL,PSTI,RESULTS,RSAI,SCIENCE,SYSTEMATIC
169,1RA,2014,945,ASIA,AUTHORS,BIOMARKERS,CSF,DATA,FGF,IFN,IRAN,LTD,LUMINEX,ODDS,PTY,PUBLISHING,SCIENCE,TNF,WILEY
HOPE,STUDIES,USING
169,2014,AIMS,AUTHORS,JOHN,LABEL,LTD,METHODS,NUCLEAR,OBJECTIVE,PUBLISHED,RESULTS,SONS,THESE,WILEY
132,160,169,175,2014,218,ALZHEIMER,ANGELES,AUTHORS,CALIFORNIA,CLINICALLY,CNS,CONCLUSION,COPYRIGHT,DLBD,GERIATRICS,JOURNAL,LABEL,LEWY,LOS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCHWANNOMA,SETTING,SOCIETY
169,2014,BOTH,CAUCASIAN,JOHN,LTD,LTX,NEITHER,ORAL,PUBLISHED,SCC,SONS,WILEY
1990S,1999,2011,2012,BLACK,EPA,HELPFUL,INITIALLY,LABEL,NATURAL,PM2,PM25,POLLUTANT,THROUGHOUT,TOXICOLOGY,UNLABELLED,WESTERN
CBCT,CIRS,CIRS008,ITV,MODEL
AFTER,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,SINCE
34A,8201,A549,AFTER,APOPTOSIS,DDP,FLOW,FOLLOWING,MTT,PEBP4,WESTERN
ARG,CAUCASIAN,CAUCASIANS,COMBINING,ORS,STRIKINGLY,STUDIES,TRP
011,027,541,662,778,8201,8226,866,BETWEEN,BLAND,COHEN,CTS,FBP,INTER,KEY,LABEL,LOW,MBIR,MCNEMAR,METHODS,OBJECTIVE,OBJECTIVES,REDUCED,RESULTS,SSN,SSNS
001,1990,8201,8226,AGREEMENT,CONTINUOUS,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ONSET,RESULTS
215,218,ABDOMINAL,BACKGROUND,BASED,CASE,CONCLUSION,FDG,IGG,IGG4,LABEL,METHODS,PET
169,2014,AFTER,AUTHORS,CELLS,CIKS,COPYRIGHT,DCS,DENDRITIC,INC,NKS,PUBLISHED,UESL
036,154,1993,2011,897,COLORECTAL,CONSENT,COVARIATES,INC,LABEL,LUNG,METHODS,NON,OBJECTIVE,ORS,OVARIAN,PLCO,PUBLISHED,RESULTS,SCREENING,TRIAL,USING
169,2015,CISPLATIN,COPYRIGHT,INC,NPS,PSQ,SINCE,THERE,THESE
SCLC
169,177,2014,COPYRIGHT,SEVERAL,SOCIETY,THESE
169,17A,2014,COPYRIGHT,KNOCKDOWN,LA1,MMP,RAS,SOCIETY,SRSF1,TAKEN,TH17,VIRUS
150,157,169,2008,2012,2014,214,232,APRIL,BASED,BETWEEN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,SUSPECTED,UNIVERSITY,WEDGE
145,151,161,169,1995,2012,2014,308,843,BACKGROUND,COPYRIGHT,INC,LABEL,MARTINI,METHODS,NSCLC,ONGOING,PUBLISHED,RESULTS,SMOKERS,SOCIETY,SPLC,SPLCS,THERE
169,177,2009,2012,2014,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE,THREE
169,177,2010,2013,2014,BACKGROUND,CHEST,COPYRIGHT,DIAGNOSING,INC,JANUARY,LABEL,MEAN,METHODS,NSCLC,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY,SURGEON
011,016,018,046,047,119,169,1992,2012,2014,BACKGROUND,COPYRIGHT,COX,FIVE,INC,JANUARY,LABEL,MEIER,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SOCIETY
1237,127,169,2000,2011,2012,2015,280,BACKGROUND,CONCLUSION,CONCURRENT,COPYRIGHT,CRT,ECOG,INC,LABEL,METHODS,NSCLC,RESULTS,SEVEN
012,017,153,588,671,815,8197,822,AUC,BACKGROUND,BIOMARKER,BMJ,ELISA,FDA,FIBULIN,GROUP,LABEL,LIMITED,MESOTHELIN,METHODS,PLEURAL,PUBLISHED,PUBLISHING,RESULTS,SOLUBLE
079,121,169,16P,19P,2014,22Q,277,370,398,423,449,8764,CIGARETTE,CNAS,GENOMIC,GIVEN,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
524,5P15,CHINA,CHINESE,CIS,CLPTM1L,HOWEVER,ORS,SPSS,TERT
3Q26,AKT,LMO,LMO1,NEXT,NON,NSCLC,PCR
169,2014,A549,BIOLOGISTS,COMPANY,EGFR,LTD,NTRK2,PUBLISHED,TES,TRKB,USING
13316,169,2014,946,COPYRIGHT,DSC,H460,LTD,NMR,XRD
169,2001,2006,2014,330,COPYRIGHT,GAMMA,GKRS,JULY,JUNE,KARNOFSKY,KNIFE,KPS,LTD,LUNG,MEAN,MEIER,SELECTION,STOCKHOLM
169,2014,AKT,COPYRIGHT,DESPITE,LTD,NSCLC,PI3K,THESE,VARIOUS
0001,0007,002,048,287,681,AFTER,CECS,LABEL,METHODS,MONITORING,NSCLC,OBJECTIVE,PERIPHERAL,PFS,PURPOSE,REGARDING,RESULTS
2014,GENERAL,SURGEON,WHILE
016,AKI1,AKT,INHIBITION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PANC1,PARP,PDK1,PI3K,RESULTS,SILENCING,TREATMENT
001,012,036,383,A549,AMONG,APOPTOSIS,APOPTOTIC,BACKGROUND,BCL,BESIDES,COX,HOWEVER,LABEL,LOG,MALAT,MCL,METHODS,NSCLC,PHAPI,RESULTS
001,004,1608,8202,AFTER,BACKGROUND,BEGG,CHINESE,DATA,EGGER,GALBRAITH,GSTM1,GSTS,GSTT1,LABEL,METHODS,ODDS,ORGSTM1,ORGSTT1,POTENTIAL,RESULTS,SCLC
233,237,243,BEN,JUR,THEREFORE
BRCA1,BRCA2,DIGESTIVE,FINALLY,JEGHERS,PEUTZ,PJS,SERTOLI,STK11,THERE
2155G,2573T,2582T,EGFR,EIGHT,G719C,HOWEVER,L858R,L861Q,NONE,SEVERAL,SNP,SNPS
946,BACKGROUND,CL1,DESPITE,FINALLY,LABEL,MAIN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,WNT
169,2014,DIFFERENT,IL6,MDSC,MDSCS,MYELOID,NOTABLY,OPN,OVERALL,SPP,SPP1,STAT3
169,2014,5256,AACR,FINALLY,GTPASES,PROFILING,RAC,RAP1A,RAP1B,RES,RNAS,SRC
169,2014,FGFR,FGFR2,GEMM,NSCLC,SOMATIC
0001,160,2011,544,COX,HOWEVER,LABEL,MCNEMAR,MEIER,METHODS,MSCC,OBJECTIVE,PURPOSE,RESULTS,REVISED,TOKUHASHI
001,130,150,158,375,425,ACCORDING,CA19,COX,EOF5,EPR,GRADE,LABEL,LOG,METHODS,MGC,OBJECTIVE,PURPOSE,RESULTS,TTP
1600,169,2014,300,COPYRIGHT,GTV,INC,ITV,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TIME,TTV,TTV80
169,2014,947,COPYRIGHT,DSB,H2AX,INC,LABEL,MATERIALS,MEFS,METHODS,NPM1,NSCLC,OBJECTIVE,PURPOSE,RAD51,RESULTS,THESE,TMA,WILDE
001,004,136,169,2007,2012,2014,339,8804,APRIL,CHART,COPYRIGHT,GOC,HOSPICE,INC,INPATIENT,JULY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,ONCOLOLOGY,PURPOSE,RADIATION,RATES,RECORDS,RESULTS,SOCIETY,THESE
0001,160,169,2014,711,956,COPYRIGHT,COX,DVH,EFS,GTV,GTVS,III,INC,LABEL,LOWER,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THESE,V10,V60,V70
169,2014,450,AC1,CONCLUSION,COPYRIGHT,GWET,INC,INTERRATER,LABEL,MATERIALS,METHODS,MULTIRATER,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,SEVENTY,SIX
003,009,169,1990,2014,CONCLUSION,COPYRIGHT,EFS,EWING,GIVEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMOKING,WLI
239,8804,AMRUBICIN,AUC,BACKGROUND,BASED,EVALUATION,FOUR,FURTHER,GRADE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC,THERE,THREE
945,954,CCL2,GCSF,GROWING,MYD88,THUS,TLR2,TLR3,TLR4,TLRS,TNF,TOLL
100,1000,A549,AD5,ANTITUMOR,CMT,CSF,CTLA4,E1A,E2F,FURTHER,UNDER,VIRUS
199,737,ABT,ALTOGETHER,BCL,LCSC,LCSCS,LUNG,NSCLC,STEM,WHEREAS
169,2014,ACIDS,BCL,EGFR,ERBB2,HIGH,HOWEVER,MAPK,NUCLEIC,PRESS,PUBLISHED,SEQ,SEQUENCING,SPLICENET,UNIVERSITY
0000024531,150,169,2010,2013,2014,500,BACKGROUND,BASEL,CTR,EGFR,FURTHER,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SEVENTEEN,THERE,UMIN
EGFR,LUNG,NSCLC,TKI
EMT,EPITHELIAL,NSCLC
1954,2007,2013,897,BACKGROUND,LABEL,LUNG,METHODS,RESULTS,TEN,THIN,THREE
PBML,PULMONARY,SINCE,VATS
126,2004,2014,BACKGROUND,BESIDES,CRYO,LABEL,LOCAL,MEIER,MELT,METHODS,RESULTS,TECHNIQUES,THEREFORE
177,2011,2014,5TH,7TH,8TH,BACKGROUND,CALIFORNIA,GENERAL,INTUITIVE,LABEL,MARCH,METHODS,MILITRARY,MOST,RESULTS,SINCE,SPN,THEIR,THERE,VINCI,WEDGE
001,007,032,165,176,186,2010,2011,308,664,701,8805,BACKGROUND,BMI,JANUARY,LABEL,METHODS,RESULTS,THESE,VATS
HOWEVER,MICRO,UNIPORTAL,VATS
100,169,183,192,200,2014,329,521,8805,CASES,ERS,GALICIA,SPAIN
CRABP,NSCLC,PROTEIN,TAKEN
142,BESIDES,FASN,HOWEVER,MEN1,MENIN,MG63,THEREFORE,U2OS
106,116,8201,967,ARG,BANGLADESH,HOWEVER,LUNG,PCR,PRO,RFLP,SNP
001,107,160,169,195,1999,2009,2015,203,673,AMONG,BACKGROUND,CNS,COPYRIGHT,IBC,III,INC,LABEL,METHODS,NCCN,NETWORK,OVERALL,RESULTS
0068,1994,2012,FIFTEEN,LABEL,METHODS,NINE,OBJECTIVE,RESULTS,SURGERY,THERE
001,COX,EGFR,HIGH,NSCLC,OVERALL,PFS,TAMS,TKI,TKIS
001,1994,1998,ACCORDING,ARRIAGADA,BACKGROUND,CONCLUSION,DIFFUSION,DLCO,FEV1,LABEL,MAY,METHODS,PFTS,PULMONARY,RESULTS,SEVENTY,THERE,TLC,V20
124,169,2014,BACKGROUND,BASEL,CONCLUSION,EGFR,EXON,L858R,LABEL,METHODS,NSCLC,RESULTS
169,2014,COPYRIGHT,INC,LUNG,SLE,THERE
100,174,181,250,8201,8764,ALK,BASED,CRIZOTINIB,MEAN,MET,UNCHANGED,XALKORI
BECAUSE,DOSE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,WHOLE
5347,6072,BACKGROUND,CIS,GSTM1,LABEL,METHODS,ODDS,ORS,RESULTS,SEVERAL
0001,0076,014,022,169,2014,COPYRIGHT,GP88,IIIA,IIIB,INC,NSCLC,SERUM,THERE
002,008,160,169,177,2014,386,433,BACKGROUND,BECAUSE,COPYRIGHT,DATA,FIO2,H2O,INC,LABEL,MATERIALS,METHODS,RESULTS,SPO2,THERE
300,DSB,DSBS,END,GFP,HOMOLOGOUS,JOINING,MMEJ,NHEJ,NON,R26NHEJ,SCEI,SINCE,USING
150H,169,2014,A549,COPYRIGHT,DRUG,MMT,MTT,SEM,TEM,THESE
169,183,2014,3H2O,4H2O,5H2O,A549,ALA,AMONG,BIOLOGICAL,COPYRIGHT,EPR,HELA,IC50,INC,MCF,PHE,TAKEN,VAL
CD4,HIV,HOWEVER,INCREASED,LOWER,PATTERN,SUCCESSFUL,TLR,TLRS,TOLL
183,A549,BOTH,CALF,COMPLEX,H2O,HOWEVER,NO3,OAC
400,FINE,IMPORTANCE,INITIAL,LABEL,MAIN,METASTASIS,METASTATIC,METHODS,OBJECTIVE,RELEVANCE,RESULTS,RETINAL,SETTING,TREATMENT
706,AMG,AREAS,ASIAN,BACKGROUND,COVERED,FURTHER,LABEL,METHODS,MOTESANIB,NSCLC,OPINION,SEVERAL,TKI
CSC,CSCS,DOX,EMT,H460,METASTASIS,NSCLC,THESE,ZEB1
ETS,SHS,SMS,TOBACCO
2014,CILIARY,COPYRIGHT,SLACK
0001,315,389,AJCC,BACKGROUND,BASED,COMMITTEE,COX,END,HOWEVER,JOINT,LABEL,MEIER,METHODS,NSCLC,OVERALL,RESULTS,SEER,USING,VPI
945,946,AGAINST,IDIOPATHIC,IPF,MOTHERS,SMAD,SMAD4,TGF
0001,0311,0359,0445,0483,MMP,MMPS,MT2,MVD,NSCLC,PCR,THUS
BRAIN,CHOP,MRI,T2W1
630,BACKGROUND,EXPRESSION,HOWEVER,LABEL,MEIER,METHODS,MICRORNAS,MIR,PCR,RESULTS,RNAS
100MG,150,169,2014,BACKGROUND,COX,EGFR,FIFTEEN,FOLLOWING,GRADE,HRS,KPS,LABEL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,UNIVERSITY,WBRT
12A,169,2014,500,8804,8805,945,946,C57BL,CONV,COPYRIGHT,FLASH,HBCX,HEP,LUC,SCIENCE,TGF,TNF
160,169,2014,BACKGROUND,CONSORTIUM,COPYRIGHT,IDS,LABEL,LTD,LUNG,METHODS,MICRORNAS,PUBLISHED,RESULTS,TARGETSCAN,THESE
011,026,036,135,169,2014,8202,8804,AFTER,EGFR,SOCIETY,THERE
0282,100,CLUSTER,E2F,EXPRESSION,FDG,GLUT,LABEL,METHODS,MOLECULAR,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL,THESE
946,BLP25,CIMAVAX,EGF,FINALLY,III,IIIB,IPILIMUMAB,MAGE,NON,NOVEL,NSCLC,THESE,TIME
001,124,181,281,AREA,AUC,BAL,CONCLUSION,EACH,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,OLC1,RESULTS,WESTERN
001,002,003,005,006,013,014,015,016,030,266,267,AIR,HRCT,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
871,929,954,976,BALB,CD31,EGR1,FDG,IHC,LABEL,METHODS,MICRO,OBJECTIVE,PET,RESULTS,THEREFORE,VEGF
233,BARR,CHEST,GM1,IGG
169,2014,COPYRIGHT,INC,LIVER,PET,URINARY
160,169,2014,COPYRIGHT,FURTHER,INC,PET
169,2014,COPYRIGHT,EFFORTS,INC,PET,REVIEWING,SEVERAL
18F,FDG,INC,PUBLISHED,SUV
1H68,BACKGROUND,CPA,CURRENTLY,FACTORS,GLV,LABEL,METHODS,MTT,PC14PE6,PRO,RESULTS,RFP,THESE,VIRAL
169,2014,COPYRIGHT,DIFFERENT,INC,METABOLIC,NETS
600
ANATOMO,DOPPLER,FDG,PALLIATIVE,PET,RVOT,THERE
BOARD,HOSPICE,MEDICAL,PALLIATIVE,THESE,THUS
CPFE,DLCO,GIVEN,HRCT
BIOMEDICAL
946,AFTER,BACKGROUND,CASE,CONCLUSION,CONTEXT,HCG,LABEL,METHODS,OBJECTIVE,PERSISTENT,RESULTS
946,ARTHRITIS,BACKGROUND,FOUR,HEK293T,IFNB1,IL1,IL6,INSTITUTE,INTRAMURAL,JAK,JANUS,LABEL,METHODS,PROGRAM,RESULTS,SAVI,SKIN,STAT1,STING,TMEM173,TNF
126,164,197,2005,2011,262,BACKGROUND,CONCLUSION,COX,DATA,HOWEVER,LABEL,LEVEL,MEIER,METASTATIC,METHODS,OBJECTIVE,PRIMARY,RESULTS,SUMMARY,UNPLANNED
001,002,009,011,089,517,8594,864,ALK,AMONG,ATS,EGFR,ERS,HISTOLOGIC,IASLC,KRAS
DESPITE,INITIALLY,THESE
177,945,BACKGROUND,CD4,CD8,COPD,DESPITE,EACH,LABEL,METHODS,NONE,RESULTS,SMOKERS,WHILE
1038,6PGD,834,A549,AMONG,BEAS,BECAUSE,EGFR,G6PD,GAPDH,H460,KRAS,LDH,MALDI,NCI,NSCLC,PKM2,PPP,PROTEIN,RAS,REGARDING,TKT,TOF,WESTERN
106B,151,187,205,215,449B,512,520B,774,MOST,NSCLC,RELAPSE
AMONG,BOTH,DESPITE,ENDOSCOPIC,SEVERAL,WHILE
035,100,139,204,BACKGROUND,CONCLUSION,DCR,ECOG,EGFR,ERLOTINIB,IQR,LABEL,METHODS,NSCLC,PFS,RESULTS
169,2014,954,A549,CHOU,EGFR,ERLOTINIB,FACT,H1975,H1993,IC50,KNOCKDOWN,L858R,MET,NSCLC,QUINACRINE,SSRP1,T790M,TALALAY
1072,1209,1365,169,1986,1991,1992,1997,1998,2003,2004,2009,2014,812,BACKGROUND,CALIFORNIA,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OTHER,RESULTS
001,002,007,011,013,020,022,027,058,160,169,179,2002,2006,2014,261,374,581,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,GENERAL,JANUARY,JUNE,LABEL,LVSI,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,RISK,SERVICE,STAGE,THERE,TRI
169,2014,400,ACTIVATED,ALCAM,BASED,CD166,COPYRIGHT,GMBH,HNSCC,MEMBRANOUS,PURE
115,677C,CAUCASIAN,CONCLUSION,ERCC1,LABEL,METHODS,MOLECULAR,MTHFR,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SNP,UTR,VNTR
A549,ADDITIONAL,BACKGROUND,CELLS,EGF,GSPT1,H1650,ID1,INHIBITOR,LABEL,METHODS,NRSF,NSCLC,PCR,RESULTS,STMN3,THESE,ZBP89
169,2014,BOTH,PRESS,PUBLISHED,SURGERY,UNIVERSITY,VATS,VIDEO
1686,169,2014,ATP,AUTHORS,AZD9291,COPYRIGHT,DESPITE,EGFR,ERBB,FIRST,HER2,HER4,HM61713,LTD,NEWER,NSCLC,PUBLISHED,T790M,THESE,TKIS,TKLS
110,169,2014,945,946,954,956,A549,ARG,COPYRIGHT,GLN,IC50,IKK,LTD,MOLECULAR,TNF,WESTERN
001,0015,349,416,905,COX,HOWEVER,MEIER,NSCLC,PCR,TBX2,TNM,WESTERN
169,201,2011,2014,231,ATS,COPYRIGHT,ERS,IASLC,LUNG,PUBLISHED,SAS,TNM,TREATMENT
946,947,948,AFTER,BARR,BCL6,CD10,CD103,CD138,CD20,CD21,CD3,CD30,CD4,CD5,CD56,CD57,CD7,CD79A,CD8,EBV,EPSTEIN,PCR,PET,TCR,TRD,TRG
000,141,145,177,274,293,8201,845,CEA,HIGH,PLC,THERE
003,007,020,047,130,2548G,762,782,8201,FURTHER,LEP,LEPR,PCR,Q223R,RFLP,TURKISH
060,563,AUC,CHINESE,CNKI,HOWEVER,KNOWLEDGE,MEDLINE,NSCLC,OVERALL,SINOMED
13Q14,169,1692,17Q23,196,1989,2014,471,5P13,708,719,779,8805,946,ADULT,AFRICAN,AMERICANS,ASIAN,BLOOD,C5ORF22,ESP,EUROPEANS,EXOME,GH2,GWAS,HEART,INSTITUTE,LUNG,MAF,NHLBI,NOTABLY,PRESS,PROJECT,PUBLISHED,SEQUENCING,THESE,UNIVERSITY,USING
000,036,041,2014,215,248,5P15,BASED,BETWEEN,CLPTM1L,GOVERNMENT,GWAS,PRESS,PUBLISHED,TERT,UNIVERSITY
000,2010,2813,5000,BACKGROUND,BANGLADESH,CONTROL,DATA,DHAKA,EVALUATION,ITC,LABEL,METHODS,RESULTS,SEVERAL,SHS,TAKA,TOBACCO
001,005,006,154,BACKGROUND,FURTHER,GSTM1,GSTS,GSTT1,HOWEVER,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TOBACCO
100,BACKGROUND,FEDERATION,FIFTY,FIGO,GYNECOLOGY,HOWEVER,LABEL,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OBSTETRICS,PRIMARY,RESULTS,STAGING,THERE,THESE
001,002,006,011,028,133,2000,2010,8201,BACKGROUND,DISEASE,DLCO,HOWEVER,LABEL,LOBECTOMY,MARCH,METHODS,NSCL,NSCLC,RESULTS,SEPTEMBER,THERE
0001,001,100,177,630,APE,CONCLUSION,EIGHT,FBP,KNOWLEDGE,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SCANS,VOLUMETRY
BINH,CUC,HEPG2,HPLC,ICR,MCF7,NINH,NMR,THEIR,VIETNAM,VIS,XYLARIA
003,006,016,042,ELISA,EMT,HGF,HIGH,MET,SCLC,SERUM,THESE
946,ELISA,GSK,PDE,PPASE,PRUNE,WNT,WNT3A
293T,8314,ALCL,ALK,ASP3026,CHOP,HOWEVER,NPM
169,2014,COPYRIGHT,HACE1,HOWEVER,INC,LYS48,OPTINEURIN,OPTN
BACKGROUND,CRC,HOWEVER,LABEL,METASTASIS,METHODS,PSF,PTB,PTBP2,RESULTS,SFPQ
BACKGROUND,EMT,FOXC2,HOXB9,LABEL,MEIER,METHODS,RESULTS,SNAIL,TWIST,ZEB1
0980,945,954,BRDU,CISPLATIN,DHMEQ,EFFECTS,EXPRESSION,GDC,NSCLC,PCR,PHASE,PI3K,TREATMENT
125,152,183,2003,2012,375,451,516,655,688,BACKGROUND,CONCLUSION,GEORG,IIA,IIB,JANUARY,LABEL,METHODS,NSCLC,PATHOLOGY,PCNB,PET,RESULTS,STUTTGART,YORK
0009,007,177,819E,8202,863E,DUE,FIFTY,ICC,RADIOMICS,THEREFORE,THESE,WHERE
ANN,ANNI,CARLO,EWING,EWS,FAS,FCGRT,FLI,FNDC5,LABEL,METHODS,MONTE,OBJECTIVE,OLFM1,RESULTS,RHO,RMS,TNNT1,WNT
1359,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
130B,169,2014,946,COLD,LABORATORY,MITRA,NETWORK,NSCLC,PRESS,PUBLISHED,SOCIETY,TFS,TGF,WHILE
160,A11,BOTH,CD59,CHI,CNT,CNTS,DPV,FABRICATED,FOURIER,FTIR,LUNG,MAGE,SEM
160,169,2014,AUTHORS,BACKGROUND,BECAUSE,COPYRIGHT,DOR,FIFTY,GRADE,HER2,INC,LABEL,METHODS,ORR,PFS,PUBLISHED,RESULTS,TTR
006,946,DACT,DACT2,III,LEF1,MEIER,RESTORING,S33Y,THESE,WHEREAS,WNT
HOMOLOG,KRAS,MTH1,MUTT,NSCLC,ONCOGENIC,RAS,ROS,THUS
001,002,004,006,169,2014,COPYRIGHT,COX,EMX,EMX2,FIFTY,HIGH,IMIG,IRELAND,LABEL,LTD,MALIGNANT,MATERIALS,MEIER,METHODS,MPM,OBJECTIVE,OBJECTIVES,PCR,RESULTS
073,2014,465,8201,APRIL,CAUCASIANS,CBM,CNKI,ETHNICITY,LIBRARY,MMP,ODDS,SCHOLAR,SCIENCE,STATA,VERSION,WEB
2014,296,8201,CEA,ELECTRONIC,HOWEVER,JUNE,MEANWHILE,NSCLC
945,946,CAFS,EXTENSIVE,IGF,MICE
001,006,033,034,046,176,2003,2013,258,310,BETWEEN,HBEAG,HBSAG,HBV,HOWEVER,JANUARY,NSCLC
169,2014,BLADDER,BONE,BOWEL,BRAIN,BRAINSTEM,CARLO,CBCT,CLINICIANS,COPYRIGHT,CORD,D50,D50S,DOSE,ESOPHAGUS,EYE,FEMORAL,HEAD,HEADS,HEART,IRELAND,LABEL,LOW,LTD,LUNG,MATERIALS,METHODS,MONTE,OBI,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SCAN,SCANS,SKIN,SOFT,THYROID,TRACHEA
001,002,008,106,114,8201,ABOUT,CLINICIANS,CRC,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,QOL,RESULTS,SURVIVORS
FIVE,MEDICAL
169,2014,COPYRIGHT,EGFR,NSCLC,PET,PUBLISHED,SAS
ENGLISH,FIRST,PNC,PSH,PSHS,THIRD
BACKGROUND,BARR,CASE,CAUCASIAN,CROHN,DIAGNOSTIC,EPSTEIN,LABEL,LYG,METHODS,PULMONARY,THIOPURINE
11C,18F,AGENT,DIPP,DISEASE,FDG,HOWEVER,IMAGING,MICAD,MOLECULAR,PET,PROBE,PROFILING,THEIR,VALIDATED,WEB
WDFA
HOWEVER
MALIGNANT
PRIMARY
AFTER,MEC
031,079,143,177,196,2000,2011,689,BACKGROUND,CEA,CONCLUSION,HOWEVER,JANUARY,JINLING,LABEL,MATERIALS,MEIER,METHODS,NANJING,NSCLC,RESULTS,ROC,SERUM
2007,2012,525,8211,BETWEEN,BOTH,CCI,CONCLUSION,FURTHER,LABEL,METHODS,MOST,OBJECTIVE,PRT,PURPOSE,RESULTS,UNI,YOUNGER
ALK,APART,BREAK,CDX,COMPANION,CRIZOTINIB,FISH,HER2,KIT,NSCLC,PATHVYSION,PROBE,VYSIS
ALK,CCR4,FISH,HER2,IHC
A549,BECAUSE,CAII,CD31,CO2,H727,KI67,NET,NETS,THUS,USING
116,CAP,FDA,H460,HCT,HDAC,HLM,MLM,NCI,ROMIDEPSIN,SAHA,U251,ZBG
048,067,171,2011,301,358,372,500,686,766,BACKGROUND,CANDIDATES,CHIBA,CONCLUSION,COPD,JAPAN,JULY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,PFT,RESULTS
5086,8197,945,947,BACKGROUND,BMJ,ERR,FOUR,GROUP,LABEL,LIMITED,MEDICAL,METHODS,POISSON,PUBLISHED,PUBLISHING,RADON,RESULTS
100,169,2004,2012,2014,436,8804,8805,BED,BODYFIX,COPYRIGHT,FAILURE,FOUR,GY10,INC,JANUARY,LABEL,LOCAL,MATERIALS,METHODS,NOVALIS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,SINCE,THERE,USING
169,200,2014,291,BRAF,COPYRIGHT,EGFR,G873R,HOTSPOT,INC,ION,KRAS,MOLECULAR,NEXT,PANEL,PATHOLOGY,PCR,PUBLISHED,SEQUENCES,SOCIETY,THESE
160,A549,ANNEXIN,BALB,BAX,BCL,CELL,HOECHST,HOWEVER,MTT,NON,NSCLC,NVB,PCR,THUS,TNF,TRAIL,USING
002,006,169,2014,432,8804,CONCLUSION,COPYRIGHT,COX,EGFR,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SOMATIC
BACKGROUND,BEIR,BOTH,CARLO,CONCLUSION,CSI,IMPORTANT,IMPT,LABEL,LAR,LIFE,METHODS,MONTE,OED,REGARDLESS,RESULTS,SECONDARY,TREATMENT,VARIATIONS,VII
169,2014,CASE,CONCLUSION,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,RAPID
8209,A549,C4B,ELISA,FURTHER,H1299,HOWEVER,PDZK1,SLC34A2,THEREFORE
1290,A549,ASIATIC,BCL2,MOLECULAR,THESE
184,408,523,528,636,642,674,722,734,747,780,823,834,856,899,908,938,ABCAM,AUCS,BACKGROUND,ENZO,HSP27,INCREASED,INVITROGEN,LABEL,LIFE,METHODS,NSCLC,RESULTS
179,484,A549,ATLAS,BACKGROUND,FOXA1,HOWEVER,LABEL,METHODS,ONCOPRINT,PCR,RESULTS,SEQ,SOX2,TCGA,WESTERN
169,2014,A549,AMONG,COPYRIGHT,ETOPOSIDE,MCF7,RESULTS,SAS,THP,U937
169,2014,COPYRIGHT,PUBLISHED
169,2014,ADDITIONAL,COPYRIGHT,CRVS,LTD,PPI,PSMA3,RIG,TCR,UBC
2926,3555,ADJUSTMENT,AFTER,BMJ,DCM,FURTHER,GROUP,ICARE,LABEL,LIMITED,METHODS,OBJECTIVE,ORS,PCE,PUBLISHED,PUBLISHING,RESULTS,SES,THESE
169,AFTER,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RADIOLOGIC,RESULTS,SOCIETY,ULTRASOUND,USUALLY,WDPMP
001,143,2014,251,ALZHEIMER,BEGG,CIS,CONCLUSION,EGGER,HOWEVER,LABEL,MAY,METHODS,NINE,OBJECTIVE,PURPOSE,RESULTS,RRS,SCIENCE,STUDIES,THESE,WEB
4HPR,CAV,HPR,HSA,PCR,SUFFICIENT,THEIR,TUNEL
169,1991,2010,2011,2014,AUSTRIA,CONCLUSION,COPYRIGHT,DEC,ENTRY,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SETTING,SMR,SMRS,STAGE,SUICIDE,THEREFORE,TYROL
046,142,169,177,181,2008,2013,2014,GRADE,III,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,PATIENT,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,THERE,THREE,UNIVERSITY,VATS,VIDEO
129,154,169,177,2014,3665,591,700,800,BACKGROUND,COSTS,CTS,FLEISCHNER,HEART,HOWEVER,INC,LABEL,METHODS,PNS,PULMONARY,RESULTS
0001,023,060,1500,1565,169,1795,1930S,1940S,2009,2014,2623,3175,4414,453,542,8937,AFTER,BACKGROUND,BIRTH,CONCLUSION,COX,HODGKIN,HOWEVER,LABEL,MEDICAL,META,METHODS,MOST,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY,USING
0001,169,2007,2011,2014,8805,945,946,BED,COPYRIGHT,INC,LABEL,LUNG,LVRS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SABR,SAVR,THERE,THESE,TLV
169,2005,2011,2014,607,8805,BOTH,COPYRIGHT,ESOPHAGEAL,GROUP,INC,LABEL,MATERIALS,METHODS,NOTABLY,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RTOG,SBRT,THERAPY,THESE,VEGF
169,2009,2012,2014,8804,8805,COMPARING,COPYRIGHT,EXACTTRAC,FIFTY,INC,LABEL,MATERIALS,METHODS,NOVALIS,OBJECTIVE,PURPOSE,RESULTS,SBRT
2009,2012,8211,BACKGROUND,CONCLUSION,INMATES,LABEL,MATERIALS,METHODS,OBJECTIVE,PALLIATIVE,RATIONALE,RESULTS,TEN,THESE,THREE,TPC,UNIVERSITY
CANCEROUS,CIP2A,INHIBITOR,MYC,PP2A
1980,1991,2013,BALKANS,FURTHER,GULF,LABEL,MATERIALS,METHODS,OBJECTIVE,PERSIAN,PURPOSE,RESULTS,STUDIES,THERE
081,189,1997,2006,352,CRC,CROSS,HOWEVER,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SETTING
AFTER,LUNG,MAP,NCBI,PPIN,THESE,USA
120,177,280,ACTH,AGRP,ANOTHER,BACKGROUND,CONTEXT,CUSHING,EAS,ELEVATIONS,EXPANDING,IPSS,LABEL,MEAN,METHODS,OBJECTIVE,POMC,RESULTS,SEM
169,2014,384,51PM,COPYRIGHT,EGFL7,ELISA,INC,PCR,UNBOUND,USING
CDK1,FINALLY,HOWEVER,IPS,PCNA,PLUNC
013,1032,129,1763,1806,2007,2012,70Y,8805,AGE,AIMS,IIIA,JULY,JUNE,LABEL,MAJOR,METHODS,MORBIDITY,MORTALITY,OBJECTIVE,PULMONARY,RESULTS,SUCCESSFUL,SURGERY,UNIVARIATE,VATS,VIDEO
100,169,2011,2012,2014,ACCORDING,APRIL,EBUS,MARCH,PRESS,PUBLISHED,SURGERY,TBNA,UNIVERSITY
1002,107,169,2014,BIOCAST,BRAF,CFDNA,CONCLUSION,EGFR,ERBB2,HOWEVER,IFCT,IONTORRENT,KRAS,LABEL,MACHINE,MATCHED,METHODS,MULTIPLEX,NGS,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE
125,169,2014,385,763,8805,BACKGROUND,BMI,CONCLUSION,COX,DATA,FINALLY,FRAMINGHAM,HEART,LABEL,METABOLIC,METHODS,OVERWEIGHT,RESULTS,THESE,WHTR
169,2014,AFTER,FOLLOWING,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RECLN,RESULTS,SABR,SFED3,VCP
169,2007,2013,2014,8805,EVALUATION,IMAGING,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,SIXTY,SOLID
182,8201,A549,BACKGROUND,LABEL,METHODS,MTT,NHBE,NSCLC,PCR,PDCD4,RESULTS,UNASSIGNED,VIRTUAL,WESTERN
057,139,161,162,169,2011,2013,2014,250,289,592,604,6MONTHS,BACKGROUND,BONE,COPYRIGHT,IQR,IRELAND,LABEL,LTD,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,TRIAL
215,8201,ADC,ADCS,BACKGROUND,BASED,CHEST,EIGHT,FUNCTIONAL,LABEL,MEAN,METHODS,MRI,PET,RESULTS
195,402,686,716,BACKGROUND,DESPITE,EPAS1,III,IL8RA,LABEL,METHODS,PFS,RESULTS,VEGF,VHL
0536,946,BACKGROUND,CD151,CONCLUSION,HIGH,LABEL,LOG,METHODS,MMTV,PYMT,RESULTS,WHILE
160,174,261,355,AFTER,CHI,CISH,CONCLUSION,FURTHER,LABEL,MANN,METHODS,MYC,OBJECTIVE,PURPOSE,RESULTS,SCLC,SMALL,WHITNEY,ZYTODOT
27B,INCREASING,NON,NSCLC,RNAS,SP1
255,COX,ENDOCAN,HOWEVER
2009,2013,BACKGROUND,CONCLUSION,HOWEVER,IIPS,ILD,LABEL,METHODS,NON,NSCLC,OVERALL,PARTICULAR,PEM,PEMETREXED,RESULTS,THREE,UIP,UNIVERSITY
169,2014,COPYRIGHT,HOWEVER,MARIJUANA,PUBLISHED,SAS,SPLF
CONCLUSION,DIFFERENT,GASTRIC,HPLC,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SAVDA,UNSAVDA
169,2014,COPYRIGHT,DN30,EBC1,FEDERATION,MECHANISMS,MET,NOTABLY,PUBLISHED,SOCIETIES,THESE,TKIS
169,2014,AFTER,BACKGROUND,BARR,CASE,COPYRIGHT,EPSTEIN,GALLIUM,INC,LABEL,METHODS,MOST,PTLD,SIXTEEN
004,011,025,029,169,2014,3A4,BACKGROUND,BASEL,DOCETAXEL,GRADE,LABEL,METHODS,P450,POTENTIAL,RESULTS
231,AHR,ARYL,BACKGROUND,CHROMATIN,CXCR4,DRES,LABEL,LUNG,MDA,METHODS,MMP,MTT,OMEPRAZOLE,RESULTS,RNAI
000,039,093,100,109,112,113,145,148,158,181,184,186,200,2010,235,248,268,403,433,509,622,739,956,969,ASR,CENTRAL,CHINA,CHINESE,GIVEN,LUNG,NCCR
CHINA,CHINESE,MOST
ASIA,CUMULATIVE,OUTDOOR,WORLD
164,169,2014,259,261,991,ADH1B,DATA,LABEL,MAIN,MENDELIAN,METHODS,OBJECTIVE,ODDS,OUTCOME,RESULTS,RS1229984
174,8804,8805,AUSTRALIA,BACKGROUND,COLORECTAL,CRC,DISCUSSION,FOXFIRE,LABEL,LIMITED,MEDICAL,METHODS,NORTH,OXMDG,PFS,RADIATION,SECONDARY,SELECTIVE,SIR,SIRFLOX,SIRT,SPHERES,THERAPY,TRIAL
169,2014,2DG,BASED,COPYRIGHT,ERSA,ERSAS,FIVE,IRELAND,LKB1,LTD,NSCLC,STUDIES
BECAUSE,COPD,HOWEVER,RNAS,THESE
100,160,169,2014,956,CDK2,COPYRIGHT,GI50,HOP,INC,INSTITUTE,LC50,LUNG,MAESTRO,MOLECULAR,NCI,NSC,SAS,USA
016,BACKGROUND,CARCINOMA,CONCLUSION,DESPITE,FIRST,IL6,LABEL,LEWIS,LLC,LUNG,MEANWHILE,METHODS,MR16,NEXT,RESULTS,SERUM,THEREFORE
LAST,VARIOUS
2008,2010,2013,2014,AFTER,EGFR,GEFITINIB,MARCH,TKI
100,105,106,115,ACCORDING,AFTER,CONF,DIFFERENT,HOWEVER,IBT,REGARDING,TREATMENT,WBI
AMONG,BOARD,CHINA,CHINESE,EVEN,FINALLY,GENERAL,HOWEVER,LABEL,LUNG,MATERIALS,METHODS,NEAT1,OBJECTIVE,PLA,RESULTS,RNAS
0001,001,227,316,3444,BACKGROUND,LABEL,METHODS,PCPS,PRIMARY,RESULTS,SIXTY

183,404,4710,8805,BACKGROUND,BPH,COLORECTAL,LABEL,LUNG,LUTS,MEN,METHODS,OVARIAN,POISSON,RESULTS,SCREENING
MALIGNANT
169,2014,344,946,CHRONIC,COPYRIGHT,FISCHER,HOWEVER,INC,PBK
ALSO,ALZHEIMER,FINALLY,FULLY,HOWEVER,MRI,PET,POTENTIAL,PROMISING,SINCE,WHILE
130,220,5MM,BACKGROUND,CARCINOMA,CASE,CELL,CONCLUSION,HEM,LABEL,LOCAL,METHODS,RCC,RENAL,RESULTS,SINCE,THERE
970,ATR,CHK1,DDR,HOWEVER,THESE
ABDOMINAL
EVALUATION,HOWEVER,POST
169,2014,BRACHYURY,LABEL,METHODS,MICROARRAY,OBJECTIVE,PIN,PURPOSE,RESULTS,SUCCESSFUL
101,124,169,2014,232,355,BACKGROUND,BRITISH,DATA,DOSES,IIA,JOURNAL,LABEL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,STAGE,TOTAL,UNIVERSITY
164,169,2014,BACKGROUND,CELL,EGFR,EXPRESSION,HIGH,LABEL,MEDICAL,METHODS,NSCLC,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
146,169,2000,2012,2014,484,8764,ACTIVATING,AMONG,ATLAS,BACKGROUND,BRAF,CRC,KRAS,LABEL,LUNG,MEDICAL,METHODS,NRAS,PRESS,PUBLISHED,RAS,RECORDS,RESULTS,SOCIETY,THESE,UNIVERSITY
0027,100,102,169,2011,2013,2014,284,705,8804,967,AELAD,ALSO,ARMS,BACKGROUND,BASED,CONCLUSION,ECOG,EGFR,IIIB,JULY,L858R,LABEL,LUNG,MAF,MAFLR,MARCH,MEDICAL,METHODS,PFS,PRESS,PUBLISHED,RESULTS,SOCIETY,THREE,TKI,UNIVERSITY,WHETHER
125,2006,2008,215,548,761,ACCORDING,ANOTHER,COMMISSION,HEALTHY,ITALY,LIFE,MOVE,NETWORK,NON,PROMOTION,USA,WHP,WORKPLACE,YEARS
169,2014,231,AKT,BACKGROUND,BRAIN,DUAL,ETAR,ETBR,GAP,H226,LABEL,MAPK,MDA,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,TYPE,UNIVERSITY
177,99M,AFTER,DUAL,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN
BRAF,EGFR,EMT,H1975,IC50,KRAS,L858R,MTT,NCI,NSCLC,T790M,THESE
945,ALPHA,BRAIN,FURTHER,GALSA,NSCLC
ADDITIONAL,AFFYMETRIX,EDC,EPIDERMAL,HNC,HNSCC,LCE3D,PCR,PLUS,QPCR,REAL,S100,S100A11,SPRR,SPRRS,THESE,TIME,U133
0004,006,168,187,2006,2007,222,266,275,763,8314,8805,AKT1,AKT2,ALK,BRAF,EGFR,ERBB2,JAK2,KIT,KRAS,MET,OVERALL,ROS1,SRC,SRCS,SURGICALLY
10001,333,ALSO,FDG,MEDICAL,PET,PUBLISHERS,SEVENTH,USA,YORK
ALSO,AMPK,ATM,CELLS,IGFBP,RASSF1A,RASSF1C,THESE
169,183,2004,2MM,CD56,CLINICALLY,CUSHING,ENDOSCOPIC,GEORG,HPF,LCNEC,PEPTIDE,PRRT,SCLC,STUTTGART,THEREFORE,TYPICAL,YORK
A549,CA2,ROS,THESE
1996,1999,2000,2005,2012,468,BETWEEN,FIVE,JANUARY,KOREA,OCTOBER
2003,2013,ACT,DESPITE,HOWEVER,IACIA,INDUSTRIAL,INSURANCE,JULY,KOREA,LABOR,LSA,ODS,SINCE,STANDARDS,THERE
116,121,169,2009,2012,2014,388,417,504,519,760,810,979,BETWEEN,CONCLUSION,COPYRIGHT,FIVE,LABEL,MEDICAL,METHODS,MODIFYING,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SOCIETY,THERE
169,2014,FURTHER,GENERAL,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,SUV,UNIVERSITY,VATS
001,123,169,2014,209,2200,290,AGE,AIMS,BACKGROUND,LABEL,LARGE,MEAN,METHODS,MORTALITY,OBJECTIVE,OVERALL,PRESS,PUBLISHED,RESULTS,SERVICE,SOCIETY,TESTICULAR,THESE,UNIVERSITY
001,007,027,169,2014,2363,874,883,AUSTRALIAN,BACKGROUND,BETWEEN,CONCLUSION,DAILY,FIFTY,GPS,LABEL,METHODS,NSCLC,PRIMARY,RESULTS,SECONDARY
001,032,049,259,375,400,8805,CHINESE,G590A,NAT2
020,042,073,085,160,237,250,263,287,357,362,619,625,EGFR,GEFITINIB,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
000,500,ARSENIC,BREEDER,CD1,HOWEVER,THESE,THUS
223,945,946,AROMATASE,BOTH,ELISA,ESTROGENS,GBM,III,PCR
009,016,022,034,121,308,324,8201,8804,BACKGROUND,DIAGNOSIS,GPA,KARNOFSKY,KPS,LABEL,METHODS,OVERALL,RADES,RADIATION,RESULTS,SCLC,SIX,SRS,WBRT
174,2009,2013,CELGENE,DRUG,EMA,FOOD,OCTOBER,USA

DEPARTMENT,ECG,EMERGENCY,QRS
LDCT,LUNG,SCREENING,SPNS,TRIAL
1994,2007,292,324,542,781,843,855,CONCLUSION,FINLAND,FINNISH,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,USING
946,954,ADC,BMP,EGFR,EMT,HES1,KRAS,NOTCH,SOX9,TARGETING,TGF,THUS,WNT
875,A549,AMONG,EARLY,SHOTGUN
946,954,AKT,COX,GSK3,IKK,ILK,MIG,MMP2,PGE2,PI3K,PIP3,THESE,VP1
ATP,EDM,EDMONSTON,PERSISTENT,TAKEN
886,954,CPG,ESCC,FOS,KNOCKDOWN,MYC,PKR,PROTEIN
169,183,GEORG,MOLECULAR,OBTAINING,STUTTGART,YORK
954,ALDH,BCSCS,CU2,DSF,FDA,HOWEVER,TREATMENT
946,AKT,EMT,GSK3,LDN193189,NANOG,NSCLC,SMAD1,SNAIL,THESE
0001,115,136,146,148,162,163,166,225,289,956,BURNING,CHINA,CHINESE,DEVIATION,GEOMETRIC,GSD,HAP,LOWER,MIXED,PM2,XUANWEI
HEP,HPLC,LC3,OVOTHIOLS,THESE
117,132,AIMS,BACKGROUND,CONCLUSION,FOLFOX7,GRADE,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
369,377,CD8,CYTOTOXIC,ERBB2,HLA,PRIMARY,TCR,USING
143,INTEGRATED,LIM,LIMK1,MICRORNAS,NSCLC
VEGF,VEGFR
CELLS,ECFCS,EPC,EPCS,MMP12,PROGENITOR
EVOLUTION,NSCLC,TRACERX
2014,3719,446,877,91533,AUC,BACKGROUND,DOR,HOWEVER,LABEL,MAY,MEDLINE,METHODS,NSCLC,RESULTS,SCIENCE,TEN,TTF,WEB
0004,001,002,009,024,033,141,155,200,200C,549,649,787,8202,BACKGROUND,CONCLUSION,EMT,FUNCTIONAL,H23,HCC,HIGH,HOWEVER,KLF6,LABEL,MET,METHODS,MICRORNAS,NSCLC,RESULTS,SCC,SEVERAL,VEGFA
519D,ALSO,AMONG,CCN2,CONNECTIVE,CTGF,ERK,MEK,MMP,MMPS,TAKEN
11A,200,946,AKT,ERK1,IC50,PTPS,SHP2,SRC,STRUCTURAL,THUS,USING
A549,AES,AMINO,BCL,BIT1,CONSISTENT,CONVERSELY,NSCLC,SPLIT,TAKEN,TLE1
169,189,2014,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,PURPOSE,RESULTS,SCLC,SOCIETY,VEGF,ZIV
001,005,023,051,233,AGE,AIDE,ARCAD,CANC,CONCLUSION,COX,DIGESTIVE,LABEL,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RECHERCHE,RESULTS,YOUNGER
169,2014,ALK,FDA
169,2014,LUNG
169,177,2007,2012,2014,BECAUSE,COPYRIGHT,IHC,III,PUBLISHED,RCC,RCCS,STAGE,SURGERY,TFE3,THREE,TREATMENT,XP11
169,2014,PRESS,PUBLISHED,S2B,SURGERY,UNIVERSITY
100,169,2014,264,ALTOGETHER,CABG,FIVE,LUNG,PRESS,PUBLISHED,STAGE,SURGERY,TEN,THERE,UNIVERSITY
169,2014,225,8764,CD133,CD34,COPYRIGHT,CXCR4,DESPITE,LTD,PES,PREVIOUSLY,THESE,UCB

000,200,DMFS,EMT,FUNCTIONAL,IFN,INTEGRATED,MEIER,MEMBERS,TGFB,THESE,WNT
001,8201,ECOG,FIFTY,FORTY,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RAPID,RESULTS,VANCOUVER,VARA,VARIABLES
001,013,038,093,169,2003,2011,2014,6960,BACKGROUND,CHANGES,CHI,COPYRIGHT,ENGLAND,IRELAND,LABEL,LTD,METHODS,MOST,NSCLC,PACIFIC,RESULTS,SBRT,UNIVARIATE
001,005,043,169,2014,375,CANDIDATE,CELL,CLAUDIN,CLDN1,CONCLUSION,COPYRIGHT,FINALLY,FURTHER,IRELAND,LABEL,LTD,MATERIALS,MES,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCC,THEREFORE
ANTITUMOUR
DISRUPTION,EGFR,PIP2
128,169,2014,A549,AKT,COPYRIGHT,ECTOPIC,ERK,LTD,NSCLC,THEREFORE,THESE,VEGF,VEGFR
000,002,008,035,051,057,120,159,175,201,8805,ACCORDING,BACKGROUND,KARNOFSKY,LABEL,LRPFS,METHODS,NSCLC,RADIATION,RESULTS,TREATMENT
169,2014,PRESS,PRIMARY,PUBLISHED,SEVERAL,SURGERY,UNIVERSITY
001,169,177,2011,2013,2014,ABLATIONS,ADJUNCT,COPYRIGHT,INC,LABEL,LESIONS,MARCH,MATERIALS,MEAN,METHODS,MICROWAVE,OBJECTIVE,PAIN,PATIENT,PRIMARY,PROCEDURE,PUBLISHED,PURPOSE,RESULTS,SIR,VAS
500,AFTER,AKT,CDK,EGFR,ERLOTINIB,FDA,LEWIS,LUX,PCR,PI3K,PROTEIN,THEREFORE,WESTERN
177,946,956,A549,AMONG,CC50,ELAEAGNUS,MAXIM,MTT,THESE
2012,213,318,373,482,589,891,AFSIN,DIFFERENT,KUTAHYA,POWER,PPP,PURCHASING,UNION,USD,VSL,WTP
CERTAIN,PRIOR,THESE
100,1275,1535,8202,ALK,BACKGROUND,BLOOD,CD24,CD44,CD45,CTC,CTCS,CURRENT,EGFR,EML4,EPCAM,FISH,LABEL,LUNG,NGS,PAN,PBMCS,PRINCIPAL,RESULTS,RETRIEVED
1969,1980S,2009,AUSTRALIA,BACKGROUND,BELGIAN,BELGIUM,ITALY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,COMPANY,INSURANCE,KNOWLEDGE,LABEL,LIFE,METHODS,METLIFE,OBJECTIVE,OBJECTIVES,ONCE,RESULTS,SOA,THERE
BESIDES,SPECT
FDG,HISTOLOGIC,PET
100,131I,131IODINE,177,237,300,457,600,639,AIRES,ARGENTINA,COX,DTC,FDG,FTC,GRT,LABEL,LUNG,METHODS,OBJECTIVE,OVERALL,PTC,RAI,RESULTS,SEVENTEEN,THOSE
FDG,PET,THERE
DFSP,FDG,PET
FDG,LABEL,LUNG,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS,SEVEN
ARMY,DELHI,FDG,INDIA,INDICATION,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEVERAL,THROMBOSIS
2004,2008,38584,8805,AMONG,BACKGROUND,CAUSE,CCI,COX,DESPITE,INDEX,INSURANCE,LABEL,LUNG,METHODS,NHI,RESULTS,THEREFORE
205,946,ABOUT,CD31,MMP2,MMP9,MVD,NSCLC,OVERALL,PAS,WNT,WNT5A
LUNG,STUDIES,WHILE
169,2014,BRAIN,COPYRIGHT,EGFR,HIGH,IRELAND,LMC,LTD,MRI,NSCLC,TKI
000,001,005,009,046,169,2014,494,551,ACCORDING,APART,BACKGROUND,BMI,COPYRIGHT,IRELAND,LABEL,LTD,LUNG,METHODS,RESULTS,WHILE
003,8197,945,946,BALF,CHANGES,DETECTION,ELISA,HOWEVER,TGF,TNF

002,017,018,032,169,2014,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,IQR,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,THERE,VEGF,WHILE
954,AKT,AMONG,FHIT,FRAGILE,HOWEVER,IC50,NSCLC,PUMA,SLUG,THEREFORE
BMP,BMPS,BONE,DMH1,MMTV,PYVMT,THESE,TREATMENT
916,AMP,AMPK,BOTH,FINALLY,H460,LKB1,NCI,SILENCING
60S,AUTOPSY,PTTM,PULMONARY
000,550,AMERICA,ASIA,HCC,LAASL,THESE
ALK,CERITINIB,CRIZOTINIB,III,NSCLC,PHASE
A549,ACCORDING,C91,DE3,DPPH,ENDS,FLOW,LATCRIPIN,LENTINULA,MTT,RACE,ROSETTA,WESTERN
2008,2010,ADULT,BACKGROUND,BANGLADESH,CHINA,INDIA,KNOWLEDGE,LABEL,MATERIALS,METHODS,POPULAR,RESULTS,THERE,TOBACCO
60S,BACKGROUND,L39,LABEL,MATERIALS,MDR,METHODS,PCR,RESULTS,RPL39,TDR,TOTAL,VIABILITY
AFTER,BACKGROUND,CDH13,LABEL,MATERIALS,METHODS,MSP,NSCLC,PATIENT,RASSF1A,RESULTS
AFTER,BACKGROUND,BEAS,CTPE,EDTA,JUN,LABEL,MATERIALS,METHODS,RESULTS,TAMS,THP
100,BESIDES,CONCLUSION,HMGB,III,LABEL,METHODS,MMP,MPP,NSCLC,OBJECTIVE,PCR,RESULTS,WESTERN
169,2014,COPYRIGHT,PUBLISHED,PULMONARY,SOCIETY,THESE
129,1523,169,1998,2002,2014,246,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,HRCT,IPF,LABEL,METHODS,PUBLISHED,RESPONSES,RESULTS,SOCIETY,UIP
016,027,034,043,057,154,169,183,2001,2011,2014,2N0M0,8804,8805,982,BACKGROUND,COPYRIGHT,ELDERLY,JANUARY,LABEL,METHODS,N0M0,NSCLC,POST,PUBLISHED,REGARDING,RESULTS,SBRT,SOCIETY
2002,2005,BACKGROUND,FARMERS,FURTHER,IC95,ITALY,LABEL,LITERATURE,MATERIALS,METHODS,RESULTS
000,080,100,175,420,577,CONCLUSION,LABEL,LPC,METHODS,NSCLC,OBJECTIVE,RESULTS,TOTALLY
200C,BACKGROUND,EMT,FURTHER,GROWING,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,SILENCING,THESE,USP25
1972,2008,208,429,725,BMI,BOTH,FINNS,HIGH
127,169,1NG,2014,2575G,48H,7NG,9NG,COPYRIGHT,EGFR,GEFITINIB,III,IRELAND,LTD,NSCLC,TKI,TKIS
014,169,2004,2010,2014,CASES,COPYRIGHT,EQD2,INC,INCIDENTAL,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,REFERENCE,RESULTS,SBRT,UNIVARIATE
127,140,169,2003,2013,2014,322,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,DFI,FIVE,HOWEVER,JANUARY,LABEL,LTD,MEDICAL,METHODS,PULMONARY,RESULTS,STS,UNIVERSITY
169,2014,2818,BACKGROUND,BARTHEL,CONCLUSION,COPYRIGHT,DESPITE,FEDERATION,FOUR,LABEL,METHODS,PUBLISHED,RESULTS,SPAIN
169,574,COPYRIGHT,FERRATA,FOUNDATION,FURTHER,INSTITUTES
054,121,143,155,169,2014,239,823,AES,BCL,CBE,CBEOB,CONCLUSION,COPYRIGHT,EASTERN,ECOG,GRADE,GROUP,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBATOCLAX,OBJECTIVE,ORR,PFS,RESPONDERS,RESULTS,SCLC
001,1248,169,2014,296,576,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FEN1,FURTHER,HDAC2,IRELAND,LABEL,LTD,LUCIFERASE,METHODS,MICA,NSCLC,RESULTS,SNPS,TYMS
0001,002,005,011,169,1995,2013,2014,50MM,ALK,BIOMARKERS,BLOOD,BRAF,BVI,CONCLUSION,COPYRIGHT,EGFR,FISH,FIVE,HER2,IRELAND,KRAS,LABEL,LTD,MATERIALS,MET,METHODS,MORPHOLOGY,NSCLC,OBJECTIVE,OBJECTIVES,P63,PAS,PCR,PULMONARY,RESULTS,SCS,SEVENTY,THEIR,TTF1
LABEL,METHODS,NOTABLY,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
1ST,2ND,3RD,8805,EGFR,FDG,FIFTEEN,FLT,HOWEVER,IIIB,NSCLC,PERCIST,PET,PFS,RESULTS,ROC,SULPEAK,THREE,TKI,TLG
ATL,AUTOPSY,FDG,PET
100,160,1992,2011,CONCLUSION,HODGKIN,LABEL,METHODS,NONE,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SCLC,SIXTY,SVCS
011,032,036,037,169,2014,219,ALSO,BACKGROUND,COPYRIGHT,DFS,EVEN,FORTY,INC,LABEL,LRC,MATERIALS,METHODS,NSCLC,PORT,PROPENSITY,RESULTS
169,2014,4T1,COPYRIGHT,DESPITE,DOX,EOSIN,GNR,IHC,LTD,NIR
160,169,2014,COPYRIGHT,DUE,INC,PUBLISHED,SOCIETY,THUS
169,2014,COPYRIGHT,CYSTS,INC,PUBLISHED,PULMONARY,SOCIETY
BASED,HOX,HOXA,HOXA9,HOXB,HOXC,HOXD
169,2014,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,FIVE,PUBLISHED,SOCIETY,ZEALAND
002,008,0128,013,240,280,APAI,BOTH,BSMI,FOKI,HAPLOTYPE,SNP,TAQI,TUNISIA,VDR,VITAMIN
ANNEXIN,BACKGROUND,CELL,DOCETAXEL,DTX,ERK,HIGH,HMGB1,III,LABEL,LAD,LUNG,MEK,METHODS,MTT,NOD,NSCLC,PARP,PI3K,RESULTS,SCID,SPC
160,169,2014,956,A549,COPYRIGHT,HOWEVER,SAS,THEREFORE
169,2009,2013,2014,2018,AGE,APC,COPYRIGHT,JOHN,LTD,POISSON,RESULTS,SONS,SWISS,WILEY
169,2014,COPYRIGHT,INC,RAS,SHAO,YAP1
169,2014,946,ASIAN,BACKGROUND,HOWEVER,LABEL,LOX,METHODS,MOST,OBJECTIVE,PACIFIC,PET,RESULTS,SCC,SCLC,SMALL,SOCIETY,TGF,THERE
001,GRADE,HELICAL,HOWEVER,OTHER,PTV,SBRT
100,AFTER,NSCLC,OTHER,RFA,SBRT,THEREFORE,VARIOUS
169,2014,COPYRIGHT,FURTHER,NETWORK,THUS
2014,BMJ,EMP,GROUP,LTD,PUBLISHING
100,153,169,2014,8805,FOUR,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,PRESS,PUBLISHED,RESULTS,SURGERY,SUV,THREE,UNIVERSITY
120,169,176,2014,NOTES,PRESS,PUBLISHED,REFINEMENT,SURGERY,UNIVERSITY,VATS
169,2014,ARMS,COPYRIGHT,CSF,EGFR,EPIDERMAL,INC,L858R,MOLECULAR,MOST,PATHOLOGY,PCR,PUBLISHED,SOCIETY,THESE
8197,FND,FNDS,HELA,ICCD
ACCORDING,BPNN,KNN,SVM
233,BACKGROUND,BHD,BIRT,CASE,CONCLUSION,DUB,FLCN,HOGG,LABEL,METHODS
802,8209,A549,H1299,H358,NCI,THEREFORE
2008,2011,315,BACKGROUND,FUNCTIONAL,HCAP,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOGENS,PDR,RESULTS,VARIABLES
BACKGROUND,CASE,ENGLISH,LABEL,METASTASIS,METHODS,THERE,THEREFORE
143,946,EGFR,EPIDERMAL,ERCC1,III,IIIB,KRAS,LABEL,LCT,METHODS,MUTATIONS,NSCLC,OBJECTIVE,RESULTS,RRM1,TUBB3,TYMS
169,177,2014,785,BACKGROUND,BASEL,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,LUNG,METHODS,RESULTS
SPARC
160,ECM,NCK,SH3,SRC,TKS5
001,169,2004,2011,2014,277,481,758,COPYRIGHT,HOWEVER,INC,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,POOR,PUBLISHED,RESULTS,SURGERY,THESE,TNM,UNIVERSITY
169,2014,COPYRIGHT
0076,0254,160,169,2014,5726,6060,8805,945,BACKGROUND,COMBINING,CONCLUSION,COPYRIGHT,EGFR,FORTY,FRA,HIGH,INC,KIRSTEN,LABEL,METHODS,NSCLC,PFS,RESULTS,SPECIMENS,THERAPIES
BACKGROUND,EBUS,GGO,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGARDING,RESULTS,TBB
BACKGROUND,CONCLUSION,DIAGNOSTIC,DUE,EBF,ENDOSCOPY,LABEL,METHODS,PLUG,POST,RESULTS,STEPS,WIRE
027,029,038,2003,2013,8201,ALSO,BACKGROUND,DFS,HOWEVER,JANUARY,JIAO,LABEL,MARCH,METHODS,NOTABLY,POOR,PRIMARY,RELATIVELY,RESULTS,THERE,THESE,TONG,UNIVERSITY
686,910,EFS,MICRORNAS,THEIR
169,2014,BASEL,CLEARLY,EGFR,FINALLY,NON,NSCLC,THESE,TKI,TKIS
0008,001,008,A549,BERBERINE,CONCLUSION,FLOW,LABEL,METHODS,OBJECTIVE,RESULTS
A549,AETC,BALB,CHINENSIS,CONCLUSION,EGFR,EIGHT,ERK1,FORTY,HOWEVER,JNK,JUN,LABEL,MAPK,METHODS,MTT,OBJECTIVE,REHD,RESULTS,TAXUS,THEREFORE,WESTERN,ZEALAND
100,200,430,ALK,COX,EGFR,EML4,FISH,IHC,PCR,VENTANA
103,128,761,8001,834,850,ATP,EGFR,FINALLY,FIRST,IC50,L858R,QSAR,THUS
BACKGROUND,CASE,DRUG,INR,LABEL,METHODS,NARANJO,PATIENT
946,BACKGROUND,EXOGENOUS,H1299,LABEL,METHODS,RCM,RESULTS,RIBES,ROS,TGF
AIDS,HIV,PULMONARY
111,BASED,CCK,CCK2,DOTA,F11,IC50,MTC,NOTA,PET,SCLC,SPECT
954,A549,AKT,CHINESE,DRUCE,DUE,GNA,HELF,MILL,MTT,POL,ROS
205,A549,ASSOCIATED,BEAS,COLO,DIATOMS,FADD,FAS,MTT,PROTEIN,PUA,PUAS,RIP,THESE,TNFR1,USING
A549,AFTER,JNK,LABEL,MAPK,MELATONIN,METHODS,MLC,MLCK,MTT,OBJECTIVE,OPN,RESULTS
1889,ALK,CRC,CRCS,CRIZOTINIB,EML4,FIG,FISH,ROS1
BACKGROUND,CARCINOID,CRYOBIOPSY,HOWEVER,LABEL,METHODS,RESULTS,THERE
100,2009,2013,BACKGROUND,DENMARK,LABEL,MARCH,METHODS,RESULTS,SEPTEMBER,SIXTY
100,102,177,2012,2013,216,BACKGROUND,EBUS,INDIA,LABEL,LITERATURE,METHODS,MOST,NORTH,OVERALL,RAPID,RESULTS,SEPTEMBER,TBNA,THERE
001,244,787,CONVERSELY,HODGKIN,MCC,MCCS,QUEENSLAND,SIR,SIRS,THESE
000,0001,002,014,063,109,132,189,1979,200,2005,2007,329,420,494,498,502,545,660,8805,948,988,AGE,BACKGROUND,INSULIN,INSURANCE,LABEL,METHODS,RESULTS,TAIWANESE
ATF3,ATF4,INHIBITION,MCL,MPM,NOXA,NSCLC,PEMETREXED,THUS,USP9X
169,2014,A549,COPYRIGHT,ESI,INC,MCF,MTPC,MTT,NMR,SIMILAR,SKOV
2005,HOWEVER,LOCAL,MIDTERM,MINOR,NSCLC,SINCE,WORLDWIDE
100,CDC27,CK18,EARLY,EGR1,KRT18,MICROARRAY,NSCLC,PRKDC,VARIOUS
001,019,160,744,946,CEA,CONCLUSION,CYFRA,FDG,HOWEVER,LABEL,METHODS,MTV,NSCLC,OBJECTIVE,PET,RESULTS,SERUM,SEVENTY,SUV,SUVMEAN,THERE
BRAF,EGFR,FFPE,HOWEVER,KRAS,NGS,PANEL,SNP
001,102,2005,2011,340,740,773,8201,AJCC,AUC,BETWEEN,CONCLUSION,EFGR,EGFR,FDG,HOWEVER,III,JANUARY,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PET,PURPOSE,RESULTS,ROC,SUVMEAN,SUVPEAK
160,177,8201,CONCLUSION,FDG,LABEL,METABOLIC,METHODS,MTV,NSCLC,OBJECTIVE,OLM,PET,PURPOSE,RESULTS,ROC,SUV,SUVMEAN,TLG,TOTAL,UNIVARIATE
219,8201,8805,AUC,BET,FOLLOWING,HOWEVER,NSCLC,PRIMARY,TEST,THERE,THESE,THUS
ASSISTANT,AUDIT,CDS,ENGLISH,HOWEVER,LCA,LUNG,MDT,MDTS,WHILE
169,174,2014,ALK,ATP,COLLEGE,CRIZOTINIB,IRT,PIC,XALKORI
169,2014,945,946,947,B16,BL6,CD4,CD8,COPYRIGHT,CTLS,DCS,DESPITE,HPV,HSPX,IFN,INC,MYD88,TH1,THEREFORE,TLR4,TNF,TRIF
00001,0005,001,8201,BAT3,CAUCASIANS,CIS,DATABASES,HLA,HOWEVER,NINE,ORS,SEVERAL,SUMMARY,THUS,WANFANG
001,009,043,104,235,654,707,859,8804,COX,III,LABEL,METHODS,NLR,NSCLC,OBJECTIVE,RESULTS,ROC,THERE,TNM,UNIVARIATE
100,2011,2012,AMONG,CEA,CK7,GGO,III,IMAGING,JULY,LABEL,LUNG,METHODS,MPP,OBJECTIVE,RESULTS,SIXTY,SPA,THERE,TTF
001,002,014,019,021,029,1997,2005,AMONG,ASPP,ASPP1,ASPP2,EXPRESSION,FIFTEEN,GUIYANG,III,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,P53,RESULTS,SEPTEMBER,UNIVERSITY
173,177,200,285,339,406,435,465,804,946,947,AAD,C57BL,CD4,CD8,CFSE,ELISA,ESAT,IFN,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,SERUM,TGF,ZEB1
169,2014,A549,AFTER,BACKGROUND,BAX,DAILY,LABEL,LUCIFERASE,LUNG,METHODS,PROTEIN,RESULTS,SOCIETY,THEN,THERE,WESTERN
149,ANISOTROPY,EUCLIDEAN,FOUR,FROBENIUS,GTV,GTVS,IMAGE,LABEL,LOG,METHODS,OBJECTIVE,PURPOSE,RESULTS,TENSORIAL,THEIR,THESE
100,177,AUTOMATIC,CBCT,CERTAIN,CORRECTION,EACH,LABEL,METHODS,OBJECTIVE,PHANTOM,POSITIONAL,PURPOSE,RESULTS,SOBEL,TEMPLATES
204,484,CBCT,FBS,FDK,HIGH,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,REGARDING,RESULTS
174,2620,2MM,500,800,BATCH,CARLO,CPU,DOSXYZNRC,DUE,GAMMA,GPU,GPUS,INTEL,K20,K40,LABEL,M2090,METHODS,MONTE,OBJECTIVE,PATIENT,PSF,PSFS,PTV,PURPOSE,RESULTS,USING
0001,0005,0030,125,2014,500,8201,BACKGROUND,GOVERNMENT,GRADE,III,LABEL,METHODS,MPM,MTD,OBJECTIVE,OTHER,PE38,PEMETREXED,PUBLISHED,RESULTS,SECONDARY,SERUM,SS1,SS1P,USA
AFTER,CHOP,EBV,FDG,HOWEVER,LYG,MICM,PCR,PET,SUV,THEREFORE
001,008,010,016,035,075,097,137,257,304,312,371,472,543,554,602,652,976,AFRICAN,ASIAN,BACKGROUND,CAUCASIAN,CAUCASIANS,CYTOCHROME,IMPACTS,LABEL,LEU,LEU432VAL,METHODS,NULL,P4501B1,RESULTS,VAL
2010,2013,400,776,BACKGROUND,HOWEVER,JANUARY,LABEL,METHODS,MLND,MOST,NSCLC,RESULTS,VATS
169,2014,ABCG2,ASIA,ATM,AUTHORS,BCL,LTD,MCL,MDR,MOST,PTY,PUBLISHING,SCIENCE,TAKEN,WILEY
BRAIN,DESPITE
KNOWING,MARRARO,OLV,UNIVENT
FEHTP,FET,H69,LAT,NCI,PET,REFERENCE,SMALL,THESE
945,CO2,HIF,HOWEVER,MMP,PARP,PGC,SCC,SCCS,TFAM,VEGF
089,183,1950,2000,2004,3984,6350,956,ALZHEIMER,BLADDER,DIGESTIVE,INCIDENCE,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,THERE
THERE,VIRTUAL
100,BACKGROUND,CASES,DFS,LABEL,LOWER,LUNGCARTA,MANN,MEIER,METHODS,NON,NSCLC,PANEL,QTA,RESULTS,WHITNEY
013,177,DICE,DSC,MRF,NSCLC,PET
001,014,104,8201,HIGH,III,MMP,NSCLC
CURRENT,HOWEVER,LABEL,OPINION,PULMONARY,STATEMENT,UNANSWERED,UNASSIGNED,VATS,WHILE
160,18F,AIM,CONCLUSION,CTS,FDG,LABEL,MAXIMUM,METHODS,NSCLC,OBJECTIVE,PALLIATIVE,PERCIST,PET,RESULTS,THREE,THUS
169,2014,B16,C26,COLON,INC,LEWIS,LLC,MTT,PEGYLATED,VEGF,WILEY
169,2014,CHEST,COPYRIGHT,HEMOPTYSIS,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PUBLISHED,PURPOSE,RESULTS,SIR
001,169,2014,4334,8201,API,ASIAN,BACKGROUND,DATA,EVEN,LABEL,METHODS,PACIFIC,RESULTS,SOCIETY,USB
169,1966,2013,2014,540,BMI,HOWEVER,INDEX,ISI,JANUARY,MAY,OVERALL,SCIENCE,SRR,WEB
2014,8805,90Y,EARLY,FLIPI,FOUR,HRQOL,MEAN,RELAPSE,SPAIN,SPANISH,TIME,TTR
169,2012,2013,2014,AFTER,BACKGROUND,CARL,COPYRIGHT,DESPITE,GERMANY,HOWEVER,INC,INTRABEAM,IORT,JUNE,LABEL,METHODS,NAC,NSM,OBERKOCHEN,RESULTS,ZEISS
2014,2691,3067,8201,BACKGROUND,CIS,CNKI,CONCLUSION,JANUARY,LABEL,LITERATURE,METHODS,ORS,RESULTS,UNASSIGNED,VIRTUAL
015,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,ELISA,ENO1,INC,LABEL,LUNG,MATERIALS,METHODS,PROTEOMICS,RESULTS,USING,WESTERN
0001,001,024,169,2004,2006,2011,2014,848,8805,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HRS,III,INC,LABEL,MATERIALS,MEIER,METHODS,OVERALL,RADIATION,RESULTS,THERE
169,2014,ALK,COPYRIGHT,DESPITE,III,INC,NSCLC,THEREFORE
NOS,PECOMAS
215,249,8202,8805,BACKGROUND,COPD,FEV1,GWAS,IL16,LABEL,ME3,METHODS,NEITHER,RESULTS,TMC3
LA1,MICHAEL,SPE,THESE
BACKGROUND,CONCLUSION,CRT,HOWEVER,IMRT,INTENSITY,LABEL,METHODS,RESULTS,THREE
143,341,360,8482,946,A279T,BACKGROUND,BRG,ESC,LABEL,MEFS,METHODS,MTS,PCR,RESULTS,SEQUENCING,TERC,TERT,THESE,WNT
169,2014,34A,AKT,COPYRIGHT,EGFR,HGF,IRELAND,LTD,MET,NSCLC,PI3K,TKIS
1997,2012,AVERAGE,BACKGROUND,DATA,FEMALES,HOWEVER,LABEL,LUNG,METHODS,RESULTS,STATISTICS,YLL
ANONYMOUS,BACKGROUND,EGFR,EQA,EVEN,FALSE,HOWEVER,LABEL,LEADING,MEDICAL,METHODS,NSCLC,PATHOLOGY,RESULTS
195,AUTOPHAGY,BACKGROUND,HIGH,INCREASED,LABEL,LC3B,METHODS,OSCC,OSCCS,RESULTS,SEVERAL
0005,003,100,8289,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,ROC,SPN,SPNS,SUV
FINALLY,HENCE
001,114,169,2014,304,ASSESSMENT,BASED,BLOOD,CHRONIC,GVHD,HCT,HEART,HEMATOLOGY,INSTITUTE,LUNG,MRD,MTX,MUCOSITIS,NEUTROPHIL,ORAL,SCALE,SIR,SOCIETY,TAC,THERE
169,2005,2007,2014,AHR,CAREFUL,CONCLUSION,COX,CVC,CVCS,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER,SOCIETY
100,169,2014,222,315,8804,CONCLUSION,HIGH,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,SRB,THERE,THREE
045,087,169,1996,2010,2014,648,AMONG,CD4,CONCLUSION,DLBCL,HIV,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TEXAS
169,2014,258,312,392,467,800,CONCLUSION,COX,FACTORS,GROUP,LABEL,MEIER,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SOCIETY,THESE
001,169,18F,18FDG,2014,273,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DUE,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OVERALL,PET,RESULTS,SEGMENT
001,0121,169,2014,ALK,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,EGFR,EML4,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,RESULTS
0001,169,2014,218,ANTICANCER,BACKGROUND,COPYRIGHT,EXPRESSION,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,PKM1,PKM2,RESULTS
169,2014,298,8F1,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,ERCC1,EXPRESSION,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,OBJECTIVE,OOUR,RESULTS,SP68,THERE
169,2014,215,ALK,ANAPLASTIC,ANTICANCER,CAUCASIAN,CNS,COPYRIGHT,INSTITUTE,JOHN,KIRSTEN,KRAS,NSCLC,RAS2,THESE
169,2014,ANTICANCER,CONCLUSION,COPYRIGHT,CRT,CTV,HOWEVER,INSTITUTE,ISC,JOHN,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TEN
169,2014,ABCB1,AMRUBICIN,ANTICANCER,BACKGROUND,C609T,CONCLUSION,COPYRIGHT,FIFTY,INSTITUTE,JOHN,LABEL,MATERIALS,MDR1,METHODS,NAD,NQO1,RESULTS,SNPS
169,2014,954,A549,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GRP78,INDUCTION,INSTITUTE,JNK,JOHN,LABEL,MATERIALS,METHODS,RESULTS,VIABILITY
169,2014,AIM,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMA,PROTEIN,RESULTS,TNF
100,169,2014,AIM,ANTICANCER,BACKGROUND,BALBC,CONCLUSION,COPYRIGHT,IGR,IMR,INSTITUTE,JOHN,LABEL,LUC,METASTATIC,METHODS,N91,OBJECTIVE,ORTHOTOPIC,RAG2,RESULTS,THESE,TREATMENT
169,2014,215,ANTICANCER,BOTH,COPYRIGHT,EXPANSION,FRESH,INSTITUTE,JOHN,MORPHOLOGY,PDX,RATES
AKT,FINALLY,HYPOXIA,KNOCKDOWN,KRAS,LUNG,NTRK2,THESE,TRKB
007,046,169,2014,631,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,PS2,RESULTS,SCLC,TFI,VALIDATION
1972,5TH,6TH,945,ASIA,BACKGROUND,BARR,CNS,CONCLUSION,DISEASE,DYSPNEA,EPSTEIN,INTERFERON,LABEL,LUNGS,LYG,NOVEL,PROGNOSIS,TREATMENT,WORLD
HOWEVER,IMAGE
169,2014,954,ACTIVATION,CD11B,CD204,CD206,CD68,CD86,COPYRIGHT,EXPRESSION,FETAL,FLOW,IKFM,INC,LPS,SIMILAR,TLR4,USING,YM1
ALK,EGFR,HOWEVER,MECHANISMS,NSCLC,TKIS
003,009,013,017,042,108,8201,945,947,A549,ALTOGETHER,BAX,H1975,H3K9,HOWEVER,HP1,NCI,NSCLC,TNM
100,155,169,2014,228,303,374,529,ARIC,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,MEAN,METHODS,MODEL,OBJECTIVE,PREDICTORS,RESULTS,RISK,SELF,TARGETING
169,2014,AMONG,GGO,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,THEREFORE,UNIVERSITY
ROBO,ROBO1,SLIT,TAKEN,UBIQUITIN,USP33
169,2014,8201,BRITISH,IMMUNOLOGY,SOCIETY,TH2
169,2014,916,A549,CLP,CLPL,COPYRIGHT,D39,GRAM,HOWEVER,INHIBITION,RAC1,RAP1,SOCIETY,THEREFORE,THESE
ALK,CERITINIB,III,NSCLC,PHASE,REGULATORY,THERAPY
AEA25,AEA4,AMONG,ATP,FGFR1,NDGA,NSCLC,THUS
125I,ABCG2,AKT,CELL,EGFR,H460,HOWEVER,LUNG,MDR,MX20,NCI,NON,NSCLC,SMALL
ADCA,FIRST,HDAC,HDACI,HISTONE,HOWEVER,MPM,NODH,THEREFORE,THESE
016,029,ASIAN,ESCC,ESOPHAGEAL,HOWEVER,NOTCH,NUMB,T288,TAKEN
127,215,240,340,441,598,946,AXIN2,CXXC4,III,LACK,LEMD3,MAYO,MDACC,NONE,NSCLC,SNP,SNPS,USING,WIF,WNT
1982,2003,2013,9559,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DATA,HEMATOLOGY,LABEL,MAIN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RANDOMIZED,RCT,RCTS,RESULTS,SELECTION,SEVERAL,SOCIETY,USING
160,169,2014,BACKGROUND,COPYRIGHT,EVEN,GROUP,INC,INTERGROUP,LABEL,METHODS,PUBLISHED,RESULTS,S0220,SOCIETY,SOUTHWEST,TRIAL
001,015,047,074,114,161,2002,2006,8201,884,BACKGROUND,DFS,LABEL,METHODS,RECURRENCE,RESULTS,THERE
169,2014,DICE,DSC,FINALLY,FIRST,GTV,GTVS,JAPAN,OCS,PET,PRESS,PUBLISHED,RADIATION,SOCIETY,UNIVERSITY
1636,280,3420,679,A549,ANNONACEAE,DIFFERENT,ESI,FTIR,FURTHER,G10,HC1,HELA,HPLC,MTT,POLYALTHIA,RUBIACEAE,SEED,TRIS,VIOLACEAE
8TH,AFTER,DENTASCAN,EXTENSION,METASTATIC
ANESTHESIA,CORMACK,GLIDESCOPE,III,WHILE
1984,2009,287,ACCORDING,BACKGROUND,HPV,IARC,LABEL,LOWER,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS,SYNCHRONIC,THESE
BECAUSE,CLINICIANS,DRY
171,2006,2011,589,BACKGROUND,CONCLUSION,FORTY,FUNDING,HODGKIN,INSTITUTE,JULY,LABEL,LIMITATION,MAY,METHODS,MULTI,NETWORK,OBJECTIVE,PHYSICIAN,PRIMARY,RESULTS,SETTING
170,2013,5599,8202,ADCS,BACKGROUND,BRAF,BRAFV600E,INDEX,ISI,LABEL,METHODS,NSCLC,OCTOBER,ORS,RESULTS,SCIENCE,TEN,THERE,THESE
000,100,120,153,1950,576,846,AMONG,BACKGROUND,CONSENSUS,EFFICIENT,GUIDELINES,LABEL,LUNG,METHODS,NLST,RESULTS,SCREENING,TRIAL
004,100,109,119,BACKGROUND,CONTEXT,FOUR,KLF4,LABEL,LACK,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
MEANWHILE,SMALL,THUS
4010,BACKGROUND,CONCLUSION,DFS,IHC,LABEL,METHODS,NSCLC,ODDS,PFS,RESULTS,SCIENCE,TNM,WEB
BRONCHIAL,PREVIOUSLY
FDG,HOWEVER,PET,PRIMARY
2013,2500,386,8211,8764,AIMS,BRCA2,CCND1,EGFR,EPHA3,FGFR1,FIFTY,GIVEN,GREATER,HISEQ,KIT,KRAS,LABEL,MARCH,MCL1,METHODS,MLL2,NF1,OBJECTIVE,PTEN,RB1,RESULTS,SCLC,SMALL,TP53,TSC1
DATA,DYSPNEA,ICU,LABEL,NIV,OBJECTIVE,PROCESSES,PURPOSE,RESULTS,SUMMARY
A549,PTPN6,STAT3,TNBC,Y705
A549,AXL,DOTA,H249,NCI,PET,WESTERN
160,169,183,231,4T1,64258,8201,956,AKT,ASTRAGALUS,GEORG,HOWEVER,MDA,MMP,PI3K,STUTTGART,THESE,TIMP,TRIFOLIUM,YORK
001,EGFR,ERBB,ERBB1,ERBB2,ERBB3,ERBB4,HER2,LUNG,LUX,NSCLC,TKI
435,47D,562,CNS,HCT,INSTITUTE,MAXIMUM,MDA,NCI
231,ASTRAGALUS,MAXIMOWICZ,MDA,SH003,STAT3,THEREFORE
011,018,024,028,048,06895,169,2014,3595,456,4695,4895,807,8201,946,9495,AFTER,ANOTHER,CBR1,FDR,HAPLOTYPE,HSD1,HSD11B1,INC,NNAL,NNK,SCC,SNP,SNPS,THESE,WILEY
169,184,2014,AKT,AUTHORS,DOWN,FOUNDATION,HOWEVER,INSTEAD,JOHN,JOURNAL,JUN,LENTIVIRAL,LTD,MOLECULAR,MYC,NSCLC,PI3K,SONS,WILEY
133,169,2014,916,A549,CB2,COMPARABLE,COPYRIGHT,FINALLY,H358,H460,HOWEVER,HUVEC,INC,INHIBITION,JWH,SIRNA,TIMP,USING,VIABILITY,WST
169,2014,A549,CHINESE,CLINICALLY,EMT,HUANG,INC,INCREASING,QIN,SNAIL,STAT3,TAKEN,THP,TWIST,WILEY,WOGONIN
003,036,169,2014,217,238,AKT,BACKGROUND,COPYRIGHT,EGFR,ERK,FIFTY,IRELAND,LABEL,LARGE,LATS2,LTD,METHODS,OVERALL,RESULTS
0001,0003,169,1825,2014,292,309,349,364,441,750,8804,AMONG,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,THERE
001,010,015,158,169,2007,2011,2014,500,525,655,8805,COPYRIGHT,CRT,IIIA,INDEX,IRELAND,JANUARY,LABEL,LTD,MATERIALS,MEAN,METHODS,MTB,NSCLC,OBJECTIVE,OBJECTIVES,PTV,RESULTS,THESE
0001,001,100,135,169,188,1991,2010,2014,321,7TH,8804,AIS,ATS,CONCLUSION,COPYRIGHT,ERS,HIROSHIMA,IASLC,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,MIA,OBJECTIVE,OBJECTIVES,RESULTS,RFI,RFIS,T1A,T1B,TNM,UNIVERSITY
138,169,2005,2013,2014,CONCLUSION,COPYRIGHT,FOUR,INC,JANUARY,LABEL,LUNG,MATERIALS,MAY,METHODS,OBJECTIVE,PULMONARY,RESULTS,SCCA
169,2014,AFTER,FORCE,PREVENTIVE,PRUDENT,SOCIETY,TASK
BECAUSE,HOWEVER,INSTEAD,RISK,UNTIL
1916,CLINICIANS,ESR,GIVEN,IIM,OVARIAN,THEREFORE
169,2014,CAC,CLINSEQ,COPYRIGHT,FINALLY,FRAMINGHAM,FURTHER,HEART,INC,KOSSA,OVERALL,PUBLISHED,SOCIETY
169,2014,945,BACKGROUND,BOTH,CONCLUSION,HOWEVER,INC,LABEL,METHODS,NUCLEAR,PRO,PROEX,RESULTS,TMA,WILEY
0001,169,2014,518,ASSESSMENT,BOWEL,COLORECTAL,COMPOSITE,CONCLUSION,COPYRIGHT,FORM,FUNCTIONAL,INC,INDEX,LABEL,LUNG,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OVARIAN,PEARSON,PUBLISHED,QOL,RESULTS,SCREENING,SHORT,THERAPY,THESE,TREATMENT,TRIAL,WHITE
AUC,BASED,DISEASE,LEAST,LUNG,MICRORNAS,MIRNA,PREDICTING,SQUARES
160,ABL,CABLES1,CDK,CDK2,CDK4,CDK5,CIP1,MACROPAIN,PROSOME,PSMA3,THUS
100,160,169,198,2015,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,DOSE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PER,PUBLISHED,RESULTS,SIMILARLY,THERE,THESE
001,147,169,2014,APA,ASIA,AUTHORS,BOTH,CPEB1,E2F1,HIGH,LTD,MCM2,MKI67,PCR,PTY,PUBLISHING,SCIENCE,TOP2A,UTR,WILEY
176,4DCT,8325,8329,BACKGROUND,BRAGG,CONCLUSION,HOWEVER,ITV,LABEL,METHODS,MIP,RESULTS,USING,WEPL
001,002,169,2014,234,8805,CETUXIMAB,CIS,HTES,KNOWLEDGE,NSCLC,RCTS,RRS,SOCIETY,UICC,WEB
169,1730,2013,2014,805,8805,925,ASIA,AUTHORS,ENGLISH,FIVE,INCLUSION,JUNE,LTD,ORS,PTY,PUBLISHING,SCHOLAR,SCIENCE,TESTS,THERE,WILEY
169,2014,EGFR,FINALLY,INC,LUNG,MET,NSCLC,RESULTS,THESE,WILEY
BACKGROUND,D50,LABEL,METHODS,NSCLC,RESULTS,SBRT,TCP
AFTER
169,2014,BECAUSE,CAREFUL,CONGENITAL,COPYRIGHT,INC,MOSBY
0001,0003,001,002,003,0498,052,108,142,146,169,173,183,2014,255,363,581,8200,946,ACADEMY,AGING,BACKGROUND,BLOOD,BPGEN,BRITISH,COHORTS,CONSORTIUM,COPYRIGHT,COUNCIL,DHCR7,FINLAND,FOUNDATION,FUNDING,GENOMIC,HEART,ICBP,INCREASED,LABEL,LOW,MEDICAL,METHODS,OPEN,PUBLISHED,RESULTS
169,2014,BECAUSE,CHALLENGES,COPYRIGHT,LTD
001,009,027,032,046,169,2000,2011,2014,AGGRESSIVE,ATT,CAREFUL,CONCLUSION,COPYRIGHT,COX,III,IRELAND,KARNOFSKY,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OPTIMAL,RECEIPT,RESULTS,SBO,SIXTY
169,2014,ASO,BRCA2,COPYRIGHT,CROWN,DECREASED,PUBLISHED,TARGETING,TCGA,THESE
169,2014,ECM,HOWEVER,INC,TFM
BACKGROUND,BASED,DISCUSSION,DISEASE,EGFR,ERBB,HEAD,HNSCC,HOWEVER,III,LABEL,LUX,METHODS,NECK,PHASE,SECONDARY
ACC,ACS,CGG,CTG,EASTERN,EGFR,EXON,KRAS,L858R,NSCLC,SCC,SCCS,SIX,THEIR,THREE,TURKISH,WESTERN
024,027,032,114,2013,8201,CD133,CIS,CSC,DFS,HOWEVER,HRS,JUNE,NSCLC,ODDS,ORS,OVERALL
001,009,5067,5422,853,AFTER,BACKGROUND,CARE,CONCLUSION,CONSORTIUM,CONTEXT,INC,LABEL,LUNG,METHODS,MOST,OBJECTIVE,OBJECTIVES,PUBLISHED,RELATIVELY,RESULTS
169,2014,A549,ATP,COPYRIGHT,HOWEVER,IRELAND,LTD,THESE,WARBURG
AKT,ALK,EML4,ERK,H2228,HOWEVER,NSCLC,PI3K,STAT3,TKIS
945,A549,APOPTOSIS,CHINESE,CURCUMA,ELEMENE,HIF,MAMMALIAN,OVERALL
001,005,033,169,177,2014,AFTER,BACKGROUND,BLS,COPYRIGHT,DFS,FGS,GREEN,HALF,INC,LABEL,MATERIALS,METHODS,RESULTS,SIX,ZOL
0010,0013,0205,100,135,169,2004,2011,2014,AMONG,BETWEEN,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SOLID,SURGERY,THERE,UNIVERSITY
A549,CCND1,CHINESE,HOWEVER
AREAS,AVAILABLE,BACKGROUND,COVERED,LABEL,METHODS,NSCLC,OPINION,ORAL,ORIGINALLY
169,4T1,945,947,AFTER,CD133,CD31,CD34,CD40,CD45,EPCS,FLK1,GIVEN,HOWEVER,PRESS,THEREFORE
004,015,034,109,451,BACKGROUND,CONCLUSION,LABEL,LMVD,METASTATIC,METHODS,NSCLC,PDGF,RESULTS,THEREFORE,UNASSIGNED,USING,VEGF,VIRTUAL
100,ADENO,BAF,BALB,DCS,EGR,FLT3,FLT3L,FOUR,GCV,HCC,HSV,LACZ,NULL,RADIATION,RADIO,THERE,THESE,WESTERN
160,169,2014,BLOOD,COPYRIGHT,FOUR,HOWEVER,MDS,PLANNED,PRIMARY,RIC,SECONDARY,SOCIETY
100,99MTC,AVP,CH2,EDA9,ET2,H69,ILE4,NS3,SCLC,TYR
BALTIMORE,INCREASED,THESE
140,169,2014,A549,COPYRIGHT,ERK,INC,INTEGRATED,LEWIS,LLC,MMD,NSCLC,THEREFORE
169,2014,946,COPYRIGHT,DEPDC1B,ECTOPIC,FURTHER,INC,LEF1,NON,NSCLC,TAKEN,TCF4,WNT
001,009,560,8202,836,CRC,HOWEVER,SATB1,SATB2,SPECIAL,STRIKINGLY,THEREFORE,THUS,TNM
945,947,AFTER,BASED,EF1,H460,IFN,MSCS,TRAIL,TREATMENT
001,169,2014,ACCORDING,CHANGES,CONCLUSION,DYNAMIC,FLT,H2O,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SIMPLIFIED,SOCIETY,SUV,TBR,TEN,TKI,UNLABELLED
169,2014,871,ACIDS,ERBB2,FGFR2,LOW,NUCLEIC,PRESS,PUBLISHED,UNIVERSITY,VALIDATION,WES
34A,34B,34C,AZ521,CD44,GASTRIC,NANOG,NUGC,OCT4,RESULTS,SOX,TAKEN,UTR,YANG,YIN,YY1
A549,BINDING,CONVERSELY,ECTOPIC,GCIP,GRAP2,H1299,ID1,NSCLC,NSCLS,TAKEN
4827,947,ADP,BOTH,CLONOGENIC,DSBS,H2AX,H2O2,NIRAPARIB,PARP,RAD51,SSBS,TAKEN,THESE
1997,2002,207,9826,AIMS,BACKGROUND,CANCERS,COLLEGE,INPATIENT,JANUARY,LABEL,MEDICAL,METHODS,RECORDS,RESULTS,ROYAL,SIR,SIRS,TAIWANESE
160,169,2005,2009,2014,ARRIAGA,COPYRIGHT,DESPITE,EXCEL,INC,LABEL,LIFE,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAS,STATA
169,2014,AMONG,HOWEVER,IL13RA2,SYCE1,THUS,VCX,VCX3A,XAGE1
2009,AIM,BACKGROUND,BARR,CD20,CD34,CD38,CD4,CD68,CK7,CMV,EPSTEIN,EVEN,FURTHER,HHV,HIV,IMT,L26,LABEL,METHODS,MYCOPLASMA,OBJECTIVE,PATIENT,PIMT,PULMONARY,RESULTS,ROMANIA
001,002,010,138,169,199,2014,402,961,9P21,CONCLUSION,CONCORDANT,COPYRIGHT,COX,INK4A,LABEL,LOW,LTD,MATERIALS,MEIER,METHODS,MTAP,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE
1400,356,495,BACKGROUND,CRT,IMRT,LABEL,LATE,MATERIALS,METHODS,PLANS,PTV,RESULTS,TANGENTIAL,V107,V20,V95
177,ADC,BAC,BACKGROUND,BOTH,DIFFUSION,DWI,FDG,HOWEVER,LABEL,MATERIALS,METHODS,PET,RESULTS,ROC,SUV
BACKGROUND,DATA,EGFR,LABEL,MATERIALS,METHODS,MUTATIONS,OSCC,OSCCS,PCR,RESULTS,SINCE
177,2006,2009,JAN,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
003,141,187,707,BACKGROUND,EGFR,EPIDERMAL,HOWEVER,LABEL,MATERIALS,METHODS,MLN,NSCLC,RESULTS,THERE,TKI
2003,2013,AUC,BACKGROUND,BIOLOGICAL,CBM,CHINESE,CNKI,DATABASES,DISCOVERY,DOR,KNOWLEDGE,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,ROC,SCHOLAR,SCIENCE,THERE,VIP,WANFANG,WEB
2008,ACCORDING,EARLY,HOWEVER,VOCS,WORLD
AAN,TAT,THUS
308G,436,573,8201,945,CAUCASIANS,CIS,NSCLC,OVERALL,SCLC,TNF
126,7901,CRK,HOWEVER,MIR,PLK2,SGC,SOX2
164,169,177,2014,FACTORS,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESECTION,RESULTS,SURGERY,UNIVARIATE,UNIVERSITY
ENGLISH,PRIMARY,THERE
169,AIDS,BACKGROUND,CONCLUSION,FOUR,HAART,HIV,HODGKIN,HOWEVER,LABEL,LIBRARY,METHODS,NADC,NADCS,PRESS,RESULTS
160,8209,95D,A549,AKT,CHINESE,CURRENT,IAP,LUNG,MATRINE,PI3K,SOPHORA
169,2014,BACKGROUND,BASEL,FIVE,GRADE,LABEL,METHODS,OPTIMOX,RESULTS,THEIR
160,1998,2002,2007,COX,DUTCH,FORCE,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,RESULTS,SURVEYS,THESE,USING,WESTERN
1996,2000,2001,2005,BACKGROUND,CONFIDENCE,DISCUSSION,HODGKIN,ICD,INCIDENCE,INTERVALS,ITALIAN,ITALY,LABEL,METHODS,NON,NORTH,NPCSS,ONGOING,PROJECT,REGISTRIES,RESULTS,SIR,SITES,SOUTH
BACKGROUND,LABEL,OBJECTIVE,RESULTS
AGE,BACKGROUND,BASES,CURRENT,DATA,ISS,ITALY,LABEL,METHODS,MORTALITY,RATES,STATISTICS,UNIT
100,HESSIAN
160,169,2012,2013,2014,AFTER,APRIL,BACKGROUND,COPYRIGHT,ENB,FIVE,FOUR,INC,LABEL,LOCALIZING,METHODS,PUBLISHED,RESECTION,RESULTS,SOCIETY,THREE,VINCI
169,2014,AKT1,BACKGROUND,BASEL,BRAF,CAUCASIAN,CONCLUSION,DESPITE,EGFR,HOWEVER,JAPAN,KRAS,LABEL,METHODS,MUTATIONS,NRAS,RESULTS,SAMPLES
169,2014,APC,BACKGROUND,BRAF,CDH13,DELETIONS,ESR1,LABEL,MBM,MBMS,METHODS,NEURO,NRAS,PRESS,PTEN,PUBLISHED,RARB,RESULTS,SOCIETY,UNIVERSITY,UNRAVELING
33258,A549,ANNEXIN,BCL,FINALLY,HOECHST,IC50,MTT,SBT,THUS,WHAT
ERK,ETS,ETS1,ETS2,MYC,RAS
001,011,133,388,451,641,8202,964,995,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LYMPHOCYTE,METHODS,NSCLC,PLR,RATIO,RESULTS
EZH2,IT1,NSCLC,RNAS,SPRY4,THESE,UPON
169,2000,2007,2014,5771,885,AGE,COMMUNITY,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PAF,PUBLISHED,RESULTS,STATISTICS,THOUSANDS,WHERE
231,AZA,BECAUSE,GPAT,GPAT2,MDA,OVERALL,USING
000,203,967,BACKGROUND,BRIER,CHRONIC,COMBINING,CONCLUSION,COPD,COX,DATA,DISEASE,HARRELL,LABEL,NAGELKERKE,PRINCIPAL,PULMONARY,RESULTS,ROC,SCORE,SEER
947,CHANGES,HOWEVER,IFN,RADIATION,THESE
CAV,EMT,H23,H292,H460,HOWEVER,THESE
2006,2013,AFFILIATED,FIRST,HOSPITALS,MEDICAL,NANJING,UNIVERSITY
THREE
215,LOCALIZED,PARTIAL
2011,2012,815,JUNE,LCT
BOTH,FINE,WILMS
182,2DC,A549,AIMS,CELL,HBE,HTB,LABEL,METHODS,MSP,MTT,OBJECTIVE,PCR,PRDM2,PRDM5,RESULTS,WESTERN
002,008,026,177,241,292,570,862,AGE,AIM,CONCLUSION,DEPARTMENT,FOUR,LABEL,MEAN,MEDICAL,METHODS,OBJECTIVE,POMERANIAN,RESULTS,UNIVERSITY
1039,169,2014,FGF,FGF2,FGFR,FGFR1,FGFS,FISH,HNSCC,LABEL,MALIGNANT,MPM,MPMS,NONE,PREVIOUSLY,RNAI,THESE,TKI,UNLABELLED
169,2014,231,23B,27B,4T1,4TO7,BIOLOGY,ECTOPIC,INC,MDA,MICRORNAS,MOLECULAR,PSAP,SCP28,SOCIETY,THESE
169,2014,BECAUSE,BLOOMBERG,HOPKINS,JOHNS,PRESS,PUBLISHED,UNIVERSITY
169,2014,3236,400,5201,HEPATITIS,PHYSICIANS,PRESS,PUBLISHED,UNIVERSITY
169,2014,2P23,945,A2M,ALK,BREAK,DISCOVERY,FETAL,FLIT,INC,USING,WILEY
169,2008,2012,2014,8201,8804,INC,LABEL,METHODS,MWA,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,WILEY
177,CD20,CK20,CK7,CONCLUSION,LABEL,MCC,MELAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
3MA,ACC,ALSO,AMP,AMPK,AMPK2,ATG5,ATG7,BESIDES,CALU6,CELL,CELLS,CONCLUSION,CONSISTENT,GFP,H460,INHIBITION,KNOCKDOWN,LABEL,LC3,LCII,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,002,007,131,2007,2012,250,414,519,AES,AMONG,ECOG,EGFR,EPIDERMAL,LABEL,METHODS,OBJECTIVE,OCTOBER,PFS,PURPOSE,RESULTS,SPSS,TKI,TKIS
001,004,143,2006,2011,243,290,410,8741,CIGARETTE,CONCLUSION,COX,EASTERN,ECOG,GROUP,LABEL,MANN,MEIER,METHODS,NEVER,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCC,STUDENT,THERE,WHITNEY
100,DLTS,FOUR,MTD,WBR
JAVASCRIPT,LUNG,NLST,QUERY,REAL,SCREENING,SEVERAL,SQL,STRUCTURED,TRIAL,USING
EGFR,ISRAELI,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,TESTING
169,2014,SDHX,SOCIETY
CLINICIANS,ROUND
1A1,275,406,462,CONCLUSION,GENOTYPES,ILE,ILE462VAL,LABEL,METHODS,OBJECTIVE,ORS,P450,PCR,RESULTS,RFLP,VAL
177,ASPC,CT26,H460,NANOSCALE,NCPS
1390,146,181,192,1993,2010,815,8202,8805,AMONG,BMI,CADMIUM,COX,DIET,IRR,LABEL,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS
DESPITE,FLOW,LUNG,SACC,SILENCING,TAKEN,THUS,ZOLEDRONIC
169,2014,BRITAIN,CALPAIN,CAPN4,COPYRIGHT,FAK,GREAT,HCC,HOWEVER,IRELAND,JOHN,KNOCK,LTD,MMP2,PROTEIN,PUBLISHED,SOCIETY,SONS,SRC,WILEY
001,002,102,1999,2008,211,287,ACCORDING,AFTER,BACKGROUND,CLM,CONCLUSION,DATA,FIVE,GIVEN,JANUARY,LABEL,METHODS,OCTOBER,RESULTS
001,2001,2011,209,216,425,8805,BACKGROUND,BOTH,CCI,COX,IIB,INDEX,JANUARY,LABEL,METHODS,NSCLC,OVERALL,RESULTS,SBRT,TNM
102,2010,2011,497,529,8805,EIGHT,KEY,LABEL,METHODS,OBJECTIVE,PATIENT,RESULTS,SPN,SPNS,THERE
001,006,009,012,028,037,045,048,385,8201,8805,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,THEREFORE,UNIVARIATE
169,2014,AIMS,BACKGROUND,CONCLUSION,COPYRIGHT,D3S1300,EBC,FHIT,FRA3B,HPV,IMSS,INC,LABEL,LUNG,MAS,METHODS,NSCLC,NSLC,OBJECTIVE,PUBLISHED,RESULTS,SITES,TNM
169,2014,AMONG,BACKGROUND,CONCLUSION,HPV,INC,LABEL,METHODS,RESULTS,SCC,WILEY
945,954,APOPTOTIC,BIRC3,CYNANCHUM,FINALLY,PCR,REMARKABLY,TNF,TNFAIP3,TNFR1
0051,0188,0211,0372,0492,169,2004,2012,2014,209,3798,466,5902,BACKGROUND,BETWEEN,COPYRIGHT,COX,HOWEVER,INC,LABEL,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY,THUS,TNM,VPI
169,2014,486,BACKGROUND,COPYRIGHT,EGFR,INC,LABEL,LUNG,METHODS,PUBLISHED,RESULTS,SOCIETY
001,004,007,169,174,18F,2014,421,452,BACKGROUND,COPYRIGHT,COX,FDG,HOWEVER,INC,LABEL,METHODS,PET,PUBLISHED,RESULTS,RFI,SOCIETY,T1B
112,147,169,200,2013,2014,2017,2020,2030,2040,513,700,800,BACKGROUND,COMMUNITY,COMPARING,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,USING
028,160,169,2014,A549,ADM,AUTHORS,CELLS,CISPLATIN,CONVERSELY,COX2,CSC,CSCS,EGR1,H460,JOHN,LTD,LUNG,NOTABLY,SONS,WILEY
A549,BACKGROUND,BESIDES,CDK4,DATA,EGFR,ELASTIC,INHIBITORS,KIEN,LABEL,NET,PHKG1,RAC,RESULTS,THESE
2009,2011,APRIL,BEST,BETWEEN,GIVEN,HOWEVER,JUNE,NSCLC,PFS,PPS
001,008,MEAN,NSCLC
215,BACKGROUND,DNAM,LABEL,METHODS,RESULTS,SIMILAR,THESE
10877,169,2014,358,AGR2,BASED,COPYRIGHT,CTA_246H3,GENMAPP,IFI6,INC,KEGG,MAST1,PEARSON,POU2AF1,SOAT2,THUS
0001,0002,001,003,006,007,117,177,183,8201,8804,8805,ACCORDING,BACKGROUND,BMI,GEORG,GROUP,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,STUTTGART,YORK
CELL,DESPITE,EMT,EPITHELIAL,LUNG,NSCLC,OCCLUDENS,SCLC,SLUG,SMALL,SNAI1,SNAI2,SNAIL,TRANSITION,ZEB1,ZONA
ALSO,ANDROSTANE,ATLAS,BACKGROUND,CAR,CELL,LABEL,LUNG,MGMT,MOST,NON,NSCLC,PACLITAXEL,PRINCIPAL,RESULTS,SMALL,TAKEN,TCGA,TCPOBOP,THEREFORE,WT1
CCCP,H157,H2O2,HDX,MPTP,NCI,PARKINSON,POST,ROS,SY5Y,THESE,UBIQUITIN,UCH
169,2014,CONCLUSION,FINALLY,LABEL,MEIER,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,ZEB1
169,2005,2012,2014,APRIL,COPYRIGHT,FIVE,HEAD,LABEL,METASTASES,METHODS,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SAS,SEPTEMBER,SMOKING,THESE
000,001,007,008,BLOOD,CHINESE,ERCC1,GSTP1,MEIER,TTP
EGFR,HOWEVER,NON,NSCLC,THUS,TKIS
005,041,056,12TH,18TH,24TH,36TH,6TH,ACCORDING,AKDENIZ,ERCIYES,KAYSERI,MPM,UNIVERSITY
039,500,CD4,CD8,DCS,ECOG,IIIB,LOG,PFS,RANK,TEN,THREE
101,169,2014,945,946,COX2,HIF1,NSCLC,OVERALL
A549,BACKGROUND,BAICALEIN,DIFFERENT,H5N1,LABEL,RESULTS,ROS,THESE
ACCORDING,BACKGROUND,CASE,III,ITALIAN,KURDISH,LABEL,METHODS
169,181,1990,2011,2014,326,COPYRIGHT,INC,INCIDENCE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PSA,RATES,RESULTS,SIR,THERE
100,1970S,1971,1973,1980,1985,1990,1990S,1995,1997,1998,2008,2010,724,8201,AMONG,BESIDES,COD,CODS,GERMANY,INSTITUTE,MAINZ,PATHOLOGY,THESE,UNIVERSITY
0530,100,169,175,2014,AZD,BACKGROUND,COPYRIGHT,EIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,PFS,PLANNED,RESULTS,SCLC,SRC
0001,0003,0048,0087,036,169,2014,827,AKT,AKTI,ATP,AZD5363,CONCLUSION,COPYRIGHT,DRUG,DUAL,EGFR,ERK,H1651,H522,HCC,IRELAND,LABEL,LTD,MATERIALS,METHODS,NCI,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,WESTERN
BACKGROUND,CONCLUSION,DBCG,DOSE,DUE,HEART,IMN,IMNS,LABEL,METHODS,MHD,NNH,NNHS,NNT,NUMBERS,OAR,REFRAINING,RESULTING,RESULTS,TEN,V90
650,8764,BACKGROUND,CBCT,CONCLUSION,CONE,GTV,HOWEVER,LABEL,METHODS,RESULTS
001,005,011,012,029,105,164,172,2001,201,2011,229,BACKGROUND,BED10,COX,JANUARY,LABEL,METHODS,PROGNOSTIC,RADIATION,RESULTS,SBRT
A549,AKT,ATP,BOTH,CO2,DEPLETION,DMM,ME2,NAD,NADP,NADPH,NSCLC,PDK1,PTEN,ROS
113,2014,299,568,758,8201,892,ASIAN,BOTH,CAUCASIAN,CIS,CRR9P,DATA,JANUARY,NSCLC,ORS,SCIENCE,WEB
15F,160,169,2014,549,956,COPYRIGHT,IC50,SAS,WHEREAS
007,013,022,024,047,048,139,2013,2014,AIM,CCGG,CONCLUSION,COX,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,RESULTS,REV1,REV3L,SNPS,TGT
001,010,038,041,049,263,491,670,878,917,AMONG,NSCLC
238,ARMS,BACKGROUND,DESORPTION,DXS,EGFR,IONISATION,KIT,KRAS,LABEL,LASER,MALDI,MASS,MATERIALS,METHODS,NSCLC,RAS,REFRACTORY,RESULTS,TIME,TOF,TP53
1007,1362,1380,1480,1847,2002,2004,2233,232,2700,2718,3013,4080,813,CONCLUSION,EARLY,ELCAP,HIPAA,LABEL,LUNG,MATERIALS,METHODS,NLST,OBJECTIVE,PROGRAM,PURPOSE,RESULTS,SCREENING,TRIAL,USING
AD5,CMV,ECS,HOWEVER,MBP,ROBO4,USING,WHILE
500,956,AZ10,AZBOCET,HOMO,QUANTUM,T10
002,009,1281,DONOR,DPA1,DPB1,GVH,HCT,HLA,NON,PROGRAM,SCT,SPLITTING,TCE,TRM
2014,APRIL,BACKGROUND,EARLY,LABEL,MEDLINE,METHODS,RESULTS,SOCIETY
2002,BACKGROUND,BRAF,HOWEVER,LABEL,METHODS,MUTATIONS,OVERCOMING,RESULTS,SINCE,V600E
132,154,286,AIM,DNAS,LABEL,METHODS,OBJECTIVE,PAI,PCR,RESULTS
100,222,COX,NSCLC,RESULTS,THROUGH
110,2010,2012,CONCLUSION,CONTROL,DEFAULT,FIFTY,JANUARY,KEY,KUWAITI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UNIT
169,2014,215,241,682,8804,AGE,CASZ1,COPYRIGHT,DBP,EHBP1L1,GOSR2,GWASS,ICBP,INC,INDEX,MAP,NINE,PUBLISHED,SBP,SINGAPORE,SNP,SNPS,SOCIETY
000,139,169,1987,1988,1997,2010,2014,600,BACKGROUND,CALIFORNIA,FARM,FARMERS,INC,LABEL,METHODS,NHW,PCIR,RESULTS,STAGE,THESE,UFW,WILEY,WORKERS
169,2012,2013,2014,COPYRIGHT,FINALLY,HEART,IMPORTANT,INC,LUNG,PUBLISHED,SOCIETY,THESE
169,2014,AFTER,COPYRIGHT,IRELAND,LTD,THREE
0026,15Q25,169,2014,5P15,6P21,ADCA,AMONG,BAG6,COPYRIGHT,EBLN2,FIRST,GON4L,GWAS,HOWEVER,IRELAND,JAK2,LABEL,LTD,MATERIALS,METHODS,NELFE,NOP58,OBJECTIVE,OBJECTIVES,RBMX,RESULTS,SPEN,STUDIES,TAF1B,TRUNCATING,WIDE,WISP3
169,2014,A549,AKT,BACKGROUND,CIP2A,COPYRIGHT,EGFR,EPIDERMAL,ERLOTINIB,EXPRESSION,FOUR,H358,H441,H460,IRELAND,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,PARP,PP2A,RESULTS
0001,160,169,177,2014,BLOOD,BOS,COPYRIGHT,INC,MEAN,PRM,PUBLISHED,PULMONARY,SOCIETY
147,169,2014,294,COPYRIGHT,EMT,FOS,INC,KRAS,RAS,YAP1
002,004,005,169,1980,2009,2014,COPYRIGHT,IRELAND,IVA,IVB,JANUARY,LABEL,LTD,MARCH,MASAOKA,METASTASIS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,SIXTY,TET
158,169,2010,2013,2014,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,THESE,TKIS
103,112,169,2014,ASIA,BACKGROUND,CONCLUSION,COPYRIGHT,EACH,INC,LABEL,MATERIALS,METHODS,NSCLC,OBTAINING,RESULTS,SBRT
130,140,150,160,169,180,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DLT,DLTS,III,IIIB,INC,LABEL,METHODS,MTD,NVBO,ONCE,RESULTS,THREE
102,153,169,2014,500,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,DISEASE,IIIB,INC,LABEL,MAIN,METHODS,NAVOTRIAL,NSCLC,ORAL,OVERALL,RESULTS,STAGE
169,2014,COPYRIGHT,INC,SURGERY,THESE
200,230,4000,500,956,BSI,CYFRA,CYRFA,ELISA,LOQ,REALIZING,USING,YET
169,2014,COPYRIGHT,DEVIC,IGG,KING,MRI,NMO,PUBLISHED,SPECIALIST
169,2014,ADP,AREAS,BACKGROUND,BLOCKER,CONCLUSION,COPYRIGHT,COVERED,CURRENT,EGFR,ERBB,HOWEVER,HSP,LABEL,LTD,MET,METHODS,NOVEL,NSCLC,OTHER,SEVERAL,T790M,TKI,TKIS,TREATMENT
129,169,2014,BIOMARKERS,COPYRIGHT,GREATER,JOHN,LTD,MRI,PARAMETERS,SONS,THERE,WILEY
169,2014,AUTHORS,COPYRIGHT,EXPRESSION,INC,LKB1,MOUSE,PUBLISHED,SCC,SCCS,SOX2,STAT,USING
002,008,10878,114,118,169,2009,2012,2014,217,236,239,23RD,250,253,27TH,500,75MG,APRIL,ASIA,ASIAN,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,EAST,EASTERN,ECOG,EGFR,ELI,FUNDING,GROUP,IPASS,ITT,LABEL,LILLY,LTD,METHODS,PAN,PATIENT,PFS,RESULTS
AFTER,COMMITTEE,NOVALIS,PTV,SBRT,UNIVERSITY
001,102,104,105,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OPERATIVE,RESULTS,SHORT,SIXTEEN
169,2014,ABSC,ABSCS,AIRWAYS,COPYRIGHT,HOWEVER,INC,NOTCH,NRF2,ROS
FIBEROPTIC,HIV,INFECTIOUS,LUNG,NON
160,169,2014,COPYRIGHT,CSC,CSCS,HOWEVER,LTD,THEREFORE
2001,BCL,HCC,HUH7,LC3,LC3II,MCL,OBATOCLAX,PLC5,PREVIOUSLY,RFX,RFX1,SHP,STAT3
169,2001,2008,2014,AGE,AIM,BACKGROUND,CASE,COPYRIGHT,FOUR,GROSS,INC,LABEL,MATERIALS,METHODS,MGCT,MGCTS,OBJECTIVE,RESULTS,THESE
169,2005,2010,2013,2014,20TH,COPYRIGHT,DRUG,FOLLOWING,FOOD,HOWEVER,INC
169,2014,COPYRIGHT,IIIA,INC,NSCLC,STAGE
169,2014,COPYRIGHT,INC,ONCE
000,100,298,8764,LQTS,RARE,SCD,SEVERAL,USING
AKT,ALECTINIB,ALK,EGFR,EML4,HGF,HOWEVER,HSP90,MET,NSCLC,THESE
CELL,G12C,G12D,G12V,KRAS,NSCLC,PCR,THESE
160,446,946,HOWEVER,KI67,MEIER,NSCLC,TRA2,WESTERN
1998,2012,ALICE,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,PURPOSE,RESULTS,USING
0016,FDG,LABEL,LOCAL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RFA,SEVEN,SEVERAL,THERE
549,BLK,CNS,CURRENTLY,DISCOVERY,DU145,HBCC,HDF,HEAT,HELA,HPCC,HSP70,IHC,LNCAP,MCF7,NG108,PC3,SHOCK,TDF,THESE,USING,WESTERN
100,169,200NM,2014,ACTA,BOTH,COPYRIGHT,DOX,FNP,FNP1,FNP2,FNPS,HOWEVER,INC,LTD,MATERIALIA,PUBLISHED
ALK,CRIZOTINIB,DOCKING,M1199,REPORTS
169,192,196,2014,345,382,CONCLUSION,ERBB,LABEL,METHODS,MICROARRAY,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TAZ,WWTR1
005,169,177,2014,492,8201,8482,ACTA,BACKGROUND,CONCLUSION,DESPITE,FNAB,FOUNDATION,LABEL,METHODS,MYLAB,OBJECTIVE,PURPOSE,RESULTS,SCC,SINCE,SUBPLEURAL,TUS,TWICE,UNDER
000,002,085,100,161,169,2008,2013,266,318,582,599,608,646,815,909,940,BACKGROUND,BSC,CANADIANS,CARLO,CONCLUSION,CRMM,ICER,ICERS,LABEL,LOBECTOMY,LUNG,MANAGEMENT,MEAN,METHODS,MODEL,MONTE,NSCLC,ONTARIO,PRESS,QALY,RESULTS,RISK,SABR,STATISTICS
001,009,169,2014,329,789,847,892,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,ROC,ROMO1,ROS,SERUM,THEN,WESTERN
001,033,169,2014,222,945,946,CHINESE,CONCLUSION,COPYRIGHT,COX,FREE,HIGH,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SERUM,SINGAPORE,USING
169,2011,2014,394,449,AFTER,AMERICA,BACKGROUND,CONVERSELY,COX,ICU,ICUS,LABEL,MEDICAL,METHODS,MORTALITY,MOST,OVERALL,POOR,PRESS,PUBLISHED,RESULTS,SOCIETY,SOUTH,UNIVERSITY
BACKGROUND,BARR,CASE,CAUCASIAN,EPSTEIN,F18,HODGKIN,HOWEVER,INTERIM,LABEL,METHODS,RELATED
169,2014,947,A549,ANNEXIN,CELL,CET,CETUXIMAB,COPYRIGHT,DTXL,EDC,EGFR,LDH,LUNG,MTT,NHS,NPS,NSCLC,PGA
ABOUT,BACKGROUND,CRC,DFS,DISEASE,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RELAPSE,RESULTS,SECA,VII
005,2000,201,2010,329,463,BACKGROUND,LABEL,METHODS,NEITHER,OBJECTIVE,PRE,RESULTS,SCPN,SCPNS,SIX,THERE,THESE
027,101,117,177,315,4208,8202,AUSTRALIA,CONCLUSION,CONTEXT,EVERY,FOLLOWING,FURTHER,LABEL,LOWER,MAIN,METHODS,OBJECTIVE,OUTCOME,PERTH,RESULTS,SETTING,SHR,WESTERN
LUNG,NSCLC,SCLC
LUNG,TTF
DEFINITION,NSCLC
DIAGNOSIS,IPILIMUMAB,SCLC,SMALL,THEREFORE
100,BACKGROUND,EGFP,HOWEVER,IIS,LABEL,METHODS,PCR,RESULTS,TYPE
1995,2012,AMONG,BACKGROUND,DOCTORS,III,LABEL,LUNG,METHODS,PRIMARY,RESULTS
2008,2013,BACKGROUND,IPSLROM,LABEL,METHODS,NSCLC,PFS,PRIMARY,RELAPSE,RESULTS,RFA,THESE,TREATMENT
009,014,019,041,132,2013,225,267,538,679,888,910,939,948,981,A750DEL,AUC,BACKGROUND,DOR,E746,EGFR,IHC,L858R,LABEL,MARCH,META,METHODS,NSCLC,RESULTS,SEAUC,SEQ,SROC,TEN,THEN,TKIS
150,300,8240,956,ASSAY,BACKGROUND,BRUCINE,CELL,CELLTITER,DMSO,FLOW,FORMATION,GLO,LABEL,METHODS,PCR,PROTEIN,RESULTS,VIABILITY,WESTERN
945,946,948,956,A549,BACKGROUND,CD133,CSCS,CYP2C19,DDP,GSK3,LABEL,METHODS,PPAR,RESULTS
A549,CASPASE,DAPI,DCF,HCT,HEP,HEPG2,MCF,NATURAL,NFKB,ROS,THESE
500,956,AMES,HOWEVER,INCUBATION
001,008,2014,231,4T1,BACKGROUND,BARD1,EXPRESSION,LABEL,MDA,METHODS,PRESS,PUBLISHED,RAD51,RESULTS,THEIR,UNIVERSITY
0001,001,108,125,130,1437,1812,2014,260,3249,ASSESSING,BACKGROUND,ITALY,LABEL,LUNG,METHODS,PRESS,PUBLISHED,RESULTS,TARGETING,TTFC,UNIVERSITY
039,041,044,663,BESIDES,COX,INCIDENCE,LUNG,NSCLC,PFS,POLK,SNPS,TLS,TREATMENT
169,2014,DESPITE,ID1,INHIBITOR,LABEL,METASTASIS,NOVEL,RHOC,UNLABELLED
169,2014,945,ACADEMY,ALSO,COPYRIGHT,H727,IFN,INSTITUTE,JV1,NET,NETS,PARTNER,PUBLISHED,THEREFORE,THUS,URBAN,VEGF
169,200,2014,300,8805,CETUXIMAB,CONCLUSION,EGFR,EVALUATION,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESPONSES,RESULTS,SOLID
169,2014,4251,AACR,BRAF,CLIN,ERK,FOUR,KRAS,LABEL,MEK,METHODS,MOST,NRAS,NSCLC,OBJECTIVE,PURPOSE,RAF,RAS,RES,RESULTS,RO4987655,SEQUENTIAL,SIXTY
2013,AFTER,BACKGROUND,JULY,LABEL,METHODS,RESULTS,SURGERY,THEN,THERE
159,169,2014,985,CONSORTIUM,HOWEVER,LUNG,ORS,RESULTS,UICC,WEAK,ZEALAND
1993,1999,273,BACKGROUND,CENTRAL,CONCLUSION,COPENHAGEN,COX,DANIELSENS,DENMARK,DIFFERENT,FOND,FUNDING,JANUARY,LABEL,METHODS,POPULATION,REGARDING,RESULTS,SIMILARLY,TRIAL,UNIVERSITY,USING,WESTERN
FOXO,FOXO3,HOWEVER,RRM2B
169,2014,945,CONSISTENT,ECS,HEART,HMOX,HYPOXIC,INC,LABEL,NTRK2,OBJECTIVE,PLD2,RESULTS,VEGF
1989,2009,8201,BACKGROUND,CONCLUSION,FACTORS,LABEL,MASS,METHODS,OVERALL,PRIMARY,RESECTION,RESULTS,SURGERY
III,SBRT
663,AIM,CDC25,CHINESE,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SNPS,THESE
FDA,FGFR,HOWEVER,III,NSCLC,PDGFR,PHASE,THEREFORE,VEGFR
169,2014,A549,CSC,CSCS,DNMT1,JAK2,KNOCKDOWN,PCR,STAT3,THESE,UICC,UPON,WESTERN
169,2014,COPYRIGHT,HOWEVER,LTD,OVERALL,SPIO,SUB
158,159,400,429,585,591,ATLAS,MUC,MUC12,MUC4,MUC6,SNVS,TCGA,THESE
000,14284,200,2004,2008,20202,486,AIMS,BACKGROUND,BLADDER,BRAIN,CANCERS,CONTEXT,EASTERN,ESOPHAGUS,GALL,HEAD,LABEL,LUNG,METHODS,OBJECTIVE,ORGAN,OROPHARYNX,OVARY,RAJASTHAN,RESULTS,THERE,USED,WESTERN
ACTIVATING,AIMS,EXON,GIST,INDIA,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,RESULTS
684,AIM,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,2014,3PRG2,8243,99M,A549,CCPM,CONCLUSION,CY7,FDG,FMI,HYNIC,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PEG4,PET,RESULTS,RGDFK,SOCIETY,SPECT,TPPTS,UNLABELLED
BACKGROUND,CASE,CHEST,HOWEVER,LABEL,MALIGNANCY,METHODS,PATHOLOGY,TAIWANESE
169,2014,945,AKT,DECREASED,ERK,ERK1,IL4,IL4R,REDUCED,RNAI,SIMILAR
0001,0003,0004,001,003,018,100,160,COLORECTAL,CRC,IHC,III,MEIER,METADHERIN,MTDH,NEXT
954,A549,AKT,H460,HOWEVER,INHIBITION,NADPH,NOX4,NSCLC,PI3K,THEREFORE
AKT,AKT2,EGFR,HOWEVER,NSCLC,TKI
1100,169,2014,BACKGROUND,CNB,CNBS,LABEL,LUNG,METHODS,RESULTS,SOCIETY,TOUCH,TPS
001,002,003,006,011,038,105,112,180,232,349,576,673,8201,946,AJCC,COMMITTEE,COX,EGFR,EHD1,EPS15,EXPRESSION,JOINT,MEIER,NSCLC,OVERALL,TGF
946,A549,BACKGROUND,BMP,BONE,CELL,CONCLUSION,H460,HIGH,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,TGF,THERE,UNASSIGNED,USING,VIRTUAL
HOWEVER,LUNG,ROBOT,SEVERAL,VINCI
1933,1960,1980S,CAHAN,THERE
3CM,FIRST,JAPAN,NSCLC,T1A,T1B,THEREFORE,THIRD,THUS
ALK,BRAF,DDR2,EGFR,FGFR1,FGFR3,HER2,HOWEVER,JAPAN,NTRK,OVERCOMING,RET,ROS1,THESE
2N0,300,ERCC1,GROUP,IIIA,JAPAN,LUNG,NSCLC,T2N0,THESE,THREE,THUS,UFT
NSCLC
057,160,169,2014,20S,945,956,CHT,COPYRIGHT,DOCKING,SAS
169,2014,A549,BSA,CAT,COPYRIGHT,FURTHER,GPX,GSH,GST,LDH,ROS,SAS,SOD,THUS
169,2014,664,8805,AKT,DOSE,EGFR,EPIDERMAL,GMBH,H1975,KGAA,NANO,PC9R,PKB,T790M,TKIS,TREATMENT,VCH,WILEY
330,ALSO,BACKGROUND,CRM1,EGFR,KPT,LABEL,METHODS,MICE,NSCLC,RAS,RESULTS,TP53
169,2014,CONFUSION,ENGLAND,FINALLY,RECURRING,UICC
145,1994,2012,BACKGROUND,DATA,DESPITE,FIFTY,FLAP,LABEL,LEVEL,LIMB,MEAN,METHODS,RESULTS
125A,30A,30E,NSCLC,PCR,THESE
141,169,2014,AKT,COPYRIGHT,FEDERATION,NSCLC,PI3K,PUBLISHED,SOCIETIES
169,2012,2014,722,APRIL,CONCLUSION,COPD,COPYRIGHT,DESPITE,FAGERSTROM,INC,ITALIAN,ITALY,LABEL,METHODS,OBJECTIVE,PCPS,RESULTS,SEPTEMBER
C5B,THROMBOTIC,VEGF
210,300,700,945,947,BOTH,LLOD,LLOQ,NSE,SCLC,SIX,SRM
100,215,8201,8764,A549,CONCLUSION,DAILY,FLANK,LABEL,METHODS,OBJECTIVE,PAZOPANIB,RESULTS,SCC
019,022,028,035,040,042,044,052,056,059,064,169,181,2014,250,277,295,296,884,AGS,BACKGROUND,BRAZILIAN,CHACO,COPYRIGHT,HPLC,IC50,IRELAND,J82,LABEL,LTD,MATERIALS,MES,METHODS,MRC,NINE,PARAGUAYAN,RELEVANCE,RESULTS,SOUTH,THESE,THREE,TOADS,UNDER
BACKGROUND,ELISA,LABEL,PRINCIPLE,RESULTS,SIMILARLY,TRANSGENIC
169,2014,ANIMALS,AURICULAR,CD3,CONCLUSION,LABEL,METHODS,OBJECTIVE,PBL,PBLS,PCR,PURPOSE,RABBITS,RESULTS,SOLID,TIL,TILS,VX2,WHITE,ZEALAND
137,169,2014,AGE,CONCLUSION,CTRA,EVEN,FIFTY,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,TRA,USING
169,2014,8764,ADDITIONAL,AKI,CONVERSELY,COPYRIGHT,DESPITE,ERK1,FINALLY,INCREASED,LLC,MAGNESIUM,PK1,SIMILAR,SOCIETY,STAT3,THESE
169,2014,946,COPYRIGHT,FINALLY,HOWEVER,INC,RII,SMAD2,TGF,THESE,WDR77
A549,A549DDP,ALTERATION,DDP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
AFRICAN,CONCLUSION,CPE,LABEL,LLC,MATERIALS,METHODS,MK2,OBJECTIVE,PURPOSE,RESULTS,VERO
467,A4T14,CAUCASIAN,CAUCASIANS,CIS,G4C14,ODDS,ORS
169,2014,AMONG,AUSTRALIAN,PRESS,PUBLISHED,THREE,TWIN,UNIVERSITY,USA,WHILE
169,2014,229,8201,AUSTRALIAN,BACKGROUND,COLLEGE,CONCLUSION,GTV,HNSCC,HOWEVER,INITIAL,LABEL,METHODS,MINIMISING,RESULTS,ROYAL,SIMILARLY,THESE,WHILE,ZEALAND
BACKGROUND,CASE,CONCLUSION,DNAEMIA,HPV,HPV11,JORRP,LABEL,MALIGNANT,METHODS,RECURRENT,REMARKABLY,RRP
169,2014,AKT,AKT3,CONVERSELY,HOWEVER,IGF,IGFBP,INSULIN,NSCLC,PRESS,PUBLISHED,UNIVERSITY
0001,019,169,175,183,196,2003,2012,2014,BACKGROUND,BETWEEN,BUPA,COPYRIGHT,FOUNDATION,FUNDING,IQR,JAN,LABEL,LTD,MALIGNANT,METHODS,OCT,OVERALL,RESULTS,TREATMENT,VAT
215,916,THUS,VERO
A549,BCL,DU145,FAK,FOCAL,FOCUSSING,FOS,MAPK,POD,THESE
000,1975,200,2009,BACKGROUND,BECAUSE,CASE,CAUCASIAN,CD31,CONCLUSION,FLI,FURTHER,LABEL,METHODS,PAIN,PERCUSSION,SINCE
001,004,160,169,171,2014,469,ALK,FINNISH,FISH,FURTHER,IHC,INC,MET,NEXT,NSCLC,SCREENING,SEVEN,TP53,WILEY
2010,2012,AGE,APRIL,CYTOLOGIC,III,JULY,PATIENT,RANDOMIZED,SIX
130,240,275,500,8805,CHK1,DLTS,H2122,H441,LY2603618,NCI,NSCLC,THESE
169,2014,8201,A549,BIOLOGY,CELL,FEDERATION,TCM,THESE
001,002,007,011,136,1999,2009,281,485,BACKGROUND,COX,HOWEVER,III,LABEL,MEIER,METHODS,OVERALL,RESULTS
169,2014,512,8201,AG490,COPYRIGHT,HILL,JOHN,LTD,MEANWHILE,SONS,U0126,WILEY
LUNG
MICROWAVE,MWA
AFTER,AIMS,CONCLUSION,EXPRESSION,LABEL,MATERIALS,MDM2,METHODS,MPM,OBJECTIVE,RESULTS,TP53
000,007,011,013,023,024,047,133,150,152,154,155,165,172,200,2011,239,ANXIETY,BPI,BRIEF,CHENGDU,CHINA,CONCLUSION,DEPRESSION,HADS,INVENTORY,JULY,LABEL,METHODS,MUTIPLE,OBJECTIVE,PAIN,RESULTS,SCALE,SICHUAN,TOTALLY,UNIVERSITY,WEST
180,200,CONCLUSION,COPD,FEV1,LABEL,METHODS,OBJECTIVE,RESULTS
HOWEVER,LOCALLY,NSCLC,PORT
315,322,673,8211,8212,STRIKINGLY,THESE,THOSE,WGD
EXOGENOUS,HOWEVER,NSCLC,THESE,THYROID
FINALLY,LUNG,SERUM
0001,037,BACKGROUND,FEV1,LABEL,METHODS,RESULTS,SMOKING,TOBACCO
114,22737,8202,BACKGROUND,CENTRAL,CONCLUSION,CURRENT,DECREASED,LABEL,MEDLINE,METHODS,NEWCASTLE,OBJECTIVE,OBJECTIVES,RESULTS,SCIENCE,WEB
AFTER,AMP,CREB,DATA,DOX,ERK5,H2373,HMESO,HOWEVER,MALIGNANT,MOST,RESULTS,USING,VAN,VANDETANIB,ZACTIMA
344SQ,916,DMXAA,ELUC,GEMM,MACROPHAGE,NSCLC,SINCE,STING,TAM,TAMS,USING
008,1982,2014,BACKGROUND,CD133,CHINESE,CNKI,CONCLUSION,HIGH,JANUARY,LABEL,MANAGER,MEDLINE,META,METHODS,NSCLC,RESULTS,SCIENCE,WEB
CAV,CNTS,CSC,CSCS,SINCE,SWCNT,THESE,USING
003,005,169,2014,433,8805,CCS,CCSS,FEV1,FVC,IQR,SMOKING,TLC,TREATMENTS
166,169,2014,CNS,COPYRIGHT,DDI,DDIS,HOWEVER,I1T,I1U,IC50,LEWIS,MDR1,PAPP,PUBLISHED,SOCIETY
169,2014,ACTIVATION,CDCP1,CUB,ERK,LABEL,MMP2,MMP9,RAS,SRC,THUS,UNLABELLED
001,020,044,055,169,177,2006,2008,2010,2014,264,267,291,297,375,397,408,495,607,713,783,8201,852,860,894,975,CROSS,DESPITE,DETERMINE,HEALTHCARE,HNCA,HYPOTHESIS,INC,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OTOLOGICAL,PANEL,RESULTS,SOCIETY
169,2014,233,8211,947,948,CD8,CRTAM,DNAM,ENGAGEMENT,IFN,NECL,TVG9VD2
000,112,2014,8197,945,AFP,AFTER,BMJ,CHEST,ENDODERMAL,FIVE,GROUP,LTD,PRIMARY,PUBLISHING
169,2014,AFTER,EWING,HOWEVER,INC,WHOLE,WILEY,WILMS,WLI
125,169,2014,8201,956,ABC,ABCB1,ABCG2,AKT,ARRY,ERBB1,ERBB2,ERK1,H460,HOWEVER,INC,LUNG,MDR,MX20,NCI,WILEY
169,2014,COPYRIGHT,LUNG,SMOKING,SOCIETY,THERE
AFTERWARDS,ALSO,BESIDES,THESE
177,519,588,945,CD31,HIF,MVD,NGF,NSCLC,THERE,VEGF
169,2014,CD31,CD34,COPYRIGHT,EHE,FLI,GMBH,PATHOLOGIC,PRIMARY,WHILE
169,2014,956,A549,ASIAN,BASED,BAX,BCL,CASPASE,CHINA,CHINESE,COPYRIGHT,GMBH,HOWEVER,LOUR,MYRICANOL,PCR,SIEB,THEREFORE,THESE,WESTERN,ZUCC
160,1975,AKT,AZD6244,COMBINING,EGF,EGFR,ERK1,H1975,H1993,H460,KRAS,LABEL,MEK,MEK1,MET,METHODS,MICE,MMP,NCI,NSCLC,OBJECTIVE,PI3K,PURPOSE,RESULTS,T790M,TKI,WESTERN
169,2014,790,CONCLUSION,COPYRIGHT,CRKL,EGFR,EPIDERMAL,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MET,METHODS,MUTATIONAL,OBJECTIVE,OBJECTIVES,PCR,RESULTS,T790M,THESE,TKI,TKIS
001,1A1,8201,926,ASIAN,BOTH,GSTM1,HOWEVER,META,MSPI,ODDS,P450
239,HIF,HIFS,INCUBATION,MVS
CELL,HYPOXIA,IHC,TAGLN,THUS,TNM,TRANSGELIN
25S,8320,8325,945,946,956,A549,COMPOUNDS,ETOAC,GBM,NMR,NSCLC,THEIR,U373
169,2014,A549,DISRUPTION,FEBS,GLUCOSE,HBP,INSULIN,LOSS,PI3K,PKB
2012,2152,ARG194TRP,ARG399GLN,BASED,BIOLOGICAL,CHINA,CHINESE,DATA,HOWEVER,KNOWLEDGE,MEDLINE,NSCLC,SIMILARLY,STATA,XRCC1
1640,33258,A549,AKT,BAD,BCL,DECOCTION,HOECHST,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,RPMI,WESTERN,XJD
286,8209,ECM,NH2,PROGNOSCAN,SNPS,SPARC
946,DNAJ,FURTHER,HLJ1,HOWEVER,METASTASIS,MTA1,NSCLC,THUS,WNT
2009,AUSTRALIAN,BACKGROUND,ENGLAND,ENGLISH,FOLLOWING,ICBP,LABEL,METHODS,NORWEGIAN,PCP,RESULTS,SWEDISH
945,AGT,AKT,ANG,CXCR4,EGF,EPC,EPCS,FLK1,HIF,SDF,TIE,VEGF
174,1982,2011,ABDOMINAL,BEP,COLLEGE,CONCLUSION,EMA,LABEL,MEDICAL,METHODS,NGOC,NGOCS,OBJECTIVE,RESULTS,SURGERY,UNION
015,035,1962,1986,2010,CONCLUSION,EMA,EMACO,FIFTEEN,FIGO,GTN,LABEL,MAC,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTEEN
AIM,BACKGROUND,CONCLUSION,DISCUSSION,ECOG,FIRST,GLASGOW,GPS,IIIB,LABEL,LUNG,METHODS,MONITORING,NON,NSCLC,OBJECTIVE,PROGNOSTIC,RESULTS,SCORE,TESTING
ABC,ABCC,BACKGROUND,FINALLY,HER2,LABEL,METHODS,MMTV,MULTIDRUG,PCR,PYVMT,REAL,RESISTANCE,RESULTS,THESE
100,CALCA,CHINA,CPG,DLEC1,EARLY,HOXA9,LUNG,MMSP,MULTIPLEX,NSCLC,PCR,PITX2,RASSF1A,SILENCING,TBX5,THUS,TSGS,USING
001,120,BACKGROUND,CONCLUSION,FFF,FLATTENING,LABEL,METHODS,RESULTS,STD,VMAT
169,2014,COPYRIGHT,EPH,INC,LOSS,MEMBERS,PICK1,THESE,THUS
4T1,A549,ACTIVATION,ADP,BAX,BCL,BESIDES,CLONOGENIC,ERK1,JNK,LABEL,MAPK,MATERIALS,METHODS,PARP,PURPOSE,RESULTS,SAPK,U251,UNLABELLED,WESTERN
11H,169,2014,COPYRIGHT,MOST,ROS,SAS
169,2014,68936,BACKGROUND,BECAUSE,COMPARING,DATA,HODGKIN,HOWEVER,LABEL,MEDLINE,METHODS,PRESS,PROLONGED,PUBLISHED,RESULTS,RRS,SCISEARCH,SEDENTARY,UNIVERSITY
111,120,139,275,321,3976,ARG112DUP,BACKGROUND,BMJ,CIS,FDRS,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,RRS,SDRS,SWEDISH,THESE
10TH,12TH,2007,2012,2165,2526,8TH,AFRICAN,AIR,BACKGROUND,BMJ,CURRENTLY,FREE,GIVEN,GROUP,LABEL,LIMITED,LUNG,METHODS,POS,PRICE,PUBLISHED,PUBLISHING,RESULTS,SINCE,SMOKE,TOBACCO
169,1995,2011,2014,ACC,ASIAN,BACKGROUND,FEV1,FORTY,INSERTION,JANUARY,LABEL,LOW,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY
8201,8805,AUC,BECK,LABEL,METHODS,OBJECTIVE,PATIENT,PHQ,PURPOSE,PURPOSIVE,RESULTS,SAS,SCALE,SPSS,SUICIDE,THEREFORE,TOBIT,VERSION
0001,ERCC1,III,NSCLC,PROGNOSTIC,SEVERAL,WHILE
169,2014,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,LABEL,LABORATORY,METHODS,MOROCCO,RABAT,SAS,UNIVERSITY,YOUSSEF
103159646,1T69,240,6CONHOH,840,956,A549,ANTI,CH2,FIRST,H1299,H460,HDAC4,HDAC8,HDACI,HISTONE,LD50,N25,PCR,PDB,RNHCO,SAHA,T98G,THESE,U251,U87
CHINA,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BACKGROUND,FHIT,GREEN,GSTP1,LABEL,MATERIALS,METHODS,MSP,NSCLC,PCR,RESULTS,SYBR,THEREFORE
ASIAN,CHINA,GANODERMA,LINGZHI,THERE
100,BACKGROUND,EBUS,HODGKIN,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,SIXTY,TBNA
041,334,545,BACKGROUND,FURTHER,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS
946,BACKGROUND,III,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,RRM1,THESE,TUBB3,XRCC1
100,1985,2005,DQB1,DRB1,HLA,PCR,SEVENTY,SSP
005,041,043,049,050,083,100,2005,2013,BACKGROUND,DEPARTMENT,DFS,ERCC1,ERCIYES,KAYSERI,LABEL,MATERIALS,MEAN,MEDICAL,METHODS,MPM,RADIATION,RESULTS,THERE,UNIVERSITY
1958,2006,2014,PAH,PAHS,THESE
160,169,2014,954,A549,COPYRIGHT,HIF,HIFS,INC,PHD,PHD1,THESE,XENOGRAFT
2006,2012,8201,8805,921,AMONG,BACKGROUND,CSS,HOWEVER,JANUARY,LABEL,LOCAL,METHODS,NSCLC,PFS,RESULTS,SBRT,THUS
186,189,500,956,AIM,CLEARANCE,CONCLUSION,CURRENT,CYTOTOXIC,EIGHT,FURTHER,HOWEVER,LABEL,METHODS,MTX,OBJECTIVE,PEM,PEMETREXED,RESULTS,THEREAFTER,USING
177,ACTUARIAL,ACUTE,AMONG,CONCLUSION,DOSE,IIIA,IIIB,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
PEMETREXED,SERUM
169,2014,ADAMTS1,BMP4,COPYRIGHT,CYR61,E2F,E2F1,E2F2,E2F3,E2FS,MMTV,NUPR1,P4HA1,PLOD,PYMT,SOCIETY,TAKEN,THESE,USING,VEGFA,WHILE
000,001,358,49A,737,ASIAN,BACKGROUND,CIS,CONCLUSION,CTLA,FURTHER,HCC,LABEL,METHODS,ODDS,ORS,OVERALL,RESULTS,STRATIFIED
012,304,442,ADVERSE,BACKGROUND,COX,HOWEVER,LABEL,MEIER,METHODS,NSCLC,RESULTS,VEGF
A549,ANTIGEN,BACKGROUND,CEA,CONCLUSION,FEW,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PERIPHERAL,REGISTERED,RESULTS,SEVENTY
0001,001,153,BACKGROUND,CLIA,CYFRA,ELISA,HE4,KETTERING,LABEL,METHODS,NSCLC,NSE,OBJECTIVE,PFS,RESULTS,SCC,SCCL,SCLC,SERUM,SLOAN,TIMP1,UNIVARIATE
METASTASES,METASTASIS,PRIMARY,THREE
1032,1037,1107,169,2014,635,AMONG,ASIAN,BACKGROUND,FIFTY,GGNS,HOWEVER,LABEL,LDCT,LDCTS,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,THUS
169,2014,946,A549,COPYRIGHT,DEPLETION,INC,NEDD4,PUBLISHED,TGF,THESE
0001,001,ALTERED,CDH1,DOWN,DVL1,DVL3,EXON,LOH,NUCLEAR,PCR,PROTEIN,SCLC,WNT
A549,ANOVA,FDR,H1650,H838,HEPES,HOPE,HOWEVER,ORGANIC,PROTECTION,THEREFORE
0001,023,100,1253,169,1825,183,2010,2013,2014,246,306,594,613,618,625,627,628,BACKGROUND,BETWEEN,COPYRIGHT,DEC,ELI,FUNDING,IGG1,IQR,JAN,LABEL,LILLY,LTD,METHODS,NSCLC,RESULTS,REVEL,TOXICITIES,VEGFR
169,2014,COPYRIGHT,PUBLISHED,SAS
008,020,028,030,037,156,161,204,244,352,402,478,617,794,934,948,ABCB1,BRCA1,CHINESE,COX,ERCC1,ERCC2,LABEL,MATERIALS,MDR1,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SNPS,XPD,XRCC1,XRCC3
160,169,2014,8804,AMONG,COPYRIGHT,DOSIMETRIC,GATED,GWS,LTD,PUBLISHED,SBRT,USING,V20
ENGLISH,HCC,IMAGING,METASTASES
HOWEVER,OSSIFYING
169,2014,BRG1,COPYRIGHT,LTD,MUTATIONS,OTHER,SNF,SWI
AMP,AMPK,FINALLY,MACROPHAGE,MIF,ROS,SEVERAL
169,192,1980,2009,2014,235,3280,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,LML,LOWER,METHODS,NSCLC,RESULTS,SAS,THERE,UML,UPPER
169,2014,COPYRIGHT,HIV,SAS
2004,2013,CASES,DOPPLER,FDG,OTHER,PET,THYROID
169,2014,BACKGROUND,CURRENTLY,DRUG,FOOD,HOWEVER,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
000,001,003,100,1390,2014,8804,AFTER,BACKGROUND,CONCLUSION,FINALLY,GOVERNMENT,GRASP,GWAS,HOWEVER,LABEL,MHC,MOTIVATION,POOLING,POTENTIAL,PRESS,PTMS,PUBLISHED,QTLS,RESULTS,RNAEDITING,SEX,SNP,SNPS,SUMMARY,UNIVERSITY
0001,0014,0073,0112,0304,0345,169,1959,2011,2014,250,577,651,700,740,967,AGE,AUTHORS,CENTRAL,CNS,COX,HODGKIN,IVL,JOHN,LDH,LTD,MANN,RITUXIMAB,SONS,WHITNEY,WILEY
BACKGROUND,C459S,EMT,ERK1,FOLLOWING,HSC3,LABEL,METHODS,RESULTS,SHP2,SNAIL,SRC,THESE
FLC,FLCS,FUNCTIONAL,INCREASED
169,2014,AUTHORS,COPYRIGHT,EGFR,INC,LUNG,PUBLISHED,T790M,THESE,TKI
8805,BASED,CONCLUSION,EACH,FIVE,FOUR,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,THEREFORE,THREE,VAS,WILEY
2005,2006,2128,8805,AGE,ASPECTS,FURTHER,INC,LABEL,METHODS,MINUTES,MVPA,NUTRITION,OBJECTIVE,PUBLISHED,RESULTS
169,2014,8320,8325,956,A549,COPYRIGHT,LTD,THREE,TOPO
A549,DU145,F276,H1299,HELA,HEME,HOWEVER,MASS,MUTATIONS,NUCLEAR,S275,SPP,THESE,TMS
0001,008,036,160,169,2009,2010,2011,2015,COPYRIGHT,DATES,EASTERN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
155,166,946,AKT,EB1,GSK3,MTA,MTAS,ROS,THREONINE
016,146,150,169,176,2014,257,8805,COPYRIGHT,EBUS,EUS,FNA,INC,LABEL,MCNEMAR,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,TBNA
100,169,200,2014,4T1,AFTER,DNP,GMBH,KGAA,METASTASIS,VCH,WILEY
HOWEVER,OTHER,PROMISING
150,FOLLOWING,VARIOUS
160,169,1999,2011,2014,239,913,BACKGROUND,COPYRIGHT,FURTHER,IIIA,INC,LABEL,METHODS,NCDB,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE
169,2014,246,COPYRIGHT,CRI,EGFR,EPIDERMAL,ERBB,ESTIMATED,IRELAND,LABEL,LTD,MATERIALS,METHODS,NMA,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TKIS
169,1995,1997,2010,2011,2014,ANTIBODIES,BORONAT,CNS,COPYRIGHT,EATON,GABAB,LAMBERT,LANCASTER,LEMS,MASON,SCLC,VGCC,VGCCS
1989,2013,ANY,ENGLISH,JANUARY,JULY,MARSDEN,MOST,OCTOBER,ROYAL,THERE,UNIT
003,160,169,193,2014,AIMS,COLLEGE,COPYRIGHT,CRUK,DECREASES,DOSE,HIGH,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLAN,PTV,PTVS,PUBLISHED,REDUCED,RESULTS,ROYAL
570,ACCORDING,ALSO,BACKGROUND,CUP,FINDING,LABEL,LUNG,METHODS,RESULTS,SWEDISH
100,169,2013,916,936,956,A549,APOPTOSIS,BAX,BCL,COPYRIGHT,IC50,NDBA,OVERALL,PHYTOLACCA,PUBLISHED
2009,2011,314,370,CHINESE,DEC,HAN,LIG1,PCR,PRODUCT,SERVICE,SNP,SPSS
111,118,169,2014,CONCLUSION,COPYRIGHT,DOSE,DRC,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TD50,UNITS
0001,0019,003,0064,0065,100,106,115,169,2014,BOTH,COPYRIGHT,DFS,GRADE,INC,LABEL,MATERIALS,METHODS,NCRT,OBJECTIVE,PURPOSE,RESULTS
002,047,160,169,2014,CONCLUSION,COPYRIGHT,COX,CUMULATIVE,EASTERN,FFS,GRAY,GROUP,GTV1,GTV2,HIGH,INC,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SBRT,SGR
001,020,100,106,143,169,2014,946,967,AMONG,BACKGROUND,COX,DUAL,EGFR,LABEL,MEDICAL,METHODS,PC9,PEARSON,PFS,PRESS,PUBLISHED,RESULTS,SMAD3,SNPS,SOCIETY,TGF,THERE,UNIVARIATE,UNIVERSITY
121,124,169,2014,250,8805,AES,BACKGROUND,COMPARABLE,CONCLUSION,DRAES,EGFR,ERBB,HNSCC,ICR,LABEL,MEDICAL,METHODS,MOST,OBJECTIVE,PRESS,PUBLISHED,RESULTS,SEQUENTIAL,SOCIETY,UNIVERSITY
1000,169,2014,251,ANGIOGRAM,COPYRIGHT,CTPA,INC,PULMONARY,VTE
148,158,169,2014,5301,AACR,CELLS,GPR81,RES,THESE
169,2014,CANCERS,COPYRIGHT,EGFR,ERBB,ERBB1,ERBB2,FOLLOWING,GEFITINIB,LTD,SEVERAL,THESE
000,014,018,020,024,126,128,141,142,169,2014,215,486,720,945,BACKGROUND,CONCLUSION,COPYRIGHT,COX,DFS,HIGH,INC,LABEL,MEIER,METHODS,NSCLC,RESULTS,SCC
0001,169,196,1973,2009,2014,228,AGE,BACKGROUND,COPYRIGHT,COX,DESPITE,END,EVEN,INC,LABEL,METHODS,MPM,PUBLISHED,RESULTS,SOCIETY,THERE
122,140,169,2014,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PRIMARY,PUBLISHED,RESULTS,SOCIETY,TECHNOLOGY,VATS,VIDEO
001,002,003,005,026,076,169,177,2014,A549,BACKGROUND,BOTH,COPYRIGHT,CSC,CSCS,H125,IIA,INC,KNOCKDOWN,LABEL,LUNG,METHODS,PROTEIN,PUBLISHED,RESULTS,SECRETORY,SOCIETY,THESE,WESTERN
107,169,2012,2013,2014,8201,BACKGROUND,CONCLUSION,LABEL,METHODS,OCTOBER,RESULTS,SPECIAL,SUSPECTED,VIRTUAL
169,AMONG,FURTHER,MTA,MTAP,PRESS,SIXTY
CAD,ECAR,EGFR,EGFRTKI,GLUT3,HOWEVER,LAD,MUTATIONS,PPP,TKI,TKIS
1347,169,2014,29A,376A,424,500A,502,542,60K,8X60K,AGILENT,CELL,CONCLUSION,COPYRIGHT,DATA,EACH,FIFTY,GROUP,IRELAND,LABEL,LTD,MATERIALS,METHODS,MOLECULAR,NSCLC,OBJECTIVE,OBJECTIVES,PATIENT,PCA,PROGNOSTIC,RESULTS,RMA,SAKK,SIX,SWISS,TEN
169,2014,COPYRIGHT,EZH2,FEDERATION,FINALLY,FURTHER,H3K27,LYS27,NRF2,PRC2,PUBLISHED,SOCIETIES
169,2014,393,435,460,468,570,620,650,680,8226,900,956,ANALOGS,CCRF,CEM,COPYRIGHT,GI50,HOP,LTD,MDA,MMB,PTL,PUBLISHED,RPMI,RXF
169,2014,945,946,BASED,BLM,COL,COPYRIGHT,ERK,GAL,IMR,INC,MAPK,PI3,SMA,SMAD2,TGF
ATM,CHK1,CHK2,DDR,H2AX,JNK,JUN,LC3,LY2603618,PARP,S296,S345,THESE,TREATMENT
169,2014,COPYRIGHT,INC,PAS,PULMONARY
177,197,CONCLUSION,LABEL,LINE,LUNG,METHODS,NON,OBJECTIVE,RESULTS,THERE,TNM
215,370,8805,ALC,AMC,COX,EASTERN,ECOG,GROUP,LMR,NSCLC,PFS
0053,169,2014,3Q26,ADCS,ALTOGETHER,CDC2,COPYRIGHT,EZH2,FURTHER,HOWEVER,LTD,MES,REDUCED,SCCS,SOX2
AFTER,MRI,NSCLC,ULTRASHORT,USRPS
1199,1228,1230,1556,169,1832,2014,2578,340,3564,376,4537,4617,627,633,642,759,838,921,934,941,BONFERRONI,CONCLUSION,DUNN,GGNS,KRUSKAL,LABEL,MASS,MATERIALS,MDT,MDTS,METHODS,OBJECTIVE,PURE,PURPOSE,RESULTS,RSNA,SSNS,THREE,VDT,VDTS
169,2014,CONCLUSION,CONSENT,FOUR,HIPAA,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,RFA,RSNA,SEQUENTIAL,STUDENT,THREE
BASED,ENDO,RADIATION
ALZHEIMER,KALLIKREIN,KLK,KLK1,KLK15,KLK3,KLKS,PARTICULAR,PSA
AKT,ERK1,NNK,RESISTANCE,TCDD
945,CAPSAICIN,COX,DESPITE,HIF,LUNG,NSCLC,SMAR1,VEGF
1135,1981,2011,CNS,LABEL,LIMITED,MEAN,METHODS,MOST,OBJECTIVE,OVERALL,PATHOLOGY,RESULTS,SITES
1133,169,2014,556,585,6MONTHS,8804,8805,AFRICAN,AMERICANS,AOR,BACKGROUND,COPYRIGHT,EACH,GREATER,LABEL,LATINOS,LTD,METHODS,RESULTS,SMOKING
8209,A549,AXL,H460,MER,NSCLC,RTK,TAKEN,TAM,THESE,TYRO,UPON,XIAP
001,2013,706,8201,EGFR,ELECTRONIC,HOWEVER,LABEL,MAY,MEDLINE,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SCIENCE,SEVERAL,STATA,THERE,THEREFORE,TKIS,VERISTRAT,WEB
HEPG2,SNAIL,TWIST
169,2014,231,233,EGFR,FRAN,GEFITINIB,NSCLC,SOCI
000,032,039,100,132,8209,8805,FURTHER,HOWEVER,LOH,SINCE,SOLE,THESE
2011,2013,AKT1,ALK,AMONG,APRIL,BACKGROUND,BETWEEN,BRAF,EGFR,EML4,FGFR1,FGFR2,HER2,JULY,KRAS,LABEL,MEK1,MET,METHODS,NRAS,PLEURAL,PTEN,RESULTS,RET,ROS1
1063,109,1247,138,215,259,386,485,532,675,725,9Q33,BACKGROUND,BOTH,CHINA,CONCLUSION,LABEL,METHODS,NORTH,RESULTS,SOUTH
866,AKT,BACKGROUND,CONCLUSION,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PTEN,RESULTS,SECONDARY,THERE
001,005,013,016,029,133,1997,2010,BACKGROUND,III,IMAGING,JULY,LABEL,MASAOKA,METHODS,RESULTS,SEPTEMBER
447,8805,BACKGROUND,ELDERLY,FINAL,HOWEVER,III,LABEL,METHODS,PARAMOUNT,PFS,PHASE,RESULTS,SUBGROUPS
0099,015,022,8805,ACUTE,BACKGROUND,CTCAE,EXHALED,FIVE,LABEL,METHODS,NEITHER,RESULTS,SABR
BACKGROUND,CIGARETTE,DATA,HOWEVER,INDUCTION,LABEL,LIBRARY,MEDLINE,METHODS,P450,RESULTS,SMOKERS,SMOKING,STUDIES,THERE,THESE
169,2N6,4N6,ADC,COPD,COPYRIGHT,FATTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,ROC,SCC,SCLC,SOCIETY,THEIR,THESE
1000,169,2014,AMERICANS,COLUMBIAN,COPYRIGHT,EAST,EUROPEANS,MEXICAN,PRE,SCIENCE,THUS
169,2014,8764,ERS,FURTHER,LOBECTOMY,THERE,THEREFORE
AIRWAYS,AREA,CARE,HEALTHY,ICPS,INNOVATION,INTEGRATED,PLAN,UNION
AAA,CARLO,ECLIPSE,IMRT,MONTE,TPS,TPSS,V10,VMAT
113,158,169,2012,2014,315,323,391,464,ALK,ANAPLASTIC,BACKGROUND,CONCLUSION,COPYRIGHT,INC,ITALIAN,JANUARY,KIRSTEN,KRAS,LABEL,LIFE,METHODS,NSCLC,RESULTS
169,174,2014,CONCLUSION,COPYRIGHT,CTCS,CYTO,DIAGNOSTIC,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCREENCELL
169,2014,AMONG,BOTH,COPYRIGHT,GATA3,INC,INTENSITY,NUCLEAR
169,2014,AVAPERL,COPYRIGHT,DATA,ECOG,FDA,GUIDELINES,NCCN,NETWORK,NSCLC,PARAMOUNT,POINTBREAK
109,119,169,2014,273,356,629,8805,BACKGROUND,BASEL,BMT,DISTANT,DMS,EAC,FOLLOWING,LABEL,METHODS,RESULTS,TMT
945,HIF,LXY6006,ORAL,THESE
8201,945,947,ACTIVATION,AMPK,BACKGROUND,CELL,CHIP,CONCLUSION,DUAL,EGR,HOWEVER,JNK,JUN,KIT,LABEL,LUCIFERASE,METHODS,MTT,NSCLC,PDK1,PEROXISOME,PPAR,PPRE,RESULTS,WESTERN
000,177,2001,2014,BEIJING,CTA,FDG,FIVE,JANUARY,LABEL,METHODS,NINE,OBJECTIVE,PAS,PET,RADICAL,RESULTS,THEIR
2013,ASSESSMENT,BACKGROUND,EVALUATION,FIXED,GRADE,HOWEVER,LABEL,MEDLINE,METHODS,OCTOBER,RCTS,RESULTS,SCIENCE,TZDS,WEB
164,169,2014,326,424,676,774,BASEL,EGFR,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS
945,946,THESE,THUS,VEGF,VEGFR
103,2281,ABCC5,ATP,BACKGROUND,BASED,CEPH,FDA,LABEL,MT1A,NAD,NQO1,RESULTS,SNP,TESTING
NATURAL,ONCE
GENERATING,MOST
2008,2012,BACILLE,BCG,EARLY,III,KLEINERMAN,MDP,MTD,MTP,PHASE,THESE,WHILE
153,223,99M,BECAUSE,EDTMP,MDP,ROUTINE
11R,945,CGRRAGGSC,NOVEL
1900S,ONCOLYTIC,SINCE,THEREFORE
000,BECAUSE,SINCE,USA
20A,AEROSOL,FAS,FASL,GCB,SUCCESS
ATP,BRIEFLY,CELLS,ERM,ERMS,EZRIN,RADIXIN,SINCE
GIVEN,OTHER
AUTOPHAGY,EVALUATION,GCB,HOWEVER,INHIBITION,K7M3,LM7
PARTICULAR
946,CD44,FURTHER,MOST,NOTCH,WNT
AXL,DESPITE,EPHB2,FGFR2,FUNCTIONAL,RET,RTK,RTKS,STUDIES,THEREFORE
946,DESPITE,DKK,EVEN,GIVEN,ULTIMATELY,WIF,WNT
1970S,ADDITIONAL,SINCE,THERE
001,2006,2009,5233,8197,967,BACKGROUND,BMJ,ENGLAND,EPISODE,FURTHER,GROUP,LABEL,LIMITED,LUNG,METHODS,PUBLISHED,PUBLISHING,RESULTS,STATISTICS
120,160,169,2014,417,99M,AREA,BODY,BSA,COPYRIGHT,DIFFERENT,FOUR,LTD,MAA,MIA,MIRD,PUBLISHED,RADIATION,SELECTIVE,SIRT,SURFACE,THERAPY,THUS,WITHOUT
000,140,169,1968,1991,1992,2001,2007,2014,31ST,CANCERS,FIRST,INDIANS,NATIONS,ONTARIANS,ONTARIO,UICC
001,006,119,169,2013,380,435,506,8201,919,967,975,ADC,BLN,CONCLUSION,DWIBS,ELN,INC,LABEL,MATERIALS,METHODS,MLN,NLN,NPV,NSCLC,OBJECTIVE,PPV,PURPOSE,RESULTS,ROC,STUDENT,WILEY
1367,160,169,1990,2010,2014,2270,267,378,777,BACKGROUND,COLORECTAL,COPYRIGHT,LABEL,LTD,METHODS,RCC,RCCS,RESULTS,RISKS,SIR,SIRS,SWEDISH

001,046,116,144,169,2014,ANTICANCER,BACKGROUND,CEA,CONCLUSION,COPYRIGHT,HIGH,IIIB,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,RESULTS
001,135,169,2011,2014,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,EGFR,INSTITUTE,JOHN,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SOCIETY,THREE
169,2014,ANTICANCER,COPYRIGHT,EGFR,INSTITUTE,JOHN,MOLECULAR,NSCLC,RENAL,TKIS
035,100,169,2014,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,RESULTS,SIXTY,THESE
169,2014,264,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GLASGOW,GPS,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,RESULTS,THREE
169,2014,AIM,AMONG,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,GLASGOW,GPS,INSTITUTE,JOHN,LABEL,METHODS,OBJECTIVE,RESULTS,UNIVARIATE
014,047,169,2014,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,EVALUATION,EVEN,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,RESULTS,SIX,TBB,TBBS
169,2014,946,AIM,ANTICANCER,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,2014,251,ANTICANCER,BACKGROUND,CONCLUSION,CONVERSELY,COPYRIGHT,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,NSCLC,RESULTS,THEREAFTER,UNIVARIATE,URINE
038,039,169,2014,ANTICANCER,BACKGROUND,CONCLUSION,COPYRIGHT,IGF1R,IHC,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,PCR,RESULTS
169,2014,AKT,ANTICANCER,CACO2,COPYRIGHT,FINALLY,FOCUSSING,INSTITUTE,JOHN,MTT,POD,PROTEIN,THESE,TREATMENT
169,2014,ANTICANCER,BACKGROUND,CELLS,CONCLUSION,COPYRIGHT,INSTITUTE,JOHN,LABEL,LUNG,MATERIALS,METHODS,RESULTS,STUDIES,TKI
169,2014,AIM,ANTICANCER,BACKGROUND,COPYRIGHT,HIGH,HOWEVER,HSP70,HSPA,HSPA2,IIIA,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM
169,2014,9ER,AIM,ANTICANCER,BACKGROUND,CAPILLARY,CONCLUSION,COPY,COPYRIGHT,EGFR,GGT1,GGT5,GSTT2,INSTITUTE,JOHN,LABEL,MATERIALS,METHODS,MYC,NSCLC,OBJECTIVE,RESULTS,TKIS
003,006,020,027,169,2007,2010,2014,404,411,475,512,ANTICANCER,ASSESSMENT,BACKGROUND,CONCLUSION,COPYRIGHT,ERCC1,III,INSTITUTE,JANUARY,JAPAN,JOHN,LABEL,MATERIALS,METHODS,OCTOBER,RESULTS,RRM1,SHIMANE,UNIVERSITY
169,2014,ANTICANCER,BACKGROUND,BECAUSE,CA15,CONCLUSION,COPYRIGHT,CYFRA,ECOG,EVALUATION,HOWEVER,INSTITUTE,JOHN,LABEL,METHODS,RESULTS,TPA,UNIVARIATE,VARIOUS
001,005,017,025,516,8202,ASIAN,BACKGROUND,CIS,GCN,INCREASED,LABEL,MET,METHODS,NSCLC,RESULTS,SCHOLAR,SCIENCE,WEB
LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
205,CONTRARILY,EMT,LNCRNAS,ROR,THUS,ZEB2
8764,8805,CD4,CHIP,CLOSE,EZH2,FINALLY,OVERALL,RE1,REST,SIN3,THESE,WHETHER
2000,2012,2013,8215,AMONG,BACKGROUND,CENTRAL,CLINICIANS,CONTROLLED,ENGLISH,FALSE,FIVE,LABEL,LDCT,LUNG,MAY,MEDLINE,METHODS,QUARTER,RCTS,RESULTS,REVIEWS,SYSTEMATIC
001,122,1500,678,779,8805,888,BACKGROUND,COMBINING,CTC,LABEL,METHODS,NCI,PFS,PRS,RESULTS,SEVERAL,THUS,V20,VS5
1780,2293,2404,2651,513,BACKGROUND,DATA,EGFR,EPIDERMAL,HOWEVER,L858R,LABEL,METHODS,NORTH,RESULTS,SAMPLES,TTF
136,158,175,187,2004,2005,204,4994,5016,5028,5203,8805,BACKGROUND,BETWEEN,COMPLIANCE,CONTINUOUS,FALSE,FIVE,HOWEVER,LABEL,LOW,METHODS,N0M0,NODULES,RESULTS,SMOKING,TRUE
146,201,6000,AFTER,AKT,BACKGROUND,BSI,COLLECTION,DEVELOPER,DRUG,H460,HCSA,HOWEVER,KRAS,LABEL,MEK1,METHODS,PARP,PI3K,RESULTS
BACKGROUND,BOTH,CAFS,EGFR,KRAS,LABEL,METHODS,RESULTS,SILTUXIMAB,STAT3
AKT,CK6,FLOW,H526,IGG1,KIT,MALME,MAPK,NCI,SCF,SCLC,STEM
10877,1456,1970S,1989,2006,267,3022,400,8764,BACKGROUND,CHINA,COX,ENDOTOXIN,LABEL,METHODS,RESULTS,SINCE
005,019,10878,187,2006,2013,205,467,BACKGROUND,GYEONGSANG,JULY,LABEL,METHODS,NLR,OCTOBER,PFS,PLR,RESULTS,SAMSUNG,SCLC,UNIVERSITY
120,BACKGROUND,CELL,HOWEVER,LABEL,METHODS,MYO10,RESULTS,SILENCING
224,A549,BACKGROUND,CIP1,DDP,HOWEVER,INCREASING,LABEL,LAS,METHODS,RESULTS,WAF1
BRAIN,EFFECTIVE,METASTATIC,STUDIES
106,124,169,170,259,327,81MO,945,AE1,AMBIGUOUS,BOTH,CDX2,CK7,EMA,GCT,GPC3,GYST,GYSTS,MOC31,MOST,MUC,PRIMITIVE,SALL4,SMS,SOMATIC,SYST,SYSTS,THESE,TTF,YST,YSTS
AMONG,CDV,CURRENTLY,HOWEVER,NEOPLASTIC,SEVERAL
139,447,928,CLUSTER,COPD,EI24,FIFTY,HOXD8,III,IRX2,LADCS,MOST,RGS5,SPARCL1
500,956,ASSESSMENT,BACKGROUND,CONCLUSION,COPD,EGFR,EMT,EPITHELIAL,ICS,LABEL,METHODS,MMP,RBM,RESULTS
168,ALK,CIGARETTE,EGFR,HOWEVER,KRAS,MET,ROS1,SIXTY,SMOKING,SRIF,THERE
169,2009,2013,2014,BLOOMBERG,HOPKINS,HOWEVER,JOHNS,METFORMIN,PRESS,PUBLISHED,THERE,UNIVERSITY
169,2014,AUTHORS,FINDING,PUBLISHED,SOX12,TCF,TMED3,TREATMENTS,USING,WNT
BACKGROUND,CHIP,CONCLUSION,CURRENT,FITTING,GWAS,LABEL,METHODS,RESULTS,SNP,SNPS
000,169,2014,500,EPIC,FRUIT,NUTRITION,SOCIETY,THERE
0013,0242,169,2014,956,BACKGROUND,BRITISH,JOURNAL,LABEL,METHODS,MOR,PRESS,PUBLISHED,RESULTS,THERE,UNIVERSITY
BRAF,ENTRAPMENT,LABEL,LHRH,MANGANESE,METHODS,MMP2,MN3O4,MRI,NLCS,NPS,OBJECTIVE,PEGYLATED,PURPOSE,RESULTS,SIZE,UNIFORM,V600E
001,003,101,150,160,169,177,2003,2011,2014,374,8804,AFTER,AIMS,ASIA,COLLEGE,CONCLUSION,COPYRIGHT,DATA,EFS,ESFT,EWING,JUNE,LABEL,LCR,LOCAL,LTD,MATERIALS,METHODS,MOST,NACT,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,UNIVARIATE
169,2014,COPYRIGHT,ECM,GMBH,KGAA,LACK,METASTASIS,SIMILAR,VCH,WILEY
169,2014,ACTIVATION,AKT,AXL,DASATINIB,EGFR,ERK,IGF,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PC9,PC9GR,PURPOSE,RESULTS,SFK,SRC,T790M,TKI
8805,AUROC,MICRORNAS,SEVERAL,THESE
166,1970,2002,613,RISK
DEFINED,IIALPHA,NOR
387,674,936,CHERNOBYL,FREE,N1B,OVERALL,THERE
8201,ADP,ASC,ASN,CYTOSOLIC,DESPITE,FIC,GTPASES,IBPA,LOSS,MEFV,MUTATIONS,OTHER,PRR,PYRIN,RHO,RHOA,T6SS,TCDB,THESE,THUS,VOPS
001,002,1000,177,215,ADC,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NCR,OBJECTIVE,RESULTS,SIXTY,SPSS,THERE
A549,ADP,AHF,ARGENTINE,CASP3,CASPASE,CONSISTENT,IFN,JUNIN,JUNV,PARP,POLY,RIG,RLH,SIMILARLY,VERO
001,011,013,BACKGROUND,EMT,KNOCKDOWN,LABEL,METADERIN,METHODS,MTDH,NSCLC,PCR,RESULTS,THESE,TNM
001,011,014,034,10878,180,2005,2011,241,AGE,BACKGROUND,CCI,CENTRES,EASTERN,ECOG,GROUP,III,IMIG,INDEX,ITALIAN,JANUARY,LABEL,METHODS,MPM,NON,RESULTS,THERE,TREATMENT
2006,2010,733,7769,BACKGROUND,EPISODE,HOWEVER,LABEL,LIKELIHOOD,METHODS,RESULTS,STATISTICS,YORKSHIRE
133,1987,2009,2012,207,214,221,224,238,HIGH,HPV,JANUARY,RRP,USING
GENERALLY,METASTATIC,THERE
174,2013,2014,ALUM,ARGENTINA,COPYRIGHT,CUBA,GM3,III,NEU,NSCLC,PROUS,SCIENCE
0001,1000,1986,200,2001,2003,2010,2012,313,474,6000,BACKGROUND,BIOBANK,BRISQ,LABEL,METHODS,RESULTS
AMONG,CSC,CSCS,LOSS,QKI,QUAKING,SOX2,TAKEN,THEREFORE,UTR
A549,FAK,TREATMENT,WESTERN
8202,BACKGROUND,CNS,CURRENTLY,GENERALLY,LABEL,OBJECTIVE,PURPOSE,STILL,THEIR
169,2014,654,ACTA,BACKGROUND,CONCLUSION,DISC,DOR,DTP,EBSCO,FDG,FOUNDATION,HOWEVER,KNOWLEDGE,LABEL,LYMPH,META,METHODS,NLR,NSCLC,OBJECTIVE,PET,PLR,PURPOSE,RESULTS,SROC,STP,SUMMARY,WEB
169,2014,COPYRIGHT,MEMO,NADPH,NOX1,ROS,SCIENCE
1994,2007,2011,MASAOKA,MAY,THEREAFTER,WHILE,WORLD
1996,2004,2005,2013,EVEN,THESE
THERE,THEREFORE
169,1996,2009,2014,320,429,CHINA,COOKING,COX,EVER,HOWEVER,IAP,THESE,UICC
1992,2006,HOWEVER,HRS,RETIREMENT,THESE
CHEST
CHEST
CEA,EGFR,NINE,SINCE,SVC
CHEST,ESS,FDG,PET
FDG,PET,RUL,TTF
2002,2007,498,8805,ACCORDING,CCI,HOWEVER,III,JAPAN,OWING,SEX,THERE
CAP,CASE,CPA,DTX,EPI,FEC,GEM,HER2,HOWEVER,PGR,PTX,THEREFORE
AFP,AFTER,METASTATIC,OCT,SERUM,THEREFORE
178,500MG,AMONG,CBDCA,CDDP,NSCLC,PEM
2006,2012,209,AFTER
EGFR,GEFITINIB,L858R,NSCLC,SOMATIC,T790M,TKIS
8594,AFTER,BACKGROUND,III,IMPORTANT,LABEL,MEIER,METHODS,RESULTS,ROC,SQCC
169,2014,481,8201,829,AFTER,CHINESE,CIS,COX,DIETARY,HRS,SWHS,TOTAL,UICC,VITAMIN,WOMEN
160,2001,2010,234,282,8805,BACKGROUND,BMI,CRS,HIPEC,LABEL,METHODS,OBESITY,RESULTS
169,2014,946,A549,BOTH,CHINESE,COPYRIGHT,COX,DSS,ERK,GMBH,INTEGRATED,PGE2
169,2014,APART,MUTATIONS,TP53
169,2014,318,3P14,ARID2,BAP1,BRD1,MOST,PBRM1,SETD2,SMARCA4,SMARCC1,SNF,SWI,THESE,UICC
0026,169,2013,2014,8804,DIAGNOSIS,DIAGNOSTIC,JAPAN,LABEL,METHODS,OBJECTIVE,OLYMPUS,PRESS,PUBLISHED,RESULTS,SEPTEMBER,SIXTY,THERE,UNIVERSITY,Y0053

MAPK,NET,NETS,NPS,NPSR1,SY5Y
160,169,2000,2009,2014,963,BACKGROUND,CALIFORNIA,CHRONIC,COX,HISTORY,HIV,HODGKIN,LABEL,MEDICAL,METHODS,PERMANENTE,PRESS,PUBLISHED,RESULTS,RISK,SOCIETY,THESE,UNIVERSITY
011,100,3OST2,8804,AIMS,APC,BMJ,BOTH,COPD,FAM19A4,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PHACTR3,PUBLISHED,PUBLISHING,RASSF1A,RESULTS,SET
032,177,1803,2001,2008,711,716,7TH,908,985,AJCC,BACKGROUND,COLLEGE,COX,GROUP,HOWEVER,IASLC,III,LABEL,LUNG,MEDICAL,METHODS,NCCN,NETWORK,NSCLC,OSI,RADIANT,RESULTS,STAGING,TNM,UNIVARIATE
002,004,006,009,018,019,021,024,025,027,030,032,037,044,048,154,185,2005,2010,CONCLUSION,COX,LABEL,LAC,METHODS,OBJECTIVE,RESULTS,THERE,TTF,TTF1,UNIVARIATE
000,019,023,ALK,ARMS,CHINESE,DFS,EGFR,FISH,FIVE,LABEL,LOG,METHODS,MUTATIONS,OBJECTIVE,RESULTS,SCORPIONS
100,2004,2012,228,CDX2,CGA,FIFTEEN,GASTRIC,GCDFP15,HMB45,LABEL,LYMPH,METASTASES,METASTATIC,METHODS,MOLECULAR,MPNST,OBJECTIVE,OVARIAN,P504S,PANCREATIC,PAX8,PSA,RESULTS,SEVEN,SYN,TTF,WT1
169,2014,A549,AICAR,BECAUSE,COPYRIGHT,HOWEVER,IRELAND,KNOCKDOWN,LTD,PML,RAPAMYCIN,SER46
001,100,188,1990,2011,323,8805,BACKGROUND,CENTERS,CONCLUSION,CONTEXT,DUTCH,LABEL,LUNG,MAIN,MEDICAL,MEN1,METHODS,NET,NETS,OBJECTIVE,OUTCOME,RESULTS,UNIVERSITY
BACKGROUND,DYSPNEA,GRADE,LABEL,LESS,MEDLINE,METHODS,RESULTS,SCHOLAR,UNTIL
DESPITE
PET,STAGING,ULTIMATELY
8323,945,946
215,ABDOMINAL,LUNG,THREE
CURRENTLY,EVEN,FINALLY,MOST,PANCREATIC,PDA,TLR2,TLR3,TLR4,TLR7,TLR9,TLRS,TOLL
169,HYGIENE,SOCIETY,TREATMENT
169,2014,BLI,COPYRIGHT,FLASH,JOHN,LTD,MRI,NSCLC,SONS,ULTRA,UTE,WILEY
094,160,251,8209,DCGS,DCLS,EXPRESSION,HOWEVER,LUNG,OMNIBUS,TFS,THESE
169,2014,600,8804,956,CHINA,EXCRETION,GST,GSTT1,RAPID,RIVER,THUS,URINARY,YANGTZE
125A,169,2014,AIG,AMONG,CXCL1,FINALLY,HBEC,P53,PEA3,VEGF
024,35U,6MV,CA125,COX,CSS,MEIER,SIXTY
109,ALK,CD74,EGFR,EML4,KIRSTEN,KRAS,NRG1,ROS1,SEVERAL,USING
177,485,754,CIS,COX,HISTORY,HOWEVER,HRS,INITIATIVE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THERE,WHILE,WOMEN
074,2014,CD44,CD44S,ENGLISH,HOWEVER,MARCH,NSCLC
956,BACKGROUND,CDC2,CHK1,GI50,H2AX,LABEL,METHODS,RESULTS,THESE,THR15,V158411
8209,946,954,AKT,ANTI,EGF,EGFR,HER2,HER3,HIGH,IIA,LUNG,PI3K,SECRETORY,THERE
169,2014,946,A549,AUTHORS,EMT,FOUNDATION,FURTHER,GNT,HOWEVER,JOHN,JOURNAL,LTD,MEANWHILE,MOLECULAR,SMAD,SONS,TAKEN,TGF,WILEY
8G7G3,CLONE,CONCLUSION,FOCAL,HOWEVER,III,LABEL,METHODS,OBJECTIVE,RESULTS,SPT24,TTF
002,0036,004,0059,1208,2003,2010,ACCURATELY,BACKGROUND,CONCLUSION,COX,ESTIMATED,HISTOLOGY,INAUGURAL,IQR,LABEL,METHODS,MEYER,NSCLC,PFS,PROGNOSIS,RATE,RESULTS,SRE,TTF,UNIVARIATE
BACKGROUND,EGFR,EPIDERMAL,FURTHER,L858R,LABEL,MEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCLC,SEVERAL,TKI
169,2014,300,8804,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,GROUP,INC,LABEL,METHODS,NON,RESULTS,VANDETANIB,VEGF
1321,BAF47,BRM,CHIP,GATA3,HDAC3,HDAC9,MEF2D,SIMILAR,USING
198,2002,2007,2008,414,504,526,630,706,8201,ADDITIONAL,AFFAIRS,BECAUSE,DEPARTMENT,DRUG,ESA,ESAS,FDA,FOOD,LABEL,MARCH,METHODS,OBJECTIVE,OTHER,POST,PRE,PURPOSE,RESULTS,THOSE
126,143,145,169,2014,239,652,742,8805,COPYRIGHT,INC,MALIGNANT,MOLECULAR,MPM,MPMS,NNP,OVERALL,PATHOLOGY,PCR,PUBLISHED,RMPS,SOCIETY,THUS
DBNL,HIP,HOWEVER,HPK1,S269,S269A,SER,SH3P7,T291,T291A,THR,THUS,USING
229,912,930,BACKGROUND,CENTRAL,CONTINUOUS,CPR,DENMARK,GPS,HOWEVER,LABEL,METHODS,OOH,RESULTS,RFE
000,1000,121,123,2000,AMONG,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,RESULTS
A549,CELL,HOWEVER,HUVEC,LUNG,PDI,THESE,TREATMENT
205,CFC,CRIPTO1,EGF,EGFR,EMT,NSCLC,PRIMARY,RESISTANCE,SRC,TKI,TKIS,WHILE,ZEB1
100,1089,15953,2012,8202,8694,8805,AREA,AUC,BACKGROUND,DOR,DORS,HOWEVER,LABEL,MAY,META,METHODS,NLR,PLR,RESULTS,STUDIES
000,233,344,625,8202,BACKGROUND,BHD,BIRT,CHANGES,CURRENT,DUB,HOGG,LABEL,METHODS,RESULTS,SIDE,TOPICAL,TRIAL
169,2002,2014,COPYRIGHT,INITIATIVE,LTD,MENOPAUSAL,SINCE,THESE,UNTIL,WOMEN
100,160,169,180,2014,711,BLOOD,COMPONENT,COPYRIGHT,FORM,HCT,MEDICAL,NETWORK,SHORT,SOCIETY,STUDIES,SUMMARY,THERE,TRANSPLANT
1663,169,2014,916,BACKGROUND,BRITISH,CBD,CHANGES,DEVELOPING,HOWEVER,ID1,KEY,LABEL,METHODS,MODULATION,MTT,OBJECTIVE,ORTHOTOPIC,PURPOSE,RESULTS,ROS,SOCIETY,THC,WESTERN
400,PARACELSUS,PERHAPS,WHILE
AFTER,BECAUSE,PULMONARY
169,2014,A549,COPYRIGHT,COX,FINALLY,HOWEVER,MRP,MRP4,PGE2,PMA,TRANSIENT
169,2014,COLLEGE,COPYRIGHT,LTD,NSCLC,PARTICULAR,PUBLISHED,ROYAL
169,2014,956,ASIAN,BACKGROUND,CERTAIN,CLE,LABEL,LUNG,METHODS,OBJECTIVE,PACIFIC,POST,PROBE,RESULTS,SOCIETY,THREE
BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS
169,2014,COPYRIGHT,LTD,STUDIES,WHILE
BACKGROUND,DISCUSSION,FIFTEEN,LABEL,LUNG,METHODS
1000,2878,BARD1,BRCA1,CHK1,KSR1,PHOSPHO,RAF,RAS,THESE
160,BRAF,DERIVED,IIIB,NRAS,RNASE,TP53
29B,AMONG,COX,FHIT,MEIER,MYC,NSCLC,RFS,THEREFORE
174,GENEXOL,PACLITAXEL,POOR,PTX,TAXOL,THESE,VARIOUS
001,005,151,169,1982,2007,2014,443,627,BACKGROUND,COPYRIGHT,GRAY,INDIVIDUAL,IRELAND,LABEL,LTD,METHODS,RESULTS,SEVERAL
0001,100,122,2008,2012,254,EXPRESSION,HIGH,JUNE,LABEL,MEAN,MEASURING,NSCLC,PROGNOSTIC,RESULTS,THUS,UNLABELLED,ZAPOROZHYE
00055,ERALPHA,EXPRESSION,LUNG,NSCLC
146,2000,2011,2013,2930,AMONG,BARR,COPD,DIAGNOSTIC,EBV,EPSTEIN,HHV,HODGKIN,MOST,PCR,PRIMARILY
116,160,BOTH,CCRF,CEM,CPG,CURRENTLY,DNMT1,EFFECTS,H23,HCT,HOWEVER,IGROV,KG1A,LABEL,METHODS,NCI,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN
169,2014,360,AKT,COPYRIGHT,EGFR,ERK,FEDERATION,MEK,NSCLC,PI3K,PUBLISHED,RAF,RAS,RESULTS,RPS6,SOCIETIES,THESE
169,2014,CHEST,COPYRIGHT,DIAGNOSIS,HISTOLOGY,INC,PULMONARY
169,2014,600,AUTHORS,COPYRIGHT,GRIT,GUIDELINES,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
001,002,013,041,169,200,2014,946,ACCORDING,ANTI,COPYRIGHT,FDA,IRELAND,LABEL,LTD,MATERIALS,METHODS,MICRO,OBJECTIVE,OBJECTIVES,PDGFR,RARE,RESULTS,TET,TMA,VEGF,VEGFA,VEGFC,VEGFD
0001,009,082,19DEL,21L858R,858,BACKGROUND,CONCLUSION,EGFR,LABEL,METHODS,NSCLC,PFS,RESULTS,TKIS
001,016,022,169,177,200,2005,2010,2014,618,925,AMONG,ANOVA,CONCLUSION,COPYRIGHT,LABEL,MEAN,METASTATIC,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,THEREFORE,THREE,TOKUHASHI
769,CHINESE,EGFR,GCG,GTG,L858R,MUTATIONS,NSCLC,THEREFORE,TKI,TKIS,V769A
170,179,1974,2014,283,462,671,BEIJING,BETWEEN,CHINA,CHINESE,DATA,FRIENDSHIP,RENAL
AGE,BACKGROUND,COLORECTAL,CRC,KATHMANDU,LABEL,LEFT,MAXIMUM,METHODS,NEPAL,RESULTS
169,2014,A549,CLAUDIN,COPYRIGHT,HOWEVER,NUCLEAR,S208A,ZONAB
000,100,169,1970S,1980,2000,2005,2009,2014,AMERICA,BACKGROUND,BETWEEN,COSTA,CUBA,HOWEVER,LABEL,LATIN,MEDICAL,METHODS,PRESS,PUBLISHED,RESULTS,RICA,SOCIETY,TOBACCO,UNIVERSITY,USA,VENEZUELA,WORLD
169,2014,AFTER,COPYRIGHT,RNAI,THEREFORE
169,2014,429,431,BACKGROUND,DENMARK,HOWEVER,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,TOBACCO,UNIVERSITY
169,2013,COPYRIGHT,DIAGNOSIS,PATHOLOGY,PUBLISHED,SEPAR
2014,8197,BMJ,GROUP,LTD,MPA,PAS,PUBLISHING
169,2014,ALDEFLUOR,ALDH,ALDH1A3,CSC,CSCS,EZH2,INHIBITION,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,STAT3,WESTERN
109,135,5P15,828,AFTER,CAUCASIANS,CLPTM1L,EAST,SINCE,SNPS
149,169,2014,ATLAS,EXPRESSION,LARGE,PRESS,PUBLISHED,TCGA,UNIVERSITY
AUSTRALIA,BACKGROUND,CASE,DATA,ICD,LABEL,LUNG,MATERIALS,METHODS,QUALITY,RESULTS,VICTORIAN
169,2014,231,233,COPYRIGHT,PROTOCOLS,PUBLISHED,SAS,SFRO,SOCI
001,169,184,196,2003,2008,2014,417,CD68,COPYRIGHT,COX,CSF,INC,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PERHAPS,PUBLISHED,RESULTS,SURGERY,TAMS,THEIR
169,2014,METHODS,VITAMIN
169,2014,A549,BALB,COPYRIGHT,DDP,FINALLY,INC,LNA,MES,NSCLC,PCR,PRE,REAL
001,2013,669,8201,983,ASIAN,HOWEVER,SEPTEMBER,SEVENTEEN,SUMMARY
001,003,121,169,189,2007,2012,2014,313,341,968,978,990,BACKGROUND,COPYRIGHT,INC,INSTEAD,LABEL,METHODS,NSCLC,ORDINAL,PUBLISHED,RESULTS,SOCIETY
169,2014,2935,AFFYMETRIX,AMONG,COPYRIGHT,GEO,IRELAND,LTD,LUNG,NSCLC,PLUS,RNAS,SCC,U133
1970,1972,1973,2008,254,350,823,ADDITIONAL,COX,FEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM,SUA,VLAGTWEDDE
000,230,CREL,CREMORPHOR,FORTY,GENEXOL,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIX
EXTENSIVE,LUNG
AUTOPHAGY,HOWEVER
001,183,8201,BACKGROUND,CONCLUSION,FACTORS,GEORG,LABEL,LVI,MATERIALS,METHODS,NSCLC,RESULTS,STUTTGART,THESE,YORK
102,169,2014,954,961,CONCLUSION,COX,FDG,HIGH,HOWEVER,HVISU,IMAGING,INC,INTRATUMOR,LABEL,MEAN,MEIER,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SOCIETY,UNLABELLED
000,001,002,100,1015,126,181,2000,2012,250,3901,438,496,700,8197,8805,AFTER,BACKGROUND,BMJ,COPD,GROUP,JANUARY,LABEL,LIMITED,LOW,METHODS,NETWORK,PUBLISHED,PUBLISHING,PYS,RESULTS,URIC
2011,2012,311,314,464,541,603,FIRST,ITALIAN,JANUARY,JULY,KIRSTEN,LABEL,LIFE,LUNG,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
100,108,2010,2012,BRONCHIAL,CONCLUSION,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,SAHARAN,SETTING,SUB
2014,BMJ,GRAM,GROUP,LTD,OWING,PUBLISHING
054,160,2000,2011,671,AFRICAN,AIMS,BACKGROUND,CAUCASIAN,CONSORTIUM,ETHNICITY,HCC,INPATIENT,LABEL,LACK,LUNGS,METASTASIS,METHODS,NATIONWIDE,NIS,OBJECTIVE,PREVALENCE,RESULTS,THERE,TREND,UHC,UNIVERSITY
000,040,073,078,169,185,2014,283,BACKGROUND,BASEL,CONCLUSION,COX,LABEL,METHODS,PNEUMONIA,PRIMARY,RESULTS,THESE
145,EMT,FINALLY,HOWEVER,LCICS,MIR,OCT4,TAKEN
126,169,195,2014,30D,CONVERSELY,PRESS,PUBLISHED,RRM2,UNIVERSITY
001,177,8201,961,AIRWAYS,ALD,AUTOMATED,AWT,KEY,L10,LABEL,LUNG,METHODS,MIXED,OBJECTIVE,OBJECTIVES,R10,RESULTS,SCREENING,SEGMENTAL,THEREFORE,TLV,TRIAL
169,179,2014,956,ABC,ABCB1,ABCC1,ABCC2,ABCG2,ASIA,ATP,AUTHORS,FURTHER,JANUS,LTD,P154,PTY,PUBLISHING,SCIENCE,WHI,WILEY
169,2014,628,632,8201,AFTER,ASIAN,BACKGROUND,CA125,CA19,CEA,FIFTY,ILD,LABEL,METHODS,NSE,OBJECTIVE,PACIFIC,RESULTS,ROC,SERUM,SOCIETY,STM
1989,2009,239,351,377,930,ASIAN,BACKGROUND,CENTRAL,EFFECTIVE,KOREA,LABEL,METHODS,PAF,RESULTS,SEX,SMOKING,STATISTICS,TOBACCO
115,120,BACKGROUND,FIFTY,FIVE,HIGH,III,LABEL,METHODS,NSCLC,PCR,PHYSICIANS,POST,RESULTS
169,182,2014,ARF6,BASEL,EGFR,HOWEVER
169,A549,AGS,AMONG,EGG,HELA,HEP,HEPG2,INC,MCF,MES,MTT,POULTRY,SCIENCE,THESE,USING
054,169,177,178,183,2002,365,680,689,705,AGE,BESIDES,BMI,DATA,GEORG,NRS,RISK,SCREENING,STUTTGART,YORK
2012,2014,8202,BACKGROUND,CHRONIC,CONCLUSION,HOWEVER,LABEL,MARCH,MEDLINE,METHODS,MRR1,RESULTS,RISK,TEN,THREE
001,132,2009,2012,242,8202,8805,AIM,AMONG,CANDIDA,CANDIDEMIA,CVC,HALF,ICU,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTEEN
000,1197,BAX,BCL,CONSISTENT,H146,H1963,MCL,MEF,USING
95D,A549,THEREFORE,THESE
049,169,1999,2007,2009,AMONG,BACKGROUND,BRITISH,COMMITTEE,CONCLUSION,COX,EASTERN,FURTHER,GROUP,JOINT,LABEL,M1A,M1B,METASTASIS,METHODS,PRESS,RESECTION,RESULTS,UNIVARIATE
169,2014,FINAL,PRESS,PUBLISHED,SIX,SURGERY,UNIVERSITY,VATS
160,169,177,2014,4T1,ASM,ATOR,COPYRIGHT,LTD,METASTASIS,MMP,PEG,PSV,SELF,TWIST,VES
179,EGFR,EGFRS,IIIB
0001,004,1990,1995,2006,2011,213,225,252,276,326,385,387,426,444,662,ACCORDING,ADMISSION,ARDS,DATA,ICUS,LABEL,METHODS,MORTALITY,NIV,OBJECTIVE,PURPOSE,RESULTS,RISK,SOFA,SOLID
002,105,238,23A,413,718,A549,COX,IRS,LABEL,LUCIFERASE,MEIER,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THERE,TRANSWELL,UTR,WESTERN
1RM,380,6MWD,BACKGROUND,DISCUSSION,ENDPOINTS,HRQOL,IIIA,LABEL,MAXIMAL,METHODS,NSCLC,PROLUCA,PROS,SIX,TRIAL,USING,VO2PEAK
169,2014,264,484,805,820,COX,LABEL,META,METHODS,OBJECTIVE,READERS,RESULTS
AFTER,BASAL,BCC,BCCS,HOWEVER,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE,SMO,SMOOTHENED,THESE
ADCC,BACKGROUND,CYTOTOX,DM1,EGFR,H1781,HER2CL1,LABEL,METHODS,MTT,NSCLC,PC9,RESULTS,TKI,TKIS,WESTERN
077,106,129,137,188,2005,215,523,940,ARRIAGA,BACKGROUND,KOREA,LABEL,METHODS,RESULTS,SOUTH,SUICIDE,YOUNG
CHANGES,PARP,PJ34,PRESENT,USING
1982,2003,2013,9559,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DATA,HEMATOLOGY,LABEL,MAIN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RANDOMIZED,RCT,RCTS,RESULTS,SELECTION,SEVERAL,SOCIETY,USING
95D,A549,AFTER,CXCR4,CXCR6,DESPITE,ELSA,H292,HOWEVER,PCNA
1131,2000,2007,BACKGROUND,CONCLUSION,FOUR,GROUP,INCA,INITIAL,INSTITUTE,JANEIRO,LABEL,METHODS,OBJECTIVE,RESULTS,RIO,SMOKING,THERE,TOBACCO
BASED,FDG,PET
CTC,CTCS,DETECTION,MOLECULAR,NON,NSCLC
124,160,177,231,549,956,ACCORDING,HELA,HOWEVER,IC50,MCF,MDA,MRC,MTT
CONCLUSION,FLC,FLCS,IMAGING,KNOWLEDGE,LABEL,LOCATIONS,METHODS,MOST,MRI,OBJECTIVE,PRIMARY,RESULTS
100,3917,497,7299,956,DRIED,MOST,MTCC,PRESENT,PROTEUS,ROOT,SALMONELLA,STEM
2014,8197,BMJ,GROUP,HOWEVER,LTD,MRI,PUBLISHING,PULMONARY,THUS
169,2014,AXL,BIOLOGY,FINALLY,HOWEVER,INC,MOLECULAR,OVERALL,R428,SILAC,SOCIETY
0016,0036,0142,038,047,085,169,16S,2014,352,454,488,8201,BACILLI,BACTERIAL,CHINA,FLX,FURTHER,INC,LUNG,OTUS,PAH,PAHS,PCR,THESE,WILEY,XUANWEI
945,A549,ADP,AML,CHROMATIN,CONVERSELY,DR5,FAS,FURTHER,K562,KNOCKDOWN,PARP,PARP1,PARP2,PARP3,PARP4,PEO1,SP1,TNFRSF10B,TRAIL
169,2014,946,AUTHORS,CONVERSELY,FOUNDATION,HBP1,HMG,HOWEVER,JOHN,JOURNAL,LTD,MOLECULAR,NSCLC,SONS,WILEY
106,8201,AMONG,CONCLUSION,INFECTION,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS
022,031,044,110,122,237,238,8201,8226,AEF,DUAL,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
103,215,471,8201,8226,994,AVERAGING,FDG,FURTHER,KEY,LABEL,MER,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SDR,SDRS,SUV,SUVPEAK
001,002,036,169,2014,339,635,682,757,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FACTORS,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,RISK,RPA,SURGERY
102,A549,ANP,B16,BALB,C57BL,ECTOPIC,LINE,NH2,NP73,NPR,THESE
169,2014,218,AMONG,COX,HIGH,HOWEVER,HPV,HPV16,MEIER,OCSCC,PRESS,PUBLISHED,PXN,RFS,THEREFORE,THESE,UNIVERSITY
BEP,CELL,CHEST,GERM,GROUP,PET
CASE,THESE
0001,003,10TH,169,2014,254,278,447,676,8201,90TH,BACKGROUND,BONFERRONI,COLORECTAL,LABEL,LUNG,METHODS,OVARIAN,OVERALL,RESULTS,SCREENING,SERUM,SOCIETY,TRIAL,USING
150,200,8804,9508,BACKGROUND,BMS,BRAIN,CONCLUSION,GRADE,IMBRT,LABEL,METHODS,NSCLC,RESULTS,RTOG,THREE,THUS,TMZ,WBRT
169,2014,ADP,ATM,BAP1,BRCA1,DDR,DUB
186,INCREASING,MICRORNAS,NSCLC,RHO,ROCK1
001,022,112,8201,945,946,A549,ARMADILLO,ARMC8,CONSISTENT,COX,H1299,MMP,MMP7,NSCLC,THEREFORE,THESE,TNM,WESTERN,WNT
020,022,406,812,8201,CHINESE,HIF,HYPOXIA,NSCLC,PHD1,THUS
ATXN2,BACKGROUND,DHX9,EGFR,KRAS,LABEL,METHODS,MYOF,NOVEL,RESULTS,RPS6KB2,SOMATIC,SP1,TEN,THESE,TP53
BACKGROUND,CONCLUSION,EGFR,ENZYMATIC,G719S,G724S,HOWEVER,INHIBITION,KRAS,LABEL,RESULTS,THESE,THROUGH
169,177,183,2014,8201,945,947,BRITISH,CD4,CD8,COX,COX2,IFN,IMMUNOLOGY,LUNG,PGE,PGE2,PREVIOUSLY,SOCIETY,THERE,THUS,TNF
1536,169,1998,2011,2014,627,679,ACUTE,BACKGROUND,CONCLUSION,COPYRIGHT,CPFE,IIP,IIPS,IRELAND,LABEL,LTD,MARCH,MEDICAL,METHODS,OCTOBER,RESULTS,THEREFORE
169,2006,2013,2014,COPYRIGHT,GGN,GGNS,HOWEVER,IRELAND,JANUARY,LABEL,LTD,MARCH,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
CIGARETTE,COPD,CSE,DESPITE,JAK2,LYN,STAT1,TAKEN
1237,169,2000,2011,2012,2014,280,AMONG,EASTERN,ECOG,EGFR,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,TKI,TKIS,UNIVERSITY
001,004,005,020,022,035,043,191,731,BACKGROUND,COX,DATA,HOWEVER,LABEL,LOG,MEIER,METHODS,NOK,NSCLC,PTK,RESULTS
001,05GY,10GY,169,2014,231,233,2GY,3GY,4GY,5GY,COPYRIGHT,DOSE,DYNAMIC,LABEL,METHODS,OBJECTIVE,POPULATION,PREX,PRIN,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI
001,003,023,101,111,186,187,196B,331,372,375,519A,626,686,766,8201,AREA,ATLAS,AUC,BACKGROUND,LABEL,LUAD,LUNG,METHODS,RESULTS,ROC,SIXTEEN,TCGA,UNDER,USING
0001,0002,0241,0358,0421,0449,169,2011,2013,2014,8804,8805,APRIL,COMPARISON,CONCLUSION,HOWEVER,JAPAN,LABEL,MARCH,METHODS,NONE,OBJECTIVE,OBJECTIVES,OPERATIVE,PRESS,PRIMARY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY,VSD,VSDS
046,169,2003,2013,2014,CCP,CHEST,FIFTY,III,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RCP,RESULTS,SURGERY,THERE,TNM,UNIVERSITY
BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,TREATMENT
169,1960S,1980S,1990S,2014,948,HOWEVER,ICMT,KRAS,PDE,RAS,RCE1,SINCE,THESE
160,AFTER,METASTASIS
200,414,455,ANTS,CHINESE,INCREASED,KNOCKDOWN,MALAT,MELANOMAS,PCR,REAL,RNAS,UCA1
491,514,BACKGROUND,CONCLUSION,EARLY,EIGHT,INCREASING,LABEL,LUNG,METHODS,RESULTS
1995,2012,A549,AMONG,CHINA,CHINESE,IIA,META,OCH3,PPD,TCHM
GIVEN,MEASLES,PVRL4
AAT,ACUTE,ALPHA,APP,APPS,CHANGES,FINALLY,SEVERAL
160,169,183,8197,898,ADMISSION,BECAUSE,COPD,DIAGNOSIS,ENDOSCOPIC,GEORG,GOLD,HISTORY,IASLC,LABEL,METHODS,ONCOCYTOMA,PAD,RESECTION,STUTTGART,TREATMENT,YORK
019,440,RADIOMICS,THESE
D1CC,IMRT,MLD,OARS,PRV,PTV,TEN,V10,V20,V30,VMAT
001,002,233,476,703,CONSENSUS,EACH,INDEX,OVERALL,PEARSON
100,300,EBT,GAFCHROMIC,OAR,RSS,TESTING
177,5CM,REGULAR,SBRT,TEN,THEREFORE
101,282,919,CRT,IMRT,PLDR,PTV,THERE,TPS,VMAT
177,BOTH,CRT,HOWEVER,IMRT,PTV,V10,V13,V20,V30,VMAT
8804,CARLO,FIRST,MONTE,SBRT
CBCT,CHANGES,EACH,GTV,MRI,SBRT,TEN
HOWEVER,MIP,NBPF,PHASE,TEN,THOSE
001,008,1054,160,169,2002,2011,2014,215,BLOOD,CD34,COPYRIGHT,HCT,HLA,INC,PBPC,PUBLISHED,REDUCED,REPORTS,RESULTS,SOCIETY,THESE
169,2014,BEATY,ERM,FERM,NHE,SILENCING,THUS
120,169,2015,H2B,H3K4,H3K79,MOST,PTM,PTMS,RING,RNF20,RNF40,SOCIETY,USP22,USP44,USP7
169,2010,2014,ACR,ALBERTA,BACKGROUND,BESIDES,BMS,BOTH,CONCLUSION,KCR,LABEL,LOW,METHODS,NEURO,PRESS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,2014,946,ALK,DISRUPTION,EML1,EML4,HSP90
169,2014,ALK,CERITINIB,NSCLC,THESE
1511,1559,1677,1679,169,2014,CHINESE,COPD,EMT,FLT1,FUNCTIONAL,HOWEVER,LUNG,MUTAGEN,PRESS,PUBLISHED,SNP,SNPS,SOCIETY,THREE,UNIVERSITY,VEGFR
195,HDGF,MICRORNAS,NON,NSCLC
169,2014,COPYRIGHT,HESSIAN,HIGH,HURWITZ,IRELAND,LTD,ROUTH,USING
8209,ARMS,EGFR,HOWEVER,NSCLC,TKI
GOVERNMENT,LAM,LAMELLARIN,USING
169,2014,COPYRIGHT,FEW,SOCIETY
169,2008,2012,2014,8805,ACUTE,ADVERSE,BETWEEN,COPYRIGHT,DOSE,HOWEVER,INC,LABEL,LOCAL,MATERIALS,MAYO,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SBRT,SOCIETY,THERE
001,169,2014,COPYRIGHT,FOUR,III,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SBRT,SOCIETY,THERE
0001,0004,001,004,008,169,2014,209,2814,8804,CTS,DIBH,DLAD,LABEL,LAD,MATERIALS,METHODS,OAR,OBJECTIVE,PURPOSE,RESULTS,THREE,V30
005,013,028,169,2014,527,740,COLLEGE,COPYRIGHT,GROUP,III,INC,LABEL,LEVEL,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,RTOG,SOCIETY,THERAPY,Z0011
10Q23,14Q24,16Q11,2Q32,3P22,4Q21,7P22,8Q23,AFFYMETRIX,BOTH,CHB,CHINA,CHINESE,CYP2C,DNAS,ESCC,GPT2,HENAN,HIGH,HOWEVER,IBD,PAIRING,PLCE1,PLINK,SIAH1,SNP,SNPS,WORLDWIDE
A549,BACKGROUND,CCK8,CONCLUSION,CXCR4,EMT,FINALLY,GEFITINIB,HFL,LABEL,METHODS,MMP2,NON,NSCLC,PCR,RESULTS,WESTERN
131,177,945,946,AFTER,ANTI,BACKGROUND,CONCLUSION,DD3,H446,HOWEVER,KUNMING,LABEL,METHODS,MONOCLONAL,NCI,RESULTS,SCLC,SIMILARLY,SUCCESSFUL,THEN,THEREBY
169,2014,BRITAIN,COPYRIGHT,GREAT,IRELAND,JOHN,LTD,PUBLISHED,RAS,RASG12D,SOCIETY,SONS,THUS,WILEY
001,040,100,104,147,1993,2002,8810,ACCORDING,AIS,ATS,BAC,BACKGROUND,ERS,IASLC,JANUARY,KI67,LABEL,MEDICAL,METHODS,MIA,OSAKA,RESULTS,UNIVERSITY,VIA
169,2014,649,COPYRIGHT,GIS,LTD,USING
945,A549,AKT,HOWEVER,NSCLC,PI3K,THESE,TLR4,TNF,TOLL
106,2004,2008,ACS,CYTOLOGIC,DIAGNOSTIC,HOWEVER,IHC,NOS,NSCLC,ROSE,SQCC
169,2014,AUTHORS,BISULPHITE,CDH1,CHROMATIN,FOUNDATION,H460,JOHN,JOURNAL,LTD,MOLECULAR,RUNX3,SONS,SOX2,THESE,WILEY
2013,ATS,BOARD,CHEST,COLLEGE,FOUNDATION,III,OCTOBER,PHYSICIANS,SOCIETY
169,1999,2009,2014,672,BACKGROUND,COX,DATA,GROUP,INC,JULY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SARCOMA,SSG,WILEY
160,ALK,AP26113,EGFR,EPIDERMAL,HISTOLOGY,III,MET,NSCLC,ROS1,TKI,TKIS,TREATMENT
160,D95
169,2014,COPYRIGHT,INC,OVERALL
100,131,99M,BECAUSE,BOTH,DTC,FIFTY,LABEL,METHODS,OBJECTIVE,OVERALL,PRE,RESULTS,SPECT,WBS
169,183,200,2014,671,681,751,871,COMMITTEE,CONCLUSION,DATA,FURTHER,IGF,III,IIIB,LABEL,METHODS,MONITORING,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SAES,SOCIETY,TREATMENT
105,169,2014,BACKGROUND,CEA,CONCLUSION,COX,INC,LABEL,METHODS,NSCLC,RESULTS,STUDENT,SYSTEMATIC,WILEY
177,181,A549,BAX,CASPASE,CCK,CELL,CHINESE,DAN,HOWEVER,IC50,IIA,JNK,KIT,MMP,NSCLC,SHEN,TAKEN,TANSHINONE,TSIIA
169,2014,510,ALK,AMONG,BACKGROUND,EGFR,FISH,INC,KRAS,LABEL,METHODS,NSCLC,PNA,RESULTS,SEVEN,WILEY
169,1996,2011,2014,BACKGROUND,BETWEEN,DFS,INC,LABEL,LATE,MALIGNANT,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,THERE,WILEY
106,124,169,176,2014,813,948,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,DISRUPT,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,PFS,RESULTS
169,2014,BRAF,COPYRIGHT,DUE,IRELAND,LTD,NSCLC,SOMATIC,V600E
169,2014,A549,ADC,ALSO,CONCLUSION,COPYRIGHT,H1688,H2170,H69,H69AR,IRELAND,JAK3,LABEL,LTD,METHODS,NICD,NOTCH,NSCLC,OBJECTIVE,OBJECTIVES,RAG2,RESULTS,SBC,SCC,SCLC
169,2013
169,2013
169,2013,STATE
169,2013
169,2013,PULMONARY
169,2013,CARDIAC
169,2013,PRIMARY,THESE
001,005,650,750,CONJUGATED,DYLIGHT,HOWEVER,NEAR,NIR,PEGYLATED,PEGYLATION,SERUM,THESE
0069,014,2003,2010,967,CRS,DIFFUSE,HIPEC,MARCH,MEAN,MEIER,STUDENT,THERE
1130,169,2006,2014,4T1,946,ALK5,BALB,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LTD,MMP,MMTV,MOON,NEU,SMAD2,TGF
169,2014,ALECTINIB,ALK,CH5424802,COPYRIGHT,EML4,IRELAND,LTD,NSCLC,THESE
177,BACKGROUND,CD4,LABEL,LUNG,MALIGNANT,METHODS,MPE,PLEURAL,RESULTS
026,044,048,373,410,CMV,GVHD,HSCT,NRM,SCT,UCBT
BACKGROUND,EGFR,ELISA,HER2,JIMT,LABEL,METHODS,RESULTS,SRC,THESE,WESTERN
GSK3,INC,NRF2,PLK2,POLO,PUBLISHED,THUS
BRAGG,FURTHER,HOWEVER
GAMMA,GKRS,KARNOFSKY,KNIFE,KPS,LOCAL,POST,WBRT
001,002,004,015,027,MACROPHAGE,MEIER,PRIMARY,QUALIFIED,TAKEN,YES
BACKGROUND,BECAUSE,CASE,CONCLUSION,FETAL,LABEL,METHODS
2012,ALZHEIMER,DRUGS,JAPAN,UNDER
BACKGROUND,CELL,CONCLUSION,FOXO,FOXO4,LABEL,METHODS,PCR,RESULTS,WESTERN
0268,0495,114,1504,160,2002,2012,2611,2662,5545,8201,BACKGROUND,DFS,JULY,JUNE,LABEL,LOCAL,METHODS,NSCLC,RESULTS,VATS,VIDEO
BACKGROUND,CASE,CONCLUSION,DOCETAXEL,LABEL,METHODS
4T1,BACKGROUND,BALB,CONCLUSION,CSF,CXCR7,FURTHER,IDC,LABEL,MCSF,METHODS,MMP,RESULTS,STAT3,THESE,VCAM
BACKGROUND,CASE,HOWEVER,LABEL,METHODS,PULMONARY,RIGHT
BACKGROUND,DUSP3,EGFR,ERK,ERK1,FGF,FITC,HOWEVER,JNK,JNK1,LABEL,LLC,PKC,RELATED,RESULTS,SINCE,THUS,USING,VHR
16TH,HOWEVER,PRIMARY
00001,0001,1994,2013,720,8804,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS,T1A,THERE
100,BACKGROUND,BRAF,CD45,CELLSEARCH,CHIP,CTCS,EGFR,EPCAM,KRAS,LABEL,METHODS,RESULTS,SAMPLES,SORT,SPIKE,USING
120,160,177,8201,ANATOMICAL,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,VATS
BACKGROUND,BARR,CASE,CAUCASIAN,EPSTEIN,III,LABEL,METHODS,RITUXIMAB
BASED,BIOLOGICAL,EAR,EFFECTS,ERR,HCC,IMRT,LABEL,LAR,METHODS,OBJECTIVE,OED,OEDS,PURPOSE,RADIATION,RESULTS,TOMO,TREATMENTS,VII,VMAT
125,160,177,8201,CONCLUSION,GOLD,HAUNS,HOWEVER,LABEL,METHODS,OBJECTIVE,PEG,RESULTS
BACKGROUND,III,LABEL,LOCAL,METHODS,NSCLC,PET,PSPT,RBE,RESULTS,WORST
001,002,8201,ALDH1,BACKGROUND,CD133,FUNCTIONAL,HOWEVER,LABEL,NON,NSCLC,PCR,RESULTS,RNAS,TIC,TICS
041,100,113,172,ALK,CONCLUSION,HIPAA,IIIA,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,TEST
BACKGROUND,CASE,CAUCASIAN,CONCLUSION,GIVEN,HOWEVER,LABEL,METHODS,PULMONARY,WORLD
018,037,119,215,217,8201,ALK,BACKGROUND,CONCLUSION,EGFR,LABEL,METHODS,NODULAR,PATHOLOGY,RESULTS
177,BACKGROUND,BSC,LABEL,METHODS,MPE,OBJECTIVE,POOR,RESULTS,SIDE,SUCCESSFUL,TIME,TPS
945,946,954,A549,BACKGROUND,CHINESE,CTX,FEI,FLP,LABEL,LEWIS,LIU,LUNG,METHODS,MMP2,MMP9,PING,RESULTS,THERE,TNF,UPON
002,005,026,048,2004,2012,8805,ADX,BACKGROUND,COX,LABEL,METASTASES,METHODS,RESULTS,RFS
124,523,ALK,ARIZONA,BACKGROUND,CALIFORNIA,CONTEXT,D5F3,DIEGO,ECHINODERM,EGFR,EML4,FISH,IHC,KRAS,LABEL,MASSARRAY,MEDICAL,METHODS,NSCLC,OBJECTIVE,RESULTS,SAN,SYSTEMS,VENTANA
177,8201,BACKGROUND,BOTH,DUE,GTV,GTVS,HOWEVER,ITV2,ITVS,ITVSLOW,LABEL,METHODS,RESULTS,SBRT,THERE,THREE,VOLUMETRIC
001,006,177,190,531,BACKGROUND,FDG,LABEL,METHODS,PET,RCC,RESULTS,THERE,TKI,TKIS
CONCLUSION,GOT1,HOWEVER,INTER,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SGR
160,956,BACKGROUND,CD133HIGH,CD24LOW,CHRONIC,CNT,CSC,LABEL,METHODS,NANOG,NON,RESULTS,SOX,SWCNT,THESE,THUS
231,300,BACKGROUND,CLINICALLY,DOWN,ECTOPIC,EMT,EPITHELIAL,HNSCC,LABEL,MCF,MDA,METHODS,MIR,PCR,RESULTS,TGF,TWIST,UTR
ALK,BACKGROUND,CASE,CHEST,CHINA,CHINESE,CONCLUSION,DRUG,EML4,FOOD,LABEL,METHODS,ONCE,RAS,REMARKABLY
2013,BACKGROUND,LABEL,LAM,LAMPOSIUM,METHODS,OBJECTIVE,RESULTS,SHORTNESS,WOMEN
145,229,260,AMONG,ARRHYTHMIC,BACKGROUND,CONFIDENCE,CVD,DISEASE,END,FURTHER,INTERVALS,LABEL,METHODS,NON,ODDS,PACE,PREDICTORS,PRIOR,RATIO,RENAL,RESULTS,STAGE,UNIVARIATE
BACKGROUND,DDR2,DISCOIDIN,EXPRESSION,G531V,LABEL,LUNG,METHODS,MMP,MMP2,MTT,NSCLC,PCR,PROTEIN,RESULTS,S131C,SCC,STUDENT,T681I,THESE
A549,BACKGROUND,D90,GFP,LABEL,LUNG,METHODS,NDV,NEWCASTLE,PREVIOUSLY,RESULTS
001,002,008,017,023,029,034,035,037,175,185,8201,BACKGROUND,ICU,LABEL,LEA,METHODS,RESULTS,TEA,TOTAL,VAS
1CM,2003,215,ACCORDING,BACKGROUND,CASE,CAUCASIAN,CLINICIANS,GLEASON,LABEL,METHODS,MOST,SIX,SKIN,SMALL,THERE
160,200,BACKGROUND,CELL,DRUG,EARLIER,EDU,GAS5,LABEL,MALIGNANT,METHODS,MPM,PCR,PI3K,PRIMARY,RESULTS,RNAS,SILENCING,ZL55SPT
160,HOWEVER,LOCAL,PARTIAL
BACKGROUND,EQUATIONS,ERK,FGF,FGF2,FGFRS,FIBROBLAST,FRS2,H1703,HSGAG,LABEL,ODES,PSO,RAF,RAS,RESULTS,SWARM,USING
0026,0041,048,0508,136,175,2002,2011,214,8201,ATS,BACKGROUND,COX,EGFR,ERS,IASLC,LABEL,LUNG,MEIER,METHODS,RESULTS,SOCIETY,UNIVARIATE
169,225,ADC,ADCS,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,NON,NSCLC,RESULTS,SQC,SQCS,THEREFORE,THUS,UNASSIGNED,VIRTUAL
LOW
153,357,ACTIVATING,AFTER,BACKGROUND,CAUCASIANS,EGFR,FIFTY,HOWEVER,LABEL,MEDICINES,METHODS,NSCLC,RESULTS,TEN,TKI
BACKGROUND,BECAUSE,CARCINOID,CASE,CAUCASIAN,CONCLUSION,HOWEVER,LABEL,METASTASIS,METHODS,UNRESOLVED
BACKGROUND,CBX2,CNTNAP2,COX,DSS,LABEL,METHODS,MOLECULAR,OSCC,PREDICTIVE,RESULTS,TAKEN
048,BACKGROUND,CLINICS,DISCUSSION,LABEL,METHODS,NHS,REGISTERED,SECONDARY,SMOKING,TRIAL
ALDEFLUOR,ALDH,ALDH1A2,ALDH1A3,BACKGROUND,CD44,CIS,CSC,CSCS,DEAB,DRUG,H2052,H28,INDUCTION,LABEL,MESO4,METHODS,MPM,PCR,RESULTS
001,5915,BACKGROUND,LABEL,MANAGER,METHODS,RESULTS,THESE
004,177,230,400,437,455,501,580,625,652,689,8201,840,895,935,946,BACKGROUND,CONCLUSION,CORE,COX,HIGH,HRQOL,LABEL,LIFE,METHODS,NSCLC,QLQ,QOL,QUALITY,RESULTS,TREATMENT
956,ARSENIC,BACKGROUND,CURRENT,DATA,DISCUSSION,FOOD,LABEL,LITERATURE,SUMMARY,TIGHTER
ARSENIC,BACKGROUND,EMT,HCC,HOWEVER,LABEL,METHODS,MTT,NEITHER,RESULTS
BACKGROUND,CARDIAC,CONCLUSION,COPD,FEV1,FVC,GOLD,INCLUSION,LABEL,METHODS,RESULTS,THERE
8594,AKT,AMONG,BACKGROUND,CONCLUSION,DOSE,EGFR,ERK1,GEFITINIB,H292,HOWEVER,IC50,INDEX,LABEL,MARSDENIA,MET,METHODS,MTE,NON,NSCLC,PI3K,RESULTS,THEREFORE,THREE,WESTERN
BACKGROUND,BOTH,BRAIN,EGFR,HOWEVER,IMRT,INDEX,LABEL,METASTASES,METHODS,NSCLC,PRIOR,RESULTS,SCORE,SIB,SIR,SIX,THREE,TKI,WBRT,WHOLE
000,100,2010,2012,AGE,AMONG,BACKGROUND,CONCLUSION,DATA,EPI,EXCEL,GHANA,HISTOLOGY,HOUSING,INFO,KOMFO,LABEL,LABORATORY,LIVER,LUNG,METHODS,MICROSOFT,OVARY,PATHOLOGY,POPULATION,RATE,REGISTRIES,RESULTS,SOUTH,STOMACH,VERSION
024,025,126,168,174,8805,APEX1,CHINA,CHINESE,COX,FOUR,GENESKY,GROUP,HAN,INC,KARNOFSKY,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,THERAPY,THREE
946,BACKGROUND,CONCLUSION,EVEN,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,TGF,THEREFORE,THESE
BACKGROUND,CASE,CDX2,CONCLUSION,HOWEVER,LABEL,METHODS,THESE
867,BACKGROUND,COD,COMPARING,GRAY,LABEL,METHODS,MOST,NCD,PETO,RESULTS
047,180,210,390,8201,ACTIVATING,AFTER,AMONG,BACKGROUND,CHIP,CRC,DETECTION,EGFR,III,KRAS,LABEL,METHODS,NSCLC,RELAPSE,RESULTS,WENCA
108,BACKGROUND,BXPC,CCK,DGE,ERBB2,HOWEVER,INCREASING,LABEL,MEF2C,METHODS,MMP10,MUC4,PCR,PDAC,PDACS,RESULTS,SPSS,YANG,YIN,YY1
100,1000,150,ADX,EGFR,HRM,KRAS,NSCLC,PCR,RESULTS,SPACE
64CU,945,946,ACD10,BINDING,D10,FURTHER,HOWEVER,M10,MULTIMERIC,NSCLC,PET,RGDLATLRQL
0001,111IN,155,177LU,4180,BASED,DOSIMETRY,DTPA,DYNAMIC,GELOFUSIN,HER2POS,MBQ,MOST,MYC,NANOBODIES,RIT,SIMILAR,SMALLER,THREE
0005,001,011,017,947,CD4,FOXP3,IFN,IL17A,TH1,TH17
945,946,B16,CYTOKINES,KNOCKDOWN,LAL,LEWIS,LYSOSOMAL,MDSCS,MYELOID,THEREFORE
169,2004,2012,2014,590,ALBERTA,APRIL,BACKGROUND,COPYRIGHT,DISCHARGE,INC,LABEL,MARCH,METHODS,PUBLISHED,RESULTS,SEVEN,SEVERAL,SOCIETY,THUS,USING
100,176,600,8201,A549,DOE,ESI,GBD,HPLC,MEAN,MINITAB,MTT,OPTIMIZED,SEL,SEOA,SEP,THUS
169,2005,2012,2014,8805,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GRADE,INCLUDING,IRELAND,JANUARY,LABEL,LTD,MALIGNANT,MARCH,MATERIALS,MEIER,METHODS,MPM,PFS,RESULTS,SEVERAL
009,169,2014,281,CELLSEARCH,CONCLUSION,CONVERSELY,COPYRIGHT,CTC,CTCS,HARRELL,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,PREVIOUSLY,PRIMARY,RESULTS,SCLC
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
100,324,AFTER,ARDS
169,2014,215,995,99M,COPYRIGHT,FEV1,HOTELLING,HOWEVER,INC,LABEL,LUNG,METHODS,OBJECTIVE,PEARSON,PPS,PUBLISHED,RESULTS,SPECT,SURGERY,THESE
008,169,2014,367,562,860,CD16,CD25,CD29,CD3,CD56,CD8,COPYRIGHT,IIIB,NKTM,NSCLC,PBMCS,PRIMARY,TKI
ABVD,HODGKIN,HOWEVER,SPE

BOTH,GPA
BILIARY,PTTM,SRCC
112,159,166,2001,2012,296,BACKGROUND,COLORECTAL,CONCLUSION,DFI,LABEL,METHODS,PRECISE,RESULTS
PREVALENCE
169,2014,ERS,IPF,STRUCTURED,THREE,WHILE
169,2014,COPYRIGHT,CTLA,IRELAND,LTD,NSCLC
169,1769,183,1980,2006,2010,2013,2014,244,BACKGROUND,BECAUSE,BILL,BMI,COMPARABLE,COPYRIGHT,DALYS,FEDERATED,FOUNDATION,FUNDING,GATES,LABEL,LIBYA,LTD,MELINDA,METHODS,MICRONESIA,PREVALENCE,QATAR,RESULTS,SAMOA,SINCE,TONGA,UIS,WORLDWIDE
169,2014,700,956,ALLERGY,BACKGROUND,CD4,CD8,COLLEGE,CONCLUSION,COPYRIGHT,CVID,IGM,ILD,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS,THESE
ERK2,KRAS,MAPK,PTHLH,WHEREAS
000,200,8764,CDX,CDXS,CTC,CTCS,GENOMIC,MOST,SCLC,SMALL,THESE
001,015,028,034,145,8201,COX,FURTHER,HOWEVER,MEIER,OLC1,PCR,REAL,THESE,THUS
2013,529,676,AUC,CHINESE,DOR,LIBRARY,MEDLINE,MOLECULAR,NLR,PLR,SIMILAR,STATA
A2780,BAX,BCL,CELL,CHINESE,CIP1,FURTHER,HOWEVER,OVCAR,TRIPTOLIDE,WAF1,WESTERN
BASED,BORN,DUE,FINALLY,MRI,RESULTS,ULTRASOUND
1000,215,246,295,348,3Q28,861,BRCA2,CHEK2,GENOMES,ILE157THR,PROJECT,THESE,TP63
160,169,2015,ACADEMY,ADHERENCE,ALGORITHM,ASSESSMENT,BACKGROUND,CDS,COMPLETION,CONCLUSION,CONTEXT,COPYRIGHT,DEPRESSION,HOSPICE,INC,LABEL,MANAGEMENT,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RESULTS,SAMI,SYMPTOM
169,2014,946,COOH,COPYRIGHT,COSY,ESI,FIVE,H460,HMBC,HSQC,NIH,NMR,NUR77,ROESY,SAR,THEIR
0001,001,135,177,204,382,496,610,701,784,8201,867,BAF,ROC,SERUM,SIXTY
169,2014,AIS,BECAUSE,LINEAGE,MIA,NOTABLY
2008,2009,2538,ACUTE,APRIL,CARE,CAT,FIRST,ITEM,LABEL,MEASURE,METHODS,OBJECTIVE,POST,RESULTS,TEST,THEIR,THIRD,THREE
388,446,834,956,ARSENIC,BESIDES,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFT,PULMONARY,RESULTS,WEST
0009,183,1990,2005,339,380,8201,ACUTE,CONCLUSION,COPD,FEV1,FVC,GEORG,INCREASED,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,STUTTGART,UNIVERSITY,YORK
169,1976,2014,CIGARETTE,COPD,COPYRIGHT,ENGLISH,HOWEVER,MEDLINE,SOCIETY,STUDIES,THEREFORE
173,471,FIVE,MOST,NON,SSCF
CAPSAICIN,DEPLETION,ELISA,SCLC,SCLCS,STUDIES,TAKEN,TRPV,TRPV1,TRPV6
ACTIVATION,EARLY,III,NSCLC,PHASE,SEVERAL
AMONG,GAMMA,HOWEVER,KNIFE,LABEL,METHODS,NONE,NSCLC,OBJECTIVE,RESULTS,THESE,TYPE
160,169,2013,2014,2992,BIBW,COPYRIGHT,DRUG,EGFR,FOOD,III,JUNE,NSCLC,SAS,SEPTEMBER,SEVERAL,TKI
169,2013,BACKGROUND,BIOLOGICAL,CASE,COPYRIGHT,LABEL,LUNG,M1A,M1B,MANAGEMENT,METHODS,PUBLISHED,SAS,SPLF,STUDIES,TTF1
160,169,2003,2013,BACKGROUND,CONCLUSION,COPYRIGHT,GETTING,HOWEVER,LABEL,METHODS,NANCY,PLAN,PUBLISHED,RESULTS,SAS,SPLF,UNIVERSITY
BACKGROUND,BOTH,CARCINOIDS,CONTEXT,LABEL,OBJECTIVE,RESULTS,VHL
001,114,132,1522,169,1852,1998,2001,2002,2005,2006,2009,2011,2014,2182,2355,3655,3697,451,6389,671,827,8805,987,ASIAN,BACKGROUND,CALIFORNIA,CCR,COPYRIGHT,COX,CSS,FEWER,III,IRELAND,LABEL,LTD,METHODS,MOST,NON,NSCLC,OCTOBER,RESULTS,VARIABLES
100,5A4,ALK,ALK1,APART,BACKGROUND,BOTH,BREAK,CLONE,CONTEXT,D5F3,ECHINODERM,EML4,FISH,HOWEVER,IHC,LABEL,LSI,METHODS,NSCLC,OBJECTIVE,PCR,PROBE,RESULTS
DESPITE,LABEL,METHODS,OBJECTIVE,PDF,PDFS,PURPOSE,RESULTS
176,270,CBCT,HOUNSFIELD,HUS,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,UPRIGHT
BEST,BLD,DRP,DSC,FUZZY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,S3P,S4R,SPATIAL,THOSE
177,CARLO,DOSE,FIVE,LABEL,METHODS,MINI,MONTE,MRF,MRFS,OBJECTIVE,PTV,PURPOSE,RESULTS,RIDGE,THERE,TOPAS,USING,V20
177,300,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RLSP,RLSPS,VARIOUS,XCTN,XCTNS
119,176,CORP,EACH,FITCHBURG,IEC,IMRT,LABEL,LDVE,MAPCHECK2,MC2,MELBOURNE,METHODS,NUCLEAR,OBJECTIVE,PHILIPS,PURPOSE,RADIATION,RESULTS,SUN,SYSTEMS,USING,VMAT
BECAUSE,DMLC,IMRT,INTENSITY,LABEL,LINAC,METHODS,MLC,MRI,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIMILAR,STUDIES
1747,948,ABOVE,ALTO,CINE,EPID,IMAGE,LABEL,LAS,LOW,MEDICAL,METHODS,OBJECTIVE,PALO,PEARSON,PHANTOM,PURPOSE,RESULTS,SYSTEMS,VEGAS
169,2014,ANOTHER,COPYRIGHT,FCFM,LABEL,LBP,LQP,METHODS,OBJECTIVE,RESULTS,TOWARDS
001,016,026,062,066,169,2014,219,248,298,694,8804,AIM,AUC,COLLEGE,CONCLUSION,COPYRIGHT,FDG,LABEL,LTD,METHODS,NPV,NSCLC,OBJECTIVE,PET,PPV,PUBLISHED,RESULTS,ROC,ROYAL
2012,213,AIM,ASR,BEIDA,CONCLUSION,EASTERN,LABEL,LIBYA,METHODS,NORTH,OBJECTIVE,POTENTIAL,RESULTS
COLORECTAL,CRC,DESPITE,HOWEVER
BCSC,BCSCS,BOTH,KNOCKDOWN,L39,MLF2,RPL39,SELECTIVE,THESE
100,120,169,2014,256,CARLO,CONCLUSION,CTPA,HOWEVER,IMAGING,INC,LABEL,LPS,MATHEMATIC,METHODS,MOLECULAR,MONTE,NORMALIZED,NUCLEAR,RESULTS,SOCIETY,UNLABELLED
169,2014,BRM,BRMNULL,DIOSMIN,FLAVONOIDS,PRESS,PUBLISHED,RUTIN,THESE,UNIVERSITY
000,169,190,2000,2008,2014,420,538,809,875,AFTER,CKD,COPYRIGHT,ESRD,NEPHROLOGY,SOCIETY
169,1779,2014,286,359,404,613,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SELECTIVE,SURGERY,UNIVERSITY
169,2014,ACUTE,ATG7,G12D,KRAS,LABEL,NSCLC,PRIOR,RAS,TRP53,UNLABELLED
947,CPT,DOX,GLU,LTD,NCA,PEG,PUBLISHED,ROP
1200,1201,1286,15B,18A,29A,29B,29C,335,340,367,384,504,513C,576,763,8764,EIGHT,MEMBERS,MICRORNAS,RNAS,THUS
TOBACCO
A549,RAS,THESE
2013,APAI,BSMI,CAUCASIANS,HOWEVER,LIBRARY,SIX,TAQI,VDR
2000,2009,8804,939,ADJUSTING,DHS,HEART,INC,LABEL,METHODS,MODEL,MULTI,NDI,NON,OBJECTIVE,PUBLISHED,RESULTS,TEXAS,THERE
169,2014,AORN,COPYRIGHT,INC,PUBLISHED
169,1972,2014,COPYRIGHT,DATA,DESPITE,ENGLISH,FIGO,HPV,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SCCS,SMALL,SMCC,SMCCS
AKT,CANCEROUS,CIP2A,HOWEVER,NSCLC,PP2A
LUNG,MAJOR
DESPITE,HOWEVER,STILL,THROUGHOUT,THUS
169,2014,CAT,DCA,FINALLY,LABEL,PULL,RY4,SZETO,TAKEN,UNLABELLED
ADP,LAM,PARP,PARP1,PCR,TARGETING,TORIN,TSC2
0004,001,005,157,169,183,2006,2011,2014,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,SIXTY,SOCIETY
149,169,196,2014,332,403,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,IIIA,LABEL,METHODS,RESULTS,SAS,SURGERY,THERE
169,2014,COPYRIGHT,CUTANEOUS,SAS
CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ONCONEURAL,RESULTS
124,169,2014,BACKGROUND,CA15,CEA,COPYRIGHT,DESPITE,HOWEVER,LABEL,LTD,METHODS,PBC,RESULTS,SIXTEEN,THERE,TMS
ACTH,DETECTION,LUNGS
COPD,FURTHER,INC,PUBLISHED,PULMONARY
195,ECTOPIC,IGF1R,INSULIN,MICRORNAS,NSCLC,RNAS
FDG,PET,RIGHT
CNT,CNTS,FSCS
488,568,ALEXA,DESPITE,FLUOR,HER2,QDS
2005,2012,JUNE,MOST
103,200,MALDI,NSCLC,PAGE,SERUM,SEVERAL
CD4,FOLLOWING,HOWEVER,NOTABLY,PATHOGENIC,TH1,TH17,TH2,TREG,TREGS
0001,001,15489,169,2002,2009,2014,607,663,706,722,724,785,811,872,912,BACKGROUND,DATA,LABEL,LUNG,METHODS,NLST,PRESS,PUBLISHED,RESULTS,SCREENING,SMOKING,TRIAL,UNIVERSITY
2014,BMJ,GROUP,LTD,PRIOR,PUBLISHING,RHF
2014,BMJ,BOSNIAK,GROUP,III,LTD,PET,PUBLISHING
2014,8197,BMJ,GROUP,LTD,PUBLISHING,RCC,TKI
001,100,169,2014,EBUS,FDG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,POSITIVITY,PRESS,PUBLISHED,RESULTS,SURGERY,SUV,TBNA,UNIVERSITY
169,176,181,2014,8804,AFTERWARDS,CISPLATIN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SUBSEQUENT,SURGERY,UNDER,UNIVERSITY
169,2014,BIOLOGY,LUNG,MICRORNAS,RNAS,SOCIETY
169,2014,CRIZOTINIB,PRESS,PUBLISHED,SINCE,UNIVERSITY
FURTHER
160,AMPS,AVBD,GLRPKYS,GW13,HEPG2,HOWEVER,MRC,RWL,SEM,SEVERAL,THESE,THUS
105,177,2007,2011,726,798,8201,CHINA,CONFIDENCE,LUNG,MALIGNANT,MORTALITY,OVERALL,STOMACH,THERE,WASTEWATER
1M0,IIIA,T4N0,TNM
963,ATM,ATR,BRCA1,BUFALIN,CHAN,CHINESE,DAPI,DDR,H460,MDC1,MGMT,NCI,WESTERN
2008,2012,ARGENTINA,MULTILEVEL,SPATIAL,TOBACCO
160,8764,ABC,DMSO,HOWEVER,MCF,NSCLC,OTHER,SSM,VINCA,VLB
DISTANT,NON,NSCLC
148,2008,2010,2020,353,404,534,614,757,786,979,ASIA,ASIAN,BACKGROUND,CHILE,CHINA,CLUSTER,COMPONENT,EAST,HCA,INDIA,INDIANS,LABEL,MATERIALS,METHODS,NORTH,PCA,PEARSON,PRINCIPAL,RESULTS,SOUTH,USA
001,2013,320,572,8804,ALA,ALA133SER,BACKGROUND,BESIDES,BOTHFIXED,CAUCASIANS,CIS,LABEL,MATERIALS,META,METHODS,ORS,OVERALL,PUBLISHED,RAS,RASSF1A,RESULTS,SCIENCE,SER,THUS,WEB
149,269,335,SNPS,UTRS
2004,2011,206,AGE,BACKGROUND,BRAIN,FORTY,LABEL,MATERIALS,METHODS,OVERALL,RESULTS,THESE,WHOLE
010,017,055,153,947,COX,FIFTY,HIGH,HOWEVER,III,MEIER,NSCLC,THEREFORE
315,8805,BACKGROUND,CEA,EGFR,HENCE,LABEL,MATERIALS,METHODS,NSCLC,PCR,RESULTS,THERE,TKI
004,ADVERSE,DCR,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RESULTS
001,002,050,414,BACKGROUND,BIOLOGY,CHINA,CHINESE,ENGLISH,HOWEVER,LABEL,LIBRARY,MATERIALS,METHODS,NSCLC,PEMETREXED,RCTS,RESULTS,SIX,STATA12,THERE
001,449,512,8201,A549,CHINESE,H1299,HAN,NSCLC,PDCD6,PDCD6IP,TNM
001,002,004,128,8201,COX,MEIER,NSCLC,PCR,TNM,WESTERN
017,027,042,160,2004,2013,459,CONCLUSION,DISTANT,HIPAA,IHCC,III,IMAGING,IRB,KNOWLEDGE,LABEL,LUNGS,MATERIALS,METHODS,OBJECTIVE,RESULTS,THREE,TYPE
MMP,MMPS,WHILE
DESPITE,MECHANISMS,PATIENT,PTH,PTHRP
405,FEV1,FORTY,FVC,LABEL,METHODS,NSCLC,PULMONARY,RAPIDPOINT,RESULTS,SAO2,SIEMENS,UNLABELLED
AMONG,ASSESSMENT,ESAS,III,ILL,LABEL,MATERIALS,METHODS,NSCLC,PULMONARY,RESULTS,SYMPTOM,THESE,UNLABELLED
CD39,DESPITE,HOWEVER,NSCLC,REGULATORY,TAKEN,TREG
001,169,2014,CONCLUSION,FDG,FLT,IMAGING,INC,LABEL,LIVER,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SIXTY,SOCIETY,SUV,THESE,UNLABELLED
169,8805,AES,BACKGROUND,CONCLUSION,CRS,CURRENTLY,DCR,EGFR,ERBB,FORTY,FREQUENTLY,HEAVILY,IIIB,LABEL,METHODS,NSCLC,PFS,PRESS,PRS,RESULTS,SECONDARY
001,150,169,174,2013,8805,BASEL,DRUG,EGFR,FOOD,INC,L858R,MAY,MOLECULAR,NORTHBROOK,NSCLC,ORR,PFS,PRESS,ROCHE,SECONDARY,SYSTEMS,TARCEVA,TEST,THERE
169,2014,C000000143,CTR,DAYS,DOSE,GRADE,LABEL,LEVEL,METHODS,OBJECTIVE,PHASE,PRESS,PUBLISHED,RESULTS,UMIN,UNASSIGNED,UNIVERSITY
169,2014,445,701,FASTING,HOWEVER,LABEL,METHODS,MUSLIMS,OBJECTIVE,PRESS,PUBLISHED,RAMADAN,RESULTS,TURKISH,UNIVERSITY
169,2014,AUTHORS,PUBLISHED,RARRES3,THUS
000,169,1999,2006,2014,240,248,BACKGROUND,CONCLUSION,GENERAL,IRISH,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,RISK,SHS,SOCIETY,THERE,TOBACCO,UNIVERSITY
0001,0007,BACKGROUND,FIFTY,III,LABEL,LEVEL,METHODS,PULMONARY,RESULTS,THERE
947,ADP,BACKGROUND,CELLS,FANCG,FOUR,H2AX,HRR,LABEL,MASSIVELY,METHODS,MPE,MPES,NSCLC,PARP1,PARPI,PRIMARY,RAD51,RESULTS,RPA1
169,2014,AUTOMATED,AUTOMATIC,CBCT,COPYRIGHT,COX,EVALUATION,INC,LABEL,LARGE,MATERIALS,MEIER,METHODS,MOST,NSCLC,OBJECTIVE,PEARSON,PURPOSE,RESULTS
1005,169,181,2003,2006,2014,228,404,BETWEEN,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRONE,PURPOSE,RADIATION,RESULTS,SEVENTY,THERAPY,THERE
043,169,186,2002,2012,2014,8805,COOPERATE,COPYRIGHT,COX,DEFINITIVE,EASTERN,GROUP,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE,USING
EUS,FNA,FNAT,FNTA,GAUGE,NSCLC
177,BAC,EFS,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEM,THEN,WEIGERT
ANAPLASTIC,ATC,CISPLATIN,EPIRUBICIN,THEREFORE
134,158,313,BACKGROUND,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,TWITTER,WORDS
001,160,177,197,6HIS,8201,A549,ANTI,CARE,DEBEE,DIM,DOC,DOCETAXEL,ENDDS,EPHA2,EVALUATION,H1650,LABEL,METHODS,NANO,NDDS,OBJECTIVE,PCR,PEG2K,PRO,PURPOSE,RESULTS
169,2000,2013,2014,COPYRIGHT,DIAGNOSTIC,EDUCATION,ENGLISH,FOUNDATION,HIGH,IDIOPATHIC,INC,IPF,JANUARY,MAYO,MEDICAL,PUBLISHED,THUS
151,A549,CD45,CTC,CTCS,EMT,EPCAM,HGF,IHC,NSCLC,PCR,RECURRENCE,TOTAL

945,954,A549,ADP,BESIDES,COX,CREBANINE,TAKEN,TNF,VEGF
160,169,183,215,8197,CONCLUSION,DIPNECH,GEORG,GIVEN,HISTORY,LABEL,METHODS,SINCE,STUTTGART,TREATMENT,YORK
0001,161,169,2014,388,773,FIVE,FURTHER,IIIB,NSCLC,OVERALL,THESE,UICC
043,169,2003,2007,2014,CASES,CNB,CONSENSUS,DIAGNOSIS,INC,MEDICAL,TFNA,WILEY
100,107,18F,2008,2009,BETWEEN,CONCLUSION,DUAL,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS
169,2014,429,A549,COPYRIGHT,INC,LUNG,MICRORNAS,NSCLC,PTEN,RNAS,TAKEN,TIMP2
0001,0003,100TH,121,169,2014,75TH,COPYRIGHT,FURTHER,INC
000,169,2014,B7H1,CD8,IHC,PCR,PD1,PDL1,PROGRAMMED,STUDENT,THEREFORE,TIL,TILS,TOTAL
169,2014,BOTH,EGFR,IHC,KRAS,MAGE,NON,NSCLC,WHEREAS
169,1818,1897,2014,ASSOCIATES,COPYRIGHT,FINALLY,LTD,PUBLISHED,THEREFORE
169,2014,COPYRIGHT,FGF10,MSC,MSCS,OCT3,SOCIETY,SOX2
100,2010,2012,8804,CBCT,JANUARY,LABEL,MATERIALS,METHODS,NPV,OBJECTIVE,PPV,PURPOSE,RESULTS,TECHNICAL,XPERGUIDE
169,2014,ALGORITHMS,ANOTHER,BMJ,FURTHER,GROUP,LTD,PUBLISHING,SCREENING,SUFFICIENT
8201,A459,DRUG,FDA,MCF7,NANOFIBRE,PCL,RELEASE
BACKGROUND,CBX7,CONCLUSION,EGR1,FINALLY,FOS,FOSB,LABEL,METHODS,PCR,RESULTS,SPP1
PULMONARY,THESE,WHILE
1990S,1993,1996,1997,2000,2001,2004,2007,BACKGROUND,CHANGES,CONCLUSION,CONTROL,JAPAN,LABEL,METHODS,OSAKA,OVERALL,PREFECTURE,PROGRAM,RESULTS
MACINTOSH,THERE,UNDER
DESPITE,EXCESSIVE,HOWEVER
169,2014,8805,ACUTE,ADAPTED,DAYS,DISEASE,GRADE,III,IIIA,IIIB,JAPAN,LATE,NONE,NSCLC,PBT,PHASE,PRESS,PUBLISHED,RADIATION,RBE,SIX,SOCIETY,STAGE,UNIVERSITY
HOUNTIS,INTENSITY,NSCLC,S100
0003,001,002,177,MALIGNANT,SY5Y,THESE
001,169,1988,1997,1998,2007,2014,474,713,8201,978,AFRICAN,AFTER,AMERICANS,BACKGROUND,END,FINE,GRAY,LABEL,METHODS,RACE,RESULTS,SOCIETY,THESE
100,120,169,1992,2005,2014,3852,958,BACKGROUND,END,HNSCC,LABEL,METHODS,RESULTS,ROUTINE,SEER,SOCIETY,SPM,SURVIVORS,THERE
01A,169,183,2014,33258,956,AIM,CELL,CHINA,CONCLUSION,COPYRIGHT,FURTHER,HOCHEST,IC50,LABEL,METHODS,MTT,OBJECTIVE,PUBLISHED,RESULTS,SPC,UNIVERSITY
169,2014,AKT,COPYRIGHT,EGFR,INC,NSCLC,PI3K,SEVERAL,THESE,WHILE
001,006,020,026,1420,169,2014,967,COCHRAN,COPYRIGHT,EXPRESSION,GTPASES,IRELAND,KRAS,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RAL,RALA,RALB,RESULTS,SINCE,THERE,WESTERN
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,FFPE,IRELAND,LABEL,LTD,MATERIALS,METHODS,MICRORNAS,OBJECTIVE,OBJECTIVES,RESULTS,RNAS,TET
100,169,2014,AIM,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LESIONS,LTD,MATERIALS,METHODS,MIBG,MRI,OBJECTIVE,PARAMETERS,PET,PUBLISHED,RESULTS,ROYAL,SRCT,STIR
293FT,947,CD3,CD31,CD4,CD68,CD8,IFN,LEWIS,RESULTS,VSIG4
169,2014,AMP,JOHN,LTD,METFORMIN,PUBLISHED,SONS,THESE,WILEY
169,2014,231,B16,COPYRIGHT,F10,FURTHER,HOWEVER,INC,MDA,NEOPLASIA,ORAL,PC3M,PRESS,PUBLISHED,THESE
119,956,A549,ACHN,IC50,K562,NEAU,THEIR,THREE
169,2014,INC,PUBLISHED,THERE,THEREFORE
OPTICAL,VOC,VOCS
169,1963,2014,ASIAN,FOGARTY,HOWEVER,LESS,PACIFIC,SOCIETY
169,2014,ACUTE,AHA,AHTR,ALR,ANR,ASSOCIATED,AVWS,COPYRIGHT,DIC,DISEASE,FEBRILE,FFP,FNHTR,FRESH,GRAFT,GVHD,HEMOLYTIC,HOST,LTD,LUNG,NON,OTHER,PLATELETS,REACTIONS,RELATED,THEREFORE,TRALI,TRASFUSION,TTB,WILLEBRAND
160,ADDITIONAL,CANDIDATE,CO2
169,2014,945,946,956,A549,COPYRIGHT,IC50,THEIR
0007,001,120,140,150,155,169,2014,309,349,469,531,540,608,695,AMONG,ORS,SYNERGY,THERE,UICC
001,013,014,017,039,945,EBC,IIA,NSCLC,TNF,VEGF
BOTH,HOWEVER,IRON,TARGETING,THEREFORE
001,002,003,014,018,020,027,COX,DFS,IIIA,NSCLC,PRE
274,988,CHINESE,CLPTM1L,HOWEVER,TERT
BACKGROUND,CHINA,CHINESE,DISCUSSION,ELDERLY,EORTC,IDENTIFIER,III,LABEL,LC43,LONGHUA,MEANWHILE,METHODS,NSCLC,PFS,QLQ,RESULTS,SEVENTY,TCM,TRIAL
CELL,HENCE,HYPOXIC,LUNG,VOCS
169,183,200,2014,722,947,COPYRIGHT,D50,D98,DVH,IMRT,IRELAND,LABEL,LESS,LTD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,USING,VMAT
169,2014,BBB,BRAIN,COPYRIGHT,CURRENTLY,EGFR,IRELAND,LTD,NSCLC,TKI,TKIS,WOULD
169,2014,BOTH,CHRONIC,COPD,COPYRIGHT,DISEASE,GPS,HOWEVER,LTD,PULMONARY
169,2014,239,APC,ATTACKING,CASC1,KRAS,NON,NOTABLY,NSCLC,RNAI
169,2014,CPG,CSS,GISTS,KIT,PGL,PGLS,SDH,SDHB,SDHC,SOCIETY,STRATAKIS
ALK,BIOMARKER,DAVID,DEGS,EGFR,EZH2,FUNCTIONAL,ICT1,KRAS,MCL,NETWORK,THEN,THEREFORE,THESE,TK1
2014,CHINA,CNKI,GIVEN,KNOWLEDGE,MARCH,ROC,SPNS,SUMMARY
000,414,BACKGROUND,BRONCHITIS,FALLS,INCIDENCE,IRS,LABEL,METHODS,MOST,RATES,RESULTS,UNLABELLED,USING,WOMEN
000,001,100,110,160,169,1958,1970,2007,2010,2014,221,508,800,8804,956,BACKGROUND,CHILE,CONCLUSION,LABEL,LUNG,METHODS,ORS,RESULTS
174,177,2008,2009,8201,COX,ERCC1,IIIB,JANUARY,MASSARRAY,NSCLC,SNPS
2011,2012,2014,239,ALK,APART,BREAK,DRUG,EMA,FDA,FISH,FOOD,GIVEN,III,JANUARY,KIT,MEDICINES,NSCLC,PROBE,VYSIS
160,231,8209,954,AKT,COX,MDA,MMP,PI3K,THEREFORE
ARHGDIA,FUNCTIONAL,GTPASES,HCC,LOW,RAC1,RHO,RHOA,TTR
160,169,2014,ASSOCIATES,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,FDG,FNAB,FOLLOWING,HOWEVER,LABEL,LTD,METHODS,PUBLISHED,SCLC,SFTP,SMALL,SURGERY,SUV,THEN
119,169,2005,2013,2014,CHINA,CHINESE,COPYRIGHT,COS,CRYO,DIAGNOSIS,DOS,INC,OVERALL,PRESENTLY,TCM,THUS
160,174,377,986,COX,FINE,GRAY,RADON,SMR
A549,BECAUSE,MCF,MDR,THESE
178,BACKGROUND,BCL,CONCLUSION,CRA,DESPITE,LABEL,METHODS,PBMCS,PFS,RESULTS,SCLC,THERE,TREATMENT
1DDD,8804,AMONG,BASIC,PPI,PPIS,THERE
100,1080,956,A375,A549,AMONG,IC50S,THESE,VI5,VI7
160,8209,946,ACE,ACE2,ANG,ANGII,AT1R,EXPRESSION,HOS,MAS,MNNG,RAS,THESE
BASED,DESPITE,FAK,FAS,GEF,RAC1,RHO,SINCE,VAV2
8201,946,947,A549,ALZHEIMER,H460,NCI,NOTCH,PS2,STAT3,TAKEN,THEREFORE
169,2014,954,A549,AUTHORS,COPYRIGHT,H1299,HRP,INC,MYC,NOXA,NRF2,PUBLISHED,PUMA,ROS,SUBSEQUENT
BASED,BMICS,BMS,BRAIN,BTICS,CSCS,DESPITE,EVEN,LACK,SIMILAR,THESE,TIC
169,19DEL,2014,ADDITIONAL,AFTER,ALK,BRAF,COPYRIGHT,E542K,EGFR,G12D,G12V,ION,IRELAND,KRAS,L858R,LABEL,LTD,METHODS,NGS,NSLAS,OBJECTIVE,PCR,PURPOSE,RESULTS,RET,ROS1,TKI,TKIS,TORRENT
169,177,2014,3DCRT,BECAUSE,COPYRIGHT,DOSIMETRIC,HOWEVER,IMRT,INC,MEDICAL,OAR,PTV,PUBLISHED,TOMODIRECT,VMAT
169,2014,COPYRIGHT,HODGKIN,INC,MEDICAL,OWING,PRIOR,PUBLISHED,UNIVERSITY,WASHINGTON
0001,0022,148,169,2014,488,545,6573,7022,7408,9198,954,960,AIM,CALCULATED,CCC,COLLEGE,CONCLUSION,COPYRIGHT,IIIB,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PERCENT,PUBLISHED,RESULTS,ROYAL,USING
183,ASIA,COBB,DISCUSSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,RESULTS,SIXTEEN
169,1BR3,2014,55933,945,947,A549,AMPK,AT5,ATM,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,DSB,FACS,H2AX,H460,HOWEVER,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,S1981,T172,WESTERN
169,2014,BASED,CELL,COPYRIGHT,CRC,HCT,KDS,LOVO,LTD,SELEX,W14
150,177,319,COX,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SRS,THERE,THESE,WBRT
BOTH,CLINICIANS,III,LARGE,SUPPLEMENT,VITAMIN
11P15,16Q,COG,GROUP,PEDIATRIC,PROGNOSTIC,REMARKABLY,SIOP,SOCIETY,WHEREAS,WILMS
NON
ASPIRATOR,DIFFERENT,GIVEN,LIVER,PRINGLE,ULTRASONIC
ALCHEMIST,ALK,EGFR,INITIATIVE,INSTITUTE,LUNG,MATCH,NCI,NCTN,NETWORK,RESPONDERS,THESE
169,2014,COPYRIGHT,OPTIMUM,SOCIETY,THERAPY
BTB,PARP,POZ,RNAS,ROS,THEREFORE,ZBTB3,ZINC
160,169,2014,COPYRIGHT,INC,PROGNOSIS,PUBLISHED,RISK,SOCIETY,TREATMENT
125,169,2014,4T1,945,947,ASIAN,BESIDES,COPYRIGHT,GMBH,IFN,MMP,THESE,TNF
169,2014,CHOLINE,COPYRIGHT,LUNG,PARTIAL,PLS,THESE,TOF,UPLC
ADVERSE,ALK,CERITINIB,NSCLC,ONGOING,PHASE
169,2014,22R1,COPYRIGHT,LTD,THUS,WHILE
EVALUATION,THEREFORE,TREATMENT
169,1975,2005,2010,2014,AFTER,BACKGROUND,END,HOWEVER,LABEL,METHODS,PROGRAM,RESULTS
CYS,ROS
AMONG,III,LABEL,METHODS,MPLC,OBJECTIVE,RESULTS
366,946,BRCA1,COX,ERCC1,HOWEVER,III,NSCLC,RMM1,RRM1,TUBB2,TUBB3
BACKGROUND,FGFR1,LABEL,LUNG,NEXT,OBJECTIVE,SCC,SEVERAL
113,177,178,2010,2013,213,BACKGROUND,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,RESULTS,VATS,VIDEO
001,002,003,032,155,162,169,311,319,479,611,BACKGROUND,COX,DESPITE,FFPE,HIGH,III,LABEL,METHODS,MIR,NSCLC,OBJECTIVE,PCR,RESULTS,THERE,TOTAL
281,BACKGROUND,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
ANALYZE,BACKGROUND,LABEL,METHODS,MSCT,OBJECTIVE,RESULTS,THERE,THEREFORE
001,017,028,2006,2010,ACADEMY,AMONG,BACKGROUND,CHINESE,DEC,EGFR,GEFITINIB,INSTITUTE,JAN,LABEL,LUNG,MEDICAL,METHODS,OBJECTIVE,PFS,RESULTS,UNKNOWN
001,002,009,011,014,017,040,046,110,114,500,535,8804,8805,945,BACKGROUND,COX,DCR,EGFR,ELISA,ERLOTINIB,KREBS,LABEL,LDH,MEIER,METHODS,MMP,MOLECULAR,OBJECTIVE,ORR,PFS,RESULTS,SERUM,TGF,THESE,TPS
177,192,A549,AFTER,BACKGROUND,BIM,CISPLATIN,DDP,IC50,LABEL,METHODS,MIR,NSCLC,OBJECTIVE,PCR,RESULTS,UTR,WESTERN
100,946,A549,AFTER,AKT,BACKGROUND,EXOGENOUS,LABEL,LK2,METHODS,OBJECTIVE,PCR,RESULTS,SPC,VEGF,WESTERN
945,954,A549,BACKGROUND,BAMH,BOTH,BP65,ECOR,LABEL,METHODS,MTT,NUCLEAR,OBJECTIVE,PCR,RESULTS,TRANSWELL,WESTERN,XHO
954,A549,AFTER,APOPTOSIS,BACKGROUND,CISPLATIN,DDP,DUAL,IC50,IKBKB,IKK,LABEL,LUNG,METHODS,MTT,OBJECTIVE,PCR,RESULTS,THEREFORE
169,2014,CHINESE,CONCLUSION,COPYRIGHT,COX,HOWEVER,INDIVIDUAL,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SMRS,WHETHER
031,110,169,2014,237,443,474,CONCLUSION,COPYRIGHT,COX,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCLC
004,007,169,2014,916,CHANGES,CONCLUSION,COPYRIGHT,FDG,IRELAND,LABEL,LTD,METABOLIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PATHOLOGY,PET,PREDICTIVE,PTL,REMAINING,RESULTS,SST,SUV,TTL
100,951,956,A549,H2O,RH2,THESE
1998,2010,2011,729,730,820,8202,910,AMONG,BACKGROUND,CONCLUSION,COPD,FURTHER,HOWEVER,INSURANCE,LABEL,METHODS,RESULTS,T2DM,THEIR,THERE
001,004,0319,2007,2012,253,320,633,BEIJING,CHEST,CHINA,CHINESE,COX,DCR,ECOG,EGFR,JULY,ORR,OVERALL,PFS,THERE,TKI,TKIS
000,100,2011,ACCORDING,ACS,CGA,GEP,GERMANY,LUNG,NET,NETS,PRRT,SERUM,TCS,TNM,WORLD
BACKGROUND,CASE,CONCLUSION,EGFR,HOWEVER,LABEL,METHODS,NSCLC,TKI,TKIS
1000,169,2014,COPYRIGHT,CRP,DISCUSSION,HOWEVER,LTD
AID,IGG,INHIBITION,LUNG,METASTASIS,MTA1,RAG1,THESE
003,007,018,049,1022,169,183,2014,473,549,ALVEOLI,ARDS,ARMA,BACKGROUND,BLOOD,COPYRIGHT,FUNDING,HEART,INSTITUTE,INSTITUTES,LABEL,LTD,LUNG,METHODS,PEEP,RESULTS
063,2013,783,8202,ADP,ARG399GLN,ASIAN,BACKGROUND,CONCLUSION,HOWEVER,LABEL,PARP,POLY,PRINCIPAL,RESULTS,THESE,THUS,VAL762ALA,XRCC1
BACKGROUND,DIAGNOSTIC,LABEL,METHODS,NSCLC,PET,RESULTS,SABR,SPN
169,2014,847,ALPHA,ATBC,BETA,COLORECTAL,FINLAND,LEUKOCYTE,LUNG,ORS,OVARIAN,PLCO,PREVENTION,SCREENING,SWHS,TOCOPHEROL,TRIAL,WOMEN
001,192,AKT,CHIP,EZH2,FURTHER,H3K27,HOX,HOXB7,MAPK,NSCLC,PRC2,RNAS,THESE,TNM,TUG1,UNIVARIATE
169,2014,ALK,EML4,HOWEVER,INCREASED,NSCLC,SOCIETY
002,169,2014,BACKGROUND,CELL,E2M,LABEL,MEIER,METHODS,MLN4924,NAE,NAE1,NEDD8,NOXA,PRESS,PUBLISHED,RESULTS,RING,UBC12,UNIVERSITY
169,2014,961,BACKGROUND,CHANGES,CONTOURING,COPYRIGHT,CROWN,EUD,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,PLANS,PTV,PUBLISHED,PURPOSE,RESULTS,SEVEN,TCP,VOLUMES
169,2014,BASEL,GUIDELINES,IMAGE,LUNG,ULTRASOUND
169,2014,COPYRIGHT,NETWORK
169,19TH,2014,CONFERENCE,COPYRIGHT,GUIDELINES,HORN,LEORA,NCCN,NETWORK,NSCLC
0001,0367,329,BACKGROUND,FGFR,FGFR1,FISH,LABEL,METHODS,NSCLC,RESULTS,SCC,TMA,UICC
ADJUSTING,BACKGROUND,GENERAL,LABEL,LIFE,METHODS,NET,RESULTS,USING
196A2
169,2013,COPYRIGHT,HRCT,PUBLISHED,SOCIETY
0MGML,169,2014,30MG,945,946,AMONG,AMR,AMRUBICIN,BACKGROUND,CBDCA,COPYRIGHT,HOWEVER,LABEL,METHODS,NON,ORR,PFS,PUBLISHED,RESULTS,SCLC,SOCIETY
169,2008,2010,2013,415,BACKGROUND,CONCURRENT,COPYRIGHT,GRADE,HOWEVER,III,JANUARY,LABEL,METHODS,MST,NSCLC,PUBLISHED,RESULTS,SOCIETY
100,101,169,2004,2012,2013,780,BACKGROUND,EBUS,EXCLUDING,JUNE,LABEL,MARCH,MASSIVE,METHODS,OTHER,PUBLISHED,RAPID,RESULTS,ROSE,SCLC,SOCIETY,TBNA
18F,AIMS,BACKGROUND,FDG,LABEL,METASTASES,METHODS,OBJECTIVE,PET,RECURRENT,RESULTS
ASIAN,SUBSEQUENT
18F,18FDG,AFTER,CEA,EGFR,ERLOTINIB,GEFITINIB,HOWEVER,L858R,PET,THREE
ASIAN,BECAUSE,HCC,HCCS
100,2010,2011,ALDH1A1,BACKGROUND,BETWEEN,DETECTION,ELISA,LABEL,METHODS,NSCLC,RESULTS
2010,2012,ACADEMY,ADVERSE,AIMS,ASSESSMENT,BACKGROUND,BETWEEN,DEPARTMENT,EVALUATION,GULHANE,JUNE,LABEL,MEDICAL,METHODS,OBJECTIVE,RADIATION,RESULTS,SOLID
002,005,007,158,171,173,248,296,AIMS,BACKGROUND,BOTH,FREE,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,V10,V20
087,1080,1984,2008,248,295,326,444,567,575,5981,634,685,785,922,967,AFTER,BACKGROUND,CAUSE,CVD,DATA,LABEL,METHODS,NORD,NORWEGIAN,RESULTS,SELF
148,BACKGROUND,CASES,FURTHER,GSTM1,GSTT1,LABEL,METHODS,RADON,RESULTS,SEVEN,SIMILAR,THESE
345,828,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POTENTIAL,RESULTS
190,537,745,8201,MCF,MCL1,SNPS
338,8201,ATP7B,CHINESE,FOUR,HAN,SNPS
EVEN,MULTIMODAL,PULMONARY
18FDG,PET
AHL,MUCA,PQS,THESE,VFR
8230,III,PHASE
169,2014,947,COPYRIGHT,GCN5,HDAC,HDACS,HIGH,IIA,MYC,REPORTS,YY1
8202,8805,BRG1,BRM,EGFR,FDG,KRAS,LABEL,MET,OBJECTIVE,PURPOSE,RADIOLOGIC,RESULTS,SEVERAL,SUMMARY
BACKGROUND,CASE,CONCLUSION,HHV,LABEL,METHODS
002,013,023,026,132,8201,8805,CEA,CONCLUSION,EGFR,FDG,FURTHER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,ROC
HOWEVER
000,101,143,AUC,BASED,CONCLUSION,GGN,GGO,GROUP,IAC,LABEL,METHODS,MIA,OBJECTIVE,RESULTS,ROC,SPSS,THEN,THROUGH
HBO2,HOWEVER,INCREASED,THEREFORE
001,016,095,169,2014,312,328,ALK,BAG4,BRAF,EGFR,FGFR,FGFR1,FGFR2,FGFR3,HER2,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,RET,ROS1,SIX,TACC3
101,169,2014,945,AZD2171,CONCLUSION,E2F3,EZH2,HIF1,LABEL,METHODS,OBJECTIVE,PARP,PURPOSE,RESULTS,VEGF,VEGFR
2014,BMJ,GROUP,LTD,PUBLISHING
AREAS,BACKGROUND,CHRONIC,COPD,COVERED,EPIGENETIC,LABEL,METHODS,OPINION
BCS,DOTA,FDG,NOC,PET,PULMONARY,TATE,TOC
169,18F,2014,COPYRIGHT,FDG,JOHN,LTD,PET,SONS,WILEY
100,239,53BP1,800,ADVERSE,AMONG,AMUVATINIB,CONCLUSION,DOSE,FIVE,FORTY,KIT,LABEL,METHODS,MTD,NSCLC,OBJECTIVE,PURPOSE,RAD51,RESULTS,SCLC
100,150,215,A549,ALP,C57BL,CONCLUSION,FORTY,FOUR,LABEL,METHODS,OBJECTIVE,RESULTS
1640,95D,A459,A549,AUTOPHAGY,BECLIN1,CONCLUSION,EARLE,EBSS,LABEL,LC3,MDC,METHODS,OBJECTIVE,RESULTS,THESE,WESTERN
EGF,EGFR,ERK,ERK1,IQGAP,THESE
160,169,2014,956,A549,AMONG,AMPICILLIN,COPYRIGHT,DU145,HOWEVER,HT29,NMR,SAS,SKOV3
COPD,TRUE
120,169,177,2014,ATPS,CONCLUSION,COPYRIGHT,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
169,2014,4718,COPYRIGHT,CSCS,DISRUPTION,ECM,FAK,MPM,NF2,SCIENCE,THESE,WHEREAS
BACKGROUND,BAFF,BAL,CCL19,CCL21,CHRONIC,DESPITE,EXPRESSION,LABEL,METHODS,MICE,RESULTS
169,2005,2010,2014,326,AUTHORITY,DISTRICTS,ENGLAND,LOCAL,LUNG,MOTIVATED
260,ERK,FINALLY,HOWEVER,KMT,KMTS,MAP,MEK,MYND,PP2A,RAF,RAS,SET,SMYD3,USING
A549,AKT,CDK2,H1299,INHIBITION,NSCLC,OVERALL,PEMETREXED,PI3K,PREVIOUSLY,THESE,TREATMENT
121,351,APC,CDX2,CRC,CRCS,EIF3E,FINALLY,PCR,PTPRK,RSPO,RSPO2,RSPO3,THESE
AFTERWARDS
CHOROIDAL,EARLY,OVERALL
169,2014,517A,95C,95D,AIMS,ALTERED,COPYRIGHT,FOXJ3,INC,KEY,LABEL,MAIN,METHODS,MIR,OBJECTIVE,RESULTS
169,2014,ADDITIONAL,AWARENESS,CASES,CD117,CD30,CD31,CD34,COPYRIGHT,ERG,FLI1,HOWEVER,IHC,INC
AFTER,ALSO,BLOOD,CISPLATIN,CONCLUSION,GFR,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
169,2014,CMC,DOX,GMBH,KGAA,ME2MO,OEGYLATED,TOWARDS,VCH,WILEY
169,2014,COPYRIGHT,CSCS,CSLCS,DRUG,H460,HCBP,IRELAND,LTD,SCREENING,SUCCESSFUL,THUS
101,2006,2013,680,ADC,AIS,AUC,GGNS,JULY,LABEL,METHODS,MIA,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,ROC
155,169,2014,2YRS,AREA,AUC,AUCS,BACKGROUND,COMPARABLE,COMPARISON,CONCLUSION,COPYRIGHT,CURVE,DPH,DPN,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,SHOWING,SUPPORT,SYSTEMS,THESE,UNDER
114,16063,MICRORNAS,RNAS,RRSM,THESE
DESPITE,DRUG,MICRORNAS,NSCLC,RNAS,THEREFORE
006,1007,122,182,2009,2012,260,275,318,466,733,8201,ACTIONABLE,AKT1,ALK,AMONG,BACKGROUND,BRAF,CONSORTIUM,EGFR,ERBB2,HER2,IDENTIFIER,IMPORTANCE,IQR,KRAS,LABEL,LUNG,MAIN,MEK1,MET,METHODS,NRAS,OBJECTIVE,OBJECTIVES,RELEVANCE,RESULTS,SETTING,TARGETING,TRIAL
169,2014,CYTOMETRY,FIRST,FTIR,HOWEVER,PCA,PRINCIPAL,SOCIETY
0305,DESPITE,GGN,LABEL,LIMITED,METHODS,OBJECTIVE,PURPOSE,REGARDING,RESULTS,SOLID
0132,150,8805,ACCORDING,EGFR,EORTC,EVALUATION,FDG,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RADIOLOGIC,RESULTS,SIXTY,SOLID,SUV,THREE,TKI,TREATMENT
169,2014,ATO,COPYRIGHT,DRP1,FIS1,INC
169,2014,946,ASSOCIATED,B16,COPYRIGHT,ECM,INC,LAMP1,PROTEIN
157,169,2014,296,COX,EPIC,HOWEVER,NUTRITION,PAH,PRESS,PUBLISHED,SPANISH,THERE,UNIVERSITY
CHINESE,FINALLY,HOWEVER,MAPK,NSCLC,SNL,SOLANUM,STAT3
2013,CAUCASIAN,DRC,FURTHER,GLN,LYS,META,OCTOBER,ODDS,REDUCED,XERODERMA,XPD
000,169,2014,COPYRIGHT,DATA,DICOM,ELECTRICAL,GSCS,LTD,NOVI,SAD,VOJVODINA
131,169,2014,8201,8805,BACKGROUND,INVENTORY,LABEL,METHODS,ORR,PFS,QUALITY,RESULTS,SECONDARY,SOCIETY,SYMPTOM
DIET,FURTHER,HOWEVER,METABOLIC,OBESE,RICO,THESE
169,2008,2011,2014,243,BRITISH,COPYRIGHT,INFECTION,IPA,IQR,LABEL,LTD,METHODS,NINE,OBJECTIVE,OBJECTIVES,ONCE,PRIMARY,PUBLISHED,RESULTS,TEN
473,AKT,ATP,CAV,CDC42,DENDROBIUM,H292,H460,HACAT,LUNG,SER,THAI,WESTERN
000,029,169,2003,2006,2014,446,454,CONCLUSION,COPYRIGHT,COSTS,FEE,FFS,HMO,HMOS,HODGKIN,IMAGING,LABEL,MATERIALS,METHODS,MRI,NETWORK,NHL,OBJECTIVE,PET,PURPOSE,RATES,RESULTS,SOCIETY,THERE
2013,BOEHRINGER,CHEMICALLY,EGFR,GMBH,HER2,HER4,INGELHEIM,JULY,L858R,NSCLC,PRESENTLY,UNION,USA,USFDA
2013,945,PEMETREXED,TCELL,V1801,VARIOUS
174,181,480,BRAF,EGFR,FDA,KRAS,ROCHE,THESE
500,ALTERED,CHINESE,FURTHER,LABEL,LOW,LRP6,MASSARRAY,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCC,SNP,SNPS,WNT
169,1992,2010,2014,441,504,8201,BACKGROUND,CONVERSELY,END,LABEL,MEN,METHODS,PROGRAM,RESULTS,SEER,SIR,SIRBLADDER,SIRRECTAL,SOCIETY,THERE
169,1987,1990,1992,1993,1995,1996,1998,2006,2012,2014,470,610,8804,8805,BACKGROUND,CIS,COPYRIGHT,DATA,HOWEVER,INC,JOURNAL,LABEL,LUNG,METHODS,OBJECTIVE,PREVENTIVE,PROLONGED,PUBLISHED,PURPOSE,RESULTS,RISK,SMOKING,THERE
8209,947,ALK,CTL,CTLS,EML4,H2228,HLA,IFN,NINE,RLSALESRV,THESE
CD68,COX,PGE2,STUDIES,THESE,TREM,TRIGGERING
169,2014,638,COPYRIGHT,FEDERATION,HOWEVER,NSCLC,PUBLISHED,SILENCING,SOCIETIES,SOX2,UTR
197,AKT,ANNEXIN,ARQ,CELL,EGFR,ERK,ERK1,FINALLY,H1975,MEK,MET,MTT,PATHWAY,PI3K,T790M,THUS,TKI
146,COLD,EGFR,HRM,L858R,MEC,PCR,T790M,TKI,TKIS
160,8209,A549,ANNEXIN,COCL2,EGR,EGR1,HRE,INFECTION,MTT,PLASMID,SMAC,USING
495,578,CLUSTER,CPG,EVEN,FDR,FURTHER,GPX2,PATHWAY
100,307,5A4,ALK,FISH,IHC,THEREFORE
2014,BMJ,GROUP,LTD,PUBLISHING
2014,BMJ,GROUP,LTD,METASTASES,PUBLISHING,RENAL
2014,8197,AFTER,BMJ,GROUP,LTD,PUBLISHING,THESE
018,025,072,079,161,1ST,2ND,BACKGROUND,ECOG,EPITHELIAL,LABEL,MALIGNANT,METHODS,OVERALL,RESULTS
109,150,151,169,2009,2012,2014,CONCLUSION,EGFR,ERLOTINIB,IIIB,JULY,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY,SOCIETY
AURKA,BAX,BCL,H1688,H446,SCLC
169,2014,945,A549,ASIA,AUTHORS,CD31,E7820,EGFR,G12S,H1650,H1975,KRAS,L858R,LTD,MOST,NSCLC,PTEN,PTY,PUBLISHING,SCIENCE,T790M,TKI,TKIS,TREATMENT,TUNEL,WILEY
100,215,945,946,HISTOLOGIC,KERATIN,LABEL,LACC,METHODS,OBJECTIVE,PCR,RESULTS,SMA,WHETHER
BASED,DONOR

BACKGROUND,CASE,CONCLUSION,DELAYED,DUE,LABEL,LITERATURE,LUNG,METHODS
ASP,ASP312ASN,ASP312ASP,CDA,GLN,HOWEVER,LYS,LYS751GLN,NSCLC,THERE,THESE,TIME,TTP,XERODERMA,XPD
013,BXPC3,CD18,FINALLY,HENCE,HOWEVER,KRAS,OVERALL,PANCREATIC,PDAC,USING,USP9X
160,169,2014,219,292,304,651,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SIXTY,SOCIETY,SYSTEMATIC
160,1973,1991,1995,2006,2010,591,962,980,BACKGROUND,COX,END,HOWEVER,IQR,LABEL,MEIER,METHODS,MPM,OVERALL,RECEIPT,RESULTS
001,106,215,238,402,8202,BACKGROUND,BIOMEDICAL,CAREFULLY,CHINESE,CIS,CONCLUSION,CRUDE,ERCC1,FUNCTIONAL,HOWEVER,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,ORS,OVERALL,REMOVAL,RESULTS,SEVERAL,SIXTEEN
169,2014,A549,ASPC1,BIOLOGY,DUE,EGFR,FAB,GA201,IGF,IGG,INC,MOLECULAR,OASCFAB,R1507,SCID,SOCIETY,XGFR
100,181,840,945,ATP,BASED,E2F,HOWEVER,SNU
945,CK2,GST,L22,RPL22,RPS,TAP
160,8209,AKT,CELL,CURRENTLY,EGFR,MTT,NSCLC,PC9,SYNERGISM,TKI,TKIS
124,169,2014,8201,AIMS,BOTH,JOHN,LABEL,LTD,MDT,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SONS,THESE,WILEY
169,2014,2020,2030,HOWEVER,LUNG
AYURVEDIC,COX,CURCUMA,EAST,LOX,LUNG,MAPK,SEVENTY,STAT
123,169,2002,2008,2014,ADC,CAVITATION,COPYRIGHT,DIFFERENT,IMAGE,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREVALENCE,RESULTS,SQCC
100,135,160,8764,CD45,CTC,CTCS,HER2,PCR,WBCS

160,8209,NDRG2,THESE
108,169,2014,BOTH,CAF,CAFS,COPYRIGHT,FEDERATION,FURTHER,GSEA,MOST,NCF,NCFS,PUBLISHED,SOCIETIES,THESE,WNT
001,069,085,106,144,169,191,2014,472,799,ADJUSTING,ANALOGOUS,CAREFIRST,CINV,CONCLUSION,COPYRIGHT,CSF,CSFS,ESA,ESAS,FREQUENCY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SOCIETY
001,169,177,183,2002,2013,8201,AFTER,BARTH,FRANCONIA,GEORG,LABEL,METASTASES,METHODS,OBJECTIVE,STUTTGART,YORK
000,100,956,A549,ANNEXIN,APOPTOSIS,DOX,H2AX,JC1,ROS,THUS,WESTERN
2006,2011,362,CUTTING,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,BECAUSE,COPYRIGHT,EGFR,IFN,INFLUENZA,IRF,IRF1,NADPH,RSV,SOCIETY,THESE,UPON,WHILE
169,2014,COPYRIGHT,HOWEVER,SOCIETY,THOSE
WJOG4607L
701,727,947,BLOT,HOWEVER,IFN,MALIGNANT,MPM,S727,SIX,SOCS1,STAT1,STAT3,WESTERN,Y701
945,CBX4,HCC,HIF,MHCC97L,SUMO,THESE,VEGF
001,002,008,013,019,029,622,ASC,THESE
001,005,ALND,CONCLUSION,CTV,DRT,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SLND,SRT,V20,V30,VD40,VD45,VD95
003,169,CD90,COPYRIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY,THEREFORE
100,131,169,CAV1,COPYRIGHT,LABEL,MALIGNANT,METHODS,MPM,MPMS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOCIETY
150,169,2014,230,400,945,AJS,BRITAIN,CIGARETTE,COPYRIGHT,EGFR,EMT,GREAT,HBE,IRELAND,JOHN,LOSS,LTD,MUC1,PUBLISHED,SIMILARLY,SMK,SMOKE,SOCIETY,SONS,SRC,THUS,TYRP,USING,WILEY
169,2014,A549,CD44,CIS,CSC,CSCS,DECREASED,FOLLOWING,H1299,LUNG,SASA,SOX,SQE,THEREFORE
169,1980,2010,2014,338,4293,BACKGROUND,COPYRIGHT,COX,DENMARK,INC,LABEL,METHODS,NEPHROTIC,RESULTS,SIR,SIRS,THEREFORE
116,169,183,2014,3H2O,A549,BSA,CACO,CH3COOH,CH3OH,COPYRIGHT,FURTHER,H2L,HCT,INC,NI2,ONNO,ONO,THREE,VIS
169,2015,ARK,CPG,INK4A,INK4B,PBMCS,RESULTS
DIFFERENT,HOWEVER,LABEL,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,SCREENING,SUMMARY
177,18F,370,ABDOMINAL,AFTER,FDG,LABEL,MBQ,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVMEAN
169,1985,2008,2014,368,4155,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,INC,KAOHSIUNG,LABEL,METHODS,POTENTIAL,RESULTS,SIR,SIRS,TOTAL,UNION,WORKERS
169,2014,ASIA,AUTHORS,LTD,MEDICAL,NETWORK,NSCLC,PTY,PUBLISHING,SCIENCE,THERE,UNIVERSITY,WILEY,ZOLEDRONIC
169,2014,CHOP,CONVERSELY,COPYRIGHT,DLBCL,END,LTD,RESULTS,SEER,USING
001,002,006,037,132,169,175,177,2014,COPYRIGHT,GROUP,INC,LABEL,MEIER,METHODS,NEOPLASTIC,OBJECTIVE,OVERALL,PREVALENT,PUBLISHED,RESULTS,SURGERY,THERE,TREATMENT
169,2014,945,BACKGROUND,BOTH,COPYRIGHT,HIF,IRELAND,LABEL,LTD,METHODS,NSCLC,NTG,REDUCTION,RESULTS,SIXTY,VEGF
169,2014,A549,COPYRIGHT,H292,HOWEVER,INHIBITION,LPS,NSCLC,TREM,TRIGGERING,UTILIZING
130,177,945,CDDP,DSPC,EPG,H596,NATURALLY,NCI,NSCLC,PEITC,THUS
001,128,160,169,177,2014,AIM,ATPS,BMI,CNR,COLLEGE,CONCLUSION,COPYRIGHT,CTDIVOL,LABEL,LTD,METHODS,OBJECTIVE,OSDR,PUBLISHED,RESULTS,ROYAL,SEVENTY,SNR
169,2014,CETUXIMAB,COPYRIGHT,EGFR,LTD,TAXANES,TTF
169,1973,2010,2014,818,AML,CCS,CONCLUSION,COPYRIGHT,END,HODGKIN,INC,INCREASES,IRR,IRRS,LABEL,METHODS,NHL,OBJECTIVE,OCCURRENCE,REGARDING,RESULTS,SEER,SPT,SPTS
A549,BTEX,EC50
017,029,032,183,2005,2011,2013,233,BACKGROUND,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,OVERALL,PROPENSITY,REPORTS,RESULTS
002,003,042,151,295,305,311,463,537,689,695,8202,958,BACKGROUND,EGFR,EVALUATION,LABEL,MEIER,METHODS,NANJING,NSCLC,PFS,RESULTS,SOLID,TKI
169,2014,215,8340,9425,956,CONFERENCE,COPYRIGHT,CZT,ICH
VARIOUS
2009,2013,2014,BMJ,GROUP,IMAGING,LTD,PUBLISHING
2014,BMJ,GROUP,ISM,LTD,LUNG,PUBLISHING
0028,104,231,8202,CD34,EXCISED,LABEL,LM2,MATERIALS,MDA,METHODS,MOST,MRI,OBJECTIVE,ORTHOTOPIC,PRIMARY,RESULTS
169,185,2014,A549,CCL,COPYRIGHT,DU145,EACH,HELA,HTB,LTD,LUNG,MBC,MCF7,PROMISING,SHARPLESS
BASED,FURTHER,QOL,WHILE
036,048,076,169,2014,728,954,956,AIN,COPYRIGHT,COX,ERK1,H1975,IKB,INC,NON,NSCLC,WESTERN
FOLLOWING,FUSED,HOWEVER,IMPORTANT,SNS,SPECT
102,104,169,177,2014,8764,AMPLITUDE,AVERAGE,D95,DCT,DOSE,FTV,FTVS,JAPAN,PRESCRIBED,PRESS,PUBLISHED,RADIATION,RBE,SOCIETY,UNIVERSITY
184,3320,BASED,EGFR,ERBB2,L858R,S310F,TP53
169,2014,COPYRIGHT,DEV,DOSE,DVH,IMRT,LABEL,LTD,METHODS,OBJECTIVE,PBI,PDF,POPULATION,PTV,PURPOSE,RESULTS,SMALL
0001,128,177,183,208,CHEST,FBP,HENCE,HOUNSFIELD,INSURANCE,IRT,LABEL,MATERIALS,METHODS,NOISE,OBJECTIVE,OVERALL,PHILIPS,PURPOSE,RESULTS,SPS,WRITTEN
100,169,2014,8805,ADVERSE,AFTER,DCMAT,FURTHER,GRADE,JAPAN,PRESS,PTV,PUBLISHED,RADIATION,SBRT,SOCIETY,TOXICITIES,UNIVERSITY,USING
0001,100,169,2014,AUSTRALIA,ERS,FOUR,IPF,LUNG,SEVEN,TELOMERASE,THESE,WHILE
169,2014,ATLAS,CLOSING,LARGE,PRESS,PUBLISHED,THESE,TP53,UNIVERSITY
003,005,023,14Q32,169,2014,356,370,376A,411,ACS,DIFFERENT,IASLC,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
0001,169,2014,368,889,ACHR,CLUSTERING,CRMP5,IGG,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIGNATURE,SOX1
169,2011,2014,ACTA,DIAGNOSTIC,FOUNDATION,MRI,WESTERN
2013,2014,2017,2050,21ST,AMERICA,EARTH,GROUP,INSTITUTES,OCTOBER,POPULATION,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
ADC,JAK1,JAK2,JAKS,JANUS,NSCLC,SCC,SIAH2,SOCS,STAT1,STAT3,THUS,TYK2
111,147,164,169,184,2014,241,355,954,COHEN,CONCLUSION,FDG,FLT,III,IMAGING,INC,LABEL,METHODS,MOLECULAR,NSCLC,NUCLEAR,PET,RESULTS,SOCIETY,THERE,UNLABELLED,WEEK
ADP,BAX,BCL,HOWEVER,LTE,MEANWHILE,MMP,PARP,RGC32,TAKEN,WESTERN
169,2014,277,635,CIRCLES,COPYRIGHT,DVH,ECLIPSE,EUD,EUDS,HOWEVER,IMRT,INC,MEDICAL,MLC,OVERALL,PUBLISHED,SEVERAL,SQUARES,THUS,TRS,TUBES,WEAVE
AMONG,MALIGNANT,MESOTHELIN,THEREFORE
120,ALSO,EASTERN,ECOG,GROUP,NTIS,SERUM
160,435,BOTH,DIETARY,MDA,PTX,RESULTS,USING
AKT,CONSISTENT,ESTRADIOL,EXPRESSION,FDG,G6PD,GLUT1,GLUT4,LAM,MOLECULAR,NADPH,PET,TARGETING,TSC2,USING
374A,548B,AXL,CCNB1,MICRORNAS,NSCLC,THESE,TKI,TKIS,WNT5A

ANOTHER,AWARENESS,BARR,CK5,CLEAR,DIFFUSE,EPSTEIN,HISTOLOGIC,NONE,SMARCB1,TREATMENT
0001,002,122,137,153,412,8804,CRLM,DRS,FIVE
017,022,031,129,134,142,143,150,169,183,2008,2012,2014,500,714,8805,APRIL,BACKGROUND,COPYRIGHT,EASTERN,EGFR,FEB,FUNDING,GROUP,IIIB,ITALIAN,ITALY,LABEL,LTD,METHODS,RESULTS,THERE
169,2014,COPD,COPYRIGHT,HIV,LTD,SCREENING,THEREFORE,THROUGH
000,001,017,048,105,160,2006,2012,250,AIMS,BACKGROUND,CD34,CMV,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCT,THERE
133,177,208,ASSESSMENT,ERLOTINIB,EVENTUALLY,HOWEVER,LITERATURE,TDM,THESE
037,090,106,133,2006,2011,241,273,299,348,379,387,507,531,570,630,643,647,774,858,8805,ACCORDING,BMI,CHINESE,CONCLUSION,CONTROL,COX,FURTHER,GUIDELINES,HBSAG,HOWEVER,HRS,LABEL,MAY,MEANWHILE,METHODS,OBESITY,OBJECTIVE,OVERWEIGHT,PREVENTION,RESULTS,STRATIFIED,THERE
169,2014,ASIAN,PACIFIC,SOCIETY,THERE

169,2014,CCR,DOES,PREDICTIVE,THUS
169,2012,2013,2014,317,945,APRIL,CHINESE,CONCLUSION,COPYRIGHT,EORTC,FORM,HIGH,IRELAND,KARNOFSKY,KPS,KRUSKAL,LABEL,LC43,LIFE,LTD,LUNG,MATERIALS,METHODS,MILD,OBJECTIVE,OBJECTIVES,PEARSON,QLQ,QOL,QUALITY,RESULTS,SHORT,TIANJIN,TREATMENT
001,005,120,169,2014,95D,CELL,COPYRIGHT,EGFR,GMBH,H460,III,LABEL,METHODS,MMP,MMP2,MMP9,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,STAGE,THUS,TRANSWELL,WESTERN
181,CDK,E2F,E2F3,E2F3A,E2F3B,H1299,HLM006474,IC50,NSCLC,SCLC,SINCE,TAKEN
141,169,186,2014,212,257,398,COLORECTAL,COPYRIGHT,JOHN,LABEL,LTD,METHODS,OBJECTIVE,QOL,RESULTS,SONS,WILEY
160,280,A549,IC50,MA148,PLGA,POOR,THESE
169,1995,2011,2014,342,496,609,625,DENMARK,JOURNAL,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,POPULATION,RESULTS,SETTING,SIR,SIRS
EXTRA,FDG,MALIGNANT,PET
169,200,2014,946,AKT,EGFR,EMT,MIG6,TGF,TKI,TKIS
169,2014,BBC3,CDH2,CONSISTENT,PARP,POLYOMA,PUMA,SLUG,SNAI2
169,2014,CHRONIC,CONVERSELY,IL6,MCL,OVERALL,THESE
138,141,181,2012,8202,DALTONICS,HOWEVER,MALDI,MICROFLEX,SAMPLES,SPECTRA,TOF
ADDITIONAL,INC,LDCT,PRIMARY,PUBLISHED
200B,E2F3,HDAC,HDAC1,HOWEVER,LAD,PREVIOUSLY,SP1,TAKEN
A549,NILE,PACLITAXEL,PEG,PMME,PTX,RED
947,HHD,HLA,HSPC,HSPCS,IL2R,NOD,NSG,USING
169,2014,COPYRIGHT,HBECS,PUBLISHED,SOCIETY,THESE,WHILE
1997,ANOTHER,MOST,WHILE
509,A549,CFTR,PNA,PNAS,UTR
100,169,181,2011,2013,2014,8804,BOTH,DECT,GSI,JAPAN,MARCH,PRESS,PUBLISHED,RADIATION,SBRT,SOCIETY,UNIVERSITY
001,030,118,125,150,227,792,848,904,937,961,963,990,AUC,BACKGROUND,CEA,HE4,LABEL,METHODS,MRI,RESULTS,ROC
100,177,8201,954,BACKGROUND,DISCREPANT,FLAIR,GADOLINIUM,GRE,LABEL,METHODS,MRI,RESULTS,SEVENTY
335,CRC,HOWEVER,MEIER,MICRORNAS,THESE,ZEB2
2007,2011,403,533,651,BACKGROUND,DIAGNOSTIC,LABEL,METHODS,PET,RESULTS
DDR2,DISCOIDIN,PROMISING
1040,2005,2012,ALK,BACKGROUND,CBL,EGFR,GNAS,KRAS,LABEL,METHODS,MYCL1,RB1,RESULTS,SCLC,SCLCS,TERT
528,AMONG,BACKGROUND,CONCLUSION,EGFR,FINNISH,KIT,L858R,LABEL,METHODS,MUTATIONS,OVERALL,PCR,RESULTS,TEST,WESTERN
AMONG,BACKGROUND,CTC,GRADING,IIIA,LABEL,METHODS,RADIATION,RESULTS,THREE
100,406,ADVERSE,BACKGROUND,CAREFUL,DISEASE,HOWEVER,LABEL,MEIER,METHODS,OVERALL,RESULTS,SBRT,THERE,THREE,TREATMENT
AKT,BACKGROUND,CONCLUSION,ECH,HOWEVER,KEAP1,KIRSTEN,KRAS,LABEL,LKB1,LOSS,METHODS,NRF2,PI3K,RESULTS,STK11
115,BACKGROUND,CONCLUSION,CRIZOTINIB,EGFR,HGF,LABEL,MET,METHODS,RESULTS,TAS,THESE,THREE,TKI,TKIS,VEGF
130,2006,2013,224,678,8804,BACKGROUND,BESIDES,CD4,DESPITE,HIV,LABEL,METHODS,NONE,RESULTS,THERE
231,234,8321,8322,8323,8326,8331,AMONG,B02,DEBIO0719,EGF,ELISA,HOWEVER,KI16425,LPA,LPA1,MCF,MDA,PC3,QPCR,THEREFORE
124,AGE,ASIR,CONCLUSION,FBP,FORTY,LABEL,MBIR,METHODS,OBJECTIVE,OPTIMIZED,RESULTS,SIMILARLY,SNR
107,165,201,956,ABOUT,AFFYMETRIX,BUFALIN,CASP9,CCAR1,CCPG1,CONSOLE,DDIT4,EXPRESSION,GADD45B,H460,HOWEVER,LUNG,MDC1,NCI,RMA,THAP1,THESE
CONTEXT,EARLY,HIGH,HOWEVER,INCREASED,NRF2,ROS,THESE,VITAMIN
163,167,174,190,2012,ABSTRACTS,ASSESSMENT,ASSUMPTION,BACKGROUND,BRANCHBURG,CARIBBEAN,CDSR,CENTRAL,CIC,CIS,CITATIONS,CONCLUSION,CONTROLLED,COST,DAILY,DARE,DATA,DIAGNOSTIC,EFFECTS,EGFR,ESTIMATES,FUNDING,HTA,INC,INDEX,INDEXED,INSTITUTE,KIT,LABEL,LATIN,LITERATURE,MEDLINE,METHODS,MOLECULAR,NIHR,NON,NSCLC,OBJECTIVE,OTHER,PCR,PROCESS,QALY,QALYS,RANDOMISED,RESULTS,REVIEWS,ROCHE,SCI,SCIENCE,SIX,SOURCES,SYSTEMATIC,SYSTEMS,TECHNOLOGY,TESTING,THERE,TKI,TKIS,USA,VENLO
2014,BARRETT,BMJ,CAUCASIAN,ENDOSCOPY,GROUP,LTD,PET,PUBLISHING,SUBSEQUENT
100,181,1SC7,AMONG,DOCKING,GI50,HOP,HOPEFULLY,INSTITUTE,LC50,LOG10GI50,LOG10LC50,MAESTRO,NCI,NON,NSC,PDB,TGI,USA
OPINION,THERE
CHEST,T1AN0M0,VIDEO
169,2014,BRITAIN,COPYRIGHT,DEPLETION,GREAT,IRELAND,JOHN,LTD,PCR,PIN,PUBLISHED,SKA1,SOCIETY,SONS,TAKEN,THESE,WILEY
169,2014,ASIA,AUTHORS,LTD,MET,PTY,PUBLISHING,SCIENCE,SU11274,THESE,WILEY
150,169,2014,8805,BACKGROUND,BOTH,CONCLUSION,LABEL,MEDICAL,METHODS,ORR,ORRS,PRESS,PUBLISHED,RESULTS,SEQUENTIAL,SOCIETY,UNIVERSITY
AUTOMATION,DEVELOPING,DNASE,LUNG,LUNGS
AKI,DIAGNOSIS,ENGLISH
GTPASES,HOWEVER,PI3K,RAS,RAS2
2000,2008,2011,8201,BASED,CEA,CONCLUSION,COST,ICER,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,QALY,QALYS,RATIO,RESULTS,THERE,TUFTS
1013,105,169,2014,247,269,659,668,727,777,782,793,796,869,8764,880,921,BIOLOGY,CHIP,EMSA,INC,MOLECULAR,PKC,PRKCE,RNAI,SER,SOCIETY,SP1,STAT1
2014,BMJ,GROUP,LTD,PUBLISHING
2000,AMERICANS,ARAB,CALIFORNIA,DETROIT,END,HISPANICS,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,PROGRAM,RESULTS,SEER
169,2014,3DCRT,COPYRIGHT,CRT,DMEAN,DOSE,IMRT,IRELAND,LABEL,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,PRESCRIBED,PTV,PURPOSE,RESULTS,VMAT

1995,2012,518,ABC,BACKGROUND,CASE,FLUID,LABEL,METHODS,SOMETIMES
112,1790G,6337,9302,CAUCASIAN,HIF,HOWEVER,OSCC,OVERALL,SNP,THESE
8201,AGE,ELISA,NSCLC,SERUM,VCAM
ALONGSIDE,BACKGROUND,CONCLUSION,DISCUSSION,FINALLY,LABEL,NPPV,THERE
001,1153,129,169,170,199,2014,365,8201,938,BACKGROUND,BRUSH,LABEL,METHODS,NEG,NPV,PPV,RESULTS,SOCIETY,SPECIMENS,THERE,WASH
047,169,2000,2009,2014,IIIA,IIIB,INDUCTION,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,POTENTIAL,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVARIATE,UNIVERSITY
8201,HOWEVER,ISSUE,LABEL,LUNG,METHODICAL,METHODS,NLST,OBJECTIVE,PRACTICAL,SCREENING,TRIAL
SPN,SPNS
945
100,110,2011,532,AMONG,BRAF,EGFR,HER2,KIRSTEN,KRAS,MEK1,NRAS,NSCLC,PTEN,RAF,THREE,USING
001,009,136,FUDR,HAI,RFA,SIXTY,THESE
169,2014,945,946,C57BL,COPYRIGHT,ERK,EXCESSIVE,HUH7,INC,NOTABLY,PP1,REDUCED,SRC,U0126
169,200,2014,767,810,ATLAS,COLD,EXOME,FINALLY,LABORATORY,PAN,PRESS,PROJECT,PTEN,PUBLISHED,TCGA,TRANSPOSEQ
160,169,2014,ANCHORAGE,COPYRIGHT,INC,SHC,SHC1
169,2014,CELL,COPYRIGHT,GOD,GREEK,INC,WIND
120,145,183,197,24H2O,335,894,A549,CUTLM,FTIR,LNCAP,N2O2,RAMAN,SEVERAL
1978,1997,CLEAR,DRESLER,HOWEVER,SOCIETY,USING
001,169,2006,2011,2014,432,677,COPYRIGHT,DATA,END,FACTORS,INC,LABEL,METHODS,METRICS,OBJECTIVE,OBJECTIVES,PATIENT,PUBLISHED,READMITTED,RESULTS,SURGERY,THERE
NON,NSCLC
CONCLUSION,CONSISTENT,FORTY,IMPORTANT,KEY,LABEL,MCC,METHODS,OBJECTIVE,PURPOSE,RESULTS
004,160,4X10,7X10,8209,BRAZILIAN,CIRCADIAN,CLOCK,DISRUPTION,NOCTURNIN,NSCLC,PER3,SNP,SNPS
160,1995,2012,ADDITIONAL,BACKGROUND,DATA,EWING,LABEL,MATERIALS,MEDLINE,METHODS,OBJECTIVE,RESULTS,THERE,WILMS
169,2014,231,233,8217,COPYRIGHT,PUBLISHED,SAS,SFAR,SOCI,THESE
169,2014,INC,PPB,SERTOLI,SLCT,TYPE,WILEY
169,2013,2014,599,CENTRAL,CONTROLLED,EIGHT,FURTHER,JUNE,MEDLINE,PEDRO,PRESS,PUBLISHED,REVIEWS,SEVEN,STUDIES,SURGERY,UNIVERSITY
000,AUC,CONCLUSION,FORTY,HOWEVER,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE

169,2001,2010,2012,AMONG,ASIAN,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,MAY,METHODS,OBJECTIVE,ORBITAL,PUBLISHED,PURPOSE,RESULTS,THEREFORE,THREE,TOTAL,UNIVERSITY
001,005,026,125,169,2007,2011,2014,276,476,820,962,AFTER,AMONG,BACKGROUND,BECAUSE,COPYRIGHT,INC,LABEL,MARKETSCAN,METHODS,PLOS,PUBLISHED,RESULTS,RISK,SOCIETY,STRATEGIES,TOTAL,VATS,VIDEO
0001,087,102,169,177,1996,2008,2014,237,249,311,435,477,560,610,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,OVERALL,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,VATS
041,095,169,177,2004,2009,2014,AFTER,BACKGROUND,COPYRIGHT,INC,INSTEAD,LABEL,LNS,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SOCIETY
006,015,058,169,1997,2009,2014,BACKGROUND,BETWEEN,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
APPLY,CONCLUSION,LABEL,METHODS,MPMN,OBJECTIVE,PAY,RESULTS,THEIR
001,169,2014,946,ABCP,ACBP,BECAUSE,HIGH,IHC,IMS,INHIBITION,MALDI,NSCLC,THESE,USING
169,2014,ANTIBODIES,ANTIGEN,BASED,COPYRIGHT,LTD,SCCHN
001,008,009,012,023,127,169,183,2014,220,393,967,COPYRIGHT,HFJV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARAMETRIC,PUBLISHED,PURPOSE,RESULTS,SIR,SOCIETY,STUDENT,SURROGATE,THERE,THERMAL
0099,191A,216G,229,497R,61A,693,ALLELIC,EGF,EGFR,ILD,NONE,TGFA,THREE,WHILE
100,111,119,1995,2010,475,630,AMONG,GTN,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,WOMEN
946,ALTOGETHER,H292,H460,MES,NCI,NRF2,NSCLC,VEGF
0001,169,2014,380,435,570,653,781,814,8805,AFTER,CONCLUSION,DATA,FOM,IMAGING,INC,LABEL,METHODS,MOLECULAR,NAF,NUCLEAR,ONCOLOGIC,OVERALL,PET,POM,RESULTS,SOCIETY,UNLABELLED
039,040,111G,487,516,8202,AFTER,ATM,BACKGROUND,CHINESE,LABEL,METHODS,RESULTS,SNPS
160,8209,CD4,CD8,DFS,HOWEVER,III,LUNG,NSCLC,THERE,THESE,TNM,UNIVARIATE
1257,946,A549,AKT1,AKT2,DAB2,EMT,FAK,ILEI,INDUCER,INDUCTION,INHIBITION,NSCLC,PCBP1,PCR,PI3K,SCHA,TGF
ADME,ALK,RESISTANT,THESE,USING
160,169,2014,6982,ACADEMY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,COX,END,HOSPICE,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RANDOMIZED,RESULTS
001,166,8201,99M,CLINICALLY,CONCLUSION,ESTIMATION,LABEL,LUNG,MAA,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SPECT
169,2014,COPYRIGHT,DIFFERENT,INVERSE,LTD,OAR,POTENTIAL,PUBLISHED
158,169,2014,665,COPYRIGHT,FINAL,INC,KEY,LABEL,METHODS,OBJECTIVE,PACS,PUBLISHED,PURPOSE,RESULTS
169,16S,177,2014,215,AFTER,ASIA,CFU,CFUS,EIKENELLA,FOUR,GEMELLA,LTD,OLSENELLA,PTY,PUBLISHING,SOCIETIES,THESE,USING,WILEY
160,945,946,CCRCC,CLEAR,CXCR4,DESPITE,FINALLY,HIF,HOWEVER,IL6,MDSC,MIG,MMP,RCC,RENAL,STAT,TAM,TGF,TGFB,TH1,THESE,TKI,TNF,VHL
160,COX,HOWEVER,LUNG,NON,NSAID,ROS
169,2014,COPYRIGHT,EVEN,INC,LIPOMAS
178,8314,8710,936,945,946,AIF,ANNEXIN,ATF6,BASED,BAX,BCL,CA2,CTD,FLOW,GRP78,H460,HOWEVER,IRE1,LUNG,RESULTS,ROS,WESTERN,XBP
734AA,BELARUS,GSTM1,GSTT1,IMBALANCE,MDR1
BOERL,MB231,MCF,MDA,MRC,SKI,SKOV
ETT,ETTS,MRSA,VAP
006,008,009,011,019,020,029,031,044,048,211,215,343,494,697,8804,AFTER,ATS,DFS,ERS,EXPRESSION,HISTOLOGIC,IASLC,LACK,THYROID,TTF1
100,823,BGC,CARDIAC,NSCLC,PCR,SEVEN,SPCA,THESE
169,2014,CANCERS,CHALLENGES,HOWEVER,SOCIETY,THEREFORE,WHILE
105,169,1992,2001,2014,286,AMONG,BACKGROUND,BJS,CONCLUSION,CRLMS,DFS,DSS,JOHN,LABEL,LTD,METHODS,PUBLISHED,REES,RESULTS,SEVENTY,SOCIETY,SONS,TEN,VARIOUS,WILEY
169,2014,4T1,7197,946,EMT,LUC,MMTV,NEU,SMAD,TGF
000,100,2003,2009,327,684,ANNUALIZED,CASES,HOWEVER,KOREA,LABEL,METHODS,NTM,OBJECTIVE,PURPOSE,RESULTS,SOUTH
001,004,012,025,414,436,AMONG,LABEL,METHODS,NSCLC,OBJECTIVE,PLC,PURPOSE,RECURRENCE,RESULTS,TNM
0001,169,191,2014,271,298,8201,AZA,CONVERSELY,H23,HOWEVER,HOXA9,INC,NSCLC,PCR,TRANSIENT,WILEY
118,177,210,219,240,252,303,501,578,8201,8226,954,AVC,CTS,HOWEVER,ICC,ICCS,INTER,KEY,LABEL,LOW,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VOLUMETRIC
001,002,017,019,037,038,046,129,CD34,DFS,LAPTM4B,MEIER,MVD,NSCLC,SPSS,THESE,TNM
133A,AKT,EGFR,IGF,MICRORNAS,MIR,NON,TGF
067,1960,1983,2010,8197,9094,949,AMONG,BMJ,GROUP,LABEL,LIMITED,METHODS,MINNESOTA,MORTALITY,OBJECTIVE,OTHER,PUBLISHED,PUBLISHING,RESULTS,SMR,SMRS,SRR
103,169,2014,CD44,CELLS,CONCLUSION,HNSCC,LABEL,METHODS,OBJECTIVE,RESULTS,SCC,SIMILARLY
100,169,2014,AMONG,BECAUSE,COPYRIGHT,GATA3,GCDFP,INC,SIXTY,WT1
001,002,003,009,014,112,AIM,BACKGROUND,CONCLUSION,III,LABEL,LUNG,MATERIALS,METHODS,NSCLC,OBJECTIVE,RCAS1,RESULTS,SISO
ALLOGRAFTS,BACKGROUND,CLARIFYING,CONCLUSION,CSCS,LABEL,MATERIALS,METHODS,PANCREATIC,RESULTS,THEREFORE,THESE
0001,0024,169,183,2009,2010,2011,2014,234,APRIL,AUG,BACKGROUND,COPYRIGHT,COX,EARLY,FUNDING,H1N1,H1N1PDM09,JAN,LABEL,LTD,MARCH,METHODS,RESULTS,ROCHE,THERE,THESE
DATA
169,2014,26B,A549,AUTHORS,COPYRIGHT,EZH2,HOWEVER,PUBLISHED,THUS,VARIOUS
001,003,004,006,022,043,230,460,BACKGROUND,GST,GSTM1,INDIA,LABEL,MATERIALS,METHODS,MIZORAM,RESULTS,RISK,SODA,WOMEN
A549,HOWEVER,MECHANISMS,TAKEN,USING
60S,A549,BACKGROUND,L39,LABEL,MATERIALS,MDR,METHODS,PCR,RESULTS,RPL39,TDR,TOTAL,VIABILITY
001,018,2012,496,511,813,831,BACKGROUND,FURTHER,IIIA,JANUARY,LABEL,MEDICAL,METHODS,OTHER,POP,RESULTS,RISK
001,017,2008,2012,267,AGE,ALK,ANAPLASTIC,BACKGROUND,D5F3,FISH,IHC,JANUARY,LABEL,MAI,MATERIALS,METHODS,NSCLC,RESULTS,THERE,UNIVERSITY,VENTANA,VPI
0000001,333,400,800,8804,BACKGROUND,CIS,CONSUMING,HOWEVER,LABEL,LUNG,MATERIALS,METHODS,ODD,ORS,OTHER,PAKISTANI,RESULTS,SMOKING,STRONGEST
E2C,ECTOPIC,MMP,MTT,THESE,UBE2C,USING
001,005,129,149,177,219,276,325,956,ARSENIC,BACKGROUND,CADMIUM,LABEL,MATERIALS,MEAN,METHODS,RESULTS,SCC,SCLC,THERE,TNM
169,2014,COPYRIGHT,FFPE,INC,MOLECULAR,PATHOLOGY,PUBLISHED,SOCIETY
160,169,2014,ALK,HCT,IMT,IMTS,JOHN,LTD,PUBLISHED,SONS,WILEY
144,169,2014,COLLEGE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS
007,160,169,2014,ALDH,ASIA,AUTHORS,CAFS,CD44,CD90,HOWEVER,LTD,PTY,PUBLISHING,SCIENCE,SQCC,WILEY,ZEB2
1030,1633,169,2014,698,946,956,A549,AFTER,BOTH,COPYRIGHT,H22,HEP,HOWEVER,HPMA,INCREASING,LTD,NEITHER,THESE,USING
AKT,AKT1,BIM,CISPLATIN,FOXO,KNOCKDOWN,PI3K,THR32
7TH,8TH,BASED,HOWEVER,LUNG,PROJECT,STAGING,THEREFORE,TNM
BACKGROUND,CONCLUSION,LABEL,LOBES,MATERIALS,METHODS,RESULTS,TC99M
001,164,169,1992,1994,2004,2006,2011,2012,2013,209,250,AFTER,BACKGROUND,COPYRIGHT,IMPORTANT,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SEPAR
021,027,2003,2011,2GY,372,4CM,54GY,ACUTE,AHRT,COX,CTCAE,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SBRT,STAGE,THREE,TIME
169,2014,AUTHORS,COPYRIGHT,EGFR,INC,LUADS,NF2,PUBLISHED,THESE,TKI,TKIS,TSC1
169,2014,956,A549,AKR1B10,AKRS,COMPARISON,COPYRIGHT,HPLC,INC,INHALATION,PCR,ROS
169,2014,90NM,945,A549,COPYRIGHT,LTD,MDM2
RNAS,SMALL,THESE
1042,177,AFTER,AIDS,BACKGROUND,CONCLUSION,GIVEN,HAART,HIV,LABEL,METHODS,NADM,NON,RESULTS,THERE,VIRUS
169,2014,ACADEMY,ADDITIONAL,BACKGROUND,BECAUSE,CD4,CD8,COPYRIGHT,CTCL,INC,LABEL,METHODS,MOSBY,MOST,OBJECTIVE,PUBLISHED,RESULTS,STAGING
169,2014,ALK,AMONG,COPYRIGHT,CREST,FISH,FURTHER,HYDRA,INC,KMT2A,MLL,MOLECULAR,PATHOLOGY,PUBLISHED,SOCIETY,STUDIES,USING

169,2014,BACKGROUND,BML,INFERRING,LABEL,LANDSCAPE,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,2014,BACKGROUND,EGFR,LABEL,MAP,METHODS,MOTIVATION,NON,NSCLC,PRESS,PUBLISHED,RESULTS,TKI,TKIS,UNIVERSITY
150,169,2006,2010,2014,CONCLUSION,FDG,IMAGING,INC,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SEVEN,SOCIETY,SUV,SUVS,TREATMENT,UNLABELLED
GUIDELINES,NCCN,PANEL
015,037,100MG,148,155,165,169,193,2014,8805,BACKGROUND,LABEL,LOWER,METHODS,PRESS,PUBLISHED,RESULTS,SIMILAR,SMOKING,SOCIETY,TOBACCO,UNIVERSITY,WEEKS
001,007,011,027,032,169,200,2000,2012,2014,450,838,956,BACKGROUND,BETWEEN,COPYRIGHT,FORTY,INC,JANUARY,LABEL,MCT,METHODS,MLND,PUBLISHED,RESULTS,RJC,SOCIETY,UNIVARIATE
A549,AEA,AKT,CB1,CDK4,EGF,EGFR,ERK,FAAH,FATTY,FURTHER,H460,MET,MMP2,MMP9,NSCLC,PARP,SINCE,TAKEN
001,1998,2009,496,BACKGROUND,DFS,LABEL,METHODS,N2A,NODAL,NSCLC,OVERALL,RESULTS,THERE
ADC,EVEN,LABEL,LCC,MOST,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
DESPITE,KI67,LABEL,LCNEC,OBJECTIVE,PURPOSE,REGARDING,RESULTS,SCC,SUMMARY
100,AAH,ADC,AIS,FURTHER,LABEL,LPA,MIA,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,THEREBY
1004,MMTV,REMARKABLY,SAC,TAKEN
8197,BMJ,EGFR,EPIDERMAL,GROUP,LEU747PRO,LIMITED,PCR,PUBLISHED,PUBLISHING,RGQ,THERE,TKI,TKIS
945,BIOLOGICAL,RANDOMIZED,TNF
MMP,MMP9,MMPS,WHILE
169,2014,956,A549,COPYRIGHT,DYSOXYLUM,ECD,FOUR,HEPG2,IC50,INC,MCF,MO2,NMR,OAC,THEIR,THREE
120,169,2014,BOTH,BPP,COPYRIGHT,LTD,MEANWHILE
2002,2008,365,COX,III,INSTITUTE,LABEL,LNR,MEDICAL,MEIER,METHODS,OBJECTIVE,PEARSON,RESULTS,THERE,TIANJIN,TNM,UNIVERSITY
A549,G4NH2,HFA,HOWEVER,PAMAM,SILENCING,SMALL,THEIR
2006,CEVARIX,HOWEVER,HPV,MOST
169,2014,945,946,954,BASED,BECAUSE,BIOLOGY,EXOGENOUS,HOWEVER,IKK,INC,MOLECULAR,NME1,NME1L,SOCIETY,TNF
MRI
002,011,027,048,11Q22,707,CASKI,CLASS,EKVX,HIPPO,LITERATURE,OVERALL,RO82,WARTS,YAP1
231,8201,CXCR4,FITC,FURTHER,HIGH,HOWEVER,MDA,MTT,PCR,THEN,THESE,TNM,WESTERN,YET
001,066,6MWT,916,CHEST,CPET,FOLLOWING,HOME,HOWEVER,JACS,LABEL,METHODS,OBJECTIVE,RESULTS,SPO,SURGERY,THERAPY
177,183,1998,2013,8201,8202,CONCLUSION,DATA,GEORG,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,STUTTGART,SURGERY,YORK
169,2014,CELLS,COPYRIGHT,DISRUPTION,GMBH
169,2014,ASIAN,BAYES,FOLLOWING,IDEALLY,MODALITIES,PACIFIC,SOCIETY
2014,BECAUSE,COPYRIGHT,MALIGNANT,SLACK,WHAT
231,549,CDH1,EMT,HDAC,MCF,MDA,SAHA,THESE,TNBC,ZEB,ZEB1,ZEB2
214,229,ALK,EGFR,FFPE,III,KRAS,LETS,LUNGCARTA,LUNGFUSION,MASSARRAY,MET,MUTATIONS,NINE,NSCLC,PANEL,RET,ROS1,STK11,TP53

2009,2013,ADDITIONAL,AREAS,BACKGROUND,COVERED,INHIBITORS,LABEL,METHODS,OPINION,PATENTS,SCIFINDER,TRK,TRKA,TRKS
022,023,031,032,10878,118,123,2003,2009,205,239,255,ADDITIONAL,ALK,BACKGROUND,BUNDANG,CEP8,DFS,EGFR,FISH,HOWEVER,KRAS,LABEL,METHODS,MYC,RESULTS,SEOUL,UNIVERSITY
INSTITUTE,LABEL,METHODS,MWA,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
106,129,131,133,137,140,153,AFB,CONCLUSION,LABEL,METHODS,NBI,OBJECTIVE,RESULTS,THERE,WLB
100,CONCLUSION,EIGHT,FIVE,HOWEVER,ICE,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TECHNICAL,TRANSIENT
CTC,CTCS,GENOMIC,INSTEAD,USING
2012,2013,260,APRIL,CONCLUSION,JAPAN,K203,LABEL,LTD,METHODS,OBJECTIVE,OLYMPUS,OVERALL,PURPOSE,RESULTS,SEPTEMBER,TOKYO
100,178,200,8322,8324,956,AUC,BACKGROUND,CMAX,DOSE,LABEL,LINIFANIB,METHODS,NSCLC,ORAL,PARTIAL,RESULTS
947,AFTER,FATIGUE,FINALLY,H2AX,LABEL,LOW,METHODS,OBJECTIVE,PARP,PURPOSE,RESULTS,TOP1
419,541,583,586,621,715,802,892,BSO,CONCLUSION,LABEL,LEVEL,METHODS,NUTRITION,OBJECTIVE,PREVENTION,RESULTS
001,108,188,AMONG,BACKGROUND,CONCLUSION,CRT,FOLLOWING,HRQOL,III,LABEL,METHODS,POOR,RESULTS
2141,400,550,627,8805,906,BACKGROUND,COMMITTEE,CONCLUSION,CORE,COX,LABEL,LUNG,MEIER,METHODS,REFINEMENT,RESULTS,STAGING,THREE,TNM,WBC
002,004,149,154,ABIGAIL,AVASTIN,BACKGROUND,BIOMARKERS,CD31,CONCLUSION,EVALUATION,INNOVATIVE,LABEL,METHODS,NRP,RESULTS,SOLID,VEGF,VEGFR
100,159,165,215,369,ATLAS,BACKGROUND,CONCLUSION,CPG,FINALLY,GATA2,HOWEVER,KRAS,LABEL,METHODS,NNK,NSCLC,RESULTS,SIMILARLY
110,111,221,396,BACKGROUND,CONCLUSION,COPD,COX,EASTERN,GROUP,III,LABEL,METHODS,NSCLC,RESULTS
AFTER,BECAUSE
060,114,2013,283,377,481,555,557,635,664,665,8201,869,8970,969,ASIAN,BSC,EFGR,EGFR,EPIDERMAL,NSCLC,PFS,SCIENCE,THROUGH,TKIS,WEB
EPA,FIRST,HOWEVER,IUR,LIBBY,MARYSVILLE,NMRD,OHIO,PROTECTION,RFC
315,322,673,STRIKINGLY,THESE,THOSE,WGD
169,2014,BOTH,RNAS,UICC
246,AFTER,HODGKIN,INCREASED,LABEL,LIMITED,METHODS,OBJECTIVE,RESULTS
EXPOSURES,LABEL,METHODS,OBJECTIVE,OTHER,RESULTS
169,2014,946,956,EMT,FINALLY,IC50,TAKEN,TBE,TGF
001,015,041,177,2008,2011,210,270,BACKGROUND,CONCLUSION,FOUR,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VATS
169,2014,365,954,CXCR4,HOWEVER,MAPK,MSC,MSCS,SDF1,UICC
0013,012,013,169,2009,2012,2014,600,786,8201,BRAF,EGFR,EGFRS,KRAS,MOABS,NONE,NRAS,UICC
120,160,648,CIP1,CPG,ESTS,GATA,GATAD2B,KNOCKDOWN,LEUCINE,MBD3
003,005,010,015,043,183,BACKGROUND,CONCLUSION,COX,EGFR,LABEL,LOG,LUNG,MEDICAL,METHODS,NSCLC,PCR,RESULTS,STUDENT,TIANJIN,UNIVERSITY
128,303,BASED,FRET,NONE,RNAS,RNASE
0278,0890,1992,2011,3447,7055,ARIZONA,CARRINGTON,CHARLES,DEPARTMENT,DIP,FOUR,LABORATORY,MALIGNANT,MAYO,NONE,NUCLEAR,PATHOLOGY
1355,2130,242,325,BASED,CRKL,H1703,H1755,MOST,NCI,NSAF,NSCLC,PROTEOMIC
107,152,153,156,158,580,ADC,ADCS,HISTOLOGIC,SQC,SQCS
016,240,543,8209,HOWEVER,NSCLC,THUS
HOWEVER,RESULTS,SIMULATION,WEIBULL
165,177,214,235,COMPATIBLE,GFP,KDR,MMP2,MMP9,PET
177,215,ACTIVATION,BBB,D122,GTPASES,LEWIS,MICE,MNSOD,RHO,THERE
100,267,A549,DOX,SLN,THUS
169,2014,COMBINING,COPYRIGHT,HOWEVER,JOHN,LTD,SONS,THEREFORE,WILEY
A549,BIC,DOX,MTX,TAKEN
1432,1818,269,3514,769,GLU,GNP,GNPS,PEG,RESULTS
036,181,203,230,8211,950,A549,AMONG,BACKGROUND,CLINICALLY,FURTHER,HOWEVER,HSP27,LABEL,METHODS,NSCLC,RESULTS
192,HOWEVER,MCNPX
A549,AFTER,AKT,HOWEVER,IGF,MTT,NSCLC,PCR,PI3K,SILENCING,WESTERN
003,004,110,169,2014,AROMATASE,EGFR,HCC4006,HIGH,INHIBITORY,LABEL,LUNG,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
160,169,2014,945,A549,AKT,AQP3,AQUAPORIN,ATP,AUTHORS,CD31,EXPRESSION,H1299,MMP2,MMP9,NON,NSCLC,NSCLS,PHYSIOLOGY,SOCIETY
100,169,2014,BACKGROUND,DIAGNOSIS,INC,LABEL,METHODS,MUCORALES,PROCEDURE,RESULTS,WILEY
177,180,246,250,BOTH,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRADESH,RESULTS,SOUTH
106,120,144,169,2014,945,946,CONCLUSION,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MINI,OBJECTIVE,PCI,PURPOSE,RESULTS,STATE,THESE,YKL
162,578,858,864,ARG,ARG415GLN,ASP,ASP1104HIS,BACKGROUND,GLN,LABEL,OVERALL,PRINCIPAL,RESULTS,XPF,XPG
DIGITAL
947,B16,F10,GCR,GCS,GSH,NADPH,NRF2,TAKEN
043,156,157,2013,220,BACKGROUND,BANGLADESH,CHRONIC,CIS,COX,CREATININE,DATA,FURTHER,LABEL,METHODS,OCTOBER,PERSONS,RESULTS,THERE
100,126,155,169,2014,20B,34A,8764,BACKGROUND,BASEL,HCC,LABEL,METHODS,MOST,NSCLC,OVERALL,PCR,PRFA,REAL,RESULTS,TREATMENT
2003,2011,APRIL,BACKGROUND,BETWEEN,GRADE,LABEL,METHODS,RECURRENCE,RESULTS,SBRT,THERE
169,2014,BASEL,CURRENTLY
169,2014,500K,AFFYMETRIX,INC,MGMT,USING,WILEY
001,016,025,026,029,031,033,041,120,8202,COX,MEIER,PFS,ROC,SCLC,SERUM,THESE,UNIVARIATE,YKL
169,2014,A549,AMINO,AMONG,GMBH,HEPG2,KGAA,MCF,VCH,WILEY
945,946,BLOOD,CD105,CD34,CELL,HOWEVER,LUNG,MMP2,MMP9,NON,NSCLC,SMALL,THESE,TNM,USING
100,162,AIMS,BACKGROUND,CONCLUSION,DIAGNOSTIC,EUS,FINAL,FNA,HOWEVER,LABEL,LNS,LYMPH,METHODS,MLAD,OBJECTIVE,RESULTS,THEREFORE
169,2014,209,639,8805,909,AFTER,DFS,HOWEVER,JAPAN,PRESS,PUBLISHED,RADIATION,SBRT,SETUP,SOCIETY,UNIVERSITY
28049,3LL,8310,8320,8325,CCRF,CELL,CEM,CHANGES,CO38P,DACA,DATA,E1000,LABEL,LEWIS,LLTC,METHODS,MRP1,NZM10,NZM4,NZM52,OBJECTIVE,PURPOSE,RESULTS,RETENTION,WHILE
001,009,013,2008,2012,245,AFFAIRS,AMONG,ARIZONA,BACKGROUND,CARE,FDG,JANUARY,LABEL,MARCH,METHODS,PET,RESULTS,SUV
1000,10878,3A4,400,800,8201,BACKGROUND,CYP,DOSE,LABEL,METHODS,MTR,OTHER,P450,PAZOPANIB,RESULTS
177,181,1B10,945,946,AKR1B10,ALDO,ANNEXIN,H460,IC50,NCI,TAKEN
EMT,ESCC,HOWEVER,KNOCKDOWN,KYSE150,RNAI,THESE
231,549,BUOH,MDA
120,177,949,INGENUITY,MRMAP,PET,PHILIPS,SUV
115,141,CONCLUSION,LABEL,METHODS,OBJECTIVE,PTC,RESULTS,SIX,THERE,ULTRASOUND
231,BCCS,CSF1,CXCR3,CXCR6,HIFS,MDA,MSCS,PRODUCTION,THESE
BRAIN,CHEST,METASTATIC,MRI,SUBSEQUENT
169,2014,573,ATS,CONCLUSION,ERS,HISTOLOGIC,IASLC,LABEL,LUNG,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,SOCIETY,SOLID,TNM
005,014,169,2014,2404,AFTER,AUTHORS,JOHN,LTD,RADIATION,RIOP,SERUM,SONS,TREATMENT,WILEY
002,048,056,206,368,425,544,593,599,677,680,690,784,811,8805,956,967,CPTP,NRS,RETRACTOR,SEVENTY
100,45TH,465,945,AFTER,ANIMALS,FRESH,LABEL,METHODS,OBJECTIVE,RESULTS,RSCC,ZEALAND
0001,AFTER,AIMS,AUC60,CHANGES,CONCLUSION,DYNAMIC,EVALUATION,LABEL,METHODS,MRI,OBJECTIVE,RESULTS,SOLID
EGFR,FURTHER,III,PHASE,T790,TKI
169,2014,A549,NAD,SILYBIN,SIRT1
1986,1995,1996,2005,2262,4602,8804,AIDS,BACKGROUND,BETWEEN,CIS,FIVE,HODGKIN,HRS,ITALIAN,LABEL,METHODS,PWA,RESULTS
169,2014,A549,CIGARETTE,CSC,GSPS,H1299,H460,INC,NADPH,NOX,NSCLC,TREATMENT,USING,WILEY
100,169,2014,215,3881,8201,991,996,AUC,CNS,CSF,FURTHER,MRI,OVERALL,UICC
000,100,126,140,145,2003,2012,260,263,BACKGROUND,BASE,BLOOD,CASE,CONCLUSION,DATA,DISEASE,FUNDING,HEART,HORIZON,INITIATIVE,INSTITUTE,LABEL,LIMITATION,LUNG,METHODS,OBJECTIVE,OUTCOME,PAYER,POPULATION,PRIMARY,RESULTS,SOURCES,THESE,TIME,WHI,WOMEN
BRIEF,CORE,DUTCH,ILLNESS,KARNOFSKY,LIFE,PERCEPTION,PRINCIPAL,QUALITY,TREATMENT
INSTITUTE,LUNG
144,169,2014,3302,561,758,956,A549,AMBIENT,COPYRIGHT,DTT,HEPG2,INDIA,NADU,PAH,PAHS,STEEL,TAMIL,THEIR,THERMAL,WHILE
956,A549,C10,C11,COMPOUNDS,FOUR,GI50,NOESY,YMJ1179
CA2,EFFECTIVE,ESCC,ORAI1,SOCE
000,008,084,132,144,178,443,550,FIG,FOUR,GRADE,HOWEVER,LABEL,META,METHODS,OBJECTIVE,OVERALL,PURPOSE,RANDOMIZED,REF,RESULTS,TAB
000,1000,130,152,169,177,183,188,1970,1990,2000,2013,2014,2015,2030,364,BACKGROUND,BILL,CHANGES,COPYRIGHT,DECREASES,FOUNDATION,FUNDING,GATES,GOAL,HIV,LABEL,LTD,MDG,MELINDA,METHODS,MILLENNIUM,REMARKABLE,RESULTS,SAHARAN,SHAPLEY,SINGAPORE,WITHOUT
0014,0034,0038,0052,0086,0103,0186,037,109,169,191,2014,2256,400,8201,9435,ASIAN,BACKGROUND,LABEL,LESS,METHODS,NINE,NSCLC,OBJECTIVE,PACIFIC,RELATIVELY,RESULTS,SCC,SOCIETY,SURGICALLY,VDT
169,2014,582,ASSESSMENT,BACKGROUND,CTX,HIGH,LABEL,LOW,METHODS,RESULTS,SCALE,SOCIETY,SYMPTOM,THESE,THREE
AIDS,ART,COPD,CXCR4,FIRST,HIV,HOWEVER,SEVERAL,THIRD
010,016,022,028,032,040,169,2014,303,AMONG,BACKGROUND,CHINESE,COPYRIGHT,COX,FOUR,FURTHER,GWAS,HAN,HORMAD2,LABEL,LOG,LTD,MASSARRAY,MATERIALS,METHODS,NSCLC,RESULTS,SIMILARLY,SNPS,THESE,THUS
169,2014,ASIAN,PACIFIC,SOCIETY
179,2006,2012,245,489,500,504,528,946,956,AMONG,AMPC,BSI,CURRENT,EARLY,GRAM,INADEQUATE,JANUARY,JULY,KLEBSIELLA,MDR
100,132,BAL,BDG,GROUP,IFI,INSTITUTES,LABEL,LTD,METHODS,MYCOSES,NIH,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,TEN,TREATMENT,USING
109,114,2001,2011,BACKGROUND,DFI,DUE,FIVE,FOUR,JAPAN,LABEL,LUNG,MEIER,METHODS,PULMONARY,RESULTS,TORANOMON,UNIVARIATE
946,CHANGES,ECLIA,LABEL,METHODS,NSE,OBJECTIVE,PERHAPS,RESULTS,USING
A549,BOTH,CONCLUSION,FITC,FLOW,FMK,HOWEVER,LABEL,METHODS,MTT,NDV,NEWCASTLE,OBJECTIVE,PBS,RESULTS,RVG,TUNEL,VAD,WESTERN
169,2014,969,ADP,CHOP,COPYRIGHT,HUA,INC,NAC,NSCLC,ORYZA,PARP,PBA,ROS,TAKEN
169,2014,709,716,CHINESE,COPYRIGHT,CRE,CREB,CREB1,HOWEVER,INC,MDR,MDR1,THESE
118,1990,2012,244,ACC,CORE,DUE,EXPRESSION,LABEL,METHODS,OBJECTIVE,RESULTS
ANOTHER,IHC,LABEL,METHODS,MSP,OBJECTIVE,RESULTS,THERE
019,101,138,2002,2006,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE,UNIVARIATE
105,124,177,240,262,268,273,276,290,313,326,327,335,537,570,608,615,617,645,669,686,735,947,A549,DMSA,FE2O3,HOWEVER,LABEL,METHODS,MRI,NPS,OBJECTIVE,RESULTS,SPIO,STERILE,T2W
001,003,004,006,007,009,011,020,023,024,048,049,053,1999,2011,8201,BACKGROUND,CONCLUSION,LABEL,METHODS,POST,PPCS,PREDICTORS,RESULTS,THESE
1137,1347,946,BACKGROUND,CNKI,CONCLUSION,CPG,FINALLY,LABEL,METHODS,NSCLC,RAR,RESULTS
CTLA,THERAPIES,TIM
001,033,139,1616,169,16Q21,2014,215,2397,2952,4013,8201,946,998,ASIA,BACKGROUND,COLORECTAL,CSNK2A2,HEART,INC,LABEL,LUNG,METHODS,NEXT,OVARIAN,RESULTS,SCREENING,SIKHS,SOUTH,TRIAL,TWIN,UKCVD
177,1995,2012,AFTER,AIMS,AMONG,BMJ,GROUP,LABEL,LIMITED,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SEVEN,THREE,TREATMENT
169,177,2014,8804,8805,BACKGROUND,COLLEGE,COPYRIGHT,FEV1,FIFTEEN,FVC,INC,INDIVIDUAL,LABEL,MEAN,METHODS,NINE,PATIENT,PFTS,PUBLISHED,RESULTS,TLC,TOTAL
169,174,2014,331NM,595ML,955,CH2,GEFITINIB,HCCH,INC,MOST,P450S,SEVERAL
169,2014,231,956,A549,COPYRIGHT,IC50,MDA,SAR,SAS,STRUCTURE,THESE
169,2014,423,ALU,AUTHORS,BRCA,COPYRIGHT,INC,OLDER,PREVALENCE,PUBLISHED,THERE
100,148,169,1991,2006,2014,COPYRIGHT,FOLLICULAR,IRELAND,LABEL,LTD,METHODS,MOST,MOTOL,MTC,OBJECTIVE,OBJECTIVES,PTC,RESULTS,RET,THYROID,TSH,WDTC
169,201,2014,231,COPYRIGHT,PUBLISHED,REGARDLESS,SAS
169,2014,BOOK,CONCLUSION,COPYRIGHT,DATA,INC,INCREASED,LABEL,METHODS,NURSING,OBJECTIVE,OBJECTIVES,SOURCES
015,110,119,121,129,169,176,2014,442,729,844,ARSENIC,BACKGROUND,ESTIMATING,LABEL,METHODS,PROTECTION,RESULTS,THESE,THUS,WHILE,WORLD
169,2014,946,A549,COPYRIGHT,EMT,GINSENG,HOWEVER,IRELAND,LTD,PANAX,RG3,SMAD2,SNAIL,TAKEN,TGF
169,2014,946,956,A549,COPYRIGHT,DU145,FURTHER,HELA,MCF7,MTT,SAS
169,2014,945,A549,AKT,CCK,CELL,COPYRIGHT,ERK1,HIF,HOWEVER,INC,NSCLC,PI3K,THESE,VEGF
10058,160,ASIAN,JQ1,LIVER,LKB1,MYC,MZF1,NKX2
020,029,169,2014,ASA,COPYRIGHT,EVLW,EVLWI,FIO2,GROUP,INC,LABEL,MAIN,METHODS,OBJECTIVE,OLV,OPERATING,PAO2,PVPI,RESULTS,SETTING,SPO2
001,023,169,2000,2011,2014,457,880,AMONG,BACKGROUND,COPYRIGHT,INC,INFLATION,INPATIENT,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,STATE,WASHINGTON
001,006,014,040,117,169,184,2011,2013,2014,204,253,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,MAJOR,MAY,METHODS,MWA,PUBLISHED,RECORDS,RESULTS,SOCIETY
000,100,160,169,2010,2013,2014,282,394,750,800,862,BACKGROUND,COPYRIGHT,DESPITE,INC,LABEL,MAJOR,METHODS,OCTOBER,PUBLISHED,RESULTS,ROBOTIC,SOCIETY
169,2014,3DRT,AIMS,BED10,COLLEGE,COPYRIGHT,EQD2,HOWEVER,III,IMRT,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
047,160,8201,BRAZILIAN,EGFR,FIFTY,L858R,NSCLC,UNICAMP,WESTERN,WHITE
HCC,HOWEVER,MMP2,MMP9,MVIH,NSCLC,RFS,RNAS,THEREFORE,TNM
001,020,169,2014,317,355,672,8805,APPLIED,BACKGROUND,BIOSYSTEMS,BMI,CHINESE,COPYRIGHT,HAN,KIT,LABEL,METHODS,MULTIPLEX,OBJECTIVE,ORS,RESULTS,SMOKING,USA
549,CONCLUSION,DEVELOPED,IC50,LABEL,METHODS,NAKED,OBJECTIVE,PRE,PURPOSE,RESULTS,RRM1,THESE
003,004,006,087,093,099,100,8201,8226,ARTIFICIAL,BETWEEN,FOM,FROC,KEY,LABEL,METHODS,OBJECTIVE,PULMONARY,RESULTS,THREE
1156,169,2014,954,COPYRIGHT,ESPECIALLY,H23,LPS,LTD,NCI,SAR
BONE,LABEL,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,SUMMARY,THERE,THESE
100,169,2014,AFTER,APART,CARDIOLOGY,DESPITE,FINALLY,PUBLISHED,SOCIETY
169,2014,ALK,CONCLUSION,COPYRIGHT,EGFR,EML4,FFPE,FISH,HOWEVER,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,USING
001,009,016,058,169,2014,AFRICAN,AMERICANS,BACKGROUND,CAUCASIANS,COPYRIGHT,CTR1,EXPRESSION,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
000,001,022,038,15MM,169,2014,234,8804,COPYRIGHT,FDG,FIRSTLY,IRELAND,LABEL,LAC,LACS,LSCC,LSCCS,LTD,METHODS,NPV,OBJECTIVE,OBJECTIVES,PET,PPV,RESULTS
169,2014,COPYRIGHT,FDG,HOWEVER,HRCT,INC,PET,PUBLISHED,SOCIETY,USING
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY,TNM
169,2014,233,BARR,COPYRIGHT,GBS,INC,PUBLISHED,SOCIETY
169,2014,COPYRIGHT,INC,PUBLISHED,SIX,SOCIETY
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2014,215,A549,COPYRIGHT,EVALUATION,H460,H520,INC,LABEL,METHODS,MICE,NSCLC,OBJECTIVE,ONTARIO,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE,UNDER
004,145,169,177,2010,2011,2013,2014,238,244,492,637,AWARENESS,BACKGROUND,BUNDLED,CARE,CENTERS,COPYRIGHT,INC,INITIATIVE,LABEL,MEAN,METHODS,PUBLISHED,RESULTS,SOCIETY,VATS
BCG,DESPITE
200,200C,200S,GAPB,LOSS,NRF2,PRDX2,SESN1,ZEB1
8804,CALGB,CTAB,MINIMALLY,REGARDING,WJTOG4607L
000,005,100,161,2003,2011,775,BACKGROUND,CAUSE,CONTROL,DISEASE,LABEL,MEDICAL,METHODS,PREVENTION,RESULTS,THERE,WHILE
169,2014,ERS
A549,ADCC,CONCLUSION,EGFP,EGFR,LABEL,METHODS,NKTM,OBJECTIVE,RESULTS
100,145,205,549,620,AMONG,CNS,COLO,FURTHER,H23,HELA,HEP,HOLARRHENA,HOWEVER,IMR,MCF,NCI,NIH,OVCAR,SIHA,SRB
DISCUSSION,FDG,FOLLOWING,PET,PPSS
142,147,183,184,215,956,A549,ACCEPTABLE,AGNO3,AGNPS,AGRIMONIAE,FOURIER
MDSC,MDSCS,MYELOID,TARGETING,TNF,TRAIL,TREATMENT
169,2014,204,248,APART,BACKGROUND,HRS,LABEL,METHODS,NMSC,RESULTS
120,169,1999,2011,2014,BACKGROUND,BLEOMYCIN,HODGKIN,INC,JANUARY,LABEL,METHODS,NON,PFT,RESULTS,WILEY
169,17A,2014,239,301A,947,DCS,DENDRITIC,IFN,LNS,LUNG,MEANWHILE,PROFILING,STRIKINGLY,TAKEN,UICC,USING
143,160,239,CNS,EGFR,NSCLC,PCR,T790M,THERE,TKI,TKIS
AKT,CCK,ERK,HOWEVER,LSCC,PROTEIN,PTK7,UPON
A549,CDDP,CISPLATIN,CONVERSELY,CX43,EMT,NSCLC,SLUG,SNAIL,THUS
CSCS,ELISPOT,MARKERS,NLSS,PADRE,SOX2,THESE,TREG,WHILE
160,EGFR,ERBB2,ERBB3,H1975,HEAT,HSP90,T790M,TKIS,WK88
163,169,2014,8201,CAREGIVER,CITY,CONCLUSION,COPYRIGHT,FCG,FCGS,HOPE,III,JOHN,LABEL,LTD,METHODS,OBJECTIVE,QOL,RESULTS,SCALE,SECONDARY,SONS,THESE,VERSION,WILEY
100,26S,A549,H1299,HOWEVER,MG132,MMP,NSCLC,TAKEN,THEN,UPS,WEE1
1643,2013,BACKGROUND,CIPN,LABEL,METHODS,QOL,RESULTS,SURVIVORS,THESE,WHILE
169,2014,BRCA,HER2,KRAS,UICC
028,031,036,109,210,360,537,653,716,782,ALTERED,BACKGROUND,COX,DFS,DISEASE,DSS,HAZARDS,HOWEVER,LABEL,MEIER,METHODS,NSCLC,RATIO,RESULTS
133,591,FACTORS,KPS,LOCAL,OVARIAN,YALE
ELISA,EMT,EPITHELIAL,HOWEVER,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,STAT3,WESTERN
169,2014,882,CEC,EOF,ESI,GMBH,HIGH,KGAA,OVERALL,QTOF,THREE,VCH,WILEY
THEREFORE
ASSESSMENT,BACKGROUND,CAD,CHEST,DIGITAL,HOWEVER,LABEL,METHODICAL,METHODS,RESULTS
169,2014,AACR,ABL,ALK,BCR,BRAF,EGF,HOWEVER,MECHANISMS,OFTEN,RESISTANCE
111,ANDALUSIA,ATNEA,DATA,FINALLY,LABEL,METHODS,NET,NETS,OBJECTIVE,PURPOSE,RESULTS,SEX,SPMS
CD137,CPG,CPG1826,HOWEVER,MC38,ORTHOTOPIC,RENCA,THUS,TLR9
00001,1167,563,604,AMIFOSTINE,ASCO,BACKGROUND,CENTRAL,CNKI,CONCLUSION,ESMO,GRADE,HNSCC,HOWEVER,LABEL,MEDLINE,METHODS,RCTS,RESULTS,SEVENTEEN
104,169,172,2014,8201,8804,BACKGROUND,DISEASE,EGFR,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMALL,TKI,WILEY
GCTB,GIANT,GLY34,H3F3A,HISTONE,LABEL,LEU,MALIGNANT,OPINION,RANKL,STATEMENT,SURGERY,TRP,UNASSIGNED
26A,8209,AKT,CPG,EXPRESSION,H460,MICRORNAS,ODN,PI3K,RNAS,TCN,THESE,TLR9,TOLL
160,181,8209,A549,CELLS,IHCH,LC3,THESE
177,181,8209,A549,BASED,DDP,FLOW,GROUP,MTT,TRANSWELL
169,2011,2013,2014,COPYRIGHT,HISTOLOGIC,INC,LABEL,MATERIALS,MAY,MEAN,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,PURPOSE,RESULTS,SIR,THERE,VATS
004,039,169,2014,8805,IGG,IGM,IIIB,L1210,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,TREATMENT
013,215,409,8201,8226,ACCORDING,ADC,AUC,DCE,IVIM,KEY,LABEL,LUNG,METHODS,MRI,OBJECTIVE,OBJECTIVES,PARAMETERS,PERFUSION,PET,POOR,RESULTS,ROC
001,041,092,8202,8310,AUROC,CAPILLARY,ELISA,III,INTRA,MANN,MEAN,MEIER,MVD,NPAA,NSCLC,THESE,TSP,VEGF,WHITNEY
100,5A4,ABCAM,ALK,ALK1,ANTIBODIES,BACKGROUND,CUTOFFS,D5F3,DAKO,DETECTION,EGFR,FIFTEEN,FISH,IHC,INTENSITY,LABEL,METHODS,OCCASIONAL,RESULTS,VENTANA
BACKGROUND,CONCLUSION,GEFITINIB,LABEL,LITERATURE,METHODS,PIS,RESULTS,THERE
18F,BACKGROUND,BOTH,CONCLUSION,FDG,HOWEVER,HRS,LABEL,METHODS,NSCLC,PET,PRIMARY,RESULTS,SBRT,STATA,SUV,VERSION
101,104,121,701,777,BACKGROUND,FOUR,LABEL,METHODS,RESULTS,SEVENTY,SOLID
1000,500,7686,ALDH1,AUC,BMI,CD133,CHINA,CSC,EPCAM,FURTHER,HOWEVER,LUNG,MUSASHI,ROC,SNPS,USING
116,169,2011,2014,2030,215,COMMUNITY,COPYRIGHT,EASTERN,HOWEVER,INC,LABEL,METHODS,MINOR,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,WESTERN
FAB,IGG,LATE,LUNG,MASS,PAGE,SDS,SEVERAL
169,2005,2014,COPYRIGHT,SAS,THUS
AIMS,ALCAM,AUC,CDH1,MPE,MRM,MUC1,PES,QCONCAT,SIS,SVEP1,THBS4
001,105,169,2014,8804,AFTER,BACKGROUND,CHEST,CONCLUSION,CONFIRMED,COPYRIGHT,GGO,HOWEVER,LABEL,LTD,METHODS,MILIARY,RESULTS,THEREFORE
110,946,953,954,955,BECAUSE,FUNCTIONAL,HER2,IDC,IL1,OVERALL,PKC,RELA,TGF,THUS,TNBC
100,169,2014,GLYCOLYTIC,INCREASED,INHIBITION,K100,K100Q,NADPH,PGAM,PGAM2,RNAI,SIRT2,THESE
120,ADMQ,BETWEEN,EGFR,HPLC,MAG,MAG3,SPECT,THEIR
1993,2001,504,AFTER,BACKGROUND,CIS,COLORECTAL,COX,HRS,LABEL,LUNG,METHODS,OVARIAN,PLCO,RESULTS,SCREENING,TRIAL,USING
120,8962,ABO,DISEASE,EMR,EMRS,IKZF1,SIMILARITY,SIMILARLY,VARIMED
033,266,307,AIM,CACA,CHINESE,CONCLUSION,GSTP1,HAN,LABEL,METHODS,MOP,MPO,OBJECTIVE,PCR,PHASE,RESULTS,SNP,SNPS
001,003,ADC,CONCLUSION,CRS,DWI,JAPAN,KNOWLEDGE,KOBE,LABEL,MANN,MCNEMAR,METHODS,MRI,NSCLC,OBJECTIVE,PULMONARY,RESULTS,SCLC,STIR,THERE,UNIVERSITY,WHITNEY
ESS
140,293,450,BACKGROUND,CONCLUSION,HEK,HELA,LABEL,METHODS,RAMOS,RESULTS,XRCC,XRCC4
100,130,131,2010,2012,AFTER,CSF,DISTANT,FFP,HISTOLOGY,HOWEVER,LABEL,LOCAL,METHODS,OBJECTIVE,PERMANENT,RESULTS,SECONDARY,SRS,THERE,THESE,WBRT
177,178,185,8309,BASED,DSA,EVERY,LABEL,METHODS,NRS,OBJECTIVE,RESULTS,TPS,UNDER
000,001,002,007,008,017,032,035,050,124,125,2005,2011,2013,6TH,AMONG,CRT,DFS,DISTANT,DMFS,IMRT,JANUARY,LABEL,LRC,LUNG,MAY,METHODS,N2B,OBJECTIVE,RESULTS,SCCHN,TNM,UNIVARIATE
117,1998,2009,AMONG,AUCB,LABEL,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,THEIR
705,814,AAH,AIS,AUC,CONCLUSION,GGN,GGNS,IAC,LABEL,METHODS,MIA,OBJECTIVE,RESULTS,SPSS,THERE
135A,169,2014,205,577,8805,896,944,ACS,COPYRIGHT,DEEP,EVALUATING,FEDERATION,NON,NSCLC,PCR,PUBLISHED,SCC,SCCS,SEVEN,SOCIETIES,SOCS4
258,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEX,SUV,THERE,UNIVARIATE
BACKGROUND,CONCLUSION,FIFTY,HOWEVER,HRS,LABEL,MATERIALS,MAXIMAL,METASTASIS,METHODS,MVM,MVN,MVT,MVWB,OVERALL,PET,RESULTS,SUV,SUVM,SUVN,SUVS,SUVT,SUVWB,TLG,TLGM,TLGN,TLGT,TLGWB
263,656,677,697,702,717,732,741,BACKGROUND,COPD,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,PRIMARY,RATIONALE,RESULTS,VARIOUS
ANTISENSE,BRCA2,IDO,NAD,PARP
001,25X,975,ALSO,CINE,LABEL,LINAC,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
EQA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBA
174,BOT,BOTH,DESPITE,DOSE,HT1,HT2,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSS,RSS2,RSS5,WBHA
029,103,177,538,ADDITIONAL,BLOCKED,CARLO,ICRP,LABEL,LAR,METHODS,MONTE,OBJECTIVE,PARA,PURPOSE,RESULTS,TESTICULAR
945,954,CONSISTENT,HELA,IFN,INTERFERON,MMP,MMP12,THESE,WHEREAS
ENDOSCOPIC,HAMARTOMAS
163,263,444,507,AFTER,ALTERED,PATIENT,PEEP,RPE
100,BACKGROUND,LABEL,MANN,METHODS,PAIN,PCEA,PTPS,RESULTS,THERE,VAS,WHITNEY
350,370,8201,BLOOD,CA19,CA242,CA724,CEA,CRC,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,THESE,TNM
003,284,285,546,630,731,8805,945,946,ALSO,PCR,PI3K,PI3KS,PIP3,REAL
181,AFTER,GIVEN,IC50,KING,LAAO,THESE,TUNEL
ASIA,EASTERN,GASTRIC,HOWEVER,THERE,THESE
139,1533,169,1966,2000,2014,477,COX,HEMATOLOGY,MINNESOTA,OLMSTED,RECURRENCE,SOCIETY,VTE
169,2014,FINALLY,FIRST,MEDICAL,PRESS,PUBLISHED,SOCIETY,THERE,THROUGH,UNIVERSITY
169,2014,482,CD98,CHINESE,FUNCTIONAL,INC,MEIER,NON,NSCLC,SNP,SNPS,WILEY
169,174,2009,2013,2014,8201,BACKGROUND,CONVERSION,COPYRIGHT,JOHN,LABEL,LTD,MAY,METHODS,RATS,RESULTS,SONS,VINCI,WILEY
2005,2006,2011,378,399A,46T,ARG194TRP,ARG399GLN,BLOOD,ERCC5,GENOMIC,HIS1104ASP,HRS,JANUARY,KIT,NSCLC,PFS,RESULTS,SIMILARLY,XRCC1
160,169,183,CTLA,ESPECIALLY,GEORG,IPILIMUMAB,IRAE,IRAES,STUTTGART,YORK
185,1988,200,DIGESTION,ECL
ATP,CHLAMYDIA,CPN,IGA,III,MEIER,NSCLC,TESTING
145,169,2014,AKT,AKT3,PI3K,SERUM,SOCIETY,VEGF
175,177,196,472,A549,IC50,III,LUNG,MDR,MDR1,NH3,RESULTS,RUCL2,TAKEN
001,237,8804,956,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
150,200,420,8201,AFRICAN,ALK,AMERICANS,CYP3A,EGFR,EML4,ERLOTINIB,KRAS,LOW,NSCLC,OSI,TTP
169,2001,2007,2014,8805,ASIAN,BASED,CCOP,COMMUNITY,CONCLUSION,COPYRIGHT,FORTY,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,PBRN,PROGRAM,PURPOSE,RESULTS,SEER,SOCIETY
008,009,022,048,0GY,10878,169,2014,362,65YEARS,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FURTHER,HOWEVER,III,LABEL,LARGE,LIN28,LTD,METHODS,MLD,NSCLC,PUBLISHED,RESULTS,SNPS
169,2014,PRESS,PUBLISHED,PULMONARY,SURGERY,UNIVERSITY
169,2014,758,847,AAL,ADLC,AGP,ALEURIA,AUROC,BIOLOGICAL,COPYRIGHT,ELISA,LABEL,MRM,THEREFORE,UNASSIGNED,UNLABELLED
169,2014,BOTH,COPYRIGHT,IDIOPATHIC,IPF,LTD
169,2014,COPYRIGHT,SAS,VISIBLE
1986,2007,279,DUTCH,HOWEVER,OFFERMANS
169,2014,COPYRIGHT,INC,SEVERAL
169,2014,COPYRIGHT,INC,INITIAL,ROBOTIC
169,2014,COPYRIGHT,INC,ROBOTIC,VATS
169,2014,COPYRIGHT,INC,ROBOTIC,TECHNICAL,THERE,VATS
169,1992,2014,ADVANTAGES,COPYRIGHT,HOWEVER,INC,LOBECTOMY,VATS
169,2014,COPYRIGHT,ENTRY,HIGH,INC,STUDIES
152,169,2014,ADAM,COPYRIGHT,FEDERATION,MICRORNAS,NSCLC,PUBLISHED,RNAS,SOCIETIES
169,2014,ADCC,BACKGROUND,CETUXIMAB,CISPLATIN,COPYRIGHT,DATA,DOCETAXEL,FREQUENCY,HOWEVER,IIIA,IRELAND,LABEL,LTD,METHODS,NSCLC,REGULATORY,RESULTS,TREG
00001,169,2014,491,499,990,BACKGROUND,COPYRIGHT,EGFR,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,ORR,PFS,RANDOMIZED,RESULTS,SIX,TKI,TKIS,WHETHER
169,2014,BRITISH,CTCL,FIVE,FMF,MYCOSIS,STUDIES,THESE
001,006,011,020,074,131,340,342,ALSO,AOPP,AOPPS,BACKGROUND,CRP,FRAP,LABEL,METHODS,MLR,PAB,PCO,RESULTS
00001,0221,101,2006,2011,AIMS,AMONG,BACKGROUND,CRC,FREE,LABEL,METHODS,OBJECTIVE,OVERALL,PFS,RESULTS
100,1996,2013,ADR,AIMS,BACKGROUND,CDDP,CITA,III,LABEL,MEDICAL,METHODS,NAC,OBJECTIVE,PLADO,PRETEXT,RESULTS,TEN,THP
089,094,095,106,177,99MTC,AIM,AMONG,BACKGROUND,CONCLUSION,CURRENTLY,INDIVIDUAL,LABEL,METHODS,MIBI,OBJECTIVE,RESULTS
001,003,6007C,938,BMP,III,NSCLC
100,160,169,200,2014,208,ASSESSMENT,CHRONIC,CNS,CONCLUSION,FACIT,FATIGUE,FUNCTIONAL,ILLNESS,LABEL,METHODS,MODAFINIL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SOCIETY,THERAPY,THERE
169,2013,3LL,AACR,ANTIBODIES,FINALLY,GAPDH,HSP90,LOWER,MOST,TAA,TAAS,USING
158V,169,2014,947,950,AACR,ADCC,CD16,CD2,CD20,CD28,CD3,IIIA,NFAT,NUCLEAR,RAJI
MICRORNAS,RNAS,SIX,TNRC6,TRIPARTITE
181,217,418,8901,HOWEVER,NADPH,TRP14,TRX,TRX1,TRXR1,TXNDC17,TXNL5
ALK,BACKGROUND,CONCLUSION,LABEL,MALIGNANT,MATERIALS,METHODS,NONE,RESULTS
CONCLUSION,CTC,CTCS,LABEL,MALIGNANT,METHODS,MPM,RESULTS,UNLABELLED
001,036,150,AIM,CCRT,CONCLUSION,EARLY,III,LABEL,METHODS,NSCLC,OBJECTIVE,PET,RESULTS,SRR
001,002,014,028,041,131,215,8805,AIM,BACKGROUND,CONCLUSION,ECOG,LABEL,METHODS,MSCC,NSCLC,OBJECTIVE,RESULTS
112,AIM,CONCLUSION,FDG,LABEL,METHODS,MTV,NSCLC,OBJECTIVE,PFS,PRIMARY,RESULTS,SUVM,TLG,TTF1
013,015,031,036,209,328,BACKGROUND,CONCLUSION,LABEL,METHODS,MIE,PCS,PULMONARY,RESULTS
100,1246,146B,199B,205,2110,216A,217,29B,29C,375,552,592,617,AIM,BACKGROUND,CONCLUSION,FORTY,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PROMINENT,RESULTS,SCLC,SCLCS
LEWIS,NATURAL,THESE,THROUGH
ALPHA,ATP,OUABAIN,SINCE
792,ASSAY,BACKGROUND,CONCLUSION,ELISA,FORTY,LABEL,MATERIALS,METHODS,RESULTS,THYMIDINE,TK1
106,145,34B,34C,486,A549,BACKGROUND,BEAS,BMP,BMP2,CONCLUSION,DMH1,DMH4,HIGH,LABEL,LDN,MATERIALS,METHODS,MICROARRAY,REDUCED,RESULTS,THREE
169,1990,2014,HODGKIN,INC,MOST,PET,PPHL,PRIMARY,WILEY
001,0013,0017,2011,2013,3145,EGFR,EGPR,GEFITINIB,HOWEVER,L858R,MAY,MEIER,MOST,OBJECTIVE,PFS,THEREFORE
01910,169,2014,AUTHORS,DNMT,JOHN,LTD,MDS,MOST,PROGNOSTIC,REVISED,RIGOSERTIB,SCORING,SONS,TRIAL,WILEY
CIMAVAX,COMBINING,EGF,HOWEVER,THEREFORE
117,119,2002,2011,MANAGEMENT
107,124,131,167,169,2013,8764,AACR,BODY,BONE,COMMISSION,GBQ,IEC,MBQ,PET,PHANTOM,RIT
169,2013,AACR,DESPITE,THESE
A549,ADP,ARA,GAL,GAS,GLC,LDH,MTT,PARP,RHA,TAKEN,WLSP
0001,0003,0004,0006,0112,107,169,2014,207,212,243,245,261,276,281,295,488,8193,CONCLUSION,COX,FDG,IMAGING,INC,LABEL,MEIER,METHODS,MOLECULAR,NUCLEAR,OVERALL,PET,RESULTS,SOCIETY,THERE,UNLABELLED
169,177,2014,A549,ADC,BRDU,CONCLUSION,EBC1,FDG,FLT,FOUR,GLUCOSE,H1975,HOWEVER,HTB56,IMAGING,INC,KI67,LABEL,METHODS,MOLECULAR,NUCLEAR,PET,RESULTS,SOCIETY,THESE,THYMIDINE,TK1,UNLABELLED,WESTERN,XENOGRAFTS
169,2014,BACKGROUND,BASEL,CASE,CONCLUSION,HOWEVER,IMAGING,LABEL,METHODS,THAI
8197,CD11B,CXCR4,FURTHER,STUDIES
160,169,2014,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PANEL,PUBLISHED,RESULTS,SOCIETY
026,142,1985,1997,2012,225,239,8201,956,AIDS,ART,BACKGROUND,CD4,HIV,HODGKIN,HOWEVER,JAPAN,LABEL,MALIGNANT,MEAN,METHODS,NON,RESULTS
006,017,022,169,2014,793,ALK,ANAPLASTIC,CHINESE,COPYRIGHT,EGFR,INC,LIMITED,SRC
0001,0089,0444,130,169,2014,COPYRIGHT,INC,PRMT5
169,194,201,2014,3CM,8804,8805,COPYRIGHT,DIAGNOSTIC,EBUS,FDG,HIGH,HOWEVER,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PLC,RESULTS,TBB,VBN
169,2014,ASIA,AUTHORS,BIOLOGY,CDC6,CELLS,CHIP,DEPLETION,JAPAN,LTD,MOLECULAR,NSCLC,PTY,PUBLISHING,SOCIETY,WILEY
169,2014,9766,BASIL,BAY86,COPYRIGHT,ERK,FURTHER,HOWEVER,INC,MEK,NEXAVAR,RAF,RAS,SORAFENIB,VEGFR
100,174,179,196,199,2008,621,BACKGROUND,BLOOD,CONCLUSION,EGFR,INC,LABEL,LUNG,MARCH,METHODS,MOLECULAR,MUTATIONAL,PAIRS,PCR,RESULTS,ROCHE,SIX,SYSTEMS,TEST,TRIAL,USA
ANTI,BACKGROUND,CASE,CONCLUSION,DISTANT,FNAB,LABEL,MALIGNANT,METHODS,SEVEN
956,COMPOUNDS,FCM29,H522,IC50,PLASMODIUM,TURRAEA
CD40,CD40L,NSCS,THROUGH
BML,LWVI
ALK,FISH
MPNST

169,178,197,1995,2013,2014,253,268,292,422,633,CASE,CASES,EMPHYSEMA,HOWEVER,JULY,LABEL,LUNG,LVRS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PRESS,PROLONGED,PUBLISHED,RESULTS,SIX,SURGERY,THERE,TREATMENT,TRIAL,UNIVERSITY
DISCOID,PULMONARY
BACKGROUND,DOX,LABEL,METHODS,MOST,RESULTS,SABOURAUD,THERE
169,2014,958,AMONG,GMBH,KGAA,METABOLIC,URINE,VCH,WILEY
169,2014,8804,AMONG,ATLAS,FGF2,FGF9,FGFR,FGFR1,GCN,IC50,KRAS,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC,SCCS,TCGA,TKI,TKIS
001,011,044,169,2008,2012,2014,202,EGFR,EMT,EPITHELIAL,JUNE,NSCLC,SEPTEMBER,TKI,TKIS,UICC
CURRENTLY,DATA,LCNEC,NETS,NEXT,NGS,SCLC,WHILE
1037,133,169,1990,2008,2014,202,639,851,944,BACKGROUND,BJS,CONCLUSION,COUNCIL,ENGLAND,JOHN,LABEL,LTD,METHODS,NETWORK,ORGAN,PUBLISHED,RESULTS,SHARING,SOCIETY,SONS,TRANSPLANT,WILEY
100,169,2014,LUNG
169,2014,PRESS,PUBLISHED,SURGERY,UNIVERSITY
ATP,ERK1,H460,MET,SINCE
282,289,744,8201,8805,DIAGNOSTIC,END,FACTORS,HRQOL,INTERVIEW,LABEL,LUNG,MDD,METHODS,MHOS,OBJECTIVE,POR,PROGRAM,PURPOSE,RESULTS,RISK,SEER,SURVIVORS,UNASSIGNED
FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
004,010,013,016,050,125,146,205,263,291,346,431,474,659,676,818,854,BACKGROUND,EGFR,HIGH,HOWEVER,LABEL,METHODS,RESULTS,THEREFORE,TKI,YAP,YES
150,2055,8805,BACKGROUND,FIVE,FOUR,GRADE,HIGH,IMO,LABEL,METHODS,NSCLC,RESULTS,RP2D,TEAES,TLR9,TOLL
000,009,015,021,547,ADAM9,BACKGROUND,CONCLUSION,HDGF,LABEL,METHODS,NSCLC,PEARSON,RESULTS,SIXTY,THESE
177,AFTER,APC,BACKGROUND,FORTY,LABEL,METHODS,PHONE,RESULTS,THEIR
100,DETECTION,EGFR,HOWEVER,KRAS,L858R,PAP,PCR,T790M,THUS
536,609,737,ABT,BCL2,BH3,CONVERSELY,H1299,K48,KU70,MCL,MEF,THESE
HEALTHCARE,LABEL,LOUISVILLE,LUNG,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,OUTPATIENT,PURPOSE,RESULTS,SELF,SETTING,VARIABLES
001,008,169,2008,2011,2014,3622,3861,AFTER,AMONG,BACKGROUND,CADMIUM,COPD,COPYRIGHT,CROSS,HOWEVER,INC,KOREA,LABEL,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,453,CONVERSELY,CSF1,FOS,HOWEVER,MMTV,NCOA1,SRC
001,169,200B,2014,COPYRIGHT,EXACT,EXPRESSION,H69AR,HOWEVER,INC,INHIBITION,KNOCKDOWN,LUCIFERASE,MEIER,SCLC,TEST,UTR,ZEB2,ZINC
12A,13A,13K,13L,169,2014,549,AMONG,ATP,COPYRIGHT,HELA,MCF,MDR,MTT,SAS
169,2014,COLORECTAL,COMMITTEE,COPYRIGHT,CRC,ENDOSCOPY,ENGLAND,FIT,FOBT,GROUP,INC,PUBLISHED,SCREENING,SOCIETY,SPH,SUCCESSFUL,WORKING,WORLD,WORLDWIDE
169,200,2014,492,500,956,970,BACKGROUND,CHINA,CONCLUSION,COPYRIGHT,FLOW,HBE,HOWEVER,IRELAND,LABEL,LTD,METHODS,PATHWAY,PM2,RESULTS,THESE,WUHAN
0001,169,174,181,2014,3337,368,BACKGROUND,COPYRIGHT,HALF,IARC,INC,LABEL,LUNG,METHODS,OTHER,RESULTS,RRS,SMR,SMRS,THERE
169,2012,2014,BRD,CONCLUSION,COPYRIGHT,DAD,III,INC,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS,T1ER
169,2014,BIOLOGICAL,COPYRIGHT,COX5,DB1,DJ1,ESI,FTL,GDP,HSP27,LABEL,MTPN,PROTEOMICS,PSME1,REMARKABLY,RHO,SH3BGRL,SOD1,THERE,TNBC,UBE2N,UNASSIGNED,UNLABELLED
169,2014,945,946,9NM,ABELSON,ABL,ASP,ATP,COPYRIGHT,DDR,DDR1,DDR2,DDRS,DFG,EXCESSIVE,GLY,IC50,LTD,PHE,PONATINIB,PUBLISHED,WHEREAS
169,17F,2014,841,C57BL,CCD,CHOP,CON,COPYRIGHT,EBP,ERLOTINIB,IEC,INC,INTESTINAL,KNOCKDOWN,NSCLC
001,169,177,1MM,2014,COPYRIGHT,EGFR,EVEROLIMUS,EXPRESSION,FOUR,INC,L858R,MTT,THESE,TRANSGENIC
INC,PUBLISHED
169,2014,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STAGE
034,169,2014,213,AIM,CONCLUSION,COPYRIGHT,DETECTION,EGFR,INCIDENCE,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,PFS,PRIMARY,RESISTANCE,RESULTS,SCLC,SIXTY,T790M,TKI,TKIS,WHETHER
016,018,077,145,147,169,175DAYS,2014,233DAYS,338,505,534,917,AMONG,AUTHORS,BACKGROUND,BECAUSE,CAUCASIAN,COPYRIGHT,EASTERN,ECOG,G12V,G12X,GROUP,III,KRAS,LABEL,LTD,METHODS,PFS,PUBLISHED,RESULTS,WHILE
116,169,2014,946,BAL,BOTH,COPYRIGHT,CROWN,IFD,INC,IPA,PCR,PUBLISHED
169,177,2014,7NM,947,99M,A549,BACKGROUND,COPYRIGHT,EPH,EPHA2,HYNIC,INC,LABEL,METHODS,MICE,OCM,PRE,RESULTS,SATURATION,SPECT,SWL,THEREFORE,THESE
169,2014,904,ALK,AMONG,BACKGROUND,BRAF,COPYRIGHT,EGFR,FISH,HER2,HISTOLOGIC,HOWEVER,IRELAND,KRAS,LABEL,LTD,LUNG,METHODS,MIB,PCR,RESULTS
001,101,121,160,169,177,196,2002,2010,2014,821,8804,BACKGROUND,BETWEEN,COPYRIGHT,INC,INCIDENCE,JANUARY,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
001,002,010,021,033,114,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CULLIN1,GMBH,IHC,LABEL,METHODS,NSCLC,PUBLISHED,RBX1,RESULTS,SKP1,THESE
169,2014,COPYRIGHT,IRELAND,LTD,SCLC,TREATMENT
0055,0181,0375,0381,0437,0443,0452,0458,169,2014,945,AFP,COPYRIGHT,GASTRIC,HEPATOCYTE,INC,PLUNC,SAL,SALL4,THERE
114,169,2014,226,COPYRIGHT,E318K,INC,MITF,V320I
160,248,BACKGROUND,DISCUSSION,ESOPHAGEAL,LABEL,METHODS,PREPARE,SECONDARY,TRIAL,WHILE
10878,169,2003,2012,2014,2MONTHS,3481,4996,6MONTHS,BACKGROUND,COPYRIGHT,CRLM,EHD,JANUARY,JUNE,LABEL,LTD,META,METHODS,PRIMARY,RESULTS
2000,ANNEXIN,APOPTOSIS,BACKGROUND,CLUSTERIN,FITC,HEP,LABEL,LSCC,METHODS,MTT,PCR,RESULTS,TUNEL,WESTERN
137,141,169,177,2014,8201,AUSTRALIAN,AVERAGE,BACKGROUND,COLLEGE,CONCLUSION,DATA,GTV,GTVS,LABEL,METHODS,MID,NSCLC,RESULTS,ROYAL,SBRT,ZEALAND
169,2014,ACADEMY,ALLERGY,BECAUSE,COPYRIGHT,DESPITE,HOWEVER,IMMUNOLOGY,INC,LARGE,META,MOSBY,PUBLISHED,STUDIES
33258,945,946,BACKGROUND,BBR,BERBERINE,BLOT,CHINESE,CIP1,CONCLUSION,ERK1,EXOGENOUS,FOXO3,HOECHST,LABEL,MAPK,METHODS,MTT,NSCLC,PD98059,PIFITHRIN,RESULTS,RNAS,SILENCING,WAF1,WESTERN
001,003,005,008,016,046,160,169,2009,2011,2014,376,4215,8804,COPYRIGHT,DLCO,FEV1,GENERAL,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PPOFEV1,PUBLISHED,RESULTS,SIMILAR,SOCIETY,SURGERY,THESE,UNIVARIATE,VATS
945,BACKGROUND,BLOOD,BUFFALO,CXCR3,EPCS,HCC,HO1,HOWEVER,IL6,LABEL,MAJOR,MCA,METHODS,RESULTS,TNF,TREGS,YQ23
169,2006,2010,2014,624,ACADEMY,AMONG,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,DYSPNEA,HOSPICE,INC,LABEL,METHODS,MINIMAL,OBJECTIVE,OBJECTIVES,PALLIATIVE,PUBLISHED,RESULTS,YOUNGER
170,2008,500,8805,BACKGROUND,CONCLUSION,III,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,ORR,ORRS,OVERALL,PFS,RESULTS,TRIAL
144,169,2000,2006,2007,2014,340,AHI,FIVE,FOUR,HISTOLOGIC,III,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,NOS,NSCLC,OBJECTIVE,PCE,PPV,PUBLISHED,PUE,PURPOSE,QUALITY,RADIATION,RESULTS,SBRT,SCLC,SOC,SOCIETY,THESE
169,2014,8776,ALIGNRT,COPYRIGHT,DIBH,DRR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY,THERE,THREE,VARIATIONS
001,007,012,016,017,034,040,049,169,2014,BETWEEN,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SABR,SIMILARLY,V10,V20,V30,VMAT
0001,0005,003,169,2014,ABC,FORTY,FURTHER,HODGKIN,IFRT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,V20
169,177,2014,4DCT,FIRST,FULL,INC,ITV,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PTVS,PUBLISHED,PURPOSE,RESULTS,SIMPLIFIED,THESE
001,8201,AP2,BACKGROUND,ERK,HOWEVER,LABEL,METHODS,NSCLC,PEDF,RESULTS,THEN,THESE,VEGF
177,946,99M,A549,ALZHEIMER,CUR,DAC,GALLIUM,NMR
945,CURRENT,FOLLOWING,LNS,NPC,NTP,PBS
1058,1650,443,AREAS,BACKGROUND,COVERED,DEPENDING,HAGE,INVENTION,LABEL,METHODS,OPINION
140,A549,C57BL,CPA,CYPB6TM,E7CD8,EXPRESSION,GDEPT,HPV,NADPH,P450,RED,TC1,THESE
383,9487,9499,AFP,AFTER,AIM,ALPHA,CONCLUSION,GLISSONEAN,LABEL,METHODS,OBJECTIVE,RESECTION,RESULTS,SEGMENT,SELECTIVE,THERE
HEREAFTER,HOWEVER,RESECTION,SBRT
ACTL8,ATLAS,CSAG,CTS,CURRENT,CXORF61,HORMAD1,MAGE,PRAME,TCGA,THESE,THUS
CD14,INCREASED,PBMC,PBMCS,PROGRAMMED,RCC,WHILE
001,169,2014,BAL,BLOT,COMPARING,HOWEVER,INC,MICROSCOPY,PCR,WESTERN,WILEY
001,AFP,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
000,011,270,COX,MCM7,MEIER,NEK2,NSCLC,THUS
BRMS1,EXPRESSION,HBEC3,NSCLC,RAS,THESE
8230,BACKGROUND,ISTAT,LABEL,MAIN,METHODS,OVERALL,RESULTS,SMR
160,169,2014,956,CNS,COMPOUNDS,COPYRIGHT,GI50,SAS
2009,2012,8201,JANUARY,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OFF,PURPOSE,RESULTS,ROME,THREE,UNIT,UNIVERSITY
916,968,A549,AKT,BCL,ERK,HOWEVER,INHIBITORS,ROS,SEC,TAKEN,TRXR,TRXR1
ALDH,ALDH1A1,ALDH3A1,ALDH7A1,BACKGROUND,DU145,LABEL,METHODS,PCSCS,PIN,RESULTS,WHEREAS,XENOGRAFT
000,136,145,147,152,177,2012,2013,525,596,AFFILIATED,CONCLUSION,DEPARTMENT,DNMT1,ELISA,FIRST,HDAC1,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIXTH,THERE,UNIVERSITY,ZHENGZHOU
000,001,113,198,2011,2012,239,612,CHI,DCR,JANUARY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,THEIR,THREE,XINQIAO
000,006,021,049,8804,946,BACKGROUND,CHINESE,EGFR,ERCC1,III,INCREASED,LABEL,MANN,METHODS,NSCLC,RESULTS,RRM1,SEVENTY,TUBB3,TYMS,WHITNEY
0001,0006,169,2014,372,716,AMONG,BACKGROUND,COMMUNITY,LABEL,MEAN,METHODS,ORS,RESULTS,SEPP1
100,210,218C9,300,43B2,6B6,CAUCASIAN,CELL,COPENHAGEN,DAKO,EGFR,EXTRACTED,HIGH,HOWEVER,NSCLC,PCR,POSITIVITY,PROTEIN,REFINEMENT,SEVEN,SIGNALING,TECHNOLOGY,USA
0001,115,143,191,225,347,368,385,406,8805,FGFR1,FISH,HIGH,LOW,SISH,THERE
IIIB
105,242,BACKGROUND,LABEL,MATERIALS,METHODS,MTS,PATIENT,RESULTS
231,540,BACKGROUND,CONCLUSION,COR,CT50,EPSILON,L105,LABEL,MDA,MTT,MTX,PLGA,RESULTS,SURFACE,THESE
183,200,945,AREG,BTC,EGFR,EMT,EPITHELIAL,ERBB2,FOG2,GATA,GATA3,GATA6,KNOCKDOWN,KRAS,PI3K,RHEB,TP53,ZEB1
HOWEVER,TBNA
160,ACT,APCS,FIRST,STIMULATED,THIRD
104,BACKGROUND,EVEN,LABEL,LUNG,MAJOR,MATERIALS,METHODS,NSCLC,PFS,RESULTS,TKI
017,043,1000,117,174,334,518,557,681,979,980,BACKGROUND,CHINESE,CLPTM1L,CONCLUSION,EACH,LABEL,METHODS,RESULTS,SIMILAR,SNPS,TERT
COBAS,CONCLUSION,EGFR,FFPE,HOWEVER,HOWOVER,KIT,KITS,LABEL,METHODS,MOLECULAR,OBJECTIVE,PCR,RESULTS,ROCHE
BACKGROUND,CD3,CD4,CD8,HOWEVER,LABEL,MATERIALS,METHODS,NKG2A,NKG2D,NSCLC,RESULTS,TNM,UNBALANCED
001,002,148,245,BACKGROUND,LABEL,LUNG,MATERIALS,METHODS,MPV,NLR,OBJECTIVE,PLR,RESULTS,TNM
000,2009,746,BACKGROUND,JAPAN,LABEL,MATERIALS,METHODS,RESULTS,SENDING,USING,WESTERN
001,027,033,042,048,111,298,ADP,CONCLUSION,COX,ERCC1,LABEL,METHODS,MSH2,MUTS,OBJECTIVE,PARP1,PURPOSE,RARP1,RESULTS,SIMILALRY,THROUGH
2013,339,391,ADDITIONAL,ASIAN,BACKGROUND,CAUCASIANS,CIS,EXO1,FURTHER,GLU,GLU589LYS,HOWEVER,JANUARY,LABEL,LYS,MATERIALS,META,METHODS,ORS,OVERALL,PUBLISHED,RESULTS,SCIENCE,THUS,WEB
001,002,003,004,145,2008,2009,8805,CA2,DECREASED,FRESH,IHC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PATIENT,PCR,PURPOSE,RESULTS,SIMILAR,TRPV,TRPV5,TRPV6,USING
A549,DHA,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,RESULTS,TCTP,THEREFORE
107,110,2001,2012,203,8804,BACKGROUND,DATA,IRAN,LABEL,LUNG,MARCH,MATERIALS,METHODS,RESULTS,SCC,SMOKING,SPSS
177,928,A549,DDP,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,RESULTS,THEN,VEGF
001,004,021,122,18F,2003,2009,2012,7TH,AJCC,BACKGROUND,COMMITTEE,COX,EASTERN,ECOG,EFS,GROUP,III,JOINT,JUNE,LABEL,MATERIALS,METHODS,NSCLC,PET,RESULTS,THERE,VARIABLES
003,004,006,AMOUNTS,CHANGES,CONCLUSION,CONVERSELY,FDG,LABEL,MANN,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,SUVMEAN,TOTAL,WHITNEY
CHEST,DESPITE,ISCM,LUNG
1217,1468,169,2008,2011,2014,2128,2176,285,5371,925,AMERICANS,BACKGROUND,BRONX,CENTRAL,CHICAGO,COMMUNITY,CONCLUSION,DIEGO,DOMINICANS,FOOD,HISPANICS,INSTITUTE,LABEL,LATINOS,METHODS,MIAMI,NUTRITION,OBJECTIVE,OVERALL,RESULTS,SAN,SOCIETY,SOUTH,VARIATIONS
169,2014,EBUS,EUS,FNA,LOOKING,SOCIETY,TBNA
083,169,2014,328,HPV,HPV11,HPV16,HPV31,THREE
001,002,012,013,016,017,138,169,2014,346,382,522,552,594,995,AMONG,EGFR,EPIDERMAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POTENTIAL,PRESS,PRS,PUBLISHED,RESULTS,SURGERY,TKI,TKIS,UNIVERSITY
AMONG,DAG,ESI,H1975,MALDI,NCI,PCS,PIS,QTOF,SMS,TAG,THREE,UHPLC
AGS,H1650,HDAC3,HOWEVER,NCI,STAT3
1998,2008,AIM,HIGH,INCREASED,ITALY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REFERENCE,RESULTS,SMR,SPATIAL,TARANTO
045,127,154,169,174,2014,945,947,A1AT,COPYRIGHT,ERK1,HIF,INC,PPAR,PROLASTIN,THUS,UO126
001,017,177,1993,1998,2012,388,431,435,8202,ADC,ADCS,AIDS,CD4,CONTROL,COX,DISEASE,EIGHT,HIV,HODGKIN,ITALIAN,JANUARY,LABEL,LOW,LOWER,MEIER,METHODS,MULTI,NADC,NADCS,NON,OBJECTIVE,OBJECTIVES,RECURRENCE,REGARDING,RESULTS,SEPTEMBER,SURVIVALS
036,132,18F,8202,8764,BACKGROUND,CHILD,FDG,HCC,HOWEVER,LABEL,LYMPH,METHODS,PET,PUGH,RESULTS
737,EGFR,ION,KRAS,LUNG,PANEL,SINCE,THUS,TORRENT,TP53,UNTIL,USING,WHILE
108,152,195,223,232,460,464,479,595,648,820,ADC,ADCS,MATTHEW,MCC,SCC,SCCS,SCLC,SCLCS,THUS
169,2014,COPYRIGHT,LTD,LUNG,NSCLC,PROGNOSTIC
169,2014,CELL,COPYRIGHT,DIFFERENT,EGFR,FIRST,HOWEVER,LTD,LUNG,NON,NSCLC,SMALL,TKI
DRUG,FDA,FOOD
000,100,138,169,1988,2009,2014,250,323,500,581,600,742,BACKGROUND,FIGURES,GERMANY,ITALY,LABEL,MEDICAL,METHODS,NOTABLE,PANCREATIC,POPULATION,PRESS,PROJECTED,PUBLISHED,RESULTS,SOCIETY,SPAIN,UNION,UNIVERSITY,WORLD
180,CA19,CYSTOSCOPY,HOWEVER,IVB,SERUM,SHELDON,THEREFORE
45TH,CYSTOSCOPY,JAPAN
140,169,1930,1950S,1953,1970S,2014,5MG,8776,BRITISH,CLYDACH,HYGIENE,PAST,PRESS,PUBLISHED,SOCIETY,UNIVERSITY,WALES,WHILE

AABS,BIGH3,HYALURONAN,SINCE,THESE
8320,8325,956,A549,GLN,PHE,TRUNCATION
100,128,2009,2013,8804,BETWEEN,DISTANT,GTV,JUNE,LOCAL,SRS,SRT
169,2014,8805,AUTHORS,BASED,COPYRIGHT,CTS,DATA,DESPITE,INC,LUNG,PUBLISHED,RADS,REPORTING
EGFR,HOWEVER,LUNG,NSCLC,THEREFORE,TKI,TKIS
NSCLC,RADIATION,SBRT,THEREFORE
LEPR,NSCLC,TREG
100,ADVERSE,AMONG,BACKGROUND,EGFR,ERBB,HOWEVER,IIIB,LABEL,METHODS,MILD,OBJECTIVE,RELATIVELY,RESULTS,THREE
012,182,813,ANOVA,BACKGROUND,BLAND,LABEL,METHODS,OBJECTIVE,RESULTS
001,010,107,121,134,276,311,318,386,450,478,810,887,918,972,BACKGROUND,CBM,CNKI,LABEL,LIBRARY,META,METHODS,NSCLC,OBJECTIVE,RCTS,RESULTS,SEVEN,STATA,THEREFORE,VIP,WANFANG
001,005,007,039,116,BACKGROUND,DCR,EGFR,EPIDERMAL,GNAS1,HOWEVER,LABEL,METHODS,NCSLC,NSCLC,OBJECTIVE,PCR,PFS,RESULTS,SPSS,T393C,TKI,TKIS,UNIVARIATE
104,946,BACKGROUND,ITF,LABEL,METHODS,OBJECTIVE,RESULTS,SCC
946,A549,AAP,AFTER,BACKGROUND,DENSITY,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SPECIES,TGF
A549,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,TCF21,TRANSWELL,WESTERN

CONCLUSION,ILC,KNOWLEDGE,LABEL,OBJECTIVE
8805,BLAND,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PET,RESULTS,THERE
100,177,COMPLEX,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PPV,PPVS,RESULTS,ROUND
169,2014,6TN,8226,946,947,A549,AUTHORS,FOUNDATION,GSPS,JOHN,JOURNAL,LTD,MOLECULAR,PGE2,RADIATION,RILI,RLE,SMAD3,SNAIL,SONS,TGF,TH1,TH2,WILEY
BACKGROUND,CASE,CHINESE,CONCLUSION,LABEL,METHODS,PAROTID
169,2014,BARR,BRITISH,CD20,DLBCL,DLCBL,EBV,EPSTEIN
007,043,100,162,225,250,400,BACKGROUND,CHINESE,LABEL,METHODS,RESULTS,SOX,THERE,THESE
160,BACKGROUND,III,IVB,LABEL,LUNG,METHODS,PULMONARY,RESULTS,THERE
003,017,026,039,049,345,832,BACKGROUND,BASED,CONCLUSION,COX,ELISA,LABEL,MALIGNANT,MANN,MEIER,METHODS,MPE,NSCLC,PFS,RESULTS,ROC,SPECIMENS,SPP1,WHITNEY
946,BACKGROUND,CATENIN,CELL,EMT,GLI,GLI1,INHIBITION,LABEL,METHODS,PROTEIN,RESULTS,SCC,SHH,VISMODEGIB,WESTERN
AKT,BCL,FHIT,FRAGILE,HOWEVER,MTT,PCR,PI3K,PROTEIN,THESE,TREATMENT
169,2014,BOTH,COPYRIGHT,COX,DETECTION,HOWEVER,JOHN,LTD,RESULTS,SONS,WILEY,YET
0449,174,2012,2013,BCC,DRUG,EMA,FDA,FOOD,GDC,JANUARY,JULY,MEDICINES,SMO,VISMODEGIB
2013,4047,AMONG,DRUG,DUE,EMA,FDA,FOOD,HIV,IMID,MEDICINES,MPNS,RRMM,SEVERAL,SINCE
0052,COOH,HODGKIN,MOST,NOTABLE,NPI,PROTEOSOME
ACTIVATION,ATP,BRAF,ERK,III,MAPK,MEK,PLX4032,RAF,RAS,UNDER,V600E,V600K
ALK,ALSO,ATP,CRIZOTINIB,EGFR,EML4,FISH,HOWEVER,MET,NSCLC,ROS,ROS1,RTK,THERE,TOXICITIES
EGFR,INHIBITORS
757,ASIAN,CIS,HOWEVER,HRS,ISI,LOW,SCIENCE,WEB
HCPS,OVERALL,TEN,THERE
0001,100,112,160,169,177,183,8199,81S,8202,8226,CONCLUSION,EEFF,FEWER,GEORG,GUIDELINES,HPCT,KEY,LABEL,MANN,MATERIALS,MDCT,METHODS,MULTISLICE,OBJECTIVE,PURPOSE,QUALITY,REDUCED,RESULTS,STUTTGART,TOMOGRAPHY,WHITNEY,YORK
5108,CELL,CONCURRENT,LABEL,METHODS,MTT,OBJECTIVE,PARP,PLK1,PURPOSE,RESULTS,TACC3
8201,ADVANTAGES,BACKGROUND,CONCLUSION,DUE,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
8201,BOTH,CENTRAL,CORE,DIAGNOSTIC,EBUS,FINE,FNA,ISSUE,LABEL,METHODICAL,METHODS,OBJECTIVE,PRACTICAL,RESULTS,SEVERAL
000,049,2004,398,500,575,700,744,8202,8764,8805,929,AMONG,ASIA,ASIAN,BACKGROUND,BANGLADESH,CHINA,EAST,EDITORS,INDIA,JAPAN,KOREA,LABEL,METHODS,RESULTS,SINGAPORE,SUMMARY,TOBACCO
001,169,2000,2007,2009,2014,488,AMONG,CONCLUSION,COPYRIGHT,COSTS,END,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER,SOCIETY,STUDIES,TEXAS,THOSE
335,371,502,946,DOB,HARVARD,HLA,KLRK1,NSCLC,SNP,SNPS,UNIVERSITY
017,239,250,500,AUC,CURRENT,EGFR,IIIB,NPR,NSCLC,ORR,PFS,PREDEFINED,SECONDARY,TKI,TREATMENT
AFTER,RCC,THEN
169,197,2014,ALK,BACKGROUND,EML4,LABEL,MAYO,MEANWHILE,METHODS,RESULTS,SHS,THESE
AUC,DUE,EARLY,HALOTAG,LUMINEX,LUNG,SERA,THERE,THEREFORE
A549,BECN1,H596,NON,NSCLC,PACLITAXEL,T24,TXR,UTR
2008,2012,A40,A41,DISTANT,GREATER,INNOV,JULY,LABEL,MEIER,METHODS,OBJECTIVE,PATHOLOGIC,PATIENT,RESULTS,THERE,VATP,VATPS,VIDEO
001,011,018,026,029,047,331,ANOVA,BLOOD,EXHALED,FORTY,LABEL,LOWER,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE,VATS
BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,PULMONARY,VIDEO
CHINESE,REPORTS
169,190,2014,272,413,468,LDCT,LUNG,NCN,NCNS,NLST,RRS,SCREENING,SPATIALLY,TRIAL
BACKGROUND,CHINESE,CHIP,E2F1,FURTHER,HAN,KNOCKDOWN,LABEL,METHODS,MMP,MMPS,PCR,RESULTS,SCLC,SP1
169,2014,A549,ADP,APPS,BALB,CDK,CDK2,COPYRIGHT,PARP,THESE,WESTERN
169,2014,ACADEMY,AFH,BACKGROUND,CFH,COPYRIGHT,CUTANEOUS,FATAL,FIVE,INC,LABEL,METASTASIS,METFH,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SEVEN
RADIATION
160,BACKGROUND,CASE,JAPAN,LABEL,METHODS
169,2014,8201,ASIA,ENDOSCOPIC,FORCE,HOWEVER,JAPAN,LTD,PLEURAL,PTY,PUBLISHING,SIXTEEN,SOCIETY,SURGERY,TASK,WILEY
133,169,2014,390,8201,ASIA,ENDOSCOPIC,FORCE,FOUR,JAPAN,LTD,PTY,PUBLISHING,SOCIETY,SURGERY,TASK,WILEY
101,2004,2011,2012,327,428,646,BACKGROUND,DATA,DESPITE,DETAILS,DUTCH,III,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,REASONS,RECURSIVE,RESULTS,RPA,SCLC,THEREFORE,WBRT
956,A549,COMPOUNDS,HCC44,IC50,NSCLC,THREE
160,168,169,2014,240,AGE,BACKGROUND,BOS,CASES,CONCLUSION,ENGLISH,FURTHER,GVHD,HSCT,JOHN,LABEL,LTD,LUNG,MEDLINE,METHODS,NON,OBJECTIVE,PUBLISHED,RELAPSE,RESULTS,SEVENTY,SONS,TOTAL,WILEY
000,100,1990,1997,1999,2009,ANS,AREA,CHSDA,COMPARISON,EFFORTS,IHS,INDIANS,LABEL,LUNG,METHODS,NATIVES,OBJECTIVE,OBJECTIVES,RESULTS,SERVICE,SOUTHWEST,WHITE
ATP,EGF,EGFR,ERBB3,ERBB4,HER2,HOWEVER,III,LUNG,LUX,NSCLC,PHASE,TKI,TKIS
ALK,BRAF,EGFR,EML4,FIRST,KRAS,NSCLC
SCLC,SMALL
160,169,2014,211H,956,ASIA,AUTHORS,H2052,H2452,H28,HRK,LTD,MSTO,NCI,NOXA,PTY,PUBLISHING,PUMA,SCIENCE,TAKEN,WILEY
954,J774A,LPS,PHT2,SIMILAR,SLC15A3,THESE,THP,USING
169,2014,ABOVE,BOTH,IGA,IGG,INC,WILEY
001,215,450,854,INITIAL,NSCLC,TNM
169,2000,2008,2014,321,615,8201,BARR,DIFFUSE,DLBCL,EPSTEIN,HODGKIN,INC,MATCH,NON,POISSON,SIR,SIRS,THEREFORE,TRANSPLANT,WILEY
169,2014,954,FINALLY,HOWEVER,IRF3,KRAS,LABEL,NSCLC,REL,S172,S386,TAKEN,TANK,TBK1,UNLABELLED
169,2014,8201,8805,AUTHORS,BACKGROUND,ERCC1,INC,LABEL,METHODS,PROTEIN,REAL,RESULTS,RRM1,SECONDARY,SOCIETY,TREATMENT,WILEY
183,2003,2009,997,AMONG,BACKGROUND,BECAUSE,BOTH,CONCLUSION,FORTY,GEORG,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,SIXTY,STUTTGART,THEIR,THERE,YORK
ASSESSMENT,CONCLUSION,DATA,GENERATED,LABEL,METHODS,MOST,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SIXTY,SMELL,SUBJECTIVE,TASTE,TSAS,TSS
169,2014,947,ABS,ACUTE,AFTER,BECAUSE,COPYRIGHT,HOWEVER,IFN,IGA,IGG1,IGG2A,INC,NTHI
169,2014,277,8805,AES,BACKGROUND,CRS,LABEL,LAR,METHODS,NET,NETS,ORR,PRIMARY,PRS,RESULTS,SDS,SIMON,SOCIETY,TREATMENT
169,2014,EGFR,SOCIETY,STRATEGIES
BECAUSE,BMP,BMPS,RGMB
ALSO,CD3,CD8,DCS,HIGH,HMGB1,LUNG,NSCLC,TILS
945,947,A549,CD25,CD4,CD69,CD8,CEA,CONCLUSION,CSF,CTL,DCS,IFN,LABEL,METHODS,MHC,OBJECTIVE,RESULTS,THESE,TNF
CONCLUSION,H460,LABEL,LCSCS,METHODS,NANOG,NCI,OBJECTIVE,OCT4,PCR,RESULTS,SOX2
169,2014,230,AMONG,CCSS,CHILDHOOD,CONCLUSION,HODGKIN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR,SOCIETY
169,2014,MODEL,PRESS,PUBLISHED,ROMANIA,STEI,UNIVERSITY
000,004,013,169,2014,2700,BEIR,BIOLOGICAL,COMMITTEE,EFFECTS,ERR,PRESS,PUBLISHED,RADIATION,UNIVERSITY,WLM
169,2014,473,A549,AIMS,AKT,BACKGROUND,BASEL,DDP,ERK1,HOWEVER,INHIBITION,LABEL,METHODS,OBJECTIVE,RESULTS,S549,SER,SEVERAL,U0126,WHEREAS
001,002,967,ANY,CONCLUSION,CORD,IMPAIRMENT,LABEL,MEASURE,METHODS,MSCC,OBJECTIVE,RESULTS,SCALE,TOKUHASHI
2000,SINCE
CONCLUSION,CSF,DIAGNOSIS,EVOLUTION,IAM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RAPID,RESULTS,SETTING,TREATMENT,VESTIBULAR
0002,004,120,169,177,2011,2014,8804,CNR,COPYRIGHT,GTV,IGRT,IIIA,IMAGING,INC,INITIAL,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER
169,2014,COPYRIGHT,DESPITE,HOWEVER,INC,PULMONARY
100,169,1997,2013,2014,243,970,BACKGROUND,BETWEEN,COPYRIGHT,INC,JANUARY,LABEL,LYMPH,METHODS,MORBIDITY,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY,SPECIALTY,THERE
001,111,139,154,169,177,2014,215,335,728,8805,AMONG,BACKGROUND,CBX3,COPYRIGHT,DSP,FOUR,GJB2,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,SEQ,THEIR
001,100,169,2008,2014,215,23MM,36MM,8805,AFTER,CONCLUSION,COPYRIGHT,FSE,FSTS,III,IRELAND,JANUARY,LABEL,LCR,LTD,MANN,MATERIALS,METHODS,MTS,OBJECTIVE,PSTS,RESULTS,SPECIMENS,WHITNEY
169,2014,APHA,COPYRIGHT,HOWEVER,LIVER,PUBLISHED,SAS,SPLF
169,2014,COPYRIGHT,HOWEVER,PUBLISHED,SAS,SPLF,THESE
169,2014,COPYRIGHT,DIFFERENT,HOWEVER,MAJOR,MINIMALLY,PUBLISHED,SAS,SPLF,VATS
2007

ACC,ADENOID
160,169,2014,ALCL,ALK,ANAPLASTIC,APMIS,CRIZOTINIB,EML4,JOHN,JUN,JUNB,JUNC,KRUSKAL,LTD,NPM,NSCLC,PDGFR,PUBLISHED,SONS,THESE,WILEY
160,169,2014,ASIA,AUTHORS,EGF,EGFR,LTD,MEK,NSCLC,PI3K,PTY,PUBLISHING,RAC1,SCIENCE,TKI,WILEY
FOUR,MATERIALS,REFERENCE
945,946,BPA,DDT,DIVERSE,EDC,ENDOCRINE,MECHANISMS,TCDD
100,300,A549,ADR,CSF,DOX,FINALLY,FIRST,FURTHER,MCF,MDC,THIRD,TNF,TNPS
CONCLUSION,LABEL,METHODS,OBJECTIVE,PFS,PSC,RESULTS,THEIR
2007,2010,202,ACCORDING,CHEST,CHINA,CONCLUSION,DEPARTMENT,LABEL,METHODS,OBJECTIVE,RESULTS,SICHUAN,STAGE,SURGERY,UNIVERSITY,WEST
001,013,041,1551,167,2000,2010,616,CHINA,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SICHUAN,UNIVERSITY,WEST
CONCLUSION,H1975,IHC,LABEL,LUNG,METHODS,MTT,OBJECTIVE,RESULTS,SIMILARLY,WESTERN
100,293T,AFTER,AKT2,ATK2,BAD,CONCLUSION,EF1,LABEL,MCS2,METHODS,OBJECTIVE,PCR,PDK1,PFU,PGEM,RESULTS,TEASY,TOTAL,WESTERN
A549,AFTER,CCK,CONCLUSION,FACS,GFP,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,SEQUENCES,WESTERN
LUNG
1998,1ST,2003,2004,2010,2ND,3RD,AVERAGE,MORTALITY,THERE,TOMSK
1109,154,177,1903,794,8805,AIMS,BACKGROUND,BMI,LABEL,METHODS,NUTRITION,OBJECTIVE,ORAL,OVERALL,RESULTS
169,2014,CHEST,PRESS,PUBLISHED,SURGERY,UNIVERSITY,VATS
1980,2008,CEA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,UNIVARIATE
169,2009,2013,2014,AMONG,COMMISSION,COUNCIL,COUNTRIES,DIRECTIVE,EURATOM,IAEA,PRESS,PUBLISHED,RESULTS,THESE,UNIVERSITY
100,125,132,2011,2012,8805,ACUTE,APREPITANT,APRIL,BEIJING,CINV,HT3,LABEL,METHODS,OBJECTIVE,RESULTS
024,036,COX,FINALLY,HIGH,MEIER,NSCLC,TNM,VASH1,VASOHIBIN
158,ADX,ARMS,EGFR,HOWEVER,NSCLC,ORR,ORRS,TKI,TKIS
176,181,300,DISTILLED,DUE,MOL,MORINGA,ROS,SINCE,THESE,WATER
DESPITE,MODULATION,NSCLC
BESIDES,DESPITE,THUS,VTE
8321,8322,8323,945,954,BBS,GLI,GPCR,GRPR,GTPASES,PAR,RHO,SCLC,SHH,SMALL,SONIC
ALZHEIMER,EMT,FURTHER,HUNTINGTON,LOSS,SNAIL,TAKEN,THESE,THUS,UBIQUILIN1,UBQLN,ZEB1
1015,1984,1985,6900,DISEASE,HOWEVER,LABEL,LIFESTYLE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,GENERAL,HEPARANASE,ISSUE,LABEL,METHODS,RESULTS,SPECIAL,TNM
EBUS,HENCE,HOWEVER,KRAS,STAGE,THUS
8323,945,946,954,KRAS,RALB,RTK,TBK1,THESE
125,BACKGROUND,CEA,CEACAM1,COLORECTAL,CYFRA,HOWEVER,LABEL,LUNG,METHODS,MOST,NSE,OPG,OPN,OVARIAN,PLCO,PRL,RESULTS,SCREENING,SEVERAL,SIXTY,TRIAL
001,036,160,5761,8804,946,ASIAN,BACKGROUND,CONCLUSION,CONTEXT,DEVELOPING,HOWEVER,INC,LABEL,LOWER,METHODS,OBJECTIVE,OBJECTIVES,PACIFIC,PUBLISHED,RESULTS
109,160,169,2014,ACADEMY,BACKGROUND,CONCLUSION,CONTEXT,COPYRIGHT,HOSPICE,INC,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PALLIATIVE,PATIENT,PUBLISHED,RESULTS,SYMPTOM,THERE
169,2014,956,A549,CALU,COMPOUNDS,COPYRIGHT,DR5,EWG,H157,H175,H1792,IC50,INC,THESE
169,2014,A549,CELL,COPYRIGHT,FURTHER,HENCE,INC,NAD,NRF2,NSCLC,NUCLEAR,PREVIOUSLY
169,2014,CD26,COPYRIGHT,INC,MALIGNANT,MPM,SRC,WHILE
160,169,2011,2012,2014,BACKGROUND,COPYRIGHT,INC,LABEL,MARCH,METHODS,MOLECULAR,MOSBY,PUBLISHED,RESULTS,SURGERY,THERE,THESE
169,1997,2012,2014,212,2336,BOTH,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,PFT,PFTS,PUBLISHED,RESULTS,SURGERY,T1A,T1B
169,2014,COPYRIGHT,FURTHER,INC,INSTITUTE,THESE
001,160,169,177,2014,8804,BACKGROUND,CONCLUSION,COPYRIGHT,EPA,FATIGUE,HRQL,LABEL,LBM,LTD,METABOLISM,METHODS,NSCLC,NUTRITION,OBJECTIVE,ONS,REGISTERED,RESULTS,SOCIETY,THERE
169,2014,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,MEDLINE,METHODS,PULMONARY,REGARDING,RESULTS,SINCE,THEREFORE
001,002,100,169,2014,COPYRIGHT,CSF,INC,LYM,PMN,THESE
102,169,2014,956,COPYRIGHT,IMR,INC,LTR,LTRS,STUDIES
169,2014,976,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,CONCLUSION,COPYRIGHT,CSANZ,DATA,EVEN,LABEL,META,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,THESE,ZEALAND
169,2012,2014,231,233,COMPARABLE,COPYRIGHT,HUANG,PUBLISHED,SAS,SFRO,SOCI
169,2014,AKT,BECAUSE,CCSP,CONCLUSION,COPYRIGHT,DRUG,EGFR,EXPRESSION,H1975,INDUCTION,IRELAND,KNOCKDOWN,L858R,LABEL,LTD,MATERIALS,MET,METHODS,NANOG,NSCLC,OBJECTIVE,OBJECTIVES,OCT4,PI3K,PRIMARY,RESULTS,SOX2,T790M,TETO,THESE,TKI,TKIS
169,2014,285,5000,AFRICAN,AIMS,COLLEGE,COPYRIGHT,EIGHT,FIFTEEN,LABEL,LOCALLY,LTD,LUNG,MATERIALS,METHODS,MOST,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,2014,295,296,486,487,496,500,CONCLUSION,COPYRIGHT,FIVE,GUIDELINES,LABEL,LUNG,METHODS,OVERALL,RESULTS,SAS,UNLABELLED
169,2014,ATP,CDK1,COPYRIGHT,INC,THUS
169,2014,COPYRIGHT,MOST
169,2014,946,A549,APOPTOSIS,BACKGROUND,C646,CELL,CHK1,CHROMATIN,COPYRIGHT,DAPI,H157,H460,HFL,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,MITOTIC,NSCLC,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,SENESCENCE
001,10878,169,2009,2011,2014,301,ATC,BACKGROUND,CONCLUSION,COPYRIGHT,COX,ELEVATIONS,FURTHER,IRELAND,LABEL,LTD,MASSARRAY,MEIER,METHODS,NOS2,OBJECTIVE,PURPOSE,RESULTS,RILI,SNPS,THEIR
169,1MM,2014,2MM,3MM,4MM,7MM,95TH,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,TEN
160,169,2014,COPYRIGHT,EEA1,FURTHER,GRAM,INC,NOD1,OMVS,RIP2
160,169,2002,2011,2014,2N0,BACKGROUND,COPYRIGHT,INC,JUNE,LABEL,METASTATIC,METHODS,PUBLISHED,RESULTS,SOCIETY
169,2014,BRAIN,COPYRIGHT,GENERAL,INDIA,MRI,SAS,STBL,TYPICALLY

GASTRODIA,H460,HEAT,HSF1,HSP,HSP27,HSP70,HSPS,MARKERS,NCI,PARP,S326,THESE
0001,143,169,2014,967,COPYRIGHT,CURRENT,GATA3,INC,NONE,SINCE
001,100,169,177,2014,2557,AMONG,COPYRIGHT,INC,NSCLC,OWING,THESE
0306,100,169,2014,946,AUTHORS,BECAUSE,CASES,CD56,CK34,COPYRIGHT,E12,INC,PUBLISHED,SCLC
169,2014,ADCS,CK5,COPYRIGHT,HOPKINS,INC,JOHNS,LUNG,NSCLC,SQCCS,TTF1
085,120,134,169,2014,239,AMONG,CINV,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
001,002,027,169,2014,768,BACKGROUND,CELL,CONCLUSION,COPYRIGHT,EARLY,ESMO,HOSPITALS,III,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,NON,NSCLC,RESULTS,SMALL,THERE,UNIVARIATE,UNIVERSITY
2011,2013,AUTOIMMUNE,CONCLUSION,EEG,EIGHT,HASHIMOTO,LABEL,MARCH,MAY,METHODS,MRI,OBJECTIVE,RESULTS,SIX,THEIR,THERE
ACTIVATING,ALK,AREAS,BACKGROUND,COVERED,EGFR,EIGHT,III,LABEL,METHODS,NSCLC,OPINION,PHASE,TKI,TKIS
169,2014,370,435,CONVERSION,COPYRIGHT,INC,MDA,MODULATION,RESULTS,THEREFORE
0001,025,169,181,2014,304,COPYRIGHT,IGF1R,INC,MEMBRANOUS,REGARDING,SNP,SNPS,THESE
125,A549,BAX,BCL2,CLDR,EBRT,H2AX
A549,CDC2,EXPRESSION,EZH2,HTB,INHIBITION,THESE
BECAUSE,DEPENDING,REGULATION,RNAS,UTR
A549,BAX,CHK2,H292,H322,H460,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TFT,TRAIL,WAF1,WESTERN,XIAP
7B7,DLKP,KU70,KU80,MAB,MABS,MIA,NHEJ,PACA,PDAC,USING
CLINICIAN,FOUR,HOWEVER,JUDGING,PCOR,SOUTH
106A,106B,132,169,192,194,2014,212,363,381,ARRAY,COPD,ERS,EXPRESSION,FOUR,LUNG,MICRORNAS,THESE
104,946,DACH1,DACHSHUND,ED2,KYSE150,KYSE510,LOSS,NETWORK,PCR,RETINAL,RNAS,TGF
160,BRITISH,KNOWLEDGE,LABEL,METHODS,NAVIGATOR,OBJECTIVE,PURPOSE,RESULTS,SELF,VANCOUVER,VOLUNTEERS
AMONG,FORMULA,NKX2,NON,NSCLC,SCC
169,2014,DESPITE,PRESS,PUBLISHED,THERE,UNIVERSITY
001,111,165,AREAS,BACKGROUND,FREE,HETE,HETES,HOWEVER,LABEL,LUNG,METHODS,RESULTS,SERUM,THERE
4T1,EPITHELIAL,HIFU,LUNG,SLUG,TAKEN,TWIST
08975,391,AFTER,BACKGROUND,C30,COX,EORTC,EVERY,HRQOL,HRS,LABEL,LC13,METHODS,NSCLC,QLQ,RESULTS
BACKGROUND,CD26,FINALLY,LABEL,MALIGNANT,METHODS,MPM,PTP,RESULTS,SHP,SST,SSTR4
153,5125,ACTIVATING,BACKGROUND,BRAF,E545K,EGFR,FIVE,KRAS,LABEL,METHODS,NSCLC,RESULTS,T790M,THESE,TKI,TKIS
956,987,CONCLUSION,EDI,HEIDELBERG,HRA,LABEL,METHODS,OBJECTIVE,OCT,OUTER,OVERLYING,PURPOSE,RESULTS,SPECTRALIS,SUBRETINAL
1279,2006,2007,5632,AMERICANS,BACKGROUND,BASE,DATA,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,STRATEGIES,THOUSANDS,USING,WIDE
001,003,177,184,192,216,223,238,317,320,385,388,945,BACKGROUND,CONCLUSION,FIO2,LABEL,LIMB,METHODS,PAO2,RESULTS,RIPC,SECONDARY,THREE
SINCE,THERE
177TH,AVR,CAREFUL,IABP,JUDE,MEDICAL,MVR,POOR
135,169,2014,253,496,BCL,FISH,HNSCC,OVERALL,PRESS,PUBLISHED,SCC,SINCE,SOX2,TARGETING,UNIVERSITY
B2A,CHEST,RIGHT
DESMOID,FIVE,SEVENTEEN,SINCE,WHILE
001,008,121,141,2010,2013,262,402,636,664,8202,967,APRIL,CONCLUSION,EGFR,EXON,FINALLY,LABEL,MATERIALS,MAY,METHODS,OBJECTIVE,RESULTS,SPSS,THERE,TTF
1992,2011,AFTER,BETWEEN,TEN
1996,2012,210,CHEST,JUNE,LUNG,NON,RECURRENCE,THERE
EGFR,FURTHER,GEFITINIB,NSCLC,THESE,TKI,TKIS
2009,2010,340,343,683,699,ADR,ADRS,ALSO,AMONG,B75,JAPAN,JUNE,MAY,NSCLC,PATIENT,PEM,PERIPHERAL,STAGE,THESE
000,146,172,2010,CELL,CIA,JAPAN,SEPTEMBER,SOCIETY,THERAPY,THEREFORE,THESE
AFTER,BECAUSE,INDUCTION,LAR,MILES,QOL,SOX,THEN
120MG,200MG,AFTER,LEUCOVORIN,QOL,STAGE
THERE,THESE
FUNCTIONAL,HT3,INDEX,QOL
0001,200ML,80MG,AUC,AUCS,CDDP,CREATININE,CSF,HOWEVER,THUS,TOTAL
11Q21,BRANDWEIN,FEW,FISH,FIVE,FORTY,FOUR,MAML2,PULMONARY,THESE,TTF
AFTER,BECAUSE,EIGHT
AVAIL,BASED,HOWEVER,III,JAPAN,NOTCH,THESE,VEGF
946,DLX5,EGR3,ERG3,EXPRESSION,POLII,SCC,SCCS,USING,WHILE
160,169,2014,A549,BESIDES,CLC,CLTX,COPYRIGHT,CURRENTLY,LTD,MMP,THESE,U87
ANNEXIN,JNK,MAPKS,PARP1,THUS,TREATMENT
BRAF,CISH,EGFR,GIVEN,KRAS,PRECISION
169,191,2011,2013,2014,322,513,COPYRIGHT,INC,JANUARY,JUNE,RESULTS,SPANISH
169,2014,CANCERS,COPYRIGHT,DISRUPTION,HEART,INC,LUNG,NON,PUBLISHED,SOCIETY
AFFYMETRIX,CONSISTENT,DMOG,H3K9,HOWEVER,MYC,PCR,TAKEN
404,ADC,ADCS,ALK,D5F3,EML4,FISH,IHC,LABEL,METHODS,NONE,NSCLC,OBJECTIVE,RESULTS,VENTANA
ACCORDING,ATLAS,FURTHER,MMP,NGAL,PROTEIN,THEREFORE,WESTERN
169,2014,956,A549,ABBS,ACADEMY,AGILENT,BIOLOGICAL,BIOLOGY,CELL,CHINESE,EDITORIAL,EXPRESSION,INSTITUTE,INSTITUTES,LUNG,MGX,MOST,PANAX,PRESS,PRIMEVIEW,PUBLISHED,THESE,UNIVERSITY
100,68GA,BACKGROUND,CONCLUSION,DOTA,DOTATOC,FOUR,LABEL,MCC,METHODS,NOTABLY,PET,PHE1,RESULTS,SSTR,TYR3
1364,ABOUT,CONCLUSION,LABEL,LITERATURE,METHODS,OBJECTIVE,RESULTS
006,486,686,BACKGROUND,CANCORS,CARE,CONSORTIUM,DATA,ENHANCING,FEW,HOWEVER,LABEL,METHODS,OBJECTIVE,PHYSICIANS,PROGNOSIS,RESULTS,SETTING
2000,2004,393,BACKGROUND,CHANGES,END,HEAD,INSTITUTE,LABEL,METHODS,RESULTS,SIR,THERE,WEST
DYSPNEA,OFTEN,PALLIATIVE,THEREFORE
103,117,212,AMONG,CADM,EIGHT,ELISA,ILD,MDA5,THESE
021,036,066,120,128,140,152,ADR,ADRS,ADULT,BMI,CONCLUSION,EASTERN,GROUP,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILAR
169,2014,BECAUSE,DESPITE,FINALLY,KRAS,LABEL,MOLECULAR,NKX2,UNLABELLED
100,113,135,1385,169,1694,177,2001,2013,2014,4338,BASED,ECMO,ICU,LABEL,MEAN,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,TEN,THERE,UNIVERSITY
169,2014,8805,AFTER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
169,2014,CO2,DLET,FIRSTLY,HOWEVER,MIE,PRESS,PUBLISHED,SLET,SURGERY,UNIVERSITY
169,2014,AKT,DU145,FABP4,FATTY,PARP,PI3K,SEVERAL,THESE,THUS,UICC
169,2014,DDR2,DDRS,DESPITE,DISCOIDIN,H1299,JM2,RTKS,TAKEN,THUS,UICC
195,HCC,HOWEVER,SRC,THEREFORE,UTR
CURRENT,EVALUATION,HOWEVER,LDH,NSE,SCLC,SOLID
093,169,2014,215,312,398,412,502,BACKGROUND,BONFERRONI,COLORECTAL,DIETARY,GIVEN,ICCS,INTRACLASS,LABEL,LARGE,LUNG,METHODS,NUTRITION,OBJECTIVE,OBJECTIVES,OTHER,OVARIAN,PEARSON,PLCO,RESULTS,SCREENING,SOCIETY,TRIAL,USUAL
323,8804,DIGE,ESI,MALDI,PANTHER,POTENTIAL,SCC,TOF
0007,1010,105,129,169,2010,2012,2014,250,400,499,500,8805,999,AMERICA,ASIA,AUSTRALIA,BACKGROUND,BETWEEN,BOTH,COPYRIGHT,EASTERN,ECOG,EGFR,FEB,GRADE,GROUP,JULY,KRAS,LABEL,LTD,METHODS,NORTH,RESULTS,SOUTH,USING
EARLY,GRAM
CHRONIC,RICHTER
ENGLISH,PRIMARY

ADDRESSED,CALD,CHINESE,CONCLUSION,FATALISTIC,FIVE,ISSUE,KNOWLEDGE,LABEL,LIMITED,METHODS,NSW,OBJECTIVE,RESULTS,SEVEN,SOUTH,THERE,VIETNAMESE,WALES
EBUS,TBNA

CUSHING,ECTOPIC
103,105,BACKGROUND,CBCT,CBCTS,ENB,INCIDENCE,LABEL,METHODS,PATIENT,RESULTS,SBRT,THROUGHOUT
BACKGROUND,DATA,LABEL,METHODS,RESULTS,VIRTUAL
ADVOCATES,CLM,CLMS,CONGENITAL,INCREASES,LABEL,MRI,OBJECTIVE,PROPONENTS,PURPOSE,RESULTS,SUMMARY,THERE
105,185,AIM,AMONG,BMJ,CNB,DIAGNOSTIC,EIGHT,FNA,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PROMINENT,PUBLISHED,PUBLISHING,RESULTS,UNIVARIATE
086,169,1992,1993,2008,2009,2014,896,AGING,AGREEMENT,AMSTERDAM,CONCLUSION,COPYRIGHT,CROSS,DATA,INC,LABEL,METHODS,MULTILEVEL,OBJECTIVE,OBJECTIVES,OLDER,RESULTS,UNDER
BECAUSE
177,931,963,BACKGROUND,CONCLUSION,DAILY,IGRT,IMAGE,INTRA,LABEL,MATERIALS,METHODS,RESULTS
8202,BACKGROUND,CASE,CONCLUSION,DESPITE,LABEL,METHODS,RENAL,WORLD
2001,2005,2006,2010,8202,BACKGROUND,CONCLUSION,CZECH,LABEL,METHODS,RESULTS,USING
169,2014,ALTOGETHER,AUTHORS,HOWEVER,JOURNAL,OCT4A,PATHOLOGY,SOX2,THESE,UTF1
9GR,AKT,EEF,EGFR,EPIMEDIUM,H1975,NAKAI,NSCLC,PI3K,SIMILARLY,T790M
BACKGROUND,LABEL,RESULTS
BRF2,EMT,NSCLC,THESE
001,169,2006,2008,2009,2014,518,573,ADHERENCE,AUDIT,CARE,CONCLUSION,COPYRIGHT,FLORIDA,III,INITIATIVE,LABEL,MEDICAL,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,QCIS,QUALITY,RESULTS,SIXTEEN,SOCIETY,THERE,WHETHER
063,121,169,2000,2004,2006,2007,2008,2014,8805,AMONG,CONCLUSION,COPYRIGHT,COX,ESA,ESAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEER,SIMILARLY,SINCE,SOCIETY
004,100,121,169,2002,2012,2014,BETWEEN,BRONCHIAL,DISEASE,FINAL,HISTOLOGY,III,LABEL,LOW,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESECTION,RESULTS,STAGE,SURGERY,UNIVERSITY
1000,120,169,197,2014,240,360,8805,ARQ,BACKGROUND,CONCLUSION,DIFFERENT,EARLY,FIFTY,GRADE,IDENTIFIER,LABEL,MEDICAL,MET,METHODS,PRESS,PUBLISHED,RESULTS,RP2D,SOCIETY,TEN,THERE,TIVANTINIB,UNASSIGNED,UNIVERSITY
001,002,003,016,166,169,2014,352,8201,BACKGROUND,BCL,BIM,CHINESE,COX,EGFR,EPIDERMAL,LABEL,METHODS,NSCLC,PFS,RESULTS,SOCIETY,TKI,TKIS
169,2001,2014,INC,MMP,MMP1,MMP1A,VARIATION,WILEY
001,009,018,065,124,169,2014,AMONG,BACKGROUND,EGFR,EPIDERMAL,GENOTYPING,HOWEVER,LABEL,METHODS,RESULTS,SOCIETY,T790M,TKIS
002,005,012,018,024,108,109,115,116,2007,2012,ACCORDING,AMONG,COX,DATA,DFS,III,JANUARY,NSCLC,TNM
169,2014,215,250,308,4Q34,558,AFFYMETRIX,AFTER,GWAS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS,SNP,SNPS
151,ADHERENCE,AES,BCS,CONCLUSION,GERMANY,LABEL,LAD,METHODS,OBJECTIVE,PTV,PTVS,PURPOSE,QOL,RESULTS,SIB,WBI
145,786,8209,A498,FOLLOWING,MMP,MTT,RCC,THESE
100,101,102,103,159,169,2014,486,8805,BACKGROUND,EDTA,EFFECTIVE,ERA,LABEL,METHODS,PARTICULAR,PRESS,PUBLISHED,RADIATION,REID,RESULTS,UNIVERSITY
1997,2011,2012,BACKGROUND,CONCLUSION,JAPAN,LABEL,METHODS,MORTALITY,REGARDING,RESULTS,SURGERY,VATS,WHAT
169,2014,916,BONE,MINERAL,RGD,SOCIETY,THEREFORE
FURTHER,ISSUE,LABEL,METHODICAL,METHODS,OBJECTIVE,PULMONARY,RESULTS
169,2014,231,BECAUSE,GGA,JAPAN,LPA,MDA,MICE,NUDE,REMARKABLY,RHO,ROCK,ROCK1,THESE,THUS,TUNEL
000,038,229,257,510,522,5647,567,6908,735,952,AFTER,ALA499VAL,ASIAN,BACKGROUND,BEGG,CAUCASIAN,CIS,CONCLUSION,EGGER,GLN939GLN,HOWEVER,LABEL,LYS939GLN,METHODS,ODDS,ORS,PAT,PUBLISHED,RESULTS,XERODERMA,XPC
001,004,008,016,021,447,8202,BACKGROUND,BRF2,FGFR1,FISH,INCREASED,LABEL,METHODS,NSCLC,RESULTS,SCC,SOX2
10878,143,183,BACKGROUND,KI67,LABEL,METHODS,MIB,RESULTS,UNIVARIATE
174,2003,2009,BACKGROUND,CXR,DATA,LABEL,LOCAL,LUNG,METHODS,OUTCOME,PATIENT,RESULTS,ROUTINE,THERE
00001,0002,025,048,169,2014,469,500,536,BOTH,IUPAC,LUNG,NANA,SMALL
BESIDES,CASES,INFECTION,NS3,RESULTS,SPLEENS,STUDIES,THESE,TISSUES
018,021,150,400,COX,IIIB,NSCLC,OVERALL,TTP
160,2002,2012,AMONG,DISTANT,HIGH,III,IMF,IMFS,LABEL,LOCAL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT
BACKGROUND,CONCLUSION,FGFR,FGFR1,FOCAL,LABEL,METHODS,RESULTS,SCLC,THERE
1192,ALK,ANAPLASTIC,BACKGROUND,HIP1,KLC1,LABEL,METHODS,MULTIPLEX,RESULTS,SEVERAL,TPR,TRK,TRP
120,8734,BACKGROUND,CONCLUSION,FIFTY,LABEL,METHODS,NORTH,PRIMARY,RESULTS,SCLC,TTP
ACTIVATING,EGFR,T790M
ALK,CH5424802,NSCLC,RO5424802
0001,001,140,1990,2010,2265,229,BACKGROUND,CUMULATIVE,FIVE,III,INCOMPLETE,KOGA,LABEL,MASAOKA,METHODS,OUTCOME,RECURRENCE,RESULTS,SOCIETY,WORLD
107,157,176,472,AMONG,BACKGROUND,DOSE,EACH,FORTY,LABEL,METHODS,PEER,PTV,PTVS,RESULTS,SBRT
945,946,BACKGROUND,EIGHT,FURTHER,LABEL,METHODS,NSCLC,PEMETREXED,RESULTS
001,1996,1997,1998,200,2004,2005,300,374,900,BACKGROUND,BETWEEN,CHANGES,LABEL,METHODS,RESULTS,TREATMENT
056,121,147,228,242,305,375,431,507,575,BACKGROUND,CONCLUSION,EASTERN,EGFR,GEFITINIB,GROUP,IIIB,L858R,LABEL,METHODS,MOST,NSCLC,PFS,RESULTS,THERE,TKI
001,005,006,1998,2012,304,383,8804,8805,AFTER,AMONG,BACKGROUND,CONCLUSION,CUSHING,CUSHINGPS,LABEL,METHODS,NOPS,OTHERPS,REDUCED,RESULTS,WORLD
705,A549,APOPTOSIS,BACKGROUND,ECTOPIC,EGFR,H292,H322,H358,H460,LABEL,METHODS,NSCLC,PTP,RESULTS,SHP,SORAFENIB,SRC,STAT3,TARGETING
001,2008,2013,227,533,547,864,BACKGROUND,BCL,BIM,COX,EGFR,JANUARY,LABEL,METHODS,PFS,POLYMERASE,RESULTS,THERE
945,A549,AZA,BACKGROUND,BISULFITE,CHIP,CYP24A1,EXPRESSION,H3K4ME2,H3K9ME2,H460,LABEL,METHODS,NCI,RESULTS,THESE,TREATMENT,TSA,VDR,VDRE
0007,0023,0129,0389,177,634,712,GGO,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTEEN,THESE
100,142,152,154,178,179,217,228,230,ALK,BACKGROUND,CONCLUSION,D5F3,DETECTION,DRUG,FISH,FOOD,IHC,LABEL,METHODS,NINE,NSCLC,ONCOGENIC,PET,RESULTS,TREATMENT
7500,BACKGROUND,BOTH,CONCLUSION,EGFR,HEREDITARY,LABEL,METHODS,RESULTS,T790M,THERE
131,2007,4804,ADHERENCE,BACKGROUND,CARE,DIAGNOSIS,END,FEW,HOWEVER,LABEL,LESS,LIFE,METHODS,OVERALL,QUALITY,RESULTS,STAGING,SUPPORTIVE,TREATMENT
ADRENAL
BELOW,CESSATION,COMMITTEE,CONTROL,LUNG,SMOKING,TOBACCO
169,2014,A549,AKT,AKT1,AKT2,CHRYSOTILE,COPYRIGHT,FINALLY,INC,JNK,JNK1,JNK2,JUN,LC3,MAPK,MEFS,NOTABLY,THESE
BACKGROUND,BRAIN,CASE,COLORECTAL,CONCLUSION,CRC,DUE,LABEL,METHODS
107,160,176,210,300,754,HIGH,HODGKIN,IMRT,LABEL,LAD,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,V107,V20,V30
169,198,2014,AFTER,AIS,ALSO,CONCLUSION,COPYRIGHT,FFPE,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RNAS,UNTIL,UTILIZING
001,169,2014,CCRT,COPYRIGHT,III,INHIBITING,IRELAND,JNK,JUN,LTD,NSCLC,OXIDATIVE,THERE,VNR
169,2014,COPYRIGHT,CTEN,HOWEVER,LTD,PTB,SH2,TNS4
000,100,1994,1997,386,390,507,GEOGRAPHIC,LABEL,LUNG,METHODS,OBJECTIVE,RADON,RESULTS,THESE
169,19OP,2014,21OH,945,BCL,COPYRIGHT,COX,DEX,GCS,HOWEVER,INC,NOS,TNF
169,2014,COPYRIGHT,EGFR,FINALLY,H1993,H2073,INC,LXR,NRS,PHA665752,TAKEN
A549,CALOTROPIS,COMPOUNDS,HELA,NMR,THEIR,THREE
263,ABT,BCL2,BCLXL,FINALLY,FIRST,LUMINEX,MCL1
1999,2011,ADULT,CONCLUSION,EES,EESS,EWING,FDG,IMAGING,KNOWLEDGE,LABEL,METASTASES,METHODS,NINE,OBJECTIVE,RESULTS
A549,ATP,BCL,COMPLEX,ECM,NPS,SOD,ZNO
EBUS,EUS,HOWEVER,NSCLC,PET,ROLE,SCLC,SINCE,SMALL
000,010,036,042,2009,2011,4000,500,8805,AFP,EIGHT,FOUR,LDLT
100,181,462,700,780,ARNEBIA,CALF,DPPH,GAE,LPO,TPC
480,BCA,BINDING,CD44,RHAMM
THERE
149,157,BASED,CHINALUNG,CONSORTIUM,HOWEVER,IMAGE,LIDC,LUNG,SINCE
FINALLY
119,169,2014,AIMS,BACKGROUND,BLOOD,ETOPOSIDE,FURTHER,GMBH,III,LABEL,MALDI,MDM2,METHODS,OBJECTIVE,RESULTS,SCLC,SNPS,TOF,TP53
169,2014,BACKGROUND,CHINA,CONCLUSION,GENOTYPING,GMBH,GST,GSTM1,GSTT1,LABEL,METHODS,PCR,RESULTS,RFLP
169,2014,BASEL,DAH,DIFFUSE,THERE
169,2014,COPYRIGHT,HOWEVER,INC,PRDM2,S100,THEN,VASH1
169,2014,ADP,ATP,COPYRIGHT,EG5,INC,THESE
018,023,034,048,10878,136,DHFR,EXOME,FOLR3,GGH,SLC19A1
99M,ASSESSING,DIFFERENT
001,169,2014,287,538,AUSTRIA,BACKGROUND,BESIDES,CONCLUSION,COPYRIGHT,CURRENT,DATA,DEPARTMENT,HOMEOPATHY,HOWEVER,LABEL,LTD,MALIGNANT,MEDICAL,METHODS,OUTPATIENT,PATIENT,RESULTS,UNIT,UNIVERSITY
169,2014,CHINA,COMMISSION,COPYRIGHT,INDIA,LTD,USA
169,2014,A549,COPYRIGHT,FOLLOWING,PRECURSOR,PRP19,SAS
128,8201,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM
100,10Z,11Z,160,200,946,A549,CCL4,RED,SEA,TME,U373
002,008,045,169,200,2014,8201,8805,945,AIM,ASIA,BACKGROUND,BARCELONA,EHMS,FDG,FOUNDATION,HCC,HEPATOLOGY,JOURNAL,LABEL,LIVER,LTD,METHODS,MILAN,OBJECTIVE,OPTIMALLY,PET,PLS,PTY,PUBLISHING,RESULTS,WILEY
APLASIA,FGF,FGF10,FGFR2,THESE
CTC,CTCS,FINALLY,HOWEVER,THEREFORE,THESE
UPON
2011,NOTABLY
109,169,2012,2014,490,789,8764,APRIL,INTENSITY,JAPAN,LABEL,METHODS,OBJECTIVE,PRESS,PUBLISHED,RESULTS,UNIVERSITY
101,17A,946,947,B16,B7H,BECAUSE,BHT,C57BL,ECS,F10,FINALLY,FOXP3,HEPG2,HOWEVER,HT29,ICOS,IL2R,JR8,M14,NOD,PAC1,PCF,PIX,RORC,SCID,THEREFORE
1000,1117,125,169,2014,226RA,337,4000,METHODS,PRESS,PUBLISHED,THERMAL,UNIVERSITY
001,003,005,009,015,023,141,141T,169,2014,235,326,399,691,718,730,8201,929,APE1,ARG399GLN,ASP148GLU,BER,NSCLC,OGG1,PFS,SER326CYS,UICC,XRCC1
169,2014,945,946,AUTHORS,BCA,CAMS,CNS,INC,PUBLISHED,SCN1B,UICC,VGSCS,VOLTAGE,WILEY
116,956,A549,ANNEXIN,ASPC,CAM,CELL,H2DCFDA,HCT,IC50,MTT,R24,ROS
001,002,155,169,1986,1990,2014,443,658,8201,CONCLUSION,COX,GIVEN,HNC,HYPOTHESIS,INC,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,ORAL,OTOLOGICAL,RESULTS,SOCIETY,SPC,SPCS
961,A313G,ASIAN,CAUCASIAN,CAUCASIANS,CNKI,EAST,GSTM1,GSTP1,INCLUSION,NSCLC,ODDS
AFTER,THERE
200,300,400,BOTH,HDAC,PERFORM,SEVENTEEN,THERE,VORINOSTAT,WBRT
105,160,BECAUSE,CRIBRIFORM,KI67,NONE,NST,OGCS
A549,BACKGROUND,CELL,CONCLUSION,CYTOTOXIC,DOCETAXEL,EGFR,H1650,H292,HOWEVER,KRAS,LABEL,MAPK,METHODS,MITOGEN,NCI,RESULTS,TKIS
2010,2013,215,FIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,TREATMENT,UNDER,V30
AFTER,AGING,AIM,BACKGROUND,CHILE,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SCREENING
10Q,11Q,12P,13Q,16P,17Q,18Q,20Q,20Q13,2621,7P21,ACCORDING,ARRAY,BAC,CGH,DUAL,FISH,GENOMIC,HIGH,PAC,PCR
160,8209,CXCR4,MMP,SDF,TAKEN
000,2000,215,250,576,GWAS,HISEQ,ION,PGM,POOLING,SNVS
177,400,ADVERSE,CONCLUSION,DTC,EIGHT,HOWEVER,LABEL,METHODS,OBJECTIVE,OFF,RESULTS,SORAFENIB,THERAPY,THESE
000,0001,181,250,4T1,500,5X10,8309,8804,AFTER,BALB,DIMENSIONS,LUNG,METASTASIS,MIGRATION,MMP,MTT,THESE,ZYMOGRAPHY
176,AFTER,BAX,BCL,H1299,HDAC6,HOWEVER,KU70,SIRT,SIRTUIN,TAKEN,TARGETING,THESE,TSA
169,2014,ALK,ANOTHER,BASEL,BRAF,DESPITE,EGFR,ERBB2,HOWEVER,KRAS,OVERCOMING,RET,ROS1,SEVERAL,THEREFORE,THESE,TKIS
026,043,177,956,A549,AIM,BALB,BAX,BCL,BOTH,CDIS,CELL,CONCLUSION,H460,IC50,LABEL,LC3,LDM,METHODS,MTT,NSCLC,OBJECTIVE,PARP,RESULTS,WESTERN
AKT,AMONG,ERK,HOWEVER,MAPK,NNK,NOTABLY,STAT,STAT3,TRP53,TSC2
ACCORDING,AIM,CONCLUSION,DETECTION,DIFFERENT,DIGE,FIFTEEN,LABEL,METHODS,OBJECTIVE,RESULTS,SCLC,SERA,SERUM,THESE
0001,ANGP,ASSESSMENT,BACKGROUND,FAILURE,FURTHER,HDIL,HIGH,HOWEVER,LABEL,METHODS,ORGAN,RESULTS,SEQUENTIAL
1985,448,AFTER,BACKGROUND,HEALTHY,HRS,LABEL,METHODS,RESULTS,RRS
169,2014,COPYRIGHT,DIGITOXIN,HOWEVER,NSCLC,THUS
169,2014,A549,COPYRIGHT,NMR,SAS
100,138,160,162,AMONG,CARLO,COV,CTDI,CTDIVOL,CTDIW,DRUG,ELSCINT,EXPO,FDA,FIRST,FOOD,GENERAL,HITACHI,KINGDOM,LUNG,MONTE,NLST,ONCE,PHILIPS,SCREENING,SIEMENS,TOSHIBA,TRIAL,VOLUMETRIC
160,169,1990,1992,2010,2013,2014,ASIA,BLOOD,BOS,COPYRIGHT,GVHD,HCT,JULY,MOST,OTHER,PATIENT,SOCIETY
169,2014,BRAF,CD74,ERBB4,EZR,HER2,HER3,IMA,IMAS,KRAS,LABEL,METHODS,NRG1,OBJECTIVE,ONCOGENIC,PURPOSE,RESULTS,RET,SIGNALING
169,2014,COPYRIGHT,HOWEVER,INC,TELOMERES,THERE
11MV,169,199NM,2014,217NM,82MV,946,ANXA2,CLG,COPYRIGHT,CSC,DIR,H1650,HOWEVER,MYC,PCR,PUBLISHED,RNAI,S100A10,SOX2,SRC,TARGETING,THESE,THUS,WESTERN
169,1995,1999,2000,2001,2004,2005,2007,2008,2009,2014,21ST,64328,BACKGROUND,COPYRIGHT,DCI,ECR,ESTONIA,HODGKIN,LABEL,LTD,METHODS,RESULTS,RSR,RSRS
169,2014,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PRIMARY,PUBLISHED,SOCIETY,ZEALAND
160,169,2014,AMD3100,CHEMOKINE,COPYRIGHT,CXCR4,DESPITE,LTD,PAMD,PLERIXAFOR,SDF
001,160,169,188,2002,2010,2014,545,643,COPYRIGHT,FURTHER,GENERAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,SURGERY,WOMEN
ABC,ABCB1,ABCC1,ABCG2,ATP,HOWEVER,LINSITINIB,LTD,MDR,OVERALL,PUBLISHED
169,2014,3758,5MM,CONCLUSION,COPYRIGHT,COX,DATA,EVALUATION,LABEL,LTD,METHODS,MODELLING,OBJECTIVE,PURPOSE,REGARDLESS,RESULTS,SOLID,THESE,TUMOURS,WORK
160,169,192,2009,2012,2014,237,302,BACKGROUND,BOTH,COPYRIGHT,DATA,FORTY,HILAR,INC,LABEL,METHODS,MOST,NSCLC,PATHOLOGIC,PUBLISHED,RESULTS,ROBOTIC,SOCIETY,VATS
117,136,169,2000,2010,2014,213,271,373,518,BACKGROUND,COPYRIGHT,EPP,INC,INDUCTION,ITALY,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
169,2014,CONCLUSION,COPYRIGHT,EGFR,FFPE,INC,KIRSTEN,KRAS,LABEL,METHODS,MUTATIONS,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,RESULTS,RFMP,SOCIETY,TESTING
160,169,2014,COPYRIGHT,EGFR,FINALLY,INC,LDH,NSCLC,RAS,THUS
169,2014,AUTHORS,CD44,COPYRIGHT,INC,KRAS,PUBLISHED
169,2014,233,AICAR,AMPK,AUTHORS,BHD,BIRT,COPYRIGHT,CRE,DUB,FLCN,HOGG,INC,LKB1,PUBLISHED
169,177,2014,CARLO,CONCLUSION,COPYRIGHT,DOSE,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RANGE,RESULTS,TPS,V10
CEREBELLAR,HODGKIN,LTD,PUBLISHED
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,MAPK,METHODS,NLP,P450,PUBLISHED,RESULTS,SAS
169,2014,6MONTHS,BACKGROUND,COPYRIGHT,DIARRHOEA,LABEL,LTD,LUNG,LUX,METHODS,NAMED,NPU,NSCLC,PATIENT,PFS,RESULTS
017,019,055,085,089,100,160,8201,AFTER,ALSO,BACKGROUND,CONCLUSION,EGFR,GENOMIC,LABEL,METHODS,NSCLC,ORR,OVERALL,PFS,RESULTS,SNP,UTR,VNTR
160,169,2014,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
120,169,177,2014,BACKGROUND,COPYRIGHT,INC,LABEL,MEAN,METHODS,NODULES,PUBLISHED,REMOVAL,RESULTS,SIXTY,SOCIETY
169,2014,4DCT,99M,COPYRIGHT,FIFTEEN,FOUR,INC,INDIVIDUAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
001,169,2014,8805,COPYRIGHT,FIFTEEN,FL1,FL2,INC,LABEL,LUNG,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SPECT,V20
106,169,2014,8805,COPYRIGHT,FDG,GTV,INC,LABEL,MATERIALS,METHODS,MMR,OBJECTIVE,PET,PURPOSE,RESULTS,VOI
169,2014,ALSO,BOTH,DDR,DDR1,DDR2,DDRS,INC
002,017,025,035,041,063,084,169,2014,219,244,421,785,928,CLUSTER,CONCLUSION,COPYRIGHT,DFS,EGFR,IRELAND,KRAS,LABEL,LTD,MATERIALS,METHODS,MUC5B,NULL,OBJECTIVE,OBJECTIVES,RESULTS,TRU,TRU1,TRU2,TTF
000,001,002,004,008,129,169,2008,2010,2014,346,491,726,8804,8805,968,AGE,CA125,CEA,COPYRIGHT,COX,III,INC,JANUARY,LABEL,MATERIALS,MEIER,METHODS,NSCLC,NSE,OBJECTIVE,PURPOSE,RESULTS
HOWEVER,THEREFORE
2010,AFTER,BOTH,CA15,CAF,CEA,CHINESE,CTM,DECOCTION,ECT,FEI,FOLLOWING,PFS,SEP,TTP
001,8807,CIS,EGFR,ILD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TKIS,TREATMENT
ANTWERP,BELGIUM,EGFR,EPIDERMAL,FLEMISH,L858R,NSCLC,RESULTS,TAT,THERE,TKI

177,BACKGROUND,C57BL,CD34,CONCLUSION,DESPITE,HELA,LABEL,METHODS,P53,RESULTS,SIXTY,TEN,THEREFORE
169,2014,ALK,ANAPLASTIC,FIVE,INC,NSCLC,PRIOR,SEVERAL,WILEY
1686,169,2014,EGFR,H1975,HOWEVER,L858R,NSCLC,T790M,THESE,THUS
169,2011,2012,2013,2014,246,ALK,AMP,ANAPLASTIC,APRIL,BACKGROUND,CAP,COLLEGE,EGFR,GUIDELINE,IASLC,LABEL,LUNG,METHODS,MOLECULAR,MTG,PATHOLOGY,RESULTS,SOCIETY,SUBTYPING,TESTING
169,2014,HOWEVER,INC,SIMULATION,WILEY
169,2014,950,9964,BASED,CRET,GMBH,HRP,KGAA,MCE,NSE,VCH,WILEY
221,222,30B,BACKGROUND,DICER,HOWEVER,III,KNOCKDOWN,LABEL,METHODS,NSCLC,PC9,RESULTS,SILENCE,SILENCING,THESE,WESTERN
578,8804,95TH,ABBOT,ARCHITECT,C28,CHINESE,CLSI,CMIA,HAN,INSTITUTE,LABEL,LABORATORY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RIS,STANDARDS
169,2014,ALPHAGUARD,BRAZILIAN,COMMITTEE,DOSEMAN,EFFECTS,HOWEVER,NATIONS,PERM,PRESS,PUBLISHED,RADIATION,SCIENTIFIC,THERE,UNIVERSITY
169,2014,PRESS,PUBLISHED,UNIVERSITY
100,125,2005,2010,CHEST,CONCLUSION,GROUP,JANUARY,JULY,LABEL,LOCAL,MEAN,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS
169,2014,902,AIM,COX,INSURANCE,LABEL,METHODS,NHI,OBJECTIVE,PHYSICIANS,PRESS,PUBLISHED,RESULTS,UNIVERSITY
001,031,042,045,135G,146,CHINESE,FORTY,GLU185GLN,HOWEVER,IIIB,LIG4,MEIER,NBS1,NSB1,NSCLC,RAD51,SNPS,THR9ILE
EBT,FORTY,HALO,NSCLC
0001,001,160,189,8201,945,ASSESSMENT,CCAT,CONTINUING,DISCLOSURE,FACT,LABEL,LIMITATION,METHODS,OBJECTIVE,PEARSON,PURPOSE,QSC,R10,RESULTS,SCNS,SUBSEQUENT,TOOL
181,EEG,GLASGOW,ROUTINE,SCALE,SERUM,VALPROATE
BOTH,LUNG
169,2014,232,605,996,ALTOGETHER,PRESS,PUBLISHED,SURGERY,THERE,UNIVERSITY,USING,VATS
029,954,AKT,ECM,MAPK,MMP,MMP2,MT1,PDZ,PI3K,SCLC,SMALL,SP1,THESE
20A,20B,946,A549,DDP,EMT,MICRORNAS,NSCLC,TGF,THESE
37LRP,A549,EMT,EPITHELIAL,PCR,THESE
946,AKT,CSF,CSF1R,INHIBITION,MPM,RNAI
123,A549,ADP,ADR,BCL,CDC2,FINALLY,FURTHER,MCL,METHOXY,MPM2,NCI,PARP,RES,THESE,TUBULIN,TYR15
HOWEVER,LUNG,NOTCH,NUMB,QKI,SF1,TAKEN
CONVERSELY,DELTA,DNP73,FINALLY,FOSB,JUN,JUNB,NP73,PAOX,TAP73
CARD9,CASPASE,TAKEN,USING
047,116,124,169,183,194,214,8805,BACKGROUND,LABEL,METHODS,PFS,RESULTS,SECONDARY
ALK,BACKGROUND,BOX2,CK5,CK7,LABEL,METHODS,RESULTS,SOX2,SRY
001,006,114,420,735,896,967,ASIAN,BACKGROUND,EGFR,EPIDERMAL,HOWEVER,LABEL,MET,METHODS,MUTATIONS,NSCLC,RESULTS,THESE,THUS,WHETHER
177,2007,2010,250,400,BACKGROUND,BETWEEN,CONCLUSION,CRT,III,LABEL,METABOLIC,METHODS,OCTOBER,RESULTS,SEPTEMBER,WORLD
100,2002,2011,BACKGROUND,FIVE,GIVEN,JANUARY,LABEL,METHODS,RESULTS,SIXTEEN,THERE
003,006,010,100,BACKGROUND,CONCLUSION,EGFR,KRAS,LABEL,LUNG,METHODS,MUTATIONS,RESULTS,SOCIETY,THESE,WORSE
2010,2013,ACTIVATED,ALK,BACKGROUND,CLEVELAND,CRIZOTINIB,HGF,HOWEVER,IHC,JANUARY,LABEL,MET,METHODS,NSCLC,RESULTS
100,103,ALK,ANAPLASTIC,BACKGROUND,D5F3,DAB,EXCELLENT,FISH,IHC,INC,LABEL,MEDICAL,METHODS,NSCLC,OVERALL,RESULTS,SIMILAR,SPECIMENS,SYSTEMS,THERE,THESE,VENTANA
671,BACKGROUND,GENOMIC,LABEL,LADC,METHODS,ONCOGENIC,RESULTS,RET
001,1998,200,2010,339,8993,9360,979,BACKGROUND,BECAUSE,BETWEEN,CAUCASIANS,CRS,IIIA,LABEL,METHODS,NSCLC,PATIENT,RESULTS,THERE
CAPILLARY,COL15A1,COL18A1,DYSPLASIA,ESM1,FOXF1,FSCN1,GRINA,IL1B,MALL,MATN2,NOS3,PRKCDBP,PULMONARY,RASL11B,SIMILAR,SIRPA,THESE,VEINS
169,2014,956,A549,AMONG,COPYRIGHT,FLOW,FURTHER,HOECHST,IC50,LTD,OVERALL
BACKGROUND,HER2,IHC,LABEL,METHODS,RESULTS,SIX,SIXTY
212,AFTER,BACKGROUND,BOTH,CASE,CHEST,CONCLUSION,LABEL,METHODS,PTH,PTHRP,SEMINOMAS,SERUM
14035,169,1991,2009,2014,270,351,38581,762,9654,9919,AIMS,AUSTRALIA,CENTRES,COLLEGE,COPYRIGHT,FRIESLAND,LABEL,LEEUWARDEN,LIVERPOOL,LTD,MACARTHUR,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,QUEENSLAND,RBWH,RESULTS,RIF,ROYAL,SOUTH,THERAPY,WALES,WOMEN
169,2014,366,756,A549,CCK,COPYRIGHT,EXPRESSION,INHIBITION,MICROARRAY,PCR,RNAS,SAS,ZXF1
169,2014,639,712,947,956,A549,CELL,CHIDAMIDE,COPYRIGHT,H157,H2A,HDAC,HDAC1,NCI,NSCLC,PARP1,SAS,SER10
116,137,145,169,2014,BACKGROUND,CHINA,COPYRIGHT,DISCUSSION,EVAL,FUEL,KRUSKAL,LABEL,LECO,LTD,METHODS,PAHS,RESULTS,ROCK,SMOKY,THESE,XRF,XUANWEI
169,1717,2010,2012,2013,2014,337,359,AIM,AUSTRALIA,AUSTRALIAN,AUTHORS,BACKGROUND,COLLEGE,EGFR,FAILURE,FNA,FULL,JOURNAL,LABEL,METHODS,MOLECULAR,NSCLC,OBJECTIVE,OCTOBER,PARTNERING,PHYSICIANS,RESULTS,ROYAL,SAMPLES,THERE,TKI,TREATMENT
1939,BRUNN,CHEST,DIAGNOSIS,IMT
1998,2012,329,BACKGROUND,COPD,FACTORS,JANUARY,JULY,LABEL,METHODS,NSCLC,RESULTS,RIGHT,SMOKING
1998,2011,750,961,BACKGROUND,BETWEEN,CONCLUSION,FIVE,LABEL,METHODS,NSCLC,OVERALL,RESECTABLE,RESECTION,RESULTS
CLASSIC,DIAGNOSTIC
CIGARETTE
AIMS,BACKGROUND,BEV,EGFR,LABEL,METHODS,OBJECTIVE,RESULTS,TTP
160,169,2014,8211,945,946,ALIKE,BIOLOGY,CELL,CIGARETTE,COMMONS,INCREASED,LICENSE,NEUROD1,OSBORNE,SCLC,SHARE,SOCIETY,THESE
BECAUSE,LARGE,LCNEC
AB12,AC29,BACKGROUND,CELL,CRS,LABEL,MALIGNANT,METHODS,MPM,MTS,ONCOLYTIC,RESULTS,THESE
169,2013,2014,CONFERENCE,CONSENSUS,ESMO,LUNG,MAY,MEDICAL,NSCLC,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
001,005,2010,2013,8805,COX,DATA,EIGHT,FOUR,KPS,MAY,OCTOBER,OVERALL,SANT,WBRT
100,160,231,8209,FN1,GANODERMA,GLE,HRAS,IDENTIFIED,LUNG,MCAM,MDA,PCR,VIL2
8805,RPLND
18F,ANNEXIN,BAX,BCL,FDG,MTT,NSCLC,PARIS,PSI,RHIZOMA
169,2014,COPYRIGHT,GEMMS,GIVEN,LTD
169,1994,2001,2010,2014,283,544,8805,COLORECTAL,IGE,IMMUNOCAP,LUNG,ODDS,ORS,OTHER,OVARIAN,OVERALL,PLCO,SCREENING,THERE,TRIAL,USING
BACKGROUND,CONCLUSION,DATA,HOWEVER,LABEL,METHODS,NTS,OBJECTIVE,PARAMEDIAN,RESULTS,SUMMARY
177,183,2011,2013,75TH,ACDF,BACKGROUND,CONCLUSION,DATA,JANUARY,LABEL,LEVEL,LOS,METHODS,OBJECTIVE,ORS,RESULTS,SUMMARY,THEIR,THERE
CARDIAC,FLUID,IMAGING,MALIGNANT
LABORATORY,SSC,VAD
HODGKIN,WHILE
IATROGENIC,LESS
030,1000,117,119,123,128,129,130,169,180,2007,2012,2014,212,2400,250,400,500,8805,BACKGROUND,CETUXIMAB,COPYRIGHT,FEB,KRAS,LABEL,LTD,METHODS,NOV,RESULTS,SURGERY,THERE
AMERICA,BRAIN,CENTRAL,METASTATIC,SOUTH
GUIDELINES,III,NCCN,PANEL,THESE
600,8594,BRAF,CONVERSELY,CTR1,ERK1,ERK2,GLU,MAPK,MEK1,MEK2,MEK5,TAKEN,TARGETING,V600E,VAL
HOWEVER,NUTRITION
109,118,2009,2012,288,AMONG,CASES,FEWER,HIV,MACCALLUM,MARCH,NINE,OVERALL,PETER,PJP
000,001,002,005,102,176,2000,2012,CHINESE,COX,GENERAL,LABEL,LCNEC,MAR,MATERIALS,METHODS,OBJECTIVE,OCT,PLA,RADICAL,RESULTS,SCLC,THERE,TNM
24H,48H,72H,A549,BAX,BCL,BCL2,HDAC1,MATRINE,MICROARRAY,MTT,SOPHORA,VEGF,WESTERN
916,968,A549,BAX,BCL,PCR,THEREFORE
040,116,146A,148,160,177,196A2,351,360,383,446,467,524,625,726,737,827,873,887,990,BACKGROUND,BOTH,HOWEVER,LABEL,SNP,SNPS
001,018,025,048,270,299,8805,AGE,BACKGROUND,BESIDES,DATA,EASTERN,GROUP,LABEL,MATERIALS,METHODS,NLR,PRIOR,RESULTS,THERE
000,001,003,004,018,026,030,177,2005,2010,300,BACKGROUND,LABEL,LDH,MATERIALS,MEAN,METHODS,MPM,NLR,OVERALL,PLR,RESULTS,THERE,WBC
0001,276,CHINESE,DATA,DAUGHTERS,WOMEN
008,009,014,020,022,040,272,544,ARG399GLN,BACKGROUND,EAST,GLN,INDIA,LABEL,LYS751GLN,MATERIALS,METHODS,NORTH,RESULTS,XPD,XRCC1
2007,2012,BESIDES,CD44,DEC,HENCE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS
138,8202,COX,GLASGOW,GPS,HRS,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,UNIVARIATE
BACKGROUND,BLADDER,CASE,ENDOSCOPIC,LABEL,METHODS
000,013,019,500,BASED,COSTS,EGFR,III,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PMPM,RESULTS,SEER
CHF,CONGESTIVE,EMERGENCY,RESULTS,THEN
133A,169,2013,CD133,DESPITE,LNA,NOVEL,OVERALL,PRESS,SILENCING
001,006,100,103,108,1140,169,2014,430,437,531,8805,AGE,BONE,COPD,FRACTURES,HOUNSFIELD,MINERAL,SOCIETY,UNITS
10001,333,BONE,MEDICAL,OSSEOUS,PATIENT,PET,PUBLISHERS,SEVENTH,USA,YORK
160,166,178,EHE,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PLEURAL,PURPOSE,RESULTS
252,8201,BACKGROUND,CONCLUSION,CTV,DEGRO,DISCUSSION,DISTANT,ESPECIALLY,GROUP,GTV,LABEL,PTV,RADIATION,RESULTS,SOCIETY,SRS,WBRT,WORKING
AFTER,THREE
001,002,009,036,042,043,044,160,AKT,EMT,FOX,FOXM1,HOWEVER,NSCLC,OTHER,PCR,THEREFORE,TMA,TNM
160,296,8201,8804,AMONG,AOR,CAM,CAUCASIAN,CONCLUSION,GIVEN,GREATER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCANT,SELF
1605,1947,2013,540,549,AMONG,CIS,CURRENT,DATA,EGFR,EXTRACTION,HOWEVER,HRS,IMPORTANCE,LABEL,MAIN,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,RELEVANCE,RESULTS,SELECTION,SOCIETY,SOURCES,SYNTHESIS,TKI,TKIS
160,8209,AAV,AAV2,C57BL,EGFP,LEWIS,LLC,MVD,PEDF,PIGMENT,THESE,VEGF
133B,786,8209,A498,FOLLOWING,MMP,RCC,THESE
160,2005,2009,486,8209,COX,DROPOUT,LIVERPOOL,LLP,LUNG,MEIER
001,169,2014,5064,AACR,CLIN,EXPRESSION,LABEL,MEMBRANOUS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RCC,RES,RESULTS,THESE
10A,231,946,BACKGROUND,EMT,EXPRESSION,FAK,H1299,LABEL,MCF,MDA,MECHANISMS,METHODS,NADPH,NOX,NOX4,R175H,R280K,REMARKABLY,RESULTS,ROS,SMAD3,TGF
008,100,107,115,141,169,182,1941,2012,2014,645,813,8805,BLOOMBERG,ENGLAND,HOPKINS,JOHNS,MORTALITY,PRESS,PUBLISHED,THESE,UNIVERSITY,WALES
660,GENOMIC,LINE,MGA,THUS,UTRS
001,002,023,035,8202,COX,GENECARDS,M38,MEIER,THESE
002,AFTER,CD3,CD4,CD8,CIK,IIIB,THERE
DIAGNOSIS,HONG,KONG,PULMONARY
169,2014,9343,ADC,ANTITUMOR,BAY,BINDING,DM4,EFFECTS,MESOTHELIN
100,121,169,196,2014,247,LERMONTOV,NORTH,PRESS,PUBLISHED,THUS,UNIVERSITY
8G7G3,ACCS,FORTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPT24,TTF
ALW,ATP,BAD,EPHA2,INDUCTION,KNOCKDOWN,KRAS,NSCLC,RTK,S6K1,TARGETING
076,100,181,2013,299,318,400,566,8202,921,BACKGROUND,CIS,CONCLUSION,DOSE,FINALLY,HIGH,LABEL,LIBRARY,OVERALL,PRINCIPAL,RESULTS,SEPTEMBER,STUDIES
169,2014,BECAUSE,CD34,COPYRIGHT,DATA,INC,PATHOLOGY,PUBLISHED,SOCIETY
2009,2013,AIDED,BACKGROUND,BASED,CADE,CHALLENGES,DETECTION,DISCUSSION,FURTHER,HOWEVER,IEEEXPLORE,LABEL,METHODS,PACS,SCIENCE
ANTIBODIES,BACKGROUND,BRAIN,CASE,LABEL,METHODS
11124,ADK,AFTER,CHINESE,IHC,ING2,NSCLC,PCR,SCC,TAKEN,TNM,WESTERN
125A,A549,AFTER,EGCG,H460,HOWEVER,MAPK,MEANWHILE,MIRNA,NCI,NSCLC,TAKEN,THESE
BRONCHIAL,HODGKIN,SJOGREN
DESPITE,THUS
BONE,EARLY,HOWEVER,PATIENT,RAPID,TOKUHASHI
8260,8805,95TH,BACKGROUND,DLCO,FEV1,FVC,INCREASED,IPF,LABEL,LUNG,MEAN,METHODS,REGARDLESS,RESULTS,TLC
169,2014,BASED,CIGARETTE,LUNG,PRESS,PUBLISHED,SMOKING,UNIVERSITY
2006,HODGKIN,LANGERHANS,LAOTIAN,OPEN
HODGKIN,PARKINSON,SPS,STIFF
001,002,025,169,1996,2005,2014,204,338,8804,8805,ALASKAN,ANS,BACKGROUND,DISEASE,EFFORTS,END,FEWER,INDIANS,LABEL,METHODS,NATIONALLY,NATIVES,NONRECEIPT,RATES,RESULTS,SOCIETY,TREATMENT
169,2014,AUTHORS,C3A,C3AR,C5A,C5AR,HOWEVER,JOHN,LTD,SEVERAL,SONS,WILEY
169,2014,FGF,FGFR,JOHN,LTD,NSCLC,OTHER,SONS,TARGETING,THERE,WHILE,WILEY
019,025,326,8201,945,946,967,978,COX,IIIA,MEIER,NSCLC,SMA,TGF,THERE
169,189,2014,A549,H1975,INC,THEREFORE,WILEY
FN14,HGF,HGFR,MET,NSCLC
1044,109,134,147,197,2012,277,300,8201,AFFAIRS,AMONG,FLEISCHNER,FORTY,GUIDELINES,IMPORTANCE,LABEL,MAIN,METHODS,NOTABLY,OBJECTIVE,OTHER,PULMONARY,RELEVANCE,RESOURCES,RESULTS,SETTING,SOCIETY,SYSTEMS
160,8201,FIFTY,GLI,PCR,PTCH,SHH,THESE
160,177,CBCT,DRR,DRRS,FINALLY,THESE
2005,2006,279,946,BACKGROUND,BECAUSE,HMHS,LABEL,LMHS,METHODS,MORTALITY,OBJECTIVE,RESULTS,THERE,THESE,USING
169,196,2014,355,8201,ALTERED,BOTH,CLDN,CLDN6,CLDNS,COX,NOTEWORTHY,NSCLC,PROTEIN,THESE,TTF,UICC
169,2014,G2M,HOWEVER,III,K48,NRAGE,PCNA,PRESS,PUBLISHED,UNIVERSITY,USP10
176,177,178,215,CARLO,CBCT,DMLC,EPID,IGRT,IMRT,MEDICAL,MLC,MONTE,PHYSICS,SABR,SMLC,VERO
178,9993,DVH,DYNALOG,ECLIPSE,EPID,IMRT,MILLENNIUM,MLC
001,007,2007,2011,2012,DOSE,DVH,FINALLY,GROUP,IMN,OAR,OARS,OVERALL,RADIATION,RTOG,SCV,THERAPY,TREATMENT,TVS,V10GY,V20GY,V30GY,V5GY,V90,V95
ASIR,FBP,GGO,GGOS,MBIR
169,2014,483,946,ALCAM,EMT,GDP,RHO,RHOGDI1,SNAIL,WNT
100,118,122,200,400,800,CONCLUSION,ICER,LIFE,METHODS,QALY,QALYS,RESULTS,RISK
169,2014,ATM,CDK1,CDK6,CELLS,COPS5,COPYRIGHT,FINALLY,JUN,PEA15,RAS,REGULATION,SOCIETY
RESULTS
CASE,HOWEVER,LABEL,NEXT,NGS,OBJECTIVE,PURPOSE,RESULTS,SEQUENCING,SUMMARY
000,0001,009,019,100,112,2003,2006,448,560,8202,8758,BACKGROUND,BETWEEN,FURTHER,HOWEVER,INSURANCE,LABEL,METHODS,OBJECTIVE,PROPENSITY,PURPOSE,RESULTS,THREE
13Q,15Q,17P,22Q,ESPECIALLY,NOVEL,RB1,SCLC,SNVS,SOMATIC,THESE,TP53,WGS
1494,1524,HOWEVER,OVERALL,THERE
169,2014,956,AFRICAN,COMPOUNDS,COPYRIGHT,FOUR,HELA,HEP,HMBC,HMQC,IC50,LTD,NMR,PENINSULA,PUBLISHED,ROESY,SAR,THEIR,VERO,YUCATAN
BACKGROUND,BRAIN,CONCLUSION,CXORF66,LABEL,MATERIALS,METHODS,ORF,ORFS,RESULTS,SGPX
169,2014,231,468,ALDH,CD44,COPYRIGHT,HOWEVER,INC,MDA,NEOPLASIA,NOTABLY,OPN,PRESS,SELL,SEVERAL,USING
144,169,2014,946,CONVERSELY,COPYRIGHT,FURTHER,INC,KRAS,LOSS,NEOPLASIA,PRESS,RAS,SMAD,TAKEN,THEREFORE,TRCP1,UBCH5
160,169,2014,BAPTA,BAX,BPC,CA074,COMPLEX,COPYRIGHT,LMP,LYSOSOMAL,NEX2,SAOS,SAS,THESE
100,160,169,2014,AIM,COLLEGE,CONCLUSION,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PNB,PUBLISHED,RADIATION,RESULTS,ROYAL,THERE,TOTAL,ULD
100,200,AAH,BACKGROUND,BOTH,CHINESE,DETECTION,FOLLOWING,HENCE,LABEL,METHODS,MICROARRAY,RESULTS,SCD,SEQUENCING,TOTAL
100,160,177,2009,2011,203,206,390,8201,BACKGROUND,CHINA,CHINESE,ICU,LABEL,MARCH,MEAN,METHODS,OBJECTIVE,OBJECTIVES,OPERATIVE,RESULTS,TNM,VABSL,VATS
160,2010,HOWEVER,VATS,VIDEO
178,239,2402,400,8TH,BACKGROUND,CRT,ESCC,GRADE,HLA,HOWEVER,KOC1,LABEL,METHODS,PEPTIDE,RESULTS,SIX,TRIAL,TTK
100,BACKGROUND,CASE,CAUCASIAN,KINGDOM,LABEL,METHODS,SERVICE,THESE
001,034,036,145,8805,BOTH,CONCLUSION,COX,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOTAL
167,176,177,EFFECTS,GEL,OPTIMAL,RNAS,SIRNA,VEGF
072,2012,8799,CASE,EGGER,PRIOR,SEPTEMBER,STATA11,THERE
A549,AKT,COMPOSITAE,H1299,MAPK,NSCLC,S6K
PRINGLE,TSC
014,150,8594,945,94INS,954,ACCORDING,ATTG,BIA,HOWEVER,LUNG,NSCLC,PCR,RFLP,TURKISH,UTR
197,8764,945,946,ALK,EMAP,EML,EML1,EML4,EMLS,HELP,HSP90,MAPPING,RECURRENT,TAPE,WD40
HOWEVER,KLEBSIELLA
169,2014,252,8197,945,956,A549,ACTA,AZ521,B16,BAX,BCL,CHIMICA,COPYRIGHT,HELVETICA,HL60,IC50,JUSS,MELIACEAE,MITF,MSH,SIAMESE,SIX,TRP,VALETON,WESTERN
169,2014,252,63743,8197,946,956,A549,ACTA,AZ521,BARR,CHIMICA,COPYRIGHT,EBV,EPSTEIN,HELVETICA,HL60,IC50,RAJI,THESE,TPA,WESTERN
115,169,2002,2006,2014,3638,AUTHORS,CSF,CSFS,DOCUMENTED,III,JOHN,LTD,RDI,RISK,SONS,WHILE,WILEY
169,2014,ETS,FINALLY,KI67,MMT,THESE,UICC
001,012,015,BCSG1,CK19,CTCS,MAM,PCR,RESULTS,THESE
A549,AIM,BACKGROUND,DMEM,EAGLE,INCREASING,LABEL,LC3,MATERIALS,METHODS,OBJECTIVE,RAPAMYCIN,RESULTS
023,2003,2006,327,617,633,674,716,766,831,928,DESPITE,HER2,MBC,THESE
0001,222,8804,954,CONCLUSION,ERCC1,ERRC1,FIRST,GENZYME,LABORATORY,METHODS,NSCLC,RESULTS,THIRD
001,2401,946,ASIAN,BACKGROUND,CAUCASIAN,CNKI,EFS,HOWEVER,IHC,III,LABEL,METHODS,NSCLC,ODDS,ORR,PCR,RESULTS,THEREFORE,TUBB3
000,200,BRAIN,CHEST,EMERGENCY,FOUR,MRA,WHILE
A549,AKT,EGF,EGFR,FOXO1,JUN,MMP9,NSCLC,PI3K,TAKEN,THUS
738,833,BACKGROUND,CONCLUSION,H7N9,HIGH,LABEL,METHODS,RESULTS,ROC
242,555,932,APE1,ARG,ASIAN,CIS,CLU,GLU,ORS,OVERALL
2014,COOH,MED,NH2,SURFACTANT
009,042,047,100,11000,8201,8650,BOTH,D21,RIST
AFTER,HIV,THUS
218,ADAM9,BECAUSE,CDH2,LUCIFERASE,LUNG,MIR,SLIT2
DUE,HPLC,PROFILING,SPE,VARIOUS
1988,1999,2004,2008,END,LUNG,RESULTS,SEER
100,8764,CAPP,FINALLY,NSCLC,SEQ
169,215,400,AGCT,CALL,EXNER,HPF,MITOTIC,MOST,NONE
1998,2013,CD10,CD31,CD34,CD56,CD99,ESS,EWING,GATA,HPF,PAX8,THREE
CATHEPSIN,EMMPRIN,HOWEVER,MMP,PCR,TCA8133,USING,WHILE
000,100,160,290,463,8201,BEIR,BIOLOGICAL,CRT,EFFECTS,IMRT,LAR,LARS,ORGAN,PLD,RADIATION,VII,VMAT
169,2014,COPYRIGHT,INC,RET
001,014,A549,ANCT,COX,HOWEVER,LAC,MMP,MMPS,MTT,TAKEN,TRANSWELL
169,2014,945,947,948,954,969,CONSISTENT,COPYRIGHT,HOWEVER,INC,P450,STAT3,THESE,TOCOPHEROL
038,169,16PTS,19PTS,2008,2011,2014,3PTS,460,662NM,AFTER,COPYRIGHT,III,IIIA,IIIB,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PDT,RESULTS,THERE
169,2013,2014,3487,ANTI,ARS,ARTHRALGIA,BOHAN,COPYRIGHT,ILD,JO1,LABEL,MEDLINE,METHODS,MI2,OBJECTIVE,PETER,RAYNAUD,RESULTS,RNP,RPH,SCL,SRP
160,169,177,2014,956,ACCORDING,ADP,ALDER,C57BL,COPYRIGHT,CUPRESSUS,DIELS,E0771,EPITHELIAL,IC50,MCF,PARP,SAS,THESE
169,2014,BEAS,COPYRIGHT,DNASE,E1B,GENOMIC,NRF2,PREVIOUSLY,SFN
169,2014,AESTHETIC,BRITISH,COPYRIGHT,EATON,III,LAMBERT,LEVEL,LTD,PLASTIC,PRE,PUBLISHED
10878,135,169,177,2014,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,DFI,LABEL,LTD,METHODS,PATIENT,RECURSIVE,RESULTS,RPA,STS
169,2014,ALK,COPYRIGHT,EGFR,IRELAND,LTD
100,169,2014,400,CAS,COPYRIGHT,DTPA,HSNSS,LTD,MRI,RGD
169,2008,2012,2014,COPYRIGHT,INC,MYC,TERRY,VIRUS
0034,0047,019,150,159,165,169,2014,2ND,500,8804,8805,B12,BACKGROUND,COPYRIGHT,EASTERN,EVALUATION,GROUP,III,LABEL,LTD,METHODS,NSCLC,PEMETREXED,PFS,RESULTS,SECONDARY,SOLID,TTTF
12MINUTES,131,169,2014,26M,BOTH,CHARTERED,COPYRIGHT,EORTC,FORM,LABEL,LC13,LTD,METHODS,NSCLC,OBJECTIVE,PUBLISHED,QLQ,RANDOMISED,REGARDLESS,RESULTS,SECONDARY,SETTING,SHORT,SHUTTLE,SOCIETY,TEST,THERE,TREATMENT,WALK
169,2014,302,5283,853,947,AUR,AUTOMATIC,BETWEEN,COPYRIGHT,FORTY,HOWEVER,INC,INTRA,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,TODAY
169,201,2014,231,COPYRIGHT,PUBLISHED,SAS
169,2014,A549,ABCB1,BASED,COPYRIGHT,D16,DOC,GMBH,HOWEVER,MDR
100,169,2014,239,COPYRIGHT,ESTIMATED,INC,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,T1A,T1B,TECHNICAL
169,1993,2010,2013,ASSOCIATED,BACKGROUND,CONCLUSION,COPYRIGHT,FIVE,IMAGING,LABEL,METHODS,RESULTS,SAS,THESE,WORLD
1114,169,2014,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,GRADE,HOWEVER,IRELAND,LABEL,LTD,METHODS,NCSLC,NSCLC,RESULTS
169,2014,COPYRIGHT,EGFRI,INC,LUNG,MEDICATION,MOSBY,NSCLC,ORAL,SURVIVING
049,2008,2011,280,417,429,778,ACCORDING,JANUARY,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BASED,FDG,HOWEVER,PET
AREAS,BACKGROUND,COVERED,DESPITE,FURTHER,IPILIMUMAB,LABEL,METHODS,NSCLC,OPINION
117,215,8805,CONCLUSION,HOWEVER,LABEL,METHODS,PATIENT,RESULTS,TSAS,UNLABELLED
001,739,822,887,904,960,988,ALS,NON,PTB
2000,2012,2013,215,AMONG,BACKGROUND,CENTRAL,CLINICIANS,CONTROLLED,ENGLISH,LABEL,LDCT,LIMITED,LUNG,MAIN,MAY,MEDLINE,METHODS,OBJECTIVE,RATIONALE,RCTS,RESULTS,REVIEWS,SYSTEMATIC,THREE
000,001,009,081,127,2000,2013,6922,8201,CENTRAL,CIS,CONTROLLED,DCR,HRS,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PFS,RESULTS,SUB
2008,2011,352,ALONG,BACKGROUND,CITY,HISPANICS,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,STRUCTURAL,USING,YORK
169,2014,955,AUNP,GMBH,HOT,KGAA,LSPR,THESE,VCH,WILEY
169,2014,2959,AACR,ANTITUMOR,CLIN,HCC,HGF,HIGH,LABEL,MET,METHODS,NOTABLY,OBJECTIVE,PURPOSE,RES,RESULTS,TOTAL
169,2014,CONSISTENT,FURTHER,INC,MET,MTT,THESE,TUNEL,WILEY
169,2014,945,FOXC2,HUVEC,INC,INCREASED,OPN,THESE,VEGF,WILEY
169,2011,2013,2014,223,411,AKT1,ALK,BACKGROUND,BETWEEN,BRAF,CONCURRENT,EGFR,FGFR1,FGFR2,HER2,JANUARY,JULY,KRAS,LABEL,LUNG,MEK1,MET,METHODS,NRAS,PTEN,RESULTS,RET,ROS1,SOCIETY,SURGICALLY,THESE
107,160,177,8201,A549,CISPLATIN,HOWEVER,LD50,LIPOSOMES
BACKGROUND,CHEST,COLLEGE,COMMITTEE,IDEALLY,LABEL,METHODS,NETWORK,PHYSICIANS,PREDEFINED,QUALITY,RESULTS,THREE

372,A549,ATLAS,AZA,BMP2,CELL,CLMP,DDP,GAS1,GDA,HSP8,ICAM1,LOW,LOXL1,NSCLC,S100P,TCGA,TEN,TIMP4,TSA,WISP2
0181,CD44,CEA,HOWEVER,LEWIS,METASTASIS,OH1,PSGL,SCLC,USING
2001,521,8804,8805,910,AIRFLOW,ATS,BACKGROUND,CONCLUSION,EMPHYSEMA,ERS,FEV1,FVC,HOUNSFIELD,LABEL,MATERIALS,METHODS,PERCENT,RESULTS,SPIROMETRY,UNITS
169,1737,177,2014,8804,DATA,LABEL,MEAN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PRESS,PUBLISHED,RECURRENCE,RESULTS,SURGERY,UNIVERSITY
100,945,APTAMER,EMPLOYING,EOL,EVOLUTION,HT29,LIGANDS,SDA,SELEX,SYSTEMATIC,TNF,UNDER
0001,0043,0063,693,ACCORDING,DESPITE,MVD,SMA,THEN
100,AGE,FORTY,HOWEVER,KARNOFSKY,KPS,MRI,NSCLC,PROGNOSIS,RPA,RRDS,SRS,TCR,THUS,WBRT
169,2014,A549,COPYRIGHT,EMT,H1299,HOWEVER,LUNG,THEREFORE,THP,THUS
169,2014,946,947,9ER,9ZD,AKT,ASIA,AUTHORS,CRKL,CT10,EGFR,ELISA,EPIDERMAL,HOWEVER,IMMUNOBLOT,LTD,NSCLC,PCR,PI3K,PPAR,PTY,PUBLISHING,SCIENCE,SMAD2,T790M,TGF,THESE,TKI,WILEY
BACKGROUND,CHEST,CONCLUSION,COPD,LABEL,METHODS,MRI,MULTI,PET,PPV,RESULTS,SCHOLAR,THERE
169,2011,2013,2014,303,8201,ASIAN,BACKGROUND,EBUS,JANUARY,JULY,LABEL,METHODS,NSCLC,OBJECTIVE,OBTAINING,PACIFIC,RESULTS,SAMPLES,SOCIETY,TBNA
169,173,2014,300,379,552,ASIAN,BACKGROUND,COPD,CRMP5,LABEL,METHODS,NONE,OBJECTIVE,PACIFIC,RESULTS,RIPA,SOCIETY,THREE
003,BOTH,CONCLUSION,DESPITE,DSS,HOWEVER,LABEL,METHODS,PFS,RESULTS,STS,UNLABELLED
A549,CHINA,COMPOUNDS,FURTHER,GLY,HELA,HEPG2,ILE,NMR,PRO,SEA,SOUTH,THR
CONCLUSION,CONSCIOUS,HALF,KNOWLEDGE,KRUSKAL,LABEL,METHODS,OBJECTIVE,RESULTS
RISK
2011,ATS,CDX2,CK20,CK7,EGFR,ERS,IASLC,KRAS,LUNG,MCRS,MUC2,PEAC,PEACS,PULMONARY,SOCIETY,TTF

BAL,HOWEVER,ISD,PAP,TEM,THEREFORE
BACKGROUND,COX,DOWN,FURTHER,ICH,LABEL,MEIER,METHODS,NOTABLY,PCR,PP2A,PROTEIN,REAL,RESULTS,THESE,WESTERN
169,2014,3810,945,BIOLOGY,CARDIAK,CSBP,DDR2,EPHA2,FGFR2,INC,LYN,MOLECULAR,NOVEL,PDGFR,SOCIETY,TAKEN,THESE,YES
169,2014,BHV,COPYRIGHT,HSV,IFN,IMPORTANCE,KRAS,LABEL,NCI,OBJECTIVE,ONCOLYTIC,OVERALL,OVS,SOCIETY,STRIKINGLY,THESE,UNLABELLED
945,946,FURTHER,GAL,REGARDING
003,006,125,167,169,193,2014,318,EGFR,IIIB,LABEL,METHODS,MUTATIONS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TP53
005,137,177,344,ELISA,HIGH,SERUM,TNC
005,2013,8201,ACCORDING,CHINA,EAST,KNOWLEDGE,REFERENCES,VIP,WANFANG,XPA
2007,2011,BETWEEN,CONCLUSION,EIGHT,FEV1,IIP,ILD,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
139,146,169,2014,8201,ACCORDING,AIM,CONCLUSION,FORTY,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
000,127,134,2009,2012,214,230,ACADEMY,CHINESE,DATA,DEPARTMENT,INSTITUTE,JANUARY,LUNG,MAY,MEDICAL,PREVENTION
16HBE,946,A549,ALTOGETHER,CREB,ERK,FURTHER,H23,H460,HOWEVER,NCI,NSCLC,TXAS
A549
A549,H1299,HBE,HOWEVER,NSCLC,PCR,RNAS,THESE,WESTERN
177,2012,2013,20MM,BETWEEN,EBUS,FIFTY,LABEL,MARCH,MEAN,METHODS,MILD,OBJECTIVE,PPL,RESULTS,SEVENTY,TBLB,TENTH
AMERICA,ASIA,CHINA,CHINESE,DATA,IARC,NORTH
BBB,BRAIN,CNS,FDG,FINALLY,PET,THERAPY,USING,USUALLY
369,FDG,MEDLINE,PET,SCLC,WHOLE
AFTER,IPAH,PAH,PROVIDING
169,2014,BLOOD,COPYRIGHT,INC,PUBLISHED,SECONDARY,SOCIETY
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2014,946,COPYRIGHT,INC,PATHOLOGIC,PUBLISHED,SOCIETY
009,187,2008,2011,BACKGROUND,CONTEXT,G12A,G12C,G12D,G12S,G12T,G12V,G13C,INCREASED,KIRSTEN,KRAS,LABEL,LUNG,METHODS,OBJECTIVE,RAS,RESULTS,SOCIETY
109,169,2014,FDG,LABEL,METHODS,MRI,OBJECTIVE,OSEM,PET,PHANTOM,PHYSICISTS,POISSON,PSF,PURPOSE,RESULTS
169,2008,2014,COV,DERENZO,DISCOVERY,FBP,FDG,FINALLY,FWHM,FWTM,HILBERT,LABEL,METHODS,NEMA,OBJECTIVE,PET,PHYSICISTS,POISSON,PURPOSE,RADON,RESULTS,SRT,STIR,USING
169,177,2014,CONSORTIUM,HAUSDORFF,IMAGE,LABEL,LIDC,LUNG,METHODS,OBJECTIVE,PHYSICISTS,PURPOSE,RESULTS,UNDER
169,2014,BETWEEN,CARLO,EXCELLENT,IDENTICAL,LABEL,MCNP,METHODS,MONTE,OBJECTIVE,PHYSICISTS,PTV,PURPOSE,RESULTS
001,100,169,177,2014,AFTER,BDE,BMR,FURTHER,LABEL,LEFT,MARGINS,METHODS,OBJECTIVE,PHYSICISTS,PROCRUSTES,PURPOSE,RESULTS,SMALL,THESE,USING
118,177,2010,2012,8201,8804,BACKGROUND,CTV,DATA,DIFFERENT,DOSE,DOSIMETRIC,LABEL,METHODS,OCTOBER,OVERALL,RESULTS,SABR,V98
144,41BBL,947,AFTER,CD152,CD274,CD275,CD70,CHANGES,CONVERSELY,CTL,CTLA,DU145,EBRT,ELISPOT,EPITHELIAL,FINALLY,ICOSL,IFN,LAST,LNCAP,OX40L,PC3,PCA,THESE
006,2003,2009,ACCORDING,AIM,CONCLUSION,III,LABEL,METHODS,NAC,OBJECTIVE,RESULTS,UNIVERSITY
018,100,110,150,198,2008,2009,242,342,419,442,540,BACKGROUND,BETWEEN,CONCLUSION,DCR,ERLOTINIB,GEFITINIB,JANUARY,LABEL,METHODS,NSCLC,PRIOR,RASH,RESULTS,SEPTEMBER
AIM,CONCLUSION,FORTY,FULL,IIIA,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PS0,PS1,RESULTS,THEIR,TREATMENT,UNTREATED
ANTI,BACKGROUND,BECAUSE,CONCLUSION,DENDROBIUM,EMT,H292,LABEL,MATERIALS,METHODS,RESULTS,SNAIL,TDB
041,112,A549,AIM,AXL,BACKGROUND,CONCLUSION,ERK,LABEL,METHODS,NSCLC,OBJECTIVE,PC9,PHOSPHO,RESULTS
100,956,ACTIVITIES,AIM,BACKGROUND,CONCLUSION,DPPE,ERK1,ERK2,H28,LABEL,MATERIALS,MET5A,METHODS,MTT,NCI,OBJECTIVE,PP1,PP2A,PPS,PTP1B,RESULTS,TUNEL
BACKGROUND,CELL,DIETARY,FURTHER,HCC,HEPG2,LABEL,MATERIALS,METHODS,MTS,Q3G,QUERCETIN,RESULTS,USING
24H,A549,CONCLUSION,HELA,ICP,LABEL,MATERIALS,MCF,MDR,METHODS,RESULTS,THERE,UNLABELLED
956,AIM,ANTI,BACKGROUND,CELL,CONCLUSION,DTS,HEN,IC50,LABEL,MATERIALS,METHODS,OBJECTIVE,PETIVERIA,RESULTS,RSK1,WEED,WST
123,231,A549,BACKGROUND,COMPOUNDS,CONCLUSION,EFFECTS,LABEL,MATERIALS,MDA,METHODS,PC3,RESULTS,THESE
CURRENTLY,EGFR,LUNG,NSCLC,VEGF
946,AKT,ANP,CATENIN,CONCLUSION,ERK,FOS,FOUR,JNK,JUN,LABEL,LANP,MAPK9,MEK,RAS,RAT,STAT,STAT1,STAT3,THEIR,THERE,THESE,UNLABELLED,VEGF,WNT
169,2014,ANCILLARY,INC,THERE,TRAP,WILEY
169,2014,8482,ENB,FNA,FNAS,INC,LOGIC,PATHOLOGIC,WILEY
169,2014,AUTHORS,CSF,GIVEN,JOHN,LTD,RAPID,SIMILARLY,SONS,WILEY
ACC,ADENOID,BACKGROUND,CASE,CONCLUSION,ENGLISH,LABEL,METHODS
036,053,169,2014,901,956,AUTHORS,COX,FOLLOWING,III,JOHN,LTD,NSCLC,RFS,SONS,UNTIL,WILEY
0001,169,2003,2005,2014,292,8201,AJCC,BACKGROUND,BASE,COX,CRT,DATA,DEFINITIVE,III,IIIA,IMRT,LABEL,METHODS,NSCLC,RESULTS,SOCIETY,THESE
138,169,2014,723,DATA,NERVOUS,OVERALL,SIR,SIRS,SWEDISH,UICC
002,022,027,056,169,187,2014,8201,8F1,945,BACKGROUND,CCT,CHOLINE,ERCC1,HIGH,HNSCC,LABEL,METHODS,NSCLC,PROTEIN,RAS,RESULTS,SIMILARLY,SOCIETY
160,181,ARSENIC,ATO,CELL,E2F1,H23,H358,IC50,NSCLC,TYMS,USING
138,947,H2AX,SENP1,SENTRIN,SUMO,THEN
EGFR,RTKS
156,200,2004,2009,2012,222,251,285,382,DISCUSSION,FRANKEL,KPT,LABEL,METHODS,MSCC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,UPT
FINALLY,GPX1,GPX2,H460,HOWEVER,LFCIN,MEANWHILE,NCI,PCR,SOD3,THESE,VEGF,WESTERN
ARSENIC,SEVERAL,STUDIES
BECAUSE,EMAST,MSI,THUS,TP53
169,2014,COPYRIGHT,UPON,WHEREAS
1042,1057,57BL,7015,CONCLUSION,EFFECTS,HIGH,LABEL,METHODS,RESULTS,UNLABELLED,XCV
945,946,954,ABIN,ADP,CARP,CCAR1,DISULFIRAM,DRUG,DSF,FOOD,INHIBITORY,JNK1,MPM,POST,SAPKS
SEVERAL
1281,169,1999,2008,2014,356,759,803,925,AMONG,CONCLUSION,COPYRIGHT,COX,FACTORS,FEDERATION,FIGO,GYNECOLOGY,INC,LABEL,METHODS,OBJECTIVE,OBSTETRICS,OSS,OVERALL,RESULTS,SOCIETY
169,2003,2010,2014,ADVERSE,COPYRIGHT,FDA,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MPM,OBJECTIVE,OBJECTIVES,PEMETREXED,RESULTS,SIXTY,THESE,VERSION
18F,AFTER,AUTHORS,FDG,PET,ROSAI,TOTAL
002,005,027,033,043,053,095,169,177,2014,324,8201,911,916,ANTI,ASIAN,BACKGROUND,CAVITATION,CHRONIC,DATA,HIGH,HRCT,LABEL,MAC,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY
100,140,8764,ATRP,DUAL,EDC,L929,MCF,MTT,NHS,NPS,PANC,PCL
169,2014,ASIAN,COX,MEIER,PACIFIC,POPULAR,SOCIETY
102,169,2002,2012,2014,205,HER2,INC,MAJOR,OTHERWISE,PATHOLOGY,UNIT,WILEY
001,ASK,CD34,DESPITE,MMP,MMP2,MMP9,MVD,TTF1
BECAUSE,BENEFITING,ECL,HOWEVER,MICRORNAS,THROUGH,THUS
177,5GY,8805,APBI,BACKGROUND,CARDIAC,CRT,CTS,DMEAN,DOSE,LABEL,MEAN,METHODS,MHD,NON,PTV,PTVS,RESULTS,VMAT
A549,BISABOLOL,DLD,ESSENTIAL,HPLC,IC50,POPULUS,U251
004,100,8804,ADC,DWI,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,ROC,SOLID
AHI,BACKGROUND,CPAP,EFFECTIVE,FUNCTIONAL,GSEA,HOWEVER,LABEL,METHODS,NETWORK,OSA,PBLS,RATIONALE,RESULTS,TREATMENT
239,500,8805,AMONG,DOSE,GRADE,LABEL,LEVEL,LIVER,METHODS,OBJECTIVE,RESULTS,SIX
169,2014,AFTER,PRESS,PUBLISHED,THESE,UNIVERSITY
169,2014,KRAS,MICROARRAY,MYC,NSCLC
169,2014,519,8805,BIOMARKERS,EGF,EGFR,ELISA,FISH,FURTHER,HGF,IHC,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,WESTERN
0039,0040,169,2014,AUTOPHAGY,BRITAIN,COPYRIGHT,EGFR,GREAT,HOWEVER,IRELAND,JOHN,LC3A,LTD,PC9,PUBLISHED,SOCIETY,SONS,THEREFORE,TKIS,WILEY
183,A549,GEORG,H460,NON,STUTTGART,THESE,YORK
215,BACO,CMVP,EGFP,GALV,HEPG2,HSV,PCR,SYNCO,THESE,UL38,UL38P,VERO
169,2014,ANOTHER,BATCH,COPYRIGHT,EVEN,JOHN,LTD,SONS,WILEY
250,EORTC,LABEL,LOW,METHODS,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,TREATMENT
1236T,2677T,3435T,AFRICAN,ASIAN,CAUCASIANS,FURTHER,MDR1,SNP,SNPS,THERE,THREE
001,007,013,049,056,131,140,154,176,301,8201,826,956,CONCLUSION,DOSIMETRIC,DTC,EORTC,FUNCTIONAL,LABEL,METHODS,NON,OBJECTIVE,OVERALL,PURPOSE,QOL,QUALITY,RESULTS,TREATMENT,TSH
AFTER,MYELOID,RECIPROCAL
AMP,CURRENTLY,GMP,HOWEVER,PDE,PDES
115,120,182,2001,2012,HAND,JANUARY,SURGERY,TOMOGRAPHY
171,187
024,032,039,15Q25,301,318,945,ADC,ADCS,CHINESE,FIVE,GWASS,III,SNPS,TNM
169,2015,COPYRIGHT,EPIGENETIC,INC,LUNG
007,052,083,112,11H,160,169,2014,215,3T3,956,A549,BALB,COPYRIGHT,HCL,IC50,MV4,SAS
BACKGROUND,CASE,CONCLUSION,EHE,LABEL,METHODS,VEGF
000,117,136,138,2001,2011,3249,427,549,672,767,8197,AFTER,BACKGROUND,BIOLOGICS,BMJ,BRITISH,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RATES,RESULTS,SOCIETY,THERE,TNF,TNFI,TREATMENT
3475,BMS,MPDL3280A,NSCLC
169,2014,945,954,AKT,COPYRIGHT,EGF,EGFR,HOWEVER,ICAM,INC,PI3K,TGF
001,100,1106,169,2014,601,8804,COPYRIGHT,GRADE,GROUP,INC,LABEL,MATERIALS,MAXIMUM,METHODS,NSCLC,OBJECTIVE,PULMONARY,PURPOSE,RADIATION,RESULTS,THERAPY,V45,V50,V55,V60
087,169,2003,2010,2014,581,COMMISSION,COPYRIGHT,CRT,FURTHER,IIIA,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PREDICTORS,PURPOSE,RESULTS
122,169,2007,2009,2014,ADDITIONAL,BACKGROUND,CARE,CONCLUSION,COPYRIGHT,DATA,HOWEVER,III,IIIB,INC,JULY,JUNE,JURAVINSKI,LABEL,METHODS,NSCLC,ONTARIO,OUTCOME,REASONS,RESULTS,THESE
002,044,169,2011,2013,2014,311,689,894,ARMS,BACKGROUND,CONCLUSION,CONTINUOUS,COPYRIGHT,EGFR,INSTITUTE,IRELAND,LABEL,LTD,MARCH,METHODS,NSCLC,OBJECTIVE,PFS1,PFS2,PURPOSE,RESULTS,T790M,TKI,TKIS,UNIVERSITY
169,2014,CARCINOID,COPYRIGHT,LCNEC,OVERALL,PNT,PUBLISHED,PULMONARY,SCLC,SEPAR,SEVERAL,TNM
169,2014,AUTHORS,BAD,BIM,COPYRIGHT,DRUGS,EGFR,ERBB2,ERBB3,INC,KRAS,MEK,MYC,PUBLISHED,RAS,THERE,THESE,USING
169,2014,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,PURPOSIVE,REDUCTIONS,RESULTS
143,162,2010,2012,8805,916,APRIL,EOD,FORTY,JAN,LABEL,METHODS,OBJECTIVE,PFT,RESULTS,SCT
001,177,LABEL,METHODS,NOET,NPV,OBJECTIVE,PPV,RESULTS,SPECT,TNM
002,008,018,037,177,D95,D99,D994D,D99CONV,GTV,LABEL,METHODS,MHD,MHD4D,MHDCONV,MLD,MLD4D,MLDCONV,OBJECTIVE,PTV,PTV4D,PTVCONV,PTVS,RESULTS,THERE,V10,V104D,V10CONV,V15,V20,V30,V304D,V30CONV,V40,V54D
001,1ST,2267,2ND,3585,500,BASED,CHINA,CHINESE,CONSISTENT,DOC,IIIA,IIIB,JMEN,JMID,LABEL,METHODS,NSCLC,OBJECTIVE,PEM,PFS,RESULTS,SIMILARLY
100,177,LABEL,METHODS,OBJECTIVE,PCR,REAL,RESULTS,SOX4,WESTERN,XUANWEI,XWLC
169,1980,2012,2014,997,AMONG,COPYRIGHT,ITALIAN,ITALY,LTD,MALIGNANT,RENAM,THERE
946,BACKGROUND,ESOPHAGEAL,EXPRESSION,FURTHER,LABEL,LYSINE166,METHODS,OE19,OE33,RAC1,RAC3,RESULTS,RHOA,SCF,SCFFBXL19,SKP1,TGF
1984,1989,2011,2586,8804,8805,AFTER,BACKGROUND,COX,DEPRESSION,EASTERN,FINLAND,FINNISH,HOWEVER,LABEL,LABORATORY,METHODS,POPULATION,RESULTS,SELF,SLEEP
1040,2012,8804,ADJUSTMENT,AFTER,AGING,ALBANIA,BACKGROUND,BATTERY,BOTH,DATA,EARLY,LABEL,METHODS,RESULTS,SHORT,SPPB
CHRONIC,COPD,HOWEVER,NOTABLY,SRC,WHILE
BACKGROUND,CHEST,DESPITE,DTC,FTC,HALF,LABEL,MALIGNANT,METHODS,MPE,PATIENT,SUMMARY
154,160,169,184,2014,338,ASIA,CHINESE,HMGB1,HMGB2,LTD,PTY,PUBLISHING,SNPS,THREE,WILEY
001,005,1997,2011,BACKGROUND,BASED,CONCLUSION,EXAMINING,INCIDENCE,LABEL,LUNG,METHODS,MONTENEGRO,MOST,NSCLC,OBJECTIVE,RATIO,RESULTS,SCLC
1281,169,2014,800,954,AMPK,AUTHORS,BASED,DICER,JOHN,LTD,MODULATION,MYC,RAS,SONS,SWISS,TGF,TLR9,WILEY
ATM,MRI,WHILE
2010,2013,CHINA,FOLFIRI,HOWEVER,KRAS,MAY,OVERALL,PFS,RASH,TEN,WEST
0001,067,8201,909,ASIA,CIS,EAST,GSTM1,HOWEVER,ORS
120,160,177,1919,CONCLUSION,HOWEVER,LABEL,METHODS,PET,RESULTS,THOSE,UNLABELLED
014,038,136,DROSOPHILA,FURTHER,HIPPO,HOWEVER,LARGE,LATS,LATS1,NSCLC,SER,THESE,THR,TNM,YAP
009,487,588,838,CHEST,ESOPHAGEAL,HNSCC,HOWEVER,SYSTEMATIC
001,004,011,023,035,148,2007,2012,246,277,APRIL,BETWEEN,EGFR,HOWEVER,JANUARY,MUTATED,STUDIED
110,BASED,HOWEVER,INSULIN,MVS,NSCLC
0001,0004,0033,0347,8197,BMJ,CSA,FEF25,FEV1,GROUP,HRCT,LABEL,LIMITED,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RESULTS,RRS,SCD,SPO2,THERE,TLC
0501,178,AMONG,BACKGROUND,CONCLUSION,DOCETAXEL,IFCT,III,JAPAN,LABEL,METHODS,NSCLC,RESULTS,SECONDARY
A549,BUNGE,THESE
620,8209,CPG,GPC5,THESE
169,177,2014,ALLOGENEIC,BACKGROUND,DONOR,HEART,HLA,INC,KEY,LABEL,LVAD,LVADS,MEAN,METHODS,MPC,MPCS,RESULTS,SUCCESSFUL,TRIAL,URL
100,126,160,215,BACKGROUND,FEV1,HOWEVER,LABEL,METHODS,PULMONARY,RESULTS,SEVERAL,THUS
BAX,FURTHER,H1975,NCI,SPC,TAKEN,THEN,THESE,THO,THOC1,WHILE
001,109,1961,2009,2010,327,714,8202,958,ASRS,DENMARK,FURTHER,ICELAND,INCREASED,LAOS,MEN,MRR,MRRS,POISSON,WOMEN
945,STAT3,STRUCTURAL
AKT,CELL,EGFR,GEFITINIB,MTT,NSCLC,TKI,TKIS
CD104,CD24LOSCA1,CD44,CD49F,EPCAM,SMAD,SOX2,TGF
LYG,MRI,MTX
A549,IAPS,SMAC,SMACS,TAXOL,THEN
028,169,199,2011,2014,554,8364,PRESS,PUBLISHED,THESE,UNION,UNIVERSITY
CIC,FINALLY,FOXO,GAIN,GOF,MUTATIONS,ONCOGENIC,SEVERAL,SLC25A1
165,18023,215,60543,BACKGROUND,BONFERRONI,CDKN2BAS1,LABEL,LSP1,LUNG,METHODS,PAGE,POPULATION,RESULTS,SNP,SNPS,TERT,TRICL
0001,124,169,177,2014,602,670HU,705,7HU,8805,AFTER,CASES,CONCLUSION,COPYRIGHT,GGN,GGNS,HOUNSFIELD,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
109,115,136,169,174,1992,2000,2001,2009,2014,300,AMONG,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
0001,001,006,009,169,196,2014,8804,8805,AIM,BODY,CONCLUSION,CONTROL,COPYRIGHT,CSS,DFS,DISEASE,FIFTY,FREE,GTV,IRELAND,LABEL,LOCAL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PRIMARY,RECURRENCE,RESULTS,SABR,SBRT,TOTAL
165,169,1999,2009,2014,967,BACKGROUND,COPYRIGHT,COX,INC,LABEL,LNM,LYMPH,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY,SYSTEMATIC
159,169,2000,2012,2014,258,ADVERSE,BACKGROUND,COPYRIGHT,EFFECTS,INC,LABEL,MAY,MEDICAL,METHODS,PUBLISHED,RESULTS,SEVEN,SOCIETY,SURGERY,THERE,VATS,VIDEO
160,169,2014,231,A549,AGI,CAKI,COMPLEX,COPYRIGHT,DOCKING,ERS,ESI,GSH,HELA,LOX,MBZT,MCF,MDA,MIXED,MOLECULAR,MRC,NMR,OAW,SAS,SRB,TPP,VIS
1341,169,2014,A549,BOTH,BRK1,CHIP,COPYRIGHT,EMSA,FOLLOWING,H1299,H520,NSCLC,RNAI,S831,SEGMENT,SP1,SP3,SP4,THEN,THEREFORE
169,2014,947,A549,COPYRIGHT,DSBS,GJIC,H2AX,HENCE,HOWEVER,MOST,RIBE,WI38
019,169,2014,ACADEMY,ADJUSTING,ASSESSMENT,BACKGROUND,COGNITIVE,CONCLUSION,CONTEXT,COPYRIGHT,FUNCTIONAL,HOSPICE,HOWEVER,INC,INDEX,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,PALLIATIVE,PUBLISHED,RESULTS,THERAPY,THOSE,TRIAL
169,2013,BACKGROUND,BRONCHIOLO,CASE,CONCLUSION,COPYRIGHT,EARLY,LABEL,METHODS,POST,PUBLISHED,SAS,SPLF
160,169,1ST,2008,2009,2011,2013,31ST,702,AMONG,BACKGROUND,BELGIAN,BELGIUM,CONCLUSION,COPYRIGHT,JANUARY,LABEL,METHODS,PATIENT,PUBLISHED,RESULTS,SAS,SEPTEMBER,SPLF,THERE,THESE
150,169,2008,2011,2013,BACKGROUND,COPYRIGHT,IIIA,IIIB,LABEL,LUNG,MATERIALS,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SAS,SPLF,THESE
001,139,169,2008,2009,2013,BACKGROUND,CONCLUSION,COPYRIGHT,EVALUATION,LABEL,LUNG,MAY,METHODS,PUBLISHED,RESULTS,SAS,SPLF,THERE
065,169,1963,1993,2014,ADH1B,ADH1C,ADH7,ALDH2,BLOOD,COPYRIGHT,FULLY,LABEL,LTD,MATERIALS,METHODS,MOUTHWASH,OBJECTIVE,ORS,POOR,RESULTS,UADT,WHETHER
000,001,005,011,027,031,032,115,140,167,169,2014,296,306,361,702,754,815,971,COPYRIGHT,HRCT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MIA,OBJECTIVE,OBJECTIVES,ODDS,RESULTS
001,002,169,2014,564,5P15,AFTER,AMERICA,BACKGROUND,CLPTM1L,CONCLUSION,COPYRIGHT,COX,GSV,GSVS,III,IRELAND,LABEL,LTD,LUNG,METHODS,NORTH,NSCLC,PFS,RESULTS,STAGE,TERT,THESE
169,2007,2010,2014,APRIL,BACKGROUND,COPYRIGHT,ECOG,FORTY,HGNEC,HOWEVER,IIB,IIIA,IRELAND,LABEL,LARGE,LCNEC,LTD,METHODS,RESULTS,RFS,SCLC,SEPTEMBER
0001,106,169,18F,2014,264,618,AMONG,BACKGROUND,COPYRIGHT,EVEN,INC,LABEL,METHODS,PUBLISHED,RECURRENCE,RESULTS,RFS,SOCIETY,T1B
169,2014,5GY,COPYRIGHT,DOSE,INSTITUTE,KYOTO,LTD,RADIATION,REACTOR,UNIVERSITY
004,110,169,2014,222,COPYRIGHT,DESPITE,EGFR,EXCLUSION,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PURPOSE,RADIATION,RESULTS,SRS,THERE,WBRT
1000,169,176,2014,500,8805,BACKGROUND,CARE,COPYRIGHT,INFECTIOUS,LABEL,LTD,OTHER,OVERALL,PUBLISHED,RISK,SOCIETY,SUPPORTIVE,THERE,TRIAL,UMIN,UNLABELLED
1000,131,169,195,2011,2012,2014,222,8805,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,CURRENT,DATA,INDEX,IRELAND,LABEL,LTD,METHODS,MORBIDITY,RESULTS
034,139,2006,2009,227,234,269,314,750,NSCLC,OCTOBER,PRE,STAGE,THESE
2010,2014,AULA,BMI,BODY,BOTH,BRAZILIAN,CONCLUSION,COPYRIGHT,CROSS,DIETARY,EDICIONES,FOOD,INADEQUACY,INDEX,LABEL,MASS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE,VITAMIN
160,162,250,280,956,BACKGROUND,CONCLUSION,CYTOTOXIC,DPPH,ELISA,HIV,HOP,LABEL,LOWER,METHODS,NON,POLAR,PRESENT,RESULTS,REVERSE,ROCHE,SEVERAL,SOLANACEAE,SOLANUM,SOXHLET,SRB,THP,TLC,TOTAL
BACKGROUND,ECLS,FOCUS,GLASGOW,GPS,LABEL,METHODS,RECRUITING,RESULTS,THREE
BACKGROUND,CONCLUSION,CONTROL,DISEASE,III,IIIA,IIIB,LABEL,METHODS,NSCLC,ORR,OVERALL,PFS,RATE,RESPONDING,RESULTS,SEVENTY,TRIAL
017,030,036,077,100,1946,1989,2008,224,234,280,690,CONCLUSION,ERR,INHALATION,LABEL,LEVEL,LOW,METHODS,OBJECTIVE,POISSON,PURPOSE,RESULTS,RISK,WLM,WORKING
005,956,A549,CALOTROPIS,CISPLATIN,EGYPT,IC50,NMR,THEIR,U373
AFTER,PULMONARY,THESE
LUNG
16HBE,945,946,A549,ACH,BACKGROUND,CARBACHOL,CHAT,DAMP,DECREASED,EMT,EPITHELIAL,ERK,LABEL,METHODS,RESULTS,SMA,SMAD2,TGF
AMERICA,ASIA,NORTH,SURGERY,THROUGHOUT,VATS,VIDEO
169,2014,945,AUTHORS,BECAUSE,IL7R,JOHN,LTD,SOMATIC,SONS,THOSE,WHETHER,WILEY
413,8201,8211,946,956,BASED,BURKITT,CF3,HSA,IC50,MRC,NMR,RAMOS
169,2014,BID,GMBH,GRANZYMES,HOWEVER,ICAD,KGAA,PARP,PROTEOMIC,THESE,VCH,WILEY
169,2014,A549,GHR,GMBH,KGAA,VCH,WILEY
13LU,250,3A1,956,A549,ALDH,ALDH1A1,ALDH1A2,ALDH1A3,ALDH1B1,ALDH2,ALDH3A1,CB29,CCD,COMPOUNDS,HOWEVER,HPCP,IFM,KINETIC,SF767,THUS
002,050,1303,702,ADJUSTING,EFFORTS,ELDERLY,END,LABEL,LUNG,MEIER,METHODS,OBJECTIVE,RESULTS
EGFR,EPIDERMAL,HOWEVER,Y845
2010,2011,2012,BACKGROUND,DATA,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESOLUTION,RESULTS,USING
500,CHINESE,CIS,NSCLC,ORS,SCC,SNP,SNPS
2005,2008,882,BACKGROUND,BETWEEN,BMJ,DETAILS,DISEASE,EASTERN,FURTHER,GROUP,LABEL,LIMITED,METHODS,PATIENT,PUBLISHED,PUBLISHING,RESULTS,THERE
A549,AAD,AMONG,DIFFERENT,FURTHER,HSP,HSP70,HSP90,HSPS,LUNG,NSCLC,THESE,VER
CONCLUSION,DAB4,DEFECTIVE,EARLY,EL4,LABEL,METHODS,PANC,UNLABELLED
AKT,CD44,ERK1,HOWEVER,IHC,MMP,SP1,SPARC,VEGF
CD34,HOWEVER,MVD
001,037,076,722,734,855,946,COX,LAPTM4B,NSCLC,PCR,THESE
JEGHERS,LKB1,MYC,PCR,PEUTZ,PJS,STAT3,TE1,THUS
0098,107,247,280,495,693,993,BACKGROUND,CTM,CTMS,INDWELLING,IPC,IPCS,LABEL,METHODS,RESULTS,SEVEN
0001,003,104,107,131,189,2001,2005,275,288,378,407,ATS,BACKGROUND,CONTROL,EGFR,ERS,HISTOLOGIC,HOWEVER,IASLC,III,KRAS,LABEL,LOW,LUNG,METHODS,RESULTS,SOCIETY,UNION
268,424,469,622,6TH,737,7TH,ACCORDING,CONCLUSION,IIA,IIB,IIIA,IIIB,LABEL,M1A,M1B,METHODS,OBJECTIVE,PURPOSE,RESULTS,TNM,UICC
001,2009,2011,673,BACKGROUND,BLOOD,CEA,DVT,FORTY,JANUARY,LABEL,METHODS,RESULTS,VTE
HRT,ULMS,UTERINE
0201,945,947,BETWEEN,CD8,EBV,HLA,HSV,RESPONSES,THUS,VARICELLA,VIRUS,VZV
AIM,CONCLUSION,FATIGUE,FIFTY,INVENTORY,LABEL,METHODS,OBJECTIVE,PEARSON,RESULTS,SYMPTOM,TAIWANESE
ULMS
EGFR,HOWEVER,NSCLC,T790M,TKI,TKIS
FIFTEEN
A549,AIMS,BACKGROUND,CONCLUSION,FURTHER,LABEL,METHODS,OBJECTIVE,REDUCED,RESULTS,RNAI,TAKEN
8805,AIMS,BACKGROUND,CHINA,CONCLUSION,COX,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,OLDER,RESULTS
001,012,57B,AIMS,BACKGROUND,ESO,LABEL,MAGE,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
AIM,LABEL,LDH,METHODS,OBJECTIVE,RESULTS,WBC
044,18F,ADVERSE,AIMS,BACKGROUND,CONCLUSION,CTCAE,FDG,IMAGE,IMRT,LABEL,LCR,METHODS,NSCLC,OBJECTIVE,OVERALL,PET,RESULTS,SBRT,SEVENTY
000,2000,2012,AIMS,BACKGROUND,JANUARY,LABEL,MAY,METHODS,MOST,OBJECTIVE,RESULTS,SCBS,THESE,WHILE
940,ALTOGETHER,JNK,KNOCKDOWN,MKK4,MKP1,RIP1
100,175,181,947,ADDITIONAL,AS3,BEAS,CD61,CD61LOW,CSC,CSCS,FLOW,IL2R,KLF4,MYC,NOD,OCT4,SCID,SOX2,TAKEN,THESE
169,2014,BCL,BIM,KRAS,MEK,MEKI,NSCLC,PI3K,PI3KI,PUMA,THESE,USING,WHILE
169,2014,EXTENSIVE,H2O,INITIATION,NOTABLY,PRUDENT,USING,YET
169,2014,III,IIIB,MOST,PPB,RNASE,SOMATIC,TP53
1964,2014,50TH,ADMIRAL,BORIS,COINCIDING,DEPARTMENT,EDUCATION,GENERAL,JANUARY,MPH,REAR,SMOKING,SURGEON,WELFARE,YEARS
235,AIM,CONCLUSION,CRS,DIFFUSE,DMPM,FURTHER,HIPEC,LABEL,METHODS,OBJECTIVE,PCI,RESULTS,SEVERAL
032,BACKGROUND,FIFTEEN,LABEL,LEVEL,METHODS,PATIENT,PREDNISONE,RESULTS,THUS,TRANSPLANT,UNIVARIATE
169,177,2014,956,ACHE,ALZHEIMER,BCHE,BENZYLOXY,CONTROLLED,COPYRIGHT,EEL,IC50,SAS
169,2014,231,562,A549,BAD,BAX,BCL,BID,BIM,CAOV,CD40,CEM,CNE,COPYRIGHT,FAS,HELA,HEPG2,HSP27,IGF,IGFBP,LIVIN,MCF,MDA,NH2,SAS,TRAIL,XIAP
169,2014,621,634,662,AACR,ALK,ALTOGETHER,HOWEVER,ISSUE,KHURI,LABEL,NON,NSCLC,RAMALINGAM,THESE,TKI,UNLABELLED
129,1976,1994,2011,359,488,494,533,961,ASIA,CHINA,CHINESE,COPD,EVER,SMOKING
8202,ADDITIONAL,HOWEVER
600,AKT,BACKGROUND,CONCLUSION,DOSE,ERK1,FURTHER,LABEL,METHODS,MOLECULAR,OBJECTIVE,PI3K,RAS,RESULTS
160,169,2014,474,COPYRIGHT,INC,PUBLISHED,SOCIETY
005,007,009,039,055,169,175,177,2014,30MIN,60MIN,781,798,ATM,BCC,BCT,BTT,COPYRIGHT,DRC,DSR,HOWEVER,MRE11,MSH2,OLIVE,OTM,RAD50,SSR,XRCC1,XRCC4
102,1447,169,177,1ST,2004,2010,2013,31ST,660,812,AIM,CONCLUSION,COPYRIGHT,DAKAR,DEPARTMENT,DRE,GENERAL,GLEASON,GRAND,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SAS,THERE,UNLABELLED,UROLOGY,YOFF
100,169,171,2014,454,729,8764,ALK,CONCLUSION,COPYRIGHT,EML4,FISH,H1299,H2228,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTIPLEX,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RECURRENT,RESULTS,WHILE
001,020,1360,1368,169,2014,BECAUSE,COPYRIGHT,DATA,EXCLUSION,GIVEN,III,IRELAND,LABEL,LRFS,LTD,METHODS,OBJECTIVE,PORT,POST,PURPOSE,REGARDLESS,RESULTS,THREE
1290,169,2011,2014,AMONG,COPYRIGHT,IRELAND,LTD,NEXT,THERE
METASTATIC,SCC
100,169,2014,AMES,BECAUSE,COMET,COPYRIGHT,HOWEVER,NPS,PUBLISHED,TIO
161,169,2014,382,ASIA,AUTHORS,FILE,HIGH,III,LTD,LUNG,MORTALITY,NUTRITION,PTY,PUBLISHING,SCIENCE,THIRD,USA,WILEY
15TH,169,2013,2014,ALK,ASIA,ATLAS,CAP,COLLEGE,CONFERENCE,EGFR,GROUP,IASLC,LTD,LUNG,MEETING,NSCLC,OCTOBER,PTY,PUBLISHING,WILEY,WORKING,WORLD
169,2014,ALK,ASIA,EML,LTD,PRECISION,PTY,PUBLISHING,WHERE,WILEY
CONTROL,CONVENTION,ESPECIALLY,FORUM,FOUR,FRAMEWORK,LARGE,SOCIETIES,THERE,TOBACCO,WORLD
DISEASE,FORUM,REALITIES,SOCIETIES,TODAY,WORLD
169,2014,A549,APMIS,EPI64,GAP,HOWEVER,JOHN,LTD,PUBLISHED,RAB27,SONS,TAKEN,WILEY
169,2014,50S,CCAM,CK5,CLARA,HOWEVER,SOCIETY,THEIR,TTF
001,101,1472,1ST,2013,3732,AIMS,CBM,CRUDE,EBSCO,LABEL,LIBRARY,MDM2,META,METHODS,NSCLC,OBJECTIVE,ORS,RESULTS,SCHOLAR,SCIENCE,SEVEN,STATA,T309G,THUS,WEB
790,ALSO,AREAS,ATP,BACKGROUND,COVERED,GREAT,III,LABEL,METHODS,MOST,NSCLC,OPINION
HOWEVER,SINCE
916,CONCLUSION,EWING,EWS,LABEL,M51,METASTATIC,METHODS,ONCOLYTIC,RESULTS,UNLABELLED,VSV
001,042,687,COX,GASTRIC,H19,MEIER,MTT,MYC,PCR,PEARSON,RNAS
8201,AVERAGE,LUNG,MOST
A431,A549,AMONG,CHINA,ELSHOLTZIA,ESI,FTIR,HPLC,NMR
169,2014,224,BOTH,CDX2,CK20,COPYRIGHT,CRC,GMBH,GSE,IHC,MOLECULAR,NOTABLY,PCR,TTF,VIS
MEN1,PSIP1,PULMONARY,RB1,SNF,SWI,THESE,TP53
1986,2012,800,BRITISH,MOST,THESE,VITAL
008,009,169,2014,AKI,AT1,AT3,AT5,BACKGROUND,KIM,LABEL,METHODS,RESULTS
CARCINOMA,HOMOLOGOUS,KU80,NSCLC,PARI,RAD51,RIF1,RPS,THEREFORE
0071,8197,BINDING,EGFR,NSCLC,TOWARDS,WIDESPREAD
METASTATIC
114,130,400,750,ALK,AMONG,BACKGROUND,CERITINIB,LABEL,METHODS,NON,NSCLC,RESPONSES,RESULTS
140,155,947,ANTI,BACKGROUND,HIV,HODGKIN,ILD,LABEL,MDA5,METHODS,MSA,NXP,RESULTS,SEVEN,SEVENTEEN,TIF
119,159,172,177,2009,290,332,509,558,628,8364,873,945,959,BACKGROUND,CNS,CONCLUSION,COSTS,IRELAND,LABEL,LOST,LUNG,METHODS,MOST,PREMATURE,RESULTS,TOTAL,VALUATION,YPPLL
100,MOST,THESE
PLC,PRIMARY,PULMONARY
ILS,INCREASED,INHIBITION,LOCAL,MMP,PRO,THERE,THESE,VEGF
169,2013,2014,2ND,CONFERENCE,CONSENSUS,ESMO,LUNG,MAY,MEDICAL,NSCLC,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
169,2014,BACKGROUND,CELL,IHC,LABEL,MALIGNANT,MATERIALS,MEDICAL,METHODS,MPM,MPMS,MSAC,NETWORK,OVERALL,PCR,PRESS,PUBLISHED,RESULTS,REVERSE,SOCIETY,UNIVERSITY
169,188,2014,486,AUTHORS,FISH,FOUR,HER2,IHC,JOHN,KRAS,LTD,SONS,WILEY
001,169,2014,206,272,478,8201,931,945,ALB,BPDE,COPYRIGHT,INC,OHDG,PAH,PAHS,PGF2,THESE,WILEY
100,147,925,99M,CONCLUSION,DEPR,DEPREOTIDE,DICHOTOMY,DIFFERENT,IMAGING,LABEL,METHODS,NSCLC,OBJECTIVE,REGARDING,RESULTS,SIXTY,SPECT
169,2001,2003,2004,2005,2006,2008,2014,306,4929,AFFAIRS,AMONG,BACKGROUND,CENTRAL,CIS,COMMITTEE,COX,DESPITE,III,IIIA,JOINT,LABEL,METHODS,NSCLC,RESULTS,SOCIETY,THERE
10001,333,CTD,CTDS,DIFFERENT,FINALLY,HIGH,HRCT,MEDICAL,PUBLISHERS,PULMONARY,SEVENTH,USA,YORK
945,946,STAT3,THUS
8211,951,956,A549,CELL,IC50,ICP,NME2,PF6,THESE
111,185,8201,AMONG,ASSESSMENT,BASED,BED,CONCLUSION,DOTATOC,EDTA,GFR,LABEL,MBQ,METHODS,MRI,OBJECTIVE,PRRT,PURPOSE,RESULTS
A549,ABP1P,ADF,AFFYMETRIX,FUNCTIONAL,HIP,HOWEVER,HPK1,PLUS,SRC,U133
160,171,1980,2006,BACKGROUND,BETWEEN,LABEL,MATCHED,METHODS,RESULTS,UICC
CAFS,CD90,CSC,CSCS,IGF,IGF1R,NANOG,NSCLC,OCT3,USING

2007,931,AMONG,CARE,DESPITE,DISCUSSION,FINALLY,INSTITUTE,LABEL,LESS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC,SMALL,WHEREAS
AFTER,DESPITE,GIVEN,SCLC,SUBSEQUENT
001,002,003,008,2004,2011,220,BACKGROUND,COX,GLASGOW,HALF,LABEL,LVI,METHODS,NLR,NSCLC,PLR,PROGNOSTIC,RESULTS,RFS,SCORE,UNIVARIATE,VPI
000,014,018,033,177,2001,2008,2011,4990,79869,8805,AIMS,CUMULATIVE,EXCLUSION,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,SHR,SHRS
001,BACKGROUND,FOUR,INCLUSION,LABEL,METHODS,RESULTS
2014,945,946,FURTHER,MYC,SCIENCE,SIGNALING,THEIR,TNBCS
100,282,333,368,410,ALK,BASED,CASES,D5F3,DAKO,EGFR,FISH,HOWEVER,IHC,PCR,RIGHT,THREE
BLP25,CIK,CTLA4,III,LUNG,MAGE,NSCLC,THESE
HENCE,HOWEVER
MICRORNAS,RNAS
LUNG
100,1128,2009,2013,215,500,ALB,BACKGROUND,DIMER,GENERAL,JULY,JUNE,LABEL,MALIGNANT,MEDICAL,MEIER,METHODS,PO2,PTE,RESULTS,TEN,THESE,TIANJIN,UNIVERSITY,WBC
049,227,945,946,AMONG,BACKGROUND,BCL,EGFR,ERCC1,HER2,LABEL,LUNG,METHODS,RESULTS,RRM1,STAGE,TTF,UNIVARIATE
BACKGROUND,BIM,HRM,LABEL,METHODS,PCR,RESULTS
BACKGROUND,BALF,CNKI,FHIT,FIHT,LABEL,METHODS,NLT,RESULTS,STATA,WANFANG
525,ALK,BACKGROUND,EGFR,FISH,IHC,LABEL,METHODS,RESULTS,TKIS,WHILE
001,068,070,117,2005,2007,206,221,414,520,650,791,794,967,BACKGROUND,CHI,COX,FINALLY,JANUARY,LABEL,LOG,MEIER,METHODS,MICRORNAS,MIRNA,NSCLC,PCR,REAL,RESULTS,TNM
2012,2013,967,AMONG,BACKGROUND,BINZHOU,CITY,LABEL,METHODS,RESULTS,ROSE,TBNA,THERE
001,012,177,215,BACKGROUND,C30,CORE,EORTC,LABEL,LC13,LIFE,LUNG,METHODS,NSCLC,QLQ,QOL,QUALITY,RESULTS,THEREAFTER,TREATMENT
000,100,2002,2009,410,AREA,BACKGROUND,CHINA,DIFFERENT,LABEL,LOG,LUNG,METHODS,PERMANENT,RESULTS
069,112,505,A549,BACKGROUND,CA2,CELLS,CONCLUSION,DAPI,H2O2,LABEL,LASER,LUNG,METHODS,OBJECTIVE,RESULTS
196,945,946,99M,99MTC,BACKGROUND,H157,LABEL,LUNG,METHODS,NCI,RESULTS,SPECT,THUS
8217,A549,BACKGROUND,CONCLUSION,FIVE,H118F,HOWEVER,LABEL,METHODS,OBJECTIVE,P96S,PCR,PURE,RESULTS,S120G,SITE,THERE,WESTERN
200,BACKGROUND,BOM,BRM,FINALLY,IVIS,L9981,LABEL,LNM,LUC,LUM,LUNG,METHODS,RESULTS,THEN,UNDER
169,2013,MARSHFIELD
110,169,2014,8482,AMONG,BIOLOGICAL,CD109,COPYRIGHT,ELISA,LABEL,NSCLC,SWATH,THESE,UNASSIGNED,UNLABELLED
169,2014,COPYRIGHT,INC,LIVER
169,2014,COPYRIGHT,INC,PULMONARY
006,007,019,022,035,169,2014,344,733,COPYRIGHT,COX,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,T1B
084,117,169,189,2014,350,50ML,548,618,727,731,761,8804,933,ACR,ALSO,BACKGROUND,BSL,CCC,COMPARISON,CONCLUSION,COPYRIGHT,FDG,FIFTY,INC,IRB,LABEL,METHODS,PET,RESULTS,SUV,THEREFORE,TIA,TLG,TLG2,TLG42,VOI,VOIS,VOLUMES
BACKGROUND,DISCUSSION,EARLY,HOWEVER,LABEL,MEDLINE,META,METHODS,SOCIO,SYSTEMATIC,TRIAL
CYPS,EXPRESSION,GST,HOWEVER,LOCAL,NAT,NAT1,SULT,UGT,XME,XMES
AREAS,BACKGROUND,CELL,COVERED,LABEL,LUNG,METHODS,OPINION,THEIR,TREATMENT
239,8201,CFD,CYP,HEC,HECS,NOAEL,PBPK,RGDR
0039,0089,010,014,127,169,2014,8201,HOWEVER,INC,NSCLC,PCR,SIX,THEREFORE,WILEY
169,2014,CRKL,ERK,H1299,HBE,HOWEVER,INC,MMP,MMP9,PCR,PD98059,THERE,THESE,TREATMENT,WESTERN,WILEY
169,2002,2008,2013,ADDITIONAL,AFFAIRS,BACKGROUND,CENTRAL,COX,EPIGENETIC,LABEL,METHODS,RESULTS,SAS,SOCIETY,VPA
169,2011,2014,BELL,BETWEEN,HYPOTHESIS,IAC,INC,JANUARY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,OTOLOGICAL,RESULTS,SOCIETY,THREE
169,191,2014,32MB,CA9,CNA,COPY,COPYRIGHT,EFT,EWING,HOWEVER,INC,MELK,MFH,MUTATIONS,NGS,PAX5,RUSC2,THUS,TLN1,WILEY
ACCORDING,DATA,LOSS,THUS
8201,CTS,KEY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POST,PRE,PULMONARY,RESULTS,TIL
019,021,105,138,148,512,699,ACCORDING,BACKGROUND,DESPITE,EGFR,HOWEVER,LABEL,METHODS,NSCLC,PFS,RESULTS,TKIS
945,A549,ANNEXIN,AUTOMATION,BACKGROUND,COLO699,CONCLUSION,IHC,KI67,LABEL,LOWER,METHODS,NSCLC,PROPIDIUM,RESULTS,SEM,SMA
001,059,100,134,8804,8805,ADDITIONAL,BACKGROUND,CONCLUSION,FREEDOM,HOWEVER,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RPA,SCALE,SRS,THREE
169,2014,ATM,ATR,CHEK1,ERCC1,ERCC4,NOTABLY,OVERALL,XPF,XRCC1
AKT,BASED,CELL,DAMGO,EGF,EMT,FURTHER,GAB,H358,IGF,MOR,NSCLC,PI3K,SRC,STAT3
1310,946,AKT,BCL,CCLE,FGFR,FGFR3,HCC1954,HOWEVER,INHIBITION,MET,MKN45,PATHWAY,SAIT301,TREATMENT
946,ACCORDING,ALZHEIMER,HOWEVER,SMAD,TGF
2001,2008,4061,4352,AFFAIRS,BACKGROUND,CENTRAL,CISPLATIN,COX,DEPARTMENT,LABEL,METHODS,RESULTS,WHILE
006,010,013,039,057,945,ACCORDING,BACKGROUND,CELLS,LABEL,LUNG,METHODS,RESULTS,SMA,SMOKING,WESTERN
0022,112,118,342,6137,620,624,725,BACKGROUND,BLOOD,CHRONIC,CONSORTIUM,HEART,HOWEVER,INSTITUTE,LABEL,LUNG,METHODS,PRIMARY,RESULTS
002,023,083,158,230,591,945,BACKGROUND,CONCLUSION,COX,KI67,LABEL,METHODS,NODAL,NSCLC,RESULTS,TTR
1125,124,133,200,300,8805,970,971,BACKGROUND,EGFR,FLEX,III,L858R,LABEL,METHODS,MUTATIONS,RESULTS,T790M,TREATMENT
AKT,ALSO,BAX,BCL,CELASTROL,CHINESE,EGFR,H1650,H1975,HSP90,NSCLC,TAKEN
169,2014,947,COPYRIGHT,EARLY,GABAB,HOWEVER,KOREA
169,2014,215,7702,A549,ART,ATS,COPYRIGHT,DHA,HEPG2,HOWEVER,HPLC,HSA,INCREASED,MEANWHILE
0005,001,006,011,805,8201,BACKGROUND,CONCLUSION,HIGH,LABEL,METHODS,RESULTS,THESE,TIAM1,TNM,UNASSIGNED,VIRTUAL
001,100,169,2014,4DCT,AMONG,COPYRIGHT,DMAX,ENDPOINTS,FOUR,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OTHER,PURPOSE,RESULTS,SABR,THREE,V20,V30
100,169,2014,8805,ACTUARIAL,COPYRIGHT,D10,DOSIMETRIC,FOUR,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,STUDENT
0236,169,2014,215,COPYRIGHT,GROUP,INC,LABEL,MATERIALS,MEIER,METHODS,NORTH,NSCLC,OBJECTIVE,PFT,POOR,PULMONARY,PURPOSE,RADIATION,RESULTS,RTOG,SBRT,THERAPY,V10,V20,WHOLE
169,2014,ASIAN,BACKGROUND,BOTH,BRONCHIAL,DETECTION,LABEL,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,SP1,VEGF
2014,BECAUSE,EVALUATION,RSNA,SOLID,STATE,WORLD
001,160,169,183,1998,2002,2014,COX,DISCUSSION,HRS,INSURANCE,JANUARY,JOHN,KNOWN,LABEL,LHID,LTD,METHODS,NHI,OBJECTIVE,PRIOR,RESULTS,SONS,TZD,TZDS,USING,WHAT,WILEY
8201,CONCLUSION,DETECTION,DFPD,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,ONCE,RESULTS,THESE
2004,2012,CONCLUSION,EWING,FDG,FORTY,HOWEVER,JANUARY,LABEL,MATERIALS,MDP,METHODS,OBJECTIVE,PATHOLOGY,PET,RESULTS,SIXTY,STUDIES
181,8320,8325,946,954,A549,COX,IKK,THUS
ASKIN
CHEST,HODGKIN,NHL
A549,BAX,BIN,MTT,RESULTS,THESE,WESTERN
8211,ANOVA,BACKGROUND,BOTH,FIELD,HODGKIN,IFRT,INRT,LABEL,LIFE,LOST,LYL,METHODS,NODE,PROCEDURE,RADIATION,RESULTS,YEARS
METASTASIS,PRIOR
169,2014,27632,A549,CELL,JAPAN,MLC2,PRESS,PUBLISHED,RADIATION,RHO,ROCK,S19,SER19,SIMILARLY,SOCIETY,THESE,UNIVERSITY,WESTERN,WST
121,177,2006,2009,99M,BETWEEN,CONCLUSION,DUE,FDG,LABEL,MDP,METHODS,NPV,OBJECTIVE,PET,PPV,PURPOSE,RESULTS,SUV
001,2002,2007,2011,AGE,C00,C96,DISEASE,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS,TREND
001,005,016,018,095,145,150,2005,2012,244,416,652,ALSO,CONCLUSION,EASTERN,ECOG,EPP,GROUP,LABEL,LOG,METHODS,MPM,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
033,AKT,BOTH,CONCLUSION,ECOG,LABEL,METHODS,NSCLC,NSCLL,OBJECTIVE,PFS,PKB,PURPOSE,RESULTS
2389,CIS,CONCLUSION,LABEL,LITERATURE,METHODS,NSCLC,NSE,OBJECTIVE,PURPOSE,RESULTS
APOPTOSIS,CALU1,CASPASE,INCREASED,JAK,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,RNAS,STAT,STAT3,THUS,WESTERN
ENGLISH,PULMONARY
CRC,DESPITE,NOTCH,NSCLL,OBVIOUSLY,PRIMARY,RCC,TARGETING,VEGF
17P,947,954,BCR,BTK,CD69,CD86,CHRONIC,CLL,ERK,IBRUTINIB,IGHV,PLC
CARE,FORCE,INITIATIVE,LEGAL,LUNG,MANAGEMENT,QUALITY,TASK,THERE
099,357,477,519,531,533,551,671,AGE,CEA,COX,HOWEVER,MEIER,OTHER,OVERALL,VPI
001,027,1945,1966,1980,1982,2013,8201,8764,BIOMEDICAL,CAUCASIANS,CBM,CHINESE,CRUDE,DAPK,ISSUE,LIBRARY,MEDLINE,META,NSCLC,SCIENCE,STATA,THUS,WEB
127,8211,ASIA,COLON,COX,FIVE,LABEL,MEIER,METHODS,PURPOSE,RESULTS,SINS,UNIVARIATE,UNLABELLED
8211,A549,AMPK,FAK,FINALLY,FURTHER,FUS1,LABEL,LKB1,LPS,METHODS,MMPS,NEDD9,OBJECTIVE,PDGF,PURPOSE,RESULTS,VEGF
169,2014,DUE,HOWEVER,PRESS,PUBLISHED,SURGERY,UNIVERSITY
106,169,2014,PRESS,PUBLISHED,RIGHT,SURGERY,UNIVERSITY,VATS
937,EGFR,G719S,HOWEVER,IC50,L858R,NSCLC,T790M
100,160,630,800,8226,8805,CNR,CONCLUSION,CTS,DATA,GGO,GGOS,INCREASING,ITERATIVE,KEY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,PATIENT,RESULTS,SLICE,STUDENT
4T1,BALB,ELISA,LPS,LUNG,PBS,PULMONARY,THEN,TREATMENT
100,BACKGROUND,CONCLUSION,FOUR,GLASGOW,INFIRMARY,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WESTERN
9500,AKT1,ASO,FLUC,MICRORNAS,THESE
1489,1534,169,2014,215,2331,3023,3077,370,5408,591,CHINESE,GWAS,HAN,HOWEVER,PRESS,PUBLISHED,THUS,TOBACCO,UNIVERSITY

CELL,CRKII,EGFR,ERBB,L858R,MAMTH,PPIS,USING
169,2014,COPYRIGHT,SOCIETY
ERK,GBC,HOWEVER,KNOCKDOWN,MAPK,METASTASIS,THESE
INCREASED,NON,NSCLC,PEMETREXED,PHASE,RAPAMYCIN
EGF,EGFR,HOWEVER,ONCOGENIC,RAB25,TAKEN,THEREFORE,TKIS
AHR,HOWEVER,IDO,INHIBITION,STAT3
HEPIN,HPN,THESE,WHILE
169,2014,4T1,947,BOTH,COPYRIGHT,ERK1,GABA,GABAB,GABAERGIC,GAD65,IRELAND,LTD,MCF
169,2014,823,AMB,BGC,COPYRIGHT,HOWEVER,MEANWHILE,MTT,NUR77
141,193,2005,2012,262,956,BETWEEN,CONCURRENT,FIO2,FOUR,INC,IQR,PAO2,PUBLISHED,VIIA
169,2014,945,947,AFTER,CD34,COPYRIGHT,EVALUATION,IFN,IGG,IL2,INC,MRC5,MSC,MSCS,NOD,NSG,SCID,TNF,WHILE
169,2014,946,BCMO1,BEAS,COPYRIGHT,FZD6,IRELAND,LTD,RNAI
169,2014,CELL,COPYRIGHT,DISULFIRAM,HOWEVER,INC,INHIBITION,MTT,NON,NSCLC,PCR,REAL
169,2011,2013,2014,AKT1,ALK,BETWEEN,BRAF,CONCLUSION,COPYRIGHT,E17K,E542K,E545K,E545Q,EGFR,FGFR1,FGFR2,G12D,G719A,GENOMIC,HER2,HOWEVER,IRELAND,JANUARY,JULY,KRAS,LABEL,LTD,LUNG,MATERIALS,MEK1,MET,METHODS,NRAS,OBJECTIVE,OBJECTIVES,PCR,PTEN,RESULTS,RET,ROS1,SAMPLES,SCLC,SCLCS
169,2014,COPYRIGHT,EGFR,FOUR,HER2,LTD
103,125,169,177,183,2014,308,BONE,CONCLUSION,COPYRIGHT,INCIDENTAL,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PURPOSE,RESULTS
169,2014,COPYRIGHT,ECM,INC,PERIOSTIN
169,2010,2013,25TH,75TH,COPYRIGHT,DEPARTMENT,EMERGENCY,FIFTEEN,HEMATOLOGY,ITEMS,LABEL,METHODS,OBJECTIVE,OCTOBER,PUBLISHED,RESULTS,SECA,SELECTION,THERE
169,2002,2010,2014,BACKGROUND,CONCLUSION,COPYRIGHT,CRT,GRADE,INC,JULY,LABEL,LOCAL,LUNG,METHODS,PFS,RESULTS,TOTAL,TRT
169,2014,AFTER,CONCLUSION,HOWEVER,INC,LABEL,MAIN,METHODS,OBJECTIVE,RESULTS,SETTING,UNASSIGNED
169,2014,AIM,CLINICALLY,CONCLUSION,COPYRIGHT,LABEL,LTD,LUNG,MEDLINE,METHODS,OBJECTIVE,PUBLISHED,RESULTS
160,169,2014,ACTH,ADRENAL,COPYRIGHT,CUSHING,ECTOPIC,SAS,TREATMENT
100,129,169,2014,221,325,COPYRIGHT,INC,IRE,LABEL,METHODS,OBJECTIVE,OVERALL,PANCREATIC,PUBLISHED,PURPOSE,RESULTS,SIR
2011,2012,BACKGROUND,LABEL,RESULTS,WHOLE
001,032,037,040,143,169,1996,2011,2014,260,AIM,CONCLUSION,COPYRIGHT,COX,HOWEVER,LABEL,LLR,LRR,LTD,METHODS,OBJECTIVE,PORT,RESULTS,SCLC,SIMILARLY
BACKGROUND,CONCLUSION,IIIA,IIIB,LABEL,METHODS,NSCLC,ONTARIO,PGS,RESULTS,SURVEYS,THERE
946,A549,AML12,BACKGROUND,CGIS,CPG,CPGS,DMRS,DNMT1,EMT,HOWEVER,LABEL,METASTATIC,METHODS,MSCC,RESULTS,TET1,TGF,UNASSIGNED,VIRTUAL
BACKGROUND,CD44,CONCLUSION,LABEL,MOST,RESULTS
113,693,APOPTOSIS,BACKGROUND,BANCR,BRAF,CONCLUSION,ECTOPIC,EMT,EXPRESSION,GAIN,HISTONE,HOECHST,HOWEVER,LABEL,METHODS,MTT,NSCLC,NUDE,PROTEIN,REDUCED,RESULTS,RNAS,THESE
1990,2009,8201,BACKGROUND,BETWEEN,BRAZILIAN,IIB,IIIA,JANUARY,LABEL,METHODS,NSCLC,REGARDING,RESULTS,THUS
ELDERLY
1213,1283,1383,1477,1640,2154,BOTH,DESPITE,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PURPOSE,RADIATION,RESULTS,V20
0001,EGFR,NSCLC,THUS,USING
ALTERED,AREAS,BACKGROUND,COVERED,KIRSTEN,LABEL,LUNG,METHODS,OPINION,RAT,SARCOMA,TARGETING,VIRAL
169,2014,AMONG,FURTHER,JNK,LUNG,MKK7,NSCLC,PTK7,SIX
LDCT,LUNG,PRIMARY,SEVILYA,THERE
0001,177,388,CONCLUSION,DIXON,FDG,FORTY,FULLY,HOWEVER,LABEL,METHODS,OVERALL,PET,PULSE,RESULTS,SUV,SUVS,THERE,THUS,UNLABELLED,VIBE
169,2014,264,823,A549,BACKGROUND,BASED,BGC,CHANG,CONCLUSION,CURRENTLY,HEPG2,HGC,LABEL,NSCLC,PEQP,PLEUROTUS,QUEL,RAW,RESULTS,SOCIETY
4DCT,DIR,DIRS,DOSE,THERE,THUS
945,986,ASSESSMENT,BRAZILIAN,C30,CORE,DATA,EORTC,ESAS,HOWEVER,LABEL,LIFE,METHODS,OBJECTIVE,PURPOSE,QLQ,QUALITY,RESULTS,SYMPTOM,TREATMENT
0001,006,282,ANXIETY,ASSESSMENT,BACKGROUND,CHANGES,COMPARING,DEPRESSION,FACT,FORM,FUNCTIONAL,GREEK,LABEL,LUNG,MATERIALS,METHODS,NSCLC,QOL,QUALITY,REGARDING,RESULTS,SCALE,SCLC,SHORT,SLSC,THERAPY
0001,FBP,IMR,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,THERE,VISIBILITY
A549,BAP,BSA,DHA,DIETARY,FURTHER,P450,PUFA,THEREFORE
MMP,MMPS,RECK,RNAS,THESE
169,2014,AMD3100,CDC42,CXCR4,EWING,GTPASES,LABEL,MIGRATION,PCR,RAC1,RHO,SDF,UNLABELLED
AKT,FURTHER,H460,JNK,TAXR,THESE
001,055,AUDIT,BACKGROUND,ENGLISH,LABEL,LUNG,MEAN,METHODS,PATIENT,PEER,RECIPROCAL,RESULTS
CURCUMA,HOWEVER,HSP90,ROS,SIMILARLY,T63,THESE,USING
110,ATDC,OVERALL,PAM50,THUS
169,2014,218,8805,BASED,CONCISE,CONCLUSION,COPYRIGHT,HOUNSFIELD,INC,LABEL,LAVS,LYMPH,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROC,UNASSIGNED,USING
169,2000,2014,A549,COPYRIGHT,HELA,INC,LABEL,NPS,PHB1,RNAI,UNASSIGNED,UNLABELLED
0001,169,2004,2006,2014,2698,444,537,BACKGROUND,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,NSCLC,RESULTS,SCLC
169,181,2011,2012,2014,280,400,450,8776,956,AFTER,ANDA,AUTOMATED,BG75,BIOMARKER,COLLEGE,COPYRIGHT,FDG,GENERATOR,H2O,H441,HPLC,JUNE,LTD,MARCH,MEV,RCY,UNIVERSITY,USP
169,2014,COPYRIGHT,INC,THERE
100,177,7P21,8201,8805,ABERRATION,AFFYMETRIX,BACKGROUND,CNV,CNVS,CONCLUSION,HDAC9,LABEL,LOH,LOSS,MCNEMAR,RESULTS,SINCE,SNP,SNPS,WIDE
A549,CASPASE,CCK,H1299,LABEL,METHODS,MYRICETIN,NUDE,OBJECTIVE,RESULTS,UNASSIGNED,VIRTUAL
CASTLEMAN,LABEL,UNASSIGNED,UNICENTRIC,UNLABELLED,VIRTUAL
22RV1,ALSO,BACKGROUND,BOTH,BXPC,CHO,CONTEXT,DISCUSSION,DMEM,DPPH,H1299,HEPG2,HILDEBR,LABEL,MATERIALS,METHODS,MILL,NCI,OBJECTIVE,RESULTS,THEIR,THUS,WST
DEBATES,HNSCC,HOWEVER,MRI,PET,THEREFORE
ALSO,CLINICALLY,EPIGENETIC,REVERSIBLE
HBV,HCC,HOWEVER
000,028,088,145,169,177,2011,2013,2014,312,331,371,392,421,426,6MWT,APRIL,BETWEEN,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,UNIVERSITY
0048,169,180,2014,313,369,387,426,493,ALK,ANAPLASTIC,BACKGROUND,BECAUSE,FIFTY,FISH,KRAS,LABEL,METHODS,NONE,NSCLC,RESULTS,SOCIETY
2014,254,255,BIOMARKERS,COLORECTAL,LUNG,MOST,ODDS,OVARIAN,PRESS,PUBLISHED,SELF,UNIVERSITY
169,2014,945,CHROMATIN,DSB,EGFR,ERK,HOWEVER,KRAS,MEK,NSCLC,PKC
169,2014,AFTER,ARF,BRITAIN,CDT1,CIP1,COPYRIGHT,CUL4A,GENOMIC,GREAT,H2170,IHC,INCREASED,INK4A,IRELAND,JOHN,KIP1,LTD,PUBLISHED,RING,SOCIETY,SONS,WILEY
124,160,169,177,179,183,196,203,224,314,423,619,724,8202,AMONG,CARDIAC,CONCLUSION,EXTRA,GEORG,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,PVI,RESULTS,STUTTGART,YORK
200C,FINALLY,H460,JNK,MICRORNAS,NOTABLY,PCR,RECK,RESV
8209,A549,HOWEVER,LKB1,SP1,VEGF
00001,0002,239,363,876,ASSESSING,HOWEVER,LUNG,NSCLC
0001,009,099,169,2014,238,268,398,636,721,HER2,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,TIL,TILS,YTMA128,YTMA201
007,012,013,041,047,229,8202,ADDITIONAL,BACKGROUND,DCR,DCRS,LABEL,METHODS,NSCLC,PFS,RESULTS,RRM1,RRMI
104,HOWEVER,KI67,MRI,NUCLEAR,THEREFORE,UNIVARIATE
CONSORTIUM,DIGITAL,IMAGE,LIDC,LUNG,USING
112,169,1991,2011,2014,304,484,BACKGROUND,COPYRIGHT,INNSBRUCK,IRELAND,LABEL,LDH,LTD,METHODS,OVERALL,PARAMETERS,RCT,RESULTS,SCLC,UNIVERSITY
169,187,1980,2013,2014,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HOWEVER,III,IRELAND,IVA,IVB,KOGA,LABEL,LTD,MASAOKA,MEIER,METHODS,OVERALL,RESULTS,STAGE
AFTER,AUTOPSY,CANDIDA,ESPECIALLY,IIIA,STAGE
169,2014,4CM,7CM,BACKGROUND,BPB,CASE,CBPB,CHEST,CLASSIC,CONCLUSION,COPYRIGHT,LABEL,METHODS,PAN,PATIENT,PPB,PULMONARY,SAS,TTF,WDFA
169,2014,4MONTHS,COPYRIGHT,MALT,SAS,THERE
945,GUNN,HOWEVER,NNK,UDP
001,1601,1992,2009,2657,2M0,4N0,BACKGROUND,COX,FURTHER,LABEL,MEIER,METHODS,MVI,NSCLC,OBJECTIVE,RESULTS,TNM,VPI
340,422,BACKGROUND,FURTHER,LABEL,METHODS,RESULTS,RNAS
HOWEVER,MRI,THEREFORE
ARRAY,ERK,H125,IGF,KIT,LABEL,MATERIALS,MEK,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RTK,SIGNALING,STAT1,TIC,TOTAL,WESTERN
ABC,BACKGROUND,CBCT,HOWEVER,LABEL,METHODS,PEARSON,PRE,PTV,RESULTS,THESE,USING
AREAS,BACKGROUND,COVERED,EGFR,ERBB,ERBB3,HER2,HER4,JAPAN,LABEL,LUNG,LUX,METHODS,NSCLC,OPINION,TKI,TKIS
000,019,033,177,2005,2013,EASTERN,ECOG,GROUP,JULY,MALIGNANT,MARCH,MPM
143,169,2014,GAGE,HOWEVER,JOHN,LTD,MAGE,NSCLC,PUBLISHED,SONS,SSX,SSX2,SSX3,SSX4,WILEY
069,130,1955,2008,620,9608,BACKGROUND,CMM,FACTORS,FURTHER,LABEL,METHODS,NORWEGIAN,RATES,RESULTS,SCC,SIR,SKIN
FREEDOM,FRESH,HALF,HOME,MODEL,MOST,RADON,SHS,SMOKING,TEACHABLE,TEST
129,CURRENT,KNOWING,PERCEIVED,PROGRAM,RADON,THOSE
0009,007,066,106,122,BACKGROUND,INVENTORY,LABEL,METHODS,MLR,OBJECTIVE,PAIN,RESULTS,SIGN,SKIN,SMALL,SYMPTOM,THESE
105,ADDRESSING,BACKGROUND,CONCLUSION,DESPITE,III,ILLNESS,LABEL,METHODS,OBJECTIVE,QOL,RESULTS
FIVE,PCI
TEN
169,2014,CONCLUSION,EGF,EGFR,EMT,FINALLY,LABEL,METFORMIN,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,STAT3,STUDIES,TKI,TKIS,WESTERN
169,2014,AACR,HOWEVER,NSCLC
169,2014,FITM,PET,UICC
946,AKT,EGFR,ERK,HOWEVER,KLK6,NSCLC,PAR2,THESE
003,011,160,8804,DFS,EGFR,FIVE,KRAS,LABEL,METHODS,MUTATIONAL,OBJECTIVE,PURPOSE,RESULTS,WHETHER
177,HOWEVER,SBRT
138,177,ASIAN,PEARSON,SIXTY
039,2008,GEOGRAPHIC,ICU,LUNG,SES,URBAN,WHITE
2004,2009,ALDH1,CONCLUSION,DEPARTMENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURGERY,THREE
945,CAPER,HCC1,HOWEVER,MTT,NSCLC,THESE,TMA,WESTERN
2010,2013,ANOTHER,APRIL,AVAILABLE,BASED,COLORECTAL,CONTROLLED,ERSPC,HARMS,HEART,IMPORTANCE,JANUARY,LABEL,LUNG,MEDLINE,METHODS,OBJECTIVE,OTHER,OVARIAN,PLCO,PSA,RANDOMIZED,RELEVANCE,RESULTS,SCORING,SCREENING
000,042,118,120,168,169,177,2002,2010,2014,886,942,962,989,BACKGROUND,CFRT,CONCLUSION,COPYRIGHT,ICER,JANUARY,JUNE,LABEL,LYG,LYGS,MEAN,METHODS,NSCLC,RESULTS,SBRT,SOCIETY,USING,VARYING
001,169,2014,ACE,ADULT,COPYRIGHT,DISEASE,EVALUATION,INDEX,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SOCIETY,STRATIFIED
2992,797,803,805,BIBW,EGFR,ERBB,ERBB4,HER2,SEVERAL,T790M
DTX,FH535,LAD,MEANWHILE,SFRP1,SPC,TAKEN,TAXANES,TREATMENT,WNT
2000S,ALK,ASIAN,EGFR,FINALLY,LUNG,THUS
WGCNA
338,AQP2,AQP9,LRP,LUNG,OCT2,SNPS,TMEM205
169,2014,ATTRIBUTES,BASEL,DRUG,FOOD,HPV,THESE
DSBS,H2AX,HOWEVER,MCF,RAD50,REMARKABLY,SKBR3,T47D,THESE
RAGE,SOLUBLE
0001,023,146,1506,296,374,617,670,889,EGFR,G12C,G12D,G12V,G13D,GTP,KRAS,MUTATIONS,RAS
GEFITINIB,NSCLC,PULMONARY
DIFFUSE,DPL,HOWEVER
177,231,8764,945,956,GELATIN,HOWEVER,IC50,MCF,MDA,NOS,NOSCAPINE
181,945,BACKGROUND,CAFS,CD31,CRC,LABEL,LVD,METHODS,MVD,PTEN,RESULTS,SMA,THEREFORE,USING
003,007,048,BACKGROUND,BRMS1,DFI,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,TOWARDS
2013,8202,946,BACKGROUND,C509T,CAUCASIANS,CHINESE,CIS,CNKI,CONCLUSION,DATABASES,G915C,LABEL,MEDLINE,METHODS,ORS,PNEUMONIA,RADIATION,RESULTS,SEPTEMBER,SUMMARY,T869C,TGF,ULTIMATELY
BACKGROUND,ENV,GAG,JSRV,LABEL,METHODS,OPA,PCR,RESULTS,SEVERAL,WHILE
231,946,ATLAS,BACKGROUND,CELL,CONCLUSION,FINALLY,FISH,HCC1428,HER2,HIGH,III,JNK,JUN,KNOCK,LABEL,MCF7,MDA,METASTASIS,METHODS,NUCLEAR,PROCESSES,RESULTS,RIP2,T47D,THESE,TNBC,WESTERN
HDL,HDLC,META,RCT,RHEUMATOID,TNF,TREATMENT
0004,10TH,2013,257,269,526,BACKGROUND,CNKI,JUNE,LABEL,MEDLINE,METHODS,NSCLC,RESULTS,THERE
100,8764,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SEVENTEEN,THERE
AFTER,CTC,CTCS,DGM,EGFR,EPCAM,FULL,PCR,TOS
HOWEVER,LUNG,TLRS,TOLL
2009,AREAS,ASM8,BACKGROUND,CCR3,CCR4,COVERED,LABEL,METHODS,OPINION,PHASE,THERE
ICT2588,MMP,PRODRUG,VDA,VDAS,WILLEBRAND
A549,BER,BERBAMINE,CONCLUSION,LABEL,LUNG,METHODS,MTT,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
183,956,A549,AKT,BAX,BCL,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,NSCNC,OBJECTIVE,PI3K,RESULTS,WITHAFERIN
109,177,AMONG,CONCLUSION,DCRT,LABEL,MAIN,METHODS,NSCLC,OBJECTIVE,OVERALL,PACLITAXEL,RESULTS
177,245,466,711,981,AMONG,CONCLUSION,DVT,ELISA,INCREASING,LABEL,METHODS,OBJECTIVE,RESULTS
BACKGROUND,FURTHER,GLUCOSE,HER2,LABEL,LDH,MATERIALS,METHODS,PLEURAL,RESULTS
000,100,1971,1973,1990,1992,2004,2005,600,CANCERS,CHINA,GUANGXI,HOWEVER,THEREFORE
BACKGROUND,GROSS,HELICAL,KOREA,LABEL,MATERIALS,METHODS,NSCLC,PUBLISHED,RESULTS
CTC,CTCS,FDA,SINCE
100,1995,2013,8201,ACT,ASPS,BRAIN,CONCLUSION,IMAGING,INSURANCE,KNOWLEDGE,LABEL,METASTASES,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS
233,A549,BROWN,H460,RADIATION
115,185,1996,2008,288,672,AIM,ATT,BACKGROUND,DATA,FIRST,FORTY,LABEL,METHODS,OBJECTIVE,POPULATION,PULMONARY,RESULTS
CASE,EBRT,NOVALIS,PALLIATIVE,RESULTS,SRT
ACUTE,ADJUNCTIVE,RECURRENCE
000,225,ACCORDING,FOUNDATION,PRECISE,THERE,USA,WORLD
EPP,MALIGNANT,MPM,THERE
169,2014,946,MMTV,ONCOGENIC,PYMT,VEC,VECS,VEGFA,WNT,WNT7B
169,2014,CD14,CSC,CSCS,CSF,CSF1,IFN,IRF5,RESISTANCE
169,2014,EMT,EXPRESSION,HCC,HNRNPAB,SNAIL
169,2010,2014,BESIDES,DESPITE,EORTC,GERIATRIC,MEDICAL,NON,NSCLC,PRESS,PUBLISHED,SINCE,SIOG,SOCIETY,TREATMENT,UNIVERSITY,WESTERN
001,215,3746,8201,ACUTE,AFTER,BACKGROUND,CHRONIC,CRITICALLY,DEEP,DESPITE,DVT,DVTS,EVALUATION,ICU,ICUS,IDENTIFIER,IMPORTANCE,LABEL,MAIN,METHODS,NLDVT,OBJECTIVE,PHYSIOLOGY,RELEVANCE,RESULTS,SETTING,THROMBOSES,TRIAL
2001,OCCURRENCE,SINCE
HPV,LUNG,PAPILLOMA,PCR,VIRUS
1519,1999,2007,280,341,6058,BACKGROUND,BIVARIATE,DATA,INCLUSION,INDEX,LABEL,MDS,METHODS,NSCLC,RESULTS,SEER,SMALL,TREATMENT
BASAL,CETUXIMAB,CRIZOTINIB,DATA,EGF,EGFR,EIGHT,ERBITUX,ERLOTINIB,FINALLY,HGF,HOWEVER,MSD,OVERALL,SPHEROIDS,THEREFORE,THREE
142,284,ADVERSE,CONCLUSION,III,JAPAN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC
127,150,344,CONCLUSION,EGFR,ERCC1,III,IIIA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SECONDARY
005,007,017,150,8202,886,924,FIRST,PCR,SCLC,SMALL,THESE
ALANINE,BIK,BIKDD,ERK1,TNBC
DNMT1,HOWEVER,PCNA,SEVERAL,THUS,UHRF1
169,2014,COPYRIGHT,FINALLY,HSA,LEVEMIR,TRESIBA,VICTOZA
169,2014,878,945,AACR,ACID,AML,APL,ATRA,CONVERSELY,LABEL,LINC00478,MOL,PML,RAR,RARES,RES,RESPONSIVE,THEREFORE,THESE,UNLABELLED
001,169,177,2009,2011,2014,8201,BACKGROUND,LABEL,MEAN,METHODS,MORTALITY,OCTOBER,PULMONARY,RESULTS,SIXTY
150,169,2014,400MG,AMONG,CONCLUSION,COPYRIGHT,EGFR,FULL,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PFSR12W,PRE,RDP2,RESULTS,SAHA,STILL,T790M,TKI,VORINOSTAT
169,2014,COPYRIGHT,EGFR,IRELAND,L858R,LTD,NSCLC,TKI
109,119,169,2014,ASIAN,BACKGROUND,BECAUSE,CAUCASIAN,CHINESE,CONCLUSION,COPYRIGHT,EGFR,FISH,FURTHER,IHC,IRELAND,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,PKCIOTA,PUBLISHED,RESULTS,TAKEN
160,169,2007,2014,204,253,255,281,317,511,954,AAA,AGREEMENT,AVAILABLE,CAPTURING,CAS,CENTERS,CONVERSELY,COPYRIGHT,ESTIMATED,FIFTEEN,INC,INITIATIVE,LABEL,METHODS,MOSBY,OBJECTIVE,PAD,PUBLISHED,RESULTS,WHI,WOMEN
146,169,2014,COPYRIGHT,CURE,EXTENSIVE,IRELAND,LOCAL,LTD,RECURRENCE
001,183,2005,2006,4419,8805,AMERICANS,AMONG,APPROACHES,CROSS,DASH,DIETARY,LABEL,METHODS,MEXICAN,NATIONALLY,NUTRITION,OBJECTIVE,PDQ,RESULTS,SETTING,STOP,USA
001,028,169,2013,482,947,BACKGROUND,EGFR,FDG,FIFTY,LABEL,LOW,METHODS,NSCLC,PEARSON,PET,PUBLISHED,RESULTS,SOCIETY,WHETHER
0146,142,169,1725,2002,2011,2013,215,306,3552,4069,5516,597,9999,BACKGROUND,CISPLATIN,HOWEVER,JULY,LABEL,METHODS,MPM,OVERALL,PUBLISHED,RESULTS,SOCIETY
169,2013,ACTIVATION,COPYRIGHT,EGFR,EMT,HGF,HOWEVER,INHIBITION,MET,NSCLC,PTEN,PUBLISHED,SOCIETY,T790M
AIR,IARC
283,3BP,ACCORDING,AFTER,CONCURRENT,GSH,LACTATE,LDH,THERE,WARBURG
008,169,2014,320,8804,ACE2,AFTER,BACKGROUND,COPYRIGHT,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,THUS
169,2014,CLINICIANS,COPYRIGHT,INC,PBML,PULMONARY,RCC
0001,1094,112,169,2014,345,749,COPYRIGHT,HOWEVER,INC,MANN,METASTASIS,SIZE,WHITNEY
1343,169,2005,2012,2014,AUTHORS,BASED,BETWEEN,COPYRIGHT,GROUP,III,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RADIATION,RESULTS,RPA,RTOG,SURGICALLY,THERAPY
2001,2012,335,BECAUSE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,TRANSPLANT
215,FATTY,RIGHT,TEN
0001,111,127,169,189,2014,239,300,812,841,AREA,AUC,AVERAGE,BERBAUM,BSIS,CAD,CONCLUSION,DORFMAN,FIVE,LABEL,MATERIALS,METHODS,METZ,OBJECTIVE,PURPOSE,READERS,RESULTS,RSNA,SELECTION,STAND,STILL,THREE,WITHOUT,WRITTEN
137,144,2008,2012,321,446,467,496,BACKGROUND,EBUS,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,USING
00157,136,8202,ABSENCE,BACKGROUND,CONCLUSION,EXPRESSION,IHC,LABEL,LUNG,MDM2,METHODS,OTHER,P53,REGARDING,RESULTS,TP53
COPD,THEIR,THEREFORE
169,2012,2013,2014,JULY,MAY,PRESS,PROLENE,PUBLISHED,SURGERY,UNIVERSITY
261,5P15,9935,ASIAN,CLPTM1L,DUE,LABEL,RESULTS,UNASSIGNED,UNLABELLED
169,177,2014,2CPP,8201,99M,COPYRIGHT,H1299,JOHN,LTD,PORPHYRINS,SONS,TECHNETIUM,THEREFORE,WIDR,WILEY
112,169,2014,252,63743,8197,945,956,958,A549,ACTA,AMONG,AZ521,B16,BARR,CHIMICA,COPYRIGHT,EBV,EPSTEIN,ETOH,HELVETICA,HL60,IC50,MSH,RAJI,SEVENTEEN,TPA,UPON,WESTERN
1846,1846C,185,AFTER,CRP,FIFTY,HOWEVER,LYMPH,USING
143,196A2,673,CAUCASIANS,CIS,HOWEVER,MICRORNAS,ORS,OVERALL,SNPS
ALTOGETHER,E2F1,NSCLC,PCR,PRC2,RHO,ROBO1,ROCK1,SUZ12,THUS,WESTERN
001,005,042,093,2007,2011,605,CNS,CONCLUSION,EARLY,EGFR,FURTHER,LABEL,METHODS,NINE,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TKI
100,AMONG,CURRENTLY,DETECTION,DUE,EACH,KIT,PCR,SEPT9
152,157,160,185,2003,2009,234,313,622,818,881,896,AMONG,BACKGROUND,COX,EASTERN,ECOG,GROUP,LABEL,METHODS,POOR,RESULTS
021,023,100,103,141,IQR,LDH,LOCALIZED,MALT,RADIATION,STAGE,THERE,TIME
215,ALK,BACKGROUND,BRAF,EML4,LABEL,METHODS,NRAS,PTC,RB1,RESULTS,RET,THERE,THESE,TRAPP,WHOLE
1471,AAD,BAK,BAX,CONCLUSION,DBD,FINALLY,H1373,HELA,LABEL,METHODS,MTSS,OBJECTIVE,PURPOSE,RESULTS,SKOV,T47D,TMRE
120,1605,2002,2004,2005,2010,BACKGROUND,BCP,COX,DRUG,FOOD,HMO,HMOS,HOWEVER,IIIB,IQR,LABEL,METHODS,NETWORK,RESULTS,USING
ALZHEIMER,HEME,HENCE,HIGH,HOWEVER,INCREASED
AMONG,ATLAS,NON
DIAGNOSIS,DISTRICTS,DPC,IWATE,JAPAN,LABOR,MEDICAL,MHLW,MORIOKA,PREFECTURE,PROCEDURE,SECONDARY,SMD,WELFARE
SCC,SEVEN,SMALL,THEREAFTER
AFTER,DESPITE,III,PAH,RIGHT,WORLD
004,008,100,BACKGROUND,EBUS,EUS,FNA,LABEL,METHODS,RESULTS,TBNA
BACKGROUND,CASE,LABEL,MESSAGE,METHODS,OUTCOME,RESULTS,UNASSIGNED
945,ANG,CSF,E47,EMT,EPITHELIAL,LOSS,LOXL2,TFS,TNF
8323,A549,H1299,H23,PCK2,PEP,PEPCK,STILL,UNDER
8201,ALK,BRD4,CBLB,HIF1A,HOWEVER,KLF6,MMP,MMP7,MMP9,NCL,NUCLEOLIN,PCM1,TFG,TNCL
100,10MM,169,2014,50MG,8AMOL,956,BENZENE,COPYRIGHT,IRELAND,LTD,PHG
169,2014,945,947,954,COPYRIGHT,DEPLETING,EXPRESSION,GST,INC,KNOCKDOWN,MMP9,RAD,RAS,RELA,TNF
169,2014,268,COPYRIGHT,CURRENT,HOWEVER,INC,LABEL,LLO,PEG,UNASSIGNED,UNLABELLED
100,169,2014,24H,956,AFTER,BALB,BOTH,COPYRIGHT,H460,IC50,LABEL,MDR,METHODS,MTT,OBJECTIVE,PTX,PURPOSE,RESULTS,TPGS
100,169,2014,8764,956,BECAUSE,COPYRIGHT,GUVS,HOFFMAN,IRELAND,KNOWLEDGE,LTD
100,1179,1573,169,2014,COPYRIGHT,CROSS,HBL,HELA,LEAVE,QSAR,RECON,SAS,STRUCTURE,VALIDATION,WIDR
169,2014,CD20,CK19,COPYRIGHT,INC
150NM,169,177,2014,5NM,A549,COPYRIGHT,CRYO,DEVELOPED,DOPE,DPPC,DSPE,LIVE,NANO,PEGYLATED,THESE
00001,169,2014,AFTER,ANN,COPYRIGHT,HOWEVER,LTD
169,2014,956,CNS,COPYRIGHT,FURTHER,GI50,SAR,SAS,THESE
169,2014,COPYRIGHT,EXPRESSION,LUNG,MICRORNAS,THESE
169,2014,COPYRIGHT,EGF,EGFR,EPIREGULIN,ERBB,ERBB1,ERBB2,ERBB3,ERBB4,HER2,HER3,HER4,LTD,NEU,THEREFORE
169,2014,946,AKT,BOTH,COPYRIGHT,EGFR,HOWEVER,INC,NSCLC,OVERALL,SIMILAR,STATINS,T790M,THESE,TKI,TKIS
007,122,1420,169,2013,2014,31ST,945,ASIA,BACKGROUND,COPYRIGHT,DATA,ELECTRONIC,ESEE,FURTHER,HIF,HYPOXIA,IHC,III,LABEL,METHODS,NSCLC,RESULTS,SCLC,STUDIES,TAKEN,TOTALLY,VARIOUS
169,2014,BALT,COPYRIGHT,EXPANSION,INC,INHIBITION,LYMPHATIC,LYMPHATICS,MYCOPLASMA,PATHOLOGY,PUBLISHED,SOCIETY,SPROUTING,TREATMENT,VEGF,VEGFR
169,2014,947,BL6J,C57,CD3,COPYRIGHT,H460,HOWEVER,IFN,INC,LEWIS,LLC,NK1,NSCLC,SEP,THESE,TLR2,TLR4
169,2014,A549,BCL,CARDIAC,CELL,COPYRIGHT,EARLY,ERK1,H1975,III,INC,JNK,LC3,OUABAIN,THESE
000,001,169,177,188,2014,458,921,922,COMPLETING,CONCLUSION,COPYRIGHT,DIFFICULTY,JAPAN,KNOWLEDGE,LABEL,LTD,METHODS,MPM,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS
169,2014,CHR19,COPYRIGHT,FINALLY,GEMM,GEMMS,INC,PTEN,RB1,SCLC,SMALL,TRP53,USING
100,143,169,177,2000,2009,2014,COPYRIGHT,FIO2,INC,LABEL,MATERIALS,METHODS,MICU,OBJECTIVE,PAO2,PURPOSE,RESULTS,THEIR
1350,1518,169,2010,2011,2012,2014,AFTER,COPYRIGHT,INSTITUTE,MAJOR,SAS,TENPATH,THESE
160,169,2004,2014,COPYRIGHT,PERITONEAL,SAS
105,10877,10878,113,123,125,132,164,169,180,188,197,1998,2010,2014,205,210,483,505,BED10,COPYRIGHT,D99,DOSE,GTV,GYX3,GYX4,GYX5,GYX8,IRELAND,LABEL,LTD,MEAN,METHODS,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,ROC,SBRT,SHORTER,T2N0,THERE
0001,006,169,1975,1993,2001,2006,2008,2014,211,AGGREGATE,BACKGROUND,CARDIAC,COPYRIGHT,DATA,END,HEART,HOWEVER,INC,JULY,LABEL,LUNG,METHODS,ONCE,PUBLISHED,RESULTS,SEER,SOCIETY,STATISTICS,TRANSPLANT
169,2013,8MM,ANOTHER,COPYRIGHT,PUBLISHED,RADIOLOGIC,SEPAR,SPN
169,2014,BACKGROUND,CARE,CCTR,CHRISTIANA,CONCLUSION,COPYRIGHT,HEALTHCARE,LABEL,LTD,METHODS,RESULTS,THERE,UNINSURED
017,169,2014,AIM,COLLEGE,CONCLUSION,COPYRIGHT,ELISA,GGO,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OTHER,PUBLISHED,RESULTS,ROYAL
1523,169,2014,COPYRIGHT,DESPITE,EPONYMS,HOWEVER,INC
001,003,012,016,020,033,169,2014,222,8805,CIGARETTE,COPYRIGHT,DCR,EGFR,IRELAND,L858R,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,ORR,PFS,RESULTS,SMOKERS,THERE,TKI,TKIS
001,169,195,2009,2010,2014,445,640,APRIL,BACKGROUND,CARCINOMA,CONCLUSION,COPYRIGHT,GCCB,GROUP,IASLC,IRELAND,LABEL,LTD,LUNG,M1A,M1B,METHODS,NON,NSCLC,PNEUMOLOGY,RESULTS,SOCIETY,SPANISH,SURGERY,TNM
001,007,1139,147,169,2014,444,8804,ALK,BACKGROUND,BRAF,CHINESE,COPYRIGHT,EGFR,HER2,IRELAND,KRAS,LABEL,LTD,METHODS,PCR,RESULTS,RET,ROS1,THERE
169,177,2014,549,945,946,956,COPYRIGHT,DPPH,FID,GMBH,IC50,SENECIO
169,2014,COPYRIGHT,DISCUSSION,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
108,150,353,567,BACKGROUND,ERM,EZRIN,HOWEVER,INCREASED,LABEL,MEIER,METHODS,NSCLC,PCR,RESULTS,THR,TYR
945,A549,AKT,ALIVE,BACKGROUND,BIO,BTC,CELL,CHX,CONCLUSION,CXCL8,EGF,EGFR,ERBB1,ERBB4,ERK,ERK1,ERLOTINIB,IMAGE,LABEL,MATERIALS,METHODS,MONITORING,PI3K,RESULTS,TNF,TREATMENTS
254,8805,A549,BACKGROUND,CONCLUSION,EGL5,FURTHER,HGF,HOWEVER,IHC,LABEL,MET,METHODS,MOST,NON,NSCLC,PA8,PAX5,PAX8,RESULTS,RON,RTK,SCLC,SU11274,SUBSEQUENT,USING,UTILIZING
3411,5184,5406,8201,BACKGROUND,BASAL,BONE,CONCLUSION,CXR,HER2,III,LABEL,LUMINAL,LUS,METHODS,RESULTS,THESE
169,2014,APMIS,CIK,FURTHER,HOWEVER,HYPOXIA,JOHN,LTD,METRONOMIC,MICE,NSCLC,PUBLISHED,SONS,WILEY
2013,ASCO,BACKGROUND,CANCERS,CONCLUSION,DUE,ENGLISH,EPSCC,ESPCC,HIGH,HOWEVER,LABEL,METHODS,OCTOBER,PCI,RESULTS,SCC,SCCS,SCLC,SCOPE,SMALL,SOCIETY,THEREFORE
2003,EGFR,FDA,GEFITINIB,HENCE,HOWEVER,IDENTIFIED,INTENSIVE,NSCLC,PHASE,THESE
2013,CBM,EBSCO,FURTHER,LIBRARY,META,NSCLC,OCTOBER,SCHOLAR,SCIENCE,SERUM,STATA,THERE,TNM,VEGF,WEB
ANATOMICAL,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PHASE,PLAN,PTV,RESULTS,THERE,TREATMENT,V10,V20,VOLUMETRIC
1990S,450,CYP,DATA,DME,GST,HENCE,HOWEVER,LEBANON,NAT,PHASE,THERE
000,1000,1388,169,2001,2014,9101,AIMS,AUTHORS,INSURANCE,LABEL,METHODS,OBJECTIVE,RESULTS,VITAL
100,169,176,2014,A549,ACCORDING,CASY,CO2,E2F1,HIF1,HIF2,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SFR,SRF,STAT3,SURGERY,THREE,UNIVERSITY,VINFLUNINE
954,CHRONIC,COPD,HOWEVER,QUIESCENT,STAT3,TREATMENT
4YL,AKT1,INHIBITORS,LTU27,THERE
169,2014,ACIDS,EGFR,EPIDERMAL,MET,NUCLEIC,PRESS,PUBLISHED,RNAI,SEVERAL,SYNTH,UNIVERSITY
946,ATP,BEAS,EGFR,H292,P2X7,RELEASE,TGF,THESE,TREATMENT
33258,8209,946,A549,ANNEXIN,APOPTOSIS,BAD,BCL,CONSISTENT,CURCUMA,CYTOSOLIC,DDP,ELE,FITC,GSH,HOECHST,MTT,THESE
BRCA2,CELL,CHINESE,DSB,DSBS,HSC3,INHIBITION,KU80,PKCS,SAS,THESE,XRCC2
A549,ADAM,CELL,NSCLC,THESE
A549,ANNEXIN,AUTOPHAGY,AVOS,HOWEVER,LC3,MTT,PARP,PEMETREXED,PTX,TAKEN
EGFR,GEFITINIB,GENOMIC,HOWEVER,MRI,OWING
699,8209,A549,APAF,ATPFQEG,AVPIAQK,CALU,COLO,FURTHER,NSCLC,TAKEN,THERMAL,TREATMENT,UPON,XIAP
145,156,2001,2010,239,CHEST,COLLEGE,COPD,CPET,FEV1,FEV1PPO,HOWEVER,LABEL,LUNG,METHODS,OBJECTIVE,OVERALL,PCS,PHYSICIANS,PREDICTED,RESULTS
EARLY,ICH,ICHS,LABEL,NOVEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
335,349,INFECTION,LASB,MUTANTS,T2SS,T3SS,TYPE
169,2014,CEC,CECS,CEP,CTEC,CTECS,FOLLOWING,TEM,TEM7,TEM8,TEMS,THESE
169,2014,946,AACR,CONSISTENT,CONVERSELY,FBX4,GSK3,NOTABLY,SILENCING
HOWEVER,LUNG,NSCLC,SCLC,VARIOUS
001,015,131,144,169,2013,8804,976,984,993,AIM,CEA,COLLEGE,COPYRIGHT,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL,TDR
2007,2012,ADMISSION,FORTY,HOWEVER,MACCALLUM,OVERALL,PCR,PETER,PJP,SHORTNESS,TODAY
169,2014,BEST,CMT,CONFORMAL,EBRT,ENDORECTAL,GERIATRIC,INTENSITY,LEVEL,MEDICAL,MGMT,NSCLC,PATIENT,PRESS,PUBLISHED,SBRT,SHORT,SHORTER,SIOG,SOCIETY,UNIVERSITY,WHERE
160,169,2004,2012,2014,BACKGROUND,BETWEEN,COPYRIGHT,DISSECTION,FIFTEEN,INC,LABEL,LEFT,MARCH,METHODS,OCTOBER,OVERALL,PUBLISHED,RESULTS,SIXTEEN,SOCIETY,THREE
AFTER,ATS,ATTAINMENT,BECAUSE,COMMITTEE,EXECUTIVE,SOCIETY
215,8201,CARLO,CONVERSELY,LABEL,MATERIALS,METHODS,MONTE,OAR,OBJECTIVE,PHILIPS,PTV,PURPOSE,RESULTS,THERE,TPSS,VMAT,XVMC
100,80TH,8201,8805,95TH,ADVERSE,BACKGROUND,CTCAEV4,ELEVATION,FDG,LABEL,MATERIALS,METHODS,NSCLC,PET,RESULTS,SUV,USING
006,100,111,128,137,300,8201,824,834,8482,AREA,AUC,BOTH,CAD,CLEARREAD,CONCLUSION,JACKKNIFE,KNOWLEDGE,LABEL,METHODS,MIAMISBURG,OBJECTIVE,RESULTS,SIX
150,BACKGROUND,CD105,CD31,ENG,FLT1,KDR,LABEL,METHODS,PCR,PDXS,RESULTS,TAKEN,TBP,THESE,VEFR2,VEGFA,VEGFR
CHANGES
2013,COPD,FINALLY
BECAUSE,C10,CYS,EXPRESSION,GFP,PRXS,SEC,SRX,THESE,TR1,TR2,TRX,TYPICAL
023,135,141,161,169,184,1940,2000,2002,2014,276,278,583,7483,782,861,8764,9423,BACKGROUND,CONCLUSION,INSURANCE,JANUARY,LABEL,MALIGNANCY,MATERIALS,METHODS,PHYSICIANS,PRESS,PUBLISHED,RESULTS,SPM,SPMS,UNIVERSITY
127,160,174,ALTOGETHER,CRIZOTINIB,LABEL,MCF,METHODS,MICELLE,OBJECTIVE,PEG,PLA,PURPOSE,RESULTS,SILDENAFIL,UPLC
MUTATIONAL,PCR,RAS,THESE,WHILE
HOWEVER,MUTATIONS
169,2013,2014,21ST,BIOLOGY,CLUB,ESTS,MEETING,PRESS,PUBLISHED,SOCIETY,SURGERY,TODAY,UNIVERSITY
0009,003,007,2000,2003,2007,222,596,8201,8805,ADDITIONAL,CIS,FILE,FTR,IMPORTANCE,LABEL,MAIN,METHODS,OBJECTIVE,OPERATIVE,RELEVANCE,RESULTS,SES,SETTING
0354,160,2005,2013,591,605,683,8201,863,904,BLOOD,DATABASES,DISC,EGFR,HOWEVER,META,STUDIES,SUMMARY
177,8201,99M,BINDING,BT474,ERBB,HER3,IMAGING,ISOLINK,LABEL,MCF7,MEMBRANOUS,METHODS,OBJECTIVE,PURPOSE,RESULTS
000,169,181,1988,200,2005,2014,400,500,600,679,749,8805,946,CARET,COX,DATA,HOWEVER,HRS,RAE,RETINOL,TOTAL,TRIAL,UICC
046,2013,554,CNKI,DEC,FURTHER,G39E,HNPCC,HOWEVER,MEDLINE,MSH6,OVERALL
EXAMINING,OVERALL,WHILE
947,DLK1,EGF,GSI,HES1,MMP9,NICD,NOTCH,WESTERN
945,BMP,CAKUT,ECM,GBM,INSTEAD,ITGA3,NEP,NEPHROTIC,OCT4,PAX8,PULMONARY,TGF,THUS,WNT
02X,169,177,2014,4DCT,COMPARISON,COPYRIGHT,INC,LABEL,MATERIALS,MAX,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,R4DCT,RADIATION,RESULTS,RMV,SBRT,SOCIETY,THESE
1390,169,2014,250,751,COPYRIGHT,FONAR,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS,SOCIETY
0006,019,039,169,2014,470,CBCT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PRIOR,PUBLISHED,PURPOSE,RADIATION,RESULTS,SBRT,SIXTY,SOCIETY
109,169,2014,8805,ALTO,AUTOMATIC,BOARD,CBCT,COPYRIGHT,DAILY,INC,ITV,LABEL,MATCHES,MATERIALS,METHODS,OBJECTIVE,PALO,PTV,PUBLISHED,PURPOSE,RADIATION,RESULTS,ROI,SOCIETY,USERS,VOI
028,470,8805,BACKGROUND,BASED,C3B,C4B,CHINESE,CIS,COMPLEMENT,CONCLUSION,CR1,HAPLOVIEW,HOWEVER,LABEL,METHODS,NSCLC,ODDS,ORS,RESULTS,SIMILARLY,SNP,SNPS
169,2014,5A4,AIM,ALK,BECAUSE,BENCHMARK,D5F3,DAKO,DATA,EGFR,FISH,HEAD,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PRE,RESULTS,SONS,TESTING,VENTANA,WILEY
2012,2014,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SABR
2008,2011,CONCLUSION,CONVERT,FEW,GTV,III,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PATIENT,PHASE,RESULTS,SEPTEMBER,THERE
AREAS,BACKGROUND,COVERED,FINALLY,FIRST,LABEL,LATER,METHODS,OPINION
2011,243,AFRICAN,BIOST,COLLEGE,EASTERN,FP7,FRAMEWORK,HUSSEIN,IRELAND,ISO,KHCC,KHCCBIO,KING,MANAGEMENT,NORTH,PROGRAMME,QMS,QUALITY,SEVENTH,SOPS,TRINITY,UNION,VALIDATION
AFTER
169,2014,COLLEGE,EGFR,INC,LUNG,MOLECULAR,PATHOLOGY,THEN,THEREFORE,UNTIL,WILEY
0001,003,081,107,122,169,179,193,1993,2011,2014,384,8201,825,957,BACKGROUND,CONCLUSION,INC,LABEL,LNI,METHODS,PULMONARY,RCC,RESULTS,SYSTEMATIC,WILEY
NANOSIZED
LUNG,MICRORNAS,PCR,REAL,TIME
CLEARLY,EGFR,ERBB2,INITIAL,NSCLC,THUS
181,18F,200,A549,ADP,ANNEXIN,AVERAGE,EGFR,ERCC1,HOWEVER,ICMT,NSCLC,PC9,PET,THERE
956,A549,BAX,BCL2,C47S,H460,HIGH,HOWEVER,NCI,PRDX6,SEVERAL,THESE,THUS
8314,8315,ATM,CUT,CUX1,G12V,KRAS,LOH,MEFS,OGG1,RAS,RNAI,ROS
001,006,194,211,946,A549,BACKGROUND,CELL,CONCLUSION,GSK3,H1299,H292,LABEL,LENTIVIRAL,MES,METHODS,NSCLC,RESULTS,THESE
ADT,EGFR,HER2,HER3,HRPCA,NOS,PCA,SEQUENCING,SGCS,TP53
231,500,945,954,AKT,FURTHER,LFG,MAPK,MDA,MEANWHILE,MMP,PI3K,STAT3,TAKEN,TNF
A549,AKT,DATA,ERK,H441,HEAT,HSP,HSP27,HSPS,JNK,MAPK,MEIER,NSCLC,PCR,PI3K
169,2014,843,946,AACR,BCL,BIM,EGFR,ERK,ERK1,LABEL,MOL,NON,NSCLC,RAS,RES,THESE,UNLABELLED
169,2014,ARF,ATLAS,CDKN2AB,HOWEVER,INK4A,KRAS,LABEL,LUNG,PRIMARY,TCGA,THESE,THUS,UNLABELLED
MOST,TRUE,WDPM,WDPMS
183,189,18F,190,2014,254,357,375,378,ABSTRACTS,ASCO,CANCERS,EVALUATION,FDG,HOWEVER,PET,SOLID,SYMPOSIUM
169,2014,AACR,NOTABLY,SCC
169,2014,AKT,COPYRIGHT,LTD,POLD4,PREVIOUSLY,SKP2,THESE
CEACAM5,LUNG,MYC,PTBP3,SCC
169,2014,COPYRIGHT,CPSF4,FEDERATION,HIGH,HOWEVER,MEIER,PUBLISHED,SOCIETIES
169,174,2014,CARE,CONCLUSION,CONSORTIUM,COPYRIGHT,INITIATIVE,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,QUALITY,RESULTS,SOCIETY,SYMPTOM,USING,WHERE
001,006,153,169,174,2014,AFTER,CELLSEARCH,CTC,CTCS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
215,AMONGST,GCT
169,2014,BESIDES,DIGITAL,DTS,HOWEVER,RSNA
169,2014,7TH,AJCC,COMMITTEE,III,JOINT,RADIOLOGIC,RSNA,TNM
160,169,2014,945,ESOT

008,120,FIVE,LUNG,NON,PRIMARY
002,107,115,160,169,172,177,2004,2014,237,AGE,GROUP,III,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,UNIVERSITY
0001,001,005,006,169,1986,2012,2014,8804,CHEST,FEW,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCWC,PRESS,PUBLISHED,RESECTIONS,RESULTS,SURGERY,UNIVERSITY,WIDE
114,183,4TH,CD59,CDC,HOWEVER,MOST,THERE
169,2014,AFT,INC,SIMULATION,WILEY
169,183,CTLA,GEORG,MALIGNANT,STUTTGART,YORK
169,183,ACCEPTANCE,AGNOR,DEFINITIVE,EMPLOYERS,GEORG,HODGKIN,INSURANCE,LIABILITY,NHL,NON,PLEURAL,STUTTGART,YORK
141,258,401,5P15,AFTER,CHINA,CIS,CNKI,DATABASES,HOWEVER,ISI,KNOWLEDGE,MEDLINE,ODDS,ORS,OVERALL,SCIENCE,SEVERAL,WEB
2007,2008,277,COX,HOWEVER,NSCLC,PFS,SIMILARLY,SNPS,XPG
CD98,ELISA,FCM,LEWIS,LLC,MDSCS
169,177,2005,2012,2014,8201,ACTA,BACKGROUND,BETWEEN,CONCLUSION,FOUNDATION,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SSNS,THEIR,TRANSIENT
ARP2,CALR,GRIA1,GRP78,NPM1,P4HB,RCN,SAOS,SRC,THESE
169,176,184,2014,276,504,AMONG,CONSORTIUM,ILCCO,LUNG,UICC,WHILE
178,1999,2013,206,8805,APRIL,BEIJING,CHINESE,CONCLUSION,COX,HOWEVER,JULY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,UNIVARIATE,VARIABLES,WESTERN
169,2014,954,DRUG,FDA,FOOD,HDAC,HOWEVER,SAHA,TAKEN,UICC
006,8201,BACKGROUND,CONCLUSION,FDG,FIVE,GTV,JOINT,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SFS
001,160,1992,2008,419,986,BACKGROUND,CONCLUSION,COX,HOWEVER,LABEL,LAC,MEIER,METHODS,RESULTS
101,108,109,129,132,138,163,169,183,200,2013,ALB,CA19,CARLO,CRP,CTRL,CTRLS,EARLY,MONTE,PDAC,SAMPLES,SERA,UICC
946,A549,CDH1,CELL,MTT,TGF,WESTERN
15TH,2013,2686,5918,771,ASIAN,CIS,FURTHER,IGF,IGF1,IGFBP,IGFR,MAY,ORS,STATA
0116,2004,2010,967,FIFTY,SCLC,SMALL,THESE
ESCC,GIVEN,SRS
215,OWING
10TH,161,241,4276,554,8201,BACKGROUND,DATE,EVENTUALLY,LABEL,MAIN,METHODS,OVERALL,PSA,RESULTS
001,006,026,1005,1008,1490,169,2006,2008,2011,2014,BACKGROUND,DATA,GREEK,LABEL,METHODS,PRESS,PREVALENCE,PUBLISHED,RESULTS,SAMPLES,SES,SMOKING,THESE,UNIVERSITY
160,BEAMNRC,DESPITE,DOSXYZNRC,IMRT,LINAC,PHASE
12469,169,2014,A549,COPYRIGHT,FE3O4,GPX,HEL,IRELAND,LTD,MNPS,PEG,PLGA,ROS,SOD,UNDER
169,2014,APOPTOTIC,COPYRIGHT,EGFR,EPIDERMAL,IRELAND,LTD,NSCLC,PI3K,THESE
ARD,ARDS,LABEL,NOA,OBJECTIVE,OPHIOLITES,PURPOSE,RESULTS,SUMMARY,THERE
185,8312,FDG,HIV,HOWEVER,LABEL,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,SUMMARY
100,188,ABI3130XL,APPLIED,BIOSYSTEMS,KRAS,MDX,PCR,PYRO,Q24,RGQ,ROTOR,SEVERAL
12Q13,ARMS,ARMSS,BCR,DDIT3,DICER,FOXO1,GAINS,GLI1,GPC5,IGF1R,LRP1B,MYCN,PAX3,PAX7,THERE,WNT6
DESPITE,HAART,HIV,HOWEVER,LYMPHOMAS,OTHER
169,2014,263,737,945,ABT,BAK,BAX,BCL,BH3,COMBINING,HIF,PDX,RAPAMYCIN,SCLC,THESE,WHILE
169,177,2014,411,434,514,597,6MWT,BACKGROUND,CONCLUSION,GMBH,HHD,LABEL,LUNG,METHODS,NSCLC,QOL,RESULTS,SCLC
001,012,029,169,2014,277,343,ACADEMY,BACKGROUND,BORG,CONCLUSION,CONTEXT,COPD,COPYRIGHT,DATA,HOSPICE,III,INC,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OUTCOME,PALLIATIVE,PUBLISHED,RESULTS,SCALE,STAGE
169,2014,CONCLUSION,COPYRIGHT,CYP,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,P450,RESULTS,SEVERAL
169,2014,COPYRIGHT,HOX,LTD,RNAS
169,2014,954,981,B16,BECAUSE,COPYRIGHT,F10,FINALLY,INC,MACROPHAGE,MEL,NMRI,RAGE
160,169,2014,ACTIVATED,AKT,AUTHORS,C3AR,C5AR,COMPLEMENT,COPYRIGHT,INC,PI3K,PUBLISHED,THESE
160,169,2014,AUTHORS,COPYRIGHT,DRUG,FINALLY,INC,PUBLISHED,TREATMENTS
169,2014,COPYRIGHT,INC,KLF9,KRUPPEL,NRF2,ROS
000,148,169,1975,1980,2005,2009,2010,2012,2014,233,355,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,INCIDENCE,LABEL,METHODS,MORTALITY,RESULTS,SAS
169,2014,231,ANTAGONISM,COPYRIGHT,DRUG,ECTOPIC,FDA,FOOD,IIA,IIIB,INC,MCF,MDA,THESE
169,2014,CASE,COPYRIGHT,HNSCC,LTD,ORAL,PLC,PUBLISHED,PULMONARY,T2N2BMX
160,169,177,193,1986,2013,2014,221,APRIL,COPYRIGHT,HAND,INC,LABEL,LEVEL,LUNG,METASTASES,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCIENCE,SOCIETY,SURGERY,THERE,TYPE
002,007,179,341,8805,BACKGROUND,CCRCC,CRP,HOWEVER,LABEL,LUNG,METHODS,ORGAN,RCC,RESULTS,TKIS
001,009,150,160,177,8201,BACKGROUND,COX,DKK,ELISA,LABEL,MEAN,MEIER,METHODS,NSCLC,NUMERICAL,RESULTS,SERUM,TNM,UNASSIGNED,VIRTUAL
150,AFTER,EGFR,ERLOTINIB,PHYSICIANS,SKIN
1000,1200,1500,400,600,800,8201,8734,8805,AST1306,AUC,BACKGROUND,BASED,BID,DLT,EGFR,FIBONACCI,FURTHER,HER2,HER4,LABEL,METHODS,MTD,RESULTS,RP2D,SEVENTY,TID,UNDER
106,956,BACKGROUND,CONCLUSION,EWING,HOWEVER,LABEL,LUNG,METHODS,MMP,RESULTS,THEREFORE,THESE,ZOLEDRONIC
169,2014,AIM,BACKGROUND,IMS,JOHN,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,RESULTS,SONS,THESE,VOCS,WILEY
169,2014,303,5A4,AIMS,ALK,ALK01,ALK1,D5F3,FISH,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,SP8,THESE,THREE,WILEY
169,2014,ASIDE,ESRD,GIVEN,INC,WHILE,WILEY
ABCG2,MRP1
A549,DOX,DSPE,EGFR,GE11,MAL,NON,NSCLC,PEG,PEG2000
169,2014,AEROSOL,BACKGROUND,BRDU,CONCLUSION,INC,LABEL,MATERIALS,METHODS,NUDE,PBS,RESULTS,TREATMENT,WILEY
169,2013,ADDISON,INC,WILEY
169,2005,2014,CAROTID,FNA,HEPATIC,INC,MOST,MRI,PRIMARY,WILEY
169,2014,A549,ATPASES,CARDIAC,CGS,ERK1,H460,HOWEVER,INC,KNOCKDOWN,MEK1,NKA,NSCLC,PP2,ROS,SRC,THESE,WILEY
18F,CILIARY,FDG,MRI
1986,1997,2003,8805,AIDS,HAART,HIV,HODGKIN,JANUARY,LABEL,LUNG,METHODS,NON,OBJECTIVE,PRE,PURPOSE,RESULTS
169,2014,CHILDHOOD,DISEASE,EARLY,FIRS,FIVE,FORUM,GREATER,INC,PEDIATRIC,PNEUMONIA,REALITIES,SOCIETIES,TODAY,WILEY,WORLD
ALZHEIMER,CHASE,CHEVY,INCIDENCE,LUNG,SMALL,WAR,WASHINGTON,WORLD
000,146,172,2010,ACCORDING,CIA,JAPAN,SEPTEMBER,THERE,THEREFORE,WELFARE
0274,0785,ACCORDING,BACKGROUND,GRADE,ILD,LABEL,METHODS,REGARDING,RESULTS,SIXTY
2000,2013,BRITISH,MEETING,SOCIETY
005,160,200,248,478,967,ADS,CAV,CHINA,KNOWLEDGE,NSCLC,SCC,SCIENCE
ADP,BYK,CDK4,H417,NCI,PARP1,POLY,POLYMERASE,ROS,SCLC
A549,C3H10T1,HEK293A,HHAT,MBOAT,PANC,PDAC,SHH,SONIC
125,A549,CHO,EDTA,EGF,EGFR,H441,III,MASS,SURFACTANT,THESE
00128,945,946,CHINA,HONG,KONG,NPC,SAA1,THESE
9373,H1299,HOWEVER,MRC,NCI,PDSS2,PEARSON,TAKEN,THERE
000,169,1992,200,2005,2014,AACR,AMONG,BACKGROUND,BOTH,CANCERS,CONCLUSION,END,FEW,HODGKIN,LABEL,METHODS,ORS,RESULTS,SEER,SHORT,STRONGEST,USING,VTE,VTES,WHILE
169,2014,946,CONVERSELY,CRC,EXPRESSION,EZH2,PRESS,PUBLISHED,STAT5,UNIVERSITY
169,2014,2444,AACR,ALDH,CSC,CSCS,DEPLETION,EPHA2,HOWEVER,JNK,JUN,KNOCKDOWN,NH2,NSCLC,RES,TREATMENT
169,1990,2014,AIMS,LABEL,LACK,METHODS,OBJECTIVE,PLACE,REDUCED,RESULTS,ROYAL,SINCE,SMOKING,SOCIETY,TOTAL
000,169,1996,2010,2014,BAYES,COPYRIGHT,LTD,SVM
169,2014,254,ADR,ADRB2,ADRS,AIMS,BACKGROUND,COPYRIGHT,EGFR,HCC,HOWEVER,HPLC,LABEL,LIVER,MAOA,METHODS,MONOAMINE,NOTABLY,OBJECTIVE,PCR,PUBLISHED,RESULTS,TAKEN
120,169,177,2014,674,800,947,956,A549,COPYRIGHT,HELA,IC50,MPPA,NIH,OVCAR,PDT,THESE
120,169,170,2014,209,215,362,8805,AMONG,COPYRIGHT,HCT,IDIOPATHIC,INC,IPS,PUBLISHED,TEN,THERAPY
169,2014,954,COPYRIGHT,FEDERATION,PUBLISHED,RAS,RASSF,SOCIETIES
000,001,031,141,169,2014,653,75ML,7TH,963,BACKGROUND,CA125,CD45,CEP8,CONCLUSION,COPYRIGHT,CTCS,EPCAM,FISH,FOUR,ICC,LABEL,METHODS,RESULTS,ROC
169,2013,2014,ASSESSMENT,AUC,BACKGROUND,COPYRIGHT,DIAGNOSTIC,ENGLISH,HOWEVER,LABEL,MARCH,METHODS,MPM,QUALITY,RESULTS,SIX,STUDIES,USING
13R,169,2014,945,COPYRIGHT,GOLGI,ILNP,THUS,TUNEL,U87
1998,2010,BACKGROUND,BETWEEN,LABEL,LOCAL,MEIER,METHODS,MSTS,PULMONARY,RESULTS,REVISIONS,SCORE,THERE,THESE,THOUGHT
123,169,2014,A549,COPYRIGHT,FLOW,FURTHER,HOWEVER,LTD,MRC,MTT,PCR,PLEUROTUS,PN50G,RDAMINE,SEM,THESE
169,2014,COPYRIGHT,LIU,LTD,STRUCTURE
172,2011,2013,237,264,8805,APRIL,BACKGROUND,CONVERSION,HOWEVER,LABEL,MAY,METHODS,PSP,REASONS,RESULTS,SITS,THEIR
001,002,100,169,2014,8805,947,A549,ADP,COPYRIGHT,EFFECTS,EGFR,GEFITINIB,H1975,H2AX,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PARP,PC9,POLY,PURPOSE,RADIATION,RESULTS,T790M,TKI,WESTERN
169,2014,8805,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
8776,A549,DOX,GLU,HELA,LYS,MAXIMUM,MTD,NPS,PHE
ALONGSIDE,HOWEVER,THC
000,100,111,137,145,170,2009,2011,765,ASRS,BACKGROUND,CHINA,DCO,DIAGNOSIS,ICD,INCIDENCE,JIANGXI,LABEL,MATERIALS,METHODS,RESULTS,SIMILARLY
130A,CURRENTLY,EXPRESSION,FINALLY,FURTHER,MET,NON,NSCLC,THESE,THUS,UTR
000,BACKGROUND,EGGER,LABEL,METHODS,NSCLC,PCI,RESULTS,SIX,THUS
2013,BACKGROUND,CIS,CONCLUSION,ENGLISH,LABEL,METHODS,ORS,REFERENCE,RESULTS,THERE,WHILE
008,012,021,100,ADC,ASIAN,BACKGROUND,CONCLUSION,COX,EXPRESSION,HOWEVER,LABEL,MEIER,METHODS,PCR,PEARSON,RESULTS,STUDENT,UNIVARIATE
001,008,020,037,043,098,1990,2000,2011,2055,362,5779,BACKGROUND,BMD,CAUSE,CONTEXT,COX,JANUARY,LABEL,LOW,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,ROTTERDAM,SETTING
HOWEVER,LUNG,MICRORNAS,RNAS,THERE
945,LUNGS
134,194,2009,226,246,284,311,357,362,AMONG,CONCLUSION,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SAKARYA,SPSS,THERE
ASBESTOSIS,DIFFUSE,HRCT,SUBPLEURAL
SURGERY
100,1000,181,220,8201,A549,CELL,HELA,HPLC,KDA,MALDI,MTT,PAGE,PEPTIDE,PYROCOCCUS,SDS,TOF
130,1996,2011,ALSO,ASPS,BACKGROUND,BECAUSE,EIGHT,LABEL,METHODS,RESULTS
244,8201,956,A549,COFILIN,HOECHST,RESULTS,RHOA,RHODAMINE,S240,SER3,THESE
017,CRT,DVHS,IMRT,PLANS,PTV,V10,V13,VOB
010,015,030,2009,2012,BACKGROUND,BOTH,CONCLUSION,FORTY,FURTHER,IMT,LABEL,LOS,MAXIMAL,METHODS,OTHER,PPCS,RESULTS
160,945,954,A549,AFTER,FURTHER,H1299,MMP,PCR,TNF
003,012,023,048,18F,8209,CDDP,FDG,MA44,NEXT,PET,SCID,SUV,VALIDATION
0006,0051,160,500,804,8201,CONCLUSION,HOWEVER,LABEL,LAD,LADSUPINE,METHODS,NONTARGET,OBJECTIVE,PRONE,PURPOSE,RCA,RESULTS,SPARING,TREATMENT,V20SUPINE,WBI
006,169,177,2014,8201,BACKGROUND,CONCLUSION,KINKING,LABEL,METHODS,RESULTS,THERE
AFTER,DUE,FOUR,GATA3,PAX8,PET,POST,S100P
ALONG,BEV,HOWEVER,NSCLC,SCM,SIX,TREATMENT
169,2014,500,750,ALT,CBR,CHINA,IIA,IIB,PFS,PHASE,UICC
A549,EFFICIENT,GPCR,INHIBITION,LUNG,PAR1,PARS,RNAI,RNAIMAX
945,947,A549,DTNB,DUE,GCS,GSH,GSS,HIF,HOWEVER,THEREFORE
8209,A549,FAS,LUNG,THESE
169,2014,215,8764,AIC,BACKGROUND,CURRENT,GIVEN,LABEL,METHODS,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
BMP,DMH1,HOWEVER,ID1,ID2,ID3,NSCLC,SMAD,SMALL
166,BACKGROUND,EACH,EBUS,EUS,LABEL,LNS,METHODS,NSCLC,RESULTS,SMS,TRIAL,URL
BAK,BCL,EPIGENETIC,IDIOPATHIC,IPF,SAHA,THESE
213,849,ASP353GLU,CBMDISC,CHINESE,CHONGQING,CIS,CNKI,EGGER,ENGLISH,GLU353ASP,HOWEVER,HWE,LABEL,LIBRARY,MEDLINE,METHODS,OBJECTIVE,ORS,RESULTS,SCIENCE,TP53BP1,VIP,WEB
CECAL,FURTHER,HDL,LABEL,OBJECTIVE,RESULTS,THERE,THYMOCYTE,USING
947,A549,EMSA,ICAM,MEANWHILE,MMP,MTT,PCR,PPAR,TAKEN
006,007,012,071,169,2014,307,656,COX,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,THESE,UNIVERSITY
ASC,ASCT2,BACKGROUND,CD34,CD98,IHC,LABEL,METHODS,NSCLC,RESULTS
001,002,004,005,021,127,1980,2009,BACKGROUND,BMJ,DISTANT,GROUP,LABEL,LIMITED,METHODS,NODAL,PROGNOSTIC,PUBLISHED,PUBLISHING,RESULTS,SEVERAL
096,097MM,169,177,2014,490,499,COPYRIGHT,PHANTOM
169,2014,A549,CARB,COPYRIGHT,DIVERSE,HELA,LOVO,LTD,MCF
169,2014,945,946,AACR,AKT,CONVERSELY,ECTOPIC,GASTRIC,HIF,HOWEVER,LABEL,METHODS,MMP2,MMP9,OBJECTIVE,PURPOSE,RESULTS,VEGF
169,2014,COPYRIGHT,PUBLISHED,SAS
100,120,160,169,2013,COPYRIGHT,HOWEVER,PUBLISHED,SAS,SPLF,THUS
1001,160,169,1996,2010,2013,AIDS,CHIVA,COPYRIGHT,HIV,IFCT,LUNG,MANAGEMENT,PUBLISHED,SAS
169,2013,8230,AFRICAN,AIDS,ART,COPD,COPYRIGHT,HIV,INITIALLY,PUBLISHED,SAS,SPLF
111,140,148,1996,2007,795,ADDITIONAL,FLORIDA,SERVICE
169,2014,COPYRIGHT,DESPITE,EPP,HOWEVER,IRELAND,LTD,MALIGNANT,PALLIATIVE,RADICAL,VARIOUS
169,2014,352,BACKGROUND,COPYRIGHT,FEW,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,SALVAGE,THERE,THREE
0001,0009,0033,0064,0076,169,2001,2010,2014,2351,8804,AFRICAN,AGE,AMERICANS,BACKGROUND,CONCLUSION,COPYRIGHT,COX,EAST,EASTERN,IRELAND,LABEL,LTD,METHODS,NORTH,OLDER,PATIENT,PRIVATELY,RACE,RESULTS,SAS,SCLC,UNIVERSITY
ACC,ACCORDING,AUTOPSY,CD56,LABEL,SLOOTEN,UNASSIGNED,UNLABELLED,VAN,VIRTUAL,WEISS
0001,001,038,090,168,169,1999,2008,2014,295,969,COPYRIGHT,F20,F21,F23,F25,ICD,INC,LABEL,METHODS,MORTALITY,OBJECTIVE,OVERALL,PHYSICIANS,PRESS,RESULTS,RISK,USING
100,181,239,468,EGFR,IC50,MDA,NCI,RESULTS,USA
APGAR,GRAVIDA,LAM,PARA,SPO2
1996,2011,GIVEN,JANUARY,JAPAN,METASTASIS
182,BACKGROUND,LABEL,LUNG,METHODS,MICROARRAY,PCR,RASA1,RESULTS
BACKGROUND,CEA,CYFRA21,FINDING,IRAN,LABEL,METHODS,NSE,RESULTS,SERUM
169,2014,AACR,FUNCTIONAL,INCREASED
169,2014,AKT,ID1,IGF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TARGETING
010,016,026,125,2011,8804,BACKGROUND,CONCLUSION,COX,LABEL,LUNG,MEIER,METHODS,PULMONARY,RESULTS,SOCIETY,VAGUE
169,2014,PRESS,PUBLISHED,SFTP,SFTPS,SURGERY,UNIVERSITY
060,180,2005,2007,2008,2009,405,450,605,709,741,956,ENROLLMENT,JANUARY,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,SMR,SMRS,THESE
001,002,016,2013,253,CIS,HOWEVER,HRS,MAT1,META,METASTASIS,MTA1,OCTOBER,ORS,OVERALL
103,129,154,169,2014,AGILENT,AUTHORS,EGFR,INC,KRAS,MICRORNAS,PUBLISHED,STILL,UICC,WILEY
003,8201,8217,CTCS
300,AFTER,CHEST,III,SEVEN,TYPE
11Q,169,17P,2014,AACR,AURANOFIN,CHRONIC,CLL,DRUG,FOOD,RIDAURA,TCL
002,005,ALLOCATION,BACKGROUND,CENTRAL,CONCLUSION,CONTROLLED,FAES,HOWEVER,INCREASED,LABEL,MEDLINE,METHODS,RESULTS
ADS,ARG,ASP,GLY,HOWEVER,ONCOLYTIC,PEG,RGD
945,946,954,ABIN1,APOPTOSIS,BOTH,CARP,CFM,CFMS,INHIBITORY,JNK,MALIGNANT,MPM,PARP1,SAPKS,TREATMENTS
013,113,183,215,441,6P21,BACKGROUND,BIOVU,CLL,CONCLUSION,DLBCL,GWAS,HODGKIN,INITIATIVE,LABEL,LSP1,METHODS,MSH5,MSMB,NHL,OBJECTIVE,PAGE,POPULATION,RESULTS,RISK,SLL,SNPS,TERT,TET2,WOMEN
197,8197,945,946,AFTER,AKR1B10,AKRS,ALDO,COMPARISON,IC50,K125R,NADP,TYR48,V301L
100,100SN,10TH,120,150SN,192,20TH,215,DIAGNOSTIC,FORCE,HIGHEST,IMAGE,LABEL,METHODS,OBJECTIVE,PROTOCOLS,PURPOSE,RESULTS,SOMATOM
169,2011,2014,ALK,AP26113,CNS,COPYRIGHT,EML4,III,IRELAND,LTD
001,008,089,155,169,2014,217,AUTOMATED,CONCLUSION,COPD,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,THERE
169,2014,445,8805,APC,CONCLUSION,COPYRIGHT,CYGB,HOWEVER,IRELAND,LABEL,LTD,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RASSF1A,RESULTS,RISK,SET
131I,CAREFUL,FALSE,WHOLE
116,160,200,211,211H,2452,8482,ACTIVATION,AKT,AMONG,BACKGROUND,BCL,CELL,H1650,H1975,HCT,HFF,INCREASED,IST,LABEL,M14,MES1,MES2,MET5A,METHODS,MPP89,MSTO,NCI,PARP,PI3K,RESULTS,SKRB3,THESE
169,2014,BALF,CD163,COPYRIGHT,SCC,SCLC,VEGF
2000,4MM,BOTH,SEVERAL
APE1,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
1120,2013,AREAS,ASCO,BACKGROUND,BIBF,COVERED,FGFR,III,LABEL,MEDLINE,METHODS,NINTEDANIB,NSCLC,OPINION,PDGFR,PHASE,VEGF,VEGFR
HOWEVER,JAPAN,NCD
EVALUATION
0037,035,231,947,BRMS,BRMS1,CONCLUSION,FINALLY,KEY,KNOCKDOWN,LABEL,MATERIALS,MCF,MDA,METHODS,PLC,RESULTS,UNLABELLED,USING
12A,946,AKT,BAX,BCL,H1299,MCF,MDM2,NITROSO,PREVIOUSLY
2012,CRT,OCTOBER,V20
8482,BACKGROUND,FIFTEEN,LABEL,MOST,PEMETREXED,PREVENTION
FORCE,PREVENTIVE,TASK
AKT1,AKT3,FGFR2,IWS1
AGGRESSIVE,DISCOVERY,LABEL,MECHANISMS,MURUGAESU,ST6GALNAC2,SUMMARY
DISCOVERY,LABEL,MAX,MYC,SUMMARY,TAKEN
APRIL
044,100,BEGG,CNKI,EGGER,ERCC5,META,SCIENCE,WEB
ALZHEIMER,CHRONIC,COPD,HIGH,RTI
160,169,183,8202,GEORG,HOWEVER,LUNG,NON,NSCLC,STAGE,STUTTGART,THERE,YORK
GBM,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,THREE
ACTIVATING,CHINESE,DELETIONS,EGFR,GLEASON,IHC,KRAS,L858R,MUTATIONS,PCA,THERE,TKIS
11Q13,29A,CBP2,FINALLY,HEAT,HOWEVER,HSP47,NEXT,PCR,RNAS,TAKEN,THEREFORE
2005,HEAD,LARGELY,NECK,TUMOURS,WORLD
AMNLM,ANATOMICAL,HOWEVER,MNLM,NLM,PET,SNR,THUS
293,945,BEAS,HEK,HIF,HPRT,NEIL2,PCR,POLB,QPCR,ROS,SECONDHAND,SHS,SSS,TAKEN,THESE
34A,A549,CD44,CSCS,H1299,H460,LUNG,MICRORNAS,NSCLC
185,276,BACKGROUND,CHROMOSOME,CRM1,EGFR,FURTHER,H1650GR,H1975,KPT,LABEL,METHODS,NOD,NSCLC,RESULTS,SCID,TKI
23S,A549,CL1,FTSJ1,FTSJ2,FTSJ3,HOWEVER,NSCLC,RIBOSOMAL,RRMJ,TE671
001,135,231,352,BACKGROUND,CD74,HIGH,LABEL,MARKERS,METHODS,MIF,MIGRATION,MPM,PROTEIN,PTEN,RESULTS
120,200,BACKGROUND,CD31,CD8,CONCLUSION,FOXP3,HOWEVER,LABEL,METHODS,NOVEL,RESULTS,WHOLE
NSE,THEREFORE,TURP
EVEROLIMUS,HALF,ILD,RCC
141,169,1945,1965,2004,2011,2014,330,773,877,APRIL,ASIAN,BIRTH,CONCLUSION,COPYRIGHT,HCV,HIV,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
177,227,5146,705,946,BMJ,BRITISH,GROUP,HOWEVER,IFN,LABEL,LIMITED,METHODS,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,STATISTICS,THERE,USING,VITAL
0001,169,2014,372,475,602,639,719,AUR,COPYRIGHT,EXP,FOM,FOUR,INC,KINGDOM,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SPECT
0001,0004,0006,003,005,007,038,169,2014,ALSO,AUR,CONFIDENCE,COPYRIGHT,EACH,EYE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
100,136,169,2009,2012,2014,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,FORTY,INC,INCIDENTAL,LABEL,LOW,MARCH,METHODS,MLNSS,NSCLC,PET,RESULTS,SBRT,SEPTEMBER
102,117,2003,2012,BACKGROUND,BETWEEN,CONCLUSION,FFDM,INC,LABEL,MARCH,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SABR,TEN,UNIVERSITY
169,2014,COPYRIGHT,HPLC,LAN,PDA,PUBLISHED,SCID,THESE
183,750,ACTIVATING,AKT,BRAF,BRAZILIAN,EGFR,INTER,KRAS,LUNG,NONE,NSCLC,PI3K,PTEN,SCC,SOMATIC,TTF
169,192,2014,BONE,CHANGES,CONSISTENT,COPYRIGHT,CXCL1,ELV,FEDERATION,ICAM,ISOLATION,PUBLISHED,SOCIETIES,WESTERN,YET
1068,1173,166,992,AKT,BACKGROUND,EGFR,LABEL,MAP,METHODS,NSCLC,PI3K,RESULTS,SCC,SCLC,THERE,THESE,TSC,TSC1,TSC2,TYR,UNASSIGNED,VIRTUAL
10R1,169,183,2014,233,8201,947,ANTI,BCG,BRITISH,EFFECTIVE,IFN,IMMUNOLOGY,INDUCTION,LUC,MB49,MICE,PBS,REMARKABLY,S12,SOCIETY,TH1,THESE,TREATMENT
APPEARANCE,AUC,AUCS,GGO,IDM,LABEL,METHODS,OBJECTIVE,PREDICTION,PURPOSE,RESULTS,RILI,SABR,TEXTURE,THREE
001,177,BASED,BOTH,CBCT,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,WHILE
ALTO,CARLO,CTV,ECLIPSE,FINALLY,FURTHER,LABEL,MEDICAL,MERT,METHODS,MONTE,OAR,OARS,OBJECTIVE,PALO,PLAN,PTV,PURPOSE,REGARDING,RESULTS,SWISS,SYSTEMS,V107,V95
001,002,039,0915,111,128,1368,150,1555,177,264,269,2SD,600,CI100,CI50,CI60,CI80,COMPARISON,DELTA,DOSIMETRIC,DUE,FFF,LABEL,MEAN,METHODS,OBJECTIVE,PARAMETERS,PTV,PURPOSE,RESULTS,RTOG,SCANDIDOS,THESE,UTILIZING,V12,V20,WHILE,X6FF,X6FFF,YET
136,161,947,9654,9981,9999,EIGHT,HOUNSFIELD,IMRT,LABEL,METHODS,OARS,OBJECTIVE,OVERALL,PTV,PURPOSE,REGARDING,RESULTS,UNIT,USING
177,8764,BOTH,EPID,FIRST,LABEL,LAST,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,RGRT
0618,063,069,092,107,BASED,BIMODAL,CTS,GEOMETRIC,LABEL,LEIBLER,METHODS,NOVEL,OBJECTIVE,PURPOSE,RESULTS,RTOG,SBRT
169,2014,JOHN,LTD,PUBLISHED,SONS,WILEY
BACKGROUND,BALF,BCG,CASE,CONCLUSION,HOWEVER,LABEL,METHODS
001,CCR6,CD3,CD4,CXCR3,CXCR5,DATA,FURTHER,III,NSCLC,RESULTS,TFH,TH1,TH17,TH2
138,167,169,2014,687,962,AIMS,AMONG,JOHN,LABEL,LTD,METHODS,MONOCLONAL,OBJECTIVE,PAX5,PAX6,PAX8,RESULTS,SONS,WILEY
169,2014,8201,AUSTRALIAN,BACKGROUND,CBCT,COLLEGE,CONCLUSION,DOSE,GTV,GTVS,INCREASES,INITIAL,LABEL,METHODS,RESULTS,ROYAL,SBRT,THERE,V95,ZEALAND
DOSE,LOW,LUNG,REFLECTING,SCREENING,TOMOGRAPHY,TRIAL
0001,001,007,945,BACKGROUND,CRP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OSI,RESULTS,SERUM,TAC,TOL
BACKGROUND,CASE,CONCLUSION,DETAILS,FNAC,LABEL,METHODS,PRIMARY,SECONDARY
001,007,021,045,046,048,967,980,AIM,BRCA1,CHINESE,CONCLUSION,ERCC1,ERCCL,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,REAL,RESULTS,RRM1
HOWEVER,IPF,LUNG
EGFR,ERBB,III,NSCLC,SEVERAL
FGF,FINALLY,HOWEVER,III,NSCLC,PDGF,THERE,VEGF
2013,BARCELONA,SOCIETY,SPAIN,VARIOUS,YEAR
LAM,PIVOTAL,THESE,TSC
949,FURTHER,G12D,KRAS,LSL,PLC,PLCE,RAM,RAS,TAKEN
BOTH,COA,FINALLY,K333Q,LARGE,LCAD,LUNG,SERUM,THESE
012,169,2014,ASTN1,AUTHORS,HOX,JOHN,LTD,NTM,PTK2B,SBC,SCLC,SMALL,SONS,WILEY
277,AIM,APPRAISAL,BACKGROUND,CASP,DUE,FINALLY,LABEL,LIBRARY,LUNG,MEDLINE,NSCLC,OBJECTIVE,PEMETREXED,PROGRAM,RESULTS,REVIEWS,SPAIN,THEN
001,002,152,1980,1990,2001,2010,203,245,413,CONCLUSION,DESPITE,III,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,PURPOSE,RESULTS
001,009,183,2002,2011,8201,BACKGROUND,CLOSE,CONCLUSION,DFS,DISTANT,GEORG,JUNE,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,STUTTGART,YORK
169,2014,BACKGROUND,DATA,LABEL,METHODS,NNAL,NNK,PRESS,PUBLISHED,RESULTS,SOCIETY,THREE,TOBACCO,UNIVERSITY
947,ABOUT,ADDITIONAL,CSF,CURRENT,DESPITE,GABAB,IMPORTANCE,LABEL,METHODS,MOST,OBJECTIVE,RELEVANCE
462,715,ASIAN,CAUCASIAN,CIS,META,ORS,SCIENCE,TERT,THEREFORE,THESE,WEB
2013,210,8201,876,ARG,ARG194TRP,HENCE,HOWEVER,META,ORS,SEPTEMBER,TRP,XRCC1
280,420,CURRENT,FLEISCHNER,LDCT,LUNG,NLST,RADIATION,SCREENING,THESE,TRIAL
169,2014,AACR,FGF19,HCC,HOWEVER,III,MEK,MET,MOLECULAR,MOST,NOVEL,RAS,REASONS,SORAFENIB,THESE
114,2009,4950,FIVE,MORTALITY,THERE,UTERINE
1780,1978,2008,6976,8764,BMI,CIS,COX,FOLLOWING,HOWEVER,HRS,LITHUANIAN,SMOKING,UADT
292,300,786,794,A172,CTL,EF292,EF786,HLA,HNSCC,HODGKIN,IGG,KNOCKDOWN,MCF7,NHL,PBMCS,PC14,PCI6,TAAS,THESE
ASM,ATLAS,DMR,FURTHER,USING
CHINESE
004,008,016,018,023,024,028,038,048,324,CONCLUSION,CXCR4,LABEL,METHODS,NRF2,NSCLC,OBJECTIVE,PCR,RESULTS,TNM
125,2008,2011,CTS,FOUR,MAY,MRIS,THEIR,THREE
125,169,177,2007,2010,2014,8805,AIM,AMONG,COLLEGE,CONCLUSION,COPYRIGHT,HCC,LABEL,LTD,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS,ROYAL,SIDE,UNDER
001,169,2014,4355,AIM,CHI,CONCLUSION,COPYRIGHT,CTC,DIAGNOSTIC,LABEL,LTD,METHODS,NPV,OBJECTIVE,OVERALL,PPV,PUBLISHED,RESULTS
025,032,048,049,169,2014,ALK,ANAPLASTIC,COPYRIGHT,LTD,SEVENTEEN,THYROID
169,2014,300,BENZENE,CHRONIC,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SCHOLAR
COLLISION,FIVE,GROSS,HISTOLOGIC
156,169,2014,BRONCHIAL,CONCLUSION,COPYRIGHT,EVEN,IRELAND,LABEL,LTD,LUNG,MAXIMUM,METHODS,OBJECTIVES,RESULTS,UNLABELLED
2009H,2011,ANTITUMOR,AREAS,BACKGROUND,BPI,CHINA,CHINESE,CONMANA,COVERED,DRUG,EGFR,FOOD,III,JUNE,LABEL,METHODS,OPINION,PHASE,STATE
BACKGROUND,CARE,COMPETENCE,EARLY,EASE,FOCUS,HOWEVER,LABEL,LUNG,METHODS,RESULTS
2010,2012,2013,8805,ADVERSE,APRIL,CONCLUSION,GRADE,IMRT,JANUARY,JULY,KNOWLEDGE,LABEL,LANSCLC,LRFS,MEIER,METHODS,OBJECTIVE,PFS,RESULTS,SIB,TREATMENT
956,A549,ADP,BCL,CDK,COSMOSPORA,IC50,LC3,MMP,TAKEN,VAD
174,99MTC,BACKGROUND,CEACAM5,CK7,DETECTION,LABEL,METASTATIC,METHODS,NANOCOL,NAVIGATOR,PLUNC,RESULTS
169,2013,8211,ABL1,BCR,BRITAIN,COPYRIGHT,DRUG,FGFR,FGFR1,FGFR2,FGFR3,GREAT,IRELAND,JOHN,LTD,PUBLISHED,SOCIETY,SONS,WILEY
CRC,HIGH,HOWEVER,RECURRENCE,SBRT
016,036,798,ANG,ATTENDING,LOG,NON,NSCLC,PCR,RANK,TEST,THESE
ARMS,BACKGROUND,EGFR,GENERALLY,LABEL,METHODS,MPE,MPES,MPTTS,RESULTS
CELL,CL1,TIME,WHILE,YOUNG
231,ASC,ASCS,BACKGROUND,BOTH,EMT,FAT,GFP,HOWEVER,LABEL,MDA,MMP,PRINCIPAL,RESULTS,RFP,VEGF
A549,DDP,UPON
500,CELL,CL1,HS68,MRC,SPR
1044,487,ASIAN,BASED,CAUCASIAN,EGFR,LDT,LDTS,NSCLC,PCR,SAMPLES,TKI,TKIS
1991,2006,203,206,505,658,832,BACKGROUND,DIFFERENT,LABEL,LUNG,METHODS,POISSON,REGARDLESS,RENTING,RESULTS,UADT
001,055,2004,2011,513,AGE,AUDIT,BACKGROUND,CONCLUSION,ENGLAND,LABEL,LUNG,METHODS,NLCA,RESULTS,SCLC,SINCE,THERE
177,ACTB,BACKGROUND,E2F1,FFPE,FITNESS,HOWEVER,LABEL,LCDT,METHODS,MYC,PCR,POISSON,RESULTS,REVERSE
001,040,041,BACKGROUND,CONCLUSION,FURTHER,HODGKIN,HOWEVER,LABEL,MALT,METHODS,NOD2,ORS,RESULTS,SCIENCE,WEB
184,214,215,308,328,349,829,ASIAN,BACKGROUND,CHINA,CHINESE,DECREASING,EGFR,LABEL,LOG,METHODS,NSCLC,PFS,QALY,RESULTS,WEIBULL,WTP
8202,BACKGROUND,CCRT,EGFR,INTENSITY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TKI,USING
181,DEPENDING,NEURITE,RGD,SCLC,SCLCS,SMALL
231,CELL,DECREASED,ECM,EMT,EPITHELIAL,HOWEVER,KNOCKDOWN,LTVC,MDA,MET,MYOF,THESE,THUS
ALZHEIMER,CANCERS,CENTRAL,CNS,COLORECTAL,LUNG,NERVOUS,P53,PARKINSON,PIN1,THERE,THESE,WNT
100,117,FORTY,OVERALL,THEREFORE
EXPRESSION,NRAS,RAS,STRIKINGLY,THESE
183,2DS4,946,DAP12,DNAX,INSTEAD,NKP44,TGF

HODGKIN,PULMONARY
BARR,EBSTEIN,PULMONARY
003,017,177,206,258,8201,BACKGROUND,LABEL,METHODS,RESULTS,THERE
1A1,BACKGROUND,CONCLUSION,CYTOCHROME,FINDING,LABEL,METHODS,P450,RESULTS,SPECIMENS,THERE,THESE,TOBACCO
032,044,144,2011,2012,4454,8201,BACKGROUND,CONCLUSION,FIFTY,LABEL,MAI,METHODS,NON,OBJECTIVE,RESULTS,SEPTEMBER,THAI,THEREFORE,UNIVERSITY
177,CONCLUSION,HODGKIN,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,TIME,TOTAL
2001,2011,215,CONCLUSION,KING,LABEL,METHODS,OBJECTIVE,RESULTS,SECONDARY,SPECIALIST
0001,125,128,253,376,500,AVAPERL,BACKGROUND,CONCLUSION,DISEASE,III,LABEL,METHODS,PFS,RESULTS
3RDS,BECAUSE,PATHOLOGY
1998,2008,457,BACKGROUND,COX,FURTHER,LABEL,MEIER,METHODS,OVERALL,RESULTS,SPECIMENS
001,1484,266,8201,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,PROPENSITY,RESULTS,UNIVARIATE
105,109,127,169,2014,LABEL,METHODS,NON,OBJECTIVE,OBJECTIVES,OPERATIVE,PRESS,PUBLISHED,RESULTS,SURGERY,THREE,UNIVERSITY
169,2014,600,CADM1,CCL3,CDH13,DESPITE,EPIGENETIC,FURTHER,HOWEVER,HZES,IL4,JAPAN,MEV,MOUSE,MTHFR,PRESS,PUBLISHED,RADIATION,SFRP1,SOCIETY,UNIVERSITY
0001,0002,169,2014,8201,BACKGROUND,GROUP,INC,LABEL,METHODS,MOST,PROCEDURE,RESULTS,TREATMENT,WHILE,WILEY,WILMS,WLI
169,2014,GDP,HOWEVER,INHIBITION,RAC1,RHO,RHOGDI2,UICC,VEGF
014,076,160,2008,2011,250,500,AUC,BACKGROUND,DFS,EGFR,EPIDERMAL,IIIA,L858R,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,TKIS
001,CONCLUSION,LABEL,METHODS,NONE,OBJECTIVE,RESULTS
125,169,183,2010,2011,2014,300,327,8201,ACUTE,BACKGROUND,CONCLUSION,FOUR,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,USUAL
946,A549,AIM,AIMS,AKT,EGF,EGFR,EMT,HOWEVER,PULLIAT,TGF,THEREFORE,VITIS
183,18F,CTS,FDG,GEORG,INTEGRATED,PET,SPNS,STUTTGART,THEREFORE,YORK
183,DATA,GEORG,NSCLC,PULMONARY,STUTTGART,T1A,VATS,YORK
000,239,315,8764,CHINA,CHRONIC,CIGARETTE,COPD,FEV1,FINALLY,GRAM,OTHER,ROS,YET
313,342,394,8201,971,FGFR,FGFR1,HLA,LLA,PEARSON
1AND,946,A549CELLS,ANIP973,ERK,ERK1,HDLEC,JAM,LMVD,LNM,NSCLC,OVERALL,VEGF
181,8209,946,954,A549,CELL,EP1,HOWEVER,NSCLC,PGE2,STATA,TARGETING,TREATMENT
BACKGROUND,CONCLUSION,ENHANCING,FIFTEEN,FIVE,KARNOFSKY,LABEL,LITT,METHODS,OBJECTIVE,PRIMARY,RESULTS,SIXTEEN
BECAUSE,ILD,SSC
125,A431,A549,CELL,E746_A750,EGFR,EPIDERMAL,H1650,H1975,H3255,IC50,L858R,NSCLC,PHY,SPECT,T790M,THEREFORE,WESTERN
169,2014,AACR,NSCLC,PROTEIN
HOWEVER,IMAGE,RFA
001,CD8,CONCLUSION,CRT,FOXP3,IIA,IIIB,LABEL,MEAN,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
HOWEVER,ROBOT,SINCE,VINCI
945,947,AEROBIC,LOSS,PGC,RIP1,THUS,WARBURG
130,226L,AMD3100,ANOIKIS,CD24,CD44,CXCR4,FACS,HOWEVER,MCF7,MFE,SDF,SKBR3,T47D
173,943,963,AFTER,AIM,AMONG,BACKGROUND,HUNGARY,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,THESE,VOLUNTEERS
ADENOVIRUS,AUTOPSIES,BOTH
EBUS,MPM,TBNA
169,2014,AFTER,CAT,CL1,COPYRIGHT,H2O2,HOWEVER,INC,ROS
116,169,18B,2014,969,COPYRIGHT,EARLY,H460,HCT,PC3,SAS,THESE
169,2014,956,A549,CELL,CHANGES,COPYRIGHT,HOWEVER,KOREA,LTD,PHMG,WESTERN
169,2014,BACKGROUND,BAX,BCL,CHINESE,CME,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MARSDENIA,MATERIALS,METHODS,MTT,MVD,PBMCS,RELEVANCE,RESULTS,THESE,TUNEL,WESTERN
169,2014,BECAUSE,COA,COPD,COPYRIGHT,FTASE,GIVEN,HMG,HMGCR,INC,INITIALLY,MVA,RHO,ROCK
160,169,2014,AUTHORS,COPYRIGHT,HOWEVER,INC,METASTASIS,MMTV,PUBLISHED,RBP2,THESE,TNC,USING
169,2014,946,COPYRIGHT,HBV,HBX,HCC,INC,LINE1,THUS,WNT
138,169,2014,COPYRIGHT,EGFR,EPIDERMAL,H1975,HOWEVER,INC,KNOCKDOWN,MICRORNAS,MIRNA,NSCLC,PC9,PC9GR,RNAS,TKI,TKIS
169,2014,AKT,BEAS,COPYRIGHT,EZH2,FIRST,H2O2,INC,JNK,NAC,ROS,SEVERAL,STAT3
160,169,2014,COPYRIGHT,DOX,LTD,MEANWHILE,MPEG,MSURVIVIN,PCL,PEI,T34A,THESE
169,2014,COPYRIGHT,HOWEVER,IRELAND,LTD,NON,NSCLC,SURGERY
001,169,177,1980,2009,2014,258,613,871,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,MEAN,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THESE
001,169,1999,2005,2014,217,425,642,BACKGROUND,BASE,COPYRIGHT,COX,DATA,FIVE,INC,LABEL,MEIER,METHODS,NSCLC,PRIMARY,PUBLISHED,RESULTS,SOCIETY,SURGERY
169,2014,COPYRIGHT,GERIATRIC,LUNG,SAS,THUS
169,2014,COPYRIGHT,INC
169,2014,BACKGROUND,CONCLUSION,CONCURRENT,COPYRIGHT,IRELAND,LABEL,LTD,LYMPH,METHODS,NSCLC,PET,RESULTS,SADN,SUV,SUVN,SUVP,SUVPT,USING
169,2014,BRAIN,COPYRIGHT,FASL,INC,L1CAM,PLASMIN
177,1997,2012,BACKGROUND,CIRT,CRC,GYE,LABEL,LCR,LCRS,MAY,METHODS,OCTOBER,OVERALL,PTV,RESULTS,TREATMENT,USING
025,100,169,2008,2010,2014,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SECONDARY,SIR
100,169,177,2002,2012,2014,AMONG,COPYRIGHT,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THERE,TNAB,TNABS
100,169,177,2004,2012,2014,8805,COPYRIGHT,FOUR,GGO,INC,LABEL,LOCAL,LUNG,MAJOR,MATERIALS,MAY,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SIR
00069,014,8805,BACKGROUND,CAG,DXS1047,LABEL,LOH,METHODS,RESULTS,SEVENTY,TAIWANESE,TSGS,XCI,XQ25
250,500,AFTER,BACKGROUND,EBB,EBNA,FOLLOWING,IIT,LABEL,METHODS,RESULTS,TEA,TRANEXAMIC,TRIAL,WANG
100,946,AKT,BACKGROUND,BASED,BUFALIN,CERTAIN,CONCLUSION,GSK3,HCC,IHC,INHIBITION,LABEL,METHODS,ORTHOTOPIC,RESULTS,SIMILAR,THESE,TUNEL
100,162,199,308,361,8805,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SCM,TOTAL
084,177,373,439,567,633,733,739,BACKGROUND,CHINA,EDUCATION,FIELD,LABEL,LDCT,METHODS,MOST,OBJECTIVE,OIL,ORS,RESULTS,TIANJIN
BACKGROUND,EGFR,EPIDERMAL,III,LABEL,METHODS,NRF2,OBJECTIVE,PFS,RESULTS,THEREFORE,TKI,TKIS
123,154,183,954,956,A549,AKT,BACKGROUND,BCL,CONCLUSION,DDP,DRUG,FINALLY,LABEL,MDR,MDR1,METHODS,MTS,OBJECTIVE,PCR,PTEN,REAL,RESULTS,SNAIL,TWIST,WESTERN
177,BACKGROUND,BASED,BOTH,CASPASE,CELL,CONCLUSION,COX,FAS,FASL,GFP,ING4,LABEL,METHODS,OBJECTIVE,PBS,RESULTS,SPC,THEIR,TUNEL
169,2013,BOTH,COPYRIGHT,ICD,INDIA,PUBLISHED,SOCIETY
169,2014,AUSTRALIAN,COLLEGE,ROYAL,ZEALAND
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
FIRST,FOLLOWING
BACKGROUND,BASED,BRIEFLY,FDR,GWAS,LABEL,RESULTS,SCAD,SNP,SSCAD,THESE
001,005,008,020,027,031,062,098,103,114,169,170,183,2014,252,405,618,709,726,8201,824,946,AMONG,BRITISH,CATS,CYTOKINES,FURTHER,IMMUNOLOGY,LUMINEX,SOCIETY,THROMBOSIS,VTE
CPG,EPIGENETIC,LUNG,THESE,WHILE
CONTROL,LUNG,SERA,SERUM,STAGE
1000,BXPC,DSPE,PEG,TPGS
AFTER,EPP
1BB,950,CAR,CD3,OFF,THESE,THUS
115,181,8201,BAK,BCL,BOERL,FTIC,MCL,MRC,PUMA,TRIHYDROXY,WESTERN,WRL
2007,2009,8804,BOTH,EBUS,ESTS,EUS,FNA,IASLC,LUNG,NSCLC,PET,SOCIETY,THEREFORE,VIDEO
100,169,2014,COPYRIGHT,FIVE,GATA,GATA3,INC,WILEY
160,HOWEVER,III,NON,NSCLC,VEGF,VEGFR
032,1994,2010,998,APRIL,FIFTEEN,FIVE,INDUCTION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEPTEMBER
101,FACTORS,IIIB,LABEL,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PURPOSE,QOL,RESULTS,SELF,SETTING,VARIABLES
174,BREATHING,BRIEF,CLASS,DATA,IIIA,INDEX,LABEL,MAIN,MEDICAL,METHODS,MOOD,NSCLC,NURSING,OBJECTIVE,OBJECTIVES,PITTSBURGH,POTENTIAL,PROFILE,PURPOSE,QOL,QUALITY,RESULTS,SETTING,SLEEP,VARIABLES,YOGA
CHALLENGES,DAILY,DATA,ENROLLMENT,FIVE,LABEL,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PATIENT,PURPOSE,RESULTS,SETTING,SYMPTOM,VARIABLES,WEST
169,2014,BACKGROUND,COLORECTAL,FINAL,FIVE,HOWEVER,IMPUTATION,INITIALLY,LABEL,LCS,LUNG,METHODS,NLST,OVARIAN,PLCO,RESULTS,SCREENING,SOCIETY,TRIAL
956,BESIDES,BLOOD,HOWEVER,STA,THESE,THUS,TTS
18F,BACKGROUND,FDG,LABEL,METHODS,NSCLC,PET,RESULTS,SBRT
002,008,401,AGE,BACKGROUND,BLOOM,CONCLUSION,ELDERLY,LABEL,METHODS,RESULTS,RICHARDSON,THESE
AFTER,EACH,ECMO,PRIOR
151,153,199,230,BACKGROUND,CONCLUSION,GPA,HIF,KI67,LABEL,LOW,METHODS,MVD,NSCLC,RESULTS,WBRT
002,021,047,063,298,384,464,944,967,COX,DCR,KDR,MAPK,MO19390,NSCLC,PCR,PFS,RAS,SAIL,THEREFORE,THUS,VEGF
136,BACKGROUND,COX,DFS,EGFR,IL8,KRAS,LABEL,LUNG,METHODS,PCR,RESULTS
4T1,DCMS,DISULFIRAM,DSF,HMEC,METASTASIS,THESE
0001,002,007,169,183,1965,2014,2385,BACKGROUND,COPYRIGHT,COUNCIL,FUNDING,GROUP,IIIA,INDIVIDUAL,JANUARY,LABEL,LTD,MEDICAL,META,METHODS,NSCLC,OPEN,PUBLISHED,RECURRENCE,RESULTS,SECONDARY,THERE,TOXIC,UPDATED
169,2013,233,COPYRIGHT,GMBH,PARTIAL
108,139,141,169,180,2014,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,USING
101,169,2004,2006,2014,682,959,BACKGROUND,BETWEEN,COLLEGE,COPYRIGHT,FALSE,FDG,FINAL,GROUP,INC,LABEL,LUNG,META,METHODS,NSCLC,PET,PUBLISHED,RESULTS,SOCIETY,Z4031
169,2014,239,376,ASSESSMENT,CHEMO,CHINA,CHINESE,CLOUD,CONCLUSION,COPYRIGHT,EGFR,FACT,FUNCTIONAL,III,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,QOL,REGRESSION,RELATIVELY,RESULTS,THERAPY
2143,945,947,956,AFTER,AKT,BACKGROUND,BRDU,CALCIUM,CASR,CELL,CELLS,EXPRESSION,JNK,LABEL,METHODS,NPS,PCR,PLC,PTEN,RCC,RESULTS,WESTERN
1000,169,2014,ACTIVATING,ADSQ,AIM,ASIA,CAUCASIAN,DELETIONS,EGFR,G719X,L861Q,LABEL,LTD,METHODS,MOST,NSCLC,OBJECTIVE,PCR,POLYMERASE,PTY,PUBLISHING,RESULTS,WILEY
003,020,042,048,182,335,945,ALSO,BACKGROUND,CONCLUSION,FGF2,HIF2,IHC,IIIA,ISH,LABEL,METHODS,MMP,NSCLC,RESULTS,SCC,TMAS
2001,2011,2030,511,570,COPD,EUROPEANS,FUND,HOUSING,MALIGNANT,MORTALITY,NUMBERS,POPULATION,WORLD
177,178,183,805,8764,ASSESSMENT,CHINA,FACT,FEMALES,FUNCTIONAL,INVENTORY,LABEL,LUNG,MDASI,METHODS,OBJECTIVE,QOL,RESULTS,SYMPTOM,THERAPY,THERE,THREE
123,A549,ACL,DOX,HEPG2,MCF,MDR,MULTIDRUG,R123,RHODAMINE,THESE,VERAPAMIL
VTE
2000,OTHER,RANDOMIZED,RFA,SHORT
100,DIPNECH
169,2014,239,AACR,ALSO,CD4,CD8,DEREG,FOXP3,HOWEVER,INHIBITION,REMOVAL,THESE,TREG,TREGS
732,938,COMBINING,COX,E3N,HRS
169,2014,CRP,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY,VATS
104,1200,169,2014,600,900,EFFECTIVE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SECONDARY,SURGERY,UNIVERSITY
BOTH,DDX58,EDM,EDMONSTON,IMPORTANCE,LABEL,MAVS,MEASLES,NSCLC,OBJECTIVE,RIG,RLRS,RNAI,THESE,UNLABELLED
169,2013,ADCC,ADENOID,HOWEVER,INC,THEREFORE,WILEY
001,008,150,169,174,2014,400,8805,AUTHORS,COX,DIFFERENCE,EIGHT,GRADE,JOHN,LTD,PFS,POOR,SONS,VERISTRAT,WILEY
169,2014,205,600,CMOS,FET,GMBH,HOWEVER,KGAA,LOD,MICRORNAS,SINW,VCH,WILEY
013,121,145,155,169,198,200C,2014,211,252,325,34A,362,430,502,583,610,678,801,8201,822,870,926,BACKGROUND,CLASSICAL,EBUS,INTEGRITY,LABEL,LUNG,METHODS,RESULTS,RIN,SOCIETY,TBNA,THEREFORE,UNDER
169,2014,HENCE,INC,PULMONARY,WILEY
155,181,200,300,8805,DATA,LABEL,METHODS,MORTALITY,NLR,OBJECTIVE,RDW,RESULTS
002,041,109,2008,2011,204,275,311,385,BONE,GROUP,NSCLC,SEVERAL,ZOLEDRONIC

2013,ALTG,AUSTRALIAN,CLINICIANS,CONCLUSION,CPG,FIFTY,GROUP,LABEL,LUNG,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER,SEVENTY
000,022,100,169,200,2014,215,AACR,BECAUSE,CD25,CD4,FOXP3,GVHD,HENCE,HSCT,LABEL,METHODS,MRD,OBJECTIVE,PURPOSE,RESULTS,SIXTEEN,TREG,TREGS,ULD
119,136,169,2011,2013,2014,250,8805,AACR,ALK,APART,BREAK,DRUG,FDA,FISH,FOOD,INC,KIT,MOLECULAR,NSCLC,ORR,ORRS,PROBE,VYSIS,XALKORI
33258,945,AGS,ANNEXIN,BAX,BID,CASPASE,FAS,FASL,FITC,FLOW,HOECHST,MMP,PFT,TANGERETIN,WESTERN
CDC20,CYTOSCAPE,DAVID,EXPRESSION,FINALLY,HRAS,KEGG,OMNIBUS,OVCAR,PCR,PPI,RAS,RASSF1A,SKOV,STK,STK4
A549,COX,EGFR,ERK,FLOW,H157,HOWEVER,MEIER,MIG,MITOGEN,NSCLC
178,8201,COX,GIVEN,IHC,III,MEIER,USING
ANCTS,CCK,ERK,FIRST,HOWEVER,IHC,LOX,LYSYL,MAPK,MMP,MMPS,NEXT,PI3K,SIMILARLY
946,A549,AG490,EMT,EPITHELIAL,H1650,HOWEVER,JAK,JAK2,MMP2,PAI,SIS3,SMAD,SMAD3,SNAIL,STAT3,TGF
135,A549,AKT,HOWEVER,IGF,IGFBP,PAPP,USING
169,2010,2012,2014,464,AMONG,BLC,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,UNIVERSITY
304,585,587,CGIS,CPG,CTCF,SNPS,THESE,THUS
1965,2013,ENGLISH,FURTHER,HOWEVER,MEDLINE,THERE
100,12MM,169,2014,630,800HU,CONCLUSION,COPYRIGHT,EACH,FBP,IMR,IRELAND,LABEL,LTD,MATERIALS,METHODS,NOISE,OBJECTIVE,PURPOSE,RESULTS,SEMI
FDG,LABEL,METHODS,MRI,OBJECTIVE,PET,POST,RESULTS
001,200,2008,2011,AMONG,ATS,BACKGROUND,BASED,CONTEXT,EGFR,EPIDERMAL,ERS,FIVE,HOWEVER,IASLC,L858R,LABEL,LUNG,METHODS,MOST,OBJECTIVE,RESULTS,SOCIETY
259,355,614,ATLAS,BACKGROUND,LABEL,LUAD,LUSC,METHODS,NOTABLY,NSCLC,PCR,RESULTS,TCGA
946,A549,AKT,BACKGROUND,COMPLEX,COMPONENTS,EMT,GSK,H2009,IGF,INCREASED,LABEL,LICL,METHODS,NSCLC,PCR,RESULTS,SER9,SNAIL,THESE,ZEB2
169,2014,293T,588,A549,BACKGROUND,BRITISH,CONCLUSION,K16,KEY,LABEL,LYS,METHODS,MOF,MOUSE,MYST,NRF2,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SAMPLES,SOCIETY
000,100,2005,ASR,BACKGROUND,CANCERS,CASABLANCA,CONCLUSION,FEW,HODGKIN,LABEL,METHODS,MOROCCO,RESULTS,STAGE,THESE,TUMOURS
056,100,1998,2009,8201,CONCLUSION,III,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,THESE,UNIVERSITY
1283,6TH,8201,BACKGROUND,COX,CRUDE,LABEL,LOBECTOMY,LUNG,METHODS,PROPENSITY,RESULTS,THREE,WEDGE
AFTER
1996,2007,APRIL,BACKGROUND,CONCLUSION,INCOMPLETE,LABEL,METHODS,RESULTS,SHORTER,THERE
2009,2010,BACKGROUND,CONCLUSION,IIB,IIIA,IIIB,JANUARY,LABEL,MAY,METHODS,NSCLC,RESULTS,SURGERY,THEIR
117,119,129,1998,2009,608,727,8201,AGE,BACKGROUND,ELDERLY,JANUARY,LABEL,METHODS,RESULTS,SEPTEMBER,THOSE,WHILE
100,177,8201,AIM,BOTH,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS
169,2014,LUNG,PHYSICIANS,PRESS,PUBLISHED,THROUGH,UNIVERSITY
ERS,HMB,LAM,OVERALL,PRS,SMA,SPECIMENS,THEREFORE,THESE,TSC,TSC1,TSC2
231,453,ARV,ARVS,ATT,CE3,CE9,EXPRESSION,FOUR,GTT,HEPG2,ILE,LNCAP,MCF,MDA,RNAS,SEQUENCING,T47D,VAL,VCAP,ZR75
739,CAUCASIAN,COMPARISON,HOWEVER,IIB,KRAS,L001,LUNG,SMC,TP53
916,B18R,BOTH,ONCOLYTIC,OVS,VSV
ATLAS,ATM,BRCA1,DATA,ERCC1,HRM,MGMT,MLH1,NEIL1,NSCLC,TCGA,XPC
BACKGROUND,FINALLY,HOWEVER,LABEL,METHODS,RESULTS
946,BACKGROUND,CONSISTENT,EMT,EXPRESSION,FINALLY,HER2,LABEL,MET,METHODS,PCR,RESULTS,SMAD,SMAD2,SMAD3,TGF,THESE,TNBC,TREATMENT
ADDITIONAL,ARAF,RAF1,S214C,THESE,WHOLE
001,007,013,019,021,026,169,1992,1997,2014,388,395,8805,AACR,AMONG,BACKGROUND,CONCLUSION,COX,LABEL,LOW,METHODS,NSABP,PREDICTORS,RESULTS,THERE,WOMEN
LUNG


TREATMENT
177,2002,2011,206,253,258,400,522,708,8201,BACKGROUND,BETWEEN,III,LABEL,MEIER,METHODS,OPERATING,RESULTS,SEPTEMBER
100,155,158,173,216,246,365,489,7TH,8201,BACKGROUND,DATA,IIA,IIB,IIIA,IIIB,LABEL,METHODS,PROGNOSTIC,RESULTS,TNM,VALIDATION
130,169,2011,2012,2014,COPYRIGHT,ECO,EUCAN,EUREG,EUROCIM,EUROCOURSE,EXCELLENCE,INCIDENCE,LTD,MORTALITY,POPULATION,REGISTRIES,SCIENTIFIC
ADMISSION,ANCA,CHEST,CONCLUSION,DEMOCRATIC,FURTHER,GERMANY,HISTORY,LABEL,LABORATORY,METHODS,RHEUMATOID,THESE,TREATMENT
169,2013,COPD,COPYRIGHT,INFECTIONS,LOWER,PUBLISHED,SEPAR
2YL,549,CELLS,MTT,NIGELLA,NRU,NSE,NSO,THEREFORE
003,384,621,696,CONCLUSION,CRP,GLASGOW,GPS,INDEX,LABEL,LYMPHOCYTE,METHODS,NEUTROPHIL,NLR,OBJECTIVE,PLR,PNI,PROGNOSTIC,PURPOSE,RATIO,RESULTS,SCORE,UNIVARIATE,UPON
500,A549,EXPRESSION,GROUP,HOWEVER,MIP1,OHDG,PAM,SIMILARLY,TIO2
294,325,619,ACCORDING,CONCLUSION,DCR,DDP,III,IIIA,IIIB,LABEL,MATERIALS,METHODS,NDP,NSCLC,OBJECTIVE,ORR,RESULTS,THERE
102,304,BACKGROUND,ECOG,EMERGENCY,LABEL,MATERIALS,METHODS,RESULTS,SOUTHWEST,STUDENT
0001,00036,0028,0051,047,111,114,148,177,BACKGROUND,CONCERNING,EGFR,GGO,LABEL,MATERIALS,MAXIMUM,METHODS,RESULTS,THERE
A549,AA8,CHINESE,CYTOTOXIC,DAPI,ETHANOLIC,HPLC,MP1,MP2,MP3,MTT,PRO,TUNEL,WHILE
A549,CD83,CTL,CTLS,DCS,DENDRITIC,ELISA,LABEL,LVS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PCR,PERIPHERAL,RESULTS,TAA
2007,2013,CONVERSION,HCC,JANUARY,LABEL,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPECIAL,THERE
945,947,948,954,ATM,B56,BACKGROUND,BALB,EXPRESSION,H1299,KU55933,LABEL,LUNG,METHODS,PARP,PDTC,PKA,PP2A,RESULTS,TRANSIENT,TREATMENT
008,012,085,169,2014,554,AACR,ATP,FINALLY,HSP,LABEL,NSCLC,PARP,THESE,TMRM,TNF,TRAP1,UNLABELLED
1140,1981,1983,1ST,2ND,3RD,4TH,5TH,809,8771,BACKGROUND,LABEL,MATERIALS,METHODS,RESULTS

011,043,250,255,379,632,725,970,ALK,AMONG,CARE,CASE,CCO,CONCLUSION,COSTING,COSTS,DRUG,EML4,FUNDING,ICER,INITIATIVE,LABEL,METHODS,MOLECULAR,NDFP,NETWORK,NSCLC,OBJECTIVE,ONTARIO,PROGRAM,PURPOSE,QALY,QALYS,RESULTS,TRANSITION,UNIVERSITY
BMJ,BONE,FINALLY,GROUP,LIMITED,MALIGNANT,MSC,MSCS,PUBLISHED,PUBLISHING,TRAIL
ALTOGETHER,AMONG,CAFS,HER2,NOD,NSG,PAM50,SCID,THESE,THREE,TME
494,945,COX,HIF1,HIF1A,HOWEVER,HYPOXIA,NSCLC,RFS,SNPS,THERE
001,0132,0382,116,H1299,H157,HBE,NSCLC,TNM
AKT,BCL,H1299,H460,HBE,NSCLC,SNF,SWI,TNM
114,1998,2012,HOWEVER,III,LABEL,LOCALLY,MASAOKA,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,SIXTY,SPARING,STAGE,THERE
1267,169,2006,2010,2014,AMONG,CLEAR,FORTY,GGNS,HOWEVER,JANUARY,LABEL,LNS,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RECURRENT,RESULTS,SURGERY,UNIVERSITY
084,092,1695,2012,304,729,CAUCASIAN,CNKI,DATA,EGGER,GSTP1,ILE105VAL,JULY,OVERALL,SCC,SCLC,ULTIMATELY
181,CHRONIC,EPIRUBICIN,HBV,HOWEVER,NOTABLY
181,956,AGS,DHA,HOWEVER,IC50,J82,MES,MRC,UNDER
574,A549,ERH
142,16S,177,316,441,508,787,920,935,ARSENIC,FIRMICUTES,GEMELLA,INDUCED,ION,MACHINE,METASTATS,MICROBIAL,NEISSERIA,PREVOTELLA,QIIME,TORRENT
169,2013,COPYRIGHT,HOWEVER,LVI,LYMPH,LYMPHATIC,NSCLC,SAS
169,2014,8230,ALK,BRAF,COPYRIGHT,EGFR,HER2,KRAS,RET,ROS,SAS,SINCE
169,2014,COPYRIGHT,INCIDENCE,LMWH,SAS,THESE,VTE
169,2014,COPYRIGHT,SAS
169,2014,COPYRIGHT,ONGOING,SAS
169,1997,2013,ANATOMY,COPYRIGHT,HOWEVER,INITIALLY,LUNG,SAS,SINCE,TNM
001,002,005,126,169,177,1980,2009,2014,564,669,733,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,SAS,THERE,UNLABELLED
169,2014,COPYRIGHT,SAS
169,2014,ALK,ATU,BRAF,COPYRIGHT,DDR2,EGFR,FINALLY,HER2,PUBLISHED,RET,ROS1,SAS,TODAY
169,2014,COPYRIGHT,DLCO,FVC,IDIOPATHIC,IPF,NON,PULMONARY,SAS,SEVERAL,UIP
169,2014,COPYRIGHT,H3K9ME3,INC,PACLITAXEL,PTX,SUV39H1
169,2013,ACADEMY,ALLERGY,COPYRIGHT,CVID,IGA,IGG,IGM,IMMUNOLOGY,INC,LIMITED,PUBLISHED
169,2014,COPYRIGHT,HOWEVER,INC,NSCLC,ONGOING,OTHER,SALVAGE,SCLC,SMALL
169,2014,COPYRIGHT,CURRENTLY,EARLY,HOWEVER,III,INC
169,2014,ALK,BRAF,COPYRIGHT,EGFR,HER2,INC,MET,NSCLC,PARTICULAR,RET,ROS1,SEVERAL
169,2014,COPYRIGHT,EGFR,HOWEVER,INC,NSCLC,PFS,TARGETING,TKIS
169,2014,COPYRIGHT,INC,NON,NSCLC
169,2014,ALK,COPYRIGHT,CURRENTLY,EGFR,EML4,EPIDERMAL,INC,MOST,NSCLC,THERE,TKI,TKIS
169,2014,COPYRIGHT,IIIA,IIIB,INC,LOCALLY,NSCLC
169,2014,COPYRIGHT,DESPITE,EGFR,IIB,INC,NEWER,NSCLC,SABR
169,2014,COPYRIGHT,INC,NSCLC,THESE,WHILE
INC,PET,PUBLISHED
169,1990S,2014,945,946,COPYRIGHT,CYP19,ERS,INC
0001,085,125,169,177,2003,2011,2014,446,679,697,BACKGROUND,COPYRIGHT,GENERAL,INC,LABEL,MAJOR,METHODS,PUBLISHED,RESULTS,SCORE,SOCIETY
028,1331,169,177,2009,2012,2014,BACKGROUND,BOARD,CONCLUSION,COPYRIGHT,COX,DIAGNOSIS,HOWEVER,INCIDENTAL,LABEL,LTD,MATERIALS,MEIER,METHODS,PET,RESULTS,VTE
022,030,169,2014,BASED,COX,HNSCC,MEIER,NINE,OVERALL
169,2013,AEC,AFTER,ARDS,BACKGROUND,BRASILEIRA,CASE,COOK,COPYRIGHT,CXR,EDITORA,ETT,EXCHANGING,ICU,LABEL,LTDA,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,SOCIEDADE
BACKGROUND,LABEL,METHODS,POLYGENIC,RESULTS
003,100,178,5000,8201,956,ARM,BACKGROUND,CSF,ELISPOT,LABEL,METHODS,MOST,NCI97C0141,PFS,RAS,RESULTS,THERE,TRIAL,WHILE
947,ASCITES,BACKGROUND,BINDING,CD3,CD8,DCS,HSP70,IFN,LABEL,METHODS,MICE,MSLN,MTB,RESULTS
BACKGROUND,LABEL,ONCOGENIC,RESULTS,SCLC,SSHN,SYK,WGCNA
AMONG,BACKGROUND,BOTH,DUE,GSEA,KEGG,LABEL,METHODS,RESULTS,THEN
6259,AMONG,BACKGROUND,LABEL,METHODS,NSCLC,RESULTS
E2F6,EARLY,HMGA1,HNRPD,HOWEVER,IRF1,LUNG,NSCLC,RBL1,SUV39H1,TFDP1
2004,2012,241,643,AMONG,AREA,CDDP,CRPC,DTX,EIGHT,HAMAMATSU,JANUARY,JULY,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OBJECTIVES,PSA,RESULTS,SALVAGE,SIX,TRANSITORY,UNIVERSITY
004,102,143,162,173,1988,2007,276,CAMPANACCI,CHINA,DEPARTMENT,FIFTY,III,METASTASES,PMMA,RECURRENCE,SICHUAN,THERE,THEREFORE,TREATMENT,UNIVERSITY,WEST
BACKGROUND,DISCUSSION,GRAY,HENCE,KEEPING,LABEL,OBJECTIVE
CONCURRENT,CTLA,HOWEVER
001,1661,194,299,422,AFFYMETRIX,BACKGROUND,EARLIER,IIIA,LABEL,LAPTM4B,METHODS,MIXED,NSCLC,ORDINAL,PROFILING,RESULTS,WHOLE
169,2014,8805,AACR,CHINESE,CHO,EGF,EGFR,HEMOGLOBIN,KIRSTEN,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERIOUS,SILTUXIMAB,TEN
CEA,COX,HGF,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SCATTER,SCC
BLOOD,COX,D4W,EGFR,HOWEVER,NSCLC,PCR,TKI,TKIS,TTP
A549,ATG12,ATG5,BORTEZOMIB,H157,LC3,NSCLC
1986,2011,780,ASSESSMENT,CONCLUSION,FIFTY,FUNCTIONAL,III,LABEL,LIFE,LUNG,METHODS,NSCLC,OBJECTIVE,OCTOBER,PHASE,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SYMPTOM,THERAPY,THERE,TREATMENT
ANCILLARY,EMPIRIC,FURTHER,TRICUSPID,TVE
095,150,186,237,288,3N0,4N0,542,8805,900,BACKGROUND,CONCLUSION,LABEL,MATERIALS,METHODS,NAC,NSCLC,PRIMARY,RESULTS
001,015,8201,A431,A549,ACHN,CELL,ENT1,FACTORS,FLT,HOP92,HOWEVER,HT29,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SKOV3,THD,THESE,THYMIDINE,TK1
003,5TH,8201,8321,8322,AMONG,CONCLUSION,DEFINITIVE,FDG,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PET2,PURPOSE,RCT,RESULTS,RTEP2
001,019,048,124,787,AMONG,ARMS,EGFR,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIX,TKI
150,CONCLUSION,FACTORS,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIXTY,THESE
169,2013,2014,2ND,CONFERENCE,CONSENSUS,ESMO,LUNG,MAY,MEDICAL,NSCLC,PRESS,PUBLISHED,SOCIETY,UNIVERSITY
MALIGNANT,RNAS
001,002,003,004,013,019,100,169,177,18F,2014,FIVE,GGO,IIA,IIB,IIIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PRESS,PUBLISHED,RECURRENCE,RESULTS,SERUM,SURGERY,UNIVERSITY
8805,A1C,BACKGROUND,FURTHER,LABEL,MCC,MCCS,METHODS,NORTH,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,SECONDARY

18F,99MTC,AFTER,CHEST,FDG,MDP,MRI,PET
ACTIVATION,HOWEVER,RET
169,2014,CHEST,COPYRIGHT,INC,LABEL,METHODS,NONE,OBJECTIVE,RESULTS,SETTING,SEVEN,SICU,THOSE,ULTRASOUND,UNIVERSITY
169,2013,COPYRIGHT,SAS
169,2014,BACKGROUND,CCS,CLEAR,COPYRIGHT,EIGHT,FIVE,INSTITUTE,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIXTEEN
169,2006,2012,2014,297,2MM,314,3MM,4MM,5MM,8MM,AFTER,BODY,COPYRIGHT,CTV,IRELAND,ITV,LABEL,LARGE,LTD,MATERIALS,METHODS,MIDV,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,SBRT,USING,VOLUMES
169,2014,5MM,COPYRIGHT,GOLD,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THUS
001,002,10878,169,2014,285,APR,BACKGROUND,BASED,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OPTIMAL,ORS,PURPOSE,RADIATION,RESULTS,UNIVARIATE
108,127,169,2014,COPYRIGHT,FDG,IMAGING,INC,LABEL,MDCT,METHODS,OBJECTIVE,PET,POSTMORTEM,RESULTS
169,193,1993,2008,2014,209,ARDS,COPYRIGHT,HOWEVER,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NINTH,OBJECTIVE,PREDICTORS,RESULTS,SAH
169,2014,BDNF,COPYRIGHT,INC
169,2014,CAF,CAFS,COPYRIGHT,EARLY,FAP,FOXF1,HOWEVER,LTD,MMPS,PDGFR,SEVERAL,SIMILARLY,SPARC,THESE,THUS,USING
000,169,2014,215,368,736,BLOOD,BONFERRONI,CDK6,COPYRIGHT,DBP,DQB1,FBN1,H19,HLA,HOXC,INC,MAP,NFAT5,NUCB2,PDE1A,PUBLISHED,RELA,SBP,SNPS,SOCIETY,VCL
103,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,COX,GAL,HOWEVER,III,IRELAND,LABEL,LTD,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS,STAGE
169,2014,ADDITIONAL,BACKGROUND,CASE,COPYRIGHT,INC,LABEL,MATERIALS,MEDLINE,METHODS,NSCLC,RESULTS,SIXTY,THYROID
169,2014,CARCINOMA,COPYRIGHT,EXTRALOBAR,IRELAND,LTD,MALIGNANCY,WHILE
169,2014,COPYRIGHT,IRELAND,LTD,LUNG
169,1968,1980S,2007,2014,AGE,AGGREGATED,AMONG,APART,APC,CHINESE,CONCLUSION,COPYRIGHT,INDIANS,IRELAND,LABEL,LTD,LUNG,MALAY,METHODS,OBJECTIVE,OBJECTIVES,POISSON,RESULTS,SINGAPORE,THERE,WHILE
0001,0005,102,140,144,150,169,2006,2008,2014,25MG,284,8805,AFTER,AUC5,BACKGROUND,BETWEEN,CHARLSONS,CONCLUSION,COPYRIGHT,EGFR,ERLOTINIB,FACT,IRELAND,JUNE,LABEL,LESS,LTD,MATERIALS,METHODS,NSCLC,PFS,PRIMARY,RESULTS,SCS,SECONDARY,TARGETING
003,169,1CM,2014,916,CON,CONCLUSION,COPYRIGHT,DATA,IRELAND,LABEL,LTD,LUNG,MCSA,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2014,AKT,CELL,CELLS,COPYRIGHT,INC,MOLECULAR,SANIDAS
160,169,2014,CHEST,COPYRIGHT,FURTHER,INC,PUBLISHED,THREE,TROUSSEAU
169,2014,ADVERSE,AES,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,ECOG,GROUP,IIIB,INC,LABEL,M30,METHODS,NSCLC,PFS,PRIMARY,RESULTS,SECONDARY,TRAIL
001,169,1988,2010,2014,701,AGE,BACKGROUND,COLLEGE,COPYRIGHT,COX,END,INC,INCREASING,LABEL,METHODS,OVERALL,PUBLISHED,RESULTS,SHORT
001,100,169,2014,COPYRIGHT,EXACT,EXPRESSION,H69,H69AR,HOX,HOXA1,INHIBITION,LOW,LTD,LUCIFERASE,MEIER,MICRORNAS,PCR,SCLC,SEVERAL,TEST,UTR
0003,169,183,2006,2011,2014,228,233,393,461,ASSESSMENT,BACKGROUND,CARE,CARES,CHRONIC,COPYRIGHT,DEC,END,ESAS,EVALUATION,FACIT,FAMCARE,FEB,FUNCTIONAL,FUNDING,GROUP,ILLNESS,LABEL,LIFE,LTD,MEDICAL,METHODS,MIS,ONTARIO,P16,QUAL,QUALITY,RESULTS,SECONDARY,SOCIETY,SPIRITUAL,SYMPTOM,TERM,THERAPY,TORONTO
4133,AMONG,COX,FEW,INSURANCE,LABEL,METHODS,NHI,OBJECTIVE,OBJECTIVES,RESULTS,TAIWANESE
103,118,2011,2012,273,AMONG,BACKGROUND,CEA,CHEST,GGO,INCIDENCE,JANUARY,LABEL,METHODS,RESULTS,T1A,T1AN0M0,THERE
174,AREAS,BACKGROUND,COVERED,CREMOPHOR,III,LABEL,MBC,MEDICINES,METHODS,NSCLC,OPINION,PHASE
002,2008,2010,2014,8482,ALBUMIN,ASSESSMENT,AULA,CONCLUSION,COPYRIGHT,CRP,EDICIONES,INDEX,INI,JULY,LABEL,MAY,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RISK,SGA,STATA,SUBJECTIVE
078,090,137,1377,349,355,381,614,8202,ASIAN,BACKGROUND,CIS,FAS,HOWEVER,LABEL,METHODS,ORS,RESULTS,SCIENCE,SIMILARLY,STATA,WEB
H1299,H460,LIMITED,MTS,THESE,TREATMENT
001,ADC,DWMRI,FLLS,MRI,SEVERAL
142,169,946,A549,FASEB,HOWEVER,NSCLC,SMAD,SMAD3,TGF,THESE,UTR
110,177,1999,2008,304,414,AFTER,BACKGROUND,CHI,DATA,FACTORS,HER2,III,LABEL,METHODS,RESULTS,TNBC
021,113,2013,308,623,A79C,CDA,CONCLUSION,HOWEVER,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
99MTC,ASC,FSC,FURTHER,LABEL,LYMPH,MBQ,METHODS,MOST,NSCLC,OBJECTIVE,RESULTS,SPECT,THERE
001,013,027,196,517,8201,946,AFTER,CRT,ELISA,FIFTY,HOWEVER,NSCLC,SERUM,TGF,THERE,VEGF
COLONIC,DEPENDING,METASTATIC
BREATHING,EUCLIDEAN,EVENTUALLY,INCREASING,LOG,MRI,THESE
108,154,177,2005,2011,ARMY,BACKGROUND,BAE,BRONCHIAL,CHINESE,GENERAL,IMMEDIATE,JANUARY,JUNE,LABEL,LIBERATION,METHODS,RESULTS
ACTIVATION,AKT,ALK,H3122CR,PF02341066,THUS
169,2014,4782,BACKGROUND,BASEL,BDU,CELL,DOWN,DUAL,HIGH,LABEL,LUNG,MEIER,METHODS,MIR,MTT,NSCLC,PCR,RESULTS,USP14,WESTERN,XIAP,ZEB2
2011,7704,8804,ATS,DATA,ERS,HISTOLOGIC,IASLC,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SAS,SOCIETY,THEREFORE
ADENOVIRUS,BACKGROUND,BOTH,CONCLUSION,DDR2,DISCOIDIN,EMT,HNSCC,METHODS,PCR,REAL,RESULTS,RTK,THEN
1997,2011,246,CONCLUSION,EIGHT,FDG,JANUARY,LABEL,MAYO,METHODS,PET,RESULTS,SEVENTEEN,TEN,UNLABELLED
169,2014,A549,AIMS,BACKGROUND,BASEL,BOTH,CELL,CONCLUSION,EIA,H23,LABEL,LUNG,METHODS,MTS,NCI,OBJECTIVE,PCR,PTEN,RESULTS,THEREFORE,THESE,TXA2,TXAS
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,FIVE,HNSCC,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METASTATIC,METHODS,PUBLISHED,RESULTS,SABR,SABRT,SURGERY
151,169,2014,A549,ARES,CONVERSELY,COPYRIGHT,CYS,HOWEVER,INC,KEAP1,NRF2
000,001,005,015,023,033,034,036,048,060,069,081,087,089,103,106,113,128,130,152,160,166,185,186,196,199,233,242,245,252,265,292,313,316,370,378,388,544,549,BEGG,CAUCASIANS,EGGER,ERCC2,FINALLY,LYS751GLN,THESE,THUS
001,003,007,021,039,046,099,164,169,199,2000,2012,2013,2539,296,570,670,COPYRIGHT,EPC,IAP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PPC,PUBLISHED,RCC,RESULTS,SMC,TIANJIN
946,B16F1,BACKGROUND,DIFFERENT,LABEL,METHODS,PKA,RESULTS,SUNITINIB,VEGF
1590,1597,2013,639,A549,ALA,ALLG,ANORG,ATR,CH1,CHEM,CL5,COMPOUNDS,ESI,GLY,NMR,PRO,RUCL3,SER,SW480,THR,TYR,VAL
100,472,CONCLUSION,GGN,GGNS,HRCT,LABEL,OBJECTIVE
11C,18F,68GA,CONCLUSION,CURRENTLY,DOTA,FDG,INCIDENTAL,LABEL,LUNG,OBJECTIVE,PET
CONCLUSION,LABEL,MRI,OBJECTIVE
001,100,157,177,BLAND,CONCLUSION,FORTY,HOWEVER,LABEL,MATERIALS,MDCT,METHODS,OBJECTIVE,OVERALL,RESULTS,SMALL
CONCLUSION,HOWEVER,LABEL,LUNG,OBJECTIVE,SCREENING,TRIAL
CLINICIANS,CONCLUSION,LABEL,MRI,OBJECTIVE
0001,8805,AFFAIRS,BECAUSE,CONCLUSION,FDG,FIFTY,HIGH,LABEL,LOW,MATERIALS,MAYO,METHODS,NET,OBJECTIVE,OUTCOME,PET,RESULTS
100,954,CONCLUSION,LABEL,MCNEMAR,MDCT,METHODS,MRA,NSCLC,OBJECTIVE,PULMONARY,RESULTS,THEN
1990S,239,ACCOUNT,PIONEERING,SINCE,TECHNICAL,THESE,WHAT
AES,BACKGROUND,CONCLUSION,CONTEXT,INJECTION,LABEL,METHODS,NINE,OBJECTIVE,RESULTS,TLR9,TOLL
13C,205,A431,A549,ALPINIA,COLO,COMPOUNDS,DCM,H460,MEOH,NCI,NMR,SHARPLESS
169,2014,322,AACR,BECAUSE,HOWEVER,HSF1,HSP,HSP70,HSP90,LABEL,PI3K,UNLABELLED
ATF3,NFKB2,R175H,R273H,TP53
169,2004,2014,GUIDELINES,HOWEVER,INC,LUNG,THESE,WILEY,WORLD
169,183,AIT,CNE1,CNE2,ERK1,GEORG,HOWEVER,MATRINE,NPC,OVERALL,SOPHORA,STUTTGART,THEREFORE,VEGF,YORK
001,005,012,018,030,043,114,132,2005,2010,406,482,499,613,704,811,995,COX,DATA,DESPITE,ECOG,JANUARY,LDH,MEIER,NLR,NSE,SCLC,THESE
111IN,139,177,237,285,374,381,423,513,522,68GA,BACKGROUND,CONCLUSION,DOTATOC,ENETS,FIRST,IMAGING,IQR,LABEL,MEAN,METHODS,NEN,NENS,OVERALL,PET,RESULTS,SRS,SWISS
0002,ADVERSE,GRADE,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VATS,VERSION
003,004,006,026,041,045,2R3RG,2R6,3RG,3RG6,ACCORDING,NSCLC,PORTUGUESE,SNP,TYMS,VNTR
GRAM
34B,34C,34S,5MM,BALB,H290,LUC,MPM,NCI,PBS
169,2014,206,210,BIOMEDICAL,BOARD,CDC,CHINA,CONCLUSION,COPYRIGHT,EDITORIAL,F344,LABEL,METHODS,NNK,OBJECTIVE,PCR,PUBLISHED,RESULTS
0001,117,169,1960,2000,2004,2005,2007,2008,2009,2012,2014,427,909,ACADEMY,ADC,BIOMEDICAL,BOARD,CDC,CHINA,CHINESE,CONCLUSION,COPYRIGHT,EDITORIAL,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCC,SMOKE
945,956,A549,ANEMONE,BUOH,ESIMS,HELA,HEPG2,IC50,NMR,THEIR
1910S,1940S,1960S,1970S,1985,1990S,BOWEN,RESIDENTS,SEVERAL,THERE
181,KRAS,NOTABLY,SNP,UTR,WHILE
558,607,GTPASES,H1703,NCI,NSCLC,ONCOGENIC,POST,RAS,RHO,RNAI,SILENCING,THESE
169,2011,2013,2014,231,646,979,ALK,BRAF,CONCLUSION,COPYRIGHT,EGFR,IRELAND,JULY,KRAS,LABEL,LTD,METHODS,NONE,NSCLC,OBJECTIVE,OBJECTIVES,OSLO,PCR,RESULTS,UNIVERSITY,V600E
947,ADULT,C57BL,HOWEVER,IFN,PTERIDIUM,TAKEN
HOWEVER,SPERMINES,THEREFORE,THESE
A549,AKT,ARF,BMI,INK4A,MLV,SPC,THESE
2100,BACKGROUND,BOTH,HOWEVER,LABEL,METHODS,MLH1,NON,POLE,RESULTS
1254,1296,1950,1970,2004,248,523,545,BACKGROUND,BRONI,CAUSE,ITALIAN,ITALY,LABEL,LAW,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,PAVIA,RESULTS,SIMILARLY,SIN,SITE,SMR,SMRS,THESE
100,239,610,BACKGROUND,COX,GGO,LABEL,METHODS,PET,RESULTS,RFS,T1A,T1B,THERE
005,006,007,009,017,CBP,COX,DFS,HIGH,LABEL,METHODS,MLL,OBJECTIVE,PURPOSE,RESULTS,SCLC
34A,EGFR,HCC,HOWEVER,IC50,MAXIMAL,NSCLC,SYNERGY,TKI,USING
001,061,237,272,CONCLUSION,IIIA,IIIB,LABEL,METHODS,MINIMAL,NSCLC,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,THEREFORE
945,946,954,ELK,ETR,ETS,FINALLY,STAT
000,AKT,BRAF,EGF,EGFR,HOWEVER,JUN,NSCLC,ONCOGENIC,RAF,THESE,V600E
100,169,2003,2009,2014,696,716,AFTER,COPYRIGHT,DIFFERENT,INC,WILEY
169,2014,503,946,ECTOPIC,IKK,NSCLC,PI3K,TAKEN,UICC
8197,BACKGROUND,BMJ,CIS,FURTHER,GROUP,LABEL,LIMITED,METHODS,MOLECULAR,PUBLISHED,PUBLISHING,RESULTS,THESE,USING
111,236,289,435,661,D03,DOTA,ERBB2,G03,LABEL,MDA,METHODS,NON,OBJECTIVE,PHAGE,PROCEDURES,PURPOSE,RESULTS,SPECT
415,AFTER,EGYPT,HAND,LABEL,METHODS,OBJECTIVE,PORT,RESULTS,SHS,SMOKE,THESE
001,0024,A549,AKT,EGFR,EPIDERMAL,ERBB3,ERK,HER3,HOWEVER,PCR,PEM,REAL,STAT3
946,ABCG2,ALDH,ATP,CD133,CD44,CSC,CSCS,FINALLY,LUNG,NOTCH,WNT
A549,BCL,COX,CXB,ERK,MEK,NSCLC,SOR,TAKEN,VEGFR
100,127,160,3894,3971,956,A549,DOCKING,ESBL,IC50,INDIA,KLEBSIELLA,MARAPALAM,MRSA,SALMONELLA,TTGR
8209,BLADDER
113,2005,2008,A549,ACTIVATION,BRDU,CONCLUSION,COX,DFS,EFFECTS,EXPRESSION,H1299,H1975,HIGH,JANUARY,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SPC,TLR5,TOLL,XIANGYA
183,20S,231,947,956,A549,C666,DCFH,FURTHER,H2AX,H2O,HELA,HK1,HL60,HONE1,HOWEVER,IC50,MCF7,MDA,NALMAWA,NCI60,NO3,NPC,PC9,ROS,SKOV3,SW48,SW480,T47D,THESE
0064,0167,0194,0372,ASSESSMENT,C30,EORTC,LABEL,LOW,METHODS,OBJECTIVE,PURPOSE,QLQ,QUALITY,RESULTS,THUS
8804,8805,CONCLUSION,FDG,FOUR,LABEL,METHODS,NONE,PEARSON,PET,REGARDLESS,RESULTS,SUV,SUVS,TEXTURE,THREE,TLG,UNLABELLED,YET
9AC,CDK,CDK4,CDK4I,CDKIS,CPT,H417,HOCPT,MODULATION,NCI,PD0332991,SCLC,SCLC26A,SN38,TPT,WHEREAS
0001,001,136,499,514,879,906,929,AUC,III,LOW,NSCLC,SERUM,VALIDATION
189,1994,2008,340,LABEL,METHODS,POISSON,RESULTS,SIR,UNLABELLED
0001,001,002,100,144,169,2004,2010,2014,235,367,544,916,ATG,BLOOD,CAMBRIDGE,CASES,CHANGES,COPYRIGHT,FEV1,GENZYME,INC,INSTITUTES,IQR,NIPS,PUBLISHED,SCT,SOCIETY,SPIROMETRY,TRANSPLANT,TREATMENT
AKT,APOPTOTIC,BACKGROUND,BCL,HOWEVER,LABEL,METHODS,RESULTS
149,158,169,2012,227,COMMISSION,COMPARING,ITALIAN,ROME,SEPTEMBER
10878,163,169,2014,ALK,BACKGROUND,BRAF,CEA,COPYRIGHT,EGFR,KIRSTEN,KRAS,LABEL,LTD,MATERIALS,METHODS,PROGRAMMED,RESULTS,RFS,THERE,TUMOURS
AIRWAYS,BACKGROUND,CONCLUSION,GIVEN,ITALY,LABEL,METHODS,RESULTS
000,001,021,057,108,136,147,177,2012,2013,238,302,344,545,768,811,928,967,997,AFFILIATED,DEPARTMENT,DNMT1,ELISA,FIRST,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIXTH,UNIVERSITY,ZHENGZHOU
028,035,152,152G,169,17A,17F,2013,239,258,7383,7488,7488G,CHAIN,COPYRIGHT,HOWEVER,LTD,PCR,POLYMERASE,RFLP,SNPS,TH17
000,019,A549,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SYK,TRANSFERED,VEGF
001,002,0024,005,112,112A,112B,210,LABEL,METHODS,OBJECTIVE,RESULTS,UNC
000,006,169,2014,215,767,BACKGROUND,BED,BED10,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMALLER
3DCRT,BACKGROUND,CONVERSELY,EARLY,FREE,HODGKIN,LABEL,LAR,METHODS,OARS,PTV,RESULTS,VMAT
006,303,8805,ODDS,RATIO
1795,2000,2005,2009,2010,2578,359,412,8804,ACUTE,ALRC,BACKGROUND,CCI,DATA,EARLY,INDEX,INSURANCE,LABEL,METHODS,NHI,NONCANCER,RESULTS,SEPTEMBER,UNLABELLED
CBD,KDS,PAH,POLYCYCLIC,PREVIOUSLY,SEPARATELY
167,252,294,384,549,THP
000,169,2014,DANGEROUS,DISCUSSION,INC,LABEL,METHODS,NINE,OBJECTIVE,OBJECTIVES,PHN,RADON,RESULTS,WILEY
384,AKT,AXL,GAS6,H1299,MER,NCI,RTKS,TAM,THESE,TYSO3,USING
18F,BASED,FDG,OTHER,PET,PPSS
004,1205,1387,169,2014,370,401,ACO1,CIS,COLORECTAL,DIETARY,HEME,HOWEVER,IRON,LUNG,ORQ4,OVARIAN,PRESS,PUBLISHED,SCREENING,SEVERAL,SNPS,TRIAL,UNIVERSITY
III,MPM,SURGERY
2007,2009,AIM,CONCLUSION,CSF,FOUR,JUNE,LABEL,METHODS,MRI,OBJECTIVE,OTHER,RESULTS,SERUM
001,330,680,CAUCASIAN,CAUCASIANS,CIS,CLPTM1L,HOWEVER,ORS,OVERALL,SUMMARY,TEN
00001,0001,002,004,464,869,CAUCASIANS,CHINA,CIS,CNKI,DATA,DATABASES,KNOWLEDGE,ORS,OVERALL,TERT,WANFANG
169,2001,2013,2014,8804,BACKGROUND,BILIARY,DEFINITIVE,ENDOSCOPIC,EUS,FNA,LABEL,MEAN,METHODS,PANCREATIC,RESULTS,SOCIETY,SPN,SURGERY
027,030,239,COX,IIIB,NSCLC,SEVERAL,SLC29A3,SULT1E1,THREE
130,A22,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,NMC,NODAL,NSCLC,OBJECTIVE,PET,RESULTS,SUV,VIDEO
001,143,2005,2012,530,825,APRIL,CONCLUSION,FRANKEL,HOWEVER,KARNORFSKY,LABEL,METHODS,OBJECTIVE,RESULTS
3P25,487,945,CA2,DAG,GPCR,HRH1,IL3,IP3,MYB,PKC,PLC,PROGNOSCAN,SNPS
1992,2007,7765,AML,AUSTRALIAN,BONE,COX,HCT,HODGKIN,INDEX,POPULATION,RECIPIENT,RECIPIENTS,SCT,SIR,SIRS,TRANSPLANT
7802,954,A549,ATG5,BAY11,BCRP,CONVERSELY,FERO,GFP,LC3,MDR1,MRP2,VAD
145,AKT,EGFR,EPIDERMAL,ERK1,STAT3,THEN,THESE
2005,2012,AFFILIATED,AMONG,DEPARTMENT,JANUARY,PROS,PRPFS,SIXTH,SRS
133,18272,18279,183,2011,A549,CHEM,INCREASED,NADPH,OVERALL,ROS,SOC,SOD,SOD1,TREATMENT,WEEKLEY
NOVEL
BASED,CXC,HARA,MC3T3,RESULTS
000,0001,0046,169,180,2005,2007,2010,2014,556,COPYRIGHT,EPITHOR,INC,JANUARY,LABEL,LOW,METHODS,MODEL,MOSBY,MULTILEVEL,OBJECTIVE,PLAN,PUBLISHED,RESULTS,SINCE,SURGERY
001,066,117,169,194,2000,2010,2014,230,665,872,8804,BACKGROUND,COLLEGE,COPYRIGHT,GROUP,HIGH,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE
001,169,2014,3018,850,884,AMONG,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,DIRECTORS,FRAILTY,FRIED,INC,LABEL,MEDICAL,METHODS,OLDER,PUBLISHED,RATES,RESULTS,WOMEN
169,2000,2010,2014,225,BACKGROUND,COPYRIGHT,DFS,FIFTEEN,JANUARY,JULY,LABEL,LRACC,LTD,METHODS,MVR,NCRT,NEO,NINE,POST,RESULTS,SECONDARY,SHORT
000,146,468,661,ACADEMY,AMONG,CHINESE,COLLEGE,EGFR,INSTITUTE,LABEL,MEDICAL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,TKI,UNION
026,177,478,BACKGROUND,CHEST,DATA,LABEL,METHODS,PULMONARY,RECORDS,RESULTS,TACE,THREE
101,2008,2012,528,BACKGROUND,CONCLUSION,FALSE,INTEGRATED,JULY,LABEL,LYMPH,METHODS,NODAL,NSCLC,PET,RESULTS
144,169,2014,285,COPYRIGHT,IRB,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PAIR,RESULTS,VARIABLES
BECAUSE,COMPELLING,HRQOL,SMOKING
0252,0315,0317,0815,0918,169,2014,AE105,CONCLUSION,COPYRIGHT,DOTA,FAVORABLE,FIVE,INC,LABEL,MBQ,METHODS,PET,RELATIVELY,RESULTS,TATE,UNLABELLED,VOI
001,003,004,022,033,141,2006,2012,8804,99M,CONCLUSION,HCC,HCCS,LABEL,LSF,LSFS,MAA,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
BESIDES,CDK,CDK2,CDK4,CDK6,CIP1,ERK,H1299,H460,HOWEVER,KIP1,MAPK,MEANWHILE,THEREFORE,TREATMENTS,WAF1
945,BACKGROUND,FLOT,FLOTILLIN,LABEL,METHODS,NSCLC,PCR,RESULTS,SPFH,STOM,STS,WESTERN
916,AFTER,ALI,EXPRESSION,HOWEVER,KNOCKDOWN,NP63,VA10
0001,001,004,024,043,108,1117,463,8202,945,AKT,AKT1,ALK,AMONG,BRAF,EGFR,HER2,KRAS,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,ONCOGENIC,PI3K,PTEN,PURPOSE,RESULTS
00001,1821,BACKGROUND,EGFR,ERLOTINIB,HOWEVER,III,LABEL,METHODS,MTCS,NSCLC,ORR,PFS,RCTS,RESULTS,SEVERAL,TKIS,TREND
34A,HDM4,HOWEVER,KRAS,TAKEN,UTR
150,BAK1,BRI1,NON,NSCLC,THUS
169,2014,ACH,CHOLINE,COPYRIGHT,CTLS,JOHN,LTD,MRS,PCR,PET,SLC44,SONS,THUS,USING,WILEY
169,177,1990,2010,2014,8201,CHEST,DESPITE,INC,NINE,PRIMARY,THERE,WILEY
001,004,011,2002,2012,241,428,494,APRIL,DFS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PLC,RESULTS
FURTHER,INITIAL,MRI,SUBSEQUENT,THUS
169,2014,A549,ERK,FURTHER,HDAC,HISTONE,INC,KAZAL,MMP,MMPS,RECK,REVERSION,SP1,TAKEN,WILEY
197,212,LABEL,LOCALLY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
2010,2012,205,CONCLUSION,FOUR,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
001,150,2012,2013,BACKGROUND,CDT,CDTS,COLLEGE,CONCLUSION,FOB,IHC,INADEQUATE,INDIA,JUNE,LABEL,LATUR,LUNG,MEDICAL,METHODS,MIMSR,MINOR,OTHER,PATHOLOGY,RESULTS,SEPTEMBER,TBNA,TOTAL,VARIOUS,YIELD
DUBS,FANCONI,ML323,PROTEIN,UAF1,USING,USP1
2006,2013,BASED,COLORECTAL,ERSPC,LUNG,OVARIAN,PLCO,RANDOMIZED,RCTS,SCREENING
COLON,DETAILS,ERSPC,HOWEVER,LUNG,OVARY,PLCO,PSA,RANDOMIZED,SCREENING,USA
000,1990S,COLORECTAL,DRE,LUNG,OVARIAN,PLCO,PSA,SCREENING,THUS,TRIAL
004,012,153,212,HOWEVER,MEIER,NSCLC,PCR,RESULTS,TBX2,WESTERN
CAR,CASE,CME,DESPITE,FOUR,LABEL,METHODS,OBJECTIVE,PURPOSE,QID,RETINAL,SINCE
0001,004,006,012,018,021,600,CARCINOMAS,REDUCTION,REMARKABLY,TRP53,TUMOURS
169,2014,COPYRIGHT,H1299,H522,INC,NCI,PARP,RV1
174,960,BRAF,CAREFUL,CLINICALLY,ERK,FOUR,GTP,RAC1,THERE,V600E
100,169,2014,257,393,956,A549,ATCC,BASED,COPYRIGHT,DOCKING,EVALUATION,GI50,INSTITUTE,LC50,LUNG,NCI,OVARIAN,RENAL,RXF,SAS,UACC
1989,1991,20TH,792,80TH,956,AFTER,ARIZONA,BACKGROUND,CADMIUM,HEART,HRS,INDIANS,LABEL,LOW,METHODS,NORTH,OBJECTIVE,RESULTS,SOUTH
ADC,LINEAGE,LKB1,LOX,NOTABLY,SCC
001,146A,19B,223,ABERRANTLY,HIGH,NSCLC,PCR,SERUM,THESE,THREE,TNM
131,1620,169,2014,210,215,260,471,8804,8805,ASCT,BLOOD,COPYRIGHT,DOSE,HODGKIN,INC,NHL,PUBLISHED,SOCIETY
169,2014,252,947,BALB,BCG,BESIDES,CD4,CD8,COPYRIGHT,IFN,INC,MTB,ORIM,PPE68,PUBLISHED,SOCIETY,TH1
169,2014,946,CDK1,COPYRIGHT,ERK1,INHIBITION,MMP,MOST,MUTATIONS,PUBLISHED,S2A,SER1038,SER2039
169,2014,956,ANTICANCER,COPYRIGHT,EVALUATION,GI50NCI,H322M,LUNG,NSC,SAS
169,181,2014,COMBINING,COPYRIGHT,H1703,H520,HOWEVER,HSP90,INC,MAPK,MKK3,MKK6,MKK6E,MSH2,MUTS,NSCLC
169,2014,8482,945,946,ANGIOSTAMP,BASED,COPYRIGHT,INC,MRI,NIR,SCAN
169,2014,956,A549,ANTICANCER,COPYRIGHT,FOUR,NON,THESE,WST
0001,0009,0128,034,169,2009,2011,2014,8804,AMR,AUTHORS,BETWEEN,COPYRIGHT,EACH,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,ORR,PFS,PUBLISHED,RESULTS,SCLC
169,2014,BACKGROUND,BLACK,CELL,CONCLUSION,CONTROLLED,COPYRIGHT,DOWNS,HOWEVER,LABEL,LTD,LUNG,MEDLINE,METHODS,NCSLC,NON,NSCLC,OBJECTIVE,PSYCHINFO,PURPOSE,RANDOMISED,RCT,RCTS,REGARDING,RESULTS,SMALL,SURGERY
169,2014,780,A549,COPYRIGHT,CURRENT,LEWIS,LTD,NIR
169,2014,956,A549,ADP,BASED,BK10040,COPYRIGHT,IC50,LTD,MTT,PARP,VAD
169,2014,CHEST,COPYRIGHT,LTD,METASTATIC,MPC,THREE,THUS
001,160,169,2001,2010,2014,2745,4394,531,7137,COPYRIGHT,FURTHER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,OPERATIVE,OVERALL,PROPENSITY,PUBLISHED,RESULTS,SOCIETY,SURGERY,VATS
019,169,201,2014,916,CCC,COPYRIGHT,D99GITV,DATA,DISO,GITV,GRAY,HOWEVER,INC,LABEL,LOCAL,MATERIALS,METHODS,NOVALIS,OBJECTIVE,PTV,PURPOSE,RESULTS,SABR,THERE,TPS,TREATMENT,V90GITV
104,10L,10R,112,169,173,2005,2011,2014,250,3N2,COPYRIGHT,CTV,IIIA,INC,LABEL,LRF,MATERIALS,METHODS,MOST,NSCLC,OBJECTIVE,PORT,PURPOSE,RESULTS
001,169,177,2014,AUTHORS,BECAUSE,COPYRIGHT,CRT,D99,IDEAL,III,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS
010,020,169,177,189,1ST,2004,2008,201,2012,2014,321,528,645,674,BOTH,COPYRIGHT,DATA,EGFR,INCIDENCE,IRELAND,KRAS,LABEL,LTD,MEAN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,POST,RESULTS,SRE,TIME
106,121,122,169,177,193,196,2006,2012,2014,222,227,321,COPYRIGHT,CYBERKNIFE,INC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SIR,SOCIETY,TECHNICAL
169,1997,2013,2014,BOERHAAVE,COPYRIGHT,EPF,EPFS,FISTULA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PLACEMENT,PUBLISHED,PURPOSE,RESULTS,SIR,STENT,TECHNICAL
169,2013,946,ACTIVATION,COPYRIGHT,ECM,HOWEVER,IDIOPATHIC,INCREASED,IPF,LTBP,LTD,LTPB,NSIP,SMAD2,TGF,UIP,WEST,WHWTS
169,2014,COPYRIGHT,INC,SCLC
169,200,2013,241,400,BACKGROUND,COPYRIGHT,DEPARTMENT,ESPA,LABEL,METHODS,OBJECTIVE,PNEUMOLOGY,RESULTS,SALAMANCA,UNIVERSITY
000,100,1996,2004,2012,BACKGROUND,CONCLUSION,DRUGS,FVC,HRCT,IDIOPATHIC,IPF,LABEL,LUNG,METHODS,RESULTS,SELECTIVE,UIP
1802,2012,215,258,2751,2966,377,391,427,464,509,511,515,5388,554,593,606,6205,622,685,686,688,694,696,700,706,741,752,781,836,8522,856,8954,8986,9125,9636,967,9935,AMONG,CHI,COLLEGE,CONCLUSION,CONTROL,CONVENTION,CURRENT,FACTORS,FRAMEWORK,GUANGDONG,GUANGZHOU,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,TOBACCO
160,169,2014,916,CLJ1,COPYRIGHT,EXLA,EXLB,III,INC,PA7,PAO1,PROTEOMIC,T3SS,VIRULENCE
ADC,BACKGROUND,CONCLUSION,IFP,LABEL,LOW,METASTATIC,METHODS,MRI,RESULTS,THERE
169,2014,ARONJ,COPYRIGHT,ENGLISH,INC,MOSBY,PUBLISHED,THERE
001,122,159,686,8805,BACKGROUND,CCA,DMAX,DMEAN,FORTY,GRADE,GROUP,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,RADIATION,RESULTS,RTOG,SEVENTY,THERAPY,UNIVARIATE,V20,V30,V40,V50,V60
100,160,177,8201,A549,BACKGROUND,CELL,CONCLUSION,LABEL,LUNG,METHODS,NON,NSCLC,PARP3,PCR,RESULTS,SAOS,SMALL,TELOMERASE,TRAP,WESTERN
493,BACKGROUND,BC28,CONCLUSION,CONTEXT,LABEL,METHODS,MMP40,OBJECTIVE,OBJECTIVES,RESULTS,RPP40
160,169,183,1980,2006,2013,6815,901,FINLAND,HODGKIN,JOHN,LTD,NHL,POISSON,RRS,SONS,WILEY
001,004,027,029,133,2002,2009,2012,8201,BETWEEN,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THUS
A549,BAX,BCL,COX,EGFR,WESTERN
000,001,1423,173,2000,2012,ANTITUMOR,BACKGROUND,BONE,EASTERN,GROUP,JANUARY,LABEL,METHODS,PATIENT,RESULTS,SOLID
AKT,ANTI,BACKGROUND,BCL,IC50,K562,LABEL,MATERIALS,METHODS,MV4,RESULTS,THERE,THESE,WESTERN
AFRO,EMRO,EURO,LDR,MDR,PAHO,SEARO,SMCB,WPRO
412,AIM,BACKGROUND,FINE,FNAC,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,RESULTS
000,0001,100,177,2000,2007,2010,206,AGE,AMONG,APC,ASR,BACKGROUND,CONTINUING,EDUCATION,IRAQ,LABEL,LUNG,MATERIALS,MEDICAL,METHODS,MOSUL,POISSON,REGISTY,RESULTS,SCC,SINCE
43NG,593,652,716,71NG,726,740,780,787,812,838,858,872,884,888,923,974,AFP,AUC,CA125,CA153,CA199,CEA,HENCE,KRUSKAL,MANN,MPES,THERE,THUS,WHITNEY
107,AIM,BACKGROUND,GROUP,GUIDELINES,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,STUDENT,TURKISH
545,AMONG,CHINESE,MPM,THERE
001,002,072,151,ASIAN,BACKGROUND,EGFR,LABEL,MALAYSIAN,MATERIALS,METHODS,MUTATIONS,NEVER,NSCLC,RESULTS
011,038,194,ADJUSTMENT,CHECKLIST,CHINA,CHINESE,CIGARETTE,LABEL,MAC,METHODS,MINI,OBJECTIVE,PURPOSE,RESULTS,ROTTERDAM,RSCL,SICHUAN,SMOKERS,SMOKING,SYMPTOM,WEST
000,120,839,BACKGROUND,CONCLUSION,LABEL,LUNG,METHODS,MODERATELY,MVD,NSCLC,OBJECTIVE,OPN,RESULTS,WHILE
100,946,CAM,IHC,LOW,MUC18,NPC,NPCS,PCR,TGF,THESE
EGFR,ERLOTINIB,NSCLC,TKI,TKIS
0001,11E,15E,191,69E,71E,79E,COX,INFLUENCE,LONELINESS,MEIER,THEN
100,177,2011,2012,365,6TH,7TH,AVERAGE,BACKGROUND,LABEL,LATE,LUNG,MATERIALS,METHODS,NEPAL,OCTOBER,RESECTION,RESULTS,SEVENTY,SURGERY,THERE,THOSE,THREE,UNIT
956,AKT,C57BL,CD31,ERK,FAK,JNK,MAPK,MAPKS,MEK3,THESE,WESTERN
155,A549,CD133,CD338,EXPRESSION,HSA,LUNG,NSCLC,TICS
2007,2012,2YEAR,ACCORDING,BACKGROUND,EASTERN,ECOG,FORTY,GROUP,HOWEVER,LABEL,LUNG,MATERIALS,METHODS,NSCLC,PATIENT,RESULTS,SCC,TURKISH
001,006,177,2009,200X109,2011,8804,A549,COX,EXPRESSION,GAPDH,III,JANUARY,MEIER,MOUSE,NSCLC,SPC,THUS,TNM,USING
008,034,377,6P21,7P15,CHINESE,ESCC,GWASS,HAN,HENCE,HOWEVER,NCGC
000,073,100,159,1944,1972,200,2006,2009,210,238,270,681,939,977,AMONG,CLL,COX,MOUND,OTHER,RUSSIAN,SMR,SMRS,THERE,VITAL
113,2010,3085,3091,451,559,8805,AFTER,APRIL,CONCLUSION,DATA,JAPAN,KIRSTEN,LABEL,METHODS,OBJECTIVE,RESULTS
ACUTE,CTEPH,HOWEVER,LABEL,MEDICAL,MICE,OBJECTIVE,RESULTS,SEVERAL
160,1998,2009,3M0,4N0,754,814,BACKGROUND,CONCLUSION,FDG,GASTRIC,GROUP,ITALIAN,LABEL,METHODS,PET,RESULTS
177,428,478,557,577,954,BACKGROUND,FOUR,INITIATIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,REFINED,RESULTS,THERE,WHEREAS,WHI,WOMEN
737,ABT,BCL,BH3,MCL,MUTATIONS,NOXA,RESULTS,SCLC
17I,BXPC,COLO320DM,EPCAM,HOWEVER,MCF7,PCI,WIDR
947,ANTIGEN,CD4,CD8,CONCLUSION,CTL,CTLS,DCS,DENDRITIC,ELISA,ELISPOT,FLOW,IFN,LABEL,METHODS,OBJECTIVE,PROTECTION,PURPOSE,RESULTS,VEGFR,WHILE
000,180,330,383,457,802,956,BACKGROUND,CONCLUSION,LABEL,LUNG,METHODS,RESULTS,SCREENING,THERE
169,2014,946,AIMS,BACKGROUND,BASEL,CD69,CONCLUSION,GANODERMA,LABEL,LUNG,METHODS,MTT,OBJECTIVE,PGE2,PHA,RESULTS,TGF,VEGF
169,2014,280,BASEL,LUNG,PAS,PET,PULMONARY,UNDER
169,2014,DUE,ERS,FURTHER,HOWEVER
169,2014,AGE,BASED,ERS,LUNG,NLST,SCREENING,TREATMENT,TRIAL
169,2014,3Q26,953,COPYRIGHT,HHAT,INC,LSCC,PKC,PRIMARY,PRKCI,PROTEIN,SOX2,THUS
160,169,2014,953,CELL,COPYRIGHT,GLI,GROWING,INC,JUSTILIEN,PKC,SOX2
002,100,CONCLUSION,FDG,HISTOLOGIC,HOUNSFIELD,LABEL,LUNG,LYMPH,METHODS,PET,RESULTS,SIXTY,THEREFORE,THESE,THREE,UNLABELLED
100,169,2014,945,946,COPYRIGHT,ESTRADIOL,INC,MALAT,MB231,MCF7
002,003,006,007,008,012,013,015,021,025,032,035,036,037,039,040,045,177,1995,2011,248,762,8805,AMERICA,BMI,EXCLUDING,FOUNDATION,FURTHER,GROUP,IIA,IIB,III,JANUARY,LABEL,METHODS,MGFA,MYASTHENIA,OBJECTIVE,OBJECTIVES,PACO2,POMC,RESULTS,THYMECTOMY,UNIVARIATE,VITAL
169,2014,A549,ANNEXIN,COPYRIGHT,DATA,DEAD,LIVE,LNC,MTT,THESE,TRETINOIN,TTN
169,2014,363,AMONG,CAUCASIANS,COPYRIGHT,GWAS,INC,MASSARRAY,NSCLC,PUBLISHED,SNPS
007,169,2003,2011,2014,BACKGROUND,CONCLUSION,COPYRIGHT,CSF,ENTERPRISE,GUIDE,INC,LABEL,MEAN,METHODS,NSCLC,RESULTS,SAS,THESE
169,1950,1980S,2014,ADC,AMERICA,AUSTRALIA,CONTINENTS,COPYRIGHT,DENMARK,EARLY,FIVE,FURTHER,ICELAND,INCIDENCE,IRELAND,LABEL,LTD,METHODS,NORTH,OBJECTIVE,OBJECTIVES,OCEANIA,RESULTS,SCC,VOLUMES
001,002,004,008,028,029,037,055,114,169,2008,2013,2014,991,BACKGROUND,COPYRIGHT,HIGH,IRELAND,JULY,LABEL,LTD,METHODS,NLR,NSCLC,RESULTS,VTE
177,293T,8764,945,946,99M,BXPC,CYSTINE,H2O,H838,HCC4006,NEXT,RENAL,S02,SAAC,SPECT,THEREFORE
1000,123,177,183,195,881,937,956,ABCB1,ASP,FITC,H441,ICC,NCI,NCL,OCT,OCT1,OCT2,OCT3,OCTN,OCTN1,OCTN2,RH123,SLC22A1,TEA,TEER,THESE,VMAX,WESTERN
169,2014,A549,BSA,DOX,FINALLY,JOHN,MTT,NPS,SONS,WILEY
1997,2009,967,BACKGROUND,EDI,INDEX,LABEL,METHODS,PAF,POISSON,POPULATION,RESULTS
15TH,2013,40TH,CONFERENCE,COPYRIGHT,IASLC,LUNG,PROUS,SCIENCE,WORLD
CYCLE,DESPITE,HOWEVER,MRI,PATIENT,SSFP,THESE
004,019,021,107,BACKGROUND,BOTH,BRF2,LABEL,METHODS,MVD,NSCLC,PCR,RESULTS,WESTERN
29C,429,534,723,727,ALTERED,BACKGROUND,BOTH,LABEL,METHODS,NSCLC,PCR,RESULTS,ROC
135,188,2009,2010,2011,2012,249,295,311,855,BLOOD,CARDS,DIETARY,DIGESTIVE,FYS,HEART,HNRIM,INSTITUTE,LUNG,MANAGEMENT,NIH,NUTRITION,ODS,THEREFORE
2014,3249,AMERICA,AMONG,ASIA,CENTRAL,FURTHER,HPV,HPV16,HPV18,NORTH,PRESS,PUBLISHED,SOUTH,UNIVERSITY,WHITE
945,946,BACKGROUND,BALF,BRONCHO,CPAP,LABEL,LUMINEX,MCP,METHODS,MIP,PARC,RESULTS,SERUM
002,AIM,BACKGROUND,C30,CONCLUSION,INDWELLING,ITEMS,LABEL,LC13,LIFE,MALIGNANT,METHODS,OBJECTIVE,QLQ,QUALITY,RESULTS,SPAIN,TREATMENT
169,2014,JOHN,LTD,SC35,SF3B1,SF3B155,SONS,SRSF2,THESE,U2AF1,URP,WILEY,ZRSR2
169,2014,353,AFTER,AKT,COPYRIGHT,FINALLY,HRS,III,MEDLINE,NSCLC,UICC
023,038,APE1,ASP148GLU,BER,CAUCASIANS,HOWEVER,ORS
001,013,032,160,179,187,1997,2011,338,355,492,902,915,AFTER,BACKGROUND,CONCLUSION,IIIA,LABEL,METHODS,PFS,RESULTS,SEVENTEEN,SURGERY,TREATMENT
002,208,315,549,BACKGROUND,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,PCR,RESULTS,SAM68,TNM,WESTERN
169,2014,916,961,AAA,ALTO,BOARD,D95,ECLIPSE,JAPAN,MEDICAL,PALO,PBC,PRESS,PTV,PUBLISHED,RADIATION,SBRT,SOCIETY,SYSTEMS,THESE,UNDER,UNIVERSITY
169,2013,750MG,AML,COPYRIGHT,EGFR,LTD,NOVEL,PRIOR,WHILE
NRP2,THESE,VEGF
169,2014,207,231,438,BACKGROUND,CONCLUSION,COPYRIGHT,IIIA,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,RESULTS,RFS,WHILE
007,039,1997,2009,467,7153,ACUTE,ANZDATA,AUSTRALIAN,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,RECIPIENTS,RESULTS,THERE,TRANSPLANT,USING,ZEALAND
200,2400,CD133,GBM,THESE
A549,GATA,GATA2,HOWEVER,KRAS,NPSIGATA2,NSCLC,SYNTHETIC
001,177,72H,956,A549,ANNEXIN,BAX,BCL,CHRYSIN,CONCLUSION,HONEY,IC50,LABEL,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,REACTIVITY,RESULTS
9552,A549,COMPOUNDS,GSTP1,ME2N,PARP
003,005,012,199,2003,2006,BACKGROUND,BUNDANG,DFS,JULY,KOREA,LABEL,MAY,METHODS,NSCLC,RESULTS,SEOUL,SPECIAL,UNIVERSITY
8764,BECAUSE,BRG1,BRM,DECODER,DEFECTS,DEPLETION,H3K9ME3,SMARCA2,SMARCA4,SNF,SWI
121,1287,169,2014,AACR,AKT,ECD,EGF,EGFR,ERK,FIRST,HER2,HER3,HER4,LESS,PI3K,RAS
250,300,400,ATP,HOWEVER,KINASES,LARGE,MRM,THEREFORE
CRITICALLY,RNAI,ST6GALNAC2,THESE,USING
182,ADAM9,CD44,CDH9,FOXO3,KNOCKDOWN,REPRESSION,SP1
1321,169,2014,562,741,993,AUTHORS,BRM,JOHN,LTD,SONS,THERE,THESE,UADT,WILEY
100,A549,EXPRESSION,FMG,GALV,GNHU,HFL,HSV,VERO,VIRAL
160,693,CONCLUSION,FOURIER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
156,2009,2012,BETWEEN,CONCLUSION,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PRFA,PURPOSE,RESULTS
008,BAL,EARLY,KRAS,NON,NSCLC,PCR
169,2014,BACKGROUND,DNB,LABEL,MOTIVATION,PRESS,PUBLISHED,RESULTS,UNIVERSITY
169,2014,LABEL,METHODS,MICRORNAS,PRESS,PUBLISHED,SURVMICRO,THEIR,THEREFORE,THUS,UNIVERSITY,UNLABELLED
3AB,3AC,7404,945,946,956,BEL,H460,HEPG2,IC50,NCI,SKOV3
100,1070,1137,142,149,1996,2004,2005,2010,2207,AICHI,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,THEREFORE
001,007,108,1471G,253,276,361,8201,CRS,LABEL,LUNG,PCR,TAKEN,UNASSIGNED,UNLABELLED,XRCC1
8201,887,HOWEVER,IFMA,MTC,NCLC,SCLC,SRM
169,2014,8320,8325,COPYRIGHT,EGFR,FURTHER,HSP90,SAS,THESE,WESTERN
215,FNAC,SCLEROSING,TOMOGRAPHY
0001,002,005,177,439,481,683,BACKGROUND,CD34,CONCLUSION,HIGH,HPF,LABEL,MAST,MATERIALS,MCD,MEAN,MEASURING,METHODS,MOST,MVD,RESULTS,THUS,TOLOUIDINE
8804,ADDITIONAL,CONCLUSION,GRADE,LABEL,LATE,LOCAL,MATERIALS,METHODS,NINE,OBJECTIVE,OBJECTIVES,RESULTS,SBRT,THERE,V10
128,177,967,DATA,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PICC,PURPOSE,RESULTS,SEM,SPSS,WINDOWS
200,AIM,ASIAN,CHINESE,GENOTYPING,LABEL,MASSARRAY,MATERIALS,METHODS,NSCLC,OBJECTIVE,PSMA4,RESULTS,SETTING,SNPS,TGM5,THERE,USED
CLINICALLY,HEAT,HSP90,HSPS
ACTIVATION,GPCRS,S1P,SIGNALING
215,BACKGROUND,COMMITTEE,FIVE,FOUR,JOINT,LABEL,LOW,M1B,M1C,METHODS,NINE,RESULTS
273,ACS,AFFYMETRIX,AMONG,BACKGROUND,CEACAM1,DATA,EXPRESSION,HIGH,IHC,LABEL,METHODS,PCR,RESULTS,TCS
111,167,169,2014,244,8804,BACKGROUND,COPYRIGHT,IIA,IIB,IIIA,IIIB,INC,LABEL,METASTASIS,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY

LUNG,NSCLC
200,946,ECM,TGF,THESE,TNBC,ZEB,ZEB2
169,2014,BASED,COPYRIGHT,EARLY,EVALUATION,FDG,INC,PET,SOLID
ALK,BACKGROUND,CONCLUSION,HIP1,LABEL,METHODS,RESULTS,REVERSE
009,063,1992,2012,AMONG,APC,BACKGROUND,CONCLUSION,DATA,FORTY,HOPKINS,JANUARY,JOHNS,LABEL,MEIER,METHODS,PATHOLOGY,RESULTS
100,10MG,178,DL1,DL2,EASTERN,EIGHT,GRADE,GROUP,PRIMARY,SECONDARY
100,132,156,5040,8805,BACKGROUND,FURTHER,GROUP,IDL,LABEL,MALIGNANCY,MASAOKA,METHODS,RESULTS,THESE
1227,1365,172,1982,2012,202,230,301,313,401,503,596,690,ACCORDING,AFTER,BACKGROUND,EPP,LABEL,METHODS,MPM,RESULTS,SURGERY
048,ANALYZING,BACKGROUND,HOWEVER,III,LABEL,METHODS,NSCLC,PET,RESULTS,SUV,TNM
0001,001,036,131,177,198,2010,2012,273,70YRS,8805,BACKGROUND,CONCLUSION,EBUS,FOUR,HOWEVER,LABEL,MARCH,MEAN,METHODS,OLDER,PROCEDURE,RESULTS,TBNA
BACKGROUND,CANDIDATE,CONCLUSION,DIGE,IHC,INGENUITY,LABEL,MAP,MAPS,METHODS,PATHWAY,PRINCIPAL,RESULTS,RSSA,RUVB1,SCLC,SCLCS,SMALL,SUBSEQUENT,THESE,WESTERN
150,3244,ALK,ANAPLASTIC,BACKGROUND,CRIZOTINIB,FISH,IHC,LABEL,METHODS,NSCLC,RESULTS,STRIKINGLY,THUS
MIB,SCLC
AAP,ALRI,BACKGROUND,COPD,ESTIMATING,HOWEVER,IER,IHD,LABEL,METHODS,OBJECTIVE,PAF,PAFS,PM2,RESULTS
346,945,EGF,EGFR,EREG,IC50,IGG4,LY3016859,TGF,TGFA
169,2011,2012,2014,COPYRIGHT,FIFTY,INC,KNOWLEDGE,LABEL,LDCT,METHODS,MOST,OBJECTIVE,RESULTS,SEPTEMBER,SMOKERS
169,2014,301,441,535,AFTER,COX,EARLY,FZD4,JOINT,MAYO,NSCLC,PRESS,PUBLISHED,RESULTS,SNP,SNPS,UNIVERSITY,WNT,WNT16
125,ACTIVATING,ARTIFICIAL,BACKGROUND,COLD,EGFR,LABEL,MATERIALS,METHODS,PCR,RESULTS,T790M,THESE,TKI,TKIS,UNTIL
001,012,028,032,114,188,ASIA,BACKGROUND,DEVELOPING,FEW,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STUDIES
100,BACKGROUND,CONCLUSION,INCREASING,LABEL,LOS,METHODS,NCSLC,OBJECTIVE,PCU,RACF,RACFS,RESULTS,SPSS
8482,AFTER,BACKGROUND,CASE,CONCLUSION,CTCAE,EGFR,GRADE,LABEL,METHODS
ENDOSCOPIC,METASTASES
000,155,2013,2470,4099,4100,53000,ACCORDING,DANTE,DLSCT,DOES,INTERIM,LOW,LUNG,MILD,NLST,PLCO,PRESCRIRE
945,ALDH1,BMI1,CD133,CSCS,EMT,EPITHELIAL,HOWEVER,HYBRIDS,MSCS,NANOG,NOD,NSCLC,OCT4,SCID,SMA,SOX2,THESE,THUS
121,183,300,CURRENT,NGS,RESTART,THESE,UTILIZING,VARWALKER,WALK
176,177,216,A549,HEPG2,MCF7,NPS,REALGAR
070,BCL,CD4,CD8,CTLA,FOXP3,GX15,PBMCS,TAKEN,THESE,TREG,TREGS
169,2014,AACR,EARLY,GENERAL,NSCLC,SURGEON
ABOUT,BONE,HOWEVER
480,CONCLUSION,COX,DATA,DCR,DITR,EVALUATION,LABEL,METHODS,METRICS,MODEL,NONE,OBJECTIVE,PURPOSE,REGARDLESS,RESULTS,SOLID,TRITR
001,169,2009,2010,2014,297,AUDIT,AUTHORS,CARE,DIAGNOSIS,ENGLISH,INC,IQR,PRIMARY,PUBLISHED,ROUTINELY,THESE,UICC,USING,WILEY
EPA,EPM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PLA,RESULTS,TTF
100,160,2007,2012,ALK,CYTOLOGIC,EGFR,HISTOLOGIC,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE
ASIAN,CHINESE,EAST,FORTY,GSTM1,HAN,P73,XRCC1
001,222,8201,AMONG,CHINA,COX,PFS,SPECIMENS,XELOX
177,2011,2013,ADVERSE,CAUTIONARY,CONTROL,CTCAE,ELECTRONIC,EPR,LABEL,MAY,METHODS,OBJECTIVE,OSCIR,PATIENT,RESULTS,SUNNYBROOK,SYMPTOM,TIME,USING
FNA,INITIAL,SUBSEQUENT,TREATMENT,ULTRASOUND
GASTRIC,UPPER
945,AMP,AMPK,KNOCK,THEREFORE,THESE
AFTER,EIGHT,ENDOSCOPY,FIVE,PRIMARY
A2780,A2780CP70,A549,BDI,CANCERS,FLOW,REMARKABLY
169,2014,946,AACR,ECTOPIC,ICAT,INHIBITOR,NEDD9,RAC,RAC1,TCF,TRANSITION
HOWEVER,LABEL,RAS,REDUCED,THESE,TREATMENT,UNLABELLED,WNT5A
0004,002,0021,027,148,364,CBCT,CBCT1,CBCT2,CBCT3,CBCT4,CBCT5,GTV,GTVS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SBRT,UNIVARIATE
ACUTE,ADH,DESPITE,SIADH
156,A114,A117,ATP,DFG,FGF,FGFR,FGFR1,FIBROBLAST,GENERALLY
169,2014,ADSQ,ADSQS,BACKGROUND,CEA,COPYRIGHT,FISH,IRELAND,LABEL,LTD,MAML2,MEC,METHODS,RESULTS,THEREFORE,THESE,TTF
021,024,169,2014,381,ALK,BACKGROUND,COPYRIGHT,EGFR,FISH,IRELAND,KRAS,LABEL,LTD,METHODS,NSCLC,RESULTS
10A,12810,169,178,2014,66027,956,A549,ATCC,ATCC66027,CANDIDA,COPYRIGHT,HEPG2,HVS,LTD,MCF,MIC,THERE
141,169,2013,208,8805,BOTH,CHS,COPYRIGHT,EBUS,LABEL,METHODS,NPV,OBJECTIVE,PPV,PUBLISHED,RESULTS,SEPAR,SIX,THESE
384,4300,460,8211,AIMS,ATM,ATMATRDNA,ATR,BACKGROUND,BRAF,HOWEVER,KRAS,LABEL,METHODS,OBJECTIVE,OIS,PIF1,RBL1,RESULTS,RNF43,SSAS,TELO2,THROUGH,XAF1
169,2014,A549,C47S,COPYRIGHT,ERK1,GPX,H460,INC,NCI,NUDE,PRDX6,THEREFORE,WESTERN
160,169,200,2014,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,EVALUATION,GANETESPIB,GROUP,HER2,HOWEVER,HSP90,INC,LABEL,MBC,METHODS,MOST,ORR,REPONSE,RESULTS,SIMON,SOLID,THERAPY,TNBC
100,BACKGROUND,DICE,LABEL,METHODS,PET,RADIATION,RESULTS,TEN
174,A549,ATM,ATR,BACKGROUND,EUTDA,GENERALLY,H23,HDAC,LABEL,METHODS,NCI,NKG2D,NSCLC,PCR,PREVIOUSLY,RAD3,RESULTS,SURFACE,THEREFORE
177,ACCORDING,BACKGROUND,LABEL,METHODS,QUICKLY,RESULTS,SEVENTY,UNDER,VATS
EARLY,III,NSCLC,PHASE,PROGRAMMED,THEIR,WHILE
13794,160,7400,7402,8805,956,AREA,CONVERSION,DEPOSIT,DIFFERENT,EMP,GIVEN,HYGIENE,INSTITUTE,IRON,ISO,JOURNAL,MICRO,MINNESOTA,MOUDI,NIOSH,ORIFICE,RANGE,THEREFORE,UNIFORM
002,036,BACKGROUND,CONCLUSION,DEPARTMENT,LABEL,LUNG,MANN,METHODS,MOST,NUTRITION,OBJECTIVE,RAJAVITHI,RESULTS,SIXTY,STUDIED,THEREFORE,UNIT,WHITNEY
100,ACETATE,AERVA,ALCF,ALEAF,CHLOROFORM,ETHYL,SRB,THERE
PULMONARY
1ST,2ND,3RD,7TH,CD133,HCC,HOWEVER,LIVER
0001,001,039,067,071,2006,2013,266,GIVEN,NON,NSCLC
305,AIM,CONCLUSION,DIFFERENCE,INTENSITY,LABEL,METHODS,NUMERICAL,OBJECTIVE,OVERALL,PAIN,RESULTS,SCALE
316,BACKGROUND,CONCERNING,CONCLUSION,LABEL,METHODS,RESULTS,THREE
500,600,ANTIGEN,BACKGROUND,CONCLUSION,DISEASE,KARNOFSKY,LABEL,LIFE,METHODS,PRIMARY,RESULTS,REVIA,TEN,THESE,THIOCTACID
177,285,AIM,CONCLUSION,ECOG,III,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVENTEEN
2007,2009,2010,2011,579,EASTERN,GROUP,MAXIMUM,PRT,RPA
BACKGROUND,CASE,DISCUSSION,EMA,GFAP,LABEL,LOCATIONS,METHODS,THERE,THREE
001,354,AIM,AMONG,CEA,CONCLUSION,CYFRA,FDG,HOWEVER,LABEL,MANN,METHODS,NSCLC,OBJECTIVE,PET,RESULTS,SCC,WHITNEY
1991,2004,BACKGROUND,BECAUSE,CONCLUSION,DESPITE,EXAMINING,LABEL,MALIGNANT,METHODS,MPNST,OVERALL,RESULTS,THEREFORE
004,019,036,AIM,BACKGROUND,HEAT,HSP90B1,HSPS,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,REAL,RESULTS,TURKISH
AIM,BRAF,CONCLUSION,EGFR,KIRSTEN,KRAS,LABEL,METHODS,MUTATIONAL,OBJECTIVE,RESULTS,SMALL
AMONG,BACKGROUND,CONCLUSION,EUKARYOTIC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,THERE
CRC,EGFR,EPIDERMAL,KIRSTEN,KRAS,L858R,NSCLC,T790M
169,2014,PHASE,UICC,UNTIL
169,2013,COPYRIGHT,DESPITE,INC,JOHN,LUNG,MOUSE,SONS,WILEY
040,042,169,2014,8805,AUTHORS,CASES,COX,DATA,GAMMA,III,INCREASED,JOHN,KNIFE,LOCAL,LTD,PROGNOSTIC,SONS,SRS,WBRT,WILEY
0354,169,2014,211H,954,AUTHORS,CHRONIC,H2052,H28,IMD,JOHN,LTD,MSTO,NCI,SONS,THESE,WILEY
1961,2005,422,DATA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,THERE
A549,BLOT,CMVP,FUSOGENIC,GALV,GNHU5,HFL,HSV,PROTEIN,TYPE,UL38,UL38P,WESTERN
001,012,2003,2008,302,304,409,HAPLOTYPES,IIIA,IIIB,JANUARY,KAZAL,NSCLC,RECK,SEPTEMBER
183,GLOW,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,ROS,UPON,USING
001,121,124,2C19,321,420,CHINESE,CYP,CYP2C19,CYTOCHROME,EETS,P450,PCR,RFLP
H460,HOWEVER,WESTERN
002,003,009,018,037,042,138,COX,ELISA,KLK11,MEIER,NSCLC,PFS,SERUM,UNIVARIATE
011,100,160,280,524,8201,8805,BLD,ELISA,LMTK3,MEIER,NSCLC,ROC,SERA
169,2014,442,946,CELLS,EASP,EMT,FOUR,GELC,PRESS,PUBLISHED,RSF,SIMILAR,THESE,UNIVERSITY,UTILIZING
2014,CHANGES,LEWIS,PRESS,PUBLISHED,THESE,UNIVERSITY
16Q23,WWOX
946,DUSP1,G12D,HES1,HOWEVER,KRAS,LUNG,MAPK,NOTCH,NSCLC,RAS,THESE,TTF1,USING
001,002,100,3Q27,BACKGROUND,DNP63,FORTY,LABEL,METHODS,P63,PCR,RESULTS,SIX,TAP63,THERE,THEREFORE
ASSOCIATED,DIAGNOSIS,HOWEVER,MALT,MALT1,PROGNOSIS,PULMONARY
CAM,CAR,CD171,CE7,CE7R,OVERALL,THUS
175,1998,2002,437,8197,874,ARP,BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,ORS,PUBLISHED,PUBLISHING,RESULTS
BRST,CDX2,CK20,CK7,FIRST,HOWEVER,METASTASES,PSA,SHIELDS,THESE,TTF,UVEAL
ALK,BECAUSE,EGFR,PRESENTLY
169,2014,A549,AIMS,BOTH,CARDAMONIN,CELL,COPYRIGHT,FK506,HOWEVER,INC,KEY,LABEL,MAIN,MEANWHILE,METHODS,MTT,OBJECTIVE,RAPAMYCIN,RESULTS,TREATED,WESTERN
169,2014,COPYRIGHT,INC,RAPAMYCIN
00001,001,004,006,1122,169,2014,895,CAD,COPYRIGHT,FOUR,GWAS,HOWEVER,MAPK,MAX,PLEKHG5,PPI,SMAD3,SNPS,T2D,THESE,TIAM1,TYPE
169,1998,2014,947,BED,CONCLUSION,COPYRIGHT,DAH,IMRT,IRELAND,LABEL,LOW,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2013,241,APAAP,COPYRIGHT,EGFR,ERCC1,ESPA,EXPRESSION,FNABS,III,LABEL,METHODS,NSCLC,OBJECTIVE,PORTUGUESA,PUBLISHED,PURPOSE,RESULTS,SOCIEDADE
169,2014,BACKGROUND,COPYRIGHT,DECORIN,GENERAL,ISSUE,LABEL,MAJOR,METHODS,PARTICULAR,SCOPE,SLRP,SLRPS,SMALL,SPECIAL
169,2014,786,COPYRIGHT,HUH,IRELAND,LTD,LU65,MAPK,MEK,MKN28,PP2A,PP2AC,TAKEN,TUNEL
000,108,169,177,2000,2012,2014,AVERAGE,COPYRIGHT,INC,JANUARY,JULY,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THREE
005,118,145,160,169,174,1996,2009,2014,204,AMONG,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METASTASIS,METHODS,MOSBY,PREDICTORS,PUBLISHED,PULMONARY,RECURRENCE,RESULTS,SURGERY
100,160,169,177,2014,COPYRIGHT,INC,LABEL,METHODS,MOSBY,MRI,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
001,108,111,122,160,169,1997,2011,2014,230,COPYRIGHT,COX,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,RESULTS,SURGERY,UNIVARIATE
0001,151,160,169,177,2004,2010,2014,458,ADULT,AGE,COPYRIGHT,DFS,EVALUATION,INC,JUNE,LABEL,METHODS,MOSBY,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SBRT,SURGERY
001,008,024,031,037,045,169,2014,568,609,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
100,169,2014,946,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,RESULTS
169,2014,COPD,COPYRIGHT,INC,THESE
169,2014,CHRONIC,COPYRIGHT,INC,OXIDATIVE,TREATMENT
005,084,157,169,2014,221,302,554,APOB,COPYRIGHT,GWASS,INC,LDL,LDLR,PCSK9,PUBLISHED,SNPS,SOCIETY
000,1511G,169,200,2014,208,330,331G,361C,482C,538,AFRICAN,ANGPTL8,ARG504HIS,ARRAY,CHD,COL18A1,COPYRIGHT,EXOME,GLY111ARG,HDL,INC,LDL,LOW,NONE,PCSK7,PCSK9,PUBLISHED,SER161LEU,SOCIETY
169,2014,ADAM,CHEMOKINES,COPYRIGHT,CXCR6,ESFT,EWING,INC,UNIVARIATE,USING
169,171,187,2013,COPYRIGHT,HOWEVER,PUBLISHED,SEPAR
2005,2012,AMONG,BACKGROUND,CAREFUL,CHINA,CONCLUSION,DEPARTMENT,EIGHT,LABEL,MEC,METHODS,RESULTS,SEVEN,SICHUAN,WEST
033,160,169,2001,2011,2014,479,557,8804,COPYRIGHT,COX,INC,JANUARY,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SUCCESSFUL,SURGERY,USING
169,2008,2013,AIMS,BACKGROUND,COPYRIGHT,HOWEVER,INCA,INSTITUTE,LABEL,MANAGEMENT,METHODS,OBJECTIVE,PRIOR,RESULTS,SAS,SINCE
037,CLARK,LABEL,METHODS,OBJECTIVE,RESULTS,TNM
2001,2012,8805,AMONG,CHINESE,CHM,CONCLUSION,JANUARY,KARNOFSKY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SEVENTY,UNDER,UNIVARIATE,UNIVERSITY
100,177,181,8314,8315,CD28,CD3,CD68,CD8,CONCLUSION,LABEL,METHODS,MULTI,OBJECTIVE,RESULTS
260,AMONG,CHINA,CONCLUSION,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,ODDS,PUBLISHED,RESULTS,XUANWEI
LUNG
107,137,160,169,177,2000,2012,2014,205,BACKGROUND,CONCLUSION,ESTIMATION,JANUARY,JOHN,LABEL,LTD,LUNG,MARCH,MEAN,METHODS,PUBLISHED,RADIATION,RESULTS,SONS,WILEY
112,4DCT,CTV,CTVS,DESPITE,III,IMPT,LABEL,METHODS,OBJECTIVE,PTVS,PURPOSE,RESULTS,UNDER,UNIFORM,V20,V40,V55
8776,COM,EUCLIDEAN,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE
208,266,ACA,CNA,CNAS,LUNG,NSCLC,SCC
000,150,BACKGROUND,CONCLUSION,FOUNDRY,HIGH,LABEL,METHODS,RESULTS,SMR
BACKGROUND,CHINESE,CHUANXIONG,CONSISTENT,CXCR4,HOWEVER,LABEL,PCR,PRINCIPAL,RESULTS,SDF,THESE,TMP,USING,WHOLE
ANTI,BACKGROUND,COPD,GCLM,HOWEVER,KEAP1,LABEL,NQO1,NRF2,NUCLEAR,PRINCIPAL,RESULTS,SKI,THUS,USING
963,A549,ATM,CDK1,CHK1,CUC,DSBS,NAC,ROS,STAT3,TAKEN,THESE
946,A549,AKT,CL1,ERK,FDA,JNK,NAD,NQO1,PI3K
001,BOTH,CELLS,DESPITE,EMT,H1299,H460,LK2,MEANWHILE,NSCLC,SPC
450,545,CDK4
CLINICALLY,DAPI,INCREASED,MINA,NO52,SILENCING,TAKEN
177,185,8202,8312,AREA,CONCLUSION,CURVE,FDG,IIIA,LABEL,LATE,METHODS,NON,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,ROC,THREE,UNDER,VALUE
BACKGROUND,BAL,LABEL,MANAGEMENT,PR8,PRINCIPAL,RESULTS,SERUM,THROUGH
METASTASES
A549,AGNO3,AGNPS,B16,CHINESE,CHO,FINALLY,FIRSTLY,H9C2,HUVEC,MCF7,OLAX,THIRDLY
111,177,945,946,99M,AAT,CONCLUSION,GIVEN,IHC,LABEL,MBQ,METHODS,MTD,OBJECTIVE,PEG4,PREVIOUSLY,PURPOSE,RESULTS,RGD,TRT,U87MG
AMONG,FIVE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,SPECIAL,THERE
033,CCAT2,CEA,NSCLC,SILENCING
0001,0007,0087,011,048,1369,177,1980,2011,703,8804,8805,ADJUSTING,AMONG,BMI,CONCLUSION,HOWEVER,KNOWLEDGE,LABEL,METHODS,MISSING,OBESITY,OBJECTIVE,OBJECTIVES,RESULTS,UNIVARIATE
163,197,2011,230,ALK,DATA,EML4,ERG,ESRRA,III,PCR,SALZMAN,TMPRSS2
0001,020,AFTER,CHANGES,CONCLUSION,FLT,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PRIMARY,PURPOSE,RESULTS,SIMILAR,SIXTEEN,SUV,THESE
013,134,600,CAUSE,FOUR,GAMMA,GKRS,KNIFE,LENT,LOCAL,MEAN,OVERALL,SOMA,UNIVARIATE
ANTI,FINALLY,FIRST,FURTHER,LABEL,NSCLC,OPINION,PATIENT,PD1,RCC,STATEMENT,THESE,THUS,UNASSIGNED,VARIOUS
128,387,414,956,AILUROPODA,FURTHER,GIANT,HEP,HISTOLOGY,L22,L22E,MEANWHILE,MTT,PANDA,PCR,PRIMARY,RPL22
21Q22,8Q21,AFTER,ALK,AML,CAREFUL,CD68,MTX,MYELOID,SUBSEQUENT
2156,421,835,843,AUSTRALIA,BACKGROUND,BRITISH,FIVE,HOUSEHOLD,LABEL,METHODS,MIDLIFE,MODEL,PANEL,RESULTS,RETIREMENT,SIBLING,THESE,WISCONSIN
001,038,051,1620,1874,203,ADC,ADCS,AMONG,BACKGROUND,CCDC6,CELLS,FISH,KIF5B,LABEL,METHODS,NSCLC,PCR,RESULTS,RET,SACS,SCCS
001,2000,2011,BACKGROUND,BETWEEN,FORTY,GROUP,JANUARY,JULY,LABEL,METHODS,RESULTS,THREE
120,1ST,4TH,8TH,947,AIM,AKP,BOTH,CONCLUSION,DAILY,DAO,III,LABEL,METHODS,OBJECTIVE,RESULTS,VIII
FDG,FREE,HOWEVER,PET,SUV
0001,100,177,BLAND,COMMITTEE,CONCLUSION,FDG,JOINT,LABEL,METHODS,NSCLC,PET,RESULTS,SIZE,SUV,THERE,THESE,UNLABELLED
118,918,99M,BESIDES,CARLO,CONCLUSION,DVH,DVHS,FINALLY,HOWEVER,LABEL,MAA,MCNPX,METHODS,MIA,MIAS,MONTE,NORMALIZED,NTL,OAR,PMCD,RESULTS,SIRT,SPECT,THOSE,THUS,UNLABELLED
2012,416,422,838,BACKGROUND,BOTH,CROSS,GROUP,JUNE,LABEL,LOBECTOMY,METHODS,NSCLC,RESULTS,SCIENCE,SOLA,VATS,WEB
1971,2008,2050,AMSRS,ASMRS,AVOIDABLE,COMMUNITY,CONCERTED,FURTHER,MORTALITY,WORLD
945,954,ADENOVIRAL,BACKGROUND,CLIC4,CONCLUSION,INCREASED,LABEL,METHODS,RESULTS,SIMILARLY
945,ADC,CILC4,CLIC4,EGFR,KRAS,S100,S100A11,THESE
VARIOUS
2009,2011,AFTER,BRAF,JANUARY,PTC,RET,V600E
AIM,C30,CHARACTER,DATA,EORTC,HRQOL,INVENTORY,LABEL,LUNG,METHODS,OBJECTIVE,QLQ,QOL,RESULTS
0008,001,012,014,1999,2008,412,426,AIM,BACKGROUND,COPD,IIB,IIIA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,WOMEN
049,123,125,151,157,180,196,200,213,273,275,298,309,316,330,376,401,AIMS,BACKGROUND,III,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS,THERE,TIME
2005,2011,249,8805,AIMS,BACKGROUND,ECOG,FEW,III,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,UNIT
142,206,26E,401,543,850,89E,ANNOTATION,DEGS,DISCOVERY,EXPRESSION,FINALLY,GATA2,HLA,INTEGRATED,MYBL2,NEXT,OMNIBUS,RAMP1,WISP1
177,178,181,198,209,269,349,476,482,590,591,795,954,955,AFFILIATED,COLLEGE,COPD,DEPARTMENT,ELISA,FEV1,FLC,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SURGERY,THEIR
160,169,2014,320,BACKGROUND,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SOCIETY,SURGERY
169,2014,ACCURAY,COPYRIGHT,CYBERKNIFE,INC,LTD,ORAL,PUBLISHED,SUNNYVALE,USA
103,143,169,16GY,2014,246,25FX,34GY,50GY,COPYRIGHT,IMRT,INC,MEDICAL,MEV,PUBLISHED,THERE,V10,V30,WITHOUT
169,2014,947,A549,CD133,CDDP,COPYRIGHT,CSC,CSCS,DAPT,DPP,FACS,FEW,FINDING,GSI,HES1,INC,NOTCH,THESE
DVT

110,154,THEREFORE,ZAPOROZHYE
BMPM,BMPMS,BOTH,EVEN,PERITONEAL
2014,8P12,AACR,DISCOVERY,FGF,FGFR1,MYC,RECURRENT
2014,AACR,EMT,EPITHELIAL,SALT
024,035,039,042,2006,2013,AMONG,BILATERAL,FEV1,FVC,JUNE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,THERE
2013,NOVEL
169,2014,372,8804,AUTHORS,BACKGROUND,EASTERN,EGFR,GROUP,HER1,HER2,HER4,INC,KRAS,LABEL,METHODS,NSCLC,ORR,RESPONDERS,RESULTS,SIX,SOCIETY,TKI,WILEY
169,2014,8201,910,CD166,CSC,DUE,EXPRESSION,FEW,FURTHER,GRADING,NSCLC,PRESS
169,180,2014,ADCA,AUTHORS,BRAF,E545K,GLY972ARG,IRS,JOHN,KRAS,LTD,MAPK,PDPK1,PI3K,PTEN,REGARDING,SCC,SONS,SSC,WILEY
1A1,ADC,CD133,CD15,DC101,HOWEVER,NSCLC,SCC,VEGF
109,8201,AGFG1,AMONG,CHKA,CTC1,CXCL1,CXCL2,CXCL3,CXCL5,CXCL8,CXCL9,CXCR3,CXCR4,EXPRESSION,IL6,IL8,ITGA5,ITGB1,ITGB3,NSCLC,PCR,TNF
001,004,006,007,024,029,048,150,158,169,2014,222,8201,8805,BACKGROUND,BOARD,BRAF,BROAD,CONVERSELY,COX,EARLY,FURTHER,LABEL,LUNG,METHODS,NRAS,RESULTS,SOCIETY,TP53,UNDER
A375,AUGMENTED,C57BL,CAV1,HOWEVER,MELANOMAS,SIMILAR,THESE
005,035,066,BIOMARKERS,CITY,CONCLUSION,EBC,LABEL,LUNG,METHODS,MEXICAN,OBJECTIVE,PAHS,RESULTS
945,948,A549,EARLIER,EPITHELIAL,GOLGI,HYPOXIA,PKC
18F,ACCORDING,CLINICALLY,CUP,FDG,IMAGING,ISSUE,LABEL,METHODICAL,METHODS,MODALITIES,MRI,OBJECTIVE,PET,PRACTICAL,RESULTS,SUBSEQUENT,WHOLE
1961,2006,219,691,BACKGROUND,BASED,CIS,CONCLUSION,GENERATION,HOWEVER,HPV,LABEL,METHODS,MULTI,POISSON,REGISTERS,RESULTS,RRS,SWEDISH,THROUGH,WHILE
160,371,BACKGROUND,CLM,LABEL,METHODS,RECURRENCE,RESULTS,RFS,TSF
ASSESSING,ECM,TGFBI
174,D95,DVHS,IMRT,LABEL,MARGINS,METHODS,MULTI,OBJECTIVE,PURPOSE,RESULTS,SINUSOIDAL,SNS,TARGETS,THESE
EPR,FIRST,HOWEVER,THESE
2010,2012,270,ASIAN,BACKGROUND,BASED,CHRONIC,COPD,DISEASE,GOLD,HOWEVER,INITIATIVE,JULY,LABEL,LUNG,METHODS,RESULTS,THUS,UNIVERSITY
COMPOUNDS,HEP,MCF7,NMR,THEIR,VARIOUS,WEAK
1HR,AFTER,CASE,DEX
268,631,8211,963,CASE,HENCE,OVERALL
166,19Q13,676,8202,8308,8315,COPD,EGLN2,GWAS,LTBP4,MASSIVE,SINCE,STRIKINGLY,TGFB1,THESE
102,237,256,DATA,LUNG,MAYO,PRE,SCREENING,TRIAL
200,A549,BIP,CAR,CONCLUSION,DKK,EGFR,GRP78,JNK,JUN,LABEL,MATERIALS,METHODS,MOI,NSCLC,OBJECTIVE,OBJECTIVES,OUMS,REIC,RESULTS,THESE,TKI
946,AZA,BACKGROUND,BASED,CHROMATIN,CPG,HOWEVER,KAISO,LABEL,LTEP,METHODS,PCR,RESULTS,SPC
946,AKT,BACKGROUND,CONVERSELY,EFFECTS,GSK3,HIGH,LABEL,METHODS,NSCLC,PCNA,RESULTS
CELLS,CIGARETTE,EGFP,FPG,GREEN,H727,HENCE,NCI,PAH,PROTEIN
131,167,182,293T,369,AML,ATLAS,CAG,CELL,CONSISTENT,HELA,S34F,SEQ,TCGA,U2AF1,UAG,USING
4T1,CTC,CTCS,METASTASIS,THESE,USING
1020,500,740,760,860,COX,DETECTION,EGFR,HOWEVER,IGG,LUMINEX,NSCLC,SOMATIC,TKIS

ACCORDING,AWARENESS,HOWEVER,TYPICAL
CD24,HIPPO,KNOCKDOWN,METASTASIS,SCA1,TAZ,THESE,TPC,TPCS,YAP,YAP1
169,2014,AFFYMETRIX,AUTHORS,CIGARETTE,FINALLY,HNC,INGENUITY,IPA,JOHN,LTD,NSCLC,PAM,PATHWAY,PLUS,SMOKING,SNC,SONS,THUS,U133,WILEY
FINALLY,FIRST,GIVEN
174,177,189,204,210,215,226,230,232,234,304,331,367,CONTINUOUS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,WHETHER
945,BAX,BCL,HENCE,THESE,WESTERN
160,2000,2012,8201,BONE,CONCLUSION,DEEP,DISTANT,EXTREMITY,HIPAA,IRB,LABEL,LMS,MATERIALS,MDCT,METHODS,MRI,OBJECTIVE,PRIMARY,RESULTS,THERE
A549,CDK4,FOLLOWING,HOWEVER,KRAS,MNPS,MNPSICDK4,NSCLC
FOREIGN
000,010,035,068,090,124,155,162,177,2009,2012,216,230,382,433,513,AIM,AMONG,CONCLUSION,COX,FEV1,FIFTEEN,FVC,LABEL,LUNG,MEAN,METHODS,NIS,NSCLC,OBJECTIVE,OCTOBER,RESULTS,THERE
MPM
2003,ASK,BACKGROUND,DLIC,DUTCH,LABEL,LUNG,METHODS,MOST,OBJECTIVE,PHYSICIAN,RESULTS,SINCE
INHIBITION
A549,AIMS,EGFR,ERK,H1299,H89,INC,KEY,LABEL,MAIN,METHODS,NCI,NSCLC,NTS,NTSR1,OBJECTIVE,PKA,PUBLISHED,RESULTS,SR48692,THESE,TIRON,TREATMENT,WESTERN
132,2001,2005,485,BACKGROUND,CONCLUSION,COX,DETROIT,END,HRS,INCREASED,INTERVIEW,LABEL,METHODS,NSCLC,OCTOBER,POPULATION,RESULTS,THESE
100,ADDITIONAL,AES,BACKGROUND,BID,CONCLUSION,DOSE,EGFR,FORTY,LABEL,METHODS,MTD,MTDS,PI3K,RESULTS,SAR245409
ALK,ALKAS,BACKGROUND,BOTH,DISCOVERY,EML4,EXON,EXPRESSION,FINALLY,HIP1,LABEL,METHODS,NANOSTRING,NSCLC,PDX,RESULTS,SCREENING,SEQ
1069,134,2001,2006,845,BACKGROUND,LABEL,LY2,LYMPHATIC,METHODS,NSCLC,RESULTS,SINCE,THERE
BACKGROUND,BONE,H1299,LABEL,METHODS,NSCLC,OPG,RANK,RANKL,RESULTS,THESE
ANXIETY,BACKGROUND,BECAUSE,CONCLUSION,DEPRESSION,FORTY,IES,LABEL,METHODS,PTSD,RESULTS,SCALE
158,182,523,652,ALK,AMONG,BACKGROUND,FISH,LABEL,METHODS,NSCLC,PCR,RESULTS,SIX
577,BACKGROUND,END,LABEL,LIMITED,METHODS,NSCLC,OVERALL,RESULTS,VATS,VIDEO
000,100,2001,2006,388,493,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
BACKGROUND,FINALLY,GOBO,HC11,LABEL,METHODS,MKL1,RESULTS,SAP,USING
169,2014,956,COPYRIGHT,DECREASED,INC,LEWIS,PATHOLOGY,PUBLISHED,SOCIETY,TAKEN
001,003,008,169,2014,BOTH,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PURPOSE,RESULTS,SRS,SSBM,TRT,WBRT
169,2002,2009,2014,AFTER,BOTH,COPYRIGHT,COX,CRT,CSS,END,III,IMRT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PROPENSITY,PURPOSE,RESULTS,SEER,USING
169,2014,ASSESSMENT,BACKGROUND,CGA,COPYRIGHT,EACH,ECOG,FIT,FRAIL,GERIATRIC,HOWEVER,INC,LABEL,MATERIALS,METHODS,NCI,RESULTS,SEVERAL,VULNERABLE
169,2014,221,524,8804,COPYRIGHT,COX,DFS,DISEASE,FEDERATION,FREE,HOWEVER,IALT,LUNG,MUTATIONS,NSCLC,OVERALL,PREDICTIVE,PUBLISHED,SOCIETIES,T53,TP53,TRIAL
181946C,8201,8227G,EGFR,EPIDERMAL,LUNG,SHORT,THERE
1000,159,2013,500,ADDITIONAL,DESPITE,EGFR,LUNG,NSCLC,SOCIETY
EGFR,NON,NSCLC,THERE
8201,BACKGROUND,BASED,CONCLUSION,CONTEXT,FLOW,FOUR,III,LABEL,METHODS,NSCLC,OBJECTIVE,OTHERWISE,RESULTS,TLF
1000,5TH,600,800,AFTER,CONCLUSION,CUMULATIVE,FEV1,FIO2,FVC,ITBVI,LABEL,METHODS,OBJECTIVE,PEF,PRIMARY,PURPOSE,RESULTS,SECONDARY,THERE
000,0001,0003,0122,0323,0364,169,2014,AACR,BCL,BCL2L11,BIM,EGF,EGFR,LABEL,LOW,METHODS,NSCLC,OBJECTIVE,OVERALL,PCR,PFS,PURPOSE,RESULTS,T790M,TP53
169,2014,6510,AFRICAN,AGE,AMERICANS,AMHR2,BRSK1,GWAS,HK3,MCM8,PRESS,PRIM1,PUBLISHED,UMC1,UNIVERSITY,USA
945,GRAMICIDIN,HIF,IONOPHORES,PREVIOUSLY,RCC,TAKEN,VHL
110,123,164,165,169,2014,COPYRIGHT,EFFORTS,JOHN,LABEL,LTD,LUNG,METHODS,MIDWESTERN,OBJECTIVE,OLDER,RESULTS,SEVENTY,SONS,WILEY
135,173,189,261,347,425,564,584,598,607,673,863,898,A683C,C626G,DR4,G422A,THEREFORE
001,029,050,067,106,174G,202,235,478,634C,893,957,BEGG,CHINA,EGGER,FIVE,IL6,KNOWLEDGE,ORS,THEREFORE
3T3,951,954,A549,C5H3,C5H5,C6H5,CISPLATIN,DMSO,H460,NCI,U2OS
ENGLISH
113,AIP,CONCLUSION,IGG4,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,STATISTICS,THERE,VITAL
108,HOWEVER,LUNG,PD1,PD2,SEVERAL,SINCE,THERE,VATS
BLOOM,CELLS,H391Y,K422R,PKM2,REMARKABLY,THESE
946,EP2,EP4,FINALLY,HLFS,NOSCAPINE,PKA,PKI,SMAD,TGF
181,A549,BCL,ENDIANDRA,HRMS,IC50,MCL,NMR,THEIR,THESE
CD56,DM1,DOSE,SCLC
949,BACKGROUND,CONCLUSION,DUE,IGE,LABEL,METHODS,RESULTS,RII,THESE
ANTIGEN,DESPITE,IGG,IGGS,RNASE,SERUM,SIMILARLY,TAKEN,TRANSIENT
AFTER,EMERGENCY,LATE,PULMONARY,RAPID,SEH,TH4,TH7
FIVE,HOWEVER,JAPAN,LUNG,PULMONARY,THERE,THREE
CHEST,RIGHT
BECAUSE,CIRT,NSCLC,PLEURAL,THUS
PULMONARY
AUTOPSY,F18,HOWEVER,SEVERAL
001,006,009,013,045,169,2014,600,8805,945,BACKGROUND,CONCLUSION,COPYRIGHT,DLT,EASTERN,ECOG,FISH,FURTHER,GROUP,IHC,INC,LABEL,METHODS,MPM,MTD,NONE,PDGFR,PFS,RESULTS,SEVENTEEN
169,2013,A549,ALSO,CELLS,COPYRIGHT,DAPI,FLOW,HUVEC,LTD,MTT,TBHQ,TERT,UMBILICAL,VEIN
169,2014,549,APOPTOTIC,BACKGROUND,BUFO,CBMN,CHAN,CHINESE,COPYRIGHT,EFFECTS,IRELAND,LABEL,LTD,MATERIALS,MCF,METHODS,RELEVANCE,RESULTS,THESE
169,2014,5A1,954,956,BEAS,CADMIUM,CDCL2,COPYRIGHT,INC,NOTABLY,SUBSEQUENT,TAKEN,THEREFORE
169,2014,ARF,BCL,COPYRIGHT,HIPPO,INK4A,LATS2,MALIGNANT,NF2,PI3K,RAS,SAV,SEVERAL,SV40,WNT
8764,945,947,954,ABC,BCL10,BCR,DLBCL,LABEL,LUBAC,MALT1,MYD88,Q622L,RBCK1,RNF31,THESE,UNLABELLED
169,2014,BACKGROUND,BEAM,CCC,CCCR,COLLAPSED,CONE,COPYRIGHT,IMRT,LABEL,LTD,MEAN,METHODS,MUS,PBC,PTV,PUBLISHED,RESULTS,SWT,THERE,V107,V95
169,2014,CONCLUSION,COPYRIGHT,CTS,GCCR,GEORGIA,IRELAND,LABEL,LTD,MATERIALS,METHODS,MULTILEVEL,NSCLC,OBJECTIVE,RESULTS,RURAL
169,2013,2014,ACE,AUTHORS,BACKGROUND,CASE,COMBINING,CONTEXT,COPYRIGHT,ELAC2,FEW,GSTM1,HUGE,JANUARY,LABEL,LUTS,META,METHODS,OBJECTIVE,PATIENT,PUBLISHED,RESULTS,REVIEWERS,SUMMARY,SYNTHESIS,TERT,VDR
002,003,008,119,169,2007,2013,2014,239,8805,BACKGROUND,COPYRIGHT,CROSS,CRPC,LABEL,MAY,MEN,METHODS,OBJECTIVE,OUTCOME,PATIENT,PFS,PSA,PUBLISHED,RESULTS,SETTING,SUMMARY,TAXANES,UROLOGY
017,022,1133,169,2013,237,243,272,345,410,500,BACKGROUND,CIENT,CONCLUSION,INSTITUTO,LABEL,METHODS,NAVARRA,RESULTS,THERE,UNIVERSITY
95D,CGG,CONCLUSION,FINALLY,LABEL,MEANWHILE,METHODS,MTT,NEXT,OBJECTIVE,PCR,RESULTS,THEN
SCLC
176,2000,233,8201,ADVERSE,BCG,BSD,EFFECTIVE,EORTC,FIFTEEN,FOLEY,HEATING,LABEL,MATERIALS,METHODS,MMC,NMIBC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT,TREATMENTS
160,1994,ALK,SINCE
AIMS,ALK,CONCLUSION,CRIZOTINIB,ID1,KNOCKDOWN,LABEL,MATERIALS,MET,METHODS,OBJECTIVE,PCR,PHA,RESULTS,SRC
024,2013,CURRENTLY,DIFFERENT,ENOBOSARM,FDA,GTX,HIV,III,INC,PHASE,SARM,SARMS,SEPTEMBER,USA
A549,AETC,AFTER,CONCLUSION,EGFR,LABEL,METHODS,OBJECTIVE,PCR,REAL,RESULTS,TAXUS,VEGF,WESTERN
AFTER,CDDP,CONCLUSION,DEX,LABEL,METHODS,MKP,MTT,OBJECTIVE,PCR,RESULTS,RNAS,SEMI,SGK,SPCA,USING
ACTUARIAL,AIM,BASED,COSTS,DEPARTMENT,FORECASTS,INSURANCE,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SLI,STATISTICS,STRUCTURAL,THESE,UNLABELLED
A50,AUC,CTPET,LABEL,LESIONS,MATV,METHODS,NON,OBJECTIVE,OBJECTIVES,PET,RESULTS,REUSING,SOLID,SUV,TLG,VOI
945,ALDH1A1,CD133,CSCS,CXCR4,EGFR,FINALLY,GRPS,HIF1,IGF1,IGF1R,KNOCKDOWN,NANOG,NSCLC,OCT4,PC9,SEVEN,SOX2,TARGETING
CIGARETTE,NNAL,SECONDHAND,SHS,THESE,THIRDHAND,THS
AKT,BRAF,BRAFV600E,C40,CRE,E38,EGFP,EGFR,ERK,G12V,G37,HOWEVER,KRAS,LUNG,MEK,NSCLC,PI3K,RAF,RAL,S35,THESE,V12
1225,1228,134,168,169,188,2014,223,30D,376,544,8201,939,940,FUNCTIONAL,HOWEVER,INGENUITY,IPA,MIR,NORMFINDER,PATHWAY,RNU6B,SEVEN,UICC
196A,200C,275,2961,BESIDES,CEBPB,DEGS,E2F,ETS,EXPRESSION,FINALLY,FIRSTLY,GEO,GSE2378,KEGG,LABEL,MAP,MATERIALS,METHODS,OBJECTIVE,OMNIBUS,POTENTIAL,RESULTS,SMALL,THEN
169,19P,200,2014,205,945,BOTH,COPYRIGHT,HOWEVER,INC,WILEY
169,176,2014,240,956,BGE,FOLLOWING,GMBH,INTER,KGAA,TWEEN,VCH,WILEY
176,177,189,AVERAGE,CO2,CONCLUSION,HIPEC,ICU,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SOFA
945,947,GRIP1,H3K4ME3,IFN,LOSS,MERM1,THESE,TNF,WBSCR22
197,A549,BH3,BMF,H460,LNA,LNAS,LUNG,NIH,NOXA,NSCLC,THUS
945,946,ALK5,AZD8931,BMP6,BOTH,EPCAM,FIBROBLAST,MMP9,NSCLC,SERPINE,SPHK1,TGF
001,008,026,029,103,220,221,ACTIVATION,AKT,EGFR,EPIDERMAL,MAPK,NSCLC,TISSUES
178,319,618,829,837,8805,918,AIM,CEA,CHINESE,CONCLUSION,EGFR,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM,SIXTY
014,177,499,789,813,ANN,AUTOMATED,CAD,CONSORTIUM,EACH,EFFECTIVE,IMAGE,LUNG,ROI,TEXTURE,USING
514,AFRICAN,BILATERAL,BLACK,CIS,COX,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,USING,WOMEN
8321,946,EVALUATION,MUTATIONS,MYO10,SEVERAL,THESE,TP53
INACCURATE,ITV,ITVS,MIP,XCAT
CLONALITY,SEQUENTIAL
BOLUS,CARLO,MEV,MONTE,SFF,STUDIES,THUS
946,AKT,CRC,MOUSE,ORT,SW48,VEGF
946,954,A549,CHROMATIN,CHRONIC,CREB,DATA,H292,HBE,HBE1,NCI,P50,THUS
100,1940,2001,2564,ACCOUNTING,BACKGROUND,FURTHER,HOWEVER,JANUARY,LABEL,METHODS,RESULTS,WEIBULL
1988,2003,2007,ALCOHOL,AMONG,BACKGROUND,FINLAND,FINNS,LABEL,LIFE,METHODS,RESULTS,WITHOUT
000,600,BONE,LOCAL
169,2014,AACR,BEADCHIPS,LA1,LABEL,METHODS,MICROARRAY,OBJECTIVE,PURPOSE,RADIATION,RESULTS,THESE
100,169,2014,300,AACR,ATLAS,CDO1,CONCLUSION,CPG,FOLLOWING,HOXA9,LABEL,METHODS,NON,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TAC1,TCGA,USING
001,169,2014,503,BISULFITE,BSP,COBRA,COPYRIGHT,FANCA,FANCONI,HOWEVER,INC,NSCLC,PCR,TAKEN,THEN,UTR
169,178,2014,231,315,916,A549,COPYRIGHT,HOWEVER,INC,RBM5,RRM,THESE
169,2014,COPYRIGHT,GLO,INC,PROMEGA,PROTEASOME,THUS
169,2014,COPYRIGHT,GLI,INC,IRREGULAR,KEY,PATCHED,PTC,RND,SMO,SMOOTHENED
169,2014,2341066,ALCL,ALK,APOPTOSIS,BCL,COPYRIGHT,CRIZOTINIB,EML4,LTD,MCL,NPM,STAT3,THESE
169,174,2003,2009,2011,2014,BACKGROUND,COPYRIGHT,COX,DIAGNOSIS,HOPKINS,IIB,INC,JOHNS,LABEL,METHODS,PUBLISHED,REASONS,RESULTS,RUSH
169,2014,946,AIMS,BACKGROUND,CONCLUSION,COPYRIGHT,CXCR4,EXPRESSION,HIGH,IMSS,INC,LABEL,LUNG,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SIXTY,STUDIES,THEREFORE,THESE
169,195,2014,COPYRIGHT,FINALLY,IRELAND,LTD,MYB,NSCLC,PUBLISHED,TAKEN,USING
169,16S,2013,946,API,COPYRIGHT,GRAM,INFECTIOUS,LTD,PUBLISHED,SOCIETY,THERE
10M,169,2013,AIM,AMONG,COPYRIGHT,DISCUSSION,FDG,HOWEVER,LABEL,METHODS,NONE,OBJECTIVE,PET,RESULTS,SAS,SIX,SUV
169,2014,A549,AKT,CELL,COPYRIGHT,INCREASING,MICRORNAS,MIGRATION,MIR,NSCLC,PCR,PI3K,RNAS,SAS,THESE,TRANSWELL
169,2014,AFTER,COPYRIGHT,EMERGENCY,PUBLISHED,SAS
169,178,2014,BACKGROUND,CONCLUSION,COPYRIGHT,FOUR,HOWEVER,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,TMAS,USING
169,2013,2014,AIOT,ALK,ANY,COPYRIGHT,EGFR,EXPERTS,FIRST,INC,ITALIAN,MAY,MEETING,NSCLC,PANEL,PANELISTS,TKI,TKIS
160,169,2008,2012,2014,AFTER,BETWEEN,BOTH,COPYRIGHT,INC,LABEL,METHODS,MOSBY,NONE,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY,THEREFORE
100,169,2014,ADDITIONAL,BECAUSE,COPYRIGHT,INC,LABEL,MAP,METHODS,MOSBY,OBJECTIVE,POST,PUBLISHED,RESULTS,SURGERY,VAL,VIRTUAL
0001,001,009,163,169,189,2014,CONCLUSION,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,MATERIALS,MCPYV,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,THESE,TKIS
169,2014,954,A549,COPYRIGHT,HDAC,HISTONE,MMP,MMPS,NSCLC,ROMIDEPSIN,SAS,SUB
109,169,2014,203,AGT,ASS1,BENJAMINI,COPYRIGHT,CRYM,EGR2,FOLR3,GJA1,INC,LMS,LMSS,MASP1,NLGN1,OSTN,PCR,RORB,SGK1,SHMT1,SLITRK4,TDO2,THBS1,TNNT1,TSPAN10,XRN2
100,169,1998,2012,2014,CONCLUSION,COPYRIGHT,CURRENT,EMC,EPITHELIAL,FOUR,IRELAND,KOREA,LABEL,LTD,MATERIALS,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SAMSUNG,SEOUL,THEREFORE,TTF
169,2014,352,ADC,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,IGF,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,SCC,THESE
0001,169,2014,ADRIAMYCIN,AFTER,BACKGROUND,CAP,CONCLUSION,COPYRIGHT,EASTERN,EVALUATION,GROUP,INC,LABEL,MASAOKA,METHODS,MYASTHENIA,NETT,RESULTS,SOLID,SURGERY,THYMOMA,WORLD
001,004,005,012,013,029,036,058,169,1983,1986,1996,2005,2006,2010,2014,383,8471,BACKGROUND,CONCLUSION,COPYRIGHT,INC,JCO,JOURNAL,LABEL,METHODS,PFS,RESULTS,SCLC,SMALL,THERE,THROUGH
169,2000,2012,2014,316,541,ARDS,CONCLUSION,COPYRIGHT,EDUCATION,FOUNDATION,HEART,INC,JANUARY,LABEL,MAYO,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SMOKING
169,176,1GY,2014,20GY,35CC,5CC,BOTH,D5CC,DMAX,MEDICAL,OVERALL,PTV,PUBLISHED,SBRT,SMALL,TREATMENT,V100,V20
169,2013,400,CLOSE,COPYRIGHT,CROSS,DATA,IATROGENIC,LABEL,LIFE,LTD,METHODS,MOOD,OBJECTIVE,PAIN,PURPOSE,QOL,RESULTS,SYMPTOM,WHAT
177,18F,2009,2011,ACCORDING,AFTER,BACKGROUND,CONCLUSION,FDG,JULY,LABEL,MAY,METHODS,PET,RESULTS,THESE,TOTALLY,USING,WHILE
116,169,2014,549,956,AMONG,COPYRIGHT,HCT,HUISGEN,IC50,LTD,MCF,MICHAEL,T98G
169,2014,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2014,CD31,CD34,COPYRIGHT,FLI1,FVIII,INC,PUBLISHED,SOCIETY,TAKEN
169,1997,2004,2013,368,8805,ADDITIONAL,CONCLUSION,DUTCH,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SCLC
005,169,2009,2011,2013,461,8804,8805,CONCLUSION,CTRC,ELDERLY,LABEL,LTD,METHODS,OBJECTIVE,PHASE,PUBLISHED,REASONS,RESULTS,THERAPY,THERE,UNASSIGNED
1000,169,1994,2007,2013,311,AMONG,BACKGROUND,BASED,COX,FALL,LABEL,METHODS,PERIPHERAL,RESULTS,SEER
200,280,343,AMP,BACKGROUND,CHINESE,CRTC2,HAN,LABEL,METHODS,NOTABLY,PCR,PROM1,R379C,RESULTS,S281R
169,2014,A549,AIM,CHINA,COMPOUNDS,CONCLUSION,COPYRIGHT,EUPHORBIA,LABEL,METHODS,MTT,NMR,OBJECTIVE,PUBLISHED,RESULTS,UNIVERSITY
169,2014,25EF,50EF,7901,85EF,AIM,CHINA,CONCLUSION,COPYRIGHT,DAD,ESI,H727,HEPG2,HPLC,KP4,LABEL,METHODS,MTT,NCI,OBJECTIVE,PANAX,PPD,PUBLISHED,RESULTS,RG3,RH2,SGC,TSF,UNIVERSITY
169,183,2014,435,945,956,AIM,CCR5,CHINA,CONCLUSION,COPYRIGHT,HIF,LABEL,MDA,METHODS,OBJECTIVE,OPHIOPOGON,PCR,PUBLISHED,RESULTS,UNIVERSITY,VEGF,WESTERN
1040,1341,16913,1989,2000,20005,2005,2009,2015,2019,20359,25910,2791,2908,46269,5870,8083,AGE,AMONG,BACKGROUND,CHANGES,FEDERAL,HODGKIN,LABEL,METHODS,RESULTS
EBUS,HOWEVER,NSCLC,OBJECTIVE,OBTAINING,REAL,TBNA,THREE
BACKGROUND,CONSISTENT,DCS,ELISA,LABEL,MAIN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,TLS
169,2014,3Q26,ARRAY,ASIA,AUTHORS,ECT2,LTD,PCR,PTY,PUBLISHING,SCIENCE,SIX,THESE,WILEY
ACTH,AFTER,BACKGROUND,CASE,CONTEXT,CUSHING,HISTOLOGY,IMAGING,LABEL,METHODS,RESULTS,THERMAL
THESE
MALIGNANT,THERE,TYPE
178,AMONG,DOSE,FINALLY,FOUR,GRADE,LABEL,METHODS,OBJECTIVE,OTHER,RESULTS,THEREFORE
001,002,009,014,018,022,041,044,112,140,169,193,2014,252,8804,EPD,EPP,FACTORS,LABEL,METHODS,MPM,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SEVENTY,SURGERY,THERE,THESE,UNIVERSITY
0554,1541,169,2014,7786,AACR,LABEL,MCR,PI3K,PTEN,SCLC,SMALL,UNLABELLED
CDK6,H3K36,HDAC3,KDM2A,NSCLC,SIMILAR,THESE
004,169,1999,2009,2014,AGE,ANGELES,BACKGROUND,CONCLUSION,FEF25,FEV1,HODGKIN,INC,LABEL,LOS,LUNG,METHODS,OLDER,PFT,PROCEDURES,RESULTS,TLC,TOTAL,WILEY
169,2014,215,430DUPG,759,ASIA,BONE,HAX1,HSCT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCN,WILEY
138,13Q,169,2014,214,230,3Q22,8201,AMONG,CNA,CNAS,EGFR,KRAS,MASS,MET,NON,NSCLC,STAGE,STK11,TP53,UICC
2004,2005,277,491,718,762,AFTER,BACKGROUND,FACILITIES,FDG,HOWEVER,JAPAN,LABEL,METHODS,OSAKA,PET,PREFECTURE,RESULTS,SCREENING,WHOLE
8209,CSE,CYTOMETRY,GSH,HOWEVER,LABEL,MTT,NAD,NHBE,NQO1,NRF2,ROS,UNASSIGNED,UNLABELLED
FDG,PET
10001,333,CURRENTLY,MEDICAL,PET,PUBLISHERS,SEVENTH,USA,YORK
000,10001,159,2013,228,333,FIVE,HYPOXIA,LUNG,MEDICAL,PUBLISHERS,SEVENTH,USA,YORK
10001,1960S,1970S,333,ADDITIONAL,CURRENTLY,FURTHER,HOWEVER,LUNG,MEDICAL,NLST,PUBLISHERS,RANDOMIZED,SCREENING,SEVENTH,TRAIL,USA,WHAT,YORK
10001,1980S,2000,333,HOWEVER,MEDICAL,MRI,PET,PUBLISHERS,SEVENTH,SINCE,STATE,UNTIL,USA,YORK
10001,333,HOWEVER,MEDICAL,PUBLISHERS,SEVENTH,STUDIES,THERE,USA,YORK
062,123,169,2014,683,8201,BACKGROUND,BOTH,EGFR,FISH,LABEL,METHODS,PFS,RESULTS,SOCIETY,THERE
EATON,GROUP,ITALIAN,LAMBERT,LEMS,MYASTHENIC,SYNDROMES,WORKING
BOTH,CHIP,ETS,ETS1,GABPA,GAIN,HOWEVER,R273H,SEQ,STRIKINGLY
BOTH,EBP2,ENBA1,FBW7,FURTHER,MYC,YET
A549,HSP70,IBUPROFEN,THUS
AKT,CSC,CSCS,H1975,HIGH,LUNG,NSCLC,OVERALL,REGULATION,SOX2,SRY
106,2002,2010,218,620,AFFILIATED,BACKGROUND,CD34,CONCLUSION,DCA,EASTERN,FACTORS,FIRST,HCC,LABEL,MEDICAL,METHODS,PMS,PULMONARY,RESULTS,SURGERY,UNIVERSITY
001,026,030,122,242,364,946,ADCS,BACKGROUND,COX,HIGH,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,SCC,SCCS,TGFBI,USING
001,102,139,188,305,676,BACKGROUND,CONCLUSION,EACH,EGFR,LABEL,METHODS,NSCLC,RESULTS,VDT
646,ADSQLCS,AKT1,ALK,BACKGROUND,BRAF,CHINESE,EGFR,ERBB2,GENOTYPING,HOWEVER,KIF5B,KRAS,LABEL,METHODS,RESULTS,RET,SEVENTY
177,2006,2011,ALSO,BECAUSE,SCC
1250,400,480,4804,5120,PCR,PDMS,POISSON,SPC,USING
0001,004,104,111,112,117,130,BACKGROUND,EBB,EBUS,GRANULOMAS,HOWEVER,LABEL,METHODS,RESULTS,TBLB,TBNA,TRIAL,URL
FURTHER,III,IIIB,RNASE,WILMS
074,DATABASES,DETECTION,HOWEVER,LABEL,LIBRARY,LUNG,METHODS,OBJECTIVE,RESULTS,SCIENCE,SCREENING,SEVEN
169,2005,2012,2014,8805,AFTER,APRIL,BACKGROUND,BASEL,CONCLUSION,FREQUENTLY,JULY,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,SIXTEEN,THERE
169,2014,946,ERK,FIBULIN,HOWEVER,MMP,PRESS,PUBLISHED,UNIVERSITY,WNT
169,2014,CCSP,CLARA,DOX,E76K,ERK1,ERK2,GAB1,GAIN,GOF,HOWEVER,LUNG,MDM2,MYC,PRESS,PUBLISHED,SHP2,SRC,THESE,UNIVERSITY
ATP,AUGMENTED,CTL,HMGB1,RADIATION,THESE
169,2014,COPYRIGHT,EVEN,HOWEVER,INC,KEGG,THEREFORE
131I,BACKGROUND,CONCLUSION,LABEL,METHODS,NONE,RENAL,RESULTS,RETRO,ULTRASOUND
169,2014,COPYRIGHT,LTD,SMALL,SYSTEMATIC
169,183,2014,COPYRIGHT,LTD,OPIUM
169,2014,A549,COPYRIGHT,HELA,HOWEVER,HYPERICIN,PBMC,PDD,PDT,PVP,STICS,TICS,WHEREAS
169,1993,1996,2014,AIM,BACKGROUND,BECAUSE,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,NONE,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
0413,10GY,111,1161,130,169,177,2014,20GY,2N0,315,621,707,APBI,BASED,COPYRIGHT,CRT,IMRT,INC,MAT,MEDICAL,MUS,OVERALL,PUBLISHED,QUALITY,RTOG,SEVERAL,THESE,V10,V20
169,177,2014,2MM,3MM,CONTROL,COPYRIGHT,EACH,GAMMA,INC,LINAC,MEDICAL,MELBOURNE,MONITOR,NUCLEAR,OVERALL,PATIENT,POINT,PUBLISHED,SBRT,SNC,SUN,UNIT,VMAT
009,014,075,080,108,169,2014,304,335,435,532,639,678,682,747,812,846,962,966,973,989,CONCLUSION,COPYRIGHT,COX,HOWEVER,INC,LABEL,MAIN,METHODS,OBJECTIVE,RECURRENCE,RESULTS,SETTING,UNIVARIATE
001,169,182,184,2008,2012,2014,207,916,975,BACKGROUND,CAPITAL,COPYRIGHT,INC,KEY,KNOWLEDGE,LABEL,LESSENING,METHODS,OPERATIVE,PUBLISHED,RESULTS,ROBOTIC,SOCIETY,THERE,VATS
124,160,169,2000,2006,2014,390,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,ROUTINE,SOCIETY
169,2006,2010,2014,686,787,BACKGROUND,BECAUSE,COPYRIGHT,CURRENTLY,DATA,END,FOUR,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE
THERE,THUS
100,169,2013,INITIAL,LTD,PUBLISHED
169,2013,CONTENT,COPYRIGHT,LTD,THUS
169,2013,ILD,ILDS,INC,LANGERHANS,PUBLISHED
169,2013,IMPORTANT,INC,POTENTIAL,PUBLISHED,UIP
0001,169,2014,204,BACKGROUND,CONCLUSION,COPYRIGHT,EIA,EXPRESSION,LABEL,METHODS,NSCLC,RESULTS,SERUM,TMA,TXB2,TXS,VEGF,WHILE
169,2014,A549,BEAS,CDK,COPYRIGHT,LOW,LTD
003,008,024,027,030,032,045,057,059,092,256,8201,8805,BACKGROUND,COX,DEFINED,FDG,KPS,LABEL,LOCAL,MEIER,METHODS,NSCLC,PET,PFS,RESULTS,SBRT,SUV
BACKGROUND,LABEL,METHODS,RESULTS,SCATTERED,THERE,THYROID,TLD,TLDS,TPS
106,136,160,169,2014,945,AACT,BACKGROUND,CLEC,HEPG2,HUH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PODOPLANIN,RESULTS,SOCIETY,THESE,THROMBOSIS
001,160,169,1762,2014,AIMS,CDX2,CK20,CK7,FIFTY,JOHN,LABEL,LTD,METHODS,MOST,OBJECTIVE,RESULTS,SONS,THESE,TTF,WILEY
133A,133B,149,34B,34C,AGILENT,ALDOA,BACKGROUND,BEAS,CELLS,CONCLUSION,COPD,FEV1,FIVE,G4470,HFL1,HNF4A,HUMANHT,KCO,LABEL,MICRORNAS,MIR,MIRNA,RESULTS,RNAS,ZNF3
11PATIENTS,149,165,1997,2011,ACCORDING,BACKGROUND,CONCLUSION,GRAWITZ,LABEL,METHODS,RESULTS,SCHWANNOMA,SURGERY,THERE,VATS,WHAT,XII
ANNEXIN,ANX,ANXS,AREAS,BACKGROUND,CCC,COVERED,LABEL,METHODS,OPINION
008,025,027,048,055,090,105,160,ALBERTA,JOBS,LIMIT,OEL,POTENTIAL,THERE,THESE,TOTAL
ANTI,DIAGNOSIS,EATON,KNOWLEDGE,LAMBERT,LEMS,SCLC,VGCC,VGGC
2009,2013,239,2774,BACKGROUND,COMPILING,EGFR,L858R,LABEL,METHODS,RESULTS,T790M,TKI,TKIS
0001,120,194,ALK,AMONG,BACKGROUND,CBPD,CONTINUING,COX,CRIZOTINIB,ECOG,LABEL,METHODS,NSCLC,RESULTS
169,2014,FOUR,FURTHER,HOWEVER,INC,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SUBJECTIVE,WILEY
0091,442,628,815,ATS,ERS,IASLC,LUNG,SOCIETY
945,946,CD103,CD8,CTL,HOWEVER,ITGAE,NFAT,OVERALL,SMAD2,TCR,TGF,USING
AIMS,BACKGROUND,CARE,COPD,DATA,INTERVIEWS,LABEL,METHODS,OBJECTIVE,RESULTS
001,048,169,2014,286,327,610,8805,COX,EVEN,FDG,HRCT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,PET,PRESS,PUBLISHED,RESULTS,RFS,SURGERY,THERE,UNIVERSITY
BACKGROUND,DENMARK,LABEL,METHODS,OBJECTIVE,RESULTS,USING
THREE
2009,2011,AVASTIN,FOUR,PALLIATIVE
169,2014,8201,CMA,COGNATE,DED,HEAT,HSC70,INC,KFERQ,PEA,PED,PROTEIN,SHOCK,THEREFORE,USING,WILEY
001,003,169,2014,AACR,EMT,FUNCTIONAL,FURTHER,SYK,TAKEN
169,2014,293,BMP4,CELL,FINALLY,HOWEVER,META,PCR,SOX2,SQC,UICC
001,159,170,998,ALK,ASIAN,EGFR,NSCLC,SINCE,VTE
MITF,MUTATIONS,NOTABLY,TFE,TFE3,TFEB,TFEC
BECAUSE,HOWEVER,NAC,RAF,RAS,ROS,THUS
100,169,2014,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,CRT,INC,LABEL,METHODS,PACLITAXEL,RESULTS
CJONEDITOR,JOURNAL,NURSING,SELECTION,SEND
AFTER,CHEST,INADEQUATE,PROGNOSTIC
AWARENESS,BACKGROUND,CONTEXT,DATA,DIFFICULTY,LABEL,LITERATURE,METHODS,OBJECTIVE,OTHER,SOMETIMES,SOURCES
8314,8315,BACKGROUND,CNS,CONTEXT,CURRENTLY,HER2,KI67,KI67LOW,LABEL,MEIER,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIMILARLY
174,2010,2011,2013,ALK,ANAPLASTIC,AREAS,BACKGROUND,COVERED,CRIZOTINIB,FDA,KEYWORD,LABEL,METHODS,NOVEL,OPINION,SCIFINDER,SEPTEMBER,SMALL
945,BACKGROUND,CASE,CONCLUSION,FURTHER,HISTOLOGIC,HOWEVER,LABEL,LABORATORY,METHODS,THROUGH,VIII
181,BACKGROUND,CHRONIC,CONCLUSION,COPD,COX,DESPITE,LABEL,METHODS,NSCLC,RESULTS,T2A,UNIVARIATE
001,028,034,100,1056,1089,1108,1116,1148,1153,177,196,2009,2011,2013,323,475,633,733,766,AMONG,CONCLUSION,CONE,DIAGNOSTIC,JANUARY,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PTNB,PTNBS,PURPOSE,RESULTS,RSNA,VARIABLES,VIRTUAL
033,2013,838,894,AVERAGE,CONCLUSION,EIGHT,FIFTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RATINGS,RESULTS,RSNA
2013,500,750,964,ACCORDING,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESOLVING,RESULTS,RSNA
1020,16HBE,410,766,8321,8776,ARG10,CELL,H2126,HOWEVER,NRE,PRE,THESE
ALK,AMONG,HIGH,NONE,PCR,STRN,SUBSEQUENT,THESE,THYROID
ALTOGETHER,KNOCK,MMP,RUNX3,STRIKINGLY,TIMP,TMA,TNM,VEGF
011,048,2000,427,8202,ASSOCIATED,BACKGROUND,BRITISH,COMPLEX,CONCLUSION,END,GENERAL,GPRD,LABEL,METHODS,OVERALL,PRS,RESULTS,SHIPMAN,THESE,WORLD
001,005,119,175,ASCO,CONCLUSION,INITIATIVE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,QOPI,QUALITY,RESULTS,USING
2013,220,III,IIIA,JAPAN,MARCH,PHASE,POST,STAGE,UMIN
169,1975,2004,2010,2014,285,448,AFTER,AMONG,AYA,BACKGROUND,BASE,DATA,LABEL,METHODS,RESULTS,SOCIETY,WILMS,ZIP
1000,169,1969,2007,2014,8201,CANCERS,COPYRIGHT,JOHN,LTD,SMRS,SONS,SWISS,WILEY
160,2000,2011,265,AIM,LABEL,METHODS,OBJECTIVE,PRE,PULMONARY,RESULTS,RFA,TIME,TTR,UNI
1995,2007,AFTER,CANCERS,IRELAND,OTHER,RISKS,VARIATIONS
006,009,015,046,085,103,18F,2009,2011,8805,BETWEEN,DESPITE,FDG,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESULTS,THERE,TOTAL
150,450,600,8734,8805,AUC0,BECAUSE,CYP,DOSES,ERLOTINIB,GROUP,LABEL,METHODS,OBJECTIVE,P450,PURPOSE,RESULTS,URINARY
945,HIF,HOWEVER,HRE,LNM35,NSCLC,SEMA,SILENCING,TAKEN,USING
169,2013,BALB,KRAS,ORTHOTOPIC,OVERALL,UICC,WWOX
HOWEVER,ILD,ILDS
108,119,120,154,1997,2011,AMONG,COX,LABEL,METHODS,OBJECTIVE,PRIMARY,RESULTS,WHITE
COMBINING,H460,LABEL,METFORMIN,METHODS,MTT,NCI,OBJECTIVE,RESULTS
1377,1377G,248,297,844,844C,844T,CHINA,ESCC,FAS,FASL,PCR,RFLP,SNP,SOUTH
001,005,009,010,ASSAY,BACKGROUND,BOTH,CD105,CD146,CD45,CEC,CECS,CELLSEARCH,DAPI,DATA,ELISA,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,THESE
177,956,ANNEXIN,CHAMP,DCFH,FURTHER,GPX,H520,IC50,NON,NSCLC,RH123,ROS
CAM,CDS,GEN,GENISTEIN,IC50,RESULTS
000,1970,2013,JEM,OVERALL
001,003,022,103,1038,344,610,8804,899,ACCORDING,AIS,ATS,CIR,CUMULATIVE,ERS,IASLC,MIA,MOST
8805,KHORANA,PATIENT,PRIMARY,VTE
169,1944,1998,2008,2010,2014,242,243,AMONG,ASIAN,BACKGROUND,CONCLUSION,HOWEVER,ILLNESS,INSURANCE,LABEL,METHODS,PATIENT,PHYSICIANS,PRESS,PUBLISHED,RESULTS,SEVERAL,THROUGH,UNIVERSITY,VTE,WESTERN
145,1522B,8201,AGO,CATCHESIDE,CLINICALLY,CONCLUSION,H460,KNOWLEDGE,LABEL,LEA,METHODS,OBJECTIVE,RESULTS,SINCE,THERE,THESE
169,201,2014,AKT,BIM,CHOP,COPYRIGHT,DR4,HOWEVER,INC,KNOCKDOWN,PARP,PI3K,S3I,STAT3,TRAIL,TREATMENT
111,169,2009,2010,2013,8805,ANOTHER,CGA,COPYRIGHT,EACH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,RESULTS,SEPTEMBER
124,169,2013,8805,ASA,CONCLUSION,FACTORS,FEDERATION,FIGO,GERIATRIC,GYNECOLOGY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OBSTETRICS,RESULTS,SOCIETY
001,120,169,2011,2012,2013,322,8805,AGING,BETWEEN,CARG,CHI,CONCLUSION,COPYRIGHT,GROUP,INC,KPS,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
0001,133,169,1995,2003,2013,377,386,8805,ADDITIONAL,AFRICAN,ASIAN,CONSORTIUM,COPYRIGHT,DATA,INC,LABEL,LOS,MATERIALS,METHODS,MORTALITY,OBJECTIVE,PRIMARY,PROLONGED,RESULTS,RISK,THERE,UNIVERSITY
169,2013,COPYRIGHT,FDA,FINALLY,GENERATION,HOWEVER,IRELAND,LTD,NEXT,NGS,SEQUENCING,TESTING,WHILE
BACKGROUND,CASE,CONCLUSION,FURTHER,HIBERNOMAS,LABEL,MALIGNANT,METHODS
ANAMORELIN,HELSINN,IGF,III,NSCLC,PHASE
011,169,2014,8G7G3,946,ADS,ASIA,AUTHORS,E12,HGNEC,LCNEC,LTD,MOST,PATHOLOGY,PTY,PUBLISHING,SCC,SOCIETY,SPT24,SQS,TTF,TTF1,WILEY
8239,CAIX,MALIGNANT,OVERALL,SPECIMENS,THERE
002,169,180,2014,BACKGROUND,CONCLUSION,EFNS,JOURNAL,LABEL,METHODS,NEUROLOGY,OBJECTIVE,PCD,PURPOSE,RESULTS,YET
169,2014,AKT,BACKGROUND,BECAUSE,BRITISH,CCK,CELL,CONCLUSION,EGF,FITC,HSP90,KEY,KIT,L858R,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PI3K,PURPOSE,RESULTS,SMALL,SOCIETY,T790M,TKI,TKIS,WESTERN
132,956,BMI,COROLLARY,LABEL,METHODS,OBJECTIVE,RESULTS,THERAPY
043,2001,2010,215,250,299,ASSESSING,BACKGROUND,BASED,CONCLUSION,COX,FRANKEL,HARRELL,KARNOFSKY,LABEL,MEDICAL,MEIER,METHODS,PREDICTIVE,RESULTS,SBM
169,2014,AACR,NON,SUBSEQUENT
169,2014,2452,8804,ACCURATELY,COPYRIGHT,EOL,HOWEVER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,THESE,WILEY
169,2014,DUE,FAP,FIBROBLAST,GMBH,HOWEVER,KGAA,VCH,WILEY
001,002,003,045,208,505,8201,CAUCASIANS,FINALLY,THUS,XRCC1
FURTHER,KRAS,PATHWAY,TAKEN
8764,946,FERM,INCREASED,KINDLIN,KNOCKDOWN,THUS,TWIST,VEGF
100,CSRS,HOWEVER,KARNOFSKY,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
HOX,LABEL,MALAT,MEG3,METHODS,NFPA,NFPAS,OBJECTIVE,PCNA,PURPOSE,RESULTS,RNAS,THERE
169,2014,AACR,COX,EXPRESSION,KNOCKDOWN,LABEL,MYC,NSCLC,PGE2,PTEN,SIMILARLY,THESE,UNLABELLED
169,2014,5148,550,954,AACR,BCL,DEPLETION,FGF,FN14,LABEL,MCL,MCL1,MOL,NSCLC,RES,TKI,TNF,TNFRSF12A,TWEAK,UNLABELLED

INHIBITION,MICRORNAS,NSCLC,RECK,REVERSION
0001,102,8211,946,AKT,CD74,ECTOPIC,EGF,ERBB2,ERBB3,III,LABEL,NRG1,PI3K,THUS,UNLABELLED
193A,1SCI,AKT,DECREASED,EMT,ERBB,ERBB4,NSCLC,S6K2,SPC,THUS,TNM
BRAF,EGFR,ERK,KRAS,MEK,NAD,RAF,RAS,RESISTANCE,SIRT2,THESE,USING
8764,ALK,BRAF,ECTOPIC,EGFR,ERBB2,HOWEVER,KRAS,LUNG,MEK,PI3K,RAS,RET,RIT1,ROS1,RTK,THESE
AKT,MTC,RAPAMYCIN
156,506,954,ECTOPIC,ROS
143,CDK4,DNMT1,H3K9ME2,HBECS,MAL,OLIG2,PRC2
100,BSA,CONCLUSION,DUAL,FDG,GLC,LABEL,LBM,METHODS,OBJECTIVE,PET,RESULTS,SPN,SPNS,SUVMEAN,SUVS,THERE
8201,A549,CSF1,CSF1R,LUNG,MICE,NOD,RESULTS,SCID
200C,946,947,A549,EMT,FINALLY,GSK,HOWEVER,INDUCTION,TBK1,THUS,WESTERN,ZEB1
169,2014,946,AMOT,ANGIOMOTIN,COPYRIGHT,HOWEVER,INC,SRSF1,TAKEN,TCF,THUS,YAP,YES
123,8805,DEPRESSION,EPL,LABEL,METHODS,OBJECTIVE,PHQ,RESULTS,ROC,SADNESS,SEVENTY,STAGE,USING
0001,048,060,169,2014,8764,AKT,AMONG,CONCLUSION,COPYRIGHT,EGFR,IRELAND,L858R,LABEL,LTD,MATERIALS,METHODS,MUTATIONS,NSCLC,OBJECTIVE,OBJECTIVES,PTEN,RESULTS,SIXTY,STK11,T790M,TKI,TKIS
0001,160,169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,FIFTY,FISH,HOWEVER,INC,INHIBITION,LABEL,MDR1,METHODS,RESULTS
169,2014,945,BALB,COPYRIGHT,EGFR,EPIDERMAL,H460,INC,SNS,THUS
001,002,007,016,022,029,160,177,8201,8805,AUC,COMBINING,CONCLUSION,FDG,FIFTY,III,LABEL,MAXIMUM,METHODS,NORMALIZED,NSCLC,NSUV,OBJECTIVE,PET,PURPOSE,RATIO,RESULTS,SUV
BACKGROUND,DOSIMETRIC,ELECTRONS,LABEL,METHODS,PTV,RESULTS,TODAY,VERO
185,BEAS,LUNG,NMR,PACLITAXEL,PTX,SLNS,THESE,THUS
BCL,BESIDES,CDK6,CHINESE,FUR,FURTHER,LC3,PARP,RHIZOMA,TAKEN,TRANSWELL
130,174,FDA,III,NSCLC,PHASE
EARLY,HOWEVER,USING
BACKGROUND,CASE,CONCLUSION,LABEL,METASTATIC,METHODS,RCC,RENAL,THEIR
1997,BACKGROUND,CONCERNING,CONCLUSION,LABEL,LNR,LNS,METHODS,RESULTS,RLN,TNM
A549,ANT,BIR3,ERK,FETMPYP,JNK,MAP,ROS,SMAC,STUDIES,TREATMENT,XIAP
3Q28,790,8202,961,AFTER,ASIAN,BACKGROUND,CAUCASIANS,CHINESE,CIS,DATA,EAST,HOWEVER,ISI,KNOWLEDGE,LABEL,METHODS,ODDS,ORS,RESULTS,SEVERAL,SIMILAR
DESPITE,FIVE,III,NON,T3SS
211H,945,946,ACC,CAS,CD26,CD9,CELL,CONSISTENT,FAK,FINALLY,MESO1,MSTO,SIRNA
ALK,EGFR,FINALLY,FIRST,ION,KRAS,MYC,NEXT
ARP2,BASED,CHINESE,CHO,LNCAP,NEOPLASTIC,THEREFORE,WHILE,XENOPUS
150,ADAM,ADAMS,ECM,ELISA,H1688,H345,HOWEVER,SCLC,SILENCING,SMALL,THEREFORE
H2373,H28,HOWEVER,ISTMES2,MERO,MET5A,MPM,MSLN,NCI
ALDOA,ATP,DEPLETION,H520,LSCC,NCI,THESE
CD8,CT26,OXP,TREG,UTILIZING
DEPREOTIDE,FIVE,PDTC,ROC,WDTC
ALSO,CT26,ECS,FINALLY,HSPB1,MMP,MMP9,PREVIOUSLY,THESE,VEGF
ASSAY,BACKGROUND,CTC,DESPITE,EGFR,LABEL,LOSS,METHODS,NON,NSCLC,ONCOGENIC,PCR,RESULTS,SEQUENTIAL
1968,CCP,FEW,LUAD,NEXT
147,150,172,2000,2009,267,424,439,AMONG,BACKGROUND,CAUSE,CURRENT,EIGHT,FACTORS,GENERAL,HOWEVER,JANUARY,KAOHSIUNG,LABEL,MAJOR,MALIGNANCY,METHODS,RESULTS,SIAD
1564,AIMS,EPCAM,EPEX,EPICD,LABEL,MEMBRANOUS,METHODS,MOC,OBJECTIVE,REGULATED,RESULTS,TMA
169,2014,AACR,EGFR,EMT,ERK,FHIT,FINALLY,FRAGILE,LABEL,MMP,PD98059,PP1,SLUG,SRC,THESE,UNLABELLED,USING
169,2013,COPYRIGHT,EATON,INC,LAMBERT,LEMS,SCLC,THUS,WILEY
001,003,242,274,391,399,663,681,C609T,CHINESE,III,LABEL,NAD,NQO1,NSCLC,UNASSIGNED,UNLABELLED
046,169,2014,720,BACKGROUND,BRITISH,COX,DFS,JOURNAL,LABEL,METHODS,NLR,PRESS,PUBLISHED,RESULTS,SIMILARLY,UNIVERSITY
8314,HCC,OPN,USING
BACKGROUND,LABEL,LARGE,METHODS,RESULTS,THERE,TPP
CDDP,INTRINSIC,PDIA4,PDIA6,THUS,USING
2005,AGREEMENT,GVHD,INSTITUTES,NIH,THERE
10H,10I,169,2014,549,8323,8327,COPYRIGHT,MDA,SAR,SAS
1990S,CREMOPHOR,DOCETAXEL,NAB,NSCLC,ORAL,PACLITAXEL,TAXANES
BARR,EBV,EPSTEIN,LABEL,LELC,MATERIALS,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS
504,AKT,ALK,EGFR,HEAT,HSP90,IPI,LABEL,NSCLC,OBJECTIVE,ONGOING,PURPOSE,RAF,RESULTS,SUMMARY
ASIAN,EGFR,KRAS,LABEL,NOVEL,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY,THERE,TKI
169,2013,8764,956,A549,COPYRIGHT,CUAAC,IC50,INC,PDE4,PDE4B,THESE,THREE
169,2014,COPYRIGHT,DTX,EDB,FINALLY,LLC,TAKEN,TWEEN,U87MG
169,2014,AUTHORS,BALB,BESIDES,COPYRIGHT,HCC,IRELAND,LTD,NANOSECOND,NSPEF,PUBLISHED,THP1
169,2014,CISPLATIN,COPYRIGHT,DESPITE,IRELAND,LTD,NER,NUCLEOTIDE
034,100,169,181,200,2014,543,915,ADDITIONAL,AUTHORS,COPYRIGHT,IRELAND,LACK,LTD,PUBLISHED,SRRE,THUS,WHILE
169,2014,ACCORDING,COPYRIGHT,PUBLISHED
001,004,169,1998,2010,2014,248,602,966,AFTER,BACKGROUND,COPYRIGHT,DATA,HEART,INC,ISHLT,LABEL,LUNG,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE,TRANSPLANT
001,169,185,2014,238,COPYRIGHT,CRC,EVEN,FOUR,HOWEVER,ILL,LABEL,LTD,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,2014,296,382,COPYRIGHT,DDR,FEDERATION,MOST,PUBLISHED,SEVERAL,SOCIETIES,STRIKINGLY,THEREFORE
169,2000,2011,2014,ALSO,COPYRIGHT,COX,CPFE,DEC,FORTY,HOWEVER,IPF,JAN,LTD,SEOUL,UNIVERSITY
12H,169,2014,239,25MG,8805,ASIAN,CAUCASIAN,COPYRIGHT,DCR,DESPITE,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,OVERALL,RESULTS,TTP
169,2002,2008,2013,557,AMONG,COPYRIGHT,INFECTIOUS,JAPAN,LTD,MARCH,MOST,PUBLISHED,SEPTEMBER,SOCIETY,THERE
0001,100,169,2014,8804,ANAPLASTIC,COPYRIGHT,CRIZOTINIB,INC,LABEL,LAT,LOCAL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OPD,PURPOSE,RESULTS
115,127,169,173,2014,207,215,406,8805,ACADEMY,ADDITIONAL,ASSESSMENT,COPYRIGHT,DIETETICS,EASTERN,GENERATED,GIVEN,GROUP,INC,NUTRITION,PATIENT,PUBLISHED,SGA,SUBJECTIVE,SYMPTOM
2011,BACKGROUND,CNS,CONCLUSION,CSF,EATON,HOWEVER,LABEL,LAMBERT,METHODS,PUBLISHED,RESULTS,SERUM,TEXAS,UNIVERSITY
160,169,2014,AKT,AKT1,AKT3,COPYRIGHT,FGFR,INC,IWS1,K36,MRG15,POL,PTB,SETD2,THESE
0001,0007,004,1086,169,183,1972,2011,2013,649,653,BACKGROUND,BLOOD,CC16,CLARA,CLUB,COPYRIGHT,COX,FUNDING,HEART,INDEX,INSTITUTE,JAN,LABEL,LTD,LUNG,METHODS,MORTALITY,RESULTS,SERUM,USA
077,119,169,183,2004,2010,2014,263,391,786,827,946,9620,AFTER,BACKGROUND,CHUNG,COPYRIGHT,FOUNDATION,FRAMEWORK,FUNDING,HEART,INSTITUTE,LABEL,LOCAL,LTD,LUNG,METHODS,MORTALITY,OPEN,PROGRAMME,PUBLISHED,REGIONS,RESULTS,SEVENTH,SWEDISH,TRUST
169,2013,COPYRIGHT,LTD,LUNG,NSCLC
1476,169,2003,2010,2013,2451,2696,501,529,6623,945,BACKGROUND,BETWEEN,COPD,COPENHAGEN,COPYRIGHT,FEV1,FOUNDATION,FUNDING,FVC,GENERAL,HOWEVER,HRS,IQR,JULY,LABEL,LLN,LTD,METHODS,NEVER,NOV,POPULATION,RESULTS,UNIVERSITY
169,1989,2013,2014,AMONG,APRIL,COLLEGE,COPYRIGHT,DESPITE,MEDICAL,OVERALL,PUBLISHED,SIX,THERE
169,1CM,2013,AFTER,COPYRIGHT,PUBLISHED,PULMONARY,REMOVAL,SAS,SPLF
169,2013,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,DEFINITIVE,FDG,LABEL,LOBECTOMY,METHODS,NODULAR,PET,PUBLISHED,SAS,SPLF
169,2013,BACKGROUND,CASE,COPYRIGHT,DISCUSSION,HOWEVER,LABEL,METHODS,MOST,PUBLISHED,SAS
169,2013,ANY,BACKGROUND,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SAS,SPLF,THERE
169,2014,COPYRIGHT,EHE,EHES,IRELAND,LTD,PLEURAL
0004,006,120,169,1986,2011,2014,ALK,BAC,BETWEEN,CONCLUSION,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RAS,RESULTS
0013,169,184,2002,2009,2014,237,238,8804,AJCC,BACKGROUND,CONCLUSION,COPYRIGHT,GUIDELINES,IIIB,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
169,2013,945,946,948,A549,ADP,ALSO,BCL,CONVERSELY,COPYRIGHT,ERK,H460,JNK,JUN,LTD,NCI,NH2,NSCLCCS,OVERALL,PARP,PKC,PMA,THUS,TUNEL
001,100,169,2014,588,774,8805,99M,HCC,LABEL,MAA,MATERIALS,MEIER,METHODS,OBJECTIVE,PEARSON,PUBLISHED,PURPOSE,PVT,RESULTS,SIR,SPECT,UNIT
210,ACK1,BOSUTINIB,IC50,KNOCKDOWN,KRAS,NSCLC
945,A549,ATF6,CHOP,HOWEVER,IRE1,LPT,LUNG,NSCLC,PCR,PEP,PERK,TRAF2,UPR,WESTERN,XBP1
BACKGROUND,CELL,CURRENT,HOWEVER,INDICATORS,INSTITUTE,IOM,LABEL,LUNG,MEDLINE,METHODS,NON,PROMS,RESULTS,THERE,THESE,USING
342,AFFYMETRIX,APOPTOSIS,BACKGROUND,CD10,DUE,HIGH,HYPOXIA,LABEL,METHODS,MME,NON,NSCLC,RESPONSES,RESULTS,VIABILITY,WHILE
ASSESSING,NOVEL
A549,CONCLUSION,GSH,HIGH,HOWEVER,LABEL,METHODS,OBJECTIVE,OTM,RESULTS,ROS,SOD,THEN
946,IGF1,IGF2,INSULINOMA,MEDICAL,OTHER,THESE,TIH
169,177,2014,215,8764,AIR,NSCLC,PRESS,PUBLISHED,SURGERY,THERE,UNIVERSITY
001,017,020,031,059,223,237,30TH,322,508,534,8201,981,ARMS,CEA,COX,EGFR,FORTY,TKI,UNIVARIATE
169,2014,EGFR,EPIDERMAL,H358,IGF1R,MET,NVP,PTEN,TKI,TKIS,UICC
160,169,177,183,8202,9658,COMPARING,CONCLUSION,FRAUNHOFER,GEORG,GERMANY,HEALTHCARE,KEY,LABEL,MATERIALS,MDCT,METHODS,MEVIS,OBJECTIVE,PHILIPS,PROTOTYPE,PURPOSE,RESULTS,SEMI,SIEMENS,STUTTGART,UNTIL,VOLUMETRIC,YORK
169,2013,BASED,BASEL,HOWEVER,LUNG,SCREENING,SWISS,TRIAL
ANOTHER,FDG,OSTEOLYTIC,PET,TRUE
DROSOPHILA,ECTOPIC,HIPPO,HPO,LUNG,TDU,TEAD,TEADS,VGLL4,YAP
013,2013,229,577,ALS,ALZHEIMER,BACKGROUND,CNS,CONCLUSION,DOWN,HUNTINGTON,INCREASED,ISI,KNOWLEDGE,LABEL,MARCH,MEDLINE,METHODS,PARKINSON,RESULTS,SCZ,SOURCES,THERE,WEB
34A,OCT4,THESE,UTR
945,OCS,PENTRAXIN,PTX3,THESE,TNF
169,2014,ABCB1,ABCG2,BACKGROUND,BASEL,CPT,DESPITE,GEFITINIB,LABEL,METHODS,RESULTS
100,ACTB,B2M,FAU,GAPDH,GUSB,HMBS,HPRT1,IPO8,NORMFINDER,PCR,PGK1,PPIA,RPLP0,RPS11,RPS14,RPS9,SEQ,TBP,TFRC,UBC,YWHAZ
169,2014,947,BASEL,CATENIN,EMT,FEW,MPM,TWIST
DUE,MPTE
AFTER,CASE,CEA,HASHIMOTO,LABEL,LCNEC,METHODS,MTC,OBJECTIVE,SERUM,THERE
100,150,18F,420,840,8805,BACKGROUND,CONCLUSION,EGFR,FDG,HER2,LABEL,METHODS,NSCLC,PET,RESULTS
177,2010,2012,227,280,453,476,8764,EBUS,FNA,LABEL,METHODS,MFB,OBJECTIVE,RESULTS,THERE
001,022,169,2007,2013,2014,APRIL,BACKGROUND,BASEL,CONCLUSION,EGFR,FURTHER,L858R,LABEL,MAJOR,MARCH,METHODS,NSCLC,PFS,PREDICTORS,RESULTS,SEVENTY,TKI,TKIS
025,067,096,ADVERSE,CCS,GRADE,GTV,MEIER,PTV,REGARDING,SBRT,TOXICITIES,V10,V15,V20,V25
169,2014,945,946,954,956,A549,COPYRIGHT,IC50,IKK,SAS,TNF
23A,27A,BACKGROUND,BISULFITE,CONCLUSION,EPIGENETIC,LABEL,MET,METHODS,MPM,PCR,RESULTS,ZIC1
125,133,199,2000,208,322,347,360,478,526,537,635,648,663,683,746,BACKGROUND,CONCLUSION,CRT,DUTCH,HOWEVER,HRT,LABEL,MART,METHODS,NMB,NMBS,NSCLC,QALYS,RESULTS,THEREFORE,VART
173,2003,2007,BACKGROUND,CONCLUSION,LABEL,METHODS,NONE,RESULTS,T1BN0M0,VARIOUS
0001,009,120,126,1995,2010,ACS,AMID,BACKGROUND,BCS,CONCLUSION,DISTANT,EVEN,JANUARY,LABEL,LYMPH,METHODS,RESULTS,SMOKE,THERE
001,1992,2001,428,BACKGROUND,COX,ELDERLY,END,FACTORS,LABEL,METHODS,RESULTS,SCLC
2001,2013,BACKGROUND,CONCLUSION,E872,EGFR,FOUR,HOWEVER,L858R,LABEL,MARIE,METHODS,MOLECULAR,RESULTS,SCLC,SCLCS,SEVEN,SIX,THERE,TKI
001,002,003,114,122,200,436,945,BACKGROUND,IHC,III,INHIBITION,LABEL,METHODS,PEMETREXED,RESULTS,THERE,THYROID,TTF
2002,2009,376,501,697,BACKGROUND,CIS,COMMUNITY,CONCLUSION,COX,FEW,HRS,LABEL,MARCH,METHODS,RESULTS,SEPTEMBER,SOUTHEAST,THESE,USING
000,1998,2000,2003,2011,BACKGROUND,CONCLUSION,FIVE,GROUP,LABEL,LUNG,METHODS,RESULTS,THUS
BACKGROUND,BASED,CARE,CHEST,COLLEGE,CONCLUSION,DEVIATIONS,LABEL,LDCT,LUNG,METHODS,NETWORK,ONTARIO,PHYSICIANS,PROGRAM,RESULTS,SCREENING,SOCIETY
MINIMALLY,REFERRING
001,133,169,2006,2011,2013,530,AUDIT,BACKGROUND,CONCLUSION,COPYRIGHT,COX,IRELAND,LABEL,LTD,LUNG,MEIER,METHODS,NSCLC,RESULTS,STAGE,THESE,WESTERN,WORK
EXUBERANT
169,2014,747,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,FISH,FURTHER,IHC,INC,LABEL,METHODS,NUT,RESULTS,SCLC,SMALL
CARCINOMA,PET
150,169,2014,A549,COPYRIGHT,ERK,FAK,FINALLY,H1975,LTD,PCR,RAS,RNAS,SCHMIDT,SRC,TAKEN,USING,UTR
169,2014,2342,298,398,599,BACKGROUND,CHINESE,COPYRIGHT,FURTHER,GPC5,GWAS,HAN,HOWEVER,LABEL,LCINS,LTD,LUNG,METHODS,RESULTS,SNP,SNPS
100,2002,2004,2012,ABSS,AJCC,BETWEEN,CIS,CONCLUSION,HNB,KIT,LABEL,LOCAL,MATERIALS,MEAN,MELAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE,T1B,T2B,T4B,TIS
177,3DCRT,AFTER,BACKGROUND,EPP,HCRT,INTENSITY,LABEL,METHODS,MPM,OVERALL,RECURRENCE,RESULTS
946,A549,BACKGROUND,BBR,BERBERINE,EMT,LABEL,METHODS,PCR,QRT,RESULTS,SINCE,SLUG,TGF,WESTERN
AFTER,BACKGROUND,CHINESE,CONCLUSION,LABEL,METHODS,MFH,RESULTS,THERAPY,UNASSIGNED,VIRTUAL
1478,169,2014,AIMS,BRAF,CAUCASIAN,EGFR,FISH,JOHN,KRAS,LABEL,LTD,METHODS,MOLECULAR,NSCLC,OBJECTIVE,RESULTS,ROS1,SIXTY,SONS,TTF1,WILEY
ANTIGEN,AREAS,BACKGROUND,COVERED,FURTHER,III,LABEL,LUNG,MAGE,METHODS,OPINION,OUTCOME,PHASE
003,2005,2010,402,833,CANCERS,PLAIN,SIMAV,SINCE
100,A549,BACKGROUND,ERK1,H1299,HOWEVER,LABEL,MAPK,METHODS,NSCLC,PAX6,PCR,RESULTS
177,AFTER,CASES,EMERGED,FIFTEEN,HOWEVER,LABEL,LARGE,LDDMM,LUNG,MAPPING,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TOMOGRAPHY
146,946,ADP,AXIN,CDK4,HOWEVER,NSCLC,STUDIES,WNT
147,415,549,8764,AFFYMETRIX,AKT,BACKGROUND,CDH1,CONCLUSION,EGFR,EMT,LABEL,MET,METHODS,PLUS2,RESISTANCE,RESULTS,SW480,TGF,U133,ZEB1
1980,1998,2003,2006,2007,2008,2009,2010,ITALY,MORTALITY,MOST,NPCS,NPCSS,PROJECT,SITES,TARANTO,THESE
036,177,3DCT,4DCT,GTV,GTV3D,III,IMRT,MLD,NSCLC,OARS,PLANEOE,PTV3D,PTVS,THERE,V10,V20,V30,V40,V55,V60,V66
CURRENTLY,FDA,GUIDELINES,MUTATIONAL,NCCN,NSCLC
025,1025,169,1959,1981,2004,2010,2014,361,500,8764,CAUCASIAN,DATA,LABEL,LUNG,MEIER,METHODS,MOST,NON,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STAGE,SURGERY,THERE,UNIVERSITY
169,2014,ADC,FOUR,GMBH,KGAA,NSCLC,PXD000438,SCC,SILAC,THERE,THESE,VCH,WILEY
0001,076,174,227,272,8201,ANXA1,DDX53,DEAD,HOWEVER,IGG,III,LUNG,NSCLC,STUDENT
11Q21,169,2014,AACR,ANOTHER
1564,2148,320,584,904,BACKGROUND,DEGS,EXPRESSION,FURTHER,GENOMES,KEGG,KYOTO,LABEL,MATERIALS,METHODS,MICROARRAY,NSCLC,OMNIBUS,RAW,RESULTS,WEBGESTALT
1603,AFTER,AIM,ANNOTATION,ARCHIVE,BASED,CUFFLINKS,EXPRESSION,FCGBP,GSM718709,GSM718710,KEGG,KOBAS,LABEL,MATERIALS,METHODS,OBJECTIVE,OMNIBUS,ORTHOLOGY,READ,RESULTS,SRA,THEN,THESE
231,600,FE3O4,FOURIER,FTIR,III,PEI,TEM,VSM,XPS,XRD
MICRORNAS,NSCLC,SIMILARLY,SINCE,USING,WHILE
160,A549,CELL,NIN,NOB1,NON,NSCLC,PCR,RPN12,THEN,THEREFORE,THESE
CASE,MANAGEMENT,REAL,THERMAL
AKT,BIM,FOXO1,H1299,JNK,KIP1,MNNG,MTT,NUCLEAR,S256,S473,THESE,USING
190,214,FGFR3,INCREASED,LCS,PCR,R248C,R248H,R273C,SOX2,TACC3
8322,A549,ATG5,CUG,CUG2,FINALLY,FURTHER,ISG15,ROS,SINCE,STAT1,TAKEN,UNDER,VSV
754,EFFORTS,ESTIMATION,LABEL,MATERIALS,MDCT,METHODS,OBJECTIVE,PSOAS,PURPOSE,RESULTS,SMMS,SONOGRAPHY
0001,0014,4122,ADX,BACKGROUND,COX,LABEL,LADX,MEIER,METHODS,MOST,OVERALL,RESULTS
001,109,484,BRCA1,CHINESE,EGFR,ERCC1,FISH,FURTHER,HIGH,HOWEVER,NSCLC
8209,945,A549,HIF,LUNG
LABEL,LARGE,MMMFS,NEWLY,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE,UNASSIGNED,VIDEO
169,2010,2014,ACCORDING,ARAB,COPYRIGHT,COST,DESPITE,DISEASE,ENGAGEMENT,LTD
0001,177,986,987,995,BLAND,CONCLUSION,FDG,ICC,ICCS,INTRACLASS,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,RESULTS,THERE
2007,2012,CONCLUSION,JANUARY,KIDNEYS,LABEL,MALIGNANT,MATERIALS,METHODS,MRI,OBJECTIVE,PECOMAS,PRIMARY,RESULTS
ADDITIONAL,HOWEVER,MALIGNANT,MPM
169,2014,AUTHORS,COLLEGE,JOURNAL,PHYSICIANS,ROYAL
100,BACKGROUND,CASE,CD1A,CD68,CK7,CONCLUSION,LABEL,LANGERHANS,LCH,LIGHT,METHODS,TTF
107,1258,125B,130B,137,375,CPG,FOUR,MICRORNAS,NSCLC,PCR
ADPGK,ALDOA,ATP,BPGM,ENO1,GAPDH,GLYCOLYSIS,GPI,HK1,PCR,PFKP,PGK1,PKM2,THUS
916,HEK293T,HEL,HELA,HEP,HOWEVER,HSV,ICP0,ICP4,IFI16,IFN,STING,US3
169,2014,946,AACR,CONCLUSION,EMT,FINALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNAS,TGF,THESE
AKT,BASIC,ERBB3,JAK,JANUS,MAPK,MEK,RTKS,STAT,THUS,TKI
004,1997,2009,351,976,977,CONCLUSION,EVALUATING,HOWEVER,LABEL,METHODS,OVERALL,PET,RESULTS,THEREFORE,UNLABELLED
160,A549,ADC,COX,DATA,EKVX,GSEA,HAG,HAGS,HIGH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,169,183,ADMISSION,GEORG,HISTORY,LABEL,METHODS,STUTTGART,TREATMENT,UNLABELLED,YORK
12Q15,169,2014,BCHE,CELL,COPY,COPYRIGHT,DAVID,EGFR,INC,MDM2,SDK1,SOMATIC,THESE,TP53,WILEY
047,127,415,490,8805,COLORECTAL,EARLIER,HRS,LUNG,OLDER,OVARIAN,SCREENING,TRIAL,USING
001,004,005,009,150,2003,2011,8805,ACCORDING,AMONG,CERTAIN,EASTERN,ECOG,FIO2,GROUP,HOWEVER,ICU,IIIB,KOREA,MECHANICAL,PAO2,REFRACTORY
DESPITE,EMP2,FAK,IGG1,SRC,THUS,TREATMENT,USING
169,2014,622,946,AACR,APC,CD44,COX,GSK3,HPLC,JEGHERS,LABEL,LKB1,MOL,MYC,PEUTZ,PJS,RES,STK11,SUBSEQUENT,TCF,UNLABELLED,WNT
000,750,8805,AES,AZD7762,CARDIAC,CHK1,FORTY,GRADE,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS
967,AMONG,LABEL,MATERIALS,MDCT,METHODS,OBJECTIVE,RESULTS,SPSS,TNM
DESPITE,FOUR,FURTHER
M1B,MRI
10B,128,134,192,273,502,662,677,ABOUT,BACKGROUND,CURRENTLY,EXPRESSION,IIIA,LABEL,METHODS,NLP,NSCLC,PCR,RESULTS,SCC
001,0097,033,043,2007,2011,320,333,496,674,696,891,940,959,APRIL,BACKGROUND,BMET,CFI,CONCLUSION,COX,GAMMA,IDL,IDLS,JULY,KNIFE,LABEL,METHODS,NON,OBJECTIVE,PER,PERFEXION,RESULTS,VARIABLES,WBRT
146,169,2013,BASED,BCIP,COPYRIGHT,CROWN,ELF,INC,MISH,NBT,NON,NSCLC,PCR,PROGNOSTIC,PUBLISHED
169,2014,HGSDC,PRIMARY
169,2014,774,AKT,COPYRIGHT,EGFR,ERK1,ERLOTINIB,H1975,H520,HOWEVER,INC,NSCLC,OSI,PI3K,TAMOXIFEN,TARCEVA,THESE,THYMIDINE,TREATMENT
169,2013,COPYRIGHT,FORMATION,HECK,LTD,NHCS,SEVERAL
169,2014,946,COPYRIGHT,EMT,HOWEVER,JNJ7777120,LTD,NSCLC,SLUG,SNAIL,TGF,THEREFORE,ZEB1
169,177,2014,AIMS,AUTHORS,BIG,COPYRIGHT,DOGS,ELISA,INC,KEY,LABEL,MAIN,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERUM,THESE
110,1951,19Q,234,8594,BACKGROUND,CNS,CONCERNING,DETECTION,HOWEVER,LABEL,METHODS,MGMT,NCBI,NONE,OGD,OGDS,PTEN,RESULTS,UNASSIGNED,VIRTUAL
1997,2011,AGE,AMONG,CD34,DFSP,DISTANT,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS
125,1999,2013,8805,945,946,CD117,CD34,CK5,CKPAN,E12,LABEL,METASTASIS,METHODS,OBJECTIVE,RESULTS,SMA,TEN,THESE
001,150,2002,2011,COX,KPS,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS
181,A549,ERLOTINIB,FLOW,IC50,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,SERD0
945,946,957,APN,CELL,CLN,CNR,CONCLUSION,DEXTRAN,DUAL,FE3O4,HUVEC,LABEL,METHODS,MRI,NGR9,OBJECTIVE,RESULTS,RGD10,ULTRASMALL,USPIO
001,002,021,177,CHINESE,LABEL,METHODS,MHCC97L,OBJECTIVE,ORTHOTOPIC,RESULTS,SONGYON,SONGYOU,THREE,YIN
100,169,177,2013,949,956,COPYRIGHT,DOX,ECM,LNCAP,LRP,LTD,MDR,MRP1,NPS,OVERALL,PCA,PCL,PEG,SEPARATELY,THREE
ACC,AMONG,AMP,AMPK,APOPTOSIS,BAX,BCL,BUOH,COA,DCM,ERICACEAE,FASN,H2O,HEMSL,NSCLC,RFL,URSOLIC
334,BACKGROUND,CONCLUSION,EGFR,HPV,KRAS,LABEL,LUNG,METHODS,PCR,RESULTS
A549,DIETARY,GSH,TAKEN
658,ADHERENCE,BOTH,ECS,FAK,SRC,VEC,VEGF,Y658,Y658F
312,375,399A,711,ARG156ARG,ARG194TRP,ARG280HIS,ARG399GLN,ASN,ASP,ASP312ASN,ASP711ASP,COX,HRS,INDIVIDUAL,LYS751GLN,NSCLC,PCR,XPD,XRCC1
4124,ADC,CDK1,CDK2,CDK4,DEGS,EXPRESSION,GENOMES,KYOTO,NON,NSCLC,OMNIBUS,SCC,SKP2,THEREFORE
961,EXPRESSION,FFPE,GIVEN,HOWEVER,NANOSTRING,NGS,OVERALL,PCR,THESE
169,2014,560,AACR,ATP,BRG1,CDH1,CDH3,DNMT,EHF,LABEL,MOL,NSCLC,RES,RRAD,SMARCA4,SNF,SWI,UNLABELLED
0002,177,2008,2012,3N0M0,AFTER,BACKGROUND,EPP,FIVE,III,IMRT,LABEL,METHODS,MPM,MPMS,OCTOBER,RADIATION,RESULTS,SMART,SURGERY,THERAPY
001,003,005,015,039,061,846,967,HCC,LABEL,LITERATURE,METHODS,OBJECTIVE,PITUITARY,PURPOSE,RESULTS
145,IRINOTECAN,THERE
CBL,DUE,EGF,EGFR,MIG6,MODEL
169,2014,956,A549,AMONG,COPYRIGHT,NOVEL,SAS,THESE
169,2014,954,A549,AKT,BEAS,COPYRIGHT,CROWN,EGFR,HBE,INC,ISG15,LOSS,PUBLISHED,THESE,UBE1L
169,2014,801D,946,956,COPYRIGHT,CURCUMA,GTPASES,HOWEVER,INC,LASER,MEANWHILE,MMP,PAK1,RAC1,RHO
169,2014,211H,956,COMPOUNDS,COPYRIGHT,H292,IC50,LOBELIA,MSTO,MTPA,NCI,NMR,THEIR,THREE
000,100,169,1968,1980,2009,2013,8805,COPYRIGHT,LTD,RESULTS,SES,STATISTICS,THESE
949,954,CCL5,IKK,JAK,JANUS,KRAS,MAPK,MEK,PI3K,RAS,TANK,TBK1,THESE
169,2014,COLLISION,COPYRIGHT,INC
169,2014,34A,BAX,BCL,COPYRIGHT,FEDERATION,FUNCTIONAL,NSCLC,PUBLISHED,SOCIETIES
001,100,10878,169,2008,2011,2012,2014,232,356,CONCLUSION,COPYRIGHT,DAILY,GFR,IRELAND,JANUARY,LABEL,LTD,METHODS,NPH,NSCLC,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SERUM,SINCE,SIXTY
006,200,BACKGROUND,CONCLUSION,EBRT,EQD2,IRELAND,LABEL,LTD,MANAGEMENT,MATERIALS,MEIER,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,SBRT,TREATMENT,UVA
169,2014,231,BACKGROUND,COPYRIGHT,GNP,GNPS,GOLD,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MDA,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
169,2014,65GY,BACKGROUND,CHEMO,CONCLUSION,COPYRIGHT,CRT,CTCAEV3,III,IIIA,INDAR,IRELAND,LABEL,LTD,MEIER,METHODS,NON,NSCLC,OVERALL,RESULTS,T4N0
169,2013,440,956,AJCC,BACKGROUND,CONCLUSION,COPYRIGHT,EGCG,ESOPHAGEAL,III,IIIA,IIIB,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
113,123,131,169,177,2013,CONCLUSION,COPYRIGHT,CRT,EAR,IMRT,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OED,OEDS,PURPOSE,RESULTS,THREE,VMAT
169,2013,956,BOTH,COPYRIGHT,H1299,IC50,LTD,LUNG,MOM,MTT
169,2014,COPYRIGHT,DIGITAL,INC,USING
945,AIMS,AKT,ATP,CONCLUSION,FOXO1,H28,HIF1,HOWEVER,INNOVATION,IRS1,LABEL,MET5A,OBJECTIVE,RESULTS,SINCE,THESE
CRP,EVALUATION,HOWEVER,METASTATIC,RCC,UPPER,WHOLE
945,946,947,BACKGROUND,CONCLUSION,IFN,LABEL,METHODS,MIC,NKG2D,RESULTS,SKOV3,THESE,TNF
8201,ACUTE,ARF,BACKGROUND,BURKITT,DIAGNOSIS,ECMO,FIO2,FIVE,HMS,HODGKIN,ICU,LABEL,METHODS,NHL,PAO2,RESULTS,SAPS,THREE
111,LABEL,LOSS,M5A,METHODS,OBJECTIVE,PURPOSE,RENAL,RESULTS,T84,TISSUES,UPTAKES,YET
100,125,151,BACKGROUND,CUP,EXPRESSION,LABEL,METHODS,POSITIVITY,RESULTS
2010,2012,221,481,506,AETNA,CONCLUSION,DATA,FEWER,IPA,IPAS,JUNE,LABEL,LEVEL,MAY,METHODS,OBJECTIVE,PATHWAY,PATIENT,PROGRAM,PSS,PURPOSE,RESULTS,SPECIALTY,SUPPORT,TEXAS,TOTAL,TXO
169,2014,AACR,BACKGROUND,BON,BOTH,H727,HOWEVER,LABEL,MEK,METHODS,NCI,NET,NETS,PD0325901,PEPTIDE,PI3K,QGP,RAS,RESULTS,THEREFORE
169,2014,336,977,AACR,ALK,CHINESE,CONCLUSION,EGFR,FISH,IHC,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,TEN,TKI,TKIS,WESTERN
108,169,2014,AACR,BAP1,DESPITE,EMT,EPITHELIAL,LABEL,METHODS,MOLECULAR,MPM,NF2,OBJECTIVE,PATHWAY,PCR,PURPOSE,RESULTS,SIMILAR,TP53
15B,169,177,2014,252,63743,8197,945,946,956,A549,ACTA,ARTEMISIA,CHIMICA,COPYRIGHT,DDP,DOX,FOUR,HELVETICA,K562,MDR,NMR,SPS
BRONCHIAL
017,019,089,189,282,8201,947,NSCLC,UNIVARIATE
2012,8201,967,BRCA1,COX,ERCC1,HIGH,HRS,IIIB,JANUARY,NSCLC,PFS,RRM1,XPG
001,2052,4104,8197,8201,8805,BACKGROUND,BMJ,DLCST,GROUP,LABEL,LIMITED,LUNG,METHODS,MISSING,OVERALL,PUBLISHED,PUBLISHING,RESULTS,SCREENING,SMOKING,THERE,TRIAL
160,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,THUS
ALTOGETHER,AML,AUSTRIA,LABEL,METHODS,OBJECTIVE,PROPORTION,PURPOSE,RESULTS,TYROL
160,AFTER,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SIMULATION,THUS,VIDEO
0001,001,105,1992,2011,215,218,320,329,387,573,686,ASSOCIATED,DISEASE,LABEL,LYMPH,METHODS,OBJECTIVE,OBJECTIVES,RESECTION,RESULTS,THERE,WHILE
0002,001,002,006,115,170,2002,2011,220,592,CONCLUSION,FDG,INITIAL,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,TEXAS,UNIVERSITY
1994,2013,APRIL,CONCLUSION,FIVE,FOUR,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RADICAL,RESULTS,SPT
169,2014,50TH,AACR,GENERAL,OWING,PERHAPS,SMOKING,SURGEON,TOBACCO
001,149,332,ALK,EGFR,KRAS,L858R,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
DCA,FURTHER,IC50,IIIB,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SYNERGY,UNDER
A549,ATR,CHK1,NSC746364
3KT,DNMT,DNMT1,FINALLY,HBEC,HDAC,HDAC1,HDAC2,HDAC3,HDACS,SFRP2,TARGETING,THESE,TREATMENT,VPA
001,452,50S,794,8804,897,AMONG,KEY,KINGDOM,LABEL,LDCT,LIVERPOOL,LUNG,OVERALL,RESULTS,SCREENING,THOSE,UKLS,UNLABELLED
129,155,172,1980S,2010,2012,CK5,CK7,HOWEVER,MAJOR,MINOR,OVERALL,TTF
CURRENTLY,LABEL,LUNG,MAJOR,NLST,OBJECTIVE,OPTIMIZED,PURPOSE,RESULTS,SCREENING,SUMMARY,THREE,TRIAL
BOTH,LABEL,LUNG,NGS,OBJECTIVE,PURPOSE,RESULTS,SQCC,SQCCS,SUMMARY
LABEL,MALIGNANT,MOST,MPM,OBJECTIVE,PROGNOSIS,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE
ANTIGENIC,BLP25,III,LABEL,MAGE,NSCLC,OBJECTIVE,PURPOSE,RCT,RCTS,RESPONSES,RESULTS,SEVERAL,START,SUMMARY,TRIAL
AXL,GL21,THEREFORE,USING,WHILE
ACCORDING,AIMS,BACKGROUND,BARR,CONTEXT,EBV,EPH,EPSTEIN,FIVE,FOLLOWING,LABEL,LMP,LUNG,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SCC,SCCS,USED
169,1MG,2013,A549,CAO,COPYRIGHT,L929,MG63,MGO,RER,SEM,SIO2,THESE,WHILE
00001,0001,500,ASIAN,III
169,2014,947,AZA,COPYRIGHT,CPG,DAC,FINALLY,HLA,IFN,MEIOB,TAKEN
169,2014,AKT,COPYRIGHT,EGFR,ERK,INC,PC9,PI3K,SRC,TKI,U0126
169,2014,490,A549,CCND1,COPYRIGHT,INC,MICRORNAS,RNAS,THESE,UTR
169,2014,A549,ACTIVATION,ANNEXIN,APOPTOSIS,BALB,BBB,CASPASE,CELL,COPYRIGHT,FAILURE,FITC,IRELAND,LTD,OVERALL,PEI,PLGA,PROPIDIUM,STAT3,VEGF
169,2014,400MG,622,665,8805,AIM,BCL,BIM,CONCLUSION,COPYRIGHT,DCR,EGFR,HAND,HFS,IIIB,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PFS,PRIMARY,RESULTS,SECONDARY,SORAFENIB,TKI,TKIS
100,169,2014,BOTH,COPYRIGHT,GLUT,IHC,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS
001,002,004,005,016,123,169,2013,CENP,CENTROMERE,COPYRIGHT,GMBH,P53,PCR,WESTERN
978,A549,BACKGROUND,CD133,CSCS,DSB,DSBS,EXO1,FINALLY,H1299,H2AX,IRELAND,LABEL,LENTIVIRAL,LTD,MATERIALS,METHODS,PCR,PRIOR,PUBLISHED,RAD51,RESULTS
169,2014,AUTHORS,BASED,COPYRIGHT,DATA,IRELAND,LIMITED,LTD,PUBLISHED,RNI,SUBSETS,WBI,WHILE
0001,1000,113,122,169,183,2014,239,242,364,910,AFTER,ASIA,ASIAN,BACKGROUND,BOEHRINGER,CHINA,CLINICIANS,COMMITTEE,COPYRIGHT,EGFR,ERBB,FIRST,FUNDING,IIIB,INGELHEIM,JOINT,KOREA,LABEL,LEU858ARG,LTD,METHODS,NSCLC,RESULTS,SOUTH,TREATMENT
169,2014,INC,USING
001,1666,169,2013,232,AOM,COPYRIGHT,DSS,NSCLC,PROTEIN,SAS,SHP,TNM
169,2009,2012,2013,340,BACKGROUND,BETWEEN,COPYRIGHT,COX,DCR,EGFR,GUSTAVE,IIIB,IRELAND,JUNE,KRAS,LABEL,LTD,MEIER,METHODS,MUT,NSCLC,PFS,RESULTS
145,148,149,150,169,174,2014,BACKGROUND,COPYRIGHT,EGFR,IRELAND,IVD,KIT,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,RGQ,SINCE,TEST,THEREFORE,THREE,TKIS
105,129,145,169,177,2009,2012,2013,BACKGROUND,COPYRIGHT,EBUS,JANUARY,LABEL,LPPS,METHODS,MHZ,OBJECTIVE,PPL,PUBLISHED,RESULTS,SEPAR
169,2013,CEREBELLAR,IGG1,MRI
169,1996,2002,2014,486,ALLERGY,BACKGROUND,CIS,COLLEGE,CONCLUSION,COPYRIGHT,HAY,HISTORY,IMMUNOLOGY,INC,LABEL,METHODS,OBJECTIVE,ORS,PUBLISHED,RESULTS
1969,1971,2004,2005,2009,ASIAN,BACKGROUND,BETWEEN,COPD,JOURNAL,LABEL,LIFE,METHODS,OBJECTIVE,PACIFIC,PREVENTIVE,PUBLISHED,PURPOSE,RESULTS,RURAL,THERE
169,2012,2014,243,4456,493,AFTER,BACKGROUND,COPYRIGHT,DVT,ENFERMEDAD,INC,LABEL,METHODS,MOSBY,PUBLISHED,RESULTS,RIETE,SOCIETY,SURGERY,THESE,TROMBOEMB
169,183,2014,215,AAV,BACKGROUND,CHM,COPYRIGHT,DEPARTMENT,DESPITE,FOUR,FUNDING,LABEL,LTD,MAXIMAL,MEAN,METHODS,RAB,REP1,RESULTS,THESE,TRUST
0001,002,110,169,2013,BACKGROUND,CELL,COPYRIGHT,EBUS,EXCLUSIVE,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR,TBNA
0001,001,0025,100,169,2011,2014,249,932,COMPLEX,CRIBRIFORM,DISEASE,LUNG,PATHOLOGIC,SOCIETY,THESE
169,176,177,2014,A549,APN,ASPARAGINE,COPYRIGHT,DOTA,INC,LABEL,MB231,MBQ,MDA,METHODS,NGR,PET,RESULTS,UNLABELLED
197,205,978,985,ACSL1,AUC,AXIN2,BACKGROUND,CDH3,CHINESE,CURRENTLY,FFPE,FOXO3,GENOMES,KEGG,KYOTO,LABEL,LUNG,METHODS,PCR,PPP1R3A,PREDICTED,RESULTS,RUNX1,SCLC,SMAD4,STK3,TBL1XR1,TEN,THEN
105,149,2011,2012,BACKGROUND,CHINESE,COX,EGFR,JULY,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,UNIVARIATE
169,2014,946,ASIA,AUTHORS,CALU3,EXPRESSION,H23,KNOCKDOWN,LTD,NCI,NOD,PTY,PUBLISHING,RERF,SB208,SCID,SCIENCE,SMAD,SMAD2,TGF,THESE,WILEY
786,ADR,ANTICANCER,EHRLICH,ERS,H460,K562,MCF7,MODULATORS,NCI,OVCAR,PSIDIUM,RECEPTORS,RES,SELECTIVE,SERMS,SOLID,UACC
169,177,2014,8201,AFTER,AUSTRALIAN,COLLEGE,CONCLUSION,DELAYED,FDG,LABEL,METHODS,NON,OBJECTIVE,PET,PURPOSE,RESULTS,ROYAL,SUL,SUV,WHILE,ZEALAND
160,945,946,947,CHIP,EMSAS,IFN,LLC1,LXR,LXRES,SEVERAL,TAKEN
012,100,177,BACKGROUND,LABEL,LUNG,MEAN,METHODS,OBJECTIVE,PCU,RESULTS,SETTING,THERE,UNIVARIATE
945,A12,AKT,BACKGROUND,BECAUSE,COX,HIF,IGF,IMC,LABEL,METHODS,MTT,NSCLC,RESULTS,TAKEN,USING
2006,2010,7514,CONCLUSION,HEALTHY,HOWEVER,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,RETIREMENT,THESE,USING
20S,BACKGROUND,DIRECTIONS,DISSECTING,LABEL,LUNG,THERE,WHEREAS
BACKGROUND,BRAIN,LABEL,METHODS,RESULTS,USING,WITHOUT
169,2014,AACR,CONSISTENT,ILLNESSES,META,SMOKING,THUS
IIA,MYH9,RNAI,SCC,SCCS,SEVEN
1950S,1964,2014,50TH,COMMITTEE,GENERAL,SURGEON,THESE
005,007,022,027,045,COX,HIGH,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,TNFSF13
169,181,2014,5MC,8804,945,ALU,AMBIENT,BEIJING,CHINA,COPYRIGHT,D4Z4,EFFECTS,HOWEVER,INC,LINE,MEASURING,NBL2,OVERALL,PM10,PM2,SAT,THERE,WILEY
169,2014,AACR,AKT,BCL,CD133,CSC,DRUG,NOTABLY,PKB,SCLC,SMALL
150,2177,515,983,AMONG,BACKGROUND,EASTERN,GROUP,INVENTORY,LABEL,METHODS,RATINGS,REGRESSION,RESULTS,SYMPTOM
148,327,ASA,DUE,PCR,RFLP,SER326CYS,SIMILARLY,SSCP
169,2014,BNCT,CARLO,LABORATORY,MCNP5,MONTE,OAK,ORNL,PRESS,PUBLISHED,RIDGE,UNIVERSITY
100,177,BASED,CONCLUSION,DOTATOC,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
131,2010,2011,APRIL,ASCT,CONCLUSION,EIGHT,FDG,FIVE,FURTHER,GBQ,HODGKIN,LABEL,MARCH,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RIT,SIP,SPECT,TENARAD
174,239,8482,EGFR,ERBB,FDA,GIOTRIF,HER3,HER4,III,L858R,LUNG,LUX,NSCLC,ORAL,TKI
169,2014,CHRONIC,COPD,DESPITE,EGFR,ERS,EUROPEANS,USING
009,023,034,313,ADC,ADCS,ATS,EASTERN,EGFR,ERS,FACTORS,GROUP,IASLC,LUNG,OVERALL,PFS,PROGNOSTIC,SINCE,SOCIETY
169,2014,BASEL,BIOLOGICAL,GWAS,HOWEVER,THUS,USING
AUTOPHAGY,CFTR,MDR
02E,1250,23E,40E,8805,946,AUGMENTED,CAFS,DCIS,EGF,FGF,FINALLY,GSEA,HOWEVER,JNK1,PDGF,RHO,TGF,THESE,THUS
160,CBCT,CONE,DUE,FOUR,LINAC,TBCT
169,2014,AKT,CLINICALLY,COPYRIGHT,DISRUPTION,IRELAND,JNK,LTD,MDIG,NSCLC,STAT3,TAKEN
100,112,1200,160,176,200,CATPHAN,FOUR,RMG
169,2013,AMPLATZER,AVP,BACKGROUND,BASEL,BPF,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SHORT
169,181,190,2012,2014,APRIL,BACKGROUND,BASEL,CASE,DISCUSSION,EBUS,EUS,INFECTIOUS,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SAE,SERIOUS
255,CDT,CDTA,CDTB,CDTC,CYTOLETHAL,GRAM,LEWIS,LFN,LUNG
231,4T1,BCL,CAM,FBW7,HOWEVER,JNK,JUN,MCL,MDA,SCF,T24,TRAIL,TUBULIN,UNRAVELING
100,1989,2013,DUE,FNA,HPC,LABEL,METHODS,OBJECTIVE,PCNS,RESULTS,SIX
205,945,BACKGROUND,CELL,CONCLUSION,H2170,H441,HOWEVER,LABEL,LUCIFERASE,METHODS,NSCLC,RESULTS,TMPRSS4
034,138,154,176,177,390,627,750,75TH,8804,8805,BACKGROUND,FIBRINOGEN,LABEL,METHODS,MOST,MPM,RESULTS
231,BACKGROUND,BALB,CARIPORIDE,CD44,ERK1,LABEL,MCF,MDA,MEK1,METHODS,NHE1,PD98059,RESULTS,TAKEN,THEN
128,169,2013,CAD,COPYRIGHT,THEREFORE
947,HEAD,LTD,PPAR,PUBLISHED
150,169,2013,956,A549,AFM,BSA,CBM,CNP,CNPS,COPYRIGHT,MTT,MTX,SEM,THESE
169,2014,460,COBRA,COPYRIGHT,H157,H446,HOWEVER,NCI,RAS,RASSF,RASSF10,SAS,SPCA,TAKEN,TREATMENT
169,189,2004,2013,300,300CC,8805,BACKGROUND,CONCLUSION,COPYRIGHT,EFS,FURTHER,III,IRELAND,LABEL,LOCO,LTD,MAGNITUDE,METHODS,NSCLC,OTHER,PTV,PTVS,RESULTS,THREE
000,001,003,021,105,112,116,161,166,177,181,2012,271,541,644,967,CEA,GGO,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,PET,RESULTS,T1A,THERE
2000,2010,8927,FOUR,HOWEVER,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OCTOBER,PLE,RESULTS,TILL
0001,169,183,189,2011,2012,2014,3052,3469,6930,APPLIED,AUG,BACKGROUND,BANKS,COPYRIGHT,DEC,ENGLAND,FUNDING,INSTITUTE,LABEL,LTD,METHODS,OPEN,OTHER,PROGRAMME,PUBLISHED,RESULTS,SELECTION
100,181,3DU6,460,956,ACD,CHEMSKETCH,DOCKING,FIVE,GIVEN,IC50,MCF,MCF7,MOLECULAR,NCI,RULE,TELOMERASE
BMPR2,BRCA1,ECS,OCCLUSIVE,PAH
023,107,162,2006,2010,240,453,490,492,502,617,8201,CONCLUSION,COPD,ETHNICITY,FURTHER,HISPANICS,ICD,LABEL,MEDICAL,MEPS,METHODS,OBJECTIVE,PANEL,RESULTS,SMOKING
946,954,ABSENCE,HMGB1,NAC,PCR,TLR,USING
003,100,101,137,181,AHI,AKERN,AURA,BACKGROUND,BCM,BIA,BMI,CRP,ECW,ELISA,FFM,GRASS,ICW,ITALY,LABEL,LITE,METHODS,MODEL,OBJECTIVE,OBJECTIVES,OSAS,PSG,RESULTS,RJL,TBW
0001,2002,2009,2012,308,335,670,916,AFTER,ERS,ESTS,LABEL,MAYBE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER
CUTANEOUS,IMPORTANCE,LABEL,METHODS,MOST,OBJECTIVE,RELEVANCE,SERPENTINE,THESE,WHILE
2004,2010,AJCC,ALONG,ATRX,CAP,CK19,CURRENT,DAXX,ENETS,FURTHER,LOSS,MEN1,MOLECULAR,MOST,NET,NETS,NORTH,OTHER,PANNETS,PER,PREVIOUSLY,SOCIETIES
954,BIM,CRL,CRLS,E3S,KRAS,MLN4924,NOXA,RBX1,RBX2,RING,SAG,TREATMENT,USING
006,100,169,2014,AACR,ADVERSE,CHK1,DISEASE,DL3,DOSE,EGF,EGFR,ERLOTINIB,FPB,FURTHER,HDAC,LABEL,LOW,METHODS,MTD,NSCLC,OBJECTIVE,PFS,PURPOSE,QTC,RESULTS
100,169,2014,AACR,BRAF,EGFR,KRAS,L858R,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,T790M
COMMITTEE,JOINT,LABEL,MEANWHILE,OPINION,PAP,RADIATION,RESULTS,STATEMENT,UNASSIGNED
119,AMONG,CHINA,FURTHER,HOWEVER,MAPK,THEREFORE,TODAY,TOTAL,YADANZI
100,HMB,THEREFORE
ACUTE,COCAINE,VARIOUS
BACKGROUND,CLARA,DESPITE,LABEL,LYMPHATIC,METHODS,OBJECTIVE,RATIONALE,RESULTS,SIDE,VEGF,VEGFR
169,2013,64257,A549,AUNBS,COPYRIGHT,GOLD,LTD
8201,CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SIR,SIRS,SLE
CONCLUSION,HIGH,LABEL,METHODS,MRI,NONE,OBJECTIVE,RESULTS
945,BACKGROUND,CASE,CRMP,IMMUNOBLOT,LABEL,METHODS,OPTICAL,RESULTS
AKT,CD226,CLAUDIN,ERBB2,ERK,HDL,HOWEVER,LDL,MICROARRAY,OCLUDIN,THESE
185,AKT1,EGFR,H358,HER1,HIF1A,MAJOR,PIR,SRSF2,VEGFA
AKT,CL1,HSP90,INHIBITION,NATURAL,PBT,SLUG,TAKEN
6000,CIGARETTE,HPHC,HPHCS,WHOLE
169,2014,AUTHORS,BALLANTYNE,CMN,GYNECOLOGY,JAPAN,JOURNAL,OBSTETRICS,SOCIETY,VARIOUS
LUNG,QOL,WHITE
119,136,347,ALK,CRIZOTINIB,FURTHER,HOWEVER,OTHER,P450,THESE,XALKORI

BMT,CD20,DOWN,EBER,EBV,LABORATORY,PTLD,THESE,THREE,THUS
0X3,100,8X3,AE1,AE3,CAM,GROSSLY,MEANWHILE,ZELLBALLEN
130,AMONG,HDAC9,KRAS,THESE
100,496,954,AKT,ERK,HOWEVER,INGENUITY,IPA,NSCLC,PATHWAY,PCR,PTEN,RAF1,THEREFORE
2008,A549,BAX,BCL,FURTHER,GAMBOGE,GAMBOGENIC,GFP,GNA,HELA,HOWEVER,LC3,LUNG,MDC,SIMILAR
146A,IAP,IAP1,IAP2,INHIBITION,RIP1,ROS,SCAVENGING,THUS,XIAP
0218,1400,2400,300,3LL,6NTAC,954,AIM,BACKGROUND,C57BL,CHAIN,CONCLUSION,GPX1,LABEL,LD50,LEWIS,MATERIALS,METHODS,NRF2,OBJECTIVE,PCR,POLYMERASE,REAL,RESULTS,SOD2,SRS,TBI,TIME,WHILE
080,169,1998,2008,2014,235,BLOOD,CONCLUSION,FEDERATION,HCC,HEART,HOWEVER,INSTITUTE,JANUARY,LABEL,LIMITED,LIVER,LUNG,METABOLIC,THERE,UNLABELLED
CHINESE,COX,EASTERN,ECOG,EGFR,GROUP,IIIB,MEIER,NON,NSCLC,PCR,PFS,TKIS
160,58CPG,946,95C,95D,AHR,AZA,CHIP,DCN,DECORIN,EMSA,HOWEVER,NSCLC,PCR,SMAD,SMAD3,TAKEN,TGF,UTR
001,006,023,148,310,419,DOCUMENTED,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,RESULTS
173,177,8201,A549,AFTER,AXL,CY5,FACS,H249,LABEL,METHODS,NCI,NIRF,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,SELECTIVE
10MM,169,2013,CARLO,CONFORMITY,COPYRIGHT,D95,DOSE,IMRT,IRELAND,ITV,LABEL,LTD,MATERIALS,METHODS,MIDP,MONTE,NSCLC,OARS,OBJECTIVE,PLANNED,PTV,PTVS,PURPOSE,RESULTS,SBRT,SIB,TOMOPEN,TVS
252,AGE,AMONG,BONE,DTC,LABEL,MEAN,MEN,METHODS,MTC,OBJECTIVE,PFS,PRIMARY,RESULTS,SEQUENTIAL,THERE,TKI,TKIS
169,1990,2012,2014,ADJUSTING,BACKGROUND,COPYRIGHT,HRS,INC,LABEL,LVI,MEDLINE,METHODS,NSCLC,PUBLISHED,RESULTS,RFS,SOCIETY
100,169,2002,2011,2014,AFTER,APRIL,BACKGROUND,BETWEEN,COPYRIGHT,III,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE
160MG,2007,2008,427,AFTER,AMONG,CAB,CENTRAL,DISTANT,M1B,NODAL,PCA,PSA,RADICAL,T1C,TREATMENT
LATE,MOST,THESE
2276,2780,650,775,BACKGROUND,CONCLUSION,CSI,HOWEVER,LABEL,METHODS,OVERALL,RESULTS,USING,WHETHER
CURRENTLY,ITV,ITVS,MIP,PET,PREDICTED,SUV,VMSBR
947,ARC,BOTH,DQA,DTA,ECLIPSE,EDR2,MOST,MVCT,PHANTOM,RAPID,SBRT,THESE
3MM,6MM,DEEP,DIBH,DIBHS,THERE
0813,215,5CM2,AAA,AXB,D2CM,ECLIPSE,GROUP,NSCLC,PTV,R100,R50,RADIATION,RTOG,SBRT,SIMILARLY,THERAPY,TPS,V20
177,3MM,HIGH,NSCLC,PEAK,THEN
0TO,100,CARLO,D95,D99,FIFTY,GTV,MONTE,PRESCRIBED,PTV,SBRT,SIMILAR
029,068,2010,2012,281,385,596,750,756,795,967,ADVERSE,CLASS,DCR,EGFR,ERCC1,FURTHER,III,JUNE,LABEL,METHODS,MOST,NSCLC,OBJECTIVE,OCTOBER,ORR,PFS,RESULTS,RRM1,SPSS,THERE
ANTIBODIES,IGE,TH2
0449,169,2014,AACR,CELL,CONCLUSION,FOUR,GDC,GLI,GLI2,HOWEVER,LABEL,LSCC,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMO,SMOOTHENED,XENOGRAFTS
169,2014,956,CIGARETTE,COPYRIGHT,HNE,INC,SCAVENGER,THUS
BACKGROUND,BREATHING,CONCLUSION,DEEP,DELIVERING,DIBH,EIGHT,FREE,HEART,HOLD,LABEL,LAD,METHODS,NTCP,RESULTS,TCP
001,026,033,132,16HBE,2011,497,703,8201,868,ACCORDING,ALSO,ATS,BACKGROUND,COX,ERS,IASLC,LABEL,LAD,LADS,LUNG,MEIER,METHODS,MPA,NOTCH,PCR,PPA,RESULTS,REVERSE,SEMI,SOCIETY,SPA,WESTERN
0006,004,0059,135,2011,2013,298,BACKGROUND,BARD,JANUARY,LABEL,MARCH,METHODS,RESULTS,TYCO
BACKGROUND,BV6,C16,CONCLUSION,CONSISTENT,FAS,HOWEVER,IAP,LABEL,LCL85,METHODS,RESULTS,SILENCING,SMAC
169,2013,AFTER,ASIA,AUTHORS,BECAUSE,CD31,CD34,FIVE,LTD,PATHOLOGY,PTY,PUBLISHING,S10,SOCIETY,SPCH,WILEY
023,045,104,169,2013,507,ALDH1,ASIA,AUTHORS,LTD,NSCLC,PATHOLOGY,PROGNOSTIC,PTY,PUBLISHING,SOCIETY,WILEY
100,297,8201,ALK,ASIAN,BACKGROUND,CHINESE,D5F3,EIGHT,FISH,HOWEVER,IHC,LABEL,METHODS,PCR,RESULTS,THREE,UNASSIGNED,VENTANA,VIRTUAL
231,549,956,ACCORDING,DYSIDEA,HELA,IC50,MCF,MDA,MRC
2002,2009,BACKGROUND,CELL,CRT,DEC,FIVE,LABEL,LUNG,MEIER,METHODS,NON,NSCLC,ORR,PFS,RESULTS,SEP,SMALL
A549,CELL,HBED,III,KINETIC,MRC5,TI2TF
AFRICAN
HOWEVER,SMALL
COMMENTARY,ERM,HIGH,INCREASING,MEMBERS,SIMILARLY,THUS
177,24H,293,48H,945,A549,AFTER,BAMHI,CEUI,CMV,CONCLUSION,DH5A,EGFP,ELISA,GFP,HIF,KPNI,LABEL,METHODS,OBJECTIVE,PACI,PCR,RESULTS,SCEI,SHUTTLE
169,2014,BACKGROUND,CELL,GATA,GATA3,GCDFP,GCFP,LABEL,METHODS,RESULTS,SOCIETY
160,169,183,CAUCASIAN,END,GEORG,LAMN,STUTTGART,USA,YORK
BRAF,DDR2,EGFR,EPIDERMAL,FGFR1,HER2,HOWEVER,KRAS,MET,NUT,OTHER,OWING,PTEN,ROS1,STAGING,THESE
CONCLUSION,GAMMA,HOUNSFIELD,ICE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TPS,TRE,VALIDATION,WHILE
001,029,046,177,183,2000,2010,211,8201,BACKGROUND,GEORG,JANUARY,LABEL,LOBECTOMY,MATERIALS,METHODS,NSCLC,RESULTS,SEPTEMBER,STUTTGART,YORK
200,400,ACCRUAL,GRADE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PDGFR,PREVIOUSLY,RAF,RESULTS,SCLC,SORAFENIB,VEGFR
169,2014,2859,540,COX,DIFFERING,FRAMINGHAM,HISTOLOGY,LABEL,LUNG,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PROPENSITY,PUBLISHED,RESULTS,SURGERY,UNIVERSITY,WEDGE
106,127,159,169,2009,2012,2014,286,CUSB,DIAGNOSTIC,EBUS,EUS,FALSE,FNA,FOLLOWING,IIIA,IIIB,JANUARY,LABEL,METHODS,NPV,NSCLC,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,STATION,SURGERY,TBNA,TEMLA,UNIVERSITY
106,1989,2010,COX,CSS,DMS,EBRT,FOLLICULAR,FTC,MEIER,PROGNOSTIC,THEIR,UNIVARIATE
740,ADJUSTING,BMJ,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,PACKS,PICTORIAL,PUBLISHED,PUBLISHING,RESULTS,SMOKERS
001,039,040,552,602,8201,DATA,HOWEVER,NSCLC,TELOMERASE,TERT,THESE
015,019,126,8201,HOWEVER,NSCLC,PCR,RAF,REAL,RKIP,TNM
001,007,009,016,032,045,086,AKT,ASIAN,EAST,EGFR,ERBB,ERK,HER2,HER3,L858R,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS
2002,215,8201,8805,AGREEMENT,BMI,FORTY,FURTHER,LABEL,MDS,METHODS,MPS,NRS,OBJECTIVE,POOR,PURPOSE,RESULTS,SGA
ASIA,ASIAN,COPD,DISEASE,HAP,HOUSEHOLD,INITIATIVE,LABEL,LUNG,NONSMOKERS,OBJECTIVE,PREVALENCE,PURPOSE,RESULTS,SMOKING,SPIROMETRY,SUMMARY,THERE
000,118,1998,2009,ADULT,ENGLAND,ENGLISH,EPISODE,HODGKIN,INCIDENCE,JANUARY,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STATISTICS,STRATEGIES,THERE
107,ALK,AMONG,BRAF,CD74,CHINESE,EGFR,HER2,HOWEVER,KRAS,LIVER,LKB1,RET,ROS,ROS1,THESE,THUS
270,A20,ALK,ANAPLASTIC,BACKGROUND,E13,EGFR,EML4,I1171FS,KRAS,LABEL,METHODS,NSCLC,RESULTS,T1312FS
124,197,2007,2009,APRIL,BACKGROUND,BONE,CONCLUSION,FACTORS,FORTY,IIIB,LABEL,METHODS,NEWLY,NSCLC,PREDICTIVE,RESULTS,SCLC,SRE,SRES,TREATMENT
026,0429,0821,1022,3241,500,BACKGROUND,CONCLUSION,DFS,EASTERN,FPGS,GGH,GROUP,IIIA,LABEL,METHODS,PATHOLOGIC,RESULTS,SLC19A1,THERE,TYMS
125,130,2008,2011,225,APRIL,BACKGROUND,BETWEEN,CONCLUSION,IIIB,LABEL,METHODS,NSCLC,PEMETREXED,PFS,PRIMARY,RESULTS,SEPTEMBER,THERE
500,539,8804,8805,BACKGROUND,EASTERN,GROUP,III,LABEL,METHODS,NINE,OTHER,PARAMOUNT,RESULTS
145,8804,8805,AMONG,BACKGROUND,BOTH,CONCLUSION,EGFR,LABEL,METHODS,NSCLC,PFS,RESULTS,SOMATIC,TKI,TKIS,TTR
001,005,026,029,079,133,138,314,BACKGROUND,EGFR,FURTHER,LABEL,METHODS,RESULTS
001,002,111,114,225,358,BACKGROUND,COX,EGFR,G719X,HOWEVER,L858R,L861Q,LABEL,METHODS,OVERALL,RESULTS
BACKGROUND,CD14,CD14CD204,CD204,CONCLUSION,LABEL,METHODS,RESULTS
0001,0014,148,5057,7017,A549,AKT,BACKGROUND,CHRONIC,CONCLUSION,COPD,DOWN,L78,LABEL,M3R,METHODS,MUSCARINIC,NSCLC,PI3K,RESULTS,WESTERN
199,1998,2012,BACKGROUND,BIOMARKER,COMPOUNDS,CONCLUSION,DRUG,FOOD,JANUARY,LABEL,METHODS,NSCLC,PHYSICIANS,RESULTS,SIX
001,009,016,1450,1482,704,746,8805,ASIA,ASIAN,BACKGROUND,CONCLUSION,COUNTRY,EGFR,IIIB,INDIA,LABEL,METHODS,PIONEER,RESULTS
DESPITE,NSCLC,THESE
0001,0004,0223,125,200,8805,ASIAN,AUC,BACKGROUND,CONCLUSION,GRADE,III,IIIB,LABEL,METHODS,NSCLC,ORR,PFS,PRIMARY,RESULTS,TRIAL
MANAGEMENT

IMAGE,LOCAL,LUNG
INDIA,LAM,THERE
BACKGROUND,EBUS,HOWEVER,LABEL,METHODS,NPV,RESULTS,SINCE,TBNA
044,EBUS,FURTHER,MACINTOSH,PLL,PLLS,THERE,VIRTUAL
8805,BACKGROUND,CYTOLOGIC,EBUS,LABEL,METHODS,RESULTS,TBNA,THERE
001,287,652,870,939,967,CONCLUSION,DETECTION,DIAGNOSTIC,HOWEVER,ITALIAN,LABEL,LDCT,LUNG,METHODS,MILD,MSC,OBJECTIVE,PURPOSE,RESULTS
001,0043,136,242,721,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SHS,TORONTO
1975,1985,1989,2000,2004,2005,BETWEEN,CONCLUSION,CVD,END,FALLING,LABEL,MEASURING,METHODS,OBJECTIVE,OTHER,PURPOSE,PYLL,RESULTS
1P36,CHD5,HOWEVER,NURD,THUS,TSG
ACTIVATION,ALK,ASP3026,ATP,ECHINODERM,EML4,FINALLY,H2228,MET,NCI,NSCLC,TAKEN
2010,AFTER,BRAIN,MAY,MRI
130,6P25,FURTHER,GIVEN,HPV,HPVS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEQUENCING,USING
NAPA,THREE,THYROID,TTF
169,2014,A549,COPYRIGHT,FURTHER,LTD,MCF,MTT,SW480
100,169,179,2014,295,ALK,COPYRIGHT,CUX1,EGFR,FISH,IHC,INC,KRAS,MOLECULAR,NSCLC,PATHOLOGY,PCR,PUBLISHED,RET,ROS1,SOCIETY,USING
947,A549,ATP,EGFR,ERK1,FIRST,H2A,H2AX,MRS2578,NEXT,P2Y12,P2Y6,PCR,SINCE,TAKEN,THEREFORE,UTP
169,2014,8758,BACKGROUND,BOTH,COPYRIGHT,ECOG,ELDERLY,III,INC,ITALIAN,LABEL,LUNG,METHODS,MILES,NSCLC,PRIMARY,SECONDARY
125B,1276,1286,169,2014,219,2467,30B,3200,340,3620,4454,4485,449C,502,548D,945,954,BMP2,CASP9,CELLS,CHIP,COPYRIGHT,HELA,HEPG2,HOWEVER,SEQ,THEREFORE,THESE,TNF,TYPE
0001,1155,1190,1342,169,2004,2010,2011,2013,2692,2798,2980,4104,567,590,750,CONCLUSION,COPYRIGHT,DLCST,EUR,EUROS,IQR,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SEPTEMBER,TOTAL
169,2014,AZD7762,BACKGROUND,CHK1,COPYRIGHT,H1299,H1993,INC,LABEL,METHODS,NSCLC,RESULTS,TARGETING,THERE,THUS,WESTERN
169,2013,CONCLUSION,COPYRIGHT,FDG,FRACTAL,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
169,2013,AUC,CAD,COPYRIGHT,FPR,LTD,ROC
000,004,040,044,047,050,2000,2010,229,426,631,967,COX,JINLING,JUNE,LABEL,LOG,MEIRE,METHODS,NSCLC,OBJECTIVE,OCTOBER,PTP1B,RESULTS
003,006,014,015,018,025,031,036,044,100,166,177,2010,2012,213,387,410,500,618,623,8804,8805,AMONG,ANOTHER,CONCLUSION,COPD,DEPARTMENT,HOWEVER,JANUARY,LABEL,MEDICAL,METHODS,NONE,OBJECTIVE,RESULTS,THEIR,THERE,THIRD,UNIVERSITY,XINQIAO
177,2010,2012,232,347,484,AMONG,FDG,JUNE,LABEL,METHODS,OBJECTIVE,OCTOBER,PET,RESULTS,ZHONGSHAN
000,177,2010,2012,708,8805,CONCLUSION,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THEN
015,034,2011,2012,222,2251,864,8805,AFFILIATED,AMONG,CEA,CONCLUSION,FUDAN,GGN,GGO,JUNE,LABEL,LDCT,METHODS,NSE,OBJECTIVE,OTHER,RESULTS,SCC,THERE,UNIVERSITY,ZHONGSHAN
009,047,2004,2010,20MM,ASA,BACKGROUND,CRC,LABEL,METHODS,PULMONARY,RESULTS,SEX,SIXTY,SIZE,SOCIETY
8201,AFTER,CNP,DEVELOPING,FPF,RESULTS,SPC,THEREFORE,USING
1111,169,172,2014,2015,954,BACKGROUND,BRITISH,FUNCTIONAL,LABEL,OPIOIDS,SOCIETY,THESE,THUS,UNLABELLED,VEGF
946,AMONG,INHIBITION,TGF
4T1,BCL,CLEAVED,DISCOVERY,FAK,FDA,FURTHER,KI67,MCL,MDSCS,MVD,NOTABLY,SRC,STAT3,TAKEN,VEGF,WESTERN
2006,BEIJING,CARLO,CHINA,MONTE,PAF,PAH,PAHS,PIF,SEVERAL,THEIR
1D11,4T1,946,947,CD11B,CD4,CD80,FOXP3,GR1,IFN,MHC,TAKEN,TGF,THUS,TREGS
2013,235,311,546,8202,BACKGROUND,JULY,LABEL,METHODS,RESULTS,SIX,THERE,THESE,VATS
004,2007,2009,8202,AUC,BACKGROUND,BETWEEN,CONCLUSION,EARLY,IRB,JANUARY,LABEL,METHODS,OCTOBER,PSN,PSNS,RESULTS,TEXTURE
117,119,136,215,2419,522,689,730,831,862,BACKGROUND,BASED,CHINA,CHINESE,IHD,LABEL,LCD,LCDS,LER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SHS,SMOKING,THESE
032,1347,188,290,408,447,472,490,6462,717,803,8202,ABOUT,EIF2,KIRSTEN,KRAS,LPS,MAPK,NETWORK,NOTABLY,NSCLC,RNAS,SNVS,THESE,UTRS
8197,BMJ,CANCERS,COLORECTAL,FIVE,GROUP,LIMITED,PUBLISHED,PUBLISHING,PULMICC,PULMONARY,SARCOMA,THERE,THESE
001,101,165,169,2013,2014,260,290,304,362,691,8201,823,996,EARLY,FATIGUE,FIFTEEN,RCC,SUMMARY,TREATMENT,UICC
278,4700,AFTER,CONCLUSION,ENGLAND,ENGLISH,FITTING,HOME,INCREASING,LABEL,MAIN,MECHANICAL,METHODS,MODELLING,OBJECTIVE,OUTCOME,RESULTS,SETTING
169,2014,2DE,AMONG,GMBH,INGENUITY,KGAA,LABEL,MALIGNANT,METHODS,MPM,OBJECTIVE,OVERALL,PURPOSE,RELEVANCE,RESULTS,VCH,WESTERN,WILEY
169,2014,ELISA,GELATIN,GMBH,GROUP,KGAA,LABEL,METHODS,MMP,OBJECTIVE,PURPOSE,RELEVANCE,RESULTS,SERUM,THERE,VCH,WILEY
169,183,8202,AFTER,AIMS,BACKGROUND,ENDOSCOPIC,EUS,FALSE,FNA,GEORG,LABEL,MALIGNANT,METHODS,OBJECTIVE,RESULTS,STUTTGART,YORK
103,160,8805,960,DCIS,LATE,MAXIMUM,QUALITY,WBRT
001,100,2013,8201,967,BETWEEN,CONCLUSION,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY
013,2006,2009,8201,A549,HIGH,HOWEVER,IMMUNOBLOT,KI67,MEIER,NSCLC,RING,RING1,TNM
A549,ARG,ASN,ASP,CA1,CA2,DOTA,GLY,MAGNEVIST,MRI,NGR,RGD
114,119,120,176,1993,2006,211,424,BEGINNING,HOWEVER,NEXT,RISKS,SWEDISH
0001,114,120,160,2006,2012,215,8201,8805,ACUTE,APRIL,BACKGROUND,CONCLUSION,ECOG,LABEL,MARCH,METHODS,NSCLC,RESULTS
100,160,AIM,CONCLUSION,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,RADIATION,RESULTS
PAST
ABSENCE,CRMP,MRI
A549,AKT,ERK1,FURTHER,JNK1,LEWIS,LLC,MMP,NSCLC,PI3K,THERE,WESTERN
0001,0164,0263,043,12H,1348,13TH,178,183,185,250,261,398,542,813,8315,8320,8322,8324,8331,8918,9623,AUC,FURTHER,LABEL,LSS,METHODS,OBJECTIVE,PURPOSE,RESULTS
AMONG,BACKGROUND,HLA,LABEL,MOTIVATION,RESULTS
ALTOGETHER,ATG5,ATP,CD39,CRE,DEPLETION,FOXP3,G12D,KRAS,SUBSEQUENT,THUS,TREG,TREGS
1038,2013,418,ACTIVATING,CHEN,GNA11,GNAQ,HENCE,HOWEVER,MAPK,MEK,PKC,UMS,UVEAL
954,AKIP1,AP2,ESCC,HENCE,HOWEVER,SP1,VEGF
100,160,169,2013,47D,956,A549,COPYRIGHT,GI50,GRAM,HBL,HELA,OVERALL,SAS,THESE,WIDR
169,2013,COPYRIGHT,EGFR,IRELAND,LTD,NSCLC,TKI
111,125,169,2013,240,ACTIVATING,CONCLUSION,COPYRIGHT,E746_A750,EGFR,IHC,IRELAND,L858R,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SP111,SP125,THEREFORE,TKIS,VARIOUS,WHILE
169,176,181,2014,24H,A549,BACKGROUND,CONCLUSION,COPYRIGHT,HENCE,IC50,IRELAND,ISOLATION,LABEL,LTD,METHODS,MIA,MTT,NMR,PACA,PETROLEUM,RELEVANCE,RESULTS,STRUCTURE,THREE
100,160,169,2014,COPYRIGHT,FNA,FNAS,HENCE,INC,LUNG,MOLECULAR,PATHOLOGY,PCR,PROGNOSIS,PUBLISHED,SOCIETY
169,2014,215,CARTESIAN,COPYRIGHT,INC,LABEL,LESS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,SLR
169,178,2014,8314,8323,A549,CACO,CHOP,COPYRIGHT,EBP,HACAT,HOWEVER,IRELAND,LTD,ROS,SOLUBLE,THEN,THESE,THREE
169,2014,2OHOA,CDK,CELL,CIP1,COPYRIGHT,ISSUE,MAPK,MLT,PATHOLOGY,PHYSIOLOGY,PKC,RAS,RELEVANCE,SGMS,SMS,SPECIAL,STRUCTURE,THERAPY,THESE,U118
160,169,176,2014,AFTER,BIOLOGY,COPYRIGHT,FEDERATION,HIFU,INC,LUNG,MHZ,PUBLISHED,RAYLEIGHS,SPEED,ULTRASOUND,WORLD
137,169,2014,BESIDES,CDDP,COPYRIGHT,H446,KIT,MDR,MIR,PUBLISHED,RESULTS,SAS,SCLC
150,169,2014,8805,AMONG,FOCAL,GIST,HOWEVER,IMP3,IMT,IMTS,INSULIN,OTHER
169,2014,945,946,BAIBA,COPYRIGHT,INC,PGC,PPAR
0019,0073,0359,1121,169,183,199,200,2008,2011,2014,206,211,2720,322,336,652,655,659,714,AFTER,BACKGROUND,BETWEEN,BOEHRINGER,COPYRIGHT,DEC,ECOG,FEB,FUNDING,GRADE,IIIB,INGELHEIM,IQR,LABEL,LTD,LUME,LUNG,METHODS,NINTEDANIB,NSCLC,PFS,RESULTS,SIMILAR
001,040,169,177,2014,399,696,789,AMONG,AUC,BACKGROUND,BED,COPYRIGHT,FEV1,INC,ISO,KARNOFSKY,LABEL,LOCAL,MATERIALS,METHODS,NSCLC,RESULTS,ROC,SBRT,SEVERAL,SVM,SVMS,TCP,THESE
003,164,169,2014,215,366,8210,8805,956,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ODDS,OPTIMAL,ORS,POST,PURPOSE,RADIATION,RESULTS,UNIVARIATE,V20,WBC,WBCS
0096,163,169,180,2007,2011,2014,8805,BETWEEN,CONCLUSION,COPYRIGHT,FDG,INC,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SBRT,STAGE,T2N0,THERE
169,2014,231,233,ANTI,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,ECG,LABEL,METHODS,PUBLISHED,SAS,SNFMI,SOCI,SYSTEMATIC
169,177,2013,956,A375,ACCORDING,CDX,CDXS,COPYRIGHT,GI50,H460,LTD,MCF,NCI,TBTU,TEA,THF
000,004,040,2008,2011,274,517,586,8201,BOTH,CTV,GRADE,IMRT,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,PCI,PTV56,PURPOSE,RESULTS
99A,BACKGROUND,CONCLUSION,ECTOPIC,IGF1,IGF1R,INHIBITORS,INSERTION,LABEL,MAPK,METHODS,MICRORNAS,ORAL,OSCC,OVERALL,PCR,PI3K,RESULTS,UTR
AFTER
001,002,031,032,035,2002,2006,261,ACCORDING,AMONG,BACKGROUND,CEA,DESPITE,JANUARY,JUNE,LABEL,METHODS,NSCLC,OVERALL,RESULTS,RISK,THERE
947,CD4,CD8,FAS,FUS1,HUPBL,MHC,NOD,SCID,STAT1,VEGF,VEGFR
ACUTE,AFTER,AIP,ALT,AST,BAL,BLOOD,CHEST,CLINICIANS,FACTS,INSIGHT,LDH,NOVEL
100,864,HOWEVER,PLEURAL,SIGN
000,060,119,120,1976,2010,2012,260,338,361,399,518,536,553,635,699,754,807,813,880,8805,881,979,AMONG,CONFIDENCE,DATA,DISCUSSION,EAR,EARS,FIRST,HODGKIN,HOWEVER,IACR,IARC,ICD,INCIDENCE,INCREASED,ISLANDS,ITALIAN,LABEL,LIFESTYLE,METHODS,MPS,NON,NORTH,OBJECTIVE,OBJECTIVES,OVERALL,RATIO,RESULTS,RISK,SIR,SIRS,SOUTH,WOMEN
EXOME,HOWEVER,WGA
HOWEVER,LIVER,POSTMORTEM,PRIMARY,THERE
ALD,CURRENTLY,THEREFORE
CTC,CTCS,SEER,VARIATION
NNAL,NNK,PAH,PHET,THERE,THESE,THUS,TOBACCO
169,2014,ACT,AFFORDABLE,CARE,CME,CNE,EACH,INC,INTERVIEW,PATIENT,PROTECTION,SOCIETY
000,100,215,8201,956,ASSAY,ERLOTINIB,MRM,NSCLC,RSD,SIMOTINIB
0001,001,004,008,012,021,025,109,164,169,2001,2010,2014,239,267,385,481,8805,AUTHORS,EGFR,EPIDERMAL,JOHN,LTD,NSCLC,SONS,TKI,WILD,WILEY
00001,0001,0003,0009,004,174C,634C,8201,CHINA,CNKI,DATA,DATABASES,HOWEVER,IL6,KNOWLEDGE,OVERALL,SEVERAL,THUS,WANFANG
001,011,015,024,028,030,046,164,8201,8804,8805,CCTTT,GENOTYPES,LACK,NOS2
154,169,2013,489,CSNK1A1,ESCC,FN1,KNOCKDOWN,LOW,MACC1,NBN,NFAT5,NOTABLY,PCR,SOX17,SRY,UICC,USING
000,100,169,16KM,181,2005,2007,2012,2013,2014,215,AIR,AMERICA,BACKGROUND,COHORTS,EFFECTIVE,EFFECTS,HARVARD,INC,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,POLLUTION,RESULTS,ROME,SIX,SOCIETY,SPAIN,SPANISH
DIBO,H460,NCI,NUCLEAR,ORTHOGONAL
131,CA19,MEASURING,PTC,THUS
169,2014,8804,AGREEMENT,BACKGROUND,JOURNAL,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCENARIOS,SMALLER,THERE,THESE
181,189,AGS,AMONG,IC50,MRC,MTT
CETUXIMAB,CRIZOTINIB,EGFR,III,IMPORTANT,KRAS,LABEL,NINTEDANIB,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY
169,2014,947,ACCESSORY,CD11B,CLP,IFN,NKT,THUS
169,2013,APOPTOSIS,COPYRIGHT,E2F,E2F1,HOWEVER,LNCAP,P53,PCR,TFDP3
GHRH,GIVEN,TUMOURS
1101,114,1190,177,332,338,396,CELL,CONCLUSION,EFFECTS,LABEL,LENTI,LENTIVIRUS,METHODS,OBJECTIVE,PBS,REAL,RESULTS,RHOA,TUNEL,WESTERN,XENOGRAFT
169,2014,617,946,ERK1,FINALLY,JNK1,JOHN,KNOCKDOWN,LTD,MAPK,OVERALL,PATHWAY,PKC,PUBLISHED,RNAI,SONS,TAKEN,WILEY
947,BACKGROUND,BLOT,CONCLUSION,H2AX,H3K27,H3K4,H3K4ME3,H3K56,H3K9,H4K16,H4K20,H4K5,LABEL,METHODS,PTM,PTMS,RADIATION,RESULTS,WESTERN
162,169,2009,2011,20GY,242,576,656,818,8201,8804,8805,ARIA,CTV,DOSE,IBR,PMRT,RADIATION,V95
169,2013,233,945,947,AFTER,BCG,CD3,CD4,CD8,COPYRIGHT,CXCR3,HOWEVER,IFN,IFNS,LTD,PBMCS,PFMCS,TAKEN,TBPF
169,1995,2004,2013,681,APRIL,ASIA,BONE,COPYRIGHT,GMBH,JANUARY,KOREA,LUNG,NETS,NON,PRIMARY,PULMONARY,SOFT
138,169,2014,A549,FINALLY,JOHN,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PDK1,RESULTS,SONS,THESE,UNDERLYING,UTR,WILEY
169,2013,223,5MG,CMCTS,COPYRIGHT,DERIVED,FAK,FGFR3,FIBROBLAST,FOCAL,INTESTINAL,IRELAND,KIT,KITR,LCK,LTD,LYMPHOCYTE,LYN,MASITINIB,MCS,STROMAL,YES
027,221,232,275,33X,43X,624,961,BACKGROUND,COMPARISON,COPY,GENERALLY,HBV,HCC,LABEL,METHODS,RESULTS,SNVS,SVS
231,946,AGILENT,BACKGROUND,CELL,CHANGES,DAVID,ELISA,FADU,FAK,GENESPRING,H522,IL1,LABEL,MAPK,MAPKK,MCF7,MDA,METHODS,MSCS,NCI,PCR,PD98059,RESULTS,TGF,THUS
001,002,139,490,8201,900,BACKGROUND,BECAUSE,CHRONIC,CMH,COPD,FURTHER,LABEL,LSC,LUNG,METHODS,MSP,PCR,PITTSBURGH,PLUSS,RESULTS,SCREENING,SMOKERS,SULF2,THESE
2009,400,8201,ASIA,BACKGROUND,CHRONIC,COPD,CVD,EAST,GOVERNMENT,KATHMANDU,LABEL,METHODS,NCD,NCDS,NEPAL,NON,OVARIAN,POPULATION,RESULTS,SOUTH,UNIVARIATE
169,2004,2011,2014,ACCEPTABLE,BACKGROUND,COPYRIGHT,IMPLANT,INC,LABEL,LARGE,LOCAL,MAY,METHODS,OCTOBER,PUBLISHED,RADICAL,RESULTS,SOCIETY,THERE,THREE,WIDE
003,169,2014,BACKGROUND,CLINICIANS,CONCLUSION,COPYRIGHT,DPD,EGFR,HIGH,HOWEVER,INC,LABEL,METHODS,NSCLC,RESULTS
001,017,029,046,164,170,20A,258,375,406,537,8211,945,MICRORNAS,NSCLC,THESE
14E1,18E1,2000,2010,2013,2062,28E1,381,382,826,ASIAN,CLINICIANS,INC,INSURANCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SDS,SIR,SIRS
026,122,166,171,173,8202,ALK,BACKGROUND,EGFR,FISH,IHC,LABEL,METHODS,NSCLC,PCR,PFS,RESULTS,SELECTIVE
916,ACTIVATING,EGFR,MODEL,NSCLC,PC9,PET,REFERENCE,SIMPLIFIED,SW620,U87,XENOGRAFTS
110,125,949,A549,BCL,DIFFERENT,EARLIER,FURTHER,HOWEVER,MMP,NPS,PCL,PVP,TET,THEREFORE,TIMP,WESTERN
200,2014,2C19,2C9,956,AMERICA,BACKGROUND,CYP2C19,GOVERNMENT,INFECTIOUS,LABEL,METHODS,PRESS,PUBLISHED,RESULTS,SOCIETY,THERE,UNIVERSITY
BASED,BRCA1,BREST,CROSS,CURRENTLY,DUE,ERCC1,NSCLC,TYPE
1960S,AMONG,HOWEVER,III,THESE
ALK,BASED,DDR2,DESPITE,EGFR,NSCLC,ONGOING,RET,ROS,SCLC,TKI
956,BRCA1,CHINESE,CHK2,CISPLATIN,DCP,MOLECULAR,PATIENT,PHASE,PRE,USA,WEST
A751C,C118T,ERCC1,NSCLC,THESE,XERODERMA,XPD
0001,001,107,150,AIM,BACKGROUND,CONCLUSION,IHC,LABEL,MATERIALS,METHODS,OBJECTIVE,OLC1,RESULTS,UICC
250,AFTER,CRF,E746,E750,EGFR,FDG,GEFITINIB,NSCLC,PET
200,AIM,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS
2009,2011,AIM,BETWEEN,CONCLUSION,EVEN,GRADE,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,RESULTS
BACKGROUND,BECAUSE,CONCLUSION,GRADE,LABEL,MALIGNANT,METHODS,PEMETREXED,PFS,PLM,RESULTS,SELECTION,SIX,THREE,TOXICITIES,TREATMENT,TREATMENTS
150,AIM,CONCLUSION,FIFTY,FOLFIRI,GRADE,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,TREATMENT
2009,2011,AIM,BACKGROUND,BETWEEN,CEA,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SINCE,SOX,THREE,XELOX
100,153,319,775,854,AIM,AMONG,CONCLUSION,FDG,JAPAN,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PPV,RESULTS,UICC
169,2014,231,A549,DDR,ECTOPIC,EMT,H1299,KNOCKDOWN,LOSS,MCF7,MDA,PRESS,PUBLISHED,SENESCENCE,SLUG,TAKEN,UNIVERSITY
NNK,ODN,RESULTS,SILICOSIS,SUP,SYNTHETIC,THERE,THESE
169,2013,956,AACR,H292,HOWEVER,IC50,NANO,SCCHN,TU212
169,1964,2014,AACR,GENERAL,SURGEON
000,0006,024,033,039,169,2000,2011,2013,700,8805,989,AUTHORS,CCRT,COMPARISON,CONCURRENT,COX,DESPITE,FIVE,III,JOHN,LTD,MEIER,NSCLC,OTHER,RADIATION,RECORDS,SEVENTY,SONS,WALD,WILEY
150,160,162,169,2013,253,AUTHORS,COX,FDG,IRB,JOHN,LTD,MBC,MEDICAL,MTV,PET,SONS,TLG,WILEY
169,1997,2006,2013,ALSO,AUTHORS,GERMANY,HODGKIN,JOHN,LTD,SONS,SPC,SPCS,SWEDISH,WILEY
160,169,2013,AUTHORS,BPH,DU145,GLCE,GLEASON,HSPG,JOHN,LNCAP,LTD,PC3,PCR,PEARSON,PNT2,PSA,SONS,TNM,WILEY
169,2013,2243,945,ANTITUMOR,ATP,AUTHORS,BAY,FURTHER,H460,HIF,HOWEVER,III,JOHN,LEAD,LTD,NSCLC,RCC4,SONS,VHL,VON,WILEY
169,2013,ALK,AUTHORS,FEW,GGO,JOHN,LTD,NSCLC,OVERALL,SONS,TIME,WILEY
169,181,2014,300,8201,870,A549,ECT,FINALLY,INC,MICE,WILEY
145,255,863
3475,AUSTRALIA,BRISTOL,CONFERENCE,LUNG,MERCK,MYERS,WORLD
169,2013,AUTHORS,EARLY,FOURIER,HHE,ICR,JOHN,LTD,NSCLC,SONS,VOC,VOCS,WILEY
8201,BOTH,FUNCTIONAL,IVS,MIB,SDH,SDHB,SDHC
2005,2009,CDC,CHANGES,END,INSTITUTE,LUNG,NPCR,PROGRAM,REGISTRIES,RESULTS,SEER
191,2010,244,BOARD,CONCLUSION,EVALUATION,GERIATRIC,HOWEVER,JANUARY,KAPPA,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,PILOT,RESULTS,SETTING,UNIT
511,A549,AFTER,BAX,FINALLY,FIRST,FLOW,NEXT,PCR,TRIB2
1000,2500,AMONG,COMPARISON,FDA,MEDICAL,NCLSC,NSCLC,THESE,TOWARDS
0076,0088,120,328,354,529,611,852,8805,901,BACKGROUND,CONCLUSION,EGFR,FORTY,LABEL,METHODS,NOTABLY,NSCLC,PFS,RESULTS,SEVENTY,THOSE,TKIS
CELL,CELLS,EMBRYONIC,ENGINEERED,ESC,ESCS,FLP,GEMM,GEMMS,LUNG,MOUSE,MYCL1,SMALL,STEM,THREE
139,160,200,2009,2012,956,ASSOCIATED,BACKGROUND,CD4,CONCLUSION,EMPHYSEMA,HIV,HOWEVER,LABEL,LUNG,METHODS,NLST,RESULTS,SCREENING,THERE,THESE,TRIAL
ADCS,AIDS,HAART,HIV,HODGKIN,INCREASING,NADCS
ACCORDING,CONCLUSION,LABEL,METHODS,NSCLC,NUMBERS,OBJECTIVE,PAIN,RESULTS,THERE,VAMT
169,2013,25TH,536,676,715,75TH,BASEL,ELISA,IQR,LABEL,MALIGNANT,METHODS,OBJECTIVE,OTHER,RESULTS,SMRP,SOLUBLE
169,2013,320,355,956,AFTER,CZE,HEP,HEX,HEXANAL,LPME,PUBLISHED,RSD,UNDER
ENGLISH,MALIGNANT,MMS
1167,174,8201,ABC,ACTUARIAL,AFTER,BACKGROUND,BED,BED2,BREATHING,CAUSE,CONCLUSION,DOSE,EQUIVALENT,INTENSITY,LABEL,METHODS,NSCLC,OUTCOME,OVERALL,PFS,RESULTS,SABR
169,2014,954,AACR,COX,EGFR,EPIDERMAL,HOWEVER,IKK,IKKS,INHIBITING,NSCLC,SH2,STAT3,THEREFORE,TKI,TKIS,TPCA
CPB,METICULOUS,VARIOUS
033,BACKGROUND,CLEARLY,ENB,LABEL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
CD81,DETECTION,EGFR,ELISA,HOWEVER,THESE,WHILE
A549,ABCC2,BCL,DDP,MODULATION,NSCLC,THUS
007,174,ABI,ALBUMIN,CREMOPHOR,HOWEVER,III,LUNG,NON,NSCLC,PACLITAXEL,PHASE
177,FILM,INDIVIDUAL,ITV,PERSPEX,SABR,WHILE
8734,AUC,BACKGROUND,CONCLUSION,EFFECTS,ERBB,LABEL,METHODS,OBJECTIVE,P450,RESULTS
100,108,1118,115,1385,159,1973,2007,212,247,254,267,405,506,879,BACKGROUND,COX,END,FOUR,LABEL,MEIER,METHODS,PRISM,RESULTS,SEER,STAT,THERE
160,A549,AKT,ANNEXIN,EGFR,MA10,PREVIOUSLY,TKI,TKIS
100,956,A549,BAX,BCL,FLOW,MCF,PARP,TBME,TERMINALIA,THESE
160,ALSO,BAX,BCL,CASPASE,HOWEVER,KANK,KANK1,THUS
160,1600,400,BRAF,HOWEVER,PDGF,SINCE,SORAFENIB,VEGF,WHEREAS
PC3,RHO,RHOA,RHOE,WILD
4T1,BAX,BCL,CD4,CD8,FGF,FGFR,FLOW,MCL,MDSCS,MEANWHILE,THEREFORE,WESTERN
500,8201,ADVERSE,CONCLUSION,EGFR,EVALUATION,INSTITUTE,LABEL,METHODS,NSCLC,OBJECTIVE,PEMETREXED,PHASE,RATES,RESULTS,SOLID,THERE,TKI,TUMOURS
169,2014,947,A549,AKT,ATM,ATR,BECAUSE,CSS,H2AX,H3S10,H3S28,JNK,MRC,PI3K,POST,PRESS,PUBLISHED,RAD3,THESE,TREATMENT,UNIVERSITY,USING
002,003,230,252,468,504,8805,CASE,CIS,COLORECTAL,HIGH,LUNG,ODDS,ORS,OVARIAN,PCR,RCC,RESULTS,SCREENING,THESE,TRIAL
001,110,122,169,2014,8804,AFTER,AMONG,CPEB1,CST6,EMILIN2,KNOCKDOWN,LAYN,LUNG,PRESS,PUBLISHED,ROBO3,STAGE,STUDIES,UNIVERSITY
091,8805,AUDIT,BACKGROUND,COX,HES,LABEL,LUNG,METHODS,NLCA,RESULTS,SCLC,STATISTICS,THESE
169,1990S,2014,945,946,AACR,BOTH,CYP19,ERS,LUNG,THUS
169,2014,945,946,AACR,AKT,ARS,E2F1,MOST,RAS,SRC,STAT,THESE,TOBACCO
NON,NSCLC,PATHOLOGY,PDGF,PDGFR
III,NOVEL,NOW,NSCLC
LUNG,MMP,MMPS,NON,NSCLC,THEREFORE
020,022,031,163,199,2010,2012,703,AFTER,BACKGROUND,BLOOD,HOWEVER,LABEL,METHODS,MMP,NSCLC,OBJECTIVE,OCTOBER,POD1,POD2,POD3,POD7,RESULTS,SERUM,THESE,TOS,USING,VATS,VEGF
109,160,9312,9313,9314,9315,BACKGROUND,BESIDES,COX,LABEL,LUNG,MEIER,METHODS,MST,OBJECTIVE,PCI,RESULTS,SCLC,SMALL
001,003,006,021,041,2001,2011,394,919,ACCORDING,BACKGROUND,CBP,COLLEGE,COX,DDP,ECOG,HOWEVER,KPS,LABEL,MEDICAL,MEIER,METHODS,OBJECTIVE,ONCE,PFS,RESULTS,SCLC,SMALL,TOTAL,UNION,UNIVARIATE
123,206,503,954,A549,AFTER,AKT,APOPTOSIS,BACKGROUND,BCL,CISPLATIN,DDP,ERCC1,LABEL,MDR1,METHODS,MIR,MRP1,MTS,OBJECTIVE,PCR,RESULTS,RHOE,WESTERN
BACKGROUND,CELL,EGFR,FIXED,GENOMIC,LABEL,LUNG,METASTATIC,METHODS,NON,NSCLC,PCR,REAL,RESULTS,SMALL,TKIS
0001,001,005,0129,0362,1454,148,169,2001,2006,2012,2013,240,548,COX,DISEASE,III,INC,JULY,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RCC,RESULTS,STAGE,THESE,UNIVARIATE
169,2013,COPYRIGHT,EARLY,LTD,NRP1,NRP1SIR,SLUG,SLUGSIR,THROUGH
SVCS,THESE
121,122,123,124,125,134,135,138,169,1B7,2013,APC,CD4,COPYRIGHT,DRB1,EBV,ESO,LTD,MINIMAL,PBMCS,TCR,USING
8902,BACKGROUND,CAM,DU145,EACH,GIVEN,H460,HCC1143,HCC1937,LABEL,METHODS,MISTLETOE,NCI,RESULTS,VAE

ABOUT,HOWEVER,III,LUNG,NON,USA
100,2004,2009,AIM,BACKROUND,CD20,CEA,CK5,CK7,CONCLUSION,EMA,HBME,INSTITUTE,LABEL,METHODS,MOC31,PATHOLOGY,PULMONARY,RESULTS,SREMSKA,TTFF,UNLABELLED
001,003,015,1168,2007,2010,2011,2ND,8211,8805,COX,ECOG,EGFR,IIIB,KEY,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TTP
019,100,2565,30002,30206,3530,39808,8211,BACKGROUND,CALGB,CARE,CONCLUSION,CURRENT,LABEL,METHODS,PATIENT,POST,PREDICTORS,RESULTS,SCLC,THEREFORE,V10,V20,V60
080,081,CONCLUSION,ERK,FERRETS,LABEL,METHODS,MUSTELA,NNK,OBJECTIVE,PREVIOUSLY,RESULTS,WESTERN
BIOMARKERS,LUNG
MRI,PRIMARY,THERE
2005,2010,CSN,NETWORK,SENTIMENT,SOCIETY,SURVIVORS,THREADS,USING
HOWEVER,LUNG,SCREENING
000,200,250,BURKITT,CD19,CD22,DAUDI,PCR,USING,WESTERN
METASTASIS,TNF,TRAIL
169,2013,CAF,CAFS,CD44,CELLS,PRESS,USING
MES,PCR,PRDM5,TAKEN,WESTERN
169,2014,INC,SIMULATION,WILEY
A549,CONSISTENT,DIFFERENT,DR4,DRS,H460,HOWEVER,JNK,MYCELIA,NCI,THESE,THUS,TRAIL
169,2013,ADP,ARCTIGENIN,ECTOPIC,H460,INC,NSCLC,NSLC,WILEY
001,027,150,169,1994,2009,2013,24CPM,330,337,98CASES,AGE,CONCLUSION,COPYRIGHT,COX,CRUDE,III,IRELAND,LABEL,LTD,MALIGNANT,METHODS,MPM,NCR,OBJECTIVE,RESULTS,ROI,THERE
0001,001,169,177,2014,ANNEXIN,CELL,CONVERSELY,FOUR,H2052,HOWEVER,ISTMES2,LABEL,MET,MET5A,METHODS,MSTO,OBJECTIVE,PRESS,PUBLISHED,PVP,RESULTS,SURGERY,UNIVERSITY
FDG,HOWEVER,IMAGE,PET,SINCE,THEREFORE
215,CASE,LABEL,METHODS,SUMMARY,SURGERY,THERE,UPON
MOHS,THEREFORE
260,PERIPHERAL,PTX
AFTER,CASE,CEF,FIVE,HOWEVER,IIB,III,STAGE,VNR
HOWEVER,LOCAL
AFTER,BEI,SCC,THREE
AFTER,EBUS,FDG,PET,RIGHT,SIX,SMALL,STEROID,TBNA
215,AFTER,CEA,GRADE,IIB,SIX,SST,TREATMENT
AFTER,CSF,IIIA,LABORATORY
188,1988,2007,HOWEVER,IIB,IIIA,IIIB,JANUARY,NSCLC
2009,2010,GGO,TBLB
100,2012,500,BAL,CDDP,CHEST,DLST,JUNE,STEROID,TBLB,THESE
AFTER,BECAUSE,CDDP,HER2,LYM,PUL
100,AFTER,ENDOSCOPIC
2010,2011,2012,CDDP,CPT,EVIDENTLY,HOWEVER,IIIB,JULY,JUNE,SEPTEMBER,STAGE,T4A

50S,60S,CASE,CONCLUSION,HEMOSTASIS,HOWEVER,LABEL,SHOCK,TAE,UNLABELLED
ADM,CDDP,CPT,FOLLOWING,THEREAFTER
ENDOSCOPY,FOLFIRI,IRIS,SIGMOID,UFT,UZEL
AFTER,LIVER,THUS,XELOX
2006,2007,2009,AFTER,CARCINOMA,COLORECTAL,FOLFIRI,JULY,JUNE,LEUCOVORIN,OKAYAMA,RFA,UNIVERSITY
AFTER,BASED,CURRENTLY,LEUCOVORIN,PET
000,100,133,2011,2013,890,APRIL,BETWEEN,EASTERN,ECOG,EIGHT,ERLOTINIB,FIVE,GEM,GRADE,GROUP,III,JAPAN,MOST,OCTOBER,OTHER,PANCREATIC
2010,AFTER,CHEST,IIIB,JANUARY,JULY
178,AFTER,CBD,CURRENTLY,EIGHT,LEUCOVORIN,N1M0,PYLORUS,RECURRENCE,THEREFORE
2007,2009,2010,2011,HCC,HCCS,ILEOCECAL,JUNE,MARCH,OCTOBER,PET,TACE
2005,2012,226,BOTH,JULY,SEPTEMBER
172,2005,2012,JULY,SEPTEMBER,THUS
001,006,008,011,079,085,088,107,11GY,169,177,2014,26GY,44GY,45GY,54GY,56GY,58GY,76GY,BREASTSIB,COPYRIGHT,CROWN,CRT,D98,DOSE,DOSIMETRIC,IMRT,INC,OVERALL,PTV,PUBLISHED,RADIATION,SIB
250,7TH,8804,8TH,ACCORDING,AFTER,AMONG,BACKGROUND,FIFTY,HISTOLOGY,LABEL,LINAX,METHODS,NSCLC,PATIENT,RESULTS,SBRT,T1A,T1B,T2A,UICC,VIEW
160,169,2013,CURRENT,FEBS,GOING,HOWEVER
0252,1725,177,901,ACTIVATION,AUC,BACKGROUND,CA15,CEA,ELISA,III,LABEL,RESULTS,ROC,TAKEN,TRX,TRX1
160,176,177,8201,AFTER,BACKGROUND,BSA,HIGH,HOWEVER,LABEL,LUNG,METHODS,RESULTS,THERE
169,2013,COPYRIGHT,DDS,DTX,LTD,NG2,PBS,TAASGVRSMH,TH10
2012,SEVERAL
125,33258,7901,8201,956,997,A549,ABOUT,AFTER,APOPTOSIS,BACKGROUND,CASPASE,CONCLUSION,CONTEXT,DIELS,DISCUSSION,HOECHST,IC50,LABEL,MATERIALS,MCF,METHODS,MTT,OBJECTIVE,PANC,PREVIOUSLY,PROTEIN,RESULTS,SGC,WESTERN
FURTHER,INVENTORY,MEAN,MOOD,PROBLEM,PROFILE,RESULTS,REVISED,SOLVING,SPS,TOTAL
198,1A1,ADDITIONAL,ASIAN,BACKGROUND,CAUCASIANS,CIS,CYP1,CYTOCHROME,FURTHER,ILE462VAL,LABEL,METHODS,MSPI,ODDS,OVERALL,P450,RESULTS
007,102,946,95C,DFS,DKK1,ESCC,HOWEVER,LTEP,NSCLC,PCR,TAB,TAKEN,WESTERN,WNT
231,CONTROL,LUC,MDA,THEREFORE,THESE,UDP,UGT8
156,177,2007,2013,426,APE,BACKGROUND,BEIJING,CTEPH,JANUARY,LABEL,METHODS,PACTA,PAS,RESULTS
001,013,069,152,2012,272,349,434,622,8202,8560,INCLUSION,JUNE,NSCLC,OUTCOME,STAGE,TESTS,VATS
FURTHER,LUNG,POST,SINCE,UNDER
000,100,1619,777,8649,AMONG,BACKGROUND,KNOWLEDGE,LABEL,LDCT,LOW,LUNG,METHODS,PLCSP,PLN,POMERANIAN,PROGRAM,RESULTS,SCREENING
001,125,129,130,135,159,290,449,BACKGROUND,DEPARTMENT,LABEL,METHODS,NSCLC,PULMONARY,RESULTS,SCLC,THERE
169,2014,239,6434,AUTHORS,CD8,CT26,DSR,INC,KHT,NKT,PUBLISHED,TLR7,UICC,WILEY
BLOOD,COX,CTCS,IIIB,NSCLC,PCR,PFS
094,2013,216,352,445,518,8201,CAUCASIANS,CNKI,DATA,LEU,MGMT,NOV,OVERALL,PHE,ULTIMATELY
12G5,143B,AKT,CURRENT,CXCR4,ERK,FACS,HOS,PCR,REPETITIVE,STUDIES
223,5P15,680,8201,CAUCASIANS,EAST,HOWEVER,TERT,USING
181,8201,AMONG,CERTAIN,H661,IC50,NCI,NPC,STUDIES,TW01
104,123,337,8805,AES,BACKGROUND,GIST,IGF,IGG1,LABEL,MAB,METHODS,ORR,PRS,R1507,RESULTS,THREE
000,1600,169,1994,2012,2014,300,AIMS,BETWEEN,CARDIOLOGY,CAREFUL,CONCLUSION,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SCD,SINCE,SOCIETY,USA
001,0015,005,014,119,CUB,EGF,EMT,HIGH,NSCLC,RESULTS,SCUBE3D,TNM
106,206,A549,CALR,CDC42,CTSD,DIGE,ENO1,HSPA5,HSPD1,MIR,POLA1,SMARCA4
BMP,CD31,DACC,HOWEVER,RNAI,TIE
ALK1,CK7,CRIBRIFORM,EGFR,KRAS,LUNG,MOLECULAR,ROS1,TTF1
27B,ECTOPIC,FINALLY,LIM,LIMK1,NON,NSCLC
A549,DHC,DHMC,H460,MTT,NCI,PMA
193,1995,2009,332,400,461,8805,AMONG,INITIATION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRE,SRES,USING
11Q13,LOH,MEN1,MENIN,MUTATIONS,NATURAL,NET,NETS,PREVALENCE,PULMONARY
000,001,002,004,006,011,018,029,039,042,045,067,071,082,129,2001,2013,518,ACC,BACKGROUND,CHINA,DFS,EMC,INTENSIVE,JANUARY,LABEL,MAY,MEC,METHODS,OVERALL,RESULTS,THEIR
018,096,BACKGROUND,CONCLUSION,EVALUATION,LABEL,METHODS,OVERALL,PARTIAL,PFS,RESULTS,SCS,SOLID,THERE
ALK,ANAPLASTIC
BACKGROUND,CONCLUSION,FOUR,GGO,HRCT,LABEL,METHODS,RESULTS,T1A,T1B,T2BN0M0,TNM
027,051,BACKGROUND,BODE,COUNCIL,COX,EVERY,LABEL,MEDICAL,METHODS,NSCLC,RESULTS,THERE
003,009,012,048,140,151,1990S,1991,2012,AFTER,BACKGROUND,FORTY,INDUCTION,LABEL,LUNG,METHODS,OVERALL,PATHOLOGIC,RESULTS,TOTAL
106,150,500,800,B12,BACKGROUND,CONCLUSION,LABEL,METHODS,PFS,RESULTS,THERE,TREATMENT
200,555,ADVERSE,BACKGROUND,CONCLUSION,LABEL,METHODS,PRIMARY,RESULTS,TTP
001,002,004,120,150,197,268,300,306,332,8805,BACKGROUND,COX,FURTHER,LABEL,METHODS,NSCLC,PTC,RESULTS,SB3
189,337,BACKGROUND,CONCLUSION,DEPLETION,GTPASES,HOWEVER,KRAS,LABEL,METHODS,NSCLC,OVERALL,RAL,RALA,RALB,RAS,RESULTS,USING
946,A549,BACKGROUND,BECAUSE,CSC,CSCS,H460,LABEL,METHODS,RESULTS,ROS
000,GROUP,LUNG
147,169,2002,2005,2007,2011,2013,4182,558,6854,BACKGROUND,CARE,COPYRIGHT,DATA,DESPITE,EVALUATION,FEDERATION,HOPE,HOSPICE,LABEL,METHODS,NCS,OVERALL,PALLIATIVE,PUBLISHED,RESULTS
169,2014,947,AACR,CD4,CD8,EPITOPE,HOWEVER,IFN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TAA,TAAS,THREE
ACTIVATING,AMONG,EGFR,EPIDERMAL,NSCLC,PI3K,THESE,THUS,TKIS
169,2013,COPYRIGHT,HOWEVER,STAT3,STATS,THERE
169,2013,A549,CHP,COPYRIGHT,GTPASES,INC,NSCLC,RHO,RHOV
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,INK4A,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR,SHOX2
005,169,2005,2010,2013,244,289,460,537,946,ALPES,BAX,BRCA1,CONCLUSION,COPYRIGHT,DCR,ERCC1,FAS,FASL,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TUBB3
004,169,2013,946,956,BIOLOGICAL,COPYRIGHT,ERLOTINIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEVERAL,THESE
001,150,169,1ST,2008,2013,2ND,3RD,462,467,CONCLUSION,COPYRIGHT,EGFR,ERLOTINIB,FOUR,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,S768I,SECONDARY,SEVEN,TEST
0001,0003,001,169,2013,CONCLUSION,COPYRIGHT,III,IRELAND,LABEL,LOSS,LTD,METHODS,MGMT,MSP,OBJECTIVE,OBJECTIVES,PCR,RESULTS,TET,THERE,THEREFORE
169,2013,946,A549,COPYRIGHT,EGFR,ELISA,EMT,FEDERATION,M30,PRE,PUBLISHED,RESULTS,SOCIETIES,TGF,TUNEL
169,2004,2011,2013,ALK,BACKGROUND,BETWEEN,COPYRIGHT,EGFR,EML4,JANUARY,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY
169,1990,2007,2013,6105,BACKGROUND,COPYRIGHT,CRP,DESPITE,HOWEVER,LABEL,LABORATORY,METHODS,PAS,PUBLISHED,RESULTS,SOCIETY,TBLB,WBC,WHILE
150,169,2013,7965,BASED,COPYRIGHT,DINACICLIB,ERLOTINIB,EVALUATION,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,RESULTS,SCH,TTP
169,2013,231,233,947,ANTI,COPYRIGHT,HMGCR,MDA,MI2,PUBLISHED,SAS,SNFMI,SOCI,SRP,TIF1
125,169,174,177,2013,600,CATPHAN,CBCT,CONCLUSION,COPYRIGHT,CTDI,FOV,HEAD,IMAGE,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SAS,XVI
112,117,169,2007,2013,2014,251,368,BACKGROUND,COPYRIGHT,DATA,HCC,HEPATIC,HRE,INC,LABEL,METHODS,MLC,MOST,OTHER,RESULTS,RFA,THERE
A549,ANNEXIN,APOPTOSIS,ATF4,BACKGROUND,BLOT,CELL,CFLAR,CONCLUSION,DDIT3,DR5,EIF2A,ERN1,FITC,FLIP,HOWEVER,HSPA5,KNOCKDOWN,LABEL,LUNG,MCL1,METHODS,MTT,NOXA,NSCLC,PTL,RESULTS,SILENCING,SRB,TNFRSF10B,WESTERN
231,A549,COMPOUNDS,HRESIMS,MDA,NMR,THESE
177,8804,961,963,DICE,DIFFERENT,HOUNSFIELD,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,VHU,VJAC
176,532,749,960,AUTOMATED,BOTH,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SBRT,SIMILAR,VMAT
ALTO,CAUTION,EDR2,LABEL,MEDICAL,METHODS,MLCS,OBJECTIVE,PALO,PURPOSE,RESULTS,SYSTEMS,THESE,VARIATIONS,VMAT,VOLUMETRIC
103,125,131,BRACHYDOSE,CARLO,DESPITE,DOSE,DOSES,FOUR,LABEL,LUNG,METHODS,MONTE,NOTABLY,OBJECTIVE,PURPOSE,RESULTS,STR,VOXEL
CARLO,LABEL,LINAC,LORENTZ,METHODS,MONTE,OBJECTIVE,PURPOSE,RESULTS,TESLA,V20
176,DCAT,DOSE,LABEL,MATERIALS,METHODS,MUS,OARS,OBJECTIVE,PURPOSE,RESULTS,SBRT
134,2002,2011,BACKGROUND,DATA,FIFTY,FULL,GOAL,KARNOFSKY,LABEL,MAIN,METHODS,MOST,OVERALL,RESULTS,SIXTY,TIME,WBRT
ABDOMINAL,BACKGROUND,CASE,LABEL,METASTASES,METHODS,MRI,VATER
956,ALDH,ALDH1A1,ALDH1A2,ALDH1A3,ALDH1B1,ALDH2,ALDH3A1,CB7,IC50,STRUCTURAL,UPON
046,ABSENCE,ARM,BACKGROUND,CANDIDATE,EGFRI,EIR,LABEL,METHODS,NSCLC,PRE,RESULTS
BACKGROUND,BASED,DISCUSSION,LABEL,LUNG,MBSR,METHODS,REDUCTION,SECONDARY,TAU,THEREFORE
8805,ADHERENCE,ADVERSE,BACKGROUND,CONTROLLED,CURRENT,IQR,LABEL,METHODS,NMES,NSCLC,QUADRICEPS,RESULTS,SECONDARY,THERE,TRIAL
568,716,852,AMONG,BACKGROUND,CHINA,COLLEGE,CONCLUSION,DESPITE,HBV,HCC,HCV,HOWEVER,LABEL,MEDICAL,METHODS,PERKING,RESULTS,THEREFORE,UNION
CRIZOTINIB,EGF,EGFR,HGF,HOWEVER,LABEL,LUNG,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,T790M,TKI,TKIS
026,031,114,129,290,355,392,479,558,5P15,624,625,635,726,734,740,753,782,786,860,897,908,910,972,978,BACKGROUND,CHINESE,CLPTM1L,ESCC,HAN,HOWEVER,LABEL,METHODS,RESULTS,TERT
001,022,028,181,362,400,509,ACTIVATION,AIM,BAL,CCL,CCSP,CELL,CHEMOKINE,CLUB,CONCLUSION,COPD,FEV1,FVC,INCREASED,LABEL,METHODS,PARC,PRO,PROTEIN,PULMONARY,RATIONALE,REGULATED,RESULTS,SECRETORY,SFTPB,SHORT,SURFACTANT,UNASSIGNED
CLINICALLY,CSLCS,LAC,LACSLCS,LUNG,MMP,THESE
159,AUC0,DOX,FUNCTIONAL,LIPO,LUNG,NSCLC,SP5
031,100,120,127,177,CAD,GGNS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VMES
130,ADP,CELL,CONCERNING,DOX,M109,MIAPACA,TAKEN
A549,ROS,THESE
8804,GROUP,JAPAN,PRIOR,SBRT,THESE,USING
AMONG,BIOMARKERS,CTCS,PREDICTIVE
160
177,956,BICKEL3,BRM3,CONCLUSION,DTATEGF,IC50,LABEL,METHODS,MTT,MVD,NSCLC,OBJECTIVE,PC9,RESULTS,SABC,SUBG0
707,BASAL,THESE
BACKGROUND,BRDU,CELL,CONCLUSION,COX,COXS,ELISA,LABEL,LUNG,METHODS,MTS,PCR,RESULTS,THEREFORE,THUS,TXA2,TXA2R,TXAS,TXB2,VARIOUS,WESTERN
AFTER,NSCLC,THESE
160,BLASTIC,BPDCN,CUTANEOUS,DUE,HODGKIN,SCT
LABEL,OBJECTIVE,OCCASIONAL,PURPOSE,RESULTS,SMOKING,SUMMARY,THERE,WHILE
169,2014,CBL,COPYRIGHT,EGFR,HER2,HGF,INC,MET,RTK,VEGFR
169,2014,ADDITIONAL,COPYRIGHT,LTD
169,2014,ALLOGENEIC,COPYRIGHT,HOWEVER,IOCS,LDF,LTD,METASTATIC,MMTS,MSTS
169,2013,203,967,COPYRIGHT,COX,FURTHER,GAC,HOWEVER,INC,MEIER,NAD,NQO1,PCR,THROUGH
169,2013,8320,8325,956,ANTI,BAP,CAM,CGS,CONDURANGO,COPYRIGHT,EGFR,FITC,MMP,NSCLC,OVERALL,ROS
169,2014,COPYRIGHT,DIFFUSE,DIPNECH,INC,PUBLISHED,SOCIETY
BACKGROUND,DAP,DAPS,DATA,DIAGNOSTIC,DISCUSSION,EMPIRICAL,ICC,INTER,INTERVIEWS,LABEL,METHODS
945,BACKGROUND,CONCLUSION,CONTROL,DPCA,EXPRESSION,GLY,HOWEVER,III,INCREASED,LABEL,METHODS,P4HA,P4HA2,PRO,REDUCED,RESULTS,SCID,SILENCING,THEREFORE,THESE,THREE,USING,WESTERN
169,2013,SBRT,SOCIETY
169,185,2013,2NM,A549,ABT,AFM,AGNPS,CCL,COPYRIGHT,EDS,FOURIER,FTIR,FURTHER,HTB,MCF,PUBLISHED,SEM,TEM,VISIBLE
169,2013,COPYRIGHT,ELISA,HOWEVER,INC,LIPH,LUNG,PLA1,THUS
1523,169,2014,223,COPYRIGHT,HARMANE,HOECHST,HUVEC,PEGANUM
100,121,169,2013,ALK,BRAF,CONCLUSION,COPYRIGHT,D4D6,EGFR,FISH,HER2,IHC,IRELAND,KRAS,LABEL,LTD,MATERIALS,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RAPID,RESULTS,ROS1,THESE
293,CRE,THESE,TPC
945,CISPLATIN,FETAL,FLAC,HIF,STUDIES,VEGF165
037,142,2559,602,858,COMPONENT,CONCLUSION,CSE,DIFFERENT,DTNB,GCG,GCGC,GSH,GSSG,IC50,LABEL,METHODS,MTT,NHBE,OBJECTIVE,PCA,PRINCIPAL,RESULTS,UPLC
FIBROUS
115,140,242,250,BRUSHINGS,FIBEROPTIC,FOB
A549,COIX,GANODERMA,LEWIS,TERNARY,THESE,TME,TMES
945,956,AEM1,AEM2,ALTOGETHER,BECAUSE,FURTHER,IC50,NAD,NOXA,PUMA,SIR2,SIRT1,SIRT2,SIRT3,SIRTUIN,THESE,WAF1
246,DUE
BAL,BALF,DESPITE,HOWEVER,LUNG
CYCLOSPORA,LIMA,MEXICAN,PERU,SIX
239,GRADE,LABEL,LEVEL,METHODS,OBJECTIVE,PHASE,RESULTS
CCK,FOXM1,GENISTEIN,H446,PCR,SCLC,THUS
081,450,CONVERSELY,LUNG,VEGF,VEGFR,WHETHER
92MI,954,956,A549,APO3L,BAX,BCL,BEE,DR3,DR6,FAS,FASL,FURTHER,H460,HENCE,NCI,NSCLC,PREVIOUSLY,THUS
157,2008,LIFE,REGRESSION,THESE,TYPES
000,100,177,190,1950,426,497,5250,550,575,576,862,910,BACKGROUND,BEST,CASE,COLORECTAL,CONCLUSION,DATA,END,FUNDING,GENERATOR,HARMS,HISTORY,HORIZON,INSTITUTE,LABEL,LUNG,METHODS,OBJECTIVE,OUTCOME,OVARIAN,POPULATION,PRIMARY,RESULTS,SCENARIOS,SCREENING,SMOKING,SOURCES,TIME,TRIAL,UNASSIGNED
100,1000,1080,116,1350,145,160,172,181,231,2OS,4510,500,549,786,872,A2058,CA2,CELL,DOTC,ECM,FADU,FBS,HCC,HCT,HELA,HEP,MCF,MDA,MIA,MMP,PMA,RAJI
2004,FORCE,LABEL,METHODS,POPULATION,PREVENTIVE,SCREENING,TASK
LABEL,METHODS,OBJECTIVE,RESULTS
082,091,101,234,276,459,494,634,698,FINALLY,GSI,HIGH,IMAGING,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SEVENTY
DESPITE,EGFR,HIGH
169,2013,239,COPYRIGHT,HOWEVER,PET,SIFT,THESE
4T1,916,936,A549,ANNEXIN,BASED,DDP,DOX,FURTHER,HNP1,HNPS,LABC,MTT,PREVIOUSLY
169,2013,A549,COPYRIGHT,INC,OPS,PLS,QSAR,SAR
134,169,2013,945,946,BACKGROUND,COPYRIGHT,EGFR,LABEL,METHODS,NSCLC,RESULTS,TGF,TKIS
119,1970,2008,8805,COX,FOLLICULAR,LABEL,LOG,MEIER,METHODS,OBJECTIVE,RESULTS
146,177,192,2006,2013,213,251,306,344,348,368,437,492,540,564,AJCC,ASC,BAC,FDG,HISTOLOGIC,III,JANUARY,LABEL,LARGE,METHODS,NSCLC,OBJECTIVE,OCTOBER,OTC,PATHOLOGIC,PET,PRIMARY,RESULTS,SCC,SUV,THERE,TNM
181,2007,2009,290,8804,APRIL,HIGH,IIIA,IIIB,JULY,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PFSS,RESULTS,TIANJIN,VEGF
151,177,215,945,AKT,EGFR,ELISA,EMT,ERK,H1975,HGF,LABEL,MAPK,MET,METHODS,MRC,MTT,OBJECTIVE,PI3K,RESULTS,TGF,WESTERN
169,2013,AJCC,COMMISSION,COPYRIGHT,GROUP,HOWEVER,IRELAND,ITMIG,JOINT,LTD,MALIGNANCY,NETS,THEIR,UICC,UNION
BACKGROUND,CASES,CONTEXT,INCORRECT,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SOCIETY
200,2004,2008,BACKGROUND,CONTEXT,GASTRIN,GRPR,GRPRS,III,LABEL,METHODS,NON,OBJECTIVE,RESULTS
001,AGE,BACKGROUND,CONTEXT,DTA,FNAC,LABEL,LITERATURE,METHODS,OBJECTIVE,POPULATION,RESULTS,SIXTEEN,STUDIES,THERE
001,2007,2011,493,6378,8201,COLLEGE,COMPARISON,CONTEXT,FNA,LUNG,NSCLC,OBJECTIVE,OVERALL,PROGRAM,RESULTS,SCC,SCCS,SUBTYPING,THERE
169,2014,320,COMPOUNDS,COPYRIGHT,GIVEN,HOWEVER,INC,SAVE
169,2014,BECAUSE,COPYRIGHT,DISORDERED,ESPECIALLY,EXPECTEDLY,GREATER,INC,WARBURG
103,159,177,220,236,925,A549,LABEL,MATERIALS,METHODS,MVD,OBJECTIVE,RESULTS,TDT,TUNEL,VEGF
001,011,043,546,BACKGROUND,CIS,DATABASES,FAES,FATAL,LABEL,METHODS,RESULTS,RISK,RRS,SCIENCE,SOCIETY,SUMMARY,TKI,VEGFR,WEB
2010,2013,500,ADVERSE,EIGHT,EVALUATION,FIVE,JANUARY,JIANGSU,LABEL,MAIN,METHODS,NCI,OBJECTIVE,OTHER,PEMETREXED,PURPOSE,RESULTS,SEPTEMBER,SOLID,THEIR,THEN
100,120,BACKGROUND,EGFR,FFPE,FURTHER,HIGH,HRM,LABEL,METHODS,RESULTS,THERE
001,177,2008,2010,BACKGROUND,ETS,GLUCS,LABEL,MANN,MATERIALS,METHODS,NNAL,RESULTS,WHITNEY
140,AFTER,ANTIGEN,CARCINOMA,CD62,CEA,CEACAM5,CELL,CONCLUSION,DKK1,GASTRIN,GMP,GRANULE,GRP,KRT,KRT19,LABEL,METHODS,OBJECTIVE,PEPTIDE,PROTEIN,RELEASING,RESULTS,SCCA,SELP,SFTPB
130,8805,BACKGROUND,ELISA,III,LABEL,METHODS,NSCLC,NSE,RESULTS,SCC,SERUM
011,030,033,059,260,318,ASIAN,BACKGROUND,CHINESE,CIS,CONCLUSION,DATA,EAST,HOWEVER,LABEL,METHODS,ORS,PCR,RESULTS,SPSS,TP63
0001,240,CHINA,DAUGHTERS,DISEASE,LUNG,MEN,SONS
FOOD
AKT,HOWEVER,RBP2
100,150,EGFR,ITALY,L858R,MUTATIONS,NEXT,R831H,SELECTION,SPECIMENS
004,008,015,028,046,107,8202,945,ALDH1,AMONG,BACKGROUND,CD204,CD34,CIC,CSC,LABEL,METHODS,NANOG,OCT4,PRIMARY,RESULTS,SOX2
0001,0008,001,002,104,124,2008,2012,239,580,8202,AMONG,BACKGROUND,EGFR,HOWEVER,LABEL,METHODS,NOTABLY,NSCLC,PFS,RESULTS,THEREFORE,TKI,TKIS,TREATMENT
007,119,130,177,292,2AM,5AM,8202,BMI,COLORECTAL,LUNG,MELATONIN,OVARIAN,PEARSON,PLCO,SCREENING,SERUM,TRIAL
003,195,422,EGFR,HOWEVER,ION,LNA,MACHINE,NSCLC,PCR,PGM,PNA,TKI,TKIS,TORRENT
169,2013,945,FL3,GMBH,KGAA,SLT4,T24,VCH,WILEY
160,AGE,CGA,COX,ECOG,FIFTY,LUNG,NSE,SCLC,SIXTY,THERE,UNIVARIATE
169,2013,CSC,CSCS,EMT,ESC,INSIGHT,NANOG,UICC
001,004,021,044,146,8201,8804,CDK,CDK1,COX,HOWEVER,NSCLC
218,219,263,270,329,605,882,ALA499VAL,ASIAN,EBSCO,HOWEVER,LYS939GLN,MEDLINE,SNPS,XERODERMA,XPC
A549,APJ,ERK1,LC3A,THESE,UNDER
169,2008,2011,2013,400,8201,BACKGROUND,CELECOXIB,CONCURRENT,COX,CRT,GRADE,III,INC,LABEL,METHODS,RESULTS,SPHINCTER,SURGERY,WILEY
169,2013,AKT,BAX,COPYRIGHT,EGFR,ERK,IGF1R,KRAS,KU70,MAPK,PI3K,TKI,TKIS,UICC
019,032,0454,074,096,159,164,173,199,221,366,409,502,517,579,580,809,816,825,870,933,CHINESE,HAN,NSCLC,SET8,SIMILAR,SNP,THEREFORE,TP53,UTR
131,177,2931,4348,4484,7011,CONCLUSION,DTC,LABEL,METHODS,OBJECTIVE,RESULTS,THEN,THEREFORE
169,2013,BACKGROUND,COPYRIGHT,DIET,HOT,HOWEVER,IGF,IRELAND,LABEL,LTD,MAP,METHODS,NCBI,OBJECTIVE,OCTOBER,P450,PI3,RESULTS,ROS,THERE
169,2014,946,A549,BOTH,COPYRIGHT,FH535,GSK,IRELAND,LTD,MMP2,MMP9,PGE2,SURGERY,THEREFORE,TRANSWELL
169,2013,474,945,A549,AKT,AUTHORS,C18,C22,COX,DHA,EGFR,ENRICHMENT,FURTHER,GAB1,GRB2,HOWEVER,INCREASED,LTD,MMP,PGE2,PI3K,PUBLISHED,PUFA,TGF,THESE,TREATMENT,WESTERN
002,003,012,109,147,169,2014,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,ENDOSTATIN,FISH,INC,KDR,LABEL,METHODS,NSCLC,REGARDING,RESULTS,THEREFORE
169,176,200,2013,24H,48H,4MBQ,956,ABOUT,AFTERWARD,APTAMER,BACKGROUND,BOTH,CONCLUSION,DOTA,FOUR,H460,LABEL,METHODS,NOTA,PERCENT,PET,RESULTS,TE2A
169,2013,COPYRIGHT,GIVEN,HOWEVER,III,IRELAND,LTD
0001,003,005,169,2006,2012,2014,2502,346,497,AUSTRALIAN,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,III,INC,LABEL,METHODS,MTS,OCTOBER,OVERALL,RESULTS,SAID,SOUTH,STS,THESE,WHETHER
2012,2013,AFTER,AIS,ASIA,BACKGROUND,CONCLUSION,IMPAIRMENT,JULY,JUNE,LABEL,METHODS,MSCC,NCT,NSCLC,RESULTS,SCALE,THEREFORE,THREE,TRIAL
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,INC,INHIBITION,LABEL,METHODS,NSCLC,RESULTS,TEN,THERE
169,2013,COPYRIGHT,GMBH
035,093,160,169,2014,225,592,645,BLACK,CAD,COPYRIGHT,FINALLY,FIRST,INC
169,2013,AUSTRALIAN,BACKGROUND,BECAUSE,COLLEGE,DFH,DVH,LABEL,METHODS,MLD,PERFUSION,RESULTS,ROC,ROYAL,SPECT,V20,V30,ZEALAND
169,2013,AFP,AFTER,BEP,FIVE,GCT,HDCT,HOWEVER,ICE,JOHN,LTD,MRI,PBSCT,PUBLISHED,SONS,TIP,WILEY
009,160,169,180,2005,2010,2013,ACUTE,ALT,AMB,AST,BACKGROUND,BETWEEN,BLACKWELL,CANDIDA,CENTRES,GMBH,IFD,IFDS,ITALIAN,JANUARY,LABEL,ORR,PMN,UNLABELLED
169,2013,ASIA,HBV,HCC,JOHN,LTD,NAS,PUBLISHED,SINCE,SONS,STUDIES,WILEY
039,046,054,100,111,2006,2010,ASSOCIATED,CHARLES,CONCLUSION,DEPARTMENT,FACULTY,GYNECOLOGY,III,KRALOVE,LABEL,LRP,LUNG,MED,MEIER,METHODS,MRP1,MRP3,MRP5,MULTIDRUG,OBJECTIVE,OBSTETRICS,PFS,PGP,PROTEIN,RELATED,RESISTANCE,RESULTS,SETTING,UNIVERSITY
004,2013,ADULT,AIM,BAL,CD4,CD8,ENGLISH,FOUR,LABEL,METHODS,MTX,OBJECTIVE,PURPOSE,RESULTS,SEVENTEEN,THESE
177,2011,209,227,232,BINDING,EFIMOVA,EPR,GSH,MAGN,MET,OVERHAUSER,PEDRI,PROBE,RESON,VRF
127,177,2012,2013,BULGARIAN,INSTITUTE,JANUARY,NET,RARE,SOCIETY

ID1,STANKIC,UNDER
100,455,479,567,737,8594,9999,ACQUITY,BEH,C18,DAH,DBD,DIACT,ESI,HCL,MEOH,MRM,SPD,SPM,UPLC
EBSCO,FURTHER,PROLONGED,SCIENCE,WEB
GCDFP,THESE
BECAUSE,IFOSFAMIDE,RMS,VINCRISTIN
001,002,003,007,MDM2,PRO,STATE,T309G,TP53
IGE
VTC
METASTASIS,PLEURAL,WHEREIN
110,152,260,430,ANY,BESIDES,FREQUENCY,HENCE
NSCLC,VATS
100,HOWEVER,INHALATION,PARTICLES,PROPERTIES,THERE,TIO2
HOWEVER,SCAD,USUALLY
EGFR
0005,003,006,013,AKT,EGFR,ERCC1,ERK1,ERK2,EXPRESSION,HISTOLOGIC,STAT3,THERAPIES,THERE
BACKGROUND,CONCLUSION,FNA,FNAC,INDIA,LABEL,MATERIALS,METHODS,NORTH,OBJECTIVE,OBJECTIVES,PRESENT,RESULTS,TTFNA
169,2014,INC,RNAS
001,007,1232,1292,1687,191,2006,2012,204,208,249,282,311,378,395,427,482,8805,967,983,DESPITE,HOP,JANUARY,JULY,LABEL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,OFF,RESULTS,TREATMENT
MET
100,169,2013,A549,AACR,DATA,FUNCTIONAL,IQCB1,MOST,PCR,SRSF1,THESE,TUBD1
100,169,177,200,2013,638,800,834,956,982,AACR,CD38,DOTA,H929,MALIGNANT,NCI,OBJECTIVE,PRIT,RIT,YTTRIUM
169,2013,AACR,AMP,COX,FUNCTIONAL,GPR109A,HOWEVER,MMTV,NEU,THESE,THUS,UPON
216,952,HOWEVER,SIMILARLY,THUS,TNM
00011,00074,016,028,036,039,043,289,GASC1,NUCLEAR,PERCENTAGE,SIMILARLY,SMOKERS,SMOKING
106,967,COX,ERCC1,MEIER,NSCLC,SNPS,XPF
169,177,2013,946,A549,AFTER,CHO,COPYRIGHT,COS7,FBS,HELA,MCF,MDA,PBAE,PLH,RECHARGING,SKOV3,SPC,THESE
169,2013,2573_2574,COPYRIGHT,EGFR,GREEN,INC,MUTATIONS,PCR,SYBR,THESE
FINALLY,FOUR,RIGHT,SCC,SCCRF
169,2013,8805,AIMS,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CVD,HOWEVER,LABEL,METHODS,OBJECTIVE,OMEGA,RESULTS,TXA,UTXB,UTXB2
CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,RESULTS
002,026,139,169,2004,2011,2013,ALSO,ATS,BAC,BOTH,CHINESE,COPYRIGHT,EGFR,ERS,GMBH,IASLC,IHC,MEANWHILE,SPA,TITF
001,030,041,169,2007,2010,2014,223,253,9TH,BACKGROUND,COPYRIGHT,HCUP,HEALTHCARE,ICD,INC,INPATIENT,LABEL,METHODS,NATIONWIDE,NIS,OPEN,POISSON,PROJECT,PUBLISHED,RESULTS,SOCIETY,THERE,VATS
0003,169,2000,2011,2013,CAUSE,COPYRIGHT,CSS,EXCLUSION,FOUR,IRELAND,ITALIAN,LABEL,LTD,METHODS,MOST,OBJECTIVE,RESULTS,SURGERY,THREE
169,2013,COPYRIGHT,EGFR,EPIDERMAL,IRELAND,LTD,NSCLC,TKI
169,2014,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,EGFR,EVER,FFPE,INC,KIRSTEN,KRAS,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,TESTING,THERE,WIDE
169,2013,956,A549,COMPOUNDS,COPYRIGHT,DICHROISM,HELA,IC50,LTD,MCF
169,2013,388,459,956,COPYRIGHT,ED50S,ESI,LTD,QCC,THEIR
020,10F,160,177,215,5GY,8201,985,BACKGROUND,CBCT,CONCLUSION,LABEL,MATERIALS,METHODS,NSCLC,PRV,RESULTS,SBRT,SEQUENTIAL,SEVENTEEN
BACKGROUND,CHINA,CIS,LABEL,METHODS,ORS,RESULTS,SNP,SNPS,TAIYUAN,TP53,VARIANT
2002,2011,331,CONCLUSION,DENMARK,DEPARTMENT,LABEL,METHODS,NON,NSCLC,RESULTS,UNIVERSITY,UNLABELLED
6474,700,BACKGROUND,COX,EGFR,LABEL,LUNG,RESULTS,SHEDDEN,TREMENDOUS
19DEL,AMONG,ASAN,ASIAN,AXL,BACKGROUND,CD56,CONCLUSION,DESPITE,EGFR,EMT,FISH,KOREA,KOREANS,L858R,LABEL,MET,METHODS,NONE,PANEL,RESULTS,SECONDARY,SEVEN,T790M,TKI,WESTERN
2008,BACKGROUND,BESIDES,HOWEVER,INSTITUTE,LABEL,METHODS,OBJECTIVE,PRIOR,RESULTS
2002,2011,AIMS,BACKGROUND,BETWEEN,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
170,BACKGROUND,BRAF,CONCLUSION,CPG,EPIGENETIC,FOXG1,GRIK3,HAND2,HLA,HOX,III,KRAS,LABEL,LUAD,NEUROG1,NKX6,PATHWAY,PRKCB,PTGDR,RAF1,RAP1A,RESULTS,STAGE,TLX3,UBC
100,1000,181,8804,ALC,ALCS,BACKGROUND,HCT,HOST,LABEL,LRD,LYMPHOCYTE,METHODS,PRE,RESULTS,RSV,URI
001,016,BACKGROUND,BECAUSE,EGFR,LABEL,METHODS,MPLCS,MUTATIONAL,NOTABLY,OBJECTIVE,RESULTS
0001,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SUVS,THERE
BACKGROUND,BEST,CSF,CYCLE,DLT,DLTS,EVEROLIMUS,LABEL,METHODS,PRIMARY,RESULTS,SCLC,SECONDARY
150,177,8805,BACKGROUND,DCR,EVEROLIMUS,GRADE,LABEL,METHODS,NSCLC,PFS,PRIMARY,RESULTS
200C,CELL,HOWEVER,KRAS,RAS,THEREBY,THUS,WESTERN,WHILE
169,194,2012,2013,280,312,399,751,CAUCASIANS,COPYRIGHT,ERCC2,HOWEVER,LABEL,LYS751GLN,MAIN,METHODS,OBJECTIVE,OUTCOME,RESULTS,SCIENCE,STATA,THREE,WEB,XPD,XRCC1
169,177,2013,BLADDER,COPYRIGHT,INC,PFS,THERE
004,006,008,012,014,029,037,043,120,130,169,2014,400,916,945,BACKGROUND,BCL,CCRT,CONCLUSION,COPYRIGHT,FDG,FORTY,GLUT,HIF,HIGH,INC,LABEL,LDH,LIMITED,MAXIMUM,METHODS,ORR,PET,RESULTS,RFS,SCLC,SEX,SUV
132,169,187,1MM,2013,ALBUMIN,COPYRIGHT,GLYCATION,GNPS,HEYNS,HSA,IC50,NBT,NITROBLUE,SAOS,SEM,SERUM,TEM,THESE
169,2014,COPYRIGHT,INC,RIGHT
126,169,2013,ADAM9,ALSO,COPYRIGHT,CRK,EGFL7,HOXA9,INC,IRS,KRAS,PI3K,SOX,THROUGH,VEGF
BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,PNS
CHIR99021,H157,H460,HES1,HEYL,NOTCH,NSCLC,OVERALL,WNT
001,749,763,892,APOPTOSIS,BACKGROUND,CONCLUSION,COPD,EXPRESSION,FEV1,LABEL,METHODS,PCR,PERCENTAGE,PRE,RESULTS,THESE,WESTERN
715,ADDITIONAL,ANXA3,CADM1,CCNE1,CD24,CDK1,COX,ERCC1,EZH2,GEO,MEIER,NSCLC,OPN,RAD51,TCGA,UNIVARIATE,VEGF
0001,0002,004,177,215,A549,CISPLATIN,EGFR,EPS8,H1975,LCL,LCLS,NSCLC,SNP,THEREFORE
COMPONENT,HPLC,MANN,PCA,PRINCIPAL,SPE,URINARY,URINE,WHITNEY
106,761,CONCLUSION,INADEQUATE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
001,388,430,444,467,555,961,AFTER,BACKGROUND,COMPELLING,HODGKIN,HOWEVER,LABEL,METHODS,PCR,RESULTS,RTL,STRATIFIED
458,CD8,HOWEVER,TAKEN,TH1,THESE,TLS
169,2013,5P15,AACR,AKT,BCL,CLPTM1L,RAS,TAKEN
000,063,100,1969,1990,1992,2005,2009,391,AGE,ALZHEIMER,CAUSE,COPD,DESPITE,INDIANS,ISLANDERS,MORTALITY,NATIVES,PACIFIC,POISSON,POOR,POVERTY,RESIDENTS,USA
CDR1,LNCAP,PCA,PCR,PNT1A,THESE,XQ26
169,2002,2005,2013,209,370,AACR,CONCLUSION,COX,CXCR2,EPCAM,EXPRESSION,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS
947,CD16,CD56,EACH,NATURAL,PERIPHERAL
CL1,CMAP,CYTOSCAPE,DAVID,FINALLY,FIVE,GEO,GNG11,GSE9315,GSM234967,GSM234968,HMGB2,JUNB,KEGG,MAPK,THP,TME,WNT
3758309,946,954,A549,AMONG,CREB,ECM,MIGRATION,MMP,MMPS,THROUGH
160,AKT,EGCG,EGF,EGFR,ERK1,SHORT,THUS
003,009,145,151,262,607,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,OUTCOME,PACS,PATIENT,PTX,PURPOSE,RESULTS,SEVEN,TRACT,WITHOUT
001,002,006,112,156,2001,2002,2005,2007,2008,535,588,8804,90TH,BACKGROUND,CONCLUSION,DIAGNOSTIC,GENERAL,GUIDELINE,GUIDELINES,LABEL,METHODS,NICE,RESULTS,SUSPECTED,TESTS,THERE,USING
8209,AMONG,BBB,BRAIN,JAMS,METASTATIC,SINCE,TJS
8226,A549,ALA,ATP,COX,THESE,WARBURG
160,A549,BECAUSE,CLOFILIUM,DOSE,FIRST,H460,SIMILARLY,THEIR
947,A549,DSB,DSBS,H2AX,H71,HSP90,RAD51,THESE
100,1000,2500,956,BACKGROUND,LABEL,METHODS,RESULTS
1775,CDK1,MALIGNANT,NOTABLY,WEE1
ABDOMINAL,AFTER,HOWEVER,THEREFORE,THUS
015,090,100,166,169,2009,2013,230,BACKGROUND,COPYRIGHT,FISH,FLOW,FURTHER,HOWEVER,INC,LABEL,MEDLINE,META,METHODS,PCR,PUBLISHED,RESULTS,THERE
0009433,029,320,500,BACKGROUND,BONFERRONI,COLOMBIAN,CROHN,LABEL,MASSARRAY,METHODS,OBJECTIVE,PTB,RESULTS,SNP,SNPS
0001,0006,006,017,026,028,036,169,185,2007,2009,2013,555,695,819,8805,897,AFTER,COX,LABEL,LCSS,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PRIMARY,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SEER,SIR,SOCIETY,UNADJUSTED
169,2014,FINALLY,HOWEVER,PNS
169,2014,BRAIN,LUNG,MOST,MRI,OVERALL,SEVERAL
169,2014,EARLY,EATON,LAMBERT,LUNG,METASTASIS,NEUROLOGIC,THERE
169,2014,660,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,VTE
033,120,169,2000,2010,2014,AMONG,BACKGROUND,BETWEEN,COPYRIGHT,INC,JANUARY,LABEL,LCT,METHODS,NPO,PUBLISHED,RESULTS,RIGHT,SOCIETY
0017,0071,102,134,169,2014,211,234,AFTER,BACKGROUND,BECAUSE,COPYRIGHT,III,INC,LABEL,METHODS,NSCLC,PATHOLOGIC,PUBLISHED,RESULTS,RML
120,169,2000,2010,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,EASTERN,FACTORS,FEW,GROUP,INC,LABEL,LACK,LDH,METHODS,MOST,RESULTS,SCLC,SIX,SMALL
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,DISEASE,FURTHER,INC,LABEL,METHODS,NSCLC,PBT,RADIATION,RBE,RESULTS,SEVENTY
002,007,169,177,2013,954,AVERAGE,CNR,CONCLUSION,COPYRIGHT,DATA,DUE,GOLD,INTER,IRELAND,LABEL,LTD,LUNG,LUSI,METHODS,MRI,NOISE,OBJECTIVE,OVERALL,RATIO,RESULTS,SCREENING,THERE,TRIAL
EBUS,PROPONENTS,TBNA
1000,400,FIVE,HAUSDORFF,JACCARD,PLATE,SNAKE,SPEEDED,SURF,THIN,THREE,TPS
916,CRC,DETECTION,EGFR,EPIDERMAL,NSCLC,PCR,RGQ,SEQUENCING,TMDA
000,185,8201,BALB,BIS,MEG,MORPHOLOGY,MPEG,NMR,PCL,PECA,THUS
023,8202,EVALUATION,FDG,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,P53,PET,RESULTS,TIGAR,TP53
051,2012,ACCORDING,CASE,DRUG,DUE,FOOD,NETWORK,ORGAN,OTRS
133,177,A549,ABCG2,ALDH1,ARIA,BOTH,CD133,CD24,CD44,CELLS,CSC,CSCS,EGF,FACS
EGFR,GEFITINIB
ALK,BACKGROUND,CASE,CONCLUSION,FISH,LABEL,METHODS,NSCLC
160,8201,BACKGROUND,CONCLUSION,DIR,LABEL,METHODS,NEITHER,RESULTS,THESE,VOLUMETRIC
169,2013,AACR,BALB,CDH2,CONVERSELY,ERBB2,FASN,FATTY,HNSCC,MMP,OTSCC,SCC,THESE,VEGFA165B,ZSGREEN
169,2013,A549,AACR,BCL,BCL2,H157,H358,HOWEVER,IRR,JAK,JAK2,JANUS,STAT3,THESE
032,945,BASED,CDK9,FLICE,HOWEVER,MCL,PI3K,PIK,PRIMARY,SNS,TRAIL
ATG7,BRAF,HOWEVER,NRF2,NSCLC,TAKEN,TDCLS,V600E
BRG1,FINALLY,MAX,MGA,MYC,SCLC,SNF,SWI
254,GAPDH,HDAC5,K254,PCAF
946,A549,AKT,CABYR,CONVERSELY,GSK,H460,HOWEVER,LABEL,NCI,PARP,SER9,TAKEN,UNLABELLED
124,169,2013,BACKGROUND,COPYRIGHT,FUNCTIONAL,HCMV,HIGH,LABEL,MICRORNAS,RESULTS,RNAS,THP,UL112,US25
169,2013,946,COPYRIGHT,CROWN,DICKKOPF1,DKK1,INC,NSCLC,PUBLISHED,RUNX2,TAKEN,WNT
1B10,300,DATA,MALIGNANT,PXD000531,SEVEN,VIIB
BASAL,BCC
169,2014,BIOLOGY,COPYRIGHT,DDR1,DDR2,DDRS,DISCOIDIN,PUBLISHED,SELECTIVE,SOCIETY,WHILE,YET
110,133,169,2013,330,945,946,954,ACORN,AT2,B1R,COPYRIGHT,GPCR,ILE,INC,NAL,OIC,OVERALL,PHE
169,2014,ADDITIONAL,AKT,AURKA,AUTHORS,BIOMARKERS,CHALLENGE,COPYRIGHT,EGFR,ERBB2,ERK,ERK1,FIRST,HIGH,HOWEVER,ISSUE,MEK,NSCLC,PI3K,PROTEOMIC,PUBLISHED,RAF,RAS,RPPA,SPECIAL,TP53,VX680
169,177,2013,956,A549,BESIDES,BPDE,CBMN,COPYRIGHT,MGMT,MMS,MNU
169,2013,32YEARS,40YEARS,78YEARS,93YEARS,AUTHORS,COPD,COPYRIGHT,INC,PUBLISHED,RRS,THERE
169,2000,2003,2013,946,956,AUTHORS,BALTIMORE,CHRISTI,COPYRIGHT,COX,CRUMP,CRVI,GERMANY,GIBB,HAYNE,INC,LEVERKUSEN,LIFE,POISSON,PUBLISHED,UERDINGEN,URF,URFS
100,116,169,2013,261,437,ASIA,AUTHORS,COPYRIGHT,EGFR,EPIDERMAL,HISTOLOGY,HOWEVER,III,IPASS,IRELAND,LABEL,LTD,METHODS,MUTATIONS,OBJECTIVE,OBJECTIVES,ORR,ORRS,PAN,PUBLISHED,RESULTS
100,146,169,2014,479,553,822,ACCORDING,ACT,BACKGROUND,CONCLUSION,COPYRIGHT,COX,EVALUATION,HIPAA,III,INC,INSURANCE,LABEL,MATERIALS,MEIER,METHODS,NSCLC,PATIENT,RESULTS,SOLID
001,003,1995,2009,414,967,AFFAIRS,AFRICAN,BACKGROUND,CAUCASIAN,CENTRAL,CONCLUSION,COX,GRADE,INC,JANUARY,KRUSKAL,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS
130,169,2014,7353,8805,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OVERALL,RESULTS,SCLC,THESE
001,004,007,012,021,160,169,2013,440,ALK,AMONG,BACKGROUND,COPYRIGHT,EGFR,EML4,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS
077,169,2013,COPYRIGHT,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEPAR,THREE
133,169,2008,2010,2013,246,522,BACKGROUND,COPYRIGHT,DISCUSSION,DISEASE,FDG,HYPOTHESIS,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PUBLISHED,RESULTS,SEPAR,TREATMENT,USING
100,110,135,169,2014,CARCINOMAS,CATEGORIES,CK20,CK7,COPYRIGHT,HOWEVER,IHC,INC,RESULTS,SEVEN,SPB,TTF
169,2013,280,4T1,CNP,CNPS,COPYRIGHT,HOWEVER,LTD,RFP,WESTERN
A549,HPGD,IC50,LNCAP,LTD,NAD,PGDH,PGE2,PUBLISHED,SAR,TOP
169,2013,ALK,COPYRIGHT,EGFR,FBXW7,IRELAND,LTD
169,2013,946,CONCLUSION,COPYRIGHT,DIANA,FAK,HUVEC,IRELAND,LABEL,LTD,MAPK,MATERIALS,METASTATIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCP,RESULTS,SRC,TARGETSCAN,TGF,THESE,THREE,WNT
169,2012,241,COPYRIGHT,CPG,ESPA,FIVE,MLH1,MSH2,PCR,PORTUGUESA,PUBLISHED,SOCIEDADE,TNM
001,10877,169,170,200MG,2013,20MG,260,306,BACKGROUND,CEDIRANIB,COPYRIGHT,DAILY,LABEL,LTD,METHODS,PFS,RESULTS
169,2013,6MWD,AUSTRALIAN,CONCLUSION,COPYRIGHT,CROWN,HRQOL,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,PUBLISHED,RESULTS
169,2013,ALK,COPYRIGHT,FISH,FURTHER,IIIA,IRELAND,LTD,NSCLC
0001,169,2013,513,632,BACKGROUND,COMPARISON,COPYRIGHT,ENDPOINTS,EPP,IRELAND,LABEL,LTD,MALIGNANT,METHODS,MPM,RESULTS,SEVEN
CONCLUSION,FOUR,LABEL,METHODS,NONE,OBJECTIVE,RESULTS
128,177,217,8805,BACKGROUND,CONCLUSION,ELDERLY,LABEL,METHODS,NEITHER,PET,RESULTS,VATS
135,176,ABC,BACKGROUND,DIBH,DOSIMETRIC,FIFTEEN,GROSS,HOWEVER,IMRT,LABEL,LUNG,METHODS,PTV,PTVS,RESULTS,THEREFORE,V10,V20,V30,VMAT
116,169,183,2013,945,946,956,A549,AIM,CANDIDA,CHINA,COPYRIGHT,EUPHORBIA,HCT,IC50,LABEL,METHODS,MTT,NMR,OBJECTIVE,PUBLISHED,RESULTS,TARAXEROL,THUS,TRITERPENE,UNIVERSITY
BACKGROUND,BOTH,CANCEROUS,CASE,CONCLUSION,HOWEVER,LABEL,METHODS,SEVERAL,THESE
CYRUS,DORMANT
BACKGROUND,BAX,BCL,BESIDES,BIP,CELL,CHOP,FLOW,J82,LABEL,METHODS,PEE,RESULTS,T24,TAIWANESE,UBUC
160,386,IMPROVING,LUNG,PERCEIVED,USING
520,APPRAISAL,BACKGROUND,BRITISH,CASP,FIVE,FURTHER,HODGKIN,LABEL,METHODS,MINIMISING,NHS,NONE,PROGRAMME,RESULTS,SEVEN,SIX,THERE,ZEALAND
CSC,CSCS,PCR,THESE
BASED,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PECOMAS,RESULTS,SEVEN
CONCLUSION,DIR,EACH,HOWEVER,LABEL,LDWV,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,THEREFORE
001,AKT,CPSF,CPSF4,ERK1,HOWEVER,JNK,KNOCKDOWN,MECHANISM,PI3K
116,BSA,BXPC,CF770,EPR,HCT,HLA,HOWEVER,IGG2A,JCK,LC11,NIR,PDX,THEREFORE,THESE,XENOLIGHT
130,177,181,A549,BAX,BCL,CDK,CELL,DPPH,FURTHER,HIGH,HPLC,IC50,MCF,PARMOTREMA,PARP,PRME,WST
440,BACKGROUND,DATA,DESPITE,LABEL,LUNG,METHODS,RESULTS
3475,BACKGROUND,CD28,CTLA,DUAL,IPILIMUMAB,KIR,LABEL,LAG,METHODS,MPDL3280A,RESULTS,SEVERAL,THESE
BACKGROUND,EGFR,EVEN,HER1,LABEL,METHODS,PREDICTIVE,RESULTS
BACKGROUND,DRUG,EGFR,ERLOTINIB,FOOD,LABEL,LUNG,METHODS,MOLECULAR,NON,NSCLC,RESULTS,TKI,USING
2012,8805,886,AMONG,BACKGROUND,CLINICIANS,HOWEVER,LABEL,MAYO,METHODS,NINE,RESULTS,SIMILARLY,SOCIETY,TEN
0139,038,2000,2008,249,3N2,534,BACKGROUND,IIIA,INT,JANUARY,LABEL,METHODS,NSCLC,RESULTS,STAGE,T3N1,THERE
001,1986,1988,1991,1993,1996,1998,2001,2003,2006,2008,997,AMONG,BACKGROUND,COX,III,LABEL,MEIER,METHODS,MOFFITT,NSCLC,RESULTS
ADDRESSING,BACKGROUND,FURTHER,HIGH,LABEL,LUNG,METHODS,RESULTS
ADDITIONAL,ALK,BACKGROUND,EGFR,GENOMIC,IMPORTANT,LABEL,METHODS,MULTIPLEX,NSCLC,RESULTS
BACKGROUND,EVEN,LABEL,METHODS,NSCLC,RESULTS,THREE,WHILE
BACKGROUND,CONTINUED,CURRENT,EBUS,EUS,FNA,LABEL,LESS,METHODS,NSCLC,RESULTS
ADVERSE,BACKGROUND,FALSE,GUIDELINES,HOWEVER,LABEL,LUNG,METHODS,NLST,RESULTS,SCREENING,TRIAL
160,ALTOGETHER,FACTORS,NSCLC,PATIENT,THESE
169,198,2013,A549,FGFR1,H460,HENCE,INC,LUNG,NCI,RESTORING,WILEY
2000,2009,2020,BACKGROUND,CHANGES,DATA,DISCUSSION,GERMANY,INSTITUTE,KOCH,LABEL,MATERIALS,METHODS,RESULTS
086,2010,252,447,578,AOK,BACKGROUND,DETMOLD,DISCUSSION,DISEASE,LABEL,MANAGEMENT,METHODS,PROGRAM,RESULTS,SIR,T2D,THUS
2010,300,429,477,900,DATA,DCO,DESPITE,GERMANY,INCLUSION
169,2013,8201,E2F1,GAS5,INC,MEANWHILE,NSCLC,PCR,RNAS,TAKEN,TNM,WILEY
009,169,1ST,2013,215,748,893,AACR,AFTER,BACKGROUND,EPIC,IMBALANCES,KTR,LABEL,METHODS,NUTRITION,OR5TH,ORS,RESULTS,TRYPTOPHAN
001,009,160,190,382,572,AHR,ARG,BACKGROUND,CCND1,EPHX1,ILE,LABEL,LUNG,LYS,MESTIZO,METHODS,MEXICAN,RESULTS,RFLP,STUDENT,TYR,VAL
169,2013,8201,949,APOPTOSIS,CD11C,CD14,CD19,CD3,CD68,COPYRIGHT,JOHN,LTD,NSCLC,PLCE1,SONS,WESTERN,WILEY
169,2013,A549,AKT,CD133,CDDP,CISPLATIN,ECTOPIC,HOWEVER,HTRA1,INC,LAC,PI3K,THEREFORE,WILEY
169,2013,CLINICALLY,CRK,CRKL,CT10,INC,SH2,SH3,SH3C,WILEY
165,169,2013,AACR,CD43,HPB,THESE,UN1
8804,945,946,947,956,ATF2,ATP,B16,CXCL8,ERK1,F10,HELA,IFN,JNK,JUN,LY2228820,MAPK,MK2,MYC,TED,TNF,WESTERN
169,183,2013,8201,BECAUSE,CALVERT,SCLC,THEREFORE
003,118,182,8805,BACKGROUND,CHRONIC,COPD,DATA,DISEASE,ETS,EXCLUSION,GOLD,INITIATIVE,LABEL,LUNG,METHODS,OLIN,PASSIVE,RESULTS
200,676,AUC,BACKGROUND,C30,EORTC,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PATIENT,Q3W,QLQ,RESULTS
169,193A,2014,954,A427,ASSAY,AZA,AZAC,BACKGROUND,BASEL,H1703,H1915,H1975,H1993,H200,H2073,LABEL,MCL,METHODS,MICRORNAS,MTT,NCI,NSCLC,PCR,PDT,REAL,RESULTS,TREATMENT,WESTERN
371,742,AFTER,EDUCATION,THUS
001,177,APE1,JEWS,MPG,OGG1,OMA,THESE
001,004,169,1999,2012,2014,210,AFTER,APRIL,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,INC,LABEL,METHODS,RESULTS,SCLC,SEOUL,TNM,UNIVERSITY
169,2013,COPYRIGHT,METHODS,PUBLISHED,SEPAR
050,126,169,2013,83YEARS,COPYRIGHT,ELISA,INC,KRUSKAL,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PUBLISHED,RESULTS,SERUM,SOCIETY
ABSENCE,ANTICANCER,K292E,LACK,NCI,PUBLISHED,TDP1,THUS,TOP1,TYROSYL
171,177,DATA,HRQL,HSCT,INC,MEAN,PUBLISHED,THESE
160,169,2013,8805,COPYRIGHT,DATA,FLORIDA,KNOWLEDGE,LTD,MOFFITT,PROGRAM,RAPID,RTD,TAMPA,USA,WHILE
2012,3RD,6TH,945,BASED,CD4,CD8,CSF,ELISPOT,FINALLY,FIRST,HLA,IDO,IFN,IFNY,IL2,INTERFERON,JUNE,KYN,LDH,MONTANIDE,NSCLC,OVERALL,PET,SINCE,SW480,TMZ,TREG,TREGS,TRP
2012,454,493,BACKGROUND,CONCLUSION,CTS,DATA,DENMARK,FOUNDATION,FUNDING,HALF,JANUARY,LABEL,LUNG,METHODS,NORDISK,NOVO,RESULTS,SOCIETY,THERE,TIME,TRIAL
169,2013,AMONG,ANALYZING,CISH,COPYRIGHT,EGFR,GMBH,HOWEVER,IHC
169,2013,ALK,COPYRIGHT,EGFR,FOLLOWING,HGFR,IRELAND,LTD,MET,NSCLC,RTKS,SEVERAL,THESE
169,2014,395,8805,BACKGROUND,COPYRIGHT,DESPITE,III,INC,LABEL,METHODS,RESULTS,WHETHER
169,2013,BACKGROUND,CD31,CELLS,CONCLUSION,COPYRIGHT,DESPITE,GMBH,LABEL,LUNG,METHODS,NOVEL,RESULTS,THESE
179,2014,290,298,CUMULATIVE,EPIDEMIOL,JOURNAL,VLAANDEREN
1985,2009
169,2013,COPYRIGHT,HDAC,IRELAND,LTD,YCW1
169,177,2013,CONCLUSION,COPYRIGHT,GIVEN,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,NONSMOKING,OBJECTIVE,OBJECTIVES,RESULTS
169,177,2013,355,365,954,ANOVA,BACKGROUND,BOTH,BP65,COPYRIGHT,COX,CPH,FDG,IHC,INCREASED,INCREASING,IRELAND,LABEL,LDHA,LTD,MEIER,METHODS,MICROARRAY,NSCLC,PET,RESULTS,STAGE,SUVMEAN,THESE
169,177,2014,COPYRIGHT,CREKA,DIM,DOGS,INC,LABEL,NCS,NTA,PCNCS,PEGYLATED,UNASSIGNED,UNLABELLED
1045,447,ANONYMOUS,BACKGROUND,DARTMOUTH,FLEISCHNER,HITCHCOCK,LABEL,MAIN,MEDICAL,METHODS,MOST,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SOCIETY
000,0012,007,018,142,158,161,307,60YS,66YS,77YS,817,BACKGROUND,BLINDED,COMBINING,HEREDITARY,HHT,IQR,LABEL,LIFE,METHODS,OVERALL,RESULTS,THESE
013,072,077,353C,353T,353TT,791,940,BACKGROUND,COPD,EMT,EPITHELIAL,HOWEVER,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SEVEN,SLUG,SNAI1,THERE,VAL118ALA,ZEB1,ZEB2
169,2014,AVM,BRAGG,JAMES,LINDA,LOMA,MEDICAL,TREATMENT,UNIVERSITY,WHILE
V95
IMRT,MLC
177,DEDICATED,IQR,MPH,RESULTS,TCS
1686,AAK,ALK,AREAS,BACKGROUND,BRAF,COVERED,DDR2,EGFR,FGFR1,HER2,KRAS,LABEL,MEK,MET,METHODS,NEXT,NSCLC,OPINION,RET,ROS1,VEGFR,WHILE
SCLC,THEREFORE,TNM,YET
1960S,EARLY,SURGERY
COPD,ENGLISH,NON,NSCLC
000,1997,2006,2012,245,273,370,440,607,618,815,985,AFTER,BACKGROUND,CXR,CXRS,ITALY,JULY,LABEL,LCS,METHODS,NHS,RESULTS,SERVICE
RIGHT
EGFR,EPIDERMAL,G719X,HOWEVER,L858R,L861Q,NSCLC,TKI,TKIS
AIM,BACKGROUND,DYSPNEA,HOSPICE,LABEL,LUKAS,METHODS,OBJECTIVE,PERCEIVED,RESULTS,RMD,SANKT,SCALE,SCM,VAS
183,230,251,8201,ADDITIONAL,LABEL,METHODS,OBJECTIVE,PCP,PCPS,PURPOSE,QUESTIONS,RCT,RESULTS,STATE,SURVIVORS,THOSE,WASHINGTON
100,1940,2001,CHARLESTON,HOWEVER,SOUTH
150,AES,ERLOTINIB,FIVE,III,IIIA,IIIB,LABEL,METHODS,MOST,NSCLC,OBJECTIVE,ORAL,PFR,PRIMARY,PURPOSE,RESULTS,SECONDARY,SIXTY,TTP
ALTERED,BASED,CISPLATIN,FDG,HKI,HKII,KNOCKDOWN,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,THREE,UNDER
145,181,268,ATTEMPTING,H460,HCT,IC50,MCF,N13,SGF,SIF
99MTC,AIM,BONE,CONCLUSION,ECT,LABEL,METHODS,NUCLEATED,OBJECTIVE,RESULTS,SUPPRESSED,ZEALAND
DESPITE,HOWEVER,RIGHT,SICK,SPECIAL,SUBSEQUENT,SVC
132,166,2324,279,AFTER,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,THERE,USING
001,047,155,235,282,293,697,ARMS,CHINESE,EGFR,EXON,G719A,G719C,G719S,G719X,L858R,L861Q,NSCLC,REFRACTORY,T790M,TKIS
2000,8805,HOWEVER,PULMONARY,SEVERAL,THESE,V10,V15,V20,VS5
AFTER,BARR,CTLS,EBV,EPSTEIN,LMP,NPC
178,1998,2004,ANSELIN,ARABIAN,EASTERN,GWR,HODGKIN,MORAN,NHL,OLS,POPULATION,SAUDI,THESE
165,2011,252,321,868,BASED,COCHRAN,CONCLUSION,FINALLY,FIRSTLY,LABEL,MEDLINE,METHODS,OBJECTIVE,OVID,RESULTS,REVIEWS,URINARY,WEB
2008,2011,556,8804,ACCORDING,AIS,AMONG,BETWEEN,CTR,GGN,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEVERAL,SOCIETY,STAGE
109,157,158,AFTER,AIM,ALARM,BACKGROUND,CONCLUSION,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,SETTING,THREE
103,AKT,CONVERSELY,EGFR,ERK2,EXPRESSION,HNSCC,MAPK,MEK,NSCLC,PD98059,PI3K,RAS,RASWT,SIMILAR
1005,141,169,177,2013,ABDOMINAL,CBCT,COPYRIGHT,DESPITE,EVERY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,TUKEY
169,2013,BASED,FOUR,MEDICAL,NSCLC,PRESS,PUBLISHED,SEVERAL,SOCIETY,UNIVERSITY
AFTER,AMONG,APC,DUE,EGFR,HOWEVER,IMIDS,KRAS,THUS
001,160,2004,2006,2011,352,493,8201,BACKGROUND,BDC,CURRENT,EGFR,HOWEVER,LABEL,METHODS,MOST,NSCLC,PERFORMING,RESULTS,STAGE
ACCORDING,AFTER,BACKGROUND,CASE,CONCLUSION,HOWEVER,LABEL,LAPATINIB,METHODS
007,008,073,2011,8201,8805,945,946,BED,NSCLC,SBRT
000,100,185,1992,1997,1998,2003,265,455,INCIDENCE,JANUARY,KOREA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SIRS,VIETNAM,WAR
100,215,3GLCNAC,4GLCNAC,945,946,BECAUSE,EBC,FURTHER,MILLETTIA,THESE,WJA
127,2004,2006,3253,338,AFTER,BECAUSE,CHRONIC,COX,FEV1,JAPAN,MEIER,SPIROMETRY,WESTERN
300,956,ARSENIC,LUNG,MTE,THESE
EGFR,HCC78,HOWEVER,NSCLC,PREVIOUSLY,ROS1
1900,1940S,1950,ADDITIONAL,BIRTH,HOWEVER,REANALYSIS,THEREFORE
1049,AKT,CHINA,CNKI,CONCLUSION,DATA,HOWEVER,KNOWLEDGE,LABEL,MATERIALS,METHODS,NINE,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
001,101,29C,320B,378,483,BACKGROUND,CONCLUSION,FOLLOWING,LABEL,METHODS,PCR,RESULTS,ROC,USING
BESIDES,DESPITE,EPH,EPHA,EPHA2,EPHA3,EPHB4,GPI,THESE
2009,ALSO,H1N1,H3N2,H7N7,HOST,HOWEVER,LUNG,SEVERAL,TMPRSS2
945,A549,AFTER,H1299,HIF,KNOCKDOWN,MICRO,RADIATION,RBE,TAKEN,THESE
1946,2012,AIM,BACKGROUND,CARE,CHECKLISTS,CONCLUSION,CUMULATIVE,CURRENT,EXCELLENCE,GENERALLY,GUIDELINES,HOWEVER,INDEX,INSTITUTE,LABEL,LITERATURE,LUNG,MEDLINE,MESH,METHODS,NETWORK,NURSING,OVID,QUALITY,REPORTING,RESULTS,THEREFORE
037,112,152,CD25,ELISA,FOXP3,IGG,STUDENT
169,2013,230,8201,BACKGROUND,BEHAVIORAL,COPYRIGHT,F2F,INTENTION,JOHN,LABEL,LTD,LUNG,METHODS,MODEL,RESULTS,SONS,VULNERABLE,WILEY
169,2013,HOWEVER,IMT,INC,WILEY
158,169,2013,455,GAP,HENCE,RAS,RHO,THESE,UICC
169,2013,A549,AKT,CXCL5,EGF,EGFR,ERK,FOS,HSP27,INHIBITING,KNOCKDOWN,RSK,RSK1,SNAIL,TARGETING,THESE,UICC
ALK,CD15,CD30,CD4,EMA,HISTOLOGY,PRIMARY,PROGNOSIS,TIA1
SKIN
000,2001,2003,700,934,AFRICAN,COX,DATA,EFFECTS,GEORGIA,MEDICAL,NHW,NON,NSCLC,SOUTHWEST,SWGA,THERE,TREATMENT,WHITE
DATA,FIFTEEN,FORTY,FULL,HYPOXEMIA,MEDICAL,PES,PRE,THERE,THESE,UCBT,UNIVERSITY
953,BHD,BIRT,DUB,HOGG,PRIMARY,TAIWANESE
952,FISH,PCR,RASGRP3,REGIONS,RNF20,SCA,SCAS,SNP,SSBP2,WIDESPREAD
0002,0003,NSCLC,RADIOMICS,THEREFORE
BRCA1,HSP90,LABEL,LARGE,MUTATIONS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SUMMARY,TNBCS
1250,195,200,600,BACKGROUND,EASTERN,GROUP,IIIB,LABEL,METHODS,PFS,RESULTS
070,215,BACKGROUND,BCL,FOUR,GX15,LABEL,MAXIMUM,METHODS,NSCLC,OBATOCLAX,OVERALL,RESULTS,THREE
0436,201T,240,947,BACKGROUND,BOTH,CCDC6,CONCLUSION,HODKGIN,KIF5B,LABEL,METHODS,NCOA4,RESULTS,RET
CHANGES
2010,2011,ALK,APRIL,BACKGROUND,BREAK,CLINICIANS,EML4,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER
003,012,130,201,225,8804,ARMS,BACKGROUND,DETECTION,DISCREPANT,EGFR,GENOMIC,LABEL,METHODS,REFRACTORY,RESULTS,THERE,THESE,TKI,WHETHER
001,002,005,ASSESSMENT,BACKGROUND,CONCLUSION,FUNCTIONAL,INSTITUTE,LABEL,MEAN,METHODS,PACLITAXEL,PATIENT,PHYSICIANS,RESULTS,THERAPY
0001,100,BACKGROUND,CONCLUSION,FIFTY,LABEL,METHODS,RESULTS,THERE
001,005,2005,2012,283,2N0M0,BACKGROUND,BETWEEN,DFS,LABEL,LOCAL,MEIER,METHODS,NSCLC,PROGNOSTIC,RESULTS,T1A
AKT,BACKGROUND,ERK,ERK1,FURTHER,H157,LABEL,MAP,MAPK,METHODS,NCI,NED,NSCLC,RESULTS,SCLC,U0126,USING
371,ABCG5,ALDH1,BACKGROUND,BER,CD133,CD166,CD24,CD44,CONCLUSION,CSC,CSCS,EP4,ESA,EXTENSIVE,LABEL,METHODS,MOC,NSCLC,OCT4,RESULTS,SEX,SOX2
134,1464,1474,AFTER,BACKGROUND,BRAF,CONCLUSION,LABEL,METHODS,NSCLC,RESULTS,RET
001,104,109,188,200,2009,2012,7344,ALK,BACKGROUND,BETWEEN,EGFR,EML4,KRAS,LABEL,METHODS,NORTH,NSCLC,PCR,RESULTS,SEPTEMBER,THESE,V5A
CSC,CSCS,DESPITE,PROVIDING
160,211H,ALTOGETHER,ARF,ARG249SER,CONVERSELY,H2052,H2452,H28,HMC,IST,MALIGNANT,MES,MSTO,NCI,RITA
169,2013,ANOVA,CD25,CD28,CD4,CD8,COPYRIGHT,FOXP3,III,LSD,NSCLC,THERE,THESE,TREG,TREGS
NON,NSCLC
000,400,ALK,AMONG,DDR2,EGFR,EML4,FGFR1,MAJOR,SQCLC,THESE
ALK,CRIZOTINIB,FURTHER,NSCLC,ROS1
AFTER,BACKGROUND,C30,ELDER,EORTC,GROUPED,HIGH,LABEL,METHODS,NAUSE,OBJECTIVE,QLQ,QUALITY,RESULTS,SIXTY
009,032,2010,2012,557,AFTER,AUG,BACKGROUND,ESS,EUTHYROID,FT3,FT4,LABEL,METHODS,NSCLC,OBJECTIVE,OCT,POD,POD1,POD2,POD3,POD7,RESULTS,THERE,TOS,TSH,VATS,VIDEO
091,BACKGROUND,BRAIN,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,USUAL
041,108,121,131,152,189,2002,2012,209,310,3N2M0,4N1M0,4N3M0,BACKGROUND,BETWEEN,CHI,COLLEGE,HOWEVER,III,IIIA,IIIB,LABEL,MARCH,MEDICAL,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PFS,RESULTS,SURGERY,T4N0,THERE,THREE,TNM,UNION
001,008,035,077,087,123,178,2009,2012,277,931,967,978,BACKGROUND,BCL,BIM,DCR,EGFR,JANUARY,LABEL,METHODS,MULTI,NON,NSCLC,OBJECTIVE,OCTOBER,PCR,PFS,RESULTS,SPSS,TKI,UNIVARIATE
1640,181,A549,AQP1,BACKGROUND,CETUXIMAB,KDR,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,RPMI,THEIR,WESTERN
A549,ABC,ANTITUMOR,ATP,DRUG,GIVEN,NSCLC,SINCE,THUS,TRAIL
169,2013,49009,AKT,COPYRIGHT,EGFR,H1975,HEAT,HER2,HSP70,HSP90,LTD,MET,PU3,SUBSEQUENT,VER
100,1513,1996,2000,203,436,BACKGROUND,CIS,COLLECTED,CONCLUSION,ETS,LABEL,METHODS,ODDS,ORS,OVERALL,RESULTS,SES,THERE,WHILE
169,2013,AMONG,BRITISH,HOWEVER,SOCIETY,TRP,TRPA1,TRPC,TRPM,TRPV
169,1952,2013,ASIAN,CAUCASIAN,CONCLUSION,DATA,HOWEVER,JOHN,LABEL,LTD,LUNG,MEDICAL,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SELECTION,SONS,SUBJECT,WILEY
BACKGROUND,BOTH,CONCLUSION,COULD,HOWEVER,LABEL,METHODS,RESULTS,THEN
169,2013,ASIA,AUTHORS,EMT,LTD,PTY,PUBLISHING,SCIENCE,THESE,WILEY,WNT,WNT3,WNT5B
ABSTRACTS,AMED,BACKGROUND,BIOLOGICAL,BRITISH,C30,CAB,CD3,CD4,CD8,CHINESE,CNKI,CQVIP,DATA,EBSCOHOST,EORCT,FURTHER,HOWEVER,INDEX,ISI,KARNOFSKY,LABEL,LIBRARY,LUNG,MEDICAL,MEDLINE,METHODS,NURSING,OVID,PLUS,QLQ,RESULTS,SCIENCE,WANFANG,WBC,WEB
001,021,1989,2004,2010,2011,399,8804,8805,COX,DATA,KI67,LUNG,OPTIMAL,WORLD
2003,2011,2675,39351,3RD,5152,CANCERS,CHILDHOOD,CONCLUSION,DEC,EDITION,GENERAL,HACETTEPE,HIGH,HOSPITALS,ICCC,JAN,LABEL,MEDICAL,METHODS,MOST,OBJECTIVE,PEDIATRICS,PURPOSE,RADIATION,RESULTS,SURGERY,UNIVERSITY,UROLOGY
000,129,177,2007,2010,209,AMONG,CONCLUSION,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SPN,SPNS,VATS
815,CONCLUSION,DYNAMIC,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,TAC
0001,432,989,CONCLUSION,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,USP8,XIAP
100,CONCLUSION,COX,HEAT,HSP,HSP27,LABEL,LCNEC,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC,SCLCS,SURGICALLY,THERE
CELL,COX,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PCR,PURPOSE,RESEARCHES,RESULTS,RNAI
001,012,031,034,040,073,233,CONCLUSION,ECOG,EGFR,IIIB,IIIIV,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,TKIS
169,2013,293,CHIP,GREEN,H1299,INC,NSCLC,POLYPHENON,SPON,TAM67,WILEY
169,2013,AUTHORS,COST,JOHN,LTD,SONS,STATISTICS,WILEY
FEWER,PATHOLOGY,RCC,SOCIETY,THEIR,TLF,UROLOGICAL,WORLD
GIST,GISTS,GIVEN,THESE,TREATMENT
BMJ,DATA,GROUP,INDWELLING,IPC,IPCS,LIMITED,MPE,PUBLISHED,PUBLISHING,SUSPECTED,THERE,THESE
001,100,CD146,EMA,FFPE,GLUT1,IMP3,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RMC,RMCS
OCT
000,047,2002,2008,AFFILIATED,BONE,CHINA,CONCLUSION,III,JANUARY,LABEL,LUNG,MAY,METHODS,OBJECTIVE,PROVINCIAL,RESULTS,UNIVERSITY
945,A549,CSA,CYP,DOX
BASAL,BCC,BCCS,CURE,MBCC
169,1975,1992,2001,2005,2010,2013,ACS,AMONG,BACKGROUND,CDC,CENTERS,CENTRAL,CONTROL,DATA,DISEASE,END,ESTIMATES,INSTITUTE,LABEL,METHODS,NCI,NORTH,OVERALL,PREVENTION,REGISTRIES,RESULTS,SEER,SOCIETY,THROUGH
116,285,353,994,AOS,CELLS,FOXM1,HOWEVER,NADPH,NRF2,ROS,THEREBY,THEREFORE
001,169,2014,244,AMONG,BACKGROUND,CNS,COPYRIGHT,EGFR,INC,LABEL,METHODS,MIXED,RECORDS,RESULTS,TKIS,TTP
169,17A,2013,945,947,A549,ACADEMY,ALLERGY,BACKGROUND,CHRONIC,CONCLUSION,COPYRIGHT,EXPRESSION,HOWEVER,IFN,IMMUNOLOGY,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,POLYP,PUBLISHED,RESULTS,SPLUNC1,TLR,TLR3,TLR4,TOLL
0001,169,2013,562,ATP,BACKGROUND,CALCIUM,CARCINOMA,CHINESE,COPYRIGHT,GENERAL,LABEL,LEWIS,LUNG,METHODS,PUBLISHED,RESULTS,THEREFORE
169,1GY,2010,2013,225,2791,2GY,5GY,991,AVERAGE,CONCLUSION,COPYRIGHT,CTC,DOSIMETRY,GRADE,ILD,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,NCI,OBJECTIVE,PURPOSE,RESULTS,WHOLE
169,2013,INC,MOLECULAR,PUBLISHED
169,2013,ALK,BRAF,EGFR,HER2,INC,KRAS,NON,NSCLC,SEVERAL
002,016,152,169,2005,2010,2013,2593,AIMS,COPYRIGHT,DPM,FURTHER,GASTRIC,JANUARY,LABEL,LTD,METHODS,MSI,OBJECTIVE,RESULTS,THEREFORE
946,A549,AKT,CKS,EMT,ERK1,GSK,INHIBITION,PI3K,PLATYCODON,SMAD,SMAD2,SMAD7,SNAIL,TGF,THESE
BACKGROUND,DGE,E2F1,HOWEVER,JOINT,LABEL,MOST,RESULTS,TOP
00004,0001,NSCLC,STAGE,UNIVARIATE
205,CHINA,MOST,POLLUTION,RESULTS,WORLD,XUANWEI
003,131,178,BACKGROUND,CONCLUSION,EBUS,INC,LABEL,MEDICAL,MERIT,METHODS,RESULTS,SOUTH,SYSTEMS,TBNA,THERE
BOTH,FILAMIN,FILIP1L,FURTHER,OVERALL,REDUCED,THUS
0001,0007,0071,0178,148,707,METASTASIS,SUBSEQUENT,TNM
1304,181A,361,608,769,946,A549,AKT,BCL,ERK,LU1,PI3K,SHORT,TGF,WNT
177,1778,1815,A431,DESPITE,EGFR,ELISA,HN11,IGF,IGFBP,IGFR,LOSS,MOST,SERUM,TKI,TKIS,WESTERN
947,AIMS,ATF6,BACKGROUND,BECAUSE,CCL4,CHOP,CONCLUSION,DEN,EBP,HCC,IFN,LABEL,OBJECTIVE,RESULTS
005,009,196,376,8805,AGE,CONCLUSION,EASTERN,ECOG,GROUP,IFD,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE
169,2013,300,350,6727,8804,BACKGROUND,FIFTY,LABEL,METHODS,PLK,PLK1,PLKS,POLO,RESULTS,SEVEN,SOCIETY,VOLASERTIB
000,001,031,043,446,ASIAN,CAUCASIANS,MMP,NSCLC,SEVEN
407,ASN,ASP312ASN,C118T,CHINA,ERCC1,ERCC2,GLN,KNOWLEDGE,LYS751GLN,NSCLC,ODDS,PFS,SNP,SNPS
169,2013,ALDRICH,AUTHORS,B16,DCS,GMBH,IMMUNOLOGY,JOURNAL,KGAA,VCH,WASP,WILEY,WISKOTT
169,2013,8853,GMBH,KGAA,PIC,PPC,RATIONALLY,USING,VCH,WILEY
BASED,CHEST,TEN,THEREAFTER
8805,BASED,BECAUSE,DAYS,GRADE,GROUP,III,JAPAN,LABEL,METHODS,OBJECTIVE,OTHER,PHASE,RESULTS,TEN
133,169,2013,321,563,686,8201,8764,881,945,946,ALPHA,BETA,BODY,FINNISH,NEITHER,PREVENTION,TOCOPHEROL,UICC
169,2013,BACKGROUND,CONCLUSION,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM,WILEY
BESIDES,DEGS,FUNCTIONAL,HRPD,KEGG,LABEL,LUNG,MATERIALS,METHODS,MICROARRAY,OBJECTIVE,OBJECTIVES,PROTEIN,REFERENCE,RESULTS
142,537,BESIDES,CLUSTER,CONCLUSION,DATA,DAVID,DEGS,EXPRESSION,FUNCTIONAL,GENECODIS,GSE3268,LABEL,MATERIALS,METHODS,MIR,OBJECTIVE,OMNIBUS,RESULTS,SLC,THESE,WEBGESTALT
000,003,006,008,011,021,054,074,172,224,559,644,675,COX,FORTY,IHC,MEIER,SCLC,THESE,VEGF
100,101,177,215,DEMODEX,RESULTS,THUS
036,403,527,COX,EGFR,FIFTY,GROUPINGS,NSCLC,OBJECTIVE,PCR,PFS,THERE,TKI,TKIS
945,954,LPS,SIMILARLY,SNO,THESE,TNF,TRX,TXNIP
115,8776,946,947,AK301,CELLS,ED50,EMPLOYING,FAS,HT29,THESE,TNF,TNFR1,TRAIL
COLORECTAL,DESPITE,HOWEVER,THEREFORE,TYPICALLY
200,931,COMPOUNDS,ESTIMATED,PAHS,PM10,PM2,USEPA
HIF,HOWEVER,METASTATIC,RCC,VEGF,VHL,VON
177,2002,2009,8805,CONCLUSION,CPRD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
A549,BAK,BCL,DHA,FAS,GEM,ROS
040,045,15Q25,200,210,ADDITIONAL,CAUCASIANS,CHINESE,HAN,HOWEVER
236,385,945,956,AKT,BP1,DMSO,EGFR,H1975,HIF1,IC50,MMP9,MTT,NVP,PCR,PI3K,T790M,THERE,THESE,THR70,VEGF,WESTERN
233,DANDY
8201,ACTIVATION,ASIAN,ATP,BACKGROUND,CONCLUSION,DCR,ECOG,GRADE,HGF,LABEL,MET,METHODS,MGC,PRE,RESULTS,TIVANTINIB
129,818,935,953,AUC,BACKGROUND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESENTING,PUBLISHED,RESULTS,ROC,THESE,UNIVARIATE,USING
231,A549,ALDH1,CD24,CD44,CSCS,MCF7,MDA
150,177,225,227,333,367,CONCLUSION,DIXON,FDG,FIFTY,INTRACLASS,LABEL,MBQ,METHODS,PET,RESULTS,THERE,THREE,UNLABELLED
000,100,120,177,240,300,500,956,99M,B12,CONCLUSION,DYNAMIC,LABEL,MBQ,METHODS,PAMA,PREDOSING,RENAL,RESULTS,SIX,SPECT,TARGETING,TEN,UNLABELLED
8209,A549,BUTEA,COX,RHUS,THESE
1997,2013,967,BACKGROUND,LABEL,LOS,LUNG,MANN,MEIER,METHODS,RESULTS,WHITNEY
8209,ATP,CONVERSELY,KATP,ROS,THESE,TRAIL
231,ALTOGETHER,MCF,MDA,NAV1,RHOA,VGSCS,VOLTAGE
ACTIN,ESPIN,FAK,GTP,HOWEVER,LABEL,MEL,RAC1,RET,UNLABELLED
127,191,2012,AIM,BACKGROUND,CHARING,CONCLUSION,CROSS,DESPITE,DETAILS,LABEL,MALIGNANT,MATERIALS,METHODS,NICE,OBJECTIVE,ONGOING,RESULTS,TREATMENT,WEST
124,173,177,2008,2010,237,363,8805,AGE,APRIL,JANUARY,LABEL,METHODS,MORBIDITY,MORTALITY,OBJECTIVE,OBJECTIVES,PAF,PEAK,RESULTS,UNIVARIATE,WHILE
1268,630,8197,8594,HOWEVER,PDT
AJUBA,HIPPO,HOWEVER,LATS,LATS2,LIM,MALIGNANT,MMS,NF2,TAKEN,YAP,YES
100,CELL,EGFR,HEMA,HOWEVER,KRAS,MOLECULAR,THERE
32P,AIM,CONCLUSION,INSTEAD,LABEL,METHODS,NONE,OBJECTIVE,RESULTS,ROI,SPECT
0001,007,106,127,224,345,CONVERSELY,ELISA,FORTY,FREE,IIPS,IPF,MMP,NSCLC,NSIP,PCR,REAL,SERUM,TIME
5FU,BAX,BCL6,CONVERSELY,HOWEVER,KNOCKDOWN,MDM2,MEFS,PATZ,PATZ1,THEREFORE
491,CONVERSELY,EGF,EGFR,ERK1,FAK,GIT1,LOWER,MICRORNAS,MMP2,OSCC,OSCCS,USING
2100,AGILENT,APPLIED,BACKGROUND,BIOSYSTEMS,CONCLUSION,FLA,LABEL,METHODS,PCR,RESULTS,STR
010,11C,889,955,ATP,COMBINING,EGF,EGFR,GBM,IHC,MRI,PET,ROI,THERE,TKI
001,018,145,169,2005,2013,277,674,676,BASEL,FDG,JUNE,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PET,PFS,RESULTS,SCLC
116,435,8320,8325,956,CALU,HCT,HNY29,HUH7,MDA,MTT,PHOMOPSIS,THREE
0001,001,177,1997,2000,2010,2012,BACKGROUND,CONCLUSION,DATA,HOWEVER,IIIB,KBP,LABEL,LUNG,METHODS,RESULTS
ASIA,ASIAN,AUSTRALIA,CHINA,COLORECTAL,HOWEVER,JAPAN,LUNG
001,002,137,169,177,2011,2012,2013,APRIL,DEFINITION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PREDICTORS,PRESS,PUBLISHED,RESULTS,SAA,SEVERAL,SURGERY,THERE,THREE,UNITS,UNIVERSITY,VATS,VIDEO
162,169,1772,2013,311,430,741,945,A588T,AIM,BASEL,CONCLUSION,HIF,HIF1,LABEL,METHODS,NSCLC,OBJECTIVE,P582S,PFS,RESULTS
109,169,2013,AMP,AMPK,BACKGROUND,BASEL,CONCLUSION,ECA,ESOPHAGUS,HOWEVER,LABEL,METHODS,RESULTS,THESE,TREATMENT,USP7
AGE,AMD,AREDS,BECAUSE,DATA,DISEASE,EYE,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATED,RESULTS
169,2013,A549,AACR,BECAUSE,CPG,HTB56,LABEL,METASTASIS,METHODS,NSCLC,OBJECTIVE,PRC2,PURPOSE,RESULTS,WIDESPREAD
001,169,2013,209,AACR,ADC,III,INCREASED,LABEL,METHODS,MSLN,OBJECTIVE,PURPOSE,RESULTS,RFS
MANAGEMENT,THERE
BMJ,COPD,EMT,EPITHELIAL,GROUP,LIMITED,PUBLISHED,PUBLISHING
AKP,CONCLUSION,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,PATIENT,PURPOSE,REGARDING,RESULTS,THERE,TOS
2000,2012,3497,AMONG,EIGHT,ENGLISH,FOUR,FURTHER,HOWEVER,JULY,KNOWLEDGE,LABEL,MATERIALS,METHODS,NONE,OBJECTIVE,OBJECTIVES,PET,RATIONALE,RESULTS
ACUTE,CONCLUSION,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,NORTH,NSCLC,OBJECTIVE,PET,PURPOSE,REASONS,RESULTS,SBRT,THESE,TREATMENT,WHILE
DDM,ECLIPSE,EMT,ITV,PTV,THEREFORE
CEA,CELLSEARCH,CTC,CTCS,FISCHER,SIX
1997,2002,954,AGREEMENT,AREA,CASES,COHEN,DOM,GREATER,JEM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISKS,TORONTO
169,2013,BESIDES,COPYRIGHT,HOWEVER,PDCD4,PROGRAMMED
169,177,2013,COPYRIGHT,H460,IRELAND,LTD,MICROARRAY
169,2013,BEL7404,COPYRIGHT,HEPG2,RIBOSOMAL
118,174,1985,200,2012,233,7130,AIM,BACKGROUND,BRONCHIAL,CBPS,CENTRAL,CONCLUSION,HUNGARY,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OTHER,PDS,PROLONGED,RESULTS,SCLC,THERE,THESE
FINALLY,FIRST,THERE,THESE
169,2013,COPYRIGHT,FURTHER,IRELAND,LTD,RADON,STUDIES
169,2013,COPYRIGHT,INCREASING,INHIBITION,IRELAND,LEWIS,LLC,LTD,PCR,TRAP,VEGF
169,2013,8710,COPYRIGHT,GALECTINS,HMEC,HUVEC
169,2013,COMPOUNDS,COPYRIGHT,NCI,PALLADIUM,SAS,THESE
169,2013,946,A549,AKT,CDDP,CISPLATIN,CONVERSELY,EMT,FINALLY,HOWEVER,INCREASED,KNOCKDOWN,NSCLC,PUBLISHED,SLUG,SNAIL,TAKEN,TWIST,ZEB1
0617,169,2013,COPYRIGHT,DESPITE,GROUP,III,LTD,NSCLC,RADIATION,STRATEGIES,THERAPY,THESE
001,169,2013,375CM,677,AAA,ARIA,AXB,BOTH,COPYRIGHT,CROWN,ECLIPSE,INITIAL,MEDICAL,MUS,NSCLC,OVERALL,PUBLISHED,RADCALC,SBRT,USING
169,2013,COLLEGE,COPYRIGHT,DIGITAL,LTD,PUBLISHED,ROYAL
0001,169,1793,2013,BACKGROUND,COPYRIGHT,HIGH,HOWEVER,III,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,STAT3
169,2005,2012,2013,233,COMPANY,COPYRIGHT,JANUARY,JOURNAL,LABEL,LTD,METHODS,OBJECTIVE,OCTOBER,ONCOLOGIE,PEDIATRIC,PUBLISHED,RADICAL,RESULTS,SEVENTEEN,SIOP,SIXTEEN,SOCI,TFE3,UROLOGY,WILMS
169,2013,ASIAN,CAUCASIAN,CONCLUSION,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THESE,TKIS
169,2013,CARCINOMAS,COLLECTIVE,COPYRIGHT,INC,K14
037,169,2013,BMI,BOTH,CONCLUSION,COPYRIGHT,CPET,DLCO,ESTIMATED,FEV1,FVC,LABEL,MANN,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SEPAR,SMIRNOV,STUDENT,VARIABLES,VO2,WHITNEY
169,2013,549,COPYRIGHT,LTD,LUNG
0001,0002,169,2013,20GY,D50,DMAX,EACH,FIF,MEDICAL,PUBLISHED,THREE
169,2013,946,AUTHORS,COPYRIGHT,EMT,ID1,INC,KNOCKDOWN,MET,PUBLISHED,TGF
006,041,169,2000,2012,2013,618,CIS,CONCLUSION,COPYRIGHT,EGFR,GEFITINIB,ILD,IRELAND,JANUARY,LABEL,LTD,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,RESULTS,RRS,SOCIETY,SUMMARY,TKIS,TREATMENT
001,009,045,169,1970,2013,2018,CONCLUSION,COPYRIGHT,COX,FOUR,HRS,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NEITHER,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,TESTS
169,177,2008,2013,2014,99M,BETWEEN,FINAL,JANUARY,JUNE,LABEL,MAA,MATERIALS,MBQ,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THERE
001,006,169,2013,3DCT,4DCT,AIMS,BEAM,COLLEGE,COPYRIGHT,DOSE,HOWEVER,KUTCHER,LABEL,LKB,LTD,LYMAN,MAASTRO,MATERIALS,METHODS,NTCP,OBJECTIVE,PLANS,POTENTIAL,PTV,PUBLISHED,RESULTS,ROYAL,THERE
169,2013,COPYRIGHT,INC,MOST,NEOPLASTIC,PRIMARY,SECONDARY
169,2013,COPYRIGHT,INC,NOTCH,NUMB,RBM10,RBM5,RBM6
008,140,169,2013,8062,CONCLUSION,CONSORTIUM,COPYRIGHT,FINALLY,IMAGE,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS
0001,160,169,1993,2005,2006,2011,2014,396,428,437,492,646,861,AMONG,COPYRIGHT,EARLY,ELCAP,INC,LABEL,LUNG,MEIER,METHODS,MOSBY,OBJECTIVE,PROGRAM,PUBLISHED,RESULTS,SCREENING,SURGERY,TRIAL,VIDEO
000,091,100,1000,101,137,153,157,183,199,200,2000,2010,264,685,AYLL,IOST,LABEL,METHODS,MORTALITY,OBJECTIVE,PRAIS,PYLL,RESULTS,SPYLL,STATA,THERE,WINSTEN
001,140,169,200,209,295,297,309,322,330,342,398,651,945,946,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,SCLC,SCLCS,SIX,THERE
001,002,006,036,058,100,106,CETUXIMAB,COX,DCR,ECOG,LABEL,METHODS,OBJECTIVE,ORR,PCR,PERIPHERAL,PFS,PNA,RESULTS
169,2013,COPYRIGHT,INC,LUNG
0001,0011,0036,007,0135,024,034,062,075,105,116,120,129,169,2013,2515,570,ACUTE,ARDS,CHRONIC,EVALUATION,III,LABEL,METHODS,NETWORK,OBJECTIVE,PHYSIOLOGY,RESULTS
169,2013,2399,ACCEPTANCE,ADS,BANGLADESH,CHINA,COPYRIGHT,EGYPT,FIVE,GRAPHIC,INDIA,INDONESIA,LTD,MESSAGE,PERCEIVED,SMOKERS,VIETNAM
0001,169,2013,961,BOTH,COPYRIGHT,DESPITE,DIXON,FDG,HIGH,IRELAND,LABEL,LTD,METABOLIC,METHODS,MRAC,MRI,MTV,MTVS,OBJECTIVE,OVERALL,PERT,PET,PURPOSE,RESULTS,SUVMEAN
100,169,2014,AE1,AE3,CAM5,CASES,CK5,OSCAR,SMA,THERE,TTF,WT1
160,169,2014,4DCT,ABC,BREATHING,COPYRIGHT,DICE,EIGHT,INC,ITV10,LABEL,MANAGEMENT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REAL,RESULTS,TIME,UNIFORM
169,2014,8734,945,946,CFRT,COPYRIGHT,INC,LABEL,MATERIALS,MCFRT,METHODS,MSBRT,OBJECTIVE,PURPOSE,RESULTS,SBRT
160,169,2014,4DCT,8804,AIP,CBCT,COPYRIGHT,DYNAMIC,INC,LABEL,MATERIALS,METHODS,MIP,OBJECTIVE,PURPOSE,RESULTS,STATIONARY
169,2014,ABOUT,CBCT,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MODEL,OBJECTIVE,PURPOSE,RESULTS
001,008,010,036,048,1500,169,1800,2014,2200,8805,AFTER,COMPETING,COPYRIGHT,COX,FINE,GRAY,INC,KARNOFSKY,KPS,LABEL,LARGE,MATERIALS,METHODS,OBJECTIVE,OTHER,PURPOSE,RESULTS,SRS
169,2013,COPYRIGHT,GMBH,PECOMAS,THESE
169,2013,AKT,ANNEXIN,ASO,BACKGROUND,BLOT,CONCLUSION,COPYRIGHT,EGFR,INHIBITING,IRELAND,LABEL,LENTIVIRAL,LTD,METHODS,MIR,MTT,NSCLC,OBJECTIVE,PC9,PC9R,PCR,PDCD4,PI3K,PTEN,PURPOSE,RESULTS,TKI,WESTERN
169,2013,954,AKT,CONCLUSION,COPYRIGHT,FURTHER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PI3K,RESULTS,S6K,THESE
001,169,1765,2013,2603,838,ASP,BACKGROUND,CONCLUSION,COPYRIGHT,CRC,EGFR,FFPE,GGT,GLY,IRELAND,KRAS,LABEL,LTD,METHODS,NSCLC,RESULTS,TGT
169,2014,ALLERGY,BACKGROUND,CASPASE,CD4,CD8,COLLEGE,CONCLUSION,COPYRIGHT,IMMUNOLOGY,INC,LABEL,LUNG,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS
FOLLOWING,WIDESPREAD
2006,2009,367,BACKGROUND,DEPARTMENT,EDS,EMERGENCY,INCREASING,JANUARY,LABEL,MATERIALS,METHODS,NATIONWIDE,NEDS,NORTHEAST,RESULTS
169,2008,2011,2014,400,AAH,ADIS,AUR,COMBINING,COPYRIGHT,ENTROPY,HOUNSFIELD,INC,JULY,LABEL,LDCT,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PPV,PUBLISHED,RATIONALE,RESULTS,TDR,THREE,USING
160,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,SIX,THREE
160,169,2001,2013,2014,322,753,801,828,843,853,855,862,909,931,AUC,AUCS,AUR,CHINA,CHINESE,CONCERNING,COPYRIGHT,DATA,DEEKS,DIAGNOSTIC,DOR,DORS,DWI,ENGLISH,INC,JANUARY,KNOWLEDGE,LABEL,LIBRARY,MATERIALS,MAY,MEDLINE,METHODS,NLR,OBJECTIVE,OBJECTIVES,PLR,POTENTIAL,PUBLISHED,RATIONALE,RESULTS,SEVENTEEN,STUDIES,SUMMARY,THERE
169,2013,BOTH,HSCT,INC
016,1006,1024,123,142,1513,169,2007,2011,2014,268,274,291,300,410,477,507,538,806,829,956,BACKGROUND,COPYRIGHT,DARMSTADT,EFFECTIVE,FEB,FUNDING,GERMANY,GRADE,HOWEVER,III,IIIA,IIIB,INJECTIONS,KGAA,LABEL,LTD,MERCK,METHODS,MUC1,NOV,RESULTS,SERIOUS,START
169,2013,7TH,COPYRIGHT,INC,M1A,THESE,TNM
169,2013,AFTER,EARLY,INC,PUBLISHED,V20
169,2013,INC,THESE
169,2013,COPYRIGHT,INC,SURVIVORS
22Q12,ABDOMINAL,BACKGROUND,CASE,CD99,CONCLUSION,EWING,LABEL,METHODS,MIC2,PAKISTANI,PRIMARY,SARCOMA,STAGING
BACKGROUND,CROHN,EARLY,LABEL,METHODS,RESULTS,SCREENING,TEST,UNIVERSAL,UST
BACKGROUND,CAPG,EXPRESSION,FREQUENTLY,FUNCTIONAL,III,LABEL,MAPPING,METHODS,NOTABLY,ORTHOTOPIC,PROTEOMIC,RESULTS,T3SS
946,ANGPTL4,BACKGROUND,CHIP,EXPRESSION,FST,GST,LABEL,METHODS,PTHLH,RESULTS,SINCE,SMAD3,TGF,WWOX
22Q13,BACKGROUND,BRCA1,LABEL,MOST,PPP2R2A,PRKDC,RESULTS,TP53
2008,2009,606,BACKGROUND,CONCLUSION,DENMARK,HOWEVER,LABEL,METHODS,RESULTS,SEAFARING
169,2013,AUTHORS,BASED,COLLEGE,JOURNAL,PHYSICIANS,ROYAL,SUBSEQUENT
1010,160,169,2013,ASIA,BECAUSE,BILD,JANSSEN,JAPAN,LTD,LUNG,MEDICAL,PANEL,PLAN,PTY,PUBLISHING,RISK,RMAP,SCIENCE,WILEY
EGCG,GREEN,GTPS
172,2009,CIS,CONCLUSION,EACH,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,SIMILARLY,SMOKING
CUTANEOUS,LIGHT,PDT
AFTER,FURTHER,PROMISING
AIMS,CONCLUSION,LABEL,LOW,MATERIALS,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS
ERBB,HNSCC,HOWEVER
169,2013,AACR,PATIENT
169,2013,AACR,JAHCHAN,SCLC,THEIR
169,2013,AACR,AKBAY,DISCOVERY,EGF,EGFR
015,169,2013,AACR,H82,HGF,HOS,MET,MNNG,PREVIOUSLY,SCLC,SIMILAR,SMALL,SU11274,TOP,TOP1
169,2013,946,FILAMIN,FILIP1L,MMP,MMP3,MMP9,MMPS,MODULATION,NUCLEAR,OVERALL,PROTEIN,UICC,USING,WNT
160,169,183,8202,ANTARES,BACKGROUND,CONCLUSION,GEORG,GERMANY,LABEL,METHODS,MHZ,REAL,RESULTS,RTE,SIEMENS,STUTTGART,YORK
169,2013,OTHER,SOCIETY
169,2013,FIRST,INC,RISK,SOCIETY,THERE,THIRD
169,2013,239,AACR,ALK,CONCORDANT,EML4,HSP90,III,LABEL,METHODS,OBJECTIVE,OVERALL,PEMETREXED,PURPOSE,RESULTS
154,BACKGROUND,CDK1,CONCLUSION,FOLLOWING,LABEL,MALIGNANT,METHODS,MPM,NDC80,PLK1,PROGNOSIS,PROTEIN,RESULTS,RNAI,THESE,USING,UTILISING
18F,2007,2010,298,345,435,855,8805,CONTROL,FDG,III,JUNE,NSCLC,PET,PFS,SUV,THERE,UICC,UNION,UNIVARIATE,ZPS
018,043,375,8197,838,BALF,CEA,CYFRA21,HOWEVER,NSE,VEGF
DESPITE,DOWN,HOWEVER,LUNG
AFTER,NTM,PET,RCC,THESE
16S,BACKGROUND,CONCLUSION,CUTANEOUS,FITE,GRAM,LABEL,MATERIALS,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS
128,129,AIMS,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL,THERE
001,018,069,1000,239,AIMS,BACKGROUND,FEBRILE,FOUR,IIIB,LABEL,METHODS,MOST,OBJECTIVE,OVERALL,PARTIAL,RESULTS
132,1999,2000,AIMS,BACKGROUND,COMPOSTELA,COX,GSTM1,GSTT1,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SPAIN,UNIVERSITY
001,010,033,046,047,100,120,133,145,179,193,540,702,ADS,ADSQC,ALK,EGFR,IHC,III,KRAS,NOS,NSCLC,PFS,SQC,SQCS,TTF1,WHETHER,WHILE
148,1M0,200,2M0,3N0,4N0,583,628,8805,ANTIBODIES,BACKGROUND,CONCLUSION,EGFR,FIVE,LABEL,MATERIALS,METHODS,NAC,NSCLC,RESULTS
ALPPS,BACKGROUND,LABEL,METHODS,RESULTS,SEVEN,SIX,STILL,TEN,THREE
100,169,2013,220,945,947,956,AZA,CK1,CK2,COPYRIGHT,LTD,MCF7,NCI,SIK,THESE,WHEREAS
169,2014,945,BLOOD,BRB,CAV,COPYRIGHT,INC,NG2,PATHOLOGY,PUBLISHED,SMA,SOCIETY,THESE,VEINS
169,2013,945,946,ABH,COPYRIGHT,ENDOGENOUS,GALECTINS,GM3,HNK,K176L,KEY,LNNT,LNT,LTD,THESE
215,8201,BPF,NSCLC,RESULTS,RFA,THERE,THEREFORE,VIRTUAL
133,229,8201,BACKGROUND,CONCLUSION,H4R3,HIGH,IMMUNOBLOT,LABEL,METHODS,NET,NSCLC,PRMT5,PROTEIN,RESULTS,SLIDE,THERE,UNASSIGNED,VIRTUAL,WESTERN
1489,1534,215,2331,2449,2512,2P32,3077,392,8804,BEIJING,BOOLEAN,BOOST,CHINESE,FOUR,GUANGZHOU,GWAS,HAN,HOWEVER,LRM,LUNG,OPERATION,PAIRS,SCREENING,TESTING,USING
THESE,TYPICAL
001,009,122,160,169,2013,8805,AIMS,ASSESSMENT,BACKGROUND,CLINICALLY,CONCLUSION,COPYRIGHT,GENERATED,LABEL,LTD,METABOLISM,METHODS,NUTRITION,OBJECTIVE,PATIENT,RESULTS,SOCIETY,SUBJECTIVE
BOARD,GENERALLY,THESE
199,230,500,ABOUT,BASED,DATA,HOWEVER,LAM,METHODS,OBJECTIVES,ODDS,OESTROGEN,RESULTS,TSC
0002,0003,0008,001,002,004,0813,0831,169,177,2014,8197,8201,8804,DOSIMETRIC,EFFICIENCY,GTV,KUTCHER,LYMAN,NINE,OAR,OARS,PTV,RTOG,SBRT,USING,VMAT,WHILE
169,2014,PET,RESULTS,TESTS
152,169,2014,215,300,8197,8201,8764,ABS,AVERAGE,BRAGG,BRCA1,BRCA2,BTG2,CCNB2,CDK1,DMC1,DNMT1,E2F1,EXO1,FEN1,GADD45A,GOLGI,GTSE1,HLE,IFNB1,JUN,KRAS,MDM4,PCR,PERCENTAGE,PRC1,PTTG1,RAD51,RPA1,SIAH1,STUDIES,TDR,TNF,WT1,XRCC2,XRCC3
33258,A549,CONCLUSION,HOECHST,LABEL,METHODS,NORA,NOXA,OBJECTIVE,PCR,RESULTS,WESTERN
100,AKT,EGFR,FCM,GEFITINIB,H1975,LABEL,MET,METHODS,MTT,OBJECTIVE,PI3K,RESULTS,THEIR,WESTERN
BAC,CHINESE,INF,LABEL,MEANWHILE,METHODS,OBJECTIVE,QSPSS,QYDS,RESULTS,TH1,TH2,THL,TOTALLY
8314,8323,CD19,CD3,CD4,CD56,CD8,FURTHER,LABEL,METHODS,NKA,NSCLC,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,SBRT,TLC
177,BASED,BNS,CAMML,ENGLISH,HOWEVER,LUNG,ROC
AMONG,BRAIN,CURRENT,FURTHER,INHIBITING,MMP,MMPS
ALTOGETHER,BASAL,BLCS,CCM,CD44,FINALLY,FIRSTLY,HOWEVER
AFTER,BACKGROUND,CONCLUSION,CTC,CTCS,III,LABEL,METHODS,NSCLC,PCR,RESULTS
001,231,4T1,CONVERSELY,DESPITE,FINALLY,MDA,PACLITAXEL,SV40,THESE,THREE,TIX
ASC,CSLC,NSG,PRIMARY,TAKEN,THERE,THESE
BLOBS,HOWEVER,SIFT,THESE
000,1995,2006,600,ADDITIONAL,DATA,INCREASED,PAH,POISSON,RRS,SES,SIR,THEREFORE
ADC,CNV,CNVS,CTC,CTCS,EVEN,THESE
2003,2011,398,AIM,APRIL,BETWEEN,CONCLUSION,CONCURRENT,DEFINITIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SBRT,UNIVERSITY
1998,2009,BACKGROUND,BMS,BRAIN,CONCLUSION,FIFTEEN,LABEL,METHODS,RESULTS
2010,2012,946,AIM,AMONG,BACKGROUND,CONCLUSION,DOCETAXEL,EGFR,EPIDERMAL,ERCC1,III,IIIA,IV1A,JUNE,LABEL,METHODS,NSCLC,OBJECTIVE,OCTOBER,PCR,POST,RESULTS,RRM1,TYMS
215,239,500,AFTER,AIM,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
001,167,AIM,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,VEGF,YKL
100,693,AIM,CONCLUSION,GIP,KARNOFSKY,LABEL,METHODS,NSCLC,OBJECTIVE,PRIMARY,RESULTS,UNTREATED,WHILE
33342,AKT,ANNEXIN,BACKGROUND,BCL2,CAV1,CONCLUSION,HOECHST,LABEL,MATERIALS,METHODS,MTT,RESULTS,THESE
11A,14C,239,945,946,AIM,BACKGROUND,CERV196,CONCLUSION,EVEROLIMUS,EXPRESSION,FURTHER,HIF,HNSCC,HPV,INCIDENCE,INCUBATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PDGFR,RAF,RESULTS,RET,THESE,THUS
A549,BACKGROUND,CELL,CELLS,CONCLUSION,LABEL,MATERIALS,METHODS,OCT4B,OCTAMER,PROPIDIUM,RESISTANCE,RESULTS,RNAI,SILENCING
A549,BACKGROUND,BAX,BCL2,CONCLUSION,H1650,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,RNAI,ZOL
184,659,956,BACKGROUND,CISPLATIN,CONCLUSION,DV90,IC50,LABEL,MATERIALS,METHODS,MTC,MTN,NSCLC,NUCLEAR,RESULTS
22Q11,9ER,AIM,AKT,AMONG,BACKGROUND,CONCLUSION,CRKL,CT10,EGFR,LABEL,MATERIALS,MECHANISMS,METHODS,NSCLC,NVP,OBJECTIVE,PCR,PI3K,REAL,RESULTS,TKI,TKIS
169,2013,AACR,HIGH,HOWEVER,RWRF
100,169,2011,2013,8804,BACKGROUND,DATA,ENB,FNA,JULY,LABEL,LITERATURE,METHODS,PET,PLLS,RESULTS,ROSE,SOCIETY,TBX,THERE
100,101,169,183,64257,DISCLOSING,FURTHER,GEORG,HOWEVER,LABEL,LUNG,METHODS,OBJECTIVE,PHYSICIAN,RESULTS,STUTTGART,TREATMENT,YORK
160,FOUR,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
002,043,8805,AMONG,BLACK,CARE,CONCLUSION,COVARIATES,DEPRESSION,III,LABEL,METHODS,OBJECTIVE,PURPOSE,RACE,RESULTS,SCALE,STUDIES,WHITE
104,261,CONCLUSION,CURRENTLY,FGFR3,KEAP1,LABEL,LUNG,METHODS,MLL2,NORTH,OBJECTIVE,PTEN,PURPOSE,RB1,RESULTS,SCC,SEVEN,TACC3,THESE,TP53
160,200,AKT,CONCLUSION,DLT,DLTS,DOSE,HER2,LABEL,METHODS,OBJECTIVE,OTHER,PI3K,PURPOSE,RESPONSES,RESULTS,SIXTY
009,160,177,8201,BACKGROUND,CONCLUSION,COX,ELISA,GTV,HIGH,HYPOXIC,LABEL,METHODS,NSCLC,OPN,RESULTS,VEGF
025,384,731,954,AGREEMENT,AMONG,BACKGROUND,LABEL,MDX,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS,SDX,SEER,TREATMENT
MFP,MRI,SUCCESSFUL
CELL,CUL3,D422N,FOUR,G186R,G333C,G423V,KEAP1,NRF2,ONCOGENIC,PROTEOMIC,R320Q,R470C,R554Q,S243C,SOMATIC,THESE,V155F,W544C
ADHERENCE,BACKGROUND,CONCLUSION,FOS,LABEL,METHODS,OVCA,RESULTS,SCID,SKOV3,USING
FDG,PET,PRIMARY,THEREFORE
HARMS,IMPORTANCE,LABEL,OBJECTIVE,RELEVANCE,RESULTS
1089,320,452,8201,969,CXR,IMPORTANCE,LABEL,LDCT,LUNG,MAIN,METHODS,NLST,OBJECTIVE,RELEVANCE,RESULTS,SCREENING,SETTING,THESE,TRIAL
00001,2001,2010,BACKGROUND,CHI,COX,CRS,HIPEC,III,LABEL,MAJOR,MEIER,METHODS,MOST,MPM,PATHOLOGIC,RESULTS,SPCI
946,FIVE,INF,PANCREATIC
138,215,945,BECAUSE,BLOOD,ERAND,HMB45,LAM,PGR
2012,FURTHER,IIB,LYMPH,MARCH,VATS
ACC,ANY,CHEST
CHEST,METASTATIC,SCLEROSING,SINCE
13TH,HOWEVER,INITIALLY,LAD,LCX,LUNG,OFF,RCA
1ST,3RD,6TH,7TH,FIBER,TORSION
001,007,123,1257,169,1996,2009,2013,945,946,AMONG,ANOTHER,COX,HOWEVER,IIIA,LABEL,LMLN,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THUS,UMLN,UNIVERSITY
001,002,011,169,2013,550,EARLY,HRS,LOBECTOMY,MEDLINE,PRESS,PUBLISHED,STAGE,SURGERY,THESE,UNIVERSITY
001,169,2013,945,ACCORDING,CA9,CRC,DATA,FORTY,HIF,HIGH,HT29,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,PULMONARY,RESULTS,STAT3,SURGERY,UNIVERSITY
945,AUTOPHAGY,CCL2,CCL20,HOWEVER,IL6,K63,LPS,LYS63,MAPK,MCP,MIP,MMP2,NFKB,REMARKABLY,THESE,TLR,TLR3,TLR4,TLRS,TNF,TRAF6,TRIF,VEGFA
10MIN,169,176,2013,AMONG,CAR,COPYRIGHT,HEADSPACE,KETONES,PDMS,PLEURAL,SPME,STUDENT,THREE,VOMS
014,031,169,2013,8805,BACKGROUND,COPYRIGHT,DCR,ECOG,EORTC,FIFTY,FORTY,IRELAND,LABEL,LTD,METHODS,MPM,PARTIAL,PEMETREXED,PFS,PS0,RESULTS,TREATMENT
169,2013,8594,945,946,A549,COPYRIGHT,FOUR,MCF,NMR,PARONYCHIA,PUBLISHED,STRUCTURES,U937
160,199,3N1M0,8201,8804,8805,BACKGROUND,CONVERSELY,FFLR,FURTHER,IMD,LABEL,META,METHODS,MLN,NONE,NSCLC,PORT,RESULTS,THESE,UNIVARIATE
169,2013,A549,HS27,INC,NRF2,TREATMENT,U937,XB05
169,2013,947,ADC,COPYRIGHT,EXTENSIVE,FEDERATION,LUNG,PUBLISHED,RHOB,SOCIETIES,THESE
10MG,120U,169,181,2013,215,25CELLS,8805,BACKGROUND,COX,HOWEVER,INC,LABEL,LDH,MEIER,METHODS,PFS,PUBLISHED,RCC,RESULTS,THESE,THREE,UNIVARIATE
BACKGROUND,CONCLUSION,COPD,CXCR2,LABEL,LEUKOCYTES,NEUTROPHIL,RESULTS,SIMILARLY,THESE
2008,283,826,APRIL,BACKGROUND,COPD,JANUARY,JULY,LABEL,MEDICAL,METHODS,OCTOBER,RESULTS,SPANISH,THERE
435,A549,K562,MCF,MDA,NMR,PORTULACA,THEIR
169,2003,2013,APMIS,JOHN,LTD,PUBLISHED,SONS,WHILE,WILEY
1000,215,4DCT,850,8725,DEEP,HUS,INCREASED,LABEL,LUNG,METHODS,MID,OBJECTIVE,ORGAN,PET,PURPOSE,RESULTS
8745,AFTER,BETWEEN,DICE,DSC,GROSS,GTV,GTVS,HISTOGRAMS,HOUNSFIELD,IMAGE,JACCARD,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,REDUNDANT,RESULTS,THREE
AVERAGE,EACH,FFMCT,FLUENCE,IQMSD,LABEL,METHODS,MODULATED,OBJECTIVE,PURPOSE,RESULTS,THESE
177,215,4DCT,85TH,8725,954,98TH,BASED,BREATHING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE,THREE,TYPE,TYPES
176,946,CARLO,COMPARING,FINALLY,HOWEVER,LABEL,METHODS,MONTE,OBJECTIVE,PCC,PEARSON,PET,PURPOSE,REGARDING,RESULTS,ROTATIONAL,SETUP,THUS
1849,1870,2009,BIOL,DIR,FIRST,GARG,HOWEVER,JOHNSON,LAB,LABEL,LUNG,MCPHAIL,MED,METHODS,OBJECTIVE,PHYS,PURPOSE,RESULTS
100,12GY,177,4DCT,5GY,8764,963,CARLO,D99,EUD,HOWEVER,IMPT,LABEL,METHODS,MLD,MONTE,OBJECTIVE,PURPOSE,RBE,RESULTS,SPOT,THESE,V90,V95
200,8725,III,IMRT,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TEN,THEREFORE
CBCT,FDK,HOWEVER,IGRT,LABEL,MCIR,METHODS,OBJECTIVE,PICCS,PURPOSE,RESULTS
136,176,177,360,8725,AFTERWARD,CBCT,COMS,DFMS,DIFFERENT,EACH,LABEL,METHODS,OBJECTIVE,PCA,PURPOSE,RESULTS,USING,VPD
8725,ANZAI,DTBZ,FINALLY,FMISO,INTEX1D,INTEX3D,LABEL,METHODS,NEMA,OBJECTIVE,PET,PURPOSE,RESULTS,THESE,THREE
100,150,300,9800,CARLO,CRITERION,DUE,FOV,FOVS,LABEL,METHODS,MONTE,OBJECTIVE,OEC,PCXMC,PURPOSE,RESULTS,ROSE,SBDX,SDD,SDDS,SNR,THESE,USING
625,ASIR,FBP,LABEL,LUNG,MBIR,METHODS,OBJECTIVE,PRECISION,PURPOSE,RESULTS,VCAR
001,947,BEV,DMLC,DOSE,LABEL,METHODS,MLC,OBJECTIVE,PEARSON,PURPOSE,RESULTS,TIME,VMAT
3DCRT,4DCT,FINALLY,HERK,HOWEVER,ICRU,IMRT,LABEL,METHODS,OBJECTIVE,ORBIT,PLAN,PTV,PTVS,PURPOSE,RAYSEARCH,RESULTS,V20
4DCT,ARMS,CBCT,EXACT,ITV,ITVS,LABEL,LIGHTSPEED,METHODS,MIP,OBJECTIVE,PURPOSE,RESULTS
169,2013,BACKGROUND,CONTEXT,FUND,KEILLOR,LABEL,LAKE,METHODS,MILBANK,RESULTS,WOBEGON
1980,2012,FIVE,MARCH,RANDOMIZED,THERE,THESE
2009,2011,237,363,BACKGROUND,CONCLUSION,ICD,ICU,JANUARY,JUNE,LABEL,METHODS,NONE,RESULTS,SEVEN,THERE,VATS
AFTER,NOR
169,2013,244,632,AACR,AMONG,BACKGROUND,CHINA,CIGARETTE,CIS,CONCLUSION,COX,DATA,HRS,LABEL,METHODS,RESULTS,THESE

953,955,LAC,LACS,LGL2,PAR6,THESE
NOW,PULMONARY
A549,EGFR,EMT,ERK,HOWEVER,LOSS,MEK,MMP2,NSCLC,NSCLS,THEREBY,THESE,ZEB1
CHEST,GADOLINIUM,JAPAN,MRI,OCCURRENCE,SHRINKAGE,SPE
001,002,009,012,021,022,026,528,572,BREATHING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
129,196,AFTER,BLACK,CLEVELAND,CPR,GREATER,LABEL,METHODS,OBJECTIVE,PURPOSE,RECEIPT,REGRESSION,RESULTS,RRR,WHITE
8Q21,900,D52,PCR,STRONGEST,THESE,TPD52
ADAM,HER2,USING
12QF1,8764,ACTIVATION,APOBEC1,CD22,DIO3,DLK1,G12D,GNAO1,KRAS,MICE,PRKG1,RGS9,RNAS,TAKEN,THESE
BCL,MET,MITF,SMASE,STUDIES
253,AKT,BECAUSE,BOTH,G660D,HER2,USING,V659E
AZD0530,AZD6244,DORMANT,ERK1,MEK1,SFK,SRC,THESE,THUS
100,2008,2010,BACKGROUND,BETWEEN,CEC,CEP,CONCLUSION,EMA,FDG,LABEL,MARCH,METHODS,NSCLC,PARTIAL,PET,RESULTS,THOSE
0070,2001,2010,351,634,717,BACKGROUND,BLACK,CONCLUSION,COX,EASTERN,HOWEVER,JENKINS,LABEL,LEO,METHODS,NORTH,RESULTS
250,450,75TH,8209,BIOMARKERS,BLOOD,EVALUATION,HIGH,INCLUSION,KRAS,NON,NSCLC,OVERALL,SIXTY
0001,1119,215,299,391,580,676,778,AFTER,ALPHA,ATBC,BETA,CIS,COLORECTAL,FINNISH,LINE1,LUNG,ORS,OVARIAN,PLCO,PREVENTION,SCREENING,THESE,TOCOPHEROL,TRIAL
HENCE,HOWEVER,MLKL,RIP3,TNF,TRPM7
169,2013,AID,AMONG,COPYRIGHT,FLS,INC,MH7A
790,EGFR,EPIDERMAL,HGF,IGF,MET,NSCLC,SEVERAL,T790M,THERE,TKI
169,2013,945,946,A1080,A1170,COPYRIGHT,FTIR,SERUM,THESE
169,2014,236,53BP1,640,685,AIMS,BACKGROUND,CHINESE,COPYRIGHT,HAN,IMSS,INC,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PUBLISHED,RESULTS,SEVERAL,SNP,SNPS,TP53
169,2013,A549,ACTA,CDDP,COPYRIGHT,GLU,INC,LTD,MATERIALIA,PHE,PTX,PUBLISHED,THUS,TSR
169,177,2013,231,233,ADVERSE,COPYRIGHT,EFFECTS,HELICAL,HOWEVER,LABEL,METHODS,OBJECTIVE,PTV,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SIX,SOCI,THERE,V107,V20,V30,V95
169,2014,2015,CA125,COLORECTAL,COPYRIGHT,DATA,INC,KINGDOM,LUNG,OVARIAN,PLCO,PUBLISHED,RISK,ROC,SCREENING,TRIAL,UKCTOCS
000,169,2014,COLLEGE,COPYRIGHT,FLEISCHNER,INC,INCIDENTAL,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY,WHETHER
169,2010,2013,2014,954,ACCORDING,BACKGROUND,CONTEXT,COPYRIGHT,DENOSUMAB,DEPARTMENT,DRUG,FDA,FOOD,INC,JUNE,LABEL,METHODS,OBJECTIVE,OHIO,PURPOSE,RADIOLOGY,RANKL,RESULTS,STATE,THEREFORE,UNIVERSITY,XGEVA
169,2013,ASSESSMENT,C30,COPYRIGHT,DISCUSSION,EORTC,INC,IPAQ,LABEL,METHODS,OBJECTIVE,PRIMARY,PURPOSE,QLQ,SCALE,SECONDARY,SYMPTOM
169,1995,2000,2004,2005,2008,2013,BACKGROUND,COPYRIGHT,CZECH,HOWEVER,LABEL,LTD,METHODS,RESULTS
001,1591,169,2005,2014,496,AVAILABLE,BLOOD,CLINICIAN,CONFERENCE,CONSENSUS,COPYRIGHT,COX,GVHD,INSTITUTES,NIH,NRM,PFT,PFTS,PRO,SOCIETY,WORSENING
001,003,005,007,047,160,169,183,2005,2008,2009,2012,2014,BETWEEN,BLOOD,BUCY,COPYRIGHT,ESTIMATED,FLU,FLUBU,HCT,INC,MEL,PUBLISHED,SOCIETY,TBI
169,18F,2011,2013,288,AIM,CARDIFF,COLLEGE,CONCLUSION,COPYRIGHT,DIAGNOSTIC,FDG,LABEL,LTD,MATERIALS,MAX,METHODS,NSCLC,OBJECTIVE,PET,PETIC,PUBLISHED,RESULTS,ROYAL,SUV,SUVMEAN,TLG,TNM,TOMOGRAPHY
133,169,2013,COPYRIGHT,SIX,TWEEN,UNDER
026,169,2013,336,8P21,CONTAINING,COPYRIGHT,HCC,HCCS,LTD,PCR,RESULTS,SH2,TMA
160,169,2014,947,BLOOD,COPYRIGHT,CTC,CTCS,H2AX,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,186,2014,COPYRIGHT,GTV,INC,INITIAL,LABEL,MATERIALS,METHODS,OAR,OARS,OBJECTIVE,PTP,PTV,PTVORIG,PTVPRED,PURPOSE,RESULTS
169,2013,AML,CMML,COPYRIGHT,FEDERATION,FGFR1,FGFR1OP,IL3,MPD,OTHER,PI3K,PMF,PUBLISHED,REARRANGED,RET,SOCIETIES,STAT
160,169,2011,2012,2013,BETWEEN,COMPARISON,CONCLUSION,COPYRIGHT,GROUP,JUNE,LABEL,MARCH,MDA,METHODS,NEUTROPHIL,OBJECTIVE,OLV,PMN,PUBLISHED,RESULTS,SOD
008,169,2008,2011,2014,BACKGROUND,BETWEEN,COIL,COPYRIGHT,FIVE,IMPALPABLE,INC,LABEL,METHODS,PATHOLOGIC,PRIMARY,PUBLISHED,RESULTS,SOCIETY,VATS
169,2013,ANZSCTS,AUSTRALIA,AUSTRALIAN,BRONCHIAL,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,THERE,ZEALAND
001,131,134,155,160,169,2002,2003,2010,2014,214,369,691,BACKGROUND,CONCLUSION,COPYRIGHT,FIVE,INC,LABEL,METHODS,MOSBY,NSCLC,OVERALL,RESULTS,SECONDARY,SURGERY,THERE,THESE
169,1946,1974,2012,2013,CENTRAL,COPYRIGHT,DUE,EIGHT,IRELAND,ISSUE,LEVEL,LIBRARY,LTD,MEDLINE,MPM,STUDIES
CUTANEOUS,HOWEVER,MOST,VARIOUS
SOT
107,169,1999,2000,2000S,2001,2002,2005,2007,2008,2014,BACKGROUND,CARIPLO,COMMISSION,COMPAGNIA,COPYRIGHT,FOUNDATION,FUNDING,FURTHER,HODGKIN,IRELAND,ITALIAN,LABEL,LTD,MAJOR,METHODS,PAOLO,RESULTS,SAN,UNIFORM,VARIATIONS
169,2014,GIVEN,INC,RADIATION
EVEN,SWEDISH,WHETHER
001,8201,AFTER,BACKGROUND,CHINESE,FLOW,FMK,LABEL,METHODS,MTT,NEC,PARP,RESULTS,RIP1,RIP3,SIZE,U2OS,VAD,WESTERN
0085,177,2011,DEC,FIFTY,H2O,HOWEVER,JAN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCLC,SVCS
146,2005,2009,AFTER,BOTH,JANUARY,LABEL,METHODS,NPC,OBJECTIVE,RESULTS
040,070,079,946,CBR,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,TTP,TTPS
AMONG,BEV,CPT11,DCR,FOUR,INTESTINAL,LABEL,METHODS,OBJECTIVE,ORR,RESULTS,SEVENTY,VARIOUS
001,1016,164,302,376,420,542,640,COX,LABEL,METHODS,NPC,OBJECTIVE,RESULTS,THERE
2011,ACADEMY,CHINESE,DEPARTMENT,EGFR,FIFTY,FNA,FOB,JANUARY,JULY,LABEL,MEDICAL,METHODS,MUTATIONS,NSCLC,OBJECTIVE,PCR,PLE,POLYMERASE,RESULTS
125,135,177,A549,AFTER,BCL,BESIDES,CCK,EGFR,FOXM1,FOXM1SIRNA,FOXML,LABEL,METHODS,MYC,NSCLC,OBJECTIVE,PARP,PCR,RESULTS,RNAI,TKI,WESTERN
078,100,169,1995,2012,2013,389,BACKGROUND,CONCLUSION,EFS,EIGHT,HOWEVER,LABEL,LMD,METHODS,NLMD,OVERALL,RESULTS
1983,BACKGROUND,CONCLUSION,FPS,GERMANY,HIGH,HOWEVER,LABEL,LUNG,METHODS,POISSON,RESULTS,RISK,ROC,THERE,THEREFORE
113,2009,2011,BACKGROUND,CONCLUSION,JUNE,LABEL,METHODS,RESULTS,SEGMENTAL,THERE
BACKGROUND,DIAGNOSTIC,DUE,LABEL,NSCLC,RESULTS
006,124,155,1998,2011,230,279,710,8201,BACKGROUND,HOWEVER,LABEL,LEWIS,METHODS,NSCLC,RADICAL,RESULTS,ROC,SKIP,SLX
1214,2560,5069,6283,GIVEN,IMAC,PRO,RAJI
169,2003,2011,2013,8805,JOHN,KARNOFSKY,KPS,LABEL,LTD,MATERIALS,METHODS,MOST,NONE,OBJECTIVE,OBJECTIVES,OSLO,PUBLISHED,RESULTS,SONS,UNIVERSITY,WILEY
LUNG
396,956,A549,ACTIVATION,ATO,BACKGROUND,CASPASE,CEL,CONCURRENT,COX,DEX,ERK,ERK1,IC50S,INDO,LABEL,MAPK,METHODS,RESULTS,TREATMENT
945,946,CRC,GAL,ST6
946,CATENIN,GSK3,NSCLC,STAT3,THUS,WNT,XANTHATIN
001,009,2000,2010,499,AMONG,BACKGROUND,CONCLUSION,COX,DISEASE,GERMANY,LABEL,LDH,MEIER,METHODS,PROGNOSTIC,RESULTS,S100B,SERUM,TUEBINGEN
GMP,MOUSE,PDE,PDES
001,012,016,017,169,2013,293,511,8201,AARP,CIS,COX,DIET,HRS,INSTITUTES,MVPA,UICC,USING
001,020,028,033,124,180,905,DFS,DISEASE,MACC1,NSCLC,TNM
956,DISCUSSION,ICFIS,ICG,LABEL,METHODS,MSA,OBJECTIVE,PURPOSE,RESULTS,SLN,SLNS
000,013,030,039,103,105,191,197,202A,224,300,332,376,413,441,719,744,776,809,831,832,834,844,849,862,882,893,902,958,959,962,968,ASIAN,CA19,HOWEVER,IGF1,IGFBP,INSULIN
CLO,HOWEVER,NCI,THESE
000,007,165,2013,438,APE1,ASP,ASP148GLU,CAUCASIANS,CNKI,DATA,GLU,OCTOBER,OVERALL,ULTIMATELY
100,CRETE,GP5,GP6,HPV,NSCLC,PCR,REAL,SIXTEEN,TIME
002,4203,8201,AGE,AMD,AREDS,BACKGROUND,CONCLUSION,DISEASE,DOCUMENTED,EYE,IDENTIFIER,IMPORTANCE,LABEL,MAIN,MEASURE,METHODS,OBJECTIVE,RELATED,RELEVANCE,RESULTS,SETTING,TRIAL
037,177,183,1ST,2ND,5TH,8201,BACKGROUND,BIFOCAL,CONCLUSION,GEORG,IIA,LABEL,MATERIALS,MEAN,METHODS,NSCLC,RESULTS,STUTTGART,YORK
A549,CPT,NSCS
ERK,GTP,H446,H460,HRAS,JNK,KNOCKDOWN,KRAS,MOLECULAR,NAC,NCI,NOVEL,NRAS,RAF,RAS,ROS,SPR,TAKEN
BOTH,FLIP,HDAC,HDAC1,NON,NSCLC,TARGETING,THUS,TRAIL,TREATMENT
ACCORDING,ALDH1A1,CICS,COA,CSC,CSCS,M30,MPE,MPES,SCD1,THESE
100,2007,2009,BETWEEN,EFS,HOWEVER,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY
005,163,264,7SNP,AVERAGE,BRCA1,COLORECTAL,CONSORTIUM,END,GAIL,LUNG,MAMMOGRAM,MRI,NUTRITION,OVARIAN,PREVENTION,QALY,RESULTS,RISK,SCREENING,THESE,TRIAL
4T1,945,946,CHRONIC,CSF,DEX,DMI,EMOTIONAL,ISO,MIP,NEITHER,SHG,SNS,THESE,TREATMENT,VEGF
169,2013,BAL,COPYRIGHT,DIAGNOSTIC,HOWEVER,LTD
947,AQUA,ATM,AUTOMATED,BECAUSE,CHK2,DDR,DIGITAL,H2AX,MOLES
169,2013,204,COPYRIGHT,JMJC,PCR,TAKEN
100,101,120,129,169,2002,2006,2014,258,281,AFTER,AHTRT,BACKGROUND,C000000095,COPYRIGHT,EASTERN,ECOG,FOUR,FUNDING,GROUP,IRINOTECAN,JAPAN,LABEL,LTD,METHODS,OCT,RESULTS,SCLC,SEPT,THERE,UMIN,WELFARE
169,2013,417,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,EGFR,GROUP,IRELAND,KMLCG,L858R,LABEL,LTD,LUNG,METHODS,MOLECULAR,NSCLC,PPS,RESULTS,SITES,SMOKING,THERE,TKI,TTP
487B,946,APC,AXIN,CDX2,CONVERSELY,DACT2,DKK,EGFR,EMX2,GSK3,HDPR1,ING4,NKD1,NSCLC,OVERALL,PORCUPINE,RUNX3,TCF,WIF,WNT
DISEASE,EVEN,SURGERY
ADDITIONAL,EGF,EGFR,PROSE,VERISTRAT
169,2013,215,8201,AFTER,ASIA,ENDOSCOPIC,FORCE,FURTHER,HER2,JAPAN,LTD,MIB,PET,PTY,PUBLISHING,SOCIETY,SURGERY,TASK,WILEY

004,8194,8201,8734,956,A549,AUC0,CACO,CMAX,HEPG2,MTT,MXN,PEGYLATED,SN38,THESE,VSS
137,177,1998,2005,2010,2011,2012,314,455,456,535,599,771,787,8201,998,AFTER,BACKGROUND,BETWEEN,EUROQOL,INSURANCE,LABEL,METHODS,OWING,QALE,QALY,QOL,RESULTS,THESE
001,100,2010,2011,AIMS,BACKGROUND,EBUS,LABEL,METHODS,OBJECTIVE,PCNB,PROCEDURE,REAL,RESULTS,TBAN,TBNA,THERE
BACKGROUND,EXPRESSION,HEFT,LABEL,LOCI,METHODS,MOTIVATION,MTRR,RESULTS,TRAIT
089,1661,1661A,1722T,2013,388,49A,8201,CTLA,CYTOTOXIC,HOWEVER,JULY
056,272,593,8201,CASE,CAUCASIANS,HENCE,INDIANS,OVERALL
169,2013,945,946,947,BRITAIN,CONVERSELY,COPYRIGHT,ECM,GREAT,IDIOPATHIC,IPF,IRELAND,JOHN,LTD,PUBLISHED,SIMILAR,SMAD,SMAD4,SOCIETY,SONS,TGF,TIF1,WILEY
169,2013,AUTHORS,BRITAIN,CRE,FOLLOWING,GEM,GEMS,GIVEN,GREAT,IRELAND,JOHN,JOURNAL,KRAS,LTD,PATHOLOGY,SELF,SOCIETY,SONS,WILEY
001,002,2011,2012,8201,BACKGROUND,FIVE,JAMES,LABEL,METHODS,OBJECTIVES,QUESTIONS,RESULTS,ROCHESTER,SCP,SCPS,SURVIVORS,TSS,UNIVERSITY
160,EGFR,HOWEVER,LUNG,NON,NSCLC,TKIS
164,215,446,512,718,8805,AIOM,ANC,CSF,DAILY,FEBRILE,ITALIAN,ITALY,PRIMARY
2012,ALCOHOL,BACKGROUND,JULY,LABEL,METHODS,RESULTS,STUDIES,UADT
ALK,EGFR,LUNG,NSCLC,THEREFORE,THESE
0001,001,352,622,AFTER,BACKGROUND,LABEL,METHODS,NSCLC,PET,RESULTS
CAUCASIAN,HEPATIC
001,033,8201,8805,956,AUC,EIGHT,FURTHER,LABEL,METHODS,OBJECTIVE,PHASE,PURPOSE,RESULTS
ALK,CBL,LUNG,LY2801653,MET,NSCLC,PAMGENE,PI3K,RON,ROS,STAT3,TAKEN,THESE,USING
115,THESE,VOCS

004,2006,2012,BACKGROUND,BRONCHIAL,CARCINOIDS,FDG,LABEL,METHODS,NONE,PET,REGARDING,RESULTS,SIXTY,SPN,SPNS
946,AGO2,ARGONAUTE,FINALLY,HMGA2,INTEGRATED,NON,NSCLC,TAKEN,TGF,THESE
008,010,011,039,169,2013,210,335,COPYRIGHT,DSS,EXPRESSION,HIGH,IIIA,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE,TMAS
012,014,018,045,058,127,181,BACKGROUND,CONCLUSION,COX,CTG,EXPRESSION,JBR,LABEL,MEIER,METHODS,NCIC,NETWORK,NSCLC,RESULTS,UNIVERSITY
210,8804,BACKGROUND,CONCLUSION,HOWEVER,LABEL,METHODS,NOTABLY,RESULTS,USING
LATER,PRIMARY
000,061,091,100,103,104,107,126,132,156,160,166,181,1982,199,2009,2116,216,3054,4986,5373,564,573,6718,6938,8040,8246,901,956,991,9943,BOTH,CENTRAL,CHINA,CHINESE,CONCLUSION,HENAN,LABEL,LINZHOU,LUNG,METHODS,NCCR,OBJECTIVE,RESULTS,SEGI,SHENQIU,THERE
000,100,107,116,139,1392,1564,161,176,1982,2009,2022,207,2272,2388,272,320,346,424,560,613,699,763,848,920,954,AGE,CHINESE,CONCLUSION,LABEL,LUNG,MEANWHILE,METHODS,OBJECTIVE,RESULTS,SEGI
000,207,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,SMOKING
001,024,169,2013,278,347,584,8201,ASIA,AUSTRALIAN,AUTHORS,BACKGROUND,BASED,BLAND,CAV,COLLEGE,DTS,IMAGING,INTER,JOURNAL,LABEL,LTD,LUNG,MEDICAL,METHODS,PTY,PUBLISHING,RADIATION,RCDIAMETER,RESULTS,ROYAL,WILEY,ZEALAND
178,8314,BACKGROUND,BIACORE,LABEL,MEIER,METHODS,RESULTS,SEC61,SEC62,TARGETING,TFP,THEREFORE,TREATMENT,USING
001,005,010,011,033,AFTER,DUNN,FURTHER,GIVEN,KI67,MEIER,PULMONARY,THERE,TUKEY
2008,EUROQOL,JULY,KOREA,LABEL,METHODS,NUTRITION,OBJECTIVE,RESULTS,THOSE
CSC,KULCHITSKY,LUNG,SCLC
029,039,040,169,2013,506,ASIA,AUTHORS,CHINESE,COX,EPCAM,FURTHER,HOWEVER,INSTEAD,LTD,MEIER,NSCLC,PTY,PUBLISHING,SCIENCE,SNP,SNPS,WILEY
007,023,026,169,183,2013,8201,947,954,BRITISH,IMMUNOLOGY,NONE,NSCLC,SERA,SOCIETY,XAGE
BASED,CHIP,PEARSON,STRUCTURE,THESE
BACKGROUND,CONCLUSION,GELA,ITALY,LABEL,METHODS,MORTALITY,RESULTS,SMRS
1992,HISTORY,INCIDENCE,ITALIAN,ITALY,RATIO,SHIP,SIR,THERE
183,200,400,EVEROLIMUS,FOLLOWING,GEORG,GERMANY,LAM,RAPID,SIROLIMUS,STUTTGART,TEN,THERAPY,THESE,TSC,YORK
PULMONARY
BETA,HCG,PRIMARY
1085,1107,1127,1175,135,149,153,157,1582,1632,441,675,746,750,AFTER,EGFR,FINALLY,IHC,L858R,PCA,PRINCIPAL,RAMAN,SOMATIC,SVM,T790M,THEN
BLACK,DOWNS,FIVE,HRQOL,VATS
643,945,CYP2C,CYP2C44,EET,NON,NOTABLY,NSCLC,P450,PPAR,RAS,THESE,THUS,WYETH
2013,8P12,AACR,FGFR,FGFR1,HOWEVER,LABEL,MYC,THUS,UNLABELLED
2013,945,AACR,EMT,ERBB3,LABEL,LOSS,PI3K,UNLABELLED
2165,2249,4414,ACCORDING,AUC,BASED,FURTHER,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,127,AIM,BOTH,DIFFERENT,EXPRESSION,HPV,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THUS
169,2013,BACKGROUND,CD56,INC,LABEL,LCNEC,METHODS,OBJECTIVE,OBJECTIVES,PULMONARY,RESULTS,SCLC,TNM,USING,WILEY
954,A549,BACKGROUND,BAX,BCL,CDDP,CONCLUSION,FAS,H1299,H460,IAP,INCREASED,LABEL,MAPK,METHODS,MTT,NCI,NSCLC,PARP,PCR,RESULTS,ROS
PREVENTION,SENSORY
003,8202,BENCHMARK,DESPITE,EGFR,GCN,SISH,THERE,ULTRA,VENTANA
945,LIFR,LUNG,NRP1,PRODUCTION
1996,2000,2003,2010,8202,ADC,ADCS,AIDS,APC,APCS,BASED,CONCLUSION,FALLING,HIV,HODGKIN,LABEL,MATCH,METHODS,NADC,NADCS,NHL,OBJECTIVE,POISSON,POPULATION,RESULTS,SIRS
215,946,971,ETT,GROSS,MOST,PET,SERUM,THERE
ABCAM,CCL39,CHINESE,GLUCOSE,HOWEVER,LS174,TITRATION
0001,177,2012,BACKGROUND,INTER,JANUARY,PET,SUV,VOI,VOIBG,VOIS,VOITUMOUR
CHEST,FDG,PET,PRIMARY,VIDEO
18F,FDG,MALIGNANT,PET
18F,FDG,HISTOLOGIC,METASTATIC,PET
110,AMONG,CEA,CONCLUSION,CYFRA21,ELISA,GRP,LABEL,METHODS,NSCLC,NSE,OBJECTIVE,PRO,SCC
0012,192,ACCORDING,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS
169,2013,A549,BCL,COPYRIGHT,ERK,IRELAND,JNK,JUN,LTD,MAP,MMP,MMPS,RECK,ROS,RY10,STAT3,TAKEN,TIMP,TIMPS,TREATMENT
118,177,180,2011,2012,ACCORDING,BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THERE,VAS
102,108,169,2013,231,ALK,ALSO,AMONGST,ANAPLASTIC,CONCLUSION,COPYRIGHT,EGFR,EVEN,HOWEVER,IRELAND,KRAS,LABEL,LTD,METHODS,NANOSTRING,NEVER,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THEREFORE
160,169,2014,BACKGROUND,COPYRIGHT,FURTHER,INC,LABEL,METHODS,PLRCS,QOL,RESULTS,SFFP
169,2014,476,AFTER,BACKGROUND,BASED,COPYRIGHT,FRANCISCO,FURTHER,INC,LABEL,MATERIALS,METHODS,RESULTS,SAN
001,012,018,021,033,036,037,087,161,177,BACKGROUND,CONCLUSION,DATA,FIFTY,HISTORY,LABEL,LEAKAGE,LEVEL,METHODS,OBJECTIVE,RESULTS,RISK,SUMMARY,VERTEBRAL
123,800,944,BACKGROUND,BMP7,GREM1,INTEGRATED,LABEL,LCC,METHODS,NDRG1,NON,NSCLC,PDGFB,RESULTS,RNF7,SCC,SOX2,SPP1,THPO,TP63,USING
2009,2011,8239,APRIL,BETWEEN,JUNE,NSCLC,PFS,PPS,THESE
101,A549,AUTOPHAGY,BCL,BH3,INHIBITION,TARGETING
A549,CD133,GOT,GPT,LUNG,VEGF
140,ANXIETY,BACKGROUND,BETWEEN,CHINESE,CONCLUSION,FATIGUE,HONG,INITIAL,INVENTORY,KONG,LABEL,METHODS,OBJECTIVE,PIPER,PURPOSE,RESULTS,SCALE,STATE,TRAIT
001,042,2001,2009,3071,BETWEEN,CONCLUSION,GPS,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PRIMARY,RESULTS,SETTING
OVERALL,SEVERAL,THESE
HCC,HOWEVER,SORAFENIB,THEREFORE,TREATMENT
AMONG,REGARDLESS,WHAT,WHILE
113,150,160,2012,377,BCL,BCL2,DOSE,DOSES,FATIGUE,FOUR,LABEL,LYMPHOCYTE,MAXIMUM,METHODS,OBJECTIVE,PNT2258,PURPOSE,RESULTS
002,139,173,183,386,8201,8804,BACKGROUND,GEORG,HOWEVER,LABEL,LOW,MEIER,METHODS,NSCLC,RESULTS,STUTTGART,YORK
001,002,114,177,183,2006,2011,203,236,260,293,439,490,553,623,8201,BETWEEN,CONCLUSION,GEORG,LABEL,LNS,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCM,SML,STATION,STUTTGART,VAM,YORK
169,8201,EGFR,L858R,LAC,PFS,THEN,THERE
121,124,2009,2011,8804,AGE,CNB,EACH,EXCLUSION,FNAB,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE
ABC,ABCC4,H1993,H2073,MET,SNP,STK11,TP53,WHILE
160,177,MDCT
EGFR,HGF,MET,NSCLC,SNX1,TAKEN,TEXAS,USING,WESTERN
945,AKT,CTCL,ERK,H460,HDAC,HIF,LCC,NCI,SAHA,THESE,VEGF
ADDITIONAL,BID,MALIGNANT,RANA,SBL,THESE,TRAIL
2001,A598T,ASIAN,BACKGROUND,BRAF,CONCLUSION,EGFR,G464E,G466R,G469A,G596R,G606R,HRMA,K601E,KRAS,LABEL,MATERIALS,METHODS,NSCLC,RESULTS,V600E
302,372,8805,BACKGROUND,CONCLUSION,LABEL,LDCT,LOW,METHODS,PPV,PPVS,RESULTS,THESE,USING
169,2013,BASEL,EBUS,HOWEVER
CELL,FAR,H1650,L1210,SMR
177,2001,2007,223,365,8804,AIAN,AIANS,ALASKAN,AMONG,BACKGROUND,BECAUSE,CALIFORNIA,CARE,COMPARING,CONCLUSION,IHSCS,INDIANS,LABEL,METHODS,NATIVES,REGISTRIES,RESULTS,SERVICE,STATE,USING,WASHINGTON
DDR2,ERK,NF1,RAS,SQCC,T654I,THESE
1Q24,241,CNAS,HCC,MPZL1,NOTABLY,SRC,TAKEN
169,2013,AACR,ACTIVATED,ALK,AMONG,BRAF,DESPITE,EML4,FISH,KRAS,LABEL,ROS1,SLC34A2,UNLABELLED
ANOTHER,MRI,PET,VARIOUS
001,117,169,200,2013,347,956,CHILE,COPYRIGHT,DMA,INC,LUNG,MMA,OVERALL
169,2013,COPYRIGHT,INC,LSPV,PUBLISHED,SOCIETY
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2013,COPYRIGHT,IIA,INC,PUBLISHED,SOCIETY,T2BN0M0
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2013,AMYLOIDOMA,COPYRIGHT,INC,PUBLISHED,SOCIETY,T11
160,169,2013,ADDITIONAL,COPYRIGHT,INC,PUBLISHED,SOCIETY
DIFFERENT,RET
001,002,003,005,012,013,016,020,106,169,2004,2013,595,663,959,AGE,COPYRIGHT,IIA,IIB,IIIA,IIIB,IRELAND,JAPAN,LABEL,LTD,LUNG,MATERIALS,METHODS,OBJECTIVE,RESULTS,SEVEN
169,2013,COLLEGE,COPYRIGHT,EARLY,INC,LUNG,PROGRAM,PUBLISHED,RADIOLOGY,SCREENING,THERE,TRIAL
001,169,2003,2011,2013,359,COPYRIGHT,CRPC,JUNE,METASTATIC,PUBLISHED,UROLOGY
0B1,945,946,COUP,ERB,FUNCTIONAL,GCNF,NOR1,NR0B2,NR1D1,NR2C1,NR2C2,NR2E1,NR2E3,NR2F1,NR2F2,NR2F6,NR4A1,NR4A2,NR4A3,NR6A1,NUR77,NURR1,PNR,RESULTS,REV,TFI,TFII,THESE,THUS
169,2013,526,AFTER,AJCC,BACKGROUND,COPYRIGHT,CRC,DUE,III,LABEL,LTD,METHODS,RESULTS
169,2013,20MG,AOM,COPYRIGHT,LTD,RATS
169,2014,CARINAL,COPYRIGHT,INC
169,2013,ANTI,COPYRIGHT,EWING,FEDERATION,GD2,PUBLISHED,SEVERAL,SINCE,SOCIETIES
0001,1366,141,3707,376,AUCS,CIS,DISEASE,EACH,THEN
4GY,A549,AREG,BMP4,EREG,ERK,GATA3,ID2,IGF2,PC3,PCR,THROUGH
HOWEVER,ONGOING,THEREFORE
131,PULMONARY
CD117,DESPITE,FURTHER,KIT,SUNITINIB
BACKGROUND,CASE,CONCLUSION,FURTHER,INTRA,LABEL,METHODS,TREATMENT
1995,2009,ANOTHER,COA,FURTHER,HMG,RAC,RAS,REGARDING,RHO,STATINS,THUS
LUNG
262,AMONG,INCIDENCE,KNOWLEDGE,VIRGINIANS,WEST
CONCLUSION,FINALLY,FIRST,LABEL,METHODS,NTCP,OBJECTIVE,PTV,RESULTS,SBRT,V10,V20
BARR,EBV,EPSTEIN,FURTHER,MOLECULAR,PET,POST,PRIMARY,PTLD,PTLDS,SUV,WESTERN
001,031,042,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OCCLUDENS,PCR,RESULTS,TNM
0001,005,013,014,027,030,041,222,ACCORDING,BESIDES,BOX2,FGFR1,INCREASED,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,RFS,SCLC,SEX,SOX2,SPECIMENS,TNM
110,189,273,EGFR,FISH,NSCLC
122,945,946,AIMS,CNS,CONCLUSION,ECM,INHIBITORS,LABEL,METHODS,OBJECTIVE,RESULTS
000,1873,298,8776,ASSISTANT,BATCH,LUNGCAGXE,SNPS
100,2000,DOTAP,DSPE,EPHA2,LNP,MICRORNAS,MPM,NSCLC,PEG,RAS
100,1000,173,175,181,215,2P23,8805,AIM,ALK,CISH,DUAL,EML4,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SAMPLES,STAINED
BLOM,CHEST,ONCE
COPD,PULMONARY
275,287,BRCA1,ERCC1,III,INITIAL,LARGE,NSCLC,PREDICTION,RRM1,THEREFORE
2020,COPD,TOBACCO
AKT,CELASTROL,CHIP,CIP2A
495,A549,CALU,HOWEVER,MIR,MTA,MTA3,NSCLC,PCR,THESE,USING
001,009,160,320,8201,CAUCASIANS,HOWEVER,META,THESE
169,2013,BRITAIN,COPYRIGHT,DDR2,DISCOIDIN,ECS,GREAT,HENCE,IRELAND,JOHN,LTD,MOST,PUBLISHED,RTK,SOCIETY,SONS,THESE,VEGF,WILEY
169,2013,AUTHORS,CISPLATIN,DCC,EMBO,JOHN,LTD,PACLITAXEL,PUBLISHED,SONS,UNC5H,WILEY
160,956,A549,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PTEN,PURPOSE,RESULTS,WESTERN
169,2013,240,2D6,8201,ADVERSE,BLOOD,COLLEGE,CYP,DOSE,FORMATION,P450,WHILE
ALK,EGFR,GIVEN,LUNG,MANAGEMENT,MET,NSCLC,RAS,ROS,SCLC
224,263,8211,ABT,ATN,BCL2,BCLXL,CURRENTLY,KRAS,MAPK,MCL1,MUTATIONS,NSCLC,P38,SOD1,TREATMENT
016,024,2002,2010,AMONG,BASED,DFI,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RECURRENCE,RESULTS
A549,AKT,ATXN3,DUB,DUBS,HDACI,HISTONE,HOWEVER,INSTEAD,JOSD1,PI3K,PTEN,SAHA,SIMILARLY,THUS,VORINOSTAT
947,MUC1,PPAR,THESE
CURRENTLY,PET,SINCE,WESTERN
BACKGROUND,CLUSTER,CONCLUSION,EXPRESSION,LABEL,METHODS,MMP,MMPS,PROTEIN,RESULTS,THESE,UNIVARIATE,VEGF
500,BACKGROUND,CASES,CAUCASIAN,CONCLUSION,EASTERN,ECOG,GROUP,LABEL,METHODS,NSCLC,ORR,PFS,PLANNED,RESULTS,RPLS,TEAE,TEAES
142,169,177,2011,2012,2013,207,239,330,550,675,AMONG,BACKGROUND,BETWEEN,CONCLUSION,JANUARY,LABEL,METHODS,NONE,RESULTS
ASSESSMENT,FIVE,FUNCTIONAL,GENERAL,LABEL,METHODS,MSAS,OBJECTIVE,OVERALL,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SURVEYS,SYMPTOM,THERAPY,WHILE
169,2014,BLOOD,COPYRIGHT,LIMA,MRD,RELAPSE,SOCIETY
169,2013,956,A549,COMPOUNDS,COPYRIGHT,EUPHORBIA,HMBC,HMQC,MCF,NMR,NOESY,SIX,THEIR
169,2013,A549,ATM,ATR,BACKGROUND,BAX,BCL2,CHK1,COPYRIGHT,DSB,DSBS,GENERAL,GIVEN,LABEL,MAL,MAPK,METHODS,RESULTS
169,2014,ATLAS,AX1,AX2,BACKGROUND,CONCLUSION,COPYRIGHT,D95,DOSE,GROUP,INC,LABEL,MATERIALS,MEAN,METHODS,MHTF,NTCP,PLANS,RADIATION,RESULTS,RISK,RTOG,STF,THERAPY,V10,V20,V25,V30
120H,169,2013,24H,AMONG,ARSENIC,COPYRIGHT,FURTHER,H2A,HOWEVER,THESE,USING
169,2013,239,CD8,COMBINING,COPYRIGHT,HOWEVER,INC,MOST,THEREFORE
145,146,169,2013,202,8804,946,956,A549,CHANGES,CIP1,COPYRIGHT,ERK1,IRELAND,LTD,PM10,SER,THESE,THR,WAF1
169,2013,CANCERS,CD8,COPYRIGHT,DCS,FCRN,IGG,INC
015,169,2014,409,440,542,578,686,967,AMONG,COLLEGE,COPYRIGHT,COX,GROUP,INC,LABEL,LOCAL,LOG,METHODS,MOSBY,OBJECTIVE,OVERALL,PROPENSITY,PUBLISHED,RESULTS,SEVEN,SURGERY,THERE,VATS,Z0030
100,169,2011,2012,2014,AGREEMENT,BLOOD,COPYRIGHT,DIAGNOSTIC,INC,LABEL,MARCH,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,OCTOBER,PUBLISHED,RESULTS,SURGERY
014,102,169,2000,2009,2013,6MONTHS,BACKGROUND,BETWEEN,CASES,CHUM,DEC,DIAGNOSIS,EGFR,EXCLUSION,IIIA,IIIB,JAN,KRAS,LABEL,METHODS,NSCLC,RESULTS,SINCE,THESE,UNDERLYING,VTE
169,2014,4T1,946,BABL,COPYRIGHT,DHA,FAS,FEEDING,HOWEVER,INC,MCF,THESE,THUS,WNT
169,2013,323,360,907,AUC,COPYRIGHT,DOR,EIGHT,FDG,IRELAND,JUNE,LABEL,LTD,METHODS,OBJECTIVE,PET,RESULTS,ROC,SUB
169,2013,COLLEGE,COPYRIGHT,DESPITE,LTD,PUBLISHED,ROYAL,THESE
703,BACKGROUND,BOTH,BRITISH,BTS,CARDIAC,INDEX,LABEL,METHODS,RCRI,RESULTS,REVISED,RISK,ROC,SOCIETY
0059,118,156,BACKGROUND,FIVE,III,IIIA,IIIB,LABEL,METHODS,NSCLC,PULMONARY,RESULTS,TECHNIQUES,THERE
169,2013,206,215,CDK2,CDK4,EXPRESSION,JOHN,LTD,MIR,PUBLISHED,SONS,THESE,UTR,WESTERN,WILEY
061,095,183,184,367,CLAD,CONCLUSION,FACT,GLM,LABEL,MAE,METHODS,OBJECTIVE,OLS,RESPONSES,RESULTS,RMSE,THUS
169,2013,AUTHORS,DCE,FUNCTIONAL,IMAGING,JOHN,LTD,LUNG,MRI,NUCLEAR,OTHER,PET,PHYSIOLOGY,SOCIETY,SONS,WILEY
130,145,169,1993,2003,2013,655,8201,AIM,ASIA,CONCLUSION,GROUP,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,PET,PTY,PUBLISHING,RESULTS,VICTORIAN,WHILE,WILEY
A549,BAX,BCL,MMP,ROS,WESTERN
A549,ACTIVATED,ANNEXIN,MTT,SAFFRON,WORLDWIDE
161,595,CEF,CHINESE,SYNERGY,TCM,THERE
27HC,CYP27A1,LXR,P450,THUS
1001,1005,1007,174,ALK,CRIZOTINIB,III,KEY,MET,NSCLC,PROFILE,THOSE,XALKORI
140,8805,ARM,CONCLUSION,ECOG,LABEL,METHODS,OBJECTIVE,PET,PIE,PURPOSE,RESULTS,SCLC,SEQUENTIAL,THERE
FUNCTIONAL,HMG,SOX,SOX7,SRY,THUS
COPD,PESTICIDES,PPE,THERE
179,1997,2002,2014,443,451,EPIDEMIOL,JOURNAL,ONTARIO,THESE,TORONTO,VILLENEUVE
181,1997,2002,425,445,523,948,EXPOSURES,FEW,FURTHER,ONTARIO,SIMILARLY,TORONTO
0001,134,169,2004,2010,2014,406,540,621,AFTER,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THEREFORE,THREE
0001,001,014,143,150,260,834,885,951,AUC,BACKGROUND,HIGH,LABEL,METHODS,MIR,NSCLC,PBMC,PCR,RESULTS,ROC,SENSITIVE,SMALL,THERE
103,203,221,222,30B,30C,ABERRANTLY,BACKGROUND,CONCLUSION,EGFR,LABEL,MEIER,MET,METHODS,NSCLC,RESULTS,TKIS
174,BACKGROUND,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,RESULTS,THERE,WEGENER
15A,AP4,EMT,MET,UTR
169,190,2014,8197,8320,8325,945,A549,COPYRIGHT,GMBH,HIF,KGAA,SAR,THEREFORE,VCH,WILEY
946,A549,AKT,DEPLETION,EGF,EPHA2,ERBB2,H1792,H1975,HEIGHTENED,HOWEVER,LKB1,MET,PEST,PTP,PTPS,RET,RTK,RTKS,SHP
169,2013,207,218,516,525,532,539,598,604,755,769,946,954,CAM,CHOP,CREB,EBP,FUS,MMP,MUTATIONAL,SW872,UICC
001,015,019,129,64257,FFPE,HOWEVER,HOX,PCR,RNAS
001,102,1047,117,2008,2011,BACKGROUND,BETWEEN,EGFR,ERMETIC,EXON,IFCT,INCA,INSTITUTE,L858R,LABEL,METHODS,NSCLC,RARE,RESULTS,THERE,TKIS,UNDER
1990S,BOTH,CASE,CASES,CRC,HOWEVER,SBRT,STUDIES
0001,0006,0022,0029,0033,0219,0289,177,18F,8804,8805,CONCLUSION,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEVENTY
1998,2009,352,423,967,BACKGROUND,COMMITTEE,CONCLUSION,JOINT,LABEL,MEAN,MEIER,METHODS,NSCLC,ONTARIO,PREDICTORS,RESULTS,THERE,TNM,WEDGE
169,2013
169,2013,2MG,630,COPYRIGHT,KPS,LABEL,METHODS,OBJECTIVE,PDT,RESULTS
127,131,169,2013,A549,COPYRIGHT,HLF,HYPERICIN,LED,PDT,PDTS,PVP,THEN,THUS
169,2013,240,820,946,AACR,ANTIBODIES,LABEL,METHODS,MOLECULAR,NSCLC,OBJECTIVE,PI3K,PTEN,PURPOSE,RESULTS,SCC,SIGNALING,THESE,TMA
169,2013,2341066,AACR,BALB,CONCLUSION,EMT,HGF,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC,THESE
BACKGROUND,BCL,CONCLUSION,CONTEXT,ELISA,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,VEGF
BIOACTIVE,BMP,BOTH,CDX2,EPIGENETIC,THREE,TREGS
BACKGROUND,CONTEXT,ELASTIN,LABEL,METHODS,OBJECTIVE,PERFUSION,RESULTS
177,2002,2013,BACKGROUND,BOTH,CONCLUSION,LABEL,LASER,LIVER,METHODS,MORBIDITY,MRSA,RECURRENCE,RESULTS,RFA,THEIR
ATM,BEAS,CK2,GIVEN,TERA
BACKGROUND,CHINA,CHINESE,CIS,CNKI,DATA,ISI,KNOWLEDGE,LABEL,LUNG,METHODS,ORS,RESULTS,SCIENCE,SIX,TERT,WANFANG,WEB
001,100,169,2013,8201,AUSTRALIAN,BACKGROUND,BREATHING,COLLEGE,FREE,GTV,HOWEVER,LABEL,METHODS,POTENTIAL,RESULTS,RGRT,ROYAL,V20,ZEALAND
169,2013,283,434,8201,8805,AIM,AUSTRALIAN,AUTHORS,CNB,COLLEGE,CONCLUSION,CUMULATIVE,IMAGING,JOURNAL,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,RADIATION,RESULTS,ROYAL,THREE,ZEALAND
CIGARETTE,H292,PTMS,THESE
ATLAS
CIE,ENDOSOMES,ONCE
010,018,105,122,195,215,707,ASIAN,AUC,COX,EGFR,LABEL,LUNG,MEASURING,MEIER,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,ROC,TIME,USING
AKT,AMONG,DESPITE,EGFR,H1650,NCI,NON,NSCLC,SHOGAOL,STAT3,THEREFORE
954,HOWEVER,SECRETORY,SLPI
945,947,CSE,ERK,EXPRESSION,MUC1,PPAR,SIMILARLY,TACE,TNF
169,2013,MALIGNANT,MPNST,PRESS,PUBLISHED,SURGERY,UNIVERSITY
0895,160,1966,1970S,1974,2012,2013,817,932,ADDITIONAL,AUTHORS,BACKGROUND,BSC,CENTRAL,COLLECTION,CONTROLLED,DATA,EXPERTS,FIVE,HOWEVER,IFOSFAMIDE,III,ISSUE,LABEL,MAIN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PARTIAL,PHASE,QUALITY,RCTS,RESULTS,SCLC,SELECTION,THREE,TREATMENT
100,125,140,2013,278,2RA,ALG,ASSESSMENT,ATG,AUTHORS,BACKGROUND,CD3,CENTRAL,CLEAR,COLLECTION,CONSENSUS,DATA,EVALUATION,FEW,FURTHER,GROUP,HOWEVER,LABEL,LUNG,MAIN,MARCH,MEDLINE,METHODS,NONE,OBJECTIVE,OBJECTIVES,OVERALL,RCTS,RENAL,RESULTS,SELECTION,STUDIES,THREE,TRIAL
177,2011,ABDERAHMAN,BACKGROUND,BMI,CONCLUSION,JANUARY,LABEL,LUNG,MAMI,MAY,MEAN,METHODS,NRI,RESULTS,SEVERAL
160,2007,2013,BETWEEN,FDG,HOWEVER,JUNE,LABEL,MAY,METHODS,MPM,OBJECTIVE,PET,RESULTS,THERE,VATS
0001,078,102,306,419,431,485,582,619,773,798,ASIAN,COMPARING,CONCLUSION,ERLOTINIB,HONG,III,IPASS,KONG,LABEL,METHODS,OBJECTIVE,OPTIMAL,RESULTS,SETTING,THOSE,WJTOG,WORLD
013,035,037,047,BACKGROUND,BRAF,CRC,DISCUSSION,EGFR,KIRSTEN,KRAS,LABEL,METHODS,MTS,PMS,PULMONARY,RESULTS,THESE,TIME,V600E
160,210,CONCLUSION,COPY,LABEL,MEASURING,METHODS,MICRORNAS,OBJECTIVE,PCR,PURPOSE,RESULTS
169,2013,AIR,BASEL,DESPITE,MRI,SEVERAL,TBNA
187,281,8805,BECK,CONCLUSION,DATA,DEPRESSION,INVENTORY,LABEL,MDASI,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,STUDIES,SYMPTOM
A549,BACKGROUND,CELL,CONCLUSION,H1299,HOWEVER,LABEL,METHODS,NSCLC,PA28GAMMA,PCR,RESULTS,THUS,TOTAL
169,1993,2011,2014,294,347,AMONG,COPYRIGHT,COX,EARLY,INC,LABEL,LUNG,MEIER,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PROGRAM,PROPENSITY,PUBLISHED,RESULTS,SURGERY
169,2013,A549,AKT,COPYRIGHT,H23,INHIBITION,IRELAND,LTD,NSCLC,PI3K,PLB,PLUMBAGIN,THERE,THESE
ACTIVATING,CURRENT,EGFR,HIGH,KRAS,TP53
AKT,EGFR,EPIDERMAL,HOWEVER,SOCS3,STAT3,TAKEN,TKIS
169,177,1999,2011,2013,2161,396,967,ACCORDING,COPYRIGHT,LABEL,MEIER,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEPAR,THERE
169,2013,CONCLUSION,COPYRIGHT,DIFFERENT,DUE,LABEL,LTD,MAXILLO,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,THESE
ANAPLASTIC,BACKGROUND,CASE,CAUCASIAN,CONCLUSION,HOWEVER,KIRSTEN,LABEL,MET,METHODS,T4N3M1B,THUS,TREATMENT
169,2013,BACKGROUND,CHO,COPYRIGHT,DTI,EPSI,FOUR,LABEL,MATERIALS,METHODS,NAA,OBJECTIVE,PARAMETRIC,PURPOSE,RESULTS,SOCIETY,THESE,WBRT,WHOLE
BCL2,BEAGLES,CASP3,CASPASE,CHAIN,FAS,FASLG,LABEL,MATERIALS,METHODS,OBJECTIVE,OTHER,PCR,PLUTONIUM,POLYMERASE,PURPOSE,RESULTS,REVERSE,THESE,TUNEL,UTILIZING
409,LESS,PCI,SCLC
ASIDE,BACKGROUND,CURRENTLY,DISCUSSION,EXCELLENCE,GPS,INSTITUTE,LABEL,METHODS,NICE,TRIAL
000,100,155,DETECTING,EGFR,TKI
946,EMT,EXPRESSION,HOWEVER,PTEN,TAKEN,TGF
BESIDES,CELL,FINALLY,FIRST,FUNCTIONAL,PDB,PPI,PPIS,PROTEIN,THEN
124,125,149,200,ANALYZING,HOWEVER,MICRORNAS,PERL,RNAS,USING
001,311,344,379,399,691,797,935,986,AGREEMENT,BACKGROUND,BLAND,CONCLUSION,DATA,LABEL,METHODS,NODULES,RATIONALE,RESULTS,SEMI,SSN,SSNS
000,054,8202,BEADCHIPS,CABYR,CLDN2,CURRENT,EXPRESSION,FDR,HABP2,HCC,HUMANHT,IGLL1,INTEGRITY,MT1E,MT1F,MT1G,MT1H,NQO1,NUMBERS,OVERALL,RIN,SCL13A5,USING
ALDEFLUOR,ALDH,ALDH1A1,CD11B,CSCS,CXCR4,H1299,H460,LLC,SDF,SOX2,TARGETING,THESE
AFTER,FDG,MRI,PET
HOWEVER,LOBECTOMY,PULMONARY
160,III
HOWEVER,LUNG,OTHER,SPANISH
014,169,2013,AACR,AZD3965,DRUG,EXPRESSION,KINGDOM,LABEL,MCT1,MCT4,METHODS,OBJECTIVE,PROOF,PURPOSE,RESISTANCE,RESULTS,SCLC,TMA,WESTERN
AIM,AUSTRALIA,BACKGROUND,CONCLUSION,FIFTY,FOUR,GPS,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,SEVEN,THERE
106,FLOT1,FURTHER,HOWEVER,NSCLC,REAL,TAKEN
CD4,CTLA,FOXP3,GBS,USING
8805,AMONG,BACKGROUND,BETWEEN,CONCLUSION,DATA,HRS,III,ITT,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,THERE
118,133,251,852,ASSESSMENT,AUTOMATED,CARE,CHRONIC,CONCLUSION,CUMULATIVE,FACT,FUNCTIONAL,GENERAL,ILLNESS,INSTITUTE,LABEL,LIFE,METHODS,NURSE,OBJECTIVE,PACIC,PATIENT,PURPOSE,QUALITY,RESULTS,SELF,THERAPY,THERE
AIF,DDH,EXPRESSION,FAK,HER2,HGF,MET,MMP,NOTEWORTHY,NSCLC,OSMRS,THESE
00010,0024,0060,0071,035,039,ALSO,BACKGROUND,CONCLUSION,CONTEXT,HGNEC,LABEL,MEN1,METHODS,OBJECTIVE,RESULTS
181,8209,969,A549,DHA,EPA,MTT,PUFA
100,215,945,946,EGFR,KI67,NSCLC,VEGFR
ABC,ABCG2,ATP,BCRP,E2F1,MULTIDRUG,MXR,THESE
945,954,EGF,FINALLY,HRAS,MEFS,RIP1,TNF,TNFR,TRAF2,V12
540,FINALLY,G12D,KRAS,LSL,LUNG,MAPK,NSCLC,RAS,SCRIB
MALIGNANT,TSC
ETV6,IFS,INFANTILE,NTRK3
IVA,NPC
100,177,215,500,800,8201,8226,ADC,ADCMEAN,ADCMEDIAN,ADCS,CONCLUSION,COV,DIFFUSION,FREE,INTER,INTRA,KEY,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,REGIONS,RESULTS
169,1990,2009,2013,619,638,AGE,AIM,ASR,ASRS,AUSSIEDLER,COPYRIGHT,DATA,DISCUSSION,GERMANY,HOWEVER,LABEL,LTD,LUNG,METHODS,OBJECTIVE,RESULTS,SIR,SIRS,STOMACH,UNION
169,2013,A375,COPYRIGHT,HOWEVER,INC,MCL,MMP,OVERALL,QUERCETIN,STAT3,VEGF
169,183,2013,2015,COPYRIGHT,FORCE,LTD,LUNG,PREVENTIVE,SCREENING,TASK,TRIAL,USA
160,2005,CONDUCTING,DANA,DATA,HOWEVER,PETER,REEVE,THESE
100,174,2008,2013,204,457,799,820,8201,8482,8804,952,BACKGROUND,CONCLUSION,DDFS,FORTY,JANUARY,KARNOFSKY,KPS,LABEL,LPFS,MATERIALS,MEIER,METASTATIC,METHODS,RESULTS,SBRT,SIX,SRS,THERE,UNASSIGNED
CHOP,CURRENT,DMSO,FINALLY,H460,TAKEN,TREATMENT
A549,EGF,FIP,FLAMMULINA,HOWEVER,MTT,PCR,RAC1,RACGAP1,RED,SILENCING,TEXAS,WESTERN
1000,169,200,2013,CA15,CEA,IDE,NPS,PUBLISHED,THESE
947,BACKGROUND,CELL,CONCLUSION,CXCL5,CXCL8,ELISA,EMT,EPITHELIAL,EXPRESSION,JAK,LABEL,METHODS,NSCLC,PRODUCTION,RESULTS,SELECTIVE,SNAIL,STAT,STAT1,STAT3,STATTIC,THESE,VEGF,WESTERN
162,2013,CHR,CHROMOSOME,CONSORTIUM,FINALLY,HPP,PROJECT,PXD000603,SNP,SNPS,TABLE
AIM,BACKGROUND,BELFAST,CONCLUSION,INCREASED,IRELAND,LABEL,METHODS,OBJECTIVE,RESULTS,USING
HOWEVER
000,00055,00061,00098,0012,0014,100,200,689,956,BACKGROUND,BASED,DEE,ELRS,ERC,ESTIMATED,LABEL,METHODS,OBJECTIVE,RESULTS
014,030,034,042,047,065,115,121,169,196,2008,2013,212,8201,945,AIR,BEIJING,CHINA,COPYRIGHT,D4Z4,DISCOVERY,ELEMENTAL,FALSE,FDR,GAMES,GEE,INC,JULY,JUNE,NBL2,OLYMPIC,PM2,POLLUTION,RATE,SAT,TRUCK,WILEY
1988,2006,2010,2040,AMONG,DATA,ESTIMATES,NUTRITION
8201,NIN,NOB1,NSCLC,PCR,THERE,TNM,WESTERN
BML,HOWEVER,TAE
002,004,1681,169,1994,1997,2013,2053,8201,8805,DATA,MEN,SELF,UICC
945,AFTER,CTP,HIGH,INTRA,LABEL,MATERIALS,METHODS,MTT,NON,NSCLC,OBJECTIVE,PEI,PRECISION,PURPOSE,RESULTS,WCV
916,BECAUSE,FINDING,NAD,THUS,VDAC,VDAC1
A549,BAX,BCL,BESIDES,TAKEN,THUS,VAD,WI38
020,062,147,177,785,H1299,HOWEVER,MTT,NSCLC,PCR,THERE,WESTERN,WIP1
160,DISTANT,HIGH,HPV,OPSCC,PCR,REAL,SEVENTEEN,THESE
CIK,FLOW,HOWEVER,HYPOXIA,NSCLC
127,201,322,337,399,558,CAUCASIANS,TP53
G6PD,H1299,NADPH,PPP,TAP73,THESE,THROUGH
1969,AFTER,AMERICA,CASE,LABEL,LUNG,METHODS,NORTH,NSCLC,OBJECTIVE,PURPOSE,STAGE
116,181,A549,COLON,COMPOUNDS,ESI,HCT,KLEBSIELLA,LUNG,MIC,NMR
CLINICIANS,COPD,HIV,WORSENING
945,954,AKT,BCL10,EGFR,HOWEVER,LATIN,MALT1,MAPK,OPEN,PI3K,SMALL,STAT,THERE
100,169,2013,215,301,8201,ACTA,BACKGROUND,CAD,CONCLUSION,DERIVED,DETECTION,FOUNDATION,LABEL,MEAN,METHODS,OBJECTIVE,PHANTOM,PURPOSE,RADIATION,RANDO,RESULTS,SEVENTY,SINCE
000,169,177,2013,24H,72H,7NM,COPYRIGHT,EPR,FREE,PHPMA,THP,THUS
169,2013,945,947,AKT,CANCERS,CETUXIMAB,COPYRIGHT,DOWNSTREAM,EGFR,ERBB,ERBB1,ERBB2,ERBB3,ERBB4,ERK1,FOLLOWING,GEFITINIB,LAPATINIB,LTD,MEK,PKB,PLC,RAF,RAS,SEVEN,SEVERAL,THESE
169,2013,947,A549,AKT,COPYRIGHT,DICKKOPF1,DKK1,H460,INC,ROMO1,ROS,THEREAFTER,WNT
100,169,174,2013,209,ACTIVATING,BACKGROUND,CHINA,CONCLUSION,COPYRIGHT,EGFR,G719X,JAPAN,L747P,L858R,LABEL,METHODS,PCR,PUBLISHED,RESULTS,RGQ,S768L,THEREFORE,USING
100,169,2013,946,956,AFM,CELL,COPYRIGHT,EGCG,EMT,H1299,INC,LU99,SLUG,STUDIES,TREATMENTS,YOUNG
169,2013,COPYRIGHT,SAFFRON,TAKEN,TH1,TH2
169,2011,237,241,CASE,COPYRIGHT,DISCUSSION,ESPA,LABEL,METHODS,OCT,OFTALMOLOG,PUBLISHED
169,1988,1998,2007,2010,2013,BACKGROUND,COPYRIGHT,DATA,DENMARK,DESPITE,GENERALLY,GIVEN,ICELAND,LABEL,LTD,METHODS,MIXED,PREVENTION,RESULTS,SMOKING,THERE,TRUNCATED,WORLD
100,10GY,11GY,160,169,2007,2011,2013,20GY,231,233,2GY,50GY,8805,BETWEEN,CLINICALLY,CONCLUSION,COPYRIGHT,HELICAL,JUNE,LABEL,LOW,MAY,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SAS,SFRO,SOCI,V10,V13,V15,V20
INC,MALIGNANT,MEH,PUBLISHED,SEVERAL
169,2012,241,COPYRIGHT,ESPA,PORTUGUESA,PUBLISHED,SOCIEDADE
169,2013,ABOUT,AKT,COPYRIGHT,EGFR,ERK,H1975,HOWEVER,MEK,NSCLC,PI3K,RAS,SAS,T790M,TAKEN,TKIS
169,2013,COPYRIGHT,CRMP,GIVEN,LTD
169,2013,231,233,246,945,CONCERNING,COPYRIGHT,HODGKIN,OTHER,PUBLISHED,SAS,SNFMI,SOCI,TNF
120,169,1999,2013,8804,8805,BACKGROUND,BETWEEN,CONCLUSION,COPYRIGHT,COX,GGO,GGOS,HRS,IRELAND,LABEL,LTD,METHODS,ODDS,PULMONARY,RESULTS,SMOKING,THESE
11L,13L,169,178,2013,CENTRAL,CONTROLLED,COPYRIGHT,DATA,FEV1,HRQOL,LABEL,LTD,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PEDRO,RCTS,RESULTS,SMD,SOURCES
1613,169,174,2013,AUTHORS,COPYRIGHT,HIPAA,IRELAND,LABEL,LTD,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,PUBLISHED,RESULTS,SIX,SIXTY,STAGING
169,180,2013,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,EBC,IRELAND,LABEL,LTD,METHODS,MSP,NON,NSCLC,P16,PUBLISHED,RESULTS
169,183,2013,258,GAD,JOHN,LAP,LEAVING,LIFE,LTD,MEANING,MOST,PATIENT,PHQ,PROFILE,REVISED,SIX,SOMP,SONS,SOURCES,WILEY
132,169,177,2013,956,A549,APOPTOTIC,BAX,BCL2,CONCLUSION,FACS,IC50,JOHN,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PARP,RESULTS,ROS,SONS,THUJA,TUNEL,WILEY
001,160,164,169,1763,2000,2009,2014,ACUTE,COPYRIGHT,INC,JANUARY,JAPAN,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,PULMONARY,RESULTS,SURGERY,UNIVARIATE
169,2013,BACKGROUND,BRONCHIAL,COMMENT,CONCLUSION,COPYRIGHT,LABEL,PUBLISHED,SAS,SPLF,THEIR
160,169,2007,2011,2013,AMONG,BACKGROUND,COPYRIGHT,DIAGNOSTIC,EBUS,JANUARY,JULY,LABEL,METHODS,PUBLISHED,RESULTS,SAS,SPLF,TBNA,THERE,THESE
169,2009,2014,AGAINST,CHANGES,COMMITTEE,COPYRIGHT,INC,JOINT,PET,THERE,UNION
169,2014,CHEST,COLLEGE,COPYRIGHT,FINALLY,FLEISCHNER,INC,PARTICULAR,PHYSICIANS,SOCIETY
169,2014,ADHERENCE,COPYRIGHT,CURRENT,INC,LDCT,SCREENING
169,18F,2014,AWARENESS,COPYRIGHT,INC,PET
169,2013,945,946,CET,CETUXIMAB,EGFR,GFP,IGG,INF,ORGAN,SKOV,SPECT,STRIKINGLY,TARGETING,VIRAL
2006,2010,ADM,FIFTEEN,FOUR,GENERAL,GOTTRON,JANUARY,LABEL,METHODS,OBJECTIVE,OVERALL,PLA,RESULTS,SIX,THERE,THREE
001,169,1998,2009,2014,650,BACKGROUND,COPYRIGHT,END,FORTY,INC,LABEL,LYMPH,METHODS,NSCLC,PUBLISHED,RESULTS,SEER,SOCIETY
0001,160,169,173,2013,888,AIMS,ANTIBODIES,BAI3,CDX2,CONCLUSION,DEGS,FFPE,JOHN,LABEL,LCNEC,LTD,METHODS,OBJECTIVE,PCR,RESULTS,SCLC,SONS,THREE,VIL1,WILEY
169,2013,ACTIVATION,AIMS,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,VALID,WILEY
118,169,2013,289,2M0,4N0,707,913,AIMS,DISCORDANT,JOHN,LABEL,LTD,MATERIALS,METHODS,NAC,NSCLC,OBJECTIVE,RESULTS,RRM1,SAMPLES,SONS,TEN,WILEY
001,003,174,AIM,AQUA,CONCLUSION,FRA,HIGH,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,THESE
7901,H460,NMR,RHIZOMA,SGC,USING
549,7721,MCF,RAUVOLFIA,SEVEN,SMMC,SW480
BACKGROUND,CASE,CONCLUSION,FOUR,LABEL,METASTATIC,METHODS,RCC
005,009,193,298,324,961,AZA,BACKGROUND,CPG,EXOGENOUS,H23,H460,HRM,LABEL,NHBE,NSCLC,PRINCIPAL,RESULTS
100,1232,177,994,CURRENTLY,EARLY,GFP
945,946,A549,AFTER,AIF,APOPTOTIC,FBW7,FURTHER,GSK3,HDAC1,HDAC2,HOWEVER,MCL,MG132,MYC,PARP,PCR,PROTEIN,SKP2,THR58,WESTERN,WOGONIN,XIAP
007,021,8202,CDK4,HIGH,JAM,NSCLC,THUS,TNM,WESTERN
945,ABSENCE,AKT,DIFFERENT,ERK,LUNG,MAPK,NON,PDK1,PI3K,RAS,SCA,SOX9,THESE,WESTERN
111,152,267,433,586,AFFYMETRIX,AGILENT,ATLAS,FINALLY,NON,PCR,PROTEIN,RAF,RNAS
024,068,072,073,098,102,130,1440,145,1536,173,177,2048,2080,215,2560,291,354,446,721,764,844,8451,871,AREA,CCFL,CONCLUSION,EIGHT,ILD,LABEL,LED,LOW,MATERIALS,METHODS,OBJECTIVE,RADIANT,RESULTS,SENSE,THERE
008,095,142,458,8805,AGE,EASTERN,FACTORS,GEFITINIB,GROUP,MOST,NSCLC,PEMETREXED,POST,PPS,TKI,TKIS
250,420,CDC42,CONCLUSION,CORTACTIN,FINALLY,GIT1,HOWEVER,LABEL,OBJECTIVE,RAC1,RESULTS,S405,SPA
BECAUSE,EARLY,FGF3,FGFR,FGFR1,FGFR2,FGFRS,VEGFR
CASES,DIAGNOSIS,MPLC
001,006,1990,2008,455,471,6TH,AIMS,AKT,COMMISSION,CONVERSELY,COX,EXPRESSION,JOINT,LABEL,LEVEL,MEIER,METHODS,NSCLC,OBJECTIVE,PATHOLOGY,RESULTS,TNM
FURTHER,HOWEVER,PML,SCT
ACTA2,CDH2,DU145,ERBB2,FAS,GLCE,HOWEVER,IFNA1,IFNB1,IGF1,IL6,IL8,ITGA1,ITGB3,LNCAP,MMP1,MMP2,MMP9,PC3,PDGFB,PNT2,TAGLN,TEK,TNF
BCL,BTG1,DECREASED,EMP,H1299,MEANWHILE,MEIER,MMP,MTT,NSCLC,PCR
2001,2010,293,544,HCC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
002,029,119,3164,320,3200,400,745,956,996,AU400,BACKGROUND,BSA,INSTITUTE,LABEL,LABORATORY,LINEARITY,LOWER,METHODS,NSCLC,OLYMPUS,PACLITAXEL,PRECISION,PTX,RESULTS,STANDARDS,TAXOL,TDM,THREE
1000,177,400,689,8804,956,9754,ADDITIONAL,AU400,AU640,BACKGROUND,BECKMAN,COULTER,DOCETAXEL,DRUG,DTX,FOOD,INSTITUTE,LABEL,LABORATORY,LINEARITY,METHODS,RESULTS,STANDARDS,TESTING
169,2013,AFTER,CHINESE,COPYRIGHT,PPL,PRIMARY,PUBLISHED
BH3,BIM,CCL39,CONSISTENT,ERK,FTY720P,HOWEVER,INSTEAD,MCL,PI3K,PKB,PKC,RESISTANCE,S1P,S1P1
106,1060,118,250,784,803,859,AES,BACKGROUND,CAUCASIAN,CONCLUSION,CTC,DCR,EGFR,FIRST,IIIA,LABEL,METHODS,MOST,NSCLC,ORR,PFS,PHASE,PRE,PRIMARY,RESULTS,SAES,SECONDARY,TREATMENT
113,131,1580,169,1995,1998,2006,2013,347,573,8805,931,AGE,ASIAN,BACKGROUND,COPYRIGHT,COX,IRELAND,LABEL,LTD,METHODS,MORTALITY,RESULTS
437,65291,946,AFTER,CPT,III,JUA,MEA,VIP
169,2013,956,A431,A549,COPYRIGHT,FURTHER,H322,IC50,MIAPACA,NCI,PARP,SAS,SIMILARLY,T47D,T98G,THESE
064,111,118,147,177,181,2010,2011,202,268,389,620,643,722,786,872,8805,928,945,946,AFFILIATED,BLOOD,CHEST,COLLEGE,DEPARTMENT,ELISA,FIRST,HMGB1,III,JUNE,LABEL,MEDICAL,METHODS,OBJECTIVE,PCR,RESULTS,SERUM,SIXTY,SURGERY,TNF,ZUNYI
000,100,133,16T,1736,236,238,252,643,8505C,BACKGROUND,BRAF,CMV,FTC,IL2RG,IVIS,LABEL,LUC2,METHODS,MOUSE,NEO,NOD,PRKDC,RESULTS,SIMILARLY,SZJ,THJ,V600E,XENOGEN,XTC
946,AKT,API,BACKGROUND,ECTOPIC,FBXW7,GSK3,HOWEVER,KNOCKDOWN,LABEL,MCL,MG132,RESULTS,S159,T163,TRCP
120,350,AFTER,GUERBET,HEALTHCARE,HISTORY,LABORATORY,LIGHTSPEED,MILWAUKEE,TECHNICAL,VCT,WHITE,WIS,XENETIX
004,2008,2010,CONCLUSION,MARCH,METHODS,OBJECTIVE,PET,RESULTS,THERE,THREE,USING
2000,2012,220,AMONG,CONCLUSION,IIIB,JANUARY,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,RFA,THERE
103,228,254,316,482,BONE,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
A431,H226,IL12,MESOTHELIN,MONOCLONAL,NCI,OVCAR,SS1,SS1P
945,AKT,CCL,FURTHER,G12D,HOWEVER,KRAS,NSCLC,STAT3,TAKEN,TNF
AKT,CD43,NF2,THESE
946,ALTERED,ALTOGETHER,AMINO,FINALLY,WNT,WNT5A
100NG,169,249,7NG,8804,9NG,APPARENTLY,BACKGROUND,INDUCTION,IRMA,LABEL,METHODS,MYOSTATIN,RESULTS,SMAD,THEREFORE,WESTERN
028,160,1772,1772C,1790,1790G,4884,7522,8154,945,9847,BACKGROUND,CAUCASIANS,HIF,LABEL,ODDS,PRINCIPAL,RESULTS
001,105,108,111,216,8804,IHC,NSCLC,PFS,ROC
120,137,177,183,215,240,320,760,8805,AMONG,CONCLUSION,ECOG,ESR,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SERUM,TOTAL
001,014,122,879,ASP312ASN,CAUCASIANS,CIS,FURTHER,HOWEVER,HRS,LABEL,LYS751GLN,METHODS,NER,NONE,NSCLC,OBJECTIVE,ORS,PFS,PRIMARY,RESULTS,SNPS,XERODERMA,XPD
129P2,C57BL,EAF2,ELL,FVB,MICE,OLA,PIN,POL,STROMAL,THESE
013,016,025,028,539,627,8202,ASIAN,BACKGROUND,CAUCASIANS,CHINESE,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,TERT
2004,2008,916,BACKGROUND,FOUR,IGRT,METHODS,RESULTS,TYPE
0001,0526,2007,2008,2009,2011,316,328,BACKGROUND,COMPARING,CONCLUSION,EBUS,LABEL,METHODS,RESULTS,TBNA,THESE
002,218,317,AZA,H23,NSCLC,TRANSIENT
CHEMOKINES
0001,052,169,2013,798,8201,AFTER,ALK,AMONG,BACKGROUND,CHRONIC,DISEASE,INCREASED,LABEL,METHODS,RESULTS,SOCIETY
10001,333,LUNG,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,THESE,USA,YORK
10001,333,HOWEVER,MEDICAL,PUBLISHERS,SABR,SBRT,SEVENTH,USA,YORK
10001,333,ALK,DIFFERENT,EGFR,MEDICAL,MET,MULTIFOCAL,PUBLISHERS,SEVENTH,T790M,TKI,TKIS,USA,YORK
10001,333,ALK,EGFR,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,USA,YORK
10001,333,MEDICAL,PUBLISHERS,SEVENTH,SEVERAL,THESE,USA,YORK
10001,333,8201,DATA,EASTERN,ECOG,FIT,GERIATRIC,GROUP,III,MEDICAL,PUBLISHERS,SEVENTH,USA,YORK
10001,1960S,333,450,LUNG,MEDICAL,PUBLISHERS,SEVENTH,SMOKING,USA,YORK
10001,333,EBUS,HOWEVER,MEDICAL,NSCLC,PUBLISHERS,SEVENTH,TBNA,USA,VATS,YORK
10001,333,AMONG,MEDICAL,PUBLISHERS,SEVENTH,THESE,USA,USING,YORK
10001,333,MEDICAL,PUBLISHERS,SEVENTH,SPN,SPNS,USA,YORK
10001,333,BAYES,KNOWLEDGE,MEDICAL,PATIENT,PUBLISHERS,SEVENTH,SPNS,THEIR,THEN,USA,YORK
10001,333,CTS,LUNG,MEDICAL,PUBLISHERS,RADIATION,SEVENTH,USA,YORK
10001,333,LUNG,MEDICAL,NLST,PUBLISHERS,SCREENING,SEVENTH,TRIAL,USA,YORK
001,18F,BACKGROUND,EORTC,ERLOTINIB,FDG,FIFTY,LABEL,METHODS,NSCLC,PET,PFS,PMD,PMR,RESULTS,SMD
134,14Q32,487B,655,946,A549,EGFR,EMT,EPITHELIAL,MAGI2,NSCLC,PCR,PDZ,PTEN,TGF,TKI
670,956,A549,ALSO,BNCT,CONJUGATE,FURTHER,STRUCTURAL
001,021,045,ASIAN,DFS,DKK1,FURTHER,HCC,WESTERN
404,499,8201,974,CAUCASIANS,HOWEVER,OVERALL,SEVENTEEN,THEREFORE
100,160,LUNG
000,100,103,2001,2012,2085,361,376,AGE,AMONG,APRIL,COX,DATA,ENGLAND,EPISODE,MARCH,STATISTICS,THERE,THUS
EDA
003,011,038,044,194,1974,2008,AMONG,CLARIFYING,COX,LABEL,LOG,MEIER,METHODS,OBJECTIVE,PURE,RESULTS,TIANJIN
ABC,CT0,CT50,CTEEH,CTEIH,DIS,GTV,GTV0,GTV50,GTVS,LABEL,METHODS,OBJECTIVE,RESULTS,WHETHER
AAA,AXB,BASED,DOSE,NPC,NSCLC,PLANS,PRO,PRO10,PRO10_AIR
D90,ECLIPSE,FFF,GTV,HOWEVER,MLC,PTV,SBRT,SIX,V100,VMAT
4MM,BASED,CBCT,DIR,DMP,DVF,FEM,FOURIER,PATIENT,REGIONS,SINUSOIDAL
037,100,177,199,200,947,987,999,BELLOWS,DICE,EIGHT,LATENCY,MANAGEMENT,MAXIMUM,MEDICAL,MIP,NEAR,NEGLIGIBLE,PEARSON,PHILIPS,REAL,RPM,SYSTEMS,THEREFORE,TIME
000,009,100,1992,2001,2002,2011,375,483,576,667,770,ALONG,BOTH,CONCLUSION,CURE,DATA,ESTIMATION,HENAN,HENNA,INSTITUTES,LABEL,LUNG,METHODS,OBJECTIVE,PER,RESULTS,TOBACCO,TREND
019,2005,2007,2008,2009,2010,271,551,606,638,800,AMONG,BETWEEN,CHINA,CHINESE,CONCLUSION,DATA,DIFFERENCE,LABEL,METHODS,OBJECTIVE,RESULTS,STATISTICS,TRAFFIC,WOMEN
001,002,177,2000,2010,967,COX,DESPITE,FEV1,FURTHER,JANUARY,LABEL,LWR,MEIER,METHODS,OBJECTIVE,RESULTS,SIMILARLY
176,AD5,CELL,FAM176A,H1299
001,103,2005,2011,COX,DCR,EGFR,EPIDERMAL,JANUARY,L858R,LTD,MEIER,NINE,NSCLC,ORR,PFS,PUBLISHED
BINDING,EFFORTS,G12C,GDP,GTP,ONCOGENIC,RAF,RAS,SOMATIC,THESE
160,2010,2012,2400,8201,945,946,BACKGROUND,BED10,CTCAE,DESPITE,FACTORS,FFF,FLATTENING,FURTHER,IMRT,JULY,LABEL,METHODS,NERVE,PULMONARY,RESULTS,SBRT,SIX,SIXTY
001,231,CXCR4,EMT,MDA,MMP,SILENCING,THESE
100,2007,2009,8804,8805,BACKGROUND,EVEN,GRADE,HCC,HCCS,LABEL,LOCAL,MATERIALS,METHODS,MOST,OVERALL,RESULTS,SBRT
025,142,203,AFTER,BACKGROUND,DISCUSSION,FGFR,FGFR1,LABEL,MATERIALS,METHODS,NSCLC,PCR,PRIOR,RESULTS,THERE,THESE,THOSE
DOK2,EGFR,KRAS,RAS,SOMATIC,THESE
169,2014,BML,COPYRIGHT
001,006,111,120,187,242,344,615,BACKGROUND,DECREASING,FORTY,LABEL,METHODS,RESULTS,SERUM,THERE,TIE,VEGF
15Q25,742,8201,967,AFRICAN,AFTER,CAUCASIANS,EAST,HOWEVER,OVERALL,SEVERAL
219,232,685,690,8201,ASIAN,CHINESE,CIS,CNKI,FURTHER,HOWEVER,KNOWLEDGE,LUNG,MICRORNAS,ORS,SNP,SNPS
231,A549,ABC,ABCC1,ABCG2,AMONG,LRP,MCF,MDA,MDR,PREVIOUSLY,RESULTS,THESE
124,131,309,AKT,CHINESE,ERK,GCS,HCC95,LCS,MKN1,OKA,PP2A,PPME1,PROTEIN
120,211H,AHNAK,H2052,H226,H2452,H28,KNOCKDOWN,MESO1,MESO4,MET,PCR,SINCE,THESE,THUS
169,2013,29B,946,AACR,BOTH,DEFINITION,EMT,ERK,HBEC,INHIBITION,MAP,MEK,MIR,NSCLC,SNAIL,SPARC,TGF,TREATMENT
001,1021,131,169,1999,2011,2014,206,259,ACCP,CHEST,COLLEGE,COPYRIGHT,COX,CURRENT,GROUP,INC,LABEL,METHODS,MOSBY,NSCLC,OBJECTIVE,PFT,PFTS,PHYSICIANS,PUBLISHED,RADIATION,RESULTS,RTOG,SBRT,SURGERY,THERAPY,THERE,THESE,USING,Z4099
001,123,134,140,169,172,2011,2012,2014,COPYRIGHT,DATA,INC,LABEL,METHODS,MORBIDITY,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,ROBOTIC,SURGERY,THERE,VATS
100,2007,2010,ACUTE,ARMY,BEIJING,CHINA,CONCLUSION,CTV,DEPARTMENT,GENERAL,GREY,GTV,JANUARY,JULY,LABEL,LIBERATION,LOCAL,METHODS,NSCLC,OBJECTIVE,PTV,QGD,RADIATION,RESULTS,SBRT
946,963,A549,AT12,DESPITE,DIGE,EPOB,EPOB8,HEY,MIA,MIAS,MSA,MSAS,WESTERN
A549,NMR,PHE,PRO
169,2014,BAE,CUMULATIVE,IMMEDIATE,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RECURRENCE,RESULTS,SIR,SOCIETY
001,002,100,111,177,2010,2012,759,844,8804,AMONG,AVERAGE,III,JUNE,LABEL,LHS,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESECTION,RESULTS,THERE,TOTAL,TOTALLY,VATS
000,100,2002,2005,BACKGROUND,HOWEVER,ITALIAN,ITALY,LABEL,LUNG,METHODS,RESULTS,USING,YET
080,1110,1553,160,169,2012,2013,2337,392,569,AMERICA,ASIA,ASIAN,BASED,CHI,COPYRIGHT,EAST,HPV,IRELAND,LTD,NON,NORTH,NSCLC,SEPTEMBER,SOUTH,THERE
001,169,177,2013,COPYRIGHT,INCREASED,LTD,MANN,SCLC,WHITNEY
100,1000,169,2013,BOTH,CASE,UROLOGICAL
169,2013,AUTHORS,FDA,FOUNDATION,HSCT,JOHN,JOURNAL,LTD,MOLECULAR,MUCOSITIS,PALIFERMIN,SEVERAL,SONS,WILEY
169,2003,2012,2013,ADRENAL,ASIA,BACKGROUND,CONCLUSION,ENDOSCOPIC,FORCE,FOUR,JAPAN,LABEL,LTD,METHODS,OCTOBER,PTY,PUBLISHING,RESULTS,SEPTEMBER,SOCIETY,SURGERY,TASK,THERE,WILEY
0001,155,160,167,169,2009,2011,2013,206,222,941,954,CONCLUSION,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
169,2013,241,43B2,6B6,AIMS,EGFR,EPIDERMAL,FULL,JOHN,L858R,LABEL,LTD,METHODS,OBJECTIVE,PCR,RESULTS,SONS,SP111,SP125,WILEY
18F,2005,2011,AGGRESSIVE,ALSO,BPCT,DIFFERENT,FDG,FIFTY,MEAN,OPERATORY,PET,SUV
1999,2012,BACKGROUND,BETWEEN,CONCLUSION,DISCUSSION,FIFTEEN,FUNCTIONAL,ILIAC,LABEL,MATERIALS,METHODS,MINIMUM,MSTS,RESULTS,SIXTEEN,VARIOUS
1RA,526,592,BACKGROUND,BCA,CCL17,CCL22,COLORECTAL,CONTROL,COX,CRP,CXCL5,CXCL9,DESPITE,ENA,LABEL,LUMINEX,LUNG,MDC,METHODS,MIG,ORS,OVARIAN,RESULTS,SAA,SCREENING,SERUM,TARC,TGF,TRIAL
160,178,2006,2010,500,AUTHORS,BACKGROUND,DFS,GUIDELINES,JANUARY,JUNE,LABEL,LEVEL,METHODS,OBJECTIVE,PATIENT,QUESTIONS,RESULTS,THREE,WHETHER
169,2013,945,954,BOTH,CHINESE,DATA,DOSE,INC,THESE,TREATMENT,WILEY
169,18B,2013,CPG,INC,NOTABLY,PCR,THESE,WILEY
021,029,048,056,100,131,533,564,967,COX,DFS,EGFR,HOWEVER,PCR,SMOKING
001,BASED,CONCLUSION,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,TYPE
0001,120,270,340,750,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,PURPOSE,RESULTS
001,220,485,604,620,669,683,696,717,727,741,761,783,853,AUC,AUCS,CARET,CONCLUSION,DETECTION,EARLY,LABEL,LUNG,METHODS,OBJECTIVE,PAN,PRO,PURPOSE,RESULTS,RETINOL,SFPTB,SFTPB,TRIAL
001,005,018,022,1993,2008,325,618,8804,CONCLUSION,HODGKIN,JULY,LABEL,METHODS,OBJECTIVE,PDMM,PDMMS,PURPOSE,RESULTS,SEVEN,SEVENTEEN,STUDIES
1983,2002,224,AMONG,AUSTRALIA,CONCLUSION,CONTINENTS,DENMARK,ESTONIA,FIVE,HPV,INCIDENCE,JAPAN,KINGDOM,LABEL,METHODS,OBJECTIVE,OCCS,OPC,OPCS,PURPOSE,RESULTS,THESE,USING,VOLUMES
160,181,730,8209,A549,APOPTOSIS,ATP,CELLS,DRB,EAGLE,EFFECTS,LUNG,PREVIOUSLY,THEREFORE,THESE,TUNEL,UNTREATED
IMT,PRIMARY
160,181,8209,A549,ANNEXIN,BAD,BAX,BCL,CHINESE,HOWEVER,PAB
160,946,A549,AKT,ANNEXIN,BAX,BCL,FITC,GSK,LACTATE,LIQUIRITIN,MDM2,PARP,PCNA,PTEN,RAF,THESE,WESTERN
218,FUNCTIONAL,HMGB1,MICRORNAS
956,A549,AKT,ALDH1,CD133,CD44,FRUCTUS,FURTHER,IC50,MMP,VITICIS
III,PREVIOUSLY
FINALLY,GPS,HOWEVER,PRIMARY,SEVERAL
169,2013,335,BASEL,CMV,CVID,DESPITE,PATIENT
110,146,2011,2012,ALK,FFPE,FISH,JAN,JULY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,VYSIS
000,008,590,946,983,AB2,CCK8,CONCLUSION,DUAL,EGFR,ERK1,FLASH,LABEL,METHODS,OBJECTIVE,PC9,RESULTS,TOP,WESTERN,WNT
CEA,CK20,EMA,ENDOSCOPIC,LABEL,METHODS,MUC,OBJECTIVE,PSA,RESULTS,THESE,THREE,VILLOUS
169,2013,COPYRIGHT,IRELAND,JNK,LTD,MMP9,NSCLC,THESE,TNM
100,150,169,200,2014,300,500,BACKGROUND,CENTRAL,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,GROUP,III,INC,LABEL,LACK,METHODS,NORTH,OBJECTIVE,OBJECTIVES,PAIN,PHASE,PUBLISHED,QALY,QALYS,QUALITY,RESULTS,TREATMENT
124,135,137,150,169,2013,25MG,BACKGROUND,COPYRIGHT,DOSE,ERLOTINIB,GRADE,LABEL,LTD,METHODS,NSCLC,OVERALL,RESULTS
008,117,160,169,177,2000,2003,2014,CARDIAC,COPYRIGHT,EVALUATION,FORTY,HODGKIN,INC,INCREASING,LABEL,MEAN,METHODS,MOSBY,OBJECTIVE,OPERATIVE,PUBLISHED,RESULTS,RISK,SURGERY,TIME
169,2013,6MWT,BOTH,CONCLUSION,COPYRIGHT,EMD,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SF36,SUPERVISED
125,140,169,2013,AICHI,BACKGROUND,COPYRIGHT,EGFR,HOWEVER,IRELAND,LABEL,LTD,MDM2,METHODS,NSCLC,PCR,RAS,RASSF,RASSF1A,RESULTS,TEN,UNIVERSITY
1000,169,2013,8805,AUC,CONCLUSION,COPYRIGHT,ECOG,FULL,GRADE,III,IIIB,IRELAND,LABEL,LOW,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PATIENT,RESULTS,SECONDARY,THREE,TTR,TUESDAY,WEDNESDAY
100,169,2013,295,COPYRIGHT,ENGLAND,LTD,RR78,THERE
10YEARS,169,2013,214,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,DUE,LABEL,LTD,METHODS,OBJECTIVE,OSJ,OSP,RESULTS,WHEREAS
1000,169,2013,215,510,894,AMONG,BASILIC,CONCLUSION,COPYRIGHT,CRT,FIVE,LABEL,LTD,METHODS,OBJECTIVE,PICC,PICCS,PURPOSE,RESULTS
147,AFTER,CONCLUSION,CSNK2A1,HPRD,KEGG,KYOTO,LABEL,MASS,MEN1,MENIN,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,SILAC
1195G,2000,2008,247,271,8804,956,994,ACADEMY,AMONG,CASE,CHINESE,CONCLUSION,COX2,HAN,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SCIENCE,THERE,TOTALLY,WHILE
EXPRESSION,PCR
007,169,379,503,623,648,659,6Q13,791,CNVS,COPY,LUNG,SNPS,THESE
006,021,285,ANCOVAS,ANGER,ANXIETY,CAREGIVERS,CHESS,CQOLI,DEPRESSION,LABEL,METHODS,OBJECTIVE,POMS,RESULTS,SUPPORT,WEB,WRITTEN
954,A549,ABCB1,ADM,CELL,CHINESE,DRUG,FOOD,HOWEVER,PARP,PDTC
A549,DOX,GPC,HELA,LCST,NMR,PNH
0134,0175,118,300,8202,8805,CK5,CK7,HIGH,IHC,MEIER,NSCLC,SCC,TTF
0001,001,002,040,122,141,259,332,BACKGROUND,CONCLUSION,COX,DIVIDED,INTO,KRUSKAL,LABEL,MEIER,METHODS,RDW,RED,RESULTS,UNIVARIATE
COMPARING,COX,HOWEVER,LEWIS,LLC,LTB4,LTC4,LTD4,LTE4,P450,PGD2,PGE2,PGF2A,TME,USING
CD4,CPG,DNMT,DNMTS,HOWEVER,IFNG,SPC,STUDIES
000,350,ATLAS,BRCA1,BRCA2,FUNCTIONAL,HIGH,HOWEVER,LUDLU,PARP,PARP2,SCC,TP53
946,ASSOCIATED,CHINESE,CRC,LOVO,LUNG,METASTASIS,MMP,MYC,POLYGONUM,TRANSCRIPT,USING,WNT
ABC,ABCC1,CD133,CD44,CELL,CONTROL,CSCS,CTL,EMT,HCC,INCREASED,MIGRATION,NOD,SCID,SORR
FINANCIAL,IRELAND,OSWS,THESE
CIC,CICS,CSC,CSCS,HOWEVER,PCR,RACE,RAPID,SMCP,TAKEN,THEREFORE
AMONG,DECREASED,FEV1,HOWEVER,LABEL,LUL,METHODS,NINE,OBJECTIVE,OBJECTIVES,RESULTS,RUL,UPPER
169,2013,225,BISPECIFIC,EGFR,EPIDERMAL,ERBITUX,INDUCED,UICC
1995,2012,IRON
169,2013,8201,959,CONSISTENT,NNAL,NNK,NNN,PHET,UICC,URINARY
137,A549,CURRENTLY,HOWEVER,NSCLC,PXN,TAKEN
8201,956,ARBUTUS,EC50,GI50,H460,NCI,ROSA,THESE
2013,AFRICAN,CONDUCTING,LAGOS,NIGERIA,PRE,STATE,UNIVERSITY
169,2013,ANCHORING,CONTEXT,COPI,COPYRIGHT,FLIP,HOWEVER,INC,KRAS,LKB1,NLRP3,NSCLC,THESE
2000,BESIDES,BRITAIN,COUNTRIES,MORTALITY,PREVALENCE,PREVENTION,SMOKING,SURVEYS
CLDN7,EACH,ERK,H460,MEK,MSCS,NCI,NSCLC,STUDIES,TNFRSF10B,TRAIL
0002,117,135,153,169,2013,215,234,419,572,689,954,AFTER,AGREEMENT,BOTH,CASES,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,UNIVERSITY
0005,018,036,038,044,139,1985,2010,BETWEEN,COX,DIAGNOSTIC,IFI,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN
006,126,19A1,BACKGROUND,CYP19A1,FIFTY,LABEL,METHODS,OTHER,P450,PCR,RESULTS,SNP,SNPS,THREE
30C,786,BACKGROUND,FFPE,HOWEVER,LABEL,METHODS,MICRORNAS,PCR,REAL,RESULTS,THERE,TOTAL
200,2000,2009,BACKGROUND,CRLM,DISEASE,LABEL,MAY,METHODS,RESULTS,SEPTEMBER,SIXTEEN,THESE,TSH
051,169,1997,2006,2013,398,8201,8805,954,AFTER,AGE,CWP,INSURANCE,RISK,SIR,SIRS,UICC
ASIDE,EPIGENETIC
945,946,954,A549,AUTOPHAGY,CCL2,CCL5,H5N1,H5N1PPS,MAPK,SINCE,THESE,TNF
2013,BIOL,GAO,MUC4
A549,ACTIVATION,ATM,ATR,CDK,CELL,CHK1,CHK2,E2F,FURTHER,HNO,KU80,MRN,PART,THESE,THUS,XLF
120,1986,852,AML,COX,CUMULATIVE,ELF,LABEL,METHODS,NONE,OBJECTIVE,PURPOSE,RESULTS,THESE,USING
A549,ACTIVATION,ATR,CHK1,DDR,FURTHER,HNO,MCL1,NHEJ,THUS
215,CARE,EIGHT,VATS
542,ECTOPIC,EGF,EGFR,SER,STAT3,TAKEN,THR,Y845
AMP,AMPK,BECAUSE,LKB1,NAD,NOTABLY,NSCLC,SIRT1,SRT1720,TAKEN
DEPLETION,EMT,ERK1,FURTHER,G12V,HBEC,HOWEVER,KIF2A,KIF2C,MAPK,RAS
145,INCREASED,MPM,OCT4,TREATMENT,UTR,ZEB1
1524,757,AFTER,BACKGROUND,CARLO,CHAIN,CONCLUSION,ESTIMATION,LABEL,METHODS,MONTE,NUTRITION,RESULTS
AFTERWARDS,CARDIAC,SAPHENOUS
169,2013,4989216,945,AACR,BCL2,BIM,LABEL,METHODS,OBJECTIVE,PI3K,PTEN,PURPOSE,RESULTS,SCLC,SCLCS,TGI,THESE
169,2013,8810,A549,COPYRIGHT,L61,PLURONICS,TBC,TBCS
169,2013,4000,COPYRIGHT,HIV,HOWEVER,RETINOIDS,THERE
169,2013,BOTH,COPYRIGHT,FET,FPTRP,H69,LAT,NCI,PET,SAS,SMALL
001,169,2014,3DCRT,BDVH,BDVHS,COPYRIGHT,DVH,IMRT,INC,MEDICAL,NSCLC,OAR,OARS,PUBLISHED,SCHEDULES,V20
0001,002,169,2014,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,SYSTEMATIC,THREE,TIME
169,2013,AUTHORS,COPYRIGHT,CRE,DDR,INC,MAPK,MK2,NSCLC,PUBLISHED
169,2013,ANTITUMOUR,CCRF,CELL,CEM,COPYRIGHT,H460,HOWEVER,LTD,LUNG,MCF7,MOLT,NCI,NON,SMALL
169,2014,COPYRIGHT,HCC,INC,PUBLISHED,WESTERN
131,142,169,2001,2008,2013,AGE,BACKGROUND,COPYRIGHT,FDG,LABEL,MALIGNANCY,MALIGNANT,METHODS,MRI,OCTREOSCAN,PET,RESULTS,SAS,SDH,THESE
001,033,169,2013,CONCLUSION,COPYRIGHT,FGF,FGF9,FIBROBLAST,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NINE,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
169,1712,1986,2010,2013,2448,AUSTRALIA,COPYRIGHT,COX,FINNISH,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SELF
169,2010,2013,231,233,359,AMONG,APRIL,BAROMETER,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADON,RESULTS,SAS,SFRO,SOCI
169,2013,3MM,90TH,BACKGROUND,BOTH,CONCLUSION,COPYRIGHT,DUAL,E90,EPID,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PAN,PURPOSE,REAL,RESULTS,RTTT,TILT
020,074,120,149,169,2009,2011,2014,APRIL,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,III,INC,LABEL,MATERIALS,METHODS,NSCLC,PET,RADIATION,RESULTS,SUV,TNM
0001,001,100,169,197,2014,50GY,COPYRIGHT,D95,DVH,HEART,IMN,IMNS,INC,LUNG,MEDICAL,MVA,PMRT,PTV,PUBLISHED,REFINEMENT,UNIVARIATE,UVA,V20GY,V25GY
169,2014,8805,919,BACKGROUND,CONCLUSION,COPYRIGHT,CRPC,ENDPOINTS,GLEASON,GRADE,INC,LABEL,METHODS,PSA,RESULTS,SERIOUS
169,2013,COPYRIGHT,LTD,MICRORNAS
100,2009,2013,AMONG,BACKGROUND,EBUS,HOWEVER,LABEL,MARCH,METHODS,RESULTS,SEPTEMBER,TBNA
169,2013,COPYRIGHT,HOWEVER,IRELAND,LTD,PLC,PUBLISHED,TNM,VARIOUS
0001,001,106,169,177,1MM,2013,217,AZD1480,CONCLUSION,COPYRIGHT,EFFECTS,EGFR,ER3,GROUP,IRELAND,JAK,JAK1,LABEL,LTD,MATERIALS,MEIER,METHODS,MTT,OBJECTIVE,OVERALL,PROTEIN,RESULTS,RPC,STAT3,STUDENT,THREE,VAN
177,550,BACKGROUND,CONCLUSION,DIAPHRAGM,FEV1,LABEL,METHODS,RESULTS
169,2013,CURRENTLY,INC
169,176,2013,EACH,INC
169,2013,8505C,8505CBRAF,956,A375,AZA,BACKGROUND,BCPAP,BRAF,BRAFV600E,CONCLUSION,COPYRIGHT,CPG,DAC,EXPRESSION,HTH7,INC,LABEL,LATER,MAGE,MAGEA,MEK,METHODS,MOSBY,PLX,PLX4720,RESULTS,TPC,TREATMENT
017,038,169,2013,213,317,8804,ADRENAL,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,MOSBY,NON,NSCLC,RESULTS,SURGERY
169,2013,COPYRIGHT,CXPA,FREY,INC,ORAL,PUBLISHED,SURGERY
000,012,021,033,045,2005,2013,239,286,321,327,499,508,582,586,605,644,8201,BACKGROUND,CONCLUSION,DRUGS,EACH,EGFR,ERCC1,FDG,HOWEVER,HY11,HY20,LABEL,MED,METHODS,MONIT,NSCLC,ONCOL,PET,RESULTS,ROC,SCI,SUPPL
169,2013,AIM,AUSTRALIA,BACKGROUND,CONCLUSION,JOHN,KEY,LABEL,LTD,OBJECTIVE,PENDING,RATIONALE,RESULTS,SEVERAL,SONS,THESE,WILEY
HOWEVER
101,125,198,2003,655,799,841,AUSTRALIA,CRITICALLY,HOWEVER,JANUARY,JUNE,LABEL,MAIN,MDM,MDMS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OUTCOME,PATIENT,RESULTS,SCLC,SETTING,SMOKING,VICTORIAN
1000,945,A549,EPR,MDR,MULTIDRUG,P85,PTX,RNAI,TAXOL,THEREFORE,TPGS
DESPITE
AIM,CER,CERS,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
1980,1991,2011,2013,368,439,715,724,BLACK,CXR,ENGL,EVALUATION,LDCT,LUNG,MED,NLST,RESULTS,SCREENING,TEAM,TRIAL
504,BRAF,EGFR,FGFR3,ION,KRAS,MET,NINE,PGM,PTEN,SMAD4,STK11,THEREFORE,TORRENT,TP53
0004,001,009,4585,8202,ASIAN,EGFR,EIGHT,HRS,NSCLC,OVERALL,THEREFORE,TKIS
127,157,B7H3,CD146,CD31,CELL,ECS,FACS,FIRST,GENOMIC,IHC,THY,VWF
CDA,FDG,FIRST,NSCLC,PET,THERE
FINALLY,MDCT,NEXT,YET
946,GATA,GATA3,SMAD,SMAD3,SMAD4,TGF
METASTASIS

10001,333,ASSOCIATED,CERTAIN,MEDICAL,PUBLISHERS,SEVENTH,USA,YORK
0001,0030,0305,0323,0422,100,CONCLUSION,LABEL,MATERIALS,METHODS,MTS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFA,TTP
002,004,009,8805,ABC,BREATHING,CONCLUSION,CRT,LABEL,LTD,MATERIALS,METHODS,MLD,OBJECTIVE,PTV,PURPOSE,RESULTS,SEVERAL,SRT,SYSTEMS,V20
100,8804,EVIDENT,LABEL,LESIONS,LTD,MATERIALS,METHODS,MICROWAVE,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,TECHNICAL
945,CLINICALLY,EVALUATION,PCR,SOX2
2012,485,805,DATA,HOWEVER,IMPROVING,MAJOR,META,OCCURRENCE,VTE
233,290,300,8211,ACL,BOTH,EGFR,FURTHER,IHC,LESER,SKS,USUALLY
100,947,AMONG,FURTHER,IDIOPATHIC,PCR,THESE,THUS
277,LUNG
90Y,MIRD
945,BACKGROUND,CELL,CONCLUSION,CURRENTLY,HNSCC,LABEL,METHODS,RESULTS,USING
75TH,BACKGROUND,CELL,CONCLUSION,FDG,FIFTY,LABEL,METHODS,MTV,NSCLC,PET,RESULTS,SUV,THERE,TLG,UNDER
15MG,18WEEKS,500MG,60MG,AUC,BEV,CBDCA,CDDP,PEM,THEREFORE,THESE,UFT
000,2006,2011,FIRST,ICHUSHI,JAPAN,NEXT,OTHER
2MSV,6MSV,CHINA,MISREPAIR,RADIATION
2006,BAP1,HOWEVER,JAPAN,PM10,PM2,SARIHIDIR
EPIGENETIC,RIGHT
0054,119,121,166,167,169,183,2005,2010,2013,250,289,292,301,304,333,400,500,605,938,939,AVAILABLE,BACKGROUND,BETWEEN,COMPANY,COPYRIGHT,EGFR,ELI,FEB,FUNDING,HOWEVER,IMCLONE,INITIALLY,JAN,LABEL,LILLY,LLC,LTD,METHODS,NINE,NSCLC,RESULTS,SYSTEMS,USA
169,1S159,2013,945,946,A549,ANOIKIS,BCL,COPYRIGHT,GSK,H460,IC50,INC,MCL,NSCLC,SCREENING,THESE
001,1281,9935,ADJUSTMENT,AFTER,AMONG,BACKGROUND,BLACK,COX,END,FURTHER,LABEL,METHODS,RESULTS,SEER,UNADJUSTED
160,169,2013,COPYRIGHT,CRC,F56,HCT,HOWEVER,HUVEC,LTD,PBS,VCR
160,169,2013,956,BMDL0,COPYRIGHT,LTD,PREY,RIVER,THESE,VENG
169,2013,5AR,8AR,A549,BAX,BCL,COPYRIGHT,DPMA,LTD,ROS,THESE,VEGF
916,946,CD28,CD57,CD8,CONVERSELY,HIV,PERIPHERAL
10A,169,17A,2013,23A,A549,COPYRIGHT,HEPG2,MCF,MOST,PYRAZOL,SAR,SAS,THEIR
101,198,1ST,BACKGROUND,COLORECTAL,HEALTHY,LABEL,LTD,LUNG,MATERIALS,METHODS,OVARIAN,PCR,PLCO,PUBLISHED,RESULTS,RTEL1,RTL,SCREENING,TERT,THERE,THEREFORE,TRIAL
100,106,133,169,2013,215,8776,BED,BEDS,CARLO,CONCLUSION,COPYRIGHT,D95,EPL,HOWEVER,IRELAND,LABEL,LTD,MARSDEN,MEAN,METHODS,MLDS,MONTE,NSCLC,OBJECTIVE,PTV,PTVS,PURPOSE,RESULTS,SABR,TCP,TREATMENT
169,2013,945,AUTHORS,COPYRIGHT,HOWEVER,INC,KRAS,MEK,MICE,PI3,PUBLISHED,RAS,TOTAL
169,2013,ARF,BRD2,CIP,COPYRIGHT,INC,RAS,RUNX3,THESE,WAF
160,169,2013,CELL,COPYRIGHT,INC,LUCHINO
169,2013,945,CASTELLANO,CELL,COPYRIGHT,HOWEVER,INC,KRAS,PI3K,RAS
LUNG,NSCLC,RET
ALK,EGFR,FGF,FGFR,HOWEVER,LUNG,SINCE,TARCEVA

001,108,151,2002,2012,3N2M0,4N1M0,ACCORDING,BACKGROUND,BETWEEN,COLLEGE,COX,IIIA,LABEL,MARCH,MEDICAL,MEIER,METHODS,NSCLC,OBJECTIVE,OCTOBER,PFS,RESULTS,T4N0,THERE,UNION,UNIVARIATE
BACKGROUND,ELISA,EXPRESSION,LABEL,MEANWHILE,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,SERUM,SOX2
021,024,147,225,266,491,925,9312,9313,BACKGROUND,BOTH,COX,LABEL,LOG,LYMPHATIC,MEIER,METHODS,NSCLC,OBJECTIVE,RESULTS
013,046,177,2010,2012,531,600,604,632,669,718,822,903,AAH,AIS,AUC,BACKGROUND,BETWEEN,BLAND,GGO,HOWEVER,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,ROC,STUDENT,THEREFORE,WHILE
001,004,005,011,017,019,028,034,181,293,914,967,BACKGROUND,COX,CPT,CURRENTLY,DXL,ECOG,HOWEVER,IFO,LABEL,MEIER,METHODS,OBJECTIVE,ONCE,PFS,RESULTS,SCLC,SMALL,TAX,THERE,TPT,UNIVARIATE
177,956,A549,ARTESUNATE,BACKGROUND,HOWEVER,ICAM,LABEL,METHODS,MMP,MTT,OBJECTIVE,RESULTS,WESTERN

8201,BACKGROUND,CONCLUSION,DOSE,DVH,ELECTRONIC,EXTRA,HISTOGRAM,IMN,LABEL,MAJOR,MEAN,META,METHODS,MLD,RESULTS,SCF,SMOKING,TAMOXIFEN,TEN,V20GY,VDOSE
HOWEVER,MRI

0001,1004,2013,CD133,CONCLUSION,IHC,JULY,LABEL,META,METHODS,NSCLC,OBJECTIVE,RESULTS,WANFANG

BAC,CAREFUL,CCAM,CONGENITAL,POLYMERASE,THEREFORE,THESE
161,THERE
946,ALTOGETHER,H1299,MTT,NSCLC,SINCE,ZFX
945,946,DDX,DHT,THESE
153,A549,BRAIN,KDM5B,NSCLC,RNAI,SIRT1
0235,177,8201,916,DFS,III,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
100,1700,210,300,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
104,122,169,2013,2014,8201,BACKGROUND,CYTOPATHOL,FFPE,FNA,HOWEVER,LABEL,METHODS,MOLECULAR,MULTIPLEX,NEXT,NGS,NON,NSCLC,READ,RESULTS,SOCIETY,THERE,THESE
142,3P26,3Q26,6P25,CNA,CNAS
181,945,A549,ALKALOIDS,ANNEXIN,ASL,BCL,C57BL,ELISA,IC50,LEWIS,LINN,MTT,NSCLC,THEIR,THESE,TNF,WESTERN
ALK,ANTIBODIES,DOG1,ERG,ETS,GIST,HMG,LACK,LANGERHANS,MUC4,OCT3,PAX8,SALL4,SCHWANN,SOX10,SOX11,SRY,SV40,TREPENOMA
488H,948,954,956,B16,DAMGO,HUVEC,KOR,LEWIS,LLC,OPIOIDS,SNC80,THESE,TREATMENT,U50
102,169,2009,2011,2013,250,400,ARM,BACKGROUND,BETWEEN,CETUXIMAB,CISPLATIN,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LPFI,LTD,MAY,METHODS,NSCLC,OLCR,RESULTS
BACKGROUND,FOUR,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
1980,2013,2015,2030,445,AMERICA,AUSTRALIA,BAP1,FINAL,IFCT,INTERGROUP,MALIGNANT,MAPS,MPM,NORTH,PEMETREXED,PLEURAL,SURGERY
169,1945,2013,ESOPHAGUS,HIROSHIMA,INC,SOCIETY,WILEY
600,AFTER,CONTROL,LABEL,METHODS,NSCLC,RESULTS,ROS,T60V,THEIR,UNLABELLED
046,146,2000,2009,AMACR,BACKGROUND,COA,CONCLUSION,DATA,JUNE,LABEL,METHODS,RESULTS,SCC
2001,2011,BACKGROUND,CSP,FIVE,LABEL,METHODS,NINE,RESULTS,THREE
2012,2013,252,APART,DGP,GROUP,HEIDELBERG,MAY,NSCLC,PATHOLOGIE,PATHOLOGY,PULMONARY,SOCIETY,TNM,WORKING
8201,8322,A549,LABEL,METHODS,MFS,MICROARRAY,OBJECTIVE,OBJECTIVES,RESULTS,SURVIVING
0001,0008,001,005,BACKGROUND,CELL,CSSCD,DISEASE,HDL,LABEL,METHODS,RESULTS,SCA,TRIAL,TRV,VOC,VOCS
295,AIM,CONCLUSION,COX,DFS,H292,III,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PFS,RESULTS,SIRT,SIRT1,SIRTUIN
ACCORDING,BACKGROUND,CENTRAL,CIS,CNS,DATA,HOWEVER,INCIDENCE,IRR,IRRS,LABEL,METHODS,NATIONWIDE,RESULTS,THERE,THEREFORE
EGFR,H2170,H358,IC50,MET,NSCLC,PFS,SIMILAR,SU11274,THEREFORE,TKI,TKIS,WNT
0201,0449,8202,947,CURRENTLY,EGFR,HLA,HOWEVER,IFN,MHC,MQLMPFGCLL,NSCLC,T790M,TKI,TKIS,TREATMENT
0001,011,027,1576,545,BACKGROUND,CIS,CONCLUSION,CTCS,FURTHER,HOWEVER,LABEL,METHODS,NSCLC,RESULTS,RRS,SCIENCE,WEB
KNOWN,RBP,STRA6,THESE,VITAMIN
135B,FINALLY,HOWEVER,MSCS,SMAD5
001,27A,576,8202,BACKGROUND,CHINESE,CONCLUSION,COX,FURTHER,LABEL,LOG,METHODS,NSCLC,RESULTS,SNP,SNPS
A549,AMONG,ANNEXIN,ANXA4,FHIT
ABOUT,AFTER,BACKGROUND,CONCLUSION,GERMANY,LABEL,LUNG,METHODS,RESULTS,SMOKING
BASED,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,VALIDATION
169,2013,AUTHORS,ENDOGENOUS,INC,KNOCKDOWN,MBT,PUBLISHED,THESE,THUS,UICC,WILEY
128,8201,BACKGROUND,COLLEGE,CONCLUSION,GSTM1,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
157,181,3125,474,509,625,662,AILUROPODA,FURTHER,HEP,L24,L24E,PRIMARY,RPL24
001,002,005,191,BACKGROUND,CONCLUSION,COR,DFS,EVEN,FDG,LABEL,METHODS,NSCLC,PET,PRE,PVE,RESULTS,SUV,SUVS
471,ABL1,BACKGROUND,CONCLUSION,DESPITE,EFGR,ERBB2,HRAS,KRAS,LABEL,METHODS,MLH1,NSCLC,ONCOMAP,RESULTS,TP53
104,BACKGROUND,CONCLUSION,EGFR,ERLOTINIB,LABEL,MEDICAL,METHODS,NSCLC,PFS,RESULTS,THERE,TKI
0091,2004,2013,208,BACKGROUND,CONCLUSION,CONFIDENCE,EGFR,FIFTY,HOWEVER,LABEL,METHODS,NSCLC,RESULTS
100,AES,AIM,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SBRT
120,140,174,2650,BACKGROUND,CONCLUSION,GRADE,HOWEVER,LABEL,MBC,METASTATIC,METHODS,RESULTS,TAXOL
AIM,BACKGROUND,CONCLUSION,CTCS,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
FDG,FLT,HOWEVER,NSCLC,PET,THESE
126,148,169,183,2010,2011,BACKGROUND,BASED,DEVIATION,EACH,GEORG,HALLE,JANUARY,LABEL,METHODS,OTHERWISE,RESULTS,SAALE,STUTTGART,THERAPY,YORK
002,169,183,469,BACKGROUND,CONCLUSION,CRYOPROBES,DIFFERENT,GEORG,HOWEVER,LABEL,METHODS,RESULTS,STUTTGART,YORK
2006,2008,661,ABOUT,CONCLUSION,LABEL,METHODS,NOPR,ONCOLOGIC,PET,PLANNED,RESULTS,UNLABELLED
945,AKT,AUGMENTED,CONCLUSION,CONVERSELY,FDG,FINALLY,GLUT,HENCE,HIF,LABEL,LEWIS,METHODS,MG132,PET,RESULTS,RNAS,ROS,SCAVENGING,T47D,UNLABELLED
121,ALK,CD56,CK5,CK7,EGFR,EXPRESSION,FISH,KIRSTEN,KRAS,L858R,LCC,LLC,MOLECULAR,TTF
100,115,135,150,160,BACKGROUND,CONCLUSION,DOSE,ERLOTINIB,IIIB,LABEL,METHODS,MTD,NON,NSCLC,RESULTS,THERE
022,124,169,3N0,414,4N0,8201,ANOTHER,BACKGROUND,CLASS,CONCLUSION,III,LABEL,MATERIALS,METHODS,NAC,NSCLC,POTENTIAL,RESULTS,THUS,TUBB3
0004,016,246,817,BACKGROUND,DIET,FURTHER,LABEL,MALM,METABOLITE,METHODS,ORS,RESULTS,SWEDISH,WHOLE
945,946
7802,954,A549,BAY11,F14,MDR,MDR1,NAM,SINCE,SIRT1,TAKEN
954,AKT,COX,ERK,MCF,METASTASIS,MMP,MOST,OVERALL,PGE2,SIMILARLY,SUBSEQUENT,THUS,TIMP,TPA
021,174,1998,2007,3480,AMONG,BACKGROUND,HIV,LABEL,METHODS,OBJECTIVE,OBJECTIVES,ODDS,RESULTS
METASTASIS,POTT
00099,001,0013,1004,169,2014,215,945,BACKGROUND,CD74,CDC53,CONCLUSION,COPYRIGHT,DIEGO,HAPLOTYPE,INC,LABEL,MACROPHAGE,METHODS,MIF,NSCLC,RESULTS,SAN,SCF,SKP1,SNPS,TFII
1985,2000,2005,2007,DATA,FUKUI,HOWEVER,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THREE
100,8805,900,947,956,ALLEIASCL,CD8,ELISPOT,HIGH,HLA,IDO,IDO5,IFN,III,KYN,LABEL,METHODS,MONTANIDE,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,TREG,TRP
001,1998,2009,8804,APRIL,BACKGROUND,LABEL,METHODS,PULMONARY,RESULTS
169,176,191C,2013,216G,956,BACKGROUND,CONCLUSION,DMSO,DUE,EGFR,GENOMIC,INC,LABEL,METHODS,MGCL2,PCR,POLYMERASE,RESULTS,WILEY
3506,4467,7639,8805,CELLSEARCH,CTC,CTCS,DETECTION,LABEL,METHODS,NINE,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
117,152,169,193,2013,2020,215,8201,CODES,COMPARISON,CONTINUUM,COPYRIGHT,DEPARTMENT,GROUP,HEALTHY,JOHN,LABEL,LTD,LUNG,METHODS,OBJECTIVE,RESULTS,RURAL,RURALNESS,SEER,SONS,URBAN,WILEY
131,218,733,ASSOCIATED,CUMULATIVE,LABEL,LOWER,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNU,SIMILAR,UTUC
0028,0061,195,298,515,ESCC,ESCCS,EXPRESSION,LABEL,METHODS,NOTCH,OBJECTIVE,PURPOSE,RESULTS,THEREFORE
2005,2013,324,653,658,946,ABSTRACTS,BACKGROUND,CENTRAL,CONCLUSION,CONTROLLED,CVD,DATA,DUAL,EFFECTS,EXTRACTION,FUNDING,HEALTHCARE,HIGH,JANUARY,LABEL,LIMITED,MEDLINE,METHODS,NEITHER,OBJECTIVE,PRIMARY,PURPOSE,QUALITY,RESULTS,REVIEWS,SELECTION,SOURCES,STUDIES,SYNTHESIS,SYSTEMATIC,VITAMIN
16S,CALU,CARIBBEAN,ESI,NMR,SMENAMIDES,STRUCTURES,THEIR
027,036,204,340,5H1,CD274,EXPRESSION,FURTHER,GREEK,NSCLC,QIF,TMA,TMAS,UNIVERSITY,YALE
001,030,CLONOGENIC,DIRECTION,H1299,H460,MLC
169,2013,COPYRIGHT,DUE,ERK,FLOTILLIN,FLOTILLINS,HOWEVER,INC,INCREASED,THESE
ASIAN,BACKGROUND,CASE,CONTEXT,ENGLISH,EUS,FNA,FOLLOWING,IPMN,LABEL,METHODS,PANCREATIC
169,2013,COPYRIGHT,INC,LUNG,MALIGNANT,OFTEN,PUBLISHED,THERE,WHETHER
169,2013,COPYRIGHT,INC,STUDIES,WAR,WORLD
169,2013,ANY,COPYRIGHT,FDG,FIVE,HIGH,IRELAND,LABEL,LRC,LTD,MATERIALS,MEIER,METHODS,MPM,OBJECTIVE,PFS,PURPOSE,RESULTS
10B,252,8201,A549,BACKGROUND,CCK,CELL,CONCLUSION,EXPRESSION,KIT,KLF4,LABEL,METHODS,NSCLC,PCR,RESULTS,THUS,WESTERN
001,019,1459,160,169,2013,239,277,BASED,BOTH,CONCLUSION,COPYRIGHT,HER2,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,PMD,RESULTS,SMD,THERE,WHILE
001,169,1970,200,2001,2011,2013,736,ADJUSTMENT,COLORECTAL,COPYRIGHT,COX,DCCG,GROUP,LABEL,LTD,MAY,METHODS,OBJECTIVE,PATHOLOGY,PATIENT,RESULTS,SCCM
1970S,1980S,8764,BOTH,CASR,CHINA,RESIDENTS,THERE
443,BACKGROUND,ELISA,HIGH,LABEL,METHODS,NSCLC,OPN,PCR,RESULTS,SERUM,SNP,THERE
486,NSCLC,RCA
ALPINIA,BACKGROUND,DAPI,JOHOR,LABEL,LC1,LC10,LC4,MCF7,MEANWHILE,METHODS,MRC,PENINSULAR,RC1,RC18,RC5,RESULTS,SKOV,SUB,TEN,TERENGGANU,THERE,VLC1,VLC17,VLC9
ANALYTICAL,CPT,HPLC,HVGGSSV,NPS,PTX,RESULTS,TEM
945,946,GSK3,HOWEVER,MET,NSCLC,SUBSEQUENT,TIVANTINIB
169,2013,945,GMBH,H1299,KGAA,MCF7,MTT,NMR,PEG,VCH,WILEY
169,2014,AKT1,CONCLUSION,EGR,EMT,HCC,LABEL,LIVER,M2B,PTEN,RRM2B,THESE,UNLABELLED
169,2013,A549,CPT,EXPRESSION,HOWEVER,KNOCKDOWN,MAPK,NOXIN,RPA1,THESE,THUS,TSA,UICC
160,ADP,ANTITUMOR,C7OX,CHOP,H1299,LDH,NSCLC,PARP,ULMUS
954,ACTIVATING,FOXM1,G12D,IKBKB,JNK,JNK1,JUN,KRAS,LUNG,MYC,NFKB1,NFKB2,PTTG1,RAS,RELA,SFTPC,TRANSGENIC
STAGE,THERE
160,181,8209,A549,BAX,H1975,NCI,NSCLC,SORAFENIB,THESE,WESTERN
177,1998,2008,243,BRITISH,DIAGNOSIS,EXCELLENCE,FURTHER,INSTITUTE,JANUARY,LABEL,MARCH,METHODS,NINE,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY
1998,2007,AMONG,BACKGROUND,CONCLUSION,COPD,CZECH,DENMARK,HUNGARY,ITALY,LABEL,METHODS,RESULTS,SMOKING,SPAIN
001,045,136,141,ALK,BACKGROUND,CNG,DFS,EGFR,KRAS,LABEL,MET,METHODS,RESULTS
2005,2008,9TH,CODES,CONCLUSION,JANUARY,LABEL,METHODS,RESULTS,THOSE,UNLABELLED,VTE
169,2013,264,4T1,945,954,956,AIV,AMERICA,BACKGROUND,BALB,BIO,CENTRAL,COX,ELISA,GMELL,HELA,IRELAND,LABEL,LPS,LTD,MACROPHAGE,MATERIALS,METHODS,PGE2,PUBLISHED,RAW,RELEVANCE,RESULTS,RUBIACEAE,SOUTH,SUB,TNF,UNCARIA
ACM,GGO,PULMONARY
3CM,4DCT,DIR
169,2013,AKT,CDH1,EGFR,FEDERATION,PUBLISHED,SOCIETIES,THESE,YBX1
100,169,2013,47D,945,946,956,COPYRIGHT,GI50,HBL,HELA,OVERALL,SAS,WIDR
0296,169,2014,COPYRIGHT,EDUCATION,INC,IQR,LABEL,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
169,2013,A427,ADP,AMONG,CONSISTENT,COPYRIGHT,H520,INC,PAR,PARG,POLY,RADIATION,THESE
1000,169,2014,215,500,COPYRIGHT,FINALLY,INC,MOLECULAR,NEXT,NGS,PATHOLOGY,PUBLISHED,SOCIETY,TOOLKIT,VAFS
001,156,169,2013,449A,95D,A549,COPYRIGHT,E2F3,FURTHER,IRELAND,LTD,THESE
169,2013,A549,CARCINOMAS,CARM1,CELL,COPYRIGHT,H1299,LUNG,NEUROMEDIN,NON,NSCLC,PRMT,PRMT1,PROTEIN,SAS,SMALL,TARGETING,THEIR
012,018,028,036,117,169,2013,ATS,COPYRIGHT,ERS,GGO,GMBH,IASLC,SICA
0001,0003,040,0959,160,169,2009,2011,2014,476,502,592,600,837,8805,BACKGROUND,COPYRIGHT,INC,INPATIENT,LABEL,METHODS,MOSBY,NINTH,PREMIER,PROCEDURES,PUBLISHED,RATS,RESULTS,SURGERY,USING,VATS,VIDEO
169,1998,2007,2013,BACKGROUND,BYM,CLASSIC,CONCLUSION,COPYRIGHT,DATA,DIC,FOUR,ISERE,LABEL,MAPPING,METHODS,MORAN,POISSON,RESULTS,SAS,SIRS
006,012,025,027,160,169,2014,ADHERENCE,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,HRQL,INC,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS
169,177,2014,288,947,COPYRIGHT,EPID,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,TRANSIT
160,169,2013,331,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FIVE,FORTY,HER2,HOWEVER,LABEL,LTD,MBC,METHODS,PFS,RESULTS,SEVENTY,TIME,TTP
0004,0009,005,028,169,184,2014,ADC,ADCS,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,EXPRESSION,HIGH,IGF1R,IHC,INC,LABEL,METHODS,NSCLC,RESULTS,SCC,SCCS,WESTERN
169,2013,CD1D,CONVERSELY,COPYRIGHT,LTD,MHC,MICROBIAL,NATURAL,NKT
001,005,169,2013,241,442,BACKGROUND,CONCLUSION,COPYRIGHT,ESPA,LABEL,METHODS,NSCLC,PFS,PORTUGUESA,PUBLISHED,RESULTS,SOCIEDADE,STAGE,UNIVARIATE
001,005,011,021,100,169,185,2004,2010,2013,8805,ADVERSE,BETWEEN,COPYRIGHT,CURRENTLY,GROSS,HOWEVER,INC,LABEL,MATERIALS,MEIER,METHODS,MOST,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SBRT,THESE
130,240,878,946,BACKGROUND,CANCERS,CONCLUSION,FFPE,LABEL,METHODS,RESULTS,SIRNA,THESE,TNBC,WNT,WNT3A
160,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,RENAL
BACKGROUND,CYP,DESPITE,ECTOPIC,H2DCFDA,LABEL,METHODS,P450,RESULTS,ROS,THESE,UPR,XBP1
169,2013,CELL,CONCLUSION,COPYRIGHT,EVALUATION,FNAC,LABEL,METHODS,NPV,NUCLEAR,OBJECTIVE,P63,PPV,PRODUCTION,PURPOSE,RESULTS,SCC,SIMILARLY,TTF
169,177,1999,2011,2014,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,NSCLC,PERFORMING,PUBLISHED,RESULTS,SOCIETY
001,005,012,040,169,2014,923,ASC,BACKGROUND,COPYRIGHT,FIFTY,GGO,INC,LABEL,METHODS,PERIPHERAL,PUBLISHED,RESULTS,SCC,SOCIETY
001,004,130,408,529,BOTH,NPC,THEREFORE,UNIVARIATE
156,169,2013,ADDITIONAL,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LEBANON,LTD,LUNG,METHODS,ORA,PUBLISHED,RESULTS,SAUDI,WATERPIPE
169,2013,9MONTHS,COPYRIGHT,LTD,PUBLISHED,SKIN
169,2013,ALK,AMONG,BECAUSE,BIOMARKERS,BRAF,COPYRIGHT,EGFR,HER2,INCA,KRAS,MET,PI3K,SAS
1119,1405,157,160,191,2009,2010,3477,348,ADELPHI,BACKGROUND,BONE,CRPC,DATA,DISEASE,DSP,GERMANY,ITALY,LABEL,LHRH,MAY,METHODS,MOST,OVERALL,PROGRAMME,REAL,RESULTS,SPAIN,WHILE,WORLD
AREAS,BACKGROUND,COVERED,DUE,LABEL,METHODS,OPINION,WHILE
AMONGST,CNS,CXCR4,HIGH,MOLECULAR
H23,MLH1,MMR,NCI
113,12P12,134,16P,192,210,21Q,309,413,457,5Q34,6Q16,7Q11,914,BACKGROUND,EGFR,GENOMIC,KRAS,LABEL,METHODS,RESULTS,SEVERAL,SUPERVISED
001,002,007,009,112,129,153,161,185,219,723,791,8312,860,8806,AUC,BACKGROUND,CONCLUSION,FACTORS,FDG,HMLN,HOWEVER,INTEGRATED,LABEL,LYMPH,METHODS,NODAL,NPV,NSCLC,PET,PPV,RESULTS,ROC,SUV,UNIVARIATE
0005,013,030,181,EGFR,HIGH,HMSH2,HOWEVER,KI67,KRAS,MMR,MUTATIONS,NSCLC,PCNA,TKIS
200C,A549,BESIDES,EMT,FCM,MICRORNAS,MIR,VEGF
051,053,060,107,177,2010,2013,682,786,810,AGE,AUC,CEA,CHINA,CYFRA21,FRIENDSHIP,JAPAN,LABEL,MAYO,METHODS,OBJECTIVE,RESULTS,ROC,SERUM,SPN,UNIVARIATE,UNIVERSITY
AUC,CENTRIFUGE,CHIP,EVALUATION,HOWEVER,KRAS
1966,2012,CIS,FIXED,FURTHER,HOWEVER,JANUARY,MEDLINE
005,100,101,106,177,244,BACKGROUND,BRCA1,CONCLUSION,EBUS,EGFR,ERCC1,LABEL,METHODS,NOS,NSCLC,OFTEN,OVERALL,RESULTS,RRM1,SAMPLES,TBNA,THERE,THUS
0010,0058,0059,0077,0149,0191,0294,0333,0425,048,2641773,BOTH,CHINESE,CONSISTENT,GGC,MUC4,MUCIN,SNPS
1559,1679,215,8202,AFTER,CHINESE,FURTHER,HOWEVER,LABEL,PP2A,PPP2R1A,PPP2R1B,PPP2R2A,PPP2R2B,PPP2R5C,PPP2R5E,PROTEIN,SNP,SNPS,UNASSIGNED,UNLABELLED
945,947,EARLIER,FRIZZLED9,GPCR,HOWEVER,PPAR,Q212L,TAKEN,WNT,WNT7A
CETUXIMAB,CTX,EGFR,H226,KI67,NCI,THESE
618,FINALLY,GNE,NAD,NAMPT,THUS,WHILE
169,2013,AACR,ATG7,BRAFV600E,STROHECKER
008,022,125,1992,2008,AMONG,CONCLUSION,HOWEVER,IIIA,LABEL,METHODS,OBJECTIVE,RESULTS,STAGE,TRUE
169,2014,33258,8197,8320,8322,8325,956,A549,ACHN,BAX,BCL,COPYRIGHT,GMBH,HOECHST,KGAA,METHOXY,MOLECULAR,THESE,VCH,WILEY
516,945,946,CKD,CONCLUSION,ESPECIALLY,EXTENSIVE,H460,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,S516
169,2013,AACR,DEPLETION,LABEL,MMP14,MMP2,MMP9,NEDD9,SIMILARLY,TIMP2,UNLABELLED
2010,2011,226,CHOROIDAL,FURTHER,HOWEVER,JANUARY,KAOHSIUNG,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THREE,TREATMENT,UNIVERSITY
001,316,BACKGROUND,END,GUIDELINE,GUIDELINES,INSTITUTE,LABEL,METHODS,NSCLC,RESULTS,SECONDARY,SEER,TBNA,TEXAS,THERE
EGFR,HERCULEAN
ACC,AMLV,GALV,MESO,NEXT,NOTABLY,PCR,PIT,RETROVIRAL,RRV,RRVS,THESE
AFTER,APL,BACKGROUND,CD117,CD34,CELL,CONCLUSION,CYTOTOXIC,LABEL,LEUKAEMIC,METHODS,MTT,NOD,PHO,PML,RARA,RESULTS,SCID,SYNTHETIC
CONCLUSION,CRT,D95,FURTHER,HOMOGENOUS,HOWEVER,IMRT,INTENSITY,LABEL,MATERIALS,MEAN,METHODS,OAR,OBJECTIVE,PTV,PURPOSE,RESULTS,THESE,VMAT
100,8322,8804,956,EGCG,THESE
169,2013,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,IVL,PBM,PUBLISHED,SOCIETY,ZEALAND
100,177,186,200,8211,8722,DYNALOG,ECLIPSE,HOWEVER,IMRT,PLDR,PTV,RMS,SIX,TEN,TPS,VMAT
169,2013,COPYRIGHT,GLUT1,H1299,LTD,PUBLISHED
DUSP3,EPIGENETIC,ERK1,H3K36,HIGH,HISTONE,KDM2A,NSCLC,THESE
10GY,169,2013,30GY,35GY,56GY,MEDICAL,OARS,PTV,PUBLISHED,THESE,V10,V20,V30,XIO
T1BN0M0,VATS,VIDEO
10908,AES,CENTRAL,CONCLUSION,GROUP,JAPAN,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVENTY,SURGERY,TOTAL
THESE
945,CHEST,CSF,NINE,TNF
1986,ENGLISH,SINCE
PAP,PULMONARY,THERE,THESE
TEN,THERE
LEFT,ONCE
169,2013,ALK,AUTHORS,CHINESE,COPYRIGHT,CRC,EGFR,EML4,FORTY,G12R,G719A,INC,INTRATUMOR,KRAS,LOW,MET,NSCLC,PUBLISHED,THREE,ULTRADEEP
100,169,2014,956,COPYRIGHT,CTC,FNA,INC,LABEL,NMR,UNASSIGNED,UNLABELLED
169,2013,AUR,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PUBLISHED,RATIONALE,RESULTS,THERE
2013,COPYRIGHT,FIFTEEN,SLACK,SURGERY,T12
169,1997,2010,2014,924,BACKGROUND,BETWEEN,COPYRIGHT,ERF,ESOPHAGEAL,INC,LABEL,METHODS,OVERALL,PUBLISHED,RESULTS,SOCIETY,TEN
946,APC,APCMUTANT,COLI,FAP,GIVEN,HOWEVER,MUTATIONS,POLYPOSIS,SEVERAL,WNT
2006,2010,2630,402,BMI,CAP,CIS,CONCLUSION,COPD,COX,FACTORS,ICS,LABEL,MEIER,METHODS,OBJECTIVE,PNEUMONIA,RESULTS,RISK,SETTING
DMAPT,GIVEN,LUNG,MCL,PARP,STAT3,THESE,WESTERN
570,590,BACKGROUND,E2F1,LABEL,LUNG,MYC,NFKB1,RB1,RESULTS,TFS
BACKGROUND,BILATERAL,LABEL,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS
ALVEOLI,BACKGROUND,CONTEXT,FRESH,LABEL,METHODS,MPM,OBJECTIVE,RESULTS
0449,200,200B,946,A549,A549M,BACKGROUND,CSC,EARLIER,ECTOPIC,EGFR,EMT,EPCAM,EPIDERMAL,EPITHELIAL,GDC,H1299,HOWEVER,INHIBITION,LABEL,METHODS,NANOG,NON,NSCLC,RESULTS,SOX2,TGF,THEREFORE,TKII,TKIS
001,002,004,016,160,169,196,2014,207,511,8804,8805,ACCORDING,COPYRIGHT,DFS,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,SURGERY,UNIVARIATE
169,2013,956,A20,ALK,BACKGROUND,COPYRIGHT,CRIZOTINIB,E13,EGFR,EML4,ERBB2,H3122,IRELAND,LABEL,LTD,METHODS,NCI,NSCLC,RESULTS,THESE,TKI,TKIS
0942,100,169,2013,998,AMONG,COPYRIGHT,EARLY,IRELAND,LTD
ARG,ASN,CYS,FINALLY,GLY,ILE,LEU,PHE
169,183,ASCO,GEORG,JUNE,SEVERAL,SOCIETY,STUTTGART,YORK
001,10B,128,160,201,634,720,COX,EGFR,EGRF,FIRSTLY,HOWEVER,MEANWHILE,NSCLC,THUS
100,136,248,594,8201,ARMS,BRAIN,CHINA,EGFR,MEIER,NSCLC,PFS,SOUTH,THEREFORE,TKI
0001,001,115,53BP1,BRCA1,MDC1,MMSET,NSCLC,PCR,PIAS4,RNF8,UBC13,UBC9
001,1999,2009,508,8201,916,AMONG,CONVERSELY,IMPORTANCE,INPATIENT,JANUARY,LABEL,MAIN,METHODS,NATIONWIDE,OBJECTIVE,RELEVANCE,RESULTS,SETTING,THERE,VTE
BCL2,BH4,NDP,REMOVAL,RNR
10B4,177,AFTER,B16,CCL4,CCR5,CHEMOKINE,CLL,ERDR1,F10,LABEL,MAP2K,MEF,MEFS,PI3K,PMC,THEREFORE,U0126,UNLABELLED
160,8201,ANOVA,AVECT,CONCLUSION,DICE,EXP,EXPCT,INSP,INSPPET,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RIGHT,SPECT,THESE,TUKEY
BLP25,DESPITE,HOWEVER,MAGE,NSCLC,REMARKABLE
100,105,177,2002,2013,CONCLUSION,FINALLY,FOUR,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX,TECHNICAL,TEMPORARY
2009,CA19,CEA,FOLFIRI,HOWEVER,JULY,OCTOBER,SKIN,THERE
2009,2010,2011,CD4,HIV,MAY,OCTOBER,THEREFORE
150,ADL,EGFR,FINALLY,FIRST,HOWEVER,OWING,QOL,THEREAFTER
COPD,EMT,HOWEVER,QIN,SMALL,TYPE,WANG
AMRUBICIN,BACKGROUND,CASE,EGFR,ERLOTINIB,GIVEN,L861Q,LABEL,LEWIS,METHODS,SERUM,SEVEN,SMALL,STAGE,WHOLE
001,002,008,015,023,026,028,213,253,361,685,899,ALK,HOWEVER,KNOWLEDGE,MOLECULAR,SPATIAL
1062,31811,36333,5P15,611,BACKGROUND,BESIDES,CHINESE,CONCLUSION,HOWEVER,LABEL,LUNG,NSCLC,ORS,RESULTS,SNP
2000,2006,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VALUE,VOI
001,006,027,106,160,215,600,8805,AFTER,ASSESSMENT,EGFR,FDG,HIGH,III,LABEL,METHODS,MTV,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,TLG,UNIVARIATE,WHOLE
945,954,A549,FURTHER,H460,LC3,OEL,ROS,THESE
450,700,DIAGNOSTIC,HIGH,HT29,HTPWS
002,003,012,109,147,CONCLUSION,KDR,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SINCE,THESE
001,013,024,029,239,307,354,947,CD11B,CD14,CD33,CD8,CHANGES,CONCLUSION,FINALLY,IFN,III,LABEL,MDSCS,METHODS,NON,NSCLC,OBJECTIVE,PBMCS,PURPOSE,RESULTS
250,305,ADVERSE,AIM,CONCLUSION,IIIA,LABEL,METHODS,OBJECTIVE,RESULTS
AIM,CONCLUSION,EACH,ENB,FORTY,HIGH,LABEL,METHODS,OBJECTIVE,PNS,RESULTS,ROSE
0437,167,179,346,ABSORBABLE,AFSP,AIM,AIR,CONCLUSION,LABEL,METHODS,OBJECTIVE,OCCURRENCE,RESULTS
8764,EGFR,L858R,LEU858ARG,PCR
110,EGFR,HOWEVER,KRAS,LAC,NLAC,PATIENT,RAS,THERE,Y1173
827,DETECTION,EGFR,FISH,H1975,HCC,INCREASED,NCI,NSCLC,TKI,TKIS
169,2013,203,3T3,AACR,DCUN1D5,KNOCKDOWN,LABEL,METHODS,NIH,NLS,OBJECTIVE,PCR,PONY,PURPOSE,RESULTS,RNAI,STRUCTURE,WESTERN
AIR,EASTERN,GOF,GWR,HIGH,HOWEVER,NO2,OVERALL,SAUDI,THESE
169,2013,BACKGROUND,BASEL,CONCLUSION,DATA,LABEL,MATERIALS,METASTASES,METASTATIC,METHODS,PRIMARY,RESULTS,THEIR,THERE,UNUSUAL
011,1958,2010,248,8805,931,AMONG,FDRS,SIRS,SWEDISH,USING
169,1V270,2013,BASEL,CD11C,H1N1,HOWEVER,PULMONARY,THEREFORE,TLR,TLR7,TOLL,VENEZUELAN
169,2013,250,ALK,CAUCASIAN,COPYRIGHT,EGFR,IRELAND,KRAS,LTD,MAJOR,MET,PET,ROS1
1209,169,2013,4D8,956,AUTHORS,B10,COPYRIGHT,EGFR,EPIDERMAL,HOWEVER,IRELAND,LOSS,LTD,MOST,NSCLC,PUBLISHED,RESISTANT,T790M,TKIS
0001,169,2010,2011,2013,548,ASIAN,BACKGROUND,BRITISH,COPYRIGHT,EGFR,IPASS,IRELAND,JUNE,LABEL,LTD,MARCH,METHODS,NORTH,NSCLC,RESULTS,SIXTY
160,229,A549,APOPTOSIS,BACKGROUND,CELL,CELLS,DAPI,FACS,LABEL,METHODS,NICOLETTI,PANC,RADIATION,RBE10,RESULTS,SMALL,TREATMENT,WIDR
8230,ADDITIONAL
ALK,CTLA4,EGF,EGFR,KRAS,NSCLC,PD1,VEGF
0001,0017,132,150,169,174,2013,220,290,916,BACKGROUND,BASEL,BGA,COX,CPX,CVB,DECLINE,DLCO,FEV1,FVC,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PULMONARY,RESULTS,TLC,TREAT
009,2000,2007,520,540,BACKGROUND,COX,END,HEREDITARY,HHT,LABEL,MEIER,METHODS,RESULTS,THERE
BRCA1,NSCLC,PARP,TREATMENT
DRUGS,EGFR,EPIDERMAL,HOWEVER,III,NSCLC,PRE,SEVERAL,VEGF,VEGFR
BMBU,BMCHF,BMET,BMHX,HOLOPTELEA,PLANT,ROXB,THESE
001,177,8201,A549,FBS,GNC,MTT,S6S,STAT6
1588,CHIP,FAP1,HCC,HDAC5,HOWEVER,MES,PTP,PTP1E,PTPL1,PTPLE,STAT3,THUS,USING
CNA,CNAS,THESE,USING
146,2003,2008,2012,ASCO,ASTRO,CNS,FIRST,MEDLINE,NEXT,QOL,THERE
A549,CRYSTAL,HETERACTIS,LUNG,MTT,THESE,VENOM
125,155,639,688,722,889,CEA,OOP,PCR,ROC,USING
176,AIM,BACKGROUND,CONCLUSION,FOUR,LABEL,LEIOMYOMAS,METHODS,OBJECTIVE,OPEN,OPERATIONS,OTHER,TECHNIQUE
BACKGROUND,COMMITTEE,CONCLUSION,ENDOSCOPIC,EUS,HOWEVER,III,JOINT,LABEL,METHODS,RESULTS,THERE
024,0773,2013,3984,4033,CANCER1,COMPLETED,ENOBOSARM,GTX,III,LABEL,LGD,MAY,OBJECTIVE,PHASE,PREVENTION,PURPOSE,RESULTS,SARM,SARMS,SUMMARY,WASTING
000,009,032,138,140,228,255,469,662,757,8201,CAUCASIANS,GSTT1,HOWEVER,THERE
1940S,2003,HOWEVER,PACKHAM,YEOW
0001,0004,3106,AFTER,BACKGROUND,CLINICIANS,CONCLUSION,DESPITE,E2Z02,EASTERN,ECOG,GROUP,LABEL,METHODS,QOL,RESULTS,SOAPP,SYMPTOM,THESE,UNIVARIATE
200,250,400,BACKGROUND,CETUXIMAB,CONCLUSION,HOWEVER,III,LABEL,METHODS,MOLECULAR,NSCLC,RESULTS,S0819,SECONDARY,THERE
169,2013,947,954,COPYRIGHT,IRELAND,LTD,NSCLC,TAKEN
263,ARAF,ARHG5,CD11A,CD11B,CELLS,EGFR,GLU2B,GRB2,MK12,SHC1,TKI,TKIS
100,181,183,946,CYANOPHORA,FLASH,THESE
0008,0245,169,2013,235,268,271,397,501,668,72492,AUC,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MEAN,METHODS,MPV,MST,NSCLC,PUBLISHED,RESULTS,ROC,THESE,UNIVARIATE
169,2013,BOTH,COPYRIGHT,INC,OSHA,OVERALL,STUDIES
3P26,3Q26,6Q25,CNV,CNVS,COPY,LUNG,THESE,THREE
001,011,015,134,136,169,187,2013,8804,8805,AFTER,BACKGROUND,CONCLUSION,COPYRIGHT,COX,INC,LABEL,METASTATIC,METHODS,NSCLC,RESULTS
169,2013,COPYRIGHT,INC,NSCLC
131,2009,2010,245,3508,BACKGROUND,CAUCASIAN,DATA,EPICLIN,HEALTHCARE,LABEL,LUNG,MANAGEMENT,METHODS,MOST,NSCLC,PATTERN,RESULTS,SURGERY,THERE
2009,2011,AFTER,CHINESE,CONCLUSION,COX,INTEGRATED,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,RESULTS,WESTERN
HEAD,LUGOL
1969,1971,2000,2007,9033,COAL,COPD,COX,HRK,LABEL,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,RESPIRABLE,RESULTS,SMR,UNDERLYING
004,017,018,023,032,034,169,2013,AOI,AOS,EACH,INC,META,SNPS,THERE,THESE,WILEY
106,2004,2011,547,BETWEEN,LABEL,LVI,MAY,METHODS,OBJECTIVE,OVERALL,RESULTS
945,CNA,EMT,METASTATIC,NOTABLY
ACTIVATION,ATP,GLS,GSH,HOWEVER,METABOLIC,PHGDH,TAP73,TCA,THESE
150,240,253,260,300,8805,CD74,D4D6,EZR,ROS1,SIMILAR,TMAS
001,002,020,042,1038,1995,2009,2011,214,824,8764,8805,ATS,CRIBRIFORM,ERS,HOWEVER,IASLC,LUNG,SOCIETY
34A,946,CD133,CONVERSELY,CRC,ECTOPIC,EMT,LGR5,MET,MYC,SNAIL,TAKEN,ZBP
INHALATION,LUNG,SEVERAL,SRRE
006,105,626,636,659,679,771,800,CEA,EBC,LUNG,MARKERS,NSCLC,NSE,ROC,SCC
160,945,AMONG,ASYMMETRIC,IC50
002,003,004,014,024,029,033,038,043,EGFR,EGYPT,FHIT,FURTHER,MSH2,NSCLC,SCC
15Q14,19P13,BRD4,DESPITE,HPV,NCS,NONE,NUT
169,174,177,2013,213,231,300,945,956,A549,ASP,CONGO,D9K,E6K,GLU,HEPG2,LC50,MDA,NH2,PIPIDAE,PRO,STRUCTURE
2000,9231,AIM,CLIA,CONCLUSION,HIGH,LABEL,MAGLUMI,METHODS,OBJECTIVE,RESULTS,ROC,SCCA,THERE,THESE
001,1516,1851,8810,HOWEVER,IDRI,KUHNIGK,LIDC,MEASURING,OVERALL
169,2013,COPYRIGHT,LTD
001,169,2014,COPYRIGHT,EGFR,EPIDERMAL,FALSE,FFPE,G179A,HOWEVER,IFCT,INC,INSTITUTE,KRAS,L858R,L861Q,MOLECULAR,MUTATED,PATHOLOGY,PCR,PUBLISHED,SOCIETY
169,2013,231,250MG,A431,A549,ALKP,ANTI,BASED,CELL,COPYRIGHT,DPPH,GMBH,GSH,HEPG2,MCF,MDA,MTT,MUSE,RESULTS,SGOT,SGPT
100,14CM,169,2013,AFTER,BECAUSE,COPYRIGHT,FIVE,FOLLOWING,INITIALLY,PUBLISHED,SAS
163,169,2013,5MM,BACKGROUND,CBCT,CHANGES,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
008,009,021,041,044,073,135,140,169,175,2013,204,457,8805,COPYRIGHT,DATA,DFS,IIIA,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,POCRT,POCT,RESULTS
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,EACH,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RST,SCANNED,TCS,THEREFORE
007,063,100,150,169,2013,868,8805,945,946,CONCLUSION,COPYRIGHT,CTCAEV4,EQD,FACTORS,GRADE,IRELAND,ITV,LABEL,LTD,METHODS,MLD,OBJECTIVE,PREDICTORS,PTV,PURPOSE,RADIATION,RESULTS,RPA,SEVENTY,TOTAL,V10,V50
169,2013,COPYRIGHT,HCC,HOWEVER,IRELAND,LTD,RNAS,THUS
012,1107,1110,1138,1353,169,1705,1797,1986,1987,1988,2006,2007,2008,2013,2259,240,242,245,267,2736,295,577,773,7827,904,AUSTRALIA,BACKGROUND,COPYRIGHT,HODGKIN,LABEL,LTD,METHODS,OTHER,RESULTS,THERE
138,169,2003,2012,2013,463,CLINICALLY,COPYRIGHT,DIAGNOSIS,DISCUSSION,ENGLISH,HOWEVER,LABEL,METHODS,MIM,OBJECTIVE,OBJECTIVES,PAGET,RESULTS,SAS,SUPPORT
001,130,169,175,2013,ALK,CHI,CONCLUSION,COPYRIGHT,FGFR1,FISH,HIF1A,IRELAND,KI67,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PI3K,RESULTS,THESE
169,2013,ABDOMINAL,COPYRIGHT,IMAGING,PUBLISHED
169,2013,BOTH,COPYRIGHT,ERLOTINIB,SAS
122,169,2013,ALK,CONCLUSION,COPYRIGHT,EBUS,EGFR,EML4,GENOTYPING,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
100,169,2013,395,945,946,BACKGROUND,BAYES,BED,BFS,CONCLUSION,COPYRIGHT,GENERALLY,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PTV,PURPOSE,RESULTS,SBRT,TCP,THERE,USING
000,169,1YEAR,2013,COGNITIVE,COPYRIGHT,PUBLISHED,SAS,SMOKING,SPLF,TOBACCO
169,2013,ASIA,ASYMMETRIC,COPYRIGHT,INC,LELC,MOST,PUBLISHED,SOCIETY,SOUTHEAST
1997,2000,2001,2006,2010,8187,8878,9572,APC,AUSTRALIA,AUSTRALIAN,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,POPULATION,RESULTS,SETTING,STATISTICS
1998,2004,347,BACKGROUND,CABG,CIS,COX,CPB,FURTHER,GIVEN,HOWEVER,LABEL,METHODS,RESULTS,THESE
153,186,188,223,PHOSPHORUS,RHENIUM,STRONTIUM
ALTOGETHER,BACKGROUND,CURRENT,FFPE,LABEL,RESULTS,XENOGRAFT
2000,2011,BACKGROUND,ITALIAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,THERE,THESE
174,400,AFTER,PEG,SOLUTOL,SPRAGUE,THESE
169,2013,LABEL,LEFT,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,RESULTS,SURGERY,THERE,UNIVERSITY
6965,8804,8805,AWARENESS,BACKGROUND,BELIEFS,CONCLUSION,LABEL,METHODS,RESULTS,STRATEGIES
2000,2005,2009,COMMUNITY,END,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SES
001,002,003,008,010,014,160,CONVERSION,CTCS,FIFTY,PCR,PFS,SCLC,SMALL
BACKGROUND,BOTH,HOWEVER,LABEL,NSCLC,THERE
009,017,038,043,118,177,CONCLUSION,CTV,CTV1,CTV2,CTV3,CTVS,EACH,LABEL,MEAN,METHODS,OBJECTIVE,PET,PTV,PTV1,PTV2,PTV3,PTVS,PURPOSE,RESULTS,STUDENT,UNGATED
954,BASED,ISL1,LIN,MEC,RAGE,SNAIL
EARLY,SKIN
169,2013,946,COPYRIGHT,HRMS,NMR,SAS,SHARPLESS
18F,CONCLUSION,FDG,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,RESULTS,TREATMENT
169,2013,AKT,COPYRIGHT,CREB,ERK,H1299,H460,ICAM,INC,NCI,NSCLC,SIHA,TXL,VCS
169,2013,945,946,956,CD133,CD44,CELL,COA,COPYRIGHT,FAK,FURTHER,H1152,HMG,INC,MYPT1,RHO,ROCK,ROCK1,THESE,WESTERN
168,199,ABCC3,COX,EXPRESSION,MDR,MTT,MULTIDRUG,NSCLC,PCR,TNM
DMAPT,FINALLY,FLIPS,JNK,JUN,LC3,MB231,MDA,NADPH,PROLONGING,RIP,ROS,TAKEN,TNBCS,VAD
169,2013,COPYRIGHT,ECM,LTD,METASTASIS,METASTATIC,MICRO,NON,NSCLC,THUS
169,2014,COPYRIGHT,HOWEVER,INC,TKI
0201,1BBL,8314,8727,946,AIMS,BACKGROUND,BOTH,CD8,CMV,FIXED,FULL,HLA,INC,K562,LABEL,METHODS,MLR,OBJECTIVE,OKT3,PBMC,PUBLISHED,RESULTS,SEB,TRANSWELL
BACKGROUND,CELL,CISPLATIN,CONCURRENT,DOCETAXEL,III,IMAGE,IMRT,LABEL,LUNG,METHODS,NON,PFS,RESULTS,SMALL,STAGE
AREAS,BACKGROUND,COVERED,LABEL,METHODS,NEWER,OPINION,PET,SPECT,THERE
2011,3MG,DRUG,FDA,FOOD,IPILIMUMAB,MARCH,SINCE,TYPICALLY
003,175,397,CONTROL,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SEVENTEEN,SEVENTY,SMALL,THERE
953,ECT2,ERK,FINALLY,GENOMIC,HOWEVER,LABEL,MEK,PKC,PROTEIN,THESE,TIC,TICS,UNLABELLED
160,2010,244,APMAX,BACKGROUND,CONCLUSION,CONVERSELY,CVP,FLOTRAC,H2O,LABEL,METHODS,PACO2,PAO2,RESULTS,THESE
0321,0498,169,2013,AUTOMATED,ESR1,NSCLC,PCR,PGR,RESULTS,THERE,UICC
AIM,BACKGROUND,BOTH,LABEL,MATERIALS,METHODS,NOW,OBJECTIVE,RESULTS,THEREFORE,VEGF
169,2013,A427,A549,CCCTC,CHROMATIN,CHROMOSOME,CTCF,DEPLETION,H838,TELOMERASE,TERT,UICC
169,2013,EMT,HOWEVER,METASTASIS,NEDD9,TAKEN,UICC
1255,3863,5145,ALK,EGFR,THUS
170,510,945,947,954,C57BL,IFN,KIOM,MMP,PCVAD,PMA,SINCE,TNF
ACHN,CHIP,GATA,LRP,MAJOR,MVP,MYOD,SP1,STAT,SW620,THESE,USF,USF1,USING
160,3LL,8209,CD4,CD40,CD40L,DCS,EXO,HOWEVER,LEWIS,THESE
160,954,A549,CA2,DMS,SPHK1,THESE
140,148,185,230,392,8312,CD34,DPD,FDG,MPM,MPMS,MVD,NSCLC,OPRT,PET,PMT,SUV,VEGF
100,215,8201,8226,ADCHIGH,CONCLUSION,DCE,DWI,FIRST,KEY,LABEL,METHODS,MRI,N0M0,OBJECTIVE,PET,RESULTS,SPL,TESLA,THESE,USING
169,2013,AACR,CONCLUSION,GANETESPIB,HSP90,LABEL,METABOLIC,METHODS,OBJECTIVE,PURPOSE,RESULTS,TNBC,TREATMENT
181,ANNEXIN,AUTOPHAGIC,AUTOPHAGY,FACS,FOLLOWING,H1299,H460,HOWEVER,LC3,LOW,MTT,NCI
1953,DIAGNOSIS,ORGAN,SLAUGHTER
181,8226,8710,968,A549,ANNEXIN,BASED,BAX,FITC,GSH,HOWEVER,IC50,MMP,MTT,NAC,ROS,TRX,VAD
8209,ADCY2,ADCY9,APC,COLORECTAL,GNB5,HDAC6,ION,JAZF1,LRP6,METASTASIS,PGM,SIGNALING,TORRENT,WHOLE
008,016,101,148,160,245,431,742,754,BACKGROUND,DIAGNOSTIC,EBUS,EUS,FNA,GROUP,HOWEVER,LABEL,METHODS,RESULTS,TBNA,THERE,TRIAL,USING
198,1998,2009,267,359,465,873,BACKGROUND,COX,DATA,ENGLAND,LABEL,MEIER,METHODS,NSCLC,RESULTS,SCLC,THESE
064,169,2014,BLAND,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,VIBRATION
BOTH,CURRENT,LARGE
A549,ATL,BAX,BCL,DAPI,WESTERN
169,2013,945,A549,BACKGROUND,BRITISH,CONCLUSION,COX,GILZ,GRS,HENCE,HIF,HOWEVER,HYPOXIA,KEY,LABEL,METHODS,OBJECTIVE,PCR,PGE2,PURPOSE,RESULTS,RU486,SOCIETY,TAKEN,WESTERN
001,2002,2010,280,AIDS,ALZHEIMER,HIV,LABEL,LOW,METHODS,OBJECTIVE,RESULTS,SUBSTANCE
EVEN,THESE
707,BACKGROUND,CHINA,CHINESE,CNIPR,CONCLUSION,CURRENT,DATA,EGFR,HOUSE,HOWEVER,IPPH,LABEL,METHODS,NET,OBJECTIVE,PUBLISHING,RESULTS,RIGHT,SIPO,STATE,TCM,THERE,THEREFORE,THESE

ONCE
100,6946,945,946,948,AKT,BAY,BECAUSE,HER2,IC50S,KPL4,PI3K,THUS
HOWEVER,MOST,RIGHT,VATS
ATP,ERLOTINIB,GREATER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TKI,TKIS,TREATMENT,VANDETANIB
169,2013,BRONCHIAL,CASE,DATA,LABEL,METHODS,MOST,NURSE,OBJECTIVE,PULMONARY,PURPOSE,SOURCES
11I,11S,599,725,CONCLUSION,INTRA,LABEL,METHODS,MLND,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,186,1986,2010,BETWEEN,CONCLUSION,GROUP,HEPATIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE
120,123,160,279,BOTH,KRUSKAL,LABEL,MESOTHELIN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SERUM
160,BACKGROUND,BASED,BCL2,CD99,CHEST,DUE,FISH,HISTOLOGIC,HOWEVER,LABEL,METHODS,PRIMARY,PULMONARY,RESULTS,TRU
12Q13,169,2013,261,AACR,CONVERSELY,NSCLC,PARP,RNAI,TAKEN,THESE
III,THEREBY,THEREFORE
CPAM,EXIT,FETAL,MRI
160,668,946,CD142,CD144,CD42,CD62P,EMV,LABEL,METHODS,OBJECTIVE,PMV,PURPOSE,RESULTS,ROC,VEGF
946,956,A549,CISPLATIN,DMSO,ESI,ICP,OES,REACTIONS,THEIR,THESE
001,007,017,022,119,374,381,536,597,CONCLUSION,ESCC,GLUT,KRUSKAL,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PTC,RESULTS
106,109,2007,2012,288,BACKGROUND,IMMEDIATE,JANUARY,LABEL,LIVERPOOL,METHODS,RESULTS,SEVENTY,UVEAL
240,360,8805,AES,AMONG,ASIAN,ATP,BACKGROUND,BID,CONCLUSION,CYP2C19,DOSES,EMS,GRADE,LABEL,MET,METHODS,NSCLC,PMS,RESULTS,THREE,TIVANTINIB,WESTERN
A549,CONCLUSION,FLOW,LABEL,METHODS,MTT,OBJECTIVE,PCR,RESULTS,RNAI,TRPC1,WESTERN
169,2014,BACKGROUND,CONCLUSION,COPYRIGHT,DISRUPTION,EGFR,EXPRESSION,INC,KRAS,LABEL,LOW,METHODS,MUTATIONS,RESULTS,TP53
169,175,2014,BACKGROUND,COPYRIGHT,EGFR,FURTHER,INC,LABEL,METHODS,NSCLC,RESULTS,SIX,THERE
2005,734,7759,BACKGROUND,CENTRAL,EFFORTS,EXCLUDING,LABEL,MEASURING,METHODS,NORTH,OBJECTIVE,RESULTS,USING,WORKFORCE
001,110,169,176,177,2013,34B,BAP,COPYRIGHT,GREEN,HVS,IRELAND,LABEL,LTD,MALIGNANT,MATERIALS,METHODS,MPM,MSP,OBJECTIVE,OBJECTIVES,PCR,RESULTS,ROC,SYBR
2009,2011,239,500,8805,EASTERN,FORTY,GRADE,GROUP,IIIB,JULY,LABEL,METHODS,OBJECTIVE,PEMETREXED,PHASE,RESULTS,STAGE
8201,ABOUT,AIM,ALSO,DECREMENT,GLEASON,LABEL,METHODS,OBJECTIVE,PCA,PSA,PURPOSE,RESULTS,SURFACTANT,THERE,TNM,WESTERN
LUNG
169,2013,JAPAN,OITA,SUNITINIB,UNIVERSITY,UROLOGICAL
2009,3508,8804,ADVERSE,AES,BACKGROUND,DATA,EPICLIN,IIIA,IIIB,JANUARY,KEY,LABEL,LUNG,MANAGEMENT,MARCH,METHODS,MOST,NSCLC,PATTERN,RESULTS,THROUGHOUT,WORLD
1048,1440,176,177,227,250,AKT,BACKGROUND,EMT,ERK,HCC,HOWEVER,HUH7,LABEL,METHODS,MIGRATION,MMP,MOLECULAR,MTT,PCNA,PD98059,RESULTS,RFA
BRAIN,DESPITE,HOWEVER
CEA,CHINA,CYFRA21,HOWEVER,MEANWHILE,NSE,SCCA
DESPITE,EGFR,EMT,GR5,H1975,MET,NSCLC,SRC,STAT5,T790M,THEREFORE,TKIS
001,012,026,027,103,264,ANTI,CCNY,COX,NSCLC
031,045,2011,2012,AMONG,APRIL,BACKGROUND,CONCLUSION,EDAC,EDAP,EDMPS,FLOW,LABEL,METHODS,MPS,PDAC,PDAP,PDMPS,RESULTS
0001,002,003,005,009,015,8201,CONCLUSION,CONFORMITY,CRT,DMEAN,IMRT,KNOWLEDGE,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,STAGE,THREE,V20,V95,VMAT
169,2013,BACKGROUND,BLUE,EGFR,ICC,LABEL,METHODS,PC9,RED,RESULTS,SOCIETY,THESE
100,119,166,169,174,2013,8201,956,COPYRIGHT,EQUAL,INC,LBC,WILEY
169,2013,INC,WILEY
012,026,048,105,169,2013,954,AACR,AMONG,APPROACHES,BIOMARKER,CONCLUSION,DCR,EGFR,EIGHT,FISH,INCREASED,INTEGRATED,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RAF,RAS,RESULTS,SORAFENIB,SSS,THERAPY,THESE
400,4EBP1,600,8764,AKT,CDD,EIGHT,ERK,LABEL,MEK,METHODS,MTD,OBJECTIVE,PI3K,PURPOSE,RESULTS,SAR245408,SIXTY
169,2013,916,ADC,CK5,COPYRIGHT,FNA,IHC,INC,NP63,SIX,SQCC,WILEY
AKT1,EGFR,ERBB2,OVERALL
8201,956,AAG,CASPASE,DEPLETION,DESPITE,EXPRESSION,GANETESPIB,IC50,MTS,RIP1,SCLC,SMALL,TNFR1,USING
946,BONE,FUNCTIONAL,FURTHER,HDAC4,HMS,PITX1,PTHRP,ROBO1,SMAD2,TGF,THESE
160,247,406,601,611,ANGELES,BAYES,COX,EVER,INDEX,LABEL,LOS,METHODS,MORTALITY,NBS1,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RHR,SNP,SNPS,UADT,USING
160,300,8804,BALB,CD200,CD200KO,CD200R1KO,CD4,CD8,CPG,DLN,EMT6,FOLLOWING,WHILE
110,184,AUC,CHEMONAIVE,CONCLUSION,CONCURRENT,HOWEVER,III,IIIA,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEVENTEEN,THEREFORE
169,2013,375,AEG,HOWEVER,IGF1R,MICRORNAS,MIR,PDK1,REDUCED,RNAS,UICC,YAP1
BACKGROUND,FIFTY,LUNG,METHODS,RESULTS,SCREENING
LDCT,LOW
DESPITE,NCMJ,SEVERAL,THERE
000,2009,324,408,BACKGROUND,BEHAVIORAL,BRFSS,CHRONIC,CONCLUSION,COPD,LABEL,METHODS,NORTH,PREDNISONE,RATES,RESULTS,RISK,THESE
0341,1541,169,2013,275,7786,AACR,FBXW7,HDAC,LABEL,MCL1,MCR,MYC,NON,NSCLC,TOP2A,UNLABELLED
215,ADDITIONAL,ANAL,ANIMALS,ECTOPIC,FURTHER,LABEL,LIVER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPRAGUE,UPON,WHEREAS
0001,005,007,1170,160,169,2013,2219,BACKGROUND,COMPARISON,ELECTRONIC,JOHN,LABEL,LIBRARY,LTD,METHODS,NSCLC,ORR,RESULTS,RRS,SEVEN,SONS,WILEY
EZH2,HOX,HOXC,HOXD,LNCRNAS,PRC2,RNAS
1034,AKT,AXL,EGFR,H820,HCC78,MET,NPS,NSCLC,ROS1,T790M,THERE,TKI,TKIS
169,2013,A549,BRAF,DFG,ERK,JOHN,MEK,MOLECULAR,ONCE,RAF,RAS,SONS,V600E,WILEY
105,110,CONCLUSION,DMAX,DMEAN,DMIN,DVH,EIGHT,IMRT,LABEL,METHODS,OBJECTIVE,PTV,RESULTS,V10,V105,V110,V13,V20,V30,V40
H2A,H2AX,HISTONE,PARP,THUS
001,169,2013,945,946,BRITAIN,BUDESONIDE,GREAT,IRELAND,PRE
AKT,FINALLY,PI3K,PKB,THEREFORE
A549,CALU,COMPARING,FURTHER,H1299,H358,HPLC,MRC,PARTIAL,PLS,THESE,TOF
183,GEORG,SMALL,STUTTGART,YORK
100,150,176,177,183,2008,2013,AFTER,APRIL,BACKGROUND,BSA,EARLY,GEORG,HOWEVER,LABEL,LOCAL,MASAOKA,METHODS,OPERATIVE,RESULTS,SEPTEMBER,STUTTGART,YORK
183,2005,2010,301,AFTER,BACKGROUND,CONCLUSION,DESPITE,GEORG,JANUARY,JUNE,LABEL,MEAN,METHODS,REGRESSION,RESECTION,RESULTS,STUTTGART,YAG,YORK
183,1991,2010,2011,EVEN,GEORG,IIIA,NSCLC,STUTTGART,THEREFORE,VATS,YORK
183,AFTER,FIRST,GEORG,HOWEVER,ILP,SINCE,STUTTGART,USING,YORK
183,DUE,GEORG,GERMANY,RADIATION,SBRT,SOCIETY,STUTTGART,THEREFORE,YORK
100,183,2011,AAH,ACIS,AIS,ATS,ERS,GEORG,IASLC,IMA,LPA,MIA,SIMILARLY,STUTTGART,THEREBY,YORK
183,EVEN,FIRST,GEORG,LUNG,NLST,SCREENING,STUTTGART,TRIAL,USA,YORK
177,181,BRCA1,CHINESE,CONCLUSION,EGFR,ERCC1,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,RRM1,STMN1,TOP2A,TUBB3
177,1978,1993,1994,2011,CONCLUSION,FURTHER,LABEL,LOCAL,MATERIALS,METHODS,OBJECTIVE,POST,RESULTS
BESIDES,EMT,EPITHELIAL,HOWEVER
CELL,EMT,EPITHELIAL,HOWEVER,LUNG,THESE
LUNG,PKC,PKCS,THERAPIES,THESE
GIVEN,JANUS,LUNG,STAT,STAT3
ANOTHER,HOWEVER
AES,AFTER,GEFITINIB,THEN
028,CHI,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,THERE
135,155,161,177,180,2004,2008,8320,8321,CONCLUSION,DFS,GGO,LABEL,MATERIALS,MEANWHILE,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
2005,2030,305,500,ACCORDING,BANGLADESH,CONTROL,HEPATITIS,PLAN,STATISTICS,WORLD
002,004,106,122,136,151,169,182,183,2013,214,229,350,BOS,DLT,DLTS,EDS,ERS,FIO2,FOUR,GROUP,LABEL,LTS,METHODS,OBJECTIVE,OBJECTIVES,ODS,ORS,PAO2,PGD,PRESS,PUBLISHED,RECIPIENTS,RESULTS,SLT,SLTS,SURGERY,THERE,THREE,UNIVERSITY
MDM2,PARTIALLY
0014,048,076,160,2005,2010,30610,BID,BRIGHAM,CALGB,COX,DANA,DERMATITIS,GRADE,INSTITUTE,JANUARY,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SCLC,STUDENT,WOMEN
BOTH,CD74,MPRIP,NTRK1,TREATMENT,TRKA
92B,EXPRESSION,INHIBITION,NSCLC,RECK,REVERSION
BACKGROUND,CONCLUSION,CONTACT,FURTHER,HKDC1,LABEL,MOTIVATION,OWING,RESULTS
MRI,THERE,THYROID
EBUS,HOWEVER,TBNA
DMM,MPM,WHILE
EBUS,TBNA,THESE
ATLAS,AZA,CELL,INNOVATIVE,IRF7,LUAD,LUNG,LUSC,NON,NSCLC,SMALL,TCGA
101,169,2013,7404,7702,803,A549,BAD,BCL,BEL,COPYRIGHT,EGFR,FURTHER,H460,INC,MCG,MOLECULAR,NCI,TAKEN
169,2013,AMONG,COPYRIGHT,HOWEVER,IRELAND,LTD,LUNG,OXIDATIVE,WESTERN
004,169,2013,AUC,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CROWN,DIAGNOSTIC,DIFFERENCE,HYALURONIC,IRELAND,LABEL,LIVER,LTD,MALIGNANT,MATERIALS,METHODS,PUBLISHED,RESULTS,SERUM
1970S,FIFTY,FORUM,NURSING,ONF,REVIEWING
169,2004,2010,2013,413,8804,8805,ACEI,ACEIS,ADVERSE,COPYRIGHT,COX,III,INC,LABEL,MATERIALS,METHODS,MLD,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,196,2014,2809,AGA,AIMS,BACKGROUND,COPYRIGHT,CROHN,EACH,IBD,INC,INSTITUTE,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,VITAMIN
169,2013,956,A549,ADP,BCL,BEAS,CORDYCEPS,IC50,JNK,JUN,MAPK,MAPKS,MILITARIN,ORAL,ROS,TREATMENT
169,2013,CD44,ICP,MDR,MULTIDRUG,NIR,NPS,OVERCOMING,PCR
169,2013,ANALYSING,COPYRIGHT,FIRST,IMPORTANT,LTD,RESULTS,SES,SMOKING,THIRD
169,2013,COPYRIGHT,INC,MOSBY,PEDIATRIC,PRIMARY,PUBLISHED,STRABISMUS,UVEAL
DESPITE,OPERATIVE,ROBOTIC,THERE,VATS
215,A549,ALSO,DAPI,SYNTHETIC,THEIR
100,109,119,2000,2012,FAR,FORTY,GAMMA,GKS,HOWEVER,KARNOFSKY,KNIFE,KPS,LABEL,MBTS,METHODS,MRI,OBJECTIVE,OCTOBER,RESULTS,WBRT
BACKGROUND,BMP,BMPS,BONE,BOTH,CONCLUSION,DMH2,ID1,ID3,INHIBITION,LABEL,LUNG,METHODS,MICROARRAY,NEUN,NSCLC,OCT4,PCR,RESULTS,SMALL,THESE
0001,231,8804,946,956,A431,A549,BACKGROUND,BAX,BCL,CDK4,CELL,CIP1AND,FACS,FURTHER,KIP1,LABEL,MDA,METHODS,RESULTS,THESE,WHEREAS,WHILE
100,169,183,1997,2012,ABOUT,GEORG,GERMANY,GPOH,MANAGEMENT,MET,METASTATIC,NEN,OUTCOME,STUTTGART,YORK
0001,BACKGROUND,CONCLUSION,EFFECTIVE,EVEROLIMUS,FINAL,INITIAL,LABEL,METHODS,NSAI,NSAIS,ORAL,OVERALL,PFS,RESULTS,THESE
2008,2011,BACKGROUND,BETWEEN,CONCLUSION,GRADE,LABEL,MALIGNANT,MARCH,METHODS,MPM,OCTOBER,PFS,RESPONSES,RESULTS
132,ACHE,ALZHEIMER,HOWEVER,MIR,NSCLC,TAKEN
169,2013,956,AACR,ANTITUMOR,AZD1480,CD31,FINALLY,GLC4,H82,IC50S,JAK,JAK1,JAK2,JAKS,JANUS,LABEL,MCL1,METHODS,OBJECTIVE,PARP,PURPOSE,RESULTS,SCLC,SCLCS,TREATMENT
0001,160,16F,25M,8201,AMONG,BACKGROUND,KRAS,LABEL,MEIER,METHODS,PROGNOSIS,RESULTS,SEVEN
EGFR,FINALLY,HOWEVER,LUNG,TTF
177,2011,2012,207,248,530,945,AFTER,AIMS,BESIDES,CONCLUSION,DATA,FEDERATION,INSTITUTE,LABEL,MEASURING,METHODS,OBJECTIVE,RESULTS,THESE,THOSE,UNLABELLED,WAITING
298,A750,E746,EGFR,HIGH,IHC,L858R,PCR,SQCC,SWEDISH,THREE
946,AKT,CPG,ECTOPIC,ROR2,THROUGH,THUS,TSG,WNT,WNT5A
4423,CONSISTENT,RNAS,SMOKING
007,2004,2012,BACKGROUND,CISPLATIN,HIPEC,JUNE,LABEL,MARCH,METHODS,MPM,RESULTS,THERE
MDCT,SURGERIES,THREE
046,118,133,138,1990S,1997,2012,ACTUARIAL,DATA,FIVE,HOWEVER,INSTITUTE,IQR,LABEL,METASTATIC,METHODS,MIFS,OBJECTIVE,PAIN,PURPOSE,RESECTION,RESULTS,RFS,RIZZOLI,SURGERY
001,215,310,AKT1,ALK,BACKGROUND,BRAF,DDR2,EGFR,EML4,HER2,KRAS,LABEL,METHODS,RESULTS,RET,SQCC,SQCCS,TEN,THREE
2009,B16,BL6,C57,HVJ,IIA,JAPAN,MEDICAL,MEWO,OSAKA,SINCE,TREG,UNIVERSITY
954,ERK,FAK,G3BP,H1299,KNOCKDOWN,MMP,SRC
AFP,ATG5,AUTOPHAGY,BECN1,CRE,EMT,FURTHER,HCC,LOXP,METASTASIS,MOUSE
95D,BCL,CD44,H358,HOWEVER,LHX6,LIM,MMP7,PCR,THESE,TREATMENT
169,2013,AVATARS,COPYRIGHT,GEMMS,GIVEN,IRELAND,LTD,MOUSE,THESE,TRIAL
APART,CRP,LABEL,OBJECTIVE,OVERALL,PURPOSE,RESULTS,STUDIES,SUMMARY,THERE
133A,346,361,RNAS
001,009,100,177,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PGA,RESULTS
169,1A2,2013,2C19,2C9,2D6,3A4,ARN,BACKGROUND,CHINA,CLINT,CONCLUSION,CYP,CYP2C19,CYP450S,GEFITINIB,HEPG2,HPLC,IRELAND,LABEL,LTD,MARSDENIA,MEANWHILE,METHODS,MTE,NSCLC,P450,PING,PUBLISHED,RELEVANCE,RESULTS,ROXB,THUS,WIGHT,XIAO
169,2007,2011,2014,8805,BACKGROUND,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NODAL,NSCLC,RESULTS,SBRT
045,109,115,122,139,162,2007,2011,8804,8805,945,BACKGROUND,BETWEEN,BLOOD,CONCLUSION,COX,EASTERN,ECOG,ELISA,EXPRESSION,JANUARY,LABEL,MAY,MEIER,METHODS,NSCLC,RESULTS,SERUM,THEIR,THESE,TNF,TTP
2006,2009,2012,AFTER,APRIL,BACKGROUND,BECAUSE,CASE,CELSIUS,CLMS,DUE,FURTHER,HCC,HOWEVER,JANUARY,LABEL,MDCT,METHODS,MILAN,NORWEGIAN,OCTOBER,PET,SINCE,SIROLIMUS,SUBSEQUENT,THEIR,THUS,TOR
169,2013,ALK,CELL,COPYRIGHT,DESPITE,DRUG,EML4,FDA,FOOD,IRELAND,LTD,LUNG,NON,NSCLC,SMALL,USA
169,174,2005,2012,2013,ACTB,AOD,BACKGROUND,CONCLUSION,COPYRIGHT,ESSEN,FFPE,GAPDH,GMBH,HOWEVER,HPRT1,INSTITUTE,LABEL,MATERIALS,METHODS,PATHOLOGY,PSMA1,THREE,UNIVERSITY
945,AKT,ALSO,AT13387,BACKGROUND,BARR,C666,CD44,CDK4,CONCLUSION,CSC,EBV,EGFR,EPSTEIN,HDAC6,HSP90,LABEL,NPC,RESULTS,SKP2,SOX2
113,B82,BACKGROUND,FINALLY,FURTHER,H460,LABEL,METHODS,MTT,NSCLC,RESULTS,TREATMENT,WESTERN
ADDITIONAL,HEAD
STUDIES
945,ADC,BECAUSE,BRDU,EFFECTS,EPO,EPOR,H1975,HOWEVER,III,NSCLC
160,A549,ALSO,CIP1,COMPLEX,DDP,FURTHER,HOTAIR1,HOWEVER,KNOCKDOWN,LAD,PRC2,REPRESSIVE,SPC,TAKEN,THUS,WAF1
2007,2009,418,8201,946,BRCA1,JANUARY,NSCLC,RRM1,RRM2,SIMILARLY
169,181,2013,BCL,BIM,BIOLOGY,CELL,FEDERATION,H1299,H460,NSCLC,OVERALL,PFT
008,149,300,967,BACKGROUND,BESIDES,CONCLUSION,HOWEVER,LABEL,METHODS,PCR,PEARSON,RESULTS,THERE
AKT,GLUT1,HK2,OVERALL,SKP2,TRAF4
4TH,BER,LUNG,NER,NSCLC,SIMILARLY,SSBS
0201,947,AURA,CTL,ELISPOT,G250,GRB,HER2,HLA,IFN,MAGE,NSCLC,PRAME,RHAMM,SCLC,TAA,TAAS,TAKEN,WT1
160,DFNA5,HEPG2,MRC5,THROUGH,UNDERLYING
127,137,157,224,347,8201,829,8805,ADULT,CSF,CSFS,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCLC
AKT,ERK1,JNK,LC3,MDR,MEANWHILE
160,LDCT,LUNG,PROGRAM,SCREENING,STUDIES
001,0042,027,174,177,BACKGROUND,BLOOD,CEA,CELLSEARCH,COLORECTAL,CRC,CTC,CTCS,DIFFUSE,EPCAM,FDA,IMAGING,KRUSKAL,LABEL,METHODS,RESULTS,SEM
231,468,47D,945,946,ANNEXIN,BACKGROUND,BRAIN,CELL,CLONOGENIC,FOLLOWING,HER2,INTEGRINS,LABEL,MCF,MDA,METHODS,MTS,RESULTS,THESE,TNBC
BECAUSE,CANCERS,CURRENT,FDG,FDOPA,NAF,PET,WHILE
BRAF,ERK,HOWEVER,LABEL,MAP,MUTATIONAL,PI3K,RAF,TAKEN,UNLABELLED,V600E
FDG,PET,THESE
FDG,PATHOLOGIC,PET
CD34,CD68,GIANT,ORBITAL,SFT
116,AIMS,BACKGROUND,FNA,FNAC,HENCE,ICC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
GPCRS,GPR65,H1299,INSTEAD,MYC,TDAG8,U937
1995,2001,2007,2663,4658,BACKGROUND,ICARE,LABEL,METHODS,RESULTS
DROSOPHILA,DUE,EXPLOITING,FURTHER,PARKINSON,SANJEEVANI,SEVERAL
0001,0018,007,0355,0384,169,2013,261,BELGIUM,EASTERN,ECOG,ERLOTINIB,GROUP,IIIB,JOHN,LTD,MOST,NSCLC,PFS,SEVERAL,SONS,TRUST,WILEY
169,2013,231,A549,ANTI,COPYRIGHT,JOHN,LTD,MCF7,MDA,MDCK,MDR,SONS,THUS,VAL,WILEY
169,2013,3032,3123,BACKGROUND,EFFECTS,KEY,LABEL,METHODS,PREDICTORS,RESULTS,SOCIETY
CONCLUSION,DEEP,DIBH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV
169,2013,AMONG,BACKGROUND,EMT,LABEL,METHODS,OSCC,RESULTS,SOCIETY,TWIST
183,AFTER,CONCLUSION,EMPLOYING,FOUR,GEORG,GIST,INDICATION,LABEL,METHODS,OBJECTIVE,STUTTGART,UICC,VATS,YORK
160,169,183,GEORG,REGULAR,STUTTGART,THERE,THEREFORE,YORK
000,001,034,136,160,1997,2010,BACKGROUND,COX,INSURANCE,LABEL,METHODS,RESULTS,THUS
713,AVERAGE,BACKGROUND,CONCLUSION,DATA,DNLS,EBS,EVEN,FIVE,FOUR,FRANKEL,HOWEVER,LABEL,LEVEL,MEAN,METHODS,MULTILEVEL,NINE,OBJECTIVE,PATIENT,RESULTS,SIX,SUMMARY,THERE,THREE,TYPE
103,112,141,2011,2012,206,AIM,ASIA,ASIAN,BOARD,CMDHB,CONCLUSION,EAST,ECOG,EGFR,IIIA,ISLANDERS,LABEL,MANUKAU,MAORI,METHODS,NSCLC,OBJECTIVE,PACIFIC,RESULTS,SOUTH,THERE,ZEALAND
006,114,169,2013,532,945,946,AACR,CONCLUSION,DCIS,EXPRESSION,LABEL,METHODS,MLEC,MMP,MMP9,OBJECTIVE,PCR,PRIMARY,PURPOSE,REAL,RESULTS,TGF,THESE,TIME
4T1,CDDP,CT26,GEM,HOWEVER,THESE,VEGF,WHILE
1000,211,226,230,2680,277,338,417,496,614,8265,967,CALL,FAILURE,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIXTY,THERE
001,005,029,031,039,121,215,290,415,706,8805,LABEL,MEAN,METHODS,MPM,OBJECTIVE,PNI,PNIS,PURPOSE,RESULTS,THESE,UNIVARIATE
2007,BACKGROUND,BUTTERFLY,KRIESEL,LABEL,METHODS,MOTIVATION,RESULTS,SUPPORTING,THUS

105,116,1635,169,177,2013,431,549,946,956,9962,9999,ARTEMISIA,BASED,COLON,COPYRIGHT,CRL,DAD,DECNE,EXCELLENT,FINALLY,HCT,HPLC,IC50,LEUKAEMIA,LUNG,MTT,THP
244,CHINESE,EXPOSURES,NONE,PAH,PAHS,PHE,PHET,URINARY
174,181,72H,914,954,COMT,EGCG,ENTACAPONE,H1299,IC50,PARKINSON,TREATMENT
BACKGROUND,BCL,CCND1,EGFR,EXPRESSION,LABEL,MALIGNANT,MATERIALS,MET,METHODS,MPM,REDUCED,RESTORING,RESULTS,USING,XENOGRAFT
169,2013,239,BACKGROUND,COPYRIGHT,DR5,ECOG,HOWEVER,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,RESULTS,SECONDARY
160,COPD,KEY,RELAPSE,SMOKERS,SMOKING,SUCCESSFUL,TOBACCO
001,002,014,018,177,916,BACKGROUND,CHRONIC,COHB,CONCLUSION,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRIOR,RESULTS,SMOKERS,SMOKING,THERE,TWISP
169,2013,AFTER,CAD,CONSORTIUM,COPYRIGHT,FINALLY,IMAGE,IRELAND,LTD,LUNG,NEXT
515,611,COX,ERR,HOWEVER,LIFE,LSS,NCRD,RADIATION,SPAN
169,2013,BLACKWELL,GMBH
ADDITIONAL,BACKGROUND,DIRECTIONS,EARLY,LABEL,RESULTS,WHILE
ATSM,CONCLUSION,DESPITE,FURTHER,HENCE,HYPOXIA,LABEL,METHODS,OBJECTIVE,PET,PTSM,RESULTS,SIX,THESE
001,148,149,159,199,229,241,268,290,305,CONCLUSION,DIAGNOSTIC,FINAL,GGO,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,USING
2010,2012,531,556,572,660,695,754,772,789,803,818,874,900,921,946,954,AXIAL,CONCLUSION,ICC,LABEL,MARCH,MATERIALS,METHODS,OBJECTIVE,PREDICTION,RADIOLOGIC,RESULTS,T1A,T1B,T2A,T2B
3T3,A549,BALB,CCRF,CEM,MCF7
ACCORDING,ELISA,HEP1,HOWEVER,IGG2A,NIEMANN,NPC2,PICK,REGARDING,THESE,TYPE,WESTERN
AKT,AMP,AMPK,H322,LKB1,NSCLC,TUSC2
001,007,031,192,502,576,BACKGROUND,CONCLUSION,FUNCTIONS,FURTHER,LABEL,LOG,LOWER,LUCIFERASE,METHODS,NSCLC,RESULTS,SET,SET8,USING
GRAM,HEPATIC,PORCINE,SAA,SAA1,SAA2,SAA3,SAA4,SERUM,THESE
001,009,568,BACKGROUND,HAIR,HHT,IRON,LABEL,ONCE,PRINCIPAL,RESULTS,THERE
GATEWAY,ONCE,RNAI,RNAS,USING
ACTIVATION,BLNK,CCL22,CD11B,CD79,CD79A,ERK,FINALLY,GR1,MDSCS,STAT3,SYK
300,IVC,MANAGEMENT,RESECTION
175,2578,2578C,634,634G,8201,LABEL,UNASSIGNED,UNLABELLED,VEGF
233,BASED,BIRT,DUB,HOGG
2008,BONE,IOF,TREATMENT,USA
8209,947,A549,CD4,CD63,CD80,CD86,CD9,CURRENTLY,DCS,GTPASES,HOWEVER,HSP,HSP90,IFN,LUNG,RAB,RAB27,THUS
EGFR,MITOSIS,NSCLC,SGOL1,SHUGOSHIN,THESE
175,BACKGROUND,COX,ECOG,HIF1A,LABEL,METHODS,NRP1,NRP2,PLGF,RESULTS,TTP,UNIVARIATE,VEGF,VEGFA,VEGFA165B,VEGFB,VEGFC,VEGFD
215,LABEL,METHODS,OBJECTIVE,RESULTS
BECAUSE,BSD,LABEL,METHODS,OBJECTIVE,OPERATIVE,RESULTS
CTC,CTCS,HOWEVER
160,945,946,947,ALSO,EMT,H460,MMP,MMP2,MMP7,MMP9,NANOG,NOTABLY,NRF,NSCLC,OCT4,OCTAMER,OVERALL,PARIS,PARKINSON,PCR,PGC,SLUG,THUS,TWIST,ZEB
2000,2010,BLOOD,EORTC,GROUP,JANUARY,MSG,MYCOSES,SKIN,TREATMENT
100,2040,460,823,AMONG,BOND,GATA3,GCDFP,L50,LEICA
000,139,180,956,LEUKEMOID
012,200,467,472,500,949,BEV,CELL,CONCLUSION,EASTERN,GROUP,IIIB,LABEL,LUNG,METHODS,NON,NSCLC,OBJECTIVE,PAC,PACCBEV,PEM,PEMCBEV,PEMETREXED,PFS,POINTBREAK,PURPOSE,RESULTS,SMALL
004,8804,CONCLUSION,ESCALATION,HOWEVER,LABEL,LATE,LOCAL,METHODS,MTD,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVENTY
169,2014,ACP,ACPS,AUSTRALIAN,BACKGROUND,CAREGIVERS,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EARLY,GIVEN,HINDRANCES,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS
169,2013,BCF,CHINESE,FAO,ICP,POTENTIAL,TCR,THEREFORE,THQ
169,1988,2013,ADC,BACKGROUND,CONCLUSION,ENGLISH,HOWEVER,LABEL,MAY,METHODS,NSCLC,RESULTS,VEGF
169,2013,AMONG,COPYRIGHT,LTD,NMR,SEMI,SINULARIA,STRUCTURES
001,1094,1100,146A,169,2013,954,BACKGROUND,LABEL,METHODS,MICRORNAS,MIR,RESULTS,THESE
102,126,203,257,465,485,584,744,8723,CONCLUSION,III,LABEL,METHODS,OBJECTIVE,RESULTS,SERUM
169,2013,CURRENTLY,DNES,DUE,INC,OVERALL
169,2013,33258,A549,AZN,COLLEGE,COPYRIGHT,HOECHST,INHIBITION,LABEL,MDA,MEDICAL,METHODS,METHYLENE,MTT,OBJECTIVE,PUBLISHED,RESULTS,SOD,SUPEROXIDE
BLP25,CTLA,FIRST,III,MAGE,MODULATION,NSCLC,PHASE
AMIDE,APT,CEST
100,788,956,AFTER,LCD,MESOPOROUS,MSNS
177,190,203,20TH,674,857,HNSCC,HOWEVER,HPV16,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,USA
028,1096,152,1950,2009,3285,403,4461,813,858,928,930,938,993,CONSISTENT,LABEL,METHODS,MORTALITY,OBJECTIVE,OBJECTIVES,RESULTS,SIR,SMR,THERE
162,1965,1970,1979,1980,2011,AIR,ICD,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMR,TEM
497,954,COHEN,JEM,JOB,LABEL,METHODS,OBJECTIVE,PAHS,REFERENCE,REGARDING,RESULTS,TBQ
4DCT,DOSE,ITV,MEAN,ROIS,WEEK,WEL
169,2013,8201,CINCINNATI,DISEASE,HUES,III,INITIAL,LIVER,MEDICAL,OLT,PRETEXT,THREE
HOWEVER,LUNG,NCCN,NSCLC,THEREFORE
8804,A549,FCM,FLOW,HRS,LC3B,WESTERN
945,A549,ATF6,CHOP,CONCLUSION,EBP,LABEL,LPT,MATERIALS,METHODS,OBJECTIVE,PCR,PEP,PERK,PKR,PURPOSE,RESULTS,TRAF2,XBP1,XTT
CONCLUSION,FXIII,III,IQR,LABEL,LOEWY,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE,TNM,XIII
677TT,C677T,CHINESE,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,MTHFR,NSCLC,OBJECTIVE,OVID,PURPOSE,RESULTS,SCLC,WANFANG
001,002,8804,COX,EPP,HOWEVER,LNR,MALIGNANT,MEIER,METASTATIC,MPM
2008,A549,CTCS,HOWEVER,LUNG,MAPK,MMP,MTT,THEREFORE,TRANSWELL
001,160,2002,2006,495,497,582,8201,991,ADDITIONAL,DATA,DISCHARGE,DUE,ICD,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPI,TEXAS,USING
A549,ATG3,HOWEVER,NRF2,VAD
0001,115,122,157,160,224,502,563,779,8804,AFTER,DATA,GROUP,HISTOLOGY,LABEL,METHODS,MPM,OBJECTIVE,PLT,PROGNOSTIC,PURPOSE,RESULTS,STAGE,WBC
946,COMET,DCF,DSBS,FURTHER,HOWEVER,NSCLC,ROS
2009,2010,500,CONCLUSION,DCR,IIIB,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,ORR,PEMETREXED,PFS,PURPOSE,RESULTS,THERE,TREATMENT
946,CINNAMOMI,EMT,FINALLY,IIIB,TGF,TNM
177,33342,945,946,A549,C57BL,CHINA,ELISA,HARA,HOECHST,ICAM,LEWIS,MCP,PARIS,PRS,ROS,SMITH,TGF,THESE,TNF,WESTERN
169,2014,BACKGROUND,BRAIN,CASE,COPYRIGHT,INC,LABEL,LASER,METHODS,THERE,TREATMENTS
169,2013,AACR,ALK,CRIZOTINIB,EGFP,MET,ROS1,THEREFORE,THESE,UVEAL
169,2013,946,954,A549,AIMS,AKT,EMT,KEY,LABEL,MAIN,METHODS,OBJECTIVE,PI3K,RESULTS,SNAIL,TGF,WHETHER
AFTER,BONE,CHEST
004,005,006,169,19Q13,2013,339,358,772KB,BACKGROUND,BOTH,CD3EA,CHINESE,CHROMOSOME,COPYRIGHT,ERCC1,ERCC2,FOUR,LABEL,LTD,MDR,METHODS,PPP1R13,RESULTS,SNP
169,2013,24H,956,ADP,AGS,B25,CELL,COPYRIGHT,DAIRY,FLOW,GASTRIC,HOWEVER,IC50,INC,LC3,PARP,PUBLISHED,SCIENCE,THEREFORE,THESE,THUS,WESTERN
169,2013,945,946,BONE,BSP,CURRENT,HOST,HOWEVER,OPG,OPN,PTHRP,RANKL,SPARC,TGF
169,2013,954,COPYRIGHT,HIGH,LTD,MMP,MMP9,THESE
169,2013,COPYRIGHT,DEFICIENCY,INC,ROS,SIRT5,SOD1,THESE
169,2013,BACKGROUND,COPYRIGHT,LABEL,LTD,METASTATIC,METHODS,REGRESSION,RESULTS,THESE
169,2013,A549,AMR,AMROL,COPYRIGHT,H460,H520,IRELAND,LTD,PEM
0001,007,1137,160,169,2007,2012,2014,271,AFTER,BETWEEN,COPYRIGHT,CXR,INC,LABEL,METHODS,MNDCT,MOSBY,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY
169,2013,COPYRIGHT,HOWEVER,INC,NR4A1,SEMAPHORIN,THESE
169,2014,ALK,AMONG,ANAPLASTIC,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,INC,KRAS,LABEL,MEDICAL,METHODS,NSCLC,PERUGIA,PFS,RESULTS,STUDIES
169,2013,3Q26,AUTHORS,COPYRIGHT,H3K27,H3K4,H3K9,INC,KDM1,LSD1,PUBLISHED,REDUCTION,SCCS,SOX2
169,2013,946,AUTHORS,COPYRIGHT,DKK1,INC,PUBLISHED,TNC,WNT
LUNGS
BACKGROUND,CARLO,CYBERKNIFE,DVHS,HOWEVER,LABEL,METHODS,MONTE,OAR,OARS,RAY,RESULTS,SABR,THEIR,THUS,TPS,TRACING
250,500,GEFITINIB,PARKINSON,PREVIOUSLY
AGREEMENT,BACKGROUND,CARCINOMA,CELL,DEFORMABLE,DICE,DIR,GROSS,GTV,GTVS,HAUSDORFF,LABEL,LUNG,METHODS,MSHD,NON,NSCLC,OARS,PRE,RESULTS,ROIS,SMALL
160,169,2013,BACKGROUND,BMI,COPYRIGHT,DISCUSSION,FINALLY,FURTHER,INS,LABEL,METHODS,OVERWEIGHT,PINI,RESULTS,SAS,STEROID
058,169,2013,379,462,945,946,COPYRIGHT,CRP,IL1B,IL6,LTD,MPO,THERE,THEREFORE,TNFA
001,003,169,190,195,200,2013,220,AFTER,COX,FISH,HRS,MOST,PRIMARY,STUDIES,THESE
169,2013,5Q22,5Q23,LOSS
BACKGROUND,CATHEPSIN,CTSB,ESI,HOWEVER,LABEL,PTCH,RESULTS,SCC,SHH,THESE,TOF
169,2012,2013,AUTHORS,BACKGROUND,BOTH,COMPLEX,CONFERENCE,CONSENSUS,COPYRIGHT,INC,JUNE,LABEL,MAMMALIAN,METHODS,MONRO,PUBLISHED,SCLEROSIS,VARIOUS
169,2013,AFTER,CELL,CONCLUSION,COPYRIGHT,GEFITINIB,H1703,H520,IRELAND,LABEL,LTD,MAPK,MATERIALS,METFORMIN,METHODS,MKK3,MKK6,MKK6E,MSH2,MTS,MUTS,OBJECTIVE,OBJECTIVES,PCR,PROTEIN,RESULTS,TRANSIENT,WESTERN
945,A549,AMONG,BACKGROUND,BCL2,ELISA,ERK1,HIF,INHIBITION,LABEL,LUNG,METHODS,MMP2,MMP7,MMP9,PROGNOSIS,PROTEOMIC,RAF,RESULTS,VEGF
ALK,EGFR,GROWING,MICRORNAS,NSCLC,THERE
EGFR,EVEN,HOWEVER,NSCLC,SIMILARLY
ALK,EGFR,EML4,NSCLC,ROS1
EGFR,TKIS
ATLAS,NETWORK
ALK,CELL,EGFR,MET,NSCLC,RTKS
100,AMONG,DESPITE,FINALLY,KEEPING,KRAS,NSCLC,RAS,THESE,THREE
AKT,ERK,MAPK,MEK,NSCLC,PI3K,RAF,RAS,TARGETING,THEREFORE
2992,BIBW,EGFR,ERLOTINIB,HOWEVER,NON,NSCLC,TKIS
CHRONIC,COA,COPD,HMG,WHILE
ADJUNCTIVE,EACH,EVENTUALLY,HIGH,SPO2,WHILE
A549,BAX,BCL,EGFR,PAR,PAR2
1086,1093,A2A,A2B,FINALLY,JUN,JUNB,LEWIS,LLC,NECA,SCA1,THUS,USING,VEGF
174,270,472,798,ASSAY,BACKGROUND,CHAIN,CONCLUSION,EPI,GERMANY,LABEL,MATERIALS,METHODS,MPE,PCR,POLYMERASE,RESULTS,SHORT,SHOX2,STATURE
DISCUSSED,PREDICTIVE,THESE
103,169,2013,8201,AEROSOL,BACKGROUND,COMBINING,CONCLUSION,FIVE,INC,LABEL,METHODS,NKG2D,PROCEDURE,RESULTS,THERE,WILEY
001,8201,CD4,CD8,DATA,NSCLC,PCR,RESULTS,SIMILARLY,THESE,TNFAIP8,WESTERN
001,006,008,120,177,8201,BDCA2,CD123,CD4,DATA,III,NSCLC,RESULTS,THESE
169,2013,3175,3182,8208,947,948,CD8,EUR,GMBH,HOWEVER,IMMUNOL,IMMUNOLOGY,JOURNAL,KGAA,MHC,MOST,NKG2D,TCR,TRAIL,ULBP2,VCH,WILEY
177,2000,2013,CONCLUSION,FEB,JAN,LABEL,MEIER,METHODS,MSTS,OBJECTIVE,RESULTS,SIX,VAS
0001,102,119,150,2010,2012,286,395,8201,8804,AFTER,AVERAGE,CONCLUSION,CPS,FACTORS,KARNOFSKY,KPS,LABEL,MDT,MEIER,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,RTT,SUMMARY,THERE
BACKGROUND,CONCLUSION,D269H,DR5,E195R,LABEL,MDM2,METHODS,OVCAR,P53,PARP,RESULTS,TNF,TRAIL
2008,2011,556,8804,AMONG,BETWEEN,HOWEVER,III,JAPAN,LABEL,METHODS,NODAL,OBJECTIVE,OBJECTIVES,PHASE,RESULTS,SEVERAL,STAGE,T1A,USA
947,CD3,EPHA2,HOWEVER,ONCOLYTIC,TEA,THUS,VVS
18D1,4G5,5B6,8211,947,956,ADCC,EXPRESSION,FGF,FN14,HIGH,IGG1,NCA,P4A8,R56P,TNF,TWEA,W42A
8314,945,947,ALTOGETHER,B16F1,CD4,CD45,CD8,IFN,TNF,TREG
000,100,169,2013,946,BASEL,BECAUSE,CHMTF,PTD
CRITICALLY,THESE,THOSE
435,BASED,BOTH,CNS,DUE,FURTHER,GHR,GHRS,III,INC,INSTITUTE,MDA,MEL,NCI60,PRL,PRLR,PUBLISHED,STAT5,STRIKINGLY,UACC,WHILE
169,2013,946,COPYRIGHT,EMT,INC,LUNG,METASTASIS,SILENCING,SPARC,TAKEN,TGF
4T1,BLI,CELL,CREMOPHOR,MIP,NPS,PEG,PTX,PTXMIP_SQ,TAXOL,USING
169,2010,2013,946,ASIA,AUTHORS,FETAL,LTD,PATHOLOGY,PTY,PUBLISHING,SOCIETY,WILEY
BACKGROUND,CASE,EXTENSIVE,LABEL,METHODS,PCD,PET
LTQ,MALDI,MEETING,MSI,TARCEVA,THESE,THIN
011,012,017,034,169,177,2013,3N0M0,8201,EIGHT,ESOPHAGUS,FITCHBURG,FURTHER,HEALTHCARE,IMRT,INC,PHILIPS,PTV,SOCIETY,USA,VMAT,WILEY
FURTHER,LIBBY
169,2013,ACTA,BECAUSE,FOUNDATION,JOHN,LTD,PUBLISHED,SONS,WILEY
EGF,EGFR,EGFR2,HER2,NSCLC
EGF,EGFR,HOWEVER,NSCLC,ONGOING,THESE,TKIS
WHILE
BECAUSE,BML,PATHOLOGY
036,042,046,HOWEVER,MEIER,NSCLC,RESULTS,SH2,SHIP2,TNM
945,AKT,EGFR,HOWEVER,NSCLC,PTEN,TGF,THERE,THUS,TOTAL
001,008,027,028,EXPRESSION,NSCLC,SEVENTY,THEREFORE,VARIOUS,VEGF
BEAS,FLOW,H157,H292,LUNG,MES,NCI,NSCLC,PCR,PHB1,WESTERN
001,103,195,A549,AFTER,CHINESE,HOWEVER,LIMITED,LOG,NSCLC,RANK,RESULTS,SARI,THESE
001,003,009,020,10F,150,2009,2011,30GY,DATA,EGFR,GRADE,LPFS,PFS,THEREAFTER,WBRT
156,ALK,CCDC6,EGFR,EML4,KIF5B,KOREANS,KRAS,NSCLC,RET
CID,HOWEVER,SEVERAL
100,174,BACKGROUND,CELLSEARCH,CTC,CTCS,FMSA,LABEL,METHODS,RESULTS,THERE
169,2013,BECAUSE,COPYRIGHT,JOHN,LOD,LTD,ROC,SONS,SUPPOSE,WILEY
001,147,169,177,2013,436,8201,ACTA,BACKGROUND,CONCLUSION,EARLY,FOUNDATION,INITIAL,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SYSTEMATIC,VDT
169,1998,2010,2013,826,8805,BACKGROUND,CONVERSELY,INC,INPATIENT,LABEL,METHODS,MOST,NATIONWIDE,OVERALL,PCA,RESULTS,THERE,THESE,WILEY
104,143,371,AHR,BECAUSE,EACH,FOS,MRM,MYC,NF2L2,NPV,THUS,USING,VALIDATION
031,A549,EZH2,H3K27,HISTONE,KNOCKDOWN,TAKEN,TIMP
105,109,1121,117,1466,177,181,1981,2002,230,345,396,FIVE,HISTOLOGY,IIIA,INDUCTION,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,2013,279,8805,ADULT,LABEL,LOBECTOMY,METHODS,OBJECTIVE,OBJECTIVES,PRESS,PUBLISHED,PULMONARY,RESULTS,RVSP,SURGERY,THERE,TTE,UNIVERSITY
COMET,E2F,EXPRESSION,HOWEVER,MAD2,SAC
100,123,160,169,2014,ATS,COPYRIGHT,ERS,FIVE,IASLC,INC,LABEL,LUNG,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE
1967,1987,600,ANOVA,BACKGROUND,BRITISH,BSC,BSM,CLASS,COX,EXPOSURES,FUELS,HOWEVER,LABEL,LUNG,MEAN,METHODS,NSF,PAHS,RESULTS,SMOKELESS,STEEL,THESE,WORKERS
102,126,169,183,184,2008,2009,2013,8364,BACKGROUND,COPYRIGHT,LABEL,LTD,LUNG,LUXEMBOURG,METHODS,RESULTS,THESE,UNION
1987,1993,2000,2007,2010,5315,649,964,CRC,FINLAND,FINNISH,IBD,INSURANCE,METHODS,OBJECTIVE,OVERALL,RESULTS,SIR
220,390,DOX,FLIM,H1299,HBA,IONP,IONPS,MCF,MCS,MRI,OEGA,USING
19A,19B,205,20A,30B,AMONG,HOWEVER,LUNG,POOR,RNAS,SCC,THESE
ECS,HOST,TDEC,TDECS,THESE,XENOGRAFTS
BURKITT,C57BL,COX,DLBCL,FOXM1,MYC
231,4T1,HDAC,MCF,MDA,MMP,SAHA,THESE,TNBC
20TH,COMMITTEE,CONCLUSION,CONFERENCE,CONSENSUS,FIFTY,LABEL,LOBECTOMY,MEETING,METHODS,NSCLC,OBJECTIVE,RESULTS,SCIENTIFIC,STATEMENT,VATS,VIDEO
033,036,268,351,AFRICAN,AMERICANS,ASIAN,ASSESSMENT,FUNCTIONAL,GENERAL,LABEL,LACK,METHODS,OBJECTIVE,PURPOSE,QUALITY,RESULTS,THERE,TREATMENT,TRIAL
100,AFTER,SV40,TAG
140,169,2013,34B,AACR,ECTOPIC,EPIGENETIC,EXPRESSION,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,TP53
169,2013,947,AACR,BRCA1,DNAPK,EGF,EGFR,H2AX,NBS1,RAD50,TAKEN,USING
169,2013,AACR,AKT,BECAUSE,ECTOPIC,ELISA,FAK,IGF,IGF1R,INSULIN,MEK,MOLECULAR,NSCLC,SRC,TREATMENT,WESTERN
10A,169,2013,252,ACTA,CHIMICA,COPYRIGHT,HELVETICA,MTT
030,BOTH,BPF,BPFS,BRONCHIAL,CENTRAL,DUET,GENERALLY,GROUP,HOWEVER,JAPAN,KNOWLEDGE,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SURGERY,TRS
ALSO,ANY,FSH,SERTOLI,THERE
BECAUSE,SBRT
1995,2007,BACKGROUND,CONCLUSION,ENGLAND,INCOMPLETE,LABEL,METHODS,OVARIAN,RESULTS,SCREENING,TRIAL,WALES
2B7,8764,ADDITIONAL,ALTERNATE,ASE,ASES,CONCLUSION,DATA,LABEL,MATERIALS,METHODS,NOVEL,OBJECTIVE,RESULTS,THESE,UDP,UGT2B7S
169,2006,2013,2038,3171,3201,3771,BACKGROUND,COPYRIGHT,FORTY,GRADE,IASLC,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SABR,STAGE,SYSTEMATIC,THERE
039,100,125,169,177,2013,COPYRIGHT,GTV,HFJV,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PLANS,PTV,PURPOSE,RBE,RESULTS,THROUGH
150,169,2013,8776,BACKGROUND,CBCT,CLINICALLY,COPYRIGHT,DISCUSSION,DOSE,EXTENSIVE,IGRT,IMAGE,IMAGING,IRELAND,LABEL,LTD,METHODS,MODALITIES,OAR,RESULTS,TLDS
2000,3Q26,AMERICA,ARSENIC,BACKGROUND,BECAUSE,HISEQ,HOWEVER,LABEL,LUSC,LUSCS,METHODS,NORTH,RESULTS,SOX2,TP53
451,ALK,ASIAN,BACKGROUND,EGFR,FOUR,KRAS,LABEL,MET,METHODS,MOST,NSCLC,RESULTS,ROS1,SIXTY
207,ALK,BACKGROUND,EBUS,EGFR,KIRSTEN,KRAS,LABEL,METHODS,NSCLC,RESULTS
127,140,226,279,8201,BACKGROUND,BRAF,EASTERN,FOUR,FURTHER,GROUP,IIIB,LABEL,METHODS,RESULTS,SEVERAL,SIMILAR,SQCC,THREE
006,121,1991,2009,BACKGROUND,BAP1,BRCA,CONCLUSION,GENOMIC,HOWEVER,LABEL,METHODS,MPM,RESULTS,THERE
BACKGROUND,BIOMARKER,CONCLUSION,COPD,FOUNDATION,IMAGING,KEY,LABEL,LUNG,METHODS,NINTH,PREVENT
056,096,126,140,195,200,2000,2010,208,229,249,625,884,BACKGROUND,BMI,JANUARY,LABEL,METHODS,NINTH,REGARDLESS,RESULTS,THERE
4T1,BACKGROUND,BE1,CCK,ENDOSTATIN,EVIDENTLY,LABEL,LDM,LDP,LIDAMYCIN,METHODS,RESULTS,TARGETING,THEREFORE
0001,160,169,2013,CONCLUSION,JOHN,LABEL,LTD,METHODS,NUCLEAR,OBJECTIVE,RESULTS,SCC,SCCS,SONS,THERE,WILEY
169,2013,APOPTOSIS,CH11,FAS,FASL,H292,JOHN,LAK,LTD,NSCLC,PCR,SONS,THESE,WESTERN,WILEY,ZB4
174,452,500,ADVERSE,BACKGROUND,CIMAVAX,CTC,EGF,EGFR,FURTHER,IMMUNOLOGY,INSTITUTE,LABEL,MEDICAL,METHODS,MOLECULAR,NCI,NONE,POST,RESULTS,THESE
8805,HSP90,INHIBITING,NOVOBIOCIN,PRESTWICK,UTILIZING
270,3440,956,MEMBERS,PDT,THESE
949,CUL3,HOWEVER,INHIBITION,INRF2,INRF2S602A,KEAP1,MOLECULAR,NRF2,PKC,RBX1,S599,S602
BRENT,CAMBRIDGE,CARLO,CENTRAL,COUNCIL,DEPARTMENT,GROUP,HODGKIN,HOWEVER,JAGER,MEDICAL,MEIER,MONTE,NATURAL,NOE,NORTH,NSERC,OWEN,STATISTICS,TREATMENT,UNIT,UNIVERSITY,VAN,VARIOUS,WELLNER
100,377,8805,AMONG,ASCT,CELL,CONCLUSION,COX,HCT,ICU,INDEX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
000,169,2013,653,ADULT,BACKGROUND,CCSS,CHILDHOOD,CNS,CONCLUSION,CSI,INC,INCIDENCE,LABEL,MEDICAL,METHODS,POISSON,RATES,RESULTS,SURVIVORS,WILEY
FURTHER,HISTOLOGY
169,2013,7417,8201,BACKGROUND,C30,CORE,COX,EORTC,HRQOL,LABEL,LIFE,METHODS,QLQ,QUALITY,RESULTS,SOCIETY,TREATMENT,WORLD
001,006,066,165,169,187,2013,260,304,362,447,599,691,CIS,MAY,RCC,SUMMARY,TKIS,TREATMENT,UICC,VEGFR
100,107,169,2013,203,356,420,593,BACKGROUND,EBUS,FNA,FNAS,HISTOLOGIC,LABEL,LTO,METHODS,RESULTS,SAT,SOCIETY,UNSAT
169,2013,63742,BECAUSE,COPYRIGHT,GMBH,HOWEVER,KGAA,VCH,WILEY
160,8209,BONE,CHEMOKINE,CHEMOKINES,CXCR4,CXCR7,EWING,MAPK,PI3K,SDF
001,010,012,031,078,102,140,HOWEVER,PCR,ROC,SERUM,SEX,SOX2,TAKEN,TNM
029,133,145,193,194,874,967,ADC,ADCS,ARHGEF5,HOWEVER,NSCLC,SCC,SCCS,SRC,THEREFORE
127,198,325,443,757,954,CK20,CK7,IHC,MATCHED,NSCLC,TEN,TTF
2008,719,8805,AFFAIRS,CENTRAL,EACH,FEW,IMPORTANCE,LABEL,MAIN,METHODS,MOST,NOTABLE,OBJECTIVE,OUTPATIENT,OVERALL,RELEVANCE,RESULTS,SETTING,THESE,USING
AKT,AKTI,CURRENTLY,LC3,NSE,THESE
131,158,177,231,AIM,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAPILLARY,PMC,PTMC,RESULTS,SURGERY,TOTAL
169,1770,2013,ACCORDING,AIMS,COLLEGE,COPYRIGHT,CRUDE,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,OVERALL,PROQEST,PUBLISHED,RESULTS,ROYAL,SCIENCE,SCLC,SMOKERS,WEB
DIMINISHED
004,006,008,157,300,ACUTE,AIMS,ARP,BACKGROUND,CONCLUSION,CTR,FEV,INDUCTION,LABEL,MATERIALS,METHODS,NSCLC,NTCP,OBJECTIVE,RESULTS,V13,V20,V25
018,100,2007,2011,BACKGROUND,EBUS,JULY,LABEL,MATERIALS,METHODS,NPV,PET,PPV,RESULTS,TBNA
169,2013,BORTEZOMIB,BTZ,CASPASE,COPYRIGHT,FINALLY,H1299,HMSNS,HOWEVER,IC50,LTD,NSCLC,THEREFORE
100,169,2013,CUTANEOUS,ERG,MMP,THESE,WHILE
DPC,INSIGHT,LIGHT,MICROSCOPY,SWISS,WORK
0001,0097,400,6NHSD,956,C57BL,GFP,LD100
100,945,956,A549,HRS
014,049,178,2009,2012,811,8804,8805,892,967,BACKGROUND,BASED,CONCLUSION,CRT,III,LABEL,MARCH,METHODS,PFS,RESULTS,WHOLE
001,BACKGROUND,HOWEVER,IDO,LABEL,METHODS,PLEURAL,RESULTS,TBP,THESE
CASE,CONCLUSION,FURTHER,INCISIONAL,LABEL,METHODS,OBJECTIVE,POST
EGFR,H1975,L858R,STRUCTURAL,T790M,THESE
1RM,216,6MWD,8322,AMERICA,BACKGROUND,DISCUSSION,FEV1,HADS,HOWEVER,HRQOL,IIIB,LABEL,LUNG,METHODS,NORTH,NSCLC,PRIMARY,SCLC,SECONDARY,TRIAL,WESTERN
2010,2012,BETWEEN,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SEPTEMBER,SURGERY,THERE,VATS,VIDEO
181,AKT,BAK,BASED,BAX,BCL,BCL2,CD31,EGFR,EPIDERMAL,H441,KI67,MAPKS,MCL,MES,NCI,NSCLC,PARP,PCNA,PI3K,USING,VEGF
907,AFRICAN,AMERICANS,ASIAN,BACKGROUND,CAUCASIANS,CENTRAL,CHINESE,CONSISTENT,EAST,EASTERNERS,EGFR,EPIDERMAL,EUROPEANS,FREQUENCY,HOWEVER,INDIA,KOREANS,LABEL,NON,NORTH,NSCLC,PRINCIPAL,RESULTS
400,NANO,PEG,PEGYLATED
1970S,1971,2000S,2005,326,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,2013,8201,9Q22,9Q31,BCC,CARDIAC,INC,NBCCS,PNET,PTCH1,WILEY,WILMS
169,2013,BACKGROUND,COPYRIGHT,INDIVIDUAL,JOHN,LABEL,LTD,METHODS,NEVER,NEXT,RESULTS,SONS,WILEY
NSCLC,OVERALL,USP17
169,2013,8201,945,ALA,BINDING,BIOLOGICAL,COPYRIGHT,HLH,HPLC,ID1,JOHN,LTD,MALDI,MCF,MTT,PEPTIDE,SAR,SOCIETY,SONS,SPPS,SPR,TOF,WILEY
169,2013,ALK,BRAF,COPYRIGHT,EGFR,EML4,EPH,EPHA1,EPHB1,EPHB6,EPHS,INC,INSR,KDR,KRAS,MET,NON,NSCLC,PIK3,PTEN,RET,RTKS,TP53,WILEY
001,101,174,2007,2010,288,386,517,538,AMERICA,BASED,CENTERS,FOUR,III,JULY,LABEL,MAIN,MEAN,MEASURE,METHODS,NINE,NSCLC,OBJECTIVE,OUTCOME,OVERALL,PATIENT,RESULTS,SELF,SETTING,SEVEN,SIX,TREATMENT
169,2013,549,ALA,ALDER,DIELS,GI50,GLU,GLY,GMBH,KGAA,MCF,PHE,VCH,WILEY
200,239,AIM,ASSESSMENT,AUC,BOTH,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PFS,RESULTS
127,215,239,252,445,BACKGROUND,CONCLUSION,LABEL,METHODS,NONE,RESULTS
176,180,360,AIM,ARC,BACKGROUND,BOTH,CASE,CONCLUSION,IMRT,INTENSITY,LABEL,METHODS,MODULATED,MODULATION,NSCLC,OBJECTIVE,PTV,RESULTS,THERAPY,VMAT,VOLUMETRIC,WHILE
100,AUC5,CONCLUSION,CONCURRENT,DOSE,FURTHER,HDAC,LABEL,METHODS,RESULTS,SIX,THEREFORE,UNLABELLED
945,947,ADSCS,DESPITE,EMT,FACS,H358,NOTCH,SMA,THESE,TIME
1573,418,705,A549,BACKGROUND,BEN,CALU,CONCLUSION,CONFLUENCE,F111,GJIC,H1299,LABEL,LUCI,MATERIALS,MES,METHODS,NSCLC,RESULTS,SHP,SINCE,SRC,STAT3
945,AKT,BACKGROUND,CD34,CONCLUSION,FDG,GLUT1,GLUT3,HIF,HOWEVER,LABEL,LCNEC,MATERIALS,METHODS,MVD,PET,PNET,PNETS,RESULTS,SCLC,VEGF
AIM,ASCS,BACKGROUND,CONCLUSION,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,RESULTS,SCIENTISTS,THREE
CAREFUL,SUCCESS,THERE,WIDE
100,110,169,176,2013,8201,996,COPYRIGHT,JOHN,LTD,SONS,SPM,THEREFORE,WILEY
169,2013,FEW,INC,METASTASES,RENAL,TREATMENT,WILEY
169,198,2013,878,CHINESE,COLLEGE,COVARIATES,DCR,DISEASE,NSCLC,PFS,PREDICTIVE,THERE,WESTERN
124,BACKGROUND,FOXO3,LABEL,METHODS,OBJECTIVE,PULMONARY,RATIONALE,RESULTS,THUS
169,2008,2011,2013,862,8804,8805,BACKGROUND,BRIGHAM,COX,DANA,EASTERN,GROUP,JULY,JUNE,LABEL,LES,METHODS,PREDICTING,RESULTS,SOCIETY,WOMEN
169,2013,BRITAIN,COPYRIGHT,GREAT,INSTEAD,IRELAND,ISSUE,JOHN,JOURNAL,LTD,PATHOLOGY,PUBLISHED,SOCIETY,SONS,WILEY
169,2013,HOWEVER,INC,NMRI,NOD,SCID,THEIR,WILEY
001,002,013,10Q22,169,197,2013,2Q11,8201,8804,945,AE1,AE3,AUTHORS,BRITAIN,CNS,COPYRIGHT,EGFR,GENOMES,GENOMIC,GREAT,HER2,IRELAND,JOHN,JOURNAL,KI67,KIT,LTD,MAJOR,PATHOLOGY,PGR,SOCIETY,SONS,THERE,WILEY
0001,0176,036,1000,2000,2010,BACKGROUND,CARCINOMA,EPSCC,EXTRA,LABEL,METHODS,RESULTS,USA
0001,153,177,8211,EDTMP,THESE
001,0021,0063,016,056,146,205,226,236,8201,8211,8217,8722,967,99TH,BASED,ELISA,IGA,IGG,NSCLC,PEARSON,STUDENT,TAAS
DGIDB,DRUG

8211,DTC,FUNCTIONAL,LABEL,METHODS,OBJECTIVE,PATHOLOGIC,PURPOSE,RESULTS,THREE
946,AKT,EMT,ERK,MET,NRP,NRP2,SMAD,TGF,ZEB1
945,946,A549,F666D,FIPI,HEK,INHIBITION,NOTABLY,PKC,PLD,PLD2,PROTEIN,THESE
044,094,150,2008,2011,301,8211,968,BACKGROUND,CONCLUSION,DAYS,EGFR,ERLOTINIB,GRADE,JANUARY,LABEL,METHODS,NSCLC,ORR,PFS,RESULTS,SEPTEMBER,SKIN,TKIS
103E,HAI,KNOCKDOWN,PCA,THESE
169,2013,8320,8325,COPYRIGHT,GI50,H460,HCT15,HELA,HEPG2,MCF,NCI,PLP2,RESULTS,SAS
169,2013,8320,8325,956,A549,COPYRIGHT,MOST,NSCLC,SAS
100,191,208,CK7,GATA3,HOWEVER,III,REMAINING,THEREFORE,UCS
100,ALT,ANCILLARY,CPM,HMGA1,HMGA2,HOWEVER,LIPOMATOUS,MOST,SEVEN,THREE,WDL
AUTOPHAGY,B16,BASED,CA755,HER2,LEWIS,LLC,OVERALL,P62,RAS,S37
0001,001,1990,2006,2011,4797,BACKGROUND,EINDHOVEN,GASTRIC,LABEL,METHODS,ORADJ,RESULTS,YOUNGER
169,2013,AACR,AML,FINALLY,INHIBITION,THESE,THUS,WEE1
169,2013,BRAF,ERK,KRAS,MEK,MEKI,RAF,RAS,TARGETING
001,1410,169,2013,263,309,328,349,351,392,426,430,470,550,605,805,AMONG,BACKGROUND,CONCLUSION,CVD,LABEL,METHODS,REGISTERED,RESULTS,SIMILAR,SUMMARY,WHILE
100,169,2013,946,A549,ALX,COPYRIGHT,EMT,EPITHELIAL,EXPRESSION,FPR2,GPR32,H1299,H1703,H838,HOWEVER,LTD,RESOLVINS,TGF,THEREFORE,THESE,THUS,WESTERN,ZEB1
169,2013,NOVEL,PUBLISHED
169,2014,COPYRIGHT,CTC,CTCS,DFS,IIIA,INC,LUNX,LUXN,MOSBY,NSCLC,RESULTS
0001,169,2013,210,338,BIOLOGICAL,HOWEVER,ILGGHLDAK,LABEL,MRM,NPANPVQ,NSCLC,PUBLISHED,SECRETION,SERUM,SID,THREE,THROUGH,UNASSIGNED,UNLABELLED
169,2014,AGA,AIMS,BACKGROUND,COPYRIGHT,DGCR8,FUNCTIONS,HMGA2,INC,INSTITUTE,KNOCKDOWN,LABEL,METHODS,NF45,NF90,NUCLEAR,OBJECTIVE,PANCREATIC,PDAC,PDACS,PUBLISHED,REDUCED,RESULTS,THESE,TNFRSF10A,TNFRSF10B,TRAIL
169,2013,327,COPYRIGHT,COX,MEN,PUBLISHED,TAX,THESE,THUS
2006,2012,ARMY,BDUMP,CAR,CASE,EACH,EIGHT,FIVE,GENERAL,LABEL,LIBERATION,MARCH,METHODS,OBJECTIVE,OCTOBER,OTHER,PNS,PON,PRON,RESULTS
1301,169,2000,2010,2012,241,3117,3529,7206,9267,9767,AIM,BACKGROUND,COMPARING,CONCLUSION,COPYRIGHT,ESPA,FEMALES,IIIB,LABEL,LUNG,METHODS,MOST,OBJECTIVE,PORTUGUESA,PUBLISHED,RESULTS,SOCIEDADE
169,2013,600,AMERICA,COPYRIGHT,LATIN,MOST,PUBLISHED,SEPAR
169,2013,ACD,ACRYLIC,COPYRIGHT,DIFFERENT,DVT,ECOG,FEMORAL,LAFN,LATERAL,LTD,LUNG,NAIL,PATHOLOGIC,PFN,PFNA,QOL,RESULTS,SIX,SYNTHES,THERE
169,2013,2474,KRAS,MMP,PRIMARY
PULMONARY
169,2013,COPYRIGHT,SAS,SMOKING,TROUSSEAU
169,2013,2CM,BOTH,CARLO,EARLY,HOWEVER,MEDICAL,MONTE,MUS,PTV,PTVS,SBRT,SIMILAR,THESE
160,215,AUC,BOTH,FOUR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
0001,120,160,169,177,2013,AUR,CONCLUSION,COPYRIGHT,DES,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS,ROC
001,169,177,2013,5GY,8201,AFTER,AUSTRALIAN,AUTHORS,BACKGROUND,BTV,COLLEGE,CRT,FIF,HOWEVER,IMAGING,JOURNAL,LABEL,MEDICAL,METHODS,RADIATION,RESULTS,ROYAL,TOTAL,V47,VMRT,WHILE,ZEALAND
100,169,2013,3RDS,8201,AUSTRALIAN,BACKGROUND,COLLEGE,COMBINING,CONCLUSION,FAT,LABEL,MEAN,METHODS,RESULTS,ROYAL,ZEALAND
001,169,2009,2011,2013,AES,BACKGROUND,CHINA,CONCLUSION,COX,EASTERN,ECOG,EGFR,FURTHER,GROUP,JANUARY,JOHN,LABEL,LTD,METHODS,MOST,NSCLC,OBJECTIVE,PFS,RESULTS,SONS,SUNITINIB,TKI,TKIS,UNIVARIATE,WILEY
169,177,184B5,2013,956,A549,AAD,BCPT,H2O2,IC50,KING,LAAO,MCF,SOCIETY
169,2013,FINALLY,JOHN,LTD,SONS,WDPM,WILEY
000,001,007,014,038,063,160,2003,201,2010,8201,8805,BACKGROUND,LABEL,METHODS,MST,NSCLC,RADIATION,REGISTERED,RESULTS,TNC,TREATMENT,TRIAL
002,160,169,2013,333,951,955,BACKGROUND,BRITISH,CONCLUSION,HOWEVER,INFORMING,LABEL,METHODS,OBJECTIVE,READING,RESPONSES,RESULTS,SMOKERS,SOCIETY,STATEMENT,THERE,UNASSIGNED,WHAT,WILKS
AKT,EGFR,EGFR1,ERK,EVEN,GENOMIC,LUNG,NSCLC,PROTEIN,RAS,STAT3,TKI
A549,AKT,AMONG,FINALLY,HIGH,HTD,KIP1,TAKEN
123,169,2013,A549,ADRIAMYCIN,B014,BACKGROUND,BRITISH,CDC,CDC2,CELL,EGF,FACSCAN,H1299,H226,INSTITUTE,KEY,LABEL,MCL,METHODS,NSCLC,OBJECTIVE,PROTEIN,PURPOSE,RESISTANT,RESULTS,SOCIETY,TYR15,WESTERN
004,082,087,116,261,2828,453,476,564,696,8202,892,929,968,ASIAN,BACKGROUND,CAUCASIAN,CIS,HRS,LABEL,MATERIALS,MET,META,METHODS,NSCLC,ORS,RESULTS,THESE,THR,THR241MET,XRCC3
EACH,K2P,K2P1,K2P10,K2P12,K2P16,K2P18,K2P2,K2P3,K2P4,K2P5,K2P6,K2P7,K2P9,POTASSIUM,THEIR,WHILE
101,169,2013,8201,946,ANTIBODIES,ATLAS,BACKGROUND,CALIF,CRUZ,EFFUSIONS,HNF1,INC,LABEL,METHODS,RESULTS,SANTA,SOCIETY,STOCKHOLM
2000,2011,2012,335,454,9679,COLORECTAL,FORCE,INSTITUTE,INSTITUTES,LUNG,OVARIAN,PLCO,PREVENTIVE,SCREENING,TASK,TRIAL
169,2013,947,A549,AFTER,ATM,CHK2,CONSISTENT,CYTOMETRY,DDS,EDU,H2AX,SER15,SER1981,SOCIETY,THESE,THR68,TK6,WTK1
34B,945,946,954,COX,ERK,NNK,TOBACCO,TXA2,TXAS

0SH,0SHCONTROL,169,2013,916,BASED,CL1,GMBH,HOWEVER,KGAA,SEVERAL,VCH,WILEY
169,2013,FOS,INC,JUN,TAKEN,VEGF,WESTERN,WILEY
089,292,451,8804,ACTIVITIES,AMONG,DAILY,ERLOTINIB,III,INITIAL,NSCLC,THERE
10B,10C,10E,10H,10M,10P,10R,11B,169,181,2013,8201,CRAF,GMBH,H460,IC50,KGAA,MKN,PAC,VCH,WILEY
575,945,946,FRET,HEK293T,SEX,SOCE,STIM1,STROMAL,THESE
169,2013,EATON,LAMBERT,THERE
BCG
169,1A2,2013,2A13,2A6,AFB1,ATR,BAX,BEAS,BRCA1,CASPASE,CYP2A13,CYTOCHROME,HOWEVER,INHIBITION,MRE11,OHDG,P30,P40,P450,P50,PARP,RAD50,RAD51,THESE,UICC
169,2013,8764,ACTIVATING,ALK,AUTHORS,BRAF,BRITAIN,EGFR,FGFR1,GREAT,HER2,IRELAND,JOHN,JOURNAL,LTD,MEK,MET,NSCLC,PATHOLOGY,PTEN,RET,ROS1,SOCIETY,SONS,THESE,WILEY
CETUXIMAB,EARLY
2961,CCNB1,CDC6,CELL,DEGS,EXPRESSION,FEN1,GEO,GSE3268,KEGG,MCM,MEANWHILE,OMNIBUS,OTOLOGY,PCNA,POLD,PTTG1,PUBLISHED,RFC,SQLC
009,169,1973,2003,2013,CALORIC,OVERALL,SIR,SMR,UICC,WOMEN
AMP,AMPK,IGF,METFORMIN,NOTABLY,PI3K,SUPPORT,THERE
198,BOTH,DATA,SNP,SNPS,THESE
1997,2007,AICR,CONTINUOUS,CUP,FUND,INSTITUTE,PROJECT,WCRF,WORLD
837,AIMS,BACKGROUND,CGH,CONCLUSION,FISH,HER2,HOWEVER,LABEL,OBJECTIVE,RESULTS,THUS,TMA,VEGFA
100,1897,300,SINCE
8201,CALU,CELL,CHK1,CONSISTENT,H2A,HELA,INHIBITION,LY2603618,RNAI,TP53,TREATMENT
169,2013,2801,3106,8805,BACKGROUND,EASTERN,FATIGUE,GROUP,LABEL,METHODS,RESULTS,SOCIETY,USING
00001,0001,002,005,1996,2013,8201,ALSO,ASIAN,CIS,CNKI,DFS,ELISA,FINALLY,HRS,INITIAL,LATEX
054,057,060,064,100,104,201,230,238,308,BACKGROUND,LABEL,LC1,LC2,LUNG,METHODS,NSCLC,RESULTS,SIMILAR,TNF
27TH,DISEASE,HOWEVER,JAPAN,MALIGNANT,THERE
2003,2004,2008,RESULTS
169,2013,946,954,ECM,H1299,INC,INHIBITING,MRLC,RHO,THESE,WHILE
169,2007,2011,2013,ACCORDING,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LOCAL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OCTOBER,PFS,RESULTS,THERE,THREE,USING
169,2013,442,8776,AFFYMETRIX,BLOT,CHK1,COPYRIGHT,ELISA,H1299,H1437,H1993,H23,INHIBITION,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,PMX,RESULTS,THESE,U133A,WESTERN,WST
169,2013,HOWEVER,THESE
0004,0007,004,111,124,136,169,189,2013,855,883,AUC,BONE,BSI,CLEARREAD,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MATERIALS,METHODS,MRMC,MULTI,OBJECTIVE,OBJECTIVES,OBSERVERS,OHIO,OPERATING,RESULTS,ROC
169,2013,231,8320,8325,956,A549,COPYRIGHT,HELA,MCF,MDA,SAS,TBAHS,THESE
169,2013,A549,COPYRIGHT,HCT15,IC50,MEL,MOST,PSA,SALMONELLA,SAS,STRUCTURE
169,176,2013,8764,956,A549,BINDING,COPYRIGHT,DIXON,HUVEC,IC50,MTA,SAS,TARGETING
100,754,AUC,BACKGROUND,CONCLUSION,DENSITY,DIAGNOSIS,DISCOVERY,FFPE,LABEL,LOW,METHODS,NSCLC,PCR,RESULTS,ROC
100,169,2013,95TH,CBCT,CONCURRENT,COPYRIGHT,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SABR,THOSE,THUS,V100,VMAT
169,177,2014,215,402,8730,8LOG,931,963,BECAUSE,COPYRIGHT,CTV,FILLING,GTV,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PTV,PTVS,PURPOSE,RESULTS,SDS,TCP
169,176,2013,270,956,A549,BRAGG,CELL,COPYRIGHT,FIT,FNTD,FNTDS,H2AX,INC,LABEL,MATERIALS,METHODS,MEV,OBJECTIVE,PURPOSE,RESULTS,RIF,RIFS
ALK,COMBINING,EGFR,EML4,SCC,THESE,TKIS,WHILE
HOWEVER,LDCT,LUNG,RANDOMIZED,SCREENING
004,006,038,BACKGROUND,BRAF,CONCLUSION,E21,EGFR,KIRSTEN,KRAS,LABEL,MEANWHILE,METHODS,NSCLC,OBJECTIVE,PI3K,RESULTS,STMN1,TUBB3
BACKGROUND,BLM,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,PCR,PEPT2,PEPTIDE,PULMONARY,RATS,RESULTS,SPRAGUE,THERE
EGFR,EPIDERMAL,HOWEVER,INTENSE,NOW,NSCLC,THEIR,THEN,THERE,TKIS
004,011,012,030,041,460,466,634,666,832,960,BACKGROUND,CONCLUSION,DATA,EGFR,HOWEVER,LABEL,METHODS,OBJECTIVE,ORR,PFS,RESULTS,SUBSEQUENT,TKIS
BACKGROUND,CONCLUSION,EGFR,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TKIS
2011,2012,AMONG,BACKGROUND,CDD,CONCLUSION,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SUNITINIB,TREATMENT
AMONG,BACKGROUND,CONCLUSION,DIFFERENT,EGFR,EPIDERMAL,LABEL,LOCAL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,TKI,TKIS
AMONG,BACKGROUND,CONCLUSION,EGFR,LABEL,METHODS,NSCLC,OBJECTIVE,RESISTANCE,RESULTS,TKI
169,2013,AMONG,COPYRIGHT,DUE,FIVE,LTD,MBC,MCRC,MOST,NSCLC,RCTS
160,169,2013,CELL,ELISA,FEBS,HOWEVER,MMP,MT1,TIMP
801,ACTIVATION,ALTERED,BACKGROUND,CELL,CHIP,CHROMATIN,ERK,EXPRESSION,FOXO,FOXO1,HEPG2,HLF,HOWEVER,HUH,INDUCTION,KNOCK,LABEL,METHODS,MTT,NBQX,NMDA,PCR,RESULTS,THR24,TXNIP,WESTERN
169,2013,INC,NYHA,WILEY
169,2013,945,A2780,EF24,GLUT1,HIF,HOWEVER,OVCAR,SKOV,THESE,TRANSWELL,WARBURG
BACKGROUND,DIRECTIONS,LABEL,MICRORNAS,RESULTS,RNAS,SINCE
004,BASED,CRT,ELISA,MAB,PAB,THEREFORE
001,1132,147,149,160,169,2013,208,839,8G7G3,905,AIMS,BOTH,IBC,IBCS,JOHN,LABEL,LTD,METHODS,NUCLEAR,OBJECTIVE,RESULTS,SONS,SPT24,TMA,TTF,WILEY
218,COPD,DLCST,FEV1,LUNG,MEASURING,SCREENING,SMOKING,TRIAL,USUALLY
0530,945,AZD,CIGARETTE,COPD,EGF,FURTHER,MCP,SAE,SIMILARLY,SRC,THESE,TNF
CIGARETTE
AFTER,FIBEROPTIC,IMAGING,PALLIATIVE
239,946,CONSISTENT,EGF,EGFR,EMT,ERK,KRAS,MAPK3,MEK,MEK1,NSCLC,OVERCOMING,TGF,THESE
100,200,ALLERGY,EORTC,FRESH,GROUP,IFD,INFECTIONS,INFECTIOUS,INSTITUTE,MSG,MYCOSES,PCR,THUS,TREATMENT
8805,CAVERNOUS,CHOROIDAL,HOWEVER,IMAGING,MELANIN,NEOPLASMS,ORBITAL
BOTH,CARCINOID,CARCINOIDS,DIFFUSE,DIPNECH,LARGE,LOCAL,THESE

005,017,098,167,169,184,1999,2010,2013,370,427,8805,907,BACKGROUND,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,STATISTICS,USING,WILEY,YPLL,YPPL
001,005,015,135,169,1984,2011,2013,8805,APART,BACKGROUND,BEP,CUMULATED,GCC,GERM,LABEL,METHODS,OCTOBER,RESULTS,SOCIETY,TREATMENT
HOWEVER,LUNG,RAGE,UNDER
600,EXPRESSION,FAMA,IMP,MYC,RNAS,SMALL
742,8220,8221,EXHAUSTIVE
169,2013,947,GMBH,PPAR
169,2013,AIDS,BACKGROUND,BOTH,CASE,CONCLUSION,GMBH,HIV,LABEL,METHODS,PRESENTING,REPORTS,THEREFORE,THESE
206,ALTOGETHER,C2C12,CCND1,TARGETING
000,006,118,133,134,516,865,8805,BACKGROUND,CONCLUSION,HOWEVER,III,LABEL,MAT3,METASTASIS,METHODS,MTA3,NSCLC,PCR,RESULTS,T3T4,THERE,TNM,UNASSIGNED,VIRTUAL
ADDITIONAL,AMONG,GRADE,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
HAZARDS,IMPAIRMENT,INDUSTRIAL,JAPAN,LAW,ORDINANCE,PREVENTION,SPECIFIED,SUBSTANCES
100,916,ADCA,CK5,CONCLUSION,FNA,IHC,LABEL,MEDICAL,METHODS,NP63,NSCCA,OBJECTIVE,RESULTS,SCCA,UNIVERSITY,WASHINGTON
160,176,1ST,2004,2010,327,775,880,AIDS,BACKGROUND,CD4,COX,CUMULATIVE,FACTORS,HIV,HODGKIN,INCIDENCE,JANUARY,LABEL,LATER,MEIER,METHODS,MODIFIABLE,NADC,NON,RESULTS,TIME,USING
169,2013,FINALLY,JOHN,LTD,MALIGNANT,PUBLISHED,SONS,WILEY
2003,2012,2013,APRIL,BACKGROUND,CHINA,D15S822,D22S689,D2S1363,D6S1056,D7S1824,DEPARTMENT,GENOMIC,LABEL,METHODS,PCR,RESULTS,SICHUAN,SINCE,SURGERY,WEST
115,170,2007,300,AFTER,INDIA,KARNATAKA,SEVENTY,SSNTD
0001,001,002,100,145,177,BACKGROUND,DUE,LABEL,MEDICAL,METHODS,RESULTS,RIGID
169,2013,B16,BASED,BCL2,BSA,CBSA,GMBH,HOWEVER,KGAA,THESE,VCH,WILEY
006,169,1983,2000,2010,2011,2013,490,8804,ALCOHOLIC,HODGKIN,JANUARY,LIVER,SIR,SIRS,SITE
CHECKPOINT,CHEK2,FOUR,I157T,IVS2,LOW,MEDICAL,MUTATIONS,STUDIES
001,120,148,169,1986,2012,2013,743,8201,BACKGROUND,BETWEEN,CONCLUSION,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGY,RESULTS,SOLID,THOSE,UNIVARIATE,WHILE,WILEY
001,169,2013,211,8201,8805,ANXIETY,AUTHORS,DEPRESSION,HADS,JOHN,LABEL,LTD,META,METHODS,OBJECTIVE,PREVALENCE,RESPECTIVE,RESULTS,SCALE,SONS,STUDIES,WILEY
000,169,2005,2012,2013,2025,AICHI,ALDH2,ASIAN,EAST,JAPAN,MICC,MULTI,THERE,THESE,UICC
2005,2013,BOTH,III,LARGE,MEDICAL,MEDLINE,METHODS,MPDL3280A,NON,NSCLC,RESULTS,SOCIETY,START,VALIDATING
169,2013,CSLCS,FACS,THEREFORE,UICC,USING
169,1940,1970,2013,FINALLY,SOCIETY
946,A549,AFTER,AIM,AKT,BALB,CHINA,CHINESE,CONCLUSION,DDP,FURTHER,HOWEVER,LABEL,MAPK,METHODS,OBJECTIVE,PI3K,PROFESSOR,RESULTS,WESTERN,WNT,ZHOU
0017,0417,169,2013,BACKGROUND,EGFR,HOWEVER,LABEL,METHODS,PPS,PPSS,RESULTS,SOCIETY,T790M,THR790MET,TKI,VARIOUS
000,001,006,160,7404,BEL,FINALLY,HCC,HUH7,MMP2,OVERALL,SERPINB,UNIVARIATE
1911,1ST,BUCHMAN,ENGLISH,PERIPHERAL,THESE
215,4TH,ASKIN,BECAUSE,CHEST,MRI
CONCLUSION,FIVE,LABEL,METHODS,OBJECTIVE,RESULTS,THESE,UNLABELLED
CONCLUSION,DYSPNEA,LABEL,LUNG,METHODS,OBJECTIVE,PCU,RESULTS
001,002,1146,8805,ACCORDING,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCORE,WBRT
001,004,022,215,472,8805,AGE,BACKGROUND,CONCLUSION,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCORE,WBRT
CYLD,HCC,HOWEVER,JNK1,JUN,LOSS,MYC,TNF
CD3,CD56,CIK,CIKIL,FURTHER,GENERATION,HOWEVER
AMONG,MUCOSAL,NKT,THEIR,WHETHER
2008,244,253,EIGENIMAGE,IMAGING,MED,ONCOL,USING,WHILE
169,8201,BACKGROUND,CONCLUSION,ESO,GAGE,HOWEVER,IIIA,LABEL,MAGE,METHODS,NSCLC,RESULTS,SP17
169,2013,3LL,945,BOTH,COPYRIGHT,EPH,EPHA2,INC,THEREFORE,THUS,TLR4,TNF
ACUTE,BASED,CONCLUSION,CTV,DATA,FORTY,HEART,LABEL,LAD,LUNG,MATERIALS,METHODS,OBJECTIVE,PRESCRIBED,PRONE,PTV,PURPOSE,RESULTS,STUDENT,V10,V105,V107,V20,V95
BACKGROUND,EXPRESSION,HOX,HOXA5,INHIBITION,LABEL,METHODS,MTT,NSCLC,PCR,PROTEIN,RESULTS,RNAI,RNAS,STUDENT,TAIL,THUS
001,110,1500,2001,2378,300,8804,ABOUT,ADMISSIONS,AEQ,ASIAN,CONCLUSION,HIGH,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PM10,POISSON,POPULATION,RESULTS,RISK,RISKS,SETTING,SMALL,SOUTH
169,2013,COPYRIGHT,CROSS,ELEVATION,EVENTHOUGH,LTD,PDGF,PLD,PLD1,PLD2,PUBLISHED,RAS,TGF
001,005,021,169,198,2010,2012,2013,377,4DCT,4DCTS,653,8201,AUSTRALIAN,BACKGROUND,COLLEGE,COUCH,LABEL,METHODS,MID,RESULTS,ROYAL,SABR,ZEALAND
177,2005,2011,5TH,8TH,AFTER,AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,STENT,THERE
169,1994,2012,2013,BACKGROUND,COLLEGE,CONCLUSION,LABEL,METHODS,PULMONARY,RESULTS,ROYAL,SEVENTY,SURGERY,THREE,UNIT
169,2013,916,968,A549,ACTIVATION,ATG5,BAX,BCL,CONCLUSION,ERK,FINALLY,FIRST,INHIBITION,KEY,LABEL,LC3,LOSS,MET,METHODS,OBJECTIVE,RESULTS,ROYAL,SOCIETY,SUBSEQUENT,THUS,VAD
A549,HNO,NSAID,STRUCTURAL
584,CONCLUSION,EASTERN,ECOG,ELDERLY,GROUP,LABEL,METASTATIC,METHODS,MOST,OBJECTIVE,PFS,PURPOSE,RESULTS,XELOX

200,350,945,BOTH,H460,HIF,HYPOXIA,P3971,STAT3
AFTER,MBS,PCR,RNAS
486,CURRENT,EBC,LUNG,MICRORNAS,NSCLC,THERE,WESTERN
169,2013,8197,945,954,A549,BACKGROUND,BAX,BCL,BID,BIS,BRITISH,COX,FURTHER,H441,ICAM,KEY,LABEL,LUNG,METHODS,MMP10,MMP9,OBJECTIVE,OVERALL,PARP,PURPOSE,RESULTS,SOCIETY,THESE,TNF,VEGF
RNAS
AGAIN,CMAX,DEFICIENCY,NCS,SCID,THESE
HIGH,MINIMAL

945,946,COX,COX2,HIF,HOWEVER,MET,P53,TGF,THEIR,THEREFORE,TNF,VEGF
A549,CD90,CSCS,H446,OCT4,SOX2,THESE
001,150,5341,AES,CONCLUSION,III,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SEVEN
002,004,137,CONCLUSION,CONVERSELY,COPRIMARY,EGFR,IHC,INCIDENCE,INCREASED,ITT,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,THESE
ALK,DESPITE,EGFR,NSCLC,THESE,TKI,TKIS
053,128,961,A549,CELL,COX,FOLLOWING,G10398A,HOWEVER,NON,NSCLC,PCR,RFLP,ROS,WARBURG
384,8209,DECREASED,HELA,MTT,SNP,SNPS,THESE,TRANSWELL,U2OS,WESTERN
946,EGFR,HOWEVER,IHC,IRS1,JCV,K19,PULMONARY,THESE,USING
003,016,019,150,178,300,525,CURRENT,DOSES,FORTY,HIGH,INTRA,MTD,TTP
CD133,CD24,HOWEVER,METFORMIN,TARGETING
BLOOD,CRC,HOWEVER,PCA,PLSDA,SPME,THREE,VOCS
1997,2013,ALK,CD34,EXPRESSION,IGG,IGG4,IMT,IPT,SINCE,SMA
2384,A2058,AMONG,CONSISTENT,JAK,JANUS,MCL,MLS,MYC,PARP,SRC,STAT,STAT3,TAKEN,UPON
AKT,BON1,ERBB,ERK,GEP,GOT1,H727,HSP,HSP70,HSP90,IGF,INHIBITION,NCI,NETS,PARP,THESE,TREATMENT
100,169,2013,8764,COPYRIGHT,EIGHT,IRELAND,LABEL,LTD,METHODS,MRIS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCLC,TREATMENT,WBRT
169,2013,238,COPYRIGHT,GTV,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MDE,MDES,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT
105,1677,169,2014,2387,357,AUTHORS,BACKGROUND,COPYRIGHT,FOUR,III,IIIA,IRELAND,LABEL,LTD,METHODS,NON,NSCLC,PORT,PUBLISHED,RESULTS
ATS,ERS,FLEISCHNER,HOWEVER,IASLC,LUNG,PULMONARY,SOCIETY,SSNS
100,160,169,2004,2008,2013,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GENERAL,GGO,GGOS,HIGH,HOWEVER,HRCT,JANUARY,LABEL,METHODS,PUBLISHED,RESULTS,SURGERY,THERE
169,2013,ABCB9,COPYRIGHT,DDP,HOWEVER,IRELAND,LTD,NOTABLY,NSCLC,UTR
169,2013,AMPK,BAX,BCL2,CD31,CDK2,CDK4,COH,COPYRIGHT,GST,H358,HENCE,INC,KI67,MAP,PARP,SR4,TREATMENT,WESTERN
169,2013,92B,A549,CDDP,COPYRIGHT,FEWER,INC,MICRORNAS,NSCLC,PCR,PTEN,THESE

001,002,008,123,124,136,181,200,247,369,7TH,ACS,AGE,COX,LABEL,MEIER,METHODS,MIB1,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SURG1,SURG2,SURG3,SURG4,SURGERY,THERE,TNM,UNITS
169,2013,467,50MG,904,COPYRIGHT,FORTY,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
1035,169,2000,2001,2013,AMONG,BACH,BACKGROUND,COPYRIGHT,DISEASE,FIVE,IIA,IIB,IIIA,IIIB,IRELAND,LABEL,LDCT,LTD,MATERIALS,METHODS,MOST,NEITHER,RESULTS,SEVENTY,SMOKERS,TEN
1976,MATSUSAKA,PRIMARY
FOXP3,HOWEVER,IDO,LEWIS,LLC,THREE,TREGS
AUSTRALIA,COMMITTEE,DRUGS,FIRST,NSCLC
160,169,2013,A549,COPYRIGHT,HEPATOCYTE,HGF,MET,MMP,MMPS,NK1,NK2,NK3,NK4,PUBLISHED,RESULTS,THUS
BACKGROUND,BISULFITE,EXPRESSION,FLOW,HOECHST,HOWEVER,LABEL,MDM2,MEG3,METHODS,MTT,NSCLC,PCR,PROTEIN,RESULTS,RNAS,STUDENT,THUS
DOCETAXEL,HOWEVER,OWING
CHINESE,FOUR,GWAS,HAN,HOWEVER,IBS,LKM,MAF,PCA,SIMULATION,SNP,SNPS
1986,1990,2009,AGE,ASR,BACKGROUND,GHIS,HBV,HEPATITIS,HIV,HODGKIN,HOWEVER,HPV,INCIDENCE,LABEL,METHODS,NCR,NHL,PBCR,RATES,RESULTS,SAHARAN,SIMILARLY
223,946,A549,COX,EMT,EP1,EP4,EXOGENOUS,PGE1,PGE2,TGF,THESE,TREATMENT
2578C,405C,460C,571,664,936C,BACKGROUND,CIS,CONCLUSION,CRUDE,LABEL,METHODS,OBJECTIVE,ORS,RESULTS,SCC,VEGF
131,AHASA,BACKGROUND,BECAUSE,CONCLUSION,CONTEXT,DTC,LABEL,OBJECTIVE,PEDIATRIC,RAI,RESULTS,THEN
0001,0002,0011,0013,009,025,169,2013,221,265,320,541,AACR,CONCLUSION,EGFR,EZH2,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS,SCC,SCCS,TNM,TTF
169,2013,AACR,CSB,CSBS,DRUG,FOOD
ATP,USING,WASHING
131,947,AFTER,BONE,DISTANT,INF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TES,THEN,THREE
FOLLICULAR,FTC,PTC
FDG,IRIS,LUNG,PET
DATA,FIVE,LUNG,STUDIES
001,163,2006,2010,CASES,LABEL,LESSONS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY
507,956,AIM,BALB,CONCLUSION,EGFR,ELISA,ERLOTINIB,IC50,KBIO,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SPC,THERE,WESTERN
CROSS,EYA4,EYA4S,EYES,NSCLC,TSG,TSGS
10A,231,252,945,954,ECTOPIC,EPITHELIAL,KLF8,MCF,MDA,THESE,USING,VCP
BCL,CL1,CREB,EGFR,ERK,H23,MEK,NSCLC,PXN,RAF,SRC,THEREFORE,Y118,Y31
1993,2010,221,249,3N0M0,823,DATA,DUE,JANUARY,JULY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2013,COPYRIGHT,DOCETAXEL,KING,PUBLISHED,SPECIALIST
169,2013,AMONG,BACKGROUND,COPD,CSE,EGFR,HBE,HEAT,HSP70,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PERIPHERAL,RESULTS
177,3920,4586,AMONG,ASSESSMENT,BACKGROUND,COLLECTED,DAS28,DATA,DISEASE,HIGH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SCORE,SYSTEMATIC
169,2013,8805,ASA,COX,DATA,HOWEVER,INC,LABEL,MAIN,METHODS,OBJECTIVE,PATIENT,RESULTS,SETTING,UNIVARIATE
0295,169,181,2013,215,231,33RD,500,8320,8325,A375,A549,ASTERACEAE,BACKGROUND,BENTH,BODY,CONCLUSION,FURTHER,HL60,IRELAND,LABEL,LTD,MATERIALS,MCF,MDA,METHODS,MIA,PACA,RELEVANCE,RESULTS,UPON,VGDE,WST
100,169,2013,241,COPYRIGHT,ESPA,FDG,FOUR,LABEL,METHODS,OBJECTIVE,PET,RESULTS,THERE
169,2013,A549,AMONG,COPYRIGHT,HEPG2,MCF,SAS
169,2013,33258,945,A549,COPYRIGHT,DHA,H460,HEPG2,HOECHST,MTT,NCI,SAS,SKOV3,THEIR,TUNEL
169,2013,BACKGROUND,BASED,CHEST,EICHINGER,HELBICH,HIGH,HRCT,HRCTS,ICC,INTRACLASS,LABEL,METHODS,MRI,REGARDING,RESULTS
169,2013,956,BASED,COPYRIGHT,EGFR,IC50,KNOWN,LIBRARY,LTD,NSCLC,PC9,T790M
0024,043,0449,160,169,177,2014,ATO,CELL,COPYRIGHT,DRUG,FOOD,GDC,GLI,GLI1,ITRA,LABEL,METHODS,MPM,MTT,OBJECTIVE,RESULTS,SELECTIVE,SMO,SURGERY,THESE
0001,0059,021,0313,119,125,169,2013,COPYRIGHT,HGF,HOWEVER,IRELAND,LTD,LUNG,MET,MPP,PHOSPHO,SCI,STAGE,THESE
169,1980,2013,AOSD,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,METHODS,NAIDS,OASD,PUBLISHED,SAS,STILL
0002,001,131,169,173,177,2013,COPYRIGHT,HISTOLOGY,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,REGARDING,RESULTS,SCLC
169,176,2013,BACK,BACKGROUND,CONCLUSION,COPYRIGHT,DIGITAL,DTS,GTV,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,VMAT
169,1999,2007,2013,609,BACKGROUND,BASIC,CAMBRIDGE,CARDIFF,CASE,CONCLUSION,COPYRIGHT,GLASGOW,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SHEFFIELD,THESE
169,2013,7TH,AFTER,AIM,BACKGROUND,BLOOD,CONCLUSION,FVIIA,LABEL,LWMH,MATERIALS,METHODS,OBJECTIVE,RESULTS,SAMPLES,TFA,TFPI,VTE
169,2013,COPYRIGHT,CRT,EIGHT,INC,MEDICAL,NSCLC,OAR,PUBLISHED,QUALITY,VMAT,VMATH
001,002,005,021,032,062,160,169,2001,2012,2013,785,ACCS,ADENOID,APRIL,BACKGROUND,BRONCHIAL,CHEST,COPYRIGHT,COX,FIVE,INC,LABEL,MARCH,MEIER,METHODS,PRIMARY,PUBLISHED,RESULTS,SOCIETY
0001,0002,0005,007,169,2004,2010,2014,204,BACKGROUND,COPYRIGHT,IIIA,IIIB,INC,LABEL,METHODS,PUBLISHED,REDUCED,RESULTS,SOCIETY
001,159,169,2003,2006,2013,967,BACKGROUND,COPYRIGHT,COX,INC,LABEL,MEIER,METHODS,NSCLC,OPN,PUBLISHED,RESULTS,SOCIETY
160,169,2013,215,AIMS,BACKGROUND,CD3,CD56,COPYRIGHT,DESPITE,FIFTEEN,INC,INFUSIONS,LABEL,METHODS,NATURAL,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY,THERAPY,THREE
169,2013,488,635,COPYRIGHT,CY5,FAM,LIF,MICRORNAS,RNAS,THESE
169,2013,AUTHORS,COPYRIGHT,HOWEVER,IRELAND,LTD,NSCLC,PUBLISHED
0001,0026,0060,086,1000,169,2013,255,336,956,AMONG,CONCLUSION,COPYRIGHT,HOWEVER,IRELAND,LABEL,LTD,LVI,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SVI
169,2013,956,A549,AFTER,CYTOMETRY,FCM,FLOW,FTIR,HOWEVER,HPLC,IC50,SLN,TEM,ZETA
169,176,2013,A549,AMF,ATRP,FE3O4,FOURIER,PEG
002,177,99M,CONCLUSION,DIAGNOSIS,LABEL,METHODS,RESULTS,SPECT,UNLABELLED
A549,AMONG,BACKGROUND,CHIP,CHROMATIN,FGA,FGB,FGG,FGL1,FOXA1,FOXA2,FURTHER,LABEL,RESULTS,SEQ,SEVERAL,SLUG,SNAIL
BAC,CCAM,CONGENITAL
1000,8201,A549,DIFFERENT,HCPT,HT29,HYDROXY,IC50,MTT,P85,PLGA,TEM,TPGS
126,1400,186,8201,8764,HACAT,HELA,MALIGNANT
30S,GRAM,H460,NCI,NSCLC,ROS,WHILE
HOWEVER

027,1996,2008,323,584,816,AMONG,BACKGROUND,COX,HOWEVER,IIP,LABEL,METHODS,RESULTS
001,1150,1170,133,1472,1794,209,636,903,945,946,957,AKT,BACKGROUND,DATA,DUAL,HNSCC,IGF,III,INCREASED,LABEL,MEAN,METHODS,NSCLC,RESULTS,SEVERAL,SRC,STUDENT,TARGETING,WESTERN
ADT,COLORECTAL,ERSPC,LUNG,MAJOR,OVARIAN,PLCO,PSA,RANDOMIZED,SCREENING,THESE
169,2013,945,946,947,AACR,AMSA,BOTH,DSB,DSBS,EGF,EGFR,H2AX,HER2,HOWEVER,SHORT,STUDIES,THESE,TKI,TKIS,TOPO
169,2013,AUTHORS,EMBO,EMT,FMR1,FMRP,FXS,HOWEVER,JOHN,LTD,PUBLISHED,SONS,THERE,TNBC,WILEY
0085,009,014,031,309,310,8201,CHINA,CITY,CURRENT,HAN,LUNG,OVERALL,SNP,SNPS,TP63
157,1995,2011,ACCORDING,ACS,AFTER,COX,DEPARTMENT,ITALY,JANUARY,LABEL,LCNCS,METHODS,NET,NETS,OBJECTIVE,OBJECTIVES,OLDER,RESULTS,SCLCS,SURGERY,TCS,TURIN
100,104,1050,2008,2010,532,946,CRC,DATA,GROUP,LABEL,MARCH,METHODS,OBJECTIVE,RESULTS,THESE,VARIABLES,VIDEO
168,AMBER,EGFR,OVERALL

NEWLY,PCA,SCID,SCLC
2006,2008,4208,4214,CHEMISTRY,DUAL,GFP,H2B,NOBEL,NUCLEAR,PRIZE,RES,RFP
METASTATIC,THERE

024,0301,037,047,11P15,12Q23,160,16Q22,1P31,7Q32,967,9P21,AJCC,COMMITTEE,FAL,FRACTIONAL,III,JOINT,KRUSKAL,LOH,LOSS,MSI,NSCLC,STAGING,THESE,TOTAL
115,124,1993,2001,2009,386,COLORECTAL,COX,DIETARY,FURTHER,HOWEVER,LUNG,OVARIAN,SCREENING,THESE,TRIAL
101,163,2005,2007,350,679,771,8805,AMONG,CCRT,CONCURRENT,HOWEVER,IIIB,JULY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,THERE,THREE
160,175,DESPITE,ENGAGEMENT,IMPORTANT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
0001,0003,0007,160,217,8201,CHINA,CHINESE,DEPRESSION,LABEL,METHODS,OBJECTIVE,POOR,PURPOSE,RESULTS
ALK,AP26113,CH5424802,HOWEVER,III,NSCLC,SEVERAL
0001,001,316,AMONG,BACKGROUND,END,GUIDELINE,GUIDELINES,LABEL,METHODS,RESULTS,TEXAS
1ST,3RD,ACCORDING,BACKGROUND,BETWEEN,C30,CONCLUSION,EORTC,LABEL,LUNG,METHODS,MOST,NONE,QLQ,QOL,RESULTS,THESE
2005,2008,307,AIMS,BACKGROUND,JUNE,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,TIMELINESS
AALDH,ALDH,CD44,FURTHER,INHIBITION,LIMITED,NOTCH,TIC
10TH,BASED,DESPITE,IFOSFAMIDE,SERUM
BECAUSE,CSF,GIVEN,IRF,IRF8,MDSC,MDSCS,MYELOID,OVERALL,STAT3,STAT5
169,2013,CIP,COLLECTED,CONCLUSION,COPYRIGHT,EIGHT,FIVE,IRELAND,LABEL,LTD,LUNG,MATERIALS,METHODS,NINE,OBJECTIVE,PREGNANCY,RESULTS
001,004,027,169,2013,8805,CELLSEARCH,COPYRIGHT,CSF,CTCS,DEB,DETECTION,GRADE,HER2,LABEL,LTD,MBC,METHODS,OBJECTIVE,ORR,PRIMARY,PURPOSE,RESULTS,THERE,UNASSIGNED,WOMEN
ALCAM,ASCL1,ATP,CD151,CD166,CD56,CXCR4,FGFRS,GLUT1,GPCRS,IGF1R,INC,MYC,NANOG,NCAM,OCT4,PAX5,PETA,PHASE,PUBLISHED,RECURRENT,RTK,SCLC,SEVERAL,SOX2
169,2013,947,A549,AFG1,AFLATOXIN,BAX,BCL,COPYRIGHT,DSBS,FAS,FASL,H2AX,HOWEVER,JNK,LTD,MAPK,NAC,PRE,ROS,THUS
142,183,227,789,8202,8807,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
0001,003,016,095,169,2008,2010,2014,238,427,430,BACKGROUND,CASE,COPYRIGHT,DATABASES,INC,INPATIENT,LABEL,METHODS,PUBLISHED,RESULTS,ROBOTIC,SID,SOCIETY,STATE,USING,VATS
001,169,177,2014,BACKGROUND,COMPONENT,COPYRIGHT,DIRECTORS,EACH,FOCUSED,GIVEN,IMMEDIATE,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
2011,500,BACKGROUND,DISCUSSION,EASTERN,ENROLMENT,GROUP,HOME,LABEL,LITERATURE,METHODS,TRIAL
CBCT,FURTHER,HOWEVER,IGRT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
CBCT,DUE,DVF,DVFS,FDK,IMAGE,LABEL,MAXE,METHODS,NACT,NCAT,OBJECTIVE,PURPOSE,RESULTS,SART,SMEIR,VIEW
177,ARTIFACTS,DICE,DSC,FOUR,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,REDUCTION,RESULTS,SPECT
176,177,8776,CBCT,DYNAMIC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,VMAT
003,110,113,146,215,372,541,564,741,837,BLOCKED,CARLO,HIP,LABEL,METHODS,MONTE,OBJECTIVE,ORGAN,PURPOSE,RESULTS
AFTER,ASPC,BACKGROUND,DESPITE,DIL,DU145,FIJI,FURTHER,HOWEVER,HT29,INDIVIDUAL,JAK1,LABEL,LNCAP,METHODS,RESULTS,SW620,T47D,USING,WASF3
945,CHIP,GATA4,GATA6,SCC,SP1
000,100,124,133,149,169,2013,259,392,40TH,542,746,759,AACR,ABC,AGE,BACKGROUND,COLORECTAL,CONCLUSION,COX,EFFECTIVE,HGBC,LABEL,LUNG,METHODS,NOMOGRAMS,OVARIAN,PLCO,RESULTS,USING
131I,BACKGROUND,CANDIDATE,CONCLUSION,DTC,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,SERUM
MDP,SPECT
2004,2010,AFTER,CLOSURE,DATA,FGCCP,JUNE,SANJO,SAPPORO,THERE,THREE,THROUGH
126,16403,2009,2010,4495,AES,BETWEEN,CENTRAL,CONCLUSION,GENERALLY,GROUP,HOWEVER,JANUARY,JAPAN,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SURGERY,TOTAL
LUNG
GENERALLY,NLH,PLAM,SLT
ADDITIONAL,AFTER,BSCC,THERE
60400,CRP,FIVE,MALIGNANT,WBC
001,114,160,191,2008,2010,CONCLUSION,GGO,GGOS,HRCT,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PURE,PURPOSE,RESULTS
215,6TH,CHEST,GROUP,LUNG,S4B,T1AN0M0
CD4,HOWEVER,MDSC,MDSCS,SHP,SIMILARLY,SRC
2005,2012,AFFILIATED,BACKGROUND,COX,DUE,FIRST,HENAN,JANUARY,LABEL,LOG,MEIER,METHODS,PSC,PULMONARY,RESULTS,SPSS,THERE,TNM,UNIVERSITY,ZHENGZHOU
169,2013,BECAUSE,COPYRIGHT,INC,PUBLISHED,SOCIETY
160,169,2013,BRONCHIAL,BSF,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2013,CARDIAC,COPYRIGHT,INC,PUBLISHED,SOCIETY,THESE
060,1426,177,2012,272,331,729,BACKGROUND,LABEL,LUNG,MAY,METHODS,RESULTS
ALK,AREAS,BACKGROUND,COVERED,DESPITE,EGFR,FURTHER,HOWEVER,LABEL,METHODS,NON,NSCLC,OPINION,TKIS
2013,ANTI,CLINICALLY,COPYRIGHT,EGFR,EPIDERMAL,ERBB,HER2,HER4,HNSCC,HOWEVER,KRAS,LUNG,LUX,NSCLC,PROUS,SCIENCE,T790M,TKI,TKIS
CTS,FDG,HOWEVER,ICT,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
001,009,014,019,027,035,048,ASIAN,BACKGROUND,CAUCASIAN,HOWEVER,LABEL,METHODS,MGMT,OVERALL,RESULTS,THESE
001,053,081,108,1990,2006,2012,233,234,581,591,6433,678,702,727,735,750,8805,AMONG,CONCLUSION,DATA,HIGH,III,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS
EXOME,HOWEVER,NEXT,NGS,SCLC,SEQ,USING
AMP,AMPK,JEGHERS,LKB1,PEUTZ,STK11
160,2001,2011,970,BACKGROUND,CNKI,CONCLUSION,HOWEVER,ISI,LABEL,METHODS,MGMT,MSP,NSCLC,ODDS,OVID,POTENTIAL,RESULTS,SCIENCE,WEB
103,169,19DEL,2004,2010,2013,APRIL,CONCLUSION,COX,EGFR,EVALUATION,L858R,LABEL,MATERIALS,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,RSNA,SMALLER,SOLID,TKI
1FUC,2HEXNAC,ALEURIA,APCS,ELISA,FOUR,HLE,IGG,INCREASED,LEWIS,PON1,SCLC,SCLCS,SMALL,WESTERN
105,720,946,CONSISTENT,CURRENT,EXPRESSION,KNOCKDOWN
945,954,AKT,APO10LA,C57BL,HCC,HFD,HUH7,NAD,OBESITY,PARP,SIRT1,STAT3,TAKEN,THLE,TNF
CONCLUSION,FDG,FINALLY,GLG,III,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RADIATION,RESULTS,SUVMEAN
106,116,271,706,8201,BANGLADESH,CHAIN,INDIVIDUAL,POLYMERASE,RISK,THEREFORE
008,013,022,220,284,ASIAN,CBM,CIS,CYS,DESPITE,FPRP,MEDLINE,ORS,SER,SER326CYS,SNPS,THESE
115,160,211,491,832,918,939,952,AUC,CEA,CYFRA,FOUR,LABEL,METHODS,MODEL,MPE,NSE,OBJECTIVE,PURPOSE,RESULTS,TPS
CREB,FMK,HOWEVER,MEA,METASTASIS,RSK,RSK2,TAKEN,THEREFORE
341,514,945,946,954,AKT,COX,FMK,GSK,HOWEVER,IKK,KIP1,LC3B,MG132,PIS,PROTEASOME,S9A,THEIR,TREATMENT,WAF1,XIAP
H2O2,MCF,NTP,NUCLEOSIDE,PPASE
AREAS,BACKGROUND,COVERED,LABEL,LUNG,METHODS,OPINION,THUS,TODAY,VEGF
AKT,HOWEVER,HTLV,LUNG,MAPK,PI3K,THESE
BASED,LUNG,NNK,SERUM,THESE
205,A549,HOWEVER,LUCIFERASE,NON,NSCLC,PCR,PTEN,UTR
CHIP,CHROMATIN,FDA,HDACI,HISTONE,IDIOPATHIC,III,IPF,PCR,SAHA,WESTERN
018,160,169,1994,2007,2008,2012,2014,AGGRESSIVE,AIM,BACKGROUND,CCRS,CONCLUSION,COPYRIGHT,HIPEC,INC,LABEL,LIVER,METHODS,MORTALITY,MOSBY,NET,OBJECTIVE,OVERALL,RESULTS
BALB,PCA
165,288,AB1,AB2,AIM,CONCLUSION,ELISA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
0013,BACKGROUND,CD44,CONVERSELY,CURRENTLY,LABEL,MALIGNANT,METHODS,MMP14,MMP7,MPM,PCR,RESULTS
001,033,034,181,450,945,946,BACKGROUND,BRAIN,EXPRESSION,KRUSKAL,LABEL,METHODS,RESULTS,THERE,THREE
169,2013,AFTER,BEAS,COPYRIGHT,GROWING,HOWEVER,IRELAND,LNCRNAS,LTD,RNAS,SILENCING,THESE
001,169,2013,BACKGROUND,COPYRIGHT,CTS,DETECTION,GGN,GGNS,INC,LABEL,LUNG,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SCREENING,SOCIETY,THERE,THREE,TRIAL
100,169,19K,200,2013,956,ALP,ALT,AST,BESIDES,COLLEGE,COPYRIGHT,CSF5,FILGRASTIM,HHPG,LABEL,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,THERE
000,002,003,004,006,010,013,023,033,050,074,076,082,095,096,101,109,174,212,229,270,285,323,382,460,500,518,535,596,697,712,755,795,824,838,841,8719,936,942,948,949,ASP312ASN,CAUCASIANS,CIS,ERCC2,ORS,THEREFORE
CLEAR
BACKGROUND,CH27,CHINA,CONCLUSION,GREEN,H2DCFDA,LABEL,METHODS,RED,RESULTS,TRACKER,WESTERN
094,116,177,8320,8325,946,A549,ALPINIA,BACKGROUND,CIOCALTEU,DPPH,FOLIN,HCT,LABEL,MCF7,METHODS,MRC,RESULTS,SKI,SOD
100,945,956,A2058,CAT,CL1,SIMILAR,THESE
ALSO,APART,OTHER
CRL4A,DDB1,DLC1,FBXW5,FINALLY,GTP,NSCLC,RHOA,RING
239,8764,8805,CHEMO,CISPLATIN,CREATININE,FOUR,GRADE,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,TEN
000,001,004,143,237,444,450,ALX1,CONCLUSION,CPG,HOXA9,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PCDHGB6,PURPOSE,RESULTS,RFS
0001,112,210,967,BACKGROUND,LABEL,LUNG,MEIER,METHODS,MOST,OVERALL,PEARSON,RESULTS,WHETHER
ALSO,ARF,HOWEVER,INK4A,PTEN,TAKEN,TP53
000,005,102,1035,18FDG,2011,273,8201,BACKGROUND,CITS,CONCLUSION,DOR,LABEL,LUNG,METHODS,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,SROC,SUMMARY
EJ1,ERBB,ERBB1,ERBB2,ERBB3,FINALLY,OVERALL,TREATMENT,WHILE
169,2013,BASEL,COPYRIGHT,EBUS,TBNA
0001,0002,0010,0058,1000,102,301,352,398,775,797,8201,843,ADVERSE,BACKGROUND,COU,CYP17,HRS,LABEL,METHODS,ORR,ORRS,PSA,RESULTS,TREATMENT
036,151,169,2013,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,FACTORS,LABEL,METHODS,RESULTS,SMOKERS,SMOKING
BECAUSE,HAART,HIV,IMPORTANCE,LABEL,METHODS,OBJECTIVE,RELEVANCE,SIMILAR
169,2013,8594,BOTH,HDACI,VPA
8202,EXPRESSION,FURTHER,IGF1,IGF2,INSULIN,THERE
063,1131,335,COX,LABEL,METHODS,N2A,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESECTION,RESULTS,SINCE,TNM
003,169,1995,2010,2013,3869,AFFAIRS,AIMS,AMONG,CLINICIANS,COLLEGE,COPYRIGHT,COX,DEPRESSION,ICD,III,INCREASED,LABEL,MATERIALS,METHODS,NETWORK,NORTHWEST,NSCLC,OBJECTIVE,RESULTS,ROYAL,THERE
HOWEVER,LUNG,SCREENING,TRIAL,UNTIL
100,169,2012,BECAUSE,COPYRIGHT,DOGS,HPD,MOST,PUBLISHED,VATS
ASIAN,BACKGROUND,CASE,CONCLUSION,LABEL,METHODS,NODULAR,PULMONARY,SUBSEQUENT
2010,2012,ALK,BACKGROUND,EBUS,EGFR,HOWEVER,KRAS,LABEL,MAIN,MARCH,METHODS,NOS,NSCLC,RESULTS,ROSE,SAMPLES,TBNA
BACKGROUND,CAARRAY,CONCLUSION,DNMT2,EPIGENETIC,EZH2,GEO,GSEA,HDAC,HDAC4,HIGHEST,LABEL,METHODS,RESULTS,SIGNATURES,SIRT1,TCGA,TGF,USING
946,CDS,DOX,MOLECULAR,MTT
III,PPB
169,2013,AACR,CTL,CTLA,CTLS,EGF,EGFR,EXPRESSION,LABEL,THESE,UNLABELLED
169,2013,239,AACR,DRUG,FDA,FOOD,LABEL,SCLC,SMALL,THESE,UNLABELLED
BACKGROUND,COLLECTING,HOWEVER,LABEL,LIFE,METHODS,MOTIVATION,RESULTS,THESE,USING,WEB
0001,169,2013,8201,ACTA,BACKGROUND,CONCLUSION,FOUNDATION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMALL,VATS
104,ARF,ARFS,ASAP3,GTP,INCREASED,LTE,NSCLC,THESE,TNM,WESTERN
CONCLUSION,DIR,FINALLY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
132,139,271,BRONCHIAL,CERTAIN,EBUS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PPL,PPLS,RESULTS,TBB,TBBW
1991,1997,2008,320,8211,842,CIS,NORWEGIAN,PAF,POISSON,RRS
AFTER,ANTI,BACKGROUND,CONCLUSION,DRUGS,LABEL,MONITORING,NON,PROMISING,RATIONALE,STEROIDAL,WHAT
005,008,019,153,232,247,265,312,8201,8211,99M,ACCORDING,CONCLUSION,EANM,EDTMP,LABEL,LBM,MDP,METHODS,MOST,OBJECTIVE,PATIENT,PLT,PURPOSE,RESULTS,ROC,USING,WBC
016,080,113,BACKGROUND,COX,ICU,LABEL,METHODS,PRIMARY,RESULTS,SECONDARY,SEVEN
1997,2009,EARLY,FIFTY,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS
106,2007,2011,8201,ADVERSE,BACKGROUND,BETWEEN,COX,GRADE,LABEL,LFFS,LOCAL,MEIER,METHODS,NSCLC,RESULTS,SBRT,T4N0,V30
100,121,135,8P12,BACKGROUND,CONCLUSION,FGFR1,FIBROBLAST,LABEL,LIMITED,METHODS,RESULTS,SIMILARLY,SQCC,SQCCS,USING
BACKGROUND,CELL,CONCLUSION,EGFR,KRAS,LABEL,METHODS,RESULTS,STK11
BACKGROUND,DATA,DENMARK,EUS,FNA,FOUR,HOWEVER,LABEL,METHODS,RESULTS
8805,AVAPERL,BACKGROUND,CORE,DESPITE,EXCEPTIONS,HRQOL,III,LABEL,LIFE,LUNG,METHODS,PATIENT,QUALITY,RESULTS,TREATMENT
000,169,2013,2281,673,AACR,AZD,BMN,ELISA,INHIBITION,LABEL,METHODS,OBJECTIVE,PAR,PARP,PARP1,PI3K,PROTEIN,PURPOSE,RESULTS,SCLC,SMALL,THESE
002,003,006,010,168,169,199,200,2013,259,317,860,875,885,902,933,AACR,AKT,AKT1,AKT2,COX,FRAP1,HRS,LABEL,MEIER,METHODS,NON,NSCLC,OBJECTIVE,PI3K,PTEN,PURPOSE,RESULTS,SNP,SNPS
946,ABS,JNK,JUN,MMP,SMAD,SMAD1,SMAD2,TGF,THERE,TRACON105
945,954,DISRUPTION,EKER,ELT3,THEREFORE,TSC,TSC1,TSC2
100,BLACK,HMB,INDEX,LABELLING,MELANOTIC,MRI,SIX
HOWEVER,PET
570,95C,95D,BESIDES,DEG,DEGS,EGR,HOWEVER,KEGG,METASTASIS
105,120,140,160,D99,DIFFERENT,GEOMETRIC,GYE,IMPT,NON,THESE,THUS
0001,004,1940,1987,1993,1995,1997,2001,2003,2004,2006,2007,SPAIN,SPANISH,SURVEYS
177,CTCS,HOWEVER,THESE
100,4818,AMONG,CHRONIC,CMV,FEW,GVHD
169,2013,BASED,HOWEVER,SEVERAL,SILTUXIMAB
000,169,2013,DESPITE,HOWEVER,VEGF
947,ANTITUMOR,BIOMARKERS,GSIS,INC,NOTCH,PUBLISHED
107,169,177,2013,BODY,BOOST,CONCERNING,COPYRIGHT,D95,DOSE,GAI,LABEL,LTD,MATERIALS,METHODS,MUS,OARS,OBJECTIVE,PLAN,PLANS,PTV,PTVS,PUBLISHED,PURPOSE,RESULTS,TEN,V10,V18,V20,V30,VMAT
0001,0004,0007,002,003,169,1997,2011,2014,421,708,ADULT,COPYRIGHT,INC,LABEL,MEIER,METHODS,OBJECTIVE,RECURSIVE,RESULTS,RPA,THESE
169,2013,ASIC1,BDNF,CANCEROUS,CIBP,COPYRIGHT,FINALLY,IRELAND,KNOWLEDGE,LTD,NGF,PART,TRPV1
169,2013,BOTH,HOWEVER,MICRORNAS,RNAS,UTRS,VIRAL
169,2013,225,956,BMDL0,CENTRAL,COPYRIGHT,ESTIMATED,FIVE,FOOD,HUNGARY,LTD,SMES,THREE,WATER
169,2013,IMPORTANT,INC,LASSO,MOTIVATED
183,239,250,8202,AFTER,AUC,IIIB,NSCLC,ORR,PFS
001,10172,1456,160,169,2014,229,ACUTE,AMONG,BACKGROUND,COPYRIGHT,INC,INSTITUTES,ISP,ISPS,LABEL,METHODS,NORSTROKE,NORWEGIAN,ORG,PUBLISHED,RESULTS,SCALE,TREATMENT,TRIAL
142,154,169,2013,231,COPYRIGHT,CUSUM,EBUS,FAILURE,INC,INDIVIDUAL,LABEL,METHODS,MOSBY,NODE,OBJECTIVE,OBJECTIVES,PREVALENCE,PUBLISHED,RAPID,RESULTS,RISK,SURGERY,TBNA
160,169,2004,2012,2014,COPYRIGHT,INC,LABEL,MARCH,METHODS,MOSBY,OBJECTIVE,PRIMARY,PUBLISHED,RESULTS,SURGERY
169,2013,2639,CASE,CCAML,CONCLUSION,COPYRIGHT,III,LABEL,METHODS,MOLECULAR,OBJECTIVE,PUBLISHED,TSC,TSC2
169,2013,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,RESULTS
169,2013,ALK,COPYRIGHT,IRELAND,LTD,RANK
0001,169,2004,2008,2013,3355,3967,4019,4241,ACEI,ARB,ARBS,BACKGROUND,BBS,CCB,CCBS,COPYRIGHT,COX,DPIN,DRUG,HOWEVER,LABEL,LTD,METHODS,NETWORK,OBJECTIVE,OBJECTIVES,PROGRAM,PROVINCIAL,PUBLISHED,RESULTS,TDS,THERE
105,147,169,1CM3,2013,210,293,945,946,CONCLUSION,COPYRIGHT,EQD,GY3,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PRESCRIBED,PURPOSE,RESULTS,SBRT,SEVENTY
169,177,2013,BECAUSE,CHANGES,COPYRIGHT,DVH,FOUR,IMAGE,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSPT,PURPOSE,RESULTS
169,171,2008,2011,2013,24FX,66GY,8805,ACUTE,AET,BACKGROUND,BOTH,CIS,COPYRIGHT,COX,EORTC,EQUIVALENT,EUD,EUDN,IMRT,IRELAND,KUTCHER,LABEL,LKB,LTD,LYMAN,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RTOG,TD50,TX50,V76
169,174,177,2007,2013,34G,421C,ABCG2,ATP,AUC0,CAUCASIANS,CHINA,CHINESE,CMAX,COPYRIGHT,ORAL,SAS,SCLC,SNPS,UHPLC,XINZE
169,2013,215,AFTER,COPYRIGHT,PERIPHERAL,SAS
169,2004,2012,2013,757,CONCLUSION,EPUB,EVALUATION,FURTHER,INT,JUN,KEY,LABEL,MAHALIK,MATERIALS,MEDLINE,METHODS,MULLICK,NARASIMHAN,OBJECTIVE,OCT,OVERALL,PEDIATR,PURPOSE,RAO,RATAN,RESULTS,ROLE,SODHI,SURG,THUS
016,063,100,120,169,2013,CAD,CAD1,CAD2,CAD3,CADS,COMBINING,COPYRIGHT,HIGHEST,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
009,0096,021,029,034,036,116,136,2008,2010,208,228,967,BESIDES,CD68,CONCLUSION,FUDAN,HUADONG,LABEL,METHODS,OBJECTIVE,RESULTS,TAM,UNIVERSITY
105,111,169,2013,2ND,616,8462,CONCLUSION,COPYRIGHT,EGFR,HOWEVER,ICER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MODEL,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,QALY,RESULTS,VERISTRAT
169,2013,BASED,HOST,HOWEVER,HPV,INC,INFECTION,LKB1,THUS
AREAS,BACKGROUND,BECAUSE,COVERED,LABEL,METHODS,OPINION,SELECTINS
160,169,2013,258,383,606,777,ABOUT,ACCORDING,AMONG,CONCLUSION,FDI,FEDERATION,INDIA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RAJASTHAN,RESULTS,RISKS,UNLABELLED,WORLD
1997,2004,2005,2009,2011,2013,HOWEVER,JANUARY,MARCH,MAY,RCC
946,ACTIVIN,BACKGROUND,BMPR,CD133,CD24,CD44,CD9,CD90,FGFR2,HONE1,IL6ST,KLF4,LABEL,LIFR,NANOG,OCT4,RB1,RESULTS,SIGNALING,SLMT1,SOX2,TGF,THERE,USING,WNT
12P,AVASTIN,BACKGROUND,KLH,LABEL,RESULTS,VEGF,VEGFR
1976,2004,2009,5858,854,9G8,A549,ALY,ASF,BANK,BOTH,DATA,FURTHER,H1N1,H5N1,HOWEVER,HPAI,PROTEIN,REF,SF2,SRSF3,TREX,UAP56,USING
20S,PULMONARY
000,894G,AUTOSOMAL,BECAUSE,E8SJM,GIVEN,LABEL,LDLRAP1,LIPA,MENDELIAN,OBJECTIVE,RESULTS
0001,007,140,2012,662,BRAZILIAN,CAUCASIANS,GSTT1,HOWEVER,JULY,LIBRARY,THERE
B16,CIN85,HOWEVER,MUC1,VNTR
108,BPE,CEA,ELISA,MPE,PLEURAL
946,A549,AKT2,CD24,CD44,DESPITE,EMT,ILEI,MODULATION,PCBP1,TGF,THESE
ECM,MMP,OPIOIDS,TIMP
106,111,160,194,1999,2009,306,308,349,351,AFTER,AMONG,CEA,ELEVATION,JANUARY
DENOSUMAB,GCTB,GIANT,LUNG,RANK,RANKL
001,945,946,CD3,CONCLUSION,III,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PBMCS,PERIPHERAL,PURPOSE,RESULTS,TIP,TNF
AFTER,CONCLUSION,EGFR,EPIDERMAL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SEVENTY,THERE,TKI,TKIS
170,2008,2010,528,ADL,DIAGNOSIS,DPC,JULY,LABEL,MARCH,METHODS,NEXT,OBJECTIVE,PROCEDURE,RESULTS,THEN
AIM,CONCLUSION,FURTHER,HOWEVER,LABEL,METHODS,NEWLY,OBJECTIVE,PRIOR,RESULTS,THREE
273,808,CONTRARILY,IMMUNOCRIT
8201,956,A549,AKT,CALU1,CALU3,COA,ERK,GEFITINIB,HMG,KRAS,NSCLC,PI3K,PTEN,RAF,SIMILAR,THEREFORE,THESE
LOW,LUNG,OTHER,SCREENING,TRIAL
169,2013,945,946,947,A549,BCMO1,CMO1,COPYRIGHT,INC,PPAR,RXR,THESE
131,148,149,152,169,2013,BRAF,CURRENTLY,IHC,RAF,THERE,V600E,VE1
1965,BESIDES,HILL,HUME,MILL,THUS
143,169,2013,949,COPYRIGHT,FEDERATION,NON,NSCLC,PKC,PUBLISHED,SOCIETIES,TREATMENT,UTR
169,2013,CURRENT,INC,LDCT,LUNG,MOSBY
001,038,044,109,134,169,2013,283,501,CONCLUSION,COPYRIGHT,COX,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
169,2013,ALK,COPYRIGHT,CURRENTLY,ECOG,EGFR,ELDERLY,EML4,GIVEN,HALF,INC,LUNG,NON,NSCLC
169,2013,70YEARS,8805,ASSESSMENT,BSA,CGA,CIRS,CONCLUSION,COPYRIGHT,COX,DESPITE,ECP,GDS,GERIATRIC,INC,INDEX,LABEL,MATERIALS,METHODS,MMSE,MPI,OBJECTIVE,PROGNOSTIC,PROGRAM,RESULTS,ROC
13Q,13Q14,162,169,2013,COPYRIGHT,GLEASON,HOWEVER,INC,OLFM4,PATHOLOGY,PUBLISHED,SOCIETY
106,1997,2011,269,708,ABOUT,COX,DISCUSSION,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PRIMARY,RCC,RESULTS,RPA,STUDENT,THESE
001,002,003,045,102,BACKGROUND,CONCLUSION,EXPRESSION,KPNA2,LABEL,METHODS,NSCLC,OCT4,REAL,RESULTS,RNAS,SMALL,TNM
A549,AKT,GNA,ISO,RHO,VEGF
003,005,008,012,047,064,143,179,2011,213,2425,283,293,343,416,457,505,5782,859,8805,898,983,ABSTRACTS,ASSESSMENT,BACKGROUND,BETWEEN,CENTRAL,CITATIONS,CONCLUSION,CONFERENCE,CONTROLLED,CURRENT,DARE,DATA,EACH,EED,EFFECTS,EVALUATION,FULL,FUNDING,GLEASON,HTA,INDEX,INDEXED,INSTITUTE,JUNE,LABEL,MEDLINE,METHODS,MRI,NETWORK,NHS,NIHR,NON,OBJECTIVE,OBJECTIVES,OTHER,OVERALL,PORTFOLIO,PROCESS,PROGRAMME,RCTS,RESULTS,REVIEWS,SCC,SCIENCE,SERVICE,SEVENTEEN,SEVERAL,SOURCES,SYSTEMATIC,TECHNOLOGY,THERE,TYPES,UKCRN,WEB
0002,0005,0006,0009,002,006,016,140,2007,2011,231,409,491,523,708,8202,895,ADULT,DISCUSSION,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,WBRT
20S,21S,945,C21,HOWEVER,LACTONE
2005,2010,946,ACCORDING,BACKGROUND,CK14,CK34,CK5,E12,LABEL,METHODS,MOST,RESULTS,SEVERAL,SQCC,SQCCS,TTF
082,161,525,835,988,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SUMMARY,TOTAL
181,946,EMT,ETOH,SEVERAL,TAKEN,TGF,THESE,WITHAFERIN,WRE
0002,001,038,128,160,164,172,177,219,261,388,8804,BACKGROUND,BLOOD,III,LABEL,PRINCIPAL,RESULTS
4T1,947,BALB,CD8,CONTROL,CTL,IFN,MMC,TRF
217,ATM,CAUCASIANS,EGFR,KRAS
260,ENDOTHELIN,IIB,POCCS,PULMONARY,SNPS
116,CONCLUSION,CSF,FIVE,GABAB,GAD65,LABEL,METHODS,NMDAR,OBJECTIVE,OMS,RESULTS,SCLC,SERUM,SEVENTEEN,SMALL,SOX1,TREATMENT
APOPTOSIS,H460,HDMX,HIGH,HOWEVER,INHIBITION,KNOCKDOWN,MDM4,NOXA,OVERALL,PUMA,SER15,SIMILAR,THUS
169,2013,215,900,CBV,CONCLUSION,COPYRIGHT,DSC,III,INC,IVIM,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,REGIONS,RESULTS,WILEY
956,AZD6244,BIM,EGFR,EPIDERMAL,ERK,H1650,H1975,IC50,KRAS,MEK,MEK1,NSCLC,PC9,RAF,TKI,TKIS
APAI,BESIDES,BSMI,CIS,HOWEVER,ORS,TAQI,VDR
RPA,TEN
2009,2012,ANOTHER,LABEL,LUNG,METHODS,NON,OBJECTIVE,RESULTS,SEVEN,WHITE
167,170,1954,1985,2010,369,674,CASE,CHINA,CONTROL,EFFECTS,INCREASED,JOINT,LUNG,OVERALL,STUDIES,ZEALAND
1963,1981,209,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PAULO,PUBLICO,RESULTS,SAO
1007,2012,2013,921,923,924,995,ARCH,EDITORS,GEBEL,MORFELD,TOXICOL
1945,2013,EIGHT,HOWEVER,JANUARY,LABEL,LIBRARY,MAY,MEDLINE,METHODS,NSCLC,OBJECTIVE,PFS,PRIMARY,PURPOSE,RESULTS,THERE
B55,H1299
0004,0005,002,004,007,009,012,036,BALF,FURTHER,IPF,NSCLC,PCR,TELOMERASE,TERC,TERT
0001,028,956,AKT,BIM,DISRUPTION,FOXO,KIP1,LNCAP,PI3K,THESE,TRAMP
1994,BACKGROUND,CASE,CHEST,GIVEN,LABEL,METHODS,NINE,SINCE
2O2,BASED,DESPITE,TPT1
100,160,169,2013,BACKGROUND,COPYRIGHT,DETECTION,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE
2013A,39000,LUNG
010,732,9151,983,AUC,BIOMEDICAL,CENTRAL,CHINA,CHINESE,CONTROLLED,DIAGNOSTIC,DOR,FULL,HOWEVER,LITERATURE,MED,MEDLINE,NLR,NON,NSCLC,PLR,PUB,SCIENTIFIC,SEN,SPE,SROC,STUDIES
BETWEEN,CCRT,ESOPHAGEAL,III,NSCLC,PFS,SCRT
GI50,HOWEVER,LC50,TGI,THEIR
0014,0373,2008,2010,696,8201,AIMS,CRYOBIOPSY,FORCEPS,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,UNLABELLED
BOLTZMANN,CARLO,EXTENSIVE,LBTE,MONTE
CD11B,GRI,HOWEVER,LPS,LY6G,MDSCS,MYD88,THESE,TLR,TLR4,TLRS
000,130,BIOLOGISTS,JAVASCRIPT,JSP,MYSQL,PHYSICIANS,THEREFORE,VALIDATION
144,BACKGROUND,EVEN,FINALLY,FINDING,FURTHER,LABEL,LUNG,METHODS,NON,NSCLC,PRINCIPAL,RELATED,RESULTS,RNAS,THUS,ZFX
001,004,009,012,256,ATM,IIIA,KU70,LABEL,METHODS,NSCLC,NUCLEAR,OBJECTIVE,PKCS,PURPOSE,RESULTS,UNIVARIATE
HOWEVER,LEWIS,LLC,THESE,VASH1,VASOHIBIN
1686,169,2013,AACR,AKT,EGF,EGFR,HOWEVER,LABEL,MINIMAL,NSCLC,ORAL,T790M,THESE,UNLABELLED
00388,1128,2013,ASIA,AUSTRALIA,EVEN,GRAM,ONCE,PRICE,SOUTHEAST,THEIR,THESE
002,006,072,8805,BMI,CONCLUSION,DESPITE,LABEL,METHODS,NLR,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERUM,SIR,THESE,TLR,WHILE
1991,1998,2009,AAPC,AMONG,CONCLUSION,HOWEVER,LABEL,LUNG,METHODS,METOHIA,OBJECTIVE,POISSON,PURPOSE,RESULTS,TREND
1980S,1990S,CDDP,NSCLC
210,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM,THESE
001,003,BACKGROUND,COX,HCT,LABEL,LRD,METHODS,RESULTS,RISK,RSV,TREATMENT
2012,APRIL,COLORED,HOWEVER,JANUARY,LABEL,MATERIALS,MDCT,METHODS,MTT,NON,OBJECTIVE,OBJECTIVES,PERFUSION,RESULTS,ROI,THERE,TTP
AKT,ALK,DESPITE,EGFR,ERK,MEK,PI3K,RTK,RTKS
160,945,946,DSS,EBC,HIP,HLC,III,LUNG,PAP,PCR,REG,SCC,THEREFORE
001,258,433,661,665,670,685,691,697,BACKGROUND,CONCLUSION,COX,LABEL,METHODS,MPS,NSCLC,OVERALL,RESULTS,STAGE
001,110,1258,346,665,AVERAGE,DOSIMETRIC,GTV,HOWEVER,LABEL,MEAN,METHODS,MLD,OBJECTIVE,OBJECTIVES,PTV,RESULTS,SIXTY,THERE,V10,V20,V30
110,1993,1997,2011,CHRONIC,CROSS,CRP,FEV1,FVC,INTO,NORFOLK,SERUM
ASTER,BELGIUM,BMJ,GROUP,LIMITED,PUBLISHED,PUBLISHING,THEREFORE
169,2013,AKT,AKT1,AKT2,AXL,BOTH,CL1,FINALLY,FURTHER,H2O2,HOWEVER,INC,PERSISTENT,PI3K,RAC1,RNAI,ROS,USING
169,2013,COX,CPH,MOTIVATED
169,2013,COPYRIGHT,PUBLISHED,SEPAR,SVCS,TREATMENT
0003,0004,001,0058,169,2005,2010,2013,308,452,668,BACKGROUND,CNS,CONCLUSION,COPYRIGHT,EGFR,EPIDERMAL,JULY,JUNE,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,TKI,TKIS
CURRENT,EIGHT,FRV,HOUNSFIELD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THESE
169,2013,COPYRIGHT,FORTY,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PARTIAL,PATIENT,PBI,PURPOSE,RESULTS
154,169,2013,598,ALZHEIMER,END,FILES,INDIVIDUAL,LOWER,MFSU,MULTI,PARKINSON,RESULTS,SEER,SERVICE,USING
AMONG,COAL,CONCLUSION,CWP,III,LABEL,METHODS,OBJECTIVE,RESULTS
104,215,710,870,873,8764,926,954,980,BALF,CONCLUSION,FEV1,FOUR,FVC,LABEL,METHODS,OBJECTIVE,PAM,RESULTS,RWLL,SIO2,SIX,WLL
177,BEAS,CENTROSOME,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS
001,002,015,2000,2010,AIMS,CONCLUSION,COX,LABEL,LTD,LUNG,MEIER,METHODS,NONE,OBJECTIVE,PUBLISHED,RESULTS,SOCIETY
169,2013,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,FRANCIM,LABEL,LTD,METHODS,NET,RESULTS
169,2013,AACR,EGF,EGFR,L858R,T790M,THESE
AACC,BLOOD,CHEMISTRY,DRUG,FDA,FOOD,HEART,IMPORTANT,INSTITUTE,LUNG,NCI,NHLBI,PROTEIN
135,613,751,761,BACKGROUND,GEO,H19,LABEL,METHODS,RESULTS,RNAS,ROC,TNM,TOTAL
677,763,ALLELIC,BACKGROUND,FIFTY,LABEL,METHODS,MTHFR,NSCLC,PCR,RESULTS,RFLP,SAH,SAM,SNP
1500,2013,500,8805,ABRUZZO,ADMISSIONS,BACKGROUND,COMMITTEE,COX,DATA,DISCUSSION,EACH,JUNE,LABEL,METHODS,MIXED,SECONDARY,TRIAL,UNIVERSITY,WHILE
174,8764,A549,BEAS,CIS,DRI,DRIS,MTT,NSCLC
179,AFFAIRS,AGREEMENT,AUC,BACKGROUND,CLINICIANS,ICC,LABEL,MAIN,MANAGEMENT,MAYO,METHODS,OBJECTIVE,OBJECTIVES,PHYSICIAN,RATIONALE,RESULTS,THERE,VIGNETTES
ALK,ARRY,AZD6244,CURRENTLY,EGFR,ERK,HOWEVER,KRAS,MEK,NSCLC,RAF,RAS

ALTOGETHER,ISOXAZOLE,USING
182,500,CTC,H1650,NCI
2000,MMP,MMP2,PEG,PEG1000,PEGYLATION,SEVERAL,USING
001,2004,2008,260,734,889,898,CONCLUSION,COX,END,EVEN,HODGKIN,LABEL,MARRIED,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
0001,001,002,005,2005,2666,635,6721,857,8804,8805,9391,AMONG,BMI,DESPITE,EPITHOR,LABEL,METHODS,OBESITY,OBJECTIVE,OBJECTIVES,OPERATIVE,RESULTS,SOCIETY,SURGERY,THEIR
177,FORTY,LABEL,LUNG,M1A,MALIGNANT,METHODS,OBJECTIVE,OBJECTIVES,PLEURAL,PULC,RESULTS,THERE
169,2013,945,AACR,TANK,TBK1,THUS
8805,AIDS,CFA,COMPETENCE,CONFIDENCE,CONSTRUCT,FACIT,HIV,ITEMS,LABEL,METHODS,NURSE,OBJECTIVE,PHYSICIAN,PURPOSE,RESULTS,STAFF,TECHNICAL,TREATMENT,TRUST
177,2002,2013,8805,AFTER,CONCLUSION,CRT,DLCO,LABEL,METHODS,OBJECTIVE,PULMONARY,RESULTS,SUN,UNIVERSITY,YAT
956,A549,ALSO,AS2O3,BAP,GSH,TAKEN
185,463,8315,8321,8322,BSA,GROUP,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
DIAGNOSIS,FURTHER,METASTATIC
001,002,003,004,012,015,025,026,033,BLD,CTC,CTCS,DISEASE,EPCAM,MUC1,NSCLC,PCR,SIXTY
176,8805,EMA,FEWER,FOCAL,HMB45,HPF,KIT,METASTASES,MITF,PECOMAS,S100,SEVENTEEN,SIXTEEN,TFE3,THREE,THUS
BCL,FIVE,FOCAL,SIX,SS18,SSX1,SSX2,TEN,TLE1
9P21,NINE,TEN,THERE
60S,HDM2,RPL11,RPL5,RPS,THUS
172,246,BACKGROUND,FIFTY,FORTY,IMPORTANT,LABEL,MATERIALS,METHODS,RESULTS
102,127,165,193,2007,2010,2N0M0,AFTER,AIMS,BACKGROUND,BETWEEN,CONCLUSION,DLCO,HYPO,LABEL,MATERIALS,METHODS,MRI,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PET,PFT,PTV,RESULTS,SBRT,SURGERY,THERE
001,1227,325,578,600,900,AFTER,BACKGROUND,COX,CSS,CUMULATIVE,DOSES,EFS,FIRST,FORTY,HSCT,INCIDENCE,LABEL,MEIER,METHODS,NEUTROPHIL,NRM,OBJECTIVE,RELAPSE,RESULTS
300,317,956,CTC,CTCS,EPCAM,FINALLY,FIRST,PET
BOTH,CBCT,FOURIER,ROI,THEREFORE,WHILE
1932,1950,1981,1990S,1995,2008,255,ANDALUSIA,SPAIN,THERE
BELGIAN,DUTCH,EVALUATION,LUNG,RANDOMIZED,SCREENING,TRIAL
2011,BAC,LUNG,PULMONARY,SOCIETY,SSN,SSNS
BIOMARKERS,LABEL,OBJECTIVE,PURPOSE,RESULTS,STUDIES,SUMMARY
169,2013,954,ABC,BCR,CD79B,CHRONIC,COPYRIGHT,DESPITE,DLBCL,HEPATITIS,LTD,MECHANISMS,PUBLISHED,THUS
ALK,NSCLC,TKI
CD34,CLEAR,HMB45,S100,SEVERAL
169,185,2013,A549,CCL,COPYRIGHT,DU145,HELA,HTB,LTD,LUNG,MCF7
1000,169,2012,375,500,ASIAN,BACKGROUND,CONCLUSION,COPYRIGHT,DECREASED,IIIB,LABEL,METHODS,OBJECTIVE,PATIENT,PUBLISHED,PURPOSE,RESULTS,TAIWANESE,THERE,THESE,WESTERN
169,2013,24H,947,A549,ADP,ATM,BACKGROUND,CASPASE,COPYRIGHT,DLD,ECM,H2AX,HDAC,HDACS,INHIBITION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PARP,POLY,POLYMERASE,PURPOSE,RESULTS,SCC15,THESE
0001,131,169,2013,387,COPYRIGHT,IMRT,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
001,169,2013,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,POST,PURPOSE,RESULTS,SABR,THEREAFTER
169,177,2013,COPYRIGHT,EFFICIENT,FDG,GTV,GTVS,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SBR,SUV,SUVS
100,CATHEPSIN,EXTRA,HMB,LABEL,METHODS,NONE,OBJECTIVE,RESULTS,TFE3,THREE
001,004,034,046,079,127,146,2007,2009,259,399,524,901,BOTH,CONCLUSION,DCR,GENERALLY,GIVEN,HOWEVER,JANUARY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,ORR,RESULTS,TTP
002,022,123,1394,1394T,142,487,501,643,842,CHINESE,CONCLUSION,DSBS,G135C,LABEL,METHODS,OBJECTIVE,PCR,RAD51,RESULTS,RFLP,XRCC4
001,002,007,008,011,014,019,021,026,028,035,046,120,131,184,ATP7B,BACKGROUND,BRCA1,CELL,ECOG,ERCC1,ERCCI,FREE,LABEL,LDH,LUNG,METHODS,MYC,PFS,PKM2,RESULTS,SCLC,SMALL,THESE,TOPOI,TOPOIIA,TOPOIIB
12G5,B16,BALB,C57,CXCR4,EGFP,ERK1,KTM2,PES43,PROOF,SN12C,THREE
158,216,AUTOPHAGIC,AUTOPHAGY,BACKGROUND,FURTHER,GFP,HCC,LABEL,LC3,METHODS,RESULTS,TEM,THEN
AKT,CDK2,CDK4,NSCLC,ORAI,ORAI3,SOCE,THESE
DYNAMIC,HOWEVER,MRI
CHEST,GGO
169,2013,945,947,AACR,CURRENT,STUDIES,THEIR,THEREFORE,THESE
013,024,038,051,058,060,2005,2011,8201,CONCLUSION,FDG,JANUARY,LABEL,MALIGNANT,METHODS,MPM,MTV,OBJECTIVE,OVERALL,PET,PROGNOSTIC,PURPOSE,RESULTS,SUV,THEREFORE,TLG
3500,PRIMARY,SRCC
140,7721,945,946,956,A549,H1975,HEP,IC50,MTT,RESULTS,SMMC,VERO
954,956,ASS,BOTH,EPM,H2S,MPM,NSAID,RNS,ROS
239,8804,8805,AES,BACKGROUND,CAUCASIAN,EASTERN,ECOG,FIFTY,GROUP,IIIB,LABEL,METHODS,NEWLY,NSCLC,ORR,PFS,PRIMARY,RESULTS
6TN,945,946,BSA,FLUX,GAPDH,H441,LOW,RLE,THESE
26A,NOTABLY,THESE,ZCCHC11
000,149,AMONG,HODGKIN,INFECTIONS,POISSON,USA
001,133,169,2013,ANN,ANNS,CONCLUSION,FDG,LABEL,MALIGNANT,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,RSNA
0001,130,135,169,2013,753,760,835,895,956,AREA,AUC,BACKGROUND,BAP,ICTP,LABEL,METHODS,NEWLY,RESULTS,ROC,SERUM,TRACP
169,2013,916,947,A549,BEAS,BOTH,CIITA,CLASS,COPYRIGHT,HLA,IFN,INC,MHC,TAG,THESE
100,15KDA,169,176,2013,20KDA,70KDA,956,BLUEHC650M,COPYRIGHT,FLOW,FULL,G0G1,GEL,GMBH,HOP62,HOWEVER,IC50,LCL,LOTUS,NACL,PAGE,SDS,THEREAFTER,THP
0108,036,141,169,201,2013,769,993,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,GEFITINIB,H322,H820,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,RESULTS,SEM,TKI,UPON,USING
169,2013,ADCS,ADSC,AKT1,ASIA,BRAF,CHINA,COPYRIGHT,EGFR,G719X,GIVEN,HER2,KRAS,L858R,LTD,LUNG,MEK1,MOST,NRAS,PTEN,SCCS,XUANWEI
169,2013,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,DISCUSSION,DUKES,LABEL,METASTASIS,METHODS,MILES,OTHER,SAS,SOON,TREATMENT
111,169,2003,2009,2013,APRIL,BACKGROUND,CIT,COPYRIGHT,GYE,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
100,169,2013,ALSO,CDCP1,COPYRIGHT,CUB,FEDERATION,HOWEVER,MCF7,PUBLISHED,SOCIETIES,SRC,THUS,TRIGGERING,WESTERN
169,201,2013,231,COPYRIGHT,FIBROVAKIM,HRCT,PUBLISHED,SAS,SYSTEMATIC,THESE
169,2013,AKT,COPYRIGHT,INHIBITION,LTD,NSCLC,PI3K
004,157,165,169,175,1998,2011,2013,COPYRIGHT,INC,LABEL,LMD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,VARIABLES,WBRT
169,2006,2013,BACKGROUND,BOTH,BRAF,CONVERSELY,CRC,EGFR,ENGLISH,HOWEVER,INC,KRAS,LABEL,MESH,MET,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PI3K,REFERENCE,RESISTANCE,RESULTS,SEVERAL,T790M,TKIS
169,2013,COPYRIGHT,IRELAND,JEGHERS,KRAS,LKB,LKB1,LTD,PEUTZ,PJS
100,103,124,169,2013,COPYRIGHT,DOSIMETRIC,GRADE,ILD,IRELAND,LABEL,LTD,MATERIALS,METHODS,MLD,OBJECTIVE,PURPOSE,RESULTS,SBRT,V10,V15,V20,V25
169,183,200,2013,3H2O,956,A549,AMONG,ANTICANCER,ATP,COPYRIGHT,FOUR,H2O,HEP3B,LTD,MTT,NMR,PC3
169,2013,BESIDES,COPYRIGHT,GMBH,INI1,LATER,SMARCB1,THESE
2011,ICU,SHIH,THESE,UNTIL
EGFR,EGFRS,IC50,L858R,T790M
BECAUSE,GRADE,PEDIATRIC,PMA,PMAS
1000,120,169,2013,345,3706,4861,661,AMONG,BJU,BLACK,CANCERS,COLORECTAL,CONCLUSION,GOVERNMENT,LABEL,LUNG,METHODS,MORTALITY,OBJECTIVE,OVARIAN,PLCO,PUBLISHED,RATES,RESULTS,SCREENING,USA
8804,BACKGROUND,BORG,CONCLUSION,FREQUENCY,GERMANY,INTERVIEWS,LABEL,METHODS,OBJECTIVE,RESULTS
AFTER,CASE,CONCLUSION,EVALUATION,HCC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SINCE,SOLID,THERE
177,956,A549,CASPASE,IC50,POLYPORUS,PRW,SENP,SENPS,SURFACE
2500,COMPARISON,FINALLY,H460,HDL,ICG,NCI,NIR
2006,2008,C34,ICD10,OPOLE
AMONG,SF3B1,THEIR,THESE
024,031,056,067,1980,2006,471,854,COX,DLCO,FEV1,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PPO,RESULTS
123,1502,160,165,2005,201,2012,283,446,AMONG,APRIL,COPD,INITIATIVE,JUNE,LABEL,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEOUL,THERE,UNIVERSITY,VATS
1985,2010,388,427,483,568,930,994,ANOTHER,CHINA,ODDS,OVERALL,SEVERAL,SYNERGY,WORK,ZEALAND
947,AKT,EGFR,EPIDERMAL,ERLOTINIB,H2AX,HER2,HOWEVER,MET,PARP,RAS,TAKEN,TARCEVA,THESE
120,2004,2005,2010,745,AUDIT,BACKGROUND,CONCLUSION,COX,ENGLAND,HRS,LABEL,LUNG,METHODS,NLCA,NORTH,NSCLC,RESULTS,USING
205,22RV1,691,945,BACKGROUND,CONCLUSION,CWR22,DLKP,DLKPA,DU145,EL102,HIF1,LABEL,MDR1,METHODS,MULTIDRUG,PARP,RESULTS,TAXANES,TUBULIN
252,BASED,BSC,DEGRO,DEUTSCHEN,EBRT,GROUP,NSCLC,RADIATION,SBRT,SOCIETY,THESE,WORKING
017,2000,2012,300,303,739,868,BACKGROUND,CONCLUSION,DATA,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
169,2013,EGFR,ERBB,GMBH,HOWEVER,III,LUNG,LUX,NON,NSCLC,SINCE,TKIS
003,045,169,2013,277,8805,BACKGROUND,GMBH,LABEL,LNS,METHODS,NSCLC,PET,RESULTS,THERE
169,2013,BASEL,COPYRIGHT,HALF
266,FIRST,HOWEVER,NEXT,NOD,SCID,STAT3,THESE,TWIST
001,1059,144,169,2013,239,398,8804,BACKGROUND,BROOKMEYER,COPYRIGHT,COX,CROWLEY,DATA,EARLY,LABEL,LTD,METHODS,PFS,RESULTS,SIXTY,TTR
169,2013,COPYRIGHT,DOWN,DSCR1,G12D,HOWEVER,IRELAND,KRAS,LSL,LTD,THESE,USING
169,2013,COPYRIGHT,RFA,SAS
007,025,169,1998,2005,2006,2011,2013,202,8805,ADVERSE,AIMS,CASES,COLLEGE,CONCLUSION,COPYRIGHT,COX,EASTERN,FACTORS,GROUP,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RESULTS,ROYAL
000,100,169,2001,2008,2013,8804,8805,946,AIMS,AMONG,BEP,COLLEGE,CONCLUSION,COPYRIGHT,EMA,GRADE,GTN,LABEL,LTD,MATERIALS,METHODS,MTX,OBJECTIVE,PUBLISHED,RESULTS,RISK,ROYAL,SALVAGE,TREATMENT,WORLD
BSCC,HPV,SCC
1182,169,2000,2007,2013,2345,535,596,812,843,969,BACKGROUND,CONCLUSION,COPYRIGHT,COX,HOWEVER,INITIAL,INSURANCE,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCC,THERE
169,2013,947,A549,COPYRIGHT,H2AX,HOWEVER,INC
0001,169,2013,BACKGROUND,BAX,BCL,CDK,CELL,COPYRIGHT,FLOW,H460,HDAC,INCUBATION,INHIBITION,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,P276,PHASE,PROPIDIUM,PUBLISHED,RESULTS,SCID,VPA
100,169,2013,2176,COPYRIGHT,DEFINITIVE,FORTY,IRELAND,LABEL,LTD,MATERIALS,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SABR,SRS
169,2003,2013,841,8804,921,BACKGROUND,CONCLUSION,COPYRIGHT,COX,ECOG,IRELAND,JANUARY,JUNE,LABEL,LTD,METHODS,NSCLC,RESULTS,SCLC,SCORE,SCS,SIMPLIFIED,THERE,USING,VICTORIAN,VICTORIANS
169,2013,883,8P11,AMONG,COPYRIGHT,FINALLY,INC,LOSS,PATHOLOGY,PCR,PUBLISHED,SOCIETY,WHSC1L1
245,497,6602,698,8073,8336,835,873,BACKGROUND,BID,DCMI,DCR,DCRS,IIIB,ITT,LABEL,METHODS,NSCLC,PFS,RESULTS,SEVEN,THERE,TREATMENT
ABCC1,ATP,GSH,MRP1,PHASE
100,110,162,210,4DCT,5MM,BACKGROUND,CHANGES,GTV,GTVS,HAUSDORFF,ISOTROPIC,ITV,ITVS,LABEL,METHODS,OVERALL,PTV,RESULTS,TEN,THESE
000,162,1993,2003,2008,349,470,9813,BACKGROUND,DISCUSSION,FEMALES,LABEL,METHODS,RESULTS,SEVENTY,SHORT,TOCD
001,1988,2008,455,612,COX,FURTHER,THESE
HODGKIN,PPHL,PRIMARY
PULMONARY,SFT,SFTS
8804,BRAIN,CURRENT,LABEL,OPINION,PCI,QOL,STATEMENT,UNASSIGNED,WBRT
1006,180,AFRICAN,AGE,AHF,AIMS,BUN,CONCLUSION,DESPITE,FAILURE,HEART,HIV,LABEL,METHODS,NIGERIA,NORTH,OBJECTIVE,PREDICTORS,PROGNOSTIC,RESULTS,SAHARAN,SOUTH
CUSHING
00014,00033,0010,0022,0026,0071,169,2013,381,AACR,CCP,CONSORTIUM,COX,FFPE,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS
179,185,8322,8323,956,A549,AMONG,HELA,HEPG2,MCF,MTT,NMR,STRUCTURE
104,166,2009,2012,258,AFFAIRS,CONCLUSION,EBUS,IMPORTANCE,JANUARY,LABEL,MAIN,METHODS,OBJECTIVE,PET,PRIMARY,RELEVANCE,RESULTS,SETTING,TBNA
945,A549,AMP,AMPK,IMR,LC3
137,25MG,50MG,GIST,JAPAN,RFA
AFTER,BRAIN,LARGE,LCNEC,MRI
159,AFTER,ALSO,CBDCA,CEA,DOC,EGFR,PTX,SOON,SRS,T2AN0M0,T2AN1,UFT
BECAUSE,CD28,CTLA
000,010,024,2011,BMS,CA184,CD152,CTLA,IGG1K,IPILIMUMAB,JAPAN,JULY,MARCH,MDX,UNION
FDG,GLUT1,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV,SUVS,THREE
174,44K,4500,916,A750,AGILENT,ALDEFLUOR,ALDH,ALDH1,ALDH1A3,CDC2,CSC,CSCS,E2F1,E746,EGFR,GSEA,KEGG,MCM4,NOTABLY,NSCLC,THUS,TKI,TKIS,USING,WHOLE
CD80,CD86,CELL,RNAS,TAT,THREE,VII
149,220,AIRV,AVAI,AVAI3,AVAI4,AVRI,BACKGROUND,BEST,COX,EACH,FDG,GTV,IIIB,IVH,LABEL,MAXIMUM,METHODS,MTV,NONE,NSCLC,PET,PRIMARY,REGRESSION,RESULTS,RVAI,RVRI,SUV,THESE
18F,BESIDES,CONCLUSION,FDG,FIFTEEN,ICC,LABEL,LESIONS,METHODS,NSCLC,OBJECTIVE,OVERALL,PET,PURPOSE,RADIOMICS,RESULTS,SIMILARITY,SUV,SUVMEAN
ANA,BALT,BONE,DESPITE,FDG,HODGKIN,INTENSIVE,PET
1A3,2B7,A549,AKRS,HPLC,MICHAELIS,PAH,PAHS,PCR,POLYCYCLIC,PROXIMATE,ROS,UDP,UGT,UGTS
181,231,945,A549,FOUR,HELA,IC50,MDA,THEIR,TOPO
293,367,AIMS,BACKGROUND,DUKES,HEPATIC,LABEL,LOCAL,METHODS,MILES,OBJECTIVE,RESULTS
A549,AKT,AMONG,NQO1,NRF2,NUCLEAR,PI3K,TAKEN
102,177,BACKGROUND,FDG,LABEL,LAD,METABOLIC,METHODS,MTV,PET,RESULTS,THEREFORE,TLG,UNIVARIATE
056,2013,682,841,945,C111A,CHINA,CNKI,DATA,FURTHER,HIF,HOWEVER,JULY,KNOWLEDGE,OVERALL,THEREFORE
001,169,2013,422,479,810,858,943,AACR,AUC,BLOOD,CA125,CEA,CYFRA21,EFFECTIVE,ELISA,IDH1,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
THERE
CURRENT,HOWEVER
1994,1998,2009,676,ADDITIONAL,CEE,CHD,CVD,HOWEVER,HRS,INITIATIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SEPTEMBER,SIMILARLY,WOMEN
2006,2008,BACKGROUND,CONCLUSION,EAST,ENGLAND,EPS,LABEL,METHODS,RESULTS
19Q13,COPD,CPD,EGLN2,SNPS,THESE
CD90,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
7P11,7P12,7P15,7P22,8209,ADC,CALM1P2,EGFR,HIGH,HOXA4,HOXA5,HOXA6,HOXA7,HOXA9,LOC442282,LOC442586,LOC442589,LOC442651,MBP,NOTABLY,VARIATIONS
2009,AFTER,ERCP,FOUR,LABORATORY,MRCP,NSCLC,OCTOBER,PET,TYPICALLY
231,956,CXCR4,IC50,MDA,THESE,THREE
118,118T,169,2010,2011,2013,239,37C,524,524T,8092,8092C,BASED,CISPLATIN,CONCLUSION,COPYRIGHT,CUSTOMIZED,ERCC1,FOUR,IIIB,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PBLS,PFS,PRIMARY,RESULTS,RRM1,SIMON,SNPS,TREATMENT
001,005,007,169,2010,2012,2013,BACKGROUND,COMPARISON,COPYRIGHT,DOSE,IMRT,IRELAND,LABEL,LAD,LTD,MATERIALS,METHODS,OBJECTIVE,PRONE,PURPOSE,RESULTS,SECONDARY,WBI
001,169,2007,2011,2013,259,8805,AUC,AUTHORS,CARDIAC,CONCLUSION,COPYRIGHT,CTCV,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PRIOR,PUBLISHED,PURPOSE,RESULTS,RILT,UNIVARIATE
169,2013,BACKGROUND,COPYRIGHT,FDG,FIVE,IRELAND,ITV,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
169,177,2013,AUTHORS,BACKGROUND,CNR,COPYRIGHT,DICE,HX4,IRELAND,LABEL,LTD,MATERIALS,MAXIMUM,METHODS,NSCLC,OBJECTIVE,OPTIMAL,PEARSON,PET,PUBLISHED,PURPOSE,RESULTS,SUV,TBR
171,443,776,833,ACID,AFFAIRS,AMERICA,AMONG,ARA,ARAS,DDI,DDIS,DEPARTMENT,GIST,HOWEVER,MARKETSCAN,NORTH,PPI,PPIS,REUTERS,SARFARI,THERE,THESE,THOMSON,WESTERN
000,100,2001,2004,2010,524,706,BACKGROUND,CAUSE,DISEASE,FURTHER,HONG,KONG,LABEL,LIFE,LOST,METHODS,RESULTS,SEYLL,TIME,USING,YEARS
125A,A549,H1299,TAKEN,THESE
177,8201,956,A549,AUTOPHAGIC,BACKGROUND,CELLS,CONCLUSION,CONTEXT,GFP,HBC,LABEL,LC3,MATERIALS,MDC,METHODS,OBJECTIVE,RESULTS,WESTERN
001,014,020,041,087,166,173,226,250,8804,COLLEGE,CONCLUSION,COX,FDG,GROUP,HOWEVER,III,IMAGING,INSTITUTE,LABEL,MEAN,METHODS,NETWORK,NSCLC,OBJECTIVE,PET,POST,PURPOSE,RADIATION,RADIOLOGY,RESULTS,SUV,SUVPEAK,SUVS,THERAPY
160,ADDITIONAL,BECAUSE,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS
100,ADVERSE,CYTOTOXIC,INDIVIDUAL,THERE,VEGF
001,018,1960,2003,546,CHINA,COX,CUMULATIVE,LYON,MONOTONIC,THESE
VIRTUAL,VRT
8209,EGFR,OVERCOMING,RAS,SMALL,THESE,TKI,TKIS
A549,B16,DCA,HISTOLOGY,LABEL,METHODS,OBJECTIVE,PCR,PURPOSE,REAL,RESULTS,WESTERN
100,624,8209,FOLLOWING,MEL,MOI,PAEP,THEREFORE
100,115,177,2005,2009,BETWEEN,CONCLUSION,FDG,LABEL,LOCAL,MAXIMUM,MEIER,METHODS,NCT,NPV,OBJECTIVE,OVERALL,PET,PPV,PURPOSE,RESULTS,RFA,ROC
LOW,LUNG,NAD,NSCLC,SCREENING,SIRT3,TAKEN
FDG,PET,SPNS

ASSESSMENT,FATIGUE,FUNCTIONAL,IIA,IIIA,IIIB,INVENTORY,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,OVERALL,PATIENT,PURPOSE,QUALITY,RESULTS,THERAPY,THOSE
169,2013,215,A549,ALLICIN,BACKGROUND,FOURIER,FTIR,GENERAL,LABEL,METHODS,MTT,RESULTS
008,169,17YEARS,2008,2013,5CM,BACKGROUND,COPYRIGHT,GROUP,III,ITALY,KINGDOM,LABEL,LESIONS,LTD,METHODS,MOST,PAEDIATRIC,PFS,PPB,RARE,RESULTS,SIXTY,THESE,TUMOURS,TYPE
169,2013,COPYRIGHT,ING,IRELAND,KIP1,LTD,NSCLC,TSP,VEGF
169,2013,AKT,B08,COPYRIGHT,EGF,EGFR,ERK1,FINALLY,GIVEN,H1975,INC,L858R,NSCLC,PI3K,SHP2,T790M
169,2013,COPYRIGHT,EGFR,GEFITINIB,IRELAND,LTD,NSCLC,PUBLISHED,THEREFORE,THESE,TKIS
169,2013,956,APOPTOTIC,ARSENIC,ATO,BACKGROUND,CHOU,COPYRIGHT,DMS79,EXPRESSION,GSH,H187,H526,H69,H841,IRELAND,LABEL,LTD,MATERIALS,METHODS,MMD,MRP1,MRP2,RESULTS,SCLC,SMALL,SYNERGISM,TALALAY,THERE,WESTERN
116,155,199A,30A,377,423,ACUTE,GVHD,HCT
169,2014,COPYRIGHT,INC,TTE
0001,169,2013,AFTER,BOTH,CELL,CONCLUSION,COPYRIGHT,DCE,FOURIER,HOWEVER,IMAGE,IRELAND,LABEL,LTD,LUNG,METHODS,MRI,NON,NSCLC,OBJECTIVE,OVERALL,RESULTS,SEMI,SMALL,SSFP,THEN,TIME
000,1464,169,1994,1998,2003,2004,2006,2011,2013,842,937,978,BASE,COPYRIGHT,COST,EXTENSIVE,INC,ISPOR,LABEL,LDCT,LIST,MEDICAL,METHODS,OBJECTIVE,PUBLISHED,QALY,REDUCED,RESULTS,SOCIETY,UNIVERSITY
114,BECAUSE,CURRENTLY,METASTASIS,MICE,PAAM,USING
177,215,ABSL1,BLOOD,BSL2,CFU,CONIDIA,FECES,HOWEVER,LUNGS,SABOURAUD,SAMPLES,SPF,THEREFORE,ZEALAND
0001,001,166,956,A549,ASIA,BACKGROUND,CONCLUSION,IC50,KDA,LABEL,METHODS,MOE,MORINGA,NRF2,PARP,RESULTS,SMAC,SOUTH,TBARS,WESTERN
100,150,181,8201,INORGANIC,IPCS,METABOLISM,MOA,PROGRAMME,PROTECTION,USEPA
273,BACKGROUND,CHANGES,GTV,HOWEVER,LABEL,METHODS,PRE,PTV,RESULTS,SCLC,TEN,THESE
A549,BASED,H1299,H157,H446,H520,HELA,HOWEVER,LUNG,MCF,NCI,NIR,RAMAN,RH6G,SERS,THEREFORE

113,118,125,140,204,251,A743V,EGFR,FFPE,G13C,KRAS,L718M,L815P,NSCLC,PCR,V819E
10A,155,195,200C,203,30A,30C,885,946,ARHGAP5,BCL2,CD36,CDH2,CXCR3,CYP27B1,GNA13,GP5,HIST1H2BF,HLF,IGF1,IGSF3,IKBKB,IL32,MAF,NON,NRP2,NSCLC,PAK7,RAB23,RAP2A,SLC11A1,SOD3,TP53,WNT
GLUCOSE,INHIBITION
00001,0001,007,798,BACKGROUND,HENCE,LABEL,LARGE,LIBRARY,LOW,METHODS,NSCLC,OVID,RESULTS,THERE,TYMS
000,480,ATLAS,BESIDES,CHG,CPG,DMRS,FASTDMA,TCGA
143B,946,CXCR4,CXCR7,HUVEC,LACZ,SCID,THESE
203,945,FINALLY,HOWEVER,PKC,PRKCA,USING
021,147,216,309T,387,617A,617C,700,CONCLUSION,LABEL,MDM2,METHODS,NRF2,OBJECTIVE,PURPOSE,RESULTS,SNP
001,004,015,111,GRADE,GVHD,HOWEVER,HRQOL,III,LIFE,QOL,QUALITY,REDUCED,RIT,TRM
945,954,BRCA1,DESPITE,FANCONI,H460,NCI,NSCLC,PROTEASOME,PSMA1,RAD51,RADIATION,RNAI,THESE
140,BOTH,IGF1R,INTEGRATED,KNOCKDOWN,MICRORNAS,NSCLC
ACTIVATING,BASED,EGFR,KIRSTEN,KRAS,NSCLC,TKIS,VEGFA
946,CDH17,HCC,LIC5,STRIKINGLY,TGI,TREATMENT,WNT
021,029,042,046,047,15Q25,174,405,460,5P15,6P12,6P21,8202,BACKGROUND,BLOOD,FOUR,LABEL,MASSARRAY,MATERIALS,MEIER,METHODS,NSCLC,PFS,PORTUGUESE,RESULTS,SNP,SNPS,THEREFORE,THREE,VEGF
169,177,2007,2013,BACKGROUND,CONCLUSION,DATA,DUE,EBUS,EIGHT,INC,LABEL,METHODS,RESULTS,TBNA,WILEY
169,1992,2011,2013,BACKGROUND,FLUID,LABEL,METHODS,MOST,RESULTS,SOCIETY,THERE,THOSE,UNIVERSITY
169,2013,A549,ARTEMISIA,CHINESE,COPYRIGHT,DHA,DUE,FITC,GEL,INC,THESE,WILEY
169,2013,HOWEVER,INC,NSCLC,THESE,TP53,WILEY
169,2013,495,ATP7A,CDDP,EGFP,FINALLY,INC,NSCLC,PCR,USING,WESTERN,WILEY
HISTOLOGY,SURGERY
169,197,2013,DISCHARGE,FIVE,HBV,HEPATITIS,HODGKIN,INC,OUTPATIENT,SIR,SIRS,SWEDISH,THESE,WHILE,WILEY
169,2013,INC,LITERATURE,PREVENTION,THERE,WILEY
169,2013,INC,MINIMAL,WILEY
169,2013,8201,8805,BACKGROUND,COPYRIGHT,CXR,LABEL,LDCT,LUNG,METHODS,MORTALITY,NLST,POISSON,RESULTS,RRS,SCREENING,SOCIETY,TRIAL
129,946,EMT,HOWEVER,LTEP,MUC4,TAKEN,USING
CTL,LEWIS,LLC,TRP,TRPA1,TRPM8,UCP2,WESTERN
169,2013,8764,ABCB1,ABCG2,ALK,ALSO,AUC,CRIZOTINIB,HIGH,NSCLC,UICC
169,2013,COPYRIGHT,INC,PANCREATIC,WILEY
169,2013,ALX4,ARISTALESS,BCL,CPG,HOWEVER,PCR,THESE,UICC,USING,WESTERN
10001,333,MEDICAL,PUBLISHERS,PULMONARY,SEVENTH,USA,YORK
DAB2,USING,UTR
141,200,200A,200B,200C,429,DESPITE,INSTEAD,THESE,ZEB1,ZEB2
007,037,367,8764,ALSO,ASCL1,CD56,HIGH,IHC,NCAM,RET,THESE
AGC,AKT,BRAF,GSK2334470,NOTABLY,PDK1,PDKI,PI3K,PKC,PTEN,SELECTIVE,V600E
201,NUCLEAR,P53,THUS
ADO,DSBS,E2F1,H1299,INDUCTION
001,044,8201,ASIAN,BLACK,CARE,CONSORTIUM,HISPANICS,OVERALL,USING
8764,ACTIVATION,AKT,C57BL,ERK,FAK,FVB,HOWEVER,MGAT,MGAT3,MMTV,POLYOMA,PREVIOUSLY,PYMT,SRC,TEC,TECS,THUS
ATLAS,NBS,SOMATIC
ALZHEIMER,BACKGROUND,CONCLUSION,EVIDENTLY,JAPAN,LABEL,MECHANISMS,METHODS,OBJECTIVE,RESULTS,WESTERN
160,1987,1996,2006,603,657,AFTER,APOC1,ARIC,CIS,COX,CRP,GRS,HNF1A,HRS,LABEL,LEPR,METHODS,OBJECTIVE,PURPOSE,RESULTS,RISK,SNPS
177,6MM,95TH,AFTER,AUDIO,E95T,FIRST,MHI,PREVIOUSLY,THUS,TOTAL
007,BHCT,BHCTS,DEEP,DEVIATIONS,FIFTEEN,FOUR,INTRA,MEAN,OVERALL,RADIO,SBRT
001,003,007,CRT,DOSIMETRIC,PTV,RESULTS,TEN,V10,V13,V20,VMAT
1SD,CYBERKNIFE,SBRT,STATISTICS
AAA,DUE,ECLIPSE,KUTCHER,LKB,LYMAN,NTCP,PBC,PUBLISHED,THREE
177,2CM,ANOTHER,CI100,CI50,DCAT,DMAX,HOWEVER,NMT,PTV,REDUCTION,SBRT,THEREFORE,V20
0236,2011,AFTER,APART,CARLO,CYBERKNIFE,DESPITE,DEVIATION,EACH,FAST,FDEV,FRACTIONAL,HOWEVER,MONTE,NSCLC,OAR,OARS,PTV,RAT,RAY,RTOG,SBRT,TRACING
260,28049,334,956,AUC,BALB,C57,COLON,CONCLUSION,LABEL,LEWIS,LL3,METHODS,NZM10,NZM4,NZM52,OBJECTIVE,PURPOSE,RAG,RESULTS,THESE
HDAC,HDACS,HISTONE,III,LABEL,METHODS,OBJECTIVE,ONGOING,PHASE,PURPOSE,RESULTS,THEREFORE
116,169,2013,8NM,AFTER,COLO205,COPYRIGHT,HCT,OFZG,PLA2,SECRETORY,TWEEN
181,335,538,640,BACKGROUND,CHILE,INDICES,LABEL,METHODS,ORS,RESULTS,ROTHMAN,SYNERGY,THESE
202,DDR,ERCC1,FANCONI,FINALLY,HDR,HOWEVER,RPA,THESE,XPA,XPF
153,737,8202,ABT,BAD,BCL2,BCL2L11,BIM,COR,DMS,L42,NEITHER,NOVEL,SCLC,SMALL
169,2013,B16,CD44,COPYRIGHT,CXC,CXCR4,F10,HOWEVER,INC,METASTASIS,MMP,SACCHARINA,TAKEN
169,2013,HOWEVER
956,A549,AFTER,CELL,DCM,ETOH,JACARANDA,K562,MCF,PC3
000,033,053,078,102,147,169,192,2013,247,255,259,359,413,419,563,736,746,761,BECAUSE,CD25,CD4,CHINESE,FOXP3,HAN,NSCLC,PCR,RFLP,SNP
000,100,101,1220,169,179,2008,2013,3189,5095,6071,872,BACKGROUND,BRAZILIAN,COPYRIGHT,DALY,DALYS,DESPITE,HOSPITALS,LABEL,LTD,METHODS,RESULTS,SANTA
169,2013,946,BACKGROUND,CASES,CONCLUSION,COPYRIGHT,HCG,LABEL,METHODS,NSCLC,PUBLISHED,REPORTS,SAS
131,169,2004,2009,2013,BACKGROUND,COPYRIGHT,DFI,DISCUSSION,JANUARY,LABEL,LTD,METHODS,OVERALL,PET,PRIMARY,RESULTS,SPN
169,2013,BRAF,COPYRIGHT,G469L,IRELAND,LTD,V600,V600E
142,169,2013,252,425,COPYRIGHT,CRT,DMFS,FOLLOWING,INC,INTERGROUP,LABEL,LRPFS,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,PRE,PRESENT,PURPOSE,RESULTS
1082,169,185,2013,348,8805,AFTER,AMERICA,ASIA,AUSTRALIA,CCRT,CLINICALLY,CONCURRENT,COPYRIGHT,EFFORTS,FACTORS,INC,LABEL,MATERIALS,METHODS,MOST,NORTH,OBJECTIVE,PURPOSE,RECURSIVE,RESULTS,THERE,V60,VALIDATED
160,169,177,2006,2013,393,620,ACCORDING,BACKGROUND,COPYRIGHT,ESL,FEV1,FUNCTIONAL,INC,JANUARY,LABEL,MEAN,METHODS,NSCLC,OKADA,OVERALL,PUBLISHED,RESULTS,SOCIETY,THERE
100,169,2010,2011,2013,BACKGROUND,COPYRIGHT,EBUS,INC,JANUARY,LABEL,METHODS,PATHOLOGIC,PUBLISHED,RESULTS,SOCIETY,TBNA,THERE
160,169,2011,2012,2013,AFTER,BACKGROUND,BLOOD,COPYRIGHT,INC,JULY,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,SPIROMETRY,TEMPORARY,THEREFORE,UPON
169,2013,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,POST,RESULTS,T790M,THERE,TKIS
169,2013,956,CNS,COPYRIGHT,GI50,LTD
INC,OCTREOTIDE,PUBLISHED
CHINA,CURRENTLY,EARLY,HOWEVER,SPNS
AFTER,CHINA,LUNG,NON,NSCLC
151,156,170,177,178,179,188,2011,2013,671,736,AFFILIATED,BACKGROUND,FIRST,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,SOOCHOW,THERE,UNIVERSITY,VAS,VATS,VIDEO
2012,2013,BACKGROUND,EBUS,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,SVCOS,TBNA
117,177,23R,BACKGROUND,CD3,CD4,CSF,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCLC,SERUM,TH17,THERE
140,2009,2012,465,704,APRIL,BACKGROUND,COX,ECOG,IRINOTECAN,LABEL,MEIER,METHODS,OBJECTIVE,PFS,PROGNOSTIC,REGRESSION,RESULTS,SCLC,THEREFORE
A549,AKT,BACKGROUND,CELL,EGFR,ERK1,GEFITINIB,H292,HGF,LABEL,MET,METHODS,MTT,NSCLC,OBJECTIVE,PC9,RESULTS,STAT3,WESTERN
008,177,BACKGROUND,BASIC,DIFFERENT,LABEL,LEWIS,LUMINEX,METHODS,MICE,OBJECTIVE,RESULTS,VEGF
A549,BACKGROUND,BALB,CELLS,DIFFERENT,H1299,HOWEVER,LABEL,METHODS,MICROCT,OBJECTIVE,PERIODICAL,RESULTS,SPC,THUS
1989,2008,BACKGROUND,CHINA,INCIDENCE,LABEL,MEANWHILE,METHODS,OBJECTIVE,POISSON,RESEARCHES,RESULTS,STRATIFIED
169,201,2013,231,COPYRIGHT,GREAT,LUNG,PUBLISHED,SAS
BETAHCG
169,2013,LTD,MWA,PUBLISHED,THRESHOLDS
100,1002,160,169,2013,ASIAN,BIOCAST,COPYRIGHT,HOWEVER,IFCT,LCINS,LUNG,PUBLISHED,SAS,SPLF
169,2013,AFTER,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,EGFR,EPIDERMAL,LABEL,METHODS,NSCLC,PUBLISHED,SAS,SPLF,T790M,TKI
169,2013,ANTI,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,LABEL,METHODS,PUBLISHED,SAS,SPLF
106,169,1ST,2008,2009,2013,31ST,BACKGROUND,CARIBBEAN,CONCLUSION,COPYRIGHT,FEW,GUADELOUPE,III,JANUARY,LABEL,MEAN,METHODS,NON,NSCLC,PUBLISHED,RESULTS,SAS,SPLF,STAGE,WEST
169,2008,2012,323,3796,562,6736,812,9161,961,BACKGROUND,CONCLUSION,COPYRIGHT,DATA,LABEL,METHODS,PMSI,PUBLISHED,RESULTS,SAS,SEX,SPLF
169,2013,CELL,COPYRIGHT,EGFR,INC,NSCLC,THUS,TKI,VPS34
104,169,2012,2013,COPYRIGHT,OVERALL,RECIPIENTS,SOCIETY,TRANSPLANT
169,2002,2012,2013,205,225,AFTER,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DNT,INC,JANUARY,LABEL,METHODS,MMF,OLT,RESULTS,TACROLIMUS,THERE
100,104,1675,169,1990,2008,2013,CIS,COPYRIGHT,DATA,HODGKIN,INC,ITALIAN,ITALY,LABEL,METHODS,NHL,OBJECTIVE,OLT,PTLD,PYS,RESULTS,SIR,SIRS,THESE
100,161,169,2013,228,567,653,878,AMONG,ASIAN,AUTHORS,BACKGROUND,CHIBA,CITY,COPD,DETECTION,GODDARD,JAPAN,LABEL,METHODS,OBJECTIVE,PACIFIC,PFT,RESULTS,SOCIETY
169,2013,BOTH,EGFR,GEFITINIB,MET,NEITHER,NON,T790M,THUS,TKI,TKIS
169,2013,4T1,JOHN,LTD,SONS,TH2,THESE,THUS,TSLP,TSLPR,WILEY
001,013,169,2005,2010,2013,240,7621,8201,8805,894,ACS,BILIARY,COLLEGE,DESPITE,ELDERLY,FACTORS,GIVEN,LABEL,METHODS,NSQIP,OBJECTIVE,OBJECTIVES,PANCREATO,PROGRAM,QUALITY,RESULTS,THESE
H460,NIH,NUR77,SEVERAL,TREATMENT
144,155,169,2013,BRITISH,HKII,INCREASING,MECHANISMS,OMM,SOCIETY
007,032,058,1998,ASSESSMENT,BACKGROUND,DIET,DIETARY,HARVARD,HISPANICS,HOWEVER,LABEL,MAIN,METHODS,NAA,NHW,NHWS,OBJECTIVE,OBJECTIVES,OVERALL,RATIONALE,RESULTS,SMOKERS,SMOKING,UNIVERSITY
DIFFUSE,FEWER,THEIR
945,946,AKT,BECAUSE,CDKS,ERS,KIP1,PI3K,PTEN,SKP2,WAF1
100,174,967,AFTER,COST,CRAIG,GRADE,INC,LABEL,METHODS,OBJECTIVE,OVERALL,PEARSON,REPORTS,RESULTS,STAPLER,THERE,USA
A549,AKTS,ATF1,EGF,ERK1,ERK2,ERKS,FOS,FURTHER,G12V,IC50,JUN,MITOGEN,NOTABLY,RAS,RSK2,TAKEN
945,AFP,CEA,CK14,CK18,CK19,CK20,CK5,CK7,CK8,EPCAM,FIVE,HEPPAR1,MOC31,THREE,TTF
0001,002,009,013,014,032,048,059,1317,1487,185,8201,8409,8805,AML,BCRP,DFS,DOWNSTREAM,FLT3,FMS,ITD,LRP,MDR,MLL,MRP,PTD
CL1,GROS,GUANINE,HT23,PU22,TBA,THESE
169,2013,945,AACR,CD31,CONCLUSION,CRC,DC101,EVALUATION,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SMA,SOLID,VEGF,VEGFI
029,204,206,218,415,8Q24,BMI,CHINA,HOWEVER,ODDS,TAIXING,THESE,UADT
169,2013,BECAUSE,CCCL,KRAS,MOLECULAR,TTF1,WORLD
100,169,1990,2009,2011,2013,340,BACKGROUND,BASED,COPYRIGHT,DMD,LABEL,LTD,METHODS,PROCEDURES,RESULTS
001,002,004,005,010,011,169,2013,CONCLUSION,COX,DATA,DFS,FDG,LABEL,MATERIALS,MAXIMUM,METHODS,MTV,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,RSNA,SBRT,SEVENTY,SUV,T2AN0M0,TLG,TLG50,TLG60
001,084,CONCLUSION,DCE,FIRST,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROI,ROIS,THIRD,THUS,USING
169,2013,AMONG,COPYRIGHT,IRELAND,LTD,NSCLC,PROGRAMMED,RCC
100,945,946,FORMULA,HOWEVER,QUADRATIC,WIF,WITHERS
CNS,T790M
001,026,169,177,2013,360,3MM,4FP,ANN,ANNS,CAD,CONSORTIUM,COPYRIGHT,FEATURE,FRAMEWORK,GENERATION,GREEN,IMAGE,LABEL,LUNG,MATERIALS,METHODS,NEAT,OBJECTIVE,RESULTS,SEARCHING,SVM,SVMS,TIME
0001,1000,140,169,183,2007,2010,2013,280,BACKGROUND,COPYRIGHT,DEC,ELDERLY,FUNDING,JULY,LABEL,LTD,METHODS,RESULTS,ROCHE,TREATMENT
VARIETIES
101,160,1987,2010,8201,BETWEEN,FIVE,HPC,LABEL,MATERIALS,METHODS,MHZ,MPM,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RFS,THERE
169,2013,AUTHORS,JOHN,LTD,SONS,STATISTICS,WILEY
001,100,145,1701,204,265,450,4586,8201,946,ASSESSMENT,DISEASE,FACT,FUNCTIONAL,IIIB,LABEL,LCSS,LOSS,LUNG,METHODS,NSCLC,OBJECTIVE,PATIENT,PURPOSE,REGRESSION,RESULTS,SCALE,SYMPTOM,THERAPY,USA
113,133,160,CRP,ECGS,HOWEVER,HRV,NSCLC,PSA,THEREFORE
946,CIGARETTE,III,IMR,PGC,SIRT1,THESE
139,266,HOWEVER,TNM
105,154,916,BACKGROUND,BASED,EBUS,HOWEVER,LABEL,METHODS,NPV,PCR,RESULTS,SHOX2,TBNA
135,1992,2010,202,AMONG,ANTITUMOR,GUIDELINES,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
205,CNS,ESTIMATES,HODGKIN,LABEL,MEDLINE,METHODS,ORS,RESULTS
145,1471,160,214,23A,3656,718,720,A549,AGILENT,FIVE,PCR,SPC,THESE
AIT,FIRSTLY,HOWEVER,NAC,NON,NSCLC,ROS,SOPHORA
169,2013,A549,AACR,CHEMOKINES,CXCR4,CXCR7,H157,HOWEVER,LABEL,NSCLC,TARGETING,THESE,UNLABELLED
A549,DDP,MAPK,PC14,TAKEN,THESE,TROP
0001,0006,001,002,146B,30C,339,370,390,550,566,616,656,939,ADC,AUC,CONVERSELY,EARLY,NSCLC,OVERALL,SIX
001,106,114,190,8805,AFTER,CONCLUSION,HE4,III,LABEL,METHODS,NSCLC,OBJECTIVE,PTB,RESULTS,SERUM,STAGE,USING
BMJ,DUTCH,GROUP,LABEL,LIMITED,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,PUBLISHING,RAPIDLY,RESULTS,SCREENEES,THERE
169,2013,279,AIMS,JOHN,KI67,LABEL,LAK,LTD,METHODS,NSCLC,OBJECTIVE,PBK,PDZ,RESULTS,SONS,TNM,TOPK,UNIVARIATE,WILEY
159,656,8804,929,END,HOWEVER,IIA,LABEL,LIMITED,MAIN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,PORT,RESULTS,SEER,SIMILAR,USING
169,2013,AIMS,CD10,ESS,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,VARIOUS,WILEY
CURRENTLY,HOWEVER,THERE,THESE
CD28,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,TNF
CHINESE,CONCLUSION,ERBANXIAO,LABEL,MEDICINES,METHODS,OBJECTIVE,RESULTS,SIXTY,THERE,THESE,TNF,VEGF
BACKGROUND,DOSIMETRY,FIF,IMRT,LABEL,LDC,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN
4945,946,A549,AKT,BACKGROUND,CK2,EMT,ERK,FAK,LABEL,MATERIALS,METHODS,MMP,PCR,RESULTS,SMAD,SMAD2,SNAIL,SRC,TGF,TWIST,WESTERN,WNT
ANG,ANG1,ANG2,ANGS,HOWEVER,RHOA,THESE,TIE2,TIGHT
001,428,7TA,7TB,8804,BACKGROUND,BASED,DATA,DFS,GUIDELINES,LABEL,LN0TA,LN0TB,LN1,LN7,LNS,METHODS,NSCLC,RESULTS
017,103,118,150,158,175,181,2010,455,464,667,BACKGROUND,FOLLOWING,HOWEVER,LABEL,METHODS,OUTDOOR,PM2,RESULTS,SHS,SUCCESSFUL,WAVE,WHILE
003,018,172,1806,302,414,432,665,8202,BACKGROUND,CENTRAL,CONTROLLED,HOWEVER,LABEL,MEDLINE,PFS,PRINCIPAL,RESULTS,SCLC
BALB,ENV,HERV,HIV,HKENV,MVA,PROTECTION,RENCA,RLZ,THESE
0045,2758,358,716,AIM,ATM,CONCLUSION,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TAIWANESE
239,945,BACKGROUND,CONCLUSION,DESPITE,LABEL,METHODS,RESULTS
001,407,714,750A,837,AHR,BACKGROUND,CONCLUSION,E746,EGFR,L858R,LABEL,METHODS,MST,NSCLC,NUCLEAR,RESULTS
CAV,PULMONARY,SURGERY
001,003,005,155,8805,AIM,BACKGROUND,CONCLUSION,DATA,KARNOFSKY,KPS,LABEL,METHODS,OBJECTIVE,OLDER,RESULTS,SCLC,SIX,WBRT
233,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,REGRESSION,RESULTS,SYMPTOM,THUS
946,947,BACKGROUND,CELL,CONCLUSION,LABEL,LEWIS,LLC,LOCAL,MATERIALS,METHODS,NOD,NOG,RESULTS,SCID,SMAD3,TGF,TIG
945,946,CAFS,EMT,FAP,GLI,GLI1,H358,HOWEVER,NSCLC,PCR,REAL,SMA,SMAD,SMAD3,SNAI1,SNAI2,TGF
BALB,BDNF,H810,LARGE,LCNEC,NCI,SINCE,THEREFORE,THESE,TRKB
143B,945,946,ALTERED,GFP,LM4,LUNG,RFP,THUS
AIM,CONCLUSION,EGFR,EKVX,EPIDERMAL,HER2,LABEL,MATERIALS,METHODS,MTD,NEITHER,OBJECTIVE,RESULTS,VEGF
ALK,ANAPLASTIC,ATP,DESPITE,EML4,HOWEVER,NSCLC
961,A549,HOWEVER,THESE
1252,1426,169,174,1764,2013,279,8201,8804,8805,956,ALK,BACKGROUND,CLINICALLY,COPYRIGHT,FISH,FURTHER,HOWEVER,INCREASES,LABEL,METHODS,NEITHER,NSCLC,OTHER,OVERALL,RESULTS,SOCIETY
946,CONVERSELY,FUNCTIONAL,FZD2,GSK3,HOWEVER,LKB1,LOSS,MMP2,MYC,PCR,TE10,TNM,WNT,WNT3A
946,EMT,EPITHELIAL,HEPATOCYTE,HNF6,HOWEVER,KNOCKDOWN,TGF
160,169,183,BLOOD,CONCLUSION,DIAGNOSTIC,GEORG,HCT,HISTORY,LABEL,LAM,LEFT,METHODS,REFRACTORY,SERUM,STUTTGART,TREATMENT,VOIDING,YORK
199A,AKT,HIF1A,MIR,NSCLC,PDK1,RNAS
1447,1948,1982,2004,366,AMONG,BACKGROUND,CIS,CONCLUSION,ERR,LABEL,MAYAK,METHODS,POISSON,PRODUCTION,RESULTS,THERE
1428,1996,2007,267,BACKGROUND,CONCLUSION,CPF,END,HIV,LABEL,METHODS,NSCLC,RESULTS,SEER,STAGE,USING
2001,2009,AFTERWARDS,BAP,FIVE,PAH,PM10,PMF,SPAIN
169,2009,2012,2013,AMRUBICIN,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,CURRENTLY,FEBRILE,GRADE,JANUARY,LABEL,METHODS,NSCLC,RESULTS,THEIR,THERE,UNIVERSITY
389,495,AMONG,BACKGROUND,CONCLUSION,DATABASES,FORTY,HOPKINS,JOHNS,LABEL,MEDICAL,METASTATIC,METHODS,OHIO,RENAL,RESULTS,STATE,THUS,UNIVERSITY
018,160,169,199,2001,2011,2013,474,995,AFTER,BACKGROUND,COPYRIGHT,INC,LABEL,MARTINI,MELAMED,METHODS,PUBLISHED,RESULTS,SMPLC,SOCIETY,SPLC,TNM,TREATMENT
001,160,169,2013,610,BACKGROUND,BOTH,COPYRIGHT,COX,GGO,INC,LABEL,METHODS,PATHOLOGIC,PET,PUBLISHED,RESULTS,SOCIETY
169,2013,26S,A549,COPYRIGHT,DSB,FEDERATION,PUBLISHED,RAD51,SOCIETIES,THESE
ALK,BACKGROUND,CD45,CTC,CTCS,EGFR,EXON,FISH,H2228,HOWEVER,LABEL,METHODS,NCI,PCR,RESULTS
223,270,300,8805,ATLAS,BACKGROUND,BLOOD,CHD,CNVS,DNAS,GATA4,GENOMIC,GJA5,HEART,INSTITUTE,LABEL,LUNG,METHODS,MYH11,PATHOGENIC,PUTATIVELY,RESULTS,SEVERAL
003,025,169,2013,250,8805,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EGFR,EXON,FAVORABLE,FORTY,GEFITINIB,IRELAND,L858R,LABEL,LTD,MATERIALS,METHODS,RESULTS,WBRT
169,2013,A549,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MICE,NSCLC,RESULTS,THESE,TRICHROME
12DYN,169,177,2013,4DYN,5DYN,A549,BMPR,BOTH,FITC,HEP3B,HOWEVER,LAMINAR,LC3B,LSS,MECHANICAL,MG63,OSS,PARP,SCC25,SMAD1,SMAD5
169,2013,AKT,ARCTIUM,ARG,CDK2,CDK7,COPYRIGHT,GMBH,GSH,NPAT,THESE
1993,2005,247,BACKGROUND,CONCLUSION,ICU,IIIB,JANUARY,LABEL,METHODS,ODDS,OUTCOME,PCP,PCPS,RESULTS,STAGE
1P36,2122,34A,ADENO,ALDH,CARCINOMA,CD44,CELLS,CSC,MPE,NCI,SINCE,STEM,THUS
197,ASYMMETRIC,EGFR,EGFRS,ERBB,L834R,MUTATED,T766M,THUS,TKD,TKDS
110,121,1273,129S1,159,175,AKR,BALB,BOTH,C3H,C57BL,CBA,DBA,DEPARTMENT,GEM,GEMS,LABORATORY,MAMMARY,NEWLY,NOVEL,SVW,WOM
169,2013,297,AMONG,INC,WILEY
169,2013,8208,947,948,CROSS,GMBH,KGAA,NKG2D,SOLUBLE,TRAIL,VCH,WHETHER,WILEY
001,002,013,116,COX,EXPRESSION,HOWEVER,LABEL,MEIER,METHODS,MIR,OBJECTIVE,PCR,PFS,PURPOSE,RESULTS,TNM,UNIVARIATE
COLORECTAL,CRC,SPAIN
169,2013,555,600,COPY,COPYRIGHT,INC,KIT,KITLG,LCNEC,PCR,POSITIVITY,SCF,SQCC,WILEY
183,8201,HRQOL,LABEL,METHODS,MOST,NSCLC,OBJECTIVE,PAIN,PURPOSE,RESULTS,ROC
00001,00002,0001,002,2012,945,BACKGROUND,CBM,CNKI,DATABASES,FANG,HIF,HOWEVER,HYPOXIA,III,LABEL,MAY,METHODS,NSCLC,RESULTS,SCLC,STUDIES,VEGF,VIP,WAN
A549,CFL1,GI50,HIGH,ICR,NSCLC
001,152,2000,2009,2010,2011,270,AJCC,ATS,BACKGROUND,COMMITTEE,CONCLUSION,ERS,IASLC,JOINT,LABEL,LUNG,MEIER,METHODS,RESULTS,SOCIETY,USING
A549,CD34,EGCG,NEXT,VEGF
001,002,005,181,193,BACKGROUND,BRAF,CLM,HOWEVER,KRAS,LABEL,LIVER,METHODS,NRAS,OBJECTIVE,RAS,RESULTS,RFS,SOMATIC
169,2013,945,AKT,COPYRIGHT,HIF1,IRELAND,LTD,MAMMALIAN,NSCLC,RAPAMYCIN,VEGF
125,160,176,180,215,360,3CM,8764,BOTH,CARLO,COUNCIL,D95,DESPITE,DOSXYZNRC,FURTHER,HOWEVER,LED,MONTE,PTV,RESULTS,SBRT,SMALL,THESE,THUS,V20
HOWEVER,MHC,MICB,NKG2D,TRAMP
ERK,KRAS,MAPK,ONCOGENIC,OVERALL,RAS,TSP,USING
8321,945,AGP,ALSO,BACKGROUND,COMPARISON,DISCUSSION,ELISA,LABEL,MAA,METHODS,NSCLC,RESULTS,SCLC,TYPICAL
ALLOGENEIC,BIOLOGY,CELL,DLI,INC,INSTITUTE,LIMA,PREVENTION,PUBLISHED,RELAPSE,SCIENTIFIC,SESSION,STEM,TREATMENT
100,169,2013,6PGD,6PGDS,COPYRIGHT,DE3,INC,MICHAELIS,NADP,THREE,USING
169,2013,BACKGROUND,BMI,FEV1,FVC,LABEL,MATCHED,METHODS,PREGNANCY,PUBLISHED,RESULTS,SOCIETY
001,163,169,2013,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,NANOG,OBJECTIVE,PCR,RESULTS,THEN
169,2013,COPYRIGHT,PUBLISHED
001,018,028,169,173,177,2006,2011,2013,482,596,AMONG,BRAIN,CONCLUSION,COPYRIGHT,IIIB,IRELAND,JANUARY,LABEL,LTD,METHODS,MLR,NOTABLY,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THEREFORE,THESE,TREATMENT
169,2012,2013,ALSO,ALTERNATE,CONFERENCE,COPYRIGHT,DYNAMIC,GROUP,IMAGING,IRELAND,LTD,MPM,MRI,PET,SEPTEMBER,THESE,USA
001,1272,169,2002,2010,2013,335,774,BACKGROUND,BPD,COPYRIGHT,DTRA,EGFR,GEFITINIB,IRELAND,JULY,LABEL,LTD,METHODS,NSCLC,OCTOBER,RESULTS,SIXTY,TKI
001,169,2001,2007,2013,3986,3DCRT,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,END,ESOPHAGUS,III,IIIA,IMRT,INTENSITY,IRELAND,KEY,LABEL,LTD,METHODS,PATIENT,PREDICTORS,RESULTS,SEER,THESE
169,2013,COPYRIGHT,DNX,DOX,DSPE,LTD,LUNG,NDS,NDX,PEG
169,177,2013,AUTOMATED,BOTH,COPYRIGHT,DCE,FOURIER,IRELAND,LABEL,LLA,LTD,MATERIALS,METHODS,OBJECTIVE,PERFUSION,PURPOSE,RESULTS,ULA
169,2013,247,COPD,COPYRIGHT,FINAL,GOLD,IRELAND,KAPPA,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREVALENCE,RESULTS,RIGHT,SMALL,VOLUMETRIC
0004,0190,169,2013,8320,8322,8805,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,INCREASED,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SBRT
169,2013,8805,BACKGROUND,COPYRIGHT,CTCAE,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,MEIER,METHODS,NINE,NSCLC,OBJECTIVE,OPTIONS,PBT,PURPOSE,RATES,RBE,RESULTS
169,2013,COPYRIGHT,DESPITE,LTD,LUNG
111,DISTANT,FOUR,III,IMRT,NPC,SIB
HEPG2,ICR,LAOS,LOUR,MCF7,NMR,STEMONA,THEIR,THESE,THREE
8320,8325,APRATOXIN,AQABA,GULF,H460,MANGROVES,NABQ,NCI,NMR,RED,SEA
169,AUTHORS,BLACKWELL,CURRENT,GMBH,JOURNAL
1990S,1999,2000S,2007,AMONG,BACKGROUND,CONCLUSION,COX,DATA,LABEL,METHODS,RESULTS,RII,THESE
ADDITIONAL,BACKGROUND,DLCO,EASTERN,EIGHT,FEV1,FOUR,GROUP,LABEL,LOBECTOMY,MAIN,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RATIONALE,RESULTS,SEVENTY,THERE
001,037,045,FURTHER,LABEL,METHODS,OBJECTIVE,OHP,PURPOSE,RESULTS,SN38,THERE,VARIOUS
500,554,592,64257,8805,ASIAN,BACKGROUND,CAUCASIANS,CYP2C19,HOWEVER,LABEL,METHODS,OVERALL,P450,PMS,RESULTS
MOLECULAR,PAM50,THESE
FINALLY,HOWEVER
176,945,946,A549,BEAS,C57BL,CONVERSELY,EMT,FURTHER,LEWIS,LLC,MNU,SIMILARLY,TGF,THESE,TNF,VEGF
102,114,115,116,117,174,2104,2913,2985,945,946,AKT,AMONG,HSP,MET,OTHER,REGARDING,SEVERAL,T790M,TAIHO,TAS,UFT,USING
0001,320,LABEL,MCNEMAR,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THREE
088,104,160,613,736,APART,APOE,DESPITE,EIGHT,SNPS
AIR,DATA,PM10,THERE
1985,2007,2012,215,225,CONCLUSION,FINAL,LABEL,MEN1,METASTATIC,METHODS,OBJECTIVE,PET,PTH,RESULTS
100,156,1993,2012,218,468,956,ACTH,CONCLUSION,CTS,DESPITE,EAS,ECTOPIC,FUNCTIONAL,IPSS,LABEL,METHODS,MRI,NOTABLY,OBJECTIVE,PET,RESULTS,SUSPICIOUS,TSS
131,215,945,CALCIUM,CONCLUSION,FURTHER,GIST,GISTS,LABEL,METHODS,OBJECTIVE,OH2,PTH,PTHRP,RESULTS,THERAPY
180,220,260,500,8804,8805,BACKGROUND,BASED,DESPITE,LABEL,METHODS,MTD,NSCLC,PEMETREXED,PHASE,PLANNED,PRIMARY,RESULTS,RP2D,THREE,TREATMENT
001,002,125,CASES,COX,DFS,EXPRESSION,HER1,HER2,HER3,HER4,HERS,MEIER,NSCLC,THERE
160,AMPUTATIVE,CURRENT,METASTASES,TREATMENT
033,114,150,373,713,A549,MMP,MMPS,NSCLC,SIRNA,TRANSIENT,VEGF
149,159,FDA,IBC,IC50,SUM,THESE,TIC,TICS,WNT
DN30,DUE,FAB,INDUCTION,KEY,LABEL,MESSAGE,MET,TET,THESE,UNLABELLED
2010,8482,AIM,BACKGROUND,CONCLUSION,CURRENTLY,EEA,FOUR,FURTHER,HIGH,LABEL,MAINZ,MEDICAL,METHODS,MIE,MINIMALLY,NONE,OBJECTIVE,ORVIL,RESECTION,RESULTS,THERE,TRANSORAL,UNIVERSITY
001,002,1572,2001,2005,AICHI,BACKGROUND,CIGARETTE,LABEL,LCS,METHODS,ORS,RESULTS,TTFC
109,158,160,186,2008,2011,641,APRIL,CTS,FDG,JUNE,LABEL,METHODS,NPV,OBJECTIVE,PET,PPV,PURPOSE,RESULTS,SPN,USING
946,A549,AKT,ALDH,CSC,CSCS,EMT,FBLN3,FBLNS,GSK3,IGF,IGF1R,OVERALL,PI3K,SNAIL,SOX2,THESE
B16,BMP4,BONE,CSCS,H460,HCI,HELA,LNM35,TSP1,VEGF
002,020,046,5YR,ACCORDING,CAFS,CD204,CONCLUSION,FOXP3,HGNEC,HOWEVER,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFS,TAMS,TREGS
169,2013,ALSO,COPD,COPYRIGHT,CVD,FEV1,FOUR,INC,PUBLISHED,SIX,THREE
169,2013,ALSO,COPYRIGHT,DOWN,HBE,HUVEC,IRELAND,LTD,THUS,VEGF
100,169,2008,2013,2030,2405,531,AFRICAN,BACKGROUND,BENIN,CONCLUSION,EVEN,LABEL,LEONE,METHODS,MOZAMBIQUE,NIGER,OVERALL,PREVALENCE,RESULTS,SAHARAN,STEPS,SUB,SWAZILAND,USING
169,2013,224,448,954,BESIDES,CHINA,CHINESE,COPYRIGHT,HAPLOTYPE,LABEL,LTD,METHODS,OBJECTIVE,PCNA,POL,PURPOSE,RESULTS,REV1,TLS
160,169,2013,674,BOTH,CONVERSELY,COPYRIGHT,HOWEVER,INC,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY,SOX7
169,2013,A549,AUTHORS,BIOMARKERS,COPYRIGHT,HRP,INC,KNOCKDOWN,NRF2,PUBLISHED,PUMA,ROS,THEREFORE
169,2013,231,ETS,HGF,LINE,MDA,MMP1,ORF
169,2013,946,CD44,CSCS,EMT,GSK3,MMP2,OVERALL,SILIBININ,T24,ZEB1
100,134,169,2013,CONCLUSION,COPYRIGHT,DFS,FDG,IRELAND,LABEL,LTD,MATERIALS,MCNEMAR,METHODS,MRI,NSCLC,OBJECTIVE,PET,PURPOSE,QUICK,RESULTS,ROC
169,2013,AFTER,COPYRIGHT,EGFR,IRELAND,LTD,NSE,SCLC,SECONDARY,TKI
946,INC,PUBLISHED,TGF
169,2013,A549,AKT,CK2,COPYRIGHT,LTD,MAPK,MMP,PI3K
169,2013,946,A549,BACKGROUND,CONCLUSION,COPYRIGHT,EMT,H358,IRELAND,LABEL,LTD,METHODS,NCI,NHLF,NSCLC,RESULTS,TGF,THESE
169,2013,AUTHORS,COPYRIGHT,HOWEVER,IRELAND,LTD,LUNG,MICROARRAY,NSCLC,PUBLISHED,SQCC,WHILE
100,169,200,2013,956,AUC,BACKGROUND,BBB,CONCLUSION,COPYRIGHT,CSF,EGFR,GEFITINIB,ICA,INCREASED,IRELAND,LABEL,LTD,MATERIALS,MDCK,MDR1,METHODS,NSCLC,RESULTS,THEREFORE
0933,169,2013,COPYRIGHT,D40,HENCE,HIPPOCAMPI,NSCLC,PUBLISHED,RTOG,SAS,SPARING,VMAT
169,1992,2007,2013,376,636,6468,COPYRIGHT,COX,ELDERLY,END,III,IRELAND,LABEL,LTD,MATERIALS,METHODS,NCSLC,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SEER,THESE,USING
169,2013,DPYSL,MYCN,THESE
PNET,PRIMARY
CD147,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THEN
ASXL1,JAK2V617F,R693X,USING
1427,160,169,2005,2012,2013,700,727,839,8805,BAL,BLACKWELL,GMBH
169,2013,COPYRIGHT,CURRENT,INC,PET
MEIER
001,1043,127,326,7901,843,AGS,BACKGROUND,BINDING,LABEL,METASTASIS,METHODS,MTA2,RESULTS,SGC,SP1,TNM
ALTERED,BACKGROUND,FOLLOWING,INCREASED,LABEL,LUNGS,MANN,METHODS,MMP13,OTHER,RESULTS,THEREFORE,THESE,WHITNEY
945,946,EXAMINING,H2009,HOWEVER,THEREFORE,THESE,THUS
100,563,607,898,BACKGROUND,FURTHER,GENOMIC,LABEL,MALAY,METHODS,PRINCIPAL,RESULTS,SNVS,THESE
0013,0141,117,2004,2011,231,282,386,397,611,806,AIMS,AMONG,BACKGROUND,BASED,CUSHING,HOUNSFIELD,JANUARY,JULY,KOREA,LABEL,MALIGNANT,MEDICAL,METHODS,MOST,OBJECTIVE,RESULTS,SAMSUNG,SCS,SEOUL,SOUTH
109,169,1968,2006,2013,897,ADDITIONAL,AREVA,BACKGROUND,BASED,BCNS,CONCLUSION,COX,HRS,INC,LABEL,METHODS,MORTALITY,NUCLEAR,RESULTS,WILEY
928,934,AUC,CXR,HOWEVER,LDCT,LUNG,NCN,NLST,PSFR,PSSZ,ROC,SCREENING,THESE,TRIAL
107,140,2000,2008,2010,2197,239,5603,642,9874,AGE,AMONG,ASIAN,CANCERS,COX,FURTHER,ICD,INCREASED,INSURANCE,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,USING
100,8482,945,956,A549,AIMS,BACKGROUND,CONCLUSION,EGCG,ELISA,HIF,IGF,LABEL,MEANWHILE,METHODS,OBJECTIVE,PCR,RESULTS,VEGF,WESTERN
8209,CD133,CSC,CSCS,FURTHER,HOWEVER,MDR1,NANOG,NSCLC,OCT4A
0002,002,003,007,330,572,902,AMONG,BACKGROUND,BMI,COEXISTING,COPD,COX,HRADJ,IIB,LABEL,METHODS,NSCLC,PFS,RESULTS,SCC
2013,AFTER,BASEL,CAKI,CLU,CLUI,CLUSTERIN,CONCLUSION,CRCC,ERK1,LABEL,METHODS,MMP,OBJECTIVE,PCR,RESULTS,WESTERN
2011,CEA,CEP,CHEST,FDG,PET,S10,SEPTEMBER,VATS

CD20,CHRONIC,MALT,SINCE
600,800,AFTER,IPF,KREBS,LDH,PULMONARY
2008,2010,246,FDG,IGA,ORAL,PET,SCH,SEGMENT
CHEST,COLON,SEVERAL,TBLB,THESE,TTF
000,100,358,AREA,BACKGROUND,CHOP,COMPLEX,III,LABEL,METHODS,PONTEVEDRA,RESULTS
160,A549,CM5,EARLY,HOWEVER,PROTEIN,WESTERN
160,ACC,ADENOID,ASSAY,CELL,QCMTM,RNAI,THERE,XAGE
945,AKT,CK2,MOLECULAR,PKB,TCF,WNT
8209,954,HOWEVER,OPN,PTM,THUS
104,152,2009,2011,283,4694,8649,BETWEEN,LABEL,LDCT,LOW,METHODS,NPV,NSCLC,OBJECTIVE,OBJECTIVES,PPV,RESULTS,STAGE,THEREFORE
169,2013,COPYRIGHT,HOWEVER,INC,PHYSICIANS,PUBLISHED,TROUSSEAU
000,100,169,2013,8230,ALTERED,COPYRIGHT,CURRENT,DUE,ENT,JAPAN,MOST,PUBLISHED,SAS,UNTIL
100,169,2013,215,24H,661,955,956,A549,AFTER,ASSAY,COPYRIGHT,METAL,MTT,PDT,POST,RESULTS
1952,2005,2006,2008,2011,254,507,BACKGROUND,BECAUSE,ESTIMATED,HRS,LABEL,METHODS,MID,MOST,OBJECTIVE,OHIO,PFOA,RESULTS,SELF
001,100,124,149,169,1ST,200C,2013,29C,375,424,COPYRIGHT,COX,DENSITY,IRELAND,KARNOFSKY,LABEL,LOW,LTD,MEIER,NSCLC,RNAS,UNLABELLED,USING
CURRENT,SEVERAL
2010,2011,954,BACKGROUND,CBCT,CONCLUSION,DIR,KAPPA,LABEL,METHODS,RESULTS,RTT,SCLC
100,177,99M,ALLC,CNPW,GIVEN,LABEL,LROC,METHODS,MODEL,NODULES,OBJECTIVE,OBSERVERS,PURPOSE,RESULTS,SPECT,THREE
145,8764,CBCT,CBCTS,DEPENDING,FARADAY,FURTHER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
176,4DCT,8804,95TH,AVIP,CBCT,DTS,FINALLY,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,REFERENCE,RESULTS,SHORT,SYSTEMS,THREE,TOOLKIT
177,8725,95TH,ABDOMINAL,AFTER,CBCT,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,THEREFORE
215,963,CURRENT,FURTHER,HERETOFORE,HOWEVER,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS
4DCT,8804,ALSO,D99,FINALLY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SBRT,TEN,THEN,VMAT,WHILE
4DMC,CARLO,LABEL,METHODS,MONTE,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THESE
110,160,BDIR,E4DM,EBD,LABEL,MEANWHILE,METHODS,MHI,OBJECTIVE,PDETECT,PIR,PURPOSE,RESULTS
632,956,AMONG,BACKGROUND,HEM,HENCE,HOWEVER,LABEL,RESULTS,RNAS
1550,1600,200,2011,2050,500,8805,APRIL,CISPLATIN,FORTY,GRADE,LABEL,METHODS,OBJECTIVE,PHASE,RESULTS
4T1,946,EMT,MAMMARY,MECS,TGF
177,181,CELL,COA,DU145,HMG,IC50,RAS
034,037,2007,2009,CIK,DENDRITIC,IIIB,NSCLC,SIXTY,TTP
160,945,CD56,DIPNECH,GRP,NECH,UPON
169,1999,2004,2011,2013,ATS,BAC,CURRENTLY,ERS,GGO,IASLC,INC,LUNG,PET,SEVERAL,SOCIETY,TNM,WILEY,WORLD
169,183,BESIDES,EGFR,GEORG,NSCLC,STUTTGART,TKI,TKIS,YORK
8201,BONE,CONCLUSION,FAMT,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
0102,1309,160,2002,2011,CONCLUSION,FDG,ILD,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SEPTEMBER,SIX,SUV,THERE
7721,8320,8325,956,A549,AMONG,H1299,HELA,K562,LOUR,SIX,SMMC,THEIR,THESE
SCLC,SEOM
AUTOPSY,HOWEVER,KYODO,SAITAMA
BACKGROUND,CCAM,EXPRESSION,FGF,FGF10,LABEL,METHODS,PBB,PPB,RESULTS,SHH,THEIR,THESE,TYPE
769,786,ADDITIONAL,BACKGROUND,CAKI,EPO,EPOR,ERK1,HOWEVER,JAK2,LABEL,METHODS,RCC,RESULTS,RPTEC,TMA,USING
CCNE1,CDK2,HGSC,LABEL,METHODS,OBJECTIVE,OVCAR,PURPOSE,RESISTANT,RESULTS,THESE
169,2013,AACR,ASSESSING,DCUN1D1,DVL3,SENP2
0001,160,1992,2008,8201,956,AIR,ANGELES,BACKGROUND,CONCLUSION,COX,END,HAZARDS,HOWEVER,LABEL,LOS,MEIER,METHODS,PM10,RESULTS,SIMILAR,WHITE
AMONG,BACKGROUND,III,INSTITUTE,LABEL,LOW,LUNG,METHODS,NLST,RESULTS,SCREENING,THESE,TRIAL
102,1090,1871,5021,7008,AMONG,BACKGROUND,BCCA,BRITISH,DETECTION,EARLY,FOX,INSTITUTE,LABEL,LUNG,MAJOR,METHODS,PAN,PREDICTIVE,PREDICTORS,RESULTS,TERRY
169,2013,238,8804,ACTA,BACKGROUND,CONCLUSION,FDG,FOUNDATION,HOWEVER,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
107,195,198,AES,ASIAN,BACKGROUND,BEV,CHEMO,CHINESE,ITT,LABEL,METHODS,MO19390,NSCLC,OBJECTIVE,RESULTS,SAIL,SECONDARY,TIME,TTP
169,2013,3SI,4T1,945,946,AACR,HOWEVER,LABEL,LAMA5,LOSS,RHOC,UNLABELLED
2005,2011,423,BACKGROUND,CONCLUSION,INCIDENTAL,LABEL,METHODS,RESULTS,SIXTY,THEIR,THERE,THOSE
001,005,160,223,400,421,8201,8805,BACKGROUND,LABEL,LNR,METHODS,RESULTS
ADX,AMONG,ARMS,EGFR,NEITHER,NSCLC,PLEURAL,REFRACTORY,THREE,TKI,TKIS,TREATMENT
001,1201,ACTIVATING,ASIAN,BACKGROUND,CAUCASIAN,CONCLUSION,EGFR,GERMANY,LABEL,METHODS,MUTATIONS,NON,NSCLC,RESULTS,THESE,THYROID
BACKGROUND,CHEMOKINES,CONCLUSION,CXCR7,LABEL,METHODS,MICE,RESULTS
1961,2609,BACKGROUND,BMI,BOTH,CONCLUSION,CONSORTIUM,HOWEVER,HRT,LABEL,LUNG,METHODS,POTENTIAL,RESULTS
0325901,178,AAG,AZD6244,BACKGROUND,CONCLUSION,EBC,FURTHER,IRINOTECAN,LABEL,METHODS,MOST,PACLITAXEL,PF2341066,RESULTS,SQCC,THESE,TOPOTECAN
100,946,AZA,DAB2,HOWEVER,MTS,PCR,TNM,TREATMENT
160,215,420,CARLO,CCE,CLOUD,COMPUTE,EC2,ELASTIC,IMRT,MONTE,STX,THREE,TVR,UNITS,VMAT
039,082,085,2004,2007,2009,AMONG,BLACK,CONCLUSION,DRUGS,EFFORTS,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RECEIPT,RESULTS,SEER
100,200,2009,2011,224,294,561,8805,956,COMPLIANCE,CONCLUSION,FIVE,GRADE,JUNE,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,SPT,SPTS
115,160,181,A549,CARLO,CURVE,EAHY296,EAHY926,HRS,MCSC,MONTE,POISSON,RESULTS,THREE
160,215,DEFORMABLE,DIR,DVF,DVFS,FEM,PEARSON,POPI,SIX
BACKGROUND,CASE,CAUCASIAN,CONCLUSION,DRUG,FDA,FOOD,LABEL,METHODS,VEGF
169,2013,ALK,ATN,COPYRIGHT,EML4,FOLLOWING,IRELAND,LTD,NSCLC,URINARY
ISCHAEMIC,PAVM
169,2013,946,AKT,CCL18,CHEMOKINE,COPYRIGHT,EMT,GSK3,HOWEVER,ISL1,LIMK,LIN,LTD,MEC,NIR1,PYK2,SNAIL,TAMS
HOWEVER,OBSERVING,ONCE,PET
947,CBCT,CBCTS,CONCLUSION,LABEL,LUNG,METHODS,PDM,RESULTS,UNLABELLED
174,2002,2011,8805,BMET,BMETS,BONE,COMMERCIAL,CUMULATIVE,IVB,IVBS,KEY,LABEL,MARKETSCAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,USA
180,2010,2011,CAUCASIAN,DOSE,FURTHER,JANUARY,LABEL,METHODS,NONE,OBJECTIVE,RESULTS,STOMATITIS,THEIR
ACRIN,BACKGROUND,COGNITIVE,COLLEGE,CONTENT,CURRENT,IMAGING,LABEL,LUNG,METHODS,MODEL,MOST,NETWORK,NLST,NVIVO,RADIOLOGY,REGULATION,RESULTS,RISK,SCREENING,SELF,SMOKING,SOCIETY,TRIAL

945,AMONG,CSC,CSCS,EMT,EPITHELIAL,G12D,INCREASED,K15,KRAS,SCC,SCCS,SMAD4
169,2013,231,ANIMALS,BOTH,COPYRIGHT,MDA,PAIN,PUBLISHED,THESE
169,2013,COMPOUNDS,COPYRIGHT,CRATAEGUS,HRESIMS,LTD,MRC5,NINE,NMR
169,177,2013,6CM,AMACR,CD10,CDC,CK20,CK5,CK7,COPYRIGHT,GATA,GATA3,GMBH,IHC,MSA,PAX2,PAX8,RCC,RCXC,RENAL,S100,SEVEN,SIMILAR,SIX,TEN
100,COMBINING,METASTATIC,THERE
166,177,199,228,255,945,947,A549,ACCORDING,CB28,CD28,CD28MAB,CHANGES,CIK,EFFECTS,ELISA,GRANB,HME1,HYPACUE,IFN,INF,MFC,PBMNC,PERIPHERAL,TNF
1287,955,EGFR,FURTHER,H226,H2AX,HER3,HNSCC,NSCLC,SCC1483,SCC6,THESE
148,160,169,2009,2012,2013,ANESTHETIC,BACKGROUND,COPYRIGHT,INC,INTUBATED,LABEL,LEFT,METHODS,OPERATIVE,PUBLISHED,RESULTS,SOCIETY,THERE
169,2010,2012,2013,211,APRIL,BACKGROUND,COPYRIGHT,III,INC,LABEL,LINE,METHODS,PUBLISHED,RESULTS,SOCIETY,UNIVERSITY
169,190,2005,2012,2013,BACKGROUND,COPYRIGHT,GRADE,HOWEVER,INC,IPSLR,LABEL,LOCAL,METHODS,PUBLISHED,RESULTS,SABR,SOCIETY,T1A,T1B,T2A,TREATMENT
002,132,143,160,169,177,1999,2008,2013,302,BACKGROUND,COPYRIGHT,COX,CURRENT,IIA,IIB,IIIA,IIIB,INC,LABEL,LNR,MEAN,MEIER,METHODS,NODAL,NSCLC,PUBLISHED,RESULTS,SEVERAL,SOCIETY,THERE,TNM,UPON
169,178,2005,2011,2013,BACKGROUND,CONCURRENT,COPYRIGHT,FORTY,FURTHER,IIIA,IIIB,INC,JUNE,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THERE,THREE
169,2013,211,605,699,756,813,AUC,BACKGROUND,COPYRIGHT,ESTIMATION,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY
0001,006,135,153,169,2013,210,ACOSG,AMONG,BACKGROUND,COLLEGE,COPYRIGHT,GROUP,HOWEVER,INC,LABEL,METHODS,NOTABLY,PUBLISHED,RESULTS,SECONDARY,SOCIETY,THERE,VATS,Z4032
160,169,2004,2013,ACC,ATS,BACKGROUND,COPYRIGHT,EIGHT,FIFTY,INC,LABEL,METHODS,PUBLISHED,RESULTS,SCC,SOCIETY,TRANSITORY
2009,2012,BETWEEN,DEFINITIVE,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS
01MG,05MG,06MG,103,70MG,BETWEEN,COMMITTEE,HIGHEST,IRELAND,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RCS,RESULTS,SCIENTIFIC,SIXTY,TWA
III,LARGE,SURGERY
HOWEVER,IPF
ACCORDING,IDIOPATHIC,IPF,VIEWING
473,946,A549,AKT,AMONG,EARLIER,EMT,HEP3B,HOWEVER,MH2,MOST,PA1,S100,SER,SEVERAL,SMAD3,TGF
EVALUATION,HOWEVER,PET,SOLID
99M,BLOOD,CONCLUSION,LABEL,MAG3,MBQ,METHODS,OBJECTIVE,RESULTS,SPECT
AMONG,CONCLUSION,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TRANSGENIC,U251,WESTERN
33258,APOPTOSIS,BAX,BCL,CONCLUSION,FITC,H460,HOECHST,LABEL,METHODS,MTT,NCI,OBJECTIVE,RESULTS,WESTERN
946,A549,AXIN1,CONCLUSION,LABEL,METHODS,OBJECTIVE,PC3,PCR,RESULTS,SMAD3,TGF,WESTERN
169,2013,ALTOGETHER,HGF,HSP27,MK2,UICC
A549,ABC,ABCG2,ATP,BINDING,KNOCKDOWN,SP1,SP3
ERLOTINIB,GIVEN,LABEL,MOST,ONGOING,OPINION,SCC,STATEMENT,UNASSIGNED
169,2013,INC,LOW,WILEY
CTC,CTCS,DESPITE,FACTORS,HOWEVER,LABEL,NSCLC,OPINION,STATEMENT,THERE,UNASSIGNED
169,2013,COPYRIGHT,JOHN,LTD,SONS,WILEY
0001,2009,2010,APRIL,BASED,COX,JUNE,NSE,THEN,THESE
CONCLUSION,FIRST,LABEL,METHODS,OBJECTIVE,ORGAN,PROMISING,PURPOSE,RESULTS
263,945,ACTA2,CONSISTENT,EXPRESSION,FAK,LABEL,MET,METASTATIC,METHODS,OBJECTIVE,PC14PE6,PURPOSE,RESULTS,RNAS,THEREFORE,THESE
001,8201,967,CONCLUSION,EACH,FORTY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
019,025,041,048,050,2010,2011,6MWT,8201,8804,ACCORDING,BARTHEL,BETWEEN,BORG,CONCLUSION,CORE,EORTC,IIIA,IIIB,INDEX,LABEL,LIFE,MANN,METHODS,OBJECTIVE,PURPOSE,QLQ,QUALITY,RESULTS,SCALE,TEST,TREATMENT,WALK,WHITNEY
231,ERK,ERK1,INHIBITION,LM2,MDA,MEK,PI3K,RAS,THESE,UO126
ASIAN,COX,HOWEVER,LKB1,NKX2,RFS,SIMILAR,SP1,TAIWANESE,THEREFORE
946,AKT,AKT1,HGPIN,HOWEVER,MUTATIONS,PTEN,TGF
000,0001,100,543,555,BACKGROUND,BEIR,BIOLOGICAL,CONCLUSION,CTO,EFFECTS,LABEL,LAR,LARS,METHODS,MINIMAL,PCI,RADIATION,RESULTS,STEMI,VII
498,DAUN,DOX,DOXOL,EACH,H460,H9C2,HCT,HEPG2,LC50,MCF,MTT,NCI,OVCAR,OVERALL,PANC,THEREFORE,WESTERN
2006,DESPITE,JANUARY,SINCE,VATS
B5B,CK7,F18,FDG,MALIGNANT,MIXED,PET,THEREFORE,THYROID
101,150,2006,2008,215,300,CD8,CSF,DESPITE,JUNE,K562,OCTOBER,OVERALL
169,2013,COPYRIGHT,EXPRESSION,INC,NSCLC,PCR,SOX1
145,169,2013,956,COPYRIGHT,EACH,FOUR,H460,IC50,LTD,MOST,NCI,OXI8006
169,2013,HOWEVER,TELOMERASE,TERT,THEREFORE,THUS
066,169,2013,COPYRIGHT,EBUS,INC,PUBLISHED,SOCIETY,TBNA
169,2013,COPYRIGHT,EVEN,INC,PPN
169,2013,COPYRIGHT,EBUS,INC,PET,TBNA
169,2013,ALSO,COPYRIGHT,EARLY,INC
169,2013,COPYRIGHT,HOWEVER,INC,LUNG,MOST,SCREENING,TRIAL
169,2013,COPYRIGHT,IASLC,INC,LUNG
001,169,2013,943,947,981,982,984,992,993,997,AMONG,AREA,CCC,CCCS,FOUR,ICC,ICCS,INC,LABEL,MATERIALS,MDCT,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
154,169,2013,308,445,900,AFTER,COLORECTAL,COPYRIGHT,DIAGNOSTIC,IRELAND,LTD,LUNG,METHODS,OVARIAN,PLCO,SCREENING,TRIAL
150,169,2013,500,BACKGROUND,COPYRIGHT,EGFR,EPIDERMAL,ERLOTINIB,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
009,051,059,169,2013,COPYRIGHT,ERCC1,HOWEVER,III,IRELAND,LTD,NSCLC,TTP
160,169,2013,684,946,ALK,AXL,COPYRIGHT,EGFR,EML4,EMT,EPITHELIAL,FEDERATION,H2228,HSP90,PHENOTYPIC,PUBLISHED,SOCIETIES,TAE,TGF
169,2013,956,AMONG,BALB,COPYRIGHT,H460,IC50,LTD,MOLECULAR
169,2013,A549,AKT,BECLIN1,COPYRIGHT,GSH,LC3B,LTD,NELUMBO,PI3K,PREVIOUSLY,ROS,TAKEN
160,169,2013,ANG2,AUTHORS,CELL,COPYRIGHT,INC,NFAT,PUBLISHED,REPORTS
001,002,169,2007,2011,2012,241,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,DEPARTMENT,DICLE,ESPA,FDG,LABEL,MEDICAL,METHODS,PET,PORTUGUESA,PUBLISHED,RESULTS,SCLC,SEPTEMBER,SOCIEDADE,THERE,UNIVARIATE,UNIVERSITY
085,169,2013,8804,8805,C30,COPYRIGHT,DYSPNEA,EORTC,FIFTY,GRADE,HOWEVER,IRELAND,LABEL,LC13,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,QLQ,QOL,RESULTS,SBRT,SECONDARY
169,2013,956,AMPS,COPYRIGHT,IC50,LTD,MAP,MCF,RESULTS,SINCE,THESE
169,2013,A549,AMONG,BSA,COPYRIGHT,HEPG2,LTD
169,2004,2012,2013,ACC,AFTER,ATS,AUTOLOGOUS,BACKGROUND,CONCLUSION,COPYRIGHT,DAILY,DESPITE,LABEL,METHODS,NEOPLASMS,PRIMARY,RESULTS,SAS,SCC,THROUGH
102,169,2000,2010,2014,267,633,799,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS
021,046,101,118,151,160,169,177,188,2011,2012,2013,223,258,292,326,403,BACKGROUND,BETWEEN,COPYRIGHT,FURTHER,H2O,HOWEVER,INC,JULY,JUNE,LABEL,LOW,LUNG,METHODS,MIE,MINIMALLY,MOSBY,PUBLISHED,PULMONARY,RESULTS,SURGERY
0001,0022,0045,0436,169,177,2013,927,955,BACKGROUND,COPYRIGHT,FDG,IRELAND,LABEL,LTD,MASAOKA,MEAN,METHODS,PET,RESULTS,ROC,THERE,THUS
0183,124,150,169,200,2007,2008,2013,ADVERSE,AUTHORS,BACKGROUND,COMBINING,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,PLANNED,PUBLISHED,RESULTS,SECONDARY,SEPTEMBER,TASK
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY,THEREFORE
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
001,169,2013,3062,357,531,726,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LTD,METHODS,NOTABLY,RESULTS
001,006,013,048,111,169,2013,945,APOPTOTIC,COPYRIGHT,GMBH,NSCLC,OPN,PROLONGED,THERE,TNM,TUNEL
1670,169,1997,2009,2013,5855,CIS,EVER,HISTORY,JAPAN,ODDS,ORS,THESE
100,169,2013,956,ANP,BACKGROUND,CONCLUSION,ELISA,ERK,FOS,FOUNDATION,FOUR,JOHN,JOURNAL,JUN,LABEL,LANP,LTD,MATERIALS,MEK,METHODS,PUBLISHED,RAS,RESULTS,SOCIETY,SONS,STAT,STICHTING,THESE,WILEY
ALK,HGF,HOWEVER,MET,THERE,THESE
124,263,629,8805,BACKGROUND,D10,DATA,DEFF,DVHS,GRADE,LABEL,METHODS,MHD,MLD,NSCLC,NTCP,PARAMETERS,RESULTS,UNIVARIATE,V65
169,2013,49G,AKT1,CONCLUDING,JOHN,LTD,PROTEUS,PUBLISHED,SONS,WILEY
BACKGROUND,CONTEXT,DATA,DESPITE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,SEVERAL,SOURCES
954,AGGREGATES,CD20,CD68,CRYSTAL,FOCAL,LUNG,THESE
ALK,BIOMARKER,COLLEGE,CURRENT,EGFR,GUIDELINE,INHIBITORS,LUNG,MOLECULAR,PATHOLOGY,SELECTION,TESTING
169,2013,ALK,DRUG,EGFR,FOOD,INHIBITORS,KRAS,LADC,LADCS,RET,XL184
FURTHER,INSTITUTE,RESULTS,SHOWS
650,ALSO,BAX,BCL,FURTHER,INCREASING,ING4,LAD,SILENCING,THUS,UNIVARIATE
100,1539,8805,CHINA,CONCLUSION,DATA,HOWEVER,INDIVIDUAL,LABEL,METHODS,NMRD,OBJECTIVE,POISSON,RESULTS,SMOKERS,SMR,SMRS,THERE
007,040,2013,8202,LABEL,MAY,METHODS,NSCLC,OBJECTIVE,RESULTS,SOX2
141,659,ATP,HOWEVER,USING
156,211,426,487,557,560,576,603,667,763,77T,8202,ARG194TRP,ARG280HIS,ARG399GLN,CAUCASIANS,HENCE,T241M,XRCC1,XRCC3
001,138,31G,B3LYP,BACKGROUND,BASED,COMPOUNDS,CONCLUSION,EGFR,EPIDERMAL,FINALLY,INSTITUTE,LABEL,METHODS,MOST,NSCLC,RESULTS,T790M,THEREFORE,THESE,THUS
001,007,008,1995,1998,2948,945,946,BIOMARKERS,CHF,CKD,CTGF,FRAMINGHAM,HEART,KIM,NRI,PRIMARY,SECONDARY,TFF,WHETHER
339,410,480,514,OVERALL,SEVEN,THERE,THEREFORE,THR241MET,XRCC3
001,146,173,C47T,CAUCASIANS,EAST,LABEL,LUNG,SOD2,SUPEROXIDE,UNASSIGNED,UNLABELLED
004,011,178,8201,BMI,COX,HOWEVER,IGF,THERE,THEREFORE
5508,EARLY,ECOG,LABEL,NSCLC,OPINION,STATEMENT,UNASSIGNED
A549
169,2013,216,AACR,B16,LEWIS,LLC,PAI,SIMILARLY,THEN,THESE,VEGF
001,069,110,113,120,132,138,154,158,168,177,203,215,219,257,336,354,407,540,LABEL,METHODS,NEITHER,OBJECTIVE,OPERATION,OPERATIVE,RESULTS
B16,CONPS,F10,METAL
169,2013,AACR,H1299,H441,LABEL,LUNG,LY2801653,MET,NCI,NSCLC,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,SUSTAINED,THESE,TREATMENT
1978,2005,614,9280,AFTER,BACKGROUND,BRITAIN,CONCLUSION,GREAT,LABEL,METHODS,RESULTS,THERE,TOTAL,TRS
203,BACKGROUND,CTPA,HENCE,HOWEVER,INCIDENTAL,LABEL,METHODS,OTHER,OVERALL,RESULTS,SIXTY,SUBSEQUENT
106,133,164,2000,2010,BACKGROUND,CRP,KETTERING,LABEL,METHODS,MSKCC,RESULTS,SLOAN,TREATMENT,UNIVARIATE
177,8201,C30,EORTC,FATIGUE,LABEL,METHODS,MFIS,MULTIMODAL,OBJECTIVE,PURPOSE,QLQ,RESULTS,SCALE,TREATMENT
18F,FDG,PET
001,002,014,ANXIETY,ASSESSMENT,DEPRESSION,FACT,FUNCTIONAL,IMPROVING,INDEX,KNOWLEDGE,LABEL,LUNG,MAIN,METHODS,NURSING,OBJECTIVE,OBJECTIVES,PITTSBURGH,POOR,PSQI,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SETTING,SLEEP,TREATMENT,VARIABLES
AIM,CONCLUSION,EBUS,FORTY,LABEL,MATERIALS,METHODS,MHZ,OBJECTIVE,RESULTS
8804,8805,AIM,BACKGROUND,CHRONIC,CONCLUSION,COPD,FEV1,LABEL,MATERIALS,METHODS,OBJECTIVE,PSA,RESULTS,THERE
354,8197,ADULT,AFTER,BACKGROUND,BMJ,CHINA,CHINESE,DATA,GROUP,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,TOBACCO
021,046,425,ADC,ADCS,BRAF,EGFR,KIRSTEN,KRAS,MORPHOLOGY,RAF,THESE,TTF,TTF1
169,2013,30C,A549,BACKGROUND,BASEL,COMPARING,CONCLUSION,HOWEVER,LABEL,METHODS,MTA1,NSCLC,PCR,QRT,RESULTS,UTR
083,169,2009,2013,354,5MM,8804,8805,BACKGROUND,BASED,COPYRIGHT,FDG,IASLC,IRELAND,JANUARY,LABEL,LTD,LUNG,MARCH,MATERIALS,METHODS,MOST,PET,RESULTS
001,100,169,2013,8804,COPYRIGHT,EGFR,INC,KRAS,MOLECULAR,PATHOLOGY,PUBLISHED,RAF,SOCIETY,SOMATIC,T790M,THESE
169,176,2013,COPYRIGHT,ENDOGENOUS,INC,MOLECULAR,PATHOLOGY,PCR,PUBLISHED,SOCIETY,USING
169,2013,233,5MM,ATS,COPYRIGHT,DIPNECH,ERS,GMBH,IASLC,INSTITUTES,JENA,PATHOLOGY,THESE,UNIVERSITY
169,2013,7901,823,ADP,ANEMONE,AUTHORS,BAX,BCL,BESIDES,BGC,COPYRIGHT,HOWEVER,INC,KAZAL,MKN,MMP,PARP,PCR,PUBLISHED,RADDEANIN,RECK,REGEL,RHOC,SGC,TRANSWELL,WESTERN
169,2010,2013,COPYRIGHT,CTV,EORTC,FINALLY,GTV,ITV,PET,PUBLISHED,RUYSSCHER,SAS,TREATMENT
009,014,016,034,163,169,2014,311,ACUTE,AMERICANS,CARE,CAT,COPYRIGHT,DATA,FIM,INC,INVENTORY,LABEL,MAIN,MEASURE,METHODS,NEITHER,NRS,OBJECTIVE,OLDER,OUTCOME,PAC,PAIN,POST,PROS,PUBLISHED,RAND,RESULTS,SES,SETTING,TEST
169,2013,33258,945,A549,CELL,COPYRIGHT,DHA,H460,HEPG2,HOECHST,LTD,MTT,NCI,PUBLISHED,SKOV3
169,2013,256,BACKGROUND,CARLO,CCTA,CTP,DECT,INDIVIDUAL,LABEL,LAR,LARS,METHODS,MONTE,RESULTS,TOTAL
0001,004,009,043,050,117,1250,138,172,196,2008,2009,2012,2013,226,330,442,BACKGROUND,BOTLING,CONCLUSION,GAPDH,GLYCOLYSIS,LABEL,LEE,METHODS,NSCLC,OKAYAMA,PCR,PET,RESULTS,ROEPMAN,SHEDDEN,TPI1
169,194,2014,229,374,ACADEMY,CHOROIDAL,CILIARY,COPYRIGHT,CURRENT,DIAGNOSIS,INC,IRIS,LABEL,MAIN,METHODS,OBJECTIVE,OUTCOME,PUBLISHED,PURPOSE,RESULTS,THERE
CNS,HOWEVER
169,2002,2011,2013,438,BACKGROUND,COPYRIGHT,FINALLY,INC,LABEL,METHODS,PUBLISHED,RESULTS,SEPTEMBER,SOCIETY
001,169,2013,289,296,BACKGROUND,COPYRIGHT,FACTORS,INC,LABEL,LOS,METHODS,PREMIER,PUBLISHED,REGRESSION,RESULTS,SOCIETY
125,BACKGROUND,BASED,ECOG,LABEL,MANAGEMENT,METHODS,RESULTS,SCLC,SIADH,TEN,THESE
1985,2005,BACKGROUND,CANDU,CONCLUSION,COX,HOWEVER,LABEL,METHODS,ONTARIO,PICKERING,RESULTS,SIR,TRITIUM
FIRST,THEN,THESE
133,ABC,ABCG2,ALDH1,ATC,ATP,BACKGROUND,CD133,CSC,CSCS,CXCR4,GP1,HIGH,LABEL,LRP,METHODS,MRP1,OBJECTIVE,OCT4,PTC,RESULTS,SOX2,SOX9,THESE,THYROID
945,A549,CRUCIALLY,EGF,EGFR,ERK1,EXPRESSION,H460,HOWEVER,INHIBITION,NAV,NAV1,NSCLC,THUS,TTX,VARIOUS
A375,A549,AMONG,CCAAT,CHOP,DR5,HOWEVER,KNOCKDOWN,ROS,TAKEN,THUS,TRAIL
TEST,THERE,VIDEO
115,116,150,AFTER,BACKGROUND,EPIDERMAL,ERLOTINIB,HOWEVER,LABEL,METHODS,NSCLC,NSQ,PFS,PRIMARY,RESULTS,TKIS,UNASSIGNED
FIRST,FOUR,THERE
300,AFP,FOUR,HCC,PIVKA,UFT
2008,2010,BACKGROUND,BECAUSE,CASE,CEREBELLAR,CHEST,CONCLUSION,CYBERKNIFE,JULY,LABEL,MARCH,THEREFORE
2011,2012,EGFR,ERLOTINIB,GEFITINIB,MARCH,MAY,T790M
BECAUSE,RADIATION
150,38TH,3RD,4TH,ANXIETY,CBDCA,CDDP,CPT,IIIB,OCTOBER,SINCE,SSRI,XXXX
HDL,HIGH,LOW
8320,8321,8322,8325,CELLS,INHALABLE,LUNG,PULMONARY,RNS,ROS
169,176,2013,AMONG,ASSOCIATED,COPYRIGHT,CXCL8,CXCR4,DFS,FIGO,FOUR,FRESH,III,LTD,MIF,PUBLISHED,TAMS,VEGF
181,8201,AKT,BXPC,COMPOUNDS,ERK,FIGS,H1299,IC50,INHIBITORY,MTT,PFBR2,PFBR3,PFBR4

0001,001,112,169,2013,8804,967,CONCLUSION,FDG,LABEL,MATERIALS,METHODS,OBJECTIVE,PAIN,PEARSON,PET,PURPOSE,RESULTS,RSNA,SUV
AREAS,ATP,BACKGROUND,COVERED,DESPITE,EGFR,ERBB,LABEL,METHODS,NSCLC,OPINION,T790M,TKIS
1013,954,HOWEVER,IKK,IKKS,TANK,TBK1
HOWEVER,NONE,PULMONARY
000,012,014,100,921,III,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,RESULTS,UNASSIGNED,VIRTUAL
947,BACKGROUND,CONCLUSION,DMLC,LABEL,METHODS,ORGAN,RESULTS,SCANDIDOS,TRILOGY,VMAT
120,400,BR5,DDR2,DISCOIDIN,IC50,NMR,USING
AFTER,AIM,LABEL,LUNG,METHODS,NSCLC,RESULTS,ROS,T60V,UNLABELLED,WHAT
AIMS,COMPLIANCE,DATA,EGFR,ERLOTINIB,GRADE,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,THESE
B12,CIP1,CLINICALLY,HOWEVER,MTA,NSCLC,PEMETREXED,VB12,WAF1
AKT,ATP,CAV,CDC42,FAK,NOTABLY
000,0001,001,024,041,053,093,109,167,313,572,884,SCC,SCCE,STUDIES,THERE,THREE,UNIVARIATE
AMPA,DESPITE,GABA,GAD,MOST,NMDA,PNS,PNSS,SCLC,VGKC
0001,130,169,2013,BACKGROUND,FINDING,LABEL,METHODS,RESULTS,SOCIETY,SOSLC
169,2013,A549,BAD,BAX,BCL2,BIOLOGY,LOTUS,LUNG,MAPKS,MOLECULAR,NELUMBO,THESE,UNION
169,2013,8776,956,A549,AMONG,CO2,FUNCTIONAL,GMBH,HOWEVER,KGAA,MICROWELL,PDMS,PMMA,VCH,WILEY
946,EMT,GSK,SDH5,THESE,USING
0001,169,196,2013,481,719,ADDITIONAL,AFTER,BONFERRONI,CHRONIC,CIS,NADPH,NAPDH,NCF4,PLCO,SCREENING,SNPS,TRIAL,UICC,WHILE
039,100,200,233,686,847,LABEL,METHODS,OBJECTIVE,ONTARIO,PURPOSE,RADON,RESULTS,THERE
778,869,CAUCASIANS,CIS,HOWEVER,ORS,OVERALL,XRCC3
2013,2578C,460C,676,861,CAUCASIANS,CBM,CIS,CRUDE,HOWEVER,LIBRARY,MAY,ORS,SCC,SCIENCE,VEGF,WEB
8201,ASIAN,FURTHER,HOWEVER,OVERALL,PIN1,SNPS
169,2013,CXR,INC,LUNG,MORTALITY,NLST,RPTS,SCREENING,TRIAL,WHILE,WILEY
310,AFTER,ALOKA,AMCO,ANATOMICAL,BACKGROUND,BECAUSE,BICLAMP,ENDO,ERBE,ETHICON,GERMANY,HITACHI,INC,JAPAN,LABEL,LAP,LTD,METHODS,OLYMPUS,RESULTS,SURGERY,TOKYO,TUEBINGEN,VII,VIII,VIO300D
001,103,122,159,274,8805,BACKGROUND,CALGB,CONCLUSION,COX,EORTC,III,LABEL,METHODS,MPM,NLR,RESULTS,UNIVARIATE
174,239,8482,ASIAN,BOEHRINGER,COMMITTEE,EGFR,ERBB,FDA,GIOTRIF,HER3,HER4,INGELHEIM,JAPAN,L858R,MEDICINAL,MEDICINES,NSCLC,ORAL
0001,0016,0104,0127,019,0414,0425,047,37C,473,581,967,COX,EGFR,ERCC1,MECHANISM,NSCLC,PBLS,PCR,RFLP,RRM1,SNPS,THERE
160,181,64258,ANNEXIN,CBF,DATA,H460,IC50,K16,LDH,LEWIS,LYS16,TEM,THESE
001,1518,288,5000,552,AFTER,ASIAN,IMRT,PTV,SWT,TANGENTIAL,V20,WBRT
001,2008,2009,258,818,8201,BACKGROUND,CONTINUED,GAMMA,GKS,IMAGING,JANUARY,KNIFE,LABEL,MEDICAL,METHODS,RESULTS,SEIZURE
169,2013,AACR,EMT,F191G,FINALLY,HOXA9,LABEL,STRUCTURE,TARGETING,THEREFORE,THESE,TWIST,UNLABELLED
169,2013,AACR,ATLAS,CXCR4,DEPLETION,DUE,INSPECTION,LABEL,MAPK,RCC,RNAI,SIMILARLY,TAKEN,TCGA,TPL2,UNLABELLED
0001,006,011,114,124,161,177,8805,FORTY,LABEL,MAJOR,METHODS,OBJECTIVE,PREDICTED,RESULTS
E2F,LENTIVIRAL
146A,146B,CDH4,EPIGENETIC,FINALLY,HOWEVER,RUNX3,SLIT3,THESE,UHRF1,UTR
ACCORDING,LIMITED,PCI,SCLC,SMALL,WHEREAS
2007,2009,BACKGROUND,BECAUSE,GRADE,HOWEVER,IIIA,JUNE,LABEL,METHODS,MOST,ORRS,PCB,PRIMARY,RESULTS,THERE
8764,BACKGROUND,BAYES,BIRF,COLON,CONCLUSION,FEATURE,ITERATIVE,LABEL,LUNG,MACHINE,MSVM,MULTI,NAIVE,NCI,RECURSIVE,RESULTS,RFE,SUPPORT,SVM
2005,2010,APRIL,DESPITE,JANUARY,NSCLC,THESE
169,2013,237,341,AFTER,AMONG,BAMB,COPYRIGHT,ECTOPIC,EPPC,H1299,IC50,INC,INSP3,ITPKA,MEPTT,TAKEN,THUS
0091,180,3P22,BACKGROUND,CKLF,CMTM7,COX,LABEL,METHODS,NSCLC,RESULTS,TSG,UNIVARIATE,WESTERN
169,2013,COPYRIGHT,DIFFERENT,HOWEVER,INHIBITION,IRELAND,ITGB3,LTD,MICRORNAS,NSCLC,TNM,UPON
169,2013,22YEARS,COPYRIGHT,IRELAND,LTD,P53,PMS2,R20Q,SEQUENCING,THESE,V157D
169,2013,AUSTRALIAN
1170,169,2013,362,3691,454,753,950,AIM,ALT,AST,BRITISH,DESPITE,III,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,TKIS
ALK,EGFR,KRAS,LUNG,NGS
174,AEROSOL,FINALLY,LUNG,UNTIL,USA
AKT,EMT,FINALLY,IFS,THERE
100,2007,BETWEEN,DOPPLER,FOUR,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER
486,IGF,IGF1,IGF1R,MICRORNAS,RNAS
169,2013,AACR,KEAP1,NRF2,NVP,PI3K
2002,242,250,251,252,344,395,503,8804,ADVERSE,CONCLUSION,DFS,EGFR,III,IIIA,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERIOUS,SIMILARLY
001,105,110,122,140,2001,2006,268,331,380,AICHI,APRIL,CEA,COX,EGFR,FIVE,III,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS
022,023,029,313,728,8201,CAUCASIANS,CIS,G463A,MPO,ORS,OVERALL,SIMILAR,STRATIFIED,WANFANG
000,169,2013,956,AACR,DEVELOPING,EGF,EGFR,ERK,ERK1,HOWEVER,IEF,MEK,MEK1,MEK2,NANOPRO,NSCLC,WESTERN
ARPE,BCRP,HCEC,ICB,LRP,MDR1,MRP1,MRP6,MRP7,WESTERN
001,004,AFTER,BACKGROUND,ELISA,ILK,LABEL,MEAN,METHODS,NSCLC,OBJECTIVE,RESULTS,SERUM
001,003,032,036,620,ALSO,AS1,CHINA,GAS6,LUNG,NSCLC,PEARSON,RNAS,UNIVARIATE
522,6XA,6XC,6YB,6YC,6YE,6ZA,6ZC,6ZE,7XA,7XD,7YD,7YE,7ZA,7ZC,7ZD,7ZE,COMPOUNDS,HCT,HEPG,NCL
BAMH1,BARR,BARTS,EBV,EPSTEIN,NPC,REPORTS,RNAS,STUDIES,THESE
BECAUSE,CASP3,CASP7,CASPASE,PPI,THESE,XIAP
1978,2002,2010,515,810,CIS,CROHN,DENMARK,HODGKIN,IBD,JUTLAND,LABEL,METHODS,NORTH,OBJECTIVE,OBJECTIVES,POPULATION,RESULTS,SIR,SIRS
065
169,2013,PUBLISHED,SFT,SFTS,SOCIETY
1278,131,133,169,177,2013,791,BACKGROUND,CIGARETTE,HOWEVER,HRCT,ILD,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY
015,046,0ML,101,115,127,15NG,169,190,2013,5NG,8ML,BACKGROUND,FEV1,FVC,HOWEVER,LABEL,LAM,LOW,METHODS,PUBLISHED,RESULTS,SIROLIMUS,SOCIETY,THESE
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,WHILE
1146,1172,169,1736,1771,2013,362,405,411,491,583,5886,7065,7889,909,9532,BOS,HORN,KANKREJ,NUCLEOTIDE,PCR,REAL,SCC,SNP,SNPS,TIME,VALIDATION
169,2013,HOWEVER,JNK,PREVIOUSLY,SP1,SP3,THESE,TMPRSS4
204,215,688,CNTNAP1,COX,FAM156A,FRMD8,GALNTL1,LUNG,SEQ,SNTB1,SNX10,TEN,THESE,TXNDC12
8320,8325,956,BIOSPIN,COMBRETUM,COMPOUNDS,ESIMS,H460,MRSA,NCI,TCI,THEIR,UTI89
REGULATION
1008,ABOUT,AUC,BACKGROUND,HENCE,IGHG1,IGHG3,LABEL,MEG3,NINE,PDIA6,PRINCIPAL,RESULTS,SDCCAG3,SEQUENCING,TAA,TAAS
038,2013,261,315,435,550,619,726,781,986,APRIL,ASIAN,ASN,ASP,ASP312ASN,ASSESSMENT,BACKGROUND,CAUCASIAN,DATABASES,HOWEVER,LABEL,LYS751GLN,MEDLINE,METHODS,NEWCASTLE,NSCLC,QUALITY,RESULTS,THESE,XPD
945,CRGDK,H460,HOWEVER,MEANWHILE,RGD,RGPD,THUS
005,007,010,016,017,027,036,038,043,1017,242,BCL,BCL2,CHINESE,CONCLUSION,IIIA,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THREE,UTR
581,BAP1,BRCA,THERE,TRUNCATING,WHOLE
102,16HBE,BACKGROUND,BOTH,HOWEVER,LABEL,LSCC,METHODS,NBE,RESULTS,WESTERN
BAC,BACKGROUND,BAG1,COX,GINS3,LABEL,LUNG,MEIER,METHODS,MSP,MTS,PCR,PFS,RESULTS,S100P,SIX3,TGFB3,WOUND
ALU,AML,BACKGROUND,EXPRESSED,LABEL,MEASURING,NSCL,RESULTS,THESE
1980,2035,BACKGROUND,COAL,ENGLISH,HILL,HOWEVER,INCIDENCE,LABEL,METHODS,OVERALL,RESULTS,WHILE
A549,H441,H520,HOWEVER,INHIBITION,KRAS,MDK,MIDKINE,NHLF,PI3K,PTN,THEREFORE,VEGF
200,CURRENTLY,EXPRESSION,HIGH,LNCRNAS,MALIGNANT,MPM,NCODE,PLEURAL,RNAS,ROC,THESE
947,A549,AKT,BACKGROUND,DSBS,EGFR,FINDING,H2AX,IGG1,LABEL,LUNG,MCF,PI3K,PKCS,PRINCIPAL,RESULTS,WESTERN

HLA,KIRSTEN,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,THERE
363,945,BOTH,GASTRIC,III,KATO,MBP,MICRORNAS,MYC,SNU,TAKEN
AKT,CONVERSELY,EMT,ERBB2,ERK,FGFR,HER2,MMTV,NEU,SLUG,SNAIL,THESE
EVALUATION,MALIGNANT,MPM,PCR,TERT,THEN
245,8201,ATF4,CRE,H157,HOWEVER,III,LTE,NCI,THESE,TNM
160,8805,ADULT,ADVERSE,CONCLUSION,LABEL,METHODS,MPD,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,SIXTY
0001,0005,100,141,158,177,198,215,956,BACKGROUND,FIBROBLAST,LABEL,MATERIALS,METHODS,RESULTS
160,AMONG,BESIDES,BUN,FORTY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SELDINGER
160,8805,GRADE,III,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SECONDARY
160,4T1,980,BALB,NIR,SWNT,SWNTS
IMAGING
001,178,2005,2010,255,967,EACH,EOC,III,JANUARY,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
956,A549,BAX,CCND1,FASL,GAPDH,HALLMARKS,IC50,MCL1,MYC,PCR,THESE
011,119,181,2010,229,233,336,531,538,795,917,ACCORDING,BETWEEN,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
18G,1970S,21G,5MM,CURRENTLY
947,ALA,ASP,CD133,CD4,CSC,DDX3X,DEAD,GLU,IFN,SINCE,THESE
222,A549,H358,HOWEVER,METFORMIN,MIR,NCI,PTEN,THEREFORE
002,028,134,AMONG,ATS,BACKGROUND,EGFR,ERS,IASLC,L858R,LABEL,LUNG,METHODS,PFS,RESULTS,SOCIETY,TKI,TKIS
169,2013,4T1,A549,ANTI,BSA,BXPC3,COPYRIGHT,DYNABEADS,EPCAM,EXFOLIATED,INC,MBS,PBS
IMT,IMTS,ORIGINALLY
169,2013,212,COPYRIGHT,LTD,TAKEN
169,2013,COPYRIGHT,FAK,FOLLOWING,INC,STRIKINGLY
169,2013,A549,COPYRIGHT,EVEN,HOWEVER,INC,USING
169,177,2013,240,A549,BOTH,CNGS,COPYRIGHT,DLS,DOX,DRUG,DTA,FTIR,NSCLC,PCL,SEM,THESE
169,2013,6PGD,COPYRIGHT,INC,MET,PPP,THEREFORE
001,106,126,134,137,160,169,2006,2009,2013,218,271,298,300,841,8804,946,BEV,CARBO,COPYRIGHT,COX,IRELAND,LTD,MEIER,NSCLC,PAC,PEM,PFS,PLAT,THREE
001,004,169,1999,2012,2013,215,8805,BESIDES,CONCLUSION,COPYRIGHT,FACTORS,FAVORABLE,HOWEVER,IRELAND,JULY,LABEL,LOCATIONS,LTD,MATERIALS,METASTATIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PFS,PTV,RADICAL,RESULTS,SAFP,SEPTEMBER,TREATMENT
005,169,2013,215,AMONG,BCL2,BIRC5,BRCA1,CASP8,COPYRIGHT,ERCC2,FOUR,IRELAND,LTD,NSCLC,SEVENTY,SNPS,THREE,XRCC1
169,2013,21G,A549,COPYRIGHT,EGFR,LTD,MOST
169,190,2013,2947,8805,COPYRIGHT,EGFR,ERBB2,HIGH,INC,MASSIVE,MOLECULAR,MPS,PATHOLOGY,PUBLISHED,SOCIETY,USING
13R,160,169,2013,945,946,AKT,AUTHORS,COPYRIGHT,HOWEVER,INC,MEMBERS,PUBLISHED,TGF,THUS,WNT
160,169,2010,2012,2013,205,ALK,APRIL,BACKGROUND,COPYRIGHT,EBUS,EGFR,FISH,INC,KIRSTEN,KRAS,LABEL,MARCH,METHODS,MOLECULAR,PUBLISHED,RESULTS,SOCIETY,TBNA
169,183,2010,2013,COPYRIGHT,LTD,LUNG,PREVENTION,SCREENING,THESE,TRIAL
169,2013,AXL,COPYRIGHT,CROSSTALK,EGFR,LTD,MED12,NON,THR790MET
169,2013,COPYRIGHT,FINALLY,LTD,NON,THEREFORE
169,2013,CARDIAC,COPYRIGHT,HOWEVER,MOST,POTENTIAL,PUBLISHED,SAS,V20,V30
169,2013,945,946,A549,AG490,AG658,AKT,COPYRIGHT,CYTOKINES,DR4,DR5,FDA,IGF,INCREASED,INHIBITION,INSTEAD,JANUS,LTD,PI3K,SINCE,SIRT1,TGF,TNF,TRAIL
169,2013,5TH,AUTHORS,BASIC,BHGI,COPYRIGHT,INITIATIVE,LMICS,LTD,PUBLISHED,REGULAR,THESE,WHILE
169,200,2013,300,8805,AUTHORS,BACKGROUND,COPYRIGHT,EGFR,FLEX,HRS,IHC,III,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,THESE
1000,169,2013,ARCHIVE,ATLAS,BLOOD,COPYRIGHT,EXOME,GENOMES,HEART,HOWEVER,INSTITUTE,LARGE,LTD,LUNG,NHLBI,PROJECT,READS,SEQUENCING,TCGA,THERE,THESE
CRICK,KRAS2,PNA,PNAS,USING
EBUS,PET,ROSE
000,001,007,015,064,091,111,122,133,137,143,160,161,163,184,187,2013,261,399,429,475,543,649,705,732,739,798,850,982,986,BIOMEDICAL,CAUCASIANS,CBM,CHINESE,CONCLUSION,LABEL,LITERATURE,MATERIALS,MAY,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,OGG1,OVERALL,RESULTS,SCIENCE,SER326CYS,SIMILARLY,UNASSIGNED,VIRTUAL,WEB
231,BACKGROUND,HER2,IDC,IMAGING,IVIS,LABEL,MDA,METHODS,MSP,PCR,PKD1,PRE,PRKD1,RESULTS,USING,VIVO
018,026,046,COMMITTEE,CONTROL,HISTOLOGIC,JOINT,LUNG,SOCIETY,THERE,TNM,UNION
087,BLAND,COMPARISON,CONCLUSION,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PACS,PERCENTAGE,RESULTS,SOLID
1099,5082,877,AFTER,AMONG,CONCLUSION,FOV,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
EARLY,FOUR
231,4T1,945,946,954,CSC,CSCS,ERBB2,HCC1806,HMGB1,MCF7,MDA,SMAD3,STAT3,TGF,THEREFORE,THESE,TLR2,TOLL,TUBO
1989,2012,237,4721,AIDS,CD4,DEPARTMENT,FORTY,HIV,JANUARY,JUNE,PNEUMOLOGY,SPAIN
169,2013,AACR,FOUR,RSK,RSKS
A549,AFTER,FINALLY,MAGOH,RBM8A,THESE,Y14
0003,0007,0161,0324,098,169,1995,2007,2013,202,210,239,408,765,8201,8804,AUTHORS,CMT,DATA,DEE,IIA,INC,JOURNAL,PUBLISHED,STAGE,WILEY
005,008,015,177,665,946,ETT,FEDERATION,FIGO,FINALLY,GYNECOLOGY,LABEL,LUNG,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OBSTETRICS,RESULTS,THESE,WOMEN
51E1,ACS,H720,H727,LCS,NCI,OCTREOSCAN,PCR,SSTR,SSTR2,SSTR3,SSTR5,SSTRS,TCS,THEREFORE
169,2004,2010,2013,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,LABEL,MATERIALS,METASTATIC,METHODS,RESULTS,THERE,TOXICITIES
002,066,187,531,CCGG,EPIGENETIC,EZH2,MEIER,NSCLC,PCNA
160,4T1,945,BALB,CHRYSIN,CURRENT,DAILY,DR5,HIF,IMMUNOBLOT,PCR,STAT3,THAI,TRAIL,VEGF
CTCS,DETECTION
1996,2006,802,BACKGROUND,DESPITE,EDINBURGH,FURTHER,INFIRMARY,LABEL,METHODS,PET,RESULTS,ROUTINE,ROYAL
169,2013,CBCT,COPYRIGHT,DEFORMABLE,DICE,DSC,GERMANY,GMBH,NORMALIZED,PUBLISHED,THESE,THREE
001,169,2013,24H,945,AUC,DEPRESSION,HPA,INCREASING,ROC,THESE,TNF,VAR
167,169,2004,2009,2013,239,478,735,774,AMONG,BACKGROUND,COPYRIGHT,DISEASE,INC,LABEL,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SOCIETY,THEIR,THERE,VATS
160,169,2004,2009,2013,BACKGROUND,BETWEEN,COPYRIGHT,FORTY,INC,JANUARY,LABEL,METHODS,NEITHER,PUBLISHED,RESULTS,SOCIETY
231,AAD,ANNEXIN,BAK,BAX,BCL,DBD,H1373,HELA,MBD,MCF,MDA,MDM2,MTS,PRD,T47D,TAKEN,TMRE,TUNEL,UPON,WHILE
3066,8201,8805,BACKGROUND,CONCLUSION,DUE,FURTHER,INDIVIDUAL,LABEL,METHODS,MPC,RESULTS
2005,2010,AIM,BACKGROUND,CONCLUSION,DATA,FACTORS,GREENLAND,LABEL,METHODS,OBJECTIVE,PREVENTION,RESULTS,SERIOUS,SMOKERS,SMOKING
398,ANTI,COX,DRUGS,FCA,FLUX,FOUR,NON,NSAID,PARTICULAR,PETRI,STEROIDAL,THEREFORE
E2F,EZH2,PRC2,SCLC,SMALL,THROUGH
000,001,033,042,069,178,2012,403,442,656,8202,BMI,CIS,EGGER,HOWEVER,HRT,LIBRARY,MAY,ORS
A549,C57BL,CCL12,CCL2,LLC,MC38,MOUSE,MPE,MPES,THESE,USING
947,ATPASES,NHES
169,2013,29A,335,AACR,BECAUSE,EXPRESSION,IGF,LABEL,RANK,RANKL,SBC,SCLC,SMALL,THESE,UNLABELLED
002,1279,196,368,BACKGROUND,BMI,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SEX
100,1000,128,1771,1993,2010,400,779,800,8805,956,AMONG,BACKGROUND,CALCIUM,COX,HOWEVER,HRS,INITIATIVE,LABEL,LOWER,METHODS,OBJECTIVE,OBJECTIVES,PRIOR,RESULTS,TRIAL,VITAMIN,WOMEN
BACKGROUND,BECAUSE,CONCLUSION,IMT,IMTS,LABEL,LEFT,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SIX,THERE,THREE
169,2014,A549,BAF,BCL,GMBH,HOWEVER,KGAA,LUC,MDR,PDMA,PDPA,PTX,RNAI,VCH,WILEY
169,2013,945,946,AACR,RCC,SLUG,STS
169,2013,AACR,CONSISTENT,EGF,EGFR,FAN1,FANCONI,HOWEVER,HRR,ICL,ICLS,PARP,RAD51
E2F1,FOXO,FOXO1,FOXO3,HDAC,NOTABLY,PI3K,RNAI
AFTER,BACKGROUND,BIOMEDICAL,CHALLENGE,DIAGNOSTIC,EXPRESSION,FIFTY,LABEL,MOTIVATION,OMNIBUS,RESULTS,SIGNATURE,TEAMS
120,945,956,A549,BCL,CHINESE,FLOW,GANODERMA,GLK,IC50,KARST,LEWIS,LEYSS,TNF
169,2013,AACR,ATG7,AUTOPHAGIC,AUTOPHAGY,BRAFV600E,LABEL,NRF2,TRP53,UNLABELLED
CHINA,KIT,SCLC,STUDIES,T801I,THERE
A549,CLINICALLY,H19,H3K9ME3,MINERAL,SILENCING,TAKEN
215,HOWEVER,THEREFORE
176,A549,AL2O3,CELL,FIT,FNTD,FNTDS
169,2013,AFTER,DLT,INC,LUNG,WHILE
8320,8325,956,A549,FOUR
1394,183,193,1958,2009,203,559,AMONG,BACKGROUND,DISCUSSION,LABEL,MEDICAL,METHODS,RESULTS,SCR,SRPC,SWEDISH
HOWEVER
200,250,945,947,956,CELL,CFSS,CSFS,IFN,NMMA,NOTABLY,PBMCS,PERIPHERAL,SEA,SEG,SEI,SELM,SELN,SELO,THUS,TNF
946,AFTER,EMA,HOWEVER,PRIMARY,RFA,SEVEN,SIX
INHIBITION,VEGF
WIEDEMANN
123,BAP1,BRCA1,FURTHER,MPM
0001,001,0015,1A1,500,76A,946,956,AIN,AKT,ALDEFLUOR,ALDH,ALDH1A1,ESCIN,H460,LUNG,NNK,RHOA,ROCK,THREE
183,400,500,8805,AUC,BEST,CDD,DOSE,GRADE,LABEL,METHODS,MTD,NSCLC,OBJECTIVE,OBJECTIVES,PEMETREXED,RESULTS,SUNITINIB
CURRENT,PRIMARY,TCM
169,2013,8201,956,ADP,AKT,BAD,BAX,BCL,BCL2,CELL,COPYRIGHT,FADDR,FAS,IGF,IGF1,IGF1R,JOHN,LTD,NIMBOLIDE,PARP,PI3K,SONS,WILEY,XIAP
2010,469,8804,956,BEAS,CELLS,DEG,IARC,NAVO3,WHILE
948,AKT,CCAAT,EBP,ERK,ERK1,EXPRESSION,HOWEVER,JAK2,LEP,LOSS,MAPK,MEK,NRF,PI3K,PTEN,STAT3,THUS
150,169,2013,250,8805,AACR,AMENDMENT,EGF,EGFR,LABORATORY,OVERALL,THERE,THEREFORE,TKI,TTF
191,BACKGROUND,CONCLUSION,ENROLMENT,FOLLOWING,FOUR,HRQOL,III,LABEL,METHODS,NORWEGIAN,RESULTS
175,AMONG,BACKGROUND,CONCLUSION,DLT,DLTS,EVEROLIMUS,LABEL,METHODS,RESULTS,SCLC
001,002,032,112,666,BACKGROUND,CONCLUSION,DFS,DSS,FIB,LABEL,METHODS,MVD,RESULTS,VEGF,WBC
169,2013,AIMS,COLLEGE,CONCLUSION,COPYRIGHT,FINALLY,INCREMENTS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PEARSON,PREDICTED,PUBLISHED,RCT,RCTS,RESULTS,ROYAL,SCATTER,SEVERAL,TOTAL
AKT,EGFR,FURTHER,HGF,MET,MRC,PF02341066,PI3K,THEREFORE
953,ATM,BLOOD,FIFTEEN,MTD,PKC,PROTEIN,SIX,THERE
AKT,BECN1,GSCS,LC3,MTOR,SAHA,TAKEN,USING
169,2013,946,ACC,ADENOID,CONCLUSION,COPYRIGHT,EMT,EXPRESSION,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PCR,RESULTS,RIIDN,SACC,SMAD,SMAD2,TGF
169,2013,A549,CTC,CTCS,H446,HIGH,HOWEVER,MES
111IN,A549,CMV,DOTAP,GAMMA,IRES,MICE,NSCLC,SPECT,SSTR2,TUSC2,WESTERN
169,2013,COPYRIGHT,GPC5,IRELAND,LTD,NSCLC,TMA
169,2013,945,954,AKT,CHINESE,COPYRIGHT,CXCR4,HER2,HIF,IRELAND,LTD,POLYGONAM,RHEUM,STAT3
169,2013,CARLO,FINALLY,GORFINE,HOEFFDING,KENDALL,MONTE,PEARSON,PRESS,PUBLISHED,SYSTEMATIC,UNIVERSITY
169,2005,2013,2218,413,4650,6868,BACKGROUND,CONCLUSION,COPYRIGHT,COSTS,DESPITE,DIAGNOSTIC,IRELAND,LABEL,LTD,METHODS,NON,OBJECTIVE,RESULTS
169,2013,211H,AD35,AD5,CAR,CD46,H2052,HOWEVER,MSTO,NCI,ONCOLYTIC
169,2013,A549,JAK,LU65,LUNG,NSCLC,PC9,SOCS,STAT,STAT3,THESE
AFP,BACKGROUND,BUN,CONCLUSION,CONTROL,DOX,ERK,HCC,HEMATOLOGY,LABEL,METHODS,PDOX,PLT,RESULTS,SERUM,WBC
120,169,1991,2009,2010,2012,2013,710,800,8201,AIHW,AIMS,ASIA,AUSTRALIA,AUSTRALIAN,CONCLUSION,INDIGENOUS,INSTITUTE,LABEL,LTD,LUNG,METHODS,OBJECTIVE,PTY,PUBLISHING,REGISTRIES,RESULTS,WELFARE,WILEY
1998,2007,2009,280,AFTER,CALIFORNIA,CONCLUSION,COX,FOREIGN,HISPANICS,LABEL,MEIER,METHODS,NHWS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
ATP,CDC42,FRAX597,GROUP,HIGH,KNOCKDOWN,NF2,PAK,PAK1,PAK2,PAKS,RAC,RNAI,THESE
000,CPS,HOWEVER,LPEI,PEGYLATED
169,2013,DUE,INC,MALIGNANT,THEREFORE,WILEY
001,009,195,305,BOTH,CHRONIC,CONCLUSION,FIFTY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SIXTEEN,THERE,UNASSIGNED
169,2013,8201,A549,GMBH,IC50,KGAA,VCH,WILEY
169,2013,ADP,BCL,MICROARRAY,NOXA,PIAS3,PROTEIN,STAT3,THUS,UICC
002,6P21,767,8201,8211,8722,890,CAUCASIANS,SIMILAR,SINCE
136,945,A549,B55,ERK1,FURTHER,HOWEVER,MICRORNAS,NSCLC,PPP2R2A
A549,CTGF,FURTHER,HBE,HIPPO,HOWEVER,KNOCKDOWN,NSCLC,WWTR1
ENGLISH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RTK,SCC
ATG7,FAO,G12D,GEMMS,KRAS,NSCLC,TRP53,USING
CD133,EPCAM,EXPRESSION,HOWEVER,LCSC,LCSCS,LUNG,SINCE,SSEA,THEN
140,169,183,2013,8764,A549,ACTA,COPYRIGHT,DLC,DOX,GLU,HCL,INC,LTD,MATERIALIA,MAXIMUM,MTD,PEG,PHE,PUBLISHED
AIM,CD117,CD5,CONCLUSION,FORTY,LABEL,METHODS,NONE,OBJECTIVE,PAX,POSITIVITY,RESULTS
102,109,817,854,920,933,934,BACKGROUND,CK20,CK7,GATA,LABEL,MCBO,METHODS,PLC,RESULTS,TTF
169,2013,COPYRIGHT,HOWEVER,LTD,MCF
BARR,CHINESE,EBV,EPSTEIN,EXTRANODAL,HOWEVER,LABEL,PGK,PRIMARY,TCR,UNASSIGNED,UNLABELLED,VIRTUAL
464,ALONGSIDE,BACKGROUND,CELSIUS,CHERNOBYL,FIFTY,FOLLICULAR,FOUR,INCREASING,LABEL,MEDULLARY,METHODS,RESULTS,SEVEN,SURGERY
001,003,004,009,010,011,022,275,698,699,8804,8805,HIGH,HOWEVER,NSCLC,THUS,UNIVARIATE
100,169,175,2013,220,8805,BACKGROUND,BMI,CONCURRENT,COPYRIGHT,CTX,ESPAT,IIIA,IIIB,INDUCTION,IRELAND,LABEL,LTD,LTS,METHODS,NOS,NSCLC,PUBLISHED,RESULTS,RTX,SURGERY
215,LCNEC
SCC
8201,AFTER,FOLFIRI,FOUR,FURTHER,HAIC,HOWEVER
169,2013,ADP,ASIA,AUTHORS,BECAUSE,EMBRYONIC,INVASIONS,LTD,NOTABLY,PARP,PATHOLOGY,PTY,PUBLISHING,SINCE,SOCIETY,TGCS,WILEY
AMONG,BACKGROUND,CBP,DCRT,DLT,HOWEVER,III,LABEL,METHODS,MTD,NSCLC,NVB,PREVIOUSLY,RESULTS,THEREFORE
177,951,954,956,A2780,BF4,IC50,MEG,MRC,NMR,OH2,PF6,PO3,RUCL,THEN,WHAT
0001,0296,2008,2012,AAA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SBRT,SEVENTY
006,101,190,2003,2004,2010,319,435,BACKGROUND,BETWEEN,CON,CONCURRENT,CRT,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,SEQ
006,103,947,BACKGROUND,CONCLUSION,D50,INDIVIDUAL,LABEL,METHODS,QUANTEC,RESULTS
0001,177,2003,CONCLUSION,CTV,CTVS,DBCG,ECLIPSE,ESTIMATED,ESTIMATES,FIELD,FIVE,GROUP,IMN,IMNS,LABEL,METHODS,OAR,OARS,OVERALL,POST,RESULTS,UNLABELLED
BACKGROUND,CONCLUSION,EXHALED,LABEL,METHODS,RESULTS
0004,002,BACKGROUND,BASED,COMPARISON,CONCLUSION,DIBH,EIG,LABEL,METHODS,RESULTS,SEVENTEEN,THESE,TREATMENT,V20
177,8805,BACKGROUND,DEFORMABLE,HOUNSFIELD,INDIVIDUAL,LABEL,METHODS,OBJECTIVE,RADIATION,RESULTS,RILD
0001,104,AMONG,ANCA,BACKGROUND,C1Q,ECS,HOWEVER,HSP,IGA,LABEL,METHODS,MGN,OTHER,RESULTS,SCHOENLEIN,SINCE,SLE,TRI,TRIS
124,131,8727,A750,DIFFERENT,E746,EGFR,H1299,HOWEVER,IPQA,L858R,MORPHOLINO,MUTATIONS,NSCLC,PET,USING
HOWEVER,SCENT,STUDIES
001,013,1458,1700,2001,2008,2612,2916,4312,AFTER,AGE,BASED,CHINA,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THREE,VATS
LMPM,MALIGNANT,MPM
002,178,4336,8804,8805,AMONG,BACKGROUND,COX,LABEL,METHODS,RESULTS
DAH,DIFFUSE
121,CD3,CD4,CD56,CD8,CIK,HCC,THUS
2007,2010,AIM,BACKGROUND,CONCLUSION,DATA,FIVE,FURTHER,IRELAND,LABEL,LINCOLN,METHODS,NCR,OBJECTIVE,REGISTRIES,RESULTS
002,015,018,0201,166,181,2000,2008,8804,962,ADC,CIR,CUMULATIVE,GROUP,JAPAN,KETTERING,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SLOAN,T1AN0M0
CD11C,DCS,HIRSCHHORN,INDUCTION,KNOCKDOWN,TADC,TADCS,THESE,TWIST,WHSC1,WOLF
945,956,A549,ANACARDIC,BECAUSE,BECLIN1,BIP,CHOP,GADD153,GFP,GRP78,HOWEVER,IRE1,LC3,PERK,TEM,UPR
011,100,ASIR,CONCLUSION,ITERATIVE,LABEL,METHODS,OBJECTIVE,RESULTS,SOLID
001,007,008,122,132,137,139,160,8201,ALK,FISH,IHC,NSCLC,OPTIMISED,PCR
129X1,953,C57BL,CRICK,DISRUPTION,NOTABLY,PAR2,POL,SVJ
AKT,ALANINE,HOWEVER,MANS,PI3K,RICH,SLUG,SUBSTRATE,THESE
160,169,2013,ANG2,AUTHORS,COPYRIGHT,DSCR1,FURTHER,HOWEVER,INC,INCREASED,NFAT,PUBLISHED,TIE2,VEGF
169,170,200,2013,BESIDES,COPYRIGHT,H460,NCI,PASN
169,2013,945,946,947,ABSENCE,BRONCHIAL,COPD,ELISA,INC,MDA,OXIDATIVE,REGARDLESS,STUDIES,TGF,TNF,VEGF
169,2013,A549,H1299,H460,TEROXIRONE
169,2013,COPYRIGHT,ECTOPIC,FEDERATION,HDGF,MICRORNAS,NSCLC,PUBLISHED,SOCIETIES
169,2013,APEX1,COPYRIGHT,CPG,FEDERATION,GUANINE,OGG1,PUBLISHED,S326C,SOCIETIES
026,044,169,2013,904,945,ATRX,COPYRIGHT,DAXX,HOWEVER,INC,MEN1,THESE,WORLD
169,2013,COPYRIGHT,FGF23,INC,MCT,MCTS,PMT,TEN
169,2013,AIDS,CASES,CONCLUSION,COPYRIGHT,GGA,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,THERE
100,115,163,169,2013,338,453,981,BACKGROUND,COPYRIGHT,EBUS,INC,LABEL,LYMPH,METHODS,PUBLISHED,RESULTS,SOCIETY,SYSTEMATIC,TBNA,THERE
160,169,177,178,2007,2012,2013,BACKGROUND,COPYRIGHT,FINAL,FOUR,GRAFT,INC,LABEL,MEAN,METHODS,MOSBY,NSCLC,OVERALL,PUBLISHED,RESULTS,SURGERY,THERE,THREE
044,060,104,109,2008,2009,8201,BACKGROUND,CHI,FEW,LABEL,LUNG,METHODS,RESULTS
0001,001,133,169,2013,8805,COPYRIGHT,CROWN,CYBERKNIFE,HISTOLOGY,INC,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SBRT,THERE
169,2013,ATF1,CLEAR,COPYRIGHT,CREB1,EWS,EWSR1,GMBH,SEVERAL,SINCE,THERE,THESE
169,2013,ACCORDING,COPYRIGHT,IRELAND,LARGE,LCNEC,LTD,THERE
001,100,169,2003,2012,2013,8805,BACKGROUND,CONCLUSION,COPYRIGHT,EARLY,HRF,HRFS,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PREVIOUSLY,PURPOSE,RESULTS,SABR
000,100,169,2013,COPYRIGHT,CROWN,CRUMP,DEPENDING,GMBH,HOWEVER,MINES,PUBLISHED,THESE,USING
112,BACKGROUND,EBL,HEMOPTYSIS,LABEL,MAIN,METHODS,MILD,REGARDLESS,RESULTS,THERE,VARIABLES
BACKGROUND,EVALUATING,EVERY,LABEL,MAIN,METHODS,MOST,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THEIR
0001,002,005,022,424,877,940,BACKGROUND,CHEST,DETERMINE,DIMENSION,EUROQOL,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RATIONALE,RESULTS,THOSE
004,005,019,126,139,177,265,339,BACKGROUND,CTS,LABEL,MAC,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,WITHOUT
11H,183,2H2O,A549,CH1,COO,COOET,CU2,ESI,ETOOC,H2O,IC50,MEOOC,MTT,NMR,SW480,ZN2
160,169,177,1985,1996,2007,2013,3765,609,AIM,BASED,DIFFERENT,ESOT,JOHN,LTD,PUBLISHED,SONS,TRANSPLANT,WHETHER,WILEY
169,2013,A549,ATG5,MITO,TEMPO,THUS
AKT,CL1,COMMERCIAL,EGF,EGFR,ERBITUX,RTK,WESTERN
181,945,CMP,DLD,DMB,DP3,HOWEVER,HPLC,NCAM,POLYSIALIC,SCLC,ST8IAII,STX,SY5Y,USING,UTILIZING
ANTICANCER,ASP,EGFR,RNAI,TAKEN
276,543,640,658,814,8202,856,871,CIS,HOWEVER,LABEL,METHODS,OBJECTIVE,ORS,PUBLISHED,RESULTS
001,003,045,279,326,410,8202,ADPRT,APE1,ASP148GLU,BACKGROUND,CHINESE,CYS,EACH,LABEL,METHODS,RESULTS,SER,SER326CYS,SNPS,THREE,VAL762ALA
945,946,A549,AKT,EGFR,EPIDERMAL,ERK1,INHIBITION,KNOCKDOWN,MEK,PI3K,SIGNALING,TREATMENT,U0126
2273,312,ALK,AMONG,BACKGROUND,CAUCASIAN,CHINESE,ECHINODERM,EGFR,EML4,FISH,HOWEVER,IHC,IHC2,IHC3,INCLUDING,KRAS,LABEL,META,METHODS,NSCLC,PCR,RESULTS,REVERSE,SITU
7404,7721,A549,BACKGROUND,BEL,CARCINOMAS,CY5,FIRSTLY,FLOW,LABEL,LS2,PRINCIPAL,RESULTS,SELEX,SMMC,TCA8113,THEIR,ZY8
BACKGROUND,HDMP,LABEL,PRINCIPAL,RESULTS,THEREFORE
001,2010,215,386,BACKGROUND,DRUG,FDA,FOOD,INCLUDING,LABEL,METHODS,RESULTS
ATF2,BOTH,CELL,EGF,GIVEN,MAPK,RNAI,TAKEN
169,2013,AACR,EGFR,FOLLOWING,GENOMIC,HER2,HER2V659E,LABEL,TP53,UNLABELLED
001,237,8201,ASSOCIATED,BACKGROUND,ILC,LABEL,NUCLEAR,PROTEIN,RESULTS,SINCE,TEAD,YAP,YES
000,160,1966,1974,1982,1990,2013,220,3973,5017,AUTHORS,BACKGROUND,CENTRAL,CISPLATIN,COLLECTION,CONTROLLED,DATA,III,ISSUE,JANUARY,LABEL,MAIN,MARCH,MEDLINE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVID,RANDOMISED,RESULTS,SELECTION,SOCIETY,THERE,THEREFORE,TRIAL
100,125,231,400,680,CD45,CTC,CTCS,DAPI,DEAN,MCF,MDA,SMALLER,T24,USING,WBCS
CURRENT,EXOGENOUS,FGF10,FIBROBLAST,III,MEK,PCR,UROTHELIAL,WESTERN
000,0001,150,1997,2006,2010,221,BACKGROUND,LABEL,LUNG,MEDICAL,METHODS,NAGELKERKE,RESULTS,SCREENING,SEVERAL,SOUTH,SWENSEN,THREE,TRIAL,UNIVERSITY
008,035,115,194,CONCLUSION,COX,FDG,III,IIIA,IIIB,LABEL,MEIER,METABOLIC,METHODS,MTV,NSCLC,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,ROC,TLG
169,1995,2013,243,311,374,BASEL,CARDIAC,COPYRIGHT,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,WHILE
169,2013,BASEL,COPYRIGHT,EXTENSION
001,006,014,027,031,169,2013,782,8804,BACKGROUND,CONCLUSION,COPYRIGHT,DISEASE,FDG,LABEL,LTD,METHODS,MTL,MTV,PET,RESULTS,TLG,UNIVARIATE
169,2013,8077,ACH,AUTHORS,BOTH,CHOLINE,COPYRIGHT,CTL1,DAMP,DMA,H69,HOWEVER,LTD,NCI,NHE,NHE1,PCR,PUBLISHED,THESE,THUS,VARIOUS
169,2013,AUCL3,GIVEN,III
169,2013,946,BACKGROUND,BPES,CELLS,COPYRIGHT,CURRENTLY,CXCL4,ELISA,FACS,IRELAND,LABEL,LTD,MALIGNANT,MCP,METHODS,MMP,MPE,MPES,PLEURAL,RESULTS,TGF,TH2,THERE,THESE,VEGF
026,CONCLUSION,EGFR,ERCC,LABEL,MDR,METHODS,NSCLC,OBJECTIVE,RESULTS,RRM
033,046,121,125,140,169,183,196,199,200,2009,2013,250,395,400,BACKGROUND,CHINA,CHINESE,COPYRIGHT,EGFR,FEB,LABEL,LTD,METHODS,NOV,RESULTS,TRC,TRIAL
154,169,2013,BASAL,BPLER,COPYRIGHT,EXPRESSION,HMLER,INC,MCL,NOXA,PROTEASOME,TNBC,TNBCS
0001,001,161,169,2013,CIK,COPYRIGHT,CURRENTLY,FIVE,INC,NSCLC
008,016,034,059,169,172,177,2009,2012,241,306,540,945,ACCORDING,BACKGROUND,COPYRIGHT,ESPA,HIF,LABEL,MEAN,METHODS,OBJECTIVE,RESULTS,STUDIES,THERE,TNM,VEGF
1998,2003,AFRICAN,AMERICANS,AMERINDIAN,CALIFORNIA,DECREASED,EDUCATION,LABEL,LATINOS,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SES
BACKGROUND,CHINA,COLLEGE,CONCLUSION,EXPRESSION,GCLC,LABEL,MEDICAL,METHODS,MTF,NQO1,NRF,NRF2,NUCLEAR,PCR,RESULTS,SURGICALLY,THESE,TOTAL,ZUNYI
5GY,946,A459,A549,BULK,CD24,CD44,COMBINING,CSC,CSCS,EMT,H460,NON,NSCLC,OCT,PDFGR,PDGFR,SNAIL,SOX2,THESE
ATS,BACKGROUND,ERS,LABEL,LUNG,METHODS,OBJECTIVE,OPTIMAL,PURPOSE,RESULTS,SOCIETY
2002,CURRENTLY,HOWEVER,NCD,NCDS,WORLD
FURTHER,JAPAN,SCLC,SMALL,UNION,USA
215,3174,560,ACTH,BLOOD,CUSHING,PLEURAL,SCLC,TREATMENT,URINARY
169,2013,4T1,6BIO,946,AACR,GSK3,HOWEVER,INSTEAD,JAK,PDK1,RNAI,SEVERAL,STAT3,TAKEN,WHILE
0001,009,031,169,2013,233,AACR,AFTER,ATLAS,ERK1,LABEL,MARKERS,METHODS,MIR,NOTABLY,OBJECTIVE,PCR,PURPOSE,RESULTS,T2N0,TCGA
116,A549,CANDIDA,HCT,JEJU,KOREA,NMR,SEPARACENE
139,141,1995,2007,BACKGROUND,BRAIN,CONCLUSION,DISEASE,EPSCC,IRELAND,LABEL,MANAGEMENT,METHODS,PATIENT,PCI,RESULTS
137,AFRICAN,ASIAN,BACKGROUND,CONCLUSION,EGFR,EPIDERMAL,FURTHER,LABEL,METHODS,MUTATIONS,NORTH,RESULTS
176,2000,2006,2011,ATS,BACKGROUND,CHEST,CHINA,CONCLUSION,COX,DFS,ERS,IASLC,LABEL,LUNG,MEIER,METHODS,RESULTS,SOCIETY,UNIVARIATE
001,007,027,2004,2009,313,625,938,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,MODEL,PET,RESULTS
159,BACKGROUND,CDH1,DUAL,H1568,H1650,LABEL,METHODS,NSCLC,REAL,RESULTS,VIA,WILMS,WOUND,WT1
100,105,139,151A,154,200B,30A,378A,379,629,742,BACKGROUND,DATA,FURTHER,LABEL,LUNG,METHODS,RESULTS,SIX,THERE,WEKA,WIDE
012,021,034,090,170,192,219,298,445,452,903,980,BACKGROUND,BESIDES,DIFFERENT,E746,EGFR,HOWEVER,IIIB,L747,L858R,L861Q,L861R,LABEL,METHODS,PFS,RESULTS,TKI
1140,161,2002,2008,364,4254,919,BACKGROUND,CONCLUSION,DATA,III,INSURANCE,LABEL,LUNG,METHODS,RESULTS,TNM
CONGO,THERE,THESE
P53
012,113,178,220,292,336,967,BACKGROUND,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS
058,076,BACKGROUND,BLOOD,CAT,CATHEPSIN,COX,ELISA,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,STUDIES,TNM,UNIVARIATE
AES,BACKGROUND,BOTH,DCR,FORTY,GEFITINIB,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PEMETREXED,QOL,RESULTS
A549,ABCG2,BACKGROUND,CD133,FACS,LABEL,LUNG,METHODS,OBJECTIVE,PCR,RESULTS,WESTERN
185,8312,BACKGROUND,BBB,CHINESE,CPA,FDG,LABEL,LUNG,METHODS,MRI,OBJECTIVE,PET,RESULTS,THUS,YANG1
ANTI,ECS,EGFL7,VEGF
004,109,111,118,215,8805,ABSENCE,BACKGROUND,CHRONIC,CTCAE,LABEL,LLN,METHODS,NSCLC,OBTAINING,RESULTS,WHETHER
160,169,2013,365,698,708,ACTIVATION,DEEP,DOX,IBSEN,LED,LOCALIZED,PCB,PHOTOBIOL,PHOTOCHEM,PRODRUG,SOCIETY,VIVO
017,2008,2010,215,438,948,CONCLUSION,DESPITE,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
004,064,2008,494,502,587,713,8805,906,BLUECROSS,BLUESHIELD,BROADLY,CAREFIRST,COMPLIANCE,CONCLUSION,DATA,FORTY,LABEL,METHODS,OBJECTIVE,PER,PURPOSE,RESULTS,SAVINGS
001,2000,2007,2009,610,AMONG,BLACK,CONCLUSION,END,FORTY,INEQUALITY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
2011,281,CONCLUSION,DRUGS,FIFTY,HEMATOLOGY,JULY,JUNE,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,THERE
0035,0087,3935,CONCLUSION,FINALLY,LABEL,MEDICAL,METHODS,OBJECTIVE,PHASE,PURPOSE,RDI,RESULTS
178,181,185,398,8308,8320,8322,8325,916,947,A549,AMONG,APOPTOTIC,CELECOXIB,COX,FINALLY,H358,H460,PGD,PGJ,PGS,PPAR
11047,169,200A,2013,275,AACR,ECH,KEAP1,NRF2,SSAT
946,CCL2,EMT,ETS,FGFR4,FGFRS,FURTHER,TAF
KRAS,NOTCH,NSCLC,THESE
143,160,2010,377,902,CONCLUSION,INPATIENT,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPANISH,SRE,SRES,UNIT
A549,ADP,AKT,ASIAN,BAX,BID,ERK1,H441,H520,HBECS,JNK,NON,NSCLC,PI3K
029,035,048,2013,433,463G,681,752,CAUCASIANS,MARCH,META,MPO,ORS,OVERALL,THERE,WANFANG
2013,463A,8201,ASIAN,CAUCASIAN,HOWEVER,JULY,MPO
2013,399,8201,AFRICAN,ASIAN,CAUCASIAN,CHINESE,HOWEVER,JUNE,ORS,XRCC1
169,2013,279,361,BACKGROUND,COPYRIGHT,JOHN,LABEL,LTD,METHODS,RATIONALE,RESULTS,SONS,USING,WILEY
ALLOGENEIC
169,2013,ACTIVATION,COPYRIGHT,EXPRESSION,JOHN,LTD,MET,PC9,RESISTANCE,SONS,STUDIES,T790M,THEREFORE,THESE,WILEY
169,200,2013,8201,ADC,ATS,BACKGROUND,CONCORDANT,ERS,IASLC,LABEL,LUNG,METHODS,RESULTS,SOCIETY
003,005,103,104,118,175,1995,2003,2010,255,627,BACKGROUND,CHI,CONCLUSION,EACH,LABEL,LUNG,METHODS,RESULTS,UNLABELLED,USING
2001,2012,500,895,ACCEPTANCE,BACKGROUND,DISCUSSION,INTUITIVE,LABEL,MEDLINE,METHODS,RESULTS,ROBOTIC,SUNNYVALE,VINCI
005,098,120,CURRENTLY,LABEL,LOW,METHODS,OBJECTIVE,ONCOLOGIST,PEPS,PURPOSE,RESULTS
000,133,148,2009,2012,368,956,965,BACKGROUND,CENTERS,JANUARY,LABEL,MARCH,METHODS,RESULTS
145,6TH,7TH,BACKGROUND,EDITION,LABEL,LYMPH,METHODS,NSCLC,RESULTS,THERE,THESE,TNM
ADMS,AIDS,ANAL,HIV,LABEL,LDCT,LIVER,LUNG,MSM,OBJECTIVE,PLWHA,PURPOSE,RESULTS,SCREENING,SUMMARY,TRIAL
AIDS,HIV,LABEL,LUNG,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,SUMMARY,THERE
169,2014,COPYRIGHT,INC,PUBLISHED
169,2013,AIMS,BACKGROUND,BASEL,BIO,COPYRIGHT,GP5,GP6,HOWEVER,HPV,ISH,LABEL,METHODS,MEXICAN,OBJECTIVE,PCR,RESULTS
1000,BACKGROUND,CONCLUSION,DATA,LABEL,METHODS,PCG,PCGS,PHC3,RESULTS
001,177,759,850,8805,BACKGROUND,BSLD,CONCLUSION,COX,DATA,E4599,EVALUATION,LABEL,METHODS,NSCLC,PFS,RESULTS,SOLID,THERE
BACKGROUND,BLOOD,CD15,CD45,CONCLUSION,CTC,GPG,LABEL,METHODS,NSCLC,RESULTS
152,234,252,296,8314,AE1,AE3,BACKGROUND,BONE,CONCLUSION,DTC,DTCS,EARLY,EPCAM,ICC,IMS,LABEL,METHODS,MOC31,NSCLC,RESULTS
946,AFTER,BACKGROUND,BCC,CASE,E12,HOWEVER,KI67,LABEL,METHODS,TURP
185,198,2011,240,284,985,BACKGROUND,DISCUSSION,LABEL,LDCT,LUNG,METHODS,QALY,QALYS,RESULTS,SCREENING,TRIAL
AMONG,BACKGROUND,COX,EGFR,ERCC1,LABEL,METHODS,NSCLC,PFS,RESULTS
954,B16,DU145,EF24,EXPRESSION,JAK,KI67,PDCD4,PTEN,STAT,TAKEN
158,415,532,8804,8805,AARP,BMI,COX,DIET,HRQ4,NIH,OVERWEIGHT,WORLDWIDE
144,AFTER,BACKGROUND,COMPARING,HOWEVER,INTERFERON,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THERE
072,099,112,198,356,509,539,618,651,710,8202,939,960,BACKGROUND,LABEL,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,THR241MET,XRCC3
IGF1,INDUCED,INTRACRINE,LOCALLY,PITUITARY,PREMATURE,THUS
001,231T,435,4T1,CONVERSELY,MCF7,MDA,NM23,USING
001,133,158,177,181,190,BACKGROUND,C1Q,C4D,COMPLEMENT,LABEL,LUNG,MANN,METHODS,RESULTS,THERE,WHITNEY
BOTH,BRAF,BRESLOW,CLARK,EASTERN,FIG,GROUP,HIGH,HMB45,HOWEVER,K642E,KIT,NINE,PATHOLOGY,S100
1991,1997,1999,2004,687,ARMS,BONE,CONCLUSION,ERMS,GROUP,INTERGROUP,LABEL,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,RMS,STAGING
169,EGFR,PRESS,SOX2
068,134,1979,2006,4205,644,678,863,8804,8805,ASIAN,CONCLUSION,LABEL,METHODS,MOST,OBJECTIVE,RESULTS,SIR,SIRS,SPM,SPMS,THERE,THUS,THYROID,USA,WESTERN
EVEN,JOINT,LUNG,NON,NSCLC,TAM
001,694,732,841,CMTM8,CONCLUSION,INCREASED,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
THUS,WHAT
NON
1999,4DCT,4DDCS,CTVS,DIFFERENT,EXTENSIVE,HOWEVER,ICRU,ITV,ITVS
169,2013,29A,29B,29C,29S,946,COPYRIGHT,DNMT1,DNMTS,HOWEVER,INC,MIR,NSCLC,PCR,TAKEN,WESTERN,WIF,WNT
8211,8242,945,956,A549,CL2,CLO4,H2O,IC50,MCF7,RESULTS,RUCL
ATG5,EGFR,HCC4006,LUNG,THESE,TKI,TKIS
200A,A549,HELF,MES,NSCLC
158,169,186,2013,215,219,522,664,AACR,CONSENSUS,CONSISTENT,EGFR,GENOMIC,KRAS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SAM,SUBGROUPS
BASED
169,2013,A549,COPYRIGHT,LTD
BACKGROUND,CASE,CONCLUSION,LABEL,LUNG,METHODS
169,2013,COPYRIGHT,CROWN,IRELAND,LTD,NSCLC,PERSISTENT,PUBLISHED
001,123,2000,2012,215,338,981,BACKGROUND,JANUARY,LABEL,MCNEMAR,METHODS,REGARDING,RESULTS,SCORE
100,DUBS,FINALLY,NSCLC,REVERSIBLE,USP1
169,2013,ARALIACEAE,ASTERACEAE,COPYRIGHT,LAM,LTD,NMR,PERS,THEIR
60GY,75GY,BACKGROUND,CBP,CONCLUSION,GRADE,HIGH,HOWEVER,III,IIIA,IIIB,INCREASING,LABEL,METHODS,NSCLC,NVB,RESULTS,THERE,UNTREATED
100,169,2013,241,BACKGROUND,COPYRIGHT,ESPA,FOUR,LABEL,LAM,MEIER,METHODS,OBJECTIVE,RESULTS,THREE
8710,947,950,BACKGROUND,BECAUSE,CAR,CD28,CD3,CD8,CONCLUSION,EXPRESSION,F19,FAP,FIBROBLAST,IFN,LABEL,MALIGNANT,METHODS,MPM,RESULTS,TAA,THEREFORE
185,51CR,8201,8309,947,A549,AFTER,BACKGROUND,EGFR,GEFITINIB,H1975,HOWEVER,IFN,L858R,LABEL,LC3,METHODS,MHC,MICA,MPR,NATURAL,NKG2D,NKP44,NKP46,NOTABLY,RESULTS,T790M,ULBP1,ULBP2
8764,AFRICAN,AMERICANS,BACKGROUND,CONCLUSION,CONTEXT,EGFR,FIRST,HISPANICS,HOWEVER,LABEL,LUNG,METHODS,MOST,MUTATIONS,OBJECTIVE,RESULTS,SAMPLES,SMOKING
AREAS,BACKGROUND,COVERED,LABEL,MAPK,METFORMIN,METHODS,NSCLC,OPINION,RAF,RAS
GFR,NSCLC,RTKIS
318C,49A,CTLA,CYTOTOXIC,HOWEVER,NSCLC,PCR
029,1966,2012,248,25307,312,365,389,410,561,595,742,836,847,871,AIMS,APRIL,DATA,HYPOTHESIS,JANUARY,LABEL,MEDLINE,METFORMIN,METHODS,OBJECTIVE,RANDOMIZED,RESULTS,THERE
158,202,360,ALK,BACKGROUND,EGFR,EML4,FISH,IHC,KRAS,LABEL,METHODS,PCR,RESULTS,SCREENING,THERE
CELL,HOWEVER,NSCLC,WILMS,WT1
174,GMP,MX35,OVCAR,PCR,PER,PHASE,REBMAB200
GAIN,MESOTHELIA,TAKEN,YET
4T1,ATTENTION,GFP,MSC,MSCS,RFP,THESE,TME,USING
AFM,AIMS,CON,CONCLUSION,DOCETAXEL,GEL,HOWEVER,LABEL,MATERIALS,METHODS,MMP,MMP2,MMPIS,NPS,OBJECTIVE,PCL,RESULTS,TEM
008,023,138,8202,BACKGROUND,ECOG,FREQUENCY,HRV,LABEL,METHODS,RESULTS,ROC
COA,DECREASING,ENDOGENOUS,HOWEVER,LUNG,THESE,WESTERN
945,954,A549,BALB,CPDA,HOWEVER,HSF1,HSP70,SIMILAR,TNF
0001,002,222,8202,CIK,CONCLUSION,COX,ECOG,LABEL,MEIER,METHODS,MHC,MICA,OBJECTIVE,RESULTS
100,8202,AKT,BLINDED,EGFR,MIG6,PI3K,TKI,TKIS
946,954,CIC,CICS,EMT,KIT,KLF4,MYCN,NSCLC,OCT4,SIP1,SLUG,SNAI1,SNAI2,SOX2,TGF,THUS,TNF,ZEB2
008,046,199,267,8202,980,AFFYMETRIX,BACKGROUND,CTA,CTAS,ESO,EXPRESSION,FURTHER,JBR,LABEL,MAGE,METHODS,NAC,NSCLC,ONCOCARTA,RESULTS,SIMILAR,THERE
AARP,AUCS,BACKGROUND,BMI,COLORECTAL,DIET,EDITORS,INSTITUTES,LABEL,LUNG,METHODS,MHT,NIH,OVARIAN,PLCO,RESULTS,SCREENING,SUMMARY,THESE,TRIAL,USING,WHILE
006,169,2013,492,954,A549,EXPRESSION,FINALLY,UICC
CTLA,DESPITE,GIVEN,HOWEVER,III,LABEL,LARGE,NON,NSCLC,OPINION,STATEMENT,UNASSIGNED
002,009,045,1239C,1239G,2E1,526,8201,8805,CHINESE,CYTOCHROME,HOWEVER,META,ODDS,ORS,P450,THUS,TNM
2004,2009,233,237,BACKGROUND,CAIBARI,CARTESIAN,CIFUENTES,CLARA,CUBA,HIGH,LABEL,METHODS,OBJECTIVE,RESULTS,SAGUA,SANTA,VARIABLES,VILLA
AKT,CONCLUSION,DLD1,GSK690693,H460,LABEL,MDR,METHODS,MULTI,NCI,OBJECTIVE,PTEN,PURPOSE,RAS,RESULTS,SNP,SNPS,THEIR,THEREFORE,TIPIFARNIB,TXR,U87
100,160,2011,2012,8201,BETWEEN,END,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OVERALL,PROPORTION,PURPOSE,RESULTS
145,179,2010,2012,218,300,322,403,820,ACTIVATING,CAUCASIAN,EGFR,FINALLY,JANUARY,JUNE,L858R,MUTATED,PCR,SIMILAR,THEREFORE,TTF,USING
EPITHELIAL,METASTASIS,NOVEL,OVCA,TME
202,2281,4827,673,8322,ADP,AZD,BMN,ERCC1,HOWEVER,NSCLC,PARP1,RAD51
505,916,BMS,CDC42,EX2,INHIBITION,LIM,LIMK,LIMK1,LIMK2,LIMKS,MSC,MSCS,NF2,PAK,PAKS,RAC,SCHWANN,SCS,SER3,SIMILARLY
006,018,946,BIOMARKERS,CHIP,COL11A1,ETS,MICROARRAY,MMP3,PCR,SMALL,TGF
1LONG,A549,ADP,BAX,BCL,FURTHER,HOWEVER,MCL,TANKYRASE,TELOMERES
DESPITE,VATS
169,2013,COPYRIGHT,DZNEP,EZH2,H3K4ME3,H3K9,H3K9ME3,HMTASES,INC,PCR,REAL,REDUCED,SUV39H1
005,006,160,169,1691,2013,389,ARTESUNATE,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METASTASIS,METHODS,MOLECULAR,MOSBY,OBJECTIVE,OVCA,RESULTS,TGF,USING,WNT
169,2013,7721,BRUCINE,CHINA,COPYRIGHT,H22,HCC,HEPG2,HIF,HYPOXIA,IRELAND,LINN,LTD,SMMC,STRYCHNOS,THERE
169,2013,540,546,554,ACLY,ATP,CBP,CONVERSELY,COPYRIGHT,INC,INCREASED,P300,PCAF,SIRT2
100,169,2013,99M,APART,CONCLUSION,COPYRIGHT,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,TECHNETIUM
001,032,169,2013,986,988,995,998,COPYRIGHT,EVALUATION,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,REVISED,SOLID,THERAPY,WORLD
169,2013,207,252,359,381,ALK,ASIAN,BACKGROUND,BLACK,COPYRIGHT,EGFR,FISH,IRELAND,KRAS,LABEL,LTD,METHODS,NSCLC,RESULTS,THESE,WHITE
165,169,2013,CAM,CONVERSELY,COPYRIGHT,FEW,GIVEN,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,177,2013,514,8804,8805,BACKGROUND,CONCLUSION,COPYRIGHT,EACH,FEW,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
169,18F,2013,CECT,FDG,INC,PET
001,169,2013,300,COPYRIGHT,DFS,E2F,HDAC,HDAC1,HIGH,IRELAND,KNOCKDOWN,LTD,NSCLC,SNIP1,THESE,TMA
100,169,2013,ALK,BOTH,COPYRIGHT,DUAL,EGFR,FISH,HOWEVER,IHC,IRELAND,KIF5B,KRAS,LTD,NONE,PCR,PRIMERS,RET,THREE
169,2013,COPYRIGHT,DDR2,IRELAND,LTD,SQCC
003,0085,017,026,169,2004,2011,2013,209,239,245,2AN0,307,AMONG,BACKGROUND,COMPLETELY,COPYRIGHT,COX,EGFR,HOWEVER,INC,LABEL,LOBECTOMY,MEIER,METHODS,MUTATIONS,NSCLC,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,THREE
169,2013,CALCIUM,GMP,LCP,LIPID,LTD,NSCLC,PHOSPHATE
169,2013,CONCLUSION,COPYRIGHT,HOPKINS,JHLP,JOHNS,LABEL,LTD,LUNG,METHODS,OBJECTIVE,PROBLEM,PROJECT,PUBLISHED,RESULTS,SAUDI,STATEMENT,USING
169,2013,ALK,AMONG,COPYRIGHT,CRIZOTINIB,CURRENTLY,DRUG,EGFR,EML4,FDA,FOOD,HOWEVER,HSP90,KRAS,LTD,MET,NSCLC,TKIS
169,2013,8314,945,ADC,ADCS,BACKGROUND,CD31,CONCLUSION,CONVERSELY,COPYRIGHT,ECS,INC,LABEL,MALIGNANT,METHODS,MPE,MVD,PCS,PDGFR,RESULTS,SMA
0277,0424,1100,169,1920,2013,3521,4913,5727,5898,ALK,BACKGROUND,CONCLUSION,COPYRIGHT,CRIZ,CRIZOTINIB,CROSS,INC,LABEL,METHODS,NEITHER,NSCLC,OBJECTIVE,OVERALL,PEM,PEMETREXED,PFS,RESULTS,THERE
167,169,2013,FE3,FER,NSCLC,PE1,PJA2,PREVIOUSLY,SEVERAL,THEREFORE
AMERICA,ASIA,EAST,FINALLY,LATIN,NORTH,PACIFIC,PREVENTIVE,WESTERN
AREAS,BACKGROUND,COVERED,FINALLY,INTRA,LABEL,METHODS,OPINION,SELECTING
169,2013,COPYRIGHT,EARLY,INC,PALLIATIVE
169,2013,COPYRIGHT,INC,QOL,QUALITY
169,2013,COPYRIGHT,INC,MOST,PUBLISHED,SURGERY,THERE
169,2013,COPYRIGHT,INC,PUBLISHED
169,2013,COPYRIGHT,INC
160,169,2013,COPYRIGHT,EFFORTS,III,INC,NSCLC
169,2013,COPYRIGHT,INC
169,2013,COPYRIGHT,EARLY,HOWEVER,INC,SURGERY,THERAPIES
169,2013,COPYRIGHT,FURTHER,INC,SLN,SLNS
169,2013,COPYRIGHT,INC
169,2013,COPYRIGHT,INC
169,2013,COPYRIGHT,IIIA,INC,MOST
169,2013,COPYRIGHT,INC
169,2013,COPYRIGHT,INC,JAPAN,LARGE
169,2013,COPYRIGHT,ESTIMATION,INC
169,2013,COPYRIGHT,III,INC,STAGE
ACTIVATING,ALK,AREAS,BACKGROUND,BRAF,COVERED,DDR2,EGFR,FGFR1,HER2,KRAS,LABEL,MET,METHODS,NSCLC,ONCOGENIC,OPINION,RET,ROS1,SCC,SEVERAL
1999,2004,COX,HODGKIN,HRS,MEIER,NHL,WHILE
100,150,200,722,AMONG,ENDPOINTS,HRS,IIIB,PFS,SCC,THERE
2008,2011,BRAF,EGFR,HOSPITALS,HOWEVER,KRAS,NICE,NSCLC,THESE,UNIVERSITY
169,2013,214,ALPK2,CDK6,COPYRIGHT,HOWEVER,INC,NSCLC,PAPP,THEREFORE,THESE,THROUGH,TNFAIP3,WILEY
169,2013,25K,ALSO,GFP,INC,LA1,MICHAEL,PDCD4,PEG,PEI,SPE,THESE,WILEY
956,AKT,DHA,HOWEVER,RH30
945,946,AKT,COX,EDA,EMT,ERK,OVERALL,PI3
00017,11Q,BIRC5,BRCA,BUB1,CD44,CDC2,CPC,FANCONI,KLK12,OTP,PCR,PULMONARY
002,042,160,AGE,EGFR,FIFTY,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,TKI
001,024,113,139,147,150,160,AIM,ALA,ARG,BACKGROUND,ETS,EXONS,GENOTYPING,HIST,HOWEVER,LABEL,METHODS,MNSOD,OBJECTIVE,RESULTS,TYR,VAL
169,2013,AACR,LABEL,LIU,LKB1,SUMMARY
A549,AREG,CTGF,CYSTEIN,DROSOPHILA,HIPPO,MAMMALIAN,MST1,MST2,NSCLC,OVERALL,PHOSPHO,STE20,YAP,YES
AKT,BCL,BRCC2,THUS
2005,2011,BACKGROUND,CCC,CONCLUSION,CONTROL,IMPROVING,LABEL,METHODS,PLAN,PROTECTION,RADON,RESULTS,THREE
0001,100,110,120,169,2013,238,406,434,CONCLUSION,COPYRIGHT,DESIGNING,DOSE,EFFECTIVE,FBP,IMAGE,IRELAND,LABEL,LTD,MDCT,METHODS,OBJECTIVE,RESULTS,THERE,THREE,TREE
AKT,CULTURING,ECM,ERK,EXPRESSION,INHIBITION,LABEL,MEK,MOST,N417,NCI,PI3K,RE1,REPRESSING,REST,SCLC,SMALL,SRRM4,TAKEN,U0126,UNLABELLED
169,2010,2011,2012,2013,5MM,956,ALK,ATS,BACKGROUND,CK5,COPYRIGHT,EGFR,ERS,IASLC,IRELAND,JANUARY,KRAS,LABEL,LTD,MARCH,MEAN,METHODS,P63,RESULTS,TTF1,TTNB
100,169,2013,239,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
169,2013,COLD,CONCLUSION,COPD,COPYRIGHT,DEPENDENT,EGFR,EPIDERMAL,HIGH,IRELAND,LABEL,LTD,MATERIALS,MELTING,METHODS,NEITHER,OBJECTIVE,OBJECTIVES,PANEL,PCR,PST,RESOLUTION,RESULTS,TECHNOLOGY,THUS
100,169,2013,599,8482,ALK,BRAF,CONCLUSION,COPYRIGHT,DAKO,DETECTION,EGFR,EML4,FLEX,IHC,IRELAND,KIF5B,KRAS,LABEL,LTD,MAPK,METHODS,MUTATIONS,N581I,OBJECTIVE,PURPOSE,RESULTS,RET,V600E,VE1
CASE,CONCLUSION,GUIDELINES,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SMALL,THERE,TREATMENT
160,BACKGROUND,EGFR,EPIDERMAL,FORTY,GROUP,KMLCG,L858R,LABEL,LUNG,METHODS,MOLECULAR,NSCLC,PCR,PNA,RESULTS,THERE
343,8201,8805,BACKGROUND,BASED,BOTH,FDG,LABEL,LITERATURE,MEDLINE,METHODS,MRI,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
A549,MCF,MOLECULAR,THREE
169,2013,293,8201,A375,A549,HEK,HELA,J774,KEY,LABEL,METHODS,MTT,OBJECTIVE,OBJECTIVES,OTF,RESULTS,ROYAL,SOCIETY,THF
169,2013,AML,BOTH,KEY,LABEL,METHODS,MINIMAL,OBJECTIVE,P123,POST,RESULTS,ROYAL,SOCIETY,USING
DUE,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SELECTING,THESE
103,112,177,2001,266,277,8725,ADF,CHAN,IEEE,IMAGE,LABEL,MCE,METHODS,MOST,MRE,OBJECTIVE,PET,PROCESS,PURPOSE,RESULTS,SOI,TBR,THEREFORE,TRANS,VESE
177,215,HOWEVER,LABEL,LTM,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROI,TABS,THESE,VALIDATION,VTM
0001,111,240,311,AREA,CURRENT,DESPITE,FOUR,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
148,2003,2009,AREAS,BOTH,DEFORMABLE,DOSE,EVALUATING,FORTY,GTV,LABEL,METHODS,OBJECTIVE,POST,PURPOSE,REGIONS,RESULTS,SBRT,THERE
8482,CARLO,EGRT,EVALUATION,FITCHBURG,GATE,GTV,HEALTHCARE,HOWEVER,IMRT,LABEL,LINAC,LOR,LORS,METHODS,MONTE,MOSEK,OARS,OBJECTIVE,PET,PHILIPS,PINNACLE3,PTV,PURPOSE,RADIATION,RESULTS
106,8201,AIR,BACKGROUND,CONCLUSION,DENSITY,GGO,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
111,150,AGG,FINALLY,KDM6A,UTUC,UTUCS,WHOLE
169,2013,5DT,A549,CDC,CDK,CELL,CIP1,CONCLUSION,FLOW,GMBH,H1299,H460,HPLC,IC50,KGAA,LABEL,METHODS,NSCLC,PARP,RESULTS,SCOPE,TAN,TANGERETIN,THESE,VCH,WAF1,WILEY
001,007,1995,1CM,2009,258,2CM,476,734,8804,8805,ADC,ATS,BACKGROUND,CIR,CUMULATIVE,ERS,GREY,IASLC,KETTERING,LABEL,LUNG,METHODS,MIP,RESULTS,SLOAN,SOCIETY
160,177,1798,2010,2012,223,239,326,513,633,8805,BETWEEN,BEV,JUNE,MOST,MPE,NSCLC,SEPTEMBER,SIXTEEN,VEGF
BESIDES,GREAT,LUNG
956,IC50,MAXF401NL
169,2013,AACR,CURRENT,DACOGEN,DNMTI,EPIGENETIC,REAL,THEREFORE,THESE
507,662,CHINESE,ETS,HAN,NSCLC,SNPS,XRCC3,XRCC4
HOWEVER,SCIENCE,SOCIETY,THUS
1121,174,181,1873,357,A549,AFFYMETRIX,AMONG,ARRAY,ASIATIC,ERK,EXPRESSION,FOUR,MEK,PC9,PLUS,RAF,RAS,U133,WESTERN
BACKGROUND,FACTORS,FEW,HISTORY,HRQOL,LABEL,MCS,METHODS,MHOS,PCS,RESULTS,SEER
CNT,CNTS,KNOCKDOWN,MALIGNANT,MMP,PCR,WESTERN,WHOLE
2009,2010,BACKGROUND,DENSITY,ITALIAN,ITALY,LABEL,LT4,METHODS,OXIDATIVE,REGIONS,RESULTS,SEQUENTIAL,THERE
WHILE
ACTC1,ADM2,CCNB1,CCNE2,DRD5,ERRB4,FLT1,FUNCTIONAL,H460,IGF1,IL1A,IL6,KIT,MYH2,MYL2,NCI,NSCLC,PCNA,PCR,SHH,TIE1
353,946,AKT,CALU,EGFR,EMT,ERK,H292,INGENUITY,IPA,MEK1,NCI,NSCLC,PATHWAY,RAF1,SNAI,SUBSEQUENT,TEC,U1752,WNT
442,8202,BACKGROUND,CONCLUSION,EGFR,FOLLOWING,GUIDELINES,KRAS,LABEL,METHODS,NSCLC,PATIENT,RESULTS,TKI
BRAF,EGFR,GENERATION,KRAS,NEXT,NGS,PCR,SEQUENCING
ALK,ALK1,CELL,CHINESE,D5F3,DAKO,FISH,IHC,PCR,SIGNALING,TECHNOLOGY,THEREFORE
CTS,DRILLER
169,2013,AACR,CXCR4
0001,007,ABL,BACKGROUND,CCL19,CCR7,CHEMOKINES,CONCLUSION,CRK,CRKL,EGFR,HIGH,LABEL,METHODS,RESULTS,TP53
128,A549,ABCG2,ALDH1A1,BACKGROUND,BMI,BOTH,CONCLUSION,H460,IHC,LABEL,METHODS,NSCLC,PCR,PYK2,RESULTS
169,2013,439,8201,COLLEGE,CRCL,DDI,DESPITE,MET,NSCLC
001,015,169,2013,405,8201,BACKGROUND,EGFR,LABEL,LOG,METHODS,NSCLC,RESULTS,SOCIETY,TKI,TKIS
ATTENUATED,SALMONELLA,THEREFORE
AFTER
169,2013,FINALLY,FIRST,GLS,IFNS,RESISTING,RIG,ROS,TAKEN,UICC
028,032,138,169,1926,1988,1997,2013,8805,BACKGROUND,COX,END,LABEL,MEIER,METHODS,OVERALL,PCI,RESULTS,SCLC,SEER,SOCIETY,USING
169,2013,COPD,NSCLC,UICC
FINALLY,GHRH
000,100,112,124,1980,1980S,1990S,1993,2000S,2002,2005,2009,235,AFTER,BACKGROUND,DENMARK,HODGKIN,HOWEVER,HUNGARY,LABEL,METHODS,RESULTS,SPAIN,UNION,WORLD
2007,2012,AFTER,BOTH,CONCLUSION,COX,EIGHT,LABEL,MAY,MEIER,METHODS,MTV,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESULTS,SBRT,SUV,THERE,TLG
169,2013,BACKGROUND,CONCLUSION,GMBH,LABEL,METHODS,NSCLC,PFS,REGARDING,RESULTS,THESE
231,8764,AGO2,DATA,FUNCTIONAL,MCF7,MDA,MICRORNAS,NOTCH,RNAI,TAKEN,UTR
100,169,2013,300,BACKGROUND,BAE,HEMOPTYSIS,IMMEDIATE,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SUCCESS
1000,169,2000,2012,2013,CISPLATIN,COPYRIGHT,CURRENT,EVALUATION,HENCE,INC,JANUARY,LACE,LUNG,MEDICAL,NSCLC,PEMETREXED,SOCIETY,SUPPORTED,THEREFORE,THESE
186,2005,2010,AMONG,BNP,LABEL,LEFT,METHODS,OBJECTIVE,RESULTS,SEPTEMBER
AMPK,FAK,HSP90,METABOLIC,THESE,TRAP,ULK1,UNC,USING
ATF3,FURTHER,HOST
179,185,206,CONVERSELY,ECH,HDAC4,KEAP1,LOSS,NADPH,NRF2,PPP,ROS,SUSTAINED,TCA,TTFA,USING
169,2013,COPYRIGHT,HPV,IRELAND,LTD,OTHER,RISK
005,169,176,2013,ARC,COPYRIGHT,IMPT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PASSIVE,PURPOSE,RBE,RESULTS,SBRT,THEREFORE,V20,V30,VMAT
005,104,119,147,169,2000,2009,2013,223,3DCRT,ACUTE,BOTH,COPYRIGHT,COX,IMRT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,SCLC,THEIR
0001,002,004,1262,150,169,2013,351,780,9633,AMONG,ANITA,BACKGROUND,CALGB,COPYRIGHT,COX,DFS,HISTOLOGY,IALT,IRELAND,JBR,LABEL,LTD,METHODS,MUCIN,NSCLC,PROGNOSTIC,RESULTS
BASED,MIP,OARS,QUALITY,SBRT,SINCE,THEREFORE
169,2013,775,A549,EMP,EMP3,EPITHELIAL,ESCC,HOWEVER,INC,KI67,LUNG,NSCLC,THUS,TNM,WHILE
169,2013,945,ALPHA,ATBC,BETA,COPYRIGHT,FURTHER,GROUP,INC,PREVENTION,TOCOPHEROL,TRIAL,VITAMIN
139,267,BACKGROUND,BAL,COPD,ELISA,HOWEVER,LABEL,METHODS,MPO,PERIPHERAL,RESULTS,ROS
301,CINV,COST,EASTERN,GROUP,LABEL,METHODS,OBJECTIVE,RESULTS,SEVERAL
106,110,ALK,BACKGROUND,CHINA,CHINESE,EGFR,EML4,HUNAN,KIRSTEN,KRAS,LABEL,MET,METHODS,MOST,PCR,RESULTS,TEN
CBCT,CBCTP10,CRT,DIR,EACH,ECLIPSE,FIVE,HOWEVER,NSCLC,PTV,THESE,TPS
001,0017,144,425,850,CONCLUSION,LABEL,METHODS,NINE,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,TOXICITIES
000,100,1591,170,1990,1991,250,460,490,5469,7068,8805,BACKGROUND,CHINA,CHINESE,COX,FEV1,HRS,LABEL,METHODS,MORTALITY,PEF,RESULTS,WESTERN
169,2013,AACR,BALB,BL6,C57,HISTOLOGY,LEWIS,LLC,LUNG,RENCA,RTKI,SUNITINIB,TOPOTECAN,TREATMENT
DNMT1,FURTHER,G12V,HRAS,MAMMARY,THESE
ASC,ASCS,BOTH,CCRL2,CD13,CD31,CD34,CD45,CSF,CXCR4,EMT,OBESITY,THEIR
003,1996,2012,BETWEEN,CPB,DHCA,INCOMPLETE,IVC,LABEL,METHODS,MORBIDITY,OBJECTIVE,OBJECTIVES,RADICAL,RESULTS
001,215,954,CONCLUSION,FDG,FLT,FMISO,LABEL,METHODS,NSCLC,NUCLEAR,PET,RESULTS,SFMN,SOCIETY,SUV,TEN,UNLABELLED
0472,086,0866,110,215,225,999,CONCLUSION,FDG,LABEL,METHODS,PET,RESULTS,SUV,SUVMEAN,TLG,UNLABELLED
169,1970S,1980S,2013,CXR,EFFORTS,ELCAP,INC,MAYO,NLST,THESE,WILEY
169,2013,947,948,A549,INC,MAJOR,MHC,MICA,VPA,WILEY
180,DFS,NSCLC,PCNA,SPHK2,USING
DESPITE,LUNG,NSCLC
169,2013,945,947,A431,AUTHORS,CD89,CURRENTLY,EGFR,EMBO,FCGAMMA,IGA,IGA2,IGG,JOHN,LTD,PUBLISHED,SONS,THESE,USING,WILEY
ALK,EGFR,EML4,MOST,NSCLC,ROS1,TKI,TKIS
160,8805,BELOTECAN,CONCLUSION,GRADE,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS,SCLC
100,110,173,181,196,2002,2005,359,460,8805,AFTER,CALIFORNIA,CHILE,KINGS
HCC
946,AVAILABLE,C57BL,CD8,CONCLUSION,DRUG,FOOD,FOXP3,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS
A2A,ANTAGONISM,ATP,CAF,CAFS,NSCLC,PC9,THESE,WARBURG
0839,EGFR,G12D,HOWEVER,III,KRAS,NSCLC,PHASE,RTOG
AKT,COLON26L5,CUG,CUG2,ERK,INHIBITION,JAK1,MAPK,STAT1,TAKEN,TYK2,VEC
DUE,HOWEVER,POD,PTE,PULMONARY,THEREFORE
S10
FIFTY,THREE
000,200,500,AFTER,DUE,PRE
SSP,THEREFORE
1ST,2ND,THROUGHOUT,WIDE
HOWEVER,SITES
ORAL,VNR
7TH,8TH
BLOOD,CEA,SCC,SUV,VATS,VIDEO
3T3,BOTH,EXPRESSION,MCP,MESO,MET,PCR,TAKEN,THESE
200MG,2A13,30MG,CYP2A13,KINETIC,MICHAELIS,NNK,P450,THESE
HMB,JAPAN,SINCE
000,LEFT,SITUS,UNIVENT
MALT,PARTIAL
169,2013,BALB,COPYRIGHT,CROWN,DAPT,EGFR,EMT,FINALLY,HOWEVER,LTD,MET,NOTCH,NSCLC,PUBLISHED,SILENCING,TKI,TKIS
169,2013,INC,SIX,STEAP,THESE,USING
113,157,169,2013,270,8805,ASSESSMENT,COPYRIGHT,COUGH,DATA,FEW,HOWEVER,IRELAND,LABEL,LTD,MATERIALS,METHODS,MSAS,OBJECTIVE,OBJECTIVES,OLDER,RESULTS,SCALE,SHORTNESS,SYMPTOM,THESE
001,004,018,038,169,177,2003,2009,2013,305,862,958,AMONG,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,PET,PUBLISHED,RESULTS,SIXTY,SOCIETY
169,2013,231,946,954,CFTR,ECTOPIC,EMT,HCO3,MCF,MDA,TAKEN,TGF,WHILE
160,APO,APOA1,APOE,ASSESSMENT,BACKGROUND,CHRONIC,CONCLUSION,CONTEXT,EBRT,FATIGUE,FUNCTIONAL,ILLNESS,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,THERAPY,THESE,TTR,WESTERN
169,2013,COPYRIGHT,ONCE,PAIN,PUBLISHED,SIMILAR,THESE
169,2013,COPYRIGHT,CROWN,ECTOPIC,H1299,HOWEVER,INC,PUBLISHED,PUMA,SOX4,TAKEN,TSA,USING
169,173,2013,8804,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,FURTHER,LABEL,LUNG,METHODS,PROTEOMICS,RESULTS,SAS
007,027,031,169,2013,427,504,582,655,677,736,805,806,932,AFP,AIMS,COPYRIGHT,EDMONDSON,HCC,LABEL,LTD,MEIER,METHODS,OBJECTIVE,PERIOSTIN,POSTN,RESULTS,RFS
169,2013,BECAUSE,CONCURRENT,COPYRIGHT,EGFR,EMT,LTD,NSCLC,SILIBININ,SILYBUM,TKI,TKIS
169,2013,ADDITIONAL,COPYRIGHT,H522,LTD,NCI,STRUCTURE
169,2013,A549,ADP,CISPLATIN,COPYRIGHT,FURTHER,H1299,HOWEVER,IRELAND,LTD,NAD,NSCLC,PUBLISHED,ROS,SEVEN,SIRT1,SIRT2,SIRTUIN,TAKEN
025,026,033,042,169,2013,266,AMONG,BACKGROUND,CDX,COPYRIGHT,COX,GPR49,HOWEVER,III,IRELAND,LABEL,LGR5,LTD,MEIER,METHODS,NSCLC,RESULTS,TNM,TTF
003,129,160,169,177,2008,2012,2013,BACKGROUND,COPYRIGHT,INC,JANUARY,LABEL,LOBECTOMY,MEIER,METHODS,PUBLISHED,RESULTS,SOCIETY,VATS
169,1993,2010,2013,291,337,AFTER,BACKGROUND,CONVERSELY,COPYRIGHT,GIVEN,HOWEVER,INC,LABEL,METHODS,MOST,PUBLISHED,RECURRENCE,RESULTS,SOCIETY,TYPICAL
BACKGROUND,CONCLUSION,EGFR,ELISA,EMSA,FINALLY,FOXA2,GCHM,GSH,HOWEVER,LABEL,METHODS,MUC5B,PCN,PCR,PREVIOUSLY,RESULTS,RNS,ROS,STAT6,THESE
2008,2010,AMONG,AVERAGE,AYLL,BACKGROUND,CENTERS,CHINA,CHRONIC,CONTROL,DISEASE,HUBEI,LABEL,LUNG,METHODS,PREVENTION,RESULTS,SRR,WHILE,YLL
843,946,AFFYMETRIX,BACKGROUND,FIBROBLAST,ILD,IPF,LABEL,METHODS,MHC,MICROARRAY,PCR,RESULTS,SSC,STAT1,TGF
A549,FURTHER,MAB,MABS,MRC,RESULTS,SELECTIVE,SELF,TEM
2GY,946,AFTER,AXIN,AXIN1,BACKGROUND,DNMTS,DOWN,FLOW,FOUR,H157,H446,H460,LABEL,LTE,LUNG,MECP2,METHODS,MMP,PCR,REAL,RESULTS
277,A549,ABC,BACKGROUND,BOTH,CONSISTENT,FTASE,FTI,FTIS,FURTHER,GILFORD,HELA,HT29,HUTCHINSON,IPA3,LABEL,MCF7,METHODS,PAK,PAKS,PDR10,RAS,RESULTS,THESE,USING
000,024,034,CONCLUSION,EGFR,EMT,EXPRESSION,IGF,LABEL,METHODS,MST,NSCLC,OBJECTIVE,ORR,RESULTS
HOWEVER,POST,YMDD
ARD,BACKGROUND,BARCELONA,DISCUSSION,HOWEVER,LABEL,METHODS,PLEURAL
160,BACKGROUND,ELISA,FINALLY,LABEL,METHODS,NON,NSCLC,PRDX1,RESULTS,THEN,TIF,WESTERN
1992,2009,CONCLUSION,DATA,END,EXCEPTIONS,HOWEVER,LABEL,METHODS,NON,OBJECTIVE,OVERALL,PROGRAM,RESULTS,SETTING
169,2013,AACR,FINALLY,USING
1253,1257,169,2014,ACC,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,FGFR1,FISH,HEAD,HPV,INC,LABEL,METHODS,NECK,NONE,RESULTS,SCC,SCCS,SNUC,SNUCS,WILEY
169,2013,300,ADULT,AMONGST,ENGLISH,HISTOLOGIC,INC,WHILE,WILEY,WILMS
1005,1050,129,169,2013,277,342,366,635,728,8805,90401,ASI,ASIS,BACKGROUND,CALGB,COPYRIGHT,GROUP,LABEL,METHODS,ORR,PFS,POISSON,PSA,RESULTS,SOCIETY,THERE
169,2013,ADC,BIO,HOWEVER,III,LA1,LIGANDS,LKR13,LUNG,NSCLC,PERIPHERAL,PLEX,SYNGENEIC,THESE,TLR9,TLRS,TOLL,UICC,VEGF,VIII
169,2013,COPYRIGHT,JOHN,LTD,MOTIVATED,SONS,WHILE,WILEY
169,2013,ALPHA,BETA,CARLO,CHAIN,COPYRIGHT,FINLAND,JOHN,LTD,LUNG,MONTE,PREVENTION,SONS,TOCOPHEROL,WILEY
174,CARBOLYZER,CO2,HOWEVER,INC,JAPAN,LABEL,METHODS,OBJECTIVE,OSAKA,RESULTS,TAIYO,UPON
160,177,8201,AREAS,BCG,CD44,CK20,CK5,DESPITE,FOUR,GROUP,HGUC,IHC,KI67,LGUC,THERE
001,005,015,046,160,8201,CK5,CK7,DONOR,HOWEVER,TTF
17R,954,BV8,CSF,ERK,THESE,VEGF,WHILE
150,153,177,189,300,956,CYP3A,EFAVIRENZ,ERLOTINIB,HIV,LINT,P450
001,269,306,431,BACKGROUND,EGFR,EXONS,FOUR,HOWEVER,L858R,LABEL,METHODS,NSCLC,PCR,PFS,RESULTS,T790M,THERE,TKI,TKIS
A549,DESPITE,JNK,JUN,NH2,NON,NSCLC
956,COMBINING,ERCC1,EXPRESSION,H1975,H520,MAPK,MKK3,MKK6,MKK6E,NSCLC,TREATMENT
039,150,8201,926,BACKGROUND,FURTHER,LABEL,METHODS,NSCLC,PFS,RESULTS,RFC,THESE
ILD,ILDS,LABEL,OBJECTIVE,PURPOSE,RESULTS,SUMMARY
169,2013,8753,9019,ALK,BIOLOGICAL,EGFR,ERK1,HOWEVER,LABEL,MEK,NCSLC,NON,NSCLC,RAF,RAS,SILAC,SITES,SUPER,THROUGH,UNASSIGNED,UNLABELLED
169,2013,COPYRIGHT,H1299,IRELAND,LTD,NM23,RAS,REGULATOR,RGS19,RGS20
169,2013,PCR
026,169,2013,AIM,BACKGROUND,CENTRAL,CISPLATIN,CONTROLLED,COPYRIGHT,EPIRUBICIN,ETOPOSIDE,HOWEVER,LABEL,LARGE,LTD,METHODS,ORR,RCTS,RESULTS,SCLC,THEN
366,415,437,473,501,528,606,670,BACKGROUND,DISCUSSION,LABEL,METHODS,OCCUPATION,ORS,RESULTS,SYNERGY
0001,169,177,2013,AFTER,COPYRIGHT,CTLC,FORTY,INC,MOST,NSCLC,PFS,SCLC
1999,2008,205,8805,BACKGROUND,CONCLUSION,HOWEVER,JANUARY,LABEL,LUNG,METHODS,RESULTS,SOCIETY,THEREFORE,UNIVARIATE,UNIVERSITY
169,181A,2013,BACKGROUND,FUNCTIONAL,GENERAL,LABEL,MAPK,MAPK1,METHODS,MIR,PCR,RESULTS,SACC,SNAI2,THEN,WESTERN
169,2013,BAYES,CPG,CPGS,EUCLIDEAN,LTD,MGMT,PUBLISHED
169,2013,211H,ATP,DUE,EGCG,H2O2,INCREASING,MME,MSTO,REN
169,2013,ACTIVATING,AXL,COPYRIGHT,EGFR,IGF1R,IRELAND,LTD,MOST,NSCLC,PI3K,PTEN,T790M,TKI,TKIS,YET
169,2013,COPYRIGHT,ERBB2,HEXOKINASE,HK1,HK2,INC,KRAS,SIMILARLY,USING
ALK,APART,BECAUSE,BRAF,EGFR,FGFR2,FINALLY,GASTRIC,HER2,KRAS,MET,PART,ROS1,RTK,WHILE
169,2013,CD34,CGA,CKPAN,CONCLUSION,EMA,JOHN,LABEL,LTD,METHODS,OBJECTIVE,P63,POLYGONAL,RESULTS,SMA,SONS,SPB,SYN,THERE,TTF,WILEY
123,1327,149,169,176,2013,259,316,335,346,631,678,774,BACKGROUND,BSC,CONCLUSION,COPYRIGHT,DATA,DEFINITION,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,SACT,THERE
0001,001,169,2013,CONCLUSION,COPYRIGHT,COX,EXACT,GRADE,IRELAND,LABEL,LTD,METHODS,MONTHLY,OBJECTIVE,OBJECTIVES,PFS,RESULTS,TEST
1988,1992,1998,2002,2007,301,437,632,8579,BACKGROUND,COX,DATA,HENCE,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,PUBLISHED,RESULTS,SEER,THERE,WHETHER
102,150,169,2012,2013,AUTHORS,BACKGROUND,CONCLUSION,COPYRIGHT,CTI,EGFR,ERLOTINIB,EXON,ILD,IRELAND,JAPIC,JUNE,L858R,LABEL,LTD,METHODS,NSCLC,PFS,PUBLISHED,RESULTS,SIX,T790M
038,1195,169,1994,1995,2000,2002,2006,2013,2801,3680,BECAUSE,CASE,COPYRIGHT,IRELAND,LTD,MAINE,NSCLC,POISSON,POPULATION,SCLC,WHILE
0001,169,2013,A549,CA9,CAIX,CAXII,COPYRIGHT,H1975,IRELAND,LTD,NSCLC,THESE
169,2013,COPYRIGHT,FACULTY,FOUR,HERNIATION,LEGAL,LTD,PPR,PRIMARY,RMS,SUBSEQUENT
169,2013,AFTER,COPYRIGHT,CURRENT,FOUR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV
169,2013,AAB,FIVE,III,MEDICAL,PAB,PTV
0001,160,169,1998,2009,2013,BACKGROUND,COPYRIGHT,END,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE
169,1970,2013,FDG,FEDERATION,PET,PUBLISHED,THESE,THUS
169,2013,241,250MG,AFTER,ALK,BID,CHEST,COPYRIGHT,CRIZOTINIB,EGFR,EML4,ESPA,PORTUGUESA,PUBLISHED,SOCIEDADE
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2013,215,AFTER,BOTH,CHEST,COPYRIGHT,IIIA,INC,PUBLISHED,SOCIETY
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
117,169,2013,268,AFRICAN,BACKGROUND,CAUCASIAN,CONCLUSION,COPYRIGHT,DCR,IIIB,INC,LABEL,MEIER,METHODS,NSCLC,PFS,RESULTS,TOOLS
1146,121,165,169,2013,220,640,AMT,BECAUSE,COPYRIGHT,COX,DATA,GROUP,HISTOLOGIC,INC,LABEL,MEIER,METHODS,NOS,NSCLC,OBJECTIVE,OVERALL,PFS,RESULTS,S0003,S9308,S9509,S9806,SOUTHWEST,SWOG
008,028,031,033,169,2013,229,AMONG,BACKGROUND,CONVERSELY,COPYRIGHT,EGFR,EPIDERMAL,HOWEVER,INC,LABEL,METHODS,NSCLC,PFS,RAS,RESULTS,THEREFORE,THESE
169,2013,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,GREAT,IMAGING,IRELAND,LABEL,METHODS,NONE,OBJECTIVE,RESULTS,SCANS,SEVENTY
1355,1463,2818,A549,DESPITE,FURTHER,HDAC,NSCLS,SAHA,SILAC,VORINOSTAT
1575,169,183,2013,380,BACKGROUND,BRITISH,LABEL,META,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,RISK,STATA,WMD
POTENTIAL,RADIATION,RILF
GALA,MEND,MENDS
3T3,8201,EAGLE,EXPRESSION,FGF,FGFA,FGFB,LPA,LPA1,LPA3,LPA6,LPAR3,THESE,VEGF
ADDRESSING,MAB,MABS,MOST,THERE
0092,022,035,351,404,ADIPOSE,BACKGROUND,BESIDES,CITY,EGFR,EPIDERMAL,HGF,HIGH,INCREASED,LABEL,METHODS,NSCLC,OSAKA,OVERALL,PREVIOUSLY,RESULTS,TKI,TKIS,UNIVERSITY
0001,0023,377,BACKGROUND,EGFR,LABEL,METHODS,NSCLC,RESULTS,SRE,SRES,TKI
003,032,107,BACKGROUND,CK19,CYFRA,CYFRA21,ELITE,LABEL,LCMS,METHODS,QSTAR,RESULTS,SCC
231,468,BCS,BRAF,CDK,CDKS,DRUG,EC50,EGFR,EGFR2,ERBB2,ERK,FPD,G13D,G464V,KRAS,MAPK,MCF,MCL,MDA,MEK,MICE,ONCOGENIC,RAF,RAS,RTK,SFN,SKBR3,T47D,THESE
213,8805,AGE,LABEL,LAG,METHODS,OBJECTIVE,OBJECTIVES,PPCS,RESULTS,SPIROMETRY,THESE
448,8201,CONCLUSION,LABEL,MEASURING,METHODS,OBJECTIVE,RESULTS,WEANING
169,2013,3Q26,593,AACR,CHROMOSOME,CONCLUSION,DCUN1D1,DVL3,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RNAI,SCC,SENP2,THROUGH,UBXN7
001,007,177,2004,AMONG,CONCLUSION,EVALUATING,KNOWLEDGE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,TTP,TUMOURS,WORLD
169,2013,215,316,483,502,5P15,894,912,CHINESE,CLPTM1L,GWAS,HAN,HAPLOTYPE,HOWEVER,INC,TERT,THESE,WILEY
169,177,181,2013,A549,AMONG,B16,COPYRIGHT,DOCKING,F10,IC50,INC,MG63,WILEY
001,006,048,169,2013,ADC,ATS,CONCLUSION,COPYRIGHT,DFS,DISEASE,DWI,ERS,FIVE,FORTY,IASLC,INC,LABEL,MATERIALS,MEIER,METHODS,MRI,OBJECTIVE,PET,PURPOSE,REGARDING,RESULTS,WILEY
169,2013,A549,BASED,C70,COPYRIGHT,FULLERENE,GMBH,KGAA,PDT,R13,ROS,TF70,VCH,WILEY
AFTER,CSF,THERAPY
ESS,METASTASES
169,181,2013,ALKYLATION,COPYRIGHT,DUE,HOWEVER,INC,LUNG,THESE,WILEY
1983,1999,2000,2008,711,AMONG,BACKGROUND,CONCLUSION,JOINPOINT,LABEL,LUNG,METHODS,OVERALL,PROGRAM,REGRESSION,RESULTS,SUSTAINED,TOBACCO
018,169,2013,272,641,869,BMI,CIS,COLORECTAL,COX,LUNG,OVARIAN,RRS,SCREENING,THEREFORE,THESE,TRIAL,TVU,UICC
120,169,2013,231,4T1,8764,945,AACR,DOCETAXEL,FITC,MDA,SMA,STUDIES,THESE
001,009,012,021,108,123,373,486,532,687,771,837,965,DFS,HOWEVER,NSCLC,THERE
40MM,5CM,AFTER,CRANIOTOMY,MCA,PYOKTANIN,STA,TEARING,USING
105,2002,2010,METASTATIC,RPA,RTOG,SEPTEMBER,TREATMENT
BRAF,CHALLENGES,CNS,DABRAFENIB,EGFR,FURTHER,HER2,III,INCREASING,LABEL,LIMITED,MOLECULAR,NEWER,NSCLC,OPINION,PHASE,RANDOMIZED,STATEMENT,UNASSIGNED,WBRT
398,BACKGROUND,COLORECTAL,CONCLUSION,GREATER,INSTITUTE,LABEL,LUNG,METHODS,OVARIAN,RESULTS,SCREENING,SIMILARLY,SIX,THESE,TRIAL
123,2009,230,946,AMONG,ANNEXIN,FIVE,HOWEVER,JANUARY,JUP,LABEL,METHODS,MOST,OBJECTIVE,PAGE,PLEURAL,PROTEOMIC,PURPOSE,RESULTS,SDS,SEPTEMBER,SEQUEST,SEVEN
100,178,8805,BACKGROUND,LABEL,METHODS,NSCLC,OAS,RCT,RESULTS,TMZ,TREATMENT,TTP,WBRT
169,2013,ALSO,BECAUSE,COPYRIGHT,LTD,PROGRAMMED,THESE,THUS
945,G12D,HIF,HIF1A,KRAS,LABEL,LSL,PLOD,PLOD2,TRP53,UNLABELLED,UPS
169,2013,CONCLUSION,FAK,INC,LABEL,LSCC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TNM
169,185,2013,216,348,405,656,760,ADVERSE,COX,EVALUATED,EVALUATION,III,INSTITUTE,INTRA,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,SIR,SOLID,TTP
169,2013,947,A549,ANALYZING,BLM,BMG,CELL,COPYRIGHT,H2AX,H460,NCI
169,1800,1991,2007,2013,209,2161,2932,3459,350,568,AIMS,AUSTRALIA,BRAIN,COLLEGE,COPYRIGHT,HIGH,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,OLDER,PUBLISHED,RESULTS,ROYAL,SEVENTEEN,WBRT,WHOLE
169,17A,1ST,2013,28TH,7TH,947,AIMS,ANOTHER,ASSAY,BEST,COPYRIGHT,ELISPOT,IFN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SPOT,TH1,THESE
233,EXTUBATION,THUS
MOST,THESE,THUS
118,129,8201,8805,ACUTE,BACKGROUND,BORG,CONCLUSION,CONTEXT,CPE,CPET,LABEL,MEAN,METHODS,OBJECTIVE,POST,RESULTS,WATERPIPE,WATT,WTS
001,024,042,152,AIM,CONCLUSION,CYFRA21,LABEL,METHODS,OBJECTIVE,OSCC,RESULTS,SCLC,THERE
0001,001,015,100,169,179,2000,2012,2013,8804,8805,AHR,BLACKWELL,COX,GMBH,LDH,PULMONARY,SEVERAL
4DCT,ANATOMICAL,BACKGROUND,CBCT,CONCLUSION,CT1,CT2,CTV,IMRT,LABEL,METHODS,NSCLC,RESULTS,SIXTEEN,TYPICALLY
143,ACCORDING,AMONG,BACKGROUND,FINALLY,HOWEVER,LABEL,MICRORNAS,NSCLC,PCR,RESULTS
100,196,8805,ADC,ADCS,ALK,AMONG,BACKGROUND,CELL,CST,D5F3,DAB,FISH,FIVE,IHC,LABEL,METHODS,PCR,RESULTS,SIGNALING,TECHNOLOGY,ULTRAVIEW,VENTANA
178,1966,1974,1978,1980,2013,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DATA,DECREASED,ELECTRONIC,FEV1,HRQOL,ISSUE,LABEL,LIBRARY,MAIN,MEDLINE,META,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVID,PEDRO,RCTS,RESULTS,SCIENTIFIC,SELECTION,SMD,THREE
180,200,250A,CHROMATIN,NOTABLY
169,2013,946,A549,BASED,BESIDES,IHC,INC,NEMO,NLK,NSCLC,TCF,WESTERN,WILEY,WNT
001,177,188,1BB,215,246,947,CD137,CD3,CD8,ELISA,FEWER,IFN,MHC,TIL,TILS
001,007,150,508,ATLAS,BCAR1,LABEL,MAYO,METHODS,NSCLC,OBJECTIVE,RESULTS,SIMILAR,TCGA
006,011,1989,2008,622,BACKGROUND,DATA,HOWEVER,LABEL,METHODS,MPCS,RESULTS,THEREFORE
18F1,BACKGROUND,BASED,COHORTS,DLTS,ICRUCUMAB,IMC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PHASE,RESULTS,SIX,VEGFR
160,209,ASSESSMENT,AVERAGE,DED,DETECTION,EMOTIONAL,ESAS,FURTHER,ILLNESS,INTERVIEW,LABEL,MEASURE,METHODS,OBJECTIVE,PICTORIAL,PRISM,PURPOSE,RESULTS,SELF,SISC,SPANISH,STRUCTURED,SUFFERING,SYMPTOM,VAS
160,CEA,CEACAM1,CEACAM5,CEACAM6,CEACAMS,THESE
HOWEVER,METASTASIS,MOST
PHG,PULMONARY
EARLY
946,954,AKT,AUTOPHAGY,BACKGROUND,DESPITE,E1B,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PI3K,RESULTS
34A,954,H1299,H460,NCI,NOTCH,NSCLC,RHAMNETIN,TAKEN,TREATMENT
132,3000,945,BASED,ENO1,FINALLY,FURTHER,HIF,HIF1,OVERALL,SUPERVISED,VDAC1
015,100,1998,2005,2011,2012,2N0M0,BACKGROUND,CONCLUSION,HOWEVER,JULY,JUNE,LABEL,LOCAL,METHODS,NSCLC,RESULTS,SBRT,UNIVERSITY
AEROSOL,FINALLY,LUNG,SEVERAL,THEREFORE
AGAINST,AMONG,AREAS,BACKGROUND,CONCERNING,COVERED,LABEL,METHODS,OPINION,SCLC,SMALL
DMT,HILIC
100,956,ALTOGETHER,DUE,SIXTY,THEREFORE,WHILE

080,2010,794,801,ACCORDING,AMONG,FURTHER,PET,SURGERY,THEREFORE
AFTER,PEC
012,8805,CONCLUSION,GGN,GGNS,HEALTHCARE,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SIEMENS,SUCCESSFUL

164,200,945,947,AMONG,BLOOD,CD3,CD4,CD8,CONCLUSION,HOWEVER,IFN,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC
001,AFTER,CRYOPROBES,EBUS,PERIPHERAL
BASED,EXCLUSION,FINAL,NINE
169,2013,COPYRIGHT,JOHN,LTD,MEIER,PARAMETRIC,SONS,WILEY
AIM,BACKGROUND,CONCLUSION,CSC,CSCS,EMT,FINALLY,LABEL,LUNG,OBJECTIVE
PULMONARY
BRAF,DESPITE,EGFR,ERK,MEK
046,2003,2011,8201,AFTER,AGGRESSIVE,CRC,DESPITE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
CD176,THEREFORE,THOMSEN
ALK,EGFR,EML4
945,A549,SEVERAL,SIRT1,SIRT2,TOXOFLAVIN
318,ALTOGETHER,BOTH,FATIGUE,MORBIDITY,NSCLC,OVERALL,SABR,SLR,STAGE,THERE,TREATMENT
169,2013,7082,954,A549,AIF,AUTHORS,BAX,BAY,CONVERSELY,COPYRIGHT,DEPLETION,EB1,H1299,H460,IRELAND,LTD,NSCLC,PUBLISHED,ROS
177,BACKGROUND,DYNAMIC,FDG,FEW,FURTHER,INCREASED,IPAH,LABEL,LUNG,METHODS,PAH,PULMONARY,RESULTS
169,1970S,2013,80S,CNT,CURRENT,THERE,THESE
1033,215,290,543,8805,ACTN,ACTN4,BACKGROUND,COX,EVEN,HOWEVER,LABEL,METHODS,RESULTS
169,2013,AUC,CONCLUSION,LABEL,METHODS,NPV,OBJECTIVE,OBJECTIVES,PCR,PREDICTIVE,REAL,RESULTS,ROC,TELOMERASE,VALUE
169,174,2013,HOWEVER,LTD,NON,NPS,PRINT,TEMPLATES
AREAS,BACKGROUND,BIOMARKER,COVERED,EARLY,LABEL,METHODS,NSCLC,OPINION,PEMETREXED,PHASE,THUS
946,BACKGROUND,CDX2,CONTEXT,E12,ESOPHAGEAL,IMP3,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THOSE,TTF
AGAINST,BACKGROUND,COLLEGE,CONTEXT,ICCR,KINGDOM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REPORTING,RESULTS,ROYAL
000,8201,ALK,BOTH,FURTHER,H3122,OVERALL,REPLICATE,SILAC
126,1988,2012,288,AMONG,HOWEVER,M1A,TNM
RESECTION,SEVEN,SIX
HOWEVER,THEREFORE,THUS
BASED,FACTORS,LUNG,SIMILARLY,TNM
ACCORDING,AFTER,AMONG,CAREFUL,GENERAL,JAPANEASE,LUNG,MINIMALLY,RECORDS,RESECTION,RULES,SOCIETY,SURGERY,SVC,T4N0,T4N1
A870G,CCND1,HOWEVER,PCR,RFLP,THERE,THUS
AGAINST,CISPLATIN,EASTERN,ECOG,EGFR,FINALLY,GROUP,IIIA,INITIALLY,STRATEGIES,THESE,TNM,UICC,UNION
0054,009,026,BACKGROUND,BLOOD,CONCLUSION,DISEASE,LABEL,METHODS,NSCLC,PCR,RESULTS
006,029,BACKGROUND,CONCLUSION,EGFR,IIIB,LABEL,METHODS,NSCLC,PEMETREXED,PFS,RESULTS
239,500,ALK,AMONG,BACKGROUND,CONCLUSION,EGFR,LABEL,METHODS,NSCLC,NSQ,OBJECTIVE,PFS,RESULTS,TOXICITIES
008,BACKGROUND,CONCLUSION,EGFR,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,THERE,TKIS
006,039,BACKGROUND,CONCLUSION,LABEL,METHODS,NSCLC,OVERALL,PFS,RESULTS
HSE,HSV,PCI,SCLC,SMALL
BACKGROUND,CONCLUSION,H19,HOX,LABEL,MATERIALS,METHODS,PCR,RESULTS,RNAS
BRDU,GAPDH,H187,H69,H82,H889,HENCE,PCR,PROX1,SCLC,THREE
0072,ALA,ASP,DDX39,DEAD,FINDING,GLU,HOWEVER,HSP27,INTRINSIC,KLM1,PROTEOMIC,STUDENT,THESE
140,AIM,CONCLUSION,LABEL,MATERIALS,METHODS,MULTI,OBJECTIVE,OXIDATIVE,PAH,RESULTS,TAC,URINARY
A549,AKT,ARTOCARPUS,ARTONIN,BACKGROUND,CDC42,CELL,CONCLUSION,FAK,H23,H292,H460,KNOWLEDGE,LABEL,MATERIALS,METHODS,MIGRATION,MTT,RESULTS,THESE
2009,2010,2011,SINCE
134,150,2004,2008,293,862,CONCLUSION,ENGLAND,HIGH,HRS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,STUDIES,THERE
169,2013,AACR,HLA,MHC
001,105,139,164,169,2005,2012,2013,239,469,AACR,ALK,BETWEEN,COX,EGF,EGFR,EML4,HOWEVER,KRAS,LABEL,LOCAL,METHODS,MOLECULAR,NON,NSCLC,OBJECTIVE,PURPOSE,RATES,RESULTS
1100,BACKGROUND,CROSS,ENGLISH,FLORIDA,HISPANICS,LABEL,METHODS,NOTABLE,POISSON,RESULTS,THERE,WHITE
188,337,AMONG,BACKGROUND,CASES,CONCLUSION,ELISA,LABEL,METHODS,PHS,PHYSICIANS,PRO,RESULTS,SFTPB,THESE
BOTH,CCN2,CTGF,HIPPO,INVERSELY,TAZ,TEA,YAP,YAP1
241,EGFR,KRAS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
2000,2004,2012,2013,BACKGROUND,BECAUSE,CENTRAL,CONCLUSION,CONTROLLED,DATA,ENGLISH,EXTRACTION,FORCE,FOUR,FUNDING,HARMS,HEALTHCARE,INCIDENTAL,LABEL,LDCT,LUNG,MAY,MEDLINE,METHODS,OBJECTIVE,PREVENTIVE,PRIMARY,PURPOSE,QUALITY,RESULTS,REVIEWS,SELECTION,SMOKING,SOURCES,SYNTHESIS,SYSTEMATIC,TASK,THREE
003,005,ACT,BACKGROUND,DSS,INSURANCE,LABEL,LOCAL,LPFS,LTP,MEIER,METHODS,PATIENT,RESULTS,TREATMENT
COLORECTAL,CRC,DESPITE,DISEASE,MANAGEMENT,WESTERN
897,904,AIM,BONFERRONI,CDP,GTPASES,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,RHO,SIX,SNPS
IIIA,MIB,NCAM,NSE,OVARIAN,ROSETTE
HOWEVER,THESE,VITAMIN
160,IPM,RCC
001,169,183,185,1998,2012,2013,217,BACKGROUND,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR
AKT,ANTI,ANTIBODIES,EGFR,ERBB3,HENCE,HER2,HOWEVER,NSCLC,PI3K,TKI,TKIS
0125,169,2013,COPYRIGHT,IRELAND,LTD,ZOL
211H,DESPITE,EHMES,H290,IGF,MPM,MSTO,NCI,PAPPA
169,2013,ALK,COPYRIGHT,HEAT,HER2,HSP90,INHIBITION,LTD
169,2013,227,946,COPYRIGHT,GMBH,MUTATIONAL,NET,NETS,NUCLEAR
169,2013,BCL,COPYRIGHT,DPT,FIRST,H460,HOWEVER,III,NCI,NSCLC,SAS
169,2013,COPYRIGHT,IRELAND,LTD,TAKEN,WHEREAS
001,008,013,028,1058,1629,169,177,1990,2010,2013,2238,261,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,HEAVY,HOWEVER,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RESULTS,SMOKING,THERE
169,2013,COPYRIGHT,GCS,JAPAN,PUBLISHED,SOCIETY,THEREFORE
001,160,169,177,178,2006,2010,2013,322,417,500,BACKGROUND,COPYRIGHT,INC,INSERTION,JANUARY,LABEL,METHODS,PROCEDURE,PUBLISHED,RESULTS,SOCIETY,VARIOUS,VIDEO
CESSATION,CONCLUSION,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SRS
2ND
174,8482,946,AFTER,AKT,ALISO,AMENDMENTS,BACKGROUND,BROWN,CAMBRIDGE,CARIS,CCND1,CGH,CKS1B,CLIA,DELETIONS,EXPLORING,FGF4,FOUNDATION,GATA3,HOUSTON,K740,LAB,LABEL,LABORATORY,LIFE,MEDICAL,METHODS,MYC,NEXT,NRAS,PDGF,PHYLLODES,PI3K,Q504,Q61L,RB1,RESULTS,SPARC,TEXAS,THERE,TLE,TP53,UNIVERSITY,USA,VIEJO,WHOLE
695,A549,AKT,CYTOSOLIC,ERK,HUVEC,LLC,LUNG,NSCLC,PLA,TREATMENT,UTILIZING
CDC42,CDK4,CDK6,FINALLY,HCC,IHC,PRIOR
945,BASED,ENOLASE,TREATMENT
169,2013,AACR,BCL,BCL2,BECAUSE,BOTH,EGF,EGFR,JAK2,JANUS,NSCLC,PTPMEG2,SRC,STAT3,THESE
169,183,2013,8201,A549,DOX,GMBH,HCL,KGAA,RAPID,VCH,WILEY
102,1985,2004,2006,795,BACKGROUND,EVER,LABEL,METHODS,POISSON,PREVENTIVE,RESULTS,SMOKING,SPC,SPCS,THESE
106,169,2013,ANXIETY,CONCLUSION,COPYRIGHT,DEPRESSION,FCS,FIRST,IIIB,JOHN,LABEL,LTD,MANAGEMENT,METHODS,OBJECTIVE,RESULTS,SCALE,SELF,SONS,SYMPTOM,WILEY
100,169,2000,2013,287,4561,AMONG,BACKGROUND,FNA,FNAS,GENOMIC,HISEQ,KRAS,LABEL,METHODS,NEXT,NOS,NSCLC,PTEN,RB1,RESULTS,SCLCS,SMAD4,SOCIETY,SOX2,TP53
169,2007,2009,2013,215,219,226,871,882,BAYES,CONSORTIUM,EHB,EPIDEMIOL,GENET,GWAS,GWASS,INC,INFERENCES,LUNG,MURCRAY,THESE,WILEY
113,169,2013,ADC,FDG,MEAN,MRI,PET,UICC
169,2013,INC,LUNG,OPENING,RESULTS,SCREENING,TRIAL,WHILE,WILEY
169,1995,2010,2013,8201,8805,BACKGROUND,CONCLUSION,COPYRIGHT,FACTORS,INC,LABEL,METHODS,PRIMARY,PULMONARY,RESULTS,WILEY
000,169,2010,2013,2015,EUCT,INC,NLST,UKLS,WILEY
169,2013,ACRIN,HOWEVER,INC,LDCT,LUNG,NLST,SCREENING,TRIAL,WILEY
259,365,BOTH,ERK,H1299,MAP,PKA,RAF,RAS,SER,THESE
169,2013,99A,ALSO,BACKGROUND,CONCLUSION,COPYRIGHT,COX,FUNCTIONAL,INC,LABEL,LOW,MEIER,METHODS,MIR,MTT,PCR,RESULTS,WESTERN,WILEY
008,230,299,463G,463GA,8201,MPO,SP1
3P12,3P22,AKT,CDK2,CDK6,CMTM,CMTM6,CMTM7,CPG,ECTOPIC,EGFR,THUS,TSG,TSGS
001,BACKGROUND,CONCLUSION,DISEASE,HCC,LABEL,METHODS,RESULTS,SIXTY
000,160,8805,AES,AZD7762,CHK1,CHK2,CTCAE,DOSE,GRADE,LABEL,METHODS,OBJECTIVE,OVERALL,PHASE,PURPOSE,RESULTS,THERE
100,177,CARLO,CTS,HENCE,HOWEVER,LUNG,MONTE,PTV,RESULTS,THEN,THEREFORE,THUS,TREATMENT
0001,100CM,176,177,235,435,500,700,788,BACKGROUND,LABEL,METHODS,NNK,POTENTIAL,RESULTS,THIRDHAND,WHILE
LUNG,PROGNOSIS,TAAS
CARCINOID,LABEL,OPINION,STATEMENT,UNASSIGNED,VEGF
143,ASP,CNS,EGFR,FLA,L858R,LNA,NSCLC,PCR,PNA,THERE
AIDS,CD4,CONCLUSION,HAART,HIV,IDUS,IRR,IRRS,LABEL,LUNG,METHODS,MOST,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SCHOLAR,SCIENCE,SIR,SIRS,SIXTY,USA,WEB
00001,001,177,COPD,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PEAK,PRP,RESULTS,STRATEGIES,THERE,TIME,TNM,VO2
169,2013,314,330,339,549,7721,956,AIM,BACKGROUND,CAI,CHINA,CHINESE,COMPOUNDS,DPPH,EACH,ETOAC,FIVE,FOUR,IC50,IRELAND,LABEL,LTD,MATERIALS,MCF,METHODS,NIU,OBJECTIVE,RELEVANCE,RESULTS,SMMC,SW480,TCM,TCMS,WEI
001,169,2013,2100,946,AGILENT,NSCLC,PCR,ROC
169,177,2013,946,956,A549,AUTHORS,BIS,CD31,COPYRIGHT,DIM,EGFR,MET,MMP2,MMP9,MYC,NUR77,PUBLISHED,RESPIRABLE,TR3,VEGF
169,2013,2206,946,AKT,AKT1,CONVERSELY,COPYRIGHT,GSK3,LTD,RUNX3,TAKEN
945,CKD,INC,PUBLISHED,SEVERAL
109,169,2013,COPYRIGHT,ECA,EGCG,ERK,INC,JNK,MAPK,PD98059,SPC,TEA,TF3
2000,2004,231,233,234,AAPC,AREA,DIC,DOLL,HOWEVER,IOWA,LABEL,LTD,METHODS,OBJECTIVE,PUBLISHED,RESULTS,TSCE
002,100,115,169,2006,2008,2013,207,BACKGROUND,COPYRIGHT,COX,INC,INCIDENTAL,JANUARY,LABEL,MEIER,METHODS,RESULTS,ROCHESTER,UNIVERSITY,VTE
169,2013,COPYRIGHT,EGFR,HOWEVER,IRELAND,LTD,MUTATIONS
169,2013,COPYRIGHT,IRELAND,LTD
169,2013,498,634,CHINA,CIS,COPD,COPYRIGHT,HISTORY,IRELAND,LTD,ODDS,ORS,THESE,USING,XUANWEI
169,2013,ALK,COPYRIGHT,CSS,EGFR,EML4,FFPET,FISH,IRELAND,KIF5B,KRAS,LTD,NSCLC,RET,THUS
00001,0111,0175,169,2013,904,ADC,AIS,ATS,BACKGROUND,COPYRIGHT,COX,EPIDERMAL,ERS,FIVE,IASLC,IDI,IRELAND,KRAS,LABEL,LEPIDIC,LTD,LUNG,METHODS,MIA,RESULTS,SOCIETY
0001,0056,0147,158,169,2013,AMONG,BACKGROUND,CD25,CD4,COPYRIGHT,CROWN,FOXP3,IRELAND,LABEL,LTD,METHODS,NSCLC,PBL,PUBLISHED,REGULATORY,RESULTS,RLNL,TREGS
0001,064,139,169,1999,2012,2013,468,607,BACKGROUND,COCHRAN,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,MEDLINE,META,METHODS,NSCLC,PEM,PEMETREXED,PFS,RESULTS,STUDENT,STUDIES,TAXS
160,169,192,1989,2011,2013,AMONG,BACKGROUND,COPYRIGHT,COX,INC,LABEL,METHODS,PREDICTORS,PUBLISHED,RESULTS,SOCIETY,SOFT,STS
169,2013,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,THEIR,ZEALAND
169,2013,500,BACKGROUND,COPYRIGHT,FORTY,III,IIIB,IRELAND,LABEL,LOW,LTD,METHODS,NSCLC,PROMISING,RESULTS,SIX,THERE
008,100,130,132,134,164,169,197,2007,2011,2013,209,332,352,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,INC,JANUARY,LABEL,METHODS,NOS,NSCLC,RESULTS,SIX,SMALL
169,189,1998,2010,2013,428,8805,BACKGROUND,COPYRIGHT,EASTERN,ECOG,ELDERLY,FACTORS,GROUP,HOWEVER,III,INC,JANUARY,LABEL,METHODS,NSCLC,RECORDS,RESULTS
169,2013,BACKGROUND,COPYRIGHT,H460,IRELAND,LABEL,LTD,MATERIALS,METHODS,NOTCH,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS
0941,169,2013,8505C,945,ACTIVATION,AUTHORS,BACKGROUND,COPYRIGHT,FAK,GDC,GRAY,GTPASES,HIF,HYPOXIA,IRELAND,LABEL,LTD,METHODS,MIGRATION,OBJECTIVE,PI3K,POST,PUBLISHED,PURPOSE,RADIATION,RESULTS,RHO,WESTERN
169,2013,COPYRIGHT,HIGH,LTD,PUBLISHED,THESE
169,174,2013,ACR,COLLEGE,COPYRIGHT,INC,PUBLISHED,RADIATION,RADIOLOGY,RTOG,SEQUENTIAL
169,2013,COPYRIGHT,PUBLISHED,SEPAR,THREE
0001,115,141,169,1993,2005,2013,256,BACKGROUND,COPYRIGHT,JANUARY,LABEL,MATERIALS,METHODS,NSCLC,PUBLISHED,RESULTS,SEPAR,THERE,VATS
111,411,416,COLORECTAL,COX,DIETARY,INC,LABEL,LUNG,METHODS,OBJECTIVE,OVARIAN,PUBLISHED,PURPOSE,RESULTS,SCREENING,THESE,TOTAL,TRIAL
002,003,005,150,169,2013,240,500,8804,ASIAN,BACKGROUND,COPYRIGHT,COX,EAST,EASTERN,ECOG,FIRSTLY,GROUP,LABEL,LTD,METHODS,NSCLC,PEMETREXED,PFS,RESULTS
0001,169,2013,392,8201,ASIAN,AUTHORS,BACKGROUND,EASTERN,ECOG,GROUP,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,THERE,USING,VO2PEAK
DRP1,DYNAMIN,GTPASES,THESE
FOXO1,THESE
100,AIMS,ARMS,EGFR,IHC,IIIB,LABEL,MATCHED,METHODS,MPE,NSCLC,OBJECTIVE,RESULTS
169,2013,4606,AACR,INCREASED,INTERPLAY,MDSC,MDSCS,OSTEOLYSIS,RES,THEREFORE,THESE
200,BACKGROUND,BORTEZOMIB,DLT,LABEL,METHODS,MTD,PHASE,RESULTS,SORAFENIB,VEGFR
2006,2011,750,BACKGROUND,GRADE,HOWEVER,LABEL,METHODS,NON,RESULTS,THERE
181,954,A549,ACTIVATION,BESIDES,CASPASE,CONTENT,HIGH,HOWEVER,MMP,PARP,SCREENING,THESE,TREATMENT
1863,1981,1992,2000,632,AMONG,FURTHER,LABEL,METHODS,OBJECTIVE,RESULTS
145,900,ALTOGETHER,BAX,BESIDES,CCAAT,EBP,EGF,GLUCOSE,GRP78,INSTEAD,PDT,PHOTOFRIN,SUBA,UPR,VAD
0001,041,2006,2009,299,770,9766,AMONG,BACKGROUND,CONCLUSION,DRUG,LABEL,METHODS,ORS,PRESCRIBED,RESULTS,SWEDISH,TNM
160,4A4,916,NP63,PHAGE,SFI,TAP63,THESE,TP63,WESTERN
ALK,APART,BREAK,COLOR,DUAL,EGFR,FISH,KITS,NONE,PCR,PYRO,Q24,VYSIS
1640,2012,307,400,8201,FGFR1,FISH,HOWEVER,MOST,SCLC,SCLCS,SMALL,THEREFORE
0001,0037,005,0093,100,CDX2,CK20,CONVERSELY,G12C,G12R,KRAS,LUNG,METASTATIC,TTF
001,100,MOLECULAR,THERE
100,1771,200,2010,2104,250,302,ASIAN,BACKGROUND,BASIC,BETWEEN,CONCLUSION,DATA,EGFR,FIVE,GEFITINIB,LABEL,MARCH,METHODS,RESULTS,THERE,WEB
001,2585,8201,8805,BACKGROUND,BMI,CONCLUSION,COX,DATA,EASTERN,GROUP,LABEL,METHODS,OBESITY,RESULTS
BACKGROUND,CONCLUSION,EPHB2,H2595,INHIBITION,LABEL,MALIGNANT,METHODS,MMP,MOST,RESULTS,USING
100,167,ACA,ACAS,ALK,D4D6,EGFR,FISH,IHC,KRAS,ROS1
169,2013,BASEL,COPYRIGHT,LTD,VEVEY
017,028,146,169,173,2013,204,841,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,EUR,FOUR,INDICATORS,INDWELLING,IPC,IPCS,LABEL,MEAN,METHODS,MPE,OBJECTIVE,OBJECTIVES,RANDOMIZED,RESULTS
1200,1284,2002,2008,C34,EMERGENCY,FACTORS,HALF,HIPE,HUNDRED,ICDO2,III,IRELAND,LABEL,LOS,METHODS,NCR,NSCLC,OBJECTIVE,OBJECTIVES,PATIENT,POISSON,RESULTS,RISK,STAGE
169,2008,2012,2013,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GRADE,INC,LABEL,LOCAL,METHODS,RESULTS,SBRT
0007,160,169,2013,454,BACKGROUND,CCI,CONCLUSION,COPYRIGHT,III,INC,INDEX,LABEL,METHODS,NON,NSCLC,RESULTS
001,005,023,039,169,2013,394,476,594,8314,8315,961,BACKGROUND,CD44,CD45,CEA,CONCLUSION,COPYRIGHT,EBUS,EPCAM,FCM,HOWEVER,INC,LABEL,LEWIS,METHODS,NSCLC,PCR,RESULTS,TBNA
005,169,2013,956,A2780,A549,COPYRIGHT,HPLC,LTD,LUBELUZOLE,MTT
116,11R,169,2013,549,945,947,956,COPYRIGHT,DIETHYL,DIVERSE,FEW,HCT,IC50,LTD,LUNG,MICHAEL,MORPHOLINE,THP
169,2013,205,AKT,ALDA,CHEMICALLY,KLN,RESULTS
004,005,169,2013,BACKGROUND,CONCLUSION,EGFR,EPIDERMAL,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,T790M
000,163,174,2001,2010,8594,AES,ASSESSMENT,BACKGROUND,BRITISH,CARE,CELGENE,CIS,COMPANY,DATA,DOC,EGFR,ELI,EXCELLENCE,FABRE,FEW,FORMULARY,FUNDING,GEF,GEM,HOWEVER,INC,INSTITUTE,LABEL,LIBRARY,LILLY,MEDLINE,META,METHODS,NAVELBINE,NICE,NONE,NSCLC,OBJECTIVE,OBJECTIVES,PAX,PEM,PFS,PLAT,POOR,QALY,RESULTS,SOURCES,TECHNOLOGY,THREE,USING
0001,ACCORDING,BACKGROUND,CEACAM1,HOWEVER,LABEL,METHODS,NSCLC,PCR,RESULTS,SERUM
169,2013,COPYRIGHT,INC,PUBLISHED,SEVERAL,SIR
134,178,A549,AEC,AECS,BCL,FINALLY,FURA,IRE,THESE,USING
946,BACKGROUND,CD3,CD4,CD8,INADEQUACY,LABEL,MAIN,MDSCS,METHODS,MYELOID,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THESE
2008,2009,946,ANOVA,BACKGROUND,CONCLUSION,CRT,EARLY,EPCS,III,LABEL,METHODS,MOST,NSCLC,RESULTS,TGF,TRIAL,USING,VARIATIONS
001,016,029,032,043,046,049,053,956,BACKGROUND,BPDE,INCREASED,LABEL,METHODS,PAH,PAHS,PBLS,PCR,POLYCYCLIC,RESULTS,WHETHER,WORKERS
8764,945,946,956
169,2013,AACR,AKT,AKT1,E17K,E278A,ECTOPIC,FULL,K276,K276R,PIAS1,PROTO,SENP1,STRIKINGLY,SUMO,SUMO1,SUMOYLATED,UBC9
101,138,2009,2011,558,581,686,8201,ALSO,BACKGROUND,BETWEEN,CONCLUSION,FDG,HALLE,IMAGING,JANUARY,LABEL,METHODS,OBJECTIVE,PET,PREVIOUSLY,PURPOSE,RESULTS,SMM,SUV,THERE
BACKGROUND,CONTEXT,DFS,LABEL,OBJECTIVE,PERSISTENT,RECURRENCE,RESULTS,SIXTY,THYROID
100,177,8201,8805,BLAND,CONCLUSION,DIFFERENT,EACH,FIVE,HOUNSFIELD,INTER,KNOWLEDGE,LABEL,MDCT,METHODS,OBJECTIVE,RESULTS
0002,009,048,227,255,357,8805,BACKGROUND,COX,KETOROLAC,LABEL,METHODS,NLR,RESULTS

ADS,EVENTUALLY,NOTABLY,PCSC,PCSCS,STAGE,THESE,TRAMP
183,BACKGROUND,CONCLUSION,EMG,GEORG,LABEL,METHODS,POSTERIOR,RESULTS,STUTTGART,VIDEO,VINCI,YORK
013,029,835,ARARG,ARG,ARG399GLN,CHINESE,DATA,GLN,META,OVERALL,THERE,XRCC1
001,046,160,ALONGSIDE,ALSO,BLOOD,DATA,FIFTY,ICAM
CONCLUSION,LABEL,METHODS,OBJECTIVE,PDE5,PURPOSE,RESULTS
160,1995,2009,477,621,721,8805,BEGINNING,JANUARY,LABEL,METHODS,OBJECTIVE,PURPOSE,RELATIVELY,RESULTS,SRES
160,2013,CATALAN,DKFZ,EXPERTS,FIRST,GERMANY,HEIDELBERG,IMPPC,JUNE,MEDICAL,PEBC
956,AGS,COMPOUNDS,COOH,IC50,J82,MES,MRC
104,107,110,112,150,169,183,2013,222,540,702,BACKGROUND,COPYRIGHT,EGFR,ERLOTINIB,HOWEVER,ITALIAN,LABEL,LTD,METHODS,NSCLC,RESULTS
146,2003,2008,2010,278,AFTER,BACKGROUND,BMP,CONCLUSION,DATA,LABEL,LEVEL,METHODS,OBJECTIVE,RESULTS,SUMMARY,THERE
AKT,BACKGROUND,BECAUSE,CONCLUSION,EGFR,ERK,ERLOTINIB,FINALLY,LABEL,METHODS,NSCLC,RESULTS,SERUM,TKI,TKIS
2011,BACKGROUND,CCT,COLLECTED,CONCLUSION,FORTY,III,LABEL,METHODS,NSCLC,PREDICTED,RESULTS,THERE,THESE
2006,2008,2011,AFTER,BACKGROUND,CASE,CONCLUSION,EMERGENCY,ESPECIALLY,LABEL,METHODS,MRI,PALLIATIVE
169,2013,2DG,AACR,AMP,AMPK,ATP,BCL,EGF,EGFR,H1975,III,MCL,NSCLC,PC9,T790M,THESE,TKI,TKIS,TREATMENT
156G,2003,2007,443,443C,8201,CHI,CONCLUSION,III,LABEL,MEIER,METHODS,OBJECTIVE,OPN,PURPOSE,RESULTS,THREE,TNM
CONCLUSION,LABEL,LARGE,OBJECTIVE
120,256,APE,CONCLUSION,GGNS,KRUSKAL,LABEL,MANN,MATERIALS,MDCT,METHODS,OBJECTIVE,RESULTS,WHITNEY
DIAGNOSTIC
001,011,014,018,032,106,177,182,239,446,580,776,946,EPC,EPCS,FACS,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,STAGE
169,2013,4T1,945,AACR,B16LACZ,BOTH,CONCLUSION,IFN,LABEL,METHODS,NEXT,OBJECTIVE,PURPOSE,RESULTS,SURGERY,THESE,TLR3,USING
ACP,CENTRAL,CUBA,ENGLISH,FLORIDA,KNOWLEDGE,LATINOS,NINE,SPANISH,USA,VENEZUELA
160,174,233,BRAF,DABRAFENIB,FDA,III,PHASE,PRE,V600E
138,SISO
001,002,011,014,033,120,2011,2012,205,541,553,NSCLC,OBJECTIVE,OCTOBER,PCR,SEPTEMBER,SERUM,SIMILARLY
1007,ALK,III,PROFILE

946,EMT,HOWEVER,PAR6,TGF
945,ACHE,APS,APS8,NATURALLY,NSCLC,RENIERA
222,249,CHRONIC,HPRT,RADON,SUGGESTED,THERE,TP53

C56BL,C57BL,HOWEVER
106,147,169,2013,946,A549,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,MTT,RESULTS,THEREFORE,TNM,WNT
169,2013,APART,CSCS,FAILURE,MDR
120,169,2013,300,370,BSA,COPYRIGHT,FDG,HOWEVER,IRELAND,LABEL,LTD,MAXIMUM,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,SUV
100,956,BAX,BCL2,H1975,H441,HOWEVER,IC50,JAK,JAK2,JANUS,LUNG,STAT,STAT3,T790M
APERT,FGF,FGFR,FGFR1,FGFR2,FGFR3,FGFR4,FIBROBLAST,FINALLY,ONTOLOGIC,SOMATIC,THESE
001,004,100,138,160,187,2009,2011,214,281,509,920,AFTER,ARF,BACKGROUND,BASED,DIAGNOSTIC,JULY,JUNE,LABEL,LOG,METHODS,RESULTS
169,2013,BECAUSE,CD163,COPYRIGHT,FOLR2,GMBH,HIGH,HOWEVER,LPL,MSR1,NSCLC,THESE
100,253,AUC,PROJECTION,REMOVAL
035,169,2013,215,625,956,APOPTOSIS,BUDR,COPYRIGHT,ED50,ELISA,FLOW,H69,IC50,IRELAND,LTD,MDR,PGP,PRE,SCLC,SILIBININ,SILYBUM,SMALL,THESE,VPA17
000,100,110,118,129,150,8201,8805,BACKGROUND,BED,CHI,COX,KARNOFSKY,KPS,LABEL,METHODS,RESULTS,SRS,UNIVARIATE,WBRT
CIGARETTE,CKD,CVD,NAFLD,SMOKERS,SMOKING,T2DM
188,CONCLUSION,DOF,INTRA,LINAC,MEAN,NSCLC,PTV,REAL,RESULTS,SBRT
ADVERSE,LABEL,LAM,MAIN,METHODS,OBJECTIVE,OPEN,OUTCOME,RESULTS,SETTING,TSC,TSC1,TSC2
0001,0012,0069,008,036,121,163,284,2NG,8805,BACKGROUND,CEA,CONCLUSION,COX,CYFRA,ECOG,EGFR,HOWEVER,LABEL,METHODS,MST,NSCLC,PCV,RESULTS,SERUM,TKI,UNIVARIATE
1990,1998,2000,2001,2008,APC,BACKGROUND,CHAMORROS,CIS,GUAMANIANS,HAWAIIANS,INSTITUTE,LABEL,LACK,METHODS,NHOPI,OTHER,PACIFIC,POPULATION,RESULTS,SAMOANS,SEER,UTILIZING
1990,1994,2003,2004,2006,2008,AMONG,APC,ASIAN,BACKGROUND,CHINESE,CIS,DECREASES,END,FILIPINAS,FILIPINOS,INCIDENCE,INDIANS,JOINPOINT,KAMPUCHEAN,KOREANS,LABEL,LAOTIAN,METHODS,PAKISTANI,PAKISTANIS,RATES,RESULTS,SEER,STAT,THESE,VIETNAMESE
100,BACKGROUND,HOWEVER,LABEL,METHODS,NONE,RESULTS
METICULOUS,ROUTINE
015,017,025,039,144,1A1,205,ALDH1A1,BACKGROUND,CD133,COX,EXPRESSION,LABEL,METHODS,NSCLC,RESULTS,THESE
144,169,16Q12,2013,423,8Q22,AMONG,ASIA,AUTHORS,BARR,BRITAIN,C666,CHINA,EBF,EBFS,EBV,EPSTEIN,GREAT,IRELAND,JOHN,JOURNAL,KNOCK,LTD,NOTABLY,NPC,NPCS,PATHOLOGY,SOCIETY,SONS,THESE,UBR5,WILEY,ZF29
169,2013,COPYRIGHT,DOCYANINE,DTXL,GMBH,ICG,KGAA,LHRH,PE40,VCH,WILEY
8482,A375,HOWEVER,MIYAURA,PKH26,POLARIC,THEREFORE,THESE
A431,A549,HOWEVER,METFORMIN,PANC,RAS,SIMILARLY,THESE
2009,2011,217,BACKGROUND,EAST,ENTRY,FIFTY,GRADE,JULY,LABEL,MARCH,MBQ,METASTRON,METHODS,NRS,REGARDING,RESULTS,SELF
BASED,FDG,HISTOLOGY,PET
EXTRA,FDG,PET,PRIMARY
99M,MRI,NAF,PET
8209,COX2,CXCR4,DESPITE,EGFR,HAART,HIV,HOWEVER,TODAY
114,ALK,BRAF,CD74,EGFR,EZR,KIF5B,KRAS,NSCLC,RET,ROS1,SLC34A2
182,A549,FINALLY,HOWEVER,LUNG,PDCD4,PROGRAMMED,SPC,THESE,TRANSWELL
200,CONCLUSION,EARLY,HOUNSFIELD,IMAGE,LABEL,LUNG,METHODS,NOISE,OBJECTIVE,PARTITION,PROGRAM,PURPOSE,RESULTS,TBE
100,DRUG,FOOD,HOWEVER,SEVEN,SUNITINIB
160,CML,ILD,NILOTINIB
10R,11R,13S,14R,866,8764,AKT,BECLIN1,CELLS,EXPRESSION,FADD,FLICE,GFP,GSK3,HUH7,KNOCKDOWN,LAMP2,LC3,LC3II,PI3K,SIMILAR,TREATMENT
1021,124,1600,162,2009,2012,271,327,AMONG,BACKGROUND,CHEST,CONCLUSION,LABEL,MAY,METHODS,NSCLC,RESULTS,THERE,VATS
169,1T1,2013,956,AFFYMETRIX,CELLS,COPYRIGHT,DEGS,DMA,EACH,HBE,III,INCREASING,INORGANIC,IRELAND,LC50,LTD,MMA,NRF2,THESE
169,188,2012,2013,267,ALK,BRAF,CONCLUSION,COPYRIGHT,CRC,DDR2,EGFR,ESTIMATED,EUR,FGFR1,HER2,JANUARY,KRAS,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PREEMPTIVE,PTEN,PURPOSE,RESULTS,WEST
1083,169,1988,2009,2012,241,AEDV,BACKGROUND,CNS,COPYRIGHT,ESPA,LABEL,MATERIALS,METASTASIS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
001,101,2010,2011,BETWEEN,BLOOD,CONCLUSION,JANUARY,LABEL,MATERIALS,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,PERFUSION,RESULTS,VALIDATION,VPCT
100,160,169,2003,2011,2013,AIM,ALK,CD117,CD34,CD68,CENTRAL,CONCLUSION,COPYRIGHT,CROWN,HEPATIC,HOWEVER,IMT,IMTS,LABEL,LTD,MATERIALS,MAY,METHODS,MRI,NONE,OBJECTIVE,PATHOLOGY,PUBLISHED,RESULTS,SEPTEMBER,SMA,SOUTH,T1WI,TEN,THEREFORE,UNIVERSITY,XIANGYA
011,100,138,142,1998,2007,AMONG,BACKGROUND,HEAD,ICU,INSURANCE,IQR,LABEL,METHODS,MORTALITY,PALLIATIVE,PMV,QALE,QUALITY,RESULTS
0003,200,2000,2010,383,956,AIDS,ART,BACKGROUND,CD4,CURRENTLY,HIV,HOWEVER,IIIA,IIIB,LABEL,LUNG,METHODS,OTHER,RESULTS
H23,HOWEVER,ROS,THEREFORE
145,BACKGROUND,HSV,ICP27,LABEL,METHODS,MICRORNAS,NON,NSCLC,ONCOLYTIC,RESULTS
1718,A549,AKT,APOPTOSIS,COX,DATA,IC20,IC5,LABEL,LEWIS,LLC,MATERIALS,METHODS,MTT,OBJECTIVE,PAEONOL,PI3K,PROTEIN,PURPOSE,RESULTS,TUNEL,WESTERN
DESPITE,HACAT,LEWIS,THESE
0063794,AIMS,AKT,ATP,CONCLUSION,EGFR,EPIDERMAL,FOXO1,H1650,H1975,IC50,LABEL,METHODS,MTT,NSCLC,OBJECTIVE,PC9,PC9GR,RESULTS,TKI,TKIS
0005,004,005,006,009,803,819,8202,APE1,BACKGROUND,CHINA,CHINESE,DATA,FURTHER,GENOTYPES,GIVEN,HAN,HAPLOTYPE,HARDY,LABEL,LUNG,MDR,METHODS,OVERALL,PALLELE,PGENOTYPE,QIQIHAR,RAGE,RESULTS
0001,2000,2005,591,929,ANOVA,BACKGROUND,CHI,CONCLUSION,JANUARY,LABEL,METHODS,OVERALL,RBC,RESULTS,TRANSFUSED
005,007,8202,III,YANG,YIN,YMR
AKT,ATP,CDC42,FAK,H292,HOWEVER,OUABAIN,ROS
009,077,184,2000,2010,371,809,910,BACKGROUND,CONCLUSION,FURTHER,INSURANCE,LABEL,METHODS,PAP,RESULTS,RNS,SIR,SIRS,TAIWANESE
946,BACKGROUND,BONE,CONCLUSION,HFE,INHIBITION,LABEL,RESULTS,SINCE,THEREFORE,USING
1824,676,8202,BACKGROUND,BIAS,DATA,LABEL,LUNG,METHODS,NONE,OBJECTIVE,PAL,RANDOMIZED,REGARDING,RESULTS,SPR,STUDIES,SUCTION,SUMMARY,SYSTEMATIC,THERE,WHETHER
AFTERWARDS,APPL1,ARF4,ARHGEF9,ASPM,BIRC5,BUB1,CBX3,CCNA2,CCNB2,CDC27,CDC42,CDCA5,CDCA8,CDK1,CDK5,CGH,CLPTM1L,DOK2,EGFR,FOXP1,FUS,GRM2,GWAS,KIF15,KIF2C,LPP,MACF1,MSX2,MYBBP1A,MYO10,NEK2,PGF,PRC1,PRKAR2A,PRPF6,PSMD2,PTK2,RAB5A,SENP2,SMARCC1,SMC4,SNP,SOX18,SP4,SRC,SYCE2,TAF15,TFDP1,TRA2B,TTK,VAPB,XIAP
469,916,BIRT,DUBE,F157,FLCN,FOLLICULIN,HOGG,K508R,SERINES,SIMILARLY,THESE
CONVERSELY,FURTHER,METASTASIS,THESE,TKS5,TKS5SHORT
2014,500,ASSURANCE,CENTRES,CONSORTIUM,EFFECTIVE,GROUP,QUALITY,SABR
177,2006,2012,BACKGROUND,CHEST,CONCLUSION,LABEL,MDCT,METHODS,OBJECTIVE,PFT,PULMONARY,PURPOSE,RESULTS,RHEUMATOID,THERE,THEREFORE
169,2013,A549,AACR,ACUTE,BER,CHRONIC,EXPRESSION,H1299,H1975,THUS,UNG
169,2013,A549,COPYRIGHT,EGFR,GMBH,HOWEVER,INPS,KGAA,NPS,OCA,OLEYL,PLGA,VCH,WILEY
000,LDCT,LUNG,NLST,SCREENING,TRIAL
057,151,169,1998,1999,200,2008,2011,2013,208,AMONG,COPYRIGHT,DATA,FEW,GERMANY,INSTITUTE,KOCH,SMOKING,TOBACCO,UICC
160,FDG,PET,SINCE
ASIAN,BESIDES,CCND1,G870A,MEDLINE,OVERALL,SEVERAL
377,LITERATURE,SEVERAL
ARKO,GENERATION,HOWEVER
CD82,DARC,DUFFY,HOWEVER,RESULTS,TAKEN
10TH,120,160,176,203,25TH,50TH,8804,8805,BMI,BRIEF,EASTERN,FATIGUE,GROUP,HGS,INVENTORY,LABEL,LIFE,METHODS,OBJECTIVE,PURPOSE,QOL,QUALITY,RESULTS,WHETHER
117,1993,2013,295,400,CASES,JANUARY,MEDICAL,THEREFORE,UNIVERSITY
19Q12,1P13,HERV,HERVS,HML,LTR,LTRS,NOVEL,PCR,SEQUENCES
103,169,2013,AACR,ALK,BRG1,BRM,DDR2,EGFR,FGFR1,HOWEVER,NSCLC,RNAI,SMARCA2,SMARCA4,SNF,SWI
169,2013,945,946,AACR,AKT,EGF,EGFR,HOWEVER,INCREASED,RNAI,SRC
15Q25,DATA,EMSAS,GATA,PUBLISHED,RESULTS,SNP,SNPS
100,169,2013,267,946,A431,ABS,COPYRIGHT,EGFR,EGFR237,EGFRS,EPIDERMAL,LEWIS,LLC,MVF,THEREFORE
001,002,005,009,033,139,169,180,2006,2012,2013,505,BACKGROUND,BRAIN,CONCLUSION,COPYRIGHT,EGFR,EPIDERMAL,FURTHER,IRELAND,JANUARY,LABEL,LTD,METHODS,RESULTS,TKIS
001,169,172,2013,ACCORDING,COPYRIGHT,DATA,KARNOFSKY,LABEL,METHODS,MONTH,OBJECTIVE,PRIMARY,RESULTS,SCLC,SCORE
169,2013,AUTHORS,COPYRIGHT,EPIDERMAL,GLI2,HOWEVER,IHH,INC,MUTATIONS,PUBLISHED,STRIKINGLY,THUS,USING
169,2013,CCAM,CCAMS,COPYRIGHT,HOWEVER,LTD,MEDICAL,WHICHEVER
001,003,009,017,036,042,114,130,169,2013,ACTIVITIES,ASSESSMENT,CAUCASIAN,CHALLENGES,CHRONIC,COGNITIVE,COPYRIGHT,DAILY,FUNCTIONAL,ILLNESS,INC,INSTITUTE,KARNOFSKY,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,OVERALL,PROGRAM,PROJECT,QOL,RESULTS,SIXTY,SUPPORT,THERAPY,TOTAL
016,034,049,135,160,169,2013,BACKGROUND,CA9,COPYRIGHT,CSF1,DUSP6,EGFR,ERBB3,EXPRESSION,FRESH,III,INC,LABEL,LCK,METASTASIS,METHODS,MMD,NSCLC,PCR,RESULTS,SCC,SEVERAL,STAT1,THERE
048,169,177,2013,COPYRIGHT,DATA,LTD,MOST,ORAL,PUBLISHED
156,169,177,2010,2012,2013,AMONG,AVERAGE,BACKGROUND,COPYRIGHT,INC,LABEL,MAY,METHODS,PUBLISHED,REPORTS,RESULTS,SOCIETY,THERE,VATS
169,2013,ADIPOKINES,ADIPOSE,AIM,BACKGROUND,COPYRIGHT,FEW,INCREASING,LABEL,LTD,MATERIALS,MEDLINE,METHODS,OBJECTIVE,RESULTS,SEVERAL
120,AMONG,BACKGROUND,CTA,LABEL,METHODS,RESULTS,SEVENTY
012,169,2013,8201,AUSTRALIAN,BACKGROUND,COLLEGE,DFS,EIGHT,FAZA,FDG,IIIA,IIIB,INTRA,LABEL,METHODS,NSCLC,PET,RESULTS,ROYAL,SEVENTEEN,THERE,ZEALAND
169,2010,2012,2013,8201,AUSTRALIAN,AUTHORS,COLLEGE,CONCLUSION,EACH,IMAGING,JOURNAL,JUNE,LABEL,LOCAL,MATERIALS,MEDICAL,METHODS,MWA,MWAS,OBJECTIVE,PURPOSE,RADIATION,RESULTS,ROYAL,TREATMENT,ZEALAND
001,169,183,2013,211,223,272,328,553,787,824,888,COPYRIGHT,COX,FOUR,INC,INDEX,LABEL,METHODS,MOSBY,NSCLC,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
HOWEVER,LUNG,SCREENING,TRIAL
105,160,169,1995,2008,2013,547,BOARD,COPYRIGHT,DISTANT,DUKE,INC,INSTITUTE,LABEL,MEIER,METHODS,MOSBY,OBJECTIVE,PATHOLOGIC,PET,PROGNOSTIC,PUBLISHED,RESULTS,SURGERY,THOSE
163,1948,1970,1980,2011,300,5400,700,APRIL,ASSESSMENT,BACKGROUND,BPS,BSC,CONCLUSION,CONFERENCE,COST,DATA,DATABASES,DENOSUMAB,FUNDING,GENERALLY,INSTITUTE,ISSUE,LABEL,LIBRARY,MARCH,MAY,MEDLINE,METHODS,NMA,NSCLC,OBJECTIVE,OBJECTIVES,OSTS,OWING,PAS,QALY,RCTS,RESULTS,SCIENCE,SOURCES,SRE,SRES,STUDIES,SYSTEMATIC,TECHNOLOGY,WEB,WITHOUT
160,169,2013,954,A549,AKT,ALA,CELLS,EFFECTS,EGFR,EGFRS,H1299,JOHN,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OFTEN,PDT,RESULTS,SONS,TKI,TKIS,WILEY
945,946,954,AKT,BAX,BBR,BCL,BERBERINE,CHINESE,COX,ERK,FURTHER,HIF,HOWEVER,KNOCKDOWN,MEK,NSCLC,PARP,PI3K,RAF,TAKEN,TREATMENT,VEGF
CELL,FIVE,KRT15,LUNG,MEIER,METASTASIS,NODE,NON,NOVEL,NSCLC,OVERALL,PKP1,SMALL,TNM
EGFR,ERK,MIG6,SPRY2,THESE,THUS
002,110,2008,2011,412,945,946,COX,FDG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,RFS,T1A,T1B
169,2013,215,293,GMBH,HEK,KGAA,NVBN,SELECTIVE,VCH,WILEY
169,2013,AACR
EMS,FINALLY,HOWEVER
109,125,129,8201,BACKGROUND,CONCLUSION,GRADE,IIIA,LABEL,METHODS,RESULTS
001,009,1997,2011,556,8201,845,BACKGROUND,CONCLUSION,CPRD,LABEL,METHODS,QRESEARCH,RESULTS,THERE
BESIDES,DESPITE,EARLY,LUNG
15A,921,BCL,DLEU2,FINALLY,HDAC3,HDACS,HISTONE,HOWEVER,THEREFORE,TSA
000,001,002,160,1904,BACKGROUND,HIGH,HYPOTHESIS,LABEL,METHODS,OBJECTIVE,POPULATION,PULMONARY,RESULTS,UTAH
169,2013,A549,BOTH,BRCA2,CELLS,COPYRIGHT,H2AX,IRELAND,LTD,MRC5
169,2013,BASEL,ILD,PHYSICIANS
1998,2008,DISCUSSION,LABEL,METHODS,OBJECTIVE,RESULTS,RETIREMENT,THESE
120,169,177,2013,240,4CK,8548,945,946,99M,BAC,COPYRIGHT,H358,INC,MOSBY,NCI,RGD
169,2013,48H,COPYRIGHT,GPX2,HCC,HCCS,HIGH,IRELAND,LTD,MIGRATION,THEREFORE
DELTA,HER2
169,2013,AACR,CC10,EGFR,FGF,FGF9,FGFR3,FIBROBLAST,NSCLC,SCA,SFTPC,THESE
011,017,019,023,049,160,169,170,2013,329,543,897,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,MEIER,METHODS,NSCLC,RESULTS
287,33342,956,A549,ACTIVATION,ADP,ANNEXIN,CONCLUSION,HOECHST,IC50,LABEL,METHODS,MTT,OBJECTIVE,RESULTS,THESE,TUNEL
945,BACKGROUND,BLOT,CELL,CONCLUSION,DUAL,HOWEVER,LABEL,LUCIFERASE,METHODS,MTT,NAC,NSCLC,PDK1,PPAR,RESULTS,RNAS,SILENCING,SMALL,TRANSIENT,WESTERN,WHILE
001,169,2013,208,672,AFTER,BACKGROUND,BOTH,COPYRIGHT,COX,DFS,HOWEVER,INC,LABEL,MEDICAL,METHODS,NSCLC,PATIENT,PUBLISHED,RESULTS,SOCIETY,VATS,VIDEO
LUNG
954,NOW,TRIPTOLIDE,VEGF
2009,2012,BACKGROUND,CHEST,LABEL,MAY,METHODS,OBJECTIVE,PULMONARY,RESULTS,VATS
AMONG,BACKGROUND,CONCLUSION,DCR,EGFR,LABEL,NSCLC,OBJECTIVE,ORR,RESULTS
BACKGROUND,FEV1,FVC,LABEL,LUNG,METHODS,MVV,PEF,RESULTS,THERE,VITAL
001,2013,288,ASIAN,BACKGROUND,CAUCASIAN,HOWEVER,LABEL,MARCH,MEDLINE,METHODS,OBJECTIVE,OVERALL,RESULTS,THERE
008,011,046,071,097,102,140,224,237,262,300,317,494,705,713,8805,984,BACKGROUND,EGFR,ERLOTINIB,GEFITINIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,TKI
A549,AFTER,ALSO,BACKGROUND,CELL,COBROTOXIN,HFL1,LABEL,LC3,MARK,METHODS,MTT,P38,P62,RESULTS,USING,WESTERN,WHAT
2011,AIS,LUNG,MIA,SOCIETY
223,ACTIVATION,BACKGROUND,CALU3,CBP,EGFR,LABEL,LYN,METHODS,PAG,PKC,RACK1,RESULTS,SILENCING,SRC,WESTERN
2008,2012,APRIL,BACKGROUND,BML,EACH,JULY,LABEL,METHODS,RESULTS,THREE,VIDEO
2J2,CYP,CYTOCHROME,EET,EETS,FURTHER,P450,SEVERAL
168,BACKGROUND,DESPITE,LABEL,METASTASES,METHODS,MTT,NODE,NSCLC,PYGO,PYGO2,PYGOPUS,RESULTS,USING,WNT
169,2013,ASIA,AUTHORS,ENGLISH,LTD,PATHOLOGY,PTY,PUBLISHING,PULMONARY,SOCIETY,WILEY
AIMS,BACKGROUND,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SCLC,SER,SHORT,SIXTEEN,THEREFORE
916,CONCLUSION,EARLY,EVALUATION,FDG,LABEL,METHODS,MTV,NSCLC,PARAMETERS,PET,PFS,RESULTS,SOLID,SUV,TLG,UNLABELLED
001,013,111,122,126,146,2007,2011,221,228,8804,BETWEEN,FEV1,FIFTY,GROUP,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PLT,PULMONARY,RESULTS,TEN,THERE
11A,11E,11I,A549,HL60,MCF7,PROLINE,THEIR,UGI
160,947,BACKGROUND,BMI1,CONCLUSION,EXPRESSION,FOXF1,GLI1,GLI2,LABEL,METHODS,NANOG,PROTEIN,PTCH1,RESULTS,SEVERAL,SMO
INITIALLY
2011,2012,2013,420,438,BLAND,BOTH,CONCLUSION,GGN,GGNS,INTERSCAN,JUNE,LABEL,MASS,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RSNA,WRITTEN
0001,100,113,120,138,174,2010,24X1,8201,APRIL,AUTOMATED,B30,B70,BACKGROUND,BETWEEN,CONCLUSION,GERMANY,JANUARY,LABEL,LMS,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,SENSATION,SIEMENS,SOMATOM,THERE,VME
9607,AMD3100,CHEMOKINES,CXCR4,DIL,ELISA,F5M2,HOWEVER,MSC,MSCS,THESE,TRANSWELL,USING,VEGF
231,916,936,BAD,BAX,BCL,BIM,CHO,DEVD,DMMP,FMK,HELA,HPV,MCF7,MDA,MRC5,NOXA,PUMA,VAD
002,004,160,169,1990,1999,2009,2013,243,COPYRIGHT,COX,DATA,DESPITE,HOWEVER,IDC,IDCS,ILC,ILCS,LTD,MEIER,ORIGINALLY,PASW,STATISTICS,TAMPERE,TNM,UNIVERSITY
166,2000,2009,464,500,644,856,8805,AMONG,CASES,DISULFIRAM,SIMILARLY
EYE,HOWEVER,THUS,WHAT
AFTER,SOX,STAGE,UFT
2MM,AFTER,STAGE
2008,2010,2012,AFTER,APRIL,CDDP,CEA,CPT,FDG,IIIA,JANUARY,MAY,OCTOBER,PET,VIRCHOW
2009,2010,APRIL,TACE,TBLB
ACD,ANTICANCER,DRUGS,HOWEVER,QOL,THEREFORE,TREATED
177,EFFECTIVE,LUNG,SRE,ZDA,ZOLEDRONIC
AFTER,FOLFIRI
120MG,CEA,EGFR,FUMP,GEM,HOWEVER,III,PEM,PEMETREXED,STAGE
104,970,AFTER,CRP,CSF,III,LABORATORY,STAGE,WBC
4MG,AFTER,HER2,HOWEVER,PGR
CENTRAL,FDG,HER2,IBARAKI,PET,PGR,PTX
APREPITANT,CDDP,CIC,CINV,DAYS,HOWEVER,HT3,NK1

138,LABEL,LDCT,LOW,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THREE
169,2013,FINALLY,NANOVIN,PEG,POLYMERIC,USING
169,2013,CH5164840,EGFR,EPIDERMAL,ERK,H1975,H292,HOWEVER,HSP90,INHIBITION,NCI,NSCLC,STAT3,T790M,TAKEN
000,147,1648,181,554,604,BACKGROUND,INSTITUTE,LABEL,LUNG,METHODS,NLST,RESULTS,SCREENING,THESE,TRIAL
621,BIOMEDICAL,CENTRAL,CHINA,CHINESE,CONTROLLED,DOR,FULL,LITERATURE,MED,MEDLINE,NLR,NSCLC,NUMBERS,PLR,PUB,REFERENCE,SCIENTIFIC,SELDI,SEN,SPE,TOF
1600,BETWEEN,BODY,CYBERKNIFE,DISRUPTING,IRIS,IRT,IRTS,LARGE,LIVER,MEAN,SBRT,SERVICE,SPINE,STOP,TBF,TECHNICAL,TIME,TIMES,TOOL,TREATMENT,WEIBULL
A549,GOLD,NIR,NRS,PTT
4DCT,GTV,RPM
ENRICHMENT,PATHWAY,SET
A82,AKT,EPO,EPOR,H838,HOWEVER,MCF,NCI,PCR,STAT3,STAT5,TAKEN,WHILE
00001,2284,8202,ABSTRACTS,ASCO,CENTRAL,CNKI,CONCLUSION,CONTROLLED,ESMO,LABEL,MANAGER,MEDLINE,METHODS,NSCLC,OBJECTIVE,ORR,PFS,RCTS,RESULTS,VANDETANIB,WANFANG
8202,BACKGROUND,CELL,CTC,CTCS,DEFINITION,EPCAM,EPITHELIAL,FDG,HIGH,IQR,LABEL,MATERIALS,METHODS,NSCLC,PET,RESULTS
AUCL,CH2PH,CHPH2,COMPLEXES,DMAP,ESI,FPYR,H1666,NCI,NHC,NMR,OPH,PPH3
001,160,169,177,178,183,187,18F,215,ADC,ADCMEAN,CONCLUSION,DWI,FDG,GEORG,LABEL,MATERIALS,METHODS,MRI,NSCLC,OBJECTIVE,PEARSON,PET,PURPOSE,REGIONS,RESULTS,ROI,STUTTGART,SUV,SUVMEAN,YORK
ANOTHER,BCVA,ERG,FAF,IHC,LABEL,METHODS,OBJECTIVE,OCT,PURPOSE,RESULTS,SCLC,SDOCT,THREE,WESTERN
101,120,AFTER,ANTI,AST,BACKGROUND,BID,DLTS,GRADE,LABEL,METHODS,MTD,NSCLC,PRS,RESULTS,RP2D,SCLC
147,1952,2003,6820,BACKGROUND,CONCLUSION,DISEASE,EMPLOYEES,ICD,JEM,LABEL,LUNG,METHODS,OBJECTIVE,PADUCAH,PGDP,REPORTS,RESULTS
200,239,8201,945,BACKGROUND,BID,CONCLUSION,DLTS,LABEL,METHODS,MTD,NSCLC,RESULTS
169,2013,BACKGROUND,BASEL,COPYRIGHT,EBUS,EGFR,FIFTY,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPECIMENS,TBFB,TBNA,THREE
000,040,139,169,2006,2010,2011,2013,260,343,408,8804,8805,ALSC,ATS,BECAUSE,BETWEEN,CONCLUSION,COPYRIGHT,ERS,GGO,IASLC,III,IRELAND,JANUARY,LABEL,LTD,MARCH,MATERIALS,METHODS,NOGUCHI,OBJECTIVE,PURPOSE,RADIOLOGIC,RESULTS,TYPE
AREAS,BACKGROUND,COVERED,DNMT,DNMTS,EPIGENETIC,FURTHER,HDAC,HDACS,LABEL,METHODS,OPINION,PRIMARY
GENOTYPIC,HIF,MYC,WARBURG
946,956,A549,BUTYL,CHINESE,EPS72,FAST,FLOW,FURTHER,HIGH,IC50,SEPHAROSE
400,ARG,ASP,BLUE,DUE,GLY,H1299,HOWEVER,ICP,MAL,MNC,MNCS,OES,PLA,RGD,SUBSEQUENT,THEREFORE,USING
A549,ALT,NPS,OVERALL
200,AUC6,BACKGROUND,BROMIDE,CIVI,CONCLUSION,FORTY,LABEL,METHODS,NSCLC,PFS,RESULTS,TREATMENT,TRIAL
169,ACTIVATION,ADCA,PRESS,THESE,TP53
000,200,BACKGROUND,BAD,CONCLUSION,EZH2,GIVEN,LABEL,METHODS,PUMA,RESULTS,SCLC,SCLCS,WESTERN
AVERAGE,BACKGROUND,BED,CONCLUSION,DOSIMETRY,GBQ,LABEL,LESIONS,METHODS,PET,PRIMARY,PRRT,RESULTS,SCLC,SST,SSTR,SSTRS
BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SCLC
100,8805,AFTER,BACKGROUND,CONCLUSION,FIFTY,IIIA,KRAS,LABEL,METHODS,NSCLC,RESULTS,SECONDARY,SIX
A549,ASO,BTG2,CELL,H282,H292,HBE,HIGH,MEANWHILE,MMP9,NCI,TRANSWELL,WESTERN
DUMON,EMERGENCY,MALIGNANT
DESPITE,DIAGNOSTIC,EBUS
HOWEVER,OPTIMAL
EXAMINING,RECURRENT

200,500,BACKGROUND,CHEST,FOUR,LABEL,MALIGNANT,METHODS,PLEURAL,RESULTS
160,A549,BESIDES,CCK,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SERUM,SGTA,SMALL,THESE,WESTERN
FURTHER,METABOLIC,OPLS,THESE
AHF,FOLLOWING,NBTE,STAGE
400,BECAUSE,CHILD,PUGH,THERE
503,A549,BCL,CDDP,DRUG,MICRORNAS,TAKEN
BOTH,FDG,METASTASIS,PET,THESE
124,198,2007,2010,ASPECTS,FNA,JANUARY,LABEL,MARCH,MATERIALS,METHODS,MPR,OBJECTIVE,PURPOSE,RESULTS,TTFNA
001,021,022,100,1391,2004,2012,2070,431,451,5071,682,876,BACKGROUND,COLORECTAL,CONCLUSION,LABEL,MARCH,METHODS,OBJECTIVE,POSTTRIAL,RESULTS,SETTING,THERE,WOMEN
169,2013,CCAM,COPYRIGHT,FINALLY,FIRST,LTD
0001,0652,0750,169,171,187,2013,759,AGE,BACKGROUND,BMI,COPD,COPYRIGHT,FACTORS,FEV1,FVC,GOLD,LABEL,LATIN,METHODS,PLATINO,PUBLISHED,RESULTS,SEPAR
012,038,207,8482,BACKGROUND,CELLSEARCH,CTCS,LABEL,MANN,METHODS,PERIPHERAL,RESULTS,WHITNEY
169,2013,5336,946,AACR,INHIBITION,LOX,OVERALL,POLYOMA,PYMT,RES,TGF
CD45,CXCR4
169,2013,5426,AACR,AKT,CONVERSELY,ECTOPIC,HOWEVER,PTEN,PTK6,RES,SH4
205,954,AKT,CONVERSELY,HOWEVER,NSCLC,PHLPP,PTEN,TAKEN
1411,169,2013,889,BOARD,COPYRIGHT,DISEASE,DUKE,IIIA,INC,INSTITUTE,LABEL,LRFS,LVI,MEIER,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RECURSIVE,RESULTS,RPA,SURGERY,THERE,THESE
169,2013,BOX,COPYRIGHT,EMT,FOXM1,IRELAND,KNOCKDOWN,LTD,SLUG
169,2013,AUTHORS,CCDC6,COPYRIGHT,IRELAND,KIF5B,LENVATINIB,LTD,NCOA4,PUBLISHED,RET,THESE
1A1,8201,8739,945,946,AHR,CYP,DATA,INCREASING,P450,TCDD,WHEREAS
LAM,LIMITED,MILES,TSC1,TSC2
013,102,120,240,300,330,954,AMONG,DISEASE,EGFR,NSCLC,PFS,SIMILARLY,TG2,TKI
001,003,005,006,007,010,013,015,017,020,027,040,101,122,204,471,490,508,524,634,697,852,926,946,967,COX,DECREASED,DFS,EFFECTIVE,LABEL,MEIER,METHODS,OBJECTIVE,RESULTS,SQCC,TUMOURS
011,2009,2015,2020,2055,684,8197,985,994,BACKGROUND,BMJ,CONTROL,CONVENTION,FCTC,FRAMEWORK,GROUP,INCREASING,LABEL,LIMITED,METHODS,PUBLISHED,PUBLISHING,RESULTS,TOBACCO,USA
RENAL,TSC
763,ACCORDING,AIM,BACKGROUND,CUFFLINKS,FURTHER,LABEL,LUNG,MATERIALS,METHODS,NCBI,OBJECTIVE,RESULTS,SHANNON,SRES,THESE
2013,ACCORDING,AFRICAN,AMERICANS,C609T,CAUCASIANS,EAST,HISPANICS,LABEL,MAY,NAD,NQO1,REFERENCES,THERE,UNASSIGNED,UNLABELLED
169,2013,500,974,AFP,ALPHALISA,ASSAY,BACKGROUND,CA19,CEA,CK18,CK8,CYFRA,DONOR,ECLIA,HOWEVER,INC,LABEL,METHODS,NSE,RESULTS,ROCHE,THERE,WILEY
183,ACCORDING,BACKGROUND,BASED,CDH,CEBM,CONCLUSION,END,ENGLISH,GEORG,HOWEVER,LABEL,LEVEL,MATERIALS,METHODS,PCO,RANDOMIZED,RCS,RESULTS,STUTTGART,SYSTEMATIC,TEF,THEREFORE,VATS,VIDEO,YORK
242,8201,ADVERSE,ASCO,IRR,MAMMALIAN,PULMONARY,WHILE
EHE,METASTATIC,TREATMENT,VARIOUS
431,ALF,ASP,CNS,EGFR,EXPRESS,FIVE,L858R,PCR,POOR,TKIS
1474,183,196,31C,599,8201,837T,ARG,GLU,IL1B,LABEL,LYS,MET,METHODS,OBJECTIVE,PPI,PTGS2,PURPOSE,RESULTS,SYMPTOM,TNFR2,USING
CURRENT,NEWER,PCI,SCLC,SMALL
247,680,954,ATLAS,HER2,TCGA
000,800,NOTABLY,THOUSANDS
PEMETREXED
945,949,HELA,IFN,INCUBATION,IPO9,RNAS,STUDIES,UTR,UTRS
947,BECAUSE,CC10,CD25,CD4,CD45,CD8,FOXP3,HOWEVER,IFN,NSCLC,TAG,TREG,TREGS
0001,001,006,015,046,BACKGROUND,CCK,EXPRESSION,HCC,HOWEVER,HUH7,LABEL,METHODS,RESULTS,RNAI,SHOX2,TNM
30A,ECTOPIC,FURTHER,MTDH,TAKEN
231,4175,946,HOWEVER,MDA,MMP,MMP8,MMPS,TGF,THESE,THUS
DICER,DISRUPTING,III,INK4A,KIP1,P16,P27,PTEN,RNASE
4SA,946,CHIP,EMT,GSK3,HSC70,KNOCKDOWN,PROTEOMIC,SLUG
169,2013,257,600,746,COPYRIGHT,HODGKIN,HOWEVER,INC,NADPH,NOX5,PUBLISHED,UACC,USING
169,2013,945,A549,COPYRIGHT,EBP,FEDERATION,FIRST,MICRORNAS,SOCIETIES,TRIB2
169,2013,2MGY,BLOOD,CHROMOSOME,COPYRIGHT
169,2013,946,A549,CELASTROL,COPYRIGHT,DARBY,EMT,INC,MADIN,MDCK,MIGRATION,SNAIL,TGF,THESE,THUS
169,2013,25K,25KDA,ADP,ATP,COPYRIGHT,H1299,PEI,PEIS,POLYCATION,STUDIES,THESE,THROUGH,UNRAVELING
169,2013,COPYRIGHT,ERG,FISH,HOWEVER,INC,SMALL,THEREFORE,TMPRSS2,URINARY
169,2013,ASXL1,BAP1,BOTH,BRCA1,COPYRIGHT,DESPITE,DROSOPHILA,H2B,HOX,INC,P19,UCH
148,169,194,2013,577,COPYRIGHT,DEPRESSION,GENERAL,LABEL,LESS,LTD,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCALE,SDS,SELF
169,179,2012,241,372,AIM,BACKGROUND,CONCLUSION,COPYRIGHT,EBUS,ESPA,GROUP,LABEL,METHODS,NSCLC,OBJECTIVE,PORTUGUESA,PUBLISHED,RESULTS,SOCIEDADE,TBNA
169,2012,241,COPYRIGHT,ESPA,PORTUGUESA,PUBLISHED,SOCIEDADE,THESE
048,160,169,2013,COPYRIGHT,HDR,INC,LABEL,METHODS,OBJECTIVE,OFS,OVERALL,PUBLISHED,PURPOSE,RESULTS,SOCIETY,THERE
100,131,160,169,2013,AFRICAN,AFTER,COMMITTEE,COPYRIGHT,IIA,INC,JOINT,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SOCIETY,SOFT,STAGE
169,2013,AMONG,AUTHORS,COPYRIGHT,HOWEVER,IIIB,LTD,NSCLC,OPHTHALMIC,PUBLISHED
0001,169,185,2013,239,797,ARG,CD4,CD8,COPYRIGHT,IRELAND,LTD,MDSC,MYELOID,NSCLC,PBMC,PCR,PMN,THERE,UNTIL
169,2013,2B17,423,449,453,622,BACKGROUND,CAUCASIANS,CENTRAL,CNV,CONCLUSION,COPY,COPYRIGHT,LABEL,LTD,METHODS,NNAL,PCR,RESULTS,THERE,UGT2B17
125,169,2013,AFTER,AIM,CONCLUSION,COPYRIGHT,FURTHER,HOWEVER,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,VATS,VIDEO
169,2006,2008,2013,3821,393,495,BACKGROUND,BETWEEN,CONCLUSION,CONTEXT,COPYRIGHT,DRG,LABEL,LTD,METHODS,PATIENT,RESULTS,SPATIAL,THERE
000,005,006,016,066,078,121,169,1990,2012,2013,COPYRIGHT,COX,ECOG,GPA,HOWEVER,LABEL,MATERIALS,MEIER,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBM,THERE
169,2013,BACKGROUND,CETUXIMAB,COPYRIGHT,EGFR,FISH,FORTY,III,IIIA,IIIB,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,TAKEN,THREE
013,100,131,169,183,2013,2095,312,4000,5000,8200,944,956,AIR,AMBIENT,BACKGROUND,COHORTS,COMMUNITY,COPYRIGHT,COX,EFFECTS,FRAMEWORK,FUNDING,HRS,LABEL,LTD,METHODS,PM10,PM2,POLLUTION,PROGRAMME,RESULTS,SEVENTH
169,1985,2011,2013,BACKGROUND,BETWEEN,COPYRIGHT,FIVE,INC,LABEL,METHODS,PUBLISHED,RESECTION,RESULTS,SOCIETY,SUBCLAVIAN,THERE
160,169,2013,BASAL,BCC,COPYRIGHT,LTD,MAXILLO,PUBLISHED,SURGERY
020,044,132,169,2013,473,491,617,709,926,934,938,CLARA,DIFFUSION,DWI,SHIMOSATO,SUV
2010,2011,BACKGROUND,BEST,BTV,BTVS,DIFFERENT,FDG,GTV,GTVS,LABEL,METHODS,PERCIST,PET,RESULTS,TLG
EGFR,HOWEVER,KRAS,THESE,VEGF
169,2012,2013,8201,AIMS,BACKGROUND,CONCLUSION,ERCIYES,GROUP,JOHN,LABEL,LTD,MAY,METHODS,NPV,OBJECTIVE,PPV,RESULTS,SONS,TBNA,UNIVERSITY,WILEY
946,EMT,THESE

8805,BACKGROUND,CD4,CD8,LABEL,METHODS,NKC,NKCS,NSCLC,RESULTS,TEN,TTP
EACH,FDA,OTHER,SEVERAL,SMALL
1000,138,2007,2009,AIMS,BACKGROUND,BOARD,CLYDE,GLASGOW,GREATER,LABEL,METHODS,NHS,OBJECTIVE,RESULTS,SERVICE,THESE
169,2013,252,8197,956,A549,ACTA,AMONG,AZ521,CHIMICA,COPYRIGHT,HELVETICA,HL60,IC50,NINE
ARGENTINA,BRAF,FDA,III,JAPAN,MAPK,MEK,MEK1,MEK2,OCEANIA,ORIGINALLY,PHASE,SEVERAL,TOBACCO,TRAMETINIB,V600,V600E,V600K
ACTIVATING,BOTH,EGFR,L861Q,PCR,T790M
A549,H446,MTT,NOTABLY,SKP2,THR62,THUS
001,362,954,AGREEMENT,BACKGROUND,LABEL,METHODS,RAPID,RESULTS,ROSE,TBNA,TBNAS,THERE
0001,001,007,BACKGROUND,CA125,CCR,DIFFUSE,DPM,EGFR,EXTRA,III,LABEL,METHODS,NON,PAX,PCI,RESULTS,RISK,SEVEN,SIXTY,THERE,TUMOURS,TYPE,WDPM
156,1969,1970,2009,284,321,831,CONCLUSION,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
006,169,2013,CENTRAL,COPYRIGHT,DSS,ENDPOINTS,HIGH,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PERIPHERAL,PULMONARY,PURPOSE,RESULTS
8805,CTV,DVH,DVHC,DVHG,DVHP,DVHPC,DVHS,GTV,INC,LABEL,LUNG,MATERIALS,METHODS,MLD,MLDC,MLDG,MLDP,MLDS,OBJECTIVE,PTV,PTVC,PUBLISHED,PURPOSE,RESULTS,RP2,THERE,V20,V20S
018,104,154,169,1998,2011,2013,289,365,444,688,704,967,AFTER,COPYRIGHT,CRT,IMRT,INC,KRUSKAL,LABEL,LUNG,MATERIALS,MEAN,METHODS,MLD,OBJECTIVE,PBT,PURPOSE,RESULTS,WHILE
169,2013,450,EUFA,FANCC,FANCONI,MICROARRAY,THESE
160,169,2013,946,C57BL,CARCINOMA,COPYRIGHT,HOWEVER,LEWIS,LLC,LUNG,MMAE,SAS
200,400,458,500,7582,SEVERAL
160,169,1990,2013,3457,8544,AIMS,CONCLUSION,COPYRIGHT,DATA,JANUARY,LABEL,LTD,MANAGER,METHODS,NSCLC,OBJECTIVE,RCTS,RESULTS,THERE,VATS,VIDEO,WEATHER
0009,0109,0121,0264,0325,0389,169,2013,COPYRIGHT,CXCR4,INC,MDM2,METASTASES,METASTASIS,OSTERIX,RANKL,RB1,THUS
160,169,174,2013,COPYRIGHT,EDUCATION,GLEASON,INC,LABEL,MALAT,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,THUS,TRANSWELL,UROLOGICAL
131,169,2013,241,COPYRIGHT,ESPA,MRI,SPECT
049,166,DATA,ENETS,GEP,KI67,LCNEC,NEC,NEN,NET,SHORT,WDNET
169,2013,CD24,COPYRIGHT,INC,ITGB4,KRAS,NOTCH,NSCLC,SUSTAINED,TPC,TPCS,WHILE
160,AMLI,BACKGROUND,CASE,CD3,EBV,LABEL,LITERATURE,METHODS,THERE
DESPITE,EPHB4,TAKEN
024,029,8202,840,866,8804,952,BACKGROUND,BECAUSE,CHINESE,CPD,ESCC,KRUSKAL,LABEL,METHODS,RESULTS,THESE
LUCIFERASE,NICOTINIC,PCR,SEVERAL,THEREFORE,UTR
148A,8209,A549,DECREASED,DNMT1,DUE,H1299,NON,NSCLC,RNAS
946,AHR,SINCE,THUS,YET
2000,2009,227,AMONG,BRAZILIAN,ICD,MORTALITY,PAULO,STATE,UNDER,UNDERLYING
BIOMARKERS,CAP1,LUNG,METASTASIS,PCR,SEVERAL,THESE
A549,AIF,ANNEXIN,FINALLY,HOWEVER,NAD,ROS,SIRT3
100,133,139,177,251,349,384,399,3MM,60MM,8804,8805,BACKGROUND,CONCLUSION,FNA,LABEL,MATERIALS,METHODS,MILD,RESULTS,THERE,TRAVERSED
105,118,2008,2011,BACKGROUND,BETWEEN,CONCLUSION,HNSCC,JULY,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SPM,THUS
1160,14TH,187,18TH,1990,2010,20TH,23RD,26TH,27TH,28TH,291,5TH,6TH,AGE,ALZHEIMER,AMONG,DALYS,DISABILITY,DISEASE,HALE,HEALTHY,HOWEVER,IMPORTANCE,LABEL,LIFE,METHODS,OBJECTIVE,OBJECTIVES,OECD,RELEVANCE,RESULTS,YEARS,YLD,YLDS,YLL,YLLS
0027,008,0121,025,027,057,138,2000,2010,271,552,ACA,BACKGROUND,BETWEEN,CONCLUSION,GAMMA,GKRS,JULY,KNIFE,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SCC,SCLC,WBRT
ANTI,BACKGROUND,DEL,EGFR,FGFR1,FINALLY,GEFITINIB,HOWEVER,KRAS,LABEL,METHODS,NSCLC,PATIENT,RESULTS,TEN,THUS
001,100,167,200,208,310,323,372,593,680,721,814,890,966,AUC,BACKGROUND,CONCLUSION,FIRST,III,LABEL,METHODS,NSCLC,ORR,ORRS,PRIMARY,RESULTS,RRR,SCC
2010,2012,8201,BACKGROUND,CONCLUSION,FOUR,IIIA,IIIB,LABEL,LOW,METHODS,NINE,NSCLC,PET,PFS,RESULTS,RISK,SBRT,SIXTEEN,TREATMENT
A549,BACKGROUND,CDK4,CYLIND1,LABEL,METHODS,NSCLC,RESULTS,SH2,SHP1
0001,004,169,177,1995,2008,2013,295,827,8805,943,APRIL,COPYRIGHT,F20,F21,F23,F25,GENERALLY,ICD,INC,LABEL,MARCH,METHODS,OBJECTIVE,PHYSICIANS,PLACE,PRESS,RESULTS
100,BACKGROUND,BECAUSE,DUE,LABEL,LUNG,METHODS,PULMONARY,RESULTS,SIMULATED,SONOGRAPHY,THERE,TUMOURS
100,1998,2011,215,6675,8201,8710,8804,BACKGROUND,BECAUSE,BOOTSTRAP,CONCLUSION,HOWEVER,JEFFERSON,LABEL,METHODS,NETWORK,PLOG,POST,RESULTS,TIME,UNIVERSITY
169,175,177,2009,2013,8201,AIM,ANZDATA,ASIAN,AUSTRALIA,AUTHORS,CONCLUSION,CREATININE,DATA,DATE,FIFTY,INACCURATE,LABEL,METHODS,MOST,NEPHROLOGY,NON,OBJECTIVE,PACIFIC,PRIMARY,RESULTS,SOCIETY,TRANSPLANT,ZEALAND
118,166,200,236,680,8201,8226,826,956,ALPINIA,BACKGROUND,CHINESE,CIOCALTEU,CONCLUSION,CONTEXT,DISCUSSION,DPPH,FOLIN,HOWEVER,IC50,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,TPC
ALK,BRAF,EGFR,HER2,KRAS,LUNG,MET,NSCLC,RET,ROS1
FINALLY,HOWEVER,RAMAN
A549,ATRA,INHIBITION,NSCLC,PCR,TRPC,TRPC1,TRPC3,TRPC4,TRPC6,TRPCS,WESTERN
0015,2888,291,BACKGROUND,CELLSEARCH,CTC,CTCS,EPCAM,EPITHELIAL,HOWEVER,LABEL,MCA,METHODS,NSCLC,RESULTS,SCLC
215,8202,BACKGROUND,BOTH,CONCLUSION,DIFFERENT,EBUS,FDG,HOWEVER,LABEL,LIPOSOMAL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,VX2,ZEALAND
263,341,3559,8202,AGE,BACKGROUND,COX,CURRENT,CVD,LABEL,METHODS,RESULTS,SMOKING
20S,BACKGROUND,CELLS,ERCC1,EXTENSIVE,LABEL,MALIGNANT,MATERIALS,METHODS,MRP,PGP,RESULTS,RRM1,VIABILITY
463G,520,600,8202,BACKGROUND,CIS,HOWEVER,LABEL,METHODS,MPO,ODDS,ORS,OVERALL,RESULTS,ROS,UNASSIGNED
055,177,8201,931
127,136,167,1993,2012,252,253,287,386,420,AIM,CONCLUSION,FIFTY,III,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,TCMA
169,2013,437,ASSESSMENT,BACKGROUND,COPYRIGHT,COX,KARNOFSKY,LABEL,LOUIS,MATCHED,MEIER,METHODS,NSCLC,PROGNOSTIC,RESULTS,SOCIETY,SRS,UNIVERSITY,WASHINGTON
ANIMALS,BACKGROUND,CONCLUSION,DIFFUSION,EWING,GD2,LABEL,METHODS,MRI,NOVEL,RESULTS,SEQUENTIAL,WHOLE
954,H1299,LZAP,NLBP,TAKEN
10B,651,BIOMARKERS,CGCC,COX,FOUR,HAPLOTYPE,NSCLC,PRESENTLY,SNP,SNPS,TCTT,THESE,TNF,TNFRSF10B,VALIDATED
HOWEVER,PHASE,Y90
001,169,188,2013,8805,BACKGROUND,BASEL,COPYRIGHT,DESPITE,ECOG,ELDERLY,LABEL,METHODS,NSCLC,OPTIMAL,PATIENT,RESULTS,THERE
EBUS,EXTENSIVE,HOWEVER,MRI,NSCLC,PET,SEVERAL,TBNA
0001,0002,0003,192,COX,DFS,HIGH,KI67,LVS,NSCLC,SPECIMENS
1035,169,2013,AMONG,CHEST,COMMITTEE,COPYRIGHT,IASLC,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,PUBLISHED,RESULTS,SEPAR,SOCIETY,SPAIN,SPANISH,STAGING,SURGERY,TNM
BACKGROUND,CARE,DESPITE,KNOWN,LABEL,NEED,PALLIATIVE,SUPPORTIVE,THERE,UNKNOWN,WHAT
124,147,HOWEVER,LABEL,METHODS,NNT,NPV,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS
169,2013,947,AACR,ANTIGEN,CONCLUSION,ELISPOT,IFN,INSTITUTE,LABEL,MAGE,METHODS,NCI,OBJECTIVE,PERIPHERAL,PRAME,PURPOSE,RESULTS,STRATEGIES,WT1
169,200,2013,5MG,946,A549,ANIMALS,AT1,FPNPS,FURTHER,LOS,MVD,TEL,TGF,VEGF
169,2013,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE,THREE
169,193,2002,2010,2013,541,566,784,IMAGING,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,THESE
136,145,247,436,768,811,889,926,AFTER,CONCLUSION,IMP3,LABEL,LOG,METHODS,OBJECTIVE,RESULTS
177,2613,2641,FREE,GLUC,NNAL,NNK,PHET
DRUGS,EGFR,NSCLC,TKIS
0001,002,004,007,010,028,031,035,040,055,057,065,103,946,A549,BACKGROUND,CONCLUSION,ESTROGENS,HOWEVER,HSD1,HSD2,LABEL,LK87,METHODS,NSCLC,RESULTS,THEREFORE,TMN,TNM
160,169,2013,231,233,468,956,A549,AKT,CELL,FRAN,INHIBITION,JOHN,LTD,MDA,MTT,PI3K,PUBLISHED,SOCI,SONS,USING,WILEY
007,019,048,169,2013,COPYRIGHT,ELISA,FACTORS,FOUR,FURTHER,HPV,SOCIETY,SOLID,TRANSPLANT
EAC,LABEL,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN,THESE
945,BH4,FLAG,HIF,M14,THESE,USING,VEGF
ERK,FGFR4,GENOMIC,MUTATIONS,PAK5
080,385,477,568,621,954,AKT,BASAL,HOWEVER,METADHERIN,PLK,PLK1,POLO,RNAI,SER,TANK,TBK1,THESE

169,2013,COPYRIGHT,JOHN,LTD,SONS,THESE,WILEY
160,177,1990,2012,ACROMEGALY,AGE,IGF,MALIGNANCY,RENAL,THEREFORE,THYROID
1209,148,156,169,1784,183,190,1940,2008,2010,731,BACKGROUND,CLINICIANS,GEORG,JANUARY,LABEL,METHODS,NSCLC,RESULTS,SCLC,STUTTGART,THUS,YORK
8201,AVERAGE,CECT,FIFTY,LABEL,LAPLACIAN,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECIST1,RESULTS
003,010,030,046,8201,8805,FEV1,FIFTY,LABEL,LNS,MEAN,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,VATS
0087,034,160,945,BACKGROUND,FAP,FIBROBLAST,GRADE,HOWEVER,LABEL,MATERIALS,METHODS,NSCLC,OVERALL,RESULTS,TARGETING,THEREFORE
1400W,ACC,ACCIM,AMD3100,CXCR4,MICE,NAME,NOS,PBS,TUNEL
001,125,128,376,500,8805,ANY,AVAPERL,CONCLUSION,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THOSE
001,0195,0498,180,234,285,359,397,500,539,939,945,AFTER,CONCLUSION,DRUG,EASTERN,GROUP,III,LABEL,LOG,METHODS,NSCLC,OBJECTIVE,PARAMOUNT,PEMETREXED,PURPOSE,RESULTS
ADDITIONAL,AFTER,EASTERN,FIG,FIGS,G12C,GROUP,KRAS,MOLECULAR,NSCLC,PET,TREATMENT
730,BCL,CASPASE,CD59,FACS,FAS,H157,IHC,LDH,MTT,NCI,NLCLC,NSCLC,PCR,REDUCED,RNAI
169,2013,945,956,A549,AMONG,COPYRIGHT,HECK,HT29,IC50,R16,SAS,THESE
4EPL,4MC,CARLO,D98,DPE,DPES,GTV,INVERSE,MONTE,OCE,OCES,V20,VARIATIONS
CHANGES,CTCAE,IMRT,LE50,LE55,LE60,LE65,LE70,NSCLC,PTV,V50,V55,V60,V65,V70
177,916,BLAND,DEFORMABLE,DEPENDENCE,DICE,DIR,DSC,HOUNSFIELD,THREE
177,CARLO,CBCT,CYBERKNIFE,FOUR,GTV,HOWEVER,MIDV,MONTE,OARS,SBRT,V10,V30,V50,V80,VMAT
1010,ECLIPSE,ESOPHAGEAL,OARS,POST,PTVS,RTOG,SES,SESS,TEN,THREE,TREATMENT,V10,V40,WHILE
100,119,177,3DVH,AFTER,CORP,DOSE,IEC,MELBOURNE,NUCLEAR,OSLD,OSLDS,SUN,TPS,VMAT
DOSE,IMRT,INCREASING,MPM,OAR,PTV,ROBUSTNESS,SIX,USING,V90,V95,VMAT
177,AFTER,DIBH,EACH,ELITETM,INTRA,OPTICALLY
ARRAY,CI100,DOSIMETRIC,DTA,EIGHT,IMRT,MUS,PLAN,PLANS,PTV,PTW,R50,SBRT
169,2013,ART,BACKGROUND,CONCLUSION,COPYRIGHT,GIVEN,HOWEVER,LABEL,PUBLISHED,SAS,SCIENTIFIC,SPLF,STATE,THERE
169,2013,AMONG,BACKGROUND,COPYRIGHT,GROUP,GSTSG,LABEL,MRI,PET,PUBLISHED,RESULTS,SAS,SPINE,SPLF,TOKUHASHI,VIEWPOINTS
169,178,188,2008,2011,2013,215,8805,BACKGROUND,CCI,CCRT,CONCLUSION,CONCURRENT,COPYRIGHT,GRADE,III,IMRT,INC,INDEX,INTENSITY,LABEL,MEIER,METHODS,MLD,NSCLC,RESULTS,TREATMENT
001,011,029,144,169,2004,2010,2013,424,967,AFFILIATED,CONCLUSION,COPYRIGHT,DATA,FINAL,INC,LABEL,MATERIALS,MEDICAL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SUV,UNIVERSITY
160,169,2013,956,A549,DOCKING,IC50,JOHN,MATRILYSIN,MTT,NMR,SONS,WILEY
169,195,1999,2012,2013,208,CHINA,CHINESE,ENGLISH,HONG,INCLUSION,JANUARY,JOHN,KONG,LTD,MEDLINE,MOST,SCIENCE,SONS,WEB,WEEK,WILEY
169,2013,4T1,AACR,ATP,INHIBITION,KD317,KD5,KD9,LABEL,LACTATE,LDH,METASTASES,METHODS,MRSI,OBJECTIVE,PURPOSE,RESULTS,ROS
169,2013,AACR,AXL,BCL,CONVERSELY,EACH,HOWEVER,MERTK,TAM,THESE,TYRO3
169,2009,2012,2013,257,297,883,AACR,ALK,BRAF,EGFR,JULY,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE,USING,V600E,WILD
215,4DCT,8201,CONCLUSION,D95,DMIN,HOWEVER,KNOWLEDGE,LABEL,METHODS,MINIMUM,OBJECTIVE,PCR,PCRS,RESULTS,TREATMENT
229,325,8201,AGE,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,PET,RESULTS,UNIVARIATE
100,2790,AFRICAN,CD34,MRI,THROUGH
153,ALTOGETHER,DESPITE,HOWEVER,VATS
117,AFTERNOON,ALONG,ASA,ASAI,ASAII,GROUP,HRV,III,LABEL,METHODS,NIGHT,OBJECTIVE,OBJECTIVES,RESULTS,RMSSD,SD1
946,AKT,ERK,LP07,LUNG,MEK1,NSCLC,PI3K,SEVERAL,SMAD,TGF
177,737,ABT,ACHN,AIM,BACKGROUND,BB94,BCL,CAKI,CD31,CELL,HTB,KETR,LABEL,MATERIALS,METHODS,MMP,MMPS,MTT,OBJECTIVE,PCR,RCC,RESULTS
169,2013,945,946,AACR,ACTIVATION,ALDEFLUOR,C5A,CD24,CD44,CD49F,EPCAM,GSK3,LIN,LRP6,PRIMARY,RNAI,THUS,WNT,ZEB1
689,CAUCASIANS,ILE,ULTIMATELY,VAL
001,036,105,113,210,693,910,LABEL,METHODS,OBJECTIVE,OVERALL,PULMONARY,RESULTS,THERE
033,040,679,876,BIOMEDICAL,CHINA,FINALLY,G463A,LITERATURE,MPO,OVERALL,THERE,WANFANG
041,160,203,514,895,934,AMONG,EGFR,FIRST,III,KOREA,SIMILAR,THERE,TKI,TKIS
108,CONCLUSION,DIFFERENT,GGN,GGNS,IAC,III,LABEL,METHODS,MIA,MULTI,OBJECTIVE,RESULTS,TYPE,TYPES
160,250,500,956,DHPN,EHTB,FAIP,HOWEVER,HRAS128,SINCE,TRACING,TREATMENT,ZINC,ZNCL2,ZNO
169,2013,215,365NM,A549,COPYRIGHT,FURTHER,HOWEVER,PDT
2010,2011,233,AMONG,BETWEEN,DESPITE,FIFTY,JANUARY,PLAN,YEAR
ATG7,BCL,CHAL,ERK,HOWEVER,IAP1,IAP2,JNK,KILLING,RIP1,RIP3,RNAS,THESE
100,169,177,2013,215,3MG,937,956,COPYRIGHT,H209,H69AR,IC50,LNCS,RELEASE,SCLC,SMALL,SOLUBILITY
100,169,183,2013,945,AFTER,AUC,BACKGROUND,COPYRIGHT,FUNDING,LABEL,LTD,METHODS,ONCOSUISSE,OTHER,RESULTS,TREATMENT
169,2013,947,CD8,COPYRIGHT,CTL,FLAB,IFN,LTD,MYD88,TAS,THESE,TLR5,TOLL
0007,003,004,169,170,2013,225,251T,781C,COPYRIGHT,INC,NSCLC,PCR,PUBLISHED,RFLP,SOCIETY
1170,169,177,2001,2010,2013,241,335,BACKGROUND,CONCLUSION,COPYRIGHT,EACH,FIFTEEN,HISTOLOGY,IRELAND,LABEL,LTD,LUNG,MEAN,METHODS,OVERALL,RECIPIENT,RESULTS,SIX,SLTX
000,1000,119,169,181,200,2013,500,50MG,AIM,ANTI,BUOH,COPYRIGHT,ETOAC,HELA,IC50,III,IRELAND,JIRADEJ,LABEL,LANNA,LTD,MATERIALS,MC50,MCH,METHODS,N040,OBJECTIVE,POOR,PROF,RELEVANCES,RESULTS,SC50,SRB,THAI,UNASSIGNED
1226,169,2013,AIMS,COLLEGE,COPYRIGHT,ESTIMATING,LABEL,LARGE,LTD,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,RESULTS,ROYAL
169,2013,231,COPYRIGHT,MDA,MMP,SLNS,SNAIL,THEREFORE,TPGS
ECM,FAS,LTD,MIGRATION,PUBLISHED
001,005,100,1000,169,177,2000,2013,215,500,ADC,CONCLUSION,COPYRIGHT,DAPP,DWI,EPI,FDG,IRELAND,KAPP,LABEL,LTD,METHODS,MRI,NON,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,ROI,STUDENT,SUV,VOI
169,2013,COPYRIGHT,CSCS,CTC,CTCS,EMT,EVEN,IRELAND,LTD
169,2013,COPYRIGHT,INC,MDCT
9P21,A2BP1,DUSP7,FAM190A,HDS,HIGH,INC,MMT,PUBLISHED,RPL29,SKY
0001,001,040,169,2013,242,BACKGROUND,COPYRIGHT,GPS,HOWEVER,INC,LABEL,LDCTS,MATERIALS,METHODS,MOST,PUS,RESULTS,SCREENING,THESE,THREE,TOS
001,169,2013,8804,AUR,CONCLUSION,COPYRIGHT,CTP,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PUBLISHED,RATIONALE,RESULTS
105,132,160,954,CONCLUSION,EXCELLENT,ICC,INC,LABEL,MEAN,METHODS,OBJECTIVE,PERCENT,PUBLISHED,PURPOSE,RESULTS
169,2013,241,BAD,COPYRIGHT,ESPA,ONJ,PORTUGUESA,PUBLISHED,SOCIEDADE
160,2004,2007,2009,2011,2012,2013,APRIL,BACKGROUND,CASE,CONCLUSION,HORMONE,HOWEVER,IIB,JANUARY,LABEL,MARCH,MAY,METHODS,PACLITAXEL,SEPTEMBER,SINCE,THEREAFTER,THEREFORE,THUS
142,169,2001,2009,2013,8804,BACKGROUND,BOTH,COPYRIGHT,INC,JANUARY,LABEL,LVI,METASTASIS,METHODS,NODE,NSCLC,RESULTS,T1A,T2A,VPI
125,169,177,2013,CONCLUSION,COPYRIGHT,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TPS
169,2013,COPYRIGHT,EGFR,IRELAND,LTD,NUCLEAR,WHILE
169,2012,AEC,COPYRIGHT,IIIA,OTHER,PUBLISHED,THERE,TREATMENT
169,2013,COPYRIGHT,EGFR,HOWEVER,LTD,NSCLC,SEVERAL,TKI
169,2013,A11,A24,A26,A31,A33,CTL,HLA,IGG,PEPTIDE,PPV,REFRACTORY,TAKEN
7402,7702,945,946,BACKGROUND,BEL,CK19,CONCLUSION,CONVERSELY,EMT,HCC,LABEL,MET,METHODS,MRC,PCR,RESULTS,SNAIL
LOCAL,LUNG,MOST,NSCLC,SABR,SINCE

150,178,200,400,AREAS,BACKGROUND,COVERED,EVEN,III,LABEL,METHODS,NSCLC,OPINION,PHASE,PICOPLATIN,RESULTS,SCLC
A549,BACKGROUND,FURTHER,III,LABEL,PC3,RESULTS,THESE,UPON
A549,FINALLY,GQDS,MB231,MDA,MDCK
HOWEVER,LEWIS,LLC,LOXL2,LYSYL,SKOV,SMALL
A549,FURTHER,LUNG,TAKEN,THUS
114,229,308,386,389,611,614,8594,945,AIM,ARMS,BACKGROUND,CONCLUSION,GASTRIC,LABEL,METHODS,OBJECTIVE,PCR,RESULTS,TNF
169,1956,1963,2007,2008,2013,BACKGROUND,BKV,CONCLUSION,COPYRIGHT,DIFFUSE,DMM,DMMS,INC,IRAN,IRANIAN,JCV,LABEL,METHODS,NONE,OBJECTIVE,PCR,RESULTS,SV40,THERE,WILEY
8209,AKT,APOPTOSIS,BCL,BEAS,CHRONIC,DESPITE,INCREASED,NICL2
444,467,777,BACKGROUND,COX,DIFFERENT,HOWEVER,HRS,LABEL,METHODS,RESULTS,RISKS
111,BACKGROUND,CONFIRMING,LABEL,METHODS,OCT,OPTICAL,RESULTS,SIX,SPN,SPNS,TBNA
185,8312,BOTH,DISTANT,FDG,PET,SOFT,STM,THESE
177,335,FOUR,HOWEVER,IMA,LABEL,MEAN,METHODS,NED,OBJECTIVE,RESULTS,SEVENTEEN,TGAB,WBS
945,AIM,CD4,CD8,CYTOKINES,III,LABEL,MATERIALS,METHODS,MIP,OBJECTIVE,PCR,RESULTS
0001,BREATHING,FEV1,HATHA,IIIA,NSCLC,STAGE,SURVIVORS,WHILE,YOGA
8209,ETBR,III,LUNG,NOTABLY,PI3K,THESE
2004,2011,282,370,APRIL,BACKGROUND,DISEASE,FIFTEEN,HOWEVER,JULY,LABEL,LOBE,LOBECTOMY,METHODS,NSCLC,PET,RESULTS,SLNS,THERE
BACKGROUND,EARLY,FURTHER,H2052,H513,LABEL,METHODS,MPM,PHENOTYPIC,RESULTS,TAKEN
160,CTC,CTCS,EGFR,HOWEVER,L858R,LCM,PCR,SEQUENCING,T790M,USING,WHOLE
2010,2012,AFTER,JANUARY,RCC,THEN
0330,169,2013,215,480,AUC,CHEST,CONCLUSION,COPYRIGHT,FPD,IRELAND,ISS,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,RESULTS,ROC,SIMULATED,SIX,THERE
169,2013,COPYRIGHT,INC
001,002,004,169,2008,2011,2013,376,513,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,EGFR,GROUP,HOWEVER,INC,INDEX,KRAS,LABEL,MAY,METHODS,MOLECULAR,NEITHER,NSCLC,RESULTS,UNIVERSITY
0001,0002,006,015,029,101,123,126,130,145,163,189,2005,2007,2010,352,AFFAIRS,BACKGROUND,CCCP,CONCLUSION,DATA,HEALTHCARE,III,INC,JANUARY,LABEL,METHODS,NSCLC,OCTOBER,PUBLISHED,RESULTS,TIMELINESS,VACHS,VARIABLES
0001,002,019,169,2013,8804,8805,BACKGROUND,COPYRIGHT,GLASGOW,INC,LABEL,METHODS,RESULTS
169,172,2013,ALTOGETHER,ATP,CFTR,COPD,COPYRIGHT,GPINH5A,HBSMC,LTD,REGULATOR,USING
1269,169,2013,203,2P12,367,392,428,508,778,ADDITIONAL,AUSTRALIA,AUSTRALIAN,COPYRIGHT,CRTAM,HOWEVER,IRELAND,ITALIAN,ITALY,LTD,MALIGNANT,PUBLISHED,RASGRF2,SDK1,SNPS,THESE,WESTERN
001,008,126,169,181B,2013,AFTER,COPYRIGHT,FINALLY,GMBH,MIR,NSCLC,PCR,THEN,TNM
169,2013,231,8320,8325,956,A549,COPYRIGHT,MCF,MDA,MDBK,RUTHENIUM,SAS,THESE
171,CONCLUSION,CONCURRENT,ECOG,LABEL,METHODS,OBJECTIVE,ORR,PFS,RESULTS,SCLC,TNM
100,BACKGROUND,BPS,GROSS,HDR,IMRT,LABEL,METHODS,NPC,PLATO,RESULTS
AAA,ALSO,LABEL,METHODS,NTCP,NTCPAAA,NTCPPBC,OBJECTIVE,PBC,PURPOSE,RESULTS,STUDENT
945,A549,AKT,ATP,AZ12253801,IGF1,IGF1R,IGF2,III,IR3,IR47,NSCLC,NVPAWD742,PHASE,SIGNALLING
BRAF,KRAS,LKB1,MAP,THESE,V600E
1992,2000,2005,2006,DATA,END,LUNG,OTHER,RESULTS
169,2013,340,680,BACKGROUND,EBUS,FNA,LABEL,LOUIS,MEDICAL,METHODS,RAPID,REPORTS,RESULTS,ROSE,SOCIETY,THERE,UNIVERSITY,WASHINGTON
120,2013,745,785,847,884,886,924,928,929,933,941,942,943,945,947,951,954,955,957,961,963,966,975,AGREEMENT,BLAND,BOTH,CONCLUSION,DEPENDING,HIPAA,INTRACLASS,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RSNA
0005,005,160,177,945,FDG,FIFTY,LABEL,MEAIB,METHODS,OBJECTIVE,OBJECTIVES,PET,PURPOSE,RESULTS,SETTING,WHOLE
737,ABT,BAK,BAX,BCL,BCL2,BFL,BH3,BXI,DOCK,MCL,NCI,TREATMENT,UCSF
169,2013,AACR,AKT,DRUG,FINALLY,FOOD,INTRINSIC,JNK,KEAP1,MAPK8,NH2,NRF2,NSCLC,PI3K,USING
0001,004,109,140,230,3536,3832,674,BACKGROUND,BANGKOK,CONCLUSION,DESPITE,FURTHER,IIIA,KING,LABEL,LYMPH,METHODS,NODAL,NSCLC,RESULTS,SHP
177,183,A549,BECAUSE,BRCA2,GEORG,H2AX,MRC5,STUTTGART,YORK
001,013,028,041,160,213,CLL,CNS,FORM,HGG,HRQOL,LGG,MCS,NHL,NSCLC,SHORT,SOS
200C,7082,954,ACTIVATION,BAY11,CIGARETTE,CSE,EMT,FINALLY,HBE,THUS
110,112,2005,2008,257,382,6MWT,AMONG,BACKGROUND,CONCLUSION,LABEL,METHODS,MIXED,POST,RESULTS
2006,DUE,HOWEVER,MANAGEMENT,NCI,NSCLC
128,1997,2012,BACKGROUND,BARR,CONCLUSION,EBV,EIGHT,EPSTEIN,HOWEVER,LABEL,METHODS,PTLD,RESULTS,TEN,THEREFORE,THREE
107,2005,2009,640,BACKGROUND,CAO,CENTRAL,CONCLUSION,EIGHT,HEIDELBERG,HOWEVER,JANUARY,LABEL,MAY,METHODS,PLACEMENT,RESULTS,SELF,STENT
051,1311,181,192,A549,ATG5,DESPITE,FMS,H460,HOWEVER,IC80,INSTEAD,NSCLC,TAKEN
424,945,946,DDR2,DDRS,G505S,I638F,L63V,LYN,NCK1,PIK3C2A,PLCL2,SCC,SH2,SHIP,SHP,SRC,TAKEN
0001,075,151,229,346,6577,8202,826,902,AFFAIRS,ARB,ARBS,BACKGROUND,CONCLUSION,DEPARTMENT,LABEL,METHODS,RESULTS,THERE
177,215,397,ALSO,BRAGG,CTV,HOWEVER,LABEL,METHODS,NEXT,OBJECTIVE,PURPOSE,RESULTS
4DCT,CARLO,DOSE,DVF,DVH,HOWEVER,LABEL,METHODS,MONTE,NEGLECTING,OBJECTIVE,PURPOSE,RESULTS,SBRT,USING,XCAT
176,8805,945,947,952,CARE,DOSE,DTA,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,THERE
177,DMR,KNOWN,LABEL,MESH,METHODS,OBJECTIVE,OUTSIDE,PURPOSE,RESULTS,SSD,VRE
166,177,8805,LABEL,MEAN,METHODS,MODEL,OBJECTIVE,PARTIAL,PURPOSE,RESULTS,SUCCESSIVE
10001,333,AMONG,CANDIDA,HOWEVER,MEDICAL,MOST,OTHER,PUBLISHERS,PULMONARY,SEVENTH,THERE,USA,YORK
160,2012,BACKGROUND,BASED,CONCLUSION,DES,EACH,EQUATIONS,LABEL,METHODS,MOST,OBJECTIVE,QUIT,RESULTS
METAZOANS
000,2012,ACT,CANCERS,DTP,EXCELLENCE,NCI,PROGRAM,SCLC,SPORE,THERE,THROUGH
CHK1,CSC,CSCS,EVALUATING,HOWEVER
0001,0003,0045,023,046,MICRORNAS,MIR,NOTEWORTHY,NSCLC,PCR,RAS
HOWEVER,JNK,LRP,MAJOR,MVP,SP1,SW620,THEREFORE,UNDER
174
169,2013,COPYRIGHT,ECH,INC,KEAP1,KELCH,NRF2,NUCLEAR,OWING
102,108,125,437,521,589,623,8201,848,AARP,AMONG,BACKGROUND,COLORECTAL,CONCLUSION,COX,DATA,DIET,INSTITUTES,LABEL,LUNG,METHODS,OVARIAN,RESULTS,RISK,SCREENING,TRIAL,WHILE
201,92A,ANTI,BACKGROUND,CONCLUSION,CONVERSELY,GELATIN,H1299,H460,LABEL,LUCIFERASE,METHODS,MMP,PCR,PROTEIN,RECK,RESULTS,S3I,STAT3,TRANSWELL,UTR
169,2013,8805,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,OLDER,RESULTS,TEXT
001,002,011,2000,2009,937,ASIAN,CONCLUSION,CUMULATIVE,ELDERLY,HNSCC,LABEL,METHODS,NINE,OBJECTIVE,RESULTS,SETTING,SPM,SPMS,UNIVARIATE,UNIVERSITY
169,1990,2013,8764,COPYRIGHT,DEPLETION,ISSUE,LTD,MOLECULAR,SINCE,THESE
ALK,APART,BECAUSE,BRAF,EGFR,FGFR2,GASTRIC,HER2,KRAS,MET,PART,ROS1,RTK,WHILE
172,214,A140D,CAUCASIAN,GSTO1,NSCLC,PCR,RFLP,TURKISH,UNTIL
169,177,2000,2013,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,FIFTY,GREAT,IRELAND,LABEL,METHODS,OBJECTIVE,OLCC,RESULTS
230,330,500,CARLO,CONVERSELY,IGPT,ION,MEV,MONTE,THERE
102,2003,2011,CONTROL,CRT,CSS,ECOG,FREE,IGRT,LOCAL,MAIN,OVERALL,PFS,PRIMARY,SABR,SECONDARY,SEVEN,THESE,TREATED,VMAT
AEC,CROSS,HNF4A,INHIBITION,RXR,TGFB,WNT
1989,2007,AFTER,MOTIVATED,NKX2,TTF
FOXE,H1299,LABEL,METHODS,OBJECTIVE,PROCEDURES,PURPOSE,RESULTS,TAFC
200,2400,CONCLUSION,CONTINUOUS,FIFTY,FOLFOX7,LABEL,METHODS,OBJECTIVE,PFS,PREVIOUSLY,PURPOSE,RESULTS
003,160,1998,2009,EGFR,EGFRS,IGF,JANUARY,UNIVERSITY
008,036,13C,31P,ATP,GENOMIC,LEWIS,NMR,TAKEN,TCA,TEM,THESE,WORKING
170,AMONG,BACKGROUND,BECAUSE,CD8,CTL,CTLS,EVERY,HLA,LABEL,LUNG,METHODS,RESULTS,SINCE
1303,160,212,331,603,660,738,ALTERED,CONCLUSION,EXPRESSION,HOWEVER,LABEL,LSCC,LSCCS,METHODS,OBJECTIVE,PURPOSE,RESULTS
160,440,BACKGROUND,CD56,LABEL,METHODS,ONCOMAP,RESULTS,THESE
169,2013,AACR,DOCETAXEL,SENSORY
001,005,007,177,793,961,ANATOMICAL,CONCLUSION,DESPITE,DIXON,IMAGE,LABEL,MBQ,METHODS,OBJECTIVE,OSEM,OVERALL,PET,PURPOSE,RESULTS,SUVS,THERE,THESE
001,100,120,177,200,211,BACKGROUND,CONCLUSION,CTDIW,DLP,HOWEVER,IMAGE,LABEL,METHODS,NPV,OBJECTIVE,PPV,PURPOSE,RESULTS,STUDENT
000,100,160,BRAF,EBUS,EGFR,FNA,KRAS,L858R,PCR,T790M,TBNA
1CH3,435,A549,CH2,CL2,DU145,MCF,MDA,MTS,NMR,SEVERAL
ALI,BACKGROUND,FIFTEEN,LABEL,MCP,METHODS,OBJECTIVE,RESULTS,STATINS,THERE
000,004,155,160,EGGER,HIGH,LABEL,METHODS,OBJECTIVE,RESULTS
DTCS,HOWEVER
ALK,BACKGROUND,CONCLUSION,IHC,LABEL,METHODS,NSCLC,RESULTS
106,164,1998,2011,582,AFTER,BACKGROUND,CONCLUSION,DATA,FFLP,LABEL,METHODS,NSCLC,RADIATION,RESULTS,SBRT,SIXTEEN,SOCIETY
100,169,2013,211H,253J,5637,786,956,A549,ACHN,BASEL,COPYRIGHT,DU145,H2052,H2452,H28,HEPG2,HUH,LNCAP,MKN,MSTO,NCI,RCC4,SBC,T24,VHL
000,169,2012,2013,8805,ASSESSMENT,BACKGROUND,BASEL,COPYRIGHT,DIAGNOSTIC,FIFTY,KNOWLEDGE,LABEL,MAJOR,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,QUALITY,RESULTS,STAGE,STUDIES,TBNA
169,2013,BACKGROUND,BRAIN,COPYRIGHT,DATA,HOWEVER,LABEL,LTD,MEETING,METHODS,RESULTS,THEREFORE
001,004,007,010,015,C30,CONCLUSION,EGFR,FATIGUE,III,LABEL,LIFE,LUNG,METHODS,OBJECTIVE,PATIENT,PURPOSE,QOL,QUALITY,RESULTS,THREE,TREATMENT
100,8805,AES,CONCLUSION,EGFR,ERBB,ERBB1,FIFTY,IIIB,L858R,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SECONDARY,T790M,TREATMENT
001,269,308,345,ASIAN,CONCLUSION,EGFR,ERBB,ERBB1,ERBB2,ERBB4,HER2,III,IIIB,L858R,LABEL,LUNG,LUX,METHODS,OBJECTIVE,PFS,PROS,PURPOSE,RESULTS,SECONDARY
1191,177,CONCLUSION,FDG,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SEVENTY,THESE
169,2013,AVAILABLE,BACKGROUND,CONCLUSION,COPYRIGHT,FORTY,GRADE,INC,ISG15,LABEL,METHODS,PATIENT,PFS,RESULTS,THERE
001,169,2013,413,483,559,BASEL,BECAUSE,CAUCASIAN,COPYRIGHT,FEW,LABEL,LCS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
141,169,2013,BACKGROUND,BASEL,COPYRIGHT,CTPA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PES,PULMONARY,RESULTS
169,178,2013,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,IIIB,LABEL,METHODS,NINE,NSCLC,RESULTS,SEVENTEEN,TREATMENT
ACUTE,DIAGNOSIS,HOWEVER,IDIOPATHIC,IPF,PROGNOSTIC,UIP
143B,160,169,2013,BACKGROUND,BT12,BT16,CELL,COPYRIGHT,FEDERATION,HOS,HS68,IMR,KCCF1,LABEL,METHODS,NEXT,ONCOLYTIC,PUBLISHED,RESULTS,RH30,SKNAS,SOCIETIES
001,116,456,588,797,936,AFTER,ASIAN,BOTH,CAUCASIAN,EGFR,FIFTEEN,III,MEDLINE,NSCLC,PBC,THESE,TKIS,USING
169,2013,CARLO,COPYRIGHT,LOW,LTD,MONTE,NOISE,SNR,USING
1980,1988,CHRONIC,FURTHER,IRAN,IRANIAN,IRAQ,IRELAND,LTD,PUBLISHED,THERE,WAR
169,2013,CONCURRENT,COPYRIGHT,INC,PUBLISHED,SOCIETY,VSD
169,2013,BILATERAL,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
8201,8230,BACKGROUND,BLOOD,CD4,CD8,COMPARING,FURTHER,HOWEVER,LABEL,MALIGNANT,METHODS,MPE,MPM,RESULTS,WHEREAS
AKT,BACKGROUND,COLON,CYQUANT,ERK,FINALLY,FURTHER,HOWEVER,INHIBITION,LABEL,MAP1D,MEK,METHODS,PDF,PI3K,PROTEIN,RESULTS
293,293T,946,A427,A549,AMONG,BACKGROUND,FOP,INHIBITION,LABEL,METHODS,NSCLC,PCR,RESULTS,SEMI,STUDENT,TCF,TOP,WNT
169,2013,A549,ADP,AKT,ERK,FEBS,HOWEVER,LC3B,RAS,SHC,SRC
AREAS,BACKGROUND,COVERED,DESPITE,LABEL,MALIGNANT,METHODS,MPM,OPINION,PHASE,THEREFORE,THESE
160,AIMP2,DX2,DXI01,TAKEN
632,A549,MTT,RAMAN,SERRS
CASE,INSTEAD
AFTER,BACKGROUND,CURRENTLY,FLAIR,GADOLINIUM,LABEL,METHODS,MRI,RESULTS,SRS,STEROID
EBUS,FINALLY,TBNA
ALK,EGFR,KRAS,NOTABLY,NSCLC,RET,ROS1,THESE
169,2013,AACR,CRITICALLY,CRT,ERK1,ESCC,KNOCKDOWN,LABEL,OVERALL,PREVIOUSLY,PTP1B,T204,THESE,UNLABELLED,Y694
0005,215,301,ADDITIONAL,BCA,BONFERRONI,COLORECTAL,HODGKIN,LUNG,NHL,OVARIAN,SCREENING,TRIAL
397,FAK,FINALLY,GDP,GTP,MIGRATION,PRECISELY,RAB5,S34N,TAKEN
1463,2002,2011,BACKGROUND,LABEL,METHODS,POOR,RESULTS,SCIENCE,THERE,WEB
001,031,167,169,2013,8201,AKT,CCD1,DIX,HBE,INC,MEIER,MMP2,MMP7,MMP9,NSCLC,PI3K,THESE,TNM,WILEY
169,2013,COPYRIGHT,GLYCOLYSIS,GMBH,HELA,KGAA,PFK,VCH,WILEY
169,2013,231,ADP,AMPK,CONVERSELY,COPYRIGHT,ERK,H460,IIA,JOHN,KBM,LC3,LTD,MDA,NCI,OVERALL,PD98059,RAF,RSK,S6K,SALVIAE,SONS,TAN,THUS,U266,WILEY
AFTER,CRMP5,GAD,IVIG,MA2,NMDA,PERM,RITUXIMAB
EWING,PNET,PRIMARY,THERE
169,2013,406,COPYRIGHT,IAPS,JOHN,LTD,PARP,PBPK,SMAC,SONS,WILEY
177,8201,CONCLUSION,HIFU,LABEL,TACE,UNLABELLED
001,160,8201,CALIBRATED,FLT,FULL,IDIF,IDIFS,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PEARSON,PROCEDURES,PURPOSE,RESULTS,SUV,VOI
METASTASES,TCC
CASES,DIAGNOSTIC,DISCUSSION,LABEL,METHODS,MOST,OBJECTIVE,OBJECTIVES,PCP,PCPS,RESILIENT,RESULTS,WHILE
549,FORMULA,HEPG2,HUCCA,MOLT,MOST
002,160,430,CIS,CISPLATIN,NSCLC,PRIMARY,RCTS,RRS,SUMMARY
WHILE
956,A549,BAX,BCL,CDK,ETOH,IC50,MCF,NMR,P21,PC3,TREATMENT
100,799,873,BACKGROUND,COLORECTAL,CONCLUSION,GENERALLY,GROUP,LABEL,MEDLINE,METHODS,RESULTS
0001,18Q,AMONG,INTEGRATED,LABEL,LOW,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THEREFORE
0070,A431,CSCC,HOWEVER,MOST,TSLC1
001,924,929,ARG,ASIAN,CIS,HOWEVER,ORARG,ORS,PRO,SIMILAR,THUS
215,PIT,PRIMARY
946,ALI,ALTERATION,CELL,FAS,THUS
AKT,BOTH,FOLLOWING,HIF,PASMC,PI3K,THESE,THUS,TRX1,WHILE
CRAMP,LEWIS,MICE,RELA,TAKEN,WILD
252,946,FAK,INHIBITION,KLF8,MMP14,MMP2,TAKEN,TCF1,USING
AKT,EGF,EGFR,FINALLY,HGF,MET
100,435S,BACKGROUND,CONCLUSION,CURRENT,G3BP1,HER2,KLAKLAK,LABEL,LTVSPWY,MATERIALS,MDA,METHODS,RAS,RESULTS,THEREFORE,TOX
2007,2011,219,ANALYZING,APRIL,CONCLUSION,EBUS,HOWEVER,JUNE,LABEL,METHODS,OBJECTIVE,RESULTS,TBNA
2008,2010,BACKGROUND,BETWEEN,CLEAR,EIGHT,JULY,JUNE,LABEL,LEVEL,METHODS,PLANNED,RESULTS,SIX,SOCIETY
160,FIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SQCLC
169,2013,945,946,ARSENIC,HBE,HIF,THUS
169,2013,956,ALSO,CADMIUM,CCT,CELLS,EXPRESSION,HIF,HPL,MMP,OVERALL,OXIDANT,RAS,SLC38A3,ZIP,ZNT
169,2013,ALPINIA,ATG,CALYXIN,COPYRIGHT,H2O2,H460,IRELAND,JNK,LTD,NCI,THEREFORE
169,2013,804,ABL,BCR,BOTH,COPYRIGHT,HOWEVER,IRELAND,LTD,PONATINIB,RET,V804M,VANDETANIB
100NM,169,2013,COPYRIGHT,DUE,HOWEVER,INC,THESE,THROUGH
136,2003,2009,8804,FORTY,FOUR,LABEL,METHODS,MOST,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,RFI,SEVENTY,STAGE,TYPES,UNIVARIATE
116,169,2013,549,COMPOUNDS,COPYRIGHT,HCT,HUISGEN,MCF,NMR,SAS,THEIR,THP
100,169,183,2008,2011,2013,300,400,ADP,ANTITUMOUR,BACKGROUND,BETWEEN,BRCA,BRCA1,BRCA2,COPYRIGHT,DOHME,DOSE,EASTERN,EIGHT,ETS,EVALUATION,FUNDING,GROUP,JAN,LABEL,LTD,MERCK,METHODS,NIRAPARIB,PARP,POLY,PTEN,RESULTS,SEPT,SHARP,SOLID,TOXIC,USA
169,2013,COMPARISON,COPYRIGHT,CPG,FFPE,INC,MOLECULAR,NEXT,NGS,PATHOLOGY,PUBLISHED,SOCIETY
001,114,153,160,169,2001,2006,2013,BACKGROUND,COPYRIGHT,EMPHYSEMA,INC,LABEL,METHODS,NON,NSCLC,RESULTS,THERE
18TH,CARDIAC,DISTANT,HEAD,INC,PUBLISHED,SINCE
147,169,2004,2012,2013,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,METHODS,NSCLC,PFS,RESULTS,TKI,TKIS
169,2013,ATP,COPYRIGHT,INC,MICE,P2Y2,THESE
001,008,150,169,177,2013,2CM,60GY,8805,CHEST,D2CM,D50,DATA,DESPITE,DMAX,FOUR,IMRT,MEDICAL,MLD,NOMINAL,NSCLC,OAR,PLAN,PTV,R50,SBRT,V10,V20,V30,V5GY,VMAT
169,2013,BTG3,BTG3B,COPYRIGHT,FULL,FUNCTIONAL,INC,THESE
125,169,2013,A549,BACKGROUND,CK19,CONCLUSION,COPYRIGHT,DETECTION,INC,LABEL,LUNX,METHODS,OVERALL,PCR,PERIPHERAL,PTHRP,RESULTS,SAMPLES
169,2007,2008,2013,232,AIMS,BACKGROUND,COMPARING,CONCLUSION,COPYRIGHT,COX,JANUARY,JUNE,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,RESULTS,TNM,VTE
169,2013,COPYRIGHT,INC,PUBLISHED,SIR
0060,015,018,047,067,132,163,169,2013,BACKGROUND,BRC,CD163,CLUSTER,CONCLUSION,COPYRIGHT,DAP12,INC,LABEL,MATERIALS,METHODS,RESULTS
10CC,169,18GY,2013,8805,AUTHORS,COPYRIGHT,CURRENTLY,CYBERKNIFE,GAMMA,HIGH,IDEALLY,KNIFE,LINAC,LOCAL,LTD,PUBLISHED,WBRT
013,160,169,2013,825,AMONG,CIS,COPYRIGHT,EGFR,EPIDERMAL,FAES,HOWEVER,INCIDENCE,LTD,RRS,TKIS
0001,0066,0080,0205,0281,032,0463,103,118,169,2013,8804,946,BACKGROUND,COPYRIGHT,ENZYMES,ERCC1,III,INC,LABEL,METHODS,MLH1,MPM,MSH,MSH2,MSH6,MUTL,MUTS,PRE,RESULTS,THEIR,THEREFORE
169,2013,225,241,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,STLN,THERE
1319,169,1992,2007,2012,ASIAN,CARCINOID,CONCLUSION,COPYRIGHT,IIA,IIIA,LABEL,LLC,METHODS,OBJECTIVE,OVERALL,PUBLISHED,RECURRENCE,RECURRENT,RESULTS,SEVEN,SIX
160,169,171,2000,2004,2013,296,325,462,496,COPYRIGHT,COX,DFS,FIVE,IIIA,INC,LABEL,LOBECTOMY,MEIER,METHODS,MOSBY,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SEX,SURGERY,SURVIVALS
169,1992,2006,2013,814,CONCLUSION,COPYRIGHT,ICERTDT,ICLINDT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SETTING,THERE
169,2001,2005,2011,2013,609,8805,AMONG,BACKGROUND,COPYRIGHT,COX,INC,LABEL,METHODS,RESULTS,THERE
2003,2012,BACKGROUND,COLORECTAL,CONCLUSION,CRC,DCCG,DENMARK,DIVERSITY,FUNDING,GROUP,HOPEFULLY,LABEL,METHODS,POS,QUESTIONS,RESULTS,TRIAL
0CM,150,169,2013,250CM,3DCRT,CHANGES,EFFECTS,EMD,IMRT,INCREASING,MEDICAL,OAR,TOMODIRECT,USING,V20GY,WBRT
215,BACKGROUND,E2F,E2F2,KNOCKDOWN,LABEL,LIVER,LXR,LXRS,METHODS,PCR,PUBLISHED,RESULTS,TAKEN
169,2013,COPYRIGHT,III,IIIA,IRELAND,LTD,NSCLC
169,2013,ALK,COPYRIGHT,EGFR,IRELAND,LTD,NSCLC,TKIS
002,019,101,169,2013,250,8805,989,BSA,COPYRIGHT,EGFR,GEFITINIB,IRELAND,LTD,NSCLC,OKAYAMA,PFS,UNIVERSITY
117,AGREEMENT,BACKGROUND,BLAND,BPI,BRIEF,CHECKLIST,CONCLUSION,FIRST,INVENTORY,LABEL,MEAN,METHODS,OBJECTIVE,OUTCOME,PAIN,PALLIATIVE,POS,QOL,RESULTS,ROTTERDAM,RSCL,SCALE,SECONDARY,SETTING,SPANISH,SYMPTOM,THERE
169,2013,INC,PRIMARY,WILEY
172,1ST,289,2ND,CASE,CONTROL,EH3,EH4,EXB,HARDY,MAYAK,P450,PHASE,THERE,TYR113HIS
001,004,015,777,8804,ADC,ADCS,AMONG,BACKGROUND,CIR,LABEL,METHODS,RESULTS,T1A,T1B,T2A,TNM,VPI
100,160,2000,2007,717,AFTER,DUTCH,HOWEVER,LABEL,METHODS,OBJECTIVE,PALGA,PATHOLOGY,PURPOSE,RESULTS,SURGERY
0001,100,126,200,300,317,400,797,BACKGROUND,CONCLUSION,EBUS,EGFR,EUS,FNA,HRM,KIRSTEN,LABEL,METHODS,RESULTS,TBNA
8209,946,DESPITE,G12D,LSL,N1ICD,NSCLC,SLUG,SNAIL,WNT
160,ARYTENOID,HOWEVER,USING
160,239,500,AUC,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
A549,ACL,ATP,BECAUSE,EGFR,EMT,FINALLY,H1650,H1975,HMLER,INDUCIBLE,MAPK,PI3K,RAS,SIMILAR,SNAIL
200,500,BOTH,CONSISTENT,HOWEVER,PHOSPHO,TWEEN
948,EXPRESSION,G361,HEL,KNOCKDOWN,PGH2,PGI2,PGIS,PPAR,PTGIS,SINCE,THESE,TIG,VEGF
0009,0376,0485,169,2013,9814,BOTH,COPYRIGHT,FIFTY,INC,THERE
169,174,2013,A549,AFTER,BCAP,COPYRIGHT,LOCAL,MEANWHILE,NAVELBINE,RESULTS,TAKEN
001,169,2008,2011,2013,497,513,AFA,AFAS,AFRICAN,AMERICANS,BACKGROUND,BASED,CAUCASIAN,COPYRIGHT,EGFR,INDEX,IRELAND,KRAS,LABEL,LTD,MAY,MEAN,METHODS,MUTATIONS,NSCLC,RESULTS,UNIVERSITY
100,169,2013,215,COPYRIGHT,CROWN,IRELAND,LTD,NSCLC,PCR,PUBLISHED,RARB2,RASSF1A,USING
169,2013,304,AMONG,COPYRIGHT,COX,FGFR1,FIBROBLAST,HIGH,IRELAND,ISH,LCC,LTD,NSCLC,SCC
169,2013,A549,AFTER,CAC1,CDK,COPYRIGHT,ERK,ERK1,INC,LUNG,MAPKS,PMA,RESULTS
169,2013,COPYRIGHT,CURRENT,HOWEVER,IMAGE,INC,PUBLISHED,SIR
169,2013,946,947,AMAXA,CALU,COPYRIGHT,DNT,HENCE,HOWEVER,IFN,NATURAL,RII,TGF,THESE
100,169,2013,ASIAN,BACKGROUND,CAUCASIAN,COPYRIGHT,DISTANT,FORTY,GGO,GGOS,IIA,INC,LABEL,M1A,MEAN,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE
EIGHT,GBM,GMB,HOWEVER,IHC,MRI,PET,SCLC
0665752,2011,ALK,AREAS,BACKGROUND,COVERED,DRUG,EML4,LABEL,MET,METHODS,NPM,NSCLC,OPINION,PHA,STUDIES
1982,2000,711,BACKGROUND,CALIFORNIA,COX,DATA,LABEL,MAIN,METHODS,NO2,OBJECTIVE,OBJECTIVES,PREVENTION,RATIONALE,RESULTS,SOCIETY,USING
013,1559,1679,215,CHINESE,ERK5,FIVE,MEK5,MITOGEN,SNPS
169,1749,2013,AACR,AXL,FGFR1,FGFR2,FGFRS,MER,MET,MOL,THER,VEGF,VEGFR
169,2013,945,946,AACR,CT26,HOWEVER,INDUCTION,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS
140,169,2013,204,AACR,BOTH,DESIGNS,DTF,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
154,A549,CTCF,DECREASED,DUAL,FURTHER,LTEP,NSCLC,PCR,PLZF,THEREFORE
143,945,ACCORDING,HUH7,NMRI,THUS,TNF,UTR
012,2004,2012,BACKGROUND,CONCLUSION,CYTOLOGIC,EGFR,FURTHER,GEFITINIB,LABEL,LMC,METHODS,NINE,NSCLC,RESULTS,SEOUL,TEN,TKI,TKIS,UNIVERSITY
00004,0071,379,489,945,946,ALPHA,ATBC,BACKGROUND,BETA,FIFTY,FINNISH,LABEL,METHODS,OBJECTIVE,P450,PREVENTION,RESULTS,THESE,TOCOPHEROL
MANAGEMENT
003,215,451,694,696,935,AMONG,BPI,CD18,CIS,COLORECTAL,INHERITED,ITGB2,LBP,LUNG,MYD88,ORS,OTHER,OVARIAN,SCREENING,SIXTEEN,SNPS,TRIAL
000,100,117,1995,2009,8764,CONCLUSION,LABEL,METHODS,OBJECTIVE,RESULTS,THERE
110,ECM,LABEL,METHODS,NPV,OBJECTIVE,OBJECTIVES,PRECAUTION,RESULTS,SELECTIVE,STAGING,VAMLA,VATS
163,CALIFORNIA,CAREGIVER,CAREGIVERS,CURRENT,INSTITUTE,KNOWLEDGE,LABEL,MAIN,METHODS,NSCLC,NURSING,OBJECTIVE,OBJECTIVES,OUTCOME,OVERALL,PERCEIVED,PURPOSE,QOL,RESULTS,SETTING,VARIABLES
169,2013,AFRICAN,AMERICANS,CARDIAC,INC,PRIMARY,WILEY
AFRICAN,AKT1,AKT3,ALK,AMERICANS,BACKGROUND,BIOMARKER,BRAF,CALIFORNIA,CONTEXT,DIEGO,EGFR,EML4,HOWEVER,JAK2,KRAS,LABEL,LUNG,MET,METHODS,MUTATIONS,OBJECTIVE,PTEN,RESULTS,SAN,STAT3,TARGETABLE
REGULAR,SEVERAL,THEREFORE
001,435,8804,AKT,MDA,MMP,PI3,PTEN
AMONG,BAL,BPI,CATHEPSIN,ELISA,LAMP2,NEUTROPHIL,SPEG
946,A549,EMT,EPITHELIAL,FH535,HOWEVER,NSCLC,TGF,THESE,WNT
7028,954,BAY,FINALLY,HOWEVER,ILK,MMP,PREVIOUSLY,TAKEN
206,207,BACKGROUND,CONCLUSION,LABEL,LUNG,MET,METHODS,N375S,PREVIOUSLY,RESULTS,SU11274,TAIWANESE,THERE
BACKGROUND,COPD,CRP,LABEL,LUNG,METHODS,PCR,PROTEIN,RESULTS,SA4,SAA,SAA1,SAA2,SAA4,THERE,THESE
CIMP,CPG,IDH1,IDH2,MAFUCCI,TET,TET2,THESE
ALK,EGFR,OTHER,THERE
2008,2012,BECAUSE,BETWEEN,COMBINING,EARLY,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PAS,PET,PULMONARY,PURPOSE,RESULTS,THEN
DESPITE,NSCLC
1998,2010,CRS,DIFFUSE,DMPM,EXPRESSION,GLUT1,HIPEC,JUNE,LABEL,MEDICAL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS
181,CHEST,IGA,LABORATORY,UPON
169,2013,AIMS,BACKGROUND,BISULFITE,CDH1,CHROMATIN,COPYRIGHT,CPG,EPIGENETIC,H460,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RUNX3,SOCIETY,THERAPY,THESE
169,1989,1991,2008,2013,20TH,386,80TH,932,956,AACR,ARIZONA,ARSENIC,BACKGROUND,HEART,HRS,INDIANS,INORGANIC,LABEL,LOW,METHODS,NORTH,RESULTS,SOUTH,THESE
ACCORDING,CONCLUSION,DEPARTMENT,GENERAL,INC,LABEL,MEAN,METHODS,OBJECTIVE,ORAL,PRIMARY,PUBLISHED,PURPOSE,RESULTS,SPAIN,SURGERY,TEN,THERE,UNIVERSITY
169,1966,1981,1985,1988,2007,2013,215,250M,8805,AIM,CHERNOBYL,CONCLUSION,COPYRIGHT,FINLAND,FINNISH,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,THERE
002,946,BACKGROUND,EMT,HOWEVER,IRON,LABEL,METHODS,NOTCH,RESULTS,SNAI1,TGF,WNT,YOUNG
1990,2000,2004,439,BACKGROUND,CONCLUSION,FIVE,JAPAN,LABEL,LIVER,METHODS,OSAKA,RESULTS,THESE
001,600,8805,BACKGROUND,DOSE,DOSES,DOSIMETRY,EARLY,IMRT,LABEL,METHODS,PRONE,RESULTS,WBI,WTF
20GY,5GY,8201,AAA,ALGORITHM,ANALYTICAL,AXB,BACKGROUND,D98,DVH,ECLIPSE,III,LABEL,METHODS,MLD,PTV,RESULTS,THERE,VMAT
2000S,8764,AFTER,AUSTRALIA,BACKGROUND,CONCLUSION,COUNTRIES,GEOGRAPHIC,ITALY,LABEL,METHODS,RESULTS,THESE,USA,WESTERN
ACC,BACKGROUND,BASAL,BBC,BOTH,COMPARISON,CONCLUSION,DIAGNOSTIC,FOXA1,GIVEN,GPM6B,HER2,LABEL,MEL,METHODS,MIA,PCR,RESULTS,ROPN1,SOX10,TRIM2
A549,ASA,ASPIRIN,BCL,COX,DHFR,FAS,MOST,MTX,NOTABLY,SRB
020,101,C10ORF137,CATALOGUE,EP300,FOUR,LPHN2,MS4A3,MYH2,NSCLC,SIXTEEN,SNVS,SOMATIC,TAKEN,TGM2,TP53
1948,1950,1982,2004,2008,373,ERR,MAYAK,POISSON,THERE
174,185,247,252,8312,FDG,PET,PHYSICIANS,TREATMENT
100,1000,1200,1998,2012,BACKGROUND,CAV,HOWEVER,INDIANA,LABEL,METASTATIC,METHODS,NED,NINE,PNET,RESULTS,RPLND,SIX,TREATMENT,UNIVERSITY
113,171,1980,2010,228,FNA,FNAS,FORTY,LABEL,MAYO,METASTASES,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROCHESTER
ARMS,FKHR,PAX3,PAX3C,PAX3D,PAX3E,RH30,TAKEN,WHILE
BACKGROUND,CIK,HOWEVER,HYPOXIA,INTRAVITAL,LABEL,METHODS,MHC,RESULTS
AKI,ATN,BACKGROUND,CASE,HOWEVER,INHIBITORS,LABEL,METHODS,THEIR,THESE,WITHDRAWAL
0001,047,101,169,2013,8201,8805,BACKGROUND,FOUR,HOWEVER,LABEL,METHODS,MPLC,OTHER,PFS,RESULTS,SABR,SOCIETY,TREATMENT
120,169,2013,8805,APE1,ASP148GLU,CERTAIN,EPHX,EPHX1,HIS139ARG,INC,NAD,NQO1,NULL,PRO187SER,WILEY
005,006,024,025,029,318,411,8211,LESS,LOWER,NSCLC,THERE,TNM,UNIVARIATE,VATS
002,022,023,026,169,2013,COX,EGFR,HPV,TAIWANESE,UICC
60S,ELISA,FURTHER,HOWEVER,L22,LTEP,NSCLC,RIBOSOMAL,RPL22,WESTERN
005,0068,160,161,ATS,EGFR,EPIDERMAL,ERS,HOWEVER,IASLC,LUNG,SOCIETY
2009,2012,CHEST,DIFFUSE,HISTOLOGIC,ILD,INITIAL,LANGERHANS,MALIGNANT
006,012,169,2013,8201,ASIA,BACKGROUND,EGFR,H157,HOWEVER,HPV,HPV16,LABEL,LUNG,METHODS,RESULTS,SOCIETY,SUPF,TAIWANESE
BASED,FDG,HISTOLOGY,PET,PMCA
111,CAUCASIAN
023,034,035,042,2007,2011,945,GLUT,HIF,LABEL,MARCH,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE,VEGF
169,2013,BASEL,COPYRIGHT,DIFFUSE,MPMNS
169,2013,COPYRIGHT,INC,LITERATURE,PUBLISHED,SBRT,SIR
169,2013,BASED,CEA,CGA,COPYRIGHT,FINALLY,LDH,LUNG,NCAM,NSE,PUBLISHED,SCC,SCLC,THEREFORE
009,049,172,177,1999,2007,300,CONCLUSION,INORGANIC,LABEL,LIFE,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,THERE,THREE,WORKERS
169,2013,26YEARS,COPYRIGHT,HODGKIN,MALIGNANT,SAS
100,169,200,2013,233,245,445,ARMS,ASIA,ASIAN,AUTHORS,BACKGROUND,BASED,CURRENTLY,EGFR,L858R,LABEL,METHODS,OBJECTIVE,PACIFIC,PCR,RESULTS,SCREENING,SOCIETY,TKIS
946,956,COMBRETUM,COMPOUNDS,ETOAC,FOUR,IC50
CISPLATIN,MOST,RESISTANCE
169,2013,AUTHORS,COPYRIGHT,CTS,DMS53,FISH,NHBE,PCC,PUBLISHED,SCHIP
169,2014,954,955,CD20,CD3,CD56,CD79A,COPYRIGHT,EMA,HIV,HMB45,HOWEVER,INC,LCA,MUM1,PBL,VMT,VS38C
169,2013,COPYRIGHT,FHF,FULMINANT,NEOPLASTIC,PUBLISHED,SCLC,SOCIETY,THESE
000,000NG,007,100,101,120,152,169,200,2013,2270,230,334,500,600,630,700,765,7920,800,8140,832,898,900,950,9550,BACKGROUND,BAP,COPYRIGHT,III,LABEL,METHODS,MPM,OMC,OMCS,PLEURAL,PUBLISHED,RESULTS,ROC,SOCIETY
CONCLUSION,GIVEN,HOWEVER,LABEL,OBJECTIVE
0001,8070,954,970,CONCLUSION,EGFR,EVALUATION,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SEVENTY,SOLID,STUDENT,TIME,TTP
002,0264,CONCLUSION,COX,FDG,IMAGING,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PET,RESULTS
013,038,052,136,157,2002,2004,454,733,95TH,ADDITIONAL,APRIL,CARLO,CONCLUSION,ESAK,LABEL,LUNG,METHODS,MONTE,NLST,OBJECTIVE,RESULTS,SCREENING,SEPTEMBER,TRIAL
258,759,CANCERS,CASES,CONCLUSION,COPD,DETECTION,DIFFUSE,FOUR,HALF,IIIA,LABEL,LUNG,MATERIALS,METASTASES,METHODS,OBJECTIVE,PATIENT,RESULTS,TEN
015,089,8211,EASTERN,ECOG,ENDPOINTS,GERIATRIC,GROUP,III,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY
32D,EGF,EGFR,ERBB,ERBB3,ERBBS,FINALLY,HOWEVER,MAPK,MET,NSCLC,OVERALL,USING
312,321,ADC,ADCS,ALK,CK14,CK5,EML4,LUNG,SQCC,THERE,TTF
CONVERSELY,EGFR,PCR,THEIR
169,2013,34A,INC,KIT,MICRORNAS,MINI,NSCLC,PCR,PEMETREXED,REAL,SPSS,TARGETSCAN,TIME,WILEY
160,1966,1999,2000,2004,2010,2012,453,8804,8805,965,AUTHORS,BACKGROUND,CENTRAL,COLLECTION,CONTROLLED,DATA,HOWEVER,ISSUE,LABEL,LIBRARY,LUNG,MAIN,MEDLINE,METHODS,OBJECTIVE,OBJECTIVES,POPULATION,PREMEDLINE,RESULTS,RRS,SELECTION,THERE,WHERE
169,2013,EGFR,EPIDERMAL,INC,THEREFORE,WILEY
115,211,CHINESE,CNKI,GSTT1,REVMAN4,STATA10,WANFANG
026,435,461,A549,H2AX,HISTONE,HOWEVER,JUN,KNOCKDOWN,MICROARRAY,NFKB1,PATHWAY,TAKEN,THESE
APOPTOSIS,BACKGROUND,BALB,CONCLUSION,DAPI,DCA,FURTHER,HOWEVER,HUVEC,INHIBITION,KI67,LABEL,LN18,MATERIALS,METHODS,MRC5,PDK,RESULTS,TK6,TUNEL,WIDR
100,CONCLUSION,DETECTION,FALSE,FROC,INITIAL,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
2004,2011,BACKGROUND,CONCLUSION,IIB,IIIA,IIIB,LABEL,MAY,METHODS,RESULTS,SECONDARY,SIX
001,177,320,8201,8226,AMONGST,DIAGNOSTIC,DIFFERENT,DUAL,FIFTY,FORMULA,KEY,LABEL,METHODS,OBJECTIVE,RESULTS,ROC,SPNS
028,033,038,145,160,177,2000,2012,217,ADRENAL,BACKGROUND,DFI,LABEL,MEIER,METHODS,NON,NSCLC,PRIMARY,RESULTS,SHORTER
000,8320,8325,8764,A2058,ATX,AUTOTAXIN,B16,C57BL,CINCINNATI,COMPOUNDS,DISCOVERY,DRUG,F10,LPA,NPP,NPP6,NPP7,THESE,UNIVERSITY
1970S,1990,7400,7402,EMP,HOWEVER,INSTITUTE,IRON,LIMIT,NIOSH,RANGE,REL,SEG,SEGS,SIMILAR,SINCE,USING
BAX,BCL,CDK,CDK4,CINK4,H23,KRAS,NOVEL,PARP,THESE
150,3512676,8805,9335,PFS,SALIENT
293,A127T,AMONG,BCL,CELL,D399N,DRP,DYNAMIN,E423K,FURTHER,G105D,GFP,HEK,K506R,MFN,MITOFUSION,P233L,P46S,P487L,P52L,PROTEIN,PXN,T255I,UTILIZING
BURKITT,E2F,FURTHER,PEGYLATED,PEP,SCLC,TREATMENT
2012,BASED,BRAF,COLORECTAL,EGFR,FDA,FOLFIRI,FURTHER,SEPTEMBER,SORAFENIB,V600E
AFTER,BRAF,COLORECTAL,CRC,FOLFIRI,KRAS,PRO,TRAIL,V600E
ACTIVATING,AKT,ANTICANCER,BRAF,CPG,HOWEVER,KRAS,MLH1,MPE,PI3K,PTGS2,QUESTIONS,REGULAR,THEREFORE
172,231,AKT,ANXA2,DEPLETION,EGF,EGFR,FGD6,GDI2,HAX1,JNK,JUN,KNOCKDOWN,MDA,RNAS,S3A,S3E,TNBC
169,2013,954,A549,COPYRIGHT,DOX,FURTHER,HSP70,IRELAND,LTD,MDR,PCR,TAKEN,USING
120,169,2013,320DM,549,945,956,AMBERLITE,BLOOD,BONE,COLO,COLON,COPYRIGHT,H23,IC50,LUNG,NCI,SAS
001,002,007,023,032,104,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,EASTERN,GROUP,INC,LABEL,METHODS,PFS,RESULTS,SCALE,THEREFORE
140,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,LARGE,LCNEC,LYMPHATIC,METHODS,NEC,NECS,RESULTS,SCLC,THERE
169,2013,A549,HOWEVER,IHC,III,INC,MEANWHILE,MIGRATION,MMP,MSF,MTT,NSCLC,PCR,PUBLISHED
169,2013,COPYRIGHT,IRELAND,LNCRNAS,LTD,RNAS
001,142,151,169,173,2013,249,457,8804,967,COPYRIGHT,INC,LABEL,LLNR,LLNRS,LPAR,LPARS,LPER,LPERS,METHODS,OBJECTIVE,OVERALL,PFI,PRS,RESULTS,SCS,SECONDARY
169,182,183,2013,AMONG,BLADDER,COPYRIGHT,FURTHER,MIR,THEREFORE
169,2013,ALSO,COPYRIGHT,GENERALLY,HOWEVER,IRELAND,KNOWLEDGE,LTD,MRI,THOSE
001,012,160,177,219,405,ADA,ELISA,GROUP,III,LABEL,LDH,LTD,METHODS,MPE,PUBLISHED,RESULTS,ROC,THERE,TPE,UNLABELLED
151,169,171,2013,BACKGROUND,COMPETING,COPYRIGHT,CTV,IRELAND,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,OVERALL,PORT,PURPOSE,RESULTS
169,2013,COPYRIGHT,EBUS,PUBLISHED,SEPAR,WHILE
169,177,2003,2010,2013,APRIL,BACKGROUND,BLOOD,COPYRIGHT,INC,JANUARY,LABEL,MEAN,METHODS,MRI,PUBLISHED,RESULTS,SIXTEEN,SOCIETY,SVC
169,2012,2013,ALK,COPYRIGHT,CRIZOTINIB,III,INC,NSCLC,ROS1
045,169,177,2013,916,CBCT,COPYRIGHT,D30CC,D5CC,DOSIMETRIC,FORTY,INC,ITV,ITV1,LABEL,MATERIALS,METHODS,OAR,OARS,OBJECTIVE,PADP,PERCENTAGE,PNON,PURPOSE,RESULTS,SBRT
169,2013,COLLEGE,COPYRIGHT,EPSCC,LTD,PET,PUBLISHED,ROYAL,SMALL
169,2013,COPYRIGHT,LTD,MRI,PCD
109,113,169,2013,250,400,500,8805,AES,CONCLUSION,COPYRIGHT,DRUG,GRADE,IIIB,IRELAND,KRAS,LABEL,LTD,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,ORR,PEMETREXED,PFS,RESULTS,SECONDARY,SEVENTY,STAGE,THERE
0001,169,2013,214,249,415,878,COPYRIGHT,EDS,IRELAND,LTD,MOST,TBSR
1000,169,2013,2500,600,956,COPYRIGHT,EARLY,FURTHER,ICG,INC,LABEL,METASTATIC,METHODS,MOSBY,NIR,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SLN,SLNS,SURGERY
115,146,169,186,2000,2010,2013,310,315,329,334,369,644,BACKGROUND,BETWEEN,COPYRIGHT,INC,INCLUSIVE,JANUARY,LABEL,METHODS,MORTALITY,PUBLISHED,RESULTS,SOCIETY,UNIPORTAL,VATS
12S,169,2013,BECLIN1,COPYRIGHT,IRELAND,LA1,LTD,MARKERS,PCNA,PROLONGED,SUCCESSFUL,TAKEN,TOTAL,VEGF
169,2013,COPYRIGHT,INCREASING,IRELAND,LTD,MALIGNANT,MPM
169,2013,CAUCASIAN,CHINESE,COPYRIGHT,MOST,NON,NSCLC,PEMETREXED,PFS,SAS,TAKEN,THERE
1120,AREAS,BACKGROUND,BIBF,COVERED,FGFR,HOWEVER,III,LABEL,METHODS,NSCLC,OPINION,PDGFR,PHASE,SEVERAL,THESE,THOSE,VEGF
008,105,208,ALK,ASIAN,BACKGROUND,CD74,EAST,EGFR,GIVEN,KRAS,LABEL,METHODS,ORR,PFS,RESULTS,ROS1
066,150,321,617,898,AES,BACKGROUND,EGFR,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,ORRS,PFS,RESULTS,SUNITINIB
0001,019,089,610,8804,BACKGROUND,BOTH,FDG,HRCT,LABEL,METHODS,PET,RECURRENCE,RESULTS,RFS
001,008,027,156,180,242,263,404,426,702,936,967,COX,IIIA,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STATION,THEREFORE
005,169,2004,2013,239,619,951,998,BACKGROUND,CONSISTENT,COPYRIGHT,INC,LABEL,METHODS,RESULTS,RRS,SMRS,WILEY
125,131,BRACHYDOSE,CAESIUM,CALCULATED,CARLO,DOSE,MONTE,RESULTS,SINCE,TREATMENT
ALTOGETHER,BRACHYURY,CHROMATIN,FINALLY
1990,2006,BRESLOW,COX,LOG,MEIER,SEVERAL
263,AUSTRALIA,BACKGROUND,CONCLUSION,EUROQOL,HRQOL,LABEL,MEAN,METHODS,NON,NSCLC,OVERALL,RESULTS,THREE,VAS
161,BACKGROUND,CONCLUSION,KIRSTEN,KRAS,LABEL,METHODS,NSCLC,PFS,RESULTS,SECONDARY,TYPE
172,75TH,AMONG,BACKGROUND,CONCLUSION,EGFR,FORTY,LABEL,METHODS,NSCLC,RESULTS,TKI,TKIS,USING
1350,1912,CUMULATIVE,GIVEN,INDEX,LABEL,METHODS,MWS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
2006,2009,271,2760,ILD,INCREASED,LABEL,METHODS,OBJECTIVE,RESULTS
PAX8,PRIMARY,THYROID,TTF
169,2013,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS
169,2013,ALK,ANAPLASTIC,COPYRIGHT,EML4,HOWEVER,IRELAND,LTD,SCLC
169,2013,AES,BNC105P,COPYRIGHT,ECOG,GRADE,IRELAND,LTD,MALIGNANT,MPM,PLEURAL,THERE
043,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,EPIDERMAL,HOWEVER,INC,INTRATUMOR,LABEL,METHODS,RESULTS
946,A549,ANGIOGENIC,ARG,ASP,BACKGROUND,GLY,LABEL,METHODS,NH3,RESULTS,RGD,TEM,USPIO
145,2002,2011,238,316,468,AFTER,BACKGROUND,CNS,COLLEGE,EGFR,HOWEVER,III,LABEL,LIVER,MEDICAL,METHODS,NSCLC,OCTOBER,OTHER,PATIENT,PFS,RESULTS,SEPTEMBER,SUBSEQUENT,TKI,TKIS,UNION
001,002,011,023,049,946,BACKGROUND,BALB,COX,DFS,ERK1,LABEL,MEIER,METHODS,PCR,PDZ,REAL,RESULTS,THESE,WESTERN
A549,DATA,FURTHER,HOWEVER,PCL
FGFR,FGFR2,FGFR3,SCC,THESE,USING
100,1000,200,384,500,956,A549,COMPLEX,SODA
004,007,016,033,106,169,2013,945,CD204,CD34,CD44,FIRST,HIGH,LARGE
FBLN2,FIBULIN,HOWEVER,LOSS
001,10MM,140,912,920,BACKGROUND,CONCLUSION,EMPHYSEMA,FEV1,FVC,GROUP,LABEL,LLN,MEAN,METHODS,PI10,RESULTS,THERE
946,GSK3,HUVEC,ILK,PARP,PROTEOMIC,THESE
0001,002,008,169,192,2013,AACR,BECAUSE,CD8,DENSITIES,HIGH,LABEL,LAMP,METASTASES,METHODS,NKP46,OBJECTIVE,PURPOSE,RCC,RESULTS,TH1
169,2013,8197,COPYRIGHT,GMBH,H292,KGAA,LABELLING,NCI,PET,THESE,VCH,WILEY
007,015,169,188,2013,224,605,644,AMONG,BMI,CRP,HCC,UICC
008,010,015,169,2013,8201,ANNEXIN,COPYRIGHT,ELISA,ILK,SOCIETY,THESE,VEGF
1050,130,160,169,177,185,2013,2368,424,ACUTE,CONCLUSION,EXPERIENCE,FIFTY,HIGH,III,INC,INSTITUTE,LABEL,MAIN,METHODS,MOST,OBJECTIVE,PARTIAL,RESULTS,SETTING,TREATMENT
954,A549,MM1S,ROS,U266
FIRST,LUNG,MSCT,NLST,USA
31T,3954,511,HOWEVER,IL1B,SEVERAL
8Q24,946,ALK,ALSO,ATAD2,CD44,EMT,FAK1,GENOMIC,IBC,IBC02,MYC,REMARKABLY,SCID,SINCE,THESE,TSPAN24
233,ALTERATION,BHD,BIRT,DUB,FLCN,HOGG,SINCE,THUS,WNT
8209,BCL,BID,EEDM,HOWEVER,IAP,KOREA,MMP,U937,VED
001,007,009,1568,2005,2010,364,487,717,8201,851,HOSPITALS,IMPORTANCE,IVOR,LABEL,LEWIS,MAIN,MCKEOWN,METHODS,MORBIDITY,OBJECTIVE,PROJECT,PULMONARY,QUALITY,RELEVANCE,RESULTS,SETTING
DECREASED,KISS1,PCR
946,IKK,MAGNESIUM,NK2,NKX2,SOD,SOD2,SP1
0001,0002,0445,2012,344,519,8209,9348,CAUCASIAN,EFFECTS,EGFR,ERLOTINIB,JULY,LDH,MOLECULAR,NSCLC,OBJECTIVE,PFS,TKI
0001,100,177,183,206,8201,8226,COMBINING,FIFTY,KEY,LABEL,METHODS,NAVIGATION,OBJECTIVE,OBJECTIVES,PLBS,PNX,RESULTS,TDLP,TECHNICAL
133,133A,160,8209,A549,ACCORDING,H1299,HOWEVER,LUNG,MMP,NCI,RNAS
A549,AKT,BCL,CISPLATIN,ERK1,PUMA,STRIKINGLY,THESE
0001,0092,0420,1250,150,169,183,2009,2010,2013,215,222,225,226,451,8200,APRIL,BACKGROUND,COPYRIGHT,EGFR,FASTACT,FUNDING,IIIB,LABEL,LTD,METHODS,PFS,RESULTS,ROCHE,SEPT,SERIOUS,TREATMENT
061,169,175,1995,2012,2013,479,684,8805,BACKGROUND,BPF,COPYRIGHT,INC,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE,THREE,UNIVARIATE
007,289,339,622,674,729,8201,943,992,AGE,ASIR,ASMR,BACKGROUND,CARCINOMA,CHINA,DESPITE,FAO,FINLAND,FOOD,FURTHER,HONG,HOWEVER,JAPAN,KINGDOM,KONG,LABEL,METHODS,NPC,PEARSON,PER,RESULTS,SINGAPORE,STATISTICS,THERE,TRADE
FINALLY,LIFESTYLE,SINCE
1000,169,1979,2010,2013,5914,CIPD,COX,DATA,HNC,ILLNESS,INSURANCE,JOHN,LTD,NHIRD,RATE,RATIO,SONS,SPC,WILEY
000,2013,345,600,AMONG,BACKGROUND,CONCLUSION,GCMAF,HOWEVER,LABEL,MARCH,METHODS,MIRAI,RESULTS
160,1F1F,1S1S,ANTITUMOR,BACKGROUND,CONCLUSION,DG3,GCMAF,GROUP,LABEL,LEWIS,MATERIALS,METHODS,RESULTS,SEPHAROSE
169,2013,AACR,ACADEMY,HOWEVER,MOLECULAR
100,169,2010,2012,2013,318,364,BACKGROUND,EGFR,EPIDERMAL,EXON,HOWEVER,JULY,L858R,LABEL,METHODS,PFS,RESULTS,SOCIETY,TKI
169,183,AFTER,AIMS,BACKGROUND,CONCLUSION,ENT,GEORG,INSERTION,LABEL,MALIGNANT,METHODS,OBJECTIVE,PEG,RESULTS,STUTTGART,THEREFORE,YORK
BECAUSE,CONCURRENT,III,MOST
ANOTHER,THEIR
8211,AGILITY,DELTA,MLC,MLCI,SCANDIDOS,STOCKHOLM,UPPSALA,VMAT
129,160,LABEL,LESIONS,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,XCAT
109,111,169,2013,COPD,COPYRIGHT,FIVE,FORTY,GMBH,HMB,LAM,PAFL,SEVEN,SIXTY
001,002,008,011,012,019,028,051,056,061,134,160,169,190,1999,2009,2013,780,912,CONTROL,COPYRIGHT,COX,ESPECIALLY,INC,JANUARY,LABEL,LYMPHATIC,MEIER,METHODS,MOSBY,NSCLC,OBJECTIVE,PATHOLOGIC,PUBLISHED,RESULTS,SURGERY,THERE,TNM,UNION
001,002,009,026,068,169,2013,603,8804,COPYRIGHT,COX,HOWEVER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PUBLISHED,RESULTS,SURGERY,THERE
001,160,169,2006,2010,2013,344,433,BETWEEN,COPYRIGHT,INC,LABEL,MAY,METHODS,MOSBY,NSCLC,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS,SURGERY,VAMLA
039,169,1900,2013,BACKGROUND,BROWN,COPYRIGHT,CSF,DEFINITION,ERASMUS,FACTORS,IMAGING,IMBCM,LABEL,MED,MEDLINE,METHODS,OBJECTIVE,OVID,PUB,RESONANCE,RESULTS,SEQUARD,TREATMENT,YALE
100,139,708,715,887,978,AUC,BACKGROUND,CEA,COMPARISON,CONCLUSION,LABEL,METHODS,MPM,RESULTS,SMRP,SOLUBLE,WHEREAS
A549,BACKGROUND,COX,DECREASED,DOWN,EXPRESSION,LABEL,MATERIALS,METHODS,MIRNA,NSCLC,RESULTS
DCA
BACKGROUND,DATA,HOWEVER,INDEX,LABEL,METHODS,OTHER,RESULTS,RISK,SCOPE,SPM,SPMS
ADP,IC50,NSCLC,ROS,THESE,THUS
CANDIDATE,SUPPRESSOR,TAKEN,TUSC1
0001,0002,0227,109,8202,946,954,A549,ATDC,FURTHER,H1299,HBE,HOWEVER,MTT,MYC,NEXT,NSCLC
169,2013,449,CASES,CONCLUSION,COPYRIGHT,HRS,INC,LABEL,METHODS,OBJECTIVE,PARTIALLY,PFT,PURPOSE,RATES,RESULTS,SIXTY,STUDIES,WILEY,WILMS
945,946,EP2,EP4,HOWEVER,THESE
154,8805,ANXIETY,CONCLUSION,DEPRESSION,FEW,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,TIME,WHILE
001,032,2008,2011,205,500,APRIL,CONCLUSION,EASTERN,ECOG,GROUP,III,JULY,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,SIMILAR,THERE
2003,2005,384,CARE,CONCLUSION,CONSORTIUM,HOWEVER,IIIB,LABEL,METHODS,OBJECTIVE,OLDER,PURPOSE,RESULTS,SEVENTY
169,2013,HOWEVER,NFAT,NUCLEAR,SUBSEQUENT,UICC
169,2013,215,CD24,COMPARISON,COPYRIGHT,HT29,THESE,UICC,USING
169,2013,385,BACKGROUND,BLOCKER,COPYRIGHT,EGFR,EIGHT,ERBB,FISH,HER2,LABEL,METHODS,RESULTS,SOCIETY
160,173,185,945,BACKGROUND,LABEL,METHODS,NON,NSCLC,RESULTS,SEVERAL
001,024,075,143,336,354,370,692,736,758,788,804,955,AAA,ALK,ANCCA,BACKGROUND,COX,EGFR,HER2,HOWEVER,KRAS,LABEL,METHODS,RESULTS
0001,002,169,19Q13,2013,328,483,AACR,CONCLUSION,LABEL,LUCIFERASE,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,SNP,SNPS
0001,0002,0004,0005,0015,0030,0036,0043,8201,AGE,ASSESSMENT,BONFERRONI,C30,EORTC,FURTHER,HRQOL,INCREASED,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,QLQ,RESULTS,UNIVARIATE
3T3,8764,946,947,CBP,CEBPG,COVALENTLY,EBP,MEFS,NIH,OIS,RAS,SASP,V12
BER,CLAUDIN,EP4,HOWEVER
ANN,ARBOR,CD20,CD30,ENGLISH,II2E,IMAGING,MUM,PAX5,PRIMARY,REED,STERNBERG
344,497,ABOUT,LITERATURE,NSE,SCLC
945,ANTI,CD47,EFFICIENT,LPH,RNAI,SIRP
ANTITUMOR,GMP,LCP,MVD,NSCLC,THERE,VEGF,VEGFS
169,2013,956,A549,ANEMONE,BUOH,COPYRIGHT,HELA,HEPG2,IC50,THEIR,U87MG
0001,278,376,654,CONCLUSION,COX,FIVE,GROUP,LABEL,LYMPH,MEIER,METHODS,MLN,NLS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE,UNIVARIATE
EVEN,LEFT,LSPV,RIGHT,THEREFORE
103,2300,BACKGROUND,BIOLOGICAL,CISPLATIN,CONCLUSION,HOWEVER,LABEL,METHODS,RESULTS,WESTERN
047,0823,178,2005,2011,BACKGROUND,CDDP,CPT,FORTY,JANUARY,LABEL,LCNEC,METHODS,RESULTS,SCLC,SMALL
BACKGROUND,BECAUSE,CONCLUSION,HOWEVER,LABEL,LUNG,METHODS,PATHOLOGY,RESULTS,THEIR
774,ACTIVATION,CBL,CTEN,EGF,EGFR,OVERALL,SRC,TNS4
140,169,191,192,2013,215,391,946,AACR,COX,MIR,NSCLC,PCR,SERUM,TGF,THOSE
169,2013,231,233,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,DIAGNOSIS,HISTOLOGY,LABEL,METHODS,MOST,PRIMARY,PUBLISHED,SAS,SNFMI,SOCI
169,2013,946,A549,BACKGROUND,CAF,CAFS,COPYRIGHT,EXPRESSION,H358,INC,LABEL,LNFS,METHODS,NCI,NSCLC,PUBLISHED,RESULTS,SOCIETY,TARGETING,TGF,THESE,THUS
160,169,2000,2006,2013,8805,ADDITIONAL,ADJUSTING,AGGREGATE,AREA,BACKGROUND,COPYRIGHT,CURRENT,END,ESTIMATES,INC,INSURANCE,LABEL,MATERIALS,METHODS,OVERALL,POPULATION,RESULTS,SMALL,THEREFORE,UNIVARIATE
169,2013,AKT,ATK,COLORECTAL,COPYRIGHT,CRC,DLD,INC,MMP,PCR,PROTEOMIC,REAL,SW480,TAGLN
169,2007,2010,2013,AIM,BRITAIN,COLORECTAL,CONCLUSION,DISEASE,FAILURE,GREAT,IRELAND,KNOWLEDGE,LABEL,METHODS,MOST,MRI,NINE,OBJECTIVE,RESULTS,SINCE,SWEDISH,THERE,TNM
131,151,169,181,1997,2004,2013,8805,CONCLUSION,COPYRIGHT,DFS,EASTERN,ESTIMATED,GROUP,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SCORE
HOWEVER,THESE
110,169,2007,2010,2013,BACKGROUND,COPYRIGHT,ESTIMATED,IRELAND,LABEL,LOCAL,LTD,METHODS,OBJECTIVE,OMD,OVERALL,PME,PURPOSE,RESULTS,SABR,SBRT,SECONDARY
169,176,2013,224,2400,244,400,8804,8805,CONCLUSION,COPYRIGHT,DYNAMIC,EBT,FFF,GAFCHROMIC,III,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PLANS,PURPOSE,RESULTS,SEVEN,UNDER
169,19Q13,2013,235,BACKGROUND,CNV,CONCLUSION,COPY,COPYRIGHT,DFS,ERCC1,FISH,IC50,INC,LABEL,MATERIALS,METHODS,NSCLC,RESULTS
ALK,EGFR,THERAPY,VEGF
000,160,169,2013,ACADEMY,AFTER,AUTHORS,CONSISTENT,CTLA,EVALUATION,III,INC,IPILIMUMAB,THESE,WILEY,YORK
009,965,ARS,AUTHORS,BASED,PTB,RRS,SEOUL,THUS
001,025,027,285,293,2P16,440,455,495,546,744,794,LUNG,SNP,SNPS,THEREFORE
407,426,BESIDES,H22,HDM,HSP70,HUVEC,THESE
038,1997,1999,532,CONCLUSION,COX,HORDALAND,LABEL,METHODS,NORWEGIAN,OBJECTIVE,PURPOSE,RESULTS,SELF,SUB
120,413,AIM,BACKGROUND,LABEL,METHODS,OBJECTIVE,RESULTS,ROSE,TBNA
339,AIM,AMONG,BACKGROUND,BESIDES,CYTOSCAPE,ERBB4,EXPRESSION,FUNCTIONAL,FURTHER,KEGG,KRAS,LABEL,MATERIALS,METHODS,MICRORNAS,OBJECTIVE,OMNIBUS,PATHWAY,PPI,RESULTS,THREE
ALK,DRUGS,EGFR,FURTHER,LUNG,NSCLC,ONGOING
179,185,200,550,8315,BASED,BECAUSE
026,033,1149,145,160,1603,177,2009,2012,215,217,677,8804,945,946,955,963,AHF,BIOL,CHF,D88,FAKIRIS,FINALLY,INT,NSCLC,OERAH,OERCH,ONCOL,PALMA,PHYS,SBRT,TCP
100,177,946,956,CH27,EMAX,HEP,HSC,IC50,LPS,M21,MTT,NONE,SOLANUM,THEIR
001,002,003,1988,1991,COLORECTAL,ERSPC,LUNG,OVARIAN,PLCO,PSA,RANDOMIZED,SCREENING,SINCE
CAVIN
DISRUPTION,HOWEVER,OVERALL
945,946,ACR,CHROMATIN,NOTABLY
083,MAJOR,THESE
169,2013,CERTAIN,COPYRIGHT,EACH,ISSUE,LTD,MOLECULAR,THERE,UPP
169,174,2013,ALBUMIN,ANOTHER,CONTINUED,COPYRIGHT,DESPITE,MBC,NSCLC,PACLITAXEL,SPARC,TAXANES,THUS
0001,033,169,2013,446,523,COPYRIGHT,GLN223ARG,LEPR,OBESITY,PCOS,POLYCYSTIC,PRO1019PRO,SNPS
169,2007,2011,2013,ASC,ASIAN,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,JANUARY,L858R,LABEL,MEIER,METHODS,NSCLC,PUBLISHED,RESULTS,TKI
000,1285,2400,440,CONCLUSION,EARLY,EPC,ICER,INC,LABEL,METHODS,MODEL,OBJECTIVE,ORS,PUBLISHED,QALY,QALYS,QOL,RESULTS
155,169,1980,2009,2013,470,AMONG,COPYRIGHT,HIGH,INDUCTION,IRELAND,LCC,LCNEC,LTD,NSCLC,PATHOLOGIC,SCLC,THERE,THEREFORE,TNM
118,145,169,2013,589,648,725,834,AGE,BACKGROUND,CARDIOLOGY,COLLEGE,COPYRIGHT,COX,FOUNDATION,GIVEN,INC,LABEL,METHODS,NEXT,OBJECTIVE,OBJECTIVES,PUBLISHED,RESULTS
730,ALK,CHINESE,EGFR,EML4,KIRSTEN,KRAS,NSCLC
AFTER,ALK,DRUG,EGFR,EML4,NSCLC,PHASE,ROS1,TKIS
CURRENT,EGFR,NSCLC,T790M,TKI
LUNG,MAGE
001,014,178,370,967,BACKGROUND,EGFR,EPIDERMAL,LABEL,METHODS,NSCLC,PFS,RESULTS,TKI,TKIS
137,AFI,BACKGROUND,EVIS,LABEL,METHODS,NBI,OLYMPUS,RESULTS,WLB
100,132,162,199,2009,2012,216,348,361,BACKGROUND,BETWEEN,COMPARING,EBUS,JULY,LABEL,METHODS,RESULTS,TBNA
ADM,BACKGROUND,CCK8,DDL1,DDP,DELTA,DLL1,EGFP,FIRSTLY,H69,H69AR,HES1,HEY1,LABEL,LIKE1,MDR,METHODS,NOTCH,PCR,RESULTS,SCLC,THEN,WESTERN
169,2013,AMPK,ANNEXIN,ATG,ATG12,ATG5,AUTOPHAGIC,AUTOPHAGY,AVO,COPYRIGHT,EGFR,ERLOTINIB,FOUR,H1975,H358,HCC4006,INHIBITION,IRELAND,L858R,LABEL,LC3II,LTD,METHODS,MTT,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SIMILARLY,T790M,TKI,WESTERN
169,1916,1985,2012,2013,BACKGROUND,COPYRIGHT,HOWEVER,IASLC,IMIG,IRELAND,LABEL,LTD,METHODS,RESULTS,THESE
169,2013,ALK,COPYRIGHT,IRELAND,LTD,NSCLC
004,125,169,177,2013,50S,8320,8321,APART,CONCLUSION,COPYRIGHT,CTP,IRELAND,LABEL,LTD,MATERIALS,METHODS,MTT,OBJECTIVE,OBJECTIVES,RESULTANT,RESULTS
100,160,169,2013,COPYRIGHT,IIIA,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,TEN,THUS
169,2013,ACTIVATION,AUTHORS,COMPLETED,COPYRIGHT,CURRENTLY,EGFR,ERBB,HOWEVER,LTD,NSCLC,PUBLISHED,TKI,TKIS
169,2013,8805,BACKGROUND,CONCLUSION,COPYRIGHT,DUE,FOUR,HIGH,HOWEVER,III,LABEL,LTD,METHODS,RESULTS,RFA,SBRT,TREATMENT
0001,048,160,1651,169,2007,2010,2012,408,687,792,9177,BACKGROUND,CHRONIC,CONCLUSION,COPD,COPYRIGHT,HOWEVER,ICS,INDEX,JANUARY,LABEL,LTD,METHODS,RESULTS
057,071,169,2006,2007,2008,2009,2011,2013,2016,2020,206,282,384,500,827,AIMS,CARE,COLLEGE,COPYRIGHT,DISCUSSION,ENGLAND,ENGLISH,GROUP,LABEL,LTD,MALTHUS,MATERIALS,METHODS,NRAG,OBJECTIVE,PCT,PRIMARY,PUBLISHED,RESULTS,ROYAL,RTDS,TRUST
BACKGROUND,IIIA,IMPT,IMRT,LABEL,METHODS,NSCLC,OARS,PORT,POST,PSPT,RBE,REDUCTIONS,RESULTS,V10,V20,V30,V40
ACADEMY,DAMP,OTHER,PHYSICIANS,PROTECTION,SOURCES,WRITTEN
001,433,HOWEVER,IIA,IIB,LABEL,LVI,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,RFS,STAGE,T2AN1,T2BN0,T2BN1,T3N0,VPI
169,2013,259,297,410,ASN,FOURIER,GMBH,IGG,IGG1,KGAA,VCH,WILEY
169,2013,8201,8804,BACKGROUND,COPYRIGHT,EIGHT,ESFT,EWING,FIVE,IMRT,INC,INITIAL,LABEL,METHODS,NINE,PROCEDURE,RESULTS,RMS,THERE,WILEY,WLI
121,209,CK5,FIFTEEN,IHC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,P63,RESULTS,THYROID,TTF1
100,BOTH,EGFR,EXTRACTED,FIFTY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,PYRO,REFRACTORY,RESULTS,RGQ,SCORPIONS,USING
169,2013,BACKGROUND,COMPANY,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,RESULTS,SDC,WILEY
1H209,1H210,1H68,A549,GFP,GLV,RBC,RBCS,TAKEN,VACV
001,8201,8226,954,CONCERNING,DIAGNOSTIC,F18,FDG,FOUR,KEY,LABEL,LNS,MATERIALS,METHODS,MRI,OBJECTIVE,OBJECTIVES,OVERALL,PET,RESULTS
EVIDENTLY,JANUS,KALLIKREIN,KLK,KLKS,MOST,REGARDING
000,001,122,181,2007,2010,300,400,640,860,CASES,CHILE,HOWEVER,ODDS
062,209,BACKGROUND,JOHNSON,LABEL,LUNG,MEDICAL,METHODS,RALPH,RESPONSES,RESULTS,SMOKERS
AFB,AFBS,AFI,MOST,REGARDING,SEVERAL,WLB
169,2013,3Q26,AACR,DDX3X,EXPRESSION,INCREASED,LABEL,PROTEOMIC,SEC62,SKIL,SLUG,SNAI2,SNON,THESE,TLOC1,UNLABELLED
110,1580,169,2003,2010,2013,300,432,500,COPYRIGHT,INC,LABEL,MARCH,METHODS,MOSBY,OBJECTIVE,OCTOBER,PUBLISHED,RESULTS,SURGERY,THESE
169,2013,A549,BAK,BAX,BCL,BID,CASPASE,COPYRIGHT,DIOSCIN,H446,H460,HOWEVER,LTD,NCI,WESTERN
100,106,169,2013,50YEARS,AUTHORS,COPYRIGHT,ESTIMATES,GIVEN,HOWEVER,INC,MODEL,PUBLISHED,RRS
169,194,2013,231,400,956,A549,COMPOUNDS,COPYRIGHT,HELA,IC50,LTD,LUNG,MCF,MDA,PEG,WHILE
160,169,2013,COPYRIGHT,DESPITE,INC,NKX2,TTF
169,2013,CELL,COPYRIGHT,GATA6,HOPX,INC
004,015,145,169,2013,281,503,8201,8805,CHT,GROUP,JOHN,KARNOFSKY,LTD,SCLC,SONS,TRT,WILEY
169,2013,AUTHORS,BRITISH,CANONICAL,JOHN,JOURNAL,KNOWN,LTD,POTENTIAL,SOCIETY,SONS,THERE,THESE,TRANSIENT,TRPC,TRPC1,TRPC3,TRPC4,TRPC5,TRPC6,TRPC7,WILEY
001,004,006,008,013,025,177,533,8202,869,880,8804,ABC,AFTER,AMONG,ARTP,CANDIDATE,CHECK,ENRICHMENT,GSEA,GWAS,JNK,NRAGE,NSCLC,PARTP,PATHWAY,PGSEA,POINT,PRODUCT,RANK,SET,SIGNALING,SIGNALS,SNP,TRUNCATED,VEGF
000X,181,30X
8202,945,946,CCL3,FIVE,IL1,IL2R,IL8,LUNG,PBMC,PBMCS,THESE
18F,BACKGROUND,CONCLUSION,FDG,FOURIER,HIGH,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PET,PURPOSE,RESULTS,THEIR,TNM
105,115,119,130,177,418,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
339,352,691,ADDITIONAL,BACKGROUND,BEIR,CONCLUSION,HENCE,LABEL,LAR,METHODS,NORMALIZED,OBJECTIVE,PURPOSE,RESULTS,SUMMATION,USING,VII
PLEURAL
101,169,2013,HEMOPHILUS,INC,SEVENTY,TREATMENT,WILEY
ACTIVATION,ARF,EGFR,HOWEVER,NOTABLY,PCR,THESE
16S,LEGIONELLA
946,AKT,GSK3,LEUCINE,LZTS2,NSCLC,THESE,WNT
239,2ND,8201,8805,BACKGROUND,DCR,ECOG,EXCLUSION,III,IIIB,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OTHER,PFS,PRIMARY,QOL,RESULTS,SECONDARY,STAGE,SUNITINIB,TREATMENT,TTP
ATM,ATR,ATRIP,CHK1,CTBP,CTIP,DDR,DISABLING,FINALLY,FURTHER,PKCS,PUMA,RPA,THESE,USING
DDR1,DDRS,DISCOIDIN,HOWEVER,III,MMP,NSCLC,VIII
169,200,2013,320,549,COPYRIGHT,DSC,EACH,ESI,INC,MTT,NGI,TGA,UPLC,UPON,WILEY
0001,485C,CAUCASIANS,FIVE,HOWEVER,ILE143VAL,LEU,LYS178ARG,MGMT,PHE,RESULTS
2006,2011,478,AIMS,BACKGROUND,III,LABEL,METHODS,OBJECTIVE,PATIENT,PCI,PFS,RESULTS,SCLC,WHITFIELD
160,167,2003,2012,227,8201,LABEL,MAJOR,MEDICAL,METHODS,NSCLC,OBJECTIVE,OPERATIVE,PURPOSE,RESULTS,THERE
947,CD14,CD16,CD86,HLA,HOWEVER,IFN,MDSC,MDSCS,NADPH,NSCLC,ROS,THESE
BACKGROUND,CONCLUSION,LABEL,MARS,MIGHT,RADICAL,SURGERY
BASED,CBI,HOWEVER,L1210,NOTABLY,PREVIOUSLY
2206,945,946,AKT,CETUXIMAB,CTX,DESPITE,EGFR,GSK3,H226,IKK,INHIBITION,IRS,MAPK,NCI,PI3K,RAF1
001,002,177,NLR,NSCLC,PFS,UNIVARIATE,VEGF
CHEST,SS18
196B,205,375,8209,HOWEVER,NSCLC,PCR,SCC,THEREFORE,THESE,THREE
1989,1991,1998,3038,602,8804,AFTER,AMONG,BACKGROUND,CHINA,CIS,COX,GRAM,IRR,IRRS,LABEL,METHODS,RESULTS
11C,945,AMT,MRI,PET,SUV,SUVS,THESE,TUMORAL
169,2013,239,ANORECTIC,BOLD,COPYRIGHT,DATA,INC,LABEL,METHODS,NSCLC,OBJECTIVE,RESULTS,SPM,THESE
012,037,039,2011,2012,AMONG,BACKGROUND,HOWEVER,LABEL,METHODS,OCTOBER,PAIN,RESULTS,SITS,VATS
010,011,043,049,119,177,428,AMONG,BACKGROUND,EASTERN,GROUP,LABEL,MEAN,METHODS,NSCLC,RESULTS,T2AN0M0
001,028,045,160,2005,2006,2008,8201,AFTER,BACKGROUND,CLINICALLY,HENCE,HOWEVER,JULY,JUNE,LABEL,METHODS,NSCLC,PFS,RESULTS,RFA
100,106,209,922,BACKGROUND,CEA,CONCLUSION,FURTHER,HOWEVER,LABEL,LDH,LUNX,METHODS,MPES,PCR,PULMONARY,RESULTS,ROC
001,004,012,115,432,8804,BACKGROUND,CHINESE,ERCC1,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS
001,003,004,023,029,048,114,11A,30A,967,ASSESSING,BACKGROUND,DATA,GENOMIC,HOWEVER,IIB,LABEL,NSCLC,RESULTS,SCC
HOWEVER,THEREFORE,THESE
PULMONARY,THERE
BACKGROUND,BOTH,CASE,CONCLUSION,LABEL,METHODS,PRIMARY,THESE,THUS
185,270,560,8315,8322,8323,A431,A549,AMONG,BACKGROUND,BRAGG,CALCEIN,CELL,CLSM,DII,FIT,FNTD,FNTDS,GLUT,HDS,HOECHST,LABEL,METHODS,MEV,NEITHER,PC3,RESULTS,SMA,U87,VMDK
131,152,164,1962,2009,4572,8201,8805,AMONG,BACKGROUND,COX,DISTANT,DTC,KOREA,LABEL,METHODS,OLDER,POOR,RESULTS,SEOUL,UNIVERSITY
169,2013,AIMS,CCR6,CKRS,CRC,CXCR2,CXCR4,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
III,SPLC,SPM
945,CERTAIN,HORMONE,INITIATIVE,THEREFORE,THUS,WOMEN
1980,2011,CONCLUSION,EIGHT,HODGKIN,LABEL,MEDICAL,METASTATIC,METHODS,OBJECTIVE,RESULTS,SECONDARY,SEVENTY,UNIVERSITY
004,019,780,AUC,CTCAE,HOWEVER,HRT,ROC,UNIVARIATE,V10,V15,V20,V25
169,2013,AACR,DLT,DLTS,FDG,HER2,HSP70,LABEL,METHODS,MTD,OBJECTIVE,PET,PURPOSE,RESULTS,RP2D,SECONDARY,THERE
FDG,GLUCOSE,GLUT,ONCOCYTIC,PET,THUS
169,2013,239,BLOOD,DATA,EXOME,HEART,INC,INSTITUTE,LUNG,PROJECT,RVA,SEQUENCING,WILEY
EXPRESSION,OATP1B1,OATP1B2,OATP1B3
1713,2007,2012,ADULT,AGE,AMONG,IMPORTANCE,JUDE,LABEL,MAIN,METHODS,OBJECTIVE,OCTOBER,RELEVANCE,RESULTS,SETTING,THESE,USING
100,204,2573T,A750,AIM,E746,EGFR,FOUR,IHC,L858R,LABEL,LEU858ARG,METHODS,OBJECTIVE,RESULTS,THERE
2A13,CYP,CYP2A,CYP2A13,CYP2B,LABEL,METHODS,NNK,OBJECTIVE,P450,PURPOSE,RESULTS,THUS
028,1316,2012,2120,954,BACKGROUND,COHEN,CURRENTLY,FIVE,INCREASING,KNOWLEDGE,LABEL,META,METHODS,RESULTS,WEB
8209,947,AFTER,ATM,DIFFERENT,ERK,ERK1,EXOGENOUS,FEN1,G418,H2AX,HBE,MAPK,MEK1,MRE11,NOTABLY,PCR,TOB1,U0126,XRCC1
001,169,2013,3MM,550,694,716,810,909,ADVANCE,CONCLUSION,COPYRIGHT,DLR,FIVE,INVERSE,IRELAND,KNOWLEDGE,LABEL,LTD,MEAN,METHODS,OBJECTIVE,RESULTS,ROC,UNASSIGNED
009,131,169,2013,APMIS,BONFERRONI,CHI,EGFR,ERBB,FIFTY,FOUR,FURTHER,HER2,HER3,JOHN,LTD,NSCLC,PUBLISHED,SIXTY,SONS,WILEY
001,002,010,012,022,037,045,048,050,065,10A,126,145,169,2013,30D,30E,320,451,732,ACCORDING,BEAD,COPYRIGHT,DFI,HIGH,HOWEVER,IRELAND,LTD,LUMINEX,NSCLC
003,005,006,007,009,012,016,023,024,025,026,031,041,169,2013,BLD,CONCLUSION,COPYRIGHT,DFS,FIFTY,IIIA,IRELAND,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,VEGF
13D,169,2013,A549,COPYRIGHT,DU145,HBA,LTD,ORAL,PDGFR
169,177,2013,956,BALB,COPYRIGHT,DOX,H226,INHALABLE,LTD,PLGA,TRAIL
C10,ERK1,MAP,MAPK,MEA,PAHS,PCR,POLYCYCLIC,THEREFORE,THESE
A50,ACR,BOTH,COLLEGE,CONCLUSION,CTN,EANM,ELECTRICAL,FDG,HOWEVER,LABEL,METHODS,NEMA,NETWORK,NUCLEAR,OBJECTIVE,PET,PHANTOM,PURPOSE,RADIOLOGY,RESULTS,SNM,SOCIETY,SUV,SUVS,THESE,VOI,VOIS
ADDITIONAL,ASIAN,EAST,ESPECIALLY,SEVERAL
169,177,2013,257,956,A2780,ANISOCYCLA,COMPOUNDS,COPYRIGHT,H460,IC50,JOHN,LTD,MCF,NMR,SONS,UACC,WILEY
005,023,169,2013,799,835,8804,AFTER,AMONG,BACKGROUND,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RADIOLOGIC,RECURRENCE,RESULTS,VARIABLES,WILEY
183,AMONG,BACKGROUND,CONCLUSION,GEORG,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,STUTTGART,YORK
181,8805,DRECHSLERA,MDR,NICOTIANA,OPHIOBOLIN,TBY
0362,160,183,1990S,2001,2008,2009,215,770,8201,BETWEEN,LABEL,METHODS,MINIMALLY,OBJECTIVE,OPERATIVE,OTHERWISE,PROCEDURAL,PURPOSE,RATS,RESULTS,SHORTER,SINCE,THERE,VATS

001,002,055,CONCLUSION,FAZA,FDG,FHV,HOWEVER,III,LABEL,METHODS,NSCLC,PARTIAL,PET,RESULTS,THERE,THEREFORE,UNLABELLED
ANTISENSE,ETE,FLAP,LOX,OXER1,SEVERAL,STUDIES
7721,916,968,BAX,BCL,FUCOIDANS,GSH,IAP,LIVIN,MMP,ROS,SMMC,THESE,UNDARIA,XIAP
GIVEN,HOWEVER,HSVTK,NSCS,USING,VSV
100,178,8314,A549,HEPES,TAQ
AP4,BESIDES,CD44,CDH1,CONVERSELY,CRC,EMT,FN1,INHIBITION,LGR5,MYC,OCLN,SNAIL,TFAP4,THEREBY,THESE,VIM
231,ALDRICH,FIRST,MCF,MDA,MIEG,PLD,PLD2,RAC2,SCID,THESE,THIRD,WISCOTT
946,AGS,EMT,EPH,EPHA2,LICL,MODULATION,MYC,SGC7901,SNAIL,TCF4,THESE,WNT
112,169,2013,8804,8805,COPYRIGHT,CYP2A13,EGFR,IHC,LTD,NSCLC,P450,TSNAS
2007,ADHERENCE,BLACK,CONCLUSION,LABEL,LESS,MEAN,METHODS,OBJECTIVE,PRIOR,PURPOSE,RESULTS,THESE,THROUGH,VHA
2005,2010,CONCLUSION,CPG,CPGS,GUIDELINES,INSTITUTE,IOM,JANUARY,LABEL,LESS,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,TRUST
FDG,PET
007,177,ASC,CENTRAL,CONCLUSION,FDG,FIVE,LABEL,MARGINS,MEAN,MEIER,METHODS,OBJECTIVE,PET,PROPORTION,PURPOSE,RESULTS
001,DELAYED,FACTORS,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS
116,169,2013,BESIDES,CD44,COPYRIGHT,FURTHER,HCT,INC,MSC,MSCS,NOTCH,TAKEN,THESE
001,008,206,AIM,BACKGROUND,CONCLUSION,HOWEVER,LABEL,MATERIALS,METHODS,NEXT,OBJECTIVE,PCR,RESULTS,THEN
169,1992,2009,2010,2013,8804,8805,ACUTE,BESIDES,CONCURRENT,COPYRIGHT,HIGH,III,INC,JANUARY,LIBRARY,MEDLINE,NSCLC,OVID,PATIENT,RCT,SEVENTEEN
018,035,049,177,178,457,535,8805,ASM,AVERAGE,SARCOPENIA
231,DOX,FURTHER,INCLUSION,LEWIS,LLC,MDA,MMP,MMP9,ND2,NDS,PXL,R221A,RSV,WHILE
078,181,200,625,8201,946,956,A549,BACKGROUND,CHANGES,CHINESE,CONCLUSION,CONTEXT,DISCUSSION,GIVEN,HANCE,HMECS,IC50,LABEL,MATERIALS,METHODS,OBJECTIVE,PCR,RESULTS,SALVICINE,VEGF
146AG,499A,ASIAN,CHINESE,CIS,CRC,HCC,HOWEVER,INDIA,KOREA,MICRORNAS,NORTH,ORS,RNAS,SNPS,WHEREAS,WHILE
100,105,108,110,136,740,BACKGROUND,H37RV,HRCA,LABEL,METHODS,MTB,MTC,NEXT,NTM,PCR,RESULTS,THEREFORE
252,272,280,323,331,553,CD8,CTL,CTLS,FIVE,H522,HLA,NCI,POTE,WHILE
148,3550,358,716,8019,APEX1,ASP,GLU,PCR,RFLP
022,033,138,201,215,247,422,482,884,943,BACKGROUND,CIN,CONCLUSION,DFS,EARLY,LABEL,METHODS,NSCLC,RESULTS
1082A,439,592G,819C,ADC,ATA,BACKGROUND,CONCLUSION,COX,IL10,LABEL,MATERIALS,MEIER,METHODS,PCR,RESLUTS,RFLP,RFS,SCC
001,858,AIM,BACKGROUND,BIO,BNG,CIS,CONCLUSION,DIAGNOSIS,DOR,ELISA,GIF,LABEL,MATERIALS,METHODS,MPM,MTS,OBJECTIVE,RESULTS,ROC,SMRP,SOLUBLE,USING
002,008,058,126,1993,2002,215,239,305,931,AMONG,BACKGROUND,BSP,CONCLUSION,CONVERSELY,LABEL,MATERIALS,METHODS,MOLECULAR,OPN,RCC,RCCS,RENAL,RESULTS
2003,2004,2C4,AIM,CONCLUSION,INC,KIT,LAB,LABEL,METHODS,NEWMARKET,OBJECTIVE,RESULTS,SPSS,TELOMERASE,TERT,TEX,THERE,UNIVERSAL,USA
AIM,CONCLUSION,LABEL,MBC,METHODS,OBJECTIVE,PACLITAXEL,RESULTS
001,003,177,402,443,945,956,AUC,BECAUSE,BMS,CEA,CTX,CYFRA,NSCLC,PINP,SIXTEEN
024,351,887,ALA,ASP,DDX39,DEAD,GLU,H2052,H2452,H28,MALIGNANT,MET,MPM,NCI,SINCE,THESE
AIM,BACKGROUND,CONCLUSION,EGFR,EMT,EPIDERMAL,ESC,LABEL,MATERIALS,METHODS,MPM,OBJECTIVE,RESULTS,TKI
CURRENT,THESE
BBB,BRAIN,JAMS,JUNCTIONAL,THERE,TIGHT,TJS
006,100,169,176,1989,2013,AACR,BACKGROUND,CLUE,LABEL,METHODS,ORS,RESULTS,S1P,THESE,WASHINGTON
LANGERHANS
001,113,135,160,195,215,236,244,345,480,8805,DATA,EBUS,FINALLY,LABEL,METHODS,NODAL,NSCLC,OBJECTIVE,RESULTS,TBNA
169,2013,946,AACR,ERK,OVERALL,PRX,PRX2,SILENCING,SRC,Y654
100,150,916,ACCORDING,CTS,HOUNSFIELD,INDEX,THEREFORE
169,2013,AACR,DISCOVERY,NSCLC,RET
019,027,045,252,300,363,398,426,439,BESIDES,C241T,CHINA,CHINESE,CIS,KNOWLEDGE,ORCT,ORS,ORT,ORTT,SCIENCE,SEVEN,THUS,WEB,XRCC3
BASED,BIRC5,GNT,H460,NCI
118,ACCORDING,BACKGROUND,EMT,LABEL,MCAM,MEIER,METHODS,NSCLC,RESULTS,THERE
0001,006,0162,212,DECREASED,DUAL,DUSP4,ERK1,INCREASED,KRAS,THERE
121,124,133,160,2006,753,792,BACKGROUND,EGFR,EPIDERMAL,FINALLY,INSTITUTE,LABEL,LYON,METHODS,MOST,PFS,RESULTS,SUBSEQUENT,THERE,TKI,UNIVERSITY
2006,2012,800,BACKGROUND,GIVEN,GRADE,JANUARY,JUNE,LABEL,METHODS,RESULTS,UNIVARIATE
EXPRESSION,GCT,GCTB,GIANT,GIVEN,GPX,LOH,MECHANISMS,MUTATIONS,NON,SECONDARY
144,HOWEVER,SECONDARY
EGF,EGFR,ERBB2,ERBB3,HOWEVER,KNOCKDOWN,LABEL,MET,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,RTK,TESTING,TKIS,USP8
143,945,954,BEAS,ERK,HEXAVALENT,HOWEVER,IGF,IRS1,THESE
100,11A,12A,13A,13I,145,169,176,2013,A549,COPYRIGHT,FURTHER,HELA,MTT,OXO,SAS
169,200,2013,COPYRIGHT,LTD,PERVASIVE,ROLES,THESE
001,177,182,186,190,BLAND,COMPARISON,CONCLUSION,ESTIMATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PEARSON,PURPOSE,RESULTS,UNENHANCED
PRIMARY,WESTERN,WHILE,WORLD
946,ALP,MTX,WNT
116,169,2013,COPYRIGHT,H460,HT26,HTC,K562,MCF,NCI,SAS,SEVERAL
169,2013,549,562,AFRICAN,COPYRIGHT,FIELD,FOURIER,HELA,MDA,PLEUROTUS,THESE,VERO
128,169,2013,AGA,AIMS,BACKGROUND,CD110,CDCP1,COPYRIGHT,CRC,CRCS,CSCS,FUNCTIONAL,INC,INSTITUTE,LABEL,MCSCS,METHODS,MICROARRAY,MIGRATING,OBJECTIVE,PUBLISHED,RESULTS,THESE
150,169,2013,COPYRIGHT,EGR2,FEDERATION,INHIBITION,LUNG,PUBLISHED,SOCIETIES,UTR
100,169,185,2013,8308,8312,8313,8320,8322,8325,8594,956,A549,ALA,ASP,COPYRIGHT,ECHIS,HPLC,HUVEC,LTD,MALDI,MIC,PLA,SER,TOF,VAL
001,146,168,169,2013,241,COPYRIGHT,ESPA,FDG,HOWEVER,LABEL,MATERIALS,METABOLIC,METHODS,MTV,NSCLC,OBJECTIVE,OBJECTIVES,OTHER,PET,RESULTS,SCLC,TLG
169,2013,500,BACKGROUND,COPYRIGHT,CROWN,EIGHT,FDG,LABEL,LTD,MEDLINE,METHODS,OVERALL,PET,PUBLISHED,RESULTS
CD8,LTD,PUBLISHED
000,024,032,11TH,12TH,13TH,169,183,1990,2010,2013,231,300,500,600,700,774,846,934,948,AGE,AMBIENT,BACKGROUND,BILL,CHINA,COPYRIGHT,DALY,DALYS,DIETARY,FACTORS,FOUNDATION,FUNDING,G20,GATES,GBD,HALE,LABEL,LEADING,LTD,MELINDA,METHODS,POPULAR,REDUCTION,RESULTS,RISK,THESE,USA,YLD,YLDS,YLLS
169,2013,BACKGROUND,COPYRIGHT,CURRENT,FOLLOWING,IRELAND,LABEL,LOCAL,LTD,MATERIALS,METHODS,MPLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SABR
BESIDES,CHI,CONCLUSION,ENG,FIVE,HBE,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,RESULTS,WESTERN
CURRENT,DESPITE,FINALLY,OVERALL
001,177,8805,ARC,GROSS,LAEC,MODULATED,OARS,PTVH,PTVL,PTVS,SIB,THERAPY,USING,V10,V20,VOLUMETRIC
ACCORDING,DICE,DIFFERENCE,DISTANCES,DSC,ESTIMATION,LEVEL,MESH,METRICS,PPV,PREDICTIVE,SIMILARITY,SURFACE,TRUTH,VALUE
103,169,183,2013,533,728,BRAZILIAN,CALCITONIN,CCH,CEA,FORTY,GLY533CYS,JOHN,LABEL,LTD,MEN2A,METHODS,MTC,OBJECTIVE,PTH,RESULTS,RET,REVIEWING,SONS,WILEY
003,004,031,035,037,038,177,33258,3LL,732,956,980,AIM,BOTH,C57,CONCLUSION,HCT,HOECHST,IC50,LABEL,LEWIS,METHODS,MTT,NOTABLY,OBJECTIVE,RESULTS,SPP,SW480
2013,CELL,GUIDELINES,LUNG,NCCN,NON,SMALL,THESE
169,2013,INC,JOHN,NSCLC,PALB2,SONS,WILEY
169,1997,2013,AML,CSC,CSCS,INC,JOHN,SONS,THESE,WILEY
177,1979,2011,BACKGROUND,CCTL,CHINA,COUGH,EARLIER,JANUARY,JUNE,LABEL,METHODS,MOST,RESULTS,THERE
117,187,326,8804,CONCLUSION,COX,FDG,LABEL,METHODS,NSCLC,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,TLGWB,UNIVARIATE,USING
1999,2009,206,BACKGROUND,CHEST,CHINESE,COMMISSION,CONTROL,COX,DFS,HOWEVER,JOINT,JUNE,LABEL,LNR,LNRS,LNS,MEIER,METHODS,NSCLC,OVERALL,PERIPHERAL,RESULTS,STRATIFIED,T1A,T2BN1M0,UNION,ZONE
8201,BACKGROUND,CASE,CONCLUSION,LABEL,MALIGNANT,METHODS,STAGING,UPON
000,1995,2011,323,8805,AFRICAN,AMERICANS,BLACK,BMI,CONCLUSION,CONTROL,COX,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USA,WHR,WOMEN
215,2500,780,8764,980,A549,HELA,HOWEVER,NIR,PEGYLATED,PTA
001,100,8805,ALK,CISH,CURRENTLY,EML4,FISH,HOWEVER,RED
100,470,594,5A4,ALK,ALK1,D5F3,FISH,NSCLC,PCR,THESE
4HNE,947,A549,H292,H2AX,KETOCAL,KETOGENIC,LABEL,METHODS,MICE,NCI,OBJECTIVE,PCNA,PURPOSE,RESULTS,THESE
169,2013,946,AACR,AMONG,CIP2A,CONCLUSION,COX,CREB,EBP,HOWEVER,HPV,LABEL,METHODS,OBJECTIVE,PCR,PI3K,PURPOSE,RESULTS,TL1,TL4
DEFINITIVE,PRIMARY,PULMONARY
100,169,2013,AKT,CDBT,COLCHICINE,COPYRIGHT,CRAF,DMAG,DOSE,EC50,ERBB2,H322,H460,HSP90,INC,NHFB,NSCLC
ESTIMATION,FOURIER,SIMULATION
10878,169,2013,A549,COPYRIGHT,HIGH,INC,NSCLC,PCR,RNAS,THESE
104,119,169,1980,2000,2009,2010,2013,229,280,AFTER,CARCINOMAS,CONCLUSION,COPYRIGHT,IRELAND,JANUARY,LABEL,LTD,MATERIALS,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS,THEIR,THEREFORE
169,2013,COPYRIGHT,FITC,FOURIER,HACC,HACC2,HACCS,MGC80,NCTD,NIR,NMR,S180,WAXD
113,169,191,2000,2011,2013,4CM,7MONTHS,8804,8805,BRITISH,COPYRIGHT,DIAGNOSIS,IRELAND,JANUARY,JUNE,KARNOFSKY,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRS,THERE,WBRT
008,050,1013,1096,1329,160,169,2013,3000,379,382,423,680,682,AUTHORS,BLACKWELL,FOUNDATION,JOURNAL,LTD,MOLECULAR,OVERALL,PUBLISHED,PUBLISHING,SCCHN,SNP,TP53,USING
8321,A549,AFB,CELLS,EPHX1,G6PD,GLUCOSE,GSH,HOWEVER,NADPH
BACKGROUND,GOLGI,GP73,HOWEVER,LABEL,METHODS,PCR,RESULTS,WESTERN
000,081,100,109,147,1971,1975,2006,2008,249,261,263,269,342,555,659,929,ADDITIONAL,AMONG,ASMR,ASMRS,AVOIDABLE,BACKGROUND,CONCLUSION,LABEL,METHODS,RESULTS,SEYLL,THERE
063,169,177,2013,215,961,976,AACR,BRAF,COIN,EGF,EGFR,KRAS,LABEL,METHODS,MSI,NRAS,OBJECTIVE,PURPOSE,RESULTS
775,ATLAS,BARR,DETECTION,EBV,EPSTEIN,HEPATITIS,HPV,SEQ,VIRAL,WHILE
335,A549,BCL,FINALLY,H1299,HOWEVER,LUCIFERASE,MICRORNAS,NSCLC,PCR,RNAS,SP1,THEREFORE,THESE,WESTERN
AMONG,CLOSE,HOWEVER,MORPHOLOGY,NOS,NSCLC,TTF
001,177,A549,BAK,BH3,HOWEVER,INF7,TAT,THESE,TIU
2T4K,BOTH,BSIF,CONCLUSION,CONTINUOUS,DYNAMIC,FAZA,FURTHER,IDIF,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SUV,TACS,VOIS,VOLUMES
160,CDX2,CK20,CK7,JAW
160,257,514,8201,BACKGROUND,CONCLUSION,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THREE,WBRT
0001,223,369,689,8805,BACKGROUND,EACH,FURTHER,HOWEVER,LABEL,LNS,METHODS,N2A,N2B,NSCLC,RESULTS
007,021,042,088,160,1993,2003,2007,238,258,527,673,734,842,882,907,AMONG,ASIRS,CATALAN,CATALONIA,CONCLUSION,DATA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SPAIN,TARRAGONA,THESE
CRS,HIPEC,HOWEVER,III,INDEX,PCI,PERITONEAL
177,947,APOPTOSIS,CHANGES,CONCLUSION,EARLY,EF5,H460,HYPOXIA,LABEL,METHODS,PET,RESULTS,SN30000,THEREFORE,THESE,UNLABELLED
1997,2011,FIVE,IIA,IIIB,MST,NINE,SCLC
A549,EAC,EHRLICH,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
145,181,AUC0,BLOOD,CHOLINE,DECREASED,FOURIER,FTIR,GNP,GNPS,GOLD,ICP,LABEL,METHODS,MTT,OBJECTIVE,PEI,PURPOSE,RESULTS,TEM,USING,XPS
393,8226,ABTS,DPPH,HOP,INSTITUTE,MOST,RXF
8805,ADC,ADCS,ALK,BACKGROUND,BOTH,CONTEXT,EGFR,IHC,KRAS,LABEL,LCC,LCCS,METHODS,OBJECTIVE,OTHER,PULMONARY,RESULTS,SEVERAL,SOLID,THERE,WORLD
001,010,018,020,035,038,049,1991,2006,767,8805,BACKGROUND,LABEL,METHODS,RESULTS
001,010,018,039,137,310,8805,BACKGROUND,EARLY,LABEL,METHODS,OBJECTIVE,POST,RESULTS,THERE
001,002,008,CONCLUSION,FDG,HIPAA,LABEL,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PEARSON,PERCENTAGE,PET,PURPOSE,RESULTS,THERE,VIBE
KNOCKDOWN,NAD,SIRT1,THESE
946,BACH1,INSTEAD,KNOCKDOWN,MAFK,NRF2,SMADS,TGF
169,2013,8764,947,AACR,BEIGE,BOTH,HER2,HOWEVER,MOST,NOD,NSG,OVERALL,SCID,THESE,XENOGRAFTS
169,2013,330,AVAILABLE,BACKGROUND,COPYRIGHT,FURTHER,III,INC,INITIAL,LABEL,METHODS,MOST,RECURRENCE,RESULTS,SEVENTY,THERAPIES,WILEY,WILMS
169,2013,4T1,COPYRIGHT,CSF,CXCL5,CXCR2,FINALLY,HOWEVER,INCREASING,KLF4,KRUPPEL,MDSC,MDSCS,NOD,REDUCED,SCID,TAKEN,UICC
020,022,025,050,074,109,112,180,254,354,357,488,500,556,668,797,961,999,CAUCASIANS,CHINESE,E375,E375G,SNPSCAN
169,2013,BASED,COPYRIGHT,EHE,EHES,FISH,FUSIONSEQ,INC,PCR,TFE3,WILEY,WWTR1,YAP1
105,A549,BESIDES,CCK8,EGFR,NSCLC,THESE,THUS,VPS4B,WESTERN
8320,8325,CNS
001,100,160,169,2013,362,529,590,634,8201,8805,BACKGROUND,COPYRIGHT,IMXT,INC,LABEL,METHODS,NBL,OAR,PROCEDURE,RADIATION,RESULTS,WILEY
001,1563,2005,2010,2171,245,BACKGROUND,COLLEGE,LABEL,METHODS,OPEN,PROGRAM,QUALITY,RESULTS,SIX,UNIVARIATE,VATS
169,2013,BEAM,CARLO,COPYRIGHT,DCART,HOWEVER,IBM,IMRT,IMRT2,IMRT5,LTD,MONTE,OAR,PBC,PTV,PUBLISHED,SEVEN,SPSS
169,2013,A549,C6H4,CH2,CHN,COPYRIGHT,DFT,LTD,MB231,MDA,MEG,NME2,SME
0007,001,169,2013,215,261,267,3RD,4TH,528,COPYRIGHT,HOWEVER,HYPOTHESIS,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PERI,PRE,RESULTS,THERE,THREE
160,OVERALL
AFTER,BACKGROUND,CASE,CONCLUSION,DIAGNOSIS,LABEL,METHODS,OPTIMAL,PRIMARY
200,550,CRCL,CRCLS,GMP,LABEL,MATERIALS,METHODS,NETWORKING,NTA,OBJECTIVE,PAGE,PROTEIN,PURPOSE,RESULTS,SDS,TEM
LABEL,LIPID,OBJECTIVE,OBJECTIVES
ATP,HER2,HSP90,THEREFORE
945,GIVEN,GPCR,GPCRS,HIGH,INCREASED,LIGANDS,RGS,RGS17
ACUTE,ANY,IDIOPATHIC,MOST,PRIMARY,SECONDARY
COPD,FURTHER,SMALL
0009,1523,1989,2012,8201,8805,AMONG,BACKGROUND,BRAIN,DTC,LABEL,MEIER,METHODS,OVERALL,PATIENT,RESULTS,SRS,SURGERY,THEREFORE,WORLD
2005,USING
CNV,COMPARING,COMPARISON,EGFR,EMT,MET,SNVS,SOMATIC,T790M,THESE,TKI
001,2002,2006,416,496,797,8805,CALIFORNIA,CONCLUSION,END,GIVEN,LABEL,METHODS,MOST,OBJECTIVE,PATIENT,PURPOSE,RESULTS,USING,YORK
2006,2010,214,286,8805,BETWEEN,COMPLIANCE,CONCLUSION,GREATER,LABEL,MEAN,METHODS,MONTHLY,OBJECTIVE,PATIENT,PRIOR,PURPOSE,RESULTS,SEPTEMBER,WEB
169,200,2013,ANXIETY,ASSESSMENT,C30,CONCLUSION,COPYRIGHT,DEPRESSION,JOHN,LABEL,LIFE,LTD,LUNG,METHODS,NEEDS,NONE,OBJECTIVE,QUALITY,RESULTS,SCALE,SONS,THERE,TREATMENT,WILEY
001,160,2012,2A6,595,607,BIOMEDICAL,CHINESE,FURTHER,JUNE,KNOWLEDGE,OVERALL,P450,THEREFORE
946,A549,AFTER,BACKGROUND,DOWN,EMT,EPITHELIAL,LABEL,METHODS,NSCLC,RESULTS,TGF,THESE,WESTERN
169,2013,231,AHR,AKT,APOPTOSIS,ARNT,COPYRIGHT,MDA,NOTABLY,PAH,PAS,PER,SIM,SUBSEQUENT,THEREFORE,UICC
100,CRMP5,HIGH,LOW,ONCONEURAL,PNS,SPR,THERE
012,016,280,660,736,924,ARG,EUROPEANS,HOWEVER,OVERALL,THEREFORE,XRCC1
2010,293,300,EASTERN,ECOG,FORTY,GROUP,INSTITUTE,RESULTS,SOUTH
ALK,BACKGROUND,CONCLUSION,EGFR,EML4,KRAS,LABEL,MET,METHODS,NON,NSCLC,OTHER,OVERCOMING,RESULTS,SCIENCE,SEVERAL,T790M,WEB
945,A549,CAFS,CAR,COMBINING,EPHA2,FAP,FIBROBLAST
2002,2004,2011,8000,AIR,BOYLE,BRITISH,SIMILARLY,SOCIETY
BECAUSE,CURRENT,LUNG,PROCEDURAL,SBRT
945,A549,AFTER,HIF,HOWEVER
ACCOUNTING,BACKGROUND,BECAUSE,CONTACT,CPG,LABEL,MOTIVATION,RESULTS
169,2008,2013,CONCLUSION,COPYRIGHT,DESPITE,GIVEN,INC,LABEL,LOPEZ,LOWER,METHODS,OBJECTIVE,PETO,PHASE,PREVALENCE,PREVENTION,RATIO,RESULTS,SIR,SIRS,SMOKING,VIETNAM,VIETNAMESE
1980,1990,2012,ANTONIO,BACKGROUND,CDC,HER2,LABEL,SAN,SOCIETY,SYMPOSIUM,THESE
169,1AE,2013,25MG,AES,AITL,BACKGROUND,CELGENE,COPYRIGHT,CRU,FUNDING,LABEL,LTD,METHODS,OVERALL,PTCL,RESULTS,SERIOUS
001,007,013,015,132,169,2013,428,804,CONCLUSION,COPYRIGHT,ECOG,EXT,FDG,IRELAND,LABEL,LTD,MATERIALS,METABOLIC,METHODS,MTV,OBJECTIVE,PET,PURPOSE,RESULTS,SCLC,THESE,TRX,UNI
169,2013,A750DEL,ALK,COPYRIGHT,E746,EGFR,EML4,IRELAND,LTD
003,012,016,108,116,169,177,1999,2009,2013,8805,BACKGROUND,COPYRIGHT,COX,FORTY,INC,ITLNM,JANUARY,LABEL,MEIER,METHODS,OVERALL,PARTIAL,PATIENT,PUBLISHED,PULMONARY,RESULTS,SOCIETY
100,101,131,169,170,2008,2011,2013,BACKGROUND,COPYRIGHT,DESPITE,EBUS,INC,JULY,LABEL,MAY,METHODS,PUBLISHED,RAPID,RESULTS,ROSE,SOCIETY,TBNA
169,2013,237,241,ABC,COPYRIGHT,ESPA,FFL,NEUROCIRUG,PUBLISHED
DDS,ROMP
169,2013,AVOIDANCE,C30,CES,CHARACTER,DEPRESSION,DEPRESSIVE,EORTC,FIFTY,HARM,INVENTORY,JOHN,LIFE,LTD,QLQ,QUALITY,SCALE,SONS,STUDIES,TCI,THESE,TREATMENT,VARIATIONS,WILEY
169,2013,FURTHER,JOHN,LTD,SONS,WHILE,WILEY
000,127,169,2006,2013,257,AIM,AUSTRALIA,AUTHORS,DALY,DALYS,DUE,LABEL,METHODS,OBJECTIVE,RESULTS,USING
AREAS,BACKGROUND,CALU,CELL,COVERED,HENCE,HOWEVER,LABEL,METHODS,OPINION,THERE,ULTIMATELY
145,946,A2780,ANNEXIN,CELL,H1299,PCDT,POOR,SKOV
169,2013,353,ANXIETY,ASIA,ASSESSMENT,CHINESE,DEPRESSION,FUNCTIONAL,FURTHER,GENERAL,HRQOL,LTD,MILD,PTY,PUBLISHING,THERAPY,WILEY,YOUNGER
945,946,BINDING,CORE,FUT8,GDP,HENCE,HOWEVER,KNOWLEDGE,NMR,SPR,STD,THEREFORE
METASTASIS,PAPILLARY
MTS,MUIR,TORRE
118,181,19A,270,945,A549,AFTER,HADV,HADV3,HADV4,LABEL,METHODS,MTS,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE
121,2009,2010,208,260,CONCLUSION,GROUP,LABEL,METHODS,OBJECTIVE,OCTOBER,RESULTS,SIX,THERE
001,103,110,1275,1385,1999,2004,2257,471,663,7921,AMS,BAC,BACS,COMMITTEE,JOINT,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,REGARDING,RESULTS,SOCIETY,STAGE,WHILE,WORLD
1970,BIOMARKERS,DESPITE,PULMONARY,REGARDLESS,THEREFORE
160,2011,MARCH,META,TP53
1120,169,2013,AACR,BIBF,CD31,DESPITE,EMT,HOWEVER,NG2,SIGNALING,VEGF
169,2013,AACR,BECAUSE,COX,MALIGNANT
ABOUT,AML,BILATERAL,LAM,MMPH,THEREFORE
100,169,2013,239,301,465,683,AACR,ALK,AMONG,ANAPLASTIC,EGFR,FISH,FOUR,FUNCTIONAL,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SCREENING,SECONDARY,SUFFICIENT,WESTERN
001,005,100,169,2013,BACKGROUND,COMPANY,CONCLUSION,COPYRIGHT,HNSCC,INC,IPN,IPNS,LABEL,METHODS,PFS,RESULTS,WILEY
000,005,006,250,8805,MBC,PFS
ENGLISH,PRIMARY
178,ATLAS,CAREFULLY,SQCC,TCGA
400,BACKGROUND,BORTEZOMIB,LABEL,METHODS,NSCLC,PFS,PRIMARY,RESULTS,THERE
EBUS,THESE
946,BCC,DTCS,TGF,THESE
1981,2009,DESPITE,LCA,SVCO,TREATMENT
C8161,DESPITE,EVEN,FINDING,GRP78,IGM,PAT,SM6,THESE
ALK,BACKGROUND,DISCUSSION,EGFR,EML4,HOWEVER,LABEL,MATERIALS,METHODS,PREDICTIVE,RESULTS,THERE
102,160,8209,945,947,AKT,AKT1,BP1,E17K,E545K,NSCLC,PI3K,PTEN,RAS,UNIVARIATE
160,947,A549,CLONOGENIC,DTNB,GCS,GSH,GSS,NAC,OLEANOLIC,THEREFORE,UNDER
007,013,043,169,2013,4606,5542,9615,C118T,COPYRIGHT,ERCC1,FURTHER,III,NSCLC,OVERALL,STAGE,THERE,THESE
007,120,162,169,177,2013,6MM,APE,COPYRIGHT,CTDI,FBP,IRELAND,LABEL,LTD,MATERIALS,MDCT,MEAN,METHODS,NOISE,OBJECTIVE,OBJECTIVES,RESULTS
169,2013,24H,8322,956,A549,COPYRIGHT,HOWEVER,LTD,NAASO
169,2013,488,5984,AREA,AUC,COPYRIGHT,IRELAND,LASSO,LTD,LUNG,ROC,ROIS,SPNS,SVM
003,020,040,116,118,168,169,2013,215,308,558,946,BACKGROUND,CONCLUSION,COPYRIGHT,CYFRA21,ELISA,LABEL,LTD,METHODS,NSE,PRESENT,RESULTS,SCC,SERUM,TGF
169,192,2013,BRITISH,CLAVIEN,COPYRIGHT,DATA,DINDO,FACTORS,III,ORAL
169,2013,945,APOPTOTIC,CO2,COPYRIGHT,DESPITE,HIF,HYPOXIA,INC,LM8,MMP,MMPS,THESE
169,2013,BACKGROUND,CASE,CONCLUSION,CONVERSELY,COPYRIGHT,JO1,LABEL,METHODS,PL12,PL7,PUBLISHED,SAS
169,2013,COPYRIGHT,EATON,IGG,LAMBERT,LEMS,MICE,PCD,SCLC,THESE,VGCC
0001,0007,100,169,2013,8639,954,COPYRIGHT,EGFR,IRELAND,LTD,NSCLC,PCR,PEPTIDE,PLEURAL,PNA,TKI
001,038,169,2013,ACUTE,COPYRIGHT,CURRENT,IIIB,IRELAND,LATE,LTD,NSCLC,RCT,TREATMENT
001,008,027,031,117,169,2008,2012,2013,220,538,ARMS,BACKGROUND,COPYRIGHT,CROWN,EGFR,EPIDERMAL,IRELAND,LABEL,LTD,MAY,METHODS,NSCLC,PUBLISHED,RESULTS,TKIS
001,169,192,2013,867,AUC,COPYRIGHT,EXAMINING,FURTHER,HOWEVER,LTD,MALAT,PCA,PCA3,PCR,RNAS,ROC
008,111,147,169,2013,ADVERSE,BACKGROUND,COPYRIGHT,DOSIMETRIC,ILC,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,UNIVARIATE
007,0MM,169,1MM,2013,2MM,5MM,8482,8804,8MM,931,963,CBCT,CONE,COPYRIGHT,DAILY,EPI,FOLLOWING,HEART,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,POPULATION,PURPOSE,RESULTS,THERE
109,169,2013,8805,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,MLD,OBJECTIVE,POST,PULMONARY,PURPOSE,RESULTS,V22,V30,VDOSE
011,169,2013,657,COPYRIGHT,HEART,HOWEVER,HRV,LTD,PUBLISHED,RATE,THESE,WHILE
100,132,169,18FDG,2006,2011,2013,3DCRT,BEAM,BOT,BOTH,COPYRIGHT,CTPET,CURRENT,FFF,IRELAND,JULY,LABEL,LTD,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SBRT,TIME,VMAT
169,2013,CAREFUL,COPYRIGHT,LTD,SABR
001,169,2013,7183,COPYRIGHT,ENGLISH,HODGKIN,HOWEVER,LABEL,LTD,METHODS,NHL,OBJECTIVE,OBJECTIVES,POTENTIAL,RAYNAUD,RESULTS,SIR,SSC

2012,293,296,378,DESPITE,INTERPLAY,JAMES,MAHIN,MASON,PEER,REBOUND,REDOX,RPR,SATO,SIGNALING
28SI,56FE,947,ACUTE,BACKGROUND,BTG2,CLONOGENIC,HBECS,HZE,LABEL,NASA,PHASE,RBE,RESULTS,SIGNALING,THEREFORE,THESE,WHILE
2032,ALK,CD74,CRIZOTINIB,RESISTANCE,ROS1
001,250,347,500,ALK,BACKGROUND,CRIZOTINIB,LABEL,METHODS,RESULTS,WHETHER
8805,ADC,ALK,ANOTHER,ASIA,ASIAN,BACKGROUND,BRAF,EGFR,EML4,ERBB2,FURTHER,KRAS,LABEL,LKB1,META,METHODS,NINE,NSCLC,POTENTIAL,PTEN,RESULTS,TP53,WESTERN
104,169,2013,AACR,ACTIVATING,GEF,HDAC6,LABEL,RAS,SIRT2,THESE,UNLABELLED
8209,A549,BEAS,ENGINEERED,GHSR,H1299,NCI,PCR,RNAS
034,163,2003,2009,738,AIMS,DM2,DMP,ENROLMENT,HYPOTHESIS,JUNE,LABEL,METHODS,OBJECTIVE,PANCREATIC,POISSON,RESULTS,RISK,SIR,SIRS,THERE
010,012,016,032,040,472,8805,AIS,AISS,BACKGROUND,DISEASE,GGNS,LABEL,METHODS,MIA,MIAS,RESULTS,THERE,TSCT
169,2013,231,945,946,AACR,AKT,ALSO,ERB3,ERBB2,FN14,HER2,INDUCED,LUC,MCF7,MDA,MDR,MDR1,TNF,TNFRSF12A,TNFSF12,TREATMENT,TWEAK
169,2013,946,AACR,EXPRESSION,ITGB1,KDM5A,MEN1,RBP2,TAKEN
004,AGS,AKT,BACKGROUND,BARR,BCL,COBRA,CONCLUSION,EBV,EPSTEIN,EXPRESSION,IL8,KNOCK,LABEL,MDM2,MET,METHODS,MKN28,MMP1,MYC,PLAUR,RESULTS,SSTR1
001,177,956,CRP,FVIII,HODGKIN,IIA,MEIER,UNDERLYING,VIII,WILLEBRAND
0001,0015,008,015,021,178,967,BACKGROUND,COX,FURTHER,IHC,IIIB,LABEL,MAXIMAL,MEIER,METHODS,PFS,RESULTS,TREATMENT
500,960,A43,A549,BOTH,CONJUGATED,FRET,OFBT,RED,TEXAS,USING
169,2013,790,EGFR,MASSARRAY,NSCLC,PFS,SABER,T790M,TKI,TKIS

EBC,EGFR,H1373,H1993,MET,NSCLC,RTK
PKM2,THESE
000,093,094,107,169,2013,216,487,500,BACKGROUND,COPYRIGHT,DISEASE,GIVEN,LABEL,METHODS,NSCLC,RESULTS,SBRT,SOCIETY
169,2013,COPYRIGHT,CURRENTLY,LUNG,TKI,TKIS,UICC,WBRT
AKT,IGF,KRAS,NSCLC,PI3K,PTEN
160,207,248,334,694,8201,BACKGROUND,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
1440,1995,2011,AMONG,ARF,BACKGROUND,CONCLUSION,DIAGNOSTIC,GOLDMAN,ICU,LABEL,LUNG,METHODS,RESULTS
ART,FINALLY,IGRT,MRI,PET
169,2013,AACR,NSCLC,ROS1,TARGETING,THESE
0001,169,2013,AACR,BCL,BCL2,HNSCC,KNOCKDOWN,LABEL,METHODS,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,RRM2
A549,RNAI
100,EIT,ELECTRICAL,THERE,THREE
BOTH,LABEL,METHODS,MIP,OBJECTIVE,OUTSIDE,PURPOSE,RESULTS
104,110,114,118,CTV,GTV,IMRT,LABEL,METHODS,MLD,OBJECTIVE,PLANS,PTV,PURPOSE,RESULTS,V20
HOWEVER,PET
169,1P34,2013,2P24,8805,8Q24,9P24,COPYRIGHT,FOCAL,HOWEVER,INC,MYC,MYCL1,MYCN,NOTABLY,PVT1,RLF,SCLC,SCLCS,THUS,WILEY
169,2013,BECAUSE,CME,CNE,COPYRIGHT,CURRENT,HOWEVER,INC,SOCIETY,THESE,THUS
169,2013,567,COPYRIGHT,INCREASED,MEIER,NSCLC,SERUM,THESE,UICC
150,169,2013,COCULTURE,CONTINUED,COPYRIGHT,COR,CYTOMETRY,DRAQ7,ENRICHMENT,H69,HOWEVER,INITIAL,L279,NCAM,NCI,POLYSIA,SCLC,SHP,SOCIETY
177,231,282,331,380,480,821,828,COLLATERAL,EVALUATION,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,THERE,THESE
140,146,8805,HRCT,LABEL,MATERIALS,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS,SSN
GPR54,IIIB,KISS1,LOSS,LUNG,NSCLC,PCR
001,002,227,973,AFTER,AVAILABLE,CHINESE,DISEASE,EGFR,FORTY,NSCLC,PREVALENCE,THERE,TKI
12B,HCC,SUPPLEMENT,THESE,VEGFR
128,2000,2012,459,AES,BACKGROUND,DATA,III,LABEL,METHODS,NSCLC,PFS,RESULTS,SEPTEMBER,THUS
1BBL,215,947,ADVANTAGE,CD3,FINALLY,GITRL,IFN,LIGHT,OX40L,SINCE,THUS,TNF
7028,954,A549,ALSO,BAY,EMT,FUNCTIONAL,HOWEVER,MMP,PCR,RGC32,SLUG,SNAIL,TAKEN,WESTERN
001,048,049,ACCORDING,ARG,BASED,CAUCASIANS,CONCERNING,DATA,ORS,PRO,SCIENCE,SIMILAR,WANFANG,WEB
233,BHD,BIRT,CERTAIN,DUB,DUE,FLCN,HOGG,RECURRENT
BACKGROUND,CONCLUSION,HEALTHCARE,KEY,LABEL,METHODS,NEUTRAL,OBJECTIVE,PHYSICIAN,PHYSICIANS,POOR,RESULTS,SHARING,SPS,SUPPORTIVE,THESE
0006,156,2000,2007,8201,COX,DRUG,ESTROGENS,LUNG,MCR,NETWORK,NSCLC,PROGRAM,SEX,USING
8209,A549,CDDP,CIS,GEM,NSCLC,RESULTS
COMPONENTS,HOWEVER,MARIJUANA,STUDIES,THC,USA
122,248,254,454,AFTER,CONCLUSION,DFI,DFS,III,LABEL,MAGE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,THESE
213,752,8805,966,BMI,CIS,COLORECTAL,CONCLUSION,DATA,HRS,LABEL,LUNG,METHODS,OBESITY,OBJECTIVE,ORS,OVARIAN,PURPOSE,RESULTS,SCREENING,TRIAL,WHETHER
AS02B,AS15,CONCLUSION,LABEL,MAGE,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THESE
A549,AGNTS,ATP,CHIT,NIR,RAMAN,SERS,THEIR,THERE
020,043,135A,215,2332,2457,BASED,CD133,COX,CSCS,FUNCTIONAL,SNP,SNPS
1000,160,177,230,948,DMLC,EPID,LINAC,STIL,UNIVERSITY,WASHINGTON
124,151,LUNG,SCREENING,SYSTEMATIC,THERE,TRIAL
023,30002,30206,39808,BACKGROUND,CONCLUSION,COX,GRADE,GROUP,LABEL,METHODS,OVERALL,PFS,PROGNOSTIC,RESULTS,SCLC
LABEL,LUNG,MOST,OBJECTIVE,PALLIATIVE,PURPOSE,RESULTS,SPECIALTY,SUMMARY,THERE
ALK,EGFR,LABEL,MUTATIONS,NSCLC,OBJECTIVE,ONGOING,PURPOSE,RESULTS,SUFFICIENT,SUMMARY,THESE
100,177,181,25TH,7TH,AFTER,DAR,EHRLICH,IPNS,PAC,PCL,POST,SEMI
ANTI,AUTONOMIC,GATA3
DTYMK,HIGH,KRAS,LKB1,STK11,THUS
BRAF,BRESLOW,PRIMARY,THREE,V600E
169,2013,AACR,MRI,PET
169,2013,A549,APB,CIS,CISPLATIN,COPYRIGHT,GMBH,H460,NSCLC,SOCE,STIM1,STROMAL,THESE
169,2013,A549,ACTIVATING,AMONGST,ATF,CONVERSELY,COPYRIGHT,HOWEVER,INC,JNK,SOLUBLE,TAKEN,THESE,VEGF
1SCI,256,5443,5818,A1SCI,CPNE3,H1299,III,MYH9,NSCLC,SPC,TAKEN,THROUGH,TNM
THESE
945,954,956,HMGB,HMGB1,HOWEVER,JNK,JUN,MCP,NHBE,NSCLC,RAGE,TNF,WESTERN
100,169,174,2010,2012,2013,231,233,300,4DCT,AFTER,CONCERNING,CONCLUSION,COPYRIGHT,DEPARTMENT,DOSE,FDG,IMRT,LABEL,MAY,METHODS,NOVALIS,OBJECTIVE,OCTOBER,PAUL,PET,PUBLISHED,PURPOSE,RESULTS,SAS,SCAN,SEVENTEEN,SFRO,SOCI,STRASBOURG,STRAUSS,SUV,V20
0001,002,0061,120,169,2013,A549,COPYRIGHT,FURTHER,H1299,IRELAND,JNK,LTD,MMP9,NSCLC,SPAG9,TNM
18F,215,CHEST,FDG,LOCAL,PULMONARY,SEVEN,SFT
0001,001,917,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,RDW,RED,RESULTS,UNIVARIATE
169,2013,8804,AIR,CHEST,CONCLUSION,COPYRIGHT,FOP,IRELAND,LABEL,LTD,MATERIALS,METHODS,MILD,MOST,OBJECTIVE,RESULTS
169,2013,AIMS,DSG3,JOHN,KRT15,LABEL,LTD,METHODS,OBJECTIVE,PKP1,RESULTS,SONS,WILEY
169,1960S,1980S,2013,ARDS,JOHN,LTD,SONS,WILEY
0801,945,947,BGC,INSTITUTE,ONX,ONYX,THUS
001,011,120,200,435,537,8594,CIGARETTE,CONCLUSION,COX,EGFR,KRAS,LABEL,MATERIALS,METHODS,NEVER,OBJECTIVE,PURPOSE,RESULTS,TKIS
001,008,1298,1610,2255,317,3RGCC,3RGGC,677,680,680CC,CONCLUSION,DHFR,FURTHER,GARFT,LABEL,MATERIALS,METHODS,MTHFR,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS
139,164,165,166,ABCG2,ATP,BACKGROUND,EGFR,GLI,HOWEVER,LABEL,METHODS,RESULTS,SHH,SONIC
160,1980,2009,BACKGROUND,EIGHT,IFS,INFANTILE,JUDE,LABEL,METHODS,NON,PRIMARY,RESULTS,SEVEN
2009,2013,AIR,BETWEEN,JANUARY,JULY
DESPITE,NEK2,NIMA,PYMT,THESE
MENDELIAN,MMP1,MMP1A,PAR1,SILENCING,TAKEN
13C,140,166,946,956,HPLC,IC50,MCF,NMR
173,8209,945,AKT,EGFR,HOWEVER,LUNG,NSCLC,PI3K,SINCE,TAKEN,THEREFORE
100,BACKGROUND,CONCLUSION,EGYPT,ENDOCAN,HOSPITALS,LABEL,METHODS,MVD,OBJECTIVE,OVERALL,RESULTS,SETTING,UNIVERSITY,VEGF,ZAGAZIG
945,ALEXANDER,FXR,LABEL,METHODS,OATP1B1,OBJECTIVE,OWING,PURPOSE,RESULTS,RXR,SVCT1,SVCT2
A549,BCL,MAPK,MCL,MMP,NAC,PARP,PDT,ROS,WESTERN
200,200A,200B,200C,8209,ATRX,BEAS,DLC1,EMT,H1299,HFE,HNRNPA3,HNRNPR3,INGENUITY,IPA,LUNG,NOVEL,NSCLC,PCR,REINFORCED,THESE
2000,2002,2009,3466,65308,AGE,BACKGROUND,CANCERS,COX,END,HRS,LABEL,LIFESTYLE,MEN,METHODS,MOST,RESULTS,VITAL
169,2013,946,BACKGROUND,CONCLUSION,COPYRIGHT,CROWN,EGFR,KNOCKDOWN,LABEL,LTD,METHODS,NSCLC,NUCLEAR,PC9,PUBLISHED,RESULTS,TKIS
169,2013,ADC,COPYRIGHT,GATA6,HOPX,INC,MOLECULAR,THESE,THUS
169,2013,A549,AMPK,COPYRIGHT,ERK,HELA,HEME,HEPG2,INC,INHIBITION,KEAP1,METFORMIN,NRF2,PD98059,RAF,RESISTANCE,THESE
169,2013,COPYRIGHT,FAA,FERULIC,H1299,LTD,MMP,MMPS,RESULTS,SIMILARLY,TAKEN
169,186,2013,BACKGROUND,BEST,CONCLUSION,COPYRIGHT,INC,LABEL,LACK,METHODS,MSKCC,PFS,RCC,RESULTS,SUNITINIB,UNIVARIATE
140,169,177,2013,916,COPYRIGHT,IRELAND,LTD,MEAN
122,160,169,177,2013,625,750HD,919,AIM,ASIR,CNR,COLLEGE,CONCLUSION,CONVERSELY,COPYRIGHT,DISCOVERY,FBP,GGO,GGOS,IMAGE,LABEL,LTD,MATERIALS,METHODS,NIS,OBJECTIVE,PUBLISHED,RESULTS,ROIS,ROYAL,USING,VEO
169,2013,COPYRIGHT,INC,INSTEAD,PUBLISHED,SOCIETY,THESE
169,2013,COPYRIGHT,INC,PUBLISHED,SOCIETY
169,2013,COPYRIGHT,INC,PUBLISHED,PULMONARY,SOCIETY
169,2013,COPYRIGHT,FACTORS,INC,PUBLISHED,SOCIETY
169,2013,ASH1,BACKGROUND,CONCLUSION,COPYRIGHT,DMS53,EXPRESSION,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,SBC3,SCLC,THERE,THEREFORE
001,012,019,082,169,2013,208,407,614,C5AR,CD88,COPYRIGHT,DATA,FINALLY,FIVE,HIGH,IHC,IRELAND,LTD,NSCLC,THEN,THUS,TMA
112,169,1963,2009,2013,467,COPYRIGHT,LTD,MOST,ORAL,PUBLISHED,SACC
001,CTCS,H69,H82,MCA,NCI,SCLC,THEREFORE,UNDER
177,7909,A549,CCK,CELL,CPG,FURTHER,KIT,ODN,ODN7909,THESE,TLR,TOLL,WESTERN
AREAS,BACKGROUND,COVERED,HOWEVER,III,LABEL,METHODS,NON,NSCLC,OPINION,PHASE

001,ACTIVATION,BACKGROUND,DECREASED,DISRUPTION,EMT,EPITHELIAL,HIC1,HYPOXIA,III,LABEL,METHODS,PIASY,PROTEIN,RESULTS,SIRT1,SP1,UBC9
169,2013,945,AACR,MOUSE,THESE,TNF
169,2013,AACR,ATG5,CONVERSELY,RHOA,UNDERLYING
169,2013,256,293,327,AACR,ATXN7L2,HOUSTON,ITIH2,LEMD3,MAYO,NSCLC,NUDT5,ROCHESTER,TAIWANESE,TEXAS,THESE,TMBIM,UNIVERSITY
169,2013,8482,ASD,CERA,CHINA,COPYRIGHT,DUE,IMAGING,INC,SCHENZHEN,WILEY
0001,108,177,2009,BACKGROUND,CONCLUSION,EBUS,GUIDELINE,LABEL,METHODS,MOST,QUALITY,RESULTS,TBNA
154,160,270,517,816,8201,CAUCASIAN,ERG,GLEASON,SEVENTY,SPANISH,THREE,THUS
AIM,BACKGROUND,CARE,CAREGIVER,CAREGIVERS,CROSS,FORM,INCLUSION,INTERVIEW,LABEL,METHODS,MOST,OBJECTIVE,OUTCOME,PALLIATIVE,RESULTS,SCALE,SETTING,SHORT,THOSE,ZARIT
132,222,CRCCS,FUHRMAN,HOWEVER,PRCC,PRCCS,RCC,RCCS
ADC,EVALUATION,SCC,STROMAL,WESTERN
0167,0201,0341,BACKGROUND,DECREASED,DISCUSSION,GFR,LABEL,METHODS,MPM,RESULTS
169,2013,BONE,BST,COPYRIGHT,HOWEVER,INC,MCF,STAT3,TAKEN,THEREFORE,TRM
0160,2007,9416,GROUP,INTERGROUP,LABEL,OBJECTIVE,PURPOSE,RESULTS,RUSCH,SINCE,SOUTHWEST,SUMMARY,VIDEO
144,169,2013,AIS,COPYRIGHT,CORTACTIN,GMBH,LARGE,NSCLC,SIRT1
169,2013,COPYRIGHT,EACH,HOWEVER,LABEL,LOCAL,LTD,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,RISK,SALVAGE,STUDIES
169,2013,AIDS,COPYRIGHT,FINALLY,HIV,HODGKIN,INC,THEN
169,200,2013,2020,CHRONIC,CIGARETTE,COPD,COPYRIGHT,LTD,LUNG
169,2013,954,COPYRIGHT,EXPRESSION,FFPE,HEP,HISTOLOGIC,INC,LUNG,MICROARRAY,PATHOLOGY,PCR,PUBLISHED,SOCIETY,THEREFORE
169,1991,2001,2011,2013,AIMS,FURTHER,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PEARSON,RESULTS,SONS,THESE,WILEY,WORD
100,106,107,108,109,114,117,122,132,133,137,143,146,149,165,170,BLAND,CONCLUSION,EACH,INTRA,LABEL,METHODS,OBJECTIVE,OVERALL,PERFUSION,RESULTS,VOI
AREAS,CONCLUSION,DYNAMIC,FIFTY,FINALLY,LABEL,MCNEMAR,METHODS,OBJECTIVE,PET,RESULTS,THEN
001,100,177,2009,2012,954,CONCLUSION,JANUARY,LABEL,MDCT,METHODS,MRI,OBJECTIVE,RESULTS,STIR
001,033,038,128,177,2011,2012,210,735,763,773,AGE,CONCLUSION,FOV,IMAGING,LABEL,LATERAL,MDCT,METHODS,OBJECTIVE,RESULTS
176,ARTIFACTS,COBRA,CONCLUSION,LABEL,LOCK,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
001,003,007,031,2004,2010,395,426,708,8804,ADULT,ADVANTAGE,ANOVA,APR,BRAIN,CHI,INCLUSION,JAN,POISSON,TOTAL
AF802,ALK,CH5424802,ROCHE,SPECIALLY
201,326,399,751,ADC,CHINA,CHINESE,GENOMIC,HAN,HOWEVER,HUNAN,LUNG,OGG1,THERE,THUS,XPD,XRCC1
185,8312,BACKGROUND,BAL,BALF,FDG,GLUCOSE,GLUT,HERMANSKY,HPS,IPF,LABEL,METHODS,PET,RESULTS,THERE,THUS
169,172,2013,952,AACR,EGFR,EPIDERMAL,FER,GTP,H1299,LABEL,MOL,NSCLC,RAC,RES,UNLABELLED,VAV2
001,010,045,8804,AUSTRALIA,BACKGROUND,DATA,GOLDFIELDS,GREAT,LABEL,METHODS,MIXED,OBJECTIVE,OBJECTIVES,REGIONS,RESULTS,SIXTY,THERE,THESE,WESTERN
233,257,264,947,ALSO,BCG,CD11C,CD4,CD8,COINFECTED,FOLLOWING,IFN,MHC,OVA,THUS
418,435,ABS,ALSO,CETUXIMAB,EGF,EGFR,EPIDERMAL,FVB
006,1112,1122,309,813,COLORECTAL,LUNG,OVARIAN,SARCOSINE,SCREENING,TRIAL
169,2013,AACR,CONVERSELY,DNAJ,EGF,EGFR,HSP70,HSP90,LOW,TID1
NEOPLASTIC
456,8201,BACKGROUND,BECAUSE,BOTH,IGF,LABEL,LABORATORY,METHODS,NICTH,NON,PATIENT,PDTC,THESE,WESTERN
169,2013,COUNTER,FITC,GMBH,HOWEVER,KGAA,PECS,PES,THEIR,THESE,VCH,WILEY
1994,ALK,ANAPLASTIC,SINCE,WHILE
169,2013,8P11,946,AKT,AZD4547,BECAUSE,DOVITINIB,EMT,FGF,FGFR,FGFR1,FGFR2,FGFR3,FGFR4,FGFRS,FGFS,FIBROBLAST,INC,KI23057,MAPK,NOTCH,PI3K,RAS,TACC1,TACC3,TGF,WHOLE,WILEY,WNT
19S,954,A549,AC17,DUB,IKK,PROTEASOME,THESE
167,216,327,ADIPOKINE,ADIPOKINES,BACKGROUND,BMI,CIS,COLORECTAL,CONCLUSION,LABEL,LUNG,METHODS,MHT,ORS,OVARIAN,RESULTS,SCREENING,THESE,TRIAL
169,2014,A549,COPYRIGHT,FMT,GMBH,KGAA,NON,VCH,WILEY
002,026,1998,2009,201,324,6551,AFTER,BACKGROUND,CONCLUSION,END,LABEL,LNR,METHODS,NSCLC,PORT,RESULTS
000,161,2000,2009,500,BARCELONA,CATALONIA,FEW,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SPAIN
CLEARLY,DESPITE,NSCLC,TARGETING
169,2013,AACR,EGF,EGFR,HOWEVER,LABEL,LKB1,MAPK,METFORMIN,METHODS,MTT,NSCLC,OBJECTIVE,PURPOSE,RAF,RAS,RESULTS,TKI,TREATMENT,WESTERN
169,2013,AACR,AMONG,CONCLUSION,CSC,CSCS,EXPRESSION,HDGF,LABEL,METHODS,NOTCH,NSCLC,OBJECTIVE,PCR,PURPOSE,RESULTS,THESE,VEGF,WNT
150
000,100,116,142,181,2010,2011,8805,AMONG,ARSENIC,BACKGROUND,CESSATION,COOKING,INORGANIC,JUNE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROXARSONE
169,2013,COPYRIGHT,GIVEN,IC50,MER,SAS,THROUGH,UNC1062
BOTH,PET
169,2013,BPDE,COPYRIGHT,PAH,PAHS
107,169,2013,BACKGROUND,CHEMONAIVE,COPYRIGHT,DATA,DLTS,LABEL,LTD,METHODS,MTD,OBJECTIVE,ORR,PERIPHERAL,RESULTS,SAGOPILONE,SCLC,SECONDARY
000,169,174,1999,200,2013,COPYRIGHT,GERMANY,LIPID,LTD,MPL,REDUCED,SINCE,TLR
169,2013,A549,AKT,BLACKWELL,CONCLUSION,FCM,HELF,LAA,LABEL,LTD,LYCORIS,METHODS,MTT,OBJECTIVE,OBJECTIVES,PI3K,PUBLISHING,RESULTS,THESE,TUNEL,WHILE
169,2013,INHIBITION,JOHN,LTD,NATURAL,SONS,WILEY
169,2013,4T1,AACR,ACUTE,ALI,AMD3100,BALF,BOTH,CXCR4,FINALLY,LABEL,LPS,METHODS,OBJECTIVE,PURPOSE,RESULTS,UBIQUITIN
275,331,CONCLUSION,ERCC1,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,RRM1
DESPITE,LUNG,THERE,THESE
BACKGROUND,CD31,CD34,DSS,FIFTY,LABEL,METASTATIC,METHODS,NINE,PRIMARY,RESULTS,SAMPLES,THREE,UNIVARIATE,UNUSUAL,VIII
014,018,028,041,129,967,ABC,ABCG2,ATP,COX,LABEL,MDR,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SNPS,THEREFORE,THUS
100,158,300,AFTER,BACKGROUND,CONCLUSION,EASTERN,FIFTY,GIVEN,GROUP,LABEL,METHODS,NEITHER,PFS,RESULTS,TOXICITIES
100,5A4,ALK,ANY,BACKGROUND,BIOSYSTEMS,CONCLUSION,EVALUATION,FIFTEEN,FISH,FORTY,ICC,LABEL,LEICA,LUNG,METHODS,NOVOCASTRA,NSCLC,RESULTS
169,2013,COPYRIGHT,CPG,FURTHER,HOWEVER,IRELAND,KNOCK,LTD,NRF2,SHC,SHC1,THUS
COLLISION,ENGLISH,RIGHT
1000,160,200,BCT,BOARD,CBCT,CONE,D95,DART,FURTHER,HOWEVER,IMAGING,LCT,PCT,PHILIPS,PTV,SBRT,SIMILARLY,THEREFORE,THESE,VMAT
100,167,177,215,4DCT,963,964,CARLO,EUD,LARGE,MONTE,RBE,TREATMENTS
169,2010,2013,228,BACKGROUND,COPYRIGHT,LABEL,LAM,LTD,LYMPHEDEMA,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEVEN,UNIVERSITY,YET
169,2010,2012,2013,BACKGROUND,CONCLUSION,CONCURRENT,COPYRIGHT,DOSE,FIFTEEN,INC,JULY,LABEL,MATERIALS,METHODS,NSCLC,PBT,PHASE,RBE,RESULTS,SEPTEMBER
169,2013,600,BOTH,COPYRIGHT,HOWEVER,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2013,ADULT,CHILDHOOD,COPYRIGHT,LYMPHANGIO,MRI,PRIMARY,SAS,THESE
169,2013,COPYRIGHT,EZH2,FOXP3,H3K27,NOW,T47D,THESE
0001,046,169,2002,2011,2013,BACKGROUND,COPYRIGHT,COX,EPP,IMIG,IRELAND,LABEL,LTD,MCR,MEIER,METHODS,MPM,RESULTS,THERE
169,2013,4T1,946,956,COPYRIGHT,IC50,INC,NADPH,NOX,NOX4,RNAI,ROS,SCH,SEVERAL,SIMILAR,TGF
CONCLUSION,DFS,ELISA,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,UNIVARIATE,VEGF
169,2013,BECAUSE,COPYRIGHT,CYTOLOGIC,HIGH,IHC,INC,KAPPA,MAY,MGG,NSCLC,SQC,WILEY
2004,2010,334,647,991,AGE,AUDIT,BACKGROUND,ENGLISH,LABEL,LUNG,METHODS,NLCA,NSCLC,RESULTS,THREE
A549,EGF,EGFR,FIRST,HOWEVER,K295R,L858R,NEXT,NSCLC,PREVIOUSLY,SRC,TKI,TKIS,Y527F
177,956,AMD3100,CXCR4,ELISA,PCR,THEREFORE,THESE,VEGFA,WESTERN
ANNEXIN,CHINESE,CHK2,FACS,HOWEVER,IHC,PLK1,REAL,RO5203280,SECURIN,THESE,THUS,WEE1,WESTERN
393P,H23,H522,HDACI,HISTONE,HOP62,KRAS,LKR,NOTABLY,OTHER,THEREFORE,THESE,THUS,VORINOSTAT
0001,100,169,177,2013,215,217,357,AREA,BOOTSTRAP,COPYRIGHT,EDI,EMPEY,FEV1,HYPOTHESIS,INC,LABEL,LTS,MEAN,METHODS,OBJECTIVE,OTOLOGICAL,PEARSON,PEFR,RESULTS,ROC,SOCIETY
0034,169,2013,341,AACR,ERK,ERK1,LABEL,NSCLC,RAS,RASEF,UNLABELLED,USING
CDC,COLLECTING,RCC,THESE
250,3A4,450,ALK,CONCLUSION,CRIZOTINIB,CYP,INC,LABEL,MET,NSCLC,OBJECTIVE,PHASE,PURPOSE,SUMMARY,XALKORI
169,2013,COPYRIGHT,INC,WILEY
947,948,ABS,B16,CCL2,CCR2,IFN,STRIKINGLY,TCR,TIL,TILS
090,160,168,1988,1990,258,798,CONCLUSION,COX,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
139,ACCORDING,EGFR,FURTHER,HOWEVER,IIIA,LUNG,MEIER,PCR,RESULTS,USING,WIF1,WNT
124,239,8804,8805,AFTER,BSC,GPA,HOWEVER,KARNOFSKY,LABEL,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE,WBRT
001,177,AIS,IPIA,LGP,LPIA,LVAF,LVD,LYMPH,PULMONARY,USING
BOTH,ERK,ERK1,ERK2,ERKS,GP130,JAKS,JANUS,LIF,OSM,STATS,U2OS
FN1,GLI,TAF9,TBP
310,945,954,A549,BDS,BRD4,JQ1,RELA,TNF
946,CLUSTERED,DEPLETION,EPH,EPHA1,HOWEVER
207,767,BACKGROUND,COX,ESCC,HOWEVER,LABEL,METHODS,NSM,NSMS,RESULTS,THERE
BACKGROUND,CONCLUSION,DIFFUSE,DMPM,HMGB1,LABEL,METHODS,MPM,RESULTS,THEREFORE
185,8312,ADDITIONAL,CONCLUSION,FDG,FOUR,HIV,LABEL,METHODS,MRI,OBJECTIVE,PCNSL,PET,PURPOSE,RESULTS,TEN,THREE
FINALLY,PULMONARY,TUMOURS
169,2013,956,A549,ATG5,BECLIN1,CAT,COPYRIGHT,CROWN,LC3,LDH,LTD,PM2,PUBLISHED,ROS,SOD,THESE
160,169,2013,COPD,COPYRIGHT,COUNTRIES,DIETS,FEV1,INC,MOSBY,NUTRITION,SEVEN,SURVEYS,TAKEN,THESE
169,2013,BECAUSE,COPYRIGHT,INC,JAPAN,LUNG,MOLECULAR,S0424,SWOG
169,2007,2011,2013,4117,COPYRIGHT,HISTOLOGIC,LTD,METASTASES,SEVERAL,THREE,TREATMENT
169,2013,BONE,BOTH,COPYRIGHT,IRELAND,LTD,MALIGNANT
169,200,2013,AKT,AXL,COPYRIGHT,ERK,GAS6,HIGH,HOWEVER,INC,MG63,MMP,U2OS
169,2013,CD36,COPYRIGHT,IRELAND,LTD
001,169,2007,2011,2013,281,513,717,796,BACKGROUND,COPYRIGHT,COX,INC,LABEL,LOBECTOMY,LUNG,METHODS,NODAL,NSCLC,OVERALL,PATIENT,PUBLISHED,RESULTS,SOCIETY,STS,SURGERY,VATS
169,2013,BACKGROUND,BRONCHIAL,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,THERE
169,2013,CONCURRENT,COPYRIGHT,INC,NSCLC,SEVERAL
169,1970S,1980,2012,2013,BETWEEN,CARE,CENTRAL,COPYRIGHT,DATA,DISEASE,EARLY,FIVE,INC,MEDLINE,SEVENTEEN
101,169,2005,2012,2013,215,BETWEEN,BRAIN,COPYRIGHT,COX,INC,KARNOFSKY,LABEL,LOCAL,MARCH,MATERIALS,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,SECONDARY,SRS
100,160,169,1940,1965,2001,2013,2975,BACKGROUND,CAUCASIAN,COPYRIGHT,FINALLY,INC,JANUARY,LABEL,METHODS,RESULTS,THREE
169,2013,956,ATP,COPYRIGHT,DOCKING,EGFR,GI50,LTD
169,2013,ALK,COPYRIGHT,EGFR,EML4,IRELAND,LTD,NSCLC
169,2013,COPYRIGHT,EGFR,IRELAND,LTD,NSE,SCLC,TKI,TKIS
169,2013,294,350,8805,B12,COPYRIGHT,IRELAND,LTD,NSCLC,THERE
169,2013,945,946,BRDU,COPYRIGHT,FURTHER,GAIN,H1299,H460,HOWEVER,INK4A,IRELAND,LTD,MDM2,NSCLC,PFT,TAKEN
647,99M,A549,AF488,ALEXA,ASCITES,CELL,CNT,EAT,EHLRICH,LYSOSOMAL,MCF,MTX,OVERALL,TECHNITIUM
8594,AGT,ESI,HBEC,HPLC,NNK,NNN,OVERALL,POB,SYNTHETIC,TAKEN,TOBACCO
131,BACKGROUND,BILATERAL,DESPITE,DISTANT,INITIAL,LABEL,METHODS,PAPILLARY,PATIENT,SUMMARY,TREATMENT,UNILATERAL
AREAS,BACKGROUND,BECAUSE,COVERED,CURRENTLY,HISTOLOGY,LABEL,LIMITED,METHODS,NON,NSCLC,OPINION,PEMETREXED
177,CDTE,HIGH,OWING,QDS
AIMS,AKT,CONCLUSION,FINALLY,INNOVATION,LABEL,METHODS,MM2,NADPH,OBJECTIVE,ONCOGENIC,PDCD4,RESULTS,ROS,TAIL,THESE,USING
176,CELL,CYP4B,EVALUATION,MTT,PET,THESE
FURTHER,YET
MOLECULAR,NON,NSCLC
001,169,2013,232,8201,8764,8804,CYPS,EAGLE,FDR,HEME,HFE,HPX,INC,LUNG,MTHFR,NCR1,SGK2,SIXTY,SLCS,THRESHOLD,TNF,TPO,U133A,UCP3,WILEY,WNT,WNTS
A549,ATDC,ERK,FOS,H1299,HBE,JNK,JUN,MMP,THESE,U0126
BIOMARKERS,MMP,MMPS
954,A549,DROSOPHILA,H292,HOWEVER,MMP9,MTT,NCI,NUMB,NUMBL,RESULTS,TRAF6,TRANSWELL
8201,BACKGROUND,CONCLUSION,FIVE,HIGH,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,RESULTS
NSCLC
277,338,8804,8805,AMONG,BACKGROUND,COMBINING,DATA,LABEL,METHODS,RESULTS,TNM
000,184,1973,1979,2000,2008,2009,230,871,BACKGROUND,DESPITE,END,LABEL,METHODS,RESULTS,SMR,SMRS,SUICIDE
946,BOTH,LEWIS
100,FOUR,HOWEVER,PAX8,THREE,TTF
0001,0004,125,8805,BACKGROUND,HOWEVER,HPF,IASLC,LABEL,LPA,LUNG,MITOTIC,USING
042,156,157,BACKGROUND,CCL15,CHEMOKINE,CIS,LABEL,MATERIALS,METHODS,ORS,RESULTS,SMOKING,THESE
169,2013,ALGORITHMS,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS,SMALL,USING
169,2013,241,ANCA,BECAUSE,COPYRIGHT,ESPA,FDG,MALIGNANCY,PET,WEGENER
169,2013,COPYRIGHT,INC,RING,SCF,SKIP,UPS
169,2013,COPYRIGHT,DESPITE,PUBLISHED,SEPAR
169,2013,ACTIVATION,AKT,COPYRIGHT,HOWEVER,SELW,TAKEN,U13C
071,169,2013,961,AVENTIS,BACKGROUND,BRITISH,COPYRIGHT,COUNCIL,DFS,FUNDING,LABEL,LIGUE,LTD,MEDICAL,METHODS,NATIONALE,PFS,PROGRAMME,RECHERCHE,RESULTS,SURROGATE
134,169,2013,ASIA,ASIAN,BACKGROUND,FEW,JOHN,LABEL,LTD,LUTS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SONS,STUDENT,THESE,WILEY
169,2013,ANAEMIA,CHRONIC,COPD,DESPITE,JOHN,LOW,LTD,SONS,WILEY
172,563,BACKGROUND,HRS,LABEL,METHODS,METS,RESULTS,SIR,SIRS,SMOKING,THESE,VAT
3LL,945,CD25,CD4,CD44,CD8,CURRENTLY,D1222,FOXP3,NK1,RELEVANTLY
946,ADC,ADCS,BASED,COX,LNM,PLNT,PNLT,PNLTS
IPC,MPM,TREATMENT,WHERE
002,008,012,026,108,166,172,177,268,526,CONCLUSION,COX,FDG,LABEL,MEIER,METHODS,MTV,OBJECTIVE,PET,PFS,RESULTS,TLG
169,2013,22RV1,ABNORMALLY,AGAIN,BASAL,COPYRIGHT,GAS5,INDUCTION,RNAS,SIMILAR,THUS,WHILE
PROGRAMMED,SCS,THESE,USING
122,177,2011,954,BACKGROUND,CONCLUSION,EIGHT,LABEL,LUNG,MEIER,METHODS,NOGUCHI,NUCLEAR,RESULTS
AGK,ESCC,JAK,JAK2,JH2,STAT3,THESE
181,2000,2008,215,BACKGROUND,LABEL,LOCAL,METHODS,PM2,RESULTS
100,1994,1997,390,507,956,BACKGROUND,FURTHER,LABEL,LUNG,METHODS,NO2,ORS,PM2,RESULTS,STILL,THERE
169,2013,ACADEMY,EPHA7,NOTABLY,YORK
549,EGFR,QSAR,THESE
ASIAN,BOTANICALS,CURIS,CURRENTLY,DUE,EGCG,FDA,GENENTECH,GLI,SOUTHEAST,THESE
169,2013,INC,WILEY
160,176,ARRHENIUS,FINALLY,RFA,VARIOUS
2013,3PO,945,AKT,DRUG,F26BP,FOOD,IND,LEWIS,PFK15,PREVIOUSLY,PTEN,RAS
135,2006,2009,231,287,540,BETWEEN,BRONCHIAL,CASES,HISTOLOGY,HOWEVER,IIA,IIB,IIIA,INTEGRITY,LABEL,MEAN,METHODS,NINE,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THERE,VATS
BECAUSE,FDG,FLT,FURTHER,PET,RAPID,SEVERAL,THYMIDINE
271,4372,AFTER,ESRC,KSRC,LUNG,MCMI,THEN,THESE
000,160,1980S,2013,230,EGFR,LUNG,MUTATIONS,THESE
160,945,CSF,DUE,ERK,ERK1,ERK2,EXPRESSION,HOWEVER,MOST,THEREFORE,THUS,TNF,TREATMENT,U0126
260,719,931,A549,FB11,FTIR,NMR
AUSTRIA,LUNG,NLST,PNEUMOLOGY,RADIOLOGY,SCREENING,SOCIETY,TRIAL
136,AKT,COX,EREG,MMP,PCR,S100P,SACC,STR,TRANSWELL
BOTH,TRAIL,WHILE
CIGARETTE,FACTORS,SMOKELESS
0001,0007,005,160,379,382,761,AFTER,ARG,ARG399GLN,CYS,GENOTYPES,GLN,HOWEVER,LYS,LYS751GLN,LYS939GLN,SER,SER326CYS,XPC,XPD,XRCC1
174,506,ALB,ALK,DATA,FREE,LABEL,METHODS,MONOLIX,OBJECTIVE,PANCREATIC,RESULTS,VEGF,ZALTRAP
002,004,013,015,036,068,129,220,325,8805,CEP17,EASTERN,ECOG,FIFTY,FISH,GROUP,HER2,IHC,LABEL,MBC,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,USING
169,2013,497,COPYRIGHT,HDGF,INC,INTEGRATED,MICRORNAS,MIRNA,NSCLC,SCID
169,2013,946,A549,CISPLATIN,CONVERSELY,COPYRIGHT,DDP,GSK,HOWEVER,IC50,IRELAND,LICL,LOW,LTD,MTT,NSCLC,TOTAL,WNT
169,2000,2011,2013,BACKGROUND,COPYRIGHT,DATA,INC,LABEL,METHODS,NSCLC,OUTCOME,PALLIATIVE,PATHOLOGIC,PUBLISHED,RESULTS,SEPTEMBER,SIXTY,SOCIETY
169,2003,2011,2013,770,AMONG,BACKGROUND,BOTH,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PREDICTIVE,PUBLISHED,RECORDS,RESULTS,SOCIETY
100,18F,8804,ADDITIONAL,BACKGROUND,CONCLUSION,FDG,HER2,IMAGE,LABEL,METHODS,PET,PRIMARY,RESULTS,SIXTY,USING
169,2013,A549,AEC,AUTHORS,BLACKWELL,FOUNDATION,FURTHER,GRE,HOWEVER,INHIBITING,JOURNAL,LTD,MOLECULAR,PUBLISHED,PUBLISHING,TAKEN,THEN
ALTOGETHER,CSE,ECH,KEAP1,NRF2,SCAL1
100,945,946,CHINESE,EACH,SALMONELLA
186,AKT,EGF,ISL1,LIN,MEC,NSCLC,PTTG1,REDUCTION,SCID
169,2013,CANCORS,CARE,COPYRIGHT,JOHN,LTD,SONS,THESE,USA,WILEY
116,169,2013,954,BP65,HCT,INC,NSAID,RKO,SP1,SP3,SP4,SW480,THESE,TOLFENAMIC,VEGF,WILEY
183,AFTER,CONCLUSION,GEORG,HISTOLOGY,LABEL,METHODS,MRI,STUTTGART,THERE,THEREFORE,UNLABELLED,YORK
169,177,2013,956,COPYRIGHT,INC,MRP1,MRP8,OATP2B1,OCTN1,ORGANIC,REGARDING,SIXTEEN,THESE,WILEY
148A,EMT,FUNCTIONAL,KNOCKDOWN,NSCLC,ROCK1,THESE
2007,2012,CONCLUSION,LABEL,MEAN,METHODS,OBJECTIVE,PRIMARY,PRIOR,PURPOSE,RESECTION,RESULTS,RFA,THERE,TREATMENT
10A,148,150,181A,182,184,34A,34C,HOWEVER,NSCLC,PCR,RNAS,TARGETSCAN,THESE,UTR
CDH1,EPIGENETIC,H460,NUCLEOSIDE,RASSF1A,RUNX3,TSG,TSGS,WIF1
A549,AKT1,ATF4,CDH1,CHOP,DDIT3,MTOR,NSCLC,TRIB3
169,1992,2012,241,BACKGROUND,CARCINOID,CONCLUSION,COPYRIGHT,CUSHING,ESPA,FIFTY,JANUARY,JUNE,LABEL,METHODS,NINE,OBJECTIVE,OVERALL,RESULTS,THERE,THREE

169,177,200,2013,38PG,45NG,500NG,945,947,999,COPYRIGHT,NSE,RSD,SCLC,SRM,TIAPALVSK
529,567,ACA,AFTER,CCA,CYP19A1,FURTHER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PERIPHERAL,RESULTS,SNPS,THERE
ALK,CONCLUSION,CTC,CTCS,FISH,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,VARIATIONS
169,2013,ALK,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,DISCORDANT,EML4,FISH,IHC,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS
1000,169,2001,2008,2013,376,8201,873,ADDICTION,AIM,COMMUNITY,COX,HRS,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,SETTING,SEX,SOCIETY,SWISS,THERE
007,029,047,12A,12K,954,956,E746_A750,EGFR,FINALLY,H1975,IC50,L858R,NSCLC,OVERALL,T790M
133,143,169,2008,2012,2013,ADVERSE,BETWEEN,CONCLUSION,JOHN,LABEL,MAY,METHODS,OBJECTIVE,REACTIONS,RESULTS,SOAC,SONS,THERE,WILEY
148B,169,2013,214,AACR,ALCAM,CONVERSELY,MALIGNANT,OVERALL,SILENCING,TFAP2,THESE

HOWEVER,THERE,THEREFORE,VATS
0001,183,557,8201,BACKGROUND,CBW,GEORG,HOWEVER,LABEL,MATERIALS,METHODS,RESULTS,SCC,STUTTGART,THERE,YORK
233,BIRT,CYST,DIFFUSE,DUB,FOCAL,HIGH,HOGG,LANGERHANS
002,138,378,ARSENIC,CIS,CONCLUSION,COX,HOWEVER,HRS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TOTAL
945,954,BASED,CD4,DCS,DUE,HLA,RELB,TPT

169,2013,AACR,BCL,CRL5908,HA14,IC50,LABEL,THREE,TREATMENT,UNLABELLED
A549,EUKARYOTIC,HMEC,MCF,NHLF,POLY
SILS,SITS,VATS,VIDEO
003,162,984,ANOVA,AXIAL,BRAIN,FLAIR,MRI,THERE,TSE,WMH
BACKGROUND,CHINA,DISCUSSION,GOING,LABEL,OBJECTIVE,OBJECTIVES,WHETHER
008,023,047,169,177,2013,32P,3PACKYEARS,956,BACKGROUND,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,MGMT,NNK,RESULTS,THERE,TOBACCO
169,2013,CD1D,COPYRIGHT,GD3,HOWEVER,INC,LAM,NKT,OVERALL,PATHOLOGY,PUBLISHED,SOCIETY,TSC1,TSC2
116,169,2013,956,A549,COPYRIGHT,FURTHER,HCT,HELA,HT29,IC50,MCF,MOST,SAS
169,2013,954,BAL,BIOLOGICAL,COPD,COPYRIGHT,INGENUITY,LABEL,LUNG,MALDI,MAPPING,PAGE,PROTEIN,TOF,UNASSIGNED,UNLABELLED
1000,11D,169,2013,2500,A549,BIOLOGICAL,COPYRIGHT,HL60,IC50,LTD
169,2013,780,BACKGROUND,CONCLUSION,COPYRIGHT,FDG,LABEL,LTD,MEDLINE,METHODS,OVERALL,PET,RESULTS,STUDIES
024,029,169,2013,8805,BACKGROUND,CONCLUSION,COPYRIGHT,CYP,EGFR,ERLOTINIB,EXISTENCE,GEFITINIB,HOWEVER,INC,LABEL,METHODS,NSCLC,P450,REDUCED,RESULTS
001,1068,1447,169,2013,2326,3728,BACKGROUND,CISPLATIN,CONCLUSION,COPYRIGHT,EVALUATION,III,INC,LABEL,LUNG,MEDLINE,METHODS,RESULTS,SEVEN,SIXTEEN
169,2013,A549,ALTOGETHER,COPYRIGHT,K562,LAMIACEAE,LTD,MOROCCO
001,002,108,120,169,2013,A549,BOTH,CALU1,COLO699,COPYRIGHT,CURRENTLY,ECFCS,ECSCR,FIRST,FURTHER,HBEPC,IRELAND,LTD,NEXT,NSCLC,PCR,ROBO4,TEM,TEMS,THEREFORE,WESTERN
169,2013,ATP,COPYRIGHT,EGFR,HER2,HER4,HOWEVER,IRELAND,L858R,LTD,LUNG,LUX,MET,NSCLC,REVERSIBLE,T790M,THESE
159,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,D19S878,D19S886,EGFR,FOUR,HOWEVER,IRELAND,LABEL,LIVER,LKB1,LOH,LTD,METHODS,MUTATIONS,RESULTS,THESE,TP53
169,2013,ALK,COPYRIGHT,CRIZOTINIB,EML4,FISH,IRELAND,LTD,NSCLC
169,2013,C32,COPYRIGHT,ERK,FAK,HETE,HETES,LOX,LTD,NOD,PD98059,SCID,SEVERAL,THESE,TREATMENT
0001,001,009,169,1999,2007,201,2013,347,591,694,7TH,BACKGROUND,BETWEEN,BVI,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,MEDICAL,METHODS,NSCLC,RESULTS,T1A,T1B,T2A,TNM,TOKYO,UNIVERSITY
169,189,2004,2011,2013,2N0M0,8764,8804,BACKGROUND,COPYRIGHT,CROWN,FDG,IRELAND,JANUARY,JULY,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PET,PUBLISHED,RESULTS,RISK,SABR,SUV,THESE
169,2013,945,947,ANTI,FURTHER,GOTTRON,IGG4,SERUM,TIF
1999,2008,DEPARTMENT,FUNCTIONAL,GRADE,GROSS,GTR,HUASHAN,LABEL,MEDICAL,METHODS,NINE,OBJECTIVE,PSAE,PSAES,RESULTS,THERE
004,074,089,2004,2010,8805,AGE,CNS,FIFTY,GAMMA,KARNOFSKY,KNIFE,LABEL,MEIER,METHODS,OBJECTIVE,OVERALL,RESULTS,SEVENTY,SIXTY,SRS,UNIVARIATE
2009,2012,ACT,CER,INSTITUTE,MAY
2000S,ALK,ASIAN,EGFR,FINALLY,LUNG,THUS
169,181,2013,8201,916,936,A549,BAX,BCL,CELL,DNMT,GSH,HPF,IC50,INC,MMP,NAC,ROS,TRXR1,WHILE,WILEY,ZEB,ZEBULARINE
012,037,1559,1679,169,2013,CHINESE,HOWEVER,INC,RAS,SIPA1,SNP,SNPS,THREE,WILEY
169,2013,AACR,ADDITIONAL,HELA,IRES,LABEL,MCF,THESE,UNLABELLED
006,169,195,2013,469,986,BACKGROUND,BOTH,EGFR,EPIDERMAL,IIIB,KIRSTEN,KRAS,LABEL,METHODS,NSCLC,RESULTS,SOCIETY,THERE,TTP
100,169,2013,ALK,AUTHORS,BRITAIN,DIAGNOSTIC,FGFR3,GREAT,IRELAND,JOHN,JOURNAL,LTD,ONCOGENIC,PATHOLOGY,SOCIETY,SONS,WILEY
A549,AIF,ARTE,BAK,BAX,BID,ROS,SMAC
0001,001,169,2013,945,946,ALSO,COPYRIGHT,INHIBITORS,INTEGRINS,LABEL,SIMILARLY,UICC,UNLABELLED
160,8710,936,A549,NAC,PREVENTION,ROS,THESE
A683C,ARMS,C626G,DR4,FOUR,G422A,PCR,POLYMERASE,REFRACTORY,RFLP
142,178,2000,2001,2008,390,COX,GRADIENTS,MORTALITY,SWISS,THERE
100,181,8710,936,A549,BOTH,GSH,HOWEVER,JNK,MAPK,MEK,MMP,ROS,TREATMENT
1995,2008,387,AAH,AMONG,BACKGROUND,CONCLUSION,COX,FOUR,III,IPF,LABEL,METHODS,NONE,RESULTS
002,025,CRUDE,DISCUSSION,LABEL,LOUISVILLE,MATERIALS,MEDICALLY,METHODS,OBJECTIVE,OBJECTIVES,PET,PRIMARY,RESULTS,SBRT,THERE,UNIVERSITY
169,2007,2009,2013,8805,AMONG,BACKGROUND,CONCLUSION,COPYRIGHT,EXCELLENT,FORTY,IMRT,INC,LABEL,METHODS,NSCLC,PET,RESULTS,SBRT,THREE,TOTAL,TREATMENT
149,2004,2009,8804,8805,CONCLUSION,DPS,EFRT,GRADE,JUNE,LABEL,LUNG,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,RPG,SEPTEMBER,THERE,V10
140MG,169,2013,50G,549,56MG,74MG,850MG,CHINESE,COPYRIGHT,FINALLY,HPCCC,HPLC,LEWIS,NMR,SIEB,ZUCC
169,177,2013,21G,8320,8325,956,A549,COPYRIGHT,DANSHEN,IIA,INDUCTION,JAPAN,NATURAL,NOTEWORTHY,PARP,PUBLISHED,SKOV3,SOCIETY,TOV,TRAIL,VAD
001,002,003,021,169,177,2013,AACR,COX,DCE,FDG,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OPTIMUM,PET,PURPOSE,RESULTS,THESE,UNIVARIATE,USING
001,009,169,201,2013,AACR,AFFYMETRIX,CONCLUSION,ETS2,HGF,IHC,LABEL,LOW,LUNG,MEIER,MET,METHODS,NSCLC,OBJECTIVE,PATIENT,PURPOSE,RESULTS
169,2013,300,8805,COPYRIGHT,EDUCATION,GUIDELINE,INC,LABEL,MATERIALS,METHODS,MODELED,OBJECTIVE,OUTSIDE,PANEL,PSA,PUBLISHED,PURPOSE,RESULTS,UROLOGICAL
001,169,177,2013,ASA,BISPECTRAL,CD4,CD8,COPYRIGHT,INC,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING,TH1,TH2,TOTAL,UNIVERSITY
100,160,169,2013,300,ACADEMY,FDA,III,ONGOING,YORK
10C,110,11C,11T,12C,12T,13C,183,410,A549,BU4N,CH1,CHCL3,ESI,H2IM,H2IND,H2PZ,HBZIM,HIND,HPZ,IC50,NMR,OSCL4,RUCL4,RUTHENIUM,SW480
001,169,2003,2010,2013,424,543,AACR,AFTER,CHINESE,EFFECTIVE,ORS,PROTECTIVE,ROR
001,016,121,1995,2010,COMPLETION,HISTOLOGY,JANUARY,LABEL,MARTINI,MELAMED,METHODS,MORBIDITY,OBJECTIVE,OBJECTIVES,OVERALL,REGARDING,RESULTS
120,THROUGH
BASED,FDG,HISTOLOGY,HODGKIN,OTHER,PET
1000,830,AGE,AMONG,BACKGROUND,CORE,FATIGUE,LABEL,LIFE,LUNG,METHODS,OBJECTIVE,QUALITY,RESULTS,THESE,TREATMENT
039,115,169,2013,946,AMONG,COPYRIGHT,INC,MALIGNANT
0001,0018,019,ANOTHER,DIFFERENT,EIGHT,THREE
BOTH,CSC,CSCS,EMT,K252A,LUNG,MPE,MPES,NTS,THESE,TREATMENT,TRK,TRKB
ALK,BACKGROUND,BRAF,COMPANION,CONTENT,EGFR,HER2,KIRSTEN,KRAS,LABEL,NSCLC,SUMMARY,THESE
1054,132,169,177,2013,2611,273,363,427,457,APMIS,ELISA,GPNMB,JOHN,LTD,OVERALL,PUBLISHED,SCLC,SCLCS,SONS,THESE,TMAS,WILEY
AKT,BCS,BRONCHIAL,ERK1,FINALLY,MAPK3,NVP,PI3K,REBOUND,RESISTANT,RPS6KB2,THESE
FFPE,HER2,IHC,OVERALL,REVERSE,RPPA,RPPAS
003,049,146,385,545,AFTER,ARG194TRP,CHINESE,HAN,HOWEVER,THERE,THEREFORE,THOSE,XRCC1
ENGLISH,TYPICALLY
IMAGING
008,2012,214,CAUCASIANS,CCND1,G870A,HOWEVER,INCREASING,MAY,META,MIXED
468,786,8209,A498,ATP,BASED,CFU,CMAX,EVALUATION,H23,H460,MCF,MDA,NCI
000,160,956,ADDITIONAL,MALDI,MASS
108,1434,1706,457,592,ANOTHER,BRCA1,CHEK2,DUE,NORTH,SCREENING,THREE,WEST,WOMEN
160,BACKGROUND,BASED,GROSSLY,LABEL,METHODS,RESULTS
2000,2010,256,530,8201,866,AFTER,BACKGROUND,CONCLUSION,DATA,HODGKIN,INSURANCE,LABEL,METHODS,RESULTS,SIR,SIRS
0001,0005,001,002,008,169,2013,245,36V2,COPYRIGHT,COX,FORM,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SAS,SAS0,SAS1,SAS2,SAS3,SHORT,SURGERY
177,209,210,956,963,DUE,HCL,PIPS,ROMANIA,TEN
169,2013,239,737,ABT,APPROACHES,BACKGROUND,BCL,BH3,BRITISH,ERK,ERK1,H1688,KEY,LABEL,MAPK,METHODS,OBJECTIVE,PCR,PURPOSE,RESULTS,SCLC,SOCIETY,THESE,WESTERN
160,169,2013,4945,945,A549,AUTHORS,BLACKWELL,CD24,CD44,CK2,CONVERSELY,DOWN,FINALLY,FOUNDATION,H1299,JOURNAL,LTD,MOLECULAR,PROTEIN,PUBLISHED,PUBLISHING,THUS
160,169,2013,BACKGROUND,CAL27,HIGH,HOWEVER,JOHN,LABEL,LTD,METHODS,OSCC,OSCCS,PUBLISHED,REPRESSION,RESULTS,SONS,THUS,WESTERN,WILEY
ADDITIONAL,ALTOGETHER,BACKGROUND,BLOT,CONCLUSION,CONTEXT,CTAB,DISCUSSION,GLC1,GLC1M13,IEF,LABEL,M13,MATERIALS,METHODS,MOST,OBJECTIVE,PAGE,RESULTS,SCLC,SDS,SMALL,THEREFORE,WESTERN
169,2013,ACH,CHT1,CONVERSELY,CTL,CTL1,CTL4,CTLS,H82,KNOCKDOWNS,SOCIETY,SUPPORTING,SYNTHESIS,THESE
100,169,2013,956,ALUM,C57BL,COPYRIGHT,INC,INJECTION,LEWIS,MACROPHAGE,PAMP,PAMPS,TH1,TH2,THREE,WILEY
169,2013,AXL,UICC
954,A1E,ADP,AKT,ASIAN,BCL,FADD,FASL,FITC,H1299,H460,NCI,NSCLC,PARP,PCR,PI3K
A549,AFTER,CCL19,CCR7,CELL,CHROMATIN,FOLLOWING,GGGGC,HOWEVER,NSCLC,SP1,THESE
2012,203,275,2A6,359,444,522,596,607,668,672,713,715,720,760,761,769,838,839,861,869,886,AMONG,ASIAN,CIS,CYTOCHROME,EIGHT,HOWEVER,LITERATURE,ORS,OVERALL,P450
169,2013,COPYRIGHT,ERK,FAK,LUNG,MACRONB,MICRONB,THESE,UICC,UTILIZING
BACKGROUND,CPG,DNAS,FFPE,HOWEVER,LABEL,MASSIVELY,METHODS,PANEL,RESULTS,SNCS,UDG
169,2013,AFTER,BCL2,COPYRIGHT,LHRH,MRP1,NLC,NLCS
16HBE,LKB1,RHO,RHOA,SER,THR
001,010,023,169,2013,8804,BASED,COPYRIGHT,INC,SMALL,THERE
152,154,169,170,196,2010,2013,235,243,436,556,606,649,799,803,8364,965,BACKGROUND,COPYRIGHT,GENOA,INSTITUTE,IRELAND,ITALY,LABEL,LTD,LUNG,METHODS,RESULTS,SERVICE,SPONSORED,UNIT
169,2013,CELL,COA,COPYRIGHT,ERK1,GIVEN,HMG,HNSCC,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,RHO,RHOC,STAT3,STATINS,THESE
001,002,018,169,176,2000,2011,2013,211,BACKGROUND,BETWEEN,COMPARING,COPYRIGHT,CPS,DESPITE,INC,JANUARY,LABEL,MAJOR,METHODS,PAST,PUBLISHED,RESULTS,SOCIETY,TEN
153,169,2013,8805,AET,BACKGROUND,CAUCASIAN,COPYRIGHT,DATES,ESOPHAGUS,IMRT,INTENSITY,IRELAND,LABEL,LTD,MAXIMUM,MEDICAL,METHODS,MODULATED,NSCLC,OBJECTIVE,PURPOSE,RESULTS,UNIVARIATE,V50
115,123,169,2013,363,590,8805,CONCLUSION,COPYRIGHT,DMAX,EIGHT,EQD2,GY3,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,V20
001,169,2013,AFTER,ARG,COPYRIGHT,IIB,III,INC,ISA51,MONTANIDE,NSCLC,PARIS,SECONDARY,TYR,VX001
169,2012,COPYRIGHT,HOWEVER,IMMEDIATE,LTD,PKP
176,A549,AFTER,CELL,H2O2,HMGB1,HOWEVER,ROS
001,108,125,1916,2011,BACKGROUND,ENGLISH,GINGIVA,LABEL,METHODS,RESULTS
A549,AKT,EGF,EGFR,ERK,MEK,PHOSPHO,PI3K,RAF
ACTIVATION,BCS,CLARA,EXPRESSION,KRAS,LUNG,REMARKABLE,THREE
0001,001,145,2006,2009,CA19,COX,GCE,LOG,MEIER,METASTATIC,SMALL,THERE
100,8201,8226,8804,KEY,LABEL,METHODS,MRI,OBJECTIVE,OBJECTIVES,RESULTS,THERE,THESE
215,CA19,CHILD,KIT,NEITHER,PUGH,RADIO,SERUM
000,106,178,200,650,8805,956,FATIGUE,KAHALALIDE,LABEL,METHODS,MTD,OBJECTIVE,PROLONGED,PURPOSE,RESULTS
AN1,CYST,H209,L929,NCI,SERA,THESE
33258,946,956,A549,AIM,CELL,COMPOUNDS,CONCLUSION,HOECHST,HOWEVER,LABEL,LDH,MAP,METHODS,MTT,NOR,OBJECTIVE,RESULTS,ROS,WESTERN
120,125,239,5HT3,BACKGROUND,CINV,HEC,LABEL,METHODS,RESULTS,TRIPLET
042,215,2331,3077,4133,4522,4Q32,798,7Q21,CDK6,CELL,HOWEVER,THESE
115,127,1997,2011,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,UNDER
0050,100,129,2002,2008,206,335,AMONG,BETWEEN,DFS,GROUP,LABEL,LOBE,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,SND,THERE
001,300,600,7288,8364,DENMARK,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PASCART,RESULTS,SURGERY,THERE,UNIVERSITY
134,136,176,EGFR,KNOWLEDGE,KRAS,LABEL,METHODS,MUTATIONAL,NSCLC,OBJECTIVE,PURPOSE,RESULTS
A750,AIMS,BACKGROUND,DEL,E746,EGFR,IHC,L858R,LABEL,METHODS,MOLECULAR,OBJECTIVE,PRIMARY,RESULTS,SIA,SIAS,TKIS
1040,1053,1054,1056,1057,169,2013,2GY,2IN,954,AIM2,BOTH,CELL,COPYRIGHT,DSBS,NRF2,OXIDATION,THESE,TLR9
169,16HBE,2013,205,620,956,CACO,CCRF,CELL,CEM,CNS,COLO,COLON,COPYRIGHT,EC50,H292,H522,HELA,LAN,LD50,LUNG,MCF,MTT,NCI,NON,SAS,SMALL,THUS,VLAK
0001,0013,02NG,1037,124,136,155,169,177,180,2013,207,267,2NG,33NG,442,65NG,88NG,BACKGROUND,CONCLUSION,COPYRIGHT,ELISA,GPC3,HCC,HOWEVER,LABEL,METHODS,RESULTS,SERUM
169,176,2013,60MIN,A549,COPYRIGHT,CYTOTOXIC,GENOTOXIC,SHORT,USING
169,2013,BAX,COPYRIGHT,FOS,HOWEVER,INC,JNK,JUN,KI67,MAPK,MAPKS,NH2,PRDX6,THESE
135,169,2012,ACP,BACKGROUND,CONCLUSION,COPYRIGHT,LABEL,METHODS,PARKINSON,PUBLISHED,RESULTS,SEGG,THERE
169,2013,CONCLUSION,COPYRIGHT,EATON,EMG,FEDERATION,HENCE,IRELAND,LABEL,LAMBERT,LEMS,LTD,METHODS,MUP,OBJECTIVE,PUBLISHED,QEMG,RESULTS
002,003,043,116,139,157,169,190,2004,2011,2013,464,BACKGROUND,CHEST,COPYRIGHT,FURTHER,HOWEVER,III,INC,LABEL,METHODS,NSCLC,PUBLISHED,REGARDING,RESULTS,SOCIETY
166,169,1998,2009,2013,952,AFTER,BACKGROUND,BETWEEN,COPYRIGHT,DFS,INC,LABEL,METHODS,N0M0,NSCLC,PUBLISHED,RESULTS,SOCIETY,T1A,T1B,T2A,T2B,USING,VPI
169,2013,946,ACTB,CELL,COPYRIGHT,FFPE,GAPDH,HOWEVER,IPO8,IRELAND,LTD,LUNG,NON,NORMFINDER,PCR,PUM1,SMALL,TBP,USING
169,2013,BACKGROUND,CHALLENGES,COPYRIGHT,GROWING,LABEL,LTD,METHODS,RESULTS,THERE,WHILE
017,039,1000,1200,169,2012,2013,285,CAPPA,COPYRIGHT,ECOG,IIIB,IRELAND,JUNE,LTD,NSCLC,PFS,PRIMARY,PS2,TNM
169,2013,400,BACKGROUND,CONCLUSION,COPYRIGHT,FURTHER,GRADE,III,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,TRT,UFT
169,2013,2063,COPYRIGHT,PNS
011,013,015,018,021,035,042,080,136,158,159,169,2013,248,409,508,625,669,992,BACKGROUND,COPYRIGHT,FIVE,INC,LABEL,METHODS,PUBLISHED,RESULTS,SOCIETY,UNIVARIATE
169,2013,ACC,ADP,AKT,ALSO,AMP,AMPK,BETA,COA,CONVERSELY,COPYRIGHT,JNK,JOHN,JUN,LTD,OVERALL,PARP,ROS,S6K,SONS,THUS,U266,VEGF,WILEY
169,2013,COPYRIGHT,EGFR,GMBH,KGAA,MOLECULAR,SEVERAL,VCH,WILEY
BP1,FGF,REDUCTION,THEREFORE,VEGF
135A,A549,CDDP,MCL1,TAKEN
FDG,IMAGING,PATHOLOGY,PET
ANALYZING,CDDP,FINALLY,H146,H526,H69,IGF,INNOVATIVE,INSULIN,R1507,SCLC
183,215,956,A549,CELL,FINALLY,FURTHER,HELA,IC50,MCF
945,946,ERK1,H522,NCOR,NUCLEAR,OVCAR,SMRT,STAT1,THYROID
100,177,185,487,489,5803,956,963,BASED,CCL,CRL
148,169,2013,291,AACR,BRCA1,COX,DLC1,EXPRESSION,HIF1A,JAPAN,MIR21,PCR,PROGNOSTIC,RFS,SEVEN,THUS,XPO1
169,190,2013,2651A,3551C,604,739,782,ALK,AMONG,COPYRIGHT,DUE,IRELAND,LTD,RET,TP53,USING
169,177,192,2008,2011,2013,255,359,447,479,494,662,BACKGROUND,COPYRIGHT,EBUS,IRELAND,LABEL,LTD,METHODS,ONCE,PPL,PPLS,RESULTS,TBB,THESE
177,8804,EARLY,FOUR,III,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,STAGE,TREATMENT
169,2012,COPYRIGHT,CROWN,III,LTD,PPB,PUBLISHED
1535,AIMS,CACS,CAD,CHRONIC,CONCLUSION,COPD,DISEASE,GOLD,HOWEVER,INITIATIVE,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SCREENING,TRIAL
169,2010,2012,2013,300,ALK,APRIL,BACKGROUND,CH5424802,COPYRIGHT,CURRENTLY,DLT,DLTS,FUNDING,JAPAN,JULY,LABEL,LTD,METHODS,MTD,NSCLC,RESULTS,SEPT,SERIOUS,TREATMENT
169,2013,946,BACKGROUND,CLINICALLY,CONCLUSION,COPYRIGHT,EGFR,ERCC1,III,INTRA,LABEL,LTD,MATERIALS,METHODS,MOST,NSCLC,PROGNOSTIC,RESULTS,RRM1,THUS,TUBB
169,2013,COPYRIGHT,INC,PANCAKE,RENAL,RMS,TREATMENT
169,2013,956,A549,APOPTOSIS,BESIDES,CELL,COPYRIGHT,DDP,HOWEVER,MMP,MTT,SAS,TAKEN,TRANSWELL,XIAP
025,032,041,102,103,111,175,186,207,8201,956,CISPLATIN,FDT,FIFTEEN,FUNCTIONAL,HFA,LABEL,METHODS,OBJECTIVE,OCT,PACLITAXEL,PSD,PURPOSE,RESULTS,RNFL,THERE,THREE
033,169,2013,8201,956,BACKGROUND,BCL,BRITISH,CH27,COMPOUNDS,CONSISTENT,GREEN,H460,HEP3B,HMJ38,HSC,IC50,JNK,KEY,LABEL,M21,METHODS,MJ65,MJ66,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,SOCIETY,TREATMENT,USING,WESTERN
001,004,005,ALK,EGFR,THESE,TREATMENT,TTF
169,2013,FINE,FNA,GCT,GIANT,HOWEVER,INC,WILEY
169,2013,COPYRIGHT,FORTY,HOPKINS,IHC,INC,JOHNS,PTC,TGB,THYROID,TTF,WILEY
109,169,2013,COPYRIGHT,CRR,INC,OVERALL,RED,TRIPATH,WILEY
0001,100,169,2013,8201,COPYRIGHT,EZH2,INC,MOC,THUS,WILEY
169,2013,946,947,A549,B16,CD40,CD86,DCS,DU145,GMBH,IFN,KGAA,STAT1,THUS,TLR3,VCH,VIRAL,WILEY
AFTER,BACKGROUND,BECAUSE,CASE,CONCLUSION,HOWEVER,LABEL,METHODS,TMD,UPON,WESTERN
AMONG,PRIMARY,SOFT,THROUGH
METASTASIS,THESE,USING,WHILE
100,2008,2011,AMONG,BETWEEN,CONCLUSION,ELEVATION,FACTORS,FDG,JUNE,LABEL,LUNG,METHODS,OBJECTIVE,OCTOBER,PET,RESULTS
MEDICAL,PRFA
177,ANESTHESIA,CO2,COPD,HFJV,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
8209,954,A549,AMONG,HELA,IMMUNOBLOT,MCL,PCR,STAT3,THAI,TRAIL
511,ALONG,COX,KIM,PGE,PGE2
954,CCL2,THESE,USING
120,166,23C,23D,32A,32B,498,A549,FINALLY,IC50,JNK1,MONOPOLAR,MPS1,THUS
3393,AES,CENTRAL,EIGHT,GENERALLY,GROUP,HOWEVER,JAPAN,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SURGERY
ALTOGETHER,BPDE,CELL,ERK,HBECS,JNK,MAPK,MAPKS,RIP1,ROS,SCAVENGING
160,HOWEVER,NOTCH,NSCLC,THESE,TRB3
0001,037,066,177,ALTOGETHER,BOTH,COA,CONCLUSION,FDG,LABEL,MAXIMAL,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS
001,069,117,160,177,8201,BOARD,CTAC,FDG,FORTY,FURTHER,HIPAA,LABEL,LOW,METHODS,MRAC,MRI,OBJECTIVE,PET,PROCEDURES,PURPOSE,REGIONS,RESULTS,SUV,SUVMEAN,USING
003,169,2013,256,440,973,996,COPYRIGHT,EGFR,IRELAND,KRAS,LTD,MPC,MPCS,PULMONARY,THESE,TKI,TKIS
000,001,169,2013,BMI,CIS,COLORECTAL,CONCLUSION,COPYRIGHT,CVD,HRS,INC,LABEL,LUNG,METHODS,OBESITY,OBJECTIVE,OVARIAN,OVERWEIGHT,PLCO,RESULTS,SCREENING,TRIAL
169,2013,AFTER,ANKLE,COLLEGE,COPYRIGHT,FOOT,INC,PUBLISHED,THEREAFTER
721,CLINICIAN,CONCLUSION,FORTY,INTEGRATED,KARNOFSKY,LABEL,METHODS,OBJECTIVE,PROS,PURPOSE,RESULTS,SEMI
001,002,005,275,300,543,763,780,ACT,AMONG,CONCLUSION,COX,G12A,G12C,G12D,G12R,G12S,G12V,HRS,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,OBS,PURPOSE,RESULTS,THERE
182,230,248,311,AMENDMENTS,AMONG,CONCLUSION,GENOMIC,LABEL,LABORATORY,METHODS,NSCLC,OBJECTIVE,PRIMARY,PURPOSE,RESULTS,TP53
116,126,169,2013,8201,8804,AFTER,ASSAY,BLOCKED,CBMNCYT,COPYRIGHT,FHIT,INC,LUNG,NNK,SEVERAL,TP53,WILEY
169,2013,C57BL,CATHEPSIN,COPYRIGHT,FURTHER,MC38,TAKEN,UICC
001,169,181,2013,AKT,BRAF,COPYRIGHT,CRAF,EVALUATION,FINALLY,FOLLOWING,H1975,HCT15,IC50,MAPK,MEK,PI3K,PI3KI,PTEN,RAF,RAS,SELECTIVE,THEREFORE,THESE,UICC
514,AGNP,FOLIC,FRS,POLY,RAMAN,REDUCED,RGO
CD34,JAZF1,PHF1,S100,SIX
945,CDX,EGFR,HISTOLOGIC,HOWEVER,KRAS,LAFM,LAFMS,LOW,SALL,THESE
151,281,675,835,BECAUSE,EGFR,NSCLC,SMALL
100,1500,FFPE,PCR
004,013,014,024,169,1ST,2012,2013,420,8594,993,ASIAN,BACKGROUND,BIOMEDICAL,CAUCASIAN,CHINESE,COPYRIGHT,CROWN,FORTY,FURTHER,HOWEVER,LABEL,META,METHODS,PUBLISHED,RESULTS,SCIENCE,SEPTEMBER,STATA,WEB
001,002,169,2013,CHIP,COPYRIGHT,H4K16,INC,MICROARRAY,NSCLC,SKP2,THESE
177,2000,2010,2011,BRONCHIAL,ENDOSCOPIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
011,014,023,028,169,2013,8805,BACKGROUND,CASES,COPYRIGHT,EGFR,EXPRESSION,IHC,IRELAND,LABEL,LTD,METHODS,NSCLC,NUCLEAR,PFS,RESULTS
123,131,169,2013,A549,AUNPS,C225,COPYRIGHT,EGFR,LTD,MICROSPECT,PEG,PUBLISHED
107,33F,66GY,8805,BACKGROUND,CONCLUSION,CTV,DOSE,GTV,HOWEVER,IMRT,INCREASED,LABEL,METHODS,NSCLC,PTV,RESULTS,T1B,TCP,THESE,V74GY
183,CCK,CHC1,CNE,ESIMS,GAMA,H460,HELA,HEPG2,IC50,NCI,NMR,USING
33A,EMT,FUNCTIONAL,HMGA2,TTF,UTR
231,ADP,DDX3,III,MDA,PARP,PUF,T47D,XENOGRAFT
169,2013,946,ADC,G12D,INC,KRAS,LUNG,NSCLC,PTEN,RII,SCC,TGF,THESE,WHETHER,WILEY
0002,0005,110,169,177,1970,2004,2013,8201,8804,8805,BACKGROUND,CR2,LABEL,LATE,METASTASIS,METHODS,PREFS,PRS,RESULTS,RL1,SOCIETY,SURGERY,THESE,TIME
169,2013,945,947,948,954,A549,ERK,GCS,INC,MES,PPAR,SIMILARLY,TP53,WILEY
DEPENDING
CHT,CURRENT,III,PCI,SCLC
231,4T1,945,956,BALB,BAX,BCL,CD31,CD45,KI67,LICE,MDA,REDUCED,VEGF
373,ACS,ADC,ADCS,ALK,BACKGROUND,CONCLUSION,DETECTION,EML4,FISH,IHC,LABEL,METHODS,MULTIPLEX,NONE,PCR,RESULTS
4000,945,AKT,BACKGROUND,EGFR,LABEL,MAPK,METHODS,NSCLC,PI3K,RESULTS,THESE,TKI,WESTERN
160,1993,1995,2006,2010,283,792,952,AARP,COLORECTAL,COX,DIET,INSTITUTES,LUNG,NIH,OVARIAN,PLCO,SCREENING,SIMILAR,TRIAL,WOMEN
LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
956,ABL,EGFR,EVEN,KINASES,MET,PHA665752,THESE
ATOX1,IHC,KNOCKDOWN,NSCLC,RNAI,THESE
8315,CFTR,DICER,POLARIZED,RNAI,THESE,USING
AFTER,HOWEVER,PAH,PULMONARY,STILL
916,968,A549,BCL,HOWEVER,JNK,MAPK,MMP,RU486,TAKEN,U937
AMONG,H2452,LOSS,MALIGNANT,MPM,NCI,NOTCH,NUMB,THESE,TP53,XIAP
108,169,177,19Q13,2013,BOTH,CHINESE,COPYRIGHT,GENOTYPING,LDR,PCR,SNPS,SPSS
100,169,2013,215,945,946,COPYRIGHT,D50,FORTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,NTD,OBJECTIVE,PURPOSE,RESULTS,SBRT,SPECT
169,2013,COLLEGE,COPYRIGHT,CURRENTLY,INC,LUNG,NETWORK,PUBLISHED,RADIOLOGY,SCREENING,TRIAL
169,2013,956,A2058,A2780,COMPOUNDS,COPYRIGHT,H522,IC50,LTD,MADAGASCAN,NMR
169,2013,COPYRIGHT,DUE,LTD,METASTASIS
135B,160,169,2013,BALB,COPYRIGHT,INC,MID1,MTCH2,PATHOLOGY,PUBLISHED,RELEVANTLY,SOCIETY,THEREFORE
100,169,2013,AKT,BACKGROUND,BALB,BOTH,COPYRIGHT,CRC,FEW,GREEN,HOWEVER,INC,LABEL,METHODS,MUTATIONAL,PTEN,RESULTS,SEVEN,TENN
169,2013,ABOUT,BRAF,COPYRIGHT,GISTS,KIT,LTD,MOST,RAS,TUMOURS
169,193,2005,2011,2013,BACKGROUND,COPYRIGHT,INC,LABEL,LUL,METHODS,PUBLISHED,RESULTS,SOCIETY,THESE,UNIVARIATE
169,2013,COPYRIGHT,INC,LOCAL,ONGOING,SBRT
004,010,169,183,2013,239,715,800,961,AACR,AUC,DOCETAXEL,LABEL,METHODS,NET,OBJECTIVE,PET,PURPOSE,RESULTS
8209,947,A549,AG490,FINALLY,MMP,PCR,RESULTS,STAT3,VEGF
DIAGNOSTIC,FDG,INTENSE,PET,PLC,PLCS
0263,8805,BACKGROUND,BECAUSE,CNS,CORD,FORTY,LABEL,LACK,MATERIALS,METHODS,OBJECTIVE,PRIMARY,PURPOSE,RESULTS
A549,CLARA,H441,HOWEVER,SFTP,SFTPA,SFTPB,SFTPC,SFTPD,THEREFORE,TREATMENT,YET
100,BACKGROUND,EGFR,HIGH,HOWEVER,IGF,IGF1,IGR,IHC,LABEL,METHODS,NEITHER,NSCLC,PPV,RESULTS,SEVEN,SEVENTEEN,SINCE,TKI,TKIS,TOTAL
LOCAL,LUNG,MORTALITY,PRIMARY
1995,2008,DATA,DUTCH,GENERALLY,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SIR,SMR,SURINAMESE
001,022,033,177,180,8805,AMONG,EGFR,KRAS,PCR,SOLID,TTF,WHETHER
147,264,555,ELISA,FIBROBLAST,MOLECULAR,PCR
183,8201,BACKGROUND,COPD,FEV1,FVC,GEORG,HOWEVER,LABEL,METHODS,PFT,PFTS,RESULTS,SEVENTY,STUTTGART,VATS,YORK
100,115,183,2000,2010,ASAN,BACKGROUND,CONCLUSION,GEORG,JANUARY,LABEL,MATERIALS,MEDICAL,METHODS,PMEC,RESULTS,STUTTGART,THERE,YORK
150,510,945,HIF,HOWEVER,HUR,HUVEC,IC50,NOTABLY,SIMILAR,TAKEN,VEGF
135,169,2013,946,CONCLUSION,COPYRIGHT,ESR2,IHC,INHERITED,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SNPS
AML,BRITISH,PULMONARY
BACKGROUND,CRT,DOSE,FIELD,HODGKIN,HOWEVER,INRT,LABEL,LYL,METHODS,RESULTS,VMAT
0001,0005,0012,120,169,2013,COPYRIGHT,INC,MBC,OVERALL
000,100,128,2500,DUE,EGFR,ISS,KRAS,NSCLC,PCR,RUNNING
106,227,AIMS,ALK,LABEL,METHODS,NECS,NEITHER,OBJECTIVE,RESULTS,SENSITIVE,THUS
169,2013,COPYRIGHT,INC,MOSBY,TELOMERES
132,156,169,1995,1997,2013,248,291,6996,701,883,ABOUT,BMD,BMI,COPYRIGHT,FEV1,HRT,INCLUSION,IRELAND,LOW,LTD,LUNG,NORD,NORWEGIAN,NSCLC,USING
169,187,1997,2009,2013,242,2N0M0,335,383,565,621,677,740,785,810,829,848,886,AMONG,BACKGROUND,COPYRIGHT,DFS,DIGITAL,GGO,IMAGING,INC,LABEL,LESS,METHODS,NSCLC,PROPORTION,PUBLISHED,REGARDLESS,RESULTS,ROC,SOCIETY
121,185,199,2006,2010,320,BACKGROUND,BETWEEN,BMI,COLLEGE,DATA,INC,LABEL,MEDICAL,METHODS,MILWAUKEE,MOSBY,OBESITY,OVERWEIGHT,PUBLISHED,RESULTS,THERE,WISCONSIN
2012,293,296,378,5AC,ADENOVIRAL,AIMS,ANG,CONCLUSION,H292,HEME,HMOX1,INNOVATION,JAMES,LABEL,MAHIN,MASON,NCI,NSCLC,OBJECTIVE,PEER,REBOUND,REDOX,RESULTS,SATO,TRACK,VEGF
ADC,DCE,GTV,MOST,MRI,MRSI,NEXT,OAR,THERE,TPS,WHILE
005,009,028,BOTH,CRT,CUMULATIVE,DOSE,DVH,LUNG,MEAN,PTV,SBRT,SHORTENED,TEN,TREATMENT,V20,V48,VMAT,VOLUMETRIC,VPTV
001,049,115,A23G,COX,LOG,LYS751GLN,NSCLC,PFS,SNPS,THUS,WHILE,XPA,XPA23,XPD
100,GRADE,HCSRT,LRFS,WBRT
0001,187,220,251,296,370,440,780,805,830,940,ICG,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
169,185,197,2013,206,31G,5914,8197,8315,946,C2GNT,COPYRIGHT,DFT,GMBH,KGAA,M06,O6H,OGLU,THESE,THREE,VCH,WILEY
169,2013,8201,CELL,COPYRIGHT,JOHN,LTD,RAS,SONS,SPROUTY,THESE,WILEY
100,131,134,141,147,229,234,368,8805,956,AFTER,BACKGROUND,BELARUSIAN,CHERNOBYL,CONTEXT,EXPERIENCE,GBQ,GERMANY,LABEL,MAIN,MBQ,METHODS,OUTCOME,RESULTS,RIT,RITS,TSH
160,905,APBI,CONCLUSION,FIF,IMRT,LABEL,METHODS,NON,OBJECTIVE,PURPOSE,RESULTS,THERE,WBI
001,005,023,028,048,074,110,160,251,CONCLUSION,CYTOMETRY,DFS,DISEASE,FACS,FLOW,GREATER,HOWEVER,IHC,INCREASED,LABEL,LNS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
A549,AKT,FOXO1,PI3K,PRX1
176,200,CASE,DIAGNOSIS,IMAGING,MOLECULAR,PCR
BACKGROUND,DISCUSSION,GERD,HEARTBURN,LABEL,USA
2008,2011,33342,AFFYMETRIX,ALK,ATP,CRIZOTINIB,DRUG,FDA,FOOD,HOECHST,LEWIS,LLC,LUNG,NSCLC,OVERALL,SMAD,SMAD3
177,2009,2011,BETWEEN,EUS,FNA,HOWEVER,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STAGE
946,BOTH,DEPLETION,EMT,H2O2,IRS,REMARKABLY,ROS,TGF
CD8,COCULTURE,DCS,EGFR,TH0,TREG,TREGS
200,8804,BID,DOSE,FIFTY,GRADE,LABEL,MAXIMUM,METHODS,OBJECTIVE,PFS,PURPOSE,RCC,RESULTS,SKIN
169,2013,HEC1A,HOWEVER,LYMPH,THESE,VEGF
945,AAT,APCS,CHANGES,CONCLUSION,EGFR,FGA,KRT10,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,RESULTS,SERUM,THESE,TKI,WESTERN
169,2013,COPYRIGHT,DTPA,FINALLY,GMBH,ICP,III,KGAA,MRI,PEG,PSQ,VCH,WILEY
027,029,081,083,121,159,2003,2010,631,982,AFTER,BETWEEN,CEA,COX,CRC,DFIS,DISEASE,GROUP,JUNE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,YOUNG
117,120,131,142,149,183,1988,2011,378,BACKGROUND,CONCERNING,CONCLUSION,GEORG,JANUARY,LABEL,METHODS,RESULTS,SEVEN,STUTTGART,THERE,YORK
177,BACKGROUND,INDURATION,ISA,LABEL,LY6K,LYMPHOCYTE,METHODS,MONTANIDE,RESULTS,THREE
150,8764,945,946,ACTIVATING,ATP,EGFR,ERBB2,GAB1,NOTABLY,PI3K,SHP2,TAKEN,USING,YVMA
117,AFTER,ALK,AMONG,BACKGROUND,EML4,FISH,H2228,H3122,H460,IHC,LABEL,METHODS,NSCLC,PCR,PLA,RESULTS,THESE,WESTERN
66KDA,8764,945,946,BALF,BAX,BCL,GAL,GLC,GM3,IGG,MAACKIA,NSCLC
600,CGH,CNV,CNVS,FOCUSED,KDM1A,LFS,MTA3,REMARKABLY,SIRT3,TP53,TRRAP,USING
132,1419,1843,1919,2010,2011,268,ACCRUAL,BACKGROUND,CONCLUSION,DIGITAL,FIRST,LABEL,METHODS,OVERALL,OWING,PULMONARY,RESULTS,SOS
1263,1593,1613,18F,741,BACKGROUND,FDG,FNAB,HIGH,ITALUNG,LABEL,LDCT,MANAGEMENT,METHODS,PET,POSITIVITY,RESULTS,SURGERY,TEN,THREE
003,100,102,2009,2010,2011,BACKGROUND,JULY,LABEL,LESS,METHODS,OBJECTIVE,OCTOBER,RESULTS,SCORE,SOCIETY,THERE,UNIVARIATE,VATS
034,120,150,BACKGROUND,CONCLUSION,CTS,DESPITE,FIVE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
102,160,169,1915,1988,2013,AIMS,BACKGROUND,BCN,CATALAN,CLASSICAL,COPYRIGHT,IBERIAN,IRELAND,LABEL,LTD,METHODS,OBJECTIVE,PENINSULA,RELEVANCE,RESULTS,VOUCHER
946,AKT,FOUR,JUN,RAS,RAT,STAT,THEIR,THESE,VEGF,WNT
CD8,RON,TREATMENT
000,108,169,2013,215,293,8308,956,COPYRIGHT,DATA,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PCR,PUBLISHED,RESULTS,SERUM,SOCIETY,SPSS,TNM
950,DESPITE,HOWEVER,RAFT,SHORT,THEREFORE,TREATMENT
169,1CC,1GY,2004,2009,2013,20GY,351,60GY,6CC,8805,AMONG,BETWEEN,COPYRIGHT,EIGHT,EVEN,GTV,INC,LESS,MEDICAL,MLD,NSCLC,NTCP,PUBLISHED,SIMULATED,STAGE,THERE,V20
169,2012,8805,AEU,BACKGROUND,BOTH,CONCLUSION,CONTEXT,COPYRIGHT,FOLLOWING,ISC,LABEL,METHODS,OBJECTIVE,PUBLISHED,SUMMARY,TUMOURS,UNASSIGNED
1200,158,169,2001,2006,2013,9410,AUC,CONCURRENT,COPYRIGHT,HOWEVER,III,IRELAND,JUNE,LTD,MAY,NSCLC,ORR,RTOG,TRT
002,1139,169,2013,423,716,AMONG,BACKGROUND,CONVERSELY,COPYRIGHT,E1594,III,IRELAND,LABEL,LCC,LOGRANK,LTD,MEN,METHODS,NOS,NSCLC,PFS,RESULTS,SCC
169,2013,946,AACR,ALSO,COLON,DDB,DDB2,DEPLETION,EMT,METASTASIS,TGF,XPE
100,800,CONCLUSION,DCR,HER2,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,THERE
106,8201,8805,BACKGROUND,DOSE,III,LABEL,MAXIMUM,METHODS,MTD,RESULTS,TAS,TOLERATED,WHILE
111,250,945,946,ARG,ASP,CONCLUSION,DOTA,FOLLOWING,GLY,JAPAN,LABEL,LUNG,LYS,METHODS,NOGUCHI,OBJECTIVE,PHE,PREVIOUSLY,RESULTS,RGDFK,SPECT
0001,139,169,2013,BACKGROUND,COPYRIGHT,EOC,IHC,INC,LABEL,METHODS,OLC1,PFS,RESULTS,UNIVARIATE,WESTERN,WILEY
LANGERHANS,LCH,WHILE
001,004,006,007,017,046,052,103,169,19A,201,2013,438,CONCLUSION,COPYRIGHT,EXPRESSION,HIGH,INC,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCR,RESULTS,SERUM,TNM,WILEY
001,007,009,013,015,023,025,030,160,8201,CONCLUSION,HISTOLOGY,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SBRT,SUV,SUVMEAN,THESE
CD44,CD47,CTC,CTCS,EPCAM,HOWEVER,MET,MIC,MICS,THESE
HMGB3,HOWEVER,MEIER,NSCLC,PCR,WESTERN
122,149,160,256,354,CONCLUSION,DFS,EGFR,FIFTEEN,HOWEVER,LABEL,METHODS,MUTATIONS,OBJECTIVE,PURPOSE,RESULTS,THERE,TKI
BOTH,CALCITONIN,HOWEVER,IMAGING,MEDULLARY,MEN2,MTC,THESE
001,006,032,037,042,2008,2011,336,359,655,EGFR,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
III,LUNG,PRESENT,STUDIES,THESE
0001,004,022,2004,215,663,AGE,BACKGROUND,COMMITTEE,JAPAN,JOINT,LABEL,LUNG,METHODS,REASONS,RESULTS,T4N0,T4N1,THERE
0001,001,008,140,945,946,BACKGROUND,EGFR,FINALLY,LABEL,METHODS,RAS,RESULTS,THERE,THESE
0001,1998,2004,242,ADULT,BACKGROUND,CIS,COLLEGE,COMMISSION,CONCLUSION,COX,CRT,FIVE,IIIA,LABEL,MEIER,METHODS,NSCLC,OPTIMAL,RESULTS,TREATMENT
2002,2010,BACKGROUND,CONCLUSION,COX,FORTY,JANUARY,LABEL,MEIER,METHODS,MOST,PET,RESULTS,SCLC
169,2013,ADDITIONAL,COPYRIGHT,HCC,SAS,SEVEN
169,2013,6939,AFTER,CIS,COPYRIGHT,DGGE,HRS,IIIA,IIIB,IRELAND,LTD,MSOP,NSCLC,PCR,RAS,RFLP,THEN
100,EIGHT,JAPAN,NONE,TECHNICAL
169,2013,ALK,COPYRIGHT,EGFR,FEW,FGFR,HOWEVER,IGFR,LTD,MET,NSCLC,ONCOGENIC,RAS,RET,ROS,THESE,TKIS
169,2013,COPYRIGHT,IMAGE,OVERALL,PUBLISHED
0180,120,160,4HU,967,BACKGROUND,DYNAMIC,LABEL,MALIGNANT,MANN,METHODS,PEAK,RESULTS,SMALLER,THERE,WHITNEY
018,140,ARNAU,CONCLUSION,CONTINUED,DIFFERENT,ERLOTINIB,HOWEVER,LABEL,LANGONE,MEDICAL,METHODS,NSCLC,NYU,OBJECTIVE,PFS,PURPOSE,RESULTS,THESE
160,ICAT,LUNG,PAGE,PROTEOMIC,SILAC
1080,169,2013,A549,ASSESSMENT,COPYRIGHT,GMBH,KGAA,MCF,P388,VCH,WILEY
500,BACKGROUND,CONCLUSION,DESPITE,III,LABEL,METHODS,OBJECTIVE,PARTIAL,RESULTS,THERE
AMONG,MMP,MT1,THESE,TJS
132,137,169,1999,2008,2013,BACKGROUND,LABEL,LRC,METHODS,NSCLC,RANDOMIZED,RESULTS,SBRT,SLR,SOCIETY,TRC,UNIVARIATE
125,131,160,177,215,99M,A549,CLEAR,SSTR2
178,8805,CONCLUSION,DLT,DLTS,LABEL,METHODS,MTD,OBJECTIVE,PURPOSE,RESULTS,SCLC
945,946,A549,CLK1,CLK4,CYR61,MCP,NOTABLY,TAKEN,THESE,VEGF
118,160,2007,2009,8201,ACCURAY,ACTUARIAL,BETWEEN,CBK,CONCLUSION,CSS,CYBERKNIFE,EORTC,EVALUATION,FURTHER,GROUP,INC,INCLUSION,LABEL,MAY,METHODS,OBJECTIVE,PFS,PRIMARY,PURPOSE,RADIATION,RESULTS,RTOG,SCALE,SOLID,SRT,SUNNYVALE,THERAPY,TREATMENT,UPON,USA
ACP5,FOXM1,HCC,HOWEVER,TRANSWELL
945,946,BASCS,CONVERSELY,FINALLY,ID1,KRAS,LA2,LSL,MAPK,NSCLC,PKC,PRKCA,PROTEIN,TGF,WILM
1980S,998,CHINA,FURTHER
100,100I,250,956,CK19,CORP,HYOGO,JAPAN,LABEL,LNS,METHODS,OBJECTIVE,OSNA,RESULTS
0255,0333,100,138,18F,2005,2010,8804,BAC,DFS,FDG,JANUARY,LABEL,METHODS,OBJECTIVE,OCTOBER,PET,PURPOSE,RESULTS
AML,BOTH,CCT,CLEAR,EACH,NEITHER,PECOMAS,THEREFORE,THESE
FDG,METASTASES,MRI,PET
SPECT
FDG,HOWEVER,MRI,PET
CPB,FDG,HISTOLOGY,PET
103,3DCT,4DCT,HOWEVER,ICRP,LOCAL,ORGAN,RADIATION
0001,169,2013,288,403,BRDU,COPYRIGHT,H3K9,IRELAND,JMJC,JUMONJI,LTD,PCR
100MG,100MM,169,174,2013,249NM,331NM,4000,956,9ML,COPYRIGHT,DUAL,FOLLOWING,HPLC,INTER,SAMPLES
169,2013,ACADEMY,CLEAR,COPYRIGHT,INC,MOSBY,PUBLISHED,SKIN
116,169,2013,956,A549,AMONG,COPYRIGHT,HCT,IC50,LTD,SUNITINIB
000,002,017,105,169,196,2013,208,341,457,520,539,632,762,789,794,811,904,CD147,COPYRIGHT,CROWN,GMBH,HIGH,NSCLC,PUBLISHED,TNM,UNIVARIATE
169,2012,241,CHEST,COPYRIGHT,ESPA,PORTUGUESA,PUBLISHED,SCLC,SOCIEDADE
169,2013,COPYRIGHT,ECT,LTD,LUNG,MICROWAVE,MWA,RFA,SURGERY,THERMAL
169,2013,CONCLUSION,COPYRIGHT,DCAIR,DICE,FDG,INC,ITV,ITVS,LABEL,MATERIALS,METHODS,MIP,NINE,OBJECTIVE,PET,PURPOSE,RESULTS
100,169,2013,BRITISH,COPYRIGHT,DETAILS,DISEASE,IQR,LTD,ORAL,PUBLISHED,SCC,SPECIALIST,THERE,THOSE,TNM
039,069,1000,105,1096,133,1553,176,1998,2011,240,2553,312,331,394,409,490,496,548,577,608,636,868,8804,8805,910,945,BECAUSE,COMPETING,GROUP,HOWEVER,KARNOFSKY,LABEL,MEIER,METHODS,METS,OBJECTIVE,RESULTS,SCALE,SRS,THERE,THESE,ULTIMATELY
000001536,004,043,047,173,334,350,8804,BACKGROUND,BECAUSE,HOWEVER,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THERE,UMIN,VBN
150,2009,2011,AFTER,EGFR,ERLOTINIB,HOWEVER,JANUARY,LABEL,MAJOR,METHODS,OBJECTIVE,RESULTS
0001,0002,0044,011,GROUP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,PULMONARY,RESULTS,SARCOMA,SEVENTY
145,252,293,300,A750,A750DEL,E746,EGFR,FALSE,L858R,MOLECULAR
20TH,EARLIER,IDIOPATHIC,IPF
001,120,2004,AFTERWARDS,FATS,FIFTY,GGO,LABEL,LOBECTOMY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,SIXTY,THERE,VBN,WWR,WWRS
001,100,169,2013,CONCLUSION,COPYRIGHT,DESPITE,F18,FDG,IRELAND,LABEL,LTD,MBQ,METHODS,NSCLC,PET,RESULTS,SOR,THERE,THEREFORE,UNLABELLED
169,174,2013,AVASTIN,COPYRIGHT,NSCLC,SAS
0001,002,0212,0214,169,173,2013,410,C30,COPYRIGHT,CORE,DECLINE,DELAYED,EORTC,GROUP,HOPKINS,HVLT,INC,LABEL,LIFE,MATERIALS,METHODS,OBJECTIVE,PCI,PURPOSE,QLQ,QUALITY,RADIATION,RESULTS,RTOG,SRCF,TEST,THERAPY,TREATMENT
005,169,2013,203,283,8804,AES,APEX1,CENPE,CONCLUSION,COPYRIGHT,EGFR,GSTP1,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROS,SNP,SNPS
BACKGROUND,CONTEXT,DATA,LABEL,LITERATURE,LUNG,METHODS,OBJECTIVE,OBJECTIVES,SOURCES
COPD,HIGH,THESE,USING
177,186,2009,813,AIM,BACKGROUND,BASED,CONCLUSION,FAME,LABEL,METHODS,NYT,OBJECTIVE,RESULTS,TIMES,YORK,YOUNGER
100,174,ANOVA,BACKGROUND,CONCLUSION,KEY,LABEL,MAIN,METHODS,OBJECTIVE,OBTAINING,PEER,PGY1,PGY1S,RESULTS,SIXTY,UNIVERSITY
THERE,USUALLY
2004,2012,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,TEN,THERE,THEREFORE,WANDERING
001,008,391,647,BACKGROUND,CAUCASIANS,HOWEVER,LABEL,METHODS,PRO,PRO72,RESULTS,STRATIFIED,TP53
160,177,214,384,8201,8MBQ,ANTI,FACBC,FDG,KI67,LABEL,MEAN,METHODS,OBJECTIVE,PET,PROCEDURES,PURPOSE,RESULTS,TEN,THERE
A549,ADP,CK2,CK2A,DIFFERENT,H2030,INHIBITION,LUNG,PARP,PML,SER,TBB,THESE,THR,THUS,WESTERN
0006,001,003,004,014,106,149,2008,2012,245,JANUARY,JUNE,LABEL,MEAN,METHODS,MOST,OBJECTIVE,OSAKA,OVERALL,PURPOSE,RESULTS,THERE
169,2013,527,618,EXPOSURES,HUNGARY,NMSC,ROMANIA,THERE,UICC,WORKPLACE
001,003,005,012,154,HOWEVER,JMJD6,MEIER,PCR,WESTERN
001,012,030,048,100,177,8805,AMONG,CONCLUSION,COX,FDG,LABEL,MAXIMUM,METHODS,MTV,NSCLC,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,ROC,SUV,TLG
169,1999,2005,2009,2013,260,386,BACKGROUND,BASEL,BETWEEN,COPYRIGHT,FDG,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,RODP,SEPTEMBER
114,160,1981,2003,271,366,DEPENDING,NORWEGIAN,SIR,USING
150,169,183,2013,8201,A375,A549,BACKGROUND,BRITISH,ERK,KEY,LABEL,MAP,MAPK,MEK,METHODS,OBJECTIVE,ORAL,PURPOSE,RAF,RESULTS,SOCIETY,SPC,VEGF165,YL529
100,126,160,177,AGGREGATE,CONCLUSION,FPR,FPRS,HIPAA,LABEL,LUNG,MATERIALS,MEAN,METHODS,NLST,OBJECTIVE,PURPOSE,RESULTS,SCREENING,THERE,TRIAL
169,2013,886,924,946,AACR,H446,NCI,PLK1,SCLC,SMALL,TGF
143,152,177,1996,2011,315,364,410,EVALUATION,III,LABEL,MAJOR,MEAN,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STAGE,THERE,VATS
DISCUSSION,HOWEVER,LABEL,METHODS,MINIMALLY,OBJECTIVE,OBJECTIVES,RESULTS,T3N0,VATS
8211,BACKGROUND,CONCLUSION,HOWEVER,LABEL,LATE,METHODS,OTHER,RESULTS,SCLC,TRT
169,2012,COPYRIGHT,EGFR,INC,MET,NSCLC,PTEN,T790M,THESE,TKI,TKIS,WILEY
EDNRA,GATA2,HOWEVER,KNOWN,PRE6
100,956,DISPASE,PATIENT
1ST,2005,2011,BACKGROUND,CONCLUSION,IDIOPATHIC,IPF,JANUARY,LABEL,METHODS,PFS,RESULTS,SCLC
235,280,661,BACKGROUND,FOUR,LABEL,METASTASES,METHODS,NET,NETS,RESULTS,THERE,UNIVERSITY,UPPSALA
215,945,CYGB,CYTOGLOBIN,DESPITE,H358,HIF1,NSCLC,TSG,UPON,VEGFA
BIOLOGICAL
169,2013,COPYRIGHT,EGFR,FURTHER,HOWEVER,LTD,LUNG,NSCLC,OVERALL,POOR,SPIO
0502,114,116,130,360,464,AES,BACKGROUND,GFPC,GRADE,IFCT,IIIB,LABEL,METHODS,NSCLC,PEMETREXED,PFS,RESULTS,STAGE
001,002,104,160,1992,2011,242,BACKGROUND,CEA,CYFRA,EGFR,LABEL,METHODS,NSCLC,PFS,RESULTS,TKI,TKIS
169,2013,BACKGROUND,BLACK,CONCLUSION,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,174,2013,4DCT,BACKGROUND,CONCLUSION,COPYRIGHT,HOWEVER,LABEL,LEGO,LTD,METHODS,MINDSTORMS,PUBLISHED,RESULTS
CELL,LITERATURE,MET,THEREFORE
ECH,HYPOXIA,KEAP1,KELCH,NRF2,NUCLEAR,OXIDATIVE,RVH,THESE
1981,1982,1983,2008,243,339,377,ASBESTOSIS,BACKGROUND,INDEX,INSULATOR,INSULATORS,LABEL,LUNG,MAIN,METHODS,NORTH,OBJECTIVE,OBJECTIVES,PREVENTION,RATIONALE,RESULTS,SMOKING
103,2002,2003,2007,205,607,835,956,BACKGROUND,COX,ENGLISH,HOWEVER,HRS,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,THERE,THESE
200,946,ADVERSE,AUC,CONCLUSION,IIIB,LABEL,METHODS,NSCLC,OBJECTIVE,PFS,PURPOSE,RESULTS,THERE
169,2013,223,237,286,631,854,AMONG,CMRI,CONCLUSION,COPYRIGHT,EIGHT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVEN,WILEY
ACTIVATION,ARSENIC,C151,KEAP1,LC3,NRF2,THUS
ACUTE,CDK8,GAS41,NUMA,PUMA,THESE
013,116,145,169,2013,209,414,956,A549,AACR,ANTITUMOR,B16,BCA,C38,C51,CAKI,GXF,H460,HCT,IC50,LABEL,LEWIS,MA16,MA17,METHODS,MIA,N87,NCI,OBJECTIVE,P02,P03,PACA,PURPOSE,RESULTS,SR475,TAXANES,THESE,TXT,UISO,XRP6258
160,8209,947,A549,BTG,ERK,H1975,H2AX,HOWEVER,MAPK,NCI,TOB,TOB1,TRANSDUCER,WESTERN
124,169,2009,2011,2013,271,800,BACKGROUND,EHE,FIFTEEN,FIVE,FURTHER,JUNE,LABEL,METHODS,RESULTS,SEVEN,SOCIETY,THERE
BECAUSE,EIGHT,HNSCC,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
169,2013,A375,A549,COPYRIGHT,INC,PYR2,ROS,THESE,WILEY
177,8805,MEAN,MISO,MOST,NINE,PET,SUV
137CS,946,967,CCK,CENTRUM,CVTL,DUE,GAL,KAROLINSKA,RCR,SCLC,THESE,U1690
160,BONE,EMT,HOWEVER,MGR1,SBC,SCLC,TAKEN,THEREFORE,USING
PATHOLOGY,PPB
320,532,BLOOD,CASE,HOWEVER,THEREFORE
8910,947,DSBS,H2AX,MCL,PARP
0138,024,026,028,151,1994,2011,208,FIVE,FURTHER,WILMS
RIGID
AFTER,EWING,PET
AKT,BAX,BCL,EGFR,EPIDERMAL,H1975,HOWEVER,NSCLC,PARP,RNAI,SINCE,T790M,THESE,TKI,TKIS,USING
100GY,BODY,CIVCO,FIVE,GROUP,INC,LOK,MDCA,NOVALIS,PRO,PUBLISHED,RADIATION,RTOG,SBRT,STAGE,THERAPY
0001,060,1151T,169,2013,4128,4678,93G,ASIAN,BACKGROUND,CBM,CNKI,COPYRIGHT,FINALLY,FURTHER,HOWEVER,ISI,LABEL,MANAGER,MED,METHODS,ODDS,OVERALL,PUB,RESULTS,VAL384ASP
003,004,169,2011,2013,8201,8804,ASIAN,AUTHORS,BACKGROUND,BETWEEN,BRONCUS,EBUS,INC,LABEL,LUNGPOINT,MAY,METHODS,MHZ,NOTABLY,OBJECTIVE,PACIFIC,PPL,RESULTS,SOCIETY,UNIVARIATE,USA,VIEW
149,215,221,241,288,8804,956,A549,CVS,H69,H69AR,LUNG,MRM,SINCE,SIS,SMAD4,STAT1,STAT2,TFS,THUS
169,2013,ALDH,ASIAN,AUTHORS,CD133,CD44,CSC,EMBRYONIC,NOTCH,PACIFIC,SIMILAR,SOCIETY,WNT
002,135,171,190,201,239,3405,402,AMONG,EGFR,GRADE,HOWEVER,III,JAPAN,LABEL,METHODS,NEJ,OBJECTIVE,PHASE,RESULTS,SMOKING,THREE,WJTOG
169,2013,912,GMBH,KGAA,MVS,NSCLC,PAGE,SDS,THESE,THREE,USING,VCH,WILEY
169,183,ELISA,GEORG,H1299,JNK,MTT,PARP,PROCASPASE,STUTTGART,TUNEL,YORK
001,003,012,017,018,105,180,183,2005,2009,2011,246,263,469,576,605,659,8201,927,CONCLUSION,COX,GEORG,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,STUTTGART,VATS,VIDEO,YORK
0012,169,2013,ALBUMIN,ALK,BACKGROUND,COPYRIGHT,CRIZOTINIB,FIVE,FSH,LABEL,LLN,MEAN,MET,METHODS,RESULTS,ROS1,SHBG,SOCIETY
AFTER,CSC,CSCS,HNSCC,HPV,LABEL,METHODS,NOD,OBJECTIVE,OBJECTIVES,RESULTS,SCID,SETTING,UNIVERSITY
102,169,1998,2012,2013,8201,COPYRIGHT,EWING,INC,RMS,WILEY
1989,2000,267,400,824,CHINA,COX,JULY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,RISK,THESE,WOMEN
194,946,BMP1,MICRORNAS,MMP2,MMP9,RHOA,TGF,THESE
A549,CONSISTENT,CONVERSELY,DDX3,H1299,MDM2,P53,SIHA,SLUG,SP1
169,2013,40MG,A549,BACKGROUND,CD34,CHINESE,COPYRIGHT,ERK,FLOW,GENERAL,GINSENG,H292,LABEL,LUNG,METHODS,MMP,MTT,NAC,RESULTS,ROS,THESE,TREATMENT,TUNEL,VEGF,WESTERN
169,185,2011,2012,2013,8312,COPYRIGHT,FDG,JANUARY,OCTOBER,PET,SAS
169,2013,33342,ABCB1,ABCC1,ABCG2,COPYRIGHT,HOECHST,INC,MDR,MTT,SAD,THESE
1000,10877,169,1MG,2009,2010,2013,2MG,5MG,BETWEEN,CONCLUSION,COPYRIGHT,DAYS,DLTS,DOSE,EASTERN,ECOG,GROUP,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,ONCE,PURPOSE,RESULTS,RP2D,SECONDARY
120,169,2013,ADDITIONAL,COPYRIGHT,EATON,ELISA,ERC1,GFP,INC,LAMBERT,LEMS,PUBLISHED,SCLC,SEVERAL,SOCIETY,VGCC
005,006,007,062,116,1232,1301,160,169,1999,2008,2013,208,242,BACKGROUND,COPYRIGHT,COX,END,FIVE,INC,LABEL,LCSS,MATERIALS,MEIER,METHODS,NRT,NSCLC,PST,RESULTS,T3N0,THERE
169,2013,871,ALPHA,BACKGROUND,CONCLUSION,COPYRIGHT,COX,CROWN,CRYAB,FOLLOWING,LABEL,METHODS,MORTALITY,NSCLC,PUBLISHED,RECURRENCE,RESULTS,THERE
0003,002,019,169,177,2013,215,945,AGE,COPYRIGHT,IMAGE,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SIR,THERE,TNF,UNIVARIATE,WHOLE
0001,0002,0003,0006,001,002,003,004,007,169,2013,777,CONCLUSION,COPYRIGHT,ECM,GPA,III,INC,KARNOFSKY,KPS,LABEL,MATERIALS,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,RPA,WBRT
169,2013,COPYRIGHT,EGFR,HOWEVER,INC,INITIALLY,OTHER
160,169,1980,1990,2009,2011,2013,AIMS,ALSO,CENTRAL,COLLEGE,CONCLUSION,CONTROLLED,COPYRIGHT,ENROLMENT,III,LABEL,LTD,MATERIALS,MEDLINE,METHODS,MOST,OBJECTIVE,PUBLISHED,REGRESSION,RESULTS,ROYAL,SEPTEMBER,SRE,SRES
169,2013,COPYRIGHT,MRI,SAS
169,2013,AIMS,CONCLUSION,ERK1,HOWEVER,JOHN,LABEL,LTD,MAPK,METHODS,MUCUS,OBJECTIVE,PCR,PUBLISHED,RESULTS,SHP,SOCIETY,SONS,WILEY
169,2013,IMAGING,INC,MALIGNANT,STAGING,WILEY
000,001,002,057,090,131,138,179,1999,2009,8314,AIDS,AUTHORITY,BRESCIA,CD4,HIV,HOWEVER,IRR,LHA,LOCAL,NADCS,POISSON,RISK,SIR,SIRS
169,2013,AACR,MTA1,POL,STAT3
003,008,024,088,138,169,2013,248,701,ACT,COPYRIGHT,DATA,ESR1,EXPRESSION,JBR,NSCLC,UICC
169,2013,945,DISEASE,GMBH,INCREASED,KGAA,TERMS,VCH,WILEY
169,2013,COPYRIGHT,HOWEVER,IIIA,IKZF1,INC,WILEY
1981,1996,ADJUSTMENT,CML,DETERMINE,LABEL,METHODS,OBJECTIVE,PROTECTIVE,RATE,REMAINING,RESULTS,RRS,ZEALAND
7643,A549,ANAMORELIN,DAILY,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,ONO,PEAK,PURPOSE,RESULTS,THEREFORE,THESE
118,160,AFTER,CONCLUSION,DIAGNOSTIC,IQR,LABEL,LCRDU,LUNG,METHODS,OBJECTIVE,PURPOSE,RAPID,RESULTS,TNM,UNIT
005,012,059,946,ALTERED,BACKGROUND,EGFR,EIGHT,EPIDERMAL,LABEL,MET,METHODS,NSCLC,ORR,PTEN,RESULTS,T790,THESE,TKI
177,200,8201,AUC,BACKGROUND,CYCLE,DLT,DLTS,END,FIFTY,LABEL,METHODS,NEITHER,NSCLC,PRIMARY,RESULTS,SECONDARY
001,021,035,169,2005,2006,2013,4T1,945,COX,ERO1,FINALLY,JAPAN,MEDICAL,SAPPORO,SEVENTY,THEREFORE,THESE,UNIVERSITY
169,2013,AKT,CCDC6,EGFR,ERK1,EXPRESSION,HOWEVER,KRAS,LAD,MUTATIONS,RET,THUS,VANDETANIB
947,A549,AFTER,CELL,EXPRESSION,H2AX,KU70,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RAD51,RESULTS,RNF8,WESTERN
169,2013,AACR,BROMO,G12D,HOWEVER,KRAS
108,1182,173,2000,2007,2345,360,640,8201,8211,8220,8221,8805,AFTER,H2RB,H2RBS,HISTAMINE,INSURANCE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCC
121,145,169,2013,354,360,956,BACKGROUND,CYTOPATHOL,GIVEN,KRAS,LABEL,METHODS,RESULTS,SOCIETY,USING
178,336,8805,AMONG,COX,HAZARDS
001,100,177,CONCLUSION,DYSPNEA,LABEL,MEAN,METHODS,OBJECTIVE,PURPOSE,RESULTS
462,509,708,BACKGROUND,CONCLUSION,CTCAE,EIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFA,THESE,THREE
169,1966,2012,2013,COLLEGE,CONCLUSION,COPYRIGHT,CUMULATIVE,FIVE,HODGKIN,INDEX,JANUARY,LABEL,LITERATURE,MAY,MEDLINE,MEN,METHODS,NURSING,OBJECTIVE,POPULATION,RESULTS,SCIENCE,SIR,SIRS,SIX,SSC,THERE,WEB
143,169,2013,317,566,945,AACR,CONCLUSION,DISCOVERY,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,THESE
2008,2009,2012,ASSESSMENT,BACKGROUND,CARE,CCO,CONCLUSION,DIAGNOSTIC,DISEASE,DPM,EIGHT,FUNDING,LABEL,MANAGEMENT,METHODS,OBJECTIVE,OBJECTIVES,ONGOING,ONTARIO,PATHWAY,RESULTS,SYMPTOM,THROUGH,UNITS,WEB
956,ATG,AUTOPHAGY,BACKGROUND,EGFR,ERLOTINIB,INHIBITION,LABEL,METHODS,NSCLC,RESULTS
41OF,ACCORDING,AIOM,BACKGROUND,CONCLUSION,EGFR,EIGHT,EQA,ITALIAN,LABEL,MEDICAL,METHODS,OVERALL,PATHOLOGY,PCR,POLYMERASE,RESULTS,SOCIETY,TEN
001,2009,2011,211,321,591,812,AMONG,ASIAN,BACKGROUND,BECAUSE,CHINESE,CONCLUSION,DARBY,DESPITE,EGFR,LABEL,MALAY,MALAYSIAN,MEDICAL,METHODS,MUTATIONS,RESULTS,SIME
001,039,2004,2005,2542,319,374,384,434,593,8805,BACKGROUND,CONCLUSION,COX,CURRENTLY,GROUP,IIIB,JAPAN,LABEL,METHODS,NSCLC,OVERALL,RESULTS,SMOKING,WEST
FINALLY,PARTIAL
FEW,IGG4,THEREFORE
461,AFTER,CASE,CONCLUSION,DESPITE
AFTER,ALSO,C57BL,HOWEVER,HPV,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,RTB,THEREFORE
004,008,2005,2010,2321,AMONG,BACKGROUND,CONCLUSION,DATA,JANUARY,LABEL,METHODS,MSCC,OBJECTIVE,RESULTS,SUMMARY
100,169,2013,5A4,8805,ANAPLASTIC,COPYRIGHT,D5F3,INC,INTERPHASE
001,004,006,030,144,169,177,2013,256,720,789,948,954,956,964,967,COPYRIGHT,COX,DOR,EC109,ESCC,HOWEVER,INC,KENDALL,KOR,KYSE150,KYSE180,MOR,WESTERN
1997,2004,2006,819,8197,AMONG,BMJ,COX,DATA,GROUP,INDEX,INTERVIEW,LABEL,LIMITED,METHODS,MORTALITY,OBJECTIVE,PUBLISHED,PUBLISHING,RESULTS,SMOKING
169,2013,BAGE1,BAGE2,BAGE4,BAGE5,BORIS,CICS,CSC,CSCS,CTS,D40,GAGE1,GAGE8,JOHN,LHK2,LIP1,LTD,MAGEA12,MCF7,PCR,PLU,SGY,SONS,SPA17,SPANXA1,SPANXB1,SW480,TDRD1,TEX15,THEREFORE,THUS,TPTE,WILEY,XAGE1,XAGE2
ALK,BRAF,COMPANION,EGFR,FDA,HER2,HOWEVER,KIT,KRAS,ROS1
169,178,2013,BORTEZOMIB,GRADE,HOWEVER
ECH,KEAP1,KELCH,NRF2,SNP,SNPS,THESE,WHILE
2006,2009,203,954,BOMR,CMR,CONCLUSION,EORTC,EVALUATION,FDG,INDIVIDUAL,LABEL,METHODS,NONE,PERCIST,PET,PMD,PMR,RESULTS,SMD,SOLID,THERE,TREATMENT,UNLABELLED
DV90,HCC44,HUR,PCR,PTHRP,THESE,WESTERN
10TH,160,2009,2012,ADDITIONAL,BACKGROUND,BETWEEN,LABEL,METHODS,REDUCED,RESULTS,SCTD,VATS,WEDGE
951,DEPLETING,DGK,EGFR,LABEL,LUNG,MAPK,METHODS,OBJECTIVE,PURPOSE,RAS,RESULTS,SINCE
177,8764,AFTER,BOTH,HER2,IGF1,MKR,MTB,NEU,TAN
ESPECIALLY,HNC,INDWELLING,IRELAND,LABEL,OBJECTIVE,PROSTHETIC,PSVR,PULMONARY,PURPOSE,RESULTS,SUMMARY,TLR,TOTAL
178,180,2011,2012,4TH,BACKGROUND,BRONCHIAL,LABEL,METHODS,NSCLC,RESULTS,SEPTEMBER,THERE,THREE,VATS,VIDEO
945,AFTER,CASES,HCC,HEP,LIVER,PAR,PARTIAL
IIIA,LATE,OPEN,STAGE
100,145,175,211,223,BACKGROUND,DUTCH,GP5,HPV,HPVE7,INFECTION,LABEL,METHODS,RESULTS,SINCE,THESE,WHEREAS
0001,001,1065,177,2004,2007,212,222,235,2958,383,534,709,8201,BACKGROUND,COX,END,IIIA,INCREASING,INDEX,LABEL,MEIER,METHODS,NSCLC,OLDER,OVERALL,RESULTS,SURGERY,TREATMENT,YOUNGER
112,DEK,DEPLETING,GTP,MEIER,MLC,MLC2,NSCLC,RHOA,ROCK,TAKEN,TNM
135,169,1994,2001,2013,245,380,ACCORDING,ADC,ADCS,CD151,COPYRIGHT,DFS,HIGH,HOWEVER,IRELAND,LTD,NSCLC,SCC,SCCS
1432,169,2013,ACORN,BACKGROUND,CONCLUSION,COPYRIGHT,IIIB,IMD,IRELAND,LABEL,LOW,LTD,LUNG,METHODS,RESULTS,SES,SIMILARLY,STAGE,THERE
169,2012,2013,500,AUTOMATIC,CLRR,CLRRS,CONCLUSION,COPYRIGHT,HYPOTHESIS,IRELAND,LABEL,LABORATORY,LTD,METHODS,OBJECTIVE,OLDER,REPORTS,RESULTS,THESE
109,169,2005,2012,2013,2N0M0,8805,BETWEEN,COPYRIGHT,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SABR
26B3,945,AGREEMENT,BACKGROUND,CONTEXT,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS
SRC
1130,321,CHINESE,CIS,HRS,LUNG,OVERALL,SINGAPORE,THERE
039,2006,2010,CASE,CONCLUSION,EIGHT,HONG,IMMEDIATE,KONG,LABEL,MAIN,MAY,METHODS,OBJECTIVE,OCTOBER,OUTCOME,PAIN,RESULTS,SETTING
400,BRAF,DESPITE,EGFR,HER2,MOST,THESE
000,150,CURRENT,FURTHER,MALIGNANT,MPE,MPES,THEREFORE,VEGF
177,478,581,AFTER,CALU,CPG,FOURIER,ODN,PAGE,PDI,SDS,THEIR,THEN,TRANSFORM,XTT
0010,0034,011,012,015,020,030,032,058,077,177,240,299,300,9392,ASSESSMENT,BAY,BECAUSE,CONCLUSION,DOSE,FDG,FSPG,IMAGE,LABEL,MBQ,METHODS,MIRD,PET,RADAR,RADIATION,RESULTS,UNLABELLED
0105,021,174,2009,2012,6050,ADDITIONAL,CONCLUSION,DATA,FDG,IMAGING,INCIDENTAL,JANUARY,KNOWLEDGE,LABEL,MALIGNANCY,METHODS,OBJECTIVE,PET,RADS,REPORTING,RESULTS,TESTS
2010,DOSE,GATED,GTV,GUNMA,HEAVY,IGTV,IMS,ION,JUNE,MEDICAL,UNIVERSITY
2009,2011,239,AUC,CONCLUSION,GRADE,IRINOTECAN,LABEL,MAJOR,MARCH,METHODS,NINE,NON,NSCLC,OBJECTIVE,OVERALL,PURPOSE,RESULTS,TREATMENT
169,2013,A549,COPYRIGHT,IRELAND,LTD,TAKEN,TW01001
169,2013,COPYRIGHT,INC,MLR,NSCLC,PCA,PLSDA
100,169,1788,2012,2013,2975,956,A549,CC16,CLARA,COPYRIGHT,DEP,GMBH,IARC,OHDG,PAHS,PM2,ROS,RPMI,SERUM,SRM
BACKGROUND,CASE,CONCLUSION,EFFECTIVE,LABEL,METHODS,OXYCODONE,RITODRINE
001,005,1513,1528,335,409,475,500,645,8805,BACKGROUND,ECOG,FID,LABEL,METHODS,PARAMETERS,RESULTS,TSAT
169,2013,COPYRIGHT,HOWEVER,IRELAND,LTD
0KB,169,2013,2066,2VD3,A549,AIMS,CHIP,COPYRIGHT,EMSA,LABEL,LUCIFERASE,METHODS,OBJECTIVE,PCR,REAL,RESULTS,VDR,VDRE
169,2013,AXL,EMT,HOWEVER,NSCLC,USING
1999,2004,2011,FINALLY,LUNG,PREDICTIVE,SOCIETY,THERE
001,177,3DCT,4DCT,990,CTV,DIS,GTV,IGTV,ITV,NSCLC
148,155,2011,257,296,CONCLUSION,FDG,FURTHER,JULY,LABEL,MATERIALS,MBQ,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SPLIT
INCREASING,SELECTIVE,SINCE
178,490,8314,945,946,947,954,ASM,ASMC,ASMCS,BAPTA,CONFLUENT,CONVERSELY,CXCL,CXCR3,CYTOMIX,DESPITE,ELISA,JAK,JAK2,JNK,NEITHER,PCR,SERCA,SIGNALING,STAT1,TNF
169,2000,2007,2013,2063,318,AMONG,BACKGROUND,BOTH,COPYRIGHT,COX,END,IIIB,IQR,LABEL,METHODS,NSCLC,OVERALL,RANDOMIZED,RESULTS,SEER,SOCIETY,STRATIFIED,THEIR
019,160,175,608,BACKGROUND,COX,HRS,LABEL,METHODS,NSCLC,PFS,RESULTS,THESE,TTF
0001,0013,037,177,BACKGROUND,EVALUATION,FINALLY,KI67,LABEL,METHODS,MOLECULAR,PRIMARY,RESULTS,VEGF
195,BLAND,CONCLUSION,EANM,EORTC,LABEL,METHODS,NEMA,NSCLC,NUCLEAR,OBJECTIVE,OSEM,OVERALL,PET,PET1,PET2,PSF,PURPOSE,RCS,RESULTS,SUV,SUVS,TEN,THESE,TREATMENT,USING
100,1000,181,211H,250,500,549,BOTH,CALU,ECM,HOWEVER,LUNG,MMP,MMPS,MSTO,PMA,PROTEASES,THESE,TIMPS
FGFR1,LUNG,NSCLC,PCR,PONATINIB
AKT,BCL,BMAL1,MMP,PI3K,SINCE,THEREFORE,THESE
DATA,FINALLY,FINDR,FOURIER,FTIR,RAMAN,SVM,SVMS,UPON
001,2004,2008,249,287,CONCLUSION,DESPITE,JANUARY,LABEL,LRC,MATERIALS,MEIER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCLC
916,946,954,CIGARETTE,LEWIS,RELA,SMOKING,WNT
A549,BESIDES,CCND1,EGFR,EPIDERMAL,HDAC1,HOWEVER,PML,PMLIV
169,2013,AACR,AKT,BCL,DTX,ECTOPIC,FURTHER,H1299,LAD,PREVIOUSLY,SPC,UTR
169,2013,24H,946,956,A549,CAO,CHINESE,COPYRIGHT,ECM,ERK,ERK1,FURTHER,HOWEVER,INCREASING,IRELAND,LTD,PCR,PI3K,TAKEN,WESTERN
169,177,2013,CBCT,COPYRIGHT,D95,FIFTEEN,INC,ITV,ITVS,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PTV,PURPOSE,RESULTS,SBRT,THEN,TREATMENT,VMAT
157,169,2013,584,861,CAUCASIANS,COPYRIGHT,HENCE,OVERALL,T241M,XRCC3
2012,337,BACKGROUND,CONTINUED,DATA,ENGLISH,III,INCLUSION,INCREASED,IRELAND,JANUARY,LABEL,LTD,MEDLINE,METHODS,NSCLC,PAIN,PUBLISHED,QOL,RESULTS,THREE
108,145,164,169,193,2013,295,COPYRIGHT,EMT,EPITHELIAL,IRELAND,LTD,NSCLC,SCC,TNM
169,2012,2013,AMONG,BACKGROUND,CIS,COPYRIGHT,FURTHER,LABEL,LIBRARY,LTD,METHODS,NEWCASTLE,RESULTS,SCALE,SEPTEMBER
169,2013,COPYRIGHT,FBXW7,GSK3,IRELAND,LTD,MCL,NVP,PI3,THUS,TRAIL
169,2013,CDC42,COPYRIGHT,GTPASES,INC,PATHOLOGY,PREVIOUSLY,PUBLISHED,RAC1,RHO,RHOA,SMK,SOCIETY,THESE,THUS,USING
1533,169,2004,2012,2013,521,ALK,ALREADY,COLLEGE,CONSENSUS,COPYRIGHT,EACH,EGFR,INC,INITIAL,JANUARY,LABEL,LUNG,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PROCESS,PUBLISHED,SOCIETY,THREE,WRITING
1107,1195,169,1999,2009,2013,COPYRIGHT,DATA,LTD,METASTASIS,OVERALL,PRIMARY,SURGERY,WHILE
001,100,118,122,145,169,170,2013,600,613,8805,946,AGE,ASSESSMENT,BACKGROUND,CAUCASIAN,CONCLUSION,COPYRIGHT,DISEASE,EUROQOL,FACT,FATIGUE,FUNCTIONAL,GERMANY,HRQOL,IIIB,IRELAND,LABEL,LTD,LUNG,METHODS,NSCLC,PATIENT,RESULTS,SCALE,SYMPTOM,THERAPY
169,2013,8243,956,A549,ADM,AMONG,AMONGST,COPYRIGHT,HOWEVER,IC50,K562,LEISHMANIA,LTD,MICROMELUM,SBC3
AREAS,BACKGROUND,COVERED,FTM,LABEL,METHODS,NSCLC,OPINION,QOL
A549,COMPOUNDS,ESPECIALLY,LUNG,THEIR
001,006,156,164,169,1987,1999,2000,2008,2013,8201,8520,AMONG,BACKGROUND,COPYRIGHT,END,ESTIMATES,HODGKIN,LABEL,MATCH,METHODS,RESULTS,SOCIETY,SOLID,SUBGROUPS,TRANSPLANT
169,2013,6294,8805,AMONG,BACKGROUND,COLORECTAL,COPYRIGHT,LABEL,LUNG,MEN,METHODS,NON,OVARIAN,PLCO,PSA,RESULTS,SOCIETY
197,239,AMONG,BACKGROUND,BCL,BIM,EGFR,HOWEVER,LABEL,METHODS,NSCLC,PFS,RESULTS,SEOUL,T790M,TKI,TKIS,TREATMENT,UNIVERSITY
0001,0002,0012,0019,0033,8805,ASBI,BACKGROUND,COX,HSB,III,LABEL,LCSS,LOW,LSB,METHODS,NSCLC,PFS,RESULTS
001,516,950,991,CHINESE,FURTHER,HOWEVER,KNOWLEDGE,PUBLISHED,T188C,WANFANG
AFTER,BECAUSE,FGFR,FGFR2,FGFR3,THROUGH
177,390,CONCLUSION,EWING,FDG,LABEL,LOCAL,METHODS,NPV,OBJECTIVE,OVERALL,PET,PPV,PURPOSE,RESULTS
2006,E14,E15,EMT,HOWEVER,ID1,INHIBITOR,MAMMARY,MMTV,MYC,NTCU,PERK,TMA,VEGF
169,2013,8201,8805,BACKGROUND,COPYRIGHT,FORTY,LABEL,METHODS,MOST,NSCLC,RESULTS,SOCIETY
BACKGROUND,DETECTION,EVEN,FURTHER,LABEL,LUNX,METHODS,MINIMAL,MRD,PCR,TNM
575,945,ADDITIONAL,ANTITUMOR,CALU,MEDI,PDGFR,SCID,THESE
169,2013,ALK,BRAF,CAUCASIAN,COPYRIGHT,DDR2,EGFR,FDG,HER2,IRELAND,LTD,PET,RAS,RET,ROS1,WHILE
CHEST,CURRENTLY,FDG,PET
AFTER,UNKNOWN
15MV,169,2013,6MV,CARLO,COPYRIGHT,DOSE,EBT,GAFCHROMIC,HOWEVER,INC,MEDICAL,MONTE,PUBLISHED,THUS,V95
467,CEA,DFS,EVEN,HIGH,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
2006,2012,COX,III,JUNE,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PRETHERAPY,RESULTS,SALVAGE,STAGE,THERE
150,165,2011,2012,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PRESERVING,RESULTS,SEPTEMBER,THERE,THREE,VATS
HCP,HCPS,INCREASING,PHYSICIANS,RTD
169,2013,COPYRIGHT,LIVER,MELD,OTHER,PUBLISHED,PULMONARY
169,2013,INC,WILEY
169,175,1992,2010,2013,2817,391,BACKGROUND,BCC,CONCLUSION,COPYRIGHT,CUTANEOUS,INC,LABEL,METHODS,ORGAN,RESULTS,SCC,SOLID,WILEY
169,2013,ATF4,BIOLOGY,CHOP,COPYRIGHT,DR5,EBP,FLIPL,FURTHER,HDMC,INC,MOLECULAR,NATURAL,ROS,THEN,UNION
169,2013,946,BIP,CDK6,CHINESE,CHOP,COPYRIGHT,FUR,JOHN,LTD,MYC,RHIZOMA,SONS,TAX,WILEY
169,200,2013,239,AACR,AES,ALK,EGFR,EIGHT,FISH,FOUR,GANETESPIB,HSP90,KRAS,LABEL,METHODS,NSCLC,OBJECTIVE,ORR,PCR,PFS,PURPOSE,RESULTS,SECONDARY
1204831,1214063,169,2013,242,AACR,BOTH,EMD,HGF,HGFR,IC50,LABEL,MET,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR
169,2013,945,946,CCN1,COPYRIGHT,IMMUNOBLOT,INC,NSCLC,SILENCING,USING,WILEY
100,233,BLOOD,COMBINING,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SELF,SMOKING,TOBACCO
0001,0005,0034,0043,0079,0128,015,0395,8201,8226,CONCLUSION,EARLY,EVALUATION,GROUP,KEY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PERFUSION,RESULTS,SOLID,TEF,TIME,TUMOURS,TVV,VEGF
076,169,1996,2002,2013,439,8201,8805,AMONG,BMI,CIS,CONVERSELY,CSI,ODDS,ORS,REVERSE,SMOKING,THERE,UICC
160,1993,2010,219,CENTRAL,MOST,OPHIOLITIC,ROCK,SIVAS,YET
0510,1607,2011,417,914,AFTER,BACKGROUND,CHINESE,CIS,COX,CVS,FFQ,HRS,LABEL,METHODS,RESULTS,WOMEN
001,890,CIS,HRS,LABEL,META,METHODS,OBJECTIVE,PFS,PURPOSE,RESULTS,VEGF
A549,AKT,AUTOPHAGY,DIOSCIN,ERK1,H1299,JNK1,LC3,MEANWHILE,PI3K,RESULTS,TAKEN,TREATMENT
CHINESE
95D,APOPTOSIS,BAX,BCL,CDK4,DAPI,FURTHER,LACTATE,PCR,TREATMENT,WHILE
250,400,500,8764,AMONG,AUC0,BEXAROTENE,GEFITINIB,HOWEVER,P450,TARGRETIN,THREE
1533,2004,2012,521,ALK,ALREADY,COLLEGE,CONSENSUS,EACH,EGFR,INITIAL,JANUARY,LABEL,LUNG,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PROCESS,THREE,WRITING
160,169,2013,ALK,DAKO,EBUS,EGFR,FISH,IHC,JOHN,KIRSTEN,KRAS,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SAMPLES,SONS,TBNA,WILEY
001,005,169,2013,8201,AIM,ASIA,BAL,BALF,CEA,CONCLUSION,CYFRA,CYFRA21,LABEL,LTD,METHODS,NSE,OBJECTIVE,PTY,PUBLISHING,RESULTS,SCC,WILEY
ACCOUNT,FIVE,GLC4,HOWEVER,INITIALLY,OBATOCLAX,ONCE,RULE,SIMILAR,THESE
1533,2004,2012,521,ALK,ALREADY,COLLEGE,CONSENSUS,EACH,EGFR,INITIAL,JANUARY,LABEL,LUNG,METHODS,MOLECULAR,OBJECTIVE,PATHOLOGY,PROCESS,THREE,WRITING
169,2013,223,AE1,BARR,CK34,CK7,E12,EPSTEIN,JOHN,LTD,PUBLISHED,SONS,WILEY
BACKGROUND,CONCLUSION,DESPITE,FOUR,LABEL,METHODS,NODULES,OBJECTIVE,PURPOSE,RESULTS,SMALL,SWENSEN,THESE
954,GINSENG,HIGH,HOWEVER,KOREA,KWG,NH2,NTCU,RB1,SCC,SCCS,SWISS,THESE,TREATMENT,WESTERN
017,088,160,1993,2010,493,931,BACKGROUND,LABEL,METHODS,PATTERN,RESULTS
008,011,022,029,110,169,2013,954,AACR,AKT,CONCLUSION,ECTOPIC,EXPRESSION,FINALLY,HCC,HCCS,LABEL,MEIER,METHODS,MYD88,OBJECTIVE,PURPOSE,RESULTS,RFS,TLR,TOLL,UNIVARIATE
126,130,A549,ERK,ERK1,ERK2,ERKS,FURTHER,GSK3,HELA,HGF,MEK1,MET,NSCLC,RTKS,THROUGH,VARIOUS
2009,2012,ANY,BETWEEN,CONCLUSION,EARLY,FDG,III,JANUARY,JUNE,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PET,RESULTS,THUS
956,IC50,RHO,ROCK1,ROCK2,SER,THEREFORE,THR
169,2013,CARDIAC,CISPLATIN,COPYRIGHT
169,2013,A549,AACR,AKT,ARSENIC,ATO,BRCA1,COMPARABLE,DSB,EGF,EGFR,FINALLY,H2AX,HOWEVER,MEK,PI3K,RAD50,RAD51,SUBSEQUENT,THUS
018,021,024,035,038,041,045,1208,1208T,169,174,1996,2011,2013,209,4349,506,785,CAUCASIAN,CHI,COPYRIGHT,CXCR,DFS,ENDOSTATIN,GENOMIC,GENOTYPING,INS,IRELAND,IVS,LTD,MEIER,NSCLC,PAR,PCR,SQCC,VEGF
EPIRUBICIN,FE3O4,FTIR,MAGNETITE,PVP,TEM,TGA,VIS
001,140,AFTER,CONCLUSION,FEV1,FVC,LABEL,MATERIALS,METHODS,OBJECTIVE,PREDICTED,PURPOSE,RESULTS,SPECT,SUM
SINCE
001,158,ASSESSMENT,BRIEF,CAREGIVER,CAREGIVING,CONCLUSION,COUPLES,HOWEVER,INVENTORY,LABEL,METHODS,MULTILEVEL,OBJECTIVE,PURPOSE,RESULTS,SYMPTOM,TARGETS,THUS,WHILE
160,8209,945,946,A549,ACE2,ANG,DX600,EMT,EPITHELIAL,FINALLY,FURTHER,RAS,SMA,TGF
945,BOTH,CYTOHESIN,DFS,EGFR,ERBB,HCC,HEPG2,IGF,INHIBITION,PCR,SECINH3,TKI,TNM,VEGF,VEGFR
100,1052,130,149,169,200,2013,318,845,8805,930,AUC,CA031,CONCLUSION,COPYRIGHT,III,IIIB,IRELAND,JAPAN,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,ORR,PURPOSE,RESULTS
131,200,239,250,500,8201,AFTER,BACKGROUND,DUE,EIGHT,H1N1,HOWEVER,LABEL,LEFT,METHODS,PAPILLARY,PATIENT,PTC,SORAFENIB,TREATMENT
AFTER,BODY,CD30,HODGKIN,HOWEVER,LUNG,PET
264,A549,BALB,ERK,HOWEVER,OVERALL,RAW,ROS
160,2011,BACKGROUND,BCC,BLOOD,BOARD,EBUS,FORTY,JANUARY,LABEL,METHODS,OHIO,RESULTS,SEPTEMBER,SEVENTY,STATE,TBNA,UNIVERSITY
AKT,ALK,BOTH,HGF,HGFR,MET,RAS,RTK,RTKS,STAT3
5857,ADDITIONAL,FOUR,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,THESE
001,034,049,164,16HBE,176,329,AMONG,BPDE,COE,CPG,FURTHER,LINE,MGMT,PAH,PAHS,PCR,THESE
026,047,8805,954,CONCLUSION,FLT,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIXTY,SUV,THREE
500,MOST,OVERALL,WBRT
001,1689,169,2013,2273,2MWT,584,ASSESSMENT,BASED,BLOOD,BONE,COPYRIGHT,FACT,FEWER,FORM,FUNCTIONAL,GVHD,HAND,HAP,HGS,HOWEVER,INC,INSTITUTES,ITEM,LEE,MOS,PROFILE,PUBLISHED,SCALE,SHORT,SOCIETY,SYMPTOM,THERAPY,USING
104,LUNG,NONE,SOCIETY
A431,C33A,EPB41L3,FINALLY,HELA,III,PCR,RAS,SIHA,TAKEN
AFTERWARDS,DOTATOC,GHRH,MEN1,MRI,PET,THREE
169,2012,6004,BACKGROUND,COPYRIGHT,LABEL,METHODS,PUBLISHED,RESULTS,SEPAR,THESE,VTE
169,2013,205,215,412,420,COLLEGE,COPYRIGHT,DATA,FLEISCHNER,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIOLOGY,RESULTS,SOCIETY
20TH,21ST,LTD,PUBLISHED,SINCE
000,100,169,1978,2002,2008,2013,BECAUSE,COPYRIGHT,CRS,EU27,LTD,NETS,OVERALL
0001,104,137,169,177,1ST,2000,2010,2013,31ST,5667,7051,8805,COLLEGE,COPYRIGHT,CPHG,GENERAL,IRELAND,JANUARY,KBP,LTD,PHYSICIANS,THESE
169,177,2008,2009,2013,COPYRIGHT,FIFTEEN,HIGH,HPLC,IASI,LTD,PAH,PAHS,PNEUMOLOGY,ROMANIA,SIMILARLY
100,169,2013,BRONCHIAL,COPYRIGHT,HDREB,INC,LABEL,MATERIALS,METHODS,MOST,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,SEVENTY,SOCIETY,THERE
100,120,169,2013,8805,COPYRIGHT,DOSE,GRADE,HIGH,III,INC,LABEL,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RADIATION,RESULTS
002,049,101,169,2013,215,335,8804,BACKGROUND,CD163,CD66B,COPYRIGHT,CRP,ENDPOINTS,FURTHER,HOWEVER,IIIA,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS,RFS,WBC
169,2013,262,ASIA,ASSESSMENT,BACKGROUND,COPYRIGHT,EFQ,EFS,EGFR,FACT,FUNCTIONAL,HRQOL,INDEX,IPASS,IRELAND,ITT,LABEL,LCS,LTD,LUNG,METHODS,NSCLC,OBJECTIVE,ORR,OUTCOME,PFS,POST,RASH,RESULTS,THERAPY,THERE,TOI,TRIAL
007,021,027,057,1027,169,177,1967,2005,2012,2013,2119,890,ANTI,BACKGROUND,COPYRIGHT,FEV,FORTY,HEART,INC,JULY,LABEL,LUNG,MARY,MAY,METHODS,MORBIDITY,MORTALITY,OPERATIVE,OVERALL,PORTSMOUTH,PUBLISHED,RESULTS,SCORE,SOCIETY
038,2003,2012,263,704,ACTUARIAL,ASSESSMENT,BETWEEN,CLASS,GAMMA,GKS,KNIFE,LABEL,METHODS,MRI,NSCLC,OBJECTIVE,OVERALL,PROGNOSTIC,RECURSIVE,RESULTS,RPA
CONVERSELY,DATA,HOWEVER,KNOCKDOWN,MICRORNAS,MMR,NSCLC
000,8201,ADVERSE,BACKGROUND,CONCLUSION,DLT,DLTS,LABEL,METHODS,MTD,ORAL,RESULTS,TIME
BLAND,DUAL,FEV1,FIFTY,LABEL,LOBAR,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,USING
001,2007,2010,353,EGFR,KRAS,LABEL,METHODS,NSCLC,PFS,RESULTS,TESTS,TKIS,UNASSIGNED
A549,C16,C17,C18,EXIGUOLIDE,H460,LEWIS,NCI
169,2013,AIMP2,COPYRIGHT,DUAL,DX2,EXON,HOWEVER,MOLECULAR,PCR,REAL
09NM,100,136,169,177,1MM,2013,77MV,956,A549,AGNO3,COPYRIGHT,FOURIER,LD50,OREGANO,SEM,XRD
169,2013,COPYRIGHT,HDAC,HDACI
100,169,2013,3HOI,A549,AACR,AKT,NATURAL,PI3,PRODUCT,RESULTS,SIXTY,TAKEN
137,169,2013,AACR,ELEVATION,ELISA,MET,NEITHER,NSCLC,OA5D5V2
101,169,2013,AACR,AXL,CUDC,EGF,EGFR,HDAC,HER2,MET,PREVIOUSLY,TAKEN
169,2013,239,AACR,EGFR,EXPRESSION,FGF2,FGFR,FGFR1,NSCLC,PC9,THESE,THUS,TKI,TKIS
169,2013,AACR,ATF3,BLADDER,CONVERSELY,CRITICALLY,GSN,TAKEN,THESE
169,2013,ALK,BACKGROUND,CBS,CELL,CONCORDANT,COPYRIGHT,CRIZOTINIB,DIFF,EML4,FISH,LABEL,METHODS,QUIK,RESULTS,REVERSE,SOCIETY,STAINED
120,154,191,2006,2011,386,455,765,8805,AMONG,JUNE,MAY,NSCLC,UNIT
001,002,M30,M65,NSCLC,PFS,SERUM,SEVERAL,STAGE
001,260,ABOUT,HOWEVER,III,IIIB,NSCLC,PBCT,THEIR
2002,2007,2011,AMPULLA,III,REPETITIVE,VATER
169,1998,2005,2013,BACKGROUND,CHANGES,COLORECTAL,COPYRIGHT,CRS,ITALIAN,ITALY,JOINPOINT,JOINPOINTS,LABEL,LTD,METHODS,PERCENT,PROGRAM,REGISTRIES,REGRESSION,RESULTS,SEER,TIME
001,169,177,2013,AAA,AIR,BESIDES,BONE,BOTH,CARLO,COPYRIGHT,ECLIPSE,INC,MAPE,MAPES,MEDICAL,MGS,MONTE,PUBLISHED,SOFT,XIO
CONFIRMED,KIF5B,RET
ALK,BACKGROUND,EGFR,EML4,FISH,LABEL,METHODS,NSCLC,RESULTS,TKIS
946,AKT,ERK,FOUR,GTP,JNK,JUN,MAPK9,MEK,RAS,STAT,STAT1,STAT3,THEIR,THERE,THESE,VEGF,WNT
004,169,2013,CGI,COBRA,COPYRIGHT,H293T,HCC,HEPG2,INC,MASSARRAY,PTPRO,TAKEN,TREATMENT,TYROSYL,VCP,WILEY
001,014,031,035,037,058,1107,1236C,150,160,1711,2677G,3253,3435C,420,421A,421C,6986A,8805,ABCB1,ABCG2,BACKGROUND,CSF,EARLY,EGFR,ERLOTINIB,ILD,LABEL,METHODS,NSCLC,OSI,POPULATION,RESULTS
001,003,AUC,CEA,CONVERSELY,CYFRA,LOW,MPM,PES,RESULTS,ROC,SMRP
123,169,1988,2007,2013,8805,956,BACKGROUND,CHRYSOTILE,CONCLUSION,DATA,HALF,INC,LABEL,METHODS,MOST,RESULTS,WILEY,WORLD
019,020,021,160,747,891,EPIC,FOUR,HOWEVER,NUTRITION,OCM,SEM,SEVERAL
169,1985,2008,2013,8805,962,AMONG,BACKGROUND,COPYRIGHT,HOWEVER,INC,KAOHSIUNG,LABEL,METHODS,RESULTS,SMR,SMRS,THOSE,UNION,WILEY,WORKERS
10001,333,HOWEVER,MEANINGFUL,MECHANISMS,MEDICAL,PUBLISHERS,SEVENTH,USA,YORK
MRI,NASAL
AFTER,MULTIPLEX,PAGE,SDS,SMARTPHONE
023,054,058,280,4531,8431,ALTOGETHER,ANOTHER,SOCIETY,VATS
038,100,2007,2011,BEV,CONCLUSION,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SRE,SRES,THEREFORE,TTP,VEGF,VEGFR
000002452,2010,2012,500,8805,APRIL,BACKGROUND,CTR,FURTHER,GRADE,III,JANUARY,LABEL,METHODS,NON,NSCLC,PARTIAL,RESULTS,SEVENTEEN,UMIN
002,004,009,028,039,074,283,ATS,ERS,IASLC,LABEL,LEPIDIC,LUNG,METHODS,OBJECTIVE,OLDER,PL2,RESULTS,SOCIETY,THEIR
2258,711,AMONG,GIST,GISTS,NONE,SDH,SDHA,SDHB,THERE,THREE
8G7G3,CSA,SPT24,TTF
FDG,MRI,PET
150,SPECT
017,14M,177,18F,2008,2011,CONCLUSION,DIFFERENCE,DISEASE,FDG,GBQ,HCC,JUNE,LABEL,MAY,MEAN,MEIER,METHODS,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,SIRT,THERE,WHILE
FDG,FINE,MPT,NSCLC,PET
FDG,PET
549,IC50,NSCLC,OVERALL,PLK,POLO,REGARDING
130,270,8201,ASO,BACKGROUND,DCS,DCSS,DOX,LABEL,METHODS,MRP1,RESULTS
139,AMONG,CXCLS,DECREASED,FURTHER,HIF1A,IL6,IMPDH,NDRG,NRP1,ORIGINALLY,PAI,PDK1,PI3K,SGK1,U87,USING,VEGF
ADC,ANNEXIN,BOTH,CONCLUSION,COX,LABEL,LSC,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
160,2006,2011,529,APRIL,BACKGROUND,HOWEVER,LABEL,METHODS,RESULTS,SURGERY
HENCE,NEAT2
026,053,177,1995,2011,967,979,ACCORDING,DATA,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OPERATIVE,RESULTS,THERE,THREE
005,169,2013,916,946,COPYRIGHT,E12,HOWEVER,INC,NP63,TEN,THESE
169,2013,AKT,COPYRIGHT,IRELAND,LTD,PERIFOSINE,PP242,REDD1,THEREFORE
0018,169,2013,AKT,COPYRIGHT,CYR61,ERK1,SCID
18F,18FDG,1966,1972,1974,1978,1989,1994,2011,415,430,8220,8244,AUC,BACKGROUND,CBM,CHINESE,CNKI,CONCLUSION,DISC,DOR,DUAL,FDG,LABEL,LIBRARY,LUNG,META,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SCIENCE,SROC,SUMMARY,VIP,WANFANG,WEB
001,1000,114,245,267,506,733,960,994,BACKGROUND,CNB,CONCLUSION,DIAGNOSTIC,FNA,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIX
017,576,AUC,AUCS,BACKGROUND,CONCLUSION,CXR,DIGITAL,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,ROC,THREE
169,2013,COPYRIGHT,EANF,HOWEVER,LTD,LUNG,SWISS,THEREFORE,WHAT
COMMISSION,FINALLY,HRTM,ICRP,MEAN,PES,PROTECTION,THESE
169,2013,AUSTRALIA,COPYRIGHT,LABEL,LTD,META,METHODS,OBJECTIVE,PUBLISHED,RESULTS,RRS
111,169,1998,2011,2013,2665,4660,ANZ,AUTHORS,BACKGROUND,COLLEGE,DISCUSSION,JOURNAL,LABEL,METHODS,RESULTS,ROYAL,SURGERY,THERE
169,2013,A549,AFM,AFTER,EGFP,INC,PCR,VEGF,WESTERN,WILEY
004,009,052,076,089,169,2013,318,322,612,988,BACKGROUND,COPYRIGHT,III,KIRSTEN,KRAS,LABEL,MASI,METHODS,RESULTS,RFS,SOCIETY,THERE
153,169,2013,AFP,CD95,CONCLUSION,DOWN,FINALLY,H19,HCC,HEPG2,IGF2,LABEL,LIVER,LOSS,NAD,SIRT6,SIRTUIN,UNLABELLED
001,950,BECAUSE,BOTH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PEARSON,RESULTS
BLM,FINALLY,H3K9,ILDS,IPF,LESS,NOTABLY,TERT,THESE
124,AMP,AMPK,AS2,BOTH,CISPLATIN,HOWEVER,JSI,LKB1,METFORMIN,PC14PE6,ROS,S3C,STAT,STAT3,THUS
GCLC,GPX1,H2O2,HOWEVER,MIF,NQO1,NRF2,PRDX1,RILI,THESE,TXN1
100,CD34,CHEST
047,089,123,145,168,256,360,659,663,675,857,862,877,896,956,AFRICAN,CAUCASIANS,CHINA,CIS,ELECTRONIC,HOWEVER,KNOWLEDGE,ORS,REFERENCES,SINOMED,XRCC3
160,ABOUT,CITY,CULTURALLY,FURTHER,SIXTY,THREE,YORK
0009,2007,2011,294,376,571,9382,CONCLUSION,FORTY,HODGKIN,LABEL,MAY,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,ROYAL,THERE
EMERGENCY,NSCLC,SUBSEQUENT
100,160,197,2001,2011,BACKGROUND,CHART,CONCLUSION,DATA,ELECTRONIC,EPC,IVATR,JANUARY,JULY,LABEL,LUNG,METHODS,OBJECTIVE,PACS,PATIENT,RADIOLOGY,RESULTS,TATTOOING,TECHNICAL
001,00375,0125,239,CELL,LABEL,LRP,MALIGNANT,METHODS,MRP2,OBJECTIVE,OVARIAN,PURPOSE,RESULTS
001,010,021,040,118,BACKGROUND,DFS,EGFR,LABEL,METHODS,PFS,RESULTS,TKI,TTF
1991,2010,AMONG,BPF,CONCLUSION,JANUARY,LABEL,METHODS,OBJECTIVE,OWT,PURPOSE,RESULTS,SUCCESSFUL
8209,A549,AKT,EGFR,FLOW,H460,H661,HOWEVER,IMMUNOBLOT,MTT,NCI,NSCLC,TKI,TKIS,TREATMENT
160,300,CEA,ELISA,HOWEVER,III,MALIGNANT,MPE,NSCLC,PLEURAL,THERAPY,THERE,VEGF
1000,130,215,BACKGROUND,LABEL,METHODS,RADICAL,RESULTS,SURGERY,TOXIC
945,947,A549,BRCA1,EB1,HOWEVER,PTX,TAKEN
2007,2010,480,8805,ALGORITHMS,BACKGROUND,CRC,GENERIC,ICD,INCLUSION,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THESE
169,2013,ANTI,COPYRIGHT,EP4,INC,PGE2
105,160,169,2013,748,APOE,AUC,BACKGROUND,COPYRIGHT,HOWEVER,INCREASED,LABEL,METHODS,MPE,NSCLC,RESULTS,SAMPLES
001,003,004,015,037,105,169,2013,BOTH,COMBINING,COPYRIGHT,ERCC1,INCREASED,IRELAND,LOW,LTD,PFS,PROTEIN
001,169,2005,2010,2013,286,320,7TH,880,CONTROL,COPYRIGHT,FURTHER,HOWEVER,IRELAND,JANUARY,LTD,LUNG,MARCH,SCLC,THERE,TNM,UICC,UNION
044,160,169,2013,278,332,ASSESSMENT,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,CST,FUNCTIONAL,GENERAL,HRQOL,III,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,QUALITY,RESULTS,STAGE,SURVIVING,THERAPY,THERE
169,2013,CALYPSO,COPYRIGHT,DRUG,FOOD,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,ONCE,PURPOSE,RESULTS,UNDER
001,002,169,2013,8804,960,COPYRIGHT,GIVEN,INC,LABEL,LUNG,MATERIALS,MAXIMUM,METHODS,OBJECTIVE,PTV,PURPOSE,R50,RESULTS,USING,V10,V20
169,2013,AFTER,COPYRIGHT,CTV,CUMULATIVE,EQD2,FBCT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TCP,WEEK
100,169,2013,ALK,ANAPLASTIC,COPYRIGHT,DETECTION,HOWEVER,ICC,IHC,IRELAND,LABEL,LTD,RESULTS,TBLB,THEREFORE,UNIVERSITY,UNLABELLED
169,2013,434,APAI,BACKGROUND,BSMI,CHINESE,CONCLUSION,COPYRIGHT,COX,FOKI,HOWEVER,III,INC,LABEL,METHODS,NSCLC,RESULTS,SEVEN,TAQI,THREE,VDR
169,2014,CASE,CLINICIANS,COPYRIGHT,INC,INSTITUTE,LANGONE,MANAGEMENT,MEDICAL,NURSING,PAIN,PUBLISHED,RUSK,SOCIETY,UNIVERSITY,YORK
169,2013,AMPLATZER,ANZSCTS,AUSTRALIA,AUSTRALIAN,CARDIAC,COPYRIGHT,CSANZ,PUBLISHED,SOCIETY,THEREAFTER,ZEALAND
127,128,169,2013,AES,BACKGROUND,CONCLUSION,COPYRIGHT,EIGHT,IIIB,IRELAND,LABEL,LTD,METHODS,MOST,RESULTS,SAGOPILONE,TREATMENT,WORLD
169,2013,AFTER,COPYRIGHT,GENERALLY,IRELAND,LTD,MPM,NEC
169,177,2013,CD31,COPYRIGHT,INC,NON,THERE,THEREFORE,THESE,VASOHIBIN
169,2013,8201,ASIAN,AUTHORS,BACKGROUND,ENB,FACTORS,HOWEVER,LABEL,LESIONS,METHODS,OBJECTIVE,PACIFIC,PERIPHERAL,RESULTS,SIXTY,SOCIETY,TECHNICAL
2006,2011,206,BETWEEN,CLASS,CONTINUOUS,HOWEVER,IOM,LABEL,MEP,MEPS,METHODS,MOTOR,OBJECTIVE,REDUCTION,RESECTION,RESULTS,SINCE
169,183,1984,1997,2011,2013,8734,BACKGROUND,BCC,BRITISH,HOWEVER,LABEL,MEIER,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,PFS,PRIOR,RESULTS,TEN,UNIVERSITY,USING
114,133,169,2013,8201,ASIAN,AUTHORS,BACKGROUND,FURTHER,LABEL,LACERATION,METHODS,OBJECTIVE,PACIFIC,RESULTS,SOCIETY,THESE
169,2008,2012,2013,8201,AFTER,ASIAN,AUTHORS,BACKGROUND,CAO,DEBAKEY,HOUSTON,LABEL,LESIONS,MALIGNANT,MEDICAL,METHODS,MICHAEL,OBJECTIVE,PACIFIC,PRE,RESULTS,SOCIETY
001,162,397,700,8364,DISEASE,NSCLC,PROGNOSTIC,RECURRENCE,THERE,USD32
177,CURRENT,FOUR,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS
0001,2008,2009,AFTER,APRIL,BACKGROUND,CONCLUSION,CPP,CRSI,CVP,DOPPLER,FIO2,H2O,ICP,LABEL,MAP,METHODS,PACO2,PAO2,PARTIAL,PEEP,RESULTS,RRS,ZEEP
2005,2009,232,ALSO,CONCLUSION,JANUARY,JUNE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SMOKING,UNIVARIATE
18F,AFTER,FINAL,GGO,SPCH,VATS
BAC,EGFR,L861Q,LCNEC
1988,2008,DFI,SECONDARY,SSP
EBUS,TBNA
169,18F,18FDG,2008,2011,2013,429,BACKGROUND,COPYRIGHT,CURRENT,HOWEVER,III,IRELAND,JANUARY,LABEL,LTD,METHODS,MRI,NSCLC,PET,RESULTS,SEPTEMBER,STAGE,THREE
111,BOARD,CONCLUSION,DOSIMETRY,DOTANOC,DOTATOC,FIVE,LABEL,METHODS,ORGAN,PET,REPORTING,RESULTS,THERE,UNLABELLED
100,118,160,180,224,287,372,441,8201,876,8805,AES,CENTRAL,CONTROLLED,DCR,HOWEVER,IIIB,MEDLINE,NSCLC,ORR,RANDOMIZED,RCTS
NOS,PECOMAS,THESE,TREATMENT
006,169,2013,906,956,AACR,AKT,CELL,ERK,H187,IC50,IGF,INSULIN,NCI,OSI,SCLC,TAKEN
174,177,EYE,HAMAMATSU,ICG,IMF,JAPAN,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PHOTONICS,RESULTS
1041,114,160,169,175,177,2013,8805,BACKGROUND,COPYRIGHT,FOCAL,FORTY,GGO,GGOS,LABEL,LARGE,LTD,MEAN,METHODS,RESECTION,RESULTS
041,392,8764,BACKGROUND,CHINESE,FFPE,LABEL,LOWER,METHODS,NSCLC,PCR,RESULTS,ROS1,THERE
33342,ABCG2,AMONG,BAX,BCL,BLOT,CD133,FINALLY,HOECHST,HOWEVER,LABEL,LUNG,MATERIALS,METHODS,MTT,OBJECTIVE,PROTEIN,PURPOSE,RESULTS,WESTERN
001,102,884,967,CONCLUSION,HIPAA,ILA,ILAS,IMAGE,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCREENING,TRIAL
169,2011,2013,901,COPYRIGHT,DESPITE,FISH,INC,LUNG,MAY,MEDLINE,META,REPORTING,REVIEWS,STUDIES,SYSTEMATIC,THREE,WILEY
130,169,2013,236,446,495,598,8805,AMONG,BMI,CLEAR,COLORECTAL,CONCLUSION,COPYRIGHT,LABEL,LUNG,METHODS,OBESITY,OBJECTIVE,OVARIAN,PLCO,RESULTS,SCREENING,SOCIETY,TRIAL
175,800,AUC,ECOG,FORTY,III,IIIA,IIIB,NSCLC,ORR,PFS,PRIMARY,SECONDARY
105,EXPRESSION,NSCLC,RHO,RHOA,TAKEN
954,A549,AEG,ALTOGETHER,EMT,FIRST,FURTHER,LUNG,THESE,URSOLIC
ABDOMINAL,EPITHELIAL,FDG,PET
PET
131,DTC,FALSE,SPECT
BARR,CHEST,EPSTEIN,FDG,PET,SKIN
0001,0004,006,107,10877,112,127,132,169,2000,2012,2013,239,AHF,BACKGROUND,COPYRIGHT,CRUDE,CTX,DATA,FIVE,III,IIIA,LABEL,LDH,LTD,METHODS,NSCLC,RADIATION,RESULTS,RTX,THERE
100,160,169,177,2001,2012,2013,AGE,BLOOD,CELL,COLLEGE,COPYRIGHT,CPB,EDINBURGH,FUHRMAN,IRELAND,IVC,LABEL,LAPAROTOMY,LTD,METHODS,OVERALL,PERI,PUBLISHED,RADICAL,RCC,RENAL,RESULTS,ROYAL,SAVER,THERE,UNLABELLED
169,2013,COPYRIGHT,DISTANT,INC,ORAL,PRIMARY
1180,169,2003,2005,2013,AIM,COPYRIGHT,ITALIAN,ITALY,LABEL,LTD,LUNG,METHODS,OBJECTIVE,OVERALL,RESULTS,ROMAGNA,STAGE,THREE
169,2013,5MG,8805,ADVERSE,BELOTECAN,COPYRIGHT,CTCAE,EVALUATION,FEBRILE,INSTITUTE,IRELAND,LTD,NCI,SCLC,SOLID,TREATMENT
012,169,2013,663,755,BACKGROUND,CHINESE,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LTD,METHODS,NSCLC,PCR,RESULTS,SUBSEQUENT,XBP1
013,106,108,378,390,700,967,ATTENDING,CONCLUSION,DATA,EOV,LABEL,LUNG,METHODS,OBJECTIVE,PCS,RESULTS,SETTING,THERE
169,2013,948,BMP1,C1R,C1S,CDCP1,CUB,EXPRESSION,FYN,HOWEVER,INHIBITION,LC3,PKC,PP2,SRC,THESE
APC,BRD7,CDC20,CDH1,HOWEVER
104,BASED,BOTH,DISEASE,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PURE,RESULTS,SEVENTY,VATS
0003,0006,001,1979,2001,2012,4212,CONCLUSION,COX,IIIA,KINGDOM,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,OCTOBER,OVERALL,PATIENT,PROPENSITY,RESULTS,SEPTEMBER,SERVICE,SEX,STAGE,STRATEGIC,SUB,TRACING,UNIVARIATE
100,169,2013,ALS,ALZHEIMER,COPYRIGHT,HUNTINGTON,INC,PARKINSON,SOD1,THESE,TODAY,WILEY
AMONG,COPD,FIFTY,FULL,LABEL,METHODS,OBJECTIVE,POST,PURPOSE,RESULTS,SELF,VO2
009,043,BACKGROUND,CONCLUSION,ENGLISH,FACE,FUNCTIONAL,HELMS,LABEL,LOW,MACCALLUM,MANAGEMENT,METHODS,PETER,RESULTS,SCALE,SHORTENED,SUBOPTIMAL,TEST,USING
0001,004,028,035,160,183,1990,2011,215,261,8201,8202,AFTER,ALSO,BACKGROUND,CDX,CONCLUSION,CUP,GEORG,INITIALLY,LABEL,METHODS,MRI,NEN,OPERATIVE,PRIMARY,RESULTS,STUTTGART,THREE,TTF,YORK
169,1989,2013,AUC,COPYRIGHT,EVALUATION,FIRST,JOHN,LTD,MCCLISH,OPERATING,ROC,SONS,WILEY
A549,BASED,C20,FOUR,GYNOSTEMMA,MTT,NMR,ODS
026,960,ADDITIONAL,ESCC,FIFTY,GST,LRP,MDR,MULTIDRUG,STUDIES
232,400,500,8226,8804,CONCLUSION,CTS,HISTOLOGY,KEY,LABEL,LUNG,MEAN,METHODS,MOST,OBJECTIVE,RESULTS,SCREENING,SHORT,SIXTY,VDT,VDTS
300,8805,ALONG,BENCHMARK,LABORATORY,LUCAS,THESE
034,160,169,2013,BACKGROUND,CAMBRIDGE,COPYRIGHT,EBC,LABEL,LTD,LUNG,METHODS,NON,NSCLC,PCR,REFERENCE,RESULTS,T16217C
169,2013,827,945,COPYRIGHT,EGFR,EGFRS,ERBB2,GEFITINIB,HCC,HGF,INSTEAD,IRELAND,LTD,MET,THESE
169,2013,365,COPYRIGHT,ECTOPIC,IRELAND,LTD,MICRORNAS,NKX2,RNAS
169,2013,BECAUSE,COPYRIGHT,DESPITE,FDA,HENCE,HOWEVER,SAS,VEGF
169,1998,2000,2007,2014,275,831,AFRICAN,AMONG,ANY,CHI,COLON,COPYRIGHT,CORPORATE,COX,DATA,HEALTHCARE,INC,JANUARY,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,OCTOBER,OVARIAN,PSA,REGULAR,RESULTS,SCREENING,SEPTEMBER,TRIAL,VHA,WAREHOUSE
105,169,1994,2009,2012,2013,ADVERSE,AIMS,AUSTRALIA,AUTHORS,BACKGROUND,COLLEGE,EIGHT,JANUARY,JOURNAL,JULY,LABEL,METHODS,NSCLC,OBJECTIVE,PHYSICIANS,RESULTS,ROYAL,THREE
002,0050,0195,0205,0336,100,1001,1005,169,2013,250,ALK,BACKGROUND,COPYRIGHT,CRIZOTINIB,FORTY,LABEL,MET,METHODS,NSCLC,PROFILE,RESULTS,SINUS,SOCIETY,THERE
18F,262,554,8804,AMONG,FDG,HOWEVER,IIA,IIIA,LABEL,METHODS,OBJECTIVE,PET,RESULTS,T1AN0M0
2009,AMONG,FOUR,GRADE,LEVEL,PRONE,SINCE,SIXTEEN,STAGE,THERE
0001,0002,020,041,104,216,8805,946,AJCC,FHIT,III,LOH,MLH1,MSI,NSCLC,PACK,RAR,SCC,TNM,YEARS
CD146,CD34,CD45,CELLSEARCH,CSF,CSFMC,CTC,EPCAM,HMW,MAA,MRI,TUBES,VERIDEX
1999,2008,981,CITY,LABEL,METHODS,NYC,OBJECTIVE,PURPOSE,RESULTS,SES,STAGE,STATE,THERE,YORK
160,1992,2009,2019,APC,ASIAN,BACKGROUND,INSTITUTE,JOINPOINT,LABEL,METHODS,NCIS,PACIFIC,REGRESSION,REPORTS,RESULTS,SEER
0001,007,177,2010,2011,353,715,8804,95TH,967,APART,CHINESE,CONCLUSION,FATIGUE,INVENTORY,LABEL,METHODS,MFI,OBJECTIVE,PURPOSE,RESULTS,SCALE
BECAUSE,BOTH,EVEN,PAX2,PAX8
1ST,2010,2011,AIM,BACKGROUND,COPD,DYING,JUNE,LABEL,MAY,METHODS,OBJECTIVE,PALLIATIVE,RESULTS,THEIR,THERE
169,177,2013,956,A549,COPYRIGHT,DSC,ED50,FTIR,GMS,IC50,NOSCAPINE,PHASE,PXRD,SSGMS
169,2013,223,945,954,A549,ADIPOR1,ADIPOR2,ADIPORS,AKT,COPD,COPYRIGHT,ERK1,FINALLY,FURTHER,LTD,MCP,TAKEN,TNF
169,2013,A549,AKT,ATP,BACKGROUND,COPYRIGHT,GENERAL,HOWEVER,LABEL,METHODS,NSCLC,PRIOR,RESULTS,ROS,SRC
169,2013,954,COPYRIGHT,IRELAND,LTD,MINNELIDE,NOTABLY,TRIPTOLIDE
169,2013,BIOLOGY,COPYRIGHT,HEPARANASE,NOTABLY,PUBLISHED,SOCIETY
169,2013,ALK,BRAF,COEXISTING,COPYRIGHT,CROWN,IRELAND,LTD,PUBLISHED
001,009,100ML,122,123,2000,2007,298,3930,8805,BACKGROUND,CERTAIN,COX,CRCL,HOWEVER,IQR,IRELAND,LABEL,LTD,METHODS,NSCLC,PUBLISHED,RENAL,RESULTS
000,169,1984,2008,2013,BACKGROUND,CNS,COLORECTAL,COPYRIGHT,EAPC,LABEL,LTD,METHODS,OVERALL,RATES,RESULTS,THERE
1506,169,2013,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PATHOLOGIC,RESULTS
169,2012,241,454,COPYRIGHT,EARLY,ESPA,PET
169,2013,954,AKT,BEAS,COPYRIGHT,DECREASED,IGFBP,IRELAND,LTD,NNK,NNKA,THESE
BCL,LUNG,PACLITAXEL,STMN1,TAX,THESE
169,2013,ALK,BACKGROUND,COPYRIGHT,EGFR,EVALUATION,KIRSTEN,KRAS,LABEL,METHODS,MOLECULAR,REPEATING,RESULTS,SOCIETY,T790M,THREE
152,169,190,2013,8201,BACKGROUND,COMMUNITY,COPYRIGHT,ESS,ESTIMATES,HOWEVER,INVENTORY,JOHN,LABEL,LTD,LUNG,METHODS,PTGI,REPORTS,RESULTS,SONS,WILEY
001,021,029,EGFR,MVD,NSCLC,PECAM
ACP,AUSTRALIAN,CONCLUSION,GIVEN,LABEL,METHODS,OBJECTIVE,PURPOSE,REACTIONS,RESPONSES,RESULTS
008,160,8804,BACKGROUND,FOXP3,IHC,LABEL,LUNG,METHODS,REGULATORY,RESULTS,THESE,TREG,TREGS
143,161,349,GEP,MEAN,MEIER,NEN,NENS,THEREFORE,TNM
137,ANNEXIN,COX,MEIER,MULTI,NSCLC,REAL
BENC,CRC,IGG1,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCID,THEREFORE,VII
2001,2012,2D6,ALK,CURRENT,EGFR,EML4,ERCC,FOUR,G13D,HER2,LIBRARY,LITERATURE,MEDICAL,NETWORK,RRM1,SEVEN,SOCIETY,V600E
100,169,2013,A549,AACR,CONSISTENT,EGF,EGFR,H1975,HEAT,HSP90,IC100,IC50,KRAS,NSCLC,NVP,THESE,XENOGRAFT
169,2013,AACR,CHIP,DAC,DACH1,DACHSHUND,DROSOPHILA,EGF,EGFR,ENDOGENOUS,EXPRESSION,GIVEN,NSCLC,SOX2
0001,098,169,2013,754,ATTENDANT,BACKGROUND,CAC,CARDIOLOGY,COLLEGE,COPYRIGHT,EARLY,FAMRI,FOUNDATION,INC,INSTITUTE,LABEL,LUNG,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,PROGRAM,PUBLISHED,RESULTS,SHTS
120,169,2013,645,ADDITIONAL,APOA1,BACKGROUND,C4A,C4B,CONCLUSION,COPYRIGHT,EGFR,HOWEVER,ILD,INC,LABEL,LOOCV,METHODS,NSCLC,RESULTS,SERUM,TKIS
169,2007,2012,2013,973,BACKGROUND,CARE,CONCLUSION,COPYRIGHT,EVALUATION,ICU,INTENSIVE,IQR,JANUARY,LABEL,LTD,MECHANICAL,METHODS,OBJECTIVE,RESULTS,UNIT
169,2013,467,610,BACKGROUND,CONCLUSION,COX,FIFTY,HOWEVER,JOHN,LABEL,METHODS,NMSC,OVERALL,RESULTS,RISK,SONS,WILEY
000,169,2013,400,ALK,ALSO,CONSORTIUM,COPYRIGHT,CROWN,DDR2,EGFR,FGFR1,IRELAND,LTD,LUNG,NSCLC,PTEN,PUBLISHED,SQCC,SUCCESSFUL,THESE
169,2013,COPYRIGHT,IRELAND,LTD,TAMS,UNDER
150,169,2013,250,AFTER,BASED,CLINICIANS,COPYRIGHT,III,INVADER,IRELAND,LTD,PCR
154,169,2004WHO,2013,474,BACKGROUND,BOTH,COPYRIGHT,EGFR,IRELAND,LABEL,LTD,METHODS,NSCLC,OVERALL,RESULTS,TKI,TREATMENT
240,360,720,8201,AMONG,BACKGROUND,BECAUSE,BRAF,EVALUATION,FURTHER,LABEL,METHODS,PTC,RAF,RESULTS,SOLID,V600E
169,1985,2003,2010,2013,552,770,AIM,AMONG,ASIA,BACKGROUND,CRC,CROHN,FOUNDATION,HEPATOLOGY,HOWEVER,JAPAN,JOURNAL,JULY,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,SIR,THERE,WILEY

AIM,BACKGROUND,CONCLUSION,DESPITE,FIFTY,FIVE,FOUR,FRAMEWORK,INTERVIEWS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,RESULTS,THESE
0001,0156,100,8804,916,ADS,ADSQC,ALSO,LCC,MEM,MEMS,NP63,PLC,PLCS,SCLCS,SGTT,SGTTS,SQC,SQCS,THERE,TTF1
024,065,2002,2010,CARCINOIDS,LABEL,MEAN,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIZE,SUV
99MTC,MDP,SPECT,THERE
139,178,615,8314,8321,8322,A549,AA861,ATP,CASPASE,CHELATION,CYSLT,DIDS,EGTA,ETH,INHIBITION,JANUS,NADPH,ROS,VSOAC
096,169,176,177,197,2013,215,945,946,956,A549,AGAIN,BINDING,COPYRIGHT,IC50,SAS
169,2013,APOPTOSIS,ATF4,BAX,BCL,CHOP,COPYRIGHT,GRP78,GRP94,H71,HEAT,HSP90,PROTEIN,TAKEN,UPR,XBP1
169,2013,COPYRIGHT,EGFR,HOWEVER,IRELAND,L858R,LTD,NSCLC,RESISTANCE,T790M,THERAPY,TKI,TKIS
077,199,1992,2005,418,ALZHEIMER,APC,BESIDES,CARE,CONCLUSION,DECREASES,END,INCIDENCE,LABEL,METHODS,NLTCS,OBJECTIVE,OBJECTIVES,PARKINSON,RESULTS,SEER,TERM,USA
132S,169,2013,20MM,210S,4MM,CAD,CONCLUSION,COPYRIGHT,FIFTY,IRELAND,LABEL,LTD,MATERIALS,METHODS,OBJECTIVE,PURPOSE,READING,RESULTS
HOWEVER,LINAC,MLC,MUS,THEN
214,AKT,HOWEVER,LTF,NPC
015,157,161,1982,1994,BACKGROUND,CD133,CONCLUSION,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,THESE,UNIVERSITY
153,188,2010,2011,634,822,AMONG,BACKGROUND,CONCLUSION,CXR,JANUARY,LABEL,METHODS,RESULTS,UNILATERAL,UVFP
007,127,139,334,AMONG,GWAS,SCLC,SNPS
001,105,2009,2012,223,244,477,BACKGROUND,BIOMARKER,CHINA,III,LABEL,METHODS,NSCLC,RESULTS,STUDIES,THERE,WEB
120,123,169,2013,225,243,500,8804,8805,9801,AMIFOSTINE,AUC,BACKGROUND,BID,CONCLUSION,COPYRIGHT,IIIA,IRELAND,KPS,LABEL,LTD,METHODS,OVERALL,RESULTS,RTOG,THERE
0001,100,103,105,125,1251,160,169,200,2013,COPYRIGHT,D90,GROUP,I125,IMPLANT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PSI,PUBLISHED,PURPOSE,RADIATION,RESULTS,RTOG,SOCIETY,STM,THERAPY,V100,V110,V150
002,15MG,169,2013,2ND,3RD,AFTER,COPYRIGHT,EGFR,HEPATOCYTE,HGF,IHC,III,MET,NSCLC,PFS,SAS,SSP,TKI
109,169,177,2013,CONCLUSION,COPYRIGHT,CTG,DIAGNOSES,DM1,LABEL,METHODS,OBJECTIVE,RESULTS,SANITAIRE,SAS,WHILE
001,005,137,169,2013,383,481,618,COPYRIGHT,INC,LABEL,LOBECTOMY,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RECURRENCE,RESULTS,RFS,SURGERY
0941,169,2013,263,963,AACR,ABT,BCL,BCL2,BH3,BIM,CELLS,ERK,GDC,H2122,KRAS,MAP,MAPK,MEK,PARP,PI3K,TAKEN
169,2013,AACR,CAF,CAFS,DIPEPTIDES,NFS
0044,169,2014,4EBP1,8201,945,AKT,ALSO,ASPC1,BELINOSTAT,BXPC3,HDACI,HIF1,HISTONE,INC,PANCREATIC,PI3K,TAKEN,TREATMENT,VEGF,WILEY
001,016,026,124,COX,MEIER,NSCLC,REAL
169,2013,945,A549,BOP,CCL2,EARLIER,INC,MCP,MMP,MMPS,PAR,PAR1,PAR2,THEIR,THESE,WILEY
946,967,BPL,COX,DFS,ESTROGENS,IHC,MEIER,NSCLC,NUCLEAR,PEARSON,WESTERN
CONCLUSION,FAST,FURTHER,HIGH,INORGANIC,LABEL,UNLABELLED,WHETHER
1574,579,CRF,FORMULA,GIVEN,HIGH,RADIATION
DEFORMABLE,FIRST,HOWEVER,MRF
106,109,183,239,500,8805,AMONG,BACKGROUND,EGFR,LABEL,METHODS,MOST,NSCLC,PEMETREXED,PFS,PRE,RESULTS,SIXTY
BECAUSE,HOWEVER
0001,0019,0156,486,ARHGAP5,LUCIFERASE,NSCLC,PCR,REDUCED,RNAS
A549,ABCB1,ABCG2,ALA,FUNCTIONAL,HOECHST,HOWEVER,MMP,MMPS,PCR,TIMP
182,4T1,ECTOPIC,HENCE,MCF10,METASTASIS,MIM,MISSING,RESTORING,RHOA
169,2013,COPYRIGHT,IRELAND,LTD,MMP,ROS
169,2013,ATUPLEXES,BT474,CALU,CD46,CD55,CD59,CDC,COPYRIGHT,FEDERATION,HER2,KNOCKDOWN,PERTUZUMAB,PUBLISHED,SKOV3,SOCIETIES,THUS
169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,DESPITE,IRELAND,LABEL,LTD,MATERIALS,METHODS
HOWEVER,IRELAND,LTD,NSCLC,PUBLISHED,TIRON,WHILE
093,118,155,169,2013,250,331,4DCT,500,544,569,580,620,AUC,BOOTSTRAP,COPYRIGHT,DOSE,FOUR,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS
001,143,148,169,2013,291,AFTER,AWARENESS,COPYRIGHT,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,OVERALL,PUBLISHED,PURPOSE,RESULTS,THERE,UROLOGICAL
001,030,035,103,1282,160,162,169,191,2013,AUR,CONCLUSION,COPYRIGHT,HOUNSFIELD,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,OPTIMAL,RATIONALE,RESULTS
169,2013,COLLEGE,COPYRIGHT,LTD,PUBLISHED,RILD,ROYAL,THESE
169,195,2013,29B,818,8764,A549,BOTH,COPYRIGHT,FAM,GMBH,KGAA,UNIFORM,VCH,WILEY
A549,HAMDOUN,HOWEVER,HT29,MCF7,MTT,OUED,RESULTS,THUS,TUNISIA
001,168,201,CENTRAL,CHINA,GENOMIC,HAN,HUNAN,LUNG,PCR,RFLP,SOUTH,THESE
121,BOTH,COX,MEIER,NSCLC,PCR,RUNX,RUNX2,WESTERN
014,2008,2011,704,8805,AFTER,AOR,AUG,CHINESE,CONCLUSION,CSF,ELDERLY,IQR,JAN,LABEL,METHODS,OBJECTIVE,RESULTS,VARIABLES
4800,6530,A549,BASED,LTQ,MALDI,TOF,VELOS
160,177,4T1,800CW,BALB,BLI,CD105,FLOW,IRDYE,NIRF,NOTA,PET,SUCCESSFUL
BACKGROUND,EARLY,FIVE,LABEL,METHODS,RESULTS,STENT,TEN,TRIAL,UMIN,URL
0002,0011,0012,003,0046,0057,0081,013,107,2009,2011,8805,BACKGROUND,CONCLUSION,LABEL,METHODS,RESTENOSIS,RESULTS,SEPTEMBER,SEVENTY
2001,2006,BACKGROUND,CAM,CONCLUSION,COUNSELING,EDUCATION,FINANCIAL,KOREA,LABEL,METHODS,NEEDS,RESULTS,SUPPORTIVE,THERE,UNMET
0001,002,004,146A,149,196A,499,BACKGROUND,DFS,LABEL,METHODS,MICRORNAS,NSCLC,RESULTS,RNAS,SNPS,THESE,THREE
169,2013,C57BL,CAV1,FINALLY,JOHN,RAC,SONS,WILEY
0001,0006,0008,003,153,177,ASIAN,ATS,CONCLUSION,EAST,EGFR,ERS,EXON,GGO,HISTOLOGIC,IASLC,IASLE,LABEL,LUNG,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,SOCIETY,STUDENT
029,100,179,2005,2011,208,253,272,905,CONCLUSION,GGNS,IPA,IPAS,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS,ROC,THERE
001,002,023,100,2010,2012,207,212,223,240,245,246,274,280,967,CONCLUSION,FDG,FLT,LABEL,MARCH,MATERIALS,MCNEMAR,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THERE,THUS
169,2013,945,AACR,ADENOVIRUS,CELL,DESPITE,EMT,FINALLY,HDGF,POMC,SMA
ADDITIONAL,BACKGROUND,BONE,CONCLUSION,DATA,DENOSUMAB,LABEL,METHODS,RANK,RESULTS,SRES,USA
8201,FUTHERMORE,SKIN,THEREFORE
001,006,046,169,2012,8804,BACKGROUND,COMPANY,CONCLUSION,COPYRIGHT,DFI,INC,LABEL,METHODS,PULMONARY,RESULTS,WILEY
000,192,2011,2197,558,8364,BMJ,CIGARETTE,GREEK,GROUP,LABEL,LIMITED,METHODS,NATIONS,OBJECTIVE,OBJECTIVES,PROJECTED,PUBLISHED,PUBLISHING,RESULTS
100,342,OWING,THERE
0001,0002,0006,0007,0033,0067,0068,0368,043,3DCRT,3DCX,7328,CGE,D95,HOWEVER,IMRT,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TEN,THERE,V20
169,2013,A549,COPYRIGHT,F68,THUS
169,2013,COPYRIGHT,INC,MOSBY,PUBLISHED,SOCIETY,SURGERY
001,017,169,177,2013,5MM,7CM,9CM,CENTRAL,CONCLUSION,COPYRIGHT,IRELAND,LABEL,LELC,LTD,MATERIALS,METHODS,OBJECTIVE,PULMONARY,PURPOSE,RESULTS
008,047,132,160,169,181,2013,735,A77G,BACKGROUND,COPYRIGHT,DECREASES,INC,LABEL,MATERIALS,METHODS,MMP,RESULTS
1000,169,1994,2010,2013,AUR,CONVERSELY,COPYRIGHT,ENGLISH,INC,JANUARY,LABEL,MATERIALS,METHODS,OBJECTIVE,OBJECTIVES,PPV,PUBLISHED,RATIONALE,RESULTS
169,2013,294,CLINICALLY,COPYRIGHT,IGG,IGG4,INC,NSCLC,TMA
169,2013,COPYRIGHT,INC
100,169,2013,A750,BASED,COPYRIGHT,E746,EGFR,IHC,INC,L858R,LUNG
160,169,2013,JOHN,LTD,MEAN,MODEL,PUBLISHED,RADON,SONS,SWISS,WILEY
169,2010,2011,2013,556,804,ACTA,BACKGROUND,CONCLUSION,FOUNDATION,FOV,FOVS,LABEL,LIMITED,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SIMILARLY
038,052,169,2008,2010,2013,8804,ACTA,BACKGROUND,CONCLUSION,FOUNDATION,JANUARY,KLEBSIELLA,LABEL,MAY,METHODS,OBJECTIVE,PURPOSE,RESULTS,THEIR,UNIVARIATE,UNTIL
103,133,177,ASSESSMENT,BLOOD,CONCLUSION,LABEL,LPS,MEAN,METHODS,MINI,MNA,NSCLC,OBJECTIVE,PFS,RESULTS,TOTALLY
177,BLOOD,CONCLUSION,DECREASED,ELISA,IL6,INCREASED,LABEL,METHODS,NSCLC,OBJECTIVE,PERIPHERAL,PURPOSE,RESULTS,THERE,TSP,VEGF
169,2013,954,COPYRIGHT,ECS,HEALTHY,LEWIS,STAT3,THESE,UICC
0001,001,102,131,8804,CONCLUSION,DTC,FDG,LABEL,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,SERUM
002,023,118,132,150,152,160,198,439,478,BACKGROUND,LABEL,MEIER,METHODS,OPEN,PATIENT,RESULTS,THERE,VATS
160
1607,2043,3677,5127,513,825,CAUCASIAN,CAUCASIANS,CHINA,CHINESE,CIS,FUNCTIONAL,FURTHER,HOWEVER,KNOWLEDGE,LAIRD,ORS,P450,SUMMARY,THESE,THREE
001,145,155,847,8804,HOWEVER,PCR,THEN,THERE,USING,VALIDATION
1607,2000,2003,2010,FPC,FPCS,NORTH,REGISTRIES,SPC,SPCS
169,2013,8776,963,CARLO,COPYRIGHT,FOUR,INC,LABEL,MATERIALS,METHODS,MONTE,OBJECTIVE,PURPOSE,RBE,RESULTS,SMALLER,TEN,USING,V20
169,177,2013,COPYRIGHT,DEFORMABLE,DICE,DIR,DSC,END,INC,INSIGHT,LABEL,MATERIALS,METHODS,OBJECTIVE,PHYSICIAN,PURPOSE,RESULTS,SICLE,TOOLKIT
169,2013,AE3,CAM,CD56,CKAE1,COPYRIGHT,HOWEVER,INC,LUNG,MOST,NASAL,TCS
15Q24,GESAT,HARVARD,SNP,SNPS,TYPE
005,2005,2010,APRIL,BACKGROUND,CURRENT,HOWEVER,JUNE,LABEL,MATERIALS,METHODS,NSCLC,RCT,RCTS,RESULTS,RPA,THERE,THEREFORE,WBRT
109,169,2008,2011,2013,AIM,CONCLUSION,DIAGNOSTIC,EBUS,FOUR,GERIATRICS,JAPAN,LABEL,METHODS,OBJECTIVE,RESULTS,SOCIETY,SPO2,TBNA,THERE,UNIVERSITY
1000,ANTIGEN,AP20178,APC,BACKGROUND,BALB,CALEDONIA,CSF1R,DCS,ELISPOT,FAS,LABEL,MAFIA,METHODS,MICE,PROTECTIVE,RESULTS
033,100,2001,2012,252,BETWEEN,CHEST,CWR,DISEASE,LABEL,LOCAL,MEAN,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESECTION,RESULTS
103,2003,2009,7TH,ADVERSE,AGAINST,APRIL,BACKGROUND,CONCLUSION,FORTY,GRADE,GRAY,GYE,LABEL,METHODS,NSCLC,RESULTS,SBRT,T2A,T2B,TOXICITIES,UICC,UNION,VERSION
0001,5HMC,5MC,BCN,BRESLOW,CMD,DCN,SEVERAL,SSM,TET2
169,2013,33A,A549,ASSAY,BACKGROUND,BONE,COPYRIGHT,CSF,ELISA,GENERAL,GLO,LABEL,LUCIFERASE,METHODS,MICRORNAS,OPG,PCR,PTHRP,RANKL,REAL,RESULTS,THESE
0GY,10MJ,169,2013,53BP1,947,A549,ATM,ATP,BACKGROUND,CONCLUSION,COPYRIGHT,EGFR,GENERAL,H2AX,KNOCKDOWN,LABEL,METHODS,P2Y,RADIATION,RELEASE,RESULTS,SIMILARLY,TRP,TRPM2,TRPV1,UVB
100,169,2006,2012,2013,AIM,BRITAIN,COLORECTAL,CONCLUSION,CRS,DENMARK,DISEASE,FAVOURABLE,GREAT,HIPEC,IRELAND,JULY,JUNE,LABEL,METHODS,MORBIDITY,OBJECTIVE,RESULTS,SHORT,SIX
016,026,035,108,169,201,2013,309,BACKGROUND,BILIARY,LABEL,MEDICAL,MEIER,METHODS,PANCREATO,RESULTS,THESE
169,2013,COPYRIGHT,CURRENTLY,JOHN,LABEL,LTD,MEASURE,METHODS,MRI,MRIS,OBJECTIVE,POST,RESULTS,SONS,WILEY
100,125,133,177,2008,2012,CONCLUSION,GROUP,LABEL,MAY,METHODS,OBJECTIVE,RESULTS,THERE,VATS
0001,105,150,164,256,8805,ASSESSMENT,BACKGROUND,CHINESE,CONCLUSION,EGFR,ERLOTINIB,FACT,FUNCTIONAL,IIIB,INDEX,L858R,LABEL,LCS,LUNG,METHODS,NSCLC,OPTIMAL,OUTCOME,PFS,QOL,RESULTS,THERAPY,TOI,TRIAL
001,015,016,219,557,956,HBXAP,HEPATITIS,HOWEVER,PCR,SERUM,SPSS,TAKEN,TNM
A549,FINALLY,FURTHER,H460,JNK,MAPKS,MCL,NOTABLY,NSCLC,RIP1,STRATEGIES,TIME,TRAIL
A549,BECAUSE,CD133,H446,MSCS,SELECTIVE
945,948,HEAT,HOWEVER,WORKERS
0241,0243,0252,104,BACKGROUND,BRACHYURY,EXPRESSION,KI67,LABEL,METHODS,RESULTS,SLUG
18F,947,AFTER,ANTI,BECAUSE,FDG,HIV,IFN,MAC,NTM,PET
99M,MDP
DIAGNOSTIC,FDG,FINAL,FIVE,FLT,HNSCC,HOWEVER,LABEL,METHODS,OBJECTIVE,OVERALL,PET,RESULTS,THERE
945,946,EM09902,EM22703,FFPE,INTEGRINS,LM609,P1F6,RABMABS
169,2008,2012,229,331,COPYRIGHT,COSTS,COUNTRY,FIGURES,LABEL,MEDICAL,METHODS,OBJECTIVE,OBJECTIVES,OSAKIDETZA,PUBLISHED,RESULTS,SCIENTIFIC,SPAIN,SPANISH
169,2013,946,AKT,COPYRIGHT,FINALLY,IRELAND,LTD,MYC,PP2A,PROTEIN
169,2013,945,COPYRIGHT,EBP,H460,JUN,LC3,LC3II,LTD,NCI,NOTABLY,TAKEN,VAD
169,2013,A549,ADP,COPYRIGHT,COROSOLIC,CRA,LTD,NAC,ROS,THESE
105MG,169,200MG,2013,2A13,2B6,4HS,5DAYS,BRDU,COPYRIGHT,CYP2F,INC,MOA,PUBLISHED,STYRENE
1128,169,2013,BACKGROUND,CONCLUSION,COPYRIGHT,DENMARK,EACH,EARLY,LABEL,LTD,METHODS,RESULTS,THUS
169,2013,COPYRIGHT,HGF,LTD,MET,ONGOING,PUBLISHED,THESE,THUS
100,116,169,177,2013,549,8243,916,936,945,946,956,BHT,COPYRIGHT,DPPH,ESI,GENTIOSIDE,GMBH,HCT,HOP,IRIDOID,LOGANIC,LUNG,MIAPACA,MSMS,PANCREATIC,SRB,SWEROSIDE,SWERTISIN,THP
151,169,175,2013,221,ALK,AMONG,ASC,BACKGROUND,COPYRIGHT,EML4,FISH,FURTHER,INCREASED,IRELAND,LABEL,LCC,LTD,METHODS,NSCLC,RESULTS,SCC,WHILE
169,2013,BBB,CNS,COPYRIGHT,EGFR,HOWEVER,IRELAND,LTD,NSCLC,TKI
169,2013,AMONG,COPYRIGHT,FISH,IRELAND,LTD
001,169,2013,272,BASED,COPYRIGHT,DATA,LABEL,LTD,METHODS,OBJECTIVE,PATIENT,PURPOSE,RESULTS,SCALE,SEEMINGLY,VARIATIONS
003,102,169,199,2013,210,454,467,8805,CIS,COPYRIGHT,EXISTENCE,HRS,INC,LABEL,LOCAL,MATERIALS,MEIER,METHODS,OBJECTIVE,PCLT,PUBLISHED,PURPOSE,RATES,RESULTS,SEVENTY,SIR
169,2013,8804,COPYRIGHT,DIBH,FREE,IMRT,INC,LAD,MEAN,MEDICAL,PUBLISHED,TEN
169,2013,BACKGROUND,CASE,COPYRIGHT,DEPARTMENT,EMERGENCY,INC,LABEL,METHODS,OBJECTIVE
036,049,069,169,2012,238,287,994,AEC,AGE,BACKGROUND,COMPLETELY,COPYRIGHT,LABEL,MAXIMUM,METHODS,NSCLC,PUBLISHED,RESULTS
AREAS,BACKGROUND,COVERED,LABEL,LUNG,METHODS,NSCLC,OPINION,PHASE,SEVERAL,SINCE,TKI
169,2013,AACR,CDK4,EMT,HBEC,HBECS,KRAS,MYC,V12
100,2010,995,996,998,CONCLUSION,INSTITUTE,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,USING
1154,177,2005,2011,318,CONCLUSION,CWT,INFECTION,JANUARY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PCWI,PCWIS,RESULTS,SCWI,SCWIS
169,2013,COPYRIGHT,CTC,CTCS,HOWEVER,PANCREATIC,THERE,UICC
DIAGNOSIS,EBUS,HOWEVER,WEDGE
174,1998,2003,2011,BPF,CONCLUSION,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,PURPOSE,RESULTS,SEVERAL,TACHOCOMB,UNIVARIATE
PRIMARY
15Q25,248,307,8201,COPD,HUNT,NORTH,NOVEL
119,956,AFTER,BJ46A,BURK,C57BL,ENZCHEK,GELATIN,IC50,KINETIC,LINEWEAVER,MHCC97H,MMP,MMP2,MMP9,MMPS,STUDIES,THUS
073,100,BACKGROUND,CEUS,CONCLUSION,LABEL,LRFA,MEANWHILE,METHODS,OBJECTIVE,PURPOSE,RESULTS,RFA,SONOVUE,THERE,THESE
169,2000,2008,2013,274,7TH,BETWEEN,CONTROL,CRT,EMR,ENDOSCOPIC,ESOPHAGUS,HOWEVER,IIA,IIB,III,INC,JANUARY,JAPAN,LOCAL,SALVAGE,SOCIETY,UNION,WILEY
100,102,14022,169,2013,3735,AIM,ASIA,BIOMARKER,CONCLUSION,EARLY,LABEL,LTD,METHODS,OBJECTIVE,PROTEIN,PTY,PUBLISHING,RESULTS,SAX,SELDI,SERUM,TOF,WILEY
169,2013,273,COPYRIGHT,JOHN,LASSO,LTD,SONS,WILEY
152,177,713,CONCLUSION,ICU,INDEX,LABEL,METHODS,OBJECTIVE,PITTSBURGH,PSQI,QUALITY,RESULTS,SLEEP,SPSS
A375,H460,MCF,NCI,SIDERIN,THREE
169,2013,COPYRIGHT,IRELAND,LTD,MDM2,SLUG,THEREFORE,WHILE
183,18F,FDG,GEORG,INCREASED,LEFT,PET,STUTTGART,YORK
2002,2007,ALSO,CURRENTLY,EBUS,SAMPLES,TBNA
017,109,509T,869C,946,BOTH,COX,LOG,MEIER,SNPS,TGF,THESE
2004,2009,445,472,816,8805,AEGJ,BACKGROUND,ECOG,GAC,JAPAN,LABEL,METHODS,RESULTS,THERE,THEREFORE
025,030,1999,2009,BACKGROUND,DFS,GROUP,HOWEVER,LABEL,MARCH,MEIER,METHODS,OVERALL,RECURRENCE,RESECTION,RESULTS,SIMILARLY,THEREFORE
0001,143,177,2006,2011,8804,CEA,CTP,CYFRA,DISTANT,JANUARY,LABEL,MARCH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS
001,127,140,177,2000,2010,340,8201,945,982,ABO,AMONG,CALCULATED,CHRONIC,GVHD,HIF,HYPOXIA,IGG,JANUARY,NIH,OCTOBER,SCT,THESE
3019,CLINICALLY,CTGF,DESPITE,HIF,METASTATIC,MOST,SCID,THEREFORE,THESE
147,169,2000,2011,2013,395,782,ALSO,COPYRIGHT,COX,EDUCATION,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,PUBLISHED,PULMONARY,PURPOSE,RECURRENCE,RESULTS,THERE,THOSE,UNIVARIATE,UROLOGICAL
169,2013,ALK,BASCA,COPYRIGHT,HOWEVER,INC,MUTATIONS,NSCLC
CTF,THEREFORE
110,160,169,2013,8593,8595,ANNEXIN,BACKGROUND,COPYRIGHT,DMAG,HDAC,HSP90,LABEL,LTD,LUNG,METHODS,MOLECULAR,NSCLC,OBJECTIVE,PROTEIN,PTACH,RESULTS,THUS,USING
119,169,2013,823,857,8805,989,BOTH,CONCLUSION,COPYRIGHT,EMPHYSEMA,FEV1,HOUNSFIELD,IRELAND,LABEL,LTD,LUNG,METHODS,MLD,OBJECTIVE,OBJECTIVES,PFT,RESULTS
169,2013,966,AMED,BACKGROUND,CONCLUSION,COPYRIGHT,DAILY,DUE,HOWEVER,LABEL,LIST,LTD,LUNG,MEDLINE,METHODS,MODE,MOST,PRE,PREMEDLINE,QOL,RCTS,RESULTS
169,2013,945,CONCLUSION,COPYRIGHT,DISTANT,FIVE,INC,LABEL,LACK,LMS,LMSS,LUNG,METHODS,OBJECTIVE,ORAL,PUBLISHED,PURPOSE,RESULTS,THESE,THREE,TREATMENT
169,1986,1997,1998,2009,2013,516,967,CONCLUSION,CONVERSELY,COPYRIGHT,FIFTY,HISTOLOGIC,INC,LABEL,LRF,MATERIALS,MEIER,METHODS,OBJECTIVE,ORAL,OVERALL,PUBLISHED,PURPOSE,RESULTS
107,123,169,2013,COPY,COPYRIGHT,FGFR1,FIBROBLAST,LABEL,LTD,MATERIALS,METHODS,NOVEL,OBJECTIVE,OBJECTIVES,OTSCC,OUTCOME,RESULTS
169,1985,2010,2013,401,BACKGROUND,DATA,EXTENSIVE,JANUARY,LABEL,MARCH,METHODS,OBJECTIVE,OBJECTIVES,PATIENT,RESULTS,RPCI,SKIN,SOCIETY
947,948,ANNATTO,UNDERLYING
946,DAE,OVERALL
002,2002,2010,213,AGGRESSIVE,BACKGROUND,BETWEEN,FORTY,LABEL,MATERIALS,METHODS,MST,MSTS,NON,NSCLC,OCTOBER,RESULTS,SRS,WBRT
0001,0003,0043,014,024,177,232,452,899,ADIPOKINES,NSCLC,SCLC,SERUM,THERE,THESE
100,150,956,CONCLUSION,EMBOLIZED,EVALUATION,FORTY,LABEL,LOCAL,METHODS,OBJECTIVE,PURPOSE,RCC,RESULTS,SAP,SIXTEEN,SOLID,TAE
2006,2010,485,8804,887,895,AWARENESS,DISEASE,FACTORS,JANUARY,LABEL,LOWER,METHODS,OBJECTIVE,PCCS,PURPOSE,RESULTS
III,NOVEL,NSCLC,STAGE
180,803,817,8805,BACKGROUND,CIS,COPD,FOLLOWING,INCENTIVE,LABEL,METHODS,PPC,RESULTS,SOCIETY
ATRX,DAXX,EPIGENETIC,NET,NETS,RASSF1A
169,2013,COPYRIGHT,FIVE,INC,LABEL,UNASSIGNED,UNLABELLED,VOCS
166,2008,2012,BETWEEN,JULY,JUNE,LABEL,METHODS,MLT,OBJECTIVE,OBJECTIVES,PORT,RESULTS,SEVEN,THERE,THREE,WHILE
100,BASED,FIVE,FSS,NSCLC,THESE
002,008,021,041,119,2000,2004,2009,567,BETWEEN,JANUARY,LABEL,MAY,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SEPTEMBER,THERE,THESE,UNIVARIATE
169,CURRENTLY,INC,THEREFORE,THESE,WILEY
001,003,004,136,2008,2010,APRIL,BACKGROUND,COMPARING,CXR,HOWEVER,JANUARY,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,THERE,THREE
025,527,BACKGROUND,CONCLUSION,DISTANT,LABEL,LRC,METHODS,PET,POST,RESULTS,SABR,VATS,VIDEO
015,FEV1,FIFTY,FVC,IVPCA,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SUBJECTIVE
169,2013,BRITAIN,CONVERSELY,COPYRIGHT,CRC,EZH2,GREAT,HMT,HOWEVER,IRELAND,JOHN,KNOCKDOWN,LTD,MMP2,PUBLISHED,SOCIETY,SONS,STAT3,VDR,WILEY
001,012,013,092,138,193,CONCLUSION,COX,DCR,III,LABEL,MEIER,METHODS,OBJECTIVE,ORR,PFS,RESULTS,SCLC
002,005,014,106,118,A549,BE1,DEC1,KNOCKDOWN,LOSS,NSCLC,TNM
102,262,266,290,329,334,402,894,95TH,BOTH,ELISA,FIXED,LABEL,METHODS,MPM,OBJECTIVE,PURPOSE,RESULTS,WHILE
AREAS,BACKGROUND,COVERED,FINALLY,FUNCTIONS,LABEL,METHODS,OPINION,RATIONALE
169,2013,954,HMGB1,HOWEVER,LMWH,LOW,RAGE,TREATMENT
0001,0004,0455,100,578,ASSESSMENT,CHRONIC,FORM,FORMULA,FUNCTIONAL,GROUP,HOWEVER,ILLNESS,KRUSKAL,LABEL,LIFE,MAYO,MEDICAL,METHODS,OBJECTIVE,ONGOING,OUTCOME,PURPOSE,QOL,QUALITY,RESULTS,SCALE,SHORT,SPIRITUAL,SWB,THERAPY,THERE
946,CTC,CTCS,CUB,DCE,EGF,EGR1,EMT,HEY1,HOWEVER,LOX,MICROARRAY,MMP,MMPS,MRI,NSCLC,YRPW
PET
160,CONCLUSION,CRT,III,LABEL,LUNG,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS
0009,001,0044,006,109,247,289,300,418,882,913,BASED,DFS,HIGH,RESULTS,TMPRSS4
100,169,177,2013,24H,956,A549,CELL,COPYRIGHT,DOPE,DOX,IRELAND,LDH,LTD,PEG,PLD
169,2013,946,ALSO,CBP,COPYRIGHT,EGCG,EMT,EPITHELIAL,IRELAND,LTD,SMAD,SMAD2,SMAD3,TGF,THEREFORE
001,1998,2000,2005,2007,544,8804,935,967,CONCLUSION,DESPITE,DUKE,END,FACTORS,IMAGING,LABEL,MATERIALS,METHODS,NORTH,NORTHEAST,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SOUTH,UNIVERSITY
169,2013,CCL2,CD11B,CONCLUSION,GMBH,KGAA,LABEL,MDSC,METHODS,RESULTS,SCOPE,SINCE,STAT3,VCH,WILEY
111,123,2006,ACTH,CUP,FDG,FDOPA,MIBG,NET,PET,PREVIOUSLY,SPECT,THEN,UNION
169,2013,8805,COPYRIGHT,HISTONE,INC
169,2013,500,AMONG,BAC,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,IIIB,INC,LABEL,METHODS,NSCLC,PEMETREXED,PFS,RESULTS,TREATMENT
169,2013,BECAUSE,COPYRIGHT,GAUSSIA,GLUC,HELA,IGM,JAPAN,PUBLISHED,SBC,SOCIETY
024,165,169,2013,ALK,AMONG,CHFR,COPYRIGHT,EGFR,EML4,EXCLUDING,INC,KIRSTEN,KRAS,REVERSE,THUS
169,2009,2011,2013,270,287,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,NSCLC,PUBLISHED,RESULTS,SOCIETY,SURGERY,THERE,THESE
169,2013,COPYRIGHT,ELEMENT,LTD,REPRESSOR,REST,SILENCING
001,169,2013,BACKGROUND,COPYRIGHT,END,INC,LABEL,MCT,MCTS,METHODS,PREDICTORS,RESULTS,SURGERY
169,2013,CATALDO,JOHN,LCS,LTD,LUNG,SONS,THERE,THESE,WILEY
120,197,240,360,ARQ,AUC,BACKGROUND,CONCLUSION,CYP2C19,EMS,FORTY,LABEL,MET,METHODS,NSCLC,PMS,REGARDLESS,RESULTS,TIVANTINIB
001,2106,2661,HOWEVER,META,THERE,VATS,VIDEO
177,3MM,7MM,LEFT,POSTERIOR,RIGHT,SETUP,SRT
HOWEVER,METASTATIC,MRI,MSD,PET,RFA,THERE
CHEST,PALLIATIVE,THERE
122,2007,2011,BACKGROUND,CONCLUSION,EBUS,JULY,LABEL,METHODS,NON,NPV,NSCLC,RESULTS,TBNA,THERE
169,2012,945,946,COPYRIGHT,HPLC,LTD
169,2013,COPYRIGHT,DIFFUSE,IRELAND,LTD
121,169,2013,344,353,388,BACKGROUND,CYTOLYT,CYTOPATHOL,EGFR,GENOTYPING,HOWEVER,LABEL,LBC,METHODS,RED,RESULTS,SEVERAL,SOCIETY,SPRAY
0001,0039,0050,169,2013,BACKGROUND,CEA,CNPES,COPYRIGHT,CYFRA,CYRFA,HER2,LABEL,LAC,MEAN,METHODS,PES,RESULTS,SOCIETY,THEIR
169,1993,2008,2013,ALK,BACKGROUND,EGFR,EML4,LABEL,METHODS,RESULTS,SOCIETY
215
041,0599,2008,2011,CHEAPER,CUMULATIVE,LABEL,MAY,METHODS,OBJECTIVE,PEMETREXED,PURPOSE,RESULTS
116,147,AUSTRALIA,BOARD,CONSENTING,DDB,DUST,LABEL,MALIGNANT,METHODS,MPM,OBJECTIVE,PATIENT,PURPOSE,RESULTS,THOSE
1420,214,215,3001,658,802,936,BACKGROUND,BMJ,DESPITE,GROUP,IHD,LABEL,LCD,LCDS,LER,LIMITED,METHODS,MINNESOTA,PUBLISHED,PUBLISHING,RESULTS,SHS,THESE
100,177,BACKGROUND,IIIB,LABEL,LCNEC,METHODS,PFS,RESULTS,SCLC
040,169,2013,203,930,963,974,ASIA,JAPAN,LTD,MODEL,PTY,PUBLISHING,WILEY
169,174,2013,CDT,COPYRIGHT,HOWEVER,INC,MOST,SVC,THROMBOSIS,UACDT,ULTRASOUND,WILEY
000,100,2004,400,HIT,ICER,LABEL,LIT,METHODS,OBJECTIVE,QALY,QALYS,RESULTS,SEK,SEK26,SEK50,SEK7,SEK8,SWEDISH,THUS,USD1
001,007,CONCLUSION,FIFTEEN,LABEL,METHODS,NSCCL,NSCLC,OBJECTIVE,PCR,PURPOSE,RCR,RESULTS,REVERSE
124,1975,2006,516,625,III,LABEL,LATE,LUNG,MATERIALS,METHODS,OBJECTIVE,RCC,RESULTS
143,1757,2008,ASIAN,BACKGROUND,CONCLUSION,EVE,EXE,GRADE,HER2,LABEL,METHODS,PBO,PFS,PRIMARY,QUALITY,RESULTS,SECONDARY,TREATMENT
169,2013,COPYRIGHT,FURTHER,GIST,LTD,THUS
169,2013,945,ACTIVATED,COPYRIGHT,HOWEVER,IRELAND,LTD,MAPK,MITOGEN,NSCLC,PROTEIN
169,2013,954,AKT,C666,CNE,COPYRIGHT,CXCL8,CXCR2,EBV,FUNCTIONAL,FURTHER,HNE,HONE,HOWEVER,IRELAND,LTD,MACROPHAGE,MIF,NPC,PI3K,SUNE,TAKEN,THEREFORE
169,2013,COPYRIGHT,IRELAND,LARGE,LTD
169,2013,947,ALDH,CD24,CD44,COPYRIGHT,HES,HEY,IRELAND,LTD,NOTABLY,NOTCH,PANCREATIC,PDA
169,2013,BIO,CD63,COPYRIGHT,EFIRM,GFP,H460
2012,CHERNOBYL,CONFERENCE,LABEL,MAINE,OBJECTIVE,PURPOSE,RADIATION,RESULTS,RUSSIAN,USA
169,2013,302,ALK,COPYRIGHT,EGFR,ERBB2,FGFR1,FGFR2,FGFR3,FISH,GFRS,IGF1R,KIT,KRAS,MET,NSCLC,OVERALL,PCR,THRESHOLDS,UICC
001,003,015,169,2013,270,432,708,877,888,ALA,ALA499VAL,ASIAN,COPYRIGHT,DESPITE,GLN,LYS,LYS939GLN,MEDLINE,OVERALL,UICC,VAL,XPC
0001,036,050,071,100,106,134,8804,956,CONCLUSION,FDG,GLUCOSE,LABEL,METHODS,MMR,MRGLC,OBJECTIVE,PET,PURPOSE,RESULTS,SKM,TCP
100,200,256,ANOVA,CNR,COMPARISON,DUNNETT,FBP,FIVE,GGO,GGOS,SIMULATED,THERE,TUKEY
2004,2007,352,AGE,AUSTRALIA,BACKGROUND,DENMARK,HOWEVER,LABEL,METHODS,NET,RESULTS,ROUTINELY,SIMILAR,STAGE,THERE,TNM
150,151,COX,DEPRESSION,EGFR,FORTY,FURTHER,LABEL,MDS,METHODS,NSCLC,OBJECTIVE,PATIENT,PHQ,RESULTS
183,8211,CVD,DENMARK,ESTIMATES,HALVING,IHD,LABEL,METHODS,OBJECTIVE,RESULTS,SETTING
169,2001,2013,219,230,CEA,COPYRIGHT,COST,HAGAN,HOWEVER,IRELAND,LTD,MEDICAL,NAG,STEVENS,UNDER
001,0201,121,160,169,2013,233,254,259,312,424,545,8804,COPYRIGHT,GROUP,INC,JAPAN,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
COPD,SASP,THESE
2004,2008,350,351,360,5043,5051,ADJ,CLIN,CONCLUSION,EFFECTIVE,ENGL,HOWEVER,IALT,IIIA,LABEL,LACE,MED,METHODS,NSCLC,OBJECTIVE,ONCOL,PURPOSE,RESULTS,THEN,VARIABLES
000,029,1999,2009,235,281,632,774,8804,950,AMONG,CHINA,FUDAN,HUASHAN,LABEL,LIVER,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,UNIVERSITY
178,1987,1996,2009,252,8309,832,8805,COX,CRT,HRS,HRTC,INCREASED,INSTITUTE,RISK,SIR,SIRS,THERE,UNIVERSITY,VILNIUS
0001,BIOVU,DISCUSSION,FINALLY,FREQUENCY,ICD,LABEL,MATERIALS,METHODS,NINTH,OBJECTIVE,RESULTS,USING,VANDERBILT
008,1152,27632,BEIGE,METASTATIC,MLC,ROCK,ROCKI,SMALL,SY5Y,TREATMENT
189,349,397,8201,956,AKT,ERK,IC50,LPA,MLC2,PAK,PDGF,RHO,RKI,RKIS,ROCK,ROCK1,ROCK2
169,2013,COPYRIGHT,INC,LUNG,MICRORNAS,PUBLISHED,RNAS,SOCIETY
169,2004,2006,2013,233,8805,BACKGROUND,BCA,COPYRIGHT,FIVE,INTUITIVE,LABEL,MEIER,METHODS,NONE,OBJECTIVE,OUTCOME,PARAMETERS,PUBLISHED,RARC,RESULTS,SETTING,SIX,THESE,THREE,URINARY,UROLOGY,USA,VINCI
169,2013,BECAUSE,BOTH,COPYRIGHT,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY,THREE,VIRTUAL
001,169,177,2012,AIDED,BACKGROUND,CAT,COLLECTING,COPYRIGHT,DATA,IRELAND,LABEL,LTD,METHODS,NSCLC,RESULTS
AOM,DSS,SRX,THESE
127,139,2008,2011,8805,BACKGROUND,BETWEEN,C30,EORTC,GIVEN,HRQOL,IIIA,LABEL,LC13,MDIS,METHODS,NSCLC,OCTOBER,OVERALL,QLQ,QOL,RESULTS,TAXOL
1990,400,AFTER,BNCT,BORON,CAPTURE,INSTITUTE,KURRI,KYOTO,NEUTRON,REACTOR,SINCE,THERAPY,UNIVERSITY
113,BSC,FURTHER,HOWEVER,SEVERAL,THEREFORE,WBRT,WHETHER
FINALLY,MRI,NSCLC,SURGERY
001,047,1980,2009,389,4603,4992,DESPITE,GROUP,JANUARY,LABEL,METHODS,NON,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,THERE
100,177,2004,2012,BETWEEN,FEW,LABEL,MEIER,METHODS,NONE,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,TYPE
017,169,2008,2010,2013,8804,AES,BACKGROUND,CONCLUSION,COPYRIGHT,DRUG,EACH,FDA,FEDERAL,INC,JULY,LABEL,MAY,METHODS,ORR,OVERALL,PFS,PUBLISHED,RESULTS,SCLC,TOPOTECAN,TREATMENT,TTR
048,127,8201,AFRICAN,BACKGROUND,EFFECTS,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS
945,946,A549,AKT,CL1,CONVERSELY,FURTHER,HOWEVER,JAGGED2,LEWIS,LUNG,THESE,THUS
125,132,139,152,2006,2011,7TH,ACCORDING,AMONG,BACKGROUND,CRC,FURTHER,IVA,IVB,JANUARY,JUNE,LABEL,METHODS,NPC,PC1,PERITONEAL,RESULTS,THERE,TNM
180,8805,BOTH,COMPARING,ECOG,LABEL,METHODS,MST,OBJECTIVE,OBJECTIVES,RESULTS,SCLC,SENSITIVE,SIXTY,TFI,THERE
1983,2011,ANOTHER,DFSP,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE
0032,011,8805,CONCURRENT,DOSE,FORTY,HOWEVER,INCLUSION,INCREASING,LABEL,MATERIALS,METHODS,OBJECTIVE,PURPOSE,RESULTS,TREATMENT
231,MAPK,MDA,METASTASIS,MMP
232,BHD,BIRT,BOTH,DUB,FLCN,HITS,HOGG,PTEN
123,160,184,1992,2010,967,BACKGROUND,COX,DATA,ESTIMATED,HOWEVER,LABEL,LAR,METHODS,OVERALL,RESULTS,THERE
100,169,2013,CORRECT,ESCC,ESOPHAGUS,INC,LOCAL,RFA,SOCIETY,THREE,WILEY
100,132,177,BAP,LABEL,MATERIALS,METHODS,OBJECTIVE,PAP,PURPOSE,RESULTS,TBP,THERE,TOTAL
001,173,ALTERED,BACKGROUND,CRMP,CRMP1,CRMP2,CRMPS,LABEL,METHODS,REDUCED,RESULTS
169,2013,A549,COPYRIGHT,GNPS,GOLD,HOWEVER,LBS,SOPG,TEM
100,111,169,2013,BACKGROUND,BASED,CLUSTER,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EARLY,FUNCTIONAL,HOWEVER,INC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS
200,8201,AUC,CAM,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,THERE
169,2013,ACTA,BACKGROUND,BECAUSE,COMPARING,COMPARISON,CONCLUSION,FOUNDATION,INCREASED,JOHN,LABEL,LTD,METHODS,PTPS,PUBLISHED,RESULTS,SONS,THEREFORE,THESE,WILEY
009,011,126,BASED,FUNCTIONAL,HCC,LOWER,PCR
152,177,2005,2009,2010,378,8804,COX,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,PET,PURPOSE,RESULTS,SCLC,TNM
160,197,BOARD,COMPARISON,CONCLUSION,FORMULA,IMAGE,LABEL,METHODS,OBJECTIVE,PLBS,PURPOSE,RESULTS,SIRIO,SISTEMA
BACKGROUND,CONCLUSION,EVIDENT,GPS,INTERVIEWS,LABEL,METHODS,OBJECTIVE,PATIENT,REASONS,RESULTS,SIMILAR,SOLUTIONS,SUBTHEMES,THOSE,ZEALAND
193,1980,2001,365,966,AFTER,BACKGROUND,CONCLUSION,FOLLOWING,LABEL,MATERIALS,METHODS,RESULTS
FDG,MARY,PET
169,2013,COPYRIGHT,DESPITE,FURTHER,ISSUE,NOVEL,REFINEMENT,SECRETOME,SPECIAL,UPDATED
169,2013,COPYRIGHT,ISSUE,SECRETOME,SPECIAL,THEREFORE,UPDATED
009,1323,169,2013,AIMS,AKT,BACKGROUND,COPYRIGHT,HCC,HEP1,HKCI,HOWEVER,LABEL,LIVER,METHODS,MIHA,OBJECTIVE,PIWI,PUBLISHED,RESULTS,RNAS,SILENCING,SMALL
100,141,169,194,2013,335,ACHAETE,COPYRIGHT,HIGH,HOWEVER,INC,USING
169,1996,2003,2013,AMONG,BECAUSE,COPYRIGHT,DATA,FURTHER,INC,LPA,LUNG,MEDLINE,OCTOBER
1990,2011,2380,3009,5389,DATA,EBMR,LND,LNS,MEAN,NSCLC,OVID,THERE,THESE,VATS
001,007,BOOTSTRAP,COX,FORM,FURTHER,INVENTORY,LABEL,MDASI,METHODS,OBJECTIVE,PATIENT,PRO,PROS,PURPOSE,RESULTS,SEVERAL,SHORT,SYMPTOM
169,177,181,2013,A549,AKT,COX,EPA,H1299,INC,PGE2,PGE3,TAKEN,WHILE,WILEY
001,104,178,2001,2011,215,948,CONCLUSION,CRC,CSS,CTX,EGFR,FIFTY,FORTY,IQR,LABEL,METHODS,NINE,OBJECTIVE,PURPOSE,RESULTS,RFS,SMR,SURGERY,VEGF
169,2013,CD138,CD20,COPYRIGHT,IGKC,IRELAND,LTD,NSCLC
169,2013,COPYRIGHT,F18,FDG,INC,PET
006,025,027,8197,8201,8804,ACUTE,DVH,GRADE,IFRT,III,NSCLC,PURPOSE,THERE,V35
AFTER,AITL,ALCL,ALK,ATLL,CHOP,EATL,FDG,HOWEVER,ICE,INTERIM,KETTERING,MOST,NKTCL,NOS,PET,PFS,PTCL,PTCLS,SLOAN,THERE
1035,1057,157,2007,2011,438,452,460,8364,BACKGROUND,FERRARA,FINALLY,ITALY,JUNE,LABEL,MATERIALS,MAY,METHODS,NSCLC,RESULTS,UNIT,UNIVERSITY
946,956,A5W9,CACO2,HELA,HEP2,HEPG2,IC50,MCF7,MTT,VIABILITY
114,121,169,2012,2013,361,369,BACKGROUND,COMPARISON,CYTOPATHOL,EGFR,FFPE,LABEL,LASER,METHODS,NSCLC,RESULTS,SOCIETY,SPECIMENS
DYSPNEA,MILD,POST,PPS,PTFE,THEN,UNDER
001,2000,2009,226,ACS,ATS,CONCLUSION,ERS,HOWEVER,IASLC,III,JANUARY,LABEL,LUNG,METHODS,OBJECTIVE,PURPOSE,RESULTS,STAGE,TUMOURS
12L,AFTER,FIVE,IIA,STAGE,T1A,T1B,TTF,WEDGE
PAPVC
SIX
001,006,019,027,046,266,277,486,521,AUSTRALIA,BACKGROUND,GEOMETRIC,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIXTY,TDI,THERE,THESE,WESTERN
969,BACKGROUND,CONCLUSION,CONTEXT,HOWEVER,LABEL,METHODS,NNN,NPS,OBJECTIVE,THERE,THESE,WESTERN
53BP1,947,ADF,ATM,CFL,CHK1,COMET,CONCLUSION,DSB,FINALLY,H1299,H2AX,HOWEVER,HRR,LABEL,MATERIALS,METHODS,NHEJ,OBJECTIVE,PURPOSE,RESULTS,S3A,S3D
169,2013,A549,ARACHIDIN,ERCC1,ERK1,H1975,JOHN,LTD,MEK1,METFORMIN,NSCLC,PUBLISHED,SOCIETY,SONS,WILEY
160,AFTER,FINE
EXPRESSION,FACS,MOST,PROPERTIES,SPC,THUS,TRANSWELL,TREATMENT,WESTERN
0074,043,098,207,420,544,648,664,701,794,967,AIMS,BACKGROUND,COX,CUGBP,EXPRESSION,LABEL,METHODS,NON,NSCLC,OBJECTIVE,PCR,RESULTS,SEMI,TNM
160,185,214,215,257,500,BACKGROUND,CISPLATIN,CONCLUSION,EACH,FIFTY,LABEL,MATERIALS,METHODS,NSCLC,RESULTS

003,113,146,160,600,CHT,CONCLUSION,DMFS,HFX,III,LABEL,LPFS,METHODS,MST,MTLP,OBJECTIVE,PURPOSE,RESULTS
8201,945,FURTHER,HOWEVER,SNP
000,105,156,HOWEVER,LABEL,METHODS,OBJECTIVE,RESULTS,SEVEN,THEREFORE
0001,056,230,ADC,ADCS,BAC,COX,EGFR,EPIDERMAL,III,KIRSTEN,KRAS,L858R,LABEL,MEIER,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SURGERY
8805,FORTY,HOWEVER,KARNOFSKY,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PALLIATIVE,RERT,RESULTS,SCLC
0001,0003,0004,001,002,AFTER,DESPITE,GROUP,LABEL,LES,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THUS
110,169,2013,BAX,BCL,BKV,BRAF,COPYRIGHT,JCV,MCPYV,NSCLC,PCR,RB1,REAL,RESULTS,RKIP,UICC
160,1987,2008,BASED,CAREFUL,EIGHT,LABEL,METASTATIC,METHODS,MTT,MTTS,OBJECTIVE,PURPOSE,RESULTS
100,2009,2011,BACKGROUND,JULY,LABEL,METHODS,NSCLC,RESULTS,UMIN
105,EARLY,EASTERN,ECOG,GROUP,UPPER
169,1994,1996,2013,253,656,8805,COPYRIGHT,GENERAL,HOWEVER,OUTCOME,PREVIOUSLY,STRONGEST,THESE,UICC
005,139,144,160,170,1982,2006,270,353,ABDOMINAL,BACKGROUND,COMPETING,DSS,GRADE,HOWEVER,LABEL,METHODS,MOST,OVERALL,RESULTS,SITE,THUS
1984,2011,BACKGROUND,CAUSE,COX,CUMULATIVE,DISEASE,LABEL,LNM,MEDICAL,MEIER,METHODS,MORTALITY,OVERALL,RECURRENCE,RESULTS,SEAC
001,002,107,160,169,198,2013,836,843,887,898,926,973,AUC,AUCS,BPE,BPES,CEA,COPYRIGHT,CYFRA,MICROARRAY,MPE,MPES,PCR,REAL,UICC
169,2013,COPYRIGHT,IPF,LTD,MUTATIONS,PCR,PROTEIN,SURFACTANT
113,169,1999,2005,2013,BACKGROUND,CNS,COPYRIGHT,COX,HER2,LABEL,LTD,MBC,MEIER,METHODS,RESULTS
169,2005,2009,2012,COPYRIGHT,DEPARTMENT,IIA,IIB,LABEL,METHODS,OBJECTIVE,OCTUBRE,PSC,PUBLISHED,RESULTS,SEPAR,SEVEN,SPAIN,SURGERY,TEN
1750,177,1824,183,2006,2007,2010,2011,787,8804,8805,APRIL,COPD,JUNE,MORTALITY,OCTOBER,THEIR,VITAL
THESE,USING
34A,947,A549,COX,H1299,LYGDI,NSCLC,RAC1,RESULTS,TAKEN
001,005,006,010,019,042,127,128,139,141,177,3DCT,4DCT,795,866,CTV,DMEAN,DVH,HOWEVER,IMRT,THERE,V30,V40,V50
0001,001,177,2004,2011,916,AUC,BETWEEN,CHANGES,DYNAMIC,FEV1,FVC,LABEL,LUNG,METHODS,MPM,NPV,OBJECTIVE,OBJECTIVES,PPV,RESULTS,ROC,STUDENT
001,004,005,008,015,040,062,118,136,170,194,236,245,273,288,297,344,379,460,478,487,518,542,585,743,783,793,801,810,853,862,919,975,BONE,EGFR,INITIAL,LABEL,METHODS,NSCLC,OBJECTIVE,PRS,PRT,RESULTS,TKIS
BACKGROUND,CRF,DESPITE,FIT,LABEL,METHODS,NSCLC,OBJECTIVE,PHASE,PLUS,RESULTS,WII
169,2013,8201,THREE,THUS,UROLOGICAL
0001,0002,002,004,2574,BOOTSTRAP,ESOS,FEV1,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,ROC,SOCIETY,STS,USING
005,174,177,228,249,8201,AXIAL,BACKGROUND,CONCLUSION,CONSENSUS,LABEL,MATERIALS,MAXIMUM,MDCT,METHODS,MIP,OBJECTIVE,OVERALL,RESULTS,THERE,THREE,USING
18F,AKT,AZD5363,CALU,DEOXY,FDG,GIVEN,LABEL,METHODS,MICE,OBJECTIVE,PET,PURPOSE,RESULTS,U87
183,8201,DSA,FOLLOWING,GEORG,LABEL,METHODS,OBJECTIVE,RESULTS,STUTTGART,VAT,VATS,YORK
183,GEORG,HOWEVER,STUTTGART,THERE,YORK
183,APVD,GEORG,STUTTGART,THERE,VATS,YORK
3DRT,CTV,EPID,FOUR,LABEL,METHODS,OBJECTIVE,PTV,PURPOSE,RESULTS,TREATMENT,TYPICALLY
110,117,126,159,164,2000,2010,212,AFTER,BACKGROUND,DFI,FIFTY,JANUARY,LABEL,LYMPH,METHODS,MINIMALLY,RESULTS,VATS
000,400,ASSOCIATED,BONE,CARCINOMA,CURRENTLY,RANK,RANKL,TREATMENT,TREATMENTS
CD34,MMP,MVD,NSCLC,SHP2,THEREFORE,TIMP,USING,VEGF,VEGFR
160,8482,AGREEMENT,CAD,CHEST,DESR,LOW,MCNEMAR,ONGUARD,SIMILARLY
169,2013,AE1,AE3,COPYRIGHT,CSF,GIVEN,INC,LMM,WILEY
AMERICANS,CANSASA,COMMERCIAL,INDIANS,LUNG,NATIVES,THESE,USING,YET
169,2013,AFTER,CD133,CELLS,CIC,COPYRIGHT,CXCR4,NOD,NOTABLY,PACA,PACIC,PANCREATIC,SCID,THUS,UICC
056,057,065,084,128,169,2013,228,406,670,800,8201,824,864,8804,930,COPYRIGHT,HOWEVER,OVERALL,THERE,UICC
109,240,267,8201,C15,C30,CONCLUSION,CORE,EORTC,LABEL,LIFE,METHODS,OBJECTIVE,PAL,PALLIATIVE,QLQ,QOL,QUALITY,RESULTS,SPECIAL,THREE,TREATMENT,UNIVARIATE
109,120,130,177,207,366,406,437,475,518,580,599,677,8201,8364,861,960,ADRS,ASYMMETRIC,COSTS,EASTERN,ECOG,EIGHT,GROUP,ICU,III,LABEL,MEAN,METHODS,NINE,NSCLC,OBJECTIVE,PURPOSE,RESULTS,TMC
ALDH,ALDH1,BACKGROUND,CONCLUSION,HER2,KI67,LABEL,METHODS,NONE,PNS,RESULTS,THERE
001,037,132,169,2013,494,AATD,COPYRIGHT,CRP,FEV1,KCO,LTD,PULMONARY,SELF,SIXTY
166,169,2013,213,379,ADDITIONAL,COPYRIGHT,EGFR,HOPKINS,INC,JOHNS,KRAS,MUTATIONAL,SEVERAL,USING
LTDDS,THEREFORE
4DCT,8805,BACKGROUND,CONCLUSION,GTV,LABEL,METHODS,MIDV,RESULTS
169,2013,947,BALB,CD8,COPYRIGHT,ELISPOT,FLOW,FOWLPOX,MALIGNANT,PCR,UICC
RIGHT
HENCE,NSCLC,PDXK,PLP,PYRIDOXAL,THUS
148,160,1983,2008,759,8805,944,BACKGROUND,BETWEEN,CRC,LABEL,METHODS,POTENTIAL,RESULTS
00001,0001,100,160,169,2013,3698,461,BARRETT,COMPARING,COPYRIGHT,CYTOLOGIC,DESPITE,GASTRIC,GERD,INC,LGL2,LOSS,MUC,MUC2,MUC6,SURFACE,THESE
169,2013,COPYRIGHT,IMPROVING,IRELAND,LTD,LUNG,THESE
169,2013,AKT,COPYRIGHT,DESPITE,EGFR,FIRST,GIVEN,HOWEVER,INC,MUTATIONS,NSCLC,PI3K,TKI,TKIS
0011,103,115,125,160,169,191,2013,209,218,ACADEMY,AJCC,AUTHORS,INTER,INTRA,JOURNAL,LABEL,METHODS,MRI,NPV,OBJECTIVE,OBJECTIVES,OVERALL,PET,PPV,RESULTS,VIBE,VOLUMETRIC,WHOLE
1979,1986,1996,2002,2046,2060,ABOUT,CASES,DATA,EXPERTS,INTERVIEWS,LABEL,METHODS,OBJECTIVE,RESULTS
177,8321,ANCHORS,BACKGROUND,FEV,HRQL,IMPACTS,LABEL,LAM,METHODS,PLOTS,RESULTS,SGRQ,SIROLIMUS,USING,WHETHER
946,CHEST,IIIB
SEVERAL,THERE,WNT
1918,1958,1980,1981,2006,626,6320,813,LABEL,METHODS,OBJECTIVE,OBJECTIVES,POISSON,PREVENTIVE,RESULTS,SIR,SIRS,SWEDISH,TOTAL
1970,2006,2040,LEE,PROJECTING,SMOKING
169,2012,2013,CONCLUSION,COPYRIGHT,COUPLED,ERK,ERK2,EXPRESSION,GIT1,HEPATOLOGY,INCREASED,LABEL,LIVER,MAT2B,MEK,MEK1,METHIONINE,PROTEIN,UNLABELLED,USING
116,117,202,AUC,EIGHT,LASSO,ROC
100,1951,1985,2004,236,568,6409,956,ERR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SMR
0001,006,177,8201,BIA,FATIGUE,LABEL,METHODS,NUMERAL,OBJECTIVE,RANK,RESULTS,SCALE
118,161,169,2013,309,613,CIS,COPYRIGHT,GIVEN,IRAN,ODDS,OPIUM,ORS,THERE,UICC
169,2013,AKT,COPYRIGHT,EGFR,EXOGENOUS,HGF,MET,PI3K,S6RP,SEVERAL,THESE,TKI,TKIS,UICC,USING
042,183,2003,2007,607,723,748,8201,905,954,ACCORDING,BACKGROUND,CONCLUSION,GEORG,JANUARY,LABEL,METHODS,OVERALL,PATHOLOGIC,PET,RESULTS,STUTTGART,THERE,YORK
12P40,169,2013,946,947,B16,CD4,COPYRIGHT,CPG,IFN,N202,ODN,STUDIES,TREATMENT,UICC,UPON
2DG,ACCORDING,ATF6,ECTOPIC,GRP78,IHC,KNOCKDOWN,LUNG,RNAS,RRBP1,TAKEN,UNRAVELING,UPR
CPG,ECSOD,EXPRESSION,HMEC,REPRESSION
FURTHER,MICE,THESE
945,AKT,HER2,HOWEVER,MMTV,NEU,NEUNT,PROTEIN,PTP,PTPRA,THUS
200,28B,EMT,HMGA2,INHIBITION,KNOCK,LIN,MCF,OSM,STAT3,THESE,ZEB1
120,169,2013,ACY1,COPYRIGHT,CRC,FURTHER,HOWEVER,INC,TNM
169,2012,241,CD20,COPYRIGHT,ESPA,FDG,HODGKIN,NON
0001,0004,002,004,148,169,177,1952,2010,2013,577,BASED,ESOPHAGUS,FIFTY,INC,OPTIMAL,SIXTY,SOCIETY,WILEY
169,2013,2248,2260,AKT,COPYRIGHT,EPH,EPHA2,ERK,HEPATOLOGY,HOWEVER,LIVER,MEK,PYK2,RAF,S897,SRC,T308,THESE,Y402
580,AMONG,BORTEZOMIB,DOSE,LABEL,METHODS,NCI,OBJECTIVE,PURPOSE,RESULTS
INCREASING,LUNG
300,8201,8805,AIM,ANOVA,ANTI,ANTICANCER,BACKGROUND,DATA,EGFR,FIFTY,GRADE,INDEX,LABEL,LIFE,METHODS,PRIMARY,QUALITY,RESULTS,SKIN,TOXICITIES,TREATMENT
2007,2009,8201,8805,ACUTE,APRIL,ASSESSMENT,CHRONIC,EASTERN,ECOG,EVALUATION,FAILURE,GROUP,HOWEVER,ICU,JANUARY,LABEL,MEDICAL,METHODS,OBJECTIVE,ORGAN,PURPOSE,RESULTS,SAMSUNG,SCALE,SEQUENTIAL,THERE
067,2001,2011,8201,ANXIETY,ASSESSMENT,DATA,DEPRESSION,ENGLISH,FORM,FORTY,FUNCTIONAL,HRQOL,INVENTORY,LABEL,MEDICAL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SCALE,SHORT,SYMPTOM,TABLE,THERAPY,THEREFORE,WHILE
169,2014,BACKGROUND,CASE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,SMART,STROKELIKE
046,ABSORBABLE,CHEST,LABEL,METHODS,OBJECTIVE,OBJECTIVES,REGARDLESS,RESULTS
169,177,2013,COPYRIGHT,DAH,HOWEVER,HRCT,INC,LABEL,MATERIALS,METHODS,OBJECTIVE,RESULTS,SCT,SIXTEEN
0001,0021,0266,0368,042,105,169,2013,8805,ADHERENCE,ASSESSMENT,BAAS,BACKGROUND,BASEL,CONCLUSION,COPYRIGHT,DCR,DISEASE,EFFECTIVE,INC,LABEL,METHODS,NSCLC,RESULTS,SCALE,VAS
001,002,010,120,169,170,2013,290,373,832,BACKGROUND,COPYRIGHT,DESPITE,EGFR,INC,LABEL,METHODS,NSCLC,PFS,RESULTS,SEOUL,TREATMENT,UNIVERSITY
007,015,203,259,429,BACKGROUND,HOWEVER,KLEBSIELLA,LABEL,LTD,METHODS,PRIOR,PUBLISHED,RESULTS,STATA
169,177,2013,BACKGROUND,CONCLUSION,COPYRIGHT,GGO,GGOS,HOWEVER,HRCT,INC,IPAH,LABEL,METHODS,PCH,PVOD,RESULTS
197,1986,2009,AFTER,AGGRESSIVE,BOARD,CONCLUSION,DSS,DUE,EBRT,ETE,FOUR,KETTERING,LABEL,LRFS,MATERIALS,MEIER,METHODS,OBJECTIVE,OVERALL,PDTC,PURPOSE,RAI,RESULTS,RRFS,SLOAN,T4A,TEN
000CM,100NM,181,22MG,26NM,545,640,6MG,ACCORDING,BACKGROUND,CMD,ELPI,FURTHER,HAZARDOUS,LABEL,METHODS,MOST,OBJECTIVE,OBJECTIVES,RESULTS,SUBSTANCES,THEREFORE
174,SUNITINIB
001,104,2008,2011,APRIL,INHALED,LABEL,METHODS,OBJECTIVE,OCTOBER,PURPOSE,RESULTS
ENGLISH,LITERATURE,PRIMARY,TREATMENT
196,203,211,298,509,8805,945,BACKGROUND,CONCLUSION,LABEL,MAIN,METHODS,OBJECTIVE,OBJECTIVES,RATIONALE,RESULTS,SERUM
343,683,700,846,8734,DATA,HODGKIN,ISRAELI,NORTH,STUDIES
CUTANEOUS,SKIN
177,BLAND,CONCLUSION,FORTY,LABEL,MATERIALS,METHODS,OBJECTIVE,PET,PURPOSE,RESULTS,THESE
120,630,8226,8320,8326,AFTER,DCE,DYNAMIC,EVALUATION,EVEN,KEY,LABEL,METABOLIC,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PET,RER,RER60,RESULTS,SOLID,USING
154,381,763,788,818,BOTH,ECOG,HOME,HOWEVER,LABEL,METHODS,NURSE,OBJECTIVE,PATIENT,PHYSICIAN,PHYSICIANS,PURPOSE,RESULTS,ZOL
AFRICAN,ARABIAN,ASIA,ASIAN,BACKGROUND,CAUCASIAN,CONCLUSION,EAST,EGFR,FINE,HOWEVER,LABEL,METHODS,POLYMERASE,RESULTS,THERE,WORLDWIDE
105,108,149,152,170,190,196,2002,2010,412,608,AFTER,DISEASE,FIVE,LABEL,METHODS,NCSLC,NSCLC,OBJECTIVE,OBJECTIVES,OPERATIVE,OVERALL,RESULTS,STAGE,VATS
109,206,443,AFTER,AMONG,HOWEVER,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PROCEEDING,PULMONARY,RESULTS,STAGE,WHETHER
169,2007,2011,2013,AIM,APRIL,ASIA,BETWEEN,BOTH,CONCLUSION,DESPITE,HOSPITALS,HOWEVER,JUNE,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RECORDS,RESULTS,RGRT,SEPTEMBER,TREATMENT,WILEY
10R,12L,12R,BOTH,LABEL,LUNG,LYMPH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SINCE,STAGE,THERE,THEREFORE,VATS,ZONE
116,1NFK,954,A549,AKT,ANALOGS,HCT,LANTADENE,MCF,P50,PDB,THESE,VERO
100NM,169,2013,48H,50NM,7DAYS,945,947,CNH,CNHS,COPYRIGHT,DATA,HISTOLOGIC,HOWEVER,IFN,INC,LABEL,TNF,UNASSIGNED,UNLABELLED
001,006,024,098,169,2003,2009,2013,226,234,451,560,898,BACKGROUND,COPYRIGHT,COX,FIFTY,FURTHER,III,INC,LABEL,METHODS,NSCLC,RESULTS,SCC,SIXTY
001,005,050,150,169,195,2013,748,844,928,BACKGROUND,COPYRIGHT,EGFR,FURTHER,IIIA,INC,LABEL,MATERIALS,METHODS,MUTATIONS,NSCLC,RESULTS
100,1150,200,ACA,ACAS,BACKGROUND,BIOCARE,BOTH,CALIFORNIA,CELL,CONCORD,CONTEXT,LABEL,MEDICAL,METHODS,OBJECTIVE,RESULTS,SCC,SCCS,SMCC,SMCCS
8201,AFTER,FDG,GROSS,GTV,III,LOCAL,MEAN,NSCLC,NUMBERS,PET,PTV,SHRINKING
A549,BONE,CD44,HYALURONAN,MES
740,783,BACKGROUND,BRAF,ION,LABEL,LANGERHANS,LIFE,MACHINE,METHODS,PANEL,PGM,PULMONARY,RESULTS,SEQUENCER,SMALL,V600E
23RD,DIAGNOSIS
2001,PDT,SEPTEMBER
TOR,TREATMENT
169,1991,2011,2012,BACKGROUND,CONCLUSION,COPYRIGHT,FIVE,INC,LABEL,METHODS,PROCEDURES,RESULTS,TEN,THERE,THREE,WILEY
169,2012,8201,BECAUSE,COPYRIGHT,III,JOHN,LTD,PFS,SONS,USING,WILEY
169,2013,COPYRIGHT,HOWEVER,UICC,USING,VIRAL
169,2012,INC,WILEY
169,2000,2010,2012,BACKGROUND,BRAIN,COPYRIGHT,LABEL,METHODS,MRI,OBJECTIVE,PURPOSE,RESULTS,SOCIETY
CD20,CD79A,HHV,HIV,HODGKIN,HOWEVER,LNA,ORF73,PEL,PRIMARY,RITUXIMAB
169,2012,232,945,946,APMIS,AXIN,EPIDERMAL,GSK,JOHN,LTD,NUCLEAR,PRESERVED,PUBLISHED,REDUCED,SONS,STROMAL,UNIVARIATE,WILEY
001,002,174,629,735,AFTER,FIFTY,KISS,METASTASIS,RCC
155,EGFR,FNA,FNAS,KRAS,NSCLC,PREP,SOMATIC,THEREFORE,THIN,TKIS
100,AMONG,BACKGROUND,DTP,LABEL,LIKELIHOOD,METHODS,PET,RESULTS,SIXTY,SUV
100,153,155,169,2013,593,712,743,807,AREA,AUC,BACKGROUND,BCE,BONE,CONCLUSION,COPYRIGHT,INC,LABEL,METHODS,NTX,OSTEOMARK,PRINCETON,RESULTS,ROC,THERE
001,004,169,2001,2009,2013,8805,APRIL,BETWEEN,COPYRIGHT,GTV,INC,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,SEPTEMBER
00001,0002,009,169,1990,2012,2013,4790,CIS,COPYRIGHT,CROWN,DEPENDING,HRS,INC,JANUARY,MARCH,PFS,PUBLISHED,RCTS
182,2000,2010,8804,BETWEEN,COX,FIFTY,III,LABEL,MEIER,METASTATIC,METHODS,OBJECTIVE,OBJECTIVES,RESULTS
00132,525,87MG,ATP,AXL,DDR1,FLT3,H441,HGF,I3O,JSBA,KOFF,KP4,LY2801653,MERTK,MET,MKN45,MKNK1,MST1R,ROS1,TEK
1920,1953,1961,1974,1990,2005,441,DEMOCRATIC,DNT,HOWEVER,LABEL,LAENDER,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIR
BASED,IIIA,IIIB,NSCLC,THERE,TREATMENT
169,2013,AKT,INC,INITIAL,MIGRATION,PI3K,PI3KS,RAS,THUS
ADENOSINE,AMP,AMPK,ATP,BECAUSE,DATA,FURTHER,LKB1,METFORMIN,ONCE,THESE,TORC2,VIRTUALLY
169,2014,COPYRIGHT,FURTHER,INC
DRF,DRFS,OPTIMAL,RESULTS,THESE
169,18F,2012,241,COPYRIGHT,ESPA,FDG,FOUR,HOWEVER,PET,SEVERAL,THEREFORE,THUS
200,300,812,8805,954,AFTER,BACKGROUND,CONTEXT,EGFR,FOLLOWING,LABEL,METHODS,OBJECTIVE,RESULTS,SPECIMENS
100,181,AMONG,EC50,HT168,K562
260,273,540,553,646,652,681,ABOUT,ASSESSMENT,CARE,GUIDELINES,LABEL,METHODS,OBJECTIVE,PROFILE,PURPOSE,RESULTS,SHEFFIELD,THOSE
215
LUNG,MDCT,VARIANT
LUNG
022,160,2008,2010,455,BACKGROUND,CRLM,DIAGNOSTIC,EHD,FOUR,LABEL,METHODS,RESULTS,THEREFORE,USING
001,004,006,150,169,179,2013,379,762,947,ADC,ADCS,AMONG,BISH,COPYRIGHT,IGF,INC,INSULIN,SCC,THESE
233,499C,BHD,BIRT,DUB,FLCN,GLN167X,HOGG,HOWEVER
001,034,055,160,181,226,272,429,578,AUC,CD25,IGA,IGG,III,LABEL,MANN,METHODS,NSCLC,OBJECTIVE,PURPOSE,RESULTS,ROC,SINCE,TREG,WHITNEY
003,2008,214,8804,8805,ANAEMIA,BACKGROUND,ESA,ESAS,LABEL,MANAGEMENT,METHODS,RESULTS,SPAIN,SPANISH
160,243,ATS,BACKGROUND,ERS,HISTOLOGIC,HOWEVER,IASLC,INCIDENCE,LABEL,LUNG,METHODS,NSCLC,PRECISE,RESULTS,SOCIETY
001,021,072,123,153,160,1998,2008,291,306,BETWEEN,FIVE,HOWEVER,III,LABEL,LRR,METHODS,NEITHER,NSCLC,OBJECTIVE,OVERALL,PATHOLOGIC,PET,PURPOSE,RESULTS,USING
004,034,042,048,160,BACKGROUND,C30,DEPRESSION,EORTC,HRQL,IIIB,INTERVIEW,LABEL,LACK,LC13,METHODS,NSCLC,QLQ,RESULTS
THESE
2008,2010,BETWEEN,CHEST,CONCLUSION,FTCWR,GUARD,LABEL,METHODS,OBJECTIVE,PATCH,PAUL,PERI,PLASTIC,RESULTS,SUCCESSFUL,SYNOVIS,USA
169,2004,2010,2013,BACKGROUND,COPYRIGHT,COX,CRT,DMFS,GIVEN,INC,LABEL,MEDICAL,MEIER,METHODS,NSCLC,OVERALL,PFS,RESULTS,RUSH,UNIVERSITY
169,1988,1998,1999,2004,2005,2008,2013,8804,BACKGROUND,COPYRIGHT,EARLY,END,GROUP,INC,LABEL,LATE,LUNG,METHODS,NSCLC,RESULTS,SINCE,STUDIES,THESE
MFH,PRIMARY,THERE
169,181,2012,8201,A549,CDC6,CNV,CONTINUOUS,FOXM1,INC,LOH,NULI,THESE,WILEY
169,2013,AMONG,COPYRIGHT,DOCETAXEL,DTX,EMT,HOWEVER,INC,NSCLC,SPC,WILEY,ZEB1
001,169,2013,ALDH,COPYRIGHT,EMT,EPCAM,EPITHELIAL,INC,MPE,MPES,PCR,SLUG,SNAIL,THEREFORE,TWIST,WILEY
HOWEVER,LATER,T10,THERE
2002,2011,BACKGROUND,CONCLUSION,FURTHER,LABEL,LCNEC,LUNG,METHODS,RESULTS,SEPTEMBER,SMALL
177,CBCT,CNR,THESE
946,HOWEVER,SEX,SOX,SOX4,TCF,THESE,WNT
945,946,CONCURRENT,EMT,HIF,HIF1,HIFS,HYPOXIA,MICE,PRIMARY,RESPONSES,ROS,SRC,Y654
155,169,2013,BIC,CLUSTER,DOWN,GIVEN,MICRORNAS,MIR,RNAS
169,2000,2012,BACKGROUND,BASED,BNI,COPYRIGHT,DAILY,EMBARKING,JANUARY,LABEL,LTD,MEDLINE,METHODS,OBJECTIVE,OVERALL,PSYCHINFO,PURPOSE,RESULTS,SEPTEMBER,SUPPORTIVE,THESE,THROUGH,YET
0006,001,003,008,029,137,160,169,2013,299,436,502,COPYRIGHT,HOWEVER,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SOLID,SURGERY
100,169,2005,2012,AIM,AML,CCMMT,CCSTS,COLLEGE,CONCLUSION,COPYRIGHT,DYNAMIC,HMB,JANUARY,KNOWLEDGE,LABEL,LAM,LTD,MARCH,MATERIALS,METHODS,MOST,MRI,OBJECTIVE,PECOMAS,PUBLISHED,RESULTS,ROYAL,T2WI,THERE,THREE,TUMOURS
174,BIOGLUE,FDG,PET,SUBSEQUENT
001,027,039,177,2002,2010,COX,HISTOLOGY,III,IMIG,LABEL,LUNG,MEIER,METHODS,MORTALITY,MPM,OBJECTIVE,OBJECTIVES,RESULTS
2008,2011,202,824,CRP,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,TREATMENT,WBC
001,042,047,054,AXL,BACKGROUND,DOWNSTREAM,GAS6,LABEL,METHODS,RESULTS,RTK,RTKS
CUTANEOUS
100,119,127,135,163,169,172,1998,2002,2004,2009,2012,270,COPYRIGHT,CTNB,GROUP,INC,THERE,THESE,WILEY
169,2013,980,CE6,COPYRIGHT,DOX,FRET,GMBH,KGAA,NIR,PDT,THREE,UCNPS,VCH,WILEY,ZNPC
006,012,017,036,051,105,169,2012,916,ACCORDING,ADC,CHANGES,CONCLUSION,COPYRIGHT,FDG,INC,LABEL,MATERIALS,METHODS,MRI,OBJECTIVE,PET,PFS,PURPOSE,RESULTS,SUV,WILEY
169,2011,2012,294,755,ASSESSMENT,CHI,CHINESE,CONCLUSION,COPYRIGHT,DEEKS,DIAGNOSTIC,DWI,ENGLISH,HOWEVER,INC,LABEL,MATERIALS,MEDICAL,METHODS,OBJECTIVE,POTENTIAL,PURPOSE,QUALITY,RESULTS,ROC,SEN,SEPTEMBER,SPE,STUDIES,WILEY
2004,2009,2010,APRIL,BACKGROUND,LABEL,MARCH,METHODS,NSCLC,RESULTS
424,945,946,AIMS,CNS,EXPRESSION,LABEL,METHODS,MOST,OBJECTIVE,OVERALL,RESULTS
169,2012,A549,COPYRIGHT,GMBH,MRC5,TREATMENT,VIABILITY
001,003,004,007,009,022,113,HOWEVER,JEGHERS,LKB1,LOSS,PEUTZ,THEREFORE,USING
118,132,258,549,IDH1,IHC,WESTERN
169,2012,306,COPYRIGHT,CUP,HRS,LIMITED,LUNG,MEIER,SWEDISH,UICC
015,033,1ST,263,AFTER,COX,LABEL,LEFT,METHODS,NEITHER,NON,OBJECTIVE,OBJECTIVES,RESULTS
0001,016,046,2008,2011,204,214,265,898,AMONG,BETWEEN,FDG,HOWEVER,LABEL,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,PET,RESULTS,SEPTEMBER
DATA,FEDERAL,GIVEN,MOST
LKB1,SINCE
100,169,2012,956,ACTIVATING,BACKGROUND,COPYRIGHT,EGFR,EXONS,LABEL,METHODS,NSCLC,RESULTS,SIXTY,SOCIETY
126,143,145,169,182,183,200B,2012,205,210,30A,30D,451A,486,528,598,COPYRIGHT,HOWEVER,UICC,USING
004,0135,035,183,1986,2005,8201,8804,929,BACKGROUND,BETWEEN,CONCLUSION,COX,GEORG,INSTITUTE,JIN,LABEL,LUNG,MALIGNANT,MEDICAL,METHODS,NSCLC,OBJECTIVE,PROGNOSTIC,RESULTS,STAGE,STUTTGART,T1AN0M0,T1BN0M0,TIAN,TNM,UNIVERSITY,YORK
160,GLY450VAL,PARK2,SER9THR,SSCP
0001,001,007,161,1990,2007,623,8804,IIIA,LABEL,METHODS,NSCLC,OBJECTIVE,OVERALL,PM1,PM2,PURPOSE,RESULTS
160,IMAGING,ORBITAL,TREATMENT
135,150,222,8201,AIMS,ASIATIC,BACKGROUND,CAUCASIAN,EGFR,ERLOTINIB,EVEN,III,IIIB,ITALIAN,LABEL,METHODS,NORTH,OBJECTIVE,RESULTS,TODAY
2000,2003,2005,5298,8804,929,BACKGROUND,CANCORS,CRN,HMO,HOWEVER,III,LABEL,METHODS,NETWORK,OBJECTIVE,PPV,RESULTS,SECONDARY
168H,169,174,200,200NM,2013,215,320,320NM,80NM,COPYRIGHT,DOC,DOCETAXEL,INC,LABEL,PRINT,SKOV,THUS,UNASSIGNED,UNLABELLED
169,2012,8194,8195,956,CONCLUSION,EBUS,FURTHER,GEP,JOHN,LABEL,LTD,METHODS,MOLECULAR,NSCLC,OBJECTIVE,RESULTS,SONS,WILEY
0004,0006,001,115,169,2012,APMIS,AUTOPHAGIC,BCL,BNIP3,GLUT,JOHN,LTD,MOST,NSCLC,PUBLISHED,SONS,STAGE,WILEY
001,002,036,090,1987,2002,2010,452,6TH,7TH,8804,BACKGROUND,CONCLUSION,COX,IASLC,IIA,IIB,KAROLINSKA,LABEL,LUNG,METHODS,NSCLC,RESULTS,SWEDISH,T1A,T1B,TNM,UNIVERSITY
100,169,2012,8201,BALT,BRONCHIAL,COPYRIGHT,JOHN,LTD,SONS,WILEY
1992,2007,BOTH,CONCLUSION,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SSTS
169,2012,A549,AMONG,COCL,COPYRIGHT,HCT,JOHN,LNCAP,LRP1,LTD,ROS,SONS,WILEY
00001,002,160,793,AIM,BEGG,EGGER,GRADE,LABEL,MANAGER,METHODS,OBJECTIVE,RESULTS,RRS,SIX,STATA,STUDIES
EGFR,MLN,NSCLC,TKI
183,BRONCHIAL,GEORG,STUTTGART,YORK
100,1072,288,AFTER,LUNG,THEREFORE
001,116,118,147,160,169,2009,2010,2013,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EIGHT,GUIDELINES,HOUSTON,INC,IQR,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS,SEPTEMBER
250,ADVERSE,ASSESSMENT,BACKGROUND,DISEASE,EVALUATION,FUNCTIONAL,IIIB,LABEL,LOCAL,LUNG,METHODS,NSCLC,RESULTS,SBRT,SOLID,THERAPY,TREATMENT
2002,2009,AMONG,BRAIN,CCR,EGFR,FORTY,KRAS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,OVERALL,PFS,RESULTS,SEPTEMBER
177,183,2006,2010,8201,BACKGROUND,DEPARTMENT,FACULTY,GEORG,III,LABEL,METHODS,PAMUKKALE,RESULTS,STUTTGART,SURGERY,UNIVERSITY,YORK
CAIX,CSC,CSCS,EMT,JAGGED1,THESE
CD44,KRAS,MAPK,USING
133,133A,133B,AFTER,BOTH,LABEL,METHODS,OBJECTIVE,RESULTS,T24,WESTERN
2009,AVILA,BMX,EGFR,IRM,MERCK,TEC,THEREFORE,THESE
176,8805,ADVERSE,AMONG,ELDERLY,GRADE,LABEL,LUNG,MEAN,METHODS,MLD,PREDICTORS,PTV,RESULTS,UNLABELLED
2010,284,BACKGROUND,BLACK,CONTROL,HISPANICS,INTERVIEW,LABEL,LATINOS,METHODS,RESULTS,SUPPLEMENT,WHITE
012,042,043,100,169,177,2012,BACKGROUND,CONCURRENT,COPYRIGHT,FIVE,HOWEVER,INC,INOUE,LABEL,MEAN,METHODS,RESULTS,WILEY
109,149,8804,BOX,HMG,SIX,SOX10,SRY
003,017,1981,2007,450,5590,962,END,HODGKIN,NHL,POISSON,PROGRAM,RESULTS,SEER,THERE
169,2012,ADP,COPYRIGHT,HELA,JOHN,LEWIS,LTD,SONS,THESE,WILEY
169,2013,INC,WILEY
160,27TH,ENGLISH,INITIALLY
167,169,2012,AMONG,CES,COPYRIGHT,DELAYED,DEPRESSION,DEPRESSIVE,FCS,FOUR,GMM,IL10,IL1R2,LABEL,LTD,METHODS,OBJECTIVE,PEAK,PURPOSE,RESILIENT,RESULTS,SNPS,STUDIES,TNFA,VARIATION,VARIATIONS,WHILE
AIMS,CONCLUSION,COUPLED,ERK,G12D,HOWEVER,INNOVATION,LABEL,METHODS,NRF2,NSCLC,OBJECTIVE,PRX,RESULTS,ROS,TAKEN,THESE,USING
106,169,1997,2011,2012,ANZ,AUTHORS,BACKGROUND,COLLEGE,COLORECTAL,CONCLUSION,EVEN,IQR,JOURNAL,LABEL,LUNG,MANN,METHODS,PATIENT,RESULTS,ROYAL,SURGERY,THERE,WHITNEY,ZEALAND
1998,2011,BETWEEN,CONCLUSION,DFS,LABEL,LOBECTOMY,METHODS,MGC,OBJECTIVE,PULMONARY,PURPOSE,RESULTS,SIX,TDT
169,2012,A549,AKT,C1Q,COPYRIGHT,CRP,DOWNSTREAM,GMBH,HIF,LLC,PDT,PI3K,PRESENT,PTX3,SAP,SINCE,TREATMENT
169,2012,COPYRIGHT,PUBLISHED,SAS
004,226,946,GYN,III,KEY,LABEL,METHODS,OBJECTIVE,QOL,RESULTS,STAGE,SWB
166,COX,EGFR,HER2,LOSS,MBT,MGMT
142,147,150,160,2000,2011,BACKGROUND,CAUSE,CLOSE,CONCLUSION,LABEL,METHODS,PATIENT,RESULTS
100,160,BACKGROUND,FIVE,HCC,HOWEVER,ICG,LABEL,METHODS,RESULTS
400,500,800,B12,BACKGROUND,EIGHT,GRADE,LABEL,METHODS,MTD,PAZOPANIB,RESULTS,VEGFA
169,170,175,194,2012,300,AIMS,ASIA,CONCLUSION,CREMOPHOR,LABEL,LTD,METHODS,NP220,NP300,OBJECTIVE,PACLITAXEL,PTY,PUBLISHING,RESULTS,WILEY
0001,0109,0896,2006,2009,8201,ALBERTA,BACKGROUND,CARE,JULY,LABEL,MEIER,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SECONDARY
169,2012,4T1,945,ALDH,COPYRIGHT,CSCS,DEAB,HIF,HIGH,HYPOXIA,IRELAND,LTD,THEREFORE,TREATMENT
002,009,2008,2010,8805,ANESTHESIA,ELDERLY,JANUARY,LABEL,LYMPH,METHODS,NSCLC,OBJECTIVE,OBJECTIVES,RESULTS,SOCIETY,THERE
1008,1015,169,2012,2013,8201,8804,BACKGROUND,DCS,FEV0,FEV1,FIFTY,FRC,HSCT,INC,INITIAL,IPFT,IPFTS,LABEL,LUNG,MAIN,METHODS,MOST,NEHI,OBJECTIVE,PEDIATR,RATIONALE,RESULTS,RVRTC,WILEY
108,169,2012,522,COPYRIGHT,CYP24A1,CYP27A1,CYP27B1,GSVS,HNC,SERUM,SPC,SPCS,THESE,THREE,UICC,VDR
001,003,169,196,2012,203,242,252,262,293,409,8201,845,847,864,8804,8923,967,AIM,ASIA,CHINESE,CONCLUSION,LABEL,LTD,METHODS,NSCLC,OBJECTIVE,PCR,PTY,PUBLISHING,RESULTS,RFLP,WILEY
148,169,1988,1997,2006,2007,2009,2012,289,389,8201,AIMS,ASIA,AUSTRALIA,BOARD,CONCLUSION,DUST,IHC,INITIAL,LABEL,LTD,MARCH,METHODS,MPM,OBJECTIVE,PANEL,PTY,PUBLISHING,REFLECTING,RESULTS,ROYAL,TESTING,WILEY
169,2012,8804,8805,BASED,CELLS,COPYRIGHT,HPF,INC,LCNEC,MITOTIC,NUCLEAR,PAPILLARY,PNET,PNETS,PULMONARY,SCLC,WILEY
169,2012,COPYRIGHT,HISTOLOGY,INC,PLEURAL,RIGHT,THESE,WILEY
001,169,2012,242,8201,AMONG,COVARIATES,FUHRMAN,LABEL,METHODS,OBJECTIVE,OVERALL,RESULTS,SOCIETY,UROLOGICAL
130,139,169,2006,2008,2012,233,904,AML,BAL,CHEST,COPYRIGHT,FOUR,INC,JANUARY,SEVEN,SIXTEEN,THERE,WILEY
169,2012,A549,COPYRIGHT,H1299,HOWEVER,IRON,THEREFORE,TREATMENT,UICC
AFTER,AMR,AMRUBICIN,CDDP,CPT,SALVAGE,SMALL,SMCCE
169,2012,954,A549,DPCS,ROS
0001,001,004,005,114,160,164,169,1983,2011,2013,BARRETT,CANCERS,COPYRIGHT,FIVE,INC,JANUARY,LABEL,LESS,METHODS,MOSBY,OBJECTIVE,OBJECTIVES,PATIENT,PUBLISHED,RESULTS,SEVEN,SEVENTY,SURGERY
001,006,183,774,946,ADOLESCENT,BLOOD,HEART,HOMA,INCREASES,INSTITUTE,LABEL,LUNG,METHODS,OBJECTIVE,RESULTS,SERUM,SETTING,UNASSIGNED,USA
169,2012,ATPASES,AUTHORS,BECAUSE,FEBS,JOURNAL,SERCA
169,2012,237,241,COPYRIGHT,ESPA,HISTOLOGY,NEUROCIRUG,PUBLISHED,SCLEROSING,SEF
001,8211,8216,8217,ANOVA,BASED,C30,COX,DESPITE,FURTHER,III,LIFE,MEIER,NSCLC,QUALITY,TREATMENT
160,200,CO2,UNDER,USING
169,2012,AMONG,COPYRIGHT,HSV,MAGE,NED,NOTABLY,THREE,UICC

000,001,100,2002,2006,349,613,AREA,BETWEEN,MEIER,TNM
001,027,160,169,2013,889T,AMONG,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,GLU_GLU,INC,INSTITUTE,LABEL,LYS_GLU,LYS_LYS,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS,T251A,THESE
123,177,1972,2008,205,ALTOGETHER,ATC,AUTOPSY,BACKGROUND,BOTH,CONCLUSION,DESPITE,LABEL,LESS,LUNG,METHODS,RESULTS
169,2012,549,BACKGROUND,CHECKLIST,COPYRIGHT,CPC,FATIGUE,FULL,JOHN,LABEL,LTD,METHODS,PAIN,PART,PROBLEM,REFERRALS,RESULTS,ROUTINE,SONS,WILEY
BASED,FLOT2,FLOTILLIN,MMTV,PYMT,SHORT
001,006,014,120,CONCLUSION,ECOG,LABEL,METHODS,OBJECTIVE,PSD,PURPOSE,RESULTS,SCLC,SMALL
AIM,ALEXA,ALSO,ARRPKLD,BASED,CONCLUSION,DTPA,LABEL,MATERIALS,METHODS,NSCLC,OBJECTIVE,RESULTS,SRXPXXX,THX
2006,2011,8804,8805,COX,FOUR,GRADE,JULY,LABEL,METHODS,OBJECTIVE,PROGNOSTIC,PURPOSE,RESULTS,SABR
007,012,017,038,20GY,35GY,LABEL,METHODS,OBJECTIVE,OVERDOSAGE,PRONE,PTV,PURPOSE,RESULTS,TEN
001,005,016,103,160,BACKGROUND,GRANT,III,IIIB,LABEL,METHODS,NCI,NSCLC,OUTCOME,PHASE,PROGRAM,PROJECT,QOL,RESULTS,STAGE,THERE
BOTH,CASE,EUS,FNAB,IMAGING,PANCREATIC
169,2012,241,COPYRIGHT,EBUS,ESPA,PUBLISHED,SEPAR
EGFR,ERLOTINIB,NSCLC,TKI
005,1998,2008,654,AGE,BACKGROUND,CASE,CLINICO,CONCLUSION,FEW,LABEL,METHODS,NSCLC,RESULTS

100,150,400,600,800,BACKGROUND,ESCALATING,LABEL,METHODS,MTD,OVERALL,RESULTS,THESE
160,177,DTPA,EOB,FIVE,HDRBT,LABEL,MEAN,METHODS,MRI,NONE,OBJECTIVE,PURPOSE,RESULTS,SIX,TEN,THREE
169,2012,A549,ADIPOSE,AFT,CONVERSELY,COPYRIGHT,DIFFERENT,HBEC,INC,THESE,TREATMENT,WILEY
003,169,2012,407,499,8805,ADDITIONAL,COPYRIGHT,LARGE,LUNG,MENOPAUSAL,UICC
AIM,BACKGROUND,CONCLUSION,INTERVIEWS,LABEL,METHODS,MIXED,NINE,NON,OBJECTIVE,RESULTS,SETTING,SEVEN,WHAT
113,ABCAM,ATM,BACKGROUND,BRCA1,CONCLUSION,DDR,DETECTION,DFS,III,LABEL,METHODS,MS110,NSCLC,PREVIOUSLY,RESULTS,S1524,TMAS
403,624,BRD4,EXON,FINALLY,GENOMIC,KNOCKDOWN,NMC,NUCLEAR,NUT,PCR,PER,SEQ,THESE,THUS
120,956,A549,DRUG,HT29,IRINOTECAN,THESE
028,036,110,160,187,363,AMONG,BACKGROUND,CONCLUSION,FIVE,HLA,HOWEVER,LABEL,MAGE,METHODS,NSCLC,PCR,RESULTS,SEVENTY
CARLO,HOWEVER,ICRP,MONTE,PROJECTION,RISK
160,CHEST,GNRH
160,169,2013,9908,BACKGROUND,CONCLUSION,COPYRIGHT,CTCE,CXCR4,EXPRESSION,INC,LABEL,MATERIALS,METHODS,OE19,RESULTS,TREATMENT
169,2000,2011,2012,AIM,CONCLUSION,COPYRIGHT,FOUR,HER2,III,LABEL,LTD,MANAGEMENT,METHODS,NINE,OBJECTIVE,RADS,RESULTS
001,002,023,2001,2002,2011,620,774,AJCC,AUC,COMMITTEE,COX,GROUP,JOINT,LUNG,NONE,ROC,SCCE,SMALL,THUS,TMN,TNM,UNIVARIATE,VALSG
117,451,8805,BACKGROUND,FURTHER,IDENTIFIER,IIIB,LABEL,METHODS,NSCLC,PULMONARY,RESULTS,SIXTY,THERE,TREATMENT,TRIAL
2000,201,2010,665,HISTOLOGY,INCREASED,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PATHOLOGIC,PET,RESULTS,SUV,UNIVERSITY
2003,2009,8804,COX,HOWEVER,JANUARY,LABEL,LRC,MEIER,METHODS,NONE,OBJECTIVE,OBJECTIVES,PET,RESULTS,SCLC,SUV,SUVPRIMARY,SUVS
A549,BAX,BCL,BECAUSE,CONSISTENT,FURTHER,H23,H292,MCL,WESTERN
1977,233,945,946,AMP,AMPK,BHD,BIRT,DUB,FLCN,FNIP1,FNIP2,HOGG,PGC1,SINCE,TFE3,TGF
4T1,562,945,946,CALU,DETROIT,ERK,H358,KI67,NCI,SCREENING,TGF,VB6
231,549,COLON,LUNG,MASS,MDA,MTT,NMR,SYNTHESIS
0078,028,030,046,143,175,177,210,BACKGROUND,EVALUATION,GGO,HOUNSFIELD,LABEL,MATERIALS,METHODS,RESULTS,RILI,SABR,SOLID,TUMOURS
1998,2010,221,237,EGC,FOUR,IIB,LABEL,LAG,METHODS,OBJECTIVE,RECURRENT,RESULTS,SIX,T1N3B,THERE
EACH
3434,8805,GENERALLY,GRAY,HOWEVER,INC,OVERALL,PUBLISHED,RAPID,THYROID
118,1990,2006,250,3412,472,64257,HODGKIN,HOWEVER,IFRT,INRT,NHL,RELATIVELY,RISKS,SMN
005,008,210,AGED,ANALYSING,BRONCHIAL,CANDIDA,GRAM,POTENTIAL
130,BVI,CEA,CLUSTERED,HOWEVER,ITC,ITCS,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RECURRENCE,RESULTS,SUV
169,2012,2759,COPYRIGHT,JOHN,LABEL,LTD,METHODS,OBJECTIVE,OVERALL,QOL,REGARDING,RESULTS,SONS,WILEY
233,AMP,AMPK,BHD,BIRT,DISCOVERY,DUB,FLCN,FOLLICULIN,HOGG,RAB35
185,ASSESSMENT,BACKGROUND,FUNCTIONAL,GODIN,HOWEVER,LABEL,LEISURE,LUNG,METHODS,OBJECTIVE,QOL,RESULTS,TAIWANESE,THERAPY,TIME
954,A549,AKT,ALTOGETHER,BEAS,COX,DESPITE,DHA,LUNG,MAG,ORAL,PTEN,THEREFORE
169,2012,COPYRIGHT,FDG,IRELAND,LTD,MRI,PET,SINCE
169,2012,ACCORDING,CISPLATIN,COPYRIGHT,DESPITE,LTD,SCLC,TOPOTECAN
010,015,017,022,169,177,2013,8804,BACKGROUND,COPYRIGHT,DTP,FCM,FDG,FLOW,FORTY,HIGH,INC,LABEL,METHODS,PET,RESULTS,SEVENTY,SPF,SUV
000,956,AGS,AIM,BALTIMORE,BASED,BECAUSE,COMMITTEE,CONCLUSION,FIVE,HAZARDOUS,LABEL,METHODS,OBJECTIVE,OHIO,RESULTS,SUBSTANCES
999,ABOUT,ARIZONA,COPD,DVT,THERE
169,2012,8201,945,CACO,EKR,ERK,IC50,INC,OLEANDRIN,SIMILARLY,THESE,WHILE,WILEY
100,8201,945,HDACI,JNJ,ORAL,SMA,SMN,TAIWANESE
122,2002,2011,256,398,BETWEEN,CONCLUSION,LABEL,MAXIMUM,MEIER,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,THREE
169,2012,COLITIS,COPYRIGHT,CROHN,PUBLISHED,TREATMENT
001,164,169,1ST,2012,2ND,4TH,8201,DFS,INC,NSCLC,WILEY
421,ARTHRITIS,FUNCTIONAL,LABEL,METHODS,NOAR,NORFOLK,OBJECTIVE,OBJECTIVES,RESULTS,RLD
169,2013,398,A549,BECAUSE,COX2,E2F1,FURIN,H292,H441,INC,INHIBITION,NCI,NCSLC,NHBE,NSCLC,PCSK,PCSK4,PCSK6,PCSKS,PTGS2,WILEY
160,4TH,5TH,6TH,AGGRESSIVE,IIIA,LEFT,PULMONARY,RIB,THERE
956,A549,DOX,DSPE,F68,KRTGQYKLC,PEG2000,SIMILAR,USING
0001,007,139,2816,AFTER,ANY,FPLC,HOWEVER,NSCLC,SPLC,SPLCS
CLINICALLY,ENGLISH
224,8G7G3,ADC,CK5,CK7,NECS,SOX2,SPT24,SQC,THESE,UNTIL
169,2012,954,A549,CELL,COPYRIGHT,DPCS,GSH,JOHN,LINES,LTD,MDA,ROS,SOD,SONS,THESE,WILEY
100,215,297,AGGREGATE,AREAS,CAD,CONCLUSION,CXR,CXRS,EACH,LABEL,MATERIALS,MEDICAL,METHODS,MIAMISBURG,OBJECTIVE,ONGUARD,PURPOSE,RESULTS,VERSION
169,2012,ADDITIONAL,COPYRIGHT,EBI,EIS,HOWEVER,IPEM,LTD,LUNG,PUBLISHED,SUCCESS
169,2012,257,AIM,ASIA,CONCLUSION,EGFR,HOWEVER,INEQUITIES,LABEL,LTD,METHODS,MOST,OBJECTIVE,PTY,PUBLISHING,QUESTIONS,RESULTS,UNDER,WHILE,WILEY,ZEALAND

AKT,CHK,DOWNSTREAM,JNK,PI3,RESULTS,WORTMANNIN
100,160,BRESENHAM
ANOTHER,BACKGROUND,CONCLUSION,III,IVC,LABEL,METHODS,RESULTS
AFTER,BAMBERGER,HOA,MARIE,SECONDARY
946,947,BACKGROUND,CD3,CHI,LABEL,METHODS,OBJECTIVE,RESULTS,TAI,TC1,TC2,TH1,TH2,WHEREAS
2000,2010,BACKGROUND,BRITISH,INDEX,JANUARY,LABEL,MEDLINE,METHODS,NURSING,OBJECTIVE,PSYCHINFO,RESULTS,SCN,SCNS,THEREFORE,WHEREAS
BACKGROUND,DISCUSSION,HRQOL,LABEL,METHODS,OBJECTIVE,RESULTS,THREE
AXL,CUB,EGFR,EPHA2,HGF,HOWEVER,MET,NSCLC,SIMILARLY,TARGETING,THEREFORE,TKI,TKIS
AKI1,AKT,CELL,DESPITE,EGFR,GATEKEEPER,H1975,PDK1,PI3K,SILENCING,T790M,TKI,TKIS,TREATMENT
1358,160,169,2012,BASED,COPYRIGHT,FIFTY,HELICAL,IEC,LTD,MVCT,NONE,PUBLISHED,THESE
160,169,1972,2012,231,233,BARR,CD20,CD3,COPYRIGHT,EBV,EPSTEIN,HISTOLOGY,III,PUBLISHED,SAS,SEVERAL,SNFMI,SOCI
150,164,2003,2011,8201,BACKGROUND,BETWEEN,CONCLUSION,GRADE,HOWEVER,IIIB,LABEL,MARCH,METHODS,MITOMYCIN,RESULTS,SEPTEMBER
160,169,194,2013,2349,5912,BECAUSE,CELLS,COPYRIGHT,COX,DETECTION,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS,SURGERY
128,147,169,2012,215,2D3,88T,945,A549,BECAUSE,COPYRIGHT,CYP24,EGFR,EPIDERMAL,H1975,ISSUE,LTD,NSCLC,SPECIAL,THESE,VDR,VITAMIN
169,2012,COPYRIGHT,EGFR,EPIDERMAL,HOWEVER,III,LTD,NSCLC,TKIS
001,009,044,2005,2010,296,448,EGFR,JUNE,L858R,MPE,MPES,PATIENT,THERE
160,169,177,2013,BACKGROUND,COMMITTEE,CONCLUSION,CONTEXT,COPYRIGHT,EXERTIONAL,FRAMEWORK,INC,INTERVIEWS,KARNOFSKY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PAIN,PUBLISHED,RESULTS
A549,BUOH,ETOAC,LEISHMANIA,MEOH,SIX,TARENNA,THEIR
000,100,160,250,342,448,5HT3,BACKGROUND,CINV,CONCLUSION,DESPITE,GUIDELINES,LABEL,METHODS,OVERALL,RESULTS,USING
1000,160,AUC,BACKGROUND,CONCLUSION,EASTERN,GROUP,IIIB,IMPROVING,LABEL,METHODS,NSCLC,PHASE,RESULTS,SEQUENTIAL,SIXTEEN,THEREAFTER
IRELAND,LTD,PUBLISHED
169,2012,BRONCHIAL,COPYRIGHT,EBUS,FNA,FOCAL,INC,MEC,NEITHER,RAPID,ROSE,THEREFORE,THESE,WILEY
CDX2,ORIGINALLY
0001,1030,1990,2008,BACKGROUND,CEA,LABEL,METASTASES,METHODS,OBJECTIVE,OVERALL,PROGNOSTIC,RESULTS,SEVERAL,THEREFORE,UNIVARIATE
522,NEOPLASTIC
160,AMONG,FINE,FOCAL,MOST,SCLEROSING
004,009,235,AIM,BACKGROUND,CAREGIVERS,CLINICIAN,CLINICIANS,DYADS,GENERAL,LABEL,METHODS,MIXED,OBJECTIVE,RESULTS,SETTING,SUPPORT,THOSE,USING
AKT,BMS,CANCERS,FLT,G2M,H292,IGF,NSCLC,PET
357,6PL,946,954,COLO,EMT,HENCE,PANC,SIMILAR,SMAD3,SMAD4,SNAIL,TAKEN,TGF
BACKGROUND,CONCLUSION,FDG,LABEL,LOUTH,METHODS,PET,RESULTS,SWEDISH,THERE,THESE,WORLDWIDE
ROBOTIC
100,169,200,2012,956,A549,BAX,COPYRIGHT,JOHN,LTD,PFOS,SONS,THESE,WILEY
006,8805,CONCURRENT,EARLY
169,2012,CARLO,COPYRIGHT,DOSE,FDG,IMRT,LABEL,LTD,MAXIMUM,METHODS,MONTE,NINE,NSCLC,OBJECTIVE,PET,PTV,PTVS,PUBLISHED,PURPOSE,RESULTS,THEREFORE
169,2013,BACKGROUND,COPYRIGHT,INC,LABEL,METHODS,RESULTS,SELDINGER,TIVAP,WILEY
FATAL,HOWEVER,SURGERY,THERE
BRAF,EGFR,EREG,ERK,FURTHER,KRAS,MEK,NSCLC,RNAS,SMALL
2206,338,378,946,A549,ACTIVATION,AKT,ALPHA,CT99021,CUL1,CUL3,DSGIS,ECH,GSK,KEAP1,KELCH,MEFS,NAD,NRF2,PI3K,PKB,PRE,RBX1,ROC1,SKP1,THESE,TRCP
67LR,8201,945,ANOTHER,BMDCS,HIF,PYMT,SIMILARLY,THUS
30B,DESPITE,T98G,TAP63,TRAIL
CALIBAN,CLBN,DROSOPHILA,FINALLY,HID,NSCLC
COUGH,NEBULIZED,PERSISTENT,STUDIES,SUCCESSFUL
000,120,163,278,BACKGROUND,HOWEVER,LABEL,LYS,METHODS,NHS,QALY,QALYS,RESULTS,SIMILARLY
2002,2008,458,461,8805,956,BAVARIA,CONCLUSION,CURRENT,LABEL,METHODS,OBJECTIVE,POISSON,RESULTS
ANCA,CHURG,SEVERAL,STRAUSS
001,150,15Q25,394,5P15,6P21,A549,CONFIRMING,CPG,DECITABINE,H1299,PA549,TERT,THESE
169,2012,CAM,CAREGIVERS,COPYRIGHT,FORTY,JOHN,LABEL,LTD,METHODS,OBJECTIVE,PRIMARY,RESULTS,SONS,SUPPORT,WILEY
169,2012,443,519,547,CAREGIVERS,COPYRIGHT,INCREASED,JOHN,LABEL,LESS,LTD,METHODS,OBJECTIVE,RESULTS,SONS,TOP,UNMET,WILEY
169,2012,A549,COPYRIGHT,IRELAND,LTD,MCF7,MIAPACA,NAS,THESE
169,2013,AFTER,COPYRIGHT,INC,LABEL,OBJECTIVE,OBJECTIVES,RESULTS,THREE
H3G,M3G,OIH,OPIOIDS,POTENTIAL
000,018,019,1186,160,169,2012,215,468,572,BEIR,COPYRIGHT,HODGKIN,LTD,PERIPHERAL,PUBLISHED,VII
012,028,029,169,2013,8201,HOWEVER,HOXB7,IHC,INC,INCREASED,LAC,SILENCING,WILEY
169,2012,BACKGROUND,COPYRIGHT,INC,KAPOSIFORM,KHE,LABEL,METHODS,PACLITAXEL,RESULTS,WILEY
AMONG,CPG,HAND1,MOTIF,NEUROD1,OWING,REST,SCLC,SMALL,THESE
400,CHINA,CHINESE,EDUCATION,PATIENT,THOSE
169,2012,AEC2,BASCS,CD133,CELL,COPYRIGHT,EPITHELIAL,HYPOTHESIS,IRELAND,LTD,NOTCH,STEM,WNT
169,2012,721,AIMS,ASIA,CONCLUSION,COX,LABEL,LTD,METHODS,OBJECTIVE,PTY,PUBLISHING,RESULTS,THUS,WILEY
169,2012,CONVERSELY,COPYRIGHT,DRAWING,JOHN,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SONS,WILEY
AKT,AXL,BCL,CREB,CURRENT,FAK,MAPK,MER,NON,NSCLC,PROMISING,RTKS,THESE
946,A549,ARMADILLO,CATENIN,CHIP,CHROMATIN,DIAP1,DROSOPHILA,ENDOCRINE,HDACS,JNK,NEOPLASIA,PP1B,RET,RHO,RHOA,SEQ,SIN3,SIN3A,SRC,TCF,TYPE,WNT
NOTABLY,RAC1,THEREFORE
169,2012,AMBIGUITY,ASSESSMENT,AVOIDANCE,BACKGROUND,COPYRIGHT,DEPRESSION,EMOTIONAL,EVENT,EYSENCK,FUNCTIONAL,GIVEN,HYPOTHESES,ILLNESS,JOHN,LABEL,LTD,LUNG,MEAN,METHODS,NON,PERCEIVED,RESULTS,REVISED,SCALE,SHORT,SONS,STUDIES,THERAPY,WILEY
10TH,169,1ST,2012,2ND,3RD,AUTHORS,CENTRAL,COPYRIGHT,ESOPHAGUS,INC,JOURNAL,LUNG,OLV,SOCIETY,TLV,WILEY
BARR,CD15,CD20,CD3,CD30,CHL,EBER,EBNA,EBV,EPSTEIN,HODGKIN,HOWEVER,ISH,LMP,LPD,LPDS,PCR,REED,STERNBERG
001,160,191,590,965,969,973,977,981,988,BOTH,I00,I99,ICD,J00,J99,LABEL,METHODS,MOST,OBJECTIVE,PURPOSE,RESULTS
160,AFTER,SEGMENTAL
PREGABALIN,THERE
165,169,2009,2010,2012,456,BACKGROUND,COPYRIGHT,DATA,GERMANY,HALF,JOHN,LABEL,LTD,METHODS,RESULTS,SONS,WILEY
045,567,BOTH,CONCLUSION,EIGHT,IPC,LABEL,METHODS,NSCLC,OBJECTIVE,PLC,PURPOSE,RESULTS,THREE
169,2012,ABL,COPYRIGHT,DESPITE,DHA,EPA,HOWEVER,III,LTD,THESE
169,2012,2014,740,749,916,936,A549,AIF,APAF,COMET,COPYRIGHT,DAPI,ENVIRON,INC,ROS,TOXICOL,WILEY
204,325,AMERICANS,CASES,COPD,HEALTHY,MEXICAN,PRIOR,THESE
112,2006,205,445,967,AIMS,DESPITE,JULY,KRUSKAL,LABEL,MANN,METHODS,OBJECTIVE,RAE,RAES,RESIDENTS,RESULTS,SEPTEMBER,WHITNEY
100,169,2012,COPYRIGHT,CRC,CRCS,EGFR,EPIDERMAL,INC,KRAS,NSCLC,WILEY
100,600,800,DLT,DOSE,EGFR,FIBONACCI,IGG1,MATUZUMAB,NSCLC,SIX,THERE
231,CDC42,CORTACTIN,ECM,EGF,MDA,METASTATIC,ORTHOTOPIC,SH3,SRC,TAKEN,TOCA
125B,BCL,CONSISTENT,HCC,MCL,SUBSEQUENT,THESE
169,2012,COPYRIGHT,IRELAND,LTD,NNAL,NNN,PHET,THEREFORE,USING
00002,001,1377A,169,200,2012,844C,844T,ARG194ARG,ARG194TRP,CART,FAS,FASL,INC,MDR,MULTI,NSCLC,PAT,SNPS,WILEY,XPC,XRCC1
169,2013,ANTIBODIES,BACKGROUND,BECAUSE,CASE,COPYRIGHT,COX,HOWEVER,INC,LABEL,METHODS,OSCC,SECONDARY,TKTL1
089,169,2012,386,826,956,AFTER,BMDL0,CAMBODIAN,CHAM,COPYRIGHT,HOWEVER,KAMPONG,RESULTS,RIVER
169,2012,COPYRIGHT,III,LTD,SCLC,THUS
106,169,2013,6Q27,946,BRITAIN,COPYRIGHT,DACT,DACT2,EIGHT,GREAT,H727,HOWEVER,IRELAND,JOHN,LEF,LOH,LOSS,LTD,MSP,PCR,PUBLISHED,SNP,SOCIETY,SONS,TCF,WILEY,WNT,XENOPUS
145,2000,2010,ASIAN,LABEL,MEDLINE,METHODS,NSCLC,OBJECTIVE,OVERALL,PURPOSE,QOL,RESULTS,STUDIES
ADAPTOR,BACKGROUND,ESCC,EXPRESSION,FURTHER,HOWEVER,KNOCKDOWN,LABEL,METHODS,RESULTS,TE2,TE5,TE9,THESE,WESTERN,XB130
169,2012,8805,ADDITIONAL,BACKGROUND,COLLEGE,CONCLUSION,CONTENT,COS,CVI,DENMARK,FOLLOWING,ITEM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RASCH,RATIONALE,RESULTS,SCALE,SCIENCE,SCREENING,SWEDISH
BRAIN,PLGF,RHO,SCLC,THESE,USING
169,2012,488,ALEXA,COPYRIGHT,EEEEPYFELV,H460,IRELAND,LCC,LIPID,LTD,NPS
169,1833,2012,231,233,435,AKT,AUTHORS,FRAN,HDAC2,HEPG2,HT29,LNM35,MB231,MCF,MDA,SOCI
2001,2006,BTC,COX,GEM,LABEL,METHODS,OBJECTIVE,OBJECTIVES,PFS,RECORDS,RESULTS
100,2009,2011,GRADE,LABEL,MATERIALS,METHODS,NINE,OBJECTIVE,OBJECTIVES,PRIMARY,RESULTS,SBRT
100,1973,2008,BOTH,FLORIDA,GCTB,JANUARY,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SIX,THREE,UNIVERSITY
ADVERSE,DLT,DLTS,LABEL,METHODS,MTX,OBJECTIVE,OBJECTIVES,RESULTS,VLP
0004,001,0042,0062,0084,0273,131,169,2012,8201,CRK,CRKL,FURTHER,H1299,HBE,HOWEVER,INC,NSCLC,TNM,WILEY
2008,2011,407,600,647,APRIL,BACKGROUND,CONCLUSION,DRUG,EVALUATION,JAPAN,LABEL,MAJOR,MARCH,METHODS,RESULTS,SORAFENIB,SPECIAL,THEREFORE
ACTH,AFTER,CUSHING,EAS,LABEL,METHODS,OBJECTIVE,RESULTS,S10,SELECTIVE
18F,1997,2009,2011,2921,8805,FDG,LABEL,METHODS,OBJECTIVE,PET,RESULTS,SUV
001,128,CONCLUSION,KNOWLEDGE,LABEL,METHODS,OBJECTIVE,OPEN,RESULTS,SCEPTICISM,SMOKING,TEST
132,172,219,BACKGROUND,C30,CELL,EORTC,HODGKIN,LABEL,LIFE,LUNG,METHODS,MYELOMA,NON,OBJECTIVE,QLQ,QUALITY,REGRESSION,RESULTS,SMALL,UTILITY,VALIDATION,YEARS
LCA,PROGNOSTIC
120,169,2012,916,AFRICAN,AIS,BLACKWELL,FOUR,GMBH,HOWEVER,STOP,THESE
169,2012,946,AMONG,BLOOD,COMT,COPYRIGHT,JOHN,LTD,LUNG,PCB,PCBS,SONS,WILEY
045,160,1913,1958,2004,2005,667,DOSE,LABEL,METHODS,OBJECTIVE,OVERALL,PAHS,PURPOSE,RESULTS,SIR,SIRS,SWEDISH
0001,001,038,146A,169,173,2012,233,3613,AGO2,ARGONAUTE2,CHINESE,FINALLY,INC,NPC,PCR,RESULTS,TAKEN,THESE,USING,WILEY
101,169,177,182,2012,BACKGROUND,BMI,CIGARETTE,COLORECTAL,COPYRIGHT,ESTIMATION,INC,LABEL,LUNG,METHODS,OVARIAN,PLCO,RESULTS,THESE,WILEY
AFTER,HOWEVER,PTTM,PULMONARY,THESE
100,1500,2005,2008,500,BETWEEN,FURTHER,LABEL,METHODS,OBJECTIVE,PFS,PLANNED,RESULTS
169,2012,COPYRIGHT,HOWEVER,LTD,METABOLISM,NUTRITION,OVERALL,SOCIETY
148,193,2003,2009,CONVERSION,INC,LABEL,METHODS,MOSBY,OBJECTIVE,PUBLISHED,RESULTS
169,2012,300,8201,BACKGROUND,BASED,CONCLUSION,COPYRIGHT,JOHN,LABEL,LTD,METHODS,RESULTS,ROBOTIC,SONS,WILEY
009,169,2012,215,559,679,8201,AFTER,CHINESE,HOWEVER,INC,TAKEN,VEGAS,WILEY,WWOX
0001,176,624,AJCC,BACKGROUND,CONCLUSION,FACTORS,IVA,IVB,LABEL,METHODS,RESULTS,STAGE
125,954,APE1,BACKGROUND,COX,CSS,H520,INCREASES,LABEL,MEIER,METHODS,NSCLC,PCR,RESULTS,RFS
CHINESE,COF,NCBI,STUDIES,THERE
169,181,2012,8201,A549,BAX,BCL,BLI,CCNA2,CCNE2,CDK1,CISPLATIN,E2F1,FLUC,HOWEVER,INC,INCREASED,P53,THUS,WESTERN,WILEY
169,2012,AUTHORS,BASAL,BCC,COLLEGE,JOURNAL,PULMONARY,THESE
100,AFTER,AMONG,ANTI,BACKGROUND,BARRETT,BCC,BOWEN,CONCLUSION,COX,GOAL,HIGH,HRP,IHC,LABEL,METHODS,OBJECTIVE,RESULTS,SCC
C8ORF34,G3D,G4N,GWAS,NSCLC,PLCB1,SNPS
AIM,CONCLUSION,FOLLOWING,LABEL,METHODS,OBJECTIVE,RESULTS,SIX
169,2012,COPYRIGHT,INC,REPORTS,SCLEROSING,WILEY
169,2012,COPYRIGHT,EPITHELIAL,FNA,INC,SMA,STROMAL,TTF,WILEY
113,160,1939,1958,1999,2001,292,488,HOWEVER,INCIDENCE,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS,SHIFT,SIR,SIRS,SWEDISH,TESTICULAR
001,002,019,274,BACKGROUND,CAUSALITY,IVC,LABEL,METHODS,OVERALL,RESULTS,VTE
8805,BACKGROUND,DOSE,LABEL,METHODS,RESULTS,TRT
009,026,039,048,169,2012,4DCT,8482,BODY,COPYRIGHT,DOSIMETRIC,FRAME,HOWEVER,ITV,LABEL,LTD,MATERIALS,MEAN,METHODS,OBJECTIVE,PUBLISHED,PURPOSE,RESULTS,SBRT,THREE
001,169,200,2012,375,537,8201,947,GAG,GCL,GCLC,GSH,INC,ODDS,PCR,SIMILARLY,THESE,WILEY
A549,ALDH,ANALYZING,CD24,CD38,EPCAM,FOS,H460,HLA,MCF7,MUC1,OVERALL,SIMILAR
169,2012,BRITISH,COPYRIGHT,LTD,ORAL,PUBLISHED,SUSPICIOUS
25TH,522,BONE,EARLY,HOWEVER,LABEL,METHODS,OBJECTIVE,PURPOSE,RESULTS,SIMILAR,THEREFORE
001,006,100,200,384,919,AMONG,BANKS,STOMACH,THYROID
169,2012,946,AKT,AMF,BAD,BRDU,HEP3B,HUH7,IC10,INC,MMP,PGI,RHOA,SRC,STAT3,TGF,THUS,WILEY
0002,8804,APBI,BACKGROUND,BOWEL,CRT,FORTY,LABEL,MATERIALS,METHODS,NSABP,OTHER,PLANS,PREOP,PROJECT,RESULTS,THESE,THREE
177,DLCO,FEV,FIFTY,HIGH,LABEL,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,THERE,VRI
0001,001,AGGRESSIVE,EWING,LABEL,LOCAL,METHODS,OBJECTIVE,RESULTS
169,2012,COPYRIGHT,IRELAND,LTD,LUNG,MOLECULAR,THESE
100,169,1974,2007,2013,COPYRIGHT,CSS,EIGHT,ESTIMATES,FORTY,IIA,IIB,IIC,INC,LABEL,MAJOR,MATERIALS,MAYO,MCE,MEIER,METHODS,MOST,MSCV,NOS,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,RFS,RISK,STAGE,TEN
112,200,400,ADM,BACKGROUND,BECAUSE,CBDCA,CDDP,CSCC,EIGHT,HOWEVER,JAPAN,LABEL,METHODS,RESULTS
2000,2007,800,ADVANTAGE,BACKGROUND,DATA,END,ENROLLEES,LABEL,MEDICAL,METHODS,MOST,NETWORK,OBJECTIVE,OBJECTIVES,OVERALL,RESULTS,SMALL,VDW,VIRTUAL,WAREHOUSE
001,100,132,1373,1600,2008,215,275,510,551,8805,945,946,BED,FACTORS,FURTHER,LABEL,LUNG,METHODS,OBJECTIVE,OBJECTIVES,RESULTS,SBRT,THREE
166,TMEM166,VARYING
1992,2009,4009,AGING,AMSTERDAM,BACKGROUND,CONCLUSION,DATA,EQUATIONS,ESTIMATING,GEE,LABEL,METHODS,MOST,RESULTS,SRH,STUDIES,THERE,THEREFORE
169,2012,4500,956,A549,BECAUSE,COPYRIGHT,EC50,GALAXOLIDE,INC,MOLECULAR,SINCE,SY5Y,SYNTHETIC,THESE,WILEY,WORLDWIDE
169,2012,CONVERSELY,COPYRIGHT,DOX,FAS,FASL,INC,LEWIS,LLC,WILEY
111,169,1999,2009,2013,306,BACKGROUND,BETWEEN,COPYRIGHT,FACTORS,GKS,INC,KARNOFSKY,KPS,LABEL,METHODS,NSCLC,RESULTS,RPA,SIXTY,UNIVERSITY
000,009,019,126,290,964,BACKGROUND,CONCLUSION,FIRST,GUIDELINES,IIA,IIB,III,JAPAN,LABEL,METHODS,RESULTS,THESE,TMS
183,GEORG,STUTTGART,YORK
275,354,375,406,80203,89803,9235,9344,9730,9732,CALGB,CENTERS,CMS,COMPARING,FOLFIRI,GROUP,LABEL,METHODS,OBJECTIVE,OVERALL,PURPOSE,RESULTS
150,176,180,1KZN,8201,956,ALSO,EIGHT,GRAM,HOP,NCI,PDB,RESULTS,UACC
001,169,193,200,2012,8201,CHINESE,COPYRIGHT,H1299,IIA,INC,LUNG,T2A,TANSHINONE,WILEY
169,177,2009,2010,2012,AIM,BACKGROUND,COPYRIGHT,DESPITE,ENGLAND,FOLLOWING,INTERVIEWS,JULY,JUNE,KEY,LABEL,LTD,METHODS,OBJECTIVE,RESULTS,SETTING
001,014,019,BACKGROUND,BRAIN,CEREBELLAR,DATA,FEW,LABEL,METHODS,MOST,RADIATION,RECORDS,RESULTS,THERE
181,A549,FAS,FATTY,MCF,SINCE,THREE
CHINESE,HOWEVER,MALIGNANT,SWNT,SWNTS,WATER,WESTERN
156,160,1991,2010,ANOTHER,BACKGROUND,FISH,HER2,HOWEVER,LABEL,LOSS,MATERIALS,MBC,METHODS,RESULTS
107,115,169,2012,ABOUT,BBX,COPYRIGHT,DIAGNOSTIC,EBUS,INC,TBNA,WILEY
946,BACKGROUND,CD34,CONCLUSION,HOWEVER,III,LABEL,METHODS,NSCLC,RESULTS,TUBB3
169,2012,945,AKT,CHINESE,COPYRIGHT,HIF,HYPOXIA,INC,MEANWHILE,THESE,VEGF,WILEY
169,2012,956,A549,COPYRIGHT,ICP,INC,PM10,SEVERAL,THUS,WILEY
169,2001,2009,2011,3CM,CONCLUSION,COPYRIGHT,JANUARY,LABEL,METHODS,OBJECTIVE,PUBLISHED,RESULTS,SERAM,THESE,TYPICAL
AKT,BECAUSE,CUZNSOD,G129E,G129R,GPX,NSCLC,PHOSPHATES,PI3K,PTEN,SOD,THEN,THEREFORE,THESE,WHILE
169,174,2011,ASPIRATION,CD31,CDX2,CEA,CK20,CK7,COPYRIGHT,DIFF,EBUS,IMAGING,INC,MUC2,QUIK,ROMANOWSKY,TBNA,THESE,ULTRASOUND,WILEY
000,001,003,027,169,201,2013,311,ARMS,CGCC,CHINESE,COPYRIGHT,COX,FURTHER,GGCC,GGTC,GTT,HAN,HAPLOVIEW,INC,LABEL,MATERIALS,METHODS,MYC,NDRG,OBJECTIVE,OBJECTIVES,PCR,RESULTS,STRUCTURAL,TP53,USING
1993,1998,1999,2004,2009,251,6003,8200,AFTER,CHINESE,CONCLUSION,DATA,LABEL,METHODS,MORTALITY,OBJECTIVE,RESULTS,RISK,SINGAPORE,SMOKING
169,2011,AE1,AE3,CA19,CD10,CD56,CDX2,CK20,CK7,CLCC,COPYRIGHT,FURTHER,INC,NESTS,PRIMARY,TTF,WILEY,WORLD
169,2013,3P12,3P13,3P14,3P21,3P24,3P25,3P26,57D6,59E22,759B7,BAC,CEP,CONCLUSION,COPYRIGHT,CRCC,D3S1560,D3S1766,D3S2406,D3S2454,FHIT,FISH,FURTHER,III,INC,LABEL,LACK,LOH,LOSS,LUNG,MEC,MECS,METHODS,MOLECULAR,OBJECTIVE,OBJECTIVES,PCR,RCC,RESULTS,ROH,RP11,VALIDATION,VHL
169,2011,COPYRIGHT,EUS,FNA,HOWEVER,HURTHLE,INC,WILEY
169,2011,AFTER,COPYRIGHT,PUBLISHED,SERAM
100,169,2000,2010,2011,COMPANY,COPYRIGHT,DIAGNOSIS,EUS,FNA,INC,USING,WILEY
169,2011,945,A549,COMPANY,COMPARISON,COPYRIGHT,INC,P450,PAH,PAHS,POLYCYCLIC,THESE,WILEY
160,CASE,GCDFP
COX,HOWEVER,KOCH,NON,TYPE
RAYNAUD,TAKEN,THESE
